PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bordoli, MR; Stiehl, DP; Borsig, L; Kristiansen, G; Hausladen, S; Schraml, P; Wenger, RH; Camenisch, G				Bordoli, M. R.; Stiehl, D. P.; Borsig, L.; Kristiansen, G.; Hausladen, S.; Schraml, P.; Wenger, R. H.; Camenisch, G.			Prolyl-4-hydroxylase PHD2-and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis	ONCOGENE			English	Article						amphiregulin; hypoxia-inducible factors; mammary carcinoma; prolyl-4-hydroxylases; tumor vascularization	HYDROXYLASE DOMAIN PROTEIN-2; GROWTH-FACTOR-ALPHA; PROLYL HYDROXYLASE; GENE-EXPRESSION; CELL CARCINOMA; HUMAN CANCERS; OVEREXPRESSION; FACTOR-1-ALPHA; ANGIOGENESIS; INDUCTION	Hypoxia-elicited adaptations of tumor cells are essential for tumor growth and cancer progression. Although ample evidence exists for a positive correlation between hypoxia-inducible factors (HIFs) and tumor formation, metastasis and bad prognosis, the function of the HIF-alpha protein stability regulating prolyl-4-hydroxylase domain enzyme PHD2 in carcinogenesis is less well understood. In this study, we demonstrate that downregulation of PHD2 leads to increased tumor growth in a hormone-dependent mammary carcinoma mouse model. Tissue microarray analysis of PHD2 protein expression in 281 clinical samples of human breast cancer showed significantly shorter survival times of patients with low-level PHD2 tumors over a period of 10 years. An angiogenesis-related antibody array identified, amongst others, amphiregulin to be increased in the absence of PHD2 and normalized after PHD2 reconstitution. Cultivation of endothelial cells in conditioned media derived from PHD2-downregulated cells resulted in enhanced tube formation that was blocked by the addition of neutralizing anti-amphiregulin antibodies. Functionally, amphiregulin was regulated on the transcriptional level specifically by HIF-2 but not HIF-1. Our data suggest that PHD2/HIF-2/amphiregulin signaling has a critical role in the regulation of breast tumor progression and propose PHD2 as a potential tumor suppressor in breast cancer. Oncogene (2011) 30, 548-560; doi: 10.1038/onc.2010.433; published online 20 September 2010	[Wenger, R. H.] Univ Zurich, Cellular Oxygen Physiol Grp, Inst Physiol, CH-8057 Zurich, Switzerland; [Bordoli, M. R.; Stiehl, D. P.; Borsig, L.; Wenger, R. H.; Camenisch, G.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kristiansen, G.; Hausladen, S.; Schraml, P.] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Wenger, RH (corresponding author), Univ Zurich, Cellular Oxygen Physiol Grp, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	roland.wenger@access.uzh.ch	Wenger, Roland H./B-7953-2009; Stiehl, Daniel/A-3622-2008	Wenger, Roland H./0000-0001-7592-4839; Borsig, Lubor/0000-0003-2263-9545; Stiehl, Daniel/0000-0002-0076-4874; Bordoli, Mattia/0000-0001-6917-8753	Swiss National Science Foundation; Krebsliga des Kantons Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Krebsliga des Kantons Zurich	We thank P Spielmann for excellent technical assistance, K Wollenick, TF Luscher, PJ Ratcliffe (University of Oxford, Oxford, UK), SB Lee (National Institutes of Health, Bethesda, MD, USA), DA Chan (University of California, San Francisco, CA, USA) for gifts of antibodies, cells and plasmids and D Neri (Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland) for helpful discussions. This work was supported by the Swiss National Science Foundation and Krebsliga des Kantons Zurich (GC).	Aebersold DM, 2001, CANCER RES, V61, P2911; Balamurugan K, 2009, ONCOGENE, V28, P3274, DOI 10.1038/onc.2009.186; BARNARD JA, 1994, J BIOL CHEM, V269, P22817; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chokki M, 2006, LIFE SCI, V78, P3051, DOI 10.1016/j.lfs.2005.12.023; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erez N, 2003, CANCER RES, V63, P8777; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Giusti C, 2003, INT J CANCER, V105, P769, DOI 10.1002/ijc.11158; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Lamber EP, 2010, CANCER RES, V70, P996, DOI 10.1158/0008-5472.CAN-09-2842; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Ma L, 1999, ONCOGENE, V18, P6513, DOI 10.1038/sj.onc.1203042; MARTINEZLACACI I, 1995, ENDOCRINOLOGY, V136, P3983, DOI 10.1210/en.136.9.3983; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Panico L, 1996, INT J CANCER, V65, P51, DOI 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; QI CF, 1994, BRIT J CANCER, V69, P903, DOI 10.1038/bjc.1994.174; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Willmarth NE, 2008, J MAMMARY GLAND BIOL, V13, P171, DOI 10.1007/s10911-008-9081-9; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029; Zhong H, 1999, CANCER RES, V59, P5830	52	60	63	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					548	560		10.1038/onc.2010.433	http://dx.doi.org/10.1038/onc.2010.433			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20856199	Green Published			2022-12-25	WOS:000286922300004
J	Sommer, G; Dittmann, J; Kuehnert, J; Reumann, K; Schwartz, PE; Will, H; Coulter, BL; Smith, MT; Heise, T				Sommer, G.; Dittmann, J.; Kuehnert, J.; Reumann, K.; Schwartz, P. E.; Will, H.; Coulter, B. L.; Smith, M. T.; Heise, T.			The RNA-binding protein La contributes to cell proliferation and CCND1 expression	ONCOGENE			English	Article						La autoantigen; La protein; cyclin D1; CCND1; cell proliferation; cervical cancer	CYCLIN D1; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; HUMAN-PAPILLOMAVIRUS; AUTOANTIGEN; TRANSLATION; SITE; CARCINOMA; NUCLEAR; CANCER	The La protein is an essential RNA-binding protein implicated in different aspects of RNA metabolism. Herein, we report that small interfering (siRNA)mediated La depletion reduces cell proliferation of different cell lines concomitant with a reduction in cyclin D1 (CCND1) protein. To exclude off-target effects we demonstrate that exogenous La expression in La-depleted cells restores cell proliferation and CCND1 protein levels. In contrast, proliferation of immortalized CCND1 knockout cells is not affected by La depletion, supporting a functional coherence between La, CCND1 and proliferation. Furthermore, we document by reversible in vivo crosslinking and ribonucleoprotein (RNP) immunoprecipitation an association of the La protein with CCND1 messengerRNA and that CCND1 internal ribosome entry site (IRES)-dependent translation is modulated by La protein level within the cell. In addition, we show elevated La protein expression in cervical cancer tissue and its correlation with aberrant CCND1 protein levels in cervical tumor tissue lysates. In conclusion, this study establishes a role of La in cell proliferation and CCND1 expression and demonstrates for the first time an overexpression of the RNA-binding protein La in solid tumors. Oncogene (2011) 30, 434-444; doi: 10.1038/onc.2010.425; published online 20 September 2010	[Sommer, G.; Dittmann, J.; Kuehnert, J.; Heise, T.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Dittmann, J.; Reumann, K.; Will, H.; Heise, T.] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Schwartz, P. E.] Prot Biotechnol Inc, Ramona, CA USA; [Coulter, B. L.; Smith, M. T.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Medical University of South Carolina; Heinrich Pette Institute; University of Hamburg; Medical University of South Carolina	Heise, T (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	heise@musc.edu			Deutsche Forschungsgemeinschaft [HE 2814/3-2]; Bundesministerium fur Gesundheit and Freie und Hansestadt Hamburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Gesundheit and Freie und Hansestadt Hamburg	We thank Arne Du "sedau (HPI) for sorting GFP-positive cells and Rick Peppler for FACS analysis (MUSC). We are grateful to R G Pestell (Thomas Jefferson University) for providing the MEF<SUP>CCND1-/-</SUP> cells, to M Bachmann (Technical University Dresden, Germany) for providing La antibodies, to Josef Gera for providing the CCND1-IRES reporter plasmid pRCD1F, to D Watson (MUSC) for experimental advice during this study, and D Fernandes (MUSC) and J Schnellmann (MUSC) for critical reading of the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft, HE 2814/3-2 (TH). The Heinrich-Pette-Institut (HPI) is financially supported by the Bundesministerium fur Gesundheit and Freie und Hansestadt Hamburg.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; Ali N, 2000, J BIOL CHEM, V275, P27531; Bae DS, 2001, GYNECOL ONCOL, V81, P341, DOI 10.1006/gyno.2001.6196; Belsham GJ, 1995, CURR TOP MICROBIOL, V203, P85; Brenet F, 2005, MOL CELL BIOL, V25, P7505, DOI 10.1128/MCB.25.17.7505-7521.2005; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Calkhoven CF, 2000, GENE DEV, V14, P1920; Carreras R, 2007, HISTOL HISTOPATHOL, V22, P587, DOI 10.14670/HH-22.587; CHANG YN, 1995, J VIROL, V69, P618, DOI 10.1128/JVI.69.1.618-619.1995; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Cheung TH, 2001, CANCER LETT, V166, P199, DOI 10.1016/S0304-3835(01)00457-8; Conesa-Zamora P, 2009, AM J CLIN PATHOL, V132, P378, DOI 10.1309/AJCPO0WY1VIFCYDC; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Cowling VH, 2010, ONCOGENE, V29, P930, DOI 10.1038/onc.2009.368; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Ehlers I, 2004, J BIOL CHEM, V279, P43437, DOI 10.1074/jbc.M402227200; Frost P, 2009, MOL CANCER THER, V8, P83, DOI 10.1158/1535-7163.MCT-08-0254; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Inge LJ, 2008, MOL CANCER THER, V7, P1386, DOI 10.1158/1535-7163.MCT-07-2029; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; Maraia RJ, 2001, J CELL BIOL, V153, pF13, DOI 10.1083/jcb.153.4.F13; McLaren RS, 1997, MOL CELL BIOL, V17, P3028, DOI 10.1128/MCB.17.6.3028; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Nichols GE, 1996, MODERN PATHOL, V9, P418; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Pudi R, 2004, J BIOL CHEM, V279, P29879, DOI 10.1074/jbc.M403417200; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	48	56	58	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					434	444		10.1038/onc.2010.425	http://dx.doi.org/10.1038/onc.2010.425			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20856207				2022-12-25	WOS:000286621600006
J	Paynter, JJ; Andres-Enguix, I; Fowler, PW; Tottey, S; Cheng, W; Enkvetchakul, D; Bavro, VN; Kusakabe, Y; Sansom, MSP; Robinson, NJ; Nichols, CG; Tucker, SJ				Paynter, Jennifer J.; Andres-Enguix, Isabelle; Fowler, Philip W.; Tottey, Stephen; Cheng, Wayland; Enkvetchakul, Decha; Bavro, Vassiliy N.; Kusakabe, Yoshio; Sansom, Mark S. P.; Robinson, Nigel J.; Nichols, Colin G.; Tucker, Stephen J.			Functional Complementation and Genetic Deletion Studies of KirBac Channels ACTIVATORY MUTATIONS HIGHLIGHT GATING-SENSITIVE DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNELS; MOLECULAR-DYNAMICS SIMULATIONS; RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; SLIDE HELIX; ION-CHANNEL; C-TERMINUS; KIR6.2; SELECTION; MUTANTS	The superfamily of prokaryotic inwardly rectifying (KirBac) potassium channels is homologous to mammalian Kir channels. However, relatively little is known about their regulation or about their physiological role in vivo. In this study, we have used random mutagenesis and genetic complementation in K+-auxotrophic Escherichia coli and Saccharomyces cerevisiae to identify activatory mutations in a range of different KirBac channels. We also show that the KirBac6.1 gene (slr5078) is necessary for normal growth of the cyanobacterium Synechocystis PCC6803. Functional analysis and molecular dynamics simulations of selected activatory mutations identified regions within the slide helix, transmembrane helices, and C terminus that function as important regulators of KirBac channel activity, as well as a region close to the selectivity filter of KirBac3.1 that may have an effect on gating. In particular, the mutations identified in TM2 favor a model of KirBac channel gating in which opening of the pore at the helix-bundle crossing plays a far more important role than has recently been proposed.	[Andres-Enguix, Isabelle; Bavro, Vassiliy N.; Kusakabe, Yoshio; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Paynter, Jennifer J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PU, England; [Fowler, Philip W.; Sansom, Mark S. P.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3PU, England; [Sansom, Mark S. P.; Tucker, Stephen J.] Univ Oxford, OXION Initiat, Oxford OX1 3PU, England; [Tottey, Stephen; Robinson, Nigel J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Disorders, St Louis, MO 63110 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Newcastle University - UK; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL)	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk	Sansom, Mark S.P./C-5157-2009; Nichols, Colin/D-6336-2012; Fowler, Philip/AAD-2392-2020; Bavro, Vassiliy/I-4846-2019; Tucker, Stephen J./ABE-7468-2020; Tucker, Stephen J./ABE-6741-2020; Robinson, Nigel J/J-6363-2012; Fowler, Philip/C-5116-2009	Sansom, Mark S.P./0000-0001-6360-7959; Fowler, Philip/0000-0003-0912-4483; Bavro, Vassiliy/0000-0003-2330-8924; Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Robinson, Nigel J/0000-0001-5586-1092; Fowler, Philip/0000-0003-0912-4483; Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [HL54171, DK069424]; British Heart Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/H006052/1]; BBSRC [BB/F013035/1, BB/H006052/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013035/1] Funding Source: researchfish; British Heart Foundation [PG/09/016/26992] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171 (to C.G.N.), DK069424 (to D.E.) and by grants from the British Heart Foundation, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council (BB/H006052/1).	Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Borrelly GPM, 2004, MOL MICROBIOL, V53, P217, DOI 10.1111/j.1365-2958.2004.04106.x; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Hegermann J, 2006, MICROBIOL-SGM, V152, P2831, DOI 10.1099/mic.0.29002-0; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nagaoka Y, 2008, CHEMBIOCHEM, V9, P1725, DOI 10.1002/cbic.200800133; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Parfenova Lyubov V., 2006, V337, P157; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	46	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40754	40761		10.1074/jbc.M110.175687	http://dx.doi.org/10.1074/jbc.M110.175687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20876570	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000285414400039
J	Zhang, WB; Wang, Z; Shu, F; Jin, YH; Liu, HY; Wang, QJ; Yang, Y				Zhang, Wen-bin; Wang, Zhuo; Shu, Fei; Jin, Yong-hua; Liu, Hong-yi; Wang, Qiu-juan; Yang, Yong			Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; CANCER CELLS; METHYLTRANSFERASE MGMT; METABOLIC CHECKPOINT; MELANOMA-CELLS; GROWTH; PHOSPHORYLATION; PATHWAY; DEATH; O-6-METHYLGUANINE	Methylating drugs such as temozolomide (TMZ) are widely used in the treatment of brain tumors including malignant glioblastoma. The mechanism of TMZ-induced glioblastoma cell death and apoptosis, however, is not fully understood. Here, we tested the potential involvement of AMP-activated protein kinase (AMPK) in this process. We found that methylating agents TMZ and N-methyl-N'-nitro-N-nitrosoguanidine induce AMPK activation in primary cultured human glioblastoma and glioblastoma cell lines. TMZ-induced O-6-methylguanine production is involved in AMPK activation. O-6-benzylguanine, an O-6-methylguanine-DNA methyltransferase inhibitor, enhances TMZ-induced O-6-methylguanine production, leading to enhanced reactive oxygen species production, which serves as an upstream signal for AMPK activation. Activation of AMPK is involved in TMZ-induced glioblastoma cell death and apoptosis. AMPK inhibitor (Compound C) or AMPK alpha siRNA knockdown inhibits TMZ-induced glioblastoma cell death and apoptosis, whereas AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside enhances it. In further studies, we found that activation of AMPK is involved in TMZ-induced p53 activation and subsequent p21, Noxa, and Bax up-regulation. Activation of AMPK by TMZ also inhibits mTOR complex 1 (mTORC1) signaling and promotes anti-apoptosis protein Bcl-2 down-regulation, which together mediate TMZ-induced pro-cell apoptosis effects. Our study suggests that activation of AMPK by TMZ contributes to glioblastoma cell apoptosis, probably by promoting p53 activation and inhibiting mTORC1 signaling.	[Zhang, Wen-bin; Wang, Zhuo; Jin, Yong-hua; Wang, Qiu-juan; Yang, Yong] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Peoples R China; [Zhang, Wen-bin; Liu, Hong-yi] Nanjing Med Univ, Dept Neurosurg, Nanjing 210029, Peoples R China; [Shu, Fei] Nanjing Med Univ, Dept Psychiat, Brain Hosp, Nanjing 210029, Peoples R China	China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University	Yang, Y (corresponding author), 24 Tongjiaxiang, Nanjing 210009, Peoples R China.	valianty@hotmail.com			National Natural Science Foundation of China [30701032, 81072661]; Ministry of Education of China; Fundamental Research Funds for the Central Universities [JKZ2009006]; Natural Science Foundation of Jiangsu Province [BK2009298]; "Major Drug Discovery" science and technology major projects of China [2009ZX09303-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery" science and technology major projects of China	This work was supported by National Natural Science Foundation of China Grants 30701032 and 81072661, the New Century Excellent Talents Program supported by Ministry of Education of China (2009) (Y. Y.), Fundamental Research Funds for the Central Universities Grant JKZ2009006, Natural Science Foundation of Jiangsu Province Grant BK2009298, and "Major Drug Discovery" science and technology major projects of China Grant 2009ZX09303-001.	Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bocangel DB, 2002, CLIN CANCER RES, V8, P2725; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; CONRAD CA, 1995, NEUROL CLIN, V13, P795, DOI 10.1016/S0733-8619(18)30018-5; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hirose M, 1998, CANCER LETT, V129, P165, DOI 10.1016/S0304-3835(98)00096-2; Hirose Y, 2001, CANCER RES, V61, P5843; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C., 2010, ONCOGENE IN PRESS; Jimenez AI, 2003, CANCER RES, V63, P1382; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kim DS, 2007, LIFE SCI, V80, P314, DOI 10.1016/j.lfs.2006.09.019; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Pan W, 2008, ONCOL REP, V20, P1553, DOI 10.3892/or_00000179; Preuss I, 1996, INT J CANCER, V65, P506, DOI 10.1002/(SICI)1097-0215(19960208)65:4<506::AID-IJC19>3.0.CO;2-7; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Zhang JF, 2007, TRANSPL IMMUNOL, V17, P162, DOI 10.1016/j.trim.2006.12.003; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006	41	148	149	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40461	40471		10.1074/jbc.M110.164046	http://dx.doi.org/10.1074/jbc.M110.164046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20880848	Green Published, hybrid			2022-12-25	WOS:000285414400008
J	Zhu, L; Sharp, JD; Kobayashi, H; Woychik, NA; Inouye, M				Zhu, Ling; Sharp, Jared D.; Kobayashi, Hiroshi; Woychik, Nancy A.; Inouye, Masayori			Noncognate Mycobacterium tuberculosis Toxin-Antitoxins Can Physically and Functionally Interact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENT-SPECIFIC PROTEIN; MESSENGER-RNA INTERFERASES; PLASMID ADDICTION SYSTEM; MEDIATED CELL-DEATH; ESCHERICHIA-COLI; MYXOCOCCUS-XANTHUS; NONREPLICATING PERSISTENCE; CONTROLLED EXPRESSION; GENOME SEQUENCE; PIN-DOMAIN	The Mycobacterium tuberculosis genome harbors a striking number (> 40) of toxin-antitoxin systems. Among them are at least seven MazF orthologs, designated MazF-mt1 through MazF-mt7, four of which have been demonstrated to function as mRNA interferases that selectively target mRNA for cleavage at distinct consensus sequences. As is characteristic of all toxin-antitoxin systems, each of the mazF-mt toxin genes is organized in an operon downstream of putative antitoxin genes. However, only one of the seven putative upstream antitoxins (designated MazE-mt1 through MazE-mt7) has significant sequence similarity to Escherichia coli MazE, the cognate antitoxin for E. coli MazF. Interestingly, the M. tuberculosis genome contains two independent operons encoding E. coli MazE orthologs, but they are not paired with mazF-mt-like genes. Instead, the genes encoding these two MazE orthologs are each paired with proteins containing a PIN domain, indicating that they may be members of the very large VapBC toxin-antitoxin family. We tested a spectrum of pair-wise combinations of cognate and noncognate Mtb toxin-antitoxins using in vivo toxicity and rescue experiments along with in vitro interaction experiments. Surprisingly, we uncovered several examples of noncognate toxin-antitoxin association, even among different families (e. g. MazF toxins and VapB antitoxins). These results challenge the "one toxin for one antitoxin" dogma and suggest that M. tuberculosis may enlist a sophisticated toxin-antitoxin network to alter its physiology in response to environmental cues.	[Sharp, Jared D.; Woychik, Nancy A.] Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Zhu, Ling; Kobayashi, Hiroshi; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Woychik, NA (corresponding author), Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu; inouye@umdnj.edu	Zhu, Ling/M-3887-2013	Zhu, Ling/0000-0003-0776-1630	National Institutes of Health [1R01GM081567, AI07403]; Takara-Bio, Inc.; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara-Bio, Inc.; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM081567 (to M. I.). This work was also supported by Takara-Bio, Inc. (to M. I. and N. A. W.) and by National Institutes of Health T32 Training Grant AI07403, Virus-Host Interactions in Eukaryotic Cells from the NIAID to J. D. S. (awarded to S. Pestka).	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; INOUYE S, 1981, J BACTERIOL, V148, P678, DOI 10.1128/JB.148.2.678-683.1981; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kobayashi H, 2009, APPL ENVIRON MICROB, V75, P5356, DOI 10.1128/AEM.00691-09; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NAKAMURA K, 1982, EMBO J, V1, P771, DOI 10.1002/j.1460-2075.1982.tb01244.x; NAKANO ET, 1987, J VIROL, V61, P302, DOI 10.1128/JVI.61.2.302-307.1987; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	45	55	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39732	39738		10.1074/jbc.M110.163105	http://dx.doi.org/10.1074/jbc.M110.163105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20876537	Green Published, hybrid			2022-12-25	WOS:000285185500017
J	Dyson, OF; Traylen, CM; Akula, SM				Dyson, Ossie F.; Traylen, Christopher M.; Akula, Shaw M.			Cell Membrane-bound Kaposi's Sarcoma-associated Herpesvirus-encoded Glycoprotein B Promotes Virus Latency by Regulating Expression of Cellular Egr-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; INDUCED LYTIC REACTIVATION; TRANSCRIPTION FACTOR EGR-1; PROTEIN-COUPLED RECEPTOR; EFFUSION LYMPHOMA-CELLS; GENE-EXPRESSION; BINDING PROTEIN; CYCLE REPLICATION; KSHV REACTIVATION	One of the important questions in the field of virus research is about the balance between latent and lytic cycles of replication. Kaposi's sarcoma-associated herpesvirus (KSHV) remains predominantly in a latent state, with only 1-3% of cells supporting a lytic replication at any time. KSHV glycoprotein B (gB) is expressed not only on the virus envelope but also on the surfaces of the few cells supporting lytic replication. Using co-culture experiments, we determined that expression of KSHV gB on as few as 1-2% of human dermal microvascular endothelial cells resulted in a 10-fold inhibition of expression of ORF50, a viral gene critical for the onset of lytic replication. Also, we demonstrate that such a profound inhibitory effect of gB on the lytic cycle of virus replication is by repressing the ability of Egr-1 (early growth response-1) to bind and activate the ORF50 promoter. In general, virus-encoded late stage structural proteins, such as gB, are said to play major roles in virus entry and egress. The present report provides initial evidence supporting a role for membrane-associated gB expressed in a minimal number of cells to promote virus latency. These findings may have ramifications leading to a better understanding of the role of virus-encoded structural proteins not only in KSHV-related diseases but also in other viruses causing latent infections.	[Dyson, Ossie F.; Traylen, Christopher M.; Akula, Shaw M.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Traylen, Christopher M.] Univ W England, Fac Sci Appl, Bristol BS16 1QY, Avon, England	University of North Carolina; East Carolina University; University of West England	Akula, SM (corresponding author), E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA.	akulas@ecu.edu			National Institutes of Health, NIBIB [R21EB006483, 5F31CA132560-02]; NATIONAL CANCER INSTITUTE [F31CA132560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006483] Funding Source: NIH RePORTER	National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health, NIBIB, Grants R21EB006483 (to S. M. A.) and 5F31CA132560-02 (to O. F. D.).	Akula SM, 2005, BLOOD, V105, P4516, DOI 10.1182/blood-2004-09-3683; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Bottero V, 2009, VIROLOGY, V392, P34, DOI 10.1016/j.virol.2009.07.002; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Bryan BA, 2006, J GEN VIROL, V87, P519, DOI 10.1099/vir.0.81603-0; Cai YY, 2006, VIROLOGY, V355, P152, DOI 10.1016/j.virol.2006.07.012; Cannon M, 2006, BLOOD, V107, P277, DOI 10.1182/blood-2005-06-2350; Cannon M, 2003, J VIROL, V77, P57, DOI 10.1128/JVI.77.1.57-67.2003; CAO XM, 1993, J BIOL CHEM, V268, P16949; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chappell WH, 2005, CELL CYCLE, V4, P1389, DOI 10.4161/cc.4.10.2028; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Choi YB, 2010, VIROLOGY, V397, P369, DOI 10.1016/j.virol.2009.11.024; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Curreli F, 2002, J VIROL, V76, P5208, DOI 10.1128/JVI.76.10.5208-5219.2002; Darbinian N, 2008, J CELL PHYSIOL, V216, P128, DOI 10.1002/jcp.21382; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Dyson OF, 2008, CELL MICROBIOL, V10, P1546, DOI 10.1111/j.1462-5822.2008.01149.x; Dyson OF, 2007, INTERVIROLOGY, V50, P245, DOI 10.1159/000101995; Dyson OF, 2009, J CELL MOL MED, V13, P1920, DOI 10.1111/j.1582-4934.2008.00481.x; Ford PW, 2005, VIRUS RES, V114, P172, DOI 10.1016/j.virusres.2005.06.011; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; Ford PW, 2004, CANCER BIOL THER, V3, P876, DOI 10.4161/cbt.3.9.1054; Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Hamden KE, 2005, LEUKEMIA, V19, P18, DOI 10.1038/sj.leu.2403532; Hamden KE, 2004, J VIROL, V78, P13381, DOI 10.1128/JVI.78.23.13381-13390.2004; Harrington W, 1997, LANCET, V349, P774; Harrison SM, 2008, FEBS LETT, V582, P3080, DOI 10.1016/j.febslet.2008.07.055; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lee BS, 2002, J VIROL, V76, P12185, DOI 10.1128/JVI.76.23.12185-12199.2002; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McAllister SC, 2005, J VIROL, V79, P2626, DOI 10.1128/JVI.79.4.2626-2630.2005; Milligan S, 2004, J VIROL, V78, P2591, DOI 10.1128/JVI.78.5.2591-2596.2004; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naranatt PP, 2002, ARCH VIROL, V147, P1349, DOI 10.1007/s00705-002-0813-7; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Palm M, 2010, VET RES, V41, DOI 10.1051/vetres/2010001; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Ralph JA, 2007, AM J PATHOL, V170, P1121, DOI 10.2353/ajpath.2007.061000; Robinson L, 1997, P NATL ACAD SCI USA, V94, P7170, DOI 10.1073/pnas.94.14.7170; Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; Shaw AM, 2000, VIROLOGY, V268, P159, DOI 10.1006/viro.1999.0164; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Subramanian R, 2008, J VIROL, V82, P7144, DOI 10.1128/JVI.00617-08; Subramanian R, 2010, J VIROL, V84, P1704, DOI 10.1128/JVI.01889-09; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; Wilson SJ, 2007, J VIROL, V81, P13578, DOI 10.1128/JVI.01663-07; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; ZALANI S, 1995, J VIROL, V69, P3816, DOI 10.1128/JVI.69.6.3816-3823.1995	72	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37491	37502		10.1074/jbc.M110.159103	http://dx.doi.org/10.1074/jbc.M110.159103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864524	Green Published, hybrid			2022-12-25	WOS:000284424000041
J	Levin, A; Fang, A; Hansen, PM; Pyle, D; Dia, O; Schwalbe, N				Levin, Ann; Fang, Arnold; Hansen, Peter M.; Pyle, David; Dia, Ousmane; Schwalbe, Nina			A Global Health Partnership's Use of Time-Limited Support to Catalyze Health Practice Change: The Case of GAVI's Injection Safety Support	PLOS ONE			English	Article							COST	This paper presents the findings of a study to assess the effectiveness and sustainability of a GAVI (Global Alliance of Vaccines and Immunization) sponsored, time-limited Injection Safety (INS) support. The support came in two forms: 1) in-kind, in the form of AD syringes and safety boxes, and 2) in cash, for those countries that already had a secure, multi-year source of AD syringes and safety boxes, but proposed to use INS support to strengthen their injection safety activities. In total, GAVI gave INS support for a three-year period to 58 countries: 46 with commodities and 12 with cash support. To identify variables that might be associated with financial sustainability, frequencies and cross-tabulations were run against various programmatic and socio-economic variables in the 58 countries. All but two of the 46 commodity-recipient countries were able to replace and sustain the use of AD syringes and safety boxes after the end of their GAVI INS support despite the fact that standard disposable syringes are less costly than ADs (10-15 percent differential). In addition, all 12 cash-recipient countries continued to use AD syringes and safety boxes in their immunization programs in the years following GAVI INS assistance. At the same time, countries were often not prepared for the increased waste management requirements associated with the use of the syringes, suggesting the importance of anticipating challenges with the introduction of new technologies. The sustained use of AD syringes in countries receiving injection safety support from GAVI, in a majority of cases through government financing, following the completion of three years of time-limited support, represents an early indication of how GHPs can contribute to improved health outcomes in immunization safety in the world's poorest countries in a sustainable way.	[Fang, Arnold; Hansen, Peter M.; Schwalbe, Nina] GAVI Alliance, Geneva, Switzerland; [Pyle, David; Dia, Ousmane] John Snow Int, Arlington, VA USA			annlevin@verizon.net						AHMEDOV M, 2008, HLTH SYSTEMS TRANSIT; Battersby A, 1999, B WORLD HEALTH ORGAN, V77, P812; Battersby A, 1999, B WORLD HEALTH ORGAN, V77, P996; CAINES K, 2004, 4 DFID STUD GLOB HLT; DZIEKAN G, 2003, B WHO, V81; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; PEARSON M, 2004, 2 DFID STUD GLOB HLT; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; *WHO, WHO INJ SAF FACT SHE	10	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12986	10.1371/journal.pone.0012986	http://dx.doi.org/10.1371/journal.pone.0012986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885995	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100004
J	Lowe, EL; Crother, TR; Rabizadeh, S; Hu, B; Wang, HL; Chen, SA; Shimada, K; Wong, MH; Michelsen, KS; Arditi, M				Lowe, Emily L.; Crother, Timothy R.; Rabizadeh, Shervin; Hu, Bing; Wang, Hanlin; Chen, Shuang; Shimada, Kenichi; Wong, Michelle H.; Michelsen, Kathrin S.; Arditi, Moshe			Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; SPONTANEOUS INTESTINAL TUMORIGENESIS; DENDRITIC CELLS; TGF-BETA; COLORECTAL-CANCER; EPITHELIAL-CELLS; CUTTING EDGE; IN-VIVO	Inflammatory bowel disease (IBD) is a disorder of chronic inflammation with increased susceptibility to colorectal cancer. The etiology of IBD is unclear but thought to result from a dysregulated adaptive and innate immune response to microbial products in a genetically susceptible host. Toll-like receptor (TLR) signaling induced by intestinal commensal bacteria plays a crucial role in maintaining intestinal homeostasis, innate immunity and the enhancement of intestinal epithelial cell (IEC) integrity. However, the role of TLR2 in the development of colorectal cancer has not been studied. We utilized the AOM-DSS model for colitis-associated colorectal cancer (CAC) in wild type (WT) and TLR2(-/-) mice. Colons harvested from WT and TLR2(-/-) mice were used for histopathology, immunohistochemistry, immunofluorescence and cytokine analysis. Mice deficient in TLR2 developed significantly more and larger colorectal tumors than their WT controls. We provide evidence that colonic epithelium of TLR2(-/-) mice have altered immune responses and dysregulated proliferation under steady-state conditions and during colitis, which lead to inflammatory growth signals and predisposition to accelerated neoplastic growth. At the earliest time-points assessed, TLR2(-/-) colons exhibited a significant increase in aberrant crypt foci (ACF), resulting in tumors that developed earlier and grew larger. In addition, the intestinal microenvironment revealed significantly higher levels of IL-6 and IL-17A concomitant with increased phospho-STAT3 within ACF. These observations indicate that in colitis, TLR2 plays a protective role against the development of CAC.	[Lowe, Emily L.; Crother, Timothy R.; Chen, Shuang; Shimada, Kenichi; Arditi, Moshe] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Lowe, Emily L.; Crother, Timothy R.; Rabizadeh, Shervin; Hu, Bing; Wang, Hanlin; Chen, Shuang; Shimada, Kenichi; Wong, Michelle H.; Michelsen, Kathrin S.; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rabizadeh, Shervin] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Gastroenterol, Los Angeles, CA 90048 USA; [Hu, Bing; Wang, Hanlin] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Wong, Michelle H.; Michelsen, Kathrin S.] Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Los Angeles, CA USA; [Wong, Michelle H.; Michelsen, Kathrin S.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Burns & Allen Res Inst, Immunobiol Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Lowe, EL (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	kathrin.michelsen@cshs.org; moshe.arditi@cshs.org	Lowe, Emily/G-1690-2010; Wang, Han/GPW-9809-2022; Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [AI-058128]; Donna and Jesse Garber Endowment; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donna and Jesse Garber Endowment; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (AI-058128 supplement to M.A.) and Donna and Jesse Garber Endowment (to K.S.M. and M.A.). In addition, K.S.M. is currently supported by the Crohns and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Becker C, 2005, CELL CYCLE, V4, P217; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boulard O, 2010, EUR J IMMUNOL, V40, P516, DOI 10.1002/eji.200939669; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ey B, 2009, J BIOL CHEM, V284, P22332, DOI 10.1074/jbc.M901619200; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Halliwell B, 1997, FEBS LETT, V411, P157, DOI 10.1016/S0014-5793(97)00469-9; Khare Sharad, 2009, V472, P373, DOI 10.1007/978-1-60327-492-0_17; Klimp AH, 2001, CANCER RES, V61, P7305; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taylor KD, 2008, INFLAMM BOWEL DIS, V14, P1185, DOI 10.1002/ibd.20478; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhang R, 2007, BIOCHEM SOC T, V35, P1375, DOI 10.1042/BST0351375; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	62	117	121	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13027	10.1371/journal.pone.0013027	http://dx.doi.org/10.1371/journal.pone.0013027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885960	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100025
J	Sasaki, K; Ishii, N				Sasaki, Kazushige; Ishii, Naokata			Unloaded Shortening Velocity of Voluntarily and Electrically Activated Human Dorsiflexor Muscles In Vivo	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MOTOR UNITS; RECRUITMENT ORDER; ISOMETRIC CONTRACTIONS; FIBER COMPOSITION; MYOSIN ISOFORMS; BODY-SIZE; FORCE; STIMULATION; LENGTH	We have previously shown that unloaded shortening velocity (V-0) of human plantar flexors can be determined in vivo, by applying the "slack test'' to submaximal voluntary contractions (J Physiol 567: 1047-1056, 2005). In the present study, to investigate the effect of motor unit recruitment pattern on V-0 of human muscle, we modified the slack test and applied this method to both voluntary and electrically elicited contractions of dorsiflexors. A series of quick releases (i.e., rapid ankle joint rotation driven by an electrical dynamometer) was applied to voluntarily activated dorsiflexor muscles at three different contraction intensities (15, 50, and 85% of maximal voluntary contraction; MVC). The quick-release trials were also performed on electrically activated dorsiflexor muscles, in which three stimulus conditions were used: submaximal (equal to 15% MVC) 50-Hz stimulation, supramaximal 50-Hz stimulation, and supramaximal 20-Hz stimulation. Modification of the slack test in vivo resulted in good reproducibility of V-0, with an intraclass correlation coefficient of 0.87 (95% confidence interval: 0.68-0.95). Regression analysis showed that V-0 of voluntarily activated dorsiflexor muscles significantly increased with increasing contraction intensity (R-2 = 0.52, P<0.001). By contrast, V-0 of electrically activated dorsiflexor muscles remained unchanged (R-2<0.001, P = 0.98) among three different stimulus conditions showing a large variation of tetanic torque. These results suggest that the recruitment pattern of motor units, which is quite different between voluntary and electrically elicited contractions, plays an important role in determining shortening velocity of human skeletal muscle in vivo.	[Sasaki, Kazushige; Ishii, Naokata] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Sasaki, K (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan.	sasaki@idaten.c.u-tokyo.ac.jp		Sasaki, Kazushige/0000-0001-6709-8581	Ministry of Education, Culture, Sports, Science and Technology, Japan [18300217]; Japan Society for the Promotion of Science [19800010]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 18300217 to NI) and from Japan Society for the Promotion of Science (No. 19800010 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; ANGEL RW, 1965, J PHYSIOL-LONDON, V180, P864, DOI 10.1113/jphysiol.1965.sp007736; Arampatzis A, 2005, J BIOMECH, V38, P885, DOI 10.1016/j.jbiomech.2004.04.027; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Bottinelli R, 1999, J ELECTROMYOGR KINES, V9, P87, DOI 10.1016/S1050-6411(98)00040-6; CABRIC M, 1987, INT J SPORTS MED, V8, P323, DOI 10.1055/s-2008-1025677; Camilleri MJ, 2005, J BIOMECH, V38, P2172, DOI 10.1016/j.jbiomech.2004.09.037; Chow JW, 1999, J APPL PHYSIOL, V86, P1025, DOI 10.1152/jappl.1999.86.3.1025; CLAFLIN DR, 1985, J PHYSIOL-LONDON, V359, P357, DOI 10.1113/jphysiol.1985.sp015589; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; De Zee M, 2002, J APPL PHYSIOL, V93, P324, DOI 10.1152/japplphysiol.00696.2001; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Elliott GF, 2001, INT J BIOL MACROMOL, V29, P211, DOI 10.1016/S0141-8130(01)00162-3; Enoka RM, 2002, MUSCLE NERVE, V25, P763, DOI 10.1002/mus.10117; Erim Z, 1996, MUSCLE NERVE, V19, P563, DOI 10.1002/(SICI)1097-4598(199605)19:5<563::AID-MUS3>3.0.CO;2-9; Feiereisen P, 1997, EXP BRAIN RES, V114, P117, DOI 10.1007/PL00005610; Fenn WO, 1935, J PHYSIOL-LONDON, V85, P277, DOI 10.1113/jphysiol.1935.sp003318; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158, DOI 10.1152/jappl.1996.80.1.158; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; GULATI J, 1985, J GEN PHYSIOL, V86, P479, DOI 10.1085/jgp.86.4.479; Hamada T, 2004, J ELECTROMYOGR KINES, V14, P531, DOI 10.1016/j.jelekin.2004.03.008; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Holmback AM, 2003, J APPL PHYSIOL, V95, P2416, DOI 10.1152/japplphysiol.00517.2002; Ishii N, 1997, BBA-BIOENERGETICS, V1319, P155, DOI 10.1016/S0005-2728(96)00156-9; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; JOSEPHSON RK, 1988, ACTA PHYSIOL SCAND, V132, P341, DOI 10.1111/j.1748-1716.1988.tb08338.x; Jubeau M, 2007, INT J SPORTS MED, V28, P901, DOI 10.1055/s-2007-965075; Karatzaferi C, 2008, AM J PHYSIOL-REG I, V294, pR948, DOI 10.1152/ajpregu.00541.2007; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; MARTYN DA, 1994, BIOPHYS J, V67, P1984, DOI 10.1016/S0006-3495(94)80681-2; Marx JO, 2006, PFLUG ARCH EUR J PHY, V452, P222, DOI 10.1007/s00424-005-0017-6; Muraoka T, 2002, CELLS TISSUES ORGANS, V171, P260, DOI 10.1159/000063128; Ochala J, 2004, EXP GERONTOL, V39, P349, DOI 10.1016/j.exger.2003.11.004; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; PETROFSKY JS, 1980, MED BIOL ENG COMPUT, V18, P381, DOI 10.1007/BF02443305; PHILLIPS CA, 1980, J BIOMECH, V13, P549, DOI 10.1016/0021-9290(80)90055-X; RANATUNGA KW, 1984, J PHYSIOL-LONDON, V351, P517, DOI 10.1113/jphysiol.1984.sp015260; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Sanchez BR, 2005, J STRENGTH COND RES, V19, P438, DOI 10.1519/00124278-200505000-00033; Sasaki K, 2005, J PHYSIOL-LONDON, V567, P1047, DOI 10.1113/jphysiol.2005.091124; SINACORE DR, 1990, PHYS THER, V70, P416, DOI 10.1093/ptj/70.7.416; Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435, DOI 10.1152/jappl.1984.57.2.435; ZAJAC FE, 1985, J NEUROPHYSIOL, V53, P1303, DOI 10.1152/jn.1985.53.5.1303	50	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13043	10.1371/journal.pone.0013043	http://dx.doi.org/10.1371/journal.pone.0013043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885951	Green Submitted, gold, Green Published			2022-12-25	WOS:000282167100029
J	Peyre, M; Commo, F; Dantas-Barbosa, C; Andreiuolo, F; Puget, S; Lacroix, L; Drusch, F; Scott, V; Varlet, P; Mauguen, A; Dessen, P; Lazar, V; Vassal, G; Grill, J				Peyre, Matthieu; Commo, Frederic; Dantas-Barbosa, Carmela; Andreiuolo, Felipe; Puget, Stephanie; Lacroix, Ludovic; Drusch, Francoise; Scott, Veronique; Varlet, Pascale; Mauguen, Audrey; Dessen, Philippe; Lazar, Vladimir; Vassal, Gilles; Grill, Jacques			Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PEDIATRIC INTRACRANIAL EPENDYMOMA; METALLOTHIONEIN MESSENGER-RNA; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; POSTOPERATIVE CHEMOTHERAPY; MOLECULAR SIGNATURES; TRANSCRIPTION FACTOR; DNA METHYLATION; CANDIDATE GENES	Background: Children with ependymoma may experience a relapse in up to 50% of cases depending on the extent of resection. Key biological events associated with recurrence are unknown. Methodology/Principal Findings: To discover the biology behind the recurrence of ependymomas, we performed CGHarray and a dual-color gene expression microarray analysis of 17 tumors at diagnosis co-hybridized with the corresponding 27 first or subsequent relapses from the same patient. As treatment and location had only limited influence on specific gene expression changes at relapse, we established a common signature for relapse. Eighty-seven genes showed an absolute fold change >= 2 in at least 50% of relapses and were defined as the gene expression signature of ependymoma recurrence. The most frequently upregulated genes are involved in the kinetochore (ASPM, KIF11) or in neural development (CD133, Wnt and Notch pathways). Metallothionein (MT) genes were downregulated in up to 80% of the recurrences. Quantitative PCR for ASPM, KIF11 and MT3 plus immunohistochemistry for ASPM and MT3 confirmed the microarray results. Immunohistochemistry on an independent series of 24 tumor pairs at diagnosis and at relapse confirmed the decrease of MT3 expression at recurrence in 17/24 tumor pairs (p = 0.002). Conversely, ASPM expression was more frequently positive at relapse (87.5% vs 37.5%, p = 0.03). Loss or deletion of the MT genes cluster was never observed at relapse. Promoter sequencing after bisulfite treatment of DNA from primary tumors and recurrences as well as treatment of short-term ependymoma cells cultures with a demethylating agent showed that methylation was not involved in MT3 downregulation. However, in vitro treatment with a histone deacetylase inhibitor or zinc restored MT3 expression. Conclusions/Significance: The most frequent molecular events associated with ependymoma recurrence were overexpression of kinetochore proteins and down-regulation of metallothioneins. Metallothionein-3 expression is epigenetically controlled and can be restored in vitro by histone deacetylase inhibitors.	[Peyre, Matthieu; Dantas-Barbosa, Carmela; Andreiuolo, Felipe; Puget, Stephanie; Scott, Veronique; Vassal, Gilles; Grill, Jacques] Univ Paris 11, CNRS, UMR Vectorol & Anticanc Treatments 8203, Inst Gustave Roussy, Villejuif, France; [Commo, Frederic; Dessen, Philippe] Inst Gustave Roussy, CNRS FRE 2939, Bioinformat Grp, Villejuif, France; [Puget, Stephanie] Univ Paris 05, Necker Sick Childrens Hosp, Dept Neurosurg, Paris, France; [Andreiuolo, Felipe; Lacroix, Ludovic; Drusch, Francoise] Inst Gustave Roussy, Translat Res Lab, Villejuif, France; [Varlet, Pascale] St Anne Hosp, Dept Neuropathol, Paris, France; [Mauguen, Audrey] Inst Gustave Roussy, Dept Biostat, Villejuif, France; [Lazar, Vladimir] Inst Gustave Roussy, Funct Genom Unit, Villejuif, France; [Vassal, Gilles; Grill, Jacques] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Peyre, M (corresponding author), Univ Paris 11, CNRS, UMR Vectorol & Anticanc Treatments 8203, Inst Gustave Roussy, Villejuif, France.	grill@igr.fr	Dantas-Barbosa, Carmela/D-3179-2013; Lazar, Vladimir/AAQ-2086-2020; Grill, Jacques/R-8093-2019; Lazar, Vladimir/AAV-2087-2020	Dantas-Barbosa, Carmela/0000-0001-6100-2585; Andreiuolo, Felipe/0000-0002-2568-6155; VARLET, pascale/0000-0002-8164-1517; Peyre, Matthieu/0000-0001-8470-9516; Mauguen, Audrey/0000-0003-3236-6093	Societe de Neurochirurgie de Langue Francaise; Institut National du Cancer; Region Ile de France; Societe Francaise des Cancers de l'Enfant/Enfants et Sante; charity "l'Etoile de Martin"	Societe de Neurochirurgie de Langue Francaise; Institut National du Cancer(Institut National du Cancer (INCA) France); Region Ile de France(Region Ile-de-France); Societe Francaise des Cancers de l'Enfant/Enfants et Sante; charity "l'Etoile de Martin"	The authors thank the Societe de Neurochirurgie de Langue Francaise for the fellowship of MP and the Institut National du Cancer and the Region Ile de France for the Fellowship of CDB and FA, as well as the grant support from the Societe Francaise des Cancers de l'Enfant/Enfants et Sante 2006 (http://www.enfants-sante.asso.fr/) and from the charity "l'Etoile de Martin" (http://www.letoiledemartin.org/) for FA and CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ME, 2002, CANCER GENET CYTOGEN, V134, P1, DOI 10.1016/S0165-4608(01)00591-X; Bizzoca A, 2009, CELL ADHES MIGR, V3, P53, DOI 10.4161/cam.3.1.7462; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bortolotto S, 2001, J NEURO-ONCOL, V54, P9, DOI 10.1023/A:1012537105775; Bouffet E, 1998, MED PEDIATR ONCOL, V30, P319, DOI 10.1002/(SICI)1096-911X(199806)30:6<319::AID-MPO1>3.0.CO;2-H; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Chin GM, 2006, MOL CANCER THER, V5, P2580, DOI 10.1158/1535-7163.MCT-06-0201; Colin C, 2007, NEUROPATH APPL NEURO, V33, P431, DOI 10.1111/j.1365-2990.2007.00829.x; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Deng DJ, 2003, CARCINOGENESIS, V24, P25, DOI 10.1093/carcin/24.1.25; Donson AM, 2009, J IMMUNOL, V183, P7428, DOI 10.4049/jimmunol.0902811; EBADI M, 1995, NEUROCHEM INT, V27, P1, DOI 10.1016/0197-0186(94)00164-P; Ferrario C, 2008, LAB INVEST, V88, P474, DOI 10.1038/labinvest.2008.17; Figarella-Branger D, 2000, J NEUROSURG, V93, P605, DOI 10.3171/jns.2000.93.4.0605; Garrett SH, 1999, TOXICOL LETT, V105, P207, DOI 10.1016/S0378-4274(99)00003-X; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Grill J, 2002, CANCER GENET CYTOGEN, V136, P121, DOI 10.1016/S0165-4608(02)00516-2; Grill J, 2001, J CLIN ONCOL, V19, P1288, DOI 10.1200/JCO.2001.19.5.1288; Grundy RG, 2007, LANCET ONCOL, V8, P696, DOI 10.1016/S1470-2045(07)70208-5; Hamilton RL, 1997, BRAIN PATHOL, V7, P807, DOI 10.1111/j.1750-3639.1997.tb01066.x; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Henrique R, 2005, CANCER EPIDEM BIOMAR, V14, P1274, DOI 10.1158/1055-9965.EPI-04-0659; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hirose Y, 2001, AM J PATHOL, V158, P1137, DOI 10.1016/S0002-9440(10)64061-8; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kilday JP, 2009, MOL CANCER RES, V7, P765, DOI 10.1158/1541-7786.MCR-08-0584; Korshunov A, 1999, J NEURO-ONCOL, V45, P219, DOI 10.1023/A:1006369829576; Korshunov A, 2010, J CLIN ONCOL, V28, P3182, DOI 10.1200/JCO.2009.27.3359; Kramer KK, 1996, TOXICOL APPL PHARM, V141, P1; Kramer KK, 1996, TOXICOL APPL PHARM, V136, P94, DOI 10.1006/taap.1996.0011; L'Esperance S, 2006, INT J ONCOL, V29, P5; Liu CJ, 2008, J PATHOL, V214, P489, DOI 10.1002/path.2306; Lu RX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-314; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Martin-Magniette ML, 2005, BIOINFORMATICS, V21, P1995, DOI 10.1093/bioinformatics/bti302; Mc Lendon RE, 2007, WHO CLASSIFICATION T, P74; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Michiels S, 2007, BRIT J CANCER, V96, P1155, DOI 10.1038/sj.bjc.6603673; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Muller C, 2007, CANCER CHEMOTH PHARM, V59, P157, DOI 10.1007/s00280-006-0254-1; Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476; Perilongo G, 1997, MED PEDIATR ONCOL, V29, P79; Peris-Bonet R, 2006, EUR J CANCER, V42, P2064, DOI 10.1016/j.ejca.2006.05.009; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195; Qi YC, 2001, DEVELOPMENT, V128, P2723; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Rome C, 2006, MOL CARCINOGEN, V45, P774, DOI 10.1002/mc.20244; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SATOH M, 1994, CANCER RES, V54, P5255; Schneider D, 2009, CANCER GENET CYTOGEN, V191, P90, DOI 10.1016/j.cancergencyto.2009.02.010; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Snuderl M, 2008, J NEUROPATH EXP NEUR, V67, P911, DOI 10.1097/NEN.0b013e318184f413; Sousa JF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-19; Sowar K, 2006, J NEURO-ONCOL, V78, P41, DOI 10.1007/s11060-005-9072-2; Suarez-Merino B, 2005, NEURO-ONCOLOGY, V7, P20; 't Hoen PAC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh038; Tabori U, 2006, J CLIN ONCOL, V24, P1522, DOI 10.1200/JCO.2005.04.2127; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; van Veelen-Vincent MLC, 2002, J NEUROSURG, V97, P827, DOI 10.3171/jns.2002.97.4.0827; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; WETJEN N, 2006, NEUROONCOLOGY CNS TU, P453; Yap XL, 2009, J PATHOL, V217, P563, DOI 10.1002/path.2489; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	77	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12932	10.1371/journal.pone.0012932	http://dx.doi.org/10.1371/journal.pone.0012932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885975	Green Submitted, gold, Green Published			2022-12-25	WOS:000282122600002
J	Choi, JW; Kim, S; Kim, TM; Kim, YM; Seo, HW; Park, TS; Jeong, JW; Song, G; Han, JY				Choi, Jin Won; Kim, Sujung; Kim, Tae Min; Kim, Young Min; Seo, Hee Won; Park, Tae Sub; Jeong, Jae-Wook; Song, Gwonhwa; Han, Jae Yong			Basic Fibroblast Growth Factor Activates MEK/ERK Cell Signaling Pathway and Stimulates the Proliferation of Chicken Primordial Germ Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; P38 MAP KINASE; SELF-RENEWAL; MOUSE; MIGRATION; TRANSMISSION; DERIVATION; EXPRESSION; CULTURE; PROTEIN	Background: Long-term maintenance of avian primordial germ cells (PGCs) in vitro has tremendous potential because it can be used to deepen our understanding of the biology of PGCs. A transgenic bioreactor based on the unique migration of PGCs toward the recipients' sex cord via the bloodstream and thereby creating a germline chimeric bird has many potential applications. However, the growth factors and the signaling pathway essential for inducing proliferation of chicken PGCs are unknown. Methodology/Principal Findings: Therefore, we conducted this study to investigate the effects of various combinations of growth factors on the survival and proliferation of PGCs under feeder-free conditions. We observed proliferation of PGCs in media containing bFGF. Subsequent characterization confirmed that the cultured PGCs maintained expression of PGC-specific markers, telomerase activity, normal migrational activity, and germline transmission. We also found that bFGF activates the mitogen-activated protein kinase kinase/extracellular-signal regulated kinase (MEK/ERK) signaling. Also, the expression of 133 transcripts was reversibly altered by bFGF withdrawal. Conclusions/Significance: Our results demonstrate that chicken PGCs can be maintained in vitro without any differentiation or dedifferentiation in feeder free culture conditions, and subsequent analysis revealed that bFGF is one of the key factors that enable proliferation of chicken PGCs via MEK/ERK signaling regulating downstream genes that may be important for PGC proliferation and survival.	[Choi, Jin Won; Kim, Sujung; Kim, Tae Min; Kim, Young Min; Seo, Hee Won; Song, Gwonhwa; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Park, Tae Sub] Optifarm Solut Inc, Avicore Biotechnol Inst, Gyeonggi Do, South Korea; [Jeong, Jae-Wook] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Seoul National University (SNU); Baylor College of Medicine	Choi, JW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	jaehan@snu.ac.kr	Lim, Whasun/F-2060-2013; Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015		Ministry of Education, Science and Technology [KRF-2006-311-F00087, R31-10056]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Research Foundation program (KRF-2006-311-F00087) and also supported by World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; ANDO Y, 1983, DEV GROWTH DIFFER, V25, P345; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; ENGLAND MA, 1993, J ANAT, V183, P67; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; Fan LC, 2008, STEM CELLS DEV, V17, P585, DOI 10.1089/scd.2007.0178; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FRITTSWI.ML, 1972, EXP CELL RES, V75, P512, DOI 10.1016/0014-4827(72)90459-4; Ginsburg M, 1997, POULTRY SCI, V76, P91, DOI 10.1093/ps/76.1.91; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; Guay J, 1997, J CELL SCI, V110, P357; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Jung JS, 2005, STEM CELLS, V23, P689, DOI 10.1634/stemcells.2004-0208; Kim JN, 2004, MOL REPROD DEV, V68, P81, DOI 10.1002/mrd.20051; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; KUWANA T, 1987, ANAT RECORD, V219, P164, DOI 10.1002/ar.1092190209; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MEYER DB, 1964, DEV BIOL, V10, P154, DOI 10.1016/0012-1606(64)90009-0; Motono M, 2008, CYTOTECHNOLOGY, V57, P199, DOI 10.1007/s10616-008-9156-x; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; NIEUWKOOP PD, 1979, PRIMORDIAL GERM CELL, pR11; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Park TS, 2003, BIOL REPROD, V68, P1657, DOI 10.1095/biolreprod.102.006825; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robinson LLL, 2001, MOL HUM REPROD, V7, P845, DOI 10.1093/molehr/7.9.845; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; Takeuchi Y, 2005, DEVELOPMENT, V132, P5399, DOI 10.1242/dev.02080; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; UKESHIMA A, 1991, J ELECTRON MICROSC, V40, P124; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; ZACCANTI F, 1990, DIFFERENTIATION, V43, P71, DOI 10.1111/j.1432-0436.1990.tb00432.x; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	59	87	100	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12968	10.1371/journal.pone.0012968	http://dx.doi.org/10.1371/journal.pone.0012968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886037	Green Published, gold			2022-12-25	WOS:000282091100057
J	Pattenden, SG; Gogol, MM; Workman, JL				Pattenden, Samantha G.; Gogol, Madelaine M.; Workman, Jerry L.			Features of Cryptic Promoters and Their Varied Reliance on Bromodomain-Containing Factors	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; HISTONE ACETYLATION; RSC; GENOME; YEAST; TRANSCRIPTION; SET2	The Set2-Rpd3S pathway is important for the control of transcription memory. Mutation of components of this pathway results in cryptic transcription initiation within the coding region of approximately 30% of yeast genes. Specifically, deletion of the Set2 histone methyltransferase or Rco1, a component of the Rpd3S histone deacetylase complex leads to hyperacetylation of certain open reading frames (ORFs). We used this mutant as a system to study the role of histone modifications and co-activator recruitment in preinitiation complex (PIC) formation. Specifically, we looked at the dependence of promoters on the bromodomain-containing RSC complex and the Bdf1 protein. We found that the dependence of cryptic promoters for these proteins varied. Overall, our data indicate that cryptic promoters are independently regulated, and their activation is dependent on factors that govern gene activation at canonical promoters.	[Pattenden, Samantha G.; Gogol, Madelaine M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO USA	Stowers Institute for Medical Research	Pattenden, SG (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	jlw@stowers.org		Gogol, Madelaine/0000-0002-8738-0995	Natural Sciences and Engineering Research Council; National Institute of General Medical Sciences [R37 GM47867]; Stowers Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Natural Sciences and Engineering Research Council Postdoctoral Fellowship (SGP), National Institute of General Medical Sciences (R37 GM47867) and the Stowers Institute (www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bungard D, 2004, EUKARYOT CELL, V3, P910, DOI 10.1128/EC.3.4.910-918.2004; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Du J, 1998, GENETICS, V150, P987; Durant M, 2006, MOL CELL BIOL, V26, P2791, DOI 10.1128/MCB.26.7.2791-2802.2006; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goodacre SL, 2001, P ROY SOC B-BIOL SCI, V268, P1, DOI 10.1098/rspb.2000.1322; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soukas A, 2000, GENE DEV, V14, P963; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; van Bakel H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1144; Yukawa M, 2002, FEMS YEAST RES, V2, P87, DOI 10.1111/j.1567-1364.2002.tb00073.x; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	58	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12927	10.1371/journal.pone.0012927	http://dx.doi.org/10.1371/journal.pone.0012927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886085	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100031
J	Silveira, JM; Barlow, J; Louzada, J; Moutinho, P				Silveira, Juliana M.; Barlow, Jos; Louzada, Julio; Moutinho, Paulo			Factors Affecting the Abundance of Leaf-Litter Arthropods in Unburned and Thrice-Burned Seasonally-Dry Amazonian Forests	PLOS ONE			English	Article							SURFACE-ACTIVE ARTHROPODS; EXPERIMENTAL FIRE REGIMES; LONG-TERM; CONSERVATION BIOLOGY; PRESCRIBED FIRES; RESPONSES; SOIL; DECOMPOSITION; AUTUMN; MICROARTHROPODS	Fire is frequently used as a land management tool for cattle ranching and annual crops in the Amazon. However, these maintenance fires often escape into surrounding forests, with potentially severe impacts for forest biodiversity. We examined the effect of experimental fires on leaf-litter arthropod abundance in a seasonally-dry forest in the Brazilian Amazon. The study plots (50 ha each) included a thrice-burned forest and an unburned control forest. Pitfall-trap samples were collected at 160 randomly selected points in both plots, with sampling stratified across four intra-annual replicates across the dry and wet seasons, corresponding to 6, 8, 10 and 12 months after the most recent fire. Arthropods were identified to the level of order (separating Formicidae). In order to better understand the processes that determine arthropod abundance in thrice-burned forests, we measured canopy openness, understory density and litter depth. All arthropod taxa were significantly affected by fire and season. In addition, the interactions between burn treatment and season were highly significant for all taxa but Isoptera. The burned plot was characterized by a more open canopy, lower understory density and shallower litter depth. Hierarchical partitioning revealed that canopy openness was the most important factor explaining arthropod order abundances in the thrice-burned plot, whereas all three environmental variables were significant in the unburned control plot. These results reveal the marked impact of recurrent wildfires and seasonality on litter arthropods in this transitional forest, and demonstrate the overwhelming importance of canopy-openness in driving post-fire arthropod abundance.	[Silveira, Juliana M.; Louzada, Julio] Univ Fed Lavras UFLA, Dept Ecol, Lavras, MG, Brazil; [Silveira, Juliana M.] Museu Paraense Emilio Goeldi MPEG, Dept Zool, Belem, Para, Brazil; [Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Moutinho, Paulo] Inst Pesquisa Ambiental Amazonia IPAM, Brasilia, DF, Brazil	Universidade Federal de Lavras; Museu Paraense Emilio Goeldi; Lancaster University	Silveira, JM (corresponding author), Univ Fed Lavras UFLA, Dept Ecol, Lavras, MG, Brazil.	silveira.juli@gmail.com	Louzada, Julio/F-1265-2010; Barlow, Jos/HGE-9486-2022; Barlow, Jos/E-7861-2014	Louzada, Julio/0000-0002-1481-3112; Moutinho, Paulo/0000-0003-0596-1823	David and Lucile Packard Foundation; NASA; NSF; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. M. Silveira gratefully acknowledges the Conselho Nacional de Pesquisa Cientifica (CNPq), which supported the data collection of her Ph.D. research. Funding for the experimental fires was provided by the David and Lucile Packard Foundation, NASA LBA-ECO program, and NSF Biocomplexity in the Environment and Ecosystems programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. M. Silveira gratefully the Instituto de Pesquisa Ambiental da Amazonia ( IPAM) field staff who helped collect the data. Grupo Amaggi provided logistical support. Secretaria de Agricultura de Querencia-MT provided the rainfall data. Mark Cochrane provided comments that improved the manuscript. Special thanks to Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG which provided a post-doctoral fellowship to the first author while she was writing the manuscript.	Alencar A, 2006, EARTH INTERACT, V10; Andersen AN, 2000, AUSTRAL ECOL, V25, P199, DOI 10.1046/j.1442-9993.2000.01038.x; Apigian KO, 2006, FOREST ECOL MANAG, V221, P110, DOI 10.1016/j.foreco.2005.09.009; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2004, PHILOS T R SOC B, V359, P367, DOI 10.1098/rstb.2003.1423; BARLOW J, 2008, PHILOS T ROYALTY SOC, V363, P1767; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Barlow Jos, 2009, P543, DOI 10.1007/978-3-540-77381-8_19; Barratt BIP, 2006, RANGELAND ECOL MANAG, V59, P383, DOI 10.2111/05-190R1.1; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Bignell D. E., 2000, ABOVE GROUND BIODIVE, P91; CAMARGO JLC, 1995, J TROP ECOL, V11, P205, DOI 10.1017/S026646740000866X; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; COCHRANE M, 2009, GLOBAL CHANGE BIOL; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Coleman TW, 2006, FOREST ECOL MANAG, V233, P52, DOI 10.1016/j.foreco.2006.06.001; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Collett N, 2003, FOREST ECOL MANAG, V182, P117, DOI 10.1016/S0378-1127(03)00009-4; Collett NG, 1998, FOREST ECOL MANAG, V107, P253, DOI 10.1016/S0378-1127(97)00332-0; Crawley M. J, 2002, STAT COMPUTING INTRO; Dawes-Gromadzki TZ, 2007, AUSTRAL ECOL, V32, P663, DOI 10.1111/j.1442-9993.2007.01752.x; DENSLOW JS, 1994, LA SELVA ECOLOGY NAT, P120; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fredericksen NJ, 2002, BIODIVERS CONSERV, V11, P27, DOI 10.1023/A:1014065510554; Hanula JL, 2003, FOREST ECOL MANAG, V175, P163, DOI 10.1016/S0378-1127(02)00130-5; Haugaasen T, 2003, ANIM CONSERV, V6, P299, DOI 10.1017/S1367943003003366; Hellmann JJ, 2003, ECOL ENTOMOL, V28, P74, DOI 10.1046/j.1365-2311.2003.00484.x; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Holldobler B., 1990, pi; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MAJER JD, 1984, PEDOBIOLOGIA, V26, P229; Malhi Y., 2009, P NATL ACAD SCI; Nadeau L, 2006, J KANSAS ENTOMOL SOC, V79, P2, DOI 10.2317/0406.02.1; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Orgeas J, 2001, J APPL ECOL, V38, P49, DOI 10.1046/j.1365-2664.2001.00575.x; R Core Team, 2022, R LANG ENV STAT COMP; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; SANTILLI M, 2005, TROPICAL DEFORESTATI, P47; Schlesinger WH., 1997, BIOGEOCHEMISTRY; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Silveira JM, 2009, J TROP ECOL, V25, P657, DOI 10.1017/S0266467409990150; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; VASCONCELOS HL, 2010, PLOSONE; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781	51	29	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12877	10.1371/journal.pone.0012877	http://dx.doi.org/10.1371/journal.pone.0012877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877720	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000282002900016
J	Glasser, J; Taneri, D; Feng, ZL; Chuang, JH; Tull, P; Thompson, W; McCauley, MM; Alexander, J				Glasser, John; Taneri, Denis; Feng, Zhilan; Chuang, Jen-Hsiang; Tull, Peet; Thompson, William; McCauley, Mary Mason; Alexander, James			Evaluation of Targeted Influenza Vaccination Strategies via Population Modeling	PLOS ONE			English	Article							PANDEMIC INFLUENZA; RATES; INTERVENTIONS; TRANSMISSION; MORTALITY; EVOLUTION; DISEASE; SPREAD	Background: Because they can generate comparable predictions, mathematical models are ideal tools for evaluating alternative drug or vaccine allocation strategies. To remain credible, however, results must be consistent. Authors of a recent assessment of possible influenza vaccination strategies conclude that older children, adolescents, and young adults are the optimal targets, no matter the objective, and argue for vaccinating them. Authors of two earlier studies concluded, respectively, that optimal targets depend on objectives and cautioned against changing policy. Which should we believe? Methods and Findings: In matrices whose elements are contacts between persons by age, the main diagonal always predominates, reflecting contacts between contemporaries. Indirect effects (e. g., impacts of vaccinating one group on morbidity or mortality in others) result from off-diagonal elements. Mixing matrices based on periods in proximity with others have greater sub-and super-diagonals, reflecting contacts between parents and children, and other off-diagonal elements (reflecting, e. g., age-independent contacts among co-workers), than those based on face-to-face conversations. To assess the impact of targeted vaccination, we used a time-usage study's mixing matrix and allowed vaccine efficacy to vary with age. And we derived mortality rates either by dividing observed deaths attributed to pneumonia and influenza by average annual cases from a demographically-realistic SEIRS model or by multiplying those rates by ratios of (versus adding to them differences between) pandemic and pre-pandemic mortalities. Conclusions: In our simulations, vaccinating older children, adolescents, and young adults averts the most cases, but vaccinating either younger children and older adults or young adults averts the most deaths, depending on the age distribution of mortality. These results are consistent with those of the earlier studies.	[Glasser, John; Taneri, Denis; Thompson, William; McCauley, Mary Mason; Alexander, James] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Feng, Zhilan] Purdue Univ, Dept Math, W Lafayette, IN 47907 USA; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Tull, Peet] European Ctr Dis Prevent & Control, Sci Advice Unit, Stockholm, Sweden	Centers for Disease Control & Prevention - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centers For Disease Control - Taiwan; European Centre for Disease Prevention & Control	Glasser, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	jglasser@cdc.gov	Chuang, Jen-Hsiang/G-4356-2010; Feng, Zhilan/L-4027-2018	Chuang, Jen-Hsiang/0000-0002-7114-3418; 				*ACIP, 2009, H1N1 VACC REC; ANDERSON R M, 1991; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Bailey NTJ, 1975, MATH THEORY INFECT D; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; CDC, 2005, NAT VIT STAT SYST; *CDC NAT CTR HLTH, 2008, NCHS HLTH E STAT VAC; *CDCP, 2010, SEAS INFL VACC SUPPL; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; *HHS, 2010, PAND INFL PLAN; Hurford A, 2010, J R SOC INTERFACE, V7, P561, DOI 10.1098/rsif.2009.0448; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; NOLD A, 1980, MATH BIOSCI, V124, P59; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Renshaw E., 1991, MODELING BIOL POPULA; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	46	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12777	10.1371/journal.pone.0012777	http://dx.doi.org/10.1371/journal.pone.0012777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862297	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800010
J	Renshaw, D; Montero-Melendez, T; Dalli, J; Kamal, A; Brancaleone, V; D'Acquisto, F; Cirino, G; Perretti, M				Renshaw, Derek; Montero-Melendez, Trinidad; Dalli, Jesmond; Kamal, Ahmad; Brancaleone, Vincenzo; D'Acquisto, Fulvio; Cirino, Giuseppe; Perretti, Mauro			Downstream Gene Activation of the Receptor ALX by the Agonist Annexin A1	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTOR; ADHESION MOLECULE-C; SPHINGOSINE 1-PHOSPHATE; SYNOVIAL INFLAMMATION; APOPTOTIC NEUTROPHILS; LEUKOCYTE ADHESION; CONNECTIVITY MAP; HDAC INHIBITOR; EXPRESSION; PHAGOCYTOSIS	Background: Our understanding of pro-resolution factors in determining the outcome of inflammation has recently gained ground, yet not many studies have investigated whether specific genes or patterns of genes, are modified by these mediators. Here, we have focussed on the glucocorticoid modulated pro-resolution factor annexin A1 (AnxA1), studying if its interaction with the ALX receptor would affect downstream genomic targets. Methodology/Principal Findings: Using microarray technology in ALX transfected HEK293 cells, we discovered an overlapping, yet distinct gene activation profile for AnxA1 compared to its N-terminal mimetic peptide Ac2-26, which may be suggestive of unique downstream inflammatory outcomes for each substance. When the up-regulated genes were explored, consistently induced was the sphingosine phosphate phosphatase-2 gene (SGPP2), involved in regulation of the sphingosine 1 phosphate chemotactic system. Up-regulation of this gene, as well as JAG1 (and down-regulation of JAM3), was confirmed using real time PCR both with transfected HEK293 cells and human peripheral blood leukocytes. Furthermore, lymph nodes taken from AnxA1(null) mice displayed lower SGPP2 gene activity. Finally, connectivity map analysis for AnxA1 and peptide Ac2-26 indicated striking similarities with known anti-inflammatory therapeutics, glucocorticoids and aspirin-like compounds, as well as with histone deacetylase inhibitors. Conclusion/Significance: We believe these new data raise the profile of AnxA1 from being solely a short-term antiinflammatory factor, to being a 'trigger' of the endogenous pro-resolution arsenal.	[Renshaw, Derek; Montero-Melendez, Trinidad; Dalli, Jesmond; Kamal, Ahmad; Brancaleone, Vincenzo; D'Acquisto, Fulvio; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Brancaleone, Vincenzo; Cirino, Giuseppe] Univ Naples Federico II, Sch Pharm, Dept Expt Pharmacol, Naples, Italy	University of London; Queen Mary University London; University of Naples Federico II	Renshaw, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.	m.perretti@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018; Montero-Melendez, Trinidad/AAF-6345-2020	D'Acquisto, Fulvio/0000-0002-4513-1608; brancaleone, vincenzo/0000-0002-0063-659X; Montero-Melendez, Trinidad/0000-0002-3563-376X; Dalli, Jesmond/0000-0001-6328-3640; Cirino, Giuseppe/0000-0003-3954-4083; Renshaw, Derek/0000-0002-2759-0229	William Harvey Research Foundation; Special Trustees of St Bartholomew's Hospital; Wellcome Trust [086867/Z/08, 069234/Z/02]; Arthritis Research Campaign UK [15755]; National Institute of Health Research	William Harvey Research Foundation; Special Trustees of St Bartholomew's Hospital; Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research Campaign UK(Versus Arthritis); National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by the William Harvey Research Foundation, the Special Trustees of St Bartholomew's Hospital, the Wellcome Trust (086867/Z/08 and 069234/Z/02) and the Arthritis Research Campaign UK (grant 15755). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Charnley M, 2008, PEPTIDES, V29, P1004, DOI 10.1016/j.peptides.2008.02.004; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; DACQUISTO F, 2009, CURR OPIN PHARM; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Elyaman W, 2007, J IMMUNOL, V179, P5990, DOI 10.4049/jimmunol.179.9.5990; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Palmer G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2223; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; PERRETTI M, 1993, J IMMUNOL, V151, P4306; Perretti M, 1997, TRENDS PHARMACOL SCI, V18, P418; Perretti M, 2004, BIOCHEM SOC T, V32, P507, DOI 10.1042/BST0320507; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petrella A, 2008, EUR J CANCER, V44, P740, DOI 10.1016/j.ejca.2008.01.023; Rabquer BJ, 2008, ARTHRITIS RHEUM, V58, P3020, DOI 10.1002/art.23867; Rempe S., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P232, DOI 10.2174/187153007782794344; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Tabe Y, 2007, CELL DEATH DIFFER, V14, P1443, DOI 10.1038/sj.cdd.4402139; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Yang YH, 1999, ARTHRITIS RHEUM, V42, P1538, DOI 10.1002/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12771	10.1371/journal.pone.0012771	http://dx.doi.org/10.1371/journal.pone.0012771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862244	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800009
J	Bartlett, JD; Dobeck, JM; Tye, CE; Perez-Moreno, M; Stokes, N; Reynolds, AB; Fuchs, E; Skobe, Z				Bartlett, John D.; Dobeck, Justine M.; Tye, Coralee E.; Perez-Moreno, Mirna; Stokes, Nicole; Reynolds, Albert B.; Fuchs, Elaine; Skobe, Ziedonis			Targeted p120-Catenin Ablation Disrupts Dental Enamel Development	PLOS ONE			English	Article							RAT INCISOR AMELOGENESIS; RHO-FAMILY GTPASES; E-CADHERIN; P120 CATENIN; SECRETORY AMELOBLASTS; TOOTH DEVELOPMENT; TRANSCRIPTION FACTOR; ACTIN CYTOSKELETON; P-CADHERIN; EXPRESSION	Dental enamel development occurs in stages. The ameloblast cell layer is adjacent to, and is responsible for, enamel formation. When rodent pre-ameloblasts become tall columnar secretory-stage ameloblasts, they secrete enamel matrix proteins, and the ameloblasts start moving in rows that slide by one another. This movement is necessary to form the characteristic decussating enamel prism pattern. Thus, a dynamic system of intercellular interactions is required for proper enamel development. Cadherins are components of the adherens junction (AJ), and they span the cell membrane to mediate attachment to adjacent cells. p120 stabilizes cadherins by preventing their internalization and degradation. So, we asked if p120-mediated cadherin stability is important for dental enamel formation. Targeted p120 ablation in the mouse enamel organ had a striking effect. Secretory stage ameloblasts detached from surrounding tissues, lost polarity, flattened, and ameloblast E-and N-cadherin expression became undetectable by immunostaining. The enamel itself was poorly mineralized and appeared to be composed of a thin layer of merged spheres that abraded from the tooth. Significantly, p120 mosaic mouse teeth were capable of forming normal enamel demonstrating that the enamel defects were not a secondary effect of p120 ablation. Surprisingly, blood-filled sinusoids developed in random locations around the developing teeth. This has not been observed in other p120-ablated tissues and may be due to altered p120-mediated cell signaling. These data reveal a critical role for p120 in tooth and dental enamel development and are consistent with p120 directing the attachment and detachment of the secretory stage ameloblasts as they move in rows.	[Bartlett, John D.; Dobeck, Justine M.; Tye, Coralee E.; Skobe, Ziedonis] Forsyth Inst, Dept Cytokine Biol, Boston, MA USA; [Bartlett, John D.; Tye, Coralee E.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Perez-Moreno, Mirna] Ctr Nacl Invest Oncol, Madrid, Spain; [Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Reynolds, Albert B.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Howard Hughes Medical Institute; Rockefeller University; Vanderbilt University	Bartlett, JD (corresponding author), Forsyth Inst, Dept Cytokine Biol, Boston, MA USA.	jbartlett@forsyth.org	Fuchs, Elaine/G-1565-2016; Perez-Moreno, Mirna/I-3687-2015; Bartlett, John/L-9832-2017	Perez-Moreno, Mirna/0000-0002-0170-6406; Tye, Coralee/0000-0002-3349-1833; Bartlett, John/0000-0003-2052-6299	National Institutes of Health (NIH) [AR27833, R01CA55724]; Forsyth Institute; NATIONAL CANCER INSTITUTE [R01CA055724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forsyth Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants AR27833 (E.F.) and R01CA55724 (A.B.R.) and by the Forsyth Institute (www.forsyth.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Fausser JL, 1998, DIFFERENTIATION, V63, P1, DOI 10.1046/j.1432-0436.1998.6310001.x; Ferber A, 2002, EXP CELL RES, V274, P35, DOI 10.1006/excr.2001.5436; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heymann R, 2002, AM J PATHOL, V160, P2123, DOI 10.1016/S0002-9440(10)61161-3; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ito Y, 2001, DEV BIOL, V236, P181, DOI 10.1006/dbio.2001.0332; KALLENBA.E, 1970, J ULTRA MOL STRUCT R, V30, P38, DOI 10.1016/S0022-5320(70)90063-8; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; LEBLOND CP, 1979, J DENT RES, V58, P950, DOI 10.1177/00220345790580024901; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; NISHIKAWA S, 1990, CELL STRUCT FUNCT, V15, P245, DOI 10.1247/csf.15.245; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Obara N, 1998, ANAT EMBRYOL, V197, P469, DOI 10.1007/s004290050157; PALACIOS J, 1995, INT J DEV BIOL, V39, P663; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perez-Moreno M, 2008, P NATL ACAD SCI USA, V105, P15399, DOI 10.1073/pnas.0807301105; REITH EJ, 1973, ARCH ORAL BIOL, V18, P445, DOI 10.1016/0003-9969(73)90170-2; RISNES S, 1979, ARCH ORAL BIOL, V24, P299, DOI 10.1016/0003-9969(79)90092-X; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Sorkin BC, 2000, J HISTOCHEM CYTOCHEM, V48, P397, DOI 10.1177/002215540004800309; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Terling C, 1998, EUR J ORAL SCI, V106, P137, DOI 10.1111/j.1600-0722.1998.tb02166.x; Thesleff I, 1995, CONNECT TISSUE RES, V32, P9, DOI 10.3109/03008209509013700; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	44	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12703	10.1371/journal.pone.0012703	http://dx.doi.org/10.1371/journal.pone.0012703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862276	gold, Green Published, Green Submitted			2022-12-25	WOS:000281864100005
J	Jamali, S; Salzmann, A; Perroud, N; Ponsole-Lenfant, M; Cillario, J; Roll, P; Roeckel-Trevisiol, N; Crespel, A; Balzar, J; Schlachter, K; Gruber-Sedlmayr, U; Pataraia, E; Baumgartner, C; Zimprich, A; Zimprich, F; Malafosse, A; Szepetowski, P				Jamali, Sarah; Salzmann, Annick; Perroud, Nader; Ponsole-Lenfant, Magali; Cillario, Jennifer; Roll, Patrice; Roeckel-Trevisiol, Nathalie; Crespel, Ariel; Balzar, Jorg; Schlachter, Kurt; Gruber-Sedlmayr, Ursula; Pataraia, Ekaterina; Baumgartner, Christoph; Zimprich, Alexander; Zimprich, Fritz; Malafosse, Alain; Szepetowski, Pierre			Functional Variant in Complement C3 Gene Promoter and Genetic Susceptibility to Temporal Lobe Epilepsy and Febrile Seizures	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IDENTIFIES VARIANTS; HUMAN C3-GENE; TRANSCRIPTION; ACTIVATION; EXPRESSION; SEQUENCES; CORTEX; NEURODEGENERATION	Background: Human mesial temporal lobe epilepsies (MTLE) represent the most frequent form of partial epilepsies and are frequently preceded by febrile seizures (FS) in infancy and early childhood. Genetic associations of several complement genes including its central component C3 with disorders of the central nervous system, and the existence of C3 dysregulation in the epilepsies and in the MTLE particularly, make it the C3 gene a good candidate for human MTLE. Methodology/Principal Findings: A case-control association study of the C3 gene was performed in a first series of 122 patients with MTLE and 196 controls. Four haplotypes (HAP1 to 4) comprising GF100472, a newly discovered dinucleotide repeat polymorphism [(CA) 8 to (CA) 15] in the C3 promoter region showed significant association after Bonferroni correction, in the subgroup of MTLE patients having a personal history of FS (MTLE-FS+). Replication analysis in independent patients and controls confirmed that the rare HAP4 haplotype comprising the minimal length allele of GF100472 [(CA) 8], protected against MTLE-FS+. A fifth haplotype (HAP5) with medium-size (CA) 11 allele of GF100472 displayed four times higher frequency in controls than in the first cohort of MTLE-FS+ and showed a protective effect against FS through a high statistical significance in an independent population of 97 pure FS. Consistently, (CA) 11 allele by its own protected against pure FS in a second group of 148 FS patients. Reporter gene assays showed that GF100472 significantly influenced C3 promoter activity (the higher the number of repeats, the lower the transcriptional activity). Taken together, the consistent genetic data and the functional analysis presented here indicate that a newly-identified and functional polymorphism in the promoter of the complement C3 gene might participate in the genetic susceptibility to human MTLE with a history of FS, and to pure FS. Conclusions/Significance: The present study provides important data suggesting for the first time the involvement of the complement system in the genetic susceptibility to epileptic seizures and to epilepsy.	[Salzmann, Annick; Malafosse, Alain] Univ Hosp Geneva, Dept Med Genet & Dev, Geneva, Switzerland; [Perroud, Nader; Malafosse, Alain] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Ponsole-Lenfant, Magali; Cillario, Jennifer; Szepetowski, Pierre] Univ Aix Marseille 2, INSERM, Mediterranean Inst Neurobiol INMED, UMR901, Marseille, France; [Crespel, Ariel] Univ Hosp Montpellier, Epilepsy Unit, Montpellier, France; [Balzar, Jorg; Pataraia, Ekaterina; Zimprich, Alexander; Zimprich, Fritz] Med Univ Vienna, Dept Clin Neurol, Vienna, Austria; [Schlachter, Kurt] LKH Bregenz, Dept Pediat, Bregenz, Austria; [Gruber-Sedlmayr, Ursula] Med Univ Graz, Dept Pediat, Graz, Austria; [Baumgartner, Christoph] Gen Hosp Hietzing, Neurol Ctr Rosenhuegel, Dept Neurol 2, Vienna, Austria; [Jamali, Sarah; Roll, Patrice; Roeckel-Trevisiol, Nathalie; Szepetowski, Pierre] Univ Aix Marseille 2, INSERM, UMR 910, Marseille, France	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU de Montpellier; Medical University of Vienna; Medical University of Graz; Hietzing Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Jamali, S (corresponding author), CINaM CNRS, Campus Luminy, Marseille, France.	alain.malafosse@hcuge.ch; szepetowski@inmed.univ-mrs.fr	Zimprich, Alexander/A-5232-2017; ROLL, Patrice/GLS-4467-2022; Zimprich, Fritz/W-1738-2017; ROLL, Patrice/I-4355-2016; Zimprich, Fritz/O-1406-2019	Zimprich, Alexander/0000-0002-1668-5177; ROLL, Patrice/0000-0002-0045-5641; Zimprich, Fritz/0000-0002-6998-5480; ROLL, Patrice/0000-0002-0045-5641; Zimprich, Fritz/0000-0002-6998-5480; Pataraia, Ekaterina/0000-0002-1454-7600; Salzmann, Annick/0000-0003-0571-251X	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur la Genetique des Epilepsies (ARGE); Agence Nationale de la Recherche (ANR MRAR/EPICOGN); Ligue Francaise contre l'Epilepsie (LFCE); French Ministere de la Recherche et de la Technologie (MRT); Swiss National; Geneva Neurocenter	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur la Genetique des Epilepsies (ARGE); Agence Nationale de la Recherche (ANR MRAR/EPICOGN)(French National Research Agency (ANR)); Ligue Francaise contre l'Epilepsie (LFCE); French Ministere de la Recherche et de la Technologie (MRT); Swiss National; Geneva Neurocenter	This study was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), by the Association pour la Recherche sur la Genetique des Epilepsies (ARGE) and by the Agence Nationale de la Recherche (ANR MRAR/EPICOGN). SJ has been a recipient of a Ligue Francaise contre l'Epilepsie (LFCE) PhD fellowship, JC is a recipient of a French Ministere de la Recherche et de la Technologie (MRT) PhD fellowship and AS has been a recipient of the Swiss National Fund PhD fellowship and is a recipient of the Geneva Neurocenter Post-Doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Baulac S, 2001, ANN NEUROL, V49, P786, DOI 10.1002/ana.1014; Berkovic SF, 1996, ANN NEUROL, V40, P227, DOI 10.1002/ana.410400214; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cendes F, 1998, NEUROLOGY, V50, P554, DOI 10.1212/WNL.50.2.554; Claes L, 2004, J MED GENET, V41, P710, DOI 10.1136/jmg.2004.019257; DELIC J, 1991, BIOCHEM BIOPH RES CO, V181, P818, DOI 10.1016/0006-291X(91)91263-C; Depondt C, 2002, NEUROLOGY, V58, P1429, DOI 10.1212/WNL.58.9.1429; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gambardella A, 2009, EPILEPSIA, V50, P55, DOI 10.1111/j.1528-1167.2009.02123.x; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hedera P, 2007, NEUROLOGY, V68, P2107, DOI 10.1212/01.wnl.0000261246.75977.89; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Kauffman MA, 2008, GENET MED, V10, P83, DOI 10.1097/GIM.0b013e318161317c; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Loscher W, 2002, TRENDS PHARMACOL SCI, V23, P113, DOI 10.1016/S0165-6147(00)01974-X; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; VIK DP, 1991, BIOCHEMISTRY-US, V30, P1080, DOI 10.1021/bi00218a029; WALLACE SJ, 2004, EPILEPSY CHILDREN, P122; Whitney KD, 2000, J NEUROSCI, V20, P7307; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	46	24	24	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12740	10.1371/journal.pone.0012740	http://dx.doi.org/10.1371/journal.pone.0012740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862287	gold, Green Published, Green Submitted			2022-12-25	WOS:000281864100008
J	Hosseini, P; Sokolow, SH; Vandegrift, KJ; Kilpatrick, AM; Daszak, P				Hosseini, Parviez; Sokolow, Susanne H.; Vandegrift, Kurt J.; Kilpatrick, A. Marm; Daszak, Peter			Predictive Power of Air Travel and Socio-Economic Data for Early Pandemic Spread	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; INFLUENZA; DETERMINANTS; GENOMICS; VIRUS	Background: Controlling the pandemic spread of newly emerging diseases requires rapid, targeted allocation of limited resources among nations. Critical, early control steps would be greatly enhanced if the key risk factors can be identified that accurately predict early disease spread immediately after emergence. Methodology/Principal Findings: Here, we examine the role of travel, trade, and national healthcare resources in predicting the emergence and initial spread of 2009 A/H1N1 influenza. We find that incorporating national healthcare resource data into our analyses allowed a much greater capacity to predict the international spread of this virus. In countries with lower healthcare resources, the reporting of 2009 A/H1N1 cases was significantly delayed, likely reflecting a lower capacity for testing and reporting, as well as other socio-political issues. We also report substantial international trade in live swine and poultry in the decade preceding the pandemic which may have contributed to the emergence and mixed genotype of this pandemic strain. However, the lack of knowledge of recent evolution of each H1N1 viral gene segment precludes the use of this approach to determine viral origins. Conclusions/Significance: We conclude that strategies to prevent pandemic influenza virus emergence and spread in the future should include: 1) enhanced surveillance for strains resulting from reassortment in traded livestock; 2) rapid deployment of control measures in the initial spreading phase to countries where travel data predict the pathogen will reach and to countries where lower healthcare resources will likely cause delays in reporting. Our results highlight the benefits, for all parties, when higher income countries provide additional healthcare resources for lower income countries, particularly those that have high air traffic volumes. In particular, international authorities should prioritize aid to those poorest countries where both the risk of emerging infectious diseases and air traffic volume is highest. This strategy will result in earlier detection of pathogens and a reduction in the impact of future pandemics.	[Hosseini, Parviez; Vandegrift, Kurt J.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Sokolow, Susanne H.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	EcoHealth Alliance; University of California System; University of California Santa Cruz	Hosseini, P (corresponding author), EcoHlth Alliance, New York, NY USA.	hosseini@ecohealthalliance.org; daszak@ecohealthalliance.org	daszak, peter/U-4588-2017; Hosseini, Parviez/F-8439-2010	daszak, peter/0000-0002-2046-5695; Sokolow, Susanne/0000-0002-5111-9322	John E. Fogarty International Center [3R01-TW005869-05S1]; NSF [EF-0622391/EF-0914866, HSD-0525216]; National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH) [NO1-AI-25490, BCS-0826779]; Eppley Foundation; New York Community Trust; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025490] Funding Source: NIH RePORTER	John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NSF(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eppley Foundation; New York Community Trust; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the following: National Institutes of Health/National Science Foundation (NIH/NSF) "Ecology of Infectious Diseases'' award from the John E. Fogarty International Center (3R01-TW005869-05S1); NSF "Predicting Spatial Variation in West Nile Virus Transmission'' (EF-0622391/EF-0914866); NSF "Socio-economic and environmental drivers of emerging infectious diseases'' (HSD-0525216); National Institute of Allergy and Infectious Diseases-National Institutes of Health (NIAID-NIH) contract # NO1-AI-25490; NSF "Human and Social Dynamics: Collaborative Research: Human-Related Factors Affecting Emerging Infectious Diseases'' (BCS-0826779); the Eppley Foundation; and the New York Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; DIIO LLC, 2009, APGDAT DIIO; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerrits RJ, 2005, THERIOGENOLOGY, V63, P283, DOI 10.1016/j.theriogenology.2004.09.013; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Huang YX, 2005, ACTA TROP, V96, P223, DOI 10.1016/j.actatropica.2005.07.015; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; R Development Core Team, 2009, R FDN STAT COMP; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; RODGERS GB, 1979, POP STUD-J DEMOG, V33, P343, DOI 10.2307/2173539; SABIROVIV M, 2009, H1N1 INFLUENZA PRELI; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; *UN STAT DIV, 2009, UN COMM TRAD STAT DA; VANDEGRIFT KJ, 2010, SCIENCES, V1195, P113; World Bank, 2009, WORLD DEV IND ONL; World Health Organization, 2009, GLOB AL RESP	31	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12763	10.1371/journal.pone.0012763	http://dx.doi.org/10.1371/journal.pone.0012763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856678	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800025
J	Wodarczyk, C; Distefano, G; Rowe, I; Gaetani, M; Bricoli, B; Muorah, M; Spitaleri, A; Mannella, V; Ricchiuto, P; Pema, M; Castelli, M; Casanova, AE; Mollica, L; Banzi, M; Boca, M; Antignac, C; Saunier, S; Musco, G; Boletta, A				Wodarczyk, Claas; Distefano, Gianfranco; Rowe, Isaline; Gaetani, Massimiliano; Bricoli, Barbara; Muorah, Mordi; Spitaleri, Andrea; Mannella, Valeria; Ricchiuto, Piero; Pema, Monika; Castelli, Maddalena; Casanova, Ariel E.; Mollica, Luca; Banzi, Manuela; Boca, Manila; Antignac, Corinne; Saunier, Sophie; Musco, Giovanna; Boletta, Alessandra			Nephrocystin-1 Forms a Complex with Polycystin-1 via a Polyproline Motif/SH3 Domain Interaction and Regulates the Apoptotic Response in Mammals	PLOS ONE			English	Article							KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; NEPHRONOPHTHISIS; PROTEINS; CILIA; GENE; ENCODES; PKD1	Mutations in PKD1, the gene encoding for the receptor Polycystin-1 (PC-1), cause autosomal dominant polycystic kidney disease (ADPKD). The cytoplasmic C-terminus of PC-1 contains a coiled-coil domain that mediates an interaction with the PKD2 gene product, Polycystin-2 (PC-2). Here we identify a novel domain in the PC-1 C-terminal tail, a polyproline motif mediating an interaction with Src homology domain 3 (SH3). A screen for interactions using the PC-1 C-terminal tail identified the SH3 domain of nephrocystin-1 (NPHP1) as a potential binding partner of PC-1. NPHP1 is the product of a gene that is mutated in a different form of renal cystic disease, nephronophthisis (NPHP). We show that in vitro pull-down assays and NMR structural studies confirmed the interaction between the PC-1 polyproline motif and the NPHP1 SH3 domain. Furthermore, the two full-length proteins interact through these domains; using a recently generated model system allowing us to track endogenous PC-1, we confirm the interaction between the endogenous proteins. Finally, we show that NPHP1 trafficking to cilia does not require PC-1 and that PC-1 may require NPHP1 to regulate resistance to apoptosis, but not to regulate cell cycle progression. In line with this, we find high levels of apoptosis in renal specimens of NPHP patients. Our data uncover a link between two different ciliopathies, ADPKD and NPHP, supporting the notion that common pathogenetic defects, possibly involving de-regulated apoptosis, underlie renal cyst formation.	[Wodarczyk, Claas; Distefano, Gianfranco; Rowe, Isaline; Pema, Monika; Castelli, Maddalena; Casanova, Ariel E.; Banzi, Manuela; Boca, Manila; Boletta, Alessandra] Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Div Genet & Cell Biol, I-20132 Milan, Italy; [Gaetani, Massimiliano; Bricoli, Barbara; Spitaleri, Andrea; Mannella, Valeria; Ricchiuto, Piero; Mollica, Luca; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Biomol NMR Lab, I-20132 Milan, Italy; [Muorah, Mordi; Antignac, Corinne; Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U574, Paris, France; [Muorah, Mordi; Antignac, Corinne; Saunier, Sophie] Univ Paris 05, Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Wodarczyk, C (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Div Genet & Cell Biol, I-20132 Milan, Italy.	musco.giovanna@hsr.it; boletta.alessandra@hsr.it	Mannella, Valeria/AAN-1946-2020; Gaetani, Massimiliano/Z-1252-2019; Spitaleri, Andrea/S-9368-2019; Saunier, Sophie/G-6044-2015; Musco, Giovanna/Q-2756-2019; Ricchiuto, Piero/G-1820-2011; distefano, gianfranco/AAN-7169-2020; musco, giovanna/I-7122-2012; rowe, isaline/AAN-1985-2020; ANTIGNAC, Corinne/H-8945-2017	Gaetani, Massimiliano/0000-0001-5610-0797; Spitaleri, Andrea/0000-0003-3012-3557; Saunier, Sophie/0000-0002-1069-0047; distefano, gianfranco/0000-0002-4956-0629; musco, giovanna/0000-0002-0469-2994; rowe, isaline/0000-0002-5398-1776; MOLLICA, LUCA/0000-0001-8164-7663; ANTIGNAC, Corinne/0000-0002-9934-4940	Italian Telethon Foundation [TCR 07005, S99035]; Cariplo Foundation; Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base [RBIP06FYF7]; European Community [MC-EXT002785]	Italian Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base; European Community(European Commission)	This work was supported by the Italian Telethon Foundation to AB (TCR 07005) and to GM (S99035); by the Cariplo Foundation to AB and GM (2004/2005), by the Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base (FIRB, N. RBIP06FYF7 to GM) and by the European Community 6th Framework Programme (MC-EXT002785 to AB). Both AB and GM are Associate Telethon Scientists. SS is laureat of the Equipe FRM (grant # DEQ20071210558), and the Agence National de la Recherche (ANR) grant # R07089KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; DE VRIES SJ, 2007, PROTEINS, V69, P726; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; LE MAIRE A, 2005, PROTEINS, V59, P347; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215	33	20	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12719	10.1371/journal.pone.0012719	http://dx.doi.org/10.1371/journal.pone.0012719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856870	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815700009
J	Wu, YG; Zhou, P; Lan, GC; Gao, D; Li, Q; Wei, DL; Wang, HL; Tan, JH				Wu, Yan-Guang; Zhou, Ping; Lan, Guo-Cheng; Gao, Da; Li, Qing; Wei, De-Li; Wang, Hui-Li; Tan, Jing-He			MPF Governs the Assembly and Contraction of Actomyosin Rings by Activating RhoA and MAPK during Chemical-Induced Cytokinesis of Goat Oocytes	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; DEMECOLCINE-ASSISTED ENUCLEATION; POLAR BODY EXTRUSION; PROTEIN-KINASE; MOUSE OOCYTES; XENOPUS-OOCYTE; SMOOTH-MUSCLE; RAT OOCYTES; SIGNALING PATHWAYS; CORTICAL GRANULES	The interplay between maturation-promoting factor (MPF), mitogen-activated protein kinase (MAPK) and Rho GTPase during actin-myosin interactions has yet to be determined. The mechanism by which microtubule disrupters induce the formation of ooplasmic protrusion during chemical-assisted enucleation of mammalian oocytes is unknown. Moreover, a suitable model is urgently needed for the study of cytokinesis. We have established a model of chemical-induced cytokinesis and have studied the signaling events leading to cytokinesis using this model. The results suggested that microtubule inhibitors activated MPF, which induced actomyosin assembly (formation of ooplasmic protrusion) by activating RhoA and thus MAPK. While MAPK controlled actin recruitment on its own, MPF promoted myosin enrichment by activating RhoA and MAPK. A further chemical treatment of oocytes with protrusions induced constriction of the actomyosin ring by inactivating MPF while activating RhoA. In conclusion, the present data suggested that the assembly and contraction of the actomyosin ring were two separable steps: while an increase in MPF activity promoted the assembly through RhoA-mediated activation of MAPK, a decrease in MPF activity triggered contraction of the ring by activating RhoA.	[Wu, Yan-Guang; Zhou, Ping; Lan, Guo-Cheng; Gao, Da; Li, Qing; Wei, De-Li; Wang, Hui-Li; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wu, YG (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	yu, qing/HGC-4611-2022; wang, hui/GRS-4730-2022		China Ministry of Science and Technology [2006CB944003, 2007CB947403, 2008AA10Z160, 2008AA101003]; China National Natural Science Foundation [30771556, 30972096]	China Ministry of Science and Technology(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Project of the China Ministry of Science and Technology (Nos. 2006CB944003 and 2007CB947403), the China National Natural Science Foundation (Nos. 30771556 and 30972096) and the National "863" Project of the China Ministry of Science and Technology (Nos. 2008AA10Z160 and 2008AA101003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bielak-Zmijewska A, 2008, DEV BIOL, V322, P21, DOI 10.1016/j.ydbio.2008.06.039; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chu CL, 2000, INVEST OPHTH VIS SCI, V41, P3374; Connors SA, 1998, DEV BIOL, V200, P103, DOI 10.1006/dbio.1998.8945; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dedieu T, 1996, MOL REPROD DEV, V45, P351; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007171; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Elbaz J., 2009, BIOL REPROD, V81; Ge L, 2008, FERTIL STERIL, V90, P2376, DOI 10.1016/j.fertnstert.2007.10.054; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; HACCARD O, 1993, MOL REPROD DEV, V36, P96, DOI 10.1002/mrd.1080360114; Hai CM, 2006, EUR J CELL BIOL, V85, P305, DOI 10.1016/j.ejcb.2005.08.008; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khurana A, 2003, DIFFERENTIATION, V71, P42, DOI 10.1046/j.1432-0436.2003.700604.x; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lan GC, 2008, CLONING STEM CELLS, V10, P189, DOI 10.1089/clo.2007.0088; Lazar S, 2004, J MOL ENDOCRINOL, V33, P73, DOI 10.1677/jme.0.0330073; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Lim GE, 2009, ENDOCRINOLOGY, V150, P5249, DOI 10.1210/en.2009-0508; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Liu D, 2000, DEV BIOL, V224, P388, DOI 10.1006/dbio.2000.9776; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; Mishima M, 1996, J BIOCHEM-TOKYO, V119, P906; Mishima M, 2004, ENCY BIOL CHEM, V1, P556; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Ohan N, 1999, J CELL SCI, V112, P2177; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Peter M, 2002, DEVELOPMENT, V129, P2129; RIME H, 1990, CELL DIFFER DEV, V29, P47, DOI 10.1016/0922-3371(90)90023-P; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; Samaj J, 2004, J EXP BOT, V55, P189, DOI 10.1093/jxb/erh012; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shulman JM, 1999, TRENDS BIOCHEM SCI, V24, pM60, DOI 10.1016/S0968-0004(99)01490-5; SMYTHE C, 1992, CELL, V68, P787, DOI 10.1016/0092-8674(92)90153-4; SOEWARTO D, 1995, HUM REPROD, V10, P2350; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61; Tani T, 2007, FRONT BIOSCI, V12, P2693, DOI 10.2741/2265; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Wang Y, 2009, CURR OPIN MICROBIOL, V12, P644, DOI 10.1016/j.mib.2009.09.002; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; YAMASHIRO S, 1991, BIOESSAYS, V13, P563, DOI 10.1002/bies.950131103; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; ZernickaGoetz M, 1997, EUR J CELL BIOL, V72, P30; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	85	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12706	10.1371/journal.pone.0012706	http://dx.doi.org/10.1371/journal.pone.0012706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856880	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700021
J	Pershing, AJ; Christensen, LB; Record, NR; Sherwood, GD; Stetson, PB				Pershing, Andrew J.; Christensen, Line B.; Record, Nicholas R.; Sherwood, Graham D.; Stetson, Peter B.			The Impact of Whaling on the Ocean Carbon Cycle: Why Bigger Was Better	PLOS ONE			English	Article							IRON FERTILIZATION; HUMPBACK WHALES; KILLER WHALES; NORTH; GROWTH; FISH; AGE; DEPLETION; COLLAPSE; ATLANTIC	Background: Humans have reduced the abundance of many large marine vertebrates, including whales, large fish, and sharks, to only a small percentage of their pre-exploitation levels. Industrial fishing and whaling also tended to preferentially harvest the largest species and largest individuals within a population. We consider the consequences of removing these animals on the ocean's ability to store carbon. Methodology/Principal Findings: Because body size is critical to our arguments, our analysis focuses on populations of baleen whales. Using reconstructions of pre-whaling and modern abundances, we consider the impact of whaling on the amount of carbon stored in living whales and on the amount of carbon exported to the deep sea by sinking whale carcasses. Populations of large baleen whales now store 9.1 x 10(6) tons less carbon than before whaling. Some of the lost storage has been offset by increases in smaller competitors; however, due to the relative metabolic efficiency of larger organisms, a shift toward smaller animals could decrease the total community biomass by 30% or more. Because of their large size and few predators, whales and other large marine vertebrates can efficiently export carbon from the surface waters to the deep sea. We estimate that rebuilding whale populations would remove 1.6 x 10(5) tons of carbon each year through sinking whale carcasses. Conclusions/Significance: Even though fish and whales are only a small portion of the ocean's overall biomass, fishing and whaling have altered the ocean's ability to store and sequester carbon. Although these changes are small relative to the total ocean carbon sink, rebuilding populations of fish and whales would be comparable to other carbon management schemes, including ocean iron fertilization.	[Pershing, Andrew J.; Record, Nicholas R.; Stetson, Peter B.] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Pershing, Andrew J.; Record, Nicholas R.; Sherwood, Graham D.; Stetson, Peter B.] Gulf Maine Res Inst, Portland, ME USA; [Christensen, Line B.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; University of British Columbia	Pershing, AJ (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	andrew.pershing@maine.edu			NASA [NNA07CN69A]; NSF [OCE0709518]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	This work was supported by NASA's Applied Sciences Program (NNA07CN69A) and NSF's Coupled Natural and Human Systems Program (OCE0709518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Barlow J, 1997, ECOLOGY, V78, P535; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; BUTMAN CA, 1995, CONSERV BIOL, V9, P462, DOI 10.1046/j.1523-1739.1995.9020462.x; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Christensen LB, 2006, MARINE MAMMAL POPULA; Doney Scott C., 2001, Oceanography, V14, P93; Ducklow Hugh W., 2001, Oceanography, V14, P50; Essington TE, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P38; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gabriele CM, 2007, MAR MAMMAL SCI, V23, P226, DOI 10.1111/j.1748-7692.2006.00100.x; Gabriele CM, 2001, CAN J ZOOL, V79, P589, DOI 10.1139/cjz-79-4-589; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Greene C. H., 2003, OCEANOGRAPHY, V16, P98, DOI DOI 10.5670/OCEANOG.2003.16; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Hofmann E, 2008, OCEANOGRAPHY, V21, P86, DOI 10.5670/oceanog.2008.70; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; IPCC, 2007, CLIM CHANG 2007 PHYS; *IWC, 2001, RIGHT WHAL WORLD STA, P1; Jelmert A, 1996, CONSERV BIOL, V10, P653, DOI 10.1046/j.1523-1739.1996.10020653.x; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Kerr S. R., 2001, COM ECO SYS; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P231; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; LAMBERTSEN RH, 1992, INT OFFICE EPIZOOTIC, V11, P1131; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Mazzochi Maria Grazia, 2009, GLOBEC International Newsletter, V15, P3; Mizroch SA, 2004, J MAMMAL, V85, P963, DOI 10.1644/BOS-123; Mizroch SA, 2006, MAR ECOL PROG SER, V310, P235, DOI 10.3354/meps310235; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nicol S, 2008, MAR FRESHWATER RES, V59, P361, DOI 10.1071/MF07161; Nicol S, 2007, ANTARCT SCI, V19, P291, DOI 10.1017/S0954102007000491; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Reeves R. R., 2002, NATL AUDUBON SOC GUI; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Sherwood GD, 2007, DEEP-SEA RES PT II, V54, P2794, DOI 10.1016/j.dsr2.2007.08.007; Smetacek V, 2008, PHILOS T R SOC A, V366, P3947, DOI 10.1098/rsta.2008.0144; SMITH CR, 2003, OCEANOGRAPHY MARINE, V311, P354; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stevick PT, 1999, MAR MAMMAL SCI, V15, P725, DOI 10.1111/j.1748-7692.1999.tb00839.x; Trick CG, 2010, P NATL ACAD SCI USA, V107, P5887, DOI 10.1073/pnas.0910579107; TYNAN CT, 2004, MARINE ECOLOGY PROGR, V300, P272; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Whitehead H, 2005, BIOL LETTERS, V1, P415, DOI 10.1098/rsbl.2005.0348; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972	55	81	84	10	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12444	10.1371/journal.pone.0012444	http://dx.doi.org/10.1371/journal.pone.0012444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865156	gold, Green Published			2022-12-25	WOS:000281292100032
J	Kanzaki, S; Yamaguchi, A; Yamaguchi, K; Kojima, Y; Suzuki, K; Koumitsu, N; Nagashima, Y; Nagahama, K; Ehara, M; Hirayasu, Y; Ryo, A; Aoki, I; Yamanaka, S				Kanzaki, Seiichi; Yamaguchi, Akira; Yamaguchi, Kayoko; Kojima, Yoshitsugu; Suzuki, Kyoko; Koumitsu, Noriko; Nagashima, Yoji; Nagahama, Kiyotaka; Ehara, Michiko; Hirayasu, Yoshio; Ryo, Akihide; Aoki, Ichiro; Yamanaka, Shoji			Thymic Alterations in GM2 Gangliosidoses Model Mice	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA; MURINE LYMPHOCYTE SUBPOPULATIONS; HUMAN TAY-SACHS; MOUSE MODELS; NALP3 INFLAMMASOME; SANDHOFF-DISEASE; T-CELLS; ACTIVATION; EXPRESSION	Background: Sandhoff disease is a lysosomal storage disorder characterized by the absence of beta-hexosaminidase and storage of GM2 ganglioside and related glycolipids. We have previously found that the progressive neurologic disease induced in Hexb(-/-) mice, an animal model for Sandhoff disease, is associated with the production of pathogenic anti-glycolipid autoantibodies. Methodology/Principal Findings: In our current study, we report on the alterations in the thymus during the development of mild to severe progressive neurologic disease. The thymus from Hexb(-/-) mice of greater than 15 weeks of age showed a marked decrease in the percentage of immature CD4(+)/CD8(+) T cells and a significantly increased number of CD4(+)/CD8(-) T cells. During involution, the levels of both apoptotic thymic cells and IgG deposits to T cells were found to have increased, whilst swollen macrophages were prominently observed, particularly in the cortex. We employed cDNA microarray analysis to monitor gene expression during the involution process and found that genes associated with the immune responses were upregulated, particularly those expressed in macrophages. CXCL13 was one of these upregulated genes and is expressed specifically in the thymus. B1 cells were also found to have increased in the thy mus. It is significant that these alterations in the thymus were reduced in FcR gamma additionally disrupted Hexb(-/-) mice. Conclusions/Significance: These results suggest that the FcR gamma chain may render the usually poorly immunogenic thymus into an organ prone to autoimmune responses, including the chemotaxis of B1 cells toward CXCL13.	[Kanzaki, Seiichi; Yamaguchi, Akira; Yamaguchi, Kayoko; Koumitsu, Noriko; Nagashima, Yoji; Nagahama, Kiyotaka; Ehara, Michiko; Aoki, Ichiro; Yamanaka, Shoji] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Kojima, Yoshitsugu; Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan; [Suzuki, Kyoko; Hirayasu, Yoshio] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Kanzaki, S (corresponding author), Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan.	yamaguchiakira@mac.com	Nagashima, Yoji/AAA-2591-2021		Japan Society for the Promotion of Science [17590355, 20590407, 19790734]; Yokohama City University, Yokohama, Japan [K200003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama City University, Yokohama, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to SY, #17590355, 20590407 and AY, 19790734; http://www.jsps.go.jp/j-grantsinaid/) and from the Yokohama City University, Yokohama, Japan (to YN, #K200003; http://www.yokohama-cu.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balreira A, 2005, BRIT J HAEMATOL, V129, P667, DOI 10.1111/j.1365-2141.2005.05503.x; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; Cavallotti D, 2005, NEUROL RES, V27, P41, DOI 10.1179/016164105X18197; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Cox NR, 1998, VET IMMUNOL IMMUNOP, V63, P335, DOI 10.1016/S0165-2427(98)00113-5; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ferri C, 2006, RHEUMATOLOGY, V45, P72, DOI 10.1093/rheumatology/kei101; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Galbiati F, 2007, J NEUROSCI, V27, P13730, DOI 10.1523/JNEUROSCI.3379-07.2007; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Ishikawa S, 2001, J EXP MED, V193, P1393, DOI 10.1084/jem.193.12.1393; Ishikawa S, 2007, FRONT BIOSCI-LANDMRK, V12, P1790, DOI 10.2741/2188; ITOH H, 1984, BRAIN DEV-JPN, V6, P467, DOI 10.1016/S0387-7604(84)80029-7; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lim MJ, 2007, NEUROBIOL DIS, V25, P239, DOI 10.1016/j.nbd.2006.09.005; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Pearce DA, 2004, NEUROLOGY, V63, P2001, DOI 10.1212/01.WNL.0000145836.72059.3B; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Ramirez-Montealegre D, 2005, NEUROLOGY, V64, P743, DOI 10.1212/01.WNL.0000151973.08426.7E; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sato T, 2004, EUR J IMMUNOL, V34, P3346, DOI 10.1002/eji.200425373; SCHWARTING GA, 1983, J BIOL CHEM, V258, P5893; SCHWARTING GA, 1981, J IMMUNOL, V126, P2403; SHOENFELD Y, 1995, J CLIN IMMUNOL, V15, P363, DOI 10.1007/BF01541326; TAKAHASHI A, 1974, BEITR PATHOL, V152, P418; TATEMATSU M, 1981, ACTA PATHOL JAPON, V31, P503; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Yamaguchi A, 2004, J CLIN INVEST, V113, P200, DOI 10.1172/JCI200419639; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou J, 1998, VET IMMUNOL IMMUNOP, V66, P25, DOI 10.1016/S0165-2427(98)00180-9; Zhou J, 1998, CELL IMMUNOL, V183, P90, DOI 10.1006/cimm.1998.1247	47	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12105	10.1371/journal.pone.0012105	http://dx.doi.org/10.1371/journal.pone.0012105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856892	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900038
J	Schouwey, K; Aydin, IT; Radtke, F; Beermann, F				Schouwey, K.; Aydin, I. T.; Radtke, F.; Beermann, F.			RBP-J kappa-dependent Notch signaling enhances retinal pigment epithelial cell proliferation in transgenic mice	ONCOGENE			English	Article						RPE; transgenic; Notch; eye; melanoma; knockout	EARLY EYE DEVELOPMENT; TUMOR-SUPPRESSOR; EXPRESSION; FATE; TRANSCRIPTION; PATHWAY; GENE; DIFFERENTIATION; MELANOCYTE; MORPHOGENESIS	The Notch signaling pathway is an ubiquitous cell-cell interaction mechanism, which is essential in controlling processes like cell proliferation, cell fate decision, differentiation or stem cell maintenance. Recent data have shown that Notch signaling is RBP-J kappa-dependent in melanocytes, being required for survival of these pigment cells that are responsible for coloration of the skin and hairs in mammals. In addition, Notch is believed to function as an oncogene in melanoma, whereas it is a tumor suppressor in mouse epidermis. In this study, we addressed the implication of the Notch signaling in the development of another population of pigment cells forming the retinal pigment epithelium (RPE) in mammalian eyes. The constitutive activity of Notch in Tyrp1::NotchIC/degrees transgenic mice enhanced RPE cell proliferation, and the resulting RPE-derived pigmented tumor severely affected the overall eye structure. This RPE cell proliferation is dependent on the presence of the transcription factor RBP-J kappa, as it is rescued in mice lacking RBP-J kappa in the RPE. In conclusion, Notch signaling in the RPE uses the canonical pathway, which is dependent on the transcription factor RBP-J kappa. In addition, it is of importance for RPE development, and constitutive Notch activity leads to hyperproliferation and benign tumors of these pigment cells. Oncogene (2011) 30, 313-322; doi:10.1038/onc.2010.428; published online 20 September 2010	[Schouwey, K.; Aydin, I. T.; Radtke, F.; Beermann, F.] Ecole Polytech Fed Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Beermann, F (corresponding author), Ecole Polytech Fed Lausanne EPFL, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, Stn 19,Batiment SV, CH-1015 Lausanne, Switzerland.	Friedrich.Beermann@epfl.ch	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045; Aydin, Iraz Toprak/0000-0001-9608-8577	Oncosuisse; Novartis; Fondation Emma Muschamps; Swiss National Science Foundation	Oncosuisse; Novartis(Novartis); Fondation Emma Muschamps; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Pierre Chambon, Tatsuko Honjo, Ursula Zimber-Strobl, Lothar Strobl and Ian J Jackson for mouse strains; to Simon Saule, Vince Hearing and Mickey Marks for antibodies; and to Alessandra Solero and Sabrina Guichard for initial help with the Tyrp1::NotchIC construct and mice. The Pax6 antibody developed by A Kawakami was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa. Work in the laboratory of FB was supported by grants from Oncosuisse, Novartis, the Fondation Emma Muschamps and The Swiss National Science Foundation.	Adler R, 1999, MOL VIS, V5; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Aydin IT, 2009, PIGM CELL MELANOMA R, V22, P854, DOI 10.1111/j.1755-148X.2009.00629.x; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; BODENSTEIN L, 1987, DEV BIOL, V121, P192, DOI 10.1016/0012-1606(87)90152-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Cao TY, 1997, J CELL SCI, V110, P1563; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Dakubo GD, 2008, DEV BIOL, V320, P242, DOI 10.1016/j.ydbio.2008.05.528; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; Defoe DM, 2007, MOL VIS, V13, P273; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Finger PT, 1996, GRAEF ARCH CLIN EXP, V234, pS22, DOI 10.1007/BF02343044; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; GARNER A, 1970, BRIT J OPHTHALMOL, V54, P715, DOI 10.1136/bjo.54.11.715; Gimenez E, 2001, LAB ANIM-UK, V35, P153, DOI 10.1258/0023677011911525; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hingorani M, 1999, OPHTHALMOLOGY, V106, P330, DOI 10.1016/S0161-6420(99)90072-6; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3799, DOI 10.1093/nar/19.14.3799; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1135; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Kumano K, 2008, PIGM CELL MELANOMA R, V21, P70, DOI 10.1111/j.1755-148X.2007.00423.x; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lutty G, 1999, MOL VIS, V5; Ma A, 2007, INVEST OPHTH VIS SCI, V48, P3576, DOI 10.1167/iovs.06-1373; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marmorstein AD, 1998, ANN NY ACAD SCI, V857, P1, DOI 10.1111/j.1749-6632.1998.tb10102.x; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; May CA, 1996, EXP EYE RES, V63, P75; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Murisier F, 2007, DEV BIOL, V303, P838, DOI 10.1016/j.ydbio.2006.11.038; Murisier F, 2006, DEV BIOL, V298, P644, DOI 10.1016/j.ydbio.2006.05.011; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nishikawa SI, 2007, PIGM CELL RES, V20, P263, DOI 10.1111/j.1600-0749.2007.00388.x; Penna D, 1998, ONCOGENE, V17, P2601, DOI 10.1038/sj.onc.1202196; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Porret Andree, 2006, V337, P185; Radtke F, 2005, EMBO REP, V6, P1120, DOI 10.1038/sj.embor.7400585; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Schmidt A, 1999, INT J CANCER, V80, P600, DOI 10.1002/(SICI)1097-0215(19990209)80:4<600::AID-IJC19>3.0.CO;2-2; Schouwey K, 2008, HISTOL HISTOPATHOL, V23, P609, DOI 10.14670/HH-23.609; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Schouwey K, 2010, PIGM CELL MELANOMA R, V23, P134, DOI 10.1111/j.1755-148X.2009.00651.x; Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shields JA, 2009, OPHTHALMOLOGY, V116, P2213, DOI 10.1016/j.ophtha.2009.04.048; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yoshida K, 2004, ANAT EMBRYOL, V208, P145, DOI 10.1007/s00429-004-0382-5; Zhao SL, 2001, MOL VIS, V7, P277; Zheng MH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-38	85	27	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					313	322		10.1038/onc.2010.428	http://dx.doi.org/10.1038/onc.2010.428			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20856205				2022-12-25	WOS:000286418800006
J	Burrell, M; Hanfrey, CC; Murray, EJ; Stanley-Wall, NR; Michael, AJ				Burrell, Matthew; Hanfrey, Colin C.; Murray, Ewan J.; Stanley-Wall, Nicola R.; Michael, Anthony J.			Evolution and Multiplicity of Arginine Decarboxylases in Polyamine Biosynthesis and Essential Role in Bacillus subtilis Biofilm Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; AMINO-ACID DECARBOXYLASES; X-RAY-STRUCTURE; ORNITHINE-DECARBOXYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DIAMINOPIMELATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; CHLAMYDOPHILA-PNEUMONIAE	Arginine decarboxylases (ADCs; EC 4.1.1.19) from four different protein fold families are important for polyamine biosynthesis in bacteria, archaea, and plants. Biosynthetic alanine racemase fold (AR-fold) ADC is widespread in bacteria and plants. We report the discovery and characterization of an ancestral form of the AR-fold ADC in the bacterial Chloroflexi and Bacteroidetes phyla. The ancestral AR-fold ADC lacks a large insertion found in Escherichia coli and plant AR-fold ADC and is more similar to the lysine biosynthetic enzyme meso-diaminopimelate decarboxylase, from which it has evolved. An E. coli acid-inducible ADC belonging to the aspartate aminotransferase fold (AAT-fold) is involved in acid resistance but not polyamine biosynthesis. We report here that the acid-inducible AAT-fold ADC has evolved from a shorter, ancestral biosynthetic AAT-fold ADC by fusion of a response regulator receiver domain protein to the N terminus. Ancestral biosynthetic AAT-fold ADC appears to be limited to firmicute bacteria. The phylogenetic distribution of different forms of ADC distinguishes bacteria from archaea, euryarchaeota from crenarchaeota, double-membraned from single-membraned bacteria, and firmicutes from actinobacteria. Our findings extend to eight the different enzyme forms carrying out the activity described by EC 4.1.1.19. ADC gene clustering reveals that polyamine biosynthesis employs diverse and exchangeable synthetic modules. We show that in Bacillus subtilis, ADC and polyamines are essential for biofilm formation, and this appears to be an ancient, evolutionarily conserved function of polyamines in bacteria. Also of relevance to human health, we found that arginine decarboxylation is the dominant pathway for polyamine biosynthesis in human gut microbiota.	[Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Burrell, Matthew; Hanfrey, Colin C.; Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Murray, Ewan J.; Stanley-Wall, Nicola R.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Dundee	Michael, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu		Stanley-Wall, Nicola/0000-0002-5936-9721	Biotechnology and Biological Sciences Research Council UK [BB/C520404/1, BB/E001572/1, BB/E024467/1]; BBSRC [BB/E024467/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024467/1, BB/C520404/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council UK Grants BB/C520404/1 and BB/E001572/1.; Supported by a Biotechnology and Biological Sciences Research Council UK CSG grant and Institute Development Fellowship BB/E024467/1. To whom correspondence should be addressed: Dept. of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041. Tel.: 214-648-4170; E-mail: anthony.michael@utsouthwestern.edu.	Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; Fuell C, 2010, PLANT PHYSIOL BIOCH, V48, P513, DOI 10.1016/j.plaphy.2010.02.008; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Hu TC, 2008, J BIOL CHEM, V283, P21284, DOI 10.1074/jbc.M801823200; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Illingworth C, 2003, FEBS LETT, V549, P26, DOI 10.1016/S0014-5793(03)00756-7; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kovacs K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000115; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Liao S, 2008, BIOSCI BIOTECH BIOCH, V72, P445, DOI 10.1271/bbb.70550; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Ohno S., 1970, EVOLUTION GENE DUPLI; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; SATISHCHANDRAN C, 1986, J BACTERIOL, V165, P843, DOI 10.1128/jb.165.3.843-848.1986; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; Smith CB, 2008, J BACTERIOL, V190, P7431, DOI 10.1128/JB.00652-08; Takatsuka Y, 2000, J BACTERIOL, V182, P6732, DOI 10.1128/JB.182.23.6732-6741.2000; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Yanai I, 2002, GENOME BIOL, V3	65	76	79	3	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39224	39238		10.1074/jbc.M110.163154	http://dx.doi.org/10.1074/jbc.M110.163154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876533	Green Published, hybrid			2022-12-25	WOS:000284941300052
J	Ferrer, NL; Gomez, AB; Neyrolles, O; Gicquel, B; Martin, C				Ferrer, Nadia L.; Gomez, Ana B.; Neyrolles, Olivier; Gicquel, Brigitte; Martin, Carlos			Interactions of Attenuated Mycobacterium tuberculosis phoP Mutant with Human Macrophages	PLOS ONE			English	Article							HUMAN ALVEOLAR MACROPHAGES; NITRIC-OXIDE; PHAGOSOME MATURATION; PROTECTIVE IMMUNITY; GUINEA-PIGS; CELLS; BCG; VIRULENCE; SUSCEPTIBILITY; STRAINS	Background: Mycobacterium tuberculosis phoP mutant SO2 derived from a clinical isolate was shown to be attenuated in mouse bone marrow-derived macrophages and in vivo mouse infection model and has demonstrated a high potential as attenuated vaccine candidate against tuberculosis. Methodology/Principal Findings: In this study, we analyze the adhesion and the intracellular growth and trafficking of SO2 in human macrophages. Our results indicate an enhanced adhesion to phagocitic cells and impaired intracellular replication of SO2 in both monocyte-derived macrophages and human cell line THP-1 in comparison with the wild type strain, consistent with murine model. Intracellular trafficking analysis in human THP-1 cells suggest that attenuation of SO2 within macrophages could be due to an impaired ability to block phagosome-lysosome fusion compared with the parental M. tuberculosis strain. No differences were found between SO2 and the wild-type strains in the release and mycobacterial susceptibility to nitric oxide (NO) produced by infected macrophages. Conclusions/Significance: SO2 has enhanced ability to bind human macrophages and differs in intracellular trafficking as to wild-type M. tuberculosis. The altered lipid profile expression of the phoP mutant SO2 and its inability to secrete ESAT-6 is discussed.	[Ferrer, Nadia L.; Gomez, Ana B.; Martin, Carlos] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, Zaragoza, Spain; [Neyrolles, Olivier; Gicquel, Brigitte; Martin, Carlos] Inst Pasteur, Unit Mycobacterial Genet, Paris, France; [Ferrer, Nadia L.; Gomez, Ana B.; Martin, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain	University of Zaragoza; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Ferrer, NL (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	carlos@unizar.es	Neyrolles, Olivier B/A-3184-2011; Neyrolles, Olivier/AAG-3692-2019; Martin, Carlos/A-7283-2008	Neyrolles, Olivier/0000-0003-0047-5885; Martin, Carlos/0000-0003-2993-5478; Gomez Aguirre, Ana Belen/0000-0002-9713-2127	Spanish Ministerio de Educacion y Ciencia [BES-2003-1088]; Ministerio de Ciencia e Innovacion [BIO2005-07949-C02-01, BIO2008-01561]; European TBVAC Project [FP6-503367]; European NEWTBVAC Project [FP7 241745]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European TBVAC Project; European NEWTBVAC Project	This work was supported by the Spanish Ministerio de Educacion y Ciencia (BES-2003-1088), Ministerio de Ciencia e Innovacion (BIO2005-07949-C02-01, BIO2008-01561) and by the European TBVAC FP6-503367 and NEWTBVAC FP7 241745 Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chen F, 1996, APMIS, V104, P176, DOI 10.1111/j.1699-0463.1996.tb00705.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jo EK, 2008, CURR OPIN INFECT DIS, V21, P279, DOI 10.1097/QCO.0b013e3282f88b5d; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Lee Ji-Sook, 2009, Immune Netw, V9, P192, DOI 10.4110/in.2009.9.5.192; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; Ludwiczak P, 2002, MICROBIOL-SGM, V148, P3029, DOI 10.1099/00221287-148-10-3029; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; PANDOLFI F, 1978, CLIN EXP IMMUNOL, V32, P504; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Saavedra R, 2006, MICROBES INFECT, V8, P533, DOI 10.1016/j.micinf.2005.08.005; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; *WHO, 2006, GLOB TUB CONTR SURV; *WHO IUATLD, 2004, 3 WHOIUATLD; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013; Young DB, 2003, NAT MED, V9, P503, DOI 10.1038/nm868	48	38	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12978	10.1371/journal.pone.0012978	http://dx.doi.org/10.1371/journal.pone.0012978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885976	Green Published, gold, Green Submitted			2022-12-25	WOS:000282122600014
J	Belloni, V; Faivre, B; Guerreiro, R; Arnoux, E; Bellenger, J; Sorci, G				Belloni, Virginia; Faivre, Bruno; Guerreiro, Romain; Arnoux, Emilie; Bellenger, Jerome; Sorci, Gabriele			Suppressing an Anti-Inflammatory Cytokine Reveals a Strong Age-Dependent Survival Cost in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFLAMMATION; STRESS	Background: The central paradigm of ecological immunology postulates that selection acts on immunity as to minimize its cost/benefit ratio. Costs of immunity may arise because the energetic requirements of the immune response divert resources that are no longer available for other vital functions. In addition to these resource-based costs, mis-directed or over-reacting immune responses can be particularly harmful for the host. In spite of the potential importance of immunopathology, most studies dealing with the evolution of the immune response have neglected such non resource-based costs. To keep the immune response under control, hosts have evolved regulatory pathways that should be considered when studying the target of the selection pressures acting on immunity. Indeed, variation in regulation may strongly modulate the negative outcome of immune activation, with potentially important fitness consequences. Methodology/Principal Findings: Here, we experimentally assessed the survival costs of reduced immune regulation by inhibiting an anti-inflammatory cytokine (IL-10) with anti-IL-10 receptor antibodies (anti-IL-10R) in mice that were either exposed to a mild inflammation or kept as control. The experiment was performed on young (3 months) and old (15 months) individuals, as to further assess the age-dependent cost of suppressing immune regulation. IL-10 inhibition induced high mortality in old mice exposed to the mild inflammatory insult, whereas no mortality was observed in young mice. However, young mice experienced a transitory lost in body mass when injected with the anti-IL-10R antibodies, showing that the treatment was to a lesser extent also costly for young individuals. Conclusions: These results suggest a major role of immune regulation that deserves attention when investigating the evolution of immunity, and indicate that the capacity to down-regulate the inflammatory response is crucial for late survival and longevity.	[Belloni, Virginia; Faivre, Bruno; Guerreiro, Romain; Arnoux, Emilie; Sorci, Gabriele] Univ Bourgogne, CNRS, UMR 5561, Dijon, France; [Bellenger, Jerome] Univ Bourgogne, INSERM, UMR U866, Dijon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Belloni, V (corresponding author), Univ Bourgogne, CNRS, UMR 5561, Dijon, France.	virginia.belloni@u-bourgogne.fr	BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Sorci, Gabriele/0000-0002-0799-3995; Belloni, Virginia/0000-0001-9807-1912; Mead, Simon/0000-0002-4326-1468	Region Bourgogne	Region Bourgogne(Region Bourgogne-Franche-Comte)	Financial support was provided by the Region Bourgogne to VB, BF, and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kolla VK, 2009, CYTOKINE, V47, P173, DOI 10.1016/j.cyto.2009.06.007; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Miteva L, 2008, HUM IMMUNOL, V69, P562, DOI 10.1016/j.humimm.2008.07.008; PAWALEC G, 2002, TRENDS IMMUNOL, V23, P330; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pawelec G, 2006, EXP GERONTOL, V41, P1239, DOI 10.1016/j.exger.2006.09.005; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; *SAS I, 2001, SAS STAT SOFTW VERS; Sell S., 2001, IMMUNOLOGY IMMUNOPAT; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Swindle EJ, 2007, IMMUNOL REV, V217, P186, DOI 10.1111/j.1600-065X.2007.00513.x; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12940	10.1371/journal.pone.0012940	http://dx.doi.org/10.1371/journal.pone.0012940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886083	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100039
J	Crowley, TJ; Dalwani, MS; Mikulich-Gilbertson, SK; Du, YPP; Lejuez, CW; Raymond, KM; Banich, MT				Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Du, Yiping P.; Lejuez, Carl W.; Raymond, Kristen M.; Banich, Marie T.			Risky Decisions and Their Consequences: Neural Processing by Boys with Antisocial Substance Disorder	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; CONDUCT DISORDER; DRUG-ABUSE; NEUROANATOMICAL CORRELATE; DIAGNOSTIC INTERVIEW; ORBITOFRONTAL CORTEX; PSYCHOPATHIC TRAITS; ALCOHOL DEPENDENCE; ANTERIOR CINGULATE; NUCLEUS-ACCUMBENS	Background: Adolescents with conduct and substance problems ("Antisocial Substance Disorder'' (ASD)) repeatedly engage in risky antisocial and drug-using behaviors. We hypothesized that, during processing of risky decisions and resulting rewards and punishments, brain activation would differ between abstinent ASD boys and comparison boys. Methodology/Principal Findings: We compared 20 abstinent adolescent male patients in treatment for ASD with 20 community controls, examining rapid event-related blood-oxygen-level-dependent (BOLD) responses during functional magnetic resonance imaging. In 90 decision trials participants chose to make either a cautious response that earned one cent, or a risky response that would either gain 5 cents or lose 10 cents; odds of losing increased as the game progressed. We also examined those times when subjects experienced wins, or separately losses, from their risky choices. We contrasted decision trials against very similar comparison trials requiring no decisions, using whole-brain BOLD-response analyses of group differences, corrected for multiple comparisons. During decision-making ASD boys showed hypoactivation in numerous brain regions robustly activated by controls, including orbitofrontal and dorsolateral prefrontal cortices, anterior cingulate, basal ganglia, insula, amygdala, hippocampus, and cerebellum. While experiencing wins, ASD boys had significantly less activity than controls in anterior cingulate, temporal regions, and cerebellum, with more activity nowhere. During losses ASD boys had significantly more activity than controls in orbitofrontal cortex, dorsolateral prefrontal cortex, brain stem, and cerebellum, with less activity nowhere. Conclusions/Significance: Adolescent boys with ASD had extensive neural hypoactivity during risky decision-making, coupled with decreased activity during reward and increased activity during loss. These neural patterns may underlie the dangerous, excessive, sustained risk-taking of such boys. The findings suggest that the dysphoria, reward insensitivity, and suppressed neural activity observed among older addicted persons also characterize youths early in the development of substance use disorders.	[Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Raymond, Kristen M.] Univ Colorado, Dept Psychiat, Subst Dependence Div, Denver, CO 80202 USA; [Du, Yiping P.; Banich, Marie T.] Univ Colorado, Brain Imaging Ctr, Denver, CO USA; [Lejuez, Carl W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Psychol, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Crowley, TJ (corresponding author), Univ Colorado, Dept Psychiat, Subst Dependence Div, Denver, CO 80202 USA.	thomas.crowley@ucdenver.edu		BANICH, MARIE/0000-0001-9373-9194; Lejuez, Carl/0000-0003-2772-7835; Du, Yiping/0000-0002-8326-7901	National Institute on Drug Abuse [DA 009842, 011015]; Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009842, R37DA009842, P60DA011015] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse (www.nida.nih.gov) Grants DA 009842, 011015; Kane Family Foundation (kanefamilyfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; ALESSI NE, 1984, J AFFECT DISORDERS, V6, P9, DOI 10.1016/0165-0327(84)90003-X; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], DRUG ALCOHOL SERVICE; ASHBURNER J, SPM5 MANUAL; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Banich MT, 2007, DRUG ALCOHOL DEPEN, V90, P175, DOI 10.1016/j.drugalcdep.2007.03.009; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI [10.1186/1744-9081-4-34, 10.1186/1744-9081-4-55]; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bjork JM, 2008, DRUG ALCOHOL DEPEN, V95, P115, DOI 10.1016/j.drugalcdep.2007.12.014; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Boes AD, 2008, BEHAV NEUROSCI, V122, P677, DOI 10.1037/0735-7044.122.3.677; Boes AD, 2009, SOC COGN AFFECT NEUR, V4, P1, DOI 10.1093/scan/nsn035; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Button TMM, 2007, DRUG ALCOHOL DEPEN, V87, P46, DOI 10.1016/j.drugalcdep.2006.07.012; Cadoret RJ, 1996, COMPR PSYCHIAT, V37, P88, DOI 10.1016/S0010-440X(96)90567-2; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Childress A. R., 2006, RETHINKING SUBSTANCE, P46; Compton WM, 1996, DRUG ALCOHOL DEPEN, V41, P179, DOI 10.1016/0376-8716(96)01249-5; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; CRISTIANA CP, 2007, PLOS ONE, V2, pE424, DOI DOI 10.1371/JOURNAL.PONE.0000424; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; CROWLEY TJ, 1972, COMPR PSYCHIAT, V13, P51, DOI 10.1016/0010-440X(72)90034-X; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V49, P225, DOI 10.1016/S0376-8716(98)00016-7; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; CROWLEY TJ, 2010, ENCY BEHAV NEUROSCIE; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; Du YPP, 2007, MAGN RESON MED, V57, P396, DOI 10.1002/mrm.21150; Elliott R, 2005, INT REV NEUROBIOL, V65, P89, DOI 10.1016/S0074-7742(04)65004-5; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; EYSENCK SBG, 1980, PERS INDIV DIFFER, V1, P73, DOI 10.1016/0191-8869(80)90006-9; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Hansen HH, 2008, ANN NEUROL, V64, P42, DOI 10.1002/ana.21287; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lane SD, 2001, EXP CLIN PSYCHOPHARM, V9, P74, DOI 10.1037//1064-1297.9.1.74; Larm P, 2008, DRUG ALCOHOL DEPEN, V96, P79, DOI 10.1016/j.drugalcdep.2008.01.026; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; McNamee RL, 2008, ALCOHOL CLIN EXP RES, V32, P405, DOI 10.1111/j.1530-0277.2007.00604.x; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neto LL, 2008, NEUROMODULATION, V11, P13, DOI 10.1111/j.1525-1403.2007.00138.x; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; *NRW RES GROUP HEM, 2003, MUNST T2T CONV; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; RANSON SW, 1959, ANATOMY NERVOUS SYST, P356; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Savage LM, 2009, BEHAV BRAIN RES, V198, P1, DOI 10.1016/j.bbr.2008.10.028; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Slutske WS, 1998, J ABNORM PSYCHOL, V107, P363, DOI 10.1037/0021-843X.107.3.363; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tapert SF, 2007, PSYCHOPHARMACOLOGY, V194, P173, DOI 10.1007/s00213-007-0823-y; Tomlinson KL, 2004, PSYCHOL ADDICT BEHAV, V18, P160, DOI 10.1037/0893-164X.18.2.160; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wechsler D., 1999, WECHSLER ABBREVIATED; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743	90	97	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12835	10.1371/journal.pone.0012835	http://dx.doi.org/10.1371/journal.pone.0012835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653AC	20877644	Green Published, gold, Green Submitted			2022-12-25	WOS:000282053100015
J	Liu, D; Meckel, T; Long, EO				Liu, Dongfang; Meckel, Tobias; Long, Eric O.			Distinct Role of Rab27a in Granule Movement at the Plasma Membrane and in the Cytosol of NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SINGLE SECRETORY GRANULES; LYTIC GRANULES; IMMUNOLOGICAL SYNAPSE; MELANOSOME TRANSPORT; ACTIN POLYMERIZATION; T-CELLS; F-ACTIN; EXOCYTOSIS; POLARIZATION	Protocols were developed to automate image analysis and to track the movement of thousands of vesicular compartments in live cells. Algorithms were used to discriminate among different types of movement (e. g. random, caged, and directed). We applied these tools to investigate the steady-state distribution and movement of lytic granules (LG) in live natural killer (NK) cells by high-speed 3-dimensional (3D) spinning disc confocal and 2-dimensional total internal reflection fluorescence microscopy. Both mouse NK cells and a human NK cell line deficient in the small GTPase Rab27a were examined. The unbiased analysis of large datasets led to the following observations and conclusions. The majority of LG in the cytosol and at the plasma membrane of unstimulated NK cells are mobile. The use of inhibitors indicated that movement in the cytosol required microtubules but not actin, whereas movement at the plasma membrane required both. Rab27a deficiency resulted in fewer LG, and in a reduced fraction of mobile LG, at the plasma membrane. In contrast, loss of Rab27a increased the fraction of mobile LG and the extent of their movement in the cytosol. Therefore, in addition to its documented role in LG delivery to the plasma membrane, Rab27a may restrict LG movement in the cytosol.	[Liu, Dongfang; Meckel, Tobias; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Liu, D (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	eLong@nih.gov	Meckel, Tobias/F-4372-2010; Long, Eric O/G-5475-2011	Meckel, Tobias/0000-0003-0759-2072; Long, Eric O/0000-0002-7793-3728; Liu, Dongfang/0000-0002-7295-8088	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CARPEN O, 1983, J IMMUNOL, V131, P2695; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Johnson JL, 2009, TRAFFIC; Jung SR, 2009, TRAFFIC, V10, P392, DOI 10.1111/j.1600-0854.2009.00884.x; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; KATZ P, 1982, J IMMUNOL, V129, P2816; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Li DD, 2004, BIOPHYS J, V87, P1991, DOI 10.1529/biophysj.104.043281; Liu DF, 2005, P NATL ACAD SCI USA, V102, P123, DOI 10.1073/pnas.0405737102; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Menasche G, 2008, BLOOD, V112, P5052, DOI 10.1182/blood-2008-02-141069; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; OHBAYASHI N, 2010, PIGMENT CELL MELANOM; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Sanal O, 2002, J CLIN IMMUNOL, V22, P237, DOI 10.1023/A:1016045026204; Sanborn KB, 2009, J IMMUNOL, V182, P6969, DOI 10.4049/jimmunol.0804337; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; WOOD SM, 2009, BLOOD; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100	62	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12870	10.1371/journal.pone.0012870	http://dx.doi.org/10.1371/journal.pone.0012870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877725	Green Published, Green Submitted, gold			2022-12-25	WOS:000282002900013
J	Sysoeva, OV; Tonevitsky, AG; Wackermann, J				Sysoeva, Olga V.; Tonevitsky, Alexander G.; Wackermann, Jiri			Genetic Determinants of Time Perception Mediated by the Serotonergic System	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; CATECHOL-O-METHYLTRANSFERASE; 5-HT2A RECEPTOR GENE; POSITRON-EMISSION; MONOAMINE-OXIDASE; VARIABLE NUMBER; HUMAN STRIATUM; POLYMORPHISM; HUMANS; BEHAVIOR	Background: The present study investigates neurobiological underpinnings of individual differences in time perception. Methodology: Forty-four right-handed Russian Caucasian males (18-35 years old) participated in the experiment. The polymorphism of the genes related to the activity of serotonin (5-HT) and dopamine (DA)-systems (such as 5-HTT, 5HT2a, MAOA, DAT, DRD2, COMT) was determined upon the basis of DNA analysis according to a standard procedure. Time perception in the supra-second range (mean duration 4.8 s) was studied, using the duration discrimination task and parametric fitting of psychometric functions, resulting in individual determination of the point of subjective equality (PSE). Assuming the 'dual klepsydra model' of internal duration representation, the PSE values were transformed into equivalent values of the parameter kappa (kappa), which is a measure of the 'loss rate' of the duration representation. An association between time representation parameters (PSE and k, respectively) and 5-HT-related genes was found, but not with DA-related genes. Higher 'loss rate' (k) of the cumulative duration representation were found for the carriers of genotypes characterized by higher 5-HT transmission, i.e., 1) lower 5-HT reuptake, known for the 5-HTTLPR SS polymorphism compared with LL, 2) lower 5-HT degradation, described for the 'low expression' variant of MAOA VNTR gene compared with 'high expression' variant, and 3) higher 5-HT2a receptor density, proposed for the TT polymorphism of 5-HT2a T102C gene compared with CC. Conclusion: Convergent findings of the present study and previous sychopharmacological studies suggest an action path from 5-HT-activity-related genes, via activity of 5-HT in the brain, to time perception. An involvement of the DA-system in the encoding of durations in the supra-second range is questioned.	[Sysoeva, Olga V.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Tonevitsky, Alexander G.] Russian Res Inst Sport & Phys Educ, Moscow, Russia; [Wackermann, Jiri] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany	Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Federal Science Center of Physical Culture & Sport (VNIIFK); Russian State University of Physical Education, Sport, Youth & Tourism	Sysoeva, OV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	olga.v.sysoeva@gmail.com	Sysoeva, Olga V/D-3540-2011; Sysoeva, Olga V/F-9301-2019; Tonevitsky, Alexander/R-5596-2019; Tonevitsky, Alexander G/F-8640-2014	Sysoeva, Olga V/0000-0002-4005-9512; Tonevitsky, Alexander/0000-0002-7079-7145; Wackermann, Jiri/0000-0001-5149-4248	RFH [10-06-00331a]	RFH	The work was supported by the RFH grant 10-06-00331a and Russian Science contract 02.740.11.0300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRATT ES, 1983, PERS INDIV DIFFER, V4, P387, DOI 10.1016/0191-8869(83)90004-1; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Brown SW, 1998, PERCEPTION, V27, P609, DOI 10.1068/p270609; BUCHWALD C, 1974, J CONSULT CLIN PSYCH, V42, P639, DOI 10.1037/h0036939; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eisler AD, 2003, NATO SCI SER II-MATH, V95, P5; Frankle WG, 2005, AM J PSYCHIAT, V162, P915, DOI 10.1176/appi.ajp.162.5.915; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Gil S, 2009, BEHAV PROCESS, V80, P169, DOI 10.1016/j.beproc.2008.11.012; Gorwood P, 2000, BIOL PSYCHIAT, V48, P259, DOI 10.1016/S0006-3223(00)00840-4; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Herken H, 2003, NEUROPSYCHOBIOLOGY, V47, P27, DOI 10.1159/000068872; Ho MY, 2002, PHARMACOL BIOCHEM BE, V71, P773, DOI 10.1016/S0091-3057(01)00672-4; Hong CC, 2003, CANCER EPIDEM BIOMAR, V12, P838; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2000, BEHAV SCI LAW, V18, P581, DOI 10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miro E, 2003, HUM FACTORS, V45, P148, DOI 10.1518/hfes.45.1.148.27227; MITRANI L, 1977, ACTIV NERV SUPER, V19, P103; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Noble E P, 1994, Alcohol Alcohol Suppl, V2, P35; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Polesskaya OO, 2002, J NEUROSCI RES, V67, P812, DOI 10.1002/jnr.10173; Portnova GV, 2007, ZH VYSSH NERV DEYAT+, V57, P450; RAMMSAYER T, 1990, INT J NEUROSCI, V53, P111, DOI 10.3109/00207459008986593; RAMMSAYER TH, 1993, BIOL PSYCHOL, V36, P209, DOI 10.1016/0301-0511(93)90018-4; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2002, PERS INDIV DIFFER, V32, P827, DOI 10.1016/S0191-8869(01)00089-7; RAMMSAYER TH, 1994, INT J NEUROSCI, V77, P61, DOI 10.3109/00207459408986019; Rammsayer TH, 1997, BIOL PSYCHOL, V46, P169, DOI 10.1016/S0301-0511(97)05251-4; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; SANO A, 1993, HUM GENET, V91, P405; Sevigny MC, 2003, BRAIN COGNITION, V53, P351, DOI 10.1016/S0278-2626(03)00141-6; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SPATI JP, 2005, THESIS A LUDWIG U; Sysoeva OV, 2009, INT J PSYCHOPHYSIOL, V72, P173, DOI 10.1016/j.ijpsycho.2008.12.005; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; TSYKANOV BI, 1988, VOP PSIKHOL+, V4, P129; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Wackermann J, 2006, J THEOR BIOL, V239, P482, DOI 10.1016/j.jtbi.2005.08.024; WACKERMANN J, 2005, ENDOPHYSICS TIME QUA, P189; Wackermann J, 2008, NEUROSCI LETT, V435, P51, DOI 10.1016/j.neulet.2008.02.006; Wackermann J, 2006, ACTA NEUROBIOL EXP, V66, P245; WARREN JT, 1993, HUM MOL GENET, V2, P338, DOI 10.1093/hmg/2.3.338; WEARDEN JH, 1993, Q J EXP PSYCHOL-B, V46, P163; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Wittmann M, 2007, J PSYCHOPHARMACOL, V21, P50, DOI 10.1177/0269881106065859; Wittmann Marc, 2006, Palliat Support Care, V4, P357	64	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12650	10.1371/journal.pone.0012650	http://dx.doi.org/10.1371/journal.pone.0012650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862259	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800003
J	Caballero, OL; Zhao, Q; Rimoldi, D; Stevenson, BJ; Svobodova, S; Devalle, S; Rohrig, UF; Pagotto, A; Michielin, O; Speiser, D; Wolchok, JD; Liu, CL; Pejovic, T; Odunsi, K; Brasseur, F; Van den Eynde, BJ; Old, LJ; Lu, X; Cebon, J; Strausberg, RL; Simpson, AJ				Caballero, Otavia L.; Zhao, Qi; Rimoldi, Donata; Stevenson, Brian J.; Svobodova, Suzanne; Devalle, Sylvie; Roehrig, Ute F.; Pagotto, Anna; Michielin, Olivier; Speiser, Daniel; Wolchok, Jedd D.; Liu, Cailian; Pejovic, Tanja; Odunsi, Kunle; Brasseur, Francis; Van den Eynde, Benoit J.; Old, Lloyd J.; Lu, Xin; Cebon, Jonathan; Strausberg, Robert L.; Simpson, Andrew J.			Frequent MAGE Mutations in Human Melanoma	PLOS ONE			English	Article							CANCER-TESTIS ANTIGENS; EXPRESSION; GENES; COMPLEXES; APOPTOSIS; PROTEINS; SURVIVAL; TUMORS	Background: Cancer/testis (CT) genes are expressed only in the germ line and certain tumors and are most frequently located on the X-chromosome (the CT-X genes). Amongst the best studied CT-X genes are those encoding several MAGE protein families. The function of MAGE proteins is not well understood, but several have been shown to potentially influence the tumorigenic phenotype. Methodology/Principal Findings: We undertook a mutational analysis of coding regions of four CT-X MAGE genes, MAGEA1, MAGEA4, MAGEC1, MAGEC2 and the ubiquitously expressed MAGEE1 in human melanoma samples. We first examined cell lines established from tumors and matching blood samples from 27 melanoma patients. We found that melanoma cell lines from 37% of patients contained at least one mutated MAGE gene. The frequency of mutations in the coding regions of individual MAGE genes varied from 3.7% for MAGEA1 and MAGEA4 to 14.8% for MAGEC2. We also examined 111 fresh melanoma samples collected from 86 patients. In this case, samples from 32% of the patients exhibited mutations in one or more MAGE genes with the frequency of mutations in individual MAGE genes ranging from 6% in MAGEA1 to 16% in MAGEC1. Significance: These results demonstrate for the first time that the MAGE gene family is frequently mutated in melanoma.	[Caballero, Otavia L.; Devalle, Sylvie; Wolchok, Jedd D.; Old, Lloyd J.] Ludwig Inst Canc Res Ltd, New York Branch, Mem Sloan Kettering Canc Ctr, New York, NY USA; [Zhao, Qi] J Craig Venter Inst, Rockville, MD USA; [Rimoldi, Donata; Stevenson, Brian J.; Roehrig, Ute F.; Michielin, Olivier; Speiser, Daniel] Ludwig Inst Canc Res Ltd, Lausanne Branch, Lausanne, Switzerland; [Svobodova, Suzanne; Cebon, Jonathan] Ludwig Inst Canc Res Ltd, Melbourne Ctr Clin Sci, Austin Hlth, Heidelberg, Vic, Australia; [Pagotto, Anna] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford Branch, Oxford, England; [Wolchok, Jedd D.; Liu, Cailian] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Wolchok, Jedd D.; Liu, Cailian] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Div Gynecol Oncol, Portland, OR 97201 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Brasseur, Francis; Van den Eynde, Benoit J.] Catholic Univ Louvain, Ludwig Inst Canc Res Ltd, Brussels Branch, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; J. Craig Venter Institute; Ludwig Institute for Cancer Research; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; University of Oxford; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Caballero, OL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	ocaball1@jhmi.edu	Speiser, Daniel E./F-2173-2013; Cebon, Jonathan S/H-1643-2013; Michielin, Olivier/ABE-7924-2020	Roehrig, Ute/0000-0002-4676-4087; Lu, Xin/0000-0002-6587-1152; Cebon, Jonathan/0000-0002-3898-950X; Devalle, Sylvie/0000-0002-9533-2571	Conrad N. Hilton Foundation; Ludwig Institute for Cancer Research; Medical Research Council [G9900991B] Funding Source: researchfish	Conrad N. Hilton Foundation; Ludwig Institute for Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was conducted as part of the Hilton-Ludwig Cancer Metastasis Initiative, funded by the Conrad N. Hilton Foundation and the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COSMIC CATALOGUE SOM; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; Brichard VG, 2008, EXPERT OPIN BIOL TH, V8, P951, DOI [10.1517/14712598.8.7.951, 10.1517/14712598.8.7.951 ]; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Grau E, 2009, J CANCER RES CLIN, V135, P523, DOI 10.1007/s00432-008-0484-1; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; JEON CH, 2010, J CLIN GASTROENTEROL; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	25	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12773	10.1371/journal.pone.0012773	http://dx.doi.org/10.1371/journal.pone.0012773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862285	Green Published, gold			2022-12-25	WOS:000281864100016
J	Tang, YA; Wen, WL; Chang, JW; Wei, TT; Tan, YHC; Salunke, S; Chen, CT; Chen, CS; Wang, YC				Tang, Yen-An; Wen, Wei-Ling; Chang, Jer-Wei; Wei, Tzi-Tang; Tan, Yi-Hung Carol; Salunke, Santosh; Chen, Chien-Tien; Chen, Ching-Shih; Wang, Yi-Ching			A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer	PLOS ONE			English	Article							T-CELL LYMPHOMA; IN-VIVO; EXPRESSION; SENSITIVITY; P21(WAF1); PROTEINS; BCL-2	Background: Lung cancer is the leading cause of cancer mortality worldwide, yet the therapeutic strategy for advanced non-small cell lung cancer (NSCLC) is limitedly effective. In addition, validated histone deacetylase (HDAC) inhibitors for the treatment of solid tumors remain to be developed. Here, we propose a novel HDAC inhibitor, OSU-HDAC-44, as a chemotherapeutic drug for NSCLC. Methodology/Principal Findings: The cytotoxicity effect of OSU-HDAC-44 was examined in three human NSCLC cell lines including A549 (p53 wild-type), H1299 (p53 null), and CL1-1 (p53 mutant). The antiproliferatative mechanisms of OSU-HDAC-44 were investigated by flow cytometric cell cycle analysis, apoptosis assays and genome-wide chromatin-immunoprecipitation-on-chip (ChIP-on-chip) analysis. Mice with established A549 tumor xenograft were treated with OSU-HDAC-44 or vehicle control and were used to evaluate effects on tumor growth, cytokinesis inhibition and apoptosis. OSU-HDAC-44 was a pan-HDAC inhibitor and exhibits 3-4 times more effectiveness than suberoylanilide hydroxamic acid (SAHA) in suppressing cell viability in various NSCLC cell lines. Upon OSU-HDAC-44 treatment, cytokinesis was inhibited and subsequently led to mitochondria-mediated apoptosis. The cytokinesis inhibition resulted from OSU-HDAC-44-mediated degradation of mitosis and cytokinesis regulators Auroroa B and survivin. The deregulation of F-actin dynamics induced by OSU-HDAC-44 was associated with reduction in RhoA activity resulting from srGAP1 induction. ChIP-on-chip analysis revealed that OSU-HDAC-44 induced chromatin loosening and facilitated transcription of genes involved in crucial signaling pathways such as apoptosis, axon guidance and protein ubiquitination. Finally, OSU-HDAC-44 efficiently inhibited A549 xenograft tumor growth and induced acetylation of histone and non-histone proteins and apoptosis in vivo. Conclusions/Significance: OSU-HDAC-44 significantly suppresses tumor growth via induction of cytokinesis defect and intrinsic apoptosis in preclinical models of NSCLC. Our data provide compelling evidence that OSU-HDAC-44 is a potent HDAC targeted inhibitor and can be tested for NSCLC chemotherapy.	[Tang, Yen-An; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wen, Wei-Ling; Tan, Yi-Hung Carol] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chang, Jer-Wei; Wei, Tzi-Tang; Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Salunke, Santosh] Natl Taiwan Normal Univ, Dept Chem, Taipei, Taiwan; [Chen, Chien-Tien] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	National Cheng Kung University; National Taiwan Normal University; National Cheng Kung University; National Taiwan Normal University; National Tsing Hua University; University System of Ohio; Ohio State University	Tang, YA (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019	Wang, Yi-Ching/0000-0002-7694-2067; Tan, Yi-Hung Carol/0000-0001-7541-007X	National Science Council [NSC97-2627-M-006-005, NSC99-2628-B-006-004-MY3]; Department of Health (The Executive Yuan, Republic of China) [DOH98-TD-G-111-024]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health (The Executive Yuan, Republic of China)	This work was supported in part by grants NSC97-2627-M-006-005 and NSC99-2628-B-006-004-MY3 from the National Science Council and grant DOH98-TD-G-111-024 from the Department of Health (The Executive Yuan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Canes D, 2005, INT J CANCER, V113, P841, DOI 10.1002/ijc.20634; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen JG, 2009, BLOOD, V113, P4038, DOI 10.1182/blood-2008-08-176024; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Danesi R, 2003, PHARMACOL REV, V55, P57, DOI 10.1124/pr.55.1.4; Glaser KB, 2003, MOL CANCER THER, V2, P151; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lu Q, 2004, J MED CHEM, V47, P467, DOI 10.1021/jm0303655; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Noh EJ, 2005, CANCER RES, V65, P11400, DOI 10.1158/0008-5472.CAN-05-1092; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stinchcombe Thomas E, 2009, Proc Am Thorac Soc, V6, P233, DOI 10.1513/pats.200809-110LC; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	34	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12417	10.1371/journal.pone.0012417	http://dx.doi.org/10.1371/journal.pone.0012417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856855	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815700003
J	Bagwell, CE; Hixson, KK; Milliken, CE; Lopez-Ferrer, D; Weitz, KK				Bagwell, Christopher E.; Hixson, Kim K.; Milliken, Charles E.; Lopez-Ferrer, Daniel; Weitz, Karl K.			Proteomic and Physiological Responses of Kineococcus radiotolerans to Copper	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; ENTEROCOCCUS-HIRAE; SP NOV.; DISULFIDE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; LIQUID-CHROMATOGRAPHY; RADIATION-RESISTANCE; INTRACELLULAR COPPER	Copper is a highly reactive, toxic metal; consequently, transport of this metal within the cell is tightly regulated. Intriguingly, the actinobacterium Kineococcus radiotolerans has been shown to not only accumulate soluble copper to high levels within the cytoplasm, but the phenotype also correlated with enhanced cell growth during chronic exposure to ionizing radiation. This study offers a first glimpse into the physiological and proteomic responses of K. radiotolerans to copper at increasing concentration and distinct growth phases. Aerobic growth rates and biomass yields were similar over a range of Cu(II) concentrations (0-1.5 mM) in complex medium. Copper uptake coincided with active cell growth and intracellular accumulation was positively correlated with Cu(II) concentration in the growth medium (R-2 = 0.7). Approximately 40% of protein coding ORFs on the K. radiotolerans genome were differentially expressed in response to the copper treatments imposed. Copper accumulation coincided with increased abundance of proteins involved in oxidative stress and defense, DNA stabilization and repair, and protein turnover. Interestingly, the specific activity of superoxide dismutase was repressed by low to moderate concentrations of copper during exponential growth, and activity was unresponsive to perturbation with paraquot. The biochemical response pathways invoked by sub-lethal copper concentrations are exceptionally complex; though integral cellular functions are preserved, in part, through the coordination of defense enzymes, chaperones, antioxidants and protective osmolytes that likely help maintain cellular redox. This study extends our understanding of the ecology and physiology of this unique actinobacterium that could potentially inspire new biotechnologies in metal recovery and sequestration, and environmental restoration.	[Bagwell, Christopher E.; Milliken, Charles E.] Savannah River Natl Lab, Dept Environm Sci & Biotechnol, Aiken, SC USA; [Hixson, Kim K.] Environm Mol Sci Lab, Richland, WA USA; [Lopez-Ferrer, Daniel; Weitz, Karl K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Savannah River National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Bagwell, CE (corresponding author), Savannah River Natl Lab, Dept Environm Sci & Biotechnol, Aiken, SC USA.	Christopher.bagwell@srnl.doe.gov	Hixson, Kim/AAJ-7714-2020; Hixson, Kim/AAW-2332-2020	Hixson, Kim/0000-0003-3716-0326; Hixson, Kim/0000-0003-3915-7040	U.S. Department of Energy, Office of Environmental Management; U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA	U.S. Department of Energy, Office of Environmental Management(United States Department of Energy (DOE)); U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA	This investigation was supported by the U.S. Department of Energy, Office of Environmental Management as administered through the SRNL Laboratory Directed Research and Development Program. A portion of this research was performed at the Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard-Joris M, 2007, BIOCHIMIE, V89, P1474, DOI 10.1016/j.biochi.2007.06.005; Albarracin VH, 2005, CHEM ERDE-GEOCHEM, V65, P145, DOI 10.1016/j.chemer.2005.06.004; Ansaldi M, 2007, MOL MICROBIOL, V66, P484, DOI 10.1111/j.1365-2958.2007.05936.x; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Bagwell CE, 2008, APPL ENVIRON MICROB, V74, P1376, DOI 10.1128/AEM.02175-07; Bagwell CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003878; BAIKUN L, 2004, WATER RES, V38, P1248; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; COOKSEY DA, 1993, MOL MICROBIOL, V7, P1, DOI 10.1111/j.1365-2958.1993.tb01091.x; COOKSEY DA, 1992, APPL ENVIRON MICROB, V58, P274, DOI 10.1128/AEM.58.1.274-278.1992; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dameron CT, 1998, AM J CLIN NUTR, V67, p1091S, DOI 10.1093/ajcn/67.5.1091S; de la Torre JR, 2003, APPL ENVIRON MICROB, V69, P3858, DOI 10.1128/AEM.69.7.3858-3867.2003; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; DENISOV ET, 2005, OXIDATION ANTIOXIDAN, P819; Ellington MJK, 2003, MICROBIOL-SGM, V149, P1533, DOI 10.1099/mic.0.26277-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ERARDI FX, 1987, APPL ENVIRON MICROB, V53, P1951, DOI 10.1128/AEM.53.8.1951-1954.1987; Fabisiak JP, 1999, ARCH BIOCHEM BIOPHYS, V363, P171, DOI 10.1006/abbi.1998.1077; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GARRITY GM, 1996, IND MICROBIOL BIOTEC, V17, P268; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; Gomez-Silva Benito, 2008, V13, P117; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Gupta D, 2009, EXPERT OPIN DRUG SAF, V8, P81, DOI [10.1517/14740330802655538, 10.1517/14740330802655538 ]; Haferburg G, 2007, J BASIC MICROB, V47, P474, DOI 10.1002/jobm.200700256; Han WD, 1998, GENE, V217, P31, DOI 10.1016/S0378-1119(98)00378-3; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; ISHIGURO EE, 1970, J BACTERIOL, V104, P566, DOI 10.1128/JB.104.1.566-580.1970; JOHNSTON DW, 1976, FRESHWATER BIOL, V6, P465, DOI 10.1111/j.1365-2427.1976.tb01636.x; KELNER MJ, 1990, J BIOL CHEM, V265, P10872; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; Kodali Vidya Prabhakar, 2008, Biotechnol J, V3, P245, DOI 10.1002/biot.200700208; Konstantinidis KT, 2003, MICROB ECOL, V45, P191, DOI 10.1007/s00248-002-1035-y; Kuhlman KR, 2006, APPL ENVIRON MICROB, V72, P1708, DOI 10.1128/AEM.72.2.1708-1715.2006; Lee SD, 2006, INT J SYST EVOL MICR, V56, P1279, DOI 10.1099/ijs.0.64128-0; Liu M, 2009, INT J SYST EVOL MICR, V59, P1090, DOI 10.1099/ijs.0.004168-0; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Lu ZH, 2003, BIOMETALS, V16, P137; Lu ZH, 2001, J BIOL CHEM, V276, P47822, DOI 10.1074/jbc.M106218200; LUEDEMANN GM, 1968, J BACTERIOL, V96, P1848, DOI 10.1128/JB.96.5.1848-1858.1968; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; MAYFIELD C I, 1972, Soil Biology and Biochemistry, V4, P79, DOI 10.1016/0038-0717(72)90045-4; Milagres AMF, 1999, J MICROBIOL METH, V37, P1, DOI 10.1016/S0167-7012(99)00028-7; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Monobe M, 2005, J RADIAT RES, V46, P117, DOI 10.1269/jrr.46.117; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Phillips RW, 2002, INT J SYST EVOL MICR, V52, P933, DOI 10.1099/00207713-52-3-933; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; QING Z, 2006, CHINESE SCI BULL, V51, P2993; Radajewski S, 2001, MICROB ECOL, V41, P233, DOI 10.1007/s002480000112; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Schabereiter-Gurtner C, 2001, ARCH MICROBIOL, V176, P347, DOI 10.1007/s002030100333; Schmidt J, 2005, J ENVIRON HEALTH, V67, P44; SCHWARTZ CE, 1983, J BIOL CHEM, V258, P6277; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Shen YF, 2001, ANAL CHEM, V73, P3011, DOI 10.1021/ac001393n; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Swaving J, 1996, J BACTERIOL, V178, P6644, DOI 10.1128/jb.178.22.6644-6646.1996; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; Urzl C, 2000, INT J SYST EVOL MICR, V50, P529, DOI 10.1099/00207713-50-2-529; Van Nostrand JD, 2007, MICROB ECOL, V53, P670, DOI 10.1007/s00248-006-9160-7; WEST TS, 1981, T ROYAL SOC LONDON B, V294, P19; Williams S. T., 1989, BERGEYS MANUAL SYSTE, V4; Wohl DL, 1998, FEMS MICROBIOL ECOL, V26, P135, DOI 10.1111/j.1574-6941.1998.tb00499.x; YOKOTA A, 1993, INT J SYST BACTERIOL, V43, P52, DOI 10.1099/00207713-43-1-52; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	91	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12427	10.1371/journal.pone.0012427	http://dx.doi.org/10.1371/journal.pone.0012427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865147	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100022
J	Motta, MCM; Catta-Preta, CMC; Schenkman, S; Martins, ACD; Miranda, K; de Souza, W; Elias, MC				Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; Schenkman, Sergio; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley; Elias, Maria Carolina			The Bacterium Endosymbiont of Crithidia deanei Undergoes Coordinated Division with the Host Cell Nucleus	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; MORPHOLOGICAL EVENTS; TOXOPLASMA-GONDII; PARAFLAGELLAR ROD; CYCLE; PROTOZOA; KINETOPLAST; CYTOSKELETON; CYTOKINESIS; ORGANELLES	In trypanosomatids, cell division involves morphological changes and requires coordinated replication and segregation of the nucleus, kinetoplast and flagellum. In endosymbiont-containing trypanosomatids, like Crithidia deanei, this process is more complex, as each daughter cell contains only a single symbiotic bacterium, indicating that the prokaryote must replicate synchronically with the host protozoan. In this study, we used light and electron microscopy combined with three-dimensional reconstruction approaches to observe the endosymbiont shape and division during C. deanei cell cycle. We found that the bacterium replicates before the basal body and kinetoplast segregations and that the nucleus is the last organelle to divide, before cytokinesis. In addition, the endosymbiont is usually found close to the host cell nucleus, presenting different shapes during the protozoan cell cycle. Considering that the endosymbiosis in trypanosomatids is a mutualistic relationship, which resembles organelle acquisition during evolution, these findings establish an excellent model for the understanding of mechanisms related with the establishment of organelles in eukaryotic cells.	[Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley] Inst Nacl Ciencia & Tecnol Biol Estrut & Bioimage, Rio De Janeiro, Brazil; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Miranda, Kildare; de Souza, Wanderley] Inst Nacl Metrol Normalizacao & Qualidade Ind In, Rio De Janeiro, Brazil; [Elias, Maria Carolina] Inst Butantan, Parasitol Lab, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan	Motta, MCM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	motta@biof.ufrj.br; carol@butantan.gov.br	Elias, Maria Carolina/E-9197-2015; Elias, Maria QB/AAW-9284-2021; Catta Preta, Carolina/J-2505-2014; Azevedo-Martins, Allan Cézar de/AAC-6883-2022; Motta, Maria Cristina M/I-3140-2014; Azevedo-Martins, Allan Cézar de/M-9298-2015; Schenkman, Sergio/A-9227-2013	Elias, Maria Carolina/0000-0002-0501-8280; Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Schenkman, Sergio/0000-0001-9353-8480; Motta, Maria Cristina/0000-0002-0947-4830; Catta-Preta, Carolina/0000-0001-8983-3487	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Conselho Nacional de Pesquisa (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN TI, 1979, J CELL PHYSIOL, V98, P49, DOI 10.1002/jcp.1040980107; BHATTACHARYA A, 1985, INDIAN J EXP BIOL, V23, P629; Brown WJ, 2000, INFECT IMMUN, V68, P708, DOI 10.1128/IAI.68.2.708-715.2000; CAMARGO EP, 1977, NATURE, V270, P52, DOI 10.1038/270052a0; Cavalcanti DP, 2008, HISTOCHEM CELL BIOL, V130, P1177, DOI 10.1007/s00418-008-0450-7; CAVALIERSMITH T, 1985, J PROTOZOOL, V32, P376, DOI 10.1111/j.1550-7408.1985.tb04031.x; COSGROVE WB, 1970, J PROTOZOOL, V17, P172, DOI 10.1111/j.1550-7408.1970.tb02350.x; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; DU YB, 1994, J BACTERIOL, V176, P3081, DOI 10.1128/JB.176.10.3081-3084.1994; Elias MC, 2007, PROTIST, V158, P147, DOI 10.1016/j.protis.2006.10.002; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; GALINARI S, 1978, EXP PARASITOL, V46, P277, DOI 10.1016/0014-4894(78)90141-8; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; MATTHIJSDEWINTE.DA, 2009, J MICROSC-OXFORD, V233, P372; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Motta Maria Cristina Machado, 1991, Microscopia Electronica y Biologia Celular, V15, P131; Motta MCM, 1997, J EUKARYOT MICROBIOL, V44, P492, DOI 10.1111/j.1550-7408.1997.tb05729.x; Motta MCM, 2004, J EUKARYOT MICROBIOL, V51, P394, DOI 10.1111/j.1550-7408.2004.tb00386.x; Motta MCM, 1997, EUR J CELL BIOL, V72, P370; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Ploubidou A, 1999, J CELL SCI, V112, P4641; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Rios RM, 2004, CELL, V118, P323; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SALZMAN TA, 1985, INT J BIOCHEM, V17, P1343, DOI 10.1016/0020-711X(85)90058-8; SILVA PMF, 1996, PARASITOL RES, V82, P125; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932; WEIS D, 1969, SPECIALIA, V15, P664; Williams A. F, 1971, SYSTEM ANAL SIMULATI, P247; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1990, J CELL SCI, V95, P49; YI QM, 1985, J MOL BIOL, V184, P399, DOI 10.1016/0022-2836(85)90290-6	44	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12415	10.1371/journal.pone.0012415	http://dx.doi.org/10.1371/journal.pone.0012415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865129	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100015
J	Hornle, M; Peters, N; Thayaparasingham, B; Vorsmann, H; Kashkar, H; Kulms, D				Hoernle, M.; Peters, N.; Thayaparasingham, B.; Voersmann, H.; Kashkar, H.; Kulms, D.			Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis	ONCOGENE			English	Article						caspase-3; XIAP; melanoma; apoptosis	X-LINKED INHIBITOR; NF-KAPPA-B; PROTEIN LIGASE ACTIVITY; DOWN-REGULATION; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASE; RESISTANCE; IAPS; SURVIVAL; SMAC	Successful treatment of melanoma is still challenging, because metastasis remain chemoresistant and radioresistant. Accordingly, combinational treatments involving death ligands are mandatory. In a recent study from our lab, the majority out of 18 melanoma cell lines remained resistant against treatment with the death ligand TRAIL (tumor necrosis factor related apoptosis inducing ligand). Resistance was shown to be mainly due to incomplete processing of caspase-3 into catalytically inactive p21 by binding of the anti-apoptotic protein X-linked inhibitor of apoptosis protein (XIAP). Co-irradiation with sub-lethal ultraviolet (UV) B caused depletion of XIAP resulting in synergistic sensitization of all but two melanoma cell lines to TRAIL. We show here the XIAP depletion to essentially require initial caspasemediated cleavage, which promotes proteasomal degradation of XIAP. Utilizing specific caspase inhibitors and small interfering RNA-mediated knockdown, we further identified caspase-3 to be responsible for performing the initial cleavage of XIAP after UVB treatment. Additional evidence suggests an accelerated mitochondrial outer membrane permeabilization in response to co-treatment with TRAIL and UVB, which directs the release of XIAP antagonizing factors including Smac. Distraction of XIAP consequently liberates caspase-3 to autocatalytically process into active p17. Activated caspase-3 cleaves XIAP and further enhances its activation in a positive regulatory feedback loop. The molecular mechanism discovered here appears to have broader implications, because cleavage of XIAP was also shown to accompany cisplatin-induced sensitization of melanoma cells to TRAIL. Oncogene (2011) 30, 575-587; doi: 10.1038/onc.2010.434; published online 20 September 2010	[Hoernle, M.; Peters, N.; Thayaparasingham, B.; Voersmann, H.; Kulms, D.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Baden Wurttembe, Germany; [Kashkar, H.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Ctr Mol Med Cologne, Cologne, Germany	University of Stuttgart; University of Cologne	Kulms, D (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Baden Wurttembe, Germany.	Dagmar.Kulms@izi.uni-stuttgart.de	Kulms, Dagmar/H-1653-2014		Deutsche Krebshilfe [108717]	Deutsche Krebshilfe(Deutsche Krebshilfe)	We thank the Deutsche Krebshilfe/108717 for funding this project.	Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Creagh EM, 2004, J BIOL CHEM, V279, P26906, DOI 10.1074/jbc.M313859200; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Desplanques G, 2009, HAEMATOL-HEMATOL J, V94, P87, DOI 10.3324/haematol.13483; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Edmondson SR, 1999, J CLIN ENDOCR METAB, V84, P1638, DOI 10.1210/jc.84.5.1638; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hougardy BMT, 2006, INT J CANCER, V118, P1892, DOI 10.1002/ijc.21580; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Hussain AR, 2009, LEUKEMIA LYMPHOMA, V50, P1204, DOI 10.1080/10428190902951799; Inoue T, 2006, ANTI-CANCER DRUG, V17, P261, DOI 10.1097/00001813-200603000-00004; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kashkar H, 2007, BLOOD, V109, P3982, DOI 10.1182/blood-2006-10-053959; Kashkar H, 2006, BLOOD, V108, P3434, DOI 10.1182/blood-2006-05-021675; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Lasithiotakis KG, 2006, CANCER-AM CANCER SOC, V107, P1331, DOI 10.1002/cncr.22126; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; Liou JY, 2007, J CELL PHYSIOL, V212, P840, DOI 10.1002/jcp.21082; Liu L, 2010, BIOCHEM PHARMACOL, V79, P137, DOI 10.1016/j.bcp.2009.08.015; Liu WH, 2007, EMBO J, V26, P1660, DOI 10.1038/sj.emboj.7601611; Maas C, 2010, CELL DEATH DIFFER, V17, P1613, DOI 10.1038/cdd.2010.39; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shi RX, 2005, CANCER RES, V65, P7815, DOI 10.1158/0008-5472.CAN-04-3875; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun HY, 2008, J MED CHEM, V51, P7169, DOI 10.1021/jm8006849; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Thayaparasingham B, 2009, ONCOGENE, V28, P345, DOI 10.1038/onc.2008.397; Twiddy Davina, 2007, Biochem J, V405, pe1; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zeise E, 2004, J INVEST DERMATOL, V123, P746, DOI 10.1111/j.0022-202X.2004.23420.x; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084	51	59	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					575	587		10.1038/onc.2010.434	http://dx.doi.org/10.1038/onc.2010.434			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20856198				2022-12-25	WOS:000286922300006
J	Oliva, CR; Nozell, SE; Diers, A; McClugage, SG; Sarkaria, JN; Markert, JM; Darley-Usmar, VM; Bailey, SM; Gillespie, GY; Landar, A; Griguer, CE				Oliva, Claudia R.; Nozell, Susan E.; Diers, Anne; McClugage, Samuel G., III; Sarkaria, Jann N.; Markert, James M.; Darley-Usmar, Victor M.; Bailey, Shannon M.; Gillespie, G. Yancey; Landar, Aimee; Griguer, Corinne E.			Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DNA MUTATIONS; GLIOBLASTOMA-MULTIFORME; CELLULAR BIOENERGETICS; SUPEROXIDE-DISMUTASE; BREAST-CANCER; IN-VIVO; CELLS; APOPTOSIS; DAMAGE	Temozolomide (TMZ) is an oral alkylating agent used for the treatment of high-grade gliomas. Acquired chemoresistance is a severe limitation to this therapy with more than 90% of recurrent gliomas showing no response to a second cycle of chemotherapy. Efforts to better understand the underlying mechanisms of acquired chemoresistance to TMZ and potential strategies to overcome chemoresistance are, therefore, critically needed. TMZ methylates nuclear DNA and induces cell death; however, the impact on mitochondria DNA (mtDNA) and mitochondrial bioenergetics is not known. Herein, we tested the hypothesis that TMZ-mediated alterations in mtDNA and respiratory function contribute to TMZ-dependent acquired chemoresistance. Using an in vitro model of TMZ-mediated acquired chemoresistance, we report 1) a decrease in mtDNA copy number and the presence of large heteroplasmic mtDNA deletions in TMZ-resistant glioma cells, 2) remodeling of the entire electron transport chain with significant decreases of complexes I and V and increases of complexes II/III and IV, and 3) pharmacologic and genetic manipulation of cytochrome c oxidase, which restores sensitivity to TMZ-dependent apoptosis in resistant glioma cells. Importantly, human primary and recurrent pairs of glioblastoma multiforme (GBM) biopsies as well as primary and TMZ-resistant GBM xenograft lines exhibit similar remodeling of the ETC. Overall these results suggest that TMZ-dependent acquired chemoresistance may be due to a mitochondrial adaptive response to TMZ genotoxic stress with a major contribution from cytochrome c oxidase. Thus, abrogation of this adaptive response may reverse chemoresistance and restore sensitivity to TMZ, providing a strategy for improved therapeutic outcomes in GBM patients.	[Oliva, Claudia R.; McClugage, Samuel G., III; Markert, James M.; Gillespie, G. Yancey; Griguer, Corinne E.] Univ Alabama Birmingham, Div Neurosurg, Dept Surg, Birmingham, AL 35294 USA; [Diers, Anne; Darley-Usmar, Victor M.; Bailey, Shannon M.; Landar, Aimee; Griguer, Corinne E.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Bailey, Shannon M.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Diers, Anne; Darley-Usmar, Victor M.; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Div Cellular & Mol Pathol, Birmingham, AL 35294 USA; [Nozell, Susan E.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic	Griguer, CE (corresponding author), Univ Alabama Birmingham, Div Neurosurg, Dept Surg, 1900 Univ Blvd,Rm 1032 THT, Birmingham, AL 35294 USA.	cgriguer@uab.edu	Landar, Aimee/F-7269-2010	Landar, Aimee/0000-0003-2306-9214; Gillespie, George/0000-0001-6436-9542; Oliva, Claudia/0000-0003-0624-5490; , Corinne/0000-0003-3877-5031; Darley-Usmar, Victor/0000-0001-8921-7086; Bailey, Shannon/0000-0003-0002-3424	National Institutes of Health (NCI, USPHS) [P30 CA13148-35]; NCI [P50 CA097247, P50 CA108961, RO1 CA127716, R21 CA139290]; NATIONAL CANCER INSTITUTE [R01CA160821, R21CA139290, P30CA013148, R01CA127716, P50CA108961, P50CA097247] Funding Source: NIH RePORTER	National Institutes of Health (NCI, USPHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 CA13148-35 (NCI, to the University of Alabama Comprehensive Cancer Center Collaborative Programmatic Development Grant Program from the USPHS) and P50 CA097247, P50 CA108961, RO1 CA127716, and R21 CA139290 (NCI).	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Chiaratti MR, 2006, GENET MOL RES, V5, P55; CRADDOCK VM, 1965, BIOCHEM J, V94, P323, DOI 10.1042/bj0940323; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dumitru CA, 2009, J CELL PHYSIOL, V221, P688, DOI 10.1002/jcp.21907; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2007, J NEURO-ONCOL, V81, P9, DOI 10.1007/s11060-006-9201-6; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; HIGUCHI Y, 1995, J BIOL CHEM, V270, P7950, DOI 10.1074/jbc.270.14.7950; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hirose Y, 2001, CANCER RES, V61, P1957; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; JONES DP, 1979, BIOCHIM BIOPHYS ACTA, V576, P17, DOI 10.1016/0005-2795(79)90480-X; KENNEDY FG, 1986, AM J PHYSIOL, V250, pC374, DOI 10.1152/ajpcell.1986.250.3.C374; KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; LeDoux SP, 1998, GLIA, V24, P304, DOI 10.1002/(SICI)1098-1136(199811)24:3<304::AID-GLIA4>3.3.CO;2-J; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Middlemas DS, 2000, CLIN CANCER RES, V6, P998; Minniti G, 2009, ANTICANCER RES, V29, P5171; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; OBERLEY LW, 1979, CANCER RES, V39, P1141; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Plummer ER, 2005, CLIN CANCER RES, V11, P3402, DOI 10.1158/1078-0432.CCR-04-2353; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Richard SM, 2000, CANCER RES, V60, P4231; ROBERTS JJ, 1963, BIOCHEM PHARMACOL, V12, P1329, DOI 10.1016/0006-2952(63)90202-8; SILBER JR, 1993, CANCER RES, V53, P3416; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; Tentori L, 1997, MOL PHARMACOL, V52, P249, DOI 10.1124/mol.52.2.249; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Watson MB, 2007, ANTI-CANCER DRUG, V18, P749, DOI 10.1097/CAD.0b013e3280a02f43; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037	70	135	136	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39759	39767		10.1074/jbc.M110.147504	http://dx.doi.org/10.1074/jbc.M110.147504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20870728	hybrid, Green Published			2022-12-25	WOS:000285185500020
J	Inanobe, A; Nakagawa, A; Matsuura, T; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Matsuura, Takanori; Kurachi, Yoshihisa			A Structural Determinant for the Control of PIP2 Sensitivity in G Protein-gated Inward Rectifier K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; SODIUM-DEPENDENT ACTIVATION; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; BINDING; DOMAIN; KIR2.1; IDENTIFICATION; MUTATIONS; MECHANISM	Inward rectifier K+ (Kir) channels are activated by phosphatidylinositol-(4,5)-bisphosphate (PIP2), but G protein-gated Kir (K-G) channels further require either G protein beta gamma subunits (G beta gamma) or intracellular Na+ for their activation. To reveal the mechanism(s) underlying this regulation, we compared the crystal structures of the cytoplasmic domain of K-G channel subunit Kir3.2 obtained in the presence and the absence of Na+. The Na+-free Kir3.2, but not the Na+-plus Kir3.2, possessed an ionic bond connecting the N terminus and the CD loop of the C terminus. Functional analyses revealed that the ionic bond between His-69 on the N terminus and Asp-228 on the CD loop, which are known to be critically involved in G beta gamma- and Na+-dependent activation, lowered PIP2 sensitivity. The conservation of these residues within the K-G channel family indicates that the ionic bond is a character that maintains the channels in a closed state by controlling the PIP2 sensitivity.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Suita, Osaka 5650871, Japan; [Matsuura, Takanori] Osaka Univ, Lab Prot Informat, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019; Matsuura, Takanori/J-1413-2012	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Matsuura, Takanori/0000-0003-2001-9537	Ministry of Education, Culture, Sports, Science and Technology of Japan [508 19036011, 516 17079005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by Grant-in-aid for Scientific Research for Priority Areas and 508 19036011 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. To whom correspondence may be addressed: Dept. of Pharmacology, Graduate School of Medicine, Osaka University, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-3512; Fax: 81-6-6879-3519; E-mail: inanobe@pharma2.med.osaka-u.ac.jp.; Supported by Grant-in-aid for Scientific Research for Priority Areas 516 17079005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. To whom correspondence may be addressed: Dept. of Pharmacology, Graduate School of Medicine, Osaka University, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-3512; Fax: 81-6-6879-3519; E-mail: ykurachi@pharma2.med.osaka-u.ac.jp.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; EISENMAN G, 1962, Biophys J, V2, P259; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mao JZ, 2003, J BIOL CHEM, V278, P7091, DOI 10.1074/jbc.M211461200; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Yamada M, 1998, PHARMACOL REV, V50, P723; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	40	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38517	38523		10.1074/jbc.M110.161703	http://dx.doi.org/10.1074/jbc.M110.161703			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880843	Green Published, hybrid			2022-12-25	WOS:000284625600057
J	Kozlov, G; Pocanschi, CL; Rosenauer, A; Bastos-Aristizabal, S; Gorelik, A; Williams, DB; Gehring, K				Kozlov, Guennadi; Pocanschi, Cosmin L.; Rosenauer, Angelika; Bastos-Aristizabal, Sara; Gorelik, Alexei; Williams, David B.; Gehring, Kalle			Structural Basis of Carbohydrate Recognition by Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; P-DOMAIN; VIRAL GLYCOPROTEINS; MUTATIONAL ANALYSIS; BINDING-PROPERTIES; IN-VITRO; CALNEXIN; LECTIN	The calnexin cycle is a process by which glycosylated proteins are subjected to folding cycles in the endoplasmic reticulum lumen via binding to the membrane protein calnexin ( CNX) or to its soluble homolog calreticulin ( CRT). CNX and CRT specifically recognize monoglucosylated Glc(1)Man(9)GlcNAc(2) glycans, but the structural determinants underlying this specificity are unknown. Here, we report a 1.95-angstrom crystal structure of the CRT lectin domain in complex with the tetrasaccharide alpha-Glc(1 -> 3)-alpha-Man-(1 -> 2)-alpha-Man-(1 -> 2)-Man.The tetrasaccharide binds to a long channel on CRT formed by a concave beta-sheet. All four sugar moieties are engaged in the protein binding via an extensive network of hydrogen bonds and hydrophobic contacts. The structure explains the requirement for glucose at the nonreducing end of the carbohydrate; the oxygen O-2 of glucose perfectly fits to a pocket formed by CRT side chains while forming direct hydrogen bonds with the carbonyl of Gly(124) and the side chain of Lys(111). The structure also explains a requirement for the Cys(105)-Cys(137) disulfide bond in CRT/CNX for efficient carbohydrate binding. The Cys(105)-Cys(137) disulfide bond is involved in intimate contacts with the third and fourth sugar moieties of the Glc(1)Man(3) tetrasaccharide. Finally, the structure rationalizes previous mutagenesis of CRT and lays a structural groundwork for future studies of the role of CNX/CRT in diverse biological pathways.	[Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Pocanschi, Cosmin L.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pocanschi, Cosmin L.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	McGill University; University of Toronto; University of Toronto	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Gorelik, Alexei/0000-0001-6236-4633	Canadian Institutes of Health [MOP-81277, MOP-53310]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes of Health Research Grants MOP-81277 (to K. G.) and MOP-53310 (to D. B. W.).; Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Award RR-01646.	BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Gopalakrishnapai J, 2006, BIOCHEM BIOPH RES CO, V351, P14, DOI 10.1016/j.bbrc.2006.09.164; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KHANNA NC, 1986, J BIOL CHEM, V261, P8883; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Peterson JR, 1999, J CELL SCI, V112, P2775; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rodan AR, 1996, EMBO J, V15, P6921, DOI 10.1002/j.1460-2075.1996.tb01084.x; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Giraldo AMV, 2010, J BIOL CHEM, V285, P4544, DOI 10.1074/jbc.M109.034512; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	55	98	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38612	38620		10.1074/jbc.M110.168294	http://dx.doi.org/10.1074/jbc.M110.168294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880849	Green Published, hybrid			2022-12-25	WOS:000284625600065
J	Boland, B; Smith, DA; Mooney, D; Jung, SS; Walsh, DM; Platt, FM				Boland, Barry; Smith, David A.; Mooney, Declan; Jung, Sonia S.; Walsh, Dominic M.; Platt, Frances M.			Macroautophagy Is Not Directly Involved in the Metabolism of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK-C DISEASE; BETA-PROTEIN; ALZHEIMERS-DISEASE; AUTOPHAGIC VACUOLES; STORAGE DISEASE; ACCUMULATION; AGGREGATION; TRAFFICKING; FRAGMENTS; NEURODEGENERATION	Alterations in the metabolism of amyloid precursor protein (APP) are believed to play a central role in Alzheimer disease pathogenesis. Burgeoning data indicate that APP is proteolytically processed in endosomal-autophagic-lysosomal compartments. In this study, we used both in vivo and in vitro paradigms to determine whether alterations in macroautophagy affect APP metabolism. Three mouse models of glycosphingolipid storage diseases, namely Niemann-Pick type C1, GM1 gangliosidosis, and Sandhoff disease, had mTOR-independent increases in the autophagic vacuole (AV)-associated protein, LC3-II, indicative of impaired lysosomal flux. APP C-terminal fragments (APP-CTFs) were also increased in brains of the three mouse models; however, discrepancies between LC3-II and APP-CTFs were seen between primary (GM1 gangliosidosis and Sandhoff disease) and secondary (Niemann-Pick type C1) lysosomal storage models. APP-CTFs were proportionately higher than LC3-II in cerebellar regions of GM1 gangliosidosis and Sandhoff disease, although LC3-II increased before APP-CTFs in brains of NPC1 mice. Endogenous murine A beta 40 from RIPA-soluble extracts was increased in brains of all three mice. The in vivo relationship between AV and APP-CTF accumulation was also seen in cultured neurons treated with agents that impair primary (chloroquine and leupeptin + pepstatin) and secondary (U18666A and vinblastine) lysosomal flux. However, A beta secretion was unaffected by agents that induced autophagy (rapamycin) or impaired AV clearance, and LC3-II-positive AVs predominantly co-localized with degradative LAMP-1-positive lysosomes. These data suggest that neuronal macroautophagy does not directly regulate APP metabolism but highlights the important anti-amyloidogenic role of lysosomal proteolysis in post-secretase APP-CTF catabolism.	[Boland, Barry] Univ Coll Dublin, Lab Neurodegenerat Res, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland; [Jung, Sonia S.] Centocor Res & Dev Inc, Radnor, PA 19087 USA; [Boland, Barry; Smith, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University College Dublin; Johnson & Johnson; Johnson & Johnson USA; University of Oxford	Boland, B (corresponding author), Univ Coll Dublin, Lab Neurodegenerat Res, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland.	barry.boland@ucd.ie; dominic.walsh@ucd.ie; frances.platt@pharm.ox.ac.uk	Boland, Barry/D-1235-2010	Boland, Barry/0000-0003-2676-4343; Platt, Frances/0000-0001-7614-0403	Health Research Board of Ireland [PD/2008/40]; University College Dublin; Wellcome Trust [069883/B/02/Z]	Health Research Board of Ireland; University College Dublin; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Health Research Board of Ireland Grant PD/2008/40, University College Dublin Seed Fund, Wellcome Trust Grant 069883/B/02/Z, and Science Foundation Ireland Grant 08/1N.1/B2033.	Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Burns M, 2003, J NEUROSCI, V23, P5645; Burns MP, 2006, NEUROMOL MED, V8, P319, DOI 10.1385/NMM:8:3:319; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1996, J NEUROPATH EXP NEUR, V55, P704, DOI 10.1097/00005072-199606000-00004; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; Dante S, 2002, BIOPHYS J, V83, P2610, DOI 10.1016/S0006-3495(02)75271-5; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; GORDON PB, 1992, BIOCHEM J, V283, P361, DOI 10.1042/bj2830361; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kim JH, 2001, J NEUROSCI, V21, P1327; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KOZLOWSKI MR, 1992, J NEUROSCI, V12, P1679; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; Ong WY, 2001, EXP BRAIN RES, V141, P218, DOI 10.1007/s002210100870; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PUNNONEN EL, 1993, EUR J CELL BIOL, V61, P54; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; SANDHOFF K, 1968, Pathologia Europaea, V3, P278; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Savage MJ, 1998, J NEUROSCI, V18, P1743; Schmidt Stephen D., 2004, V299, P279; Schmidt Stephen D., 2004, V299, P267; SIMAN R, 1993, J BIOL CHEM, V268, P16602; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; Taniguchi M, 2001, BRAIN DEV-JPN, V23, P414, DOI 10.1016/S0387-7604(01)00252-2; van der Voorn JP, 2004, ACTA NEUROPATHOL, V107, P539, DOI 10.1007/s00401-004-0848-9; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	71	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37415	37426		10.1074/jbc.M110.186411	http://dx.doi.org/10.1074/jbc.M110.186411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864542	Green Published, hybrid			2022-12-25	WOS:000284424000034
J	Rhodes, CJ; Demetrius, L				Rhodes, Christopher J.; Demetrius, Lloyd			Evolutionary Entropy Determines Invasion Success in Emergent Epidemics	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; INFECTIOUS-DISEASES; INFLUENZA; STRAIN; PERSISTENCE; IMPACT	Background: Standard epidemiological theory claims that in structured populations competition between multiple pathogen strains is a deterministic process which is mediated by the basic reproduction number (R-0) of the individual strains. A new theory based on analysis, simulation and empirical study challenges this predictor of success. Principal Findings: We show that the quantity R-0 is a valid predictor in structured populations only when size is infinite. In this article we show that when population size is finite the dynamics of infection by multi-strain pathogens is a stochastic process whose outcome can be predicted by evolutionary entropy, S, an information theoretic measure which describes the uncertainty in the infectious age of an infected parent of a randomly chosen new infective. Evolutionary entropy characterises the demographic stability or robustness of the population of infectives. This statistical parameter determines the duration of infection and thus provides a quantitative index of the pathogenicity of a strain. Standard epidemiological theory based on R-0 as a measure of selective advantage is the limit as the population size tends to infinity of the entropic selection theory. The standard model is an approximation to the entropic selection theory whose validity increases with population size. Conclusion: An epidemiological analysis based on entropy is shown to explain empirical observations regarding the emergence of less pathogenic strains of human influenza during the antigenic drift phase. Furthermore, we exploit the entropy perspective to discuss certain epidemiological patterns of the current H1N1 swine 'flu outbreak.	[Rhodes, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England; [Demetrius, Lloyd] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Demetrius, Lloyd] Max Planck Inst Mol Genet, Berlin, Germany	Imperial College London; Harvard University; Max Planck Society	Rhodes, CJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England.	c.rhodes@imperial.ac.uk			Research Councils of the United Kingdom; Medical Research Council [G0600719B] Funding Source: researchfish	Research Councils of the United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Research Councils of the United Kingdom (www.rcuk.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Creanza N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008544; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEMETRIUS L, 1983, J STAT PHYS, V30, P709, DOI 10.1007/BF01009685; DEMETRIUS L, 1974, P NATL ACAD SCI USA, V71, P4645, DOI 10.1073/pnas.71.12.4645; Demetrius L, 1997, P NATL ACAD SCI USA, V94, P3491, DOI 10.1073/pnas.94.8.3491; Demetrius L, 1999, STOCHASTIC DYNAMICS, P371, DOI 10.1007/0-387-22655-9_16; Demetrius L, 2007, THEOR POPUL BIOL, V72, P323, DOI 10.1016/j.tpb.2007.05.004; Demetrius L, 2009, PHYSICA A, V388, P651, DOI 10.1016/j.physa.2008.10.048; Demetrius L, 2009, B MATH BIOL, V71, P800, DOI 10.1007/s11538-008-9382-6; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Enserink M, 2003, SCIENCE, V300, P1351; Fisher R.A., 1930, GENETICAL THEORY NAT; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gomes MGM, 2002, P ROY SOC B-BIOL SCI, V269, P227, DOI 10.1098/rspb.2001.1869; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling, 2008, MODELLING INFECT DIS; Kowald A, 2005, P ROY SOC B-BIOL SCI, V272, P741, DOI 10.1098/rspb.2004.3012; Levine A., 1992, VIRUSES; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; Meyers LA, 2007, B AM MATH SOC, V44, P63; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; [No title captured]	42	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12951	10.1371/journal.pone.0012951	http://dx.doi.org/10.1371/journal.pone.0012951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886082	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100046
J	Gul, N; Smith, LA; Ahmed, SA				Gul, Nizamettin; Smith, Leonard A.; Ahmed, S. Ashraf			Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form	PLOS ONE			English	Article							RECEPTOR-BINDING-SITE; HEAVY-CHAIN; SEROTYPE-A; SUBSTRATE RECOGNITION; STRUCTURAL-ANALYSIS; IDENTIFICATION; TRANSLOCATION; PROTEINS; CLEAVAGE; PROTEASE	Botulinum neurotoxins (BoNT) are the most potent of all toxins. The 50 kDa N-terminal endopeptidase catalytic light chain (LC) of BoNT is located next to its central, putative translocation domain. After binding to the peripheral neurons, the central domain of BoNT helps the LC translocate into cytosol where its proteolytic action on SNARE (soluble NSF attachment protein receptor) proteins blocks exocytosis of acetyl choline leading to muscle paralysis and eventual death. The translocation domain also contains 105 angstrom -long stretch of similar to 100 residues, known as "belt,'' that crosses over and wraps around the LC to shield the active site from solvent. It is not known if the LC gets dissociated from the rest of the molecule in the cytosol before catalysis. To investigate the structural identity of the protease, we prepared four variants of type A BoNT (BoNT/A) LC, and compared their catalytic parameters with those of BoNT/A whole toxin. The four variants were LC + translocation domain, a trypsin-nicked LC + translocation domain, LC + belt, and a free LC. Our results showed that K(m) for a 17-residue SNAP-25 (synaptosomal associated protein of 25 kDa) peptide for these constructs was not very different, but the turnover number (k(cat)) for the free LC was 6-100-fold higher than those of its four variants. Moreover, none of the four variants of the LC was prone to autocatalysis. Our results clearly demonstrated that in vitro, the LC minus the rest of the molecule is the most catalytically active form. The results may have implication as to the identity of the active, toxic moiety of BoNT/A in vivo.	[Gul, Nizamettin; Smith, Leonard A.; Ahmed, S. Ashraf] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Integrated Toxicol Div, Ft Detrick, MD 21702 USA; [Smith, Leonard A.] USA, Med Res & Mat Command, Ft Detrick, MD USA		Gul, N (corresponding author), CBMS, MITS, Ft Detrick, MD USA.	syed.ahmed@amedd.army.mil			Joint Science and Technology Office - Chemical and Biological Defense [CBS.MEDBIO.01.10.RD.002]	Joint Science and Technology Office - Chemical and Biological Defense	The research described herein was supported by Joint Science and Technology Office - Chemical and Biological Defense project number CBS.MEDBIO.01.10.RD.002 to SAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; Ahmed SA, 2000, J PROTEIN CHEM, V19, P475, DOI 10.1023/A:1026549431380; Alderton JM, 2000, CELL CALCIUM, V28, P161, DOI 10.1054/ceca.2000.0144; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Beecher DJ, 1997, J PROTEIN CHEM, V16, P701, DOI 10.1023/A:1026358504860; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Brown DR, 1997, HYBRIDOMA, V16, P447, DOI 10.1089/hyb.1997.16.447; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cai SW, 2001, BIOCHEMISTRY-US, V40, P15327, DOI 10.1021/bi011350g; CANTOR CH, 1982, PROTEINS, P145; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; DanielsHolgate PU, 1996, J NEUROSCI RES, V44, P263, DOI 10.1002/(SICI)1097-4547(19960501)44:3<263::AID-JNR7>3.0.CO;2-E; DasGupta BR, 2005, PROTEIN J, V24, P337, DOI 10.1007/s10930-005-7589-z; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Jayaraman S, 2005, BIOCHEM BIOPH RES CO, V330, P97, DOI 10.1016/j.bbrc.2005.02.123; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; Maurel MC, 2006, PHYS LIFE REV, V3, P56, DOI 10.1016/j.plrev.2005.12.001; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Ringe D, 2008, NAT CHEM BIOL, V4, P325, DOI 10.1038/nchembio0608-325; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12872	10.1371/journal.pone.0012872	http://dx.doi.org/10.1371/journal.pone.0012872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877571	gold, Green Submitted, Green Published			2022-12-25	WOS:000282053100024
J	Wang, YC; Huang, CC; Hsu, KS				Wang, Yu-Chen; Huang, Chiung-Chun; Hsu, Kuei-Sen			The Role of Growth Retardation in Lasting Effects of Neonatal Dexamethasone Treatment on Hippocampal Synaptic Function	PLOS ONE			English	Article							MATERNAL-CARE; TOTAL NUMBER; OUTCOMES; NEURONS; LTD; RAT; ACTIVATION; PLASTICITY; SYNAPSES; BEHAVIOR	Background: Dexamethasone (DEX), a synthetic glucocorticoid, is commonly used to prevent or lessen the morbidity of chronic lung disease in preterm infants. However, evidence is now increasing that this clinical practice negatively affects somatic growth and may result in long-lasting neurodevelopmental deficits. We therefore hypothesized that supporting normal somatic growth may overcome the lasting adverse effects of neonatal DEX treatment on hippocampal function. Methodology/Principal Findings: To test this hypothesis, we developed a rat model using a schedule of tapering doses of DEX similar to that used in premature infants and examined whether the lasting influence of neonatal DEX treatment on hippocampal synaptic plasticity and memory performance are correlated with the deficits in somatic growth. We confirmed that neonatal DEX treatment switched the direction of synaptic plasticity in hippocampal CA1 region, favoring low-frequency stimulation-and group I metabotropic glutamate receptor agonist (S)-3,5,-dihydroxyphenylglycine-induced long-term depression (LTD), and opposing the induction of long-term potentiation (LTP) by high-frequency stimulation in the adolescent period. The effects of DEX on LTP and LTD were correlated with an increase in the autophosphorylation of Ca2+/ calmodulin-dependent protein kinase II at threonine-286 and a decrease in the protein phosphatase 1 expression. Neonatal DEX treatment resulted in a disruption of memory retention subjected to object recognition task and passive avoidance learning. The adverse effects of neonatal DEX treatment on hippocampal synaptic plasticity and memory performance of the animals from litters culled to 4 pups were significantly less than those for the 8-pup litters. However, there was no significant difference in maternal care between groups. Conclusion/Significance: Our results demonstrate that growth retardation plays a crucial role in DEX-induced long-lasting influence of hippocampal function. Our findings suggest that therapeutic strategies designed to support normal development and somatic growth may exert beneficial effects to reduce lasting adverse effects following neonatal DEX treatment.	[Wang, Yu-Chen; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Hsu, Kuei-Sen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021		National Science Council, Taiwan [NSC98-2321-B-006-008, NSC98-2320-B-006-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants (NSC98-2321-B-006-008; NSC98-2320-B-006-005-MY3) from the National Science Council, Taiwan (http://web1.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnish ND, 1997, FUND APPL TOXICOL, V38, P2, DOI 10.1006/faat.1997.2318; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bashir ZI, 2003, NEUROSCI RES, V45, P363, DOI 10.1016/S0168-0102(03)00002-6; Berry MA, 1997, PEDIATRICS, V100, P640; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Ferguson SA, 1999, NEUROTOXICOL TERATOL, V21, P71, DOI 10.1016/S0892-0362(98)00029-4; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huang CC, 2007, PEDIATR RES, V62, P267, DOI 10.1203/PDR.0b013e318123f744; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kamphuis PJGH, 2004, NEUROPHARMACOLOGY, V47, P461, DOI 10.1016/j.neuropharm.2004.04.008; Kamphuis PJGH, 2003, FASEB J, V17, P911, DOI 10.1096/fj.02-0333fje; Kreckmann K. H., 1994, Teratology, V49, P402; Kreider ML, 2006, NEUROPSYCHOPHARMACOL, V31, P12, DOI 10.1038/sj.npp.1300783; KUMARESAN P, 1967, P SOC EXP BIOL MED, V126, P41, DOI 10.3181/00379727-126-32363; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; Leitch CA, 1999, PEDIATR RES, V46, P109, DOI 10.1203/00006450-199907000-00018; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lin HJ, 2006, ANN NEUROL, V59, P939, DOI 10.1002/ana.20885; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MINGS JJ, 1989, NEW ENGL J MED, V320, P1505; Morrow BA, 2005, J COMP NEUROL, V488, P215, DOI 10.1002/cne.20599; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P29, DOI 10.1002/dev.420220104; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Palmer AK, 1997, FUND APPL TOXICOL, V38, P7, DOI 10.1006/faat.1997.2319; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Shiroma S, 2005, NEUROPHARMACOLOGY, V49, P97, DOI 10.1016/j.neuropharm.2005.02.002; Shrivastava A, 2000, EUR J PEDIATR, V159, P380, DOI 10.1007/s004310051291; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	44	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12806	10.1371/journal.pone.0012806	http://dx.doi.org/10.1371/journal.pone.0012806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877626	gold, Green Submitted, Green Published			2022-12-25	WOS:000282002900006
J	Yang, M; Zhang, XW; Liu, GM; Yin, YX; Chen, KF; Yun, QZ; Zhao, DJ; Al-Mssallem, IS; Yu, J				Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Al-Mssallem, Ibrahim S.; Yu, Jun			The Complete Chloroplast Genome Sequence of Date Palm (Phoenix dactylifera L.)	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; STRUCTURAL ORGANIZATION; PLASTID DNA; EVOLUTION; ANGIOSPERMS; INVERSIONS	Background: Date palm (Phoenix dactylifera L.), a member of Arecaceae family, is one of the three major economically important woody palms-the two other palms being oil palm and coconut tree-and its fruit is a staple food among Middle East and North African nations, as well as many other tropical and subtropical regions. Here we report a complete sequence of the data palm chloroplast (cp) genome based on pyrosequencing. Methodology/Principal Findings: After extracting 369,022 cp sequencing reads from our whole-genome-shotgun data, we put together an assembly and validated it with intensive PCR-based verification, coupled with PCR product sequencing. The date palm cp genome is 158,462 bp in length and has a typical quadripartite structure of the large (LSC, 86,198 bp) and small single-copy (SSC, 17,712 bp) regions separated by a pair of inverted repeats (IRs, 27,276 bp). Similar to what has been found among most angiosperms, the date palm cp genome harbors 112 unique genes and 19 duplicated fragments in the IR regions. The junctions between LSC/IRs and SSC/IRs show different features of sequence expansion in evolution. We identified 78 SNPs as major intravarietal polymorphisms within the population of a specific cp genome, most of which were located in genes with vital functions. Based on RNA-sequencing data, we also found 18 polycistronic transcription units and three highly expression-biased genes-atpF, trnA-UGC, and rrn23. Conclusions: Unlike most monocots, date palm has a typical cp genome similar to that of tobacco-with little rearrangement and gene loss or gain. High-throughput sequencing technology facilitates the identification of intravarietal variations in cp genomes among different cultivars. Moreover, transcriptomic analysis of cp genes provides clues for uncovering regulatory mechanisms of transcription and translation in chloroplasts.	[Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Al-Mssallem, Ibrahim S.; Yu, Jun] KACST, DPGP, Riyadh, Saudi Arabia; [Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Coll Agr & Food Sci, Dept Biotechnol, Al Hssa, Hofuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; King Faisal University	Yang, M (corresponding author), KACST, DPGP, Riyadh, Saudi Arabia.	imssallem@kacst.edu.sa; junyu@big.ac.cn	郑, 征/C-8514-2011; Yin, Yuxin/G-2694-2014	Yin, Yuxin/0000-0002-1639-285X; , Meng/0000-0002-2672-3069	King Abdulaziz city for science and technology, Riyadh, Saudi Arabia [KACST 428-29]	King Abdulaziz city for science and technology, Riyadh, Saudi Arabia	The project is supported by a project grant from KACST 428-29, King Abdulaziz city for science and technology, Riyadh, Saudi Arabia. The funder had no role in study design and analysis.	Al-Mssallem IS, 1996, ARABIAN GLOBAL ENCY, V7, P182; Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; CAROEBTER JB, 1976, 56 DAT GROW I; CHABANE AAD, 2007, CR BIOL, P330; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fray R, 2003, PHILOS T ROY SOC B, V358, P106; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim KJ, 2005, MOL CELLS, V19, P104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee B, 2006, INT J AUTO TECH-KOR, V7, P61; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; MARY M, 2010, J MOL EVOL, V70, P149; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; SASAKI Y, 1993, FEBS LETT, V316, P93, DOI 10.1016/0014-5793(93)81743-J; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Sghaier-Hammami B, 2009, PROTEOMICS, V9, P2543, DOI 10.1002/pmic.200800523; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; TANGPHATSORNRUA S, 2009, DNA RES, P1; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	196	209	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12762	10.1371/journal.pone.0012762	http://dx.doi.org/10.1371/journal.pone.0012762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856810	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800024
J	Larsen, MV; Lelic, A; Parsons, R; Nielsen, M; Hoof, I; Lamberth, K; Loeb, MB; Buus, S; Bramson, J; Lund, O				Larsen, Mette Voldby; Lelic, Alina; Parsons, Robin; Nielsen, Morten; Hoof, Ilka; Lamberth, Kasper; Loeb, Mark B.; Buus, Soren; Bramson, Jonathan; Lund, Ole			Identification of CD8(+) T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL	PLOS ONE			English	Article							CLASS-I BINDING; INFLUENZA-A; PEPTIDE BINDING; HLA MOLECULES; CTL EPITOPES; GENOME-WIDE; RESPONSES; RECOGNITION; PREDICTION; SPECIFICITY	Background: West Nile virus (WNV) is a growing threat to public health and a greater understanding of the immune response raised against WNV is important for the development of prophylactic and therapeutic strategies. Methodology/Principal Findings: In a reverse-immunology approach, we used bioinformatics methods to predict WNV-specific CD8(+) T cell epitopes and selected a set of peptides that constitutes maximum coverage of 20 fully-sequenced WNV strains. We then tested these putative epitopes for cellular reactivity in a cohort of WNV-infected patients. We identified 26 new CD8(+) T cell epitopes, which we propose are restricted by 11 different HLA class I alleles. Aiming for optimal coverage of human populations, we suggest that 11 of these new WNV epitopes would be sufficient to cover from 48% to 93% of ethnic populations in various areas of the World. Conclusions/Significance: The 26 identified CD8(+) T cell epitopes contribute to our knowledge of the immune response against WNV infection and greatly extend the list of known WNV CD8(+) T cell epitopes. A polytope incorporating these and other epitopes could possibly serve as the basis for a WNV vaccine.	[Larsen, Mette Voldby; Nielsen, Morten; Hoof, Ilka; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lelic, Alina; Parsons, Robin; Loeb, Mark B.; Bramson, Jonathan] McMaster Univ, Inst Mol Med & Hlth, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Lamberth, Kasper; Buus, Soren] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Div Expt Immunol, DK-2200 Copenhagen, Denmark	Technical University of Denmark; McMaster University; University of Copenhagen	Larsen, MV (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	metteb@cbs.dtu.dk	Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014; Buus, Soren/F-5446-2010; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Bramson, Jonathan/0000-0003-2874-6886; Buus, Soren/0000-0001-8363-1999; Hoof, Ilka/0000-0003-3827-7227	National Institutes of Health (NIH) [HHSN266200400025C, HHSN266200400083C]; Danish Research Council for Technology and Production Sciences;  [N01-AI-40066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040066] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (contracts HHSN266200400025C and HHSN266200400083C) and N01-AI-40066 to J.L.B. and M. B. L. as well as by a grant from the Danish Research Council for Technology and Production Sciences (project title "Disease Gene Finding, Somatic Mutations, and Vaccine Design'', principal funding recipient is Soeren Brunak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; DE GROOT AS, 2001, EMERG INFECT DIS, V7, P706; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; HOOF I, 2008, IMMUNOGENETICS; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Klein RS, 2008, TRENDS MOL MED, V14, P286, DOI 10.1016/j.molmed.2008.05.004; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Loeb M, 2005, EMERG INFECT DIS, V11, P1433; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; SETTE A, 1994, J IMMUNOL, V153, P5586; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sylvester-Hvid C, 2004, TISSUE ANTIGENS, V63, P395, DOI 10.1111/j.0001-2815.2004.00221.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010533	41	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12697	10.1371/journal.pone.0012697	http://dx.doi.org/10.1371/journal.pone.0012697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856867	Green Submitted, gold, Green Published			2022-12-25	WOS:000281815700007
J	Hatakeyama, H; Cheng, HX; Wirth, P; Counsell, A; Marcrom, SR; Wood, CB; Pohlmann, PR; Gilbert, J; Murphy, B; Yarbrough, WG; Wheeler, DL; Harari, PM; Guo, Y; Shyr, Y; Slebos, RJ; Chung, CH				Hatakeyama, Hiromitsu; Cheng, Haixia; Wirth, Pamela; Counsell, Ashley; Marcrom, Samuel R.; Wood, Carey Burton; Pohlmann, Paula R.; Gilbert, Jill; Murphy, Barbara; Yarbrough, Wendell G.; Wheeler, Deric L.; Harari, Paul M.; Guo, Yan; Shyr, Yu; Slebos, Robbert J.; Chung, Christine H.			Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; LUNG-CANCER; GEFITINIB RESISTANCE; EXPRESSION PROFILES; PLUS CETUXIMAB; DISTINCT ROLES; NUCLEAR EXPORT; TGF-ALPHA; PHASE-II; GENE	Background: We hypothesized that chronic inhibition of epidermal growth factor receptor (EGFR) by cetuximab, a monoclonal anti-EGFR antibody, induces up-regulation of its ligands resulting in resistance and that microRNAs (miRs) play an important role in the ligand regulation in head and neck squamous cell carcinoma (HNSCC). Methodology/Principal Findings: Genome-wide changes in gene and miR expression were determined in cetuximab-sensitive cell line, SCC1, and its resistant derivative 1Cc8 using DNA microarrays and RT-PCR. The effects of differentially expressed EGFR ligands and miRs were examined by MTS, colony formation, ELISA, and western blot assays. Heparin-binding EGF-like growth factor (HB-EGF) and its regulator, miR-212, were differentially expressed with statistical significance when SCC1 and 1Cc8 were compared for gene and miR expression. Stimulation with HB-EGF induced cetuximab resistance in sensitive cell lines. Inhibition of HB-EGF and the addition of miR-212 mimic induced cetuximab sensitivity in resistant cell lines. MicroRNA-212 and HB-EGF expression were inversely correlated in an additional 33 HNSCC and keratinocyte cell lines. Six tumors and 46 plasma samples from HNSCC patients were examined for HB-EGF levels. HB-EGF plasma levels were lower in newly diagnosed HNSCC patients when compared to patients with recurrent disease. Conclusions/Significance: Increased expression of HB-EGF due to down-regulation of miR-212 is a possible mechanism of cetuximab resistance. The combination of EGFR ligand inhibitors or miR modulators with cetuximab may improve the clinical outcome of cetuximab therapy in HNSCC.	[Hatakeyama, Hiromitsu; Wirth, Pamela; Counsell, Ashley; Marcrom, Samuel R.; Wood, Carey Burton; Pohlmann, Paula R.; Gilbert, Jill; Murphy, Barbara; Guo, Yan] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA; [Cheng, Haixia; Chung, Christine H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Yarbrough, Wendell G.] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Yarbrough, Wendell G.; Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Wheeler, Deric L.; Harari, Paul M.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI USA; [Guo, Yan; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Johns Hopkins University; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University	Hatakeyama, H (corresponding author), Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA.	cchung11@jhmi.edu	Marcrom, Samuel/K-5034-2019; Cheng, Haixia/F-5736-2015	Pohlmann, Paula/0000-0001-7914-5162	Damon Runyon Clinical Investigator Award [CL-28-05]; National Institutes of Health [R01-DE-017982, R01-CA-113448]; Vanderbilt-Ingram Cancer Center; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA113448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017982] Funding Source: NIH RePORTER	Damon Runyon Clinical Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The project was funded in part by Damon Runyon Clinical Investigator Award (CL-28-05) and National Institutes of Health (R01-DE-017982) to CHC, and by Vanderbilt-Ingram Cancer Center and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation. The Vanderbilt-Ingram Cancer Center and an endowment from Barry and Amy Baker to The Barry Baker Laboratory for Head and Neck Cancer provided funds for collection and storage of biospecimens. The PMH laboratory is supported in part by the National Institutes of Health (R01-CA-113448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BISSADA E, 2008, J CLIN ONCOL, V26; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CHAN E, 2010, AM J CLIN O IN PRESS; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Cohen EEW, 2005, CLIN CANCER RES, V11, P8105, DOI 10.1158/1078-0432.CCR-05-0926; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; *IMCLONE SYST INC, 2007, ERB CET PRESCR INF; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; LICITRA L, 2009, J CLIN ONCOL, V27; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mutsaers AJ, 2009, CLIN CANCER RES, V15, P2397, DOI 10.1158/1078-0432.CCR-08-1627; Nanba D, 2004, CYTOKINE GROWTH F R, V15, P13, DOI 10.1016/j.cytogfr.2003.10.002; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Troyer KL, 2001, GASTROENTEROLOGY, V121, P68, DOI 10.1053/gast.2001.25478; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wang F, 2007, CANCER RES, V67, P8486, DOI 10.1158/0008-5472.CAN-07-0498; WHEELER DL, 2008, ONCOGENE; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	47	110	119	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12702	10.1371/journal.pone.0012702	http://dx.doi.org/10.1371/journal.pone.0012702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856931	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700019
J	Nabuurs, C; Huijbregts, B; Wieringa, B; Hilbers, CW; Heerschap, A				Nabuurs, Christine; Huijbregts, Bertolt; Wieringa, Be; Hilbers, Cees W.; Heerschap, Arend			P-31 Saturation Transfer Spectroscopy Predicts Differential Intracellular Macromolecular Association of ATP and ADP in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; CREATINE-KINASE; EXCHANGE-REACTIONS; PHOSPHORYL CONVERSION; RAT-HEART; KINETICS; DIFFUSION; INVIVO; PHOSPHOCREATINE; MITOCHONDRIAL	The kinetics of phosphoryl exchange involving ATP and ADP have been investigated successfully by in vivo P-31 magnetic resonance spectroscopy using magnetization transfer. However, magnetization transfer effects seen on the signals of ATP also could arise from intramolecular cross-relaxation. This relaxation process carries information on the association state of ATP in the cell. To disentangle contributions of chemical exchange and cross-relaxation to magnetization transfer effects seen in 31P magnetic resonance spectroscopy of skeletal muscle, we performed saturation transfer experiments on wild type and double-mutant mice lacking the cytosolic muscle creatine kinase and adenylate kinase isoforms. We find that cross-relaxation, observed as nuclear Overhauser effects (NOEs), is responsible for magnetization transfer between ATP phosphates both in wild type and in mutant mice. Analysis of P-31 relaxation properties identifies these effects as transferred NOEs, i.e. underlying this process is an exchange between free cellular ATP and ATP bound to slowly rotating macromolecules. This explains the beta-ATP signal decrease upon saturation of the gamma-ATP resonance. Although this usually is attributed to beta-ADP <-> beta-ATP phosphoryl exchange, we did not detect an effect of this exchange on the beta-ATP signal as expected for free [ADP], derived from the creatine kinase equilibrium reaction. This indicates that in resting muscle, conditions prevail that prevent saturation of beta-ADP spins and puts into question the derivation of free [ADP] from the creatine kinase equilibrium. We present a model, matching the experimental result, for ADP <-> ATP exchange, in which ADP is only transiently present in the cytosol.	[Nabuurs, Christine; Huijbregts, Bertolt; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands; [Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Hilbers, Cees W.] Radboud Univ Nijmegen, Fac Sci, Phys Chem Lab, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Heerschap, A (corresponding author), Prof Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands.	A.Heerschap@rad.umcn.nl	Nabuurs, Christine I/I-6044-2012; Wieringa, Berend/A-5346-2011; Heerschap, Arend/G-5228-2010	Wieringa, Berend/0000-0001-9192-8020; 	Netherlands Organization for Scientific Research [834.04.007, 40-00506-98-06021]; Prinses Beatrixfonds [WAR06-0217]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Prinses Beatrixfonds	This work was supported by Netherlands Organization for Scientific Research Grants 834.04.007 and 40-00506-98-06021) and the Prinses Beatrixfonds (Grant WAR06-0217).	ALGER JR, 1984, Q REV BIOPHYS, V17, P83, DOI 10.1017/S0033583500005266; Askenasy N, 2002, AM J PHYSIOL-CELL PH, V282, pC338, DOI 10.1152/ajpcell.00404.2001; BACHERT P, 1992, J MAGN RESON, V100, P146, DOI 10.1016/0022-2364(92)90372-E; BRAUER M, 1981, BIOCHEMISTRY-US, V20, P2060, DOI 10.1021/bi00510a050; BRINDLE KM, 1988, PROG NUCL MAG RES SP, V20, P257, DOI 10.1016/0079-6565(88)80003-7; BRINDLE KM, 1985, BIOCHIM BIOPHYS ACTA, V829, P188, DOI 10.1016/0167-4838(85)90188-8; CAMPBELL SL, 1985, FEBS LETT, V193, P189, DOI 10.1016/0014-5793(85)80148-4; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; de Graaf RA, 2000, BIOPHYS J, V78, P1657, DOI 10.1016/S0006-3495(00)76717-8; DU F, 2008, P INT SOC MAGN RES M, P2337; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; GOUDEMANT JF, 1994, NMR BIOMED, V7, P101, DOI 10.1002/nbm.1940070302; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; HENTRICH S, 1993, EUR BIOPHYS J BIOPHY, V22, P31, DOI 10.1007/BF00205810; HORVATH LI, 1989, BIOCHEMISTRY-US, V28, P407, DOI 10.1021/bi00427a056; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; KORETSKY AP, 1985, MAGNET RESON MED, V2, P586, DOI 10.1002/mrm.1910020610; KORETSKY AP, 1986, BIOCHEMISTRY-US, V25, P77, DOI 10.1021/bi00349a012; LeRumeur E, 1997, NMR BIOMED, V10, P67, DOI 10.1002/(SICI)1099-1492(199704)10:2<67::AID-NBM451>3.0.CO;2-D; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; MARTONOSI A, 1960, J BIOL CHEM, V235, P1700; Mathur-De Vre R, 1990, Magn Reson Imaging, V8, P691, DOI 10.1016/0730-725X(90)90003-K; MATTHEWS PM, 1981, BIOCHEM BIOPH RES CO, V103, P1052, DOI 10.1016/0006-291X(81)90915-3; MCGILVERY RW, 1974, J BIOL CHEM, V249, P5845; MOON RB, 1973, J BIOL CHEM, V248, P7276; MURALI N, 1993, BIOCHEMISTRY-US, V32, P12941, DOI 10.1021/bi00210a049; NEEMAN M, 1987, BIOCHIM BIOPHYS ACTA, V930, P179, DOI 10.1016/0167-4889(87)90030-9; Ravalec X, 1999, MAGN RESON MATER PHY, V9, P52; Sehy JV, 2002, MAGN RESON MED, V48, P42, DOI 10.1002/mrm.10181; SHOUBRIDGE EA, 1984, BIOCHIM BIOPHYS ACTA, V805, P72, DOI 10.1016/0167-4889(84)90038-7; SHOUBRIDGE EA, 1982, FEBS LETT, V140, P288, DOI 10.1016/0014-5793(82)80916-2; UGURBIL K, 1987, ANN NY ACAD SCI, V508, P265; VANDEVEN FJM, 1988, J MAGN RESON, V79, P221, DOI 10.1016/0022-2364(88)90216-8; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; WISEMAN RW, 1995, J BIOL CHEM, V270, P12428, DOI 10.1074/jbc.270.21.12428; Zandt HJAI, 2003, J PHYSIOL-LONDON, V548, P847, DOI 10.1113/jphysiol.2002.034538	39	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39588	39596		10.1074/jbc.M110.164665	http://dx.doi.org/10.1074/jbc.M110.164665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20884612	hybrid, Green Published			2022-12-25	WOS:000285185500003
J	McFie, PJ; Stone, SL; Banman, SL; Stone, SJ				McFie, Pamela J.; Stone, Sandra L.; Banman, Shanna L.; Stone, Scot J.			Topological Orientation of Acyl-CoA:Diacylglycerol Acyltransferase-1 (DGAT1) and Identification of a Putative Active Site Histidine and the Role of the N Terminus in Dimer/Tetramer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; CHOLESTEROL ACYLTRANSFERASE-1; MONOACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; MEMBRANE TOPOLOGY; ENZYME; METABOLISM; CLONING	Acyl CoA: diacylglycerol acyltransferase (DGAT) is an integral membrane protein of the endoplasmic reticulum that catalyzes the synthesis of triacylglycerols. Two DGAT enzymes have been identified (DGAT1 and DGAT2) with unique roles in lipid metabolism. DGAT1 is a multifunctional acyltransferase capable of synthesizing diacylglycerol, retinyl, and wax esters in addition to triacylglycerol. Here, we report the membrane topology for murine DGAT1 using protease protections assays and indirect immunofluorescence in conjunction with selective permeabilization of cellular membranes. Topology models based on prediction algorithms suggested that DGAT1 had eight transmembrane domains. In contrast, our data indicate that DGAT1 has three transmembrane domains with the N terminus oriented toward the cytosol. The C-terminal region of DGAT1, which accounts for similar to 50% of the protein, is present in the endoplasmic reticulum lumen and contains a highly conserved histidine residue (His-426) that may be part of the active site. Mutagenesis of His-426 to alanine impaired the ability of DGAT1 to synthesize triacylglycerols as well as retinyl and wax esters in an in vitro acyltransferase assay. Finally, we show that the N-terminal domain of DGAT1 is not required for the catalytic activity of DGAT1 but, instead, may be involved in regulating enzyme activity and dimer/tetramer formation.	[McFie, Pamela J.; Stone, Sandra L.; Banman, Shanna L.; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Stone, SJ (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			CIHR [88063-1, 88063] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; BROADWAY NM, 1995, BIOCHEM J, V310, P989, DOI 10.1042/bj3100989; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cho KH, 2003, BIOCHEM BIOPH RES CO, V309, P864, DOI 10.1016/j.bbrc.2003.08.077; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Friedman J, 2002, NATURE, V415, P268, DOI 10.1038/415268a; Guo ZY, 2007, BIOCHEMISTRY-US, V46, P10063, DOI 10.1021/bi7011367; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; LILLY K, 1990, ARCH BIOCHEM BIOPHYS, V280, P167, DOI 10.1016/0003-9861(90)90532-4; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; MARKWELL MAK, 1976, ARCH BIOCHEM BIOPHYS, V176, P479, DOI 10.1016/0003-9861(76)90191-0; Owen MR, 1997, BIOCHEM J, V323, P17, DOI 10.1042/bj3230017; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang SJY, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-2; Washington L, 2003, J LIPID RES, V44, P1395, DOI 10.1194/jlr.M300123-JLR200; Waterman IJ, 2002, INT J OBESITY, V26, P742, DOI 10.1038/sj.ijo.0801981; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yu CJ, 2002, BIOCHEMISTRY-US, V41, P3762, DOI 10.1021/bi0120188; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139	52	98	111	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37377	37387		10.1074/jbc.M110.163691	http://dx.doi.org/10.1074/jbc.M110.163691			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876538	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000284424000030
J	Merregaert, J; Van Langen, J; Hansen, U; Ponsaerts, P; El Ghalbzouri, A; Steenackers, E; Van Ostade, X; Sercu, S				Merregaert, Joseph; Van Langen, Johanna; Hansen, Uwe; Ponsaerts, Peter; El Ghalbzouri, Abdoelwaheb; Steenackers, Ellen; Van Ostade, Xaveer; Sercu, Sandy			Phospholipid Scramblase 1 Is Secreted by a Lipid Raft-dependent Pathway and Interacts with the Extracellular Matrix Protein 1 in the Dermal Epidermal Junction Zone of Human Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LIPOID PROTEINOSIS; HUMAN KERATINOCYTES; LICHEN-SCLEROSUS; PLASMA-MEMBRANE; COLLAGEN FIBRILS; GENE-EXPRESSION; ECM1; CELLS; DIFFERENTIATION	We examined the interaction of ECM1 (extracellular matrix protein 1) using yeast two-hybrid screening and identified the type II transmembrane protein, PLSCR1 (phospholipid scramblase 1), as a binding partner. This interaction was then confirmed by in vitro and in vivo co-immunoprecipitation experiments, and additional pull-down experiments with GST-tagged ECM1a fragments localized this interaction to occur within the tandem repeat region of ECM1a. Furthermore, immunohistochemical staining revealed a partial overlap of ECM1 and PLSCR1 in human skin at the basal epidermal cell layer. Moreover, in human skin equivalents, both proteins are expressed at the basal membrane in a dermal fibroblast-dependent manner. Next, immunogold electron microscopy of ultrathin human skin sections showed that ECM1 and PLSCR1 co-localize in the extracellular matrix, and using antibodies against ECM1 or PLSCR1 cross-linked to magnetic immunobeads, we were able to demonstrate PLSCR1-ECM1 interaction in human skin extracts. Furthermore, whereas ECM1 is secreted by the endoplasmic/Golgi-dependent pathway, PLSCR1 release from HaCaT keratinocytes occurs via a lipid raft-dependent mechanism, and is deposited in the extracellular matrix. In summary, we here demonstrate that PLSCR1 interacts with the tandem repeat region of ECM1a in the dermal epidermal junction zone of human skin and provide for the first time experimental evidence that PLSCR1 is secreted by an unconventional secretion pathway. These data suggest that PLSCR1 is a multifunctional protein that can function both inside and outside of the cell and together with ECM1 may play a regulatory role in human skin.	[Merregaert, Joseph; Van Langen, Johanna; Steenackers, Ellen; Sercu, Sandy] Univ Antwerp, Mol Biotechnol Lab, B-2610 Antwerp, Belgium; [Van Ostade, Xaveer] Univ Antwerp, Lab Prot Sci Prote & Epigenet Signaling, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Ponsaerts, Peter] Univ Antwerp, Lab Expt Hematol, Vaccine & Infect Dis Inst, B-2610 Antwerp, Belgium; [Hansen, Uwe] Univ Hosp Muenster, Dept Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [El Ghalbzouri, Abdoelwaheb] Leiden Univ, Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands	University of Antwerp; University of Antwerp; University of Antwerp; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Merregaert, J (corresponding author), Univ Pl 1, B-2610 Antwerp, Belgium.	joseph.merregaert@ua.ac.be	Van Ostade, Xaveer/AAG-9587-2020; Ponsaerts, Peter/B-6213-2017; Van Ostade, Xaveer WMP/D-1702-2015	Ponsaerts, Peter/0000-0002-1892-6499; Van Ostade, Xaveer WMP/0000-0003-4078-3014	Deutsche Forschungsgemeinschaft [SFB492, TPA2]; Fund for Scientific Research Flanders; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fund for Scientific Research Flanders(FWO); Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB492, TPA2).; Recipient of a postdoctoral fellowship of the "Fund for Scientific Research Flanders.; Recipient of a Ph. D. fellowship from the "Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen." Present address: EggCentris NV, J. Wybranlaan 40, 1070 Anderlecht, Belgium.	Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BHALERAO J, 1995, J BIOL CHEM, V270, P16385, DOI 10.1074/jbc.270.27.16385; Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108; Chan I, 2004, CLIN EXP DERMATOL, V29, P499, DOI 10.1111/j.1365-2230.2004.01573.x; Chan I, 2007, EXP DERMATOL, V16, P881, DOI 10.1111/j.1600-0625.2007.00608.x; Huang Ying, 2006, Shengli Xuebao, V58, P501; Deckers MML, 2001, BONE, V28, P14, DOI 10.1016/S8756-3282(00)00428-2; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Fujimoto N, 2005, BIOCHEM BIOPH RES CO, V333, P1327, DOI 10.1016/j.bbrc.2005.06.046; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Horev L, 2005, EXP DERMATOL, V14, P891, DOI 10.1111/j.1600-0625.2005.00374.x; Johnson MR, 1997, MATRIX BIOL, V16, P289, DOI 10.1016/S0945-053X(97)90017-2; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nakamaki T, 2002, EXP HEMATOL, V30, P421, DOI 10.1016/S0301-472X(02)00779-8; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Oyama N, 2004, J CLIN INVEST, V113, P1550, DOI 10.1172/GCI200420373; Oyama N, 2003, LANCET, V362, P118, DOI 10.1016/S0140-6736(03)13863-9; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; Ponsaerts P, 2004, GENE THER, V11, P1606, DOI 10.1038/sj.gt.3302342; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sander CS, 2006, BRIT J DERMATOL, V154, P218, DOI 10.1111/j.1365-2133.2005.07001.x; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Sercu S., 2010, TXB AGING SKIN, P77; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Smits P, 2000, J INVEST DERMATOL, V114, P718, DOI 10.1046/j.1523-1747.2000.00916.x; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Urbach E, 1929, VIRCHOWS ARCH A, V273, P285, DOI 10.1007/BF02158983; Van Hougenhouck-Tulleken W, 2004, BRIT J DERMATOL, V151, P413, DOI 10.1111/j.1365-2133.2004.06076.x; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Yu A, 2004, BIOCHEM J, V381, P609, DOI 10.1042/BJ20031857; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	55	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37823	37837		10.1074/jbc.M110.136408	http://dx.doi.org/10.1074/jbc.M110.136408			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870722	Green Published, hybrid			2022-12-25	WOS:000284424000073
J	Lau, AW; Pringle, LM; Quick, L; Riquelme, DN; Ye, Y; Oliveira, AM; Chou, MM				Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Oliveira, Andre M.; Chou, Margaret M.			TRE17/Ubiquitin-specific Protease 6 (USP6) Oncogene Translocated in Aneurysmal Bone Cyst Blocks Osteoblastic Maturation via an Autocrine Mechanism Involving Bone Morphogenetic Protein Dysregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA; KAPPA-B LIGAND; MC3T3-E1 CELLS; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; UBIQUITIN LIGASE; IN-VITRO; DIFFERENTIATION; TRE2; EXPRESSION	Aneurysmal bone cyst (ABC) is a pediatric osseous tumor characterized by extensive destruction of the surrounding bone. The molecular mechanisms underlying its pathogenesis are completely unknown. Recent work showed that translocation of the TRE17/USP6 locus occurs in over 60% of ABC cases resulting in TRE17 overexpression. Immature osteoblasts are presumed to be the cell type harboring translocation of TRE17 in at least a subset of ABCs. However, the effects of TRE17 overexpression on transformation and osteoblast function are unknown. TRE17 encodes a ubiquitin-specific protease (USP) and a TBC (TRE2-Bub2-Cdc16) domain that promotes activation of the Arf6 GTPase. Here we report that TRE17 potently inhibits the maturation of MC3T3 pre-osteoblasts in a USP-dependent and Arf6-independent manner. Notably, we find that TRE17 function is mediated through an autocrine mechanism. Transcriptome analysis of TRE17-expressing cells reveals dysregulation of several pathways with established roles in osteoblast maturation. In particular, signaling through the bone morphogenetic protein (BMP) pathway, a key regulator of osteogenesis, is profoundly altered. TRE17 simultaneously inhibits the expression of BMP-4 while augmenting the BMP antagonist, Gremlin-1. Osteoblastic maturation is restored in TRE17-expressing cells by the addition of exogenous BMP-4, thus establishing a functional role for BMP-4 during TRE17-induced transformation. Because bone homeostasis involves a precise balance between the activities of osteoblasts and osteoclasts, our studies raise the possibility that attenuated osteoblast maturation caused by TRE17 overexpression may contribute to the bone loss/destruction observed in ABC.	[Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Chou, Margaret M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Chou, Margaret M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Oliveira, Andre M.] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Mayo Clinic	Chou, MM (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 3615 Civ Ctr Blvd,ARC 816E, Philadelphia, PA 19104 USA.	mmc@mail.med.upenn.edu			National Institutes of Health [RO1 CA081415]; NCI and NIH [P30 AR050950]; National Research Service [F31CA126488]; NIAMS [P30 AR050950]; NATIONAL CANCER INSTITUTE [R01CA081415, F31CA126488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI and NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA081415 (to M. M. C.) from the NCI and NIH Grant P30 AR050950 (Penn Center for Musculoskeletal Disorders). This work was also supported by National Research Service Award Grant F31CA126488 (to L. M. P.).; The Penn Center for Musculoskeletal Disorders was supported by National Institutes of Health Grant P30 AR050950 from the NIAMS.	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bizimungu C, 2005, BIOCHEM BIOPH RES CO, V335, P883, DOI 10.1016/j.bbrc.2005.07.159; Bizimungu C, 2007, BIOTECHNOL LETT, V29, P1927, DOI 10.1007/s10529-007-9475-6; Cottalorda J, 2007, ARCH ORTHOP TRAUM SU, V127, P105, DOI 10.1007/s00402-006-0223-5; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fujikawa Y, 2001, BONE, V28, P261, DOI 10.1016/S8756-3282(00)00453-1; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Giuliani N, 2004, EXP HEMATOL, V32, P685, DOI 10.1016/j.exphem.2004.03.015; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; Nomura K, 2008, BIOCHEM BIOPH RES CO, V367, P881, DOI 10.1016/j.bbrc.2008.01.023; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Oliveira AM, 2004, CANCER RES, V64, P1920, DOI 10.1158/0008-5472.CAN-03-2827; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Saccomanni B, 2008, ARCH ORTHOP TRAUM SU, V128, P1145, DOI 10.1007/s00402-007-0477-6; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Scheven BAA, 1999, BIOCHEM BIOPH RES CO, V254, P773, DOI 10.1006/bbrc.1998.9909; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shih C, 1996, Zhonghua Yi Xue Za Zhi (Taipei), V57, P85; van de Luijtgaarden ACM, 2009, VIRCHOWS ARCH, V455, P455, DOI 10.1007/s00428-009-0845-4; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	36	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37111	37120		10.1074/jbc.M110.175133	http://dx.doi.org/10.1074/jbc.M110.175133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864534	Green Published, hybrid			2022-12-25	WOS:000284146100063
J	Bru, A; Cardona, PJ				Bru, Antonio; Cardona, Pere-Joan			Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; GRANULOMA-FORMATION; MURINE MACROPHAGES; TUBERCLE-BACILLI; SERUM THERAPY; BCG INFECTION; IN-VITRO	Background: Mycobacterium tuberculosis is a particularly aggressive microorganism and the host's defense is based on the induction of cellular immunity, in which the creation of a granulomatous structure has an important role. Methodology: We present here a new 2D cellular automata model based on the concept of a multifunctional process that includes key factors such as the chemokine attraction of the cells; the role of innate immunity triggered by natural killers; the presence of neutrophils; apoptosis and necrosis of infected macrophages; the removal of dead cells by macrophages, which induces the production of foamy macrophages (FMs); the life cycle of the bacilli as a determinant for the evolution of infected macrophages; and the immune response. Results: The results obtained after the inclusion of two degrees of tolerance to the inflammatory response triggered by the infection shows that the model can cover a wide spectrum, ranging from highly-tolerant (i.e. mice) to poorly-tolerant hosts (i.e. mini-pigs or humans). Conclusions: This model suggest that stopping bacillary growth at the onset of the infection might be difficult and the important role played by FMs in bacillary drainage in poorly-tolerant hosts together with apoptosis and innate lymphocytes. It also shows the poor ability of the cellular immunity to control the infection, provides a clear protective character to the granuloma, due its ability to attract a sufficient number of cells, and explains why an already infected host can be constantly reinfected.	[Bru, Antonio] Univ Complutense Madrid, Dept Matemat Aplicada, Fac Matemat, Madrid, Spain; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain; [Cardona, Pere-Joan] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Palma de Mallorca, Spain	Complutense University of Madrid; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Bru, A (corresponding author), Univ Complutense Madrid, Dept Matemat Aplicada, Fac Matemat, Madrid, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Mas, Maria Teresa/AAC-2082-2020; Cardona, Pere-Joan/A-5258-2011	Mas, Maria Teresa/0000-0001-6914-5329; Cardona, Pere-Joan/0000-0001-5623-7873	Universidad Complutense de Madrid; Institut Germans Trias i Pujol (IGTP)	Universidad Complutense de Madrid; Institut Germans Trias i Pujol (IGTP)	The authors have been funded by the Universidad Complutense de Madrid and the Institut Germans Trias i Pujol (IGTP). The funders had no role in the decision to publish or preparation of the manuscript.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; BARER M, 2003, DORMANCY LOW GROWTH; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Buchanan RE, 1918, J INFECT DIS, V23, P109, DOI 10.1086/infdis/23.2.109; Buddle BM, 2005, TUBERCULOSIS, V85, P19, DOI 10.1016/j.tube.2004.09.003; Bui TD, 1998, J APPL PHYSIOL, V84, P2070, DOI 10.1152/jappl.1998.84.6.2070; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Canetti G., 1955, TUBERCLE BACILLUS PU; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona Pere-Joan, 2007, Inflammation & Allergy Drug Targets, V6, P27; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Cardona PJ, 2004, EUR RESPIR J, V24, P1044, DOI 10.1183/09031936.04.00072604; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Converse PJ, 1996, INFECT IMMUN, V64, P4776, DOI 10.1128/IAI.64.11.4776-4787.1996; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Dannenberg AM, 2006, PATHOGENESIS OF HUMAN PULMONARY TUBERCULOSIS: INSIGHTS FROM THE RABBIT MODEL, P1; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DesJardin LE, 2002, MICROBIOL-SGM, V148, P3161, DOI 10.1099/00221287-148-10-3161; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2006, MICROBES INFECT, V8, P628, DOI 10.1016/j.micinf.2005.08.014; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Gordillo S, 2006, SCAND J IMMUNOL, V64, P30, DOI 10.1111/j.1365-3083.2006.01765.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guillier L, 2005, APPL ENVIRON MICROB, V71, P2940, DOI 10.1128/AEM.71.6.2940-2948.2005; Guirado E, 2006, MICROBES INFECT, V8, P1252, DOI 10.1016/j.micinf.2005.12.004; HEMSWORTH GR, 1978, INFECT IMMUN, V19, P170, DOI 10.1128/IAI.19.1.170-177.1978; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Holt PG, 2000, J AEROSOL MED, V13, P361, DOI 10.1089/jam.2000.13.361; Holt PG, 2000, AM J RESP CRIT CARE, V162, pS151, DOI 10.1164/ajrccm.162.supplement_3.15tac2; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kipnis A, 2003, J LEUKOCYTE BIOL, V74, P992, DOI 10.1189/jlb.0603301; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Morita RY, 1993, STARVATION BACTERIA, P1, DOI [10.1007/978-1-4899-2439-1_1, DOI 10.1007/978-1-4899-2439-1_1]; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Murray JF, 2010, INT J TUBERC LUNG D, V14, P391; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Otto SP, 2007, BIOL GUIDE MATH MODE; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Paul S, 1996, J INFECT DIS, V174, P105, DOI 10.1093/infdis/174.1.105; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Prats C, 2008, J THEOR BIOL, V252, P56, DOI 10.1016/j.jtbi.2008.01.019; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roberts Esteban A., 2008, V445, P439, DOI 10.1007/978-1-59745-157-4_28; Rodrigues MF, 2009, IMMUNOLOGY, V128, pe691, DOI 10.1111/j.1365-2567.2009.03062.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Silver RF, 1998, INFECT IMMUN, V66, P1190, DOI 10.1128/IAI.66.3.1190-1199.1998; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; WAYNE LG, 1976, AM REV RESPIR DIS, V114, P807; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	82	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12985	10.1371/journal.pone.0012985	http://dx.doi.org/10.1371/journal.pone.0012985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886087	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000282091100062
J	Devi, L; Ohno, M				Devi, Latha; Ohno, Masuo			Phospho-eIF2 alpha Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; BETA-SECRETASE ACTIVITY; CLEAVING ENZYME 1; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VIVO; MOUSE MODELS; A-BETA; SYNAPTIC PLASTICITY	beta-Site APP-cleaving enzyme 1 (BACE1) initiates amyloid-beta (A beta) generation and thus represents a prime therapeutic target in treating Alzheimer's disease (AD). Notably, increasing evidence indicates that BACE1 levels become elevated in AD brains as disease progresses; however, it remains unclear how the BACE1 upregulation may affect efficacies of therapeutic interventions including BACE1-inhibiting approaches. Here, we crossed heterozygous BACE1 knockout mice with AD transgenic mice (5XFAD model) and compared the abilities of partial BACE1 reduction to rescue AD-like phenotypes at earlier (6-month-old) and advanced (15-18-month-old) stages of disease, which expressed normal (similar to 100%) and elevated (similar to 200%) levels of BACE1, respectively. BACE1(+/-) deletion rescued memory deficits as tested by the spontaneous alternation Y-maze task in 5XFAD mice at the earlier stage and prevented their septohippocampal cholinergic deficits associated with significant neuronal loss. Importantly, BACE1(+/-) deletion was no longer able to rescue memory deficits or cholinergic neurodegeneration in 5XFAD mice at the advanced stage. Moreover, BACE1(+/-) deletion significantly reduced levels of A beta 42 and the beta-secretase-cleaved C-terminal fragment (C99) in 6-month-old 5XFAD mouse brains, while these neurotoxic beta-cleavage products dramatically elevated with age and were not affected by BACE1(+/-) deletion in 15-18-month-old 5XFAD brains. Interestingly, although BACE1(+/-) deletion lowered BACE1 expression by similar to 50% in 5XFAD mice irrespective of age in concordance with the reduction in gene copy number, BACE1 equivalent to wild-type controls remained in BACE1(+/-) . 5XFAD mice at the advanced age. In accord, phosphorylation of the translation initiation factor eIF2 alpha, an important mediator of BACE1 elevation, was dramatically increased (similar to 9-fold) in 15-18-month-old 5XFAD mice and remained highly upregulated (similar to 6-fold) in age-matched BACE1(+/-) . 5XFAD mice. Together, our results indicate that partial reduction of BACE1 is not sufficient to block the phospho-eIF2 alpha-dependent BACE1 elevation during the progression of AD, thus limiting its abilities to reduce cerebral A beta/C99 levels and rescue memory deficits and cholinergic neurodegeneration.	[Devi, Latha; Ohno, Masuo] NYU, Sch Med, Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA	Nathan Kline Institute for Psychiatric Research; New York University	Devi, L (corresponding author), NYU, Sch Med, Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA.	mohno@nki.rfmh.org			National Institutes of Health [R01 MH067251]; Alzheimer's Association [IIRG-08-91231]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant R01 MH067251 (M.O.) and Alzheimer's Association grant IIRG-08-91231 (M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RR, 2010, J NEUROCHEM, V112, P1045, DOI 10.1111/j.1471-4159.2009.06528.x; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chang Q, 2004, HIPPOCAMPUS, V14, P170, DOI 10.1002/hipo.10160; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang WP, 2007, FASEB J, V21, P3184, DOI 10.1096/fj.06-7993com; Choi SH, 2001, FASEB J, V15, P1816, DOI 10.1096/fj.00-0859fje; Christensen DZ, 2010, NEUROBIOL AGING, V31, P1153, DOI 10.1016/j.neurobiolaging.2008.07.022; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Contestabile A, 2008, NEUROCHEM RES, V33, P318, DOI 10.1007/s11064-007-9497-4; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; FEASEYTRUGER KJ, 1992, BRAIN RES, V591, P296, DOI 10.1016/0006-8993(92)91711-M; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frisardi V, 2010, CURR ALZHEIMER RES, V7, P40, DOI 10.2174/156720510790274400; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; JAWHAR S, 2010, NEUROBIOL A IN PRESS; John V, 2006, CURR TOP MED CHEM, V6, P569, DOI 10.2174/156802606776743084; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee KW, 2006, NEUROBIOL DIS, V22, P10, DOI 10.1016/j.nbd.2005.09.011; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; OHNO M, 1992, J PHARMACOL EXP THER, V263, P943; Ohno M, 2008, RECENT ADV BIOL SECR, P1; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ohno M, 2006, REV NEUROSCIENCE, V17, P429; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Sanchez G, 2009, J NEUROSCI RES, V87, P691, DOI 10.1002/jnr.21876; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Song DK, 1998, J NEUROCHEM, V71, P875; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	60	82	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12974	10.1371/journal.pone.0012974	http://dx.doi.org/10.1371/journal.pone.0012974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886088	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100058
J	Nufio, CR; McGuire, CR; Bowers, MD; Guralnick, RP				Nufio, Cesar R.; McGuire, Chris R.; Bowers, M. Deane; Guralnick, Robert P.			Grasshopper Community Response to Climatic Change: Variation Along an Elevational Gradient	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; ALTITUDINAL VARIATION; ORTHOPTERA-ACRIDIDAE; NORTHERN COLORADO; ROCKY MOUNTAINS; THERMAL TIME; BUTTERFLIES; ABUNDANCE; IMPACTS; MODEL	Background: The impacts of climate change on phenological responses of species and communities are well-documented; however, many such studies are correlational and so less effective at assessing the causal links between changes in climate and changes in phenology. Using grasshopper communities found along an elevational gradient, we present an ideal system along the Front Range of Colorado USA that provides a mechanistic link between climate and phenology. Methodology/Principal Findings: This study utilizes past (1959-1960) and present (2006-2008) surveys of grasshopper communities and daily temperature records to quantify the relationship between amount and timing of warming across years and elevations, and grasshopper timing to adulthood. Grasshopper communities were surveyed at four sites, Chautauqua Mesa (1752 m), A1 (2195 m), B1 (2591 m), and C1 (3048 m), located in prairie, lower montane, upper montane, and subalpine life zones, respectively. Changes to earlier first appearance of adults depended on the degree to which a site warmed. The lowest site showed little warming and little phenological advancement. The next highest site (A1) warmed a small, but significant, amount and grasshopper species there showed inconsistent phenological advancements. The two highest sites warmed the most, and at these sites grasshoppers showed significant phenological advancements. At these sites, late-developing species showed the greatest advancements, a pattern that correlated with an increase in rate of late-season warming. The number of growing degree days (GDDs) associated with the time to adulthood for a species was unchanged across the past and present surveys, suggesting that phenological advancement depended on when a set number of GDDs is reached during a season. Conclusions: Our analyses provide clear evidence that variation in amount and timing of warming over the growing season explains the vast majority of phenological variation in this system. Our results move past simple correlation and provide a stronger process-oriented and predictive framework for understanding community level phenological responses to climate change.	[Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Nufio, Cesar R.; McGuire, Chris R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA; [McGuire, Chris R.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Nufio, CR (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	nufio@colorado.edu		BOWERS, M/0000-0002-5697-888X	National Science Foundation [1543813]; University of Colorado Museum of Natural History; Chancellor's Office of the University of Colorado, Boulder	National Science Foundation(National Science Foundation (NSF)); University of Colorado Museum of Natural History; Chancellor's Office of the University of Colorado, Boulder	This research was supported by the National Science Foundation (Grant #1543813), the University of Colorado Museum of Natural History's Walker Van Riper research grant and a post-doctoral diversity fellowship from the Chancellor's Office of the University of Colorado, Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; ALEXANDE.G, 1969, ECOL MONOGR, V39, P385, DOI 10.2307/1942354; ALEXANDER G, 1964, ECOLOGY, V45, P77, DOI 10.2307/1937109; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; Berner D, 2006, J ANIM ECOL, V75, P130, DOI 10.1111/j.1365-2656.2005.01028.x; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; Brust ML, 2009, ENVIRON ENTOMOL, V38, P1521, DOI 10.1603/022.038.0521; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chappell M.A., 1990, P143; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; COXWELL CC, 1995, OECOLOGIA, V104, P433, DOI 10.1007/BF00341340; DALY C, 2009, INT J CLIMATOLOGY, DOI DOI 10.1002/JOC.2007; DEARN JM, 1977, OECOLOGIA, V28, P67, DOI 10.1007/BF00346837; DINGLE H, 1990, OECOLOGIA, V84, P199, DOI 10.1007/BF00318272; Fielding DJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P607, DOI 10.1086/521801; Fielding DJ, 2004, ENVIRON ENTOMOL, V33, P1513, DOI 10.1603/0046-225X-33.6.1513; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; GAGE SH, 1976, CAN ENTOMOL, V108, P245, DOI 10.4039/Ent108245-3; GAGE SH, 1977, ENVIRON ENTOMOL, V6, P469, DOI 10.1093/ee/6.3.469; Gerten D, 2002, FRESHWATER BIOL, V47, P2163, DOI 10.1046/j.1365-2427.2002.00970.x; Gienapp P, 2005, GLOBAL CHANGE BIOL, V11, P600, DOI 10.1111/j.1365-2486.2005.00925.x; Grenier M, 2009, BOTANY, V87, P492, DOI 10.1139/B09-018; Guo K, 2009, GLOBAL CHANGE BIOL, V15, P2539, DOI 10.1111/j.1365-2486.2009.01861.x; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Hassall M, 2006, J EVOLUTION BIOL, V19, P267, DOI 10.1111/j.1420-9101.2005.00967.x; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; INOUYE DW, 1991, AM J BOT, V78, P997, DOI 10.2307/2445179; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Joern A., 1990, P415; Laws AN, 2010, ENVIRON ENTOMOL, V39, P312, DOI 10.1603/EN09294; MARR JW, 1967, U COLORADO STUDIES S; Menzel A, 2003, INT J CLIMATOL, V23, P793, DOI 10.1002/joc.915; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Olfert Owen, 2006, Journal of Orthoptera Research, V15, P65, DOI 10.1665/1082-6467(2006)15[65:BMOMSF]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pepin N, 2000, ARCT ANTARCT ALP RES, V32, P135, DOI 10.2307/1552445; Pitt WC, 1999, EVOL ECOL, V13, P499, DOI 10.1023/A:1006792726166; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Primack RB, 2009, BIOL CONSERV, V142, P1943, DOI 10.1016/j.biocon.2009.03.016; Richter O, 2008, FRESHWATER BIOL, V53, P1868, DOI 10.1111/j.1365-2427.2008.02012.x; Roltsch WJ, 1999, INT J BIOMETEOROL, V42, P169, DOI 10.1007/s004840050101; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; SALSER MA, 2003, THESIS U CALIFORNIA; Samietz J, 2005, J EVOLUTION BIOL, V18, P1087, DOI 10.1111/j.1420-9101.2005.00893.x; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; Telfer MG, 1999, OECOLOGIA, V121, P245, DOI 10.1007/s004420050926; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Wilson L. T., 1983, California Agriculture, V37, P4	61	49	53	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12977	10.1371/journal.pone.0012977	http://dx.doi.org/10.1371/journal.pone.0012977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886093	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100060
J	Wang, YL; Lacroix, G; Haines, J; Doukhanine, E; Almazan, G; Richard, S				Wang, Yunling; Lacroix, Genevieve; Haines, Jeffery; Doukhanine, Evgueni; Almazan, Guillermina; Richard, Stephane			The QKI-6 RNA Binding Protein Localizes with the MBP mRNAs in Stress Granules of Glial Cells	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; QUAKING; MYELIN; REVEALS; DYSMYELINATION; TRANSLATION; SPECIFICITY; MUTATION; SIGNAL; QK1	Background: The quaking viable (qk(v)) mouse has several developmental defects that result in rapid tremors in the hind limbs. The qkl gene expresses three major alternatively spliced mRNAs (5, 6 and 7 kb) that encode the QKI-5, QKI-6 and QKI-7 RNA binding proteins that differ in their C-terminal 30 amino acids. The QKI isoforms are known to regulate RNA metabolism within oligodendrocytes, however, little is known about their roles during cellular stress. Methodology/Principal Findings: In this study, we report an interaction between the QKI-6 isoform and a component of the RNA induced silencing complex (RISC), argonaute 2 (Ago2). We show in glial cells that QKI-6 co-localizes with Ago2 and the myelin basic protein mRNA in cytoplasmic stress granules. Conclusions: Our findings define the QKI isoforms as Ago2-interacting proteins. We also identify the QKI-6 isoform as a new component of stress granules in glial cells.	[Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni; Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni; Richard, Stephane] McGill Univ, Dept Oncol, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni] McGill Univ, Dept Med, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Haines, Jeffery; Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Wang, YL (corresponding author), McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	stephane.richard@mcgill.ca			Multiple Sclerosis Society of Canada (MSSOC); le Fonds Quebecois de la recherche sur la Nature et les Technolgies; MSSOC	Multiple Sclerosis Society of Canada (MSSOC); le Fonds Quebecois de la recherche sur la Nature et les Technolgies; MSSOC	This work was supported by grants from the Multiple Sclerosis Society of Canada (MSSOC) to G. A. and S. R. Y.W. was a recipient of a postdoctoral fellowship from le Fonds Quebecois de la recherche sur la Nature et les Technolgies and is supported by a fellowship from the MSSOC. E. V. and G. L. were recipients of MSSOC studentships. S. R. is a Chercheur National des Fonds en Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; [Anonymous], MYELIN; Bockbrader K, 2008, FUTUR NEUROL, V3, P655, DOI 10.2217/14796708.3.6.655; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Dapper JD, 2005, MOVEMENT DISORD, V20, P1369, DOI 10.1002/mds.20595; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hardy RJ, 1996, J NEUROSCI RES, V46, P246, DOI 10.1002/(SICI)1097-4547(19961015)46:2<246::AID-JNR13>3.0.CO;2-0; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Keene JD, 2003, NAT GENET, V33, P111, DOI 10.1038/ng0203-111; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Larocque D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005867; Lee Min-Ho, 2006, WormBook, P1; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Li ZZ, 2000, J NEUROSCI, V20, P4944; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12824	10.1371/journal.pone.0012824	http://dx.doi.org/10.1371/journal.pone.0012824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862255	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800019
J	Lovatt, M; Bijlmakers, MJ				Lovatt, Matthew; Bijlmakers, Marie-Jose			Stabilisation of beta-Catenin Downstream of T Cell Receptor Signalling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; WNT; EXPRESSION; ACTIVATION; TRANSCRIPTION; SELECTION; LITHIUM; MEMORY; LOCALIZATION; SURVIVAL	Background: The role of TCF/beta-catenin signalling in T cell development is well established, but important roles in mature T cells have only recently come to light. Methodology/Principal Findings: Here we have investigated the signalling pathways that are involved in the regulation of beta-catenin in primary human T cells. We demonstrate that beta-catenin expression is upregulated rapidly after T cell receptor (TCR) stimulation and that this involves protein stabilisation rather than an increase in mRNA levels. Similar to events in Wnt signalling, the increase in beta-catenin coincides with an inhibition of GSK3, the kinase that is required for beta-catenin degradation. beta-catenin stabilisation in T cells can also be induced by the activation of PKC with phorbol esters and is blocked by inhibitors of phosphatidylinositol 3-kinase (PI3K) and phospholipase C (PKC). Upon TCR signalling, b-catenin accumulates in the nucleus and, parallel to this, the ratio of TCF1 isoforms is shifted in favour of the longer beta-catenin binding isoforms. However, phosphorylated beta-catenin, which is believed to be inactive, can also be detected and the expression of Wnt target genes Axin2 and dickkopf is down regulated. Conclusions/Significance: These data show that in mature human T cells, TCR signalling via PI3K and PKC can result in the stabilisation of beta-catenin, allowing beta-catenin to migrate to the nucleus. They further highlight important differences between beta-catenin activities in TCR and Wnt signalling.	Kings Coll London, Peter Gorer Dept Immunobiol, Sch Med, Kings Coll Hosp,Guys Hosp, London WC2R 2LS, England; Kings Coll London, Peter Gorer Dept Immunobiol, Sch Med, St Thomas Hosp,Guys Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lovatt, M (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	matthew.lovatt@imb.a-star.edu.sg	bijlmakers, marie-jose/N-5369-2014	bijlmakers, marie-jose/0000-0001-6762-1168	The Wellcome Trust [078170]	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant (078170) from The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; BRAGA VMM, 1995, CELL ADHES COMMUN, V3, P201, DOI 10.3109/15419069509081287; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kovalovsky D, 2009, J IMMUNOL, V183, P3873, DOI 10.4049/jimmunol.0901369; Lafont V, 2000, FEBS LETT, V486, P38, DOI 10.1016/S0014-5793(00)02235-3; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sadot E, 2002, J CELL SCI, V115, P2771; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Welsh GI, 1996, J BIOL CHEM, V271, P11410, DOI 10.1074/jbc.271.19.11410; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu M, 2009, J IMMUNOL, V182, P759, DOI 10.4049/jimmunol.182.2.759; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199	36	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12794	10.1371/journal.pone.0012794	http://dx.doi.org/10.1371/journal.pone.0012794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862283	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100024
J	Beraldo, FH; Arantes, CP; Santos, TG; Machado, CF; Roffe, M; Hajj, GN; Lee, KS; Magalhaes, AC; Caetano, FA; Mancini, GL; Lopes, MH; Americo, TA; Magdesian, MH; Ferguson, SSG; Linden, R; Prado, MAM; Martins, VR				Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Machado, Cleiton F.; Roffe, Martin; Hajj, Glaucia N.; Lee, Kil S.; Magalhaes, Ana C.; Caetano, Fabiana A.; Mancini, Gabriel. L.; Lopes, Marilene H.; Americo, Tatiana A.; Magdesian, Margaret H.; Ferguson, Stephen S. G.; Linden, Rafael; Prado, Marco A. M.; Martins, Vilma R.			Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma 1 chain	FASEB JOURNAL			English	Article						GPI-anchored proteins; G-coupled protein receptors; signal transduction; multiprotein complexes; neurotrophic signals	STRESS-INDUCIBLE PROTEIN-1; CELLULAR PRION; PROMOTING DOMAIN; KDI-DOMAIN; CALCIUM; PHOSPHORYLATION; DIFFERENTIATION; INTERNALIZATION; IDENTIFICATION; TRAFFICKING	The prion protein (PrPC) is highly expressed in the nervous system, and its abnormal conformer is associated with prion diseases. PrPC is anchored to cell membranes by glycosylphosphatidylinositol, and transmembrane proteins are likely required for PrPC-mediated intracellular signaling. Binding of laminin (Ln) to PrPC modulates neuronal plasticity and memory. We addressed signaling pathways triggered by PrPC-Ln interaction in order to identify transmembrane proteins involved in the transduction of PrPC-Ln signals. The Ln gamma 1-chain peptide, which contains the Ln binding site for PrPC, induced neuritogenesis through activation of phospholipase C (PLC), Ca2+ mobilization from intracellular stores, and protein kinase C and extracellular signal-regulated kinase (ERK1/2) activation in primary cultures of neurons from wild-type, but not PrPC-null mice. Phage display, coimmunoprecipitation, and colocalization experiments showed that group I metabotropic glutamate receptors (mGluR1/5) associate with PrPC. Expression of either mGluR1 or mGluR5 in HEK293 cells reconstituted the signaling pathways mediated by PrPC-Ln gamma 1 peptide interaction. Specific inhibitors of these receptors impaired PrPC-Ln gamma 1 peptide-induced signaling and neuritogenesis. These data show that group I mGluRs are involved in the transduction of cellular signals triggered by PrPC-Ln, and they support the notion that PrPC participates in the assembly of multiprotein complexes with physiological functions on neurons.-Beraldo, F. H., Arantes, C. P., Santos, T. G., Machado, C. F., Roffe, M., Hajj, G. N., Lee, K. S., Magalhaes, A. C., Caetano, F. A., Mancini, G. L., Lopes, M. H., Americo, T. A., Magdesian, M. H., Ferguson, S. S. G., Linden, R., Prado, M. A. M., Martins, V. R. Metabotropic glutamate receptors trans-duce signals for neurite outgrowth after binding of the prion protein to laminin gamma 1 chain. FASEB J. 25, 265-279 (2011). www.fasebj.org	[Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Machado, Cleiton F.; Hajj, Glaucia N.; Lee, Kil S.; Mancini, Gabriel. L.; Lopes, Marilene H.; Martins, Vilma R.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Arantes, Camila P.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Santos, Tiago G.; Machado, Cleiton F.] Hosp AC Camargo Fund Antonio Prudente, Ctr Tratamento & Pesquisa, Sao Paulo, Brazil; [Roffe, Martin] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Beraldo, Flavio H.; Magalhaes, Ana C.; Caetano, Fabiana A.; Ferguson, Stephen S. G.; Prado, Marco A. M.] Univ Western Ontario, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, Robarts Res Inst, London, ON, Canada; [Beraldo, Flavio H.; Magalhaes, Ana C.; Caetano, Fabiana A.; Ferguson, Stephen S. G.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Caetano, Fabiana A.] Univ Fed Minas Gerais, Program Mol Pharmacol, Belo Horizonte, MG, Brazil; [Americo, Tatiana A.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Magdesian, Margaret H.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Ludwig Institute for Cancer Research; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade Federal de Sao Paulo (UNIFESP); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Martins, VR (corresponding author), Ludwig Inst Canc Res, Rua Joao Juliao 245 1A, BR-01323903 Sao Paulo, Brazil.	mprado@robarts.ca; vmartins@ludwig.org.br	dos Santos, Tiago Goss/A-1538-2019; Fisiologia, Ciencias Biologicas/C-2407-2012; Santos, Tiago Goss/AAQ-4272-2020; Martins, Vilma/N-5446-2019; Neurociencia, Inct/I-1011-2013; Roffé, Martín/I-1864-2013; Santos, Tiago/F-2387-2012; Linden, Rafael/F-2275-2011; Martins, Vilma R/E-2547-2012; Lee, Kil S/D-3678-2012; Prado, Marco Antonio Maximo/K-7638-2013; Machado, Cleiton/I-5907-2014; Hajj, Glaucia N M/I-8176-2015; Roffe, Martin/S-1124-2019; Lee, Kil Sun/AAL-8564-2020; Lopes, Marilene/GLV-4734-2022	dos Santos, Tiago Goss/0000-0001-6641-7413; Santos, Tiago Goss/0000-0001-6641-7413; Roffé, Martín/0000-0001-7247-3067; Santos, Tiago/0000-0001-6641-7413; Linden, Rafael/0000-0003-3287-336X; Martins, Vilma R/0000-0002-2909-8502; Lee, Kil S/0000-0002-2390-2774; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Machado, Cleiton/0000-0002-3313-3868; Hajj, Glaucia N M/0000-0003-2342-7384; Roffe, Martin/0000-0001-7247-3067; Lopes, Marilene/0000-0003-2496-0674	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [03-13189-2]; Programa Institutos Nacionais de Ciencia e Tecnologia; do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MCT); PrioNet-Canada; CNPq; Canada Department of Foreign Affairs and International Trade; Canadian Institute of Health Research (CIHR) [MA-15506]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa Institutos Nacionais de Ciencia e Tecnologia; do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PrioNet-Canada; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Canada Department of Foreign Affairs and International Trade; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 03-13189-2), Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MCT), and PrioNet-Canada. V. R. M. is an International Scholar of the Howard Hughes Medical Institute. Fellowships from FAPESP to F. H. B., C. P. A., M. R., T. G. S., C. F. M., K. S. L., G.N.H.; from CNPq to G. L. M.; and the Canada Department of Foreign Affairs and International Trade to F. H. B. are gratefully acknowledged. A. C. M. is supported by the Canadian Institute of Health Research (CIHR). R. L., T. A. A., and M. M. are supported by CNPq and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and S. S. G. F. is funded by CIHR grant MA-15506. S. S. G. F is a Canada Research Chair in Molecular Neurobiology and a Career Investigator of the Heart and Stroke Foundation of Ontario. The authors are also grateful to Dr. Joao Bosco Pesquero (Universidade Federal de Sao Paulo, Sao Paulo, Brazil) for providing bradykinin for some experiments.	Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Castiglione M, 2008, NEUROPHARMACOLOGY, V55, P560, DOI 10.1016/j.neuropharm.2008.05.021; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Hager G, 1998, NEUROSCIENCE, V86, P1145, DOI 10.1016/S0306-4522(98)00082-7; Hagg T, 1997, BRAIN RES, V764, P17, DOI 10.1016/S0006-8993(97)00419-8; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kingston AE, 2002, NEUROSCI LETT, V330, P127, DOI 10.1016/S0304-3940(02)00751-6; Krebs B, 2007, J NEUROCHEM, V100, P358, DOI 10.1111/j.1471-4159.2006.04256.x; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; Liesi P, 2001, J NEUROSCI RES, V66, P1047, DOI 10.1002/jnr.1250; LIESI P, 1989, FEBS LETT, V244, P141, DOI 10.1016/0014-5793(89)81180-9; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Maiese K, 2005, CURR NEUROVASC RES, V2, P425, DOI 10.2174/156720205774962692; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Policha A, 2006, J BIOL CHEM, V281, P26340, DOI 10.1074/jbc.M605437200; Putney JW, 2001, J CELL SCI, V114, P2223; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schrock Y, 2009, FEBS LETT, V583, P389, DOI 10.1016/j.febslet.2008.12.038; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Vaananen AJ, 2006, J NEUROSCI RES, V84, P655, DOI 10.1002/jnr.20961; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wiksten M, 2004, J NEUROSCI RES, V78, P411, DOI 10.1002/jnr.20158; Wiksten M, 2003, J NEUROSCI RES, V71, P338, DOI 10.1002/jnr.10495; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	64	97	97	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					265	279		10.1096/fj.10-161653	http://dx.doi.org/10.1096/fj.10-161653			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876210				2022-12-25	WOS:000285869500024
J	Froese, DS; Kochan, G; Muniz, JRC; Wu, XC; Gileadi, C; Ugochukwu, E; Krysztofinska, E; Gravel, RA; Oppermann, U; Yue, WW				Froese, D. Sean; Kochan, Grazyna; Muniz, Joao R. C.; Wu, Xuchu; Gileadi, Carina; Ugochukwu, Emelie; Krysztofinska, Ewelina; Gravel, Roy A.; Oppermann, Udo; Yue, Wyatt W.			Structures of the Human GTPase MMAA and Vitamin B-12-dependent Methylmalonyl-CoA Mutase and Insight into Their Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBLB COMPLEMENTATION GROUP; COENZYME B-12; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION; GENE; ADENOSYLTRANSFERASE; ACIDEMIA; ACIDURIA; METABOLISM	Vitamin B-12 (cobalamin, Cbl) is essential to the function of two human enzymes, methionine synthase (MS) and methylmalonyl-CoA mutase (MUT). The conversion of dietary Cbl to its cofactor forms, methyl-Cbl (MeCbl) for MS and adenosyl-Cbl (AdoCbl) for MUT, located in the cytosol and mitochondria, respectively, requires a complex pathway of intracellular processing and trafficking. One of the processing proteins, MMAA (methylmalonic aciduria type A), is implicated in the mitochondrial assembly of AdoCbl into MUT and is defective in children from the cblA complementation group of cobalamin disorders. To characterize the functional interplay between MMAA and MUT, we have crystallized human MMAA in the GDP-bound form and human MUT in the apo, holo, and substrate-bound ternary forms. Structures of both proteins reveal highly conserved domain architecture and catalytic machinery for ligand binding, yet they show substantially different dimeric assembly and interaction, compared with their bacterial counterparts. We show that MMAA exhibits GTPase activity that is modulated by MUT and that the two proteins interact in vitro and in vivo. Formation of a stable MMAA-MUT complex is nucleotide selective for MMAA (GMPPNP over GDP) and apoenzyme-dependent for MUT. The physiological importance of this interaction is highlighted by a recently identified homoallelic patient mutation of MMAA, G188R, which, we show, retains basal GTPase activity but has abrogated interaction. Together, our data point to a gatekeeping role for MMAA by favoring complex formation with MUT apoenzyme for AdoCbl assembly and releasing the AdoCbl-loaded holoenzyme from the complex, in a GTP-dependent manner.	[Froese, D. Sean; Kochan, Grazyna; Muniz, Joao R. C.; Gileadi, Carina; Ugochukwu, Emelie; Krysztofinska, Ewelina; Oppermann, Udo; Yue, Wyatt W.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DU, England; [Froese, D. Sean; Wu, Xuchu; Gravel, Roy A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Oppermann, Udo] NIHR, Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England	University of Oxford; University of Calgary; University of Oxford	Oppermann, U (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DU, England.	udo.oppermann@sgc.ox.ac.uk; wyatt.yue@sgc.ox.ac.uk	Kochan, Grazyna/A-1094-2009; Froese, D. Sean Sean/AAW-6899-2021; Muniz, Joao R/B-7782-2016; Froese, Sean/J-6665-2017	Froese, D. Sean Sean/0000-0003-1557-3517; Muniz, Joao R/0000-0003-2731-3966; Froese, Sean/0000-0003-1557-3517; Kochan, Grazyna/0000-0002-0534-9661	Canadian Institutes for Health Research [MGP-44353]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; CIHR at the University of Calgary	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); CIHR at the University of Calgary(Canadian Institutes of Health Research (CIHR))	The Structural Genomics Consortium is a registered charity (Number 1097737) funded by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. D. S. F. acknowledges funding support by the CIHR Training Program in Genetics, Child Development and Health at the University of Calgary. R. A. G. acknowledges funding support by the Canadian Institutes for Health Research Grant MGP-44353.	Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BATRA JK, 1987, BIOCHEMISTRY-US, V26, P5925, DOI 10.1021/bi00392a052; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENTON WA, 1981, BIOCHEM BIOPH RES CO, V98, P283, DOI 10.1016/0006-291X(81)91900-8; FENTON WA, 1982, ARCH BIOCHEM BIOPHYS, V214, P815, DOI 10.1016/0003-9861(82)90088-1; Froese DS, 2009, MICROBIOL RES, V164, P1, DOI 10.1016/j.micres.2008.08.006; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; KOLHOUSE JF, 1980, J BIOL CHEM, V255, P2708; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; MAHONEY MJ, 1975, P NATL ACAD SCI USA, V72, P2799, DOI 10.1073/pnas.72.7.2799; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; MARSH EN, 1989, BIOCHEM J, V260, P353, DOI 10.1042/bj2600353; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merinero B, 2008, J INHERIT METAB DIS, V31, P55, DOI 10.1007/s10545-007-0667-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Ruzheinikov SN, 2004, J MOL BIOL, V339, P265, DOI 10.1016/j.jmb.2004.03.043; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WILKEMEYER MF, 1990, BIOCHEM J, V271, P449, DOI 10.1042/bj2710449; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008; Yang X, 2004, MOL GENET METAB, V82, P329, DOI 10.1016/j.ymgme.2004.05.002	40	79	83	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38204	38213		10.1074/jbc.M110.177717	http://dx.doi.org/10.1074/jbc.M110.177717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876572	Green Published, hybrid			2022-12-25	WOS:000284625600028
J	Wilderman, PR; Shah, MB; Liu, T; Li, S; Hsu, S; Roberts, AG; Goodlett, DR; Zhang, QH; Woods, VL; Stout, CD; Halpert, JR				Wilderman, P. Ross; Shah, Manish B.; Liu, Tong; Li, Sheng; Hsu, Simon; Roberts, Arthur G.; Goodlett, David R.; Zhang, Qinghai; Woods, Virgil L., Jr.; Stout, C. David; Halpert, James R.			Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; OPEN CONFORMATION; LIGAND-BINDING; H/D EXCHANGE; P4502B4; ALPHA; SITE	Crystal structures of the xenobiotic metabolizing cytochrome P450 2B4 have demonstrated markedly different conformations in the presence of imidazole inhibitors or in the absence of ligand. However, knowledge of the plasticity of the enzyme in solution has remained scant. Thus, hydrogen-deuterium exchange mass spectrometry (DXMS) was utilized to probe the conformations of ligand-free P450 2B4 and the complex with 4-(4-chlorophenyl) imidazole (4-CPI) or 1-biphenyl-4-methyl-1H-imidazole (1-PBI). The results of DXMS indicate that the binding of 4-CPI slowed the hydrogen-deuterium exchange rate over the B`-and C-helices and portions of the F-Ghelix cassette compared with P450 2B4 in the absence of ligands. In contrast, there was little difference between the ligand-free and 1-PBI-bound exchange sets. In addition, DXMS suggests that the ligand-free P450 2B4 is predominantly open in solution. Interestingly, a new high resolution structure of ligand-free P450 2B4 was obtained in a closed conformation very similar to the 4-CPI complex. Molecular dynamics simulations performed with the closed ligand-free structure as the starting point were used to probe the energetically accessible conformations of P450 2B4. The simulations were found to equilibrate to a conformation resembling the 1-PBI-bound P450 2B4 crystal structure. The results indicate that conformational changes observed in available crystal structures of the promiscuous xenobiotic metabolizing cytochrome P450 2B4 are consistent with its solution structural behavior.	[Wilderman, P. Ross; Shah, Manish B.; Roberts, Arthur G.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Liu, Tong; Li, Sheng; Hsu, Simon; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Zhang, Qinghai; Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Scripps Research Institute	Shah, MB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,PSB 2131,MC 0703, La Jolla, CA 92093 USA.	m7shah@ucsd.edu	Hsu, Simon/GXZ-6548-2022; Wilderman, Paul/J-8315-2012; Shah, Manish/H-6158-2011	Hsu, Simon/0000-0003-3780-294X; Wilderman, Paul/0000-0002-0264-1704; Shah, Manish/0000-0001-8593-6446	National Institutes of Health [ES003619, CA099835, CA118595, AI076961, AI081982, AI2008031, GM020501, GM066170, RR029388, GM073197, T32-DK07233]; NCRR; United States Department of Energy of Biological and Environmental Research; NATIONAL CANCER INSTITUTE [R21CA099835, R21CA118595, R33CA099835] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, F32GM020501, P50GM073197, R01GM066170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES003619 (to J. R. H.), CA099835, CA118595, AI076961, AI081982, AI2008031, GM020501, GM066170, and RR029388 (to V. L. W.), and GM073197 (to Q. Z.).; Supported by National Institutes of Health Grant T32-DK07233.; We are grateful to Dr. Sean Gay for critical reading of the manuscript and also to the staff at the Stanford Synchrotron Radiation Lightsource, operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences for assistance with data collection. The Stanford Synchrotron Radiation Lightsource is supported by the National Institutes of Health, NCRR, the Biomedical Technology Program, and the United States Department of Energy of Biological and Environmental Research.	Al-Omari A, 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821; Anzenbacher P, 2008, ACTA CHIM SLOV, V55, P63; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bo W, 2008, CHINESE J CHEM PHYS, V21, P217, DOI 10.1088/1674-0068/21/03/217-220; Bumpus NN, 2010, J INORG BIOCHEM, V104, P485, DOI 10.1016/j.jinorgbio.2009.12.017; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Delano WL., 2002, PYMOL MOL GRAPHICS S; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyles SJ, 2004, METHODS, V34, P88, DOI 10.1016/j.ymeth.2004.03.015; Ferguson PL, 2009, CURR ANAL CHEM, V5, P186, DOI 10.2174/157341109787846180; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; FROELICH J W, 1985, Henry Ford Hospital Medical Journal, V33, P122; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y, 2008, J INORG BIOCHEM, V102, P364, DOI 10.1016/j.jinorgbio.2007.10.001; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Kaltashov IA, 2006, ANAL BIOANAL CHEM, V386, P472, DOI 10.1007/s00216-006-0636-6; Kaltashov IA, 2009, ANAL CHEM, V81, P7892, DOI 10.1021/ac901366n; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; Muralidhara BK, 2007, DRUG METAB REV, V39, P539, DOI 10.1080/03602530701498182; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; OMURA T., 1965, FEDERATION PROC, V24, P1181; OMURA T, 1964, J BIOL CHEM, V239, P2370; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; Poulos TL, 2005, BIOCHEM BIOPH RES CO, V338, P337, DOI 10.1016/j.bbrc.2005.07.204; Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596; Wade RC, 2005, BBA-PROTEINS PROTEOM, V1754, P239, DOI 10.1016/j.bbapap.2005.07.044; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wani AH, 2009, P NATL ACAD SCI USA, V106, P20711, DOI 10.1073/pnas.0908617106; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006	81	50	50	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38602	38611		10.1074/jbc.M110.180646	http://dx.doi.org/10.1074/jbc.M110.180646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880847	Green Published, hybrid			2022-12-25	WOS:000284625600064
J	Bruhova, I; Auerbach, A				Bruhova, Iva; Auerbach, Anthony			Subunit Symmetry at the Extracellular Domain-Transmembrane Domain Interface in Acetylcholine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; NICOTINIC RECEPTORS; AGONIST-BINDING; CYS-LOOP; CRYSTAL-STRUCTURE; CHARGED RESIDUES; TRANSITION-STATE; PRE-M1; LINKER	Transmitter molecules bind to synaptic acetylcholine receptor channels (AChRs) to promote a global channel-opening conformational change. Although the detailed mechanism that links ligand binding and channel gating is uncertain, the energy changes caused by mutations appear to be more symmetrical between subunits in the transmembrane domain compared with the extracellular domain. The only covalent connection between these domains is the pre-M1 linker, a stretch of five amino acids that joins strand beta 10 with the M1 helix. In each subunit, this linker has a central Arg(Arg(3)'), which only in the non-alpha-subunits is flanked by positively charged residues. Previous studies showed that mutations of Arg(3)' in the alpha-subunit alter the gating equilibrium constant and reduce channel expression. We recorded single-channel currents and estimated the gating rate and equilibrium constants of adult mouse AChRs with mutations at the pre-M1 linker and the nearby residue Glu(45) in non-alpha-subunits. In all subunits, mutations of Arg(3)' had similar effects as in the alpha-subunit. In the epsilon-subunit, mutations of the flanking residues and Glu(45) had only small effects, and there was no energy coupling between epsilon Glu(45) and epsilon Arg(3)'. The non-alpha-subunit Arg3' residues had Phi-values that were similar to those for the alpha-subunit. The results suggest that there is a general symmetry between the AChR subunits during gating isomerization in this linker and that the central Arg is involved in expression more so than gating. The energy transfer through the AChR during gating appears to mainly involve Glu(45), but only in the alpha-subunits.	[Bruhova, Iva; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 309 Cary Hall, Buffalo, NY 14214 USA.	auerbach@buffalo.edu			National Institutes of Health [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513, R56NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-23513.	Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Engel AG, 2010, J MOL NEUROSCI, V40, P143, DOI 10.1007/s12031-009-9229-0; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jha A, 2009, BIOPHYS J, V96, P4075, DOI 10.1016/j.bpj.2009.02.030; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; TAMAMIZU S, 1995, CELL MOL NEUROBIOL, V15, P427, DOI 10.1007/BF02071878; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200	32	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38898	38904		10.1074/jbc.M110.169110	http://dx.doi.org/10.1074/jbc.M110.169110			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20864527	hybrid, Green Published			2022-12-25	WOS:000284941300019
J	Binder, BM; Rodriguez, FI; Bleecker, AB				Binder, Brad M.; Rodriguez, Fernando I.; Bleecker, Anthony B.			The Copper Transporter RAN1 Is Essential for Biogenesis of Ethylene Receptors in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE DOMAIN; P-TYPE ATPASE; MENKES DISEASE; CANDIDATE GENE; SUBCELLULAR-LOCALIZATION; ETR1; BINDING; FAMILY; GROWTH; PERCEPTION	Plants utilize ethylene as a hormone to regulate multiple developmental processes and to coordinate responses to biotic and abiotic stress. In Arabidopsis thaliana, a small family of five receptor proteins typified by ETR1 mediates ethylene perception. Our previous work suggested that copper ions likely play a role in ethylene binding. An independent study indicated that the ran1 mutants, which display ethylene-like responses to the ethylene antagonist trans-cyclooctene, have mutations in the RAN1 copper-transporting P-type ATPase, once again linking copper ions to the ethylene-response pathway. The results presented herein indicate that genetically engineered Saccharomyces cerevisiae expressing ETR1 but lacking the RAN1 homolog Ccc2p (Delta ccc2) lacks ethylene-binding activity. Ethylene-binding activity was restored when copper ions were added to the Delta ccc2 mutants, showing that it is the delivery of copper that is important. Additionally, transformation of the Delta ccc2 mutant yeast with RAN1 rescued ethylene-binding activity. Analysis of plants carrying loss-of-function mutations in ran1 showed that they lacked ethylene-binding activity, whereas seedlings carrying weak alleles of ran1 had normal ethylene-binding activity but were hypersensitive to copper-chelating agents. Altogether, the results show an essential role for RAN1 in the biogenesis of the ethylene receptors and copper homeostasis in Arabidopsis seedlings. Furthermore, the results indicate cross-talk between the ethylene-response pathway and copper homeostasis in Arabidopsis seedling development.	[Binder, Brad M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Rodriguez, Fernando I.; Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Rodriguez, Fernando I.; Bleecker, Anthony B.] Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA	University of Tennessee System; University of Tennessee Knoxville; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Binder, BM (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, M407 Walters Life Sci Bldg,1414 Cumberland Ave, Knoxville, TN 37996 USA.	bbinder@utk.edu		Binder, Brad/0000-0002-8172-2034	National Science Foundation [MCB-0918430, MCB-0131564]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-0918430 (to B.M.B.) and MCB-0131564 (to A.B B.).	Abeles F, 1992, ETHYLENE PLANT BIOL; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Binder BM, 2003, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2003.628.21; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2008, PLANT SCI, V175, P8, DOI 10.1016/j.plantsci.2007.12.001; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hall BP, 2007, J PLANT GROWTH REGUL, V26, P118, DOI 10.1007/s00344-007-9000-0; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Hyodo H., 1991, PLANT HORMONE ETHYLE; Li HJ, 2007, J PLANT GROWTH REGUL, V26, P106, DOI 10.1007/s00344-007-0015-3; Ma B, 2006, PLANT PHYSIOL, V141, P587, DOI 10.1104/pp.106.080523; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; SIKORSKI RS, 1989, GENETICS, V122, P19; SISLER E C, 1977, Tobacco Science, V21, P43; SISLER EC, 1979, PLANT PHYSIOL, V64, P538, DOI 10.1104/pp.64.4.538; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; THOMPSON JS, 1983, J AM CHEM SOC, V105, P3522, DOI 10.1021/ja00349a026; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021	61	78	83	5	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37263	37270		10.1074/jbc.M110.170027	http://dx.doi.org/10.1074/jbc.M110.170027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876528	Green Published, hybrid			2022-12-25	WOS:000284424000019
J	Chen, TS; Nayak, N; Majee, SM; Lowenson, J; Schafermeyer, KR; Eliopoulos, AC; Lloyd, TD; Dinkins, R; Perry, SE; Forsthoefel, NR; Clarke, SG; Vernon, DM; Zhou, ZS; Rejtar, T; Downie, AB				Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Lowenson, Jonathan; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Dinkins, Randy; Perry, Sharyn E.; Forsthoefel, Nancy R.; Clarke, Steven G.; Vernon, Daniel M.; Zhou, Zhaohui Sunny; Rejtar, Tomas; Downie, A. Bruce			Substrates of the Arabidopsis thaliana Protein Isoaspartyl Methyltransferase 1 Identified Using Phage Display and Biopanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; BOX RNA HELICASE; SEED DORMANCY; O-METHYLTRANSFERASE; MESSENGER-RNA; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CARBOXYL METHYLATION; PROTEOMIC ANALYSIS; ASPARTYL RESIDUES	The role of protein isoaspartyl methyltransferase (PIMT) in repairing a wide assortment of damaged proteins in a host of organisms has been inferred from the affinity of the enzyme for isoaspartyl residues in a plethora of amino acid contexts. The identification of PIMT target proteins in plant seeds, where the enzyme is highly active and proteome long-lived, has been hindered by large amounts of isoaspartate-containing storage proteins. Mature seed phage display libraries circumvented this problem. Inclusion of the PIMT co-substrate, S-adenosylmethionine (AdoMet), during panning permitted PIMT to retain aged phage in greater numbers than controls lacking co-substrate or when PIMT protein binding was poisoned with S-adenosyl homocysteine. After four rounds, phage titer plateaued in AdoMet-containing pans, whereas titer declined in both controls. This strategy identified 17 in-frame PIMT target proteins, including a cupin-family protein similar to those identified previously using on-blot methylation. All recovered phage had at least one susceptible Asp or Asn residue. Five targets were recovered independently. Two in-frame targets were produced in Escherichia coli as recombinant proteins and shown by on-blot methylation to acquire isoAsp, becoming a PIMT target. Both gained isoAsp rapidly in solution upon thermal insult. Mutant analysis of plants deficient in any of three in-frame PIMT targets resulted in demonstrable phenotypes. An over-representation of clones encoding proteins involved in protein production suggests that the translational apparatus comprises a subgroup for which PIMT-mediated repair is vital for orthodox seed longevity. Impaired PIMT activity would hinder protein function in these targets, possibly resulting in poor seed performance.	[Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Downie, A. Bruce] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Perry, Sharyn E.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Lowenson, Jonathan; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Eliopoulos, Alyssa C.] Paul Laurence Dunbar High Sch, Math Sci & Technol Ctr, Lexington, KY 40515 USA; [Dinkins, Randy] Univ Kentucky, Agr Sci Ctr N220C, USDA ARS, Forage Anim Prod Res Unit, Lexington, KY 40546 USA; [Forsthoefel, Nancy R.; Vernon, Daniel M.] Whitman Coll, Dept Biol, Program Biochem Biophys & Mol Biol, Walla Walla, WA 99362 USA; [Zhou, Zhaohui Sunny; Rejtar, Tomas] Northeastern Univ, Dept Chem & Chem Biol, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Perry, Sharyn E.; Downie, A. Bruce] Univ Kentucky, Seed Biol Grp, Lexington, KY 40546 USA	University of Kentucky; University of Kentucky; University of California System; University of California Los Angeles; United States Department of Agriculture (USDA); University of Kentucky; Whitman College; Northeastern University; University of Kentucky	Downie, AB (corresponding author), 401A Plant Sci Bldg,1405 Vet Dr, Lexington, KY 40546 USA.	adownie@uky.edu	Vernon, Daniel/L-1333-2016; Lowenson, Jonathan/AAN-6768-2020; Perry, Sharyn/M-9177-2013	Vernon, Daniel/0000-0002-4182-3105; Perry, Sharyn/0000-0002-3011-8240; Dinkins, Randy/0000-0002-2127-273X	National Science Foundation [0449649]; University of Kentucky [14-28]; Paul Laurence Dunbar High School; Direct For Biological Sciences [0922845] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0922978] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Kentucky; Paul Laurence Dunbar High School; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Molecular and Cellular Biochemistry Grant 0449649 (to A. B. D. and S. G. C.). This work was also supported by University of Kentucky undergraduate research and creativity Grant 14-28 (to A. B. D. and T. D. L.).; We acknowledge David Martin and Manoj Majee for excellent technical advice, assistance, and troubleshooting during the phage cDNA library construction and biopanning optimization, Venkata Krishna Doppalapudi for excellent technical assistance planting, screening, harvesting, cleaning, and sowing seeds of the various mutant lines, Dr. Lynnette Dirk for expert advice in recombinant protein production and purification using FPLC, and Dr. Sarah Villa for work defining enzyme kinetics for rAtPIMT1. This work was also supported by the Math Science and Technology Center program, Paul Laurence Dunbar High School (to A. B. D. and A. C. E.) and by the University of Kentucky eUreKa! program.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bennett EJ, 2003, BIOCHEMISTRY-US, V42, P12844, DOI 10.1021/bi034891+; Bewley J. D., 1994, SEED PHYSL DEV GERMI, P81; Bidinosti M, 2010, J BIOL CHEM, V285, P19402, DOI 10.1074/jbc.M110.120774; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Clerkx EJM, 2003, PLANT PHYSIOL, V132, P1077, DOI 10.1104/pp.103.022715; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; D'Angelo S, 2001, FREE RADICAL BIO MED, V31, P1, DOI 10.1016/S0891-5849(01)00518-4; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DESROSIERS RR, 1990, J BIOL CHEM, V265, P21368; Dinkins RD, 2008, PLANT J, V55, P1, DOI 10.1111/j.1365-313X.2008.03471.x; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Forsthoefel NR, 2005, PLANT CELL PHYSIOL, V46, P913, DOI 10.1093/pcp/pci097; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Gershater MC, 2007, J BIOL CHEM, V282, P21460, DOI 10.1074/jbc.M701985200; Hara K, 2000, PLANT CELL PHYSIOL, V41, P684, DOI 10.1093/pcp/41.6.684; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hudson ME, 2007, CROP SCI, V47, pS96, DOI 10.2135/cropsci2006.12.0758tpg; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; Ingrosso D, 1997, J NUTR BIOCHEM, V8, P535, DOI 10.1016/S0955-2863(97)00085-5; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Kern R, 2005, J BACTERIOL, V187, P1377, DOI 10.1128/JB.187.4.1377-1383.2005; Kester ST, 1997, J EXP BOT, V48, P943, DOI 10.1093/jxb/48.4.943; LADINO CA, 1992, J CELL PHYSIOL, V153, P297, DOI 10.1002/jcp.1041530209; Lanthier J, 2004, EXP CELL RES, V293, P96, DOI 10.1016/j.yexcr.2003.10.003; Lanthier J, 2002, J NEUROCHEM, V83, P581, DOI 10.1046/j.1471-4159.2002.01150.x; Li SC, 2001, PLANT MOL BIOL, V47, P761, DOI 10.1023/A:1013687412020; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lorkovic ZJ, 1997, MOL CELL BIOL, V17, P2257, DOI 10.1128/MCB.17.4.2257; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mudgett MB, 1996, PLANT MOL BIOL, V30, P723, DOI 10.1007/BF00019007; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; MUDGETT MB, 1993, BIOCHEMISTRY-US, V32, P11100, DOI 10.1021/bi00092a020; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; OCONNOR CM, 1984, J BIOL CHEM, V259, P2570; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; OWENS MK, 1995, J ARID ENVIRON, V29, P15, DOI 10.1016/S0140-1963(95)80060-3; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROBERTS E H, 1973, Seed Science and Technology, V1, P499; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Robinson NE, 2001, J PEPT RES, V57, P483, DOI 10.1034/j.1399-3011.2001.00863.x; Rudgers GW, 2001, PROTEIN ENG, V14, P487, DOI 10.1093/protein/14.7.487; Salaita L, 2005, J EXP BOT, V56, P2059, DOI 10.1093/jxb/eri204; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; SHENMILLER J, 1995, AM J BOT, V82, P1367, DOI 10.2307/2445863; Smith CD, 2002, PROTEIN SCI, V11, P625, DOI 10.1110/ps.37802; Statistical Analysis System, 1988, SAS STAT US GUID STA; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura N, 2006, PLANT CELL PHYSIOL, V47, P1081, DOI 10.1093/pcp/pcj078; Thapar N, 2000, PROTEIN EXPRES PURIF, V20, P237, DOI 10.1006/prep.2000.1311; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Wolschin F, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-9; Xu Q., 2004, THESIS U KENTUCKY LE; Xu QL, 2004, PLANT PHYSIOL, V136, P2652, DOI 10.1104/pp.104.046094; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	83	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37281	37292		10.1074/jbc.M110.157008	http://dx.doi.org/10.1074/jbc.M110.157008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870712	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000284424000021
J	Jia, HG; Liu, YJ; Xia, RH; Tong, C; Yue, T; Jiang, J; Jia, JH				Jia, Hongge; Liu, Yajuan; Xia, Ruohan; Tong, Chao; Yue, Tao; Jiang, Jin; Jia, Jianhang			Casein Kinase 2 Promotes Hedgehog Signaling by Regulating both Smoothened and Cubitus Interruptus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT MECHANISMS; ANIMAL DEVELOPMENT; UBIQUITIN LIGASE; REPRESSOR FORMS; PROTEIN; DROSOPHILA; PHOSPHORYLATION; RECEPTOR; DEGRADATION; EXPRESSION	Casein kinase 2 (CK2) is a typical serine/threonine kinase consisting of alpha and beta subunits and has been implicated in many cellular and developmental processes. In this study, we demonstrate that CK2 is a positive regulator of the Hedgehog (Hh) signal transduction pathway. We found that inactivation of CK2 by CK2 beta RNAi enhances the loss-of-Hh wing phenotype induced by a dominant negative form of Smoothened (Smo). CK2 beta RNAi attenuates Hh-induced Smo accumulation and down-regulates Hh target gene expression, whereas increasing CK2 activity by coexpressing CK2 alpha and CK2 beta increases Smo accumulation and induces ectopic Hh target gene expression. We identified the serine residues in Smo that can be phosphorylated by CK2 in vitro. Mutating these serine residues attenuates the ability of Smo to transduce high level Hh signaling activity in vivo. Furthermore, we found that CK2 plays an additional positive role downstream of Smo by regulating the stability of full-length Cubitus-interruptus(Ci). CK2 beta RNAi promotes Ci degradation whereas coexpressing CK2 alpha and CK2 beta increases the half-life of Ci. We showed that CK2 prevents Ci ubiquitination and degradation by the proteasome. Thus, CK2 promotes Hh signaling activity by regulating multiple pathway components.	Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Jia, Hongge; Liu, Yajuan; Xia, Ruohan; Jia, Jianhang] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Tong, Chao; Yue, Tao; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Tong, Chao; Yue, Tao; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas		Jianhang.jia@uky.edu		Jia, Jianhang/0000-0002-9313-3843; Tong, Chao/0000-0001-6521-5465	National Institutes of Health [GM079684, GM067045, GM061269]; American Heart Association [0830009N]; Welch Foundation [I-1603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM079684, R01GM061269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079684 (to J. Jia) and GM067045 and GM061269 (to J. Jiang). This work was also supported by American Heart Association Grant 0830009N (to J. Jia) and Welch Foundation Grant I-1603 (to J. Jiang).	Aikin RA, 2008, EMBO REP, V9, P330, DOI 10.1038/embor.2008.38; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chen YB, 2010, GENE DEV, V24, P2054, DOI 10.1101/gad.1948710; Cheng SF, 2010, DEV BIOL, V337, P99, DOI 10.1016/j.ydbio.2009.10.014; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Molnar C, 2007, P NATL ACAD SCI USA, V104, P7963, DOI 10.1073/pnas.0702374104; Penner CG, 1997, J CELL BIOCHEM, V64, P525; RUSSO GL, 1992, J BIOL CHEM, V267, P20317; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, FLY, V1, P333, DOI 10.4161/fly.5570; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	40	63	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37218	37226		10.1074/jbc.M110.174565	http://dx.doi.org/10.1074/jbc.M110.174565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876583	Green Published, hybrid			2022-12-25	WOS:000284424000015
J	Komori, T; Doi, A; Furuta, H; Wakao, H; Nakao, N; Nakazato, M; Nanjo, K; Senba, E; Morikawa, Y				Komori, Tadasuke; Doi, Asako; Furuta, Hiroto; Wakao, Hiroshi; Nakao, Naoyuki; Nakazato, Masamitsu; Nanjo, Kishio; Senba, Emiko; Morikawa, Yoshihiro			Regulation of Ghrelin Signaling by a Leptin-induced Gene, Negative Regulatory Element-binding Protein, in the Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETAGOGUE RECEPTOR GENE; DORSAL-ROOT GANGLIA; ARCUATE NUCLEUS; ONCOSTATIN-M; OBESE GENE; OB/OB MICE; EXPRESSION; IDENTIFICATION; INSULIN; GLUCOSE	Leptin, the product of the ob gene, plays important roles in the regulation of food intake and body weight through its receptor in the hypothalamus. To identify novel transcripts induced by leptin, we performed cDNA subtraction based on selective suppression of the polymerase chain reaction by using mRNA prepared from the forebrain of leptin-injected ob/ob mice. One of the genes isolated was a mouse homolog of human negative regulatory element-binding protein (NREBP). Its expression was markedly increased by leptin in the growth hormone secretagogue-receptor (GHS-R)-positive neurons of the arcuate nucleus and ventromedial hypothalamic nucleus. The promoter region of GHS-R contains one NREBP binding sequence, suggesting that NREBP regulates GHS-R transcription. Luciferase reporter assays showed that NREBP repressed GHS-R promoter activity in a hypothalamic neuronal cell line, GT1-7, and its repressive activity was abolished by the replacement of negative regulatory element in GHS-R promoter. Overexpression of NREBP reduced the protein expression of endogenous GHS-R without affecting the expression of ob-Rb in GT1-7 cells. To determine the functional importance of NREBP in the hypothalamus, we assessed the effects of NREBP on ghrelin action. Although phosphorylation of AMP-activated protein kinase alpha (AMPK alpha) was induced by ghrelin in GT1-7 cells, NREBP repressed ghrelin-induced AMPK alpha phosphorylation. These results suggest that leptin-induced NREBP is an important regulator of GHS-R expression in the hypothalamus and provides a novel molecular link between leptin and ghrelin signaling.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Doi, Asako; Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Nakao, Naoyuki] Wakayama Med Univ, Dept Neurol Surg, Wakayama 6418509, Japan; [Wakao, Hiroshi] Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan; [Nakazato, Masamitsu] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki 8891692, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Hokkaido University; University of Miyazaki	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp	WAKAO, Hiroshi/A-4242-2012		Ministry of Economic Affairs [98_EC_17_A_17_S2_0101]; National Science Council [99-3112-B-400-008, 99-2321-B-400-002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019047, 13204074]; Ichiro Kanehara Foundation; Wakayama Medical University	Ministry of Economic Affairs; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Wakayama Medical University	This work was supported by Grant-in-aid for Scientific Research 17019047 on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Grant-in-aid for Scientific Research 13204074 on Priority Areas "Medical Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant provided by the Ichiro Kanehara Foundation; and a research grant on Priority Areas from Wakayama Medical University.	Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; BAILEY CJ, 1975, HORM RES, V6, P380, DOI 10.1159/000178689; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hisaoka T, 2006, EUR J NEUROSCI, V23, P3149, DOI 10.1111/j.1460-9568.2006.04851.x; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kaji H, 1998, J BIOL CHEM, V273, P33885, DOI 10.1074/jbc.273.51.33885; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Nakano Y, 2005, DIABETES, V54, P3560, DOI 10.2337/diabetes.54.12.3560; Nogueiras R, 2004, DIABETES, V53, P2552, DOI 10.2337/diabetes.53.10.2552; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tamura S, 2003, EUR J NEUROSCI, V17, P2287, DOI 10.1046/j.1460-9568.2003.02681.x; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; White DW, 2000, DIABETES, V49, P1443, DOI 10.2337/diabetes.49.9.1443; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	33	17	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37884	37894		10.1074/jbc.M110.148973	http://dx.doi.org/10.1074/jbc.M110.148973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876580	Green Published, hybrid			2022-12-25	WOS:000284424000078
J	Kumar, P; Garg, R; Bolden, G; Pandey, KN				Kumar, Prerna; Garg, Renu; Bolden, Gevoni; Pandey, Kailash N.			Interactive Roles of Ets-1, Sp1, and Acetylated Histones in the Retinoic Acid-dependent Activation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RESPONSE ELEMENT; DOWN-REGULATION; PROTEIN-KINASE; MESANGIAL CELLS; EMERGING ROLES; LEUKEMIA-CELLS; STEM-CELLS; CYCLIC-GMP; EXPRESSION	Cardiac hormones atrial and brain natriuretic peptides activate guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA), which plays a critical role in reduction of blood pressure and blood volume. Currently, the mechanisms responsible for regulating the Npr1 gene (coding for GC-A/NPRA) transcription are not well understood. The present study was conducted to examine the interactive roles of all-trans retinoic acid (ATRA), Ets-1, Sp1, and histone acetylation on the transcriptional regulation and function of the Npr1 gene. Deletion analysis of the Npr1 promoter and luciferase assays showed that ATRA enhanced a 16-fold Npr1 promoter activity and greatly stimulated guanylyl cyclase (GC) activity of the receptor protein in both atrial natriuretic peptide (ANP)-dependent and -independent manner. As confirmed by gel shift and chromatin immunoprecipitation assays, ATRA enhanced the binding of both Ets-1 and Sp1 to the Npr1 promoter. The retinoic acid receptor alpha (RAR alpha) was recruited by Ets-1 and Sp1 to form a transcriptional activator complex with their binding sites in the Npr1 promoter. Interestingly, ATRA also increased the acetylation of histones H3 and H4 and enhanced their recruitment to Ets-1 and Sp1 binding sites within the Npr1 promoter. Collectively, the present results demonstrate that ATRA regulates Npr1 gene transcription and GC activity of the receptor by involving the interactive actions of Ets-1, Sp1, and histone acetylation.	[Pandey, Kailash N.] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Pandey, Kailash N.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University; Tulane University	Pandey, KN (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Physiol, SL 39,1430 Tulane Ave, New Orleans, LA 70112 USA.	kpandey@tulane.edu			National Institutes of Health [HL 57531, HL 62147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL057531, R01HL057531, R01HL062147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 57531 and HL 62147.	AGUI T, 1995, J BIOCHEM-TOKYO, V118, P500, DOI 10.1093/oxfordjournals.jbchem.a124936; Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; APPEL RG, 1992, AM J PHYSIOL, V262, pF911, DOI 10.1152/ajprenal.1992.262.6.F911; Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; BALLERMANN BJ, 1985, J CLIN INVEST, V76, P2049, DOI 10.1172/JCI112207; Bjorklund S, 1999, CELL, V96, P759, DOI 10.1016/S0092-8674(00)80586-3; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cao L, 1998, AM J PHYSIOL-RENAL, V275, pF119, DOI 10.1152/ajprenal.1998.275.1.F119; Cederberg A, 1999, J BIOL CHEM, V274, P165, DOI 10.1074/jbc.274.1.165; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; DE LUCA LM, 1991, FASEB J, V5, P2924; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Garg R, 2002, GENE, V291, P123, DOI 10.1016/S0378-1119(02)00589-9; Gomez R Aruek, 1999, Current Opinion in Pediatrics, V11, P135, DOI 10.1097/00008480-199904000-00007; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Khurana ML, 1996, MOL CELL BIOCHEM, V158, P97; Konta T, 2001, J BIOL CHEM, V276, P12697, DOI 10.1074/jbc.M011000200; Kumar P, 2006, PEPTIDES, V27, P1762, DOI 10.1016/j.peptides.2006.01.004; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Kumar P, 2009, BIOSCIENCE REP, V29, P57, DOI 10.1042/BSR20080094; Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li YH, 2009, ENDOCRINOLOGY, V150, P3759, DOI 10.1210/en.2008-1353; Lie-Venema H, 2003, CIRC RES, V92, P749, DOI 10.1161/01.RES.0000066662.70010.DB; Love WK, 2008, INT J ONCOL, V32, P625; Lu L, 2003, AM J PHYSIOL-HEART C, V285, pH1370, DOI 10.1152/ajpheart.00260.2003; Lucas KA, 2000, PHARMACOL REV, V52, P375; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Manzano VM, 2000, BRIT J PHARMACOL, V131, P1673, DOI 10.1038/sj.bjp.0703728; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Masaki T, 2006, BIOCHEM J, V397, P345, DOI 10.1042/BJ20051863; Nishikimi T, 2005, CARDIOVASC RES, V66, P94, DOI 10.1016/j.cardiores.2004.12.014; Palm-Leis A, 2004, J BIOL CHEM, V279, P54905, DOI 10.1074/jbc.M407383200; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Pandey KN, 2008, J AM SOC HYPERTENS, V2, P210, DOI 10.1016/j.jash.2008.02.001; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Pandey KN, 2002, J BIOL CHEM, V277, P4618, DOI 10.1074/jbc.M106436200; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; PANDEY KN, 1992, BIOCHEM J, V288, P55, DOI 10.1042/bj2880055; Pitzalis MV, 2003, J HYPERTENS, V21, P1491, DOI 10.1097/00004872-200308000-00012; Qi HL, 2006, CANCER RES, V66, P5875, DOI 10.1158/0008-5472.CAN-05-4048; Raouf A, 2000, ONCOGENE, V19, P1969, DOI 10.1038/sj.onc.1203505; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Sanz-Gonzalez SM, 2000, FRONT BIOSCI, V5, pD619, DOI 10.2741/sanz; Shi SJ, 2003, AM J PHYSIOL-RENAL, V285, pF694, DOI 10.1152/ajprenal.00097.2003; So EN, 2000, IUBMB LIFE, V50, P365, DOI 10.1080/713803742; Tremblay J, 2003, HYPERTENSION, V41, P16, DOI 10.1161/01.HYP.0000042664.75193.1B; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Vellaichamy E, 2005, J BIOL CHEM, V280, P19230, DOI 10.1074/jbc.M411373200; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Zhou XF, 1999, MOL ENDOCRINOL, V13, P276, DOI 10.1210/me.13.2.276	68	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37521	37530		10.1074/jbc.M110.132795	http://dx.doi.org/10.1074/jbc.M110.132795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864529	Green Published, hybrid			2022-12-25	WOS:000284424000044
J	Namba, T; Hoshino, T; Suemasu, S; Takarada-Iemata, M; Hori, O; Nakagata, N; Yanaka, A; Mizushima, T				Namba, Takushi; Hoshino, Tatsuya; Suemasu, Shintaro; Takarada-Iemata, Mika; Hori, Osamu; Nakagata, Naomi; Yanaka, Akinori; Mizushima, Tohru			Suppression of Expression of Endoplasmic Reticulum Chaperones by Helicobacter pylori and Its Role in Exacerbation of Non-steroidal Anti-inflammatory Drug-induced Gastric Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXYGEN-REGULATED PROTEIN; PEPTIC-ULCER DISEASE; INDUCED APOPTOSIS; STRESS-RESPONSE; MUCOSAL CELLS; MONGOLIAN GERBILS; EPITHELIAL-CELLS; CONTROLLED-TRIAL; GENE-EXPRESSION	Both the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, and infection with Helicobacter pylori are major causes of gastric ulcers. Although some clinical studies suggest that infection with H. pylori increases the risk of developing NSAID-induced gastric lesions, the molecular mechanism governing this effect is unknown. We recently found that in cultured gastric cells, expression of endoplasmic reticulum (ER) chaperones (such as 150-kDa oxygen-regulated protein (ORP150) and glucose-regulated protein 78 (GRP78)) is induced by NSAIDs and confers protection against NSAID-induced apoptosis, which is important in the development of NSAID-induced gastric lesions. In this study we have found that co-culture of gastric cells with H. pylori suppresses the expression of ER chaperones. This suppression was regulated at the level of transcription and accompanied by a reduction in the level of activating transcription factor 6 (ATF6), one of the transcription factors for ER chaperone genes. In vivo, inoculation of mice with H. pylori suppressed the expression of ER chaperones at gastric mucosa both with and without administration of indomethacin. Inoculation with H. pylori also stimulated formation of indomethacin-induced gastric lesions and mucosal cell death. In addition, we found that heterozygous ORP150-deficient mice are sensitive to the development of indomethacin-induced gastric lesions and mucosal cell death. The results of this study suggest that H. pylori exacerbates NSAID-induced gastric lesions through suppression of expression of ER chaperones, which stimulates NSAID-induced mucosal cell death.	[Namba, Takushi; Hoshino, Tatsuya; Suemasu, Shintaro; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Takarada-Iemata, Mika; Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa 9208640, Japan; [Nakagata, Naomi] Kumamoto Univ, Inst Resource Dev & Anal, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Yanaka, Akinori] Tokyo Univ Sci, Fac Pharmaceut Sci, Div Clin Pharmacol, Noda, Chiba 2788510, Japan	Kumamoto University; Kanazawa University; Kumamoto University; Tokyo University of Science	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp		Nakagata, Naomi/0000-0002-5737-9993; Takarada-Iemata, Mika/0000-0002-2113-0707	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid of Scientific Research from the Ministry of Health, Labour, and Welfare of Japan, grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid of the Japan Science and Technology Agency.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Asahi H, 2002, BJU INT, V90, P462, DOI 10.1046/j.1464-410X.2002.02915.x; Ashktorab H, 2002, MICROBES INFECT, V4, P713, DOI 10.1016/S1286-4579(02)01591-5; Boquet P, 2003, TRENDS MICROBIOL, V11, P410, DOI 10.1016/S0966-842X(03)00211-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Chang CC, 2005, WORLD J GASTROENTERO, V11, P104, DOI 10.3748/wjg.v11.i1.104; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; de Leest HTJI, 2007, HELICOBACTER, V12, P477, DOI 10.1111/j.1523-5378.2007.00543.x; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Huang T, 2009, J CELL BIOCHEM, V107, P973, DOI 10.1002/jcb.22202; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Kanatani K, 2004, J PHYSIOL PHARMACOL, V55, P207; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim H, 2003, ANN NY ACAD SCI, V1010, P90, DOI 10.1196/annals.1299.014; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Li Y, 2004, MOL BIOL CELL, V15, P1946, DOI 10.1091/mbc.e03-08-0618; Lichtenberger LM, 2001, BIOCHEM PHARMACOL, V61, P631, DOI 10.1016/S0006-2952(00)00576-1; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; Lou LX, 2006, LIFE SCI, V79, P1856, DOI 10.1016/j.lfs.2006.06.022; Mine T, 2000, ALIMENT PHARM THERAP, V14, P199, DOI 10.1046/j.1365-2036.2000.014s1199.x; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; Mori K, 2003, TRAFFIC, V4, P519, DOI 10.1034/j.1600-0854.2003.00112.x; Murakami K, 2009, J GASTROENTEROL, V44, P40, DOI 10.1007/s00535-008-2259-5; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Papatheodoridis GV, 2006, CLIN GASTROENTEROL H, V4, P130, DOI 10.1016/j.cgh.2005.10.006; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Shibata W, 2006, J PATHOL, V210, P306, DOI 10.1002/path.2040; Shirin H, 1999, CANCER RES, V59, P2277; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tomisato W, 2004, BIOCHEM PHARMACOL, V67, P575, DOI 10.1016/j.bcp.2003.09.020; Tomisato W, 2001, AM J PHYSIOL-GASTR L, V281, pG1092, DOI 10.1152/ajpgi.2001.281.4.G1092; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yeo M, 2004, PROTEOMICS, V4, P3335, DOI 10.1002/pmic.200400951; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida N, 2002, GUT, V50, P594, DOI 10.1136/gut.50.5.594	58	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37302	37313		10.1074/jbc.M110.148882	http://dx.doi.org/10.1074/jbc.M110.148882			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861013	Green Published, hybrid			2022-12-25	WOS:000284424000023
J	Ren, RY; Hong, ZN; Gong, HY; Laporte, K; Skinner, M; Seldin, DC; Costello, CE; Connors, LH; Trinkaus-Randall, V				Ren, Ruiyi; Hong, Zhenning; Gong, Haiyan; Laporte, Kate; Skinner, Martha; Seldin, David C.; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery			Role of Glycosaminoglycan Sulfation in the Formation of Immunoglobulin Light Chain Amyloid Oligomers and Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; CARDIAC FIBROBLASTS; PROTEIN; PROTEOGLYCANS; AMYLOIDOGENESIS; BLUE; IDENTIFICATION; ACCUMULATION; FIBRILLATION; ASSOCIATION	Primary amyloidosis (AL) results from overproduction of unstable monoclonal immunoglobulin light chains (LCs) and the deposition of insoluble fibrils in tissues, leading to fatal organ disease. Glycosaminoglycans (GAGs) are associated with AL fibrils and have been successfully targeted in the treatment of other forms of amyloidosis. We investigated the role of GAGs in LC fibrillogenesis. Ex vivo tissue amyloid fibrils were extracted and examined for structure and associated GAGs. The GAGs were detected along the length of the fibril strand, and the periodicity of heparan sulfate (HS) along the LC fibrils generated in vitro was similar to that of the ex vivo fibrils. To examine the role of sulfated GAGs on AL oligomer and fibril formation in vitro, a kappa 1 LC purified from urine of a patient with AL amyloidosis was incubated in the presence or absence of GAGs. The fibrils generated in vitro at physiologic concentration, temperature, and pH shared morphologic characteristics with the ex vivo kappa 1 amyloid fibrils. The presence of HS and over-O-sulfated-heparin enhanced the formation of oligomers and fibrils with HS promoting the most rapid transition. In contrast, GAGs did not enhance fibril formation of a non-amyloidogenic kappa 1 LC purified from urine of a patient with multiple myeloma. The data indicate that the characteristics of the full-length kappa 1 amyloidogenic LC, containing post-translational modifications, possess key elements that influence interactions of the LC with HS. These findings highlight the importance of the variable and constant LC regions in GAG interaction and suggest potential therapeutic targets for treatment.	[Ren, Ruiyi; Hong, Zhenning; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Gong, Haiyan] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Skinner, Martha; Seldin, David C.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Gong, Haiyan; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Ren, Ruiyi; Laporte, Kate; Skinner, Martha; Seldin, David C.; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Amyloid Treatment & Res Program, Boston, MA 02118 USA; [Hong, Zhenning; Costello, Catherine E.] Boston Univ, Sch Med, Dept Mass Spectrometry Resource, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Trinkaus-Randall, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, 80 E Concord St L904, Boston, MA 02118 USA.	vickery@bu.edu	Hong, Zhenning/C-6803-2011	Gong, Haiyan/0000-0002-7204-5019; Connors, Lawreen/0000-0002-4672-4296; Seldin, David C/0000-0003-0168-2333; Ren, Ruiyi/0000-0001-5785-2165; Costello, Catherine/0000-0003-1594-5122; Trinkaus-Randall, Vickery/0000-0002-8573-9108	National Institutes of Health [P01 HL-068705, EY06000, P41 RR10888]; Gerry Foundation and Amyloid Research Foundation; Young Travel Award; Departmental Massachusetts Lions Eye Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerry Foundation and Amyloid Research Foundation; Young Travel Award; Departmental Massachusetts Lions Eye Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL-068705 (to M. S.), EY06000 (V. T.-R.), and P41 RR10888 (C. E. C.). This work was also supported by grants from the Gerry Foundation and Amyloid Research Foundation (to M. S.), the Young Travel Award (to V. T.-R.), and the Departmental Massachusetts Lions Eye Research Fund.	AILLES L, 1993, LAB INVEST, V69, P443; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GONG HY, 1992, EXP EYE RES, V55, P691, DOI 10.1016/0014-4835(92)90174-Q; Gruys E, 2006, AMYLOID, V13, P13, DOI 10.1080/13506120500535768; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Ionescu-Zanetti C, 1999, P NATL ACAD SCI USA, V96, P13175, DOI 10.1073/pnas.96.23.13175; Jiang XL, 1997, BIOCHEMISTRY-US, V36, P13187, DOI 10.1021/bi970408h; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Lim A, 2001, ANAL BIOCHEM, V295, P45, DOI 10.1006/abio.2001.5187; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; OHISHI H, 1990, CLIN CHEM, V36, P88; Prokaeva T, 2007, ARTHRITIS RHEUM-US, V56, P3858, DOI 10.1002/art.22959; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; SKINNER M, 1982, PREP BIOCHEM, V12, P461, DOI 10.1080/10826068208070597; SNOW AD, 1987, LAB INVEST, V56, pA75; SNOW AD, 1985, LAB INVEST, V53, P37; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Trinkaus-Randall V., 2000, CORNEA BIOL RESPONSE, P383; Yamamoto K, 2010, FEBS LETT, V584, P3348, DOI 10.1016/j.febslet.2010.06.019; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	39	37	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37672	37682		10.1074/jbc.M110.149575	http://dx.doi.org/10.1074/jbc.M110.149575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870723	hybrid, Green Published			2022-12-25	WOS:000284424000059
J	West, LE; Roy, S; Lachmi-Weiner, K; Hayashi, R; Shi, XB; Appella, E; Kutateladze, TG; Gozani, O				West, Lisandra E.; Roy, Siddhartha; Lachmi-Weiner, Karin; Hayashi, Ryo; Shi, Xiaobing; Appella, Ettore; Kutateladze, Tatiana G.; Gozani, Or			The MBT Repeats of L3MBTL1 Link SET8-mediated p53 Methylation at Lysine 382 to Target Gene Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE-SPECIFIC RECOGNITION; DNA-DAMAGE; STRUCTURAL BASIS; HISTONE H4; CHROMATIN; PROTEIN; BINDING; METHYLTRANSFERASE; 53BP1; TUDOR	The p53 tumor suppressor protein is regulated by multiple post-translational modifications, including lysine methylation. We previously found that monomethylation of p53 at lysine 382 (p53K382me1) by the protein lysine methyltransferase (PKMT) SET8/PR-Set7 represses p53 transactivation of target genes. However, the molecular mechanism linking p53K382 monomethylation to repression is not known. Here we show in biochemical and crystallographic studies the preferential recognition of p53K382me1 by the triple malignant brain tumor (MBT) repeats of the chromatin compaction factor L3MBTL1. We demonstrate that SET8-mediated methylation of p53 at Lys-382 promotes the interaction between L3MBTL1 and p53 in cells, and the chromatin occupancy of L3MBTL1 at p53 target promoters. In the absence of DNA damage, L3MBTL1 interacts with p53K382me1 and p53-target genes are repressed, whereas depletion of L3MBTL1 results in a p53-dependent increase in p21 and PUMA transcript levels. Activation of p53 by DNA damage is coupled to a decrease in p53K382me1 levels, abrogation of the L3MBTL1-p53 interaction, and disassociation of L3MBTL1 from p53-target promoters. Together, we identify L3MBTL1 as the second known methyl-p53 effector protein, and provide a molecular explanation for the mechanism by which p53K382me1 is transduced to regulate p53 activity.	[West, Lisandra E.; Lachmi-Weiner, Karin; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Roy, Siddhartha; Kutateladze, Tatiana G.] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Hayashi, Ryo; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Kutateladze, TG (corresponding author), 12801 E 17th Ave, Aurora, CO 80045 USA.	tatiana.kutateladze@UCHSC.edu; ogozani@stanford.edu	Gozani, Or P/I-6157-2013	Gozani, Or/0000-0002-1365-4463; Shi, Xiaobing/0000-0001-5242-8189; Kutateladze, Tatiana/0000-0001-7375-6990	National Institutes of Health [GM079641, CA113472]; NATIONAL CANCER INSTITUTE [R01CA113472, ZIABC005599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM079641 (to O. G.) and CA113472 (to T. G. K.) from the National Institutes of Health and the Intramural Research Program of the National Institutes of Health (to E. A.).; Supported by a grant from the National Institutes of Health Stanford Genome Training Grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jang H, 2009, NAT STRUCT MOL BIOL, V16, P910, DOI 10.1038/nsmb.1657; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y., 2007, T Methods Enzymol, V25, P1; Trojer P, 2008, CELL CYCLE, V7, P578, DOI 10.4161/cc.7.5.5544; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	35	72	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37725	37732		10.1074/jbc.M110.139527	http://dx.doi.org/10.1074/jbc.M110.139527			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870725	Green Published, hybrid			2022-12-25	WOS:000284424000064
J	Datta, D; Banerjee, P; Gasser, M; Waaga-Gasser, AM; Pal, S				Datta, Dipak; Banerjee, Pallavi; Gasser, Martin; Waaga-Gasser, Ana Maria; Pal, Soumitro			CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR3; BREAST-CANCER; SPLICE VARIANT; EPITHELIAL-CELLS; UP-REGULATION; MURINE MODEL; I-TAC; METASTASIS; INFLAMMATION; CARCINOMA	The chemokine receptor CXCR3 may play a critical role in the growth and metastasis of tumor cells, including renal tumors. It has been shown that CXCR3 has two splice variants with completely opposite functions; CXCR3-A promotes cell proliferation, whereas CXCR3-B inhibits cell growth. We recently demonstrated that the expression of growth-promoting CXCR3-A is up-regulated, and the growth-inhibitory CXCR3-B is markedly down-regulated in human renal cancer tissues; and the overexpression of CXCR3-B in renal cancer cells can significantly inhibit cell proliferation. However, the growth-inhibitory signal( s) through CXCR3-B are not well characterized. Here, we investigated the effector molecule(s) involved in CXCR3-B-mediated signaling events. We found that the overexpression of CXCR3-B in human renal cancer cells (Caki-1) promoted cellular apoptosis as observed by FACS analysis through Annexin-V staining. To examine whether the overexpression of CXCR3-B could alter the expression of any apoptosis-related genes in renal cancer cells, we performed a protein array. We found that CXCR3-B overexpression significantly down-regulated the expression of antiapoptotic heme oxygenase-1 (HO-1). By utilizing a HO-1 promoter-luciferase plasmid, we showed that CXCR3-B-mediated down-regulation of HO-1 was controlled at the transcriptional level as observed by luciferase assay. We also demonstrated that the inhibition of HO-1 expression using siRNA promoted apoptosis of renal cancer cells. Finally, we observed that human renal cancer tissues expressing low amounts of CXCR3-B significantly overexpress HO-1 at both mRNA and protein level. Together, we suggest that the overexpression of CXCR3-B may prevent the growth of renal tumors through the inhibition of antiapoptotic HO-1.	[Datta, Dipak; Banerjee, Pallavi; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Datta, Dipak; Banerjee, Pallavi; Pal, Soumitro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2008, J AM SOC NEPHROL, V19, P2437, DOI 10.1681/ASN.2008040394; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kelsen SG, 2004, AM J PHYSIOL-LUNG C, V287, pL584, DOI 10.1152/ajplung.00453.2003; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kuroumalis A, 2005, J IMMUNOL, V175, P5403, DOI 10.4049/jimmunol.175.8.5403; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Laxmanan S, 2005, J AM SOC NEPHROL, V16, P2714, DOI 10.1681/ASN.2005010045; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Romagnani P, 2005, J ALLERGY CLIN IMMUN, V116, P1372, DOI 10.1016/j.jaci.2005.09.035; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	38	52	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36842	36848		10.1074/jbc.M110.170324	http://dx.doi.org/10.1074/jbc.M110.170324			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855888	Green Published, hybrid			2022-12-25	WOS:000284146100033
J	Shimobayashi, M; Takematsu, H; Eiho, K; Yamane, Y; Kozutsumi, Y				Shimobayashi, Mitsugu; Takematsu, Hiromu; Eiho, Kazuo; Yamane, Yukari; Kozutsumi, Yasunori			Identification of Ypk1 as a Novel Selective Substrate for Nitrogen Starvation-triggered Proteolysis Requiring Autophagy System and Endosomal Sorting Complex Required for Transport (ESCRT) Machinery Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; CELL-GROWTH; TRYPTOPHAN PERMEASE; SECRETORY PATHWAY; AMINOPEPTIDASE-I; BUDDING YEAST; TOR	Nitrogen starvation-mediated reduction of Ypk1 is suggested to suppress translational initiation, possibly in parallel with the target of rapamycin complex 1 (TORC1) signaling. However, the molecular mechanism that regulates Ypk1 in nitrogen-starved cells is poorly understood. Here we report that Ypk1 is a novel selective substrate for nitrogen starvation-triggered proteolysis requiring autophagy system. Among various nutrient starvation methods used to elicit autophagy, rapid Ypk1 degradation was specific to nitrogen starvation. In screening genes required for such nitrogen starvation-specific vacuolar proteolysis, we found that autophagy-related degradation of Ypk1 depended on the endosomal sorting complex required for transport (ESCRT) machinery, which is conventionally thought to function in endosomal trafficking. In microscopic analyses, the disruption of ESCRT subunits resulted in the accumulation of both Ypk1 and autophagosomal Atg8 at a perivacuolar site that was distinct from conventional endosomes. ESCRT machinery was not involved in autophagic flux induced by the TORC1 inhibitor rapamycin, thus suggesting that ESCRT represents an exclusive mechanism of nitrogen starvation-specific proteolysis of Ypk1. Overall, we propose a novel regulation of Ypk1 that is specific to nitrogen limitation.	[Shimobayashi, Mitsugu; Takematsu, Hiromu; Eiho, Kazuo; Yamane, Yukari; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan; [Shimobayashi, Mitsugu; Takematsu, Hiromu; Yamane, Yukari; Kozutsumi, Yasunori] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kozutsumi, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan.	yasu@pharm.kyoto-u.ac.jp		Shimobayashi, Mitsugu/0000-0002-6936-0990	Japan Society for the Promotion of Science [19590065]; CREST; Ministry of Education, Culture, Sports, Science and Technology, Japan [16GS0313]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 19590065 (to Y. K.) from the Japan Society for the Promotion of Science and CREST and by Grant-in-aid for Creative Scientific Research 16GS0313 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Brachmann CB, 1998, YEAST, V14, P115; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gelperin D, 2002, GENETICS, V161, P1453; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Horst M, 1999, MOL BIOL CELL, V10, P2879, DOI 10.1091/mbc.10.9.2879; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen H, 2002, APPL MICROBIOL BIOT, V59, P310, DOI 10.1007/s00253-002-1017-5; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Prick T, 2006, AUTOPHAGY, V2, P241, DOI 10.4161/auto.2743; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Silles E, 2000, J BIOL CHEM, V275, P34054, DOI 10.1074/jbc.M003514200; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485	57	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36984	36994		10.1074/jbc.M110.119180	http://dx.doi.org/10.1074/jbc.M110.119180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855891	hybrid, Green Published			2022-12-25	WOS:000284146100074
J	Alvarez-Tabares, I; Perez-Martin, J				Alvarez-Tabares, Isabel; Perez-Martin, Jose			Septins from the Phytopathogenic Fungus Ustilago maydis Are Required for Proper Morphogenesis but Dispensable for Virulence	PLOS ONE			English	Article							CEREVISIAE CELL-CYCLE; CORN SMUT FUNGUS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; HYPHAL GROWTH; PATHOGENIC DEVELOPMENT; GENE-PRODUCT; FILAMENTOUS GROWTH; ASHBYA-GOSSYPII; PROTEIN-KINASE	Background: Septins are a highly conserved family of GTP-binding proteins involved in multiple cellular functions, including division and morphogenesis. Studies of septins in fungal cells underpin a clear correlation between septin-based structures and fungal morphology, providing clues to understand the molecular frame behind the varied morphologies found in fungal world. Methodology/Principal Findings: Ustilago maydis genome has the ability to encode four septins. Here, using loss-of-function as well as GFP-tagged alleles of these septin genes, we investigated the roles of septins in the morphogenesis of this basidiomycete fungus. We described that septins in U. maydis could assemble into at least three different structures coexisting in the same cell: bud neck collars, band-like structures at the growing tip, and long septin fibers that run from pole to pole near the cell cortex. We also found that in the absence of septins, U. maydis cells lost their elongated shape, became wider at the central region and ended up losing their polarity, pointing to an important role of septins in the morphogenesis of this fungus. These morphological defects were alleviated in the presence of an osmotic stabilizer suggesting that absence of septins affected the proper formation of the cell wall, which was coherent with a higher sensitivity of septin defective cells to drugs that affect cell wall construction as well as exocytosis. As U. maydis is a phytopathogen, we analyzed the role of septins in virulence and found that in spite of the described morphological defects, septin mutants were virulent in corn plants. Conclusions/Significance: Our results indicated a major role of septins in morphogenesis in U. maydis. However, in contrast to studies in other fungal pathogens, in which septins were reported to be necessary during the infection process, we found a minor role of septins during corn infection by U. maydis.	[Alvarez-Tabares, Isabel; Perez-Martin, Jose] Ctr Nacl Biotecnol CSIC, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alvarez-Tabares, I (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Biotecnol Microbiana, Madrid, Spain.	jperez@cnb.csic.es	Perez-Martin, Jose/K-5117-2014	Perez-Martin, Jose/0000-0001-9849-7382	Spanish Government [BIO2008-04054]	Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by a Spanish Government grant (BIO2008-04054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Banuett F, 1996, DEVELOPMENT, V122, P2965; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2005, EUKARYOT CELL, V4, P121, DOI 10.1128/EC.4.1.121-133.2005; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; Beites CL, 2001, METHOD ENZYMOL, V329, P499; BLACKETER MJ, 1993, MOL CELL BIOL, V13, P5567, DOI 10.1128/MCB.13.9.5567; Bohmer C, 2009, MOL MICROBIOL, V74, P1484, DOI 10.1111/j.1365-2958.2009.06948.x; Bouquin N, 2000, J CELL SCI, V113, P1435; Boyce KJ, 2005, EUKARYOT CELL, V4, P2044, DOI 10.1128/EC.4.12.2044-2056.2005; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Canovas D, 2009, FUNGAL GENET BIOL, V46, P190, DOI 10.1016/j.fgb.2008.11.003; Carbo N, 2008, FUNGAL GENET BIOL, V45, P1315, DOI 10.1016/j.fgb.2008.06.010; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; DEMAY BS, 2009, MOL BIOL CELL; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Pablo-Hernando ME, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-55; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Flor-Parra I, 2007, PLANT CELL, V19, P3280, DOI 10.1105/tpc.107.052738; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2004, EUKARYOT CELL, V3, P847, DOI 10.1128/EC.3.4.847-854.2004; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gladfelter AS, 2006, NAT REV MICROBIOL, V4, P223, DOI 10.1038/nrmicro1345; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215; HOLLIDAY R, 1974, HDB GENETICS, P575; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; KOZUBOWSKI L, 2009, MOL MICROBIOL; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Martin SW, 2005, EUKARYOT CELL, V4, P1191, DOI 10.1128/EC.4.7.1191-1202.2005; Martin SW, 2004, J BIOL CHEM, V279, P40861, DOI 10.1074/jbc.M406422200; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; SHAH N, 1993, J BIOL CHEM, V268, P5345; Steinberg G, 2001, J CELL SCI, V114, P609; Steinberg G, 1998, J CELL SCI, V111, P2235; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; Straube A, 2005, EMBO J, V24, P1674, DOI 10.1038/sj.emboj.7600644; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Sudbery PE, 2001, MOL MICROBIOL, V41, P19, DOI 10.1046/j.1365-2958.2001.02459.x; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Thomas CL, 2003, YEAST, V20, P813, DOI 10.1002/yea.1003; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; VOGEL JP, 1993, J BIOL CHEM, V268, P3040; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Warenda AJ, 2002, MOL BIOL CELL, V13, P2732, DOI 10.1091/mbc.E02-01-0013; Weber I, 2003, PLANT CELL, V15, P2826, DOI 10.1105/tpc.016246; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407	69	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12933	10.1371/journal.pone.0012933	http://dx.doi.org/10.1371/journal.pone.0012933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885997	Green Submitted, gold, Green Published			2022-12-25	WOS:000282167100002
J	Meng, JR; Fang, BL; Liao, Y; Chresta, CM; Smith, PD; Roth, JA				Meng, Jieru; Fang, Bingliang; Liao, Yong; Chresta, Christine M.; Smith, Paul D.; Roth, Jack A.			Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim	PLOS ONE			English	Article							PATHWAY PROMOTES PHOSPHORYLATION; FORKHEAD TRANSCRIPTION FACTORS; BH3-ONLY PROTEIN; AKT ACTIVITY; AZD6244; FOXO3A; DEATH; ACTIVATION; EXPRESSION; DEGRADATION	AZD6244 (ARRY-142886) is an inhibitor of MEK1/2 and can inhibit cell proliferation or induce apoptosis in a cell-type dependent manner. The precise molecular mechanism of AZD6244-induced apoptosis is not clear. To investigate mechanisms of AZD6244 induced apoptosis in human lung cancer, we determined the molecular changes of two subgroups of human lung cancer cell lines that are either sensitive or resistant to AZD6244 treatment. We found that AZD6244 elicited a large increase of Bim proteins and a smaller increase of PUMA and NOXA proteins, and induced cell death in sensitive lung cancer cell lines, but had no effect on other Bcl-2 related proteins in those cell lines. Knockdown of Bim by siRNA greatly increased the IC50 and reduced apoptosis for AZD6244 treated cells. We also found that levels of endogenous p-Thr32-FOXO3a and p-Ser253-FOXO3a were lower in AZD6244-sensitive cells than in AZD6244-resistant cells. In the sensitive cells, AZD6244 induced FOXO3a nuclear translocation required for Bim activation. Moreover, the silencing of FOXO3a by siRNA abrogated AZD6244-induced cell apoptosis. In addition, we found that transfection of constitutively active AKT up-regulated p-Thr32-FOXO3a and p-Ser253-FOXO3a expression and inhibited AZD6244-induced Bim expression in sensitive cells. These results show that Bim plays an important role in AZD6244-induced apoptosis in lung cancer cells and that the PI3K/AKT/FOXO3a pathway is involved in Bim regulation and susceptibility of lung cancer cells to AZD6244. These results have implications in the development of strategies to overcome resistance to MEK inhibitors.	[Meng, Jieru; Fang, Bingliang; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Liao, Yong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Chresta, Christine M.; Smith, Paul D.] Astrazeneca, Canc & Infect Res, Macclesfield, Cheshire, England	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; AstraZeneca	Meng, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	jmeng@mdanderson.org			National Cancer Institute Specialized Program of Research Excellence (SPORE) [CA-70907, CA-092487]; Cancer Center [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907, R01CA092487] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence (SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant CA-70907 (J. Minna and J. Roth), R01 Grant CA-092487 (B. Fang), and Cancer Center Support Grant CA-16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by a Sponsored Research Grant from AstraZeneca Pharmaceutics who did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Clark AS, 2002, MOL CANCER THER, V1, P707; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huynh H, 2007, MOL CANCER THER, V6, P2468, DOI 10.1158/1535-7163.MCT-07-0162; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leung KT, 2008, CARCINOGENESIS, V29, P544, DOI 10.1093/carcin/bgm294; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	37	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13026	10.1371/journal.pone.0013026	http://dx.doi.org/10.1371/journal.pone.0013026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885957	Green Submitted, gold, Green Published			2022-12-25	WOS:000282167100024
J	Oxnard, C; Obendorf, PJ; Kefford, BJ				Oxnard, Charles; Obendorf, Peter J.; Kefford, Ben J.			Post-Cranial Skeletons of Hypothyroid Cretins Show a Similar Anatomical Mosaic as Homo floresiensis	PLOS ONE			English	Article							LATE PLEISTOCENE; HOMININ	Human remains, some as recent as 15 thousand years, from Liang Bua (LB) on the Indonesian island of Flores have been attributed to a new species, Homo floresiensis. The definition includes a mosaic of features, some like modern humans (hence derived: genus Homo), some like modern apes and australopithecines (hence primitive: not species sapiens), and some unique (hence new species: floresiensis). Conversely, because only modern humans (H. sapiens) are known in this region in the last 40 thousand years, these individuals have also been suggested to be genetic human dwarfs. Such dwarfs resemble small humans and do not show the mosaic combination of the most complete individuals, LB1 and LB6, so this idea has been largely dismissed. We have previously shown that some features of the cranium of hypothyroid cretins are like those of LB1. Here we examine cretin postcrania to see if they show anatomical mosaics like H. floresiensis. We find that hypothyroid cretins share at least 10 postcranial features with Homo floresiensis and unaffected humans not found in apes (or australopithecines when materials permit). They share with H. floresiensis, modern apes and australopithecines at least 11 postcranial features not found in unaffected humans. They share with H. floresiensis, at least 8 features not found in apes, australopithecines or unaffected humans. Sixteen features can be rendered metrically and multivariate analyses demonstrate that H. floresiensis co-locates with cretins, both being markedly separate from humans and chimpanzees (P<0.001: from analysis of similarity (ANOSIM) over all variables, ANOSIM, global R>0.999). We therefore conclude that LB1 and LB6, at least, are, most likely, endemic cretins from a population of unaffected Homo sapiens. This is consistent with recent hypothyroid endemic cretinism throughout Indonesia, including the nearby island of Bali.	[Oxnard, Charles] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia; [Oxnard, Charles] Univ Western Australia, Forens Sci Ctr, Crawley, WA, Australia; [Obendorf, Peter J.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Kefford, Ben J.] Univ Technol Sydney, Ctr Environm Sustainabil, Dept Environm Sci, Broadway, NSW, Australia	University of Western Australia; University of Western Australia; Royal Melbourne Institute of Technology (RMIT); University of Technology Sydney	Oxnard, C (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia.	charles.oxnard@uwa.edu.au		Kefford, Ben/0000-0001-6789-4254	Australian Research Council [DP0557157, 0772742, 0984372]	Australian Research Council(Australian Research Council)	Australian Research Council Discovery Grants DP0557157, 0772742 and 0984372 to Charles Oxnard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2010, AM J PHYS ANTHROPOL, V142, P167, DOI 10.1002/ajpa.21255; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Berger LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001780; BOYAGES SC, 1988, J CLIN ENDOCR METAB, V67, P1262, DOI 10.1210/jcem-67-6-1262; Broom R, 1950, TRANSVAAL MUSEUM MEM, V4; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Chen ZP, 2010, BEST PRACT RES CL EN, V24, P39, DOI 10.1016/j.beem.2009.08.014; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; DEQUERVAIN F, 1936, ENDEMISCHE KRETINISM; EERLAND LD, 1932, GENEESK TIJDSCHR NED, V72, P1299; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Falk D, 2009, AM J PHYS ANTHROPOL, V140, P52, DOI 10.1002/ajpa.21035; Fuge R., 2005, ESSENTIALS MED GEOLO, P417; He T Y, 1984, Zhonghua Fang She Xue Za Zhi, V18, P279; Hershkovitz I, 2007, AM J PHYS ANTHROPOL, V134, P198, DOI 10.1002/ajpa.20655; HILL WCO, 1936, CEYLON J SCI, V4, P71; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; JUNGERS WL, 2009, SIGNIFICANCE, V6, P159, DOI DOI 10.1111/J.1740-9713.2009.00389.X; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; LOVEJOY CO, 2009, SCIENCE, V326; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; NOOSTEN D, 1935, GENEESK TIJDSCHR NED, V75, P1420; O'Connor S, 2007, ANTIQUITY, V81, P523, DOI 10.1017/S0003598X00095569; Obendorf PJ, 2008, P ROY SOC B-BIOL SCI, V275, P1287, DOI 10.1098/rspb.2007.1488; ORTNER DJ, 1993, BONE GROWTH; OXNARD C, 2008, GHOSTLY MUSCLES WRIN; OXNARD CE, 1968, AM J PHYS ANTHROPOL, V29, P429, DOI 10.1002/ajpa.1330290317; OXNARD CE, 1968, AM J PHYS ANTHROPOL, V28, P213, DOI 10.1002/ajpa.1330280218; Oxnard CE, 1983, ORDER MAN BIOMATHEMA; Preedy VR, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P1; Rencher AC, 2002, METHODS MULTIVARIATE; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; WILKINS L., 1941, AMER JOUR DIS CHILDREN, V61, P13	40	18	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13018	10.1371/journal.pone.0013018	http://dx.doi.org/10.1371/journal.pone.0013018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885948	gold, Green Published, Green Submitted			2022-12-25	WOS:000282167100019
J	Parra, P; Serra, F; Palou, A				Parra, Pilar; Serra, Francisca; Palou, Andreu			Expression of Adipose MicroRNAs Is Sensitive to Dietary Conjugated Linoleic Acid Treatment in Mice	PLOS ONE			English	Article							LIPID-METABOLISM; SUBCUTANEOUS ADIPOSE; PANTOTHENATE KINASE; GENES; EFFICACY; OBESITY; MIRNAS	Background: Investigation of microRNAs (miRNAs) in obesity, their genetic targets and influence by dietary modulators is of great interest because it may potentially identify novel pathways involved in this complex metabolic disorder and influence future therapeutic approaches. This study aimed to determine whether miRNAs expression may be influenced by conjugated linoleic acid (CLA), currently used to induce fat loss. Methodology/Principal Findings: We determined retroperitoneal adipose tissue (rWAT) expression of five miRNAs related to adipocyte differentiation (miRNA-143) and lipid metabolism (miRNA-103 and -107) and altered in obesity (miRNA-221 and -222), using the TaqMan (R) MicroRNA Assay (Applied-Biosystems). In the first experiment, mice were fed with a standard fat diet and orally treated with sunflower oil (control group) and 3 or 10 mg CLA/day for 37 days. In the second experiment, mice were fed with a high fat diet for 65 days. For the first 30 days, mice received the same doses of CLA described above and, from that time onwards, animals received a double dose. Results showed that expression of selected miRNAs was modified in response to CLA treatment and metabolic status. Interestingly, a strong correlation was observed between miR-103 and -107 expression, as well as miR-221 and -222 in both experiments. Moreover, changes in miRNAs expression correlated with several adipocyte gene expressions: miR-103 and -107 correlated with genes involved in fatty acid metabolism whereas miR-221 and miR-222 correlated with the expression of adipocytokines. Regarding the minor changes observed in miR-143 expression, no differences in expression of adipogenic markers were observed. Conclusions/Significance: Although elucidating the functional implications of miRNAs is beyond the scope of this study, these findings provide the first evidence that miRNAs expression may be influenced by dietary manipulation, reflecting or even contributing to the new metabolic state originated by CLA treatment.	[Parra, Pilar] Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Baleares, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma de Mallorca, Baleares, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Parra, P (corresponding author), Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Baleares, Spain.	francisca.serra@uib.es	Palou, Andreu/K-9881-2014; Serra, Francisca/B-8641-2008; Xie, Huangming/B-2260-2012	Palou, Andreu/0000-0002-0295-4452; Serra, Francisca/0000-0002-8307-9732; 	Spanish Government [AGL2009-11277]; European Union [FP6-506360]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	This work was supported by Spanish Government (grant AGL2009-11277). The authors' Laboratory is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, European Union Contract No. FP6-506360). CIBER de Fisiopatologi-a de la Obesidad y Nutricion is an initiative from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Parra P, 2010, J NUTR BIOCHEM, V21, P107, DOI 10.1016/j.jnutbio.2008.10.010; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; Whigham LD, 2007, AM J CLIN NUTR, V85, P1203; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Ying SY, 2006, J BIOMED SCI, V13, P5, DOI 10.1007/s11373-005-9036-8	34	81	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13005	10.1371/journal.pone.0013005	http://dx.doi.org/10.1371/journal.pone.0013005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886002	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100012
J	Too, WCS; Wong, MT; Few, LL; Konrad, M				Too, Wei Cun See; Wong, Mun Teng; Few, Ling Ling; Konrad, Manfred			Highly Specific Antibodies for Co-Detection of Human Choline Kinase alpha 1 and alpha 2 Isoforms	PLOS ONE			English	Article							BREAST-CANCER CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; ETHANOLAMINE KINASE; ESCHERICHIA-COLI; GROWTH-FACTORS; GENE; RAT; OVEREXPRESSION; PHOSPHOCHOLINE; EXPRESSION	Background: Choline kinase is the first enzyme in the CDP-choline pathway that synthesizes phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. In humans, choline kinase exists as three isoforms (CK alpha 1, alpha 2, and beta). Specific inhibition of CK alpha has been reported to selectively kill tumoral cells. Monoclonal and polyclonal antibodies against CKa used in previous studies to detect the level of this isozyme in different cellular or biochemical contexts were able to detect either the alpha 1 or the alpha 2 isoform. Methodology/Principal Findings: In this study, an antiserum against CK alpha was produced by immunizing rabbits with denatured, purified recombinant CK alpha 2 full-length protein. This antiserum was highly specific for CK alpha when tested with extracts from different cell lines, and there was no cross reactivity with purified CK beta and other related proteins like human ethanolamine kinases (EK) and yeast choline or ethanolamine kinases. The antiserum simultaneously detected both CK alpha 1 and alpha 2 isoforms in MCF-7 and HepG2 cell extracts, but not in HeLa, HCT-116, and mouse embryonic stem cell extracts. Subsequent protein dot blot assay of total CK alpha in a human normal/tumor protein array of 30 tissue samples by using the antiserum showed that CK alpha was not overexpressed in all tumor tissues when compared to their normal counterparts. Most striking differences between tumor and normal CK alpha expression levels were observed in kidney (11-fold higher in tumor) and liver (15-fold lower in tumor) samples. Conclusion/Significance: Apart from its high sensitivity and specificity, the antiserum produced in this work, which does not require further purification, has the advantage of co-detecting both alpha 1 and alpha 2 isoforms in cell extracts for direct comparison of their expression levels.	[Too, Wei Cun See; Wong, Mun Teng; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia; [Too, Wei Cun See; Konrad, Manfred] Max Planck Inst Biophys Chem, Gottingen, Germany	Universiti Sains Malaysia; Max Planck Society	Too, WCS (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia.	stweicun@kb.usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Ministry of Higher Education [203/PPSK/6170023]; Universiti Sains Malaysia Research University [1001/PPSK/813008]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Universiti Sains Malaysia Research University(Universiti Sains Malaysia)	This work was partly supported by the Fundamental Research Grant Scheme, Ministry of Higher Education (203/PPSK/6170023) and Universiti Sains Malaysia Research University Grant (1001/PPSK/813008). MTW is supported by a Universiti Sains Malaysia Research University Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2000, J LIPID RES, V41, P452; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Banez-Coronel M, 2008, CURR CANCER DRUG TAR, V8, P709, DOI 10.2174/156800908786733432; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Gallego-Ortega D, 2006, INT J ONCOL, V29, P335; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Kiss Z, 1999, CELL SIGNAL, V11, P149, DOI 10.1016/S0898-6568(98)00057-6; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; PORTER TJ, 1990, J BIOL CHEM, V265, P414; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Sydor Jens R, 2003, Proteome Sci, V1, P3, DOI 10.1186/1477-5956-1-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA T, 1990, BIOCHIM BIOPHYS ACTA, V1043, P281, DOI 10.1016/0005-2760(90)90028-V; WARDEN CH, 1985, J BIOL CHEM, V260, P6006; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2010, BIOCHEM CELL BIOL, V88, P559, DOI 10.1139/O09-160	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12999	10.1371/journal.pone.0012999	http://dx.doi.org/10.1371/journal.pone.0012999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886003	Green Published, Green Submitted, gold			2022-12-25	WOS:000282167100008
J	Bento, CF; Marques, F; Fernandes, R; Pereira, P				Bento, Carla Figueira; Marques, Filipa; Fernandes, Rosa; Pereira, Paulo			Methylglyoxal Alters the Function and Stability of Critical Components of the Protein Quality Control	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; HEAT-SHOCK PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; RETINAL-PIGMENT EPITHELIUM; GLYCATION END-PRODUCTS; BOVINE SERUM-ALBUMIN; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; ALPHA-CRYSTALLIN; REDOX REGULATION	Background: Increased production and accumulation of methylglyoxal (MGO), as well as increased modification of proteins by glycoxidation, are hallmarks of aging and diabetes. MGO was shown to modify proteins and to contribute to the accumulation of damaged proteins that can be toxic to cells. However, the effect of MGO on the cell systems responsible for repairing or degrading damaged proteins is still unclear. In this study, the effect of MGO on the function of the ubiquitin-proteasome system (UPS) and on molecular chaperones, two cooperative mechanisms associated with protein quality control, was investigated. Principal Findings: In this work it is shown that treatment of cells with MGO leads to accumulation of ubiquitin conjugates and depletion of free ubiquitin. Moreover, MGO significantly decreases the proteolytic activity of the 20S proteasome. Data further shows that MGO decreases the levels of the molecular chaperones Hsc70 and Hsp90 and leads to accumulation of CHIP-, Hsp40- and ubiquitin-containing aggregates. The formation of large aggregates containing CHIP is a consequence of its binding to misfolded proteins and to molecular chaperones. Moreover, dysfunction of the chaperones/CHIP/UPS axis is associated with accumulation of oxidized and argpyrimidine-modified proteins, which is likely to be associated with decreased cell viability. Interestingly, data further shows that MGO-induced stress induces the activation of heat shock factor-1 (Hsf-1), the main transcription factor involved in the regulation of the expression of heat shock proteins (HSPs) and cell response to stress. Conclusions: The data obtained in this work suggests that MGO impairs both the UPS and the protein quality control dependent on CHIP and molecular chaperones, leading to accumulation of toxic aggregates and increased cell death. However, these MGO-induced changes appear to elicit a response from the Hsf-1 system, which is crucial to help cells to cope with cellular stress and to re-establish homeostasis.	[Bento, Carla Figueira; Marques, Filipa; Fernandes, Rosa; Pereira, Paulo] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Bento, Carla Figueira] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, PhD Programme Expt Biol & Biomed, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Bento, CF (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Res Light & Image IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	ppereira@ibili.uc.pt	Pereira, Paulo/AAD-8375-2022; Fernandes, Rosa/P-1102-2014	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Rosa/0000-0001-7828-2296; Bento, Carla F./0000-0001-8377-4543	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/15229/2004, POCI/SAU-OBS/57772/2004, PDTC/SAU-OBS/67498/2006]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the PhD fellowship SFRH/BD/15229/2004 (Carla F. Bento) and the grants POCI/SAU-OBS/57772/2004 and PDTC/SAU-OBS/67498/2006 (FCT - Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Biswas A, 2008, BIOCHEM J, V409, P771, DOI 10.1042/BJ20071006; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1; Du J, 2006, INT J BIOCHEM CELL B, V38, P1084, DOI 10.1016/j.biocel.2005.10.019; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hammes HP, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00275-1; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hooper Philip L., 2007, Metabolic Syndrome and Related Disorders, V5, P220, DOI 10.1089/met.2007.0005; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Kang JH, 2006, J BIOCHEM MOL BIOL, V39, P335; Kumar MS, 2004, EXP EYE RES, V79, P577, DOI 10.1016/j.exer.2004.07.003; Kumar PA, 2007, BIOCHEM J, V408, P251, DOI 10.1042/BJ20070989; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; LO TWC, 1994, J BIOL CHEM, V269, P32299; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Merforth S, 2003, INT J BIOCHEM CELL B, V35, P740, DOI 10.1016/S1357-2725(02)00381-3; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Monnier VM, 1996, NEPHROL DIAL TRANSPL, V11, P20; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; OBIN M, 1994, BIOCHEM BIOPH RES CO, V200, P1169, DOI 10.1006/bbrc.1994.1574; Okouchi M, 2005, CURR NEUROVASC RES, V2, P13, DOI 10.2174/1567202052773535; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Portero-Otin M, 1999, DIABETES, V48, P2215, DOI 10.2337/diabetes.48.11.2215; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rondeau P, 2008, FREE RADICAL BIO MED, V45, P799, DOI 10.1016/j.freeradbiomed.2008.06.004; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Schalkwijk CG, 2006, FEBS LETT, V580, P1565, DOI 10.1016/j.febslet.2006.01.086; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zeng JM, 2006, CHEM RES TOXICOL, V19, P1668, DOI 10.1021/tx0602158	69	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13007	10.1371/journal.pone.0013007	http://dx.doi.org/10.1371/journal.pone.0013007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885985	Green Published, gold, Green Submitted			2022-12-25	WOS:000282122600024
J	Benedetti-Cecchi, L; Iken, K; Konar, B; Cruz-Motta, J; Knowlton, A; Pohle, G; Castelli, A; Tamburello, L; Mead, A; Trott, T; Miloslavich, P; Wong, M; Shirayama, Y; Lardicci, C; Palomo, G; Maggi, E				Benedetti-Cecchi, Lisandro; Iken, Katrin; Konar, Brenda; Cruz-Motta, Juan; Knowlton, Ann; Pohle, Gerhard; Castelli, Alberto; Tamburello, Laura; Mead, Angela; Trott, Tom; Miloslavich, Patricia; Wong, Melisa; Shirayama, Yoshihisa; Lardicci, Claudio; Palomo, Gabriela; Maggi, Elena			Spatial Relationships between Polychaete Assemblages and Environmental Variables over Broad Geographical Scales	PLOS ONE			English	Article							TAXONOMIC SUFFICIENCY; BETA DIVERSITY; RUN-OFF; CLIMATE; IMPACTS; BIODIVERSITY; RESOLUTION; COMMUNITY; FRAMEWORK; PATTERNS	This study examined spatial relationships between rocky shore polychaete assemblages and environmental variables over broad geographical scales, using a database compiled within the Census of Marine Life NaGISA (Natural Geography In Shore Areas) research program. The database consisted of abundance measures of polychaetes classified at the genus and family levels for 74 and 93 sites, respectively, from nine geographic regions. We tested the general hypothesis that the set of environmental variables emerging as potentially important drivers of variation in polychaete assemblages depend on the spatial scale considered. Through Moran's eigenvector maps we indentified three submodels reflecting spatial relationships among sampling sites at intercontinental (>10000 km), continental (1000-5000 km) and regional (20-500 km) scales. Using redundancy analysis we found that most environmental variables contributed to explain a large and significant proportion of variation of the intercontinental submodel both for genera and families (54% and 53%, respectively). A subset of these variables, organic pollution, inorganic pollution, primary productivity and nutrient contamination was also significantly related to spatial variation at the continental scale, explaining 25% and 32% of the variance at the genus and family levels, respectively. These variables should therefore be preferably considered when forecasting large-scale spatial patterns of polychaete assemblages in relation to ongoing or predicted changes in environmental conditions. None of the variables considered in this study were significantly related to the regional submodel.	[Benedetti-Cecchi, Lisandro; Castelli, Alberto; Tamburello, Laura; Lardicci, Claudio; Maggi, Elena] Univ Pisa, Dept Biol, CoNISMa Natl Interuniv Consortium Marine Sci, Pisa, Italy; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Cruz-Motta, Juan; Miloslavich, Patricia] Univ Simon Bolivar, Dept Estudios Ambient, Ctr Biodiversidad Marina, Caracas, Venezuela; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Mead, Angela] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Trott, Tom] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Wong, Melisa] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Shirahama, Japan; [Palomo, Gabriela] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecosistemas Costeros, Buenos Aires, DF, Argentina	University of Pisa; University of Alaska System; University of Alaska Fairbanks; Simon Bolivar University; University of Cape Town; Suffolk University; Bedford Institute of Oceanography; Kyoto University; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Benedetti-Cecchi, L (corresponding author), Univ Pisa, Dept Biol, CoNISMa Natl Interuniv Consortium Marine Sci, Pisa, Italy.	lbenedetti@biologia.unipi.it	lardicci, claudio/K-8698-2018; Maggi, Elena/AAR-9910-2021; Benedetti-Cecchi, Lisandro/J-8225-2019; Trott, Thomas J/N-4660-2018	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Trott, Thomas J/0000-0002-1851-5243; Palomo, Maria Gabriela/0000-0002-9102-1282; CASTELLI, ALBERTO/0000-0002-0762-1403; Cruz Motta, Juan Jose/0000-0001-6117-9014; TAMBURELLO, LAURA/0000-0003-1305-8802; Miloslavich, Patricia/0000-0001-5409-1401; MAGGI, Elena/0000-0001-6934-9380; LARDICCI, CLAUDIO/0000-0001-5356-7914	Alfred P. Sloan Foundation; Nippon Foundation; History of Near Shore (HNS)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Nippon Foundation(Nippon Foundation); History of Near Shore (HNS)	This work is part of the Census of Marine Life program and the authors would like to express their sincerest gratitude to the Alfred P. Sloan Foundation for funding. Additional support was provided by a PRIN Project from the Italian Ministry of University and Research and by the University of Pisa to LBC. Nippon Foundation provided financial support to YS for carrying out sampling in the western Pacific. Suffolk University provided generous financial support for sampling in Maine and data processing. The Gulf Ecosystem Monitoring program provided funds for sampling in Alaska to BK and KI. The History of Near Shore (HNS) initiative provided financial support for field collections in South Africa, and Maine, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Bertrand Y, 2006, SYST BIODIVERS, V4, P149, DOI 10.1017/S1477200005001908; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Broitman BR, 2006, MAR ECOL PROG SER, V327, P15, DOI 10.3354/meps327015; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Corfield J, 2000, ICES J MAR SCI, V57, P1517, DOI 10.1006/jmsc.2000.0901; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; ELLIS D, 1985, MAR POLLUT BULL, V16, P459, DOI 10.1016/0025-326X(85)90362-5; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hewitt JE, 2009, GLOBAL CHANGE BIOL, V15, P1911, DOI 10.1111/j.1365-2486.2008.01825.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Josefson AB, 1997, MAR ECOL PROG SER, V147, P49, DOI 10.3354/meps147049; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Lee HW, 2006, MAR ECOL PROG SER, V307, P175, DOI 10.3354/meps307175; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; Musco L, 2009, MAR ECOL PROG SER, V383, P199, DOI 10.3354/meps07989; Olsgard F, 2003, BIODIVERS CONSERV, V12, P1033, DOI 10.1023/A:1022800405253; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peters DPC, 2008, FRONT ECOL ENVIRON, V6, P229, DOI 10.1890/070098; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Salen-Picard C, 2002, OECOLOGIA, V133, P380, DOI 10.1007/s00442-002-1032-3; Selman P, 2009, LAND USE POLICY, V26, pS142, DOI 10.1016/j.landusepol.2009.08.005; Terlizzi A, 2009, DIVERS DISTRIB, V15, P450, DOI 10.1111/j.1472-4642.2008.00551.x; THRUSH SF, 1994, ECOL APPL, V4, P31, DOI 10.2307/1942112; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894; Wilmers CC, 2007, AM NAT, V169, P673, DOI 10.1086/513484; Witman J.D., 2009, MARINE MACROECOLOGY, DOI 10.7208/chicago/9780226904146.001.0001; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; [No title captured]	50	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12946	10.1371/journal.pone.0012946	http://dx.doi.org/10.1371/journal.pone.0012946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886075	Green Published, gold			2022-12-25	WOS:000282091100043
J	Honma, M; Soshi, T; Kim, Y; Kuriyama, K				Honma, Motoyasu; Soshi, Takahiro; Kim, Yoshiharu; Kuriyama, Kenichi			Right Prefrontal Activity Reflects the Ability to Overcome Sleepiness during Working Memory Tasks: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							BRAIN ACTIVATION; OLDER-ADULTS; CHEWING GUM; REM-SLEEP; ATTENTION; DEPRIVATION; PERFORMANCE; TIME; DYNAMICS; CORTEX	It has been speculated that humans have an inherent ability to overcome sleepiness that counteracts homeostatic sleep pressure. However, it remains unclear which cortical substrate activities are involved in the ability to overcome sleepiness during the execution of cognitive tasks. Here we sought to confirm that this ability to overcome sleepiness in task execution improves performance on cognitive tasks, showing activation of neural substrates in the frontal cortex, by using a modified n-back (2- and 0-back) working memory task and functional near-infrared spectroscopy. The change in alertness was just correlated with performances on the 2- back task. Activity in the right prefrontal cortex changed depending on alertness changes on the 2- and 0-back tasks independently, which indicates that activity in this region clearly reflects the ability to overcome sleepiness; it may contribute to the function of providing sufficient activity to meet the task load demands. This study reveals characteristics of the ability to overcome sleepiness during the n-back working memory task which goes beyond the attention-control function traditionally proposed.	[Honma, Motoyasu; Soshi, Takahiro; Kim, Yoshiharu; Kuriyama, Kenichi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan	Honma, M (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan.	kenichik@ncnp.go.jp	Honma, Motoyasu/M-7124-2018	Honma, Motoyasu/0000-0003-4612-0115; Soshi, Takahiro/0000-0003-1924-936X	Ministry of Education, Sports, Science, and Culture of Japan [21790235]; Ministry of Health, Labour and Welfare, Japan [20300701-009]; Grants-in-Aid for Scientific Research [21790235] Funding Source: KAKEN	Ministry of Education, Sports, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (grant number 21790235) from the Ministry of Education, Sports, Science, and Culture of Japan, and a research grant for Nervous and Mental Disorders, 20300701-009, Health Science Grant from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1992, INT J PSYCHOPHYSIOL, V12, P95, DOI 10.1016/0167-8760(92)90001-R; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Bennett CL, 2008, AM J PSYCHOL, V121, P349, DOI 10.2307/20445471; Cannestra AF, 2003, NEUROREPORT, V14, P1961, DOI 10.1097/00001756-200310270-00016; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Engstrom M, 2009, SLEEP, V32, P681, DOI 10.1093/sleep/32.5.681; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Giam G. C. K., 1997, Annals Academy of Medicine Singapore, V26, P88; GROSVENOR A, 1984, SLEEP, V7, P155, DOI 10.1093/sleep/7.2.155; Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820; Harmening D, 1996, LAB MED, V27, P25, DOI 10.1093/labmed/27.1.25; Herrmann MJ, 2008, PSYCHOPHYSIOLOGY, V45, P480, DOI 10.1111/j.1469-8986.2007.00633.x; Hidalgo MPL, 2004, PSYCHOL REP, V95, P75, DOI 10.2466/PR0.95.5.75-85; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; IDZIKOWSKI C, 1984, BRIT J PSYCHOL, V75, P439, DOI 10.1111/j.2044-8295.1984.tb01914.x; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Moorcroft WH, 1997, SLEEP, V20, P40, DOI 10.1093/sleep/20.1.40; Mu QW, 2005, SLEEP, V28, P433, DOI 10.1093/sleep/28.4.433; O'Grada C, 2009, SCHIZOPHR RES, V107, P319, DOI 10.1016/j.schres.2008.07.013; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ohayon MM, 2005, SLEEP, V28, P981; Okamoto M, 2004, NEUROIMAGE, V21, P1275, DOI 10.1016/j.neuroimage.2003.12.003; Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Shechter-Amir D, 2000, SLEEP MED, V1, P101, DOI 10.1016/S1389-9457(99)00016-7; Short M, 2010, SLEEP, V33, P123, DOI 10.1093/sleep/33.1.123; Silva EJ, 2008, BEHAV NEUROSCI, V122, P928, DOI 10.1037/0735-7044.122.4.928; Smith A, 2009, HUM PSYCHOPHARM CLIN, V24, P239, DOI 10.1002/hup.1020; Smith ME, 2002, SLEEP, V25, P784; Soshi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008395; Swann CE, 2006, J SLEEP RES, V15, P23, DOI 10.1111/j.1365-2869.2006.00495.x; TILLEY AJ, 1978, BIOL PSYCHOL, V6, P293, DOI 10.1016/0301-0511(78)90031-5; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tucha O, 2004, APPETITE, V42, P327, DOI 10.1016/j.appet.2004.01.003; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Xu JS, 2006, PSYCHIAT RES-NEUROIM, V148, P103, DOI 10.1016/j.pscychresns.2006.09.005	51	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12923	10.1371/journal.pone.0012923	http://dx.doi.org/10.1371/journal.pone.0012923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653KV	20886073	Green Submitted, Green Published, gold			2022-12-25	WOS:000282091100027
J	Liu, J; Hu, B; Yang, Y; Ma, ZY; Yu, YA; Liu, SP; Wang, BJ; Zhao, XP; Lu, MJ; Yang, DL				Liu, Jia; Hu, Bin; Yang, Yan; Ma, Zhiyong; Yu, Yuan; Liu, Shenpei; Wang, Baoju; Zhao, Xiping; Lu, Mengji; Yang, Dongliang			A New Splice Variant of the Major Subunit of Human Asialoglycoprotein Receptor Encodes a Secreted Form in Hepatocytes	PLOS ONE			English	Article							INTERNAL SIGNAL SEQUENCE; HEPATITIS-C VIRUS; LIGAND-BINDING; LIVER; CELLS; AUTOANTIBODIES; PROTEINS; DOMAIN; GENES; H2	Background: The human asialoglycoprotein receptor (ASGPR) is composed of two polypeptides, designated H1 and H2. While variants of H2 have been known for decades, the existence of H1 variants has never been reported. Principal Findings: We identified two splice variants of ASGPR H1 transcripts, designated H1a and H1b, in human liver tissues and hepatoma cells. Molecular cloning of ASGPR H1 variants revealed that they differ by a 117 nucleotide segment corresponding to exon 2 in the ASGPR genomic sequence. Thus, ASGPR variant H1b transcript encodes a protein lacking the transmembrane domain. Using an H1b-specific antibody, H1b protein and a functional soluble ASGPR (sASGPR) composed of H1b and H2 in human sera and in hepatoma cell culture supernatant were identified. The expression of ASGPR H1a and H1b in Hela cells demonstrated the different cellular loctions of H1a and H1b proteins at cellular membranes and in intracellular compartments, respectively. In vitro binding assays using flourescence-labeled sASGPR or the substract ASOR revealed that the presence of sASGPR reduced the binding of ASOR to cells. However, ASOR itself was able to enhance the binding of sASGPR to cells expressing membrane-bound ASGPR. Further, H1b expression is reduced in liver tissues from patients with viral hepatitis. Conclusions: We conclude that two naturally occurring ASGPR H1 splice variants are produced in human hepatocytes. A hetero-oligomeric complex sASGPR consists of the secreted form of H1 and H2 and may bind to free substrates in circulation and carry them to liver tissue for uptake by ASGPR-expressing hepatocytes.	[Liu, Jia; Hu, Bin; Ma, Zhiyong; Wang, Baoju; Zhao, Xiping; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Hubei Province, Peoples R China; [Yang, Yan; Yu, Yuan; Liu, Shenpei; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Ctr Med Expt, Wuhan 430074, Hubei Province, Peoples R China; [Lu, Mengji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Hubei Province, Peoples R China; [Lu, Mengji] Duisburg Essen Univ, Sch Med, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen	Liu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Hubei Province, Peoples R China.	mengji.lu@uni-due.de; dlyang@tjh.tjmu.edu.cn	Lu, Mengji/ABF-9410-2020		National Natural Science Foundation of China [30571646]; National High Technology Research and Development Program of China [2006AA02Z128]; Major State Basic Research Development Program of China [2005CB522901, 2007CB512804, 2009CB522500]; National Major Science and Technology Special Project for Infectious Diseases of China [2008ZX10002-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); National Major Science and Technology Special Project for Infectious Diseases of China	This work was supported by grants from the National Natural Science Foundation of China (30571646), the National High Technology Research and Development Program of China (863 program) (No. 2006AA02Z128), the Major State Basic Research Development Program of China (973 Program) (No. 2005CB522901, 2007CB512804, 2009CB522500), and the National Major Science and Technology Special Project for Infectious Diseases of China (No. 2008ZX10002-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, FEBS LETT, V338, P295, DOI 10.1016/0014-5793(94)80287-4; ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; BIDER MD, 1995, EUR J BIOCHEM, V230, P207, DOI 10.1111/j.1432-1033.1995.tb20552.x; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; BISCHOFF J, 1987, J BIOL CHEM, V262, P11825; BRAITERMAN LT, 1989, J BIOL CHEM, V264, P1682; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CHIACCHIA KB, 1984, J BIOL CHEM, V259, P5440; CROWE PD, 1993, J IMMUNOL, V151, P6882; Dotzauer A, 2000, J VIROL, V74, P10950, DOI 10.1128/JVI.74.23.10950-10957.2000; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; Hilgard P, 2004, HEPATOLOGY, V39, P1398, DOI 10.1002/hep.20172; MCFARLANE BM, 1986, J HEPATOL, V3, P196, DOI 10.1016/S0168-8278(86)80026-5; OKA JA, 1990, BIOCHEM BIOPH RES CO, V170, P1308, DOI 10.1016/0006-291X(90)90536-V; PAIETTA E, 1992, HEPATOLOGY, V15, P395, DOI 10.1002/hep.1840150307; Ruiz NI, 1996, GLYCOBIOLOGY, V6, P551, DOI 10.1093/glycob/6.5.551; Saunier B, 2003, J VIROL, V77, P546, DOI 10.1128/JVI.77.1.546-559.2003; SAWAMURA T, 1984, GASTROENTEROLOGY, V87, P1217; Saxena A, 2002, J BIOL CHEM, V277, P35297, DOI 10.1074/jbc.M205653200; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SPIESS M, 1987, EMBO J, V6, P2683, DOI 10.1002/j.1460-2075.1987.tb02560.x; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SPIESS M, 1985, J BIOL CHEM, V260, P1979; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; STOCKERT RJ, 1983, HEPATOLOGY, V3, P750; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; TREICHEL U, 1995, PROTEIN EXPRES PURIF, V6, P251, DOI 10.1006/prep.1995.1032; TREICHEL U, 1993, J HEPATOL, V19, P55, DOI 10.1016/S0168-8278(05)80176-X; TREICHEL U, 1990, HEPATOLOGY, V11, P606, DOI 10.1002/hep.1840110413; Treichel U, 1997, ARCH VIROL, V142, P493, DOI 10.1007/s007050050095; TYCKO B, 1983, J CELL BIOL, V97, P1762, DOI 10.1083/jcb.97.6.1762; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; YAGO H, 1995, HEPATOLOGY, V21, P383, DOI 10.1016/0270-9139(95)90096-9	42	11	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12934	10.1371/journal.pone.0012934	http://dx.doi.org/10.1371/journal.pone.0012934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886072	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100033
J	Lo Presti, M; Ferro, A; Contino, F; Mazzarella, C; Sbacchi, S; Roz, E; Lupo, C; Perconti, G; Giallongo, A; Migliorini, P; Marrazzo, A; Feo, S				Lo Presti, Mariavera; Ferro, Arianna; Contino, Flavia; Mazzarella, Claudia; Sbacchi, Silvia; Roz, Elena; Lupo, Carmelo; Perconti, Giovanni; Giallongo, Agata; Migliorini, Paola; Marrazzo, Antonio; Feo, Salvatore			Myc Promoter-Binding Protein-1 (MBP-1) Is a Novel Potential Prognostic Marker in Invasive Ductal Breast Carcinoma	PLOS ONE			English	Article							CELL LUNG-CANCER; ALPHA-ENOLASE; PROTEOMIC ANALYSIS; GLYCOLYTIC ENZYME; NUDE-MICE; GENE; IDENTIFICATION; PROGRESSION; EXPRESSION; METASTASES	Background Alpha-enolase is a glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm. alpha-Enolase and the predominantly nuclear Myc promoter-binding protein-1 (MBP-1) originate from a single gene through the alternative use of translational starting sites. MBP-1 binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription. Although several studies have shown an antiproliferative effect of MBP-1 overexpression on several human cancer cells, to date detailed observations of alpha-enolase and MBP-1 relative expression in primary tumors versus normal tissues and their correlation with clinicopathological features have not been undertaken. Methodology and Findings: We analyzed alpha-enolase and MBP-1 expression in normal breast epithelium and primary invasive ductal breast carcinoma (IDC) from 177 patients by Western blot and immunohistochemical analyses, using highly specific anti-alpha-enolase monoclonal antibodies. A significant increase in the expression of cytoplasmic alpha-enolase was observed in 98% of the tumors analysed, compared to normal tissues. Nuclear MBP-1 was found in almost all the normal tissues while its expression was retained in only 35% of the tumors. Statistically significant associations were observed among the nuclear expression of MBP-1 and ErbB2 status, Ki-67 expression, node status and tumor grade. Furthermore MBP-1 expression was associated with good survival of patients with IDC. Conclusions: MBP-1 functions in repressing c-myc gene expression and the results presented indicate that the loss of nuclear MBP-1 expression in a large number of IDC may be a critical step in the development and progression of breast cancer and a predictor of adverse outcome. Nuclear MBP-1 appears to be a novel and valuable histochemical marker with potential prognostic value in breast cancer.	[Lo Presti, Mariavera; Ferro, Arianna; Contino, Flavia; Mazzarella, Claudia; Sbacchi, Silvia; Perconti, Giovanni; Marrazzo, Antonio; Feo, Salvatore] Univ Palermo, Dipartimento Oncol Sperimentale & Applicaz Clin, Palermo, Italy; [Perconti, Giovanni; Giallongo, Agata; Feo, Salvatore] CNR, Ist Biomed & Immunol Mol, Palermo, Italy; [Migliorini, Paola] Univ Pisa, Dipartimento Med Interna, Pisa, Italy; [Roz, Elena; Lupo, Carmelo] Dipartimento Oncol III Iivello La Maddalena, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Pisa	Lo Presti, M (corresponding author), Univ Palermo, Dipartimento Oncol Sperimentale & Applicaz Clin, Palermo, Italy.	feo@unipa.it	Feo, Salvatore/C-1333-2012; Migliorini, Paola/P-6176-2015; Giallongo, Agata/ABD-1103-2020; antonio, marrazzo/E-9598-2013; Perconti, Giovanni/ABG-9327-2021	Feo, Salvatore/0000-0003-3877-2906; Migliorini, Paola/0000-0001-6433-4964; Giallongo, Agata/0000-0001-9998-4481; antonio, marrazzo/0000-0002-6341-3094; Lupo, Carmelo/0000-0003-3287-7299	Italian Space Agency (ASI) [I/014/06/0]; Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR'' [RBNE08YYBM]; Regione Sicilia	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR''(Ministry of Education, Universities and Research (MIUR)); Regione Sicilia(Regione Sicilia)	G. P. was partially supported by Italian Space Agency (ASI), project contract no. I/014/06/0. This work was supported in part by grants from Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR'' (FIRB-MERIT: n RBNE08YYBM), and from Regione Sicilia (POR misura 3.14 DiaMol) to S. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; BORG A, 1992, GENE CHROMOSOME CANC, V5, P311, DOI 10.1002/gcc.2870050406; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chang YS, 2003, CLIN CANCER RES, V9, P3641; CHAUDHARY D, 1995, BIOCHEMISTRY-US, V34, P3438, DOI 10.1021/bi00010a036; Demir AY, 2005, CELL TISSUE RES, V322, P299, DOI 10.1007/s00441-005-0002-6; Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ghosh AK, 1999, BIOCHEM BIOPH RES CO, V260, P405, DOI 10.1006/bbrc.1999.0921; Ghosh AK, 2005, CANCER RES, V65, P718; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Ghosh AK, 2005, J BIOL CHEM, V280, P14325, DOI 10.1074/jbc.M413313200; Ghosh AK, 2006, J BIOL CHEM, V281, P23652, DOI 10.1074/jbc.M602930200; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; Ghosh AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003384; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; HENNIPMAN A, 1988, TUMOR BIOL, V9, P241, DOI 10.1159/000217568; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Hsu KW, 2009, MOL BIOL CELL, V20, P5127, DOI 10.1091/mbc.E09-05-0386; Ito S, 2007, CANCER SCI, V98, P499, DOI 10.1111/j.1349-7006.2007.00411.x; Jeyabalan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010646; Kanda T, 2009, CANCER RES, V69, P9354, DOI 10.1158/0008-5472.CAN-09-2974; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; LIU KJ, 2007, J CANC MOL, V2, P45; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Peebles KA, 2003, CARCINOGENESIS, V24, P651, DOI 10.1093/carcin/bgg008; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; RAY RB, 1995, CANCER RES, V55, P3747; Sedoris KC, 2007, BIOCHEMISTRY-US, V46, P8659, DOI 10.1021/bi7003558; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; TOMAINO B, 2010, J PROTEOME RES; Wang WY, 2005, J ENDOCRINOL, V184, P85, DOI 10.1677/joe.1.05909; White RA, 1997, GENOMICS, V39, P406, DOI 10.1006/geno.1996.4499; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Zhang L, 2000, J SURG RES, V93, P108, DOI 10.1006/jsre.2000.5957	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12961	10.1371/journal.pone.0012961	http://dx.doi.org/10.1371/journal.pone.0012961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886042	Green Published, gold			2022-12-25	WOS:000282091100054
J	Vandegehuchte, ML; de la Pena, E; Bonte, D				Vandegehuchte, Martijn L.; de la Pena, Eduardo; Bonte, Dries			Relative Importance of Biotic and Abiotic Soil Components to Plant Growth and Insect Herbivore Population Dynamics	PLOS ONE			English	Article							BELOW-GROUND INTERACTIONS; GRASS AMMOPHILA-ARENARIA; ROOT-FEEDING NEMATODES; MYCORRHIZAL FUNGI; COASTAL DUNES; ENDOPARASITIC NEMATODES; PARASITIC NEMATODES; MARRAM GRASS; L LINK; COMMUNITY	Background: Plants are affected by several aspects of the soil, which have the potential to exert cascading effects on the performance of herbivorous insects. The effects of biotic and abiotic soil characteristics have however mostly been investigated in isolation, leaving their relative importance largely unexplored. Such is the case for the dune grass Ammophila, whose decline under decreasing sand accretion is argued to be caused by either biotic or abiotic soil properties. Methodology/Principal Findings: By manipulating dune soils from three different regions, we decoupled the contributions of region, the abiotic and biotic soil component to the variation in characteristics of Ammophila arenaria seedlings and Schizaphis rufula aphid populations. Root mass fraction and total dry biomass of plants were affected by soil biota, although the latter effect was not consistent across regions. None of the measured plant properties were significantly affected by the abiotic soil component. Aphid population characteristics all differed between regions, irrespective of whether soil biota were present or absent. Hence these effects were due to differences in abiotic soil properties between regions. Although several chemical properties of the soil mixtures were measured, none of these were consistent with results for plant or aphid traits. Conclusions/Significance: Plants were affected more strongly by soil biota than by abiotic soil properties, whereas the opposite was true for aphids. Our results thus demonstrate that the relative importance of the abiotic and biotic component of soils can differ for plants and their herbivores. The fact that not all effects of soil properties could be detected across regions moreover emphasizes the need for spatial replication in order to make sound conclusions about the generality of aboveground-belowground interactions.	[Vandegehuchte, Martijn L.; de la Pena, Eduardo; Bonte, Dries] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	Ghent University	Vandegehuchte, ML (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	martijn.vandegehuchte@ugent.be	de la Pena, Eduardo/B-8037-2015; Bonte, Dries/AAH-3913-2021	de la Pena, Eduardo/0000-0002-6057-6664; Bonte, Dries/0000-0002-3320-7505; Vandegehuchte, Martijn L./0000-0003-1283-4654	FWO [G.0057.09N]	FWO(FWO)	The first author is a Ph.D. candidate and Eduardo de la Pena is a postdoctoral fellow of the Research Foundation - Flanders (FWO). The project is partially funded by FWO research project G.0057.09N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bardgett RD, 1999, PLANT SOIL, V212, P23, DOI 10.1023/A:1004642218792; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Borowicz VA, 1997, OECOLOGIA, V112, P534, DOI 10.1007/s004420050342; Boudreau S, 2001, ECOSCIENCE, V8, P392, DOI 10.1080/11956860.2001.11682667; Brinkman EP, 2005, SOIL BIOL BIOCHEM, V37, P2077, DOI 10.1016/j.soilbio.2005.03.011; Brinkman EP, 2005, NEMATOLOGY, V7, P169, DOI 10.1163/1568541054879647; Brinkman EP, 2005, OIKOS, V110, P417, DOI 10.1111/j.0030-1299.2005.13659.x; Brinkman EP, 2004, APPL SOIL ECOL, V27, P65, DOI 10.1016/j.apsoil.2004.02.004; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; de la Pena E, 2008, PLANT SOIL, V310, P113, DOI 10.1007/s11104-008-9636-y; de la Pena E, 2007, NEMATOLOGY, V9, P881, DOI 10.1163/156854107782331289; DEROOIJVANDERGOES PCEM, 1995, NEW PHYTOL, V129, P661, DOI 10.1111/j.1469-8137.1995.tb03035.x; ELDRED RA, 1982, CAN J BOT, V60, P1371, DOI 10.1139/b82-174; Gange AC, 1999, OECOLOGIA, V120, P123, DOI 10.1007/s004420050840; Gange AC, 1997, NEW PHYTOL, V137, P335, DOI 10.1046/j.1469-8137.1997.00813.x; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Hol WHG, 2007, BASIC APPL ECOL, V8, P500, DOI 10.1016/j.baae.2006.09.013; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; HUISKES AHL, 1979, J ECOL, V67, P363, DOI 10.2307/2259356; Joosten L, 2009, PLANT SOIL, V325, P133, DOI 10.1007/s11104-009-9963-7; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Kooijman AM, 2002, J ECOL, V90, P394, DOI 10.1046/j.1365-2745.2001.00661.x; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Little LR, 1996, J ECOL, V84, P1, DOI 10.2307/2261694; MARSHALL JK, 1965, J ECOL, V53, P447, DOI 10.2307/2257988; MASTERS GJ, 1995, ACTA OECOL, V16, P135; McGuinness KA, 2002, AUSTRAL ECOL, V27, P681, DOI 10.1046/j.1442-9993.2002.01233.x; Neter J., 1996, APPL LINEAR STAT MOD; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Piskiewicz AM, 2008, SOIL BIOL BIOCHEM, V40, P2729, DOI 10.1016/j.soilbio.2008.07.006; Piskiewicz AM, 2009, FUNCT ECOL, V23, P621, DOI 10.1111/j.1365-2435.2008.01510.x; Poll J, 2007, FEMS MICROBIOL ECOL, V62, P268, DOI 10.1111/j.1574-6941.2007.00383.x; ROWNTREE JK, 2010, OECOLOGIA IN PRESS; Staley JT, 2008, BASIC APPL ECOL, V9, P673, DOI 10.1016/j.baae.2007.10.006; Staley JT, 2007, GLOBAL CHANGE BIOL, V13, P866, DOI 10.1111/j.1365-2486.2007.01338.x; Van der Putten WH, 1998, APPL SOIL ECOL, V10, P253, DOI 10.1016/S0929-1393(98)00124-3; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van der Stoel CD, 2002, J ECOL, V90, P978, DOI 10.1046/j.1365-2745.2002.00727.x; Vandegehuchte ML, 2010, OIKOS, V119, P1011, DOI 10.1111/j.1600-0706.2009.18360.x; VANDERPUTTEN WH, 1988, OECOLOGIA, V76, P313, DOI 10.1007/BF00379970; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wall JW, 2002, BIOL FERT SOILS, V35, P293, DOI 10.1007/s00374-002-0478-0; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997; WILLIS AJ, 1965, J ECOL, V53, P735, DOI 10.2307/2257632	51	23	23	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12937	10.1371/journal.pone.0012937	http://dx.doi.org/10.1371/journal.pone.0012937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886078	gold, Green Published			2022-12-25	WOS:000282091100036
J	Bishai, JD; Bishai, WR; Bishai, DM				Bishai, Jason D.; Bishai, William R.; Bishai, David M.			Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; EXOGENOUS REINFECTION; EMERGENCE; DYNAMICS; RUSSIA; PATTERNS; MODEL; COST	Background: Prior infection with one strain TB has been linked with diminished likelihood of re-infection by a new strain. This paper attempts to determine the role of declining prevalence of drug-susceptible TB in enabling future epidemics of MDR-TB. Methods: A computer simulation of MDR-TB epidemics was developed using an agent-based model platform programmed in NetLogo (See http://mdr.tbtools.org/). Eighty-one scenarios were created, varying levels of treatment quality, diagnostic accuracy, microbial fitness cost, and the degree of immunogenicity elicited by drug-susceptible TB. Outcome measures were the number of independent MDR-TB cases per trial and the proportion of trials resulting in MDR-TB epidemics for a 500 year period after drug therapy for TB is introduced. Results: MDR-TB epidemics propagated more extensively after TB prevalence had fallen. At a case detection rate of 75%, improving therapeutic compliance from 50% to 75% can reduce the probability of an epidemic from 45% to 15%. Paradoxically, improving the case-detection rate from 50% to 75% when compliance with DOT is constant at 75% increases the probability of MDR-TB epidemics from 3% to 45%. Conclusions: The ability of MDR-TB to spread depends on the prevalence of drug-susceptible TB. Immunologic protection conferred by exposure to drug-susceptible TB can be a crucial factor that prevents MDR-TB epidemics when TB treatment is poor. Any single population that successfully reduces its burden of drug-susceptible TB will have reduced herd immunity to externally or internally introduced strains of MDR-TB and can experience heightened vulnerability to an epidemic. Since countries with good TB control may be more vulnerable, their self interest dictates greater promotion of case detection and DOTS implementation in countries with poor control to control their risk of MDR-TB.	[Bishai, Jason D.] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA; [Bishai, William R.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Bishai, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bishai, JD (corresponding author), Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA.	dbishai@jhsph.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062	Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE); National Institutes of Health [5R01AI036973-15, 5R01AI037856-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037856, R01AI036973] Funding Source: NIH RePORTER	Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) and National Institutes of Health grants 5R01AI036973-15 and NIH 5R01AI037856-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balabanova Y, 2004, J ANTIMICROB CHEMOTH, V54, P673, DOI 10.1093/jac/dkh383; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Burzynski J, 2008, SEMIN RESP CRIT CARE, V29, P492, DOI 10.1055/s-0028-1085701; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Ginsberg AM, 2008, SEMIN RESP CRIT CARE, V29, P552, DOI 10.1055/s-0028-1085706; GLAZIOU P, 2006, MATH MODELING TB EPI; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3; JOESOEF MR, 1989, INT J EPIDEMIOL, V18, P174, DOI 10.1093/ije/18.1.174; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mitnick CD, 2008, SEMIN RESP CRIT CARE, V29, P499, DOI 10.1055/s-0028-1085702; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; Roberts C. A., 2003, BIOARCHEOLOGY TUBERC; Sawert H, 1997, SOC SCI MED, V44, P1805, DOI 10.1016/S0277-9536(96)00289-4; Schneider E, 2005, CLIN CHEST MED, V26, P183, DOI 10.1016/j.ccm.2005.02.007; SHAFER RW, 1995, J INFECT DIS, V171, P170, DOI 10.1093/infdis/171.1.170; Shilova MV, 2001, ANN NY ACAD SCI, V953, P124, DOI 10.1111/j.1749-6632.2001.tb11369.x; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Stott H, 1973, Tubercle, V54, P1; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; *WHO, 2008, ANT DRUG RES WORLD; Wilensky U, 1999, NETLOGO; Yerokhin VV, 2001, ANN NY ACAD SCI, V953, P133, DOI 10.1111/j.1749-6632.2001.tb11370.x	37	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12843	10.1371/journal.pone.0012843	http://dx.doi.org/10.1371/journal.pone.0012843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877639	Green Published, gold, Green Submitted			2022-12-25	WOS:000282053100016
J	Degl'Innocenti, D; Alberti, C; Castellano, G; Greco, A; Miranda, C; Pierotti, MA; Seregni, E; Borrello, MG; Canevari, S; Tomassetti, A				Degl'Innocenti, Debora; Alberti, Chiara; Castellano, Giancarlo; Greco, Angela; Miranda, Claudia; Pierotti, Marco A.; Seregni, Ettore; Borrello, Maria Grazia; Canevari, Silvana; Tomassetti, Antonella			Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; OVARIAN-CARCINOMA; MONOCLONAL-ANTIBODY; HUMAN THYROCYTES; EGF-RECEPTOR; CELL-LINES; CANCER; GROWTH; MECHANISMS; REVEALS	Background: Papillary thyroid carcinoma (PTCs), the most frequent thyroid cancer, is usually not life threatening, but may recur or progress to aggressive forms resistant to conventional therapies. A more detailed understanding of the signaling pathways activated in PTCs may help to identify novel therapeutic approaches against these tumors. The aim of this study is to identify signaling pathways activated in PTCs. Methodology/Principal Findings: We examined coordinated gene expression patterns of ligand/receptor (L/R) pairs using the L/R database DRLP-rev1 and five publicly available thyroid cancer datasets of gene expression on a total of 41 paired PTC/normal thyroid tissues. We identified 26 (up) and 13 (down) L/R pairs coordinately and differentially expressed. The relevance of these L/R pairs was confirmed by performing the same analysis on REarranged during Transfection (RET)/PTC1-infected thyrocytes with respect to normal thyrocytes. TGFA/EGFR emerged as one of the most tightly regulated L/R pair. Furthermore, PTC clinical samples analyzed by real-time RT-PCR expressed EGFR transcript levels similar to those of 5 normal thyroid tissues from patients with pathologies other than thyroid cancer, whereas significantly elevated levels of TGFA transcripts were only present in PTCs. Biochemical analysis of PTC cell lines demonstrated the presence of EGFR on the cell membrane and TGFA in conditioned media. Moreover, conditioned medium of the PTC cell line NIM-1 activated EGFR expressed on HeLa cells, culminating in both ERK and AKT phosphorylation. In NIM-1 cells harboring BRAF mutation, TGFA stimulated proliferation, contributing to P13K/AKT activation independent of MEK/ERK signaling. Conclusions/Significance: We compiled a reliable list of L/R pairs associated with PTC and validated the biological role of one of the emerged L/R pair, the TGFA/EGFR, in this cancer, in vitro. These data provide a better understanding of the factors involved in the biology of PTCs and would be useful in developing combination therapeutic approaches against these cancers.	[Degl'Innocenti, Debora; Alberti, Chiara; Castellano, Giancarlo; Greco, Angela; Miranda, Claudia; Pierotti, Marco A.; Seregni, Ettore; Borrello, Maria Grazia; Canevari, Silvana; Tomassetti, Antonella] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Degl'Innocenti, D (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.borrello@istitutotumori.mi.it; silvana.canevari@istitutotumori.mi.it	Borrello, Maria Grazia/C-3161-2017; Seregni, Ettore/C-2597-2017; Tomassetti, Antonella/G-7906-2015; Pierotti, Marco Alessandro/AAC-4728-2022; Greco, Angela/C-1953-2017	Borrello, Maria Grazia/0000-0002-6854-2848; Seregni, Ettore/0000-0002-5097-049X; Tomassetti, Antonella/0000-0001-6772-9937; Pierotti, Marco Alessandro/0000-0002-7431-8332; Greco, Angela/0000-0003-2994-0349; Castellano, Giancarlo/0000-0002-5715-7733	Ministry of Health, Grant Alleanza contro il Cancro (ACC); Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBIPO6LCA9]; Programma Integrato in Oncologia (PIO) [RFPS-2006-2-3491988.4]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Ministry of Health, Grant Alleanza contro il Cancro (ACC); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Programma Integrato in Oncologia (PIO); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Ministry of Health, Grant Alleanza contro il Cancro (ACC) to S. C., Fondo per gli Investimenti della Ricerca di Base (FIRB) n. RBIPO6LCA9 to M. A. P. and Programma Integrato in Oncologia (PIO) n. RFPS-2006-2-3491988.4 to A. T., and from Associazione Italiana per la Ricerca sul Cancro (AIRC) to A. G. and S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Cassinelli G, 2009, NEOPLASIA, V11, P10, DOI 10.1593/neo.08916; Castellano G, 2006, CANCER RES, V66, P10709, DOI 10.1158/0008-5472.CAN-06-1327; Castellone MD, 2008, BEST PRACT RES CL EN, V22, P1023, DOI 10.1016/j.beem.2008.09.012; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Croyle M, 2008, CANCER RES, V68, P4183, DOI 10.1158/0008-5472.CAN-08-0413; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; GORGOULIS V, 1992, In Vivo (Attiki), V6, P291; Graeber TG, 2001, NAT GENET, V29, P295, DOI 10.1038/ng755; Greco A, 2009, Q J NUCL MED MOL IM, V53, P440; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; Harding J, 2005, DRUG TODAY, V41, P107, DOI 10.1358/dot.2005.41.2.882662; HAUGEN DRF, 1993, INT J CANCER, V55, P37, DOI 10.1002/ijc.2910550108; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Middendorp M, 2010, SEMIN NUCL MED, V40, P145, DOI 10.1053/j.semnuclmed.2009.10.006; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Pennell NA, 2008, THYROID, V18, P317, DOI 10.1089/thy.2007.0120; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; TOHYAMA K, 1992, JPN J CANCER RES, V83, P153, DOI 10.1111/j.1349-7006.1992.tb00080.x; Tomassetti A, 2003, CANCER RES, V63, P696; TOSI E, 1995, INT J CANCER, V62, P643, DOI 10.1002/ijc.2910620525; Ulisse S, 2006, EUR J CANCER, V42, P2631, DOI 10.1016/j.ejca.2006.04.017; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Westermark K, 1996, HISTOPATHOLOGY, V28, P221, DOI 10.1046/j.1365-2559.1996.d01-427.x	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12701	10.1371/journal.pone.0012701	http://dx.doi.org/10.1371/journal.pone.0012701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877637	gold, Green Submitted, Green Published			2022-12-25	WOS:000282053100005
J	Ranjith-Kumar, CT; Lai, Y; Sarisky, RT; Kao, CC				Ranjith-Kumar, C. T.; Lai, Yvonne; Sarisky, Robert T.; Kao, C. Cheng			Green Tea Catechin, Epigallocatechin Gallate, Suppresses Signaling by the dsRNA Innate Immune Receptor RIG-I	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; B KINASE-ACTIVITY; T-CELL-RECEPTOR; KAPPA-B; ANTIVIRAL RESPONSES; STRANDED-RNA; POLYPHENOL; (-)-EPIGALLOCATECHIN-3-GALLATE; LIPOPOLYSACCHARIDE; ACTIVATION	Background: The Innate immune system constitutes the first line of defense against pathogen infections. The Retinoic acid-inducible gene I (RIG-I) receptor recognizes triphosphorylated ssRNAs and dsRNA to initiate downstream signaling of interferon response. However, unregulated activity of these receptors could lead to autoimmune diseases. We seek to identify small molecules that can specifically regulate RIG-I signaling. Methodology/Principal Findings: Epigallocatechin gallate (EGCG), a polyphenolic catechin present in green tea, was identified in a small molecule screen. It was found to bind RIG-I and inhibits its signaling at low micromolar concentrations in HEK293T cells. Furthermore, EGCG dose-dependently inhibited the ATPase activity of recombinant RIG-I but did not compete with RIG-I interaction with RNA or with ATP. EGCG did not inhibit signaling by Toll-like receptors 3, 4, 9 or constitutive signaling by the adapter protein IPS-1. Structure activity relationship analysis showed that EGCG, its epimer GCG and a digallate-containing compound, theaflavin 3,3' digallate (TFDG) were potent RIG-I inhibitors. EGCG also inhibited IL6 secretion and IFN- beta mRNA synthesis in BEAS-2B cells, which harbors intact endogenous RIG-I signaling pathway. Conclusions/Significance: EGCG and its derivatives could have potential therapeutic use as a modulator of RIG-I mediated immune responses.	[Ranjith-Kumar, C. T.; Lai, Yvonne; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Sarisky, Robert T.] Johnson & Johnson, Pharmaceut Res & Dev, Raritan, NJ USA	Indiana University System; Indiana University Bloomington; Johnson & Johnson; Johnson & Johnson USA	Ranjith-Kumar, CT (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ctrkumar@indiana.edu	Kumar CT, Ranjith/J-5701-2016; Mackie, Ken/E-3384-2013		NIH [RAI075015A]; Johnson and Johnson Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson and Johnson Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CK acknowledges NIH grant RAI075015A that partially supported members of the laboratory and a gift from Johnson & Johnson Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by an unrestricted research grant from Johnson and Johnson Pharmaceuticals, where J&J does not have any restriction for the research direction, the use of reagents, the interpretation of the results, or any claim for intellectual property.	Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Hayakawa S, 2001, BIOCHEM BIOPH RES CO, V285, P1102, DOI 10.1006/bbrc.2001.5293; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee KM, 2004, HELICOBACTER, V9, P632, DOI 10.1111/j.1083-4389.2004.00281.x; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Pan MH, 2000, BIOCHEM PHARMACOL, V59, P357, DOI 10.1016/S0006-2952(99)00335-4; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shim JH, 2008, J BIOL CHEM, V283, P28370, DOI 10.1074/jbc.M802200200; Suzuki Y, 2001, CANCER LETT, V173, P15, DOI 10.1016/S0304-3835(01)00685-1; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Veranth JM, 2004, TOXICOL SCI, V82, P88, DOI 10.1093/toxsci/kfh248; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021	39	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12878	10.1371/journal.pone.0012878	http://dx.doi.org/10.1371/journal.pone.0012878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877565	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100026
J	Hoving, S; Heeneman, S; Gijbels, MJJ; Poele, JAMT; Bolla, M; Pol, JFC; Simons, MY; Russell, NS; Daemen, MJ; Stewart, FA				Hoving, Saske; Heeneman, Sylvia; Gijbels, Marion J. J.; Poele, Johannes A. M. Te; Bolla, Manlio; Pol, Jeffrey F. C.; Simons, Michelle Y.; Russell, Nicola S.; Daemen, Mat J.; Stewart, Fiona A.			NO-Donating Aspirin and Aspirin Partially Inhibit Age-Related Atherosclerosis but Not Radiation-Induced Atherosclerosis in ApoE Null Mice	PLOS ONE			English	Article							OXIDE-RELEASING ASPIRIN; INFLAMMATORY PLAQUE PHENOTYPE; PROGRESSION; THROMBOEMBOLISM; INITIATION; PLATELET; ADHESION; NECK; THROMBOMODULIN; ATHEROGENESIS	Background: We previously showed that irradiation to the carotid arteries of ApoE(-/-) mice accelerated the development of macrophage-rich, inflammatory atherosclerotic lesions, prone to intra-plaque hemorrhage. In this study we investigated the potential of anti-inflammatory and anti-coagulant intervention strategies to inhibit age-related and radiation-induced atherosclerosis. Methodology/Principal Findings: ApoE(-/-) mice were given 0 or 14 Gy to the neck and the carotid arteries and aortic arches were harvested at 4 or 30 weeks after irradiation. Nitric oxide releasing aspirin (NCX 4016, 60 mg/kg/day) or aspirin (ASA, 30 or 300 mg/kg/day) were given continuously in the chow. High dose ASA effectively blocked platelet aggregation, while the low dose ASA or NCX 4016 had no significant effect on platelet aggregation. High dose ASA, but not NCX 4016, inhibited endothelial cell expression of VCAM-1 and thrombomodulin in the carotid arteries at 4 weeks after irradiation; eNOS and ICAM-1 levels were unchanged. After 30 weeks of follow-up, NCX 4016 significantly reduced the total number of lesions and the number of initial macrophage-rich lesions in the carotid arteries of unirradiated mice, but these effects were not seen in the brachiocephalic artery of the aortic arch (BCA). In contrast, high dose ASA lead to a decrease in the number of initial lesions in the BCA, but not in the carotid artery. Both high dose ASA and NCX 4016 reduced the collagen content of advanced lesions and increased the total plaque burden in the BCA of unirradiated mice. At 30 weeks after irradiation, neither NCX 4016 nor ASA significantly influenced the number or distribution of lesions, but high dose ASA lead to formation of collagen-rich "stable" advanced lesions in carotid arteries. The total plaque area of the irradiated BCA was increased after ASA, but the plaque burden was very low compared with the carotid artery. Conclusions/Significance: The development and characteristics of radiation-induced atherosclerosis varied between different arteries but could not be circumvented by anti-inflammatory and anti-coagulant therapies. This implicates other underlying mechanistic pathways compared to age-related atherosclerosis.	[Hoving, Saske; Poele, Johannes A. M. Te; Stewart, Fiona A.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Russell, Nicola S.] Netherlands Canc Inst, Div Radiotherapy, NL-1066 CX Amsterdam, Netherlands; [Heeneman, Sylvia; Pol, Jeffrey F. C.; Simons, Michelle Y.; Daemen, Mat J.] Univ Maastricht, Dept Pathol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J. J.] Univ Maastricht, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Bolla, Manlio] NicOx SA, Sophia Antipolis, France	Netherlands Cancer Institute; Netherlands Cancer Institute; Maastricht University; Maastricht University	Hoving, S (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.stewart@nki.nl		Daemen, Mat/0000-0003-1076-199X	Dutch Cancer Society [NKI 2055-3373]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (project number NKI 2055-3373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baluna RG, 2006, RADIAT RES, V166, P819, DOI 10.1667/RR0380.1; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bolla M, 2006, EUR J CLIN PHARMACOL, V62, P145, DOI 10.1007/s00228-005-0026-6; Cheng SWK, 2004, J VASC SURG, V39, P409, DOI 10.1016/j.jvs.2003.08.031; Cottin Y, 2001, Cardiovasc Radiat Med, V2, P231, DOI 10.1016/S1522-1865(02)00129-4; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; Dorresteijn LDA, 2002, J CLIN ONCOL, V20, P282, DOI 10.1200/JCO.20.1.282; Gresele P, 2006, CARDIOVASC DRUG REV, V24, P148, DOI 10.1111/j.1527-3466.2006.00148.x; Hallahan DE, 1999, RADIAT RES, V152, P6, DOI 10.2307/3580044; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Li M, 2007, ATHEROSCLEROSIS, V194, P348, DOI 10.1016/j.atherosclerosis.2006.11.006; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mackay J, 2006, CANC ATLAS; Martin JD, 2005, INT J RADIAT ONCOL, V63, P1197, DOI 10.1016/j.ijrobp.2005.04.017; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Momi S, 2005, THROMB HAEMOSTASIS, V93, P535, DOI 10.1160/TH04-07-0464; Momi S, 2001, HAEMATOLOGICA, V86, P297; Momi S, 2000, EUR J PHARMACOL, V397, P177, DOI 10.1016/S0014-2999(00)00223-5; Napoli C, 2002, P NATL ACAD SCI USA, V99, P12467, DOI 10.1073/pnas.192244499; Napoli C, 2001, P NATL ACAD SCI USA, V98, P2860, DOI 10.1073/pnas.041602898; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tailor A, 2007, AM J PHYSIOL-HEART C, V293, pH3636, DOI 10.1152/ajpheart.01105.2006; Tous M, 2004, BASIC CLIN PHARMACOL, V95, P15, DOI 10.1111/j.1742-7843.2004.pto950104.x; Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387; Van Assche T, 2011, J VASC RES, V48, P31, DOI 10.1159/000317398; Van Kleef EM, 2000, INT J RADIAT BIOL, V76, P1565; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; WEBER C, 1995, CIRCULATION, V91, P1914, DOI 10.1161/01.CIR.91.7.1914; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yu J, 2002, LAB INVEST, V82, P825, DOI 10.1097/01.LAB.0000018828.61722.BD; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646	39	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12874	10.1371/journal.pone.0012874	http://dx.doi.org/10.1371/journal.pone.0012874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877628	Green Submitted, Green Published, gold			2022-12-25	WOS:000282002900015
J	Harscoet, E; Dubreucq, B; Palauqui, JC; Lepiniec, L				Harscoet, Erwana; Dubreucq, Bertrand; Palauqui, Jean-Christophe; Lepiniec, Loic			NOF1 Encodes an Arabidopsis Protein Involved in the Control of rRNA Expression	PLOS ONE			English	Article							DNA METHYLATION; NUCLEOLAR PROTEIN; GENE ENCODES; JMJC DOMAIN; AUXIN; SACCHAROMYCES; TRANSCRIPTION; EMBRYO; YEAST; EMBRYOGENESIS	The control of ribosomal RNA biogenesis is essential for the regulation of protein synthesis in eukaryotic cells. Here, we report the characterization of NOF1 that encodes a putative nucleolar protein involved in the control of rRNA expression in Arabidopsis. The gene has been isolated by T-DNA tagging and its function verified by the characterization of a second allele and genetic complementation of the mutants. The nof1 mutants are affected in female gametogenesis and embryo development. This result is consistent with the detection of NOF1 mRNA in all tissues throughout plant life's cycle, and preferentially in differentiating cells. Interestingly, the closely related proteins from zebra fish and yeast are also necessary for cell division and differentiation. We showed that the nof1-1 mutant displays higher rRNA expression and hypomethylation of rRNA promoter. Taken together, the results presented here demonstrated that NOF1 is an Arabidopsis gene involved in the control of rRNA expression, and suggested that it encodes a putative nucleolar protein, the function of which may be conserved in eukaryotes.	[Harscoet, Erwana; Dubreucq, Bertrand; Palauqui, Jean-Christophe; Lepiniec, Loic] INRA AgroParisTech, INRA, IJPB, UMR 1318, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Harscoet, E (corresponding author), INRA AgroParisTech, INRA, IJPB, UMR 1318, Versailles, France.	lepiniec@versailles.inra.fr	Lepiniec, Loic/G-5808-2012; DUBREUCQ, Bertrand/AAY-9948-2020	Lepiniec, Loic/0000-0002-5845-3323; DUBREUCQ, Bertrand/0000-0003-2661-5479	French Genoplante Program	French Genoplante Program	This work was supported by the French Genoplante Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Balzergue S, 2001, BIOTECHNIQUES, V30, P496, DOI 10.2144/01303bm06; Baserga S J, 1997, Nucleic Acids Symp Ser, P64; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown JWS, 2005, NUCLEIC ACIDS RES, V33, pD633, DOI 10.1093/nar/gki052; Browne SE, 1998, EUR J NEUROSCI, V10, P649, DOI 10.1046/j.1460-9568.1998.00084.x; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dubreucq B, 2000, PLANT J, V23, P643, DOI 10.1046/j.1365-313x.2000.00829.x; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Fleurdepine S, 2007, NUCLEIC ACIDS RES, V35, P3306, DOI 10.1093/nar/gkm200; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2000, PLANT GROWTH REGUL, V32, P187, DOI 10.1023/A:1010765914644; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Griffith ME, 2007, PLANT CELL, V19, P2246, DOI 10.1105/tpc.106.042697; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jiang L, 2007, PLANT J, V50, P1020, DOI 10.1111/j.1365-313X.2007.03106.x; JURGENS G, 1995, PHILOS T R SOC B, V350, P19, DOI 10.1098/rstb.1995.0132; Kamakaka RT, 1998, GENETICS, V149, P903; Keener J, 1997, P NATL ACAD SCI USA, V94, P13458, DOI 10.1073/pnas.94.25.13458; KONCZ C, 1984, EMBO J, V3, P1029, DOI 10.1002/j.1460-2075.1984.tb01923.x; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lawrence RJ, 2004, CELL CYCLE, V3, P880; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LEPINIEC L, 2005, GENETIC MOL CONTROL, P511; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; MEINKE DW, 1995, ANNU REV PLANT PHYS, V46, P369, DOI 10.1146/annurev.pp.46.060195.002101; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; TRUERNIT E, 2008, PLANT CELL; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VASQUEZ JS, 2008, ADV BOT RES, V47, P2; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wehner KA, 2002, MOL CELL BIOL, V22, P7258, DOI 10.1128/MCB.22.20.7258-7267.2002; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	75	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12829	10.1371/journal.pone.0012829	http://dx.doi.org/10.1371/journal.pone.0012829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877469	Green Published, gold, Green Submitted			2022-12-25	WOS:000281963200011
J	Gessmann, R; Kourtis, N; Petratos, K; Tavernarakis, N				Gessmann, Renate; Kourtis, Nikos; Petratos, Kyriacos; Tavernarakis, Nektarios			Molecular Modeling of Mechanosensory Ion Channel Structural and Functional Features	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; HYDROPHOBIC MOMENT; PROTEIN STRUCTURES; DEG/ENAC CHANNEL; C-ELEGANS; MEC-4; TRANSMEMBRANE; SUBUNIT; FAMILY; MECHANOTRANSDUCTION	The DEG/ENaC (Degenerin/Epithelial Sodium Channel) protein family comprises related ion channel subunits from all metazoans, including humans. Members of this protein family play roles in several important biological processes such as transduction of mechanical stimuli, sodium re-absorption and blood pressure regulation. Several blocks of amino acid sequence are conserved in DEG/ENaC proteins, but structure/function relations in this channel class are poorly understood. Given the considerable experimental limitations associated with the crystallization of integral membrane proteins, knowledge-based modeling is often the only route towards obtaining reliable structural information. To gain insight into the structural characteristics of DEG/ENaC ion channels, we derived three-dimensional models of MEC-4 and UNC-8, based on the available crystal structures of ASIC1 (Acid Sensing Ion Channel 1). MEC-4 and UNC-8 are two DEG/ENaC family members involved in mechanosensation and proprioception respectively, in the nematode Caenorhabditis elegans. We used these models to examine the structural effects of specific mutations that alter channel function in vivo. The trimeric MEC-4 model provides insight into the mechanism by which gain-of-function mutations cause structural alterations that result in increased channel permeability, which trigger cell degeneration. Our analysis provides an introductory framework to further investigate the multimeric organization of the DEG/ENaC ion channel complex.	[Gessmann, Renate; Kourtis, Nikos; Petratos, Kyriacos; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece		Gessmann, R (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Petratos, Kyriacos/AAV-9957-2021	Tavernarakis, Nektarios/0000-0002-5253-1466; Petratos, Kyriacos/0000-0003-0876-1835	European Commission [LSHM-CT-2005-19063]; Manasaki scholarship	European Commission(European CommissionEuropean Commission Joint Research Centre); Manasaki scholarship	This work was supported by the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). N.K. is a recipient of a Manasaki scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 2001, ANN NY ACAD SCI, V940, P28; Tavernarakis N, 2001, CURR BIOL, V11, pR205, DOI 10.1016/S0960-9822(01)00106-3; Tavernarakis N, 2000, J NEUROGENET, V13, P257, DOI 10.3109/01677060009084497; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014	29	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12814	10.1371/journal.pone.0012814	http://dx.doi.org/10.1371/journal.pone.0012814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20877470	Green Submitted, gold, Green Published			2022-12-25	WOS:000281864100027
J	Diallo, TO; Remoue, F; Gaayeb, L; Schacht, AM; Charrier, N; De Clerck, D; Dompnier, JP; Pillet, S; Garraud, O; N'Diaye, AA; Riveau, G				Diallo, Tamsir O.; Remoue, Franck; Gaayeb, Lobna; Schacht, Anne-Marie; Charrier, Nicole; De Clerck, Dick; Dompnier, Jean-Pierre; Pillet, Sophie; Garraud, Olivier; N'Diaye, Abdoulaye A.; Riveau, Gilles			Schistosomiasis Coinfection in Children Influences Acquired Immune Response against Plasmodium falciparum Malaria Antigens	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL FRAGMENT; IMMUNOGLOBULIN-G; INFLAMMATORY MARKERS; ANTIBODY-RESPONSES; INDIVIDUALS; SUBCLASSES; SENEGAL; MECHANISMS; INFECTION	Background: Malaria and schistosomiasis coinfection frequently occurs in tropical countries. This study evaluates the influence of Schistosoma haematobium infection on specific antibody responses and cytokine production to recombinant merozoite surface protein-1-19 (MSP1-(19)) and schizont extract of Plasmodium falciparum in malaria-infected children. Methodology: Specific IgG1 to MSP1-(19), as well as IgG1 and IgG3 to schizont extract were significantly increased in coinfected children compared to P. falciparum mono-infected children. Stimulation with MSP1-(19) lead to a specific production of both interleukin-10 (IL-10) and interferon-gamma (IFN-gamma), whereas the stimulation with schizont extract produced an IL-10 response only in the coinfected group. Conclusions: Our study suggests that schistosomiasis coinfection favours anti-malarial protective antibody responses, which could be associated with the regulation of IL-10 and IFN-gamma production and seems to be antigen-dependent. This study demonstrates the importance of infectious status of the population in the evaluation of acquired immunity against malaria and highlights the consequences of a multiple infection environment during clinical trials of anti-malaria vaccine candidates.	[Diallo, Tamsir O.; Gaayeb, Lobna; Schacht, Anne-Marie; Riveau, Gilles] Inst Pasteur, INSERM, U547, F-59019 Lille, France; [Diallo, Tamsir O.; Remoue, Franck; Gaayeb, Lobna; Schacht, Anne-Marie; Charrier, Nicole; De Clerck, Dick; Dompnier, Jean-Pierre; Pillet, Sophie; N'Diaye, Abdoulaye A.; Riveau, Gilles] ONG ESPOIR Sante, Lab Rech Med, St Louis, Senegal; [Remoue, Franck] IRD, UR Caracterisat & Controle Populat Vecteurs 016, F-34394 Montpellier, France; [Garraud, Olivier] Univ St Etienne, GIMAP, EA3064, St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut de Recherche pour le Developpement (IRD); Universite Jean Monnet	Diallo, TO (corresponding author), Inst Pasteur, INSERM, U547, F-59019 Lille, France.	tamsird@yahoo.fr			French Ministry of Education and Scientific Research [02MENRT00123]; Conseil Regional Nord-Pas de Calais (France) [04170049]	French Ministry of Education and Scientific Research; Conseil Regional Nord-Pas de Calais (France)(Region Hauts-de-France)	This work was supported by VIHPAL Program (French Ministry of Education and Scientific Research) - Grant number 02MENRT00123 - 2002-2005. Malaria in schistosomiasis infected populations. Immunological studies in humans and rats. The Conseil Regional Nord-Pas de Calais (France) - Grant number 04170049 - 2004-2007. Epidemiological studies for schistosomiasis control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Diallo TO, 2002, AM J TROP MED HYG, V66, P137, DOI 10.4269/ajtmh.2002.66.137; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Garraud O, 2003, TRENDS IMMUNOL, V24, P30, DOI 10.1016/S1471-4906(02)00012-1; Garraud O, 2002, INFECT IMMUN, V70, P2820, DOI 10.1128/IAI.70.6.2820-2827.2002; Garraud O, 1999, IMMUNOLOGY, V97, P204, DOI 10.1046/j.1365-2567.1999.00763.x; Hartgers FC, 2008, PARASITOLOGY, V135, P855, DOI 10.1017/S0031182008000401; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Joseph S, 2004, INFECT IMMUN, V72, P728, DOI 10.1128/IAI.72.2.728-734.2004; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Mutapi F, 2000, PARASITE IMMUNOL, V22, P207, DOI 10.1046/j.1365-3024.2000.00288.x; Nacher M, 2001, TRENDS PARASITOL, V17, P563, DOI 10.1016/S1471-4922(01)02117-1; Parija SC, 2009, INDIAN J PATHOL MICR, V52, P200, DOI 10.4103/0377-4929.48917; Picquet M, 1996, T ROY SOC TROP MED H, V90, P340, DOI 10.1016/S0035-9203(96)90501-5; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Taylor-Robinson AW, 1998, INT J PARASITOL, V28, P135, DOI 10.1016/S0020-7519(97)00173-2; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Van Geertruyden JP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-258; *WHO, 2009, GLOB MAL EL REP TECH; Widhe M, 1998, SCAND J IMMUNOL, V47, P575; Winkler S, 1998, INFECT IMMUN, V66, P6040, DOI 10.1128/IAI.66.12.6040-6044.1998; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	38	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12764	10.1371/journal.pone.0012764	http://dx.doi.org/10.1371/journal.pone.0012764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856680	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815800026
J	Gossens, K; Naus, S; Hollander, GA; Ziltener, HJ				Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.; Ziltener, Hermann J.			Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity	PLOS ONE			English	Article							CELL-MIGRATION; THYMOCYTE DEVELOPMENT; EPITHELIAL-CELLS; T-CELL; EXPRESSION; MICE; MICROENVIRONMENTS; PROGENITORS; ADHESION; DIFFERENTIATION	Background: Thymopoiesis requires thymocyte-stroma interactions and proteases that promote cell migration by degrading extracellular matrix and releasing essential cytokines and chemokines. A role for several members of the A Disintegrin and Metalloprotease (ADAM) family in T cell development has been reported in the past. Methodology/Principal Findings: Here, we present data indicating that the family member ADAM8 plays a role in thymic T cell development. We used qrtPCR on FACS sorted thymic subsets together with immunofluorescene to analyze thymic ADAM8 expression. We found that ADAM8 was expressed in murine thymic stromal cells and at lower levels in thymocytes where its expression increased as cell matured, suggesting involvement of ADAM8 in thymopoiesis. Further flow cytometry analysis revealed that ADAM8 deficient mice showed normal development and expansion of immature thymocyte subsets. There was however an intrathymic accumulation of single positive CD4 and CD8 T cells which was most noticeable in the late mature T cell subsets. Accumulation of single positive T cells coincided with changes in the thymic architecture manifest in a decreased cortex/medulla ratio and an increase in medullary epithelial cells as determined by histology and flow cytometry. The increase in single positive T cells was thymus-intrinsic, independent of progenitor homing to the thymus or thymic exit rate of mature T cells. Chemotaxis assays revealed that ADAM8 deficiency was associated with reduced migration of single positive thymocytes towards CCL21. Conclusions/Significance: Our results show that ADAM8 is involved in T cell maturation in the medulla and suggest a role for this protease in fine-tuning maturation of thymocytes in the medulla. In contrast to ADAM10 and ADAM17 lack of ADAM8 appears to have a relatively minor impact on T cell development, which was unexpected given that maturation of thymocytes is dependent on proper localization and timing of migration.	[Gossens, Klaus; Naus, Silvia; Ziltener, Hermann J.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Ziltener, Hermann J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.] Univ Basel, Dept Biomed, Lab Pediat Immunol, Basel, Switzerland; [Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.] Univ Childrens Hosp UKBB, Basel, Switzerland	University of British Columbia; University of British Columbia; University of Basel	Gossens, K (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	hermann@brc.ubc.ca		Hollander, Georg/0000-0002-8790-0874	Canadian Institutes of Health Research [MOP-64267, MOP-77552]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by Grants MOP-64267 and MOP-77552 (to H.J.Z.) from the Canadian Institutes of Health Research. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gossens K, 2009, J EXP MED, V206, P761, DOI 10.1084/jem.20082502; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Haidl ID, 2006, SCAND J IMMUNOL, V64, P280, DOI 10.1111/j.1365-3083.2006.01820.x; Haidl ID, 2002, GENE, V283, P163, DOI 10.1016/S0378-1119(01)00871-X; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Johansson MW, 2004, AM J RESP CELL MOL, V31, P413, DOI 10.1165/rcmb.2004-0099OC; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; KUBBUTAT MHG, 1994, J CLIN PATHOL, V47, P524, DOI 10.1136/jcp.47.6.524; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Manilay JO, 2005, J IMMUNOL, V174, P6732, DOI 10.4049/jimmunol.174.11.6732; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Richens J, 2007, IMMUNOBIOLOGY, V212, P29, DOI 10.1016/j.imbio.2006.06.012; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Valkovskaya N, 2007, J CELL MOL MED, V11, P1162, DOI 10.1111/j.1582-4934.2007.00082.x; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; YOSHIDA S, 1990, INT IMMUNOL, V2, P585, DOI 10.1093/intimm/2.6.585; Yoshiyama K, 1997, GENOMICS, V41, P56, DOI 10.1006/geno.1997.4607; Zack MD, 2009, ARTHRITIS RHEUM-US, V60, P2704, DOI 10.1002/art.24753	43	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12766	10.1371/journal.pone.0012766	http://dx.doi.org/10.1371/journal.pone.0012766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856819	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800028
J	Pointon, AV; Walker, TM; Phillips, KM; Luo, JL; Riley, J; Zhang, SD; Parry, JD; Lyon, JJ; Marczylo, EL; Gant, TW				Pointon, Amy V.; Walker, Tracy M.; Phillips, Kate M.; Luo, Jinli; Riley, Joan; Zhang, Shu-Dong; Parry, Joel D.; Lyon, Jonathan J.; Marczylo, Emma L.; Gant, Timothy W.			Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation	PLOS ONE			English	Article							IRON REGULATORY PROTEIN-1; ANTHRACYCLINE CARDIOTOXICITY; CARDIAC MITOCHONDRIA; CYTOCHROME-C; HEART; CELLS; REDUCTION; STRESS; OVEREXPRESSION; ADRIAMYCIN	Background: Doxorubicin is one of the most effective anti-cancer drugs but its use is limited by cumulative cardiotoxicity that restricts lifetime dose. Redox damage is one of the most accepted mechanisms of toxicity, but not fully substantiated. Moreover doxorubicin is not an efficient redox cycling compound due to its low redox potential. Here we used genomic and chemical systems approaches in vivo to investigate the mechanisms of doxorubicin cardiotoxicity, and specifically test the hypothesis of redox cycling mediated cardiotoxicity. Methodology/Principal Findings: Mice were treated with an acute dose of either doxorubicin (DOX) (15 mg/kg) or 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) (25 mg/kg). DMNQ is a more efficient redox cycling agent than DOX but unlike DOX has limited ability to inhibit gene transcription and DNA replication. This allowed specific testing of the redox hypothesis for cardiotoxicity. An acute dose was used to avoid pathophysiological effects in the genomic analysis. However similar data were obtained with a chronic model, but are not specifically presented. All data are deposited in the Gene Expression Omnibus (GEO). Pathway and biochemical analysis of cardiac global gene transcription and mRNA translation data derived at time points from 5 min after an acute exposure in vivo showed a pronounced effect on electron transport chain activity. This led to loss of ATP, increased AMPK expression, mitochondrial genome amplification and activation of caspase 3. No data gathered with either compound indicated general redox damage, though site specific redox damage in mitochondria cannot be entirely discounted. Conclusions/Significance: These data indicate the major mechanism of doxorubicin cardiotoxicity is via damage or inhibition of the electron transport chain and not general redox stress. There is a rapid response at transcriptional and translational level of many of the genes coding for proteins of the electron transport chain complexes. Still though ATP loss occurs with activation caspase 3 and these events probably account for the heart damage.	[Pointon, Amy V.; Phillips, Kate M.; Luo, Jinli; Riley, Joan; Zhang, Shu-Dong; Marczylo, Emma L.; Gant, Timothy W.] Syst Toxicol Grp, Med Res Council Toxicol Unit, Leicester, Leics, England; [Walker, Tracy M.; Parry, Joel D.; Lyon, Jonathan J.] GlaxoSmithKline PLC, Ware, Herts, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; GlaxoSmithKline	Pointon, AV (corresponding author), AstraZeneca, Dept Mol Toxicol, Macclesfield, Cheshire, England.	twg1@le.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167; Gant, Timothy/0000-0001-9057-4937; Luo, Jinli/0000-0002-9241-5283	Medical Reseach Council; Biotechnology and Biological Sciences Research Council; GSK PLC	Medical Reseach Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GSK PLC	Funding for this study was received from the Medical Reseach Council (TWG, JL, JR, KMP, SDZ, ELM and TWG) the Biotechnology and Biological Sciences Research Council (AVP) and GSK PLC (AVP, TMW, JDP and JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TMW, JDP and JJL are all employees of GSK while AVP received a stipend from the company while undertaking this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERS JC, 1984, J ANAL TOXICOL, V8, P260, DOI 10.1093/jat/8.6.260; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; BIRONAITE DA, 1991, BIOCHIM BIOPHYS ACTA, V1060, P203, DOI 10.1016/S0005-2728(09)91008-8; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Childs AC, 2002, CANCER RES, V62, P4592; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Davies R, 2005, AM J PATHOL, V166, P1041, DOI 10.1016/S0002-9440(10)62325-5; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; Forrest GL, 2000, CANCER RES, V60, P5158; GANT TW, 1988, CHEM-BIOL INTERACT, V65, P157, DOI 10.1016/0009-2797(88)90052-X; Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007; GOORMAGHTIGH E, 1987, BIOCHEMISTRY-US, V26, P1789, DOI 10.1021/bi00380a043; HIRABAYSHI N, 1987, JAPENSE J SURG, V17, P406; HUANG C, CIRCULATION, V121, P675; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; JOHANSEN PB, 1981, CANCER CHEMOTH PHARM, V5, P267, DOI 10.1007/BF00434396; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kogan NM, 2007, J PHARMACOL EXP THER, V322, P646, DOI 10.1124/jpet.107.120865; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; LAND EJ, 1983, ARCH BIOCHEM BIOPHYS, V225, P116, DOI 10.1016/0003-9861(83)90013-9; LEBRECHT D, 2009, CARDIOVAS P IN PRESS; MARCILLAT O, 1989, BIOCHEM J, V259, P181, DOI 10.1042/bj2590181; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Melamed D, 2009, METHODS, V48, P301, DOI 10.1016/j.ymeth.2009.04.020; Mik EG, 2009, J MOL CELL CARDIOL, V46, P943, DOI 10.1016/j.yjmcc.2009.02.002; Minotti G, 1998, FASEB J, V12, P541, DOI 10.1096/fasebj.12.7.541; Minotti G, 2001, CANCER RES, V61, P8422; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; NICOLAY K, 1987, BIOCHIM BIOPHYS ACTA, V892, P320, DOI 10.1016/0005-2728(87)90236-2; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; OLSON RD, 1988, P NATL ACAD SCI USA, V85, P3585, DOI 10.1073/pnas.85.10.3585; Parry JD, 2009, CHEM RES TOXICOL, V22, P717, DOI 10.1021/tx800472z; Pouillart P, 2004, CANCER TREAT REV, V30, P643, DOI 10.1016/j.ctrv.2004.06.002; POWIS G, 1980, BIOCHEM PHARMACOL, V29, P2567, DOI 10.1016/0006-2952(80)90068-4; Quinones A, 2001, MUTAT RES-GEN TOX EN, V494, P73, DOI 10.1016/S1383-5718(01)00179-6; Robert J, 2007, CARDIOVASC TOXICOL, V7, P135, DOI 10.1007/s12012-007-0022-4; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8; Shell SA, 2008, CELL CYCLE, V7, P1769, DOI 10.4161/cc.7.12.6016; Simunek T, 2009, PHARMACOL REP, V61, P154; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sullivan M, 2006, MOL HUM REPROD, V12, P653, DOI 10.1093/molehr/gal081; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; TEICHERT F, 2008, RAP COMMUNICATIONS M, V23, P151; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; XIAOMING Y, 2006, AM J PATHOL, V290, pH1098; Zhang J, 2004, CURR PHARM BIOTECHNO, V5, P1; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	58	86	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12733	10.1371/journal.pone.0012733	http://dx.doi.org/10.1371/journal.pone.0012733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856801	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800014
J	Henry, KA; Blank, HM; Hoose, SA; Polymenis, M				Henry, Kelsey A.; Blank, Heidi M.; Hoose, Scott A.; Polymenis, Michael			The Unfolded Protein Response Is Not Necessary for the G1/S Transition, but It Is Required for Chromosome Maintenance in Saccharomyces cerevisiae	PLOS ONE			English	Article							CONTINUOUS CULTURES; DNA-REPLICATION; ENDOPLASMIC-RETICULUM; METABOLIC CYCLE; CELL-DIVISION; YEAST; STRESS; GROWTH; DIFFERENTIATION; COORDINATION	Background: The unfolded protein response (UPR) is a eukaryotic signaling pathway, from the endoplasmic reticulum (ER) to the nucleus. Protein misfolding in the ER triggers the UPR. Accumulating evidence links the UPR in diverse aspects of cellular homeostasis. The UPR responds to the overall protein synthesis capacity and metabolic fluxes of the cell. Because the coupling of metabolism with cell division governs when cells start dividing, here we examined the role of UPR signaling in the timing of initiation of cell division and cell cycle progression, in the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: We report that cells lacking the ER-resident stress sensor Ire1p, which cannot trigger the UPR, nonetheless completed the G1/S transition on time. Furthermore, loss of UPR signaling neither affected the nutrient and growth rate dependence of the G1/S transition, nor the metabolic oscillations that yeast cells display in defined steady-state conditions. Remarkably, however, loss of UPR signaling led to hypersensitivity to genotoxic stress and a ten-fold increase in chromosome loss. Conclusions/Significance: Taken together, our results strongly suggest that UPR signaling is not necessary for the normal coupling of metabolism with cell division, but it has a role in genome maintenance. These results add to previous work that linked the UPR with cytokinesis in yeast. UPR signaling is conserved in all eukaryotes, and it malfunctions in a variety of diseases, including cancer. Therefore, our findings may be relevant to other systems, including humans.	[Henry, Kelsey A.; Blank, Heidi M.; Hoose, Scott A.; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Henry, KA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Polymenis, Michael/AAJ-3389-2021		National Science Foundation [MCB-0818248]; Div Of Molecular and Cellular Bioscience [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Blank HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008018; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Castellano C, 2007, REV CONSTR, V6, P4; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; CREANOR J, 1979, J GEN MICROBIOL, V112, P385, DOI 10.1099/00221287-112-2-385; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Guo JB, 2004, ARCH MICROBIOL, V182, P326, DOI 10.1007/s00203-004-0704-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kaiser C., 1994, METHODS YEAST GENETI; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Niwa M, 2005, GENOME BIOL, V6; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; SPENCER F, 1990, GENETICS, V124, P237; Strome ED, 2008, GENETICS, V178, P1193, DOI 10.1534/genetics.107.084103; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12732	10.1371/journal.pone.0012732	http://dx.doi.org/10.1371/journal.pone.0012732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856872	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815700018
J	Roosild, TP; Castronovo, S				Roosild, Tarmo P.; Castronovo, Samantha			Active Site Conformational Dynamics in Human Uridine Phosphorylase 1	PLOS ONE			English	Article							DEPRIVATION-INDUCED DEATH; ESCHERICHIA-COLI; IDENTIFICATION; EXPRESSION; INHIBITORS; BENZYLACYCLOURIDINE; METABOLISM; ENZYME; LIVER; MODEL	Uridine phosphorylase (UPP) is a central enzyme in the pyrimidine salvage pathway, catalyzing the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. Human UPP activity has been a focus of cancer research due to its role in activating fluoropyrimidine nucleoside chemotherapeutic agents such as 5-fluorouracil (5-FU) and capecitabine. Additionally, specific molecular inhibitors of this enzyme have been found to raise endogenous uridine concentrations, which can produce a cytoprotective effect on normal tissues exposed to these drugs. Here we report the structure of hUPP1 bound to 5-FU at 2.3 A resolution. Analysis of this structure reveals new insights as to the conformational motions the enzyme undergoes in the course of substrate binding and catalysis. The dimeric enzyme is capable of a large hinge motion between its two domains, facilitating ligand exchange and explaining observed cooperativity between the two active sites in binding phosphate-bearing substrates. Further, a loop toward the back end of the uracil binding pocket is shown to flexibly adjust to the varying chemistry of different compounds through an "induced-fit'' association mechanism that was not observed in earlier hUPP1 structures. The details surrounding these dynamic aspects of hUPP1 structure and function provide unexplored avenues to develop novel inhibitors of this protein with improved specificity and increased affinity. Given the recent emergence of new roles for uridine as a neuron protective compound in ischemia and degenerative diseases, such as Alzheimer's and Parkinson's, inhibitors of hUPP1 with greater efficacy, which are able to boost cellular uridine levels without adverse side-effects, may have a wide range of therapeutic applications.	[Roosild, Tarmo P.; Castronovo, Samantha] Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA	University of California System; University of California San Diego	Roosild, TP (corresponding author), Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA.	troosild@nvcancer.org			National Institutes of Health (NIH) [P20 RR-016464]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds to TPR from National Institutes of Health (NIH) Grant Number P20 RR-016464 from the INBRE Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL SAFARJALANI ON, 2006, CANCER CHEMOTH PHARM, V58, P692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bu WM, 2005, ACTA CRYSTALLOGR D, V61, P863, DOI 10.1107/S0907444905007882; Burling FT, 2003, ACTA CRYSTALLOGR D, V59, P73, DOI [10.1107/S0907444902018929, 10.1107/s0907444902018929]; Cansev M, 2008, NEUROSCI RES, V62, P206, DOI 10.1016/j.neures.2008.07.005; Cao DL, 2004, DRUG TODAY, V40, P431, DOI 10.1358/dot.2004.40.5.850491; Cao DL, 2002, CANCER RES, V62, P2313; Cappiello M, 1998, BBA-GEN SUBJECTS, V1425, P273, DOI 10.1016/S0304-4165(98)00071-3; Caradoc-Davies TT, 2004, J MOL BIOL, V337, P337, DOI 10.1016/j.jmb.2004.01.039; Choi JW, 2008, J NEUROTRAUM, V25, P695, DOI 10.1089/neu.2007.0409; Choi JW, 2006, NEUROSCI RES, V56, P111, DOI 10.1016/j.neures.2006.06.004; CHU MYW, 1984, CANCER RES, V44, P1852; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dontsova MV, 2005, ACTA CRYSTALLOGR F, V61, P337, DOI 10.1107/S1744309105007463; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holguin S, 2008, FASEB J, V22, P3938, DOI 10.1096/fj.08-112425; Johansson M, 2003, BIOCHEM BIOPH RES CO, V307, P41, DOI 10.1016/S0006-291X(03)01062-3; Kawamura K, 2006, ANTICANCER RES, V26, P4647; Klecker RW, 2006, BIOORGAN MED CHEM, V14, P62, DOI 10.1016/j.bmc.2005.07.053; Kong XX, 2009, MOL PHARMACOL, V76, P854, DOI 10.1124/mol.109.056424; Larson ET, 2010, J MOL BIOL, V396, P1244, DOI 10.1016/j.jmb.2010.01.013; Lashkov AA, 2009, ACTA CRYSTALLOGR F, V65, P601, DOI 10.1107/S1744309109016133; Lashkov AA, 2010, ACTA CRYSTALLOGR D, V66, P51, DOI 10.1107/S0907444909044175; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu MP, 1998, CANCER RES, V58, P5418; MORGUNOVA EY, 1995, FEBS LETT, V367, P183, DOI 10.1016/0014-5793(95)00489-V; NIEDZWICKI JG, 1982, BIOCHEM PHARMACOL, V31, P1857, DOI 10.1016/0006-2952(82)90488-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul D, 2010, BIOCHEMISTRY-US, V49, P3499, DOI 10.1021/bi902073b; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; Roosild TP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-14; Russell RL, 2001, J BIOL CHEM, V276, P13302, DOI 10.1074/jbc.M008512200; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WATANABE SI, 1995, BIOCHEM BIOPH RES CO, V216, P265, DOI 10.1006/bbrc.1995.2619; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	37	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12741	10.1371/journal.pone.0012741	http://dx.doi.org/10.1371/journal.pone.0012741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856879	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815700022
J	Khan, E; Kisat, M; Khan, N; Nasir, A; Ayub, S; Hasan, R				Khan, Erum; Kisat, Mehreen; Khan, Nabil; Nasir, Amna; Ayub, Salma; Hasan, Rumina			Demographic and Clinical Features of Dengue Fever in Pakistan from 2003-2007: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; KARACHI; EPIDEMIOLOGY; DEFINITION; OUTBREAK; VIRUS	Background: Demographic features of dengue fever have changed tremendously in Pakistan over the past two decades. Small scale studies from all over the country have reported different aspects of individual outbreaks during this time. However, there is scarcity of data looking at the overall trend of dengue virus infection in the country. In this study, we examined annual trends, seasonality, and clinical features of dengue fever in the Pakistani population. Methods: Demographic information and dengue IgM status of all patients tested for dengue IgM antibody at Aga Khan University Hospital from January 2003 to December 2007 were analyzed to look for trends of IgM-positive cases in Pakistan. In addition, clinical and biochemical parameters were abstracted retrospectively from medical records of all patients hospitalized with IgM-proven dengue fever between January 2006 and December 2007. These patients were categorized into dengue fever and dengue hemorrhagic fever according to the WHO severity grading scale. Results: Out of a total of 15040 patients (63.2% male and 36.8% female), 3952 (26.3%) tested positive for dengue IgM antibody. 209 IgM proven dengue patients were hospitalized during the study period. During 2003, IgM positive cases were seen only during the months of July-December. In contrast, such cases were detected throughout the year from the 2004-2007. The median age of IgM positive patients decreased every year from 32.0 years in 2003 to 24.0 years in 2007 (p<0.001). Among hospitalized patients, nausea was the most common presenting feature found in 124/209 (59.3%) patients. Children presented with a higher median body temperature than adults (p=0.010). In addition, neutropenia was seen more commonly in children while raised serum ALT levels were seen more commonly in adults (both p=0.006). While a low total white cell count was more common in patients with dengue fever as compared to Dengue Hemorrhagic Fever (p=0.020), neutropenia (p=0.019), monocytosis (p=0.001) and raised serum ALT level (p=0.005) were observed more commonly in the latter group. Conclusions: Dengue virus is now endemic in Pakistan, circulating throughout the year with a peak incidence in the post monsoon period. Median age of dengue patients has decreased and younger patients may be more susceptible. Total and differential leukocyte counts may help identify patients at risk of hemorrhage.	[Khan, Erum; Khan, Nabil; Nasir, Amna; Ayub, Salma; Hasan, Rumina] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Kisat, Mehreen] Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Khan, E (corresponding author), Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan.	erum.khan@aku.edu	Hasan, Rumina/F-4420-2015		Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan; University Research Council, Aga Khan University Hospital, Pakistan	Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan(United States Agency for International Development (USAID)); University Research Council, Aga Khan University Hospital, Pakistan	This work was supported in part through a grant from the Joint Pakistan-United States Academic and Research Program, Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan; and University Research Council, Aga Khan University Hospital, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Dure Samin, 1998, Indian Journal of Pediatrics, V65, P735, DOI 10.1007/BF02731055; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; DE SOUZA LJ, 2007, BRAZ J INFECT DIS, V11, P407; DIETZ VJ, 1992, B WORLD HEALTH ORGAN, V70, P745; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2007, T ROY SOC TROP MED H, V101, P1114, DOI 10.1016/j.trstmh.2007.06.016; Murgue B, 1999, TROP MED INT HEALTH, V4, P765, DOI 10.1046/j.1365-3156.1999.00478.x; Paul R E, 1998, Int J Infect Dis, V2, P197, DOI 10.1016/S1201-9712(98)90052-2; Petersen LR, 2005, J TRAVEL MED, V12, pS3; POTTS JA, 2008, TROP MED INT HLTH; PREMARATNA R, 2008, T R SOC TROP MED HYG; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Strobel M, 2001, REV MED INTERNE, V22, P638, DOI 10.1016/S0248-8663(01)00401-5; SUMARMO, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P269; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tripathi P, 2008, INDIAN PEDIATR, V45, P315; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd; Ying Ruo-su, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P123	25	78	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12505	10.1371/journal.pone.0012505	http://dx.doi.org/10.1371/journal.pone.0012505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856935	gold, Green Published, Green Submitted			2022-12-25	WOS:000281735700003
J	Yu, YL; Zeng, PY; Xiong, JB; Liu, ZY; Berger, SL; Merlino, G				Yu, Yanlin; Zeng, Pingyao; Xiong, Jingbo; Liu, Ziyang; Berger, Shelley L.; Merlino, Glenn			Epigenetic Drugs Can Stimulate Metastasis through Enhanced Expression of the Pro-Metastatic Ezrin Gene	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; ERM PROTEINS; PROSTATE-CANCER; DNA METHYLATION; CARCINOMA CELLS; MELANOMA-CELLS; LINKER EZRIN; THERAPY; MIGRATION; MECHANISM	Ezrin has been reported to be upregulated in many tumors and to participate in metastatic progression. No study has addressed epigenetic modification in the regulation of Ezrin gene expression, the importance of which is unknown. Here, we report that highly metastatic rhabdomyosarcoma (RMS) cells with high levels of Ezrin have elevated acetyl-H3-K9 and tri-methyl-H3-K4 as well as reduced DNA methylation at the Ezrin gene promoter. Conversely, poorly metastatic RMS cells with low levels of Ezrin have reduced acetyl-H3-K9 and elevated methylation. Thus epigenetic covalent modifications to histones within nucleosomes of the Ezrin gene promoter are linked to Ezrin expression, which in fact can be regulated by epigenetic mechanisms. Notably, treatment with histone deacetylase (HDAC) inhibitors or DNA demethylating agents could restore Ezrin expression and stimulate the metastatic potential of poorly metastatic RMS cells characterized by low Ezrin levels. However, the ability of epigenetic drugs to stimulate metastasis in RMS cells was inhibited by expression of an Ezrin-specific shRNA. Our data demonstrate the potential risk associated with clinical application of broadly acting covalent epigenetic modifiers, and highlight the value of combination therapies that include agents specifically targeting potent pro-metastatic genes.	[Yu, Yanlin; Liu, Ziyang; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Zeng, Pingyao; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Xiong, Jingbo] So Med Univ, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Southern Medical University - China	Yu, YL (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	YuY@mail.nih.gov		Berger, Shelley/0000-0001-5398-4400	National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA078831, ZIABC010871, ZIABC008756] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fahrner JA, 2002, CANCER RES, V62, P7213; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ilmonen S, 2005, MODERN PATHOL, V18, DOI 10.1038/modpathol.3800429; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Nestl A, 2001, CANCER RES, V61, P1569; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yu YL, 2002, CANCER RES, V62, P2951	58	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12710	10.1371/journal.pone.0012710	http://dx.doi.org/10.1371/journal.pone.0012710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856924	Green Published, gold, Green Submitted			2022-12-25	WOS:000281735700022
J	Guantes, R; Estrada, J; Poyatos, JF				Guantes, Raul; Estrada, Javier; Poyatos, Juan F.			Trade-offs and Noise Tolerance in Signal Detection by Genetic Circuits	PLOS ONE			English	Article							FEEDFORWARD LOOP; INPUT FUNCTIONS; NETWORK; PROPAGATION	Genetic circuits can implement elaborated tasks of amplitude or frequency signal detection. What type of constraints could circuits experience in the performance of these tasks, and how are they affected by molecular noise? Here, we consider a simple detection process-a signal acting on a two-component module-to analyze these issues. We show that the presence of a feedback interaction in the detection module imposes a trade-off on amplitude and frequency detection, whose intensity depends on feedback strength. A direct interaction between the signal and the output species, in a type of feed-forward loop architecture, greatly modifies these trade-offs. Indeed, we observe that coherent feed-forward loops can act simultaneously as good frequency and amplitude noise-tolerant detectors. Alternatively, incoherent feed-forward loop structures can work as high-pass filters improving high frequency detection, and reaching noise tolerance by means of noise filtering. Analysis of experimental data from several specific coherent and incoherent feed-forward loops shows that these properties can be realized in a natural context. Overall, our results emphasize the limits imposed by circuit structure on its characteristic stimulus response, the functional plasticity of coherent feed-forward loops, and the seemingly paradoxical advantage of improving signal detection with noisy circuit components.	[Guantes, Raul; Estrada, Javier] Univ Autonoma Madrid, Fac Sci, Dept Condensed Matter Phys, Madrid, Spain; [Guantes, Raul; Estrada, Javier] Univ Autonoma Madrid, Fac Sci, Inst Mat Sci Nicolas Cabrera, Madrid, Spain; [Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Guantes, R (corresponding author), Univ Autonoma Madrid, Fac Sci, Dept Condensed Matter Phys, Madrid, Spain.	raul.guantes@uam.es	Guantes, Raul/B-7271-2014	Guantes, Raul/0000-0003-1916-944X; Estrada Diez, Francisco Javier/0000-0001-8918-2573; Estrada, Javier/0000-0003-3646-204X	Ministerio de Ciencia, Tecnologia e Innovacion (Spain) [BFU2008-03632/BMC]; Comunidad Autonoma de Madrid (Spain) [CCG08-CSIC/SAL-3651]; UAM-FPI	Ministerio de Ciencia, Tecnologia e Innovacion (Spain); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); UAM-FPI	This work was supported by the Ministerio de Ciencia, Tecnologia e Innovacion (Spain), grant BFU2008-03632/BMC, (JFP and RG) and Comunidad Autonoma de Madrid (Spain), grant CCG08-CSIC/SAL-3651, (JFP). JE acknowledges a UAM-FPI postgraduate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cournac A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-29; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keizer J, 1987, STAT THERMODYNAMICS; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Ljung L., 1999, SYSTEM IDENTIFICATIO; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Richet E, 2000, EMBO J, V19, P5222, DOI 10.1093/emboj/19.19.5222; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Tan CM, 2007, BIOPHYS J, V93, P3753, DOI 10.1529/biophysj.107.110403; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12314	10.1371/journal.pone.0012314	http://dx.doi.org/10.1371/journal.pone.0012314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865033	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100007
J	De Arcangelis, V; Serra, F; Cogoni, C; Vivarelli, E; Monaco, L; Naro, F				De Arcangelis, Valeria; Serra, Filippo; Cogoni, Carlo; Vivarelli, Elisabetta; Monaco, Lucia; Naro, Fabio			beta 1-Syntrophin Modulation by miR-222 in mdx Mice	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED PROTEINS; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; EXPRESSION; DUCHENNE; DYSTROGLYCAN; SYNTROPHINS; MICRORNAS; COMPLEX; DIFFERENTIATION	Background: In mdx mice, the absence of dystrophin leads to the deficiency of other components of the dystrophin-glycoprotein complex (DAPC), making skeletal muscle fibers more susceptible to necrosis. The mechanisms involved in the disappearance of the DAPC are not completely understood. The muscles of mdx mice express normal amounts of mRNA for the DAPC components, thus suggesting post-transcriptional regulation. Methodology/Principal Findings: We investigated the hypothesis that DAPC reduction could be associated with the microRNA system. Among the possible microRNAs (miRs) found to be upregulated in the skeletal muscle tissue of mdx compared to wt mice, we demonstrated that miR-222 specifically binds to the 3'-UTR of beta 1-syntrophin and participates in the downregulation of b1-syntrophin. In addition, we documented an altered regulation of the 3'-UTR of beta 1-syntrophin in muscle tissue from dystrophic mice. Conclusion/Significance: These results show the importance of the microRNA system in the regulation of DAPC components in dystrophic muscle, and suggest a potential role of miRs in the pathophysiology of dystrophy.	[De Arcangelis, Valeria; Serra, Filippo; Vivarelli, Elisabetta; Naro, Fabio] Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy; [Monaco, Lucia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Cogoni, Carlo] Univ Roma La Sapienza, Dept Cellular Biotechnol & Ematol, Rome, Italy; [Naro, Fabio] IIM, Pavia, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	De Arcangelis, V (corresponding author), Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy.	lucia.monaco@uniroma1.it			Italian Ministry of University; AFM	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); AFM(Association Francaise contre les Myopathies)	Grants from the Italian Ministry of University (FIRB to FN; PRIN to FN, LDA), Faculty (to FN and LM) and AFM (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Gazzerro E, 2010, AM J PATHOL, V176, P1863, DOI 10.2353/ajpath.2010.090468; Gee SH, 1998, J NEUROSCI, V18, P128; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Komati H, 2004, FEBS LETT, V577, P409, DOI 10.1016/j.febslet.2004.10.036; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; MATTHEW L, 2001, CURRENT PROTOCOLS HU; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Sandona D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001203; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029	51	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12098	10.1371/journal.pone.0012098	http://dx.doi.org/10.1371/journal.pone.0012098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856896	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900035
J	Bao, B; Jiang, J; Yanase, T; Nishi, Y; Morgan, JR				Bao, Brian; Jiang, Jean; Yanase, Toshihiko; Nishi, Yoshihiro; Morgan, Jeffrey R.			Connexon-mediated cell adhesion drives microtissue self-assembly	FASEB JOURNAL			English	Article						aggregation; 3D; spheroid; gap junction	GAP-JUNCTION; INTERCELLULAR COMMUNICATION; MIMETIC PEPTIDES; N-CADHERIN; CONNEXIN-43; MORPHOGENESIS; KERATINOCYTES; ORGANIZATION; MIGRATION; ZEBRAFISH	Microtissue self-assembly is thought to be driven primarily by cadherins, while connexons have been examined mainly in intercellular coupling. We investigated whether connexon 43 (Cx43)-mediated cell adhesion modulates self-assembly of human KGN granulosa cells, normal human fibroblasts (NHFs), and MCF-7 breast cancer cells seeded into nonadhesive agarose gels. We found that treatment with anti-Cx43 E2 (112 mu g/ml), which suppresses Cx43 docking, significantly inhibited the kinetics of KGN and NHF self-assembly compared to the preimmune sera control (41.1 +/- 4.5 and 24.5 +/- 10.4% at 8 h, respectively). Likewise, gap junction inhibitor carbenoxolone also inhibited self-assembly of KGN, NHF, and MCF-7 cells in a dose-dependent manner that was specific to cell type. In contrast, Gap26 connexin mimetic peptide, which inhibits channel permeability but not docking, accelerated self-assembly of KGN and NHF microtissues. Experiments using selective enzymatic digestion of cell adhesion molecules and neutralizing N-cadherin antibodies further showed that self-assembly was comparably disrupted by inhibiting connexin-and cadherin-mediated adhesion. These findings demonstrate that connexon-mediated cell adhesion and intercellular communication differentially influence microtissue self-assembly, and that their contributions are comparable to those of cadherins.-Bao, B., Jiang, J., Yanase, T., Nishi, Y., Morgan, J. R. Connexon-mediated cell adhesion drives microtissue self-assembly. FASEB J. 25, 255-264 (2011). www.fasebj.org	[Bao, Brian; Morgan, Jeffrey R.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Ctr Biomed Engn, Providence, RI 02912 USA; [Jiang, Jean; Yanase, Toshihiko; Nishi, Yoshihiro] Univ Texas San Antonio, Dept Biochem, Univ Texas Hlth Sci Ctr, San Antonio, TX USA; Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan	Brown University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Kyushu University	Morgan, JR (corresponding author), Brown Univ, Biomed Ctr, G-B 393,171 Meeting St, Providence, RI 02912 USA.	jeffrey_morgan@brown.edu		Nishi, Yoshihiro/0000-0001-7529-1103; Morgan, Jeffrey/0000-0002-7546-3443; Jiang, Jean/0000-0002-2185-5716	Brown University; Rhode Island Research Alliance; National Institutes of Health (NIH) [RO1EB008664-01A1t, AR46798]; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008664] Funding Source: NIH RePORTER	Brown University; Rhode Island Research Alliance; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded, in part, by the Brown University M.D./Ph.D. program, a Rhode Island Research Alliance collaborative grant, National Institutes of Health (NIH) grant RO1EB008664-01A1t, NIH grant AR46798, and Welch Foundation grant AQ-1507.	ANDERSON E, 1976, J CELL BIOL, V71, P680, DOI 10.1083/jcb.71.2.680; BASTIAANSE EML, 1993, J MEMBRANE BIOL, V136, P135, DOI 10.1007/BF02505758; BEAUPAIN R, 1993, IN VITRO CELL DEV-AN, V29A, P893; BRAUN J, 1984, NATURE, V310, P316, DOI 10.1038/310316a0; Buauskas F. F., 2000, P NATL ACAD SCI USA, V97, P2556; Chalabi N, 2007, J HISTOCHEM CYTOCHEM, V55, P877, DOI 10.1369/jhc.7A7185.2007; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; De Maio A, 2002, J CELL PHYSIOL, V191, P269, DOI 10.1002/jcp.10108; Dean DM, 2009, CELL MOTIL CYTOSKEL, V66, P129, DOI 10.1002/cm.20335; Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; FITZGERALD DJ, 1990, TERATOGEN CARCIN MUT, V10, P89; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; Fonseca PC, 2006, CYTOM PART A, V69A, P487, DOI 10.1002/cyto.a.20255; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Grazul-Bilska, 1997, BIOL REPROD, V57, P947; Guan XJ, 1996, MOL CARCINOGEN, V16, P157; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Huang GY, 1998, DEV BIOL, V198, P32, DOI 10.1006/dbio.1998.8891; Isakson BE, 2001, AM J PHYSIOL-LUNG C, V280, pL221, DOI 10.1152/ajplung.2001.280.2.L221; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; LARSEN WJ, 1979, J CELL BIOL, V83, P576, DOI 10.1083/jcb.83.3.576; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; MOSCONA A, 1952, J ANAT, V86, P287; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Preus, 1981, J ULTRASTRUCT RES, V77, P263; Rago AP, 2009, TISSUE ENG PT A, V15, P387, DOI 10.1089/ten.tea.2008.0107; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527	49	55	60	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					255	264		10.1096/fj.10-155291	http://dx.doi.org/10.1096/fj.10-155291			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876208	Green Published			2022-12-25	WOS:000285869500023
J	Zhu, YJ; Zhang, W; Veerapen, N; Besra, G; Cresswell, P				Zhu, Yajuan; Zhang, Wei; Veerapen, Natacha; Besra, Gurdyal; Cresswell, Peter			Calreticulin Controls the Rate of Assembly of CD1d Molecules in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; CLASS-I MOLECULES; NKT CELLS; ANTIGEN PRESENTATION; ALPHA-GALACTOSYLCERAMIDE; LIPID-BINDING; MOUSE CD1; CRYSTAL-STRUCTURE; HEAVY-CHAIN; RECOGNITION	CD1d is an MHC class I-like molecule comprised of a transmembrane glycoprotein (heavy chain) associated with beta(2)-microglobulin (beta(2)m) that presents lipid antigens to NKT cells. Initial folding of the heavy chain involves its glycan-dependent association with calreticulin (CRT), calnexin (CNX), and the thiol oxidoreductase ERp57, and is followed by assembly with beta(2)m to form the heterodimer. Here we show that in CRT-deficient cells CD1d heavy chains convert to beta(2)m-associated dimers at an accelerated rate, indicating faster folding of the heavy chain, while the rate of intracellular transport after assembly is unaffected. Unlike the situation with MHC class I molecules, antigen presentation by CD1d is not impaired in the absence of CRT. Instead, there are elevated levels of stable and functional CD1d on the surface of CRT-deficient cells. Association of the heavy chains with the ER chaperones Grp94 and Bip is observed in the absence of CRT, and these may replace CRT in mediating CD1d folding and assembly. ER retention of free CD1d heavy chains is impaired in CRT-deficient cells, allowing their escape and subsequent expression on the plasma membrane. However, these free heavy chains are rapidly internalized and degraded in lysosomes, indicating that beta(2)m association is required for the exceptional resistance of CD1d to lysosomal degradation that is normally observed.	[Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Veerapen, Natacha; Besra, Gurdyal] Univ Birmingham, Sch Biosci, Dept Microbial Physiol & Chem, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; University of Birmingham	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 300 Cedar St,POB 208011, New Haven, CT 06520 USA.	peter.cresswell@yale.edu		Besra, Gurdyal/0000-0002-5605-0395	National Institutes of Health [R01 AI059167]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI059167 (to P. C.) and the Howard Hughes Medical Institute.	Amano M, 1998, J IMMUNOL, V161, P1710; BALK SP, 1994, SCIENCE, V265, P259, DOI 10.1126/science.7517575; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1997, J IMMUNOL, V159, P1216; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Burdin N, 1998, J IMMUNOL, V161, P3271; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Liu JY, 2010, J IMMUNOL, V184, P4973, DOI 10.4049/jimmunol.0901448; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Somnay-Wadgaonkar K, 1999, INT IMMUNOL, V11, P383, DOI 10.1093/intimm/11.3.383; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	54	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38283	38292		10.1074/jbc.M110.170530	http://dx.doi.org/10.1074/jbc.M110.170530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861015	Green Published, hybrid			2022-12-25	WOS:000284625600035
J	Durrington, HJ; Upton, PD; Hoer, S; Boname, J; Dunmore, BJ; Yang, J; Crilley, TK; Butler, LM; Blackbourn, DJ; Nash, GB; Lehner, PJ; Morrell, NW				Durrington, Hannah J.; Upton, Paul D.; Hoer, Simon; Boname, Jessica; Dunmore, Benjamin J.; Yang, Jun; Crilley, Trina K.; Butler, Lynn M.; Blackbourn, David J.; Nash, Gerard B.; Lehner, Paul J.; Morrell, Nicholas W.			Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY PULMONARY-HYPERTENSION; TGF-BETA RECEPTOR; MHC CLASS-I; KAPOSIS-SARCOMA; ARTERIAL-HYPERTENSION; CASTLEMANS-DISEASE; GERMLINE MUTATIONS; UBIQUITIN LIGASE; DOWN-REGULATION	Bone morphogenetic proteins (BMPs) are critically involved in early development and cell differentiation. In humans, dysfunction of the bone morphogenetic protein type II receptor (BMPR-II) is associated with pulmonary arterial hypertension (PAH) and neoplasia. The ability of Kaposi sarcoma-associated herpesvirus (KSHV), the etiologic agent of Kaposi sarcoma and primary effusion lymphoma, to down-regulate cell surface receptor expression is well documented. Here we show that KSHV infection reduces cell surface BMPR-II. We propose that this occurs through the expression of the viral lytic gene, K5, a ubiquitin E3 ligase. Ectopic expression of K5 leads to BMPR-II ubiquitination and lysosomal degradation with a consequent decrease in BMP signaling. The down-regulation by K5 is dependent on both its RING domain and a membrane-proximal lysine in the cytoplasmic domain of BMPR-II. We demonstrate that expression of BMPR-II protein is constitutively regulated by lysosomal degradation in vascular cells and provide preliminary evidence for the involvement of the mammalian E3 ligase, Itch, in the constitutive degradation of BMPR-II. Disruption of BMP signaling may therefore play a role in the pathobiology of diseases caused by KSHV infection, as well as KSHV-associated tumorigenesis and vascular disease.	[Durrington, Hannah J.; Hoer, Simon; Boname, Jessica; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Durrington, Hannah J.; Upton, Paul D.; Dunmore, Benjamin J.; Yang, Jun; Crilley, Trina K.; Morrell, Nicholas W.] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Butler, Lynn M.; Blackbourn, David J.] Univ Birmingham, Canc Res UK Canc Ctr, Birmingham B15 2TT, W Midlands, England; [Butler, Lynn M.; Blackbourn, David J.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Butler, Lynn M.; Nash, Gerard B.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Birmingham; University of Birmingham; University of Birmingham	Lehner, PJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	pjl30@cam.ac.uk; nwm23@cam.ac.uk	Nash, Gerard B/E-4182-2010; Durrington, Hannah/B-4564-2016	Nash, Gerard B/0000-0002-5935-2831; Durrington, Hannah/0000-0002-9990-9446; Blackbourn, David/0000-0002-6703-4497; Boname, Jessica/0000-0002-5149-5934; Lehner, Paul Joseph/0000-0001-9383-1054	Wellcome Trust; British Heart Foundation; Cancer Research UK [C7934/A9468]; MRC [G0800784, G1000847] Funding Source: UKRI; British Heart Foundation [RG/08/002/24718] Funding Source: researchfish; Medical Research Council [G0800784, G1000847] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Research Training fellowship (to H. J. D.). Additional support was provided by a British Heart Foundation Programme Grant (to N. W. M.) and a Wellcome Trust grant (to P. J. L.). L. M. B. was supported by Cancer Research UK Project Grant C7934/A9468 (to D. J. B. and G. B. N.).	Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bull TM, 2003, EUR RESPIR J, V22, P403, DOI 10.1183/09031936.03.00006903; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Henke-Gendo C, 2005, AM J RESP CRIT CARE, V172, P1581, DOI 10.1164/rccm.200504-546OC; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Katano H, 2005, J INFECT DIS, V191, P743, DOI 10.1086/427824; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Laney AS, 2005, CHEST, V127, P762, DOI 10.1378/chest.127.3.762; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Pouliot F, 2003, CANCER RES, V63, P277; REGEZI JA, 1993, J ORAL PATHOL MED, V22, P292, DOI 10.1111/j.1600-0714.1993.tb01075.x; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; TUDER RM, 1994, AM J PATHOL, V144, P275; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	48	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37641	37649		10.1074/jbc.M110.132415	http://dx.doi.org/10.1074/jbc.M110.132415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870717	Green Published, hybrid			2022-12-25	WOS:000284424000056
J	Eid, AA; Ford, BM; Block, K; Kasinath, BS; Gorin, Y; Ghosh-Choudhury, G; Barnes, JL; Abboud, HE				Eid, Assaad A.; Ford, Bridget M.; Block, Karen; Kasinath, Balakuntalam S.; Gorin, Yves; Ghosh-Choudhury, Goutam; Barnes, Jeffrey L.; Abboud, Hanna E.			AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASES; MEMBRANE THICKNESS; PODOCYTE DEPLETION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SKELETAL-MUSCLE; TRANSGENIC MICE; GLUCOSE-UPTAKE; RAT-KIDNEY; YEAST SNF1	Diabetes and high glucose (HG) increase the generation of NADPH oxidase-derived reactive oxygen species and induce apoptosis of glomerular epithelial cells (podocytes). Loss of podocytes contributes to albuminuria, a major risk factor for progression of kidney disease. Here, we show that HG inactivates AMP-activated protein kinase (AMPK), up-regulates Nox4, enhances NADPH oxidase activity, and induces podocyte apoptosis. Activation of AMPK blocked HG-induced expression of Nox4, NADPH oxidase activity, and apoptosis. We also identified the tumor suppressor protein p53 as a mediator of podocyte apoptosis in cells exposed to HG. Inactivation of AMPK by HG up-regulated the expression and phosphorylation of p53, and p53 acted downstream of Nox4. To investigate the mechanism of podocyte apoptosis in vivo, we used OVE26 mice, a model of type 1 diabetes. Glomeruli isolated from these mice showed decreased phosphorylation of AMPK and enhanced expression of Nox4 and p53. Pharmacologic activation of AMPK by 5-aminoimidazole-4-carboxamide-1-riboside in OVE26 mice attenuated Nox4 and p53 expression. Administration of 5-aminoimidazole-4-carboxamide-1-riboside also prevented renal hypertrophy, glomerular basement thickening, foot process effacement, and podocyte loss, resulting in marked reduction in albuminuria. Our results uncover a novel function of AMPK that integrates metabolic input to Nox4 and provide new insight for activation of p53 to induce podocyte apoptosis. The data indicate the potential therapeutic utility of AMPK activators to block Nox4 and reactive oxygen species generation and to reduce urinary albumin excretion in type 1 diabetes.	[Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [Block, Karen; Kasinath, Balakuntalam S.; Ghosh-Choudhury, Goutam; Barnes, Jeffrey L.; Abboud, Hanna E.] Vet Affairs Res, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam] S Texas Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Abboud, HE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, MC 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	abboud@uthscsa.edu		Gorin, Yves/0000-0003-4048-6925; Ford, Bridget/0000-0002-3923-3210	National Institutes of Health [CA131272, R01 DK079996, R01 DK50190, R01 DK080106, DK-R01-078971]; George O'Brien Kidney Center [DK061597]; National Kidney Foundation; Juvenile Diabetes Research Foundation; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R01DK080106, P50DK061597, R01DK078971, R01DK079996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George O'Brien Kidney Center; National Kidney Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131272 (to K. B.), R01 DK079996 (to Y. G.), R01 DK50190 (to G. G.-C.), R01 DK080106 (to J. L. B.), and DK-R01-078971 (to H. E. A.) and George O'Brien Kidney Center-Morphology Core Grant DK061597 (to J. L. B.). This work was also supported by a National Kidney Foundation postdoctoral fellowship grant and a Juvenile Diabetes Research Foundation grant (to A. A. E.), a Juvenile Diabetes Research Foundation regular research grant (to Y. G.), and a Juvenile Diabetes Research Foundation grant and a Veterans Affairs merit review grant (to H. E. A.).	ABBOUD HE, 1982, J CLIN INVEST, V69, P327, DOI 10.1172/JCI110456; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cammisotto PG, 2008, J MOL HISTOL, V39, P579, DOI 10.1007/s10735-008-9198-6; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Carlson EC, 1997, ANAT REC, V247, P9; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; DeRubertis FR, 2007, METABOLISM, V56, P1256, DOI 10.1016/j.metabol.2007.04.024; DISCHE FE, 1992, ARCH PATHOL LAB MED, V116, P43; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Hardie D. Grahame, 1994, Seminars in Cell Biology, V5, P409, DOI 10.1006/scel.1994.1048; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; Jo YI, 2007, NEPHRON EXP NEPHROL, V107, P87, DOI 10.1159/000108653; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanwar YS, 1996, J CLIN INVEST, V98, P2478, DOI 10.1172/JCI119066; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim J, 2007, EXP EYE RES, V84, P886, DOI 10.1016/j.exer.2007.01.009; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Moir H, 2010, J APPL PHYSIOL, V108, P1284, DOI 10.1152/japplphysiol.00737.2009; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sanden SK, 2003, J AM SOC NEPHROL, V14, P2484, DOI 10.1097/01.ASN.0000089829.45296.7C; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6	71	207	216	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37503	37512		10.1074/jbc.M110.136796	http://dx.doi.org/10.1074/jbc.M110.136796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861022	Green Published, hybrid			2022-12-25	WOS:000284424000042
J	Tamboli, IY; Barth, E; Christian, L; Siepmann, M; Kumar, S; Singh, S; Tolksdorf, K; Heneka, MT; Lutjohann, D; Wunderlich, P; Walter, J				Tamboli, Irfan Y.; Barth, Esther; Christian, Leonie; Siepmann, Martin; Kumar, Sathish; Singh, Sandesh; Tolksdorf, Karen; Heneka, Michael T.; Luetjohann, Dieter; Wunderlich, Patrick; Walter, Jochen			Statins Promote the Degradation of Extracellular Amyloid beta-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A REDUCTASE INHIBITORS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PROTEOLYTIC DEGRADATION; MULTIVESICULAR BODIES; PRECURSOR PROTEIN; LIPID RAFTS; MOUSE-BRAIN; CHOLESTEROL; CLEARANCE	Epidemiological studies indicate that intake of statins decrease the risk of developing Alzheimer disease. Cellular and in vivo studies suggested that statins might decrease the generation of the amyloid beta-peptide (A beta) from the beta-amyloid precursor protein. Here, we show that statins potently stimulate the degradation of extracellular A beta by microglia. The statin-dependent clearance of extracellular A beta is mainly exerted by insulindegrading enzyme (IDE) that is secreted in a nonconventional pathway in association with exosomes. Stimulated IDE secretion and A beta degradation were also observed in blood of mice upon peripheral treatment with lovastatin. Importantly, increased IDE secretion upon lovastatin treatment was dependent on protein isoprenylation and up-regulation of exosome secretion by fusion of multivesicular bodies with the plasma membrane. These data demonstrate a novel pathway for the nonconventional secretion of IDE via exosomes. The modulation of this pathway could provide a new strategy to enhance the extracellular clearance of A beta.	[Tamboli, Irfan Y.; Barth, Esther; Christian, Leonie; Siepmann, Martin; Kumar, Sathish; Singh, Sandesh; Tolksdorf, Karen; Heneka, Michael T.; Wunderlich, Patrick; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Luetjohann, Dieter] Univ Bonn, Dept Clin Pharmacol & Biochem, D-53127 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Kumar, Sathish/L-1367-2019; Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047; Heneka, Michael/0000-0003-4996-1630	Deutsche Forschungsgemeinschaft [SFB645, KFO177]; Federal Ministry for Education and Research (BMBF) [01GI0708]; BONFOR; NICHD, National Institutes of Health; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BONFOR; NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hans and Ilse Breuer Foundation	This work was supported in part by the Deutsche Forschungsgemeinschaft, Grants SFB645 and KFO177, the Federal Ministry for Education and Research (BMBF), Grant 01GI0708, and the BONFOR program.; Recipient of a fellowship from the Hans and Ilse Breuer Foundation.; We thank Dr. Sascha Weggen for advice with the transfection of N9 cells. The E7 antibody against beta-tubulin developed by Dr. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank developed under auspices of the NICHD, National Institutes of Health, and maintained by the Department of Biology, University of Iowa, Iowa City, IA 52242.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Boche D, 2008, BRAIN PATHOL, V18, P267, DOI 10.1111/j.1750-3639.2008.00134.x; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Brendza RP, 2002, MOL PSYCHIATR, V7, P132, DOI 10.1038/sj.mp.4001006; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cleves AE, 1996, CURR BIOL, V6, P276, DOI 10.1016/S0960-9822(02)00477-3; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Eckert GP, 2005, SUB CELL BIOCHEM, V38, P319; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hoglund K, 2007, CNS DRUGS, V21, P449; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Ledesma MD, 2006, FEBS LETT, V580, P5525, DOI 10.1016/j.febslet.2006.06.038; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; McGuinness B, 2010, J ALZHEIMERS DIS, V20, P925, DOI 10.3233/JAD-2010-091570; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Parsons RB, 2007, BIOCHEM SOC T, V35, P577, DOI 10.1042/BST0350577; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Taylor DR, 2007, SEMIN CELL DEV BIOL, V18, P638, DOI 10.1016/j.semcdb.2007.07.008; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Whitfield JF, 2007, EXPERT OPIN THER TAR, V11, P1257, DOI 10.1517/14728222.11.10.1257; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	66	152	161	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37405	37414		10.1074/jbc.M110.149468	http://dx.doi.org/10.1074/jbc.M110.149468			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876579	Green Published, hybrid			2022-12-25	WOS:000284424000033
J	Wang, Y; Liu, L; Davies, DR; Segal, DM				Wang, Yan; Liu, Lin; Davies, David R.; Segal, David M.			Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RECOGNITION; SITE	TLR3 (Toll-like receptor 3) recognizes dsRNA, a potent indicator of viral infection. The extracellular domain of TLR3 dimerizes when it binds dsRNA, and the crystal structure of the dimeric complex reveals three sites of interaction on each extracellular domain, two that bind dsRNA and one that is responsible for dimer formation. The goal of this study was to determine which amino acid residues are essential for forming a stable receptor.ligand complex and whether dimerization of TLR3 is required for dsRNA binding. Using a novel ELISA to analyze dsRNA binding by mutant TLR3 constructs, we identified the essential interacting residues and determined that the simultaneous interaction of all three sites is required for ligand binding. In addition, we show that TLR3 is unable to bind dsRNA when dimerization is prevented by mutating residues in the dimerization site or by immobilizing TLR3 at low density. We conclude that dimerization of TLR3 is essential for ligand binding and that the three TLR3 contact sites individually interact weakly with their binding partners but together form a high affinity receptor.ligand complex.	[Segal, David M.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Liu, Lin; Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Segal, DM (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36,9000 Rockville Pike, Bethesda, MD 20892 USA.	dave_segal@nih.gov			National Institutes of Health (NCI and NIDDK); National Institutes of Health/Food and Drug Administration, NIAID; NATIONAL CANCER INSTITUTE [ZIABC009254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002] Funding Source: NIH RePORTER	National Institutes of Health (NCI and NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Food and Drug Administration, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (NCI and NIDDK) and by a National Institutes of Health/Food and Drug Administration intramural biodefense award from NIAID.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Fukuda K, 2008, J BIOL CHEM, V283, P22787, DOI 10.1074/jbc.M802284200; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x	18	53	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36836	36841		10.1074/jbc.M110.167973	http://dx.doi.org/10.1074/jbc.M110.167973			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861016	Green Published, hybrid			2022-12-25	WOS:000284146100041
J	Hamada, T; Kurachi, S; Kurachi, K				Hamada, Toshiyuki; Kurachi, Sumiko; Kurachi, Kotoku			Heterogeneous Nuclear Ribonucleoprotein A3 Is the Liver Nuclear Protein Binding to Age Related Increase Element RNA of the Factor IX Gene	PLOS ONE			English	Article							MESSENGER-RNA; ARGININE METHYLATION; PROTEOMIC ANALYSIS; BLOOD-COAGULATION; HNRNP PROTEINS; HEMOPHILIA-B; IN-VITRO; PHOSPHORYLATION; MECHANISMS; CELLS	Background: In the ASE/AIE-mediated genetic mechanism for age-related gene regulation, a recently identified age-related homeostasis mechanism, two genetic elements, ASE (age-related stability element) and AIE (age-related increase element as a stem-loop forming RNA), play critical roles in producing specific age-related expression patterns of genes. Principal Finding: We successfully identified heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3) as a major mouse liver nuclear protein binding to the AIE-derived RNAs of human factor IX (hFIX) as well as mouse factor IX (mFIX) genes. HnRNP A3 bound to the AIE RNA was not phosphorylated at its Ser(359), while hnRNP A3 in the mouse liver nuclear extracts was a mixture of phosphorylated and unphosphorylated Ser(359). HepG2 cells engineered to express recombinant hFIX transduced with adenoviral vectors harboring an effective siRNA against hnRNP A3 resulted in a substantial reduction in hFIX expression only in the cells carrying a hFIX expression vector with AIE, but not in the cells carrying a hFIX expression vector without AIE. The nuclear hnRNP A3 protein level in the mouse liver gradually increased with age, while its mRNA level stayed age-stable. Conclusions: We identified hnRNP A3 as a major liver nuclear protein binding to FIX-AIE RNA. This protein plays a critical role in age-related gene expression, likely through an as yet unidentified epigenetic mechanism. The present study assigned a novel functional role to hnRNP A3 in age-related regulation of gene expression, opening up a new avenue for studying age-related homeostasis and underlying molecular mechanisms.	[Hamada, Toshiyuki; Kurachi, Sumiko; Kurachi, Kotoku] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hamada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Adv Photon Bioimaging Ctr, Sapporo, Hokkaido, Japan.	fuku-kurachi@hq.kyushu-u.ac.jp	Hamada, Toshiyuki/AAZ-2258-2020; Hamada, Toshiyuki/G-6482-2012	Hamada, Toshiyuki/0000-0002-3998-2916; Hamada, Toshiyuki/0000-0002-1901-933X	National Institute of Advanced Industrial Science and Technology (AIST)	National Institute of Advanced Industrial Science and Technology (AIST)	This study was supported by the internal funding of the National Institute of Advanced Industrial Science and Technology (AIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kurachi K, 2005, J THROMB HAEMOST, V3, P909, DOI 10.1111/j.1538-7836.2005.01123.x; Kurachi S, 1999, SCIENCE, V285, P739, DOI 10.1126/science.285.5428.739; KURACHI S, 1995, J BIOL CHEM, V270, P5276, DOI 10.1074/jbc.270.10.5276; Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Ma ASW, 2002, J BIOL CHEM, V277, P18010, DOI 10.1074/jbc.M200050200; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Makeyev AV, 2005, J EXP ZOOL PART A, V303A, P259, DOI 10.1002/jez.a.164; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Plomaritoglou A, 2000, BBA-GENE STRUCT EXPR, V1490, P54, DOI 10.1016/S0167-4781(99)00054-8; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka E, 2007, BIOCHEM BIOPH RES CO, V358, P608, DOI 10.1016/j.bbrc.2007.04.177; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; Zhang KZ, 2002, J BIOL CHEM, V277, P4532, DOI 10.1074/jbc.M109524200	30	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12971	10.1371/journal.pone.0012971	http://dx.doi.org/10.1371/journal.pone.0012971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885981	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600010
J	Kane, NM; Jones, M; Brosens, JJ; Kelly, RW; Saunders, PTK; Critchley, HOD				Kane, Nicole M.; Jones, Marius; Brosens, Jan J.; Kelly, Rodney W.; Saunders, Philippa T. K.; Critchley, Hilary O. D.			TGF beta 1 Attenuates Expression of Prolactin and IGFBP-1 in Decidualized Endometrial Stromal Cells by Both SMAD-Dependent and SMAD-Independent Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VITRO; PROGESTERONE-RECEPTOR; OVARIAN-STEROIDS; EARLY-PREGNANCY; HUMAN PLACENTA; RELAXIN; PROLIFERATION; MECHANISMS; RELEASE	Background: Decidualization (differentiation) of the endometrial stromal cells during the secretory phase of the menstrual cycle is essential for successful implantation. Transforming Growth Factor beta 1 (TGF beta 1) canonically propagates its actions via SMAD signalling. A role for TGF beta 1 in decidualization remains to be established and published data concerning effects of TGF beta 1 on markers of endometrial decidualization are inconsistent. Methodology/Principal Findings: Non-pregnant endometrial stromal cells (ESC) and first trimester decidual stromal cells (DSC) were cultured in the presence or absence of a decidualizing stimulus. Incubation of ESCs with TGF beta 1 (10 ng/ml) down-regulated the expression of transcripts encoding the decidual marker proteins prolactin (PRL), insulin-like growth factor binding protein-1 (IGFBP-1) and tissue factor (TF). TGF beta 1 also inhibited secretion of PRL and IGFBP-1 proteins by ESCs and surprisingly this response preceded down-regulation of their mRNAs. In contrast, DSCs were more refractory to the actions of TGF beta 1, characterized by blunted and delayed down-regulation of PRL, IGFBP-1, and TF transcripts, which was not associated with a significant reduction in secretion of PRL or IGFBP-1 proteins. Addition of an antibody directed against TGF beta 1 increased expression of IGFBP-1 mRNA in decidualised cells. Knockdown of SMAD 4 using siRNAs abrogated the effect of TGF beta 1 on expression of PRL in ESCs but did not fully restore expression of IGFBP-1 mRNA and protein. Conclusions/Significance: TGF beta 1 inhibits the expression and secretion of decidual marker proteins. The impact of TGF beta 1 on PRL is SMAD-dependent but the impact on IGFBP1 is via an alternative mechanism. In early pregnancy, resistance of DSC to the impact of TGF beta 1 may be important to ensure tissue homeostasis.	[Kane, Nicole M.; Kelly, Rodney W.; Saunders, Philippa T. K.] Queens Med Res Inst, Ctr Reprod Biol, Med Res Council Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Jones, Marius; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Reprod & Dev Biol, London, England; [Critchley, Hilary O. D.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; Imperial College London; University of Edinburgh	Kane, NM (corresponding author), Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	hilary.critchley@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; CRITCHLEY, HILARY/0000-0003-1913-4044; Brosens, Jan/0000-0003-0116-9329	Medical Research Council [G0500047]; Medical Research Council Reproductive Sciences Unit [U1276.00.002.00005.01]; MRC [G0500047, MC_U127685844] Funding Source: UKRI; Medical Research Council [MC_U127685844, G9900991B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Reproductive Sciences Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NMK was the recipient of a Medical Research Council PhD studentship to the Medical Research Council Human Reproductive Sciences Unit. RK and PTKS were funded by the core grant to the Medical Research Council Reproductive Sciences Unit (U1276.00.002.00005.01). Support to HODC came from Medical Research Council Programme Grant G0500047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SC, 1990, BRIT MED BULL, V46, P720, DOI 10.1093/oxfordjournals.bmb.a072427; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Chang HJ, 2008, FERTIL STERIL, V90, P1357, DOI 10.1016/j.fertnstert.2007.09.010; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; Coya R, 1999, J NEUROENDOCRINOL, V11, P351; CRABTREE JS, 2008, MOL CELL ENDOCRINOL; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dimitriadis E, 2005, J CLIN ENDOCR METAB, V90, P3458, DOI 10.1210/jc.2004-1014; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Finn CA, 1996, EUR J OBSTET GYN R B, V70, P3, DOI 10.1016/S0301-2115(96)02565-1; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Hendy GN, 2005, HORM METAB RES, V37, P375, DOI 10.1055/s-2005-870152; Jokhi PP, 1997, CYTOKINE, V9, P126, DOI 10.1006/cyto.1996.0146; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kimatrai M, 2003, J CLIN ENDOCR METAB, V88, P844, DOI 10.1210/jc.2002-021224; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Krikun G, 2009, THROMB RES, V124, P393, DOI 10.1016/j.thromres.2009.06.013; Kubota T, 1997, EUR J ENDOCRINOL, V137, P200, DOI 10.1530/eje.0.1370200; LANE B, 1994, HUM REPROD, V9, P259, DOI 10.1093/oxfordjournals.humrep.a138492; Lessey BA, 2000, BEST PRACT RES CL OB, V14, P775, DOI 10.1053/beog.2000.0118; Lockwood CJ, 1999, SEMIN REPROD ENDOCR, V17, P45, DOI 10.1055/s-2007-1016211; LYSIAK JJ, 1995, PLACENTA, V16, P221, DOI 10.1016/0143-4004(95)90110-8; Mazella J, 2004, HUM REPROD, V19, P1513, DOI 10.1093/humrep/deh274; Milne SA, 1999, J CLIN ENDOCR METAB, V84, P2563, DOI 10.1210/jc.84.7.2563; Nasu K, 2005, FERTIL STERIL, V84, P1114, DOI 10.1016/j.fertnstert.2005.02.055; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; OMWANDHO CO, 2009, HUM REPROD; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647, DOI 10.1016/0002-9378(76)90068-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simpson H, 2002, PLACENTA, V23, P44, DOI 10.1053/plac.2001.0746; Singer CF, 1997, P NATL ACAD SCI USA, V94, P10341, DOI 10.1073/pnas.94.19.10341; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; VICOVAC LM, 1994, J CLIN ENDOCR METAB, V79, P1877, DOI 10.1210/jc.79.6.1877; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0	43	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12970	10.1371/journal.pone.0012970	http://dx.doi.org/10.1371/journal.pone.0012970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885978	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000282122600009
J	Kot, CY; Fujioka, E; Hazen, LJ; Best, BD; Read, AJ; Halpin, PN				Kot, Connie Y.; Fujioka, Ei; Hazen, Lucie J.; Best, Benjamin D.; Read, Andrew J.; Halpin, Patrick N.			Spatio-Temporal Gap Analysis of OBIS-SEAMAP Project Data: Assessment and Way Forward	PLOS ONE			English	Article							AERIAL SURVEYS; MARINE; CONSERVATION; CETACEANS; BEHAVIOR; WATERS; SHIP; TOOL	The OBIS-SEAMAP project has acquired and served high-quality marine mammal, seabird, and sea turtle data to the public since its inception in 2002. As data accumulated, spatial and temporal biases resulted and a comprehensive gap analysis was needed in order to assess coverage to direct data acquisition for the OBIS-SEAMAP project and for taxa researchers should true gaps in knowledge exist. All datasets published on OBIS-SEAMAP up to February 2009 were summarized spatially and temporally. Seabirds comprised the greatest number of records, compared to the other two taxa, and most records were from shipboard surveys, compared to the other three platforms. Many of the point observations and polyline tracklines were located in northern and central Atlantic and the northeastern and central-eastern Pacific. The Southern Hemisphere generally had the lowest representation of data, with the least number of records in the southern Atlantic and western Pacific regions. Temporally, records of observations for all taxa were the lowest in fall although the number of animals sighted was lowest in the winter. Oceanographic coverage of observations varied by platform for each taxa, which showed that using two or more platforms represented habitat ranges better than using only one alone. Accessible and published datasets not already incorporated do exist within spatial and temporal gaps identified. Other related open-source data portals also contain data that fill gaps, emphasizing the importance of dedicated data exchange. Temporal and spatial gaps were mostly a result of data acquisition effort, development of regional partnerships and collaborations, and ease of field data collection. Future directions should include fostering partnerships with researchers in the Southern Hemisphere while targeting datasets containing species with limited representation. These results can facilitate prioritizing datasets needed to be represented and for planning research for true gaps in space and time.	[Kot, Connie Y.; Fujioka, Ei; Hazen, Lucie J.; Best, Benjamin D.; Halpin, Patrick N.] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Beaufort, NC USA	Duke University	Kot, CY (corresponding author), Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Beaufort, NC USA.	connie.kot@duke.edu	Read, Andrew/AAE-8386-2019	Kot, Connie/0000-0002-4900-5289	National Science Foundation; National Oceanic Partnership Program [NSF-OCE-07-39199]	National Science Foundation(National Science Foundation (NSF)); National Oceanic Partnership Program	Current funding for OBIS-SEAMAP comes from the National Science Foundation (http://www.nsf.gov) and the National Oceanic Partnership Program (http://www.nopp.org) 3-year award number NSF-OCE-07-39199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Best BD, 2007, ECOL INFORM, V2, P210, DOI 10.1016/j.ecoinf.2007.07.007; Bodkin JL, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P13; Bowman AW, 2003, COMPUT STAT DATA AN, V42, P545, DOI 10.1016/S0167-9473(02)00118-4; Bowman AW, 1997, APPL SMOOTHING TECHN; BRIGGS KT, 1985, J WILDLIFE MANAGE, V49, P405, DOI 10.2307/3801542; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Certain G, 2008, ICES J MAR SCI, V65, P656, DOI 10.1093/icesjms/fsn046; Clapham Phillip J., 2004, Journal of Cetacean Research and Management, V6, P1; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Decker CJ, 2002, OCEANOL ACTA, V25, P179, DOI 10.1016/S0399-1784(02)01208-2; DiSciara GN, 1997, MAR FRESHW BEHAV PHY, V30, P125; ESRI, 2009, ARCGIS 9 3 1; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Hooker, 1992, NASA TECHNICAL MEMOR; Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; Jennings S., 2001, MARINE FISHERIES ECO; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Luschi P, 2006, S AFR J SCI, V102, P51; Lydersen C, 2008, ARCTIC, V61, P119; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; McManus RJ, 1998, BMJ-BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562; O'Brien J, 2009, BIOL ENVIRON, V109B, P63, DOI 10.3318/BIOE.2009.109.2.63; OCorry-Crowe G.M., 2002, ENCY MARINE MAM MALS, P94; Peters J.L., 1934, CHECK LIST BIRDS WOR; Potter JR, 2007, IEEE J OCEANIC ENG, V32, P469, DOI 10.1109/JOE.2006.880427; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P1; Schreiber EA, 2001, BIOL MARINE BIRDS; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Shaffer SA, 2006, IEEE J OCEANIC ENG, V31, P82, DOI 10.1109/JOE.2006.872210; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Stevinson C, 2004, COMPLEMENT THER MED, V12, P228, DOI 10.1016/j.ctim.2004.09.003; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	55	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12990	10.1371/journal.pone.0012990	http://dx.doi.org/10.1371/journal.pone.0012990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886047	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600019
J	Zhao, YH; Ayoub, NA; Hayashi, CY				Zhao, Yonghui; Ayoub, Nadia A.; Hayashi, Cheryl Y.			Chromosome Mapping of Dragline Silk Genes in the Genomes of Widow Spiders (Araneae, Theridiidae)	PLOS ONE			English	Article							MAJOR AMPULLATE SILK; MECHANICAL-PROPERTIES; SEX-CHROMOSOMES; EVOLUTION; FIBROIN; LATRODECTUS; SEQUENCE; PROTEIN; FISH; KARYOTYPES	With its incredible strength and toughness, spider dragline silk is widely lauded for its impressive material properties. Dragline silk is composed of two structural proteins, MaSp1 and MaSp2, which are encoded by members of the spidroin gene family. While previous studies have characterized the genes that encode the constituent proteins of spider silks, nothing is known about the physical location of these genes. We determined karyotypes and sex chromosome organization for the widow spiders, Latrodectus hesperus and L. geometricus (Araneae, Theridiidae). We then used fluorescence in situ hybridization to map the genomic locations of the genes for the silk proteins that compose the remarkable spider dragline. These genes included three loci for the MaSp1 protein and the single locus for the MaSp2 protein. In addition, we mapped a MaSp1 pseudogene. All the MaSp1 gene copies and pseudogene localized to a single chromosomal region while MaSp2 was located on a different chromosome of L. hesperus. Using probes derived from L. hesperus, we comparatively mapped all three MaSp1 loci to a single region of a L. geometricus chromosome. As with L. hesperus, MaSp2 was found on a separate L. geometricus chromosome, thus again unlinked to the MaSp1 loci. These results indicate orthology of the corresponding chromosomal regions in the two widow genomes. Moreover, the occurrence of multiple MaSp1 loci in a conserved gene cluster across species suggests that MaSp1 proliferated by tandem duplication in a common ancestor of L. geometricus and L. hesperus. Unequal crossover events during recombination could have given rise to the gene copies and could also maintain sequence similarity among gene copies over time. Further comparative mapping with taxa of increasing divergence from Latrodectus will pinpoint when the MaSp1 duplication events occurred and the phylogenetic distribution of silk gene linkage patterns.	[Zhao, Yonghui; Ayoub, Nadia A.; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zhao, YH (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	yonghuiz@ucr.edu		Ayoub, Nadia/0000-0003-4404-1472	Army Research Office [W911NF-06-1-0455]; National Science Foundation [IOS-0951086, IOS-0951061]; Division Of Integrative Organismal Systems [0951086] Funding Source: National Science Foundation	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was funded by the Army Research Office (W911NF-06-1-0455 to CH) and National Science Foundation (IOS-0951086 to NA, IOS-0951061 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo D, 2010, MICRON, V41, P165, DOI 10.1016/j.micron.2009.10.002; Araújo F. G, 2005, Braz. J. Biol., V65, P1, DOI 10.1590/S1519-69842005000100002; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Ayoub Nadia A., 2009, P255; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Chen SH, 1999, ZOOL STUD, V38, P423; Chinali A, 2010, J MOL EVOL, V70, P325, DOI 10.1007/s00239-010-9326-2; COPPIETERS W, 1994, MAMM GENOME, V5, P591, DOI 10.1007/BF00354938; Datta SN, 1983, CHROMOSOME INF SERV, V35, P6; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Foelix R. F., 2011, BIOL SPIDERS; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; GANAL MW, 1991, MOL GEN GENET, V225, P501, DOI 10.1007/BF00261693; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; GREGORY TR, 2006, ANIMAL GENOME SIZE D; Guerrero B, 2010, COMP BIOCHEM PHYS C, V151, P113, DOI 10.1016/j.cbpc.2009.09.005; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Kral J, 2007, CHROMOSOME RES, V15, P863, DOI 10.1007/s10577-007-1169-3; Kral J, 2006, CHROMOSOME RES, V14, P859, DOI 10.1007/s10577-006-1095-9; Kukekova AV, 2009, J HERED, V100, pS42, DOI 10.1093/jhered/esp037; LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; MADDISON WP, 1982, CHROMOSOMA, V85, P23, DOI 10.1007/BF00344592; MARTINDALE C, 1980, P ENT C ENT SOC SO A, V3, P45; MITA K, 1994, J MOL EVOL, V38, P583; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Peng Yu, 1998, Acta Arachnologica Sinica, V7, P142; PLATNICK NI, 2010, WORLD SPIDER CATALOG; Repping S, 2003, MOL HUM REPROD, V9, P183, DOI 10.1093/molehr/gag032; Rezac M, 2006, HEREDITAS, V143, P123; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; ROWELL DM, 1985, CHROMOSOMA, V93, P169, DOI 10.1007/BF00293165; Swanson BO, 2006, EVOLUTION, V60, P2539; TUGMON CR, 1990, J ARACHNOL, V18, P41; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	53	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12804	10.1371/journal.pone.0012804	http://dx.doi.org/10.1371/journal.pone.0012804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877726	gold, Green Published, Green Submitted			2022-12-25	WOS:000282002900004
J	Fu, LP; Van Doorslaer, K; Chen, ZG; Ristriani, T; Masson, M; Trave, G; Burk, RD				Fu, Leiping; Van Doorslaer, Koenraad; Chen, Zigui; Ristriani, Tutik; Masson, Murielle; Trave, Gilles; Burk, Robert D.			Degradation of p53 by Human Alphapapillomavirus E6 Proteins Shows a Stronger Correlation with Phylogeny than Oncogenicity	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; DNA; IMMORTALIZATION; CLASSIFICATION; PATHOGENESIS; ONCOPROTEIN; INFECTION; BINDING; LESIONS; CANCER	Background: Human Papillomavirus (HPV) E6 induced p53 degradation is thought to be an essential activity by which high-risk human Alphapapillomaviruses (alpha-HPVs) contribute to cervical cancer development. However, most of our understanding is derived from the comparison of HPV16 and HPV11. These two viruses are relatively distinct viruses, making the extrapolation of these results difficult. In the present study, we expand the tested strains (types) to include members of all known HPV species groups within the Alphapapillomavirus genus. Principal Findings: We report the biochemical activity of E6 proteins from 27 HPV types representing all alpha-HPV species groups to degrade p53 in human cells. Expression of E6 from all HPV types epidemiologically classified as group 1 carcinogens significantly reduced p53 levels. However, several types not associated with cancer (e. g., HPV53, HPV70 and HPV71) were equally active in degrading p53. HPV types within species groups alpha 5, 6, 7, 9 and 11 share a most recent common ancestor (MRCA) and all contain E6 ORFs that degrade p53. A unique exception, HPV71 E6 ORF that degraded p53 was outside this clade and is one of the most prevalent HPV types infecting the cervix in a population-based study of 10,000 women. Alignment of E6 ORFs identified an amino acid site that was highly correlated with the biochemical ability to degrade p53. Alteration of this amino acid in HPV71 E6 abrogated its ability to degrade p53, while alteration of this site in HPV71-related HPV90 and HPV106 E6s enhanced their capacity to degrade p53. Conclusions: These data suggest that the alpha-HPV E6 proteins' ability to degrade p53 is an evolved phenotype inherited from a most recent common ancestor of the high-risk species that does not always segregate with carcinogenicity. In addition, we identified an amino-acid residue strongly correlated with viral p53 degrading potential.	[Fu, Leiping; Van Doorslaer, Koenraad; Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Ristriani, Tutik; Masson, Murielle; Trave, Gilles] Ecole Super Biotechnol Strasbourg, Equipe Oncoprot, CNRS, UMR 7100, Illkirch Graffenstaden, France; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth & Obstet, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fu, LP (corresponding author), Cornell Univ, Dept Pharmacol, Joan & Sanford I Weill Med Sch, New York, NY 10021 USA.	Robert.Burk@einstein.yu.edu	Chen, Zigui/E-8490-2017; TRAVE, Gilles/P-8577-2016	Chen, Zigui/0000-0002-8577-1298; Van Doorslaer, Koenraad/0000-0002-2985-0733	National Cancer Institute [CA78527]; Einstein Cancer Research Center; Center for AIDS Research (CFAR); NATIONAL CANCER INSTITUTE [U01CA078527, R01CA078527] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Cancer Research Center; Center for AIDS Research (CFAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Public Health Service awards CA78527 from the National Cancer Institute (RDB) and center grants to the Einstein Cancer Research Center and the Center for AIDS Research (CFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1964, J NATL CANCER I, V32, P135; Berkhout RJM, 2000, J CLIN MICROBIOL, V38, P2087; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen Z, 2007, INT J CANCER, V121, P2947; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hiller T, 2006, CANCER EPIDEM BIOMAR, V15, P1262, DOI 10.1158/1055-9965.EPI-05-0778; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li N, 2010, INT J CANC; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MUNGER K, 1989, J VIROL, V63, P4417; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pim D, 1999, ONCOGENE, V18, P7403, DOI 10.1038/sj.onc.1203134; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schironi F, 2009, SOZOMENA-STUD RECOV, V4, P8; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; YEE C, 1985, AM J PATHOL, V119, P361; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	35	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12816	10.1371/journal.pone.0012816	http://dx.doi.org/10.1371/journal.pone.0012816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862247	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800017
J	Bender, A; Opel, D; Naumann, I; Kappler, R; Friedman, L; von Schweinitz, D; Debatin, KM; Fulda, S				Bender, A.; Opel, D.; Naumann, I.; Kappler, R.; Friedman, L.; von Schweinitz, D.; Debatin, K-M; Fulda, S.			PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis	ONCOGENE			English	Article						apoptosis; PI3K; neuroblastoma; chemotherapy	TRAIL-INDUCED APOPTOSIS; PHOSPHATIDYLINOSITOL 3-KINASE; MEMBRANE PERMEABILIZATION; CONFORMATIONAL-CHANGE; PANCREATIC-CARCINOMA; UP-REGULATION; IN-VIVO; CANCER; MCL-1; BAX	We recently identified activation of phosphatidylinositol 30'-kinase (PI3K)/Akt as a novel predictor of poor outcome in neuroblastoma. Here, we investigated the effect of small-molecule PI3K inhibitors on chemosensitivity. We provide first evidence that PI3K inhibitors, for example PI103, synergize with various chemotherapeutics (Doxorubicin, Etoposide, Topotecan, Cisplatin, Vincristine and Taxol) to trigger apoptosis in neuroblastoma cells (combination index: high synergy). Mechanistic studies reveal that PI103 cooperates with Doxorubicin to reduce Mcl-1 expression and Bim(EL) phosphorylation and to upregulate Noxa and BimEL levels. This shifted ratio of pro-and antiapoptotic Bcl-2 proteins results in increased Bax/Bak conformational change, loss of mitochondrial membrane potential, cytochrome c release, caspase activation and caspase-dependent apoptosis. Although Mcl-1 knockdown enhances Doxorubicin- and PI103-induced apoptosis, silencing of Noxa, Bax/Bak or p53 reduces apoptosis, underscoring the functional relevance of the Doxorubicin-and PI103-mediated modulation of these proteins for chemosensitization. Bcl-2 overexpression inhibits Bax activation, mitochondrial perturbations, cleavage of caspases and Bid, and apoptosis, confirming the central role of the mitochondrial pathway for chemosensitization. Interestingly, the broad-range caspase inhibitor zVAD.fmk does not interfere with Bax activation or mitochondrial outer membrane permeabilization, whereas it blocks caspase activation and apoptosis, thus placing mitochondrial events upstream of caspase activation. Importantly, PI103 and Doxorubicin cooperate to induce apoptosis and to suppress tumor growth in patients' derived primary neuroblastoma cells and in an in vivo neuroblastoma model, underlining the clinical relevance of the results. Thus, targeting PI3K presents a novel and promising strategy to sensitize neuroblastoma cells for chemotherapy-induced apoptosis, which has important implications for the development of targeted therapies for neuroblastoma. Oncogene (2011) 30, 494-503; doi: 10.1038/onc.2010.429; published online 20 September 2010	[Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Bender, A.; Opel, D.; Naumann, I.; Debatin, K-M] Univ Childrens Hosp, Dept Hematol Oncol, Ulm, Germany; [Kappler, R.; von Schweinitz, D.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat Surg, Munich, Germany; [Friedman, L.] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA	Goethe University Frankfurt; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Roche Holding; Genentech	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de	Fulda, Simone/D-5864-2011; Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Kappler, Roland/0000-0002-8581-2803; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; BMBF; Novartis Stiftung fur Therapeutische Forschung; European Community [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); Novartis Stiftung fur Therapeutische Forschung; European Community(European Commission)	We thank CA Schmitt (Berlin, Germany) for providing mouse Bcl-2 vector, C Haag (Ulm, Germany) for providing Mcl-1 knockdown SH-EP cells, A Dittrich (Ulm, Germany) for providing expert technical assistance and B Welz (Ulm, Germany) for providing excellent secretarial assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe, BMBF, Novartis Stiftung fur Therapeutische Forschung, European Community (ApopTrain, APO-SYS) and IAP6/18 (to SF).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chiarini F, 2009, CANCER RES, V69, P3520, DOI 10.1158/0008-5472.CAN-08-4884; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Fei PW, 2002, CANCER RES, V62, P7316; Flinterman M, 2005, J BIOL CHEM, V280, P5945, DOI 10.1074/jbc.M406661200; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2009, CURR CANCER DRUG TAR, V9, P729, DOI 10.2174/156800909789271521; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Jaboin J, 2002, CANCER RES, V62, P6756; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Niedermeier M, 2009, BLOOD, V113, P5549, DOI 10.1182/blood-2008-06-165068; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Warr MR, 2008, CURR MOL MED, V8, P138; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200	40	77	79	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					494	503		10.1038/onc.2010.429	http://dx.doi.org/10.1038/onc.2010.429			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20856197				2022-12-25	WOS:000286621600011
J	Zhang, SJ; Wang, JL; Wang, QA; Toyoda, T				Zhang, Shijian; Wang, Jinlan; Wang, Qiang; Toyoda, Tetsuya			Internal Initiation of Influenza Virus Replication of Viral RNA and Complementary RNA in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; MESSENGER-RNA; A-VIRUS; NUCLEOCAPSID PROTEIN; ABORTIVE INITIATION; VIRION RNA; 5' END; POLYMERASE; TRANSCRIPTION; IDENTIFICATION	Influenza virus transcription is a prototype of primer-dependent initiation. Its replication mechanism is thought to be primer-independent. The internal initiation and realignment model for influenza virus genome replication has been recently proposed (Deng, T., Vreede, F. T., and Brownlee, G. G. (2006) J. Virol. 80, 2337-2348). We obtained new results, which led us to propose a novel model for the initiation of viral RNA (vRNA) replication. In our study, we analyzed the initiation mechanisms of influenza virus vRNA and complementary RNA (cRNA) synthesis in vitro, using purified RNA polymerase (RdRp) and 84-nt model RNA templates. We found that, for vRNA -> cRNA ->, RdRp initiated replication from the second nucleotide of the 3'-end. Therefore, host RNA-specific ribonucleotidyltransferases are required to add one nucleotide (purine residues are preferred) to the 3'-end of vRNA to make the complete copy of vRNA. This hypothesis was experimentally proven using poly(A) polymerase. For cRNA -> vRNA, the dinucleotide primer AG was synthesized from UC (fourth and fifth from the 3'-end) by RdRp pausing at the sixth U of UUU and realigning at the 3'-end of cRNA template; then RdRp was able to read through the entire template RNA. The RdRp initiation complex was not stable until it had read through the UUU of cRNA and the UUUU of vRNA at their respective 3'-ends. This was because primers overlapping with the first U of the clusters did not initiate transcription efficiently, and the initiation product of v84+G (the v84 template with an extra G at its 3'-end), AGC, realigned to the 3'-end.	[Zhang, Shijian; Wang, Jinlan; Wang, Qiang; Toyoda, Tetsuya] Chinese Acad Sci, Unit Viral Genome Regulat, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Toyoda, T (corresponding author), Chinese Acad Sci, Unit Viral Genome Regulat, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, 411 Hefei Rd, Shanghai 200025, Peoples R China.	toyoda_tetsuya@yahoo.co.jp	Zhang, Shijian/P-9353-2015; WANG, QIANG/P-4519-2017	Zhang, Shijian/0000-0002-2017-6754; WANG, QIANG/0000-0002-6141-0068	Chinese Academy of Sciences [0514P51131]; National Science Foundation of China [30670090]; Li Ka Shing Foundation [0682P11131]; RESPARI [0581P14131]; FLUINNATE [SP5B-CT-2006-044161]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation; RESPARI; FLUINNATE(European CommissionEuropean Commission Joint Research Centre)	This work was supported Chinese Academy of Sciences Grant 0514P51131, National Science Foundation of China Grant 30670090, Li Ka Shing Foundation Grant 0682P11131, RESPARI Grant 0581P14131, and FLUINNATE Grant SP5B-CT-2006-044161.	BALL LA, 2007, FIELDS VIROLOGY, P119; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BEATON AR, 1981, NUCLEIC ACIDS RES, V9, P4423, DOI 10.1093/nar/9.17.4423; BEATON AR, 1986, P NATL ACAD SCI USA, V83, P6282, DOI 10.1073/pnas.83.17.6282; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Honda A, 1998, VIRUS RES, V55, P199, DOI 10.1016/S0168-1702(98)00048-3; HONDA A, 1990, J BIOCHEM-TOKYO, V107, P624, DOI 10.1093/oxfordjournals.jbchem.a123097; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; ISHIHAMA A, 1988, CRC CR REV BIOCH MOL, V23, P27, DOI 10.3109/10409238809103119; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; KAWAKAMI K, 1981, J BIOCHEM-TOKYO, V89, P1751, DOI 10.1093/oxfordjournals.jbchem.a133374; Kobayashi M, 1996, ARCH VIROL, V141, P525, DOI 10.1007/BF01718315; KRUG RM, 1983, GENETICS INFLUENZA V, P70; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LING ML, 1989, NUCLEIC ACIDS RES, V17, P1605, DOI 10.1093/nar/17.4.1605; LUO GX, 1991, J VIROL, V65, P2861, DOI 10.1128/JVI.65.6.2861-2867.1991; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; MORONEY SE, 1991, BIOCHEMISTRY-US, V30, P10343, DOI 10.1021/bi00106a036; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Palese P., 2007, FIELDS VIROLOGY, P1647; PARVIN JD, 1989, J VIROL, V63, P5142, DOI 10.1128/JVI.63.12.5142-5152.1989; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1977, J VIROL, V21, P24, DOI 10.1128/JVI.21.1.24-34.1977; PLOTCH SJ, 1978, J VIROL, V25, P579, DOI 10.1128/JVI.25.2.579-586.1978; Poon LLM, 1998, J VIROL, V72, P8214, DOI 10.1128/JVI.72.10.8214-8219.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; ROBERTSON HD, 1980, NUCLEIC ACIDS RES, V8, P925, DOI 10.1093/nar/8.5.925; Toyoda T, 2003, ARCH VIROL, V148, P1687, DOI 10.1007/s00705-003-0140-7; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; YAMANAKA K, 1991, P NATL ACAD SCI USA, V88, P5369, DOI 10.1073/pnas.88.12.5369; Yang Y, 2004, J BIOL CHEM, V279, P12659, DOI 10.1074/jbc.M312992200; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	40	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41194	41201		10.1074/jbc.M110.130062	http://dx.doi.org/10.1074/jbc.M110.130062			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20858902	hybrid, Green Published			2022-12-25	WOS:000285414400081
J	Morisaki, N; Moriwaki, S; Sugiyama-Nakagiri, Y; Haketa, K; Takema, Y; Imokawa, G				Morisaki, Naoko; Moriwaki, Shigeru; Sugiyama-Nakagiri, Yoriko; Haketa, Keiichi; Takema, Yoshinori; Imokawa, Genji			Neprilysin Is Identical to Skin Fibroblast Elastase ITS ROLE IN SKIN AGING AND UV RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL ENDOPEPTIDASE; NEUROGENIC INFLAMMATION; VISCOELASTIC PROPERTIES; ELASTOLYTIC ACTIVITY; ENKEPHALINASE; IRRADIATION; MODULATION; INHIBITION; EXPRESSION; CYTOKINES	Although human skin fibroblast (HSF) elastase has been characterized as a membrane-bound metalloproteinase, little is known about its structure, amino acid sequence, and encoding gene. As there are similarities in the molecular weights and inhibitory profiles of HSF elastase and neprilysin (neutral endopeptidase 24.11 (NEP)), in this study we tested the hypothesis that they are identical using immunoprecipitation and transfection methods. An immunoprecipitation study demonstrated that HSF elastase activity co-immunoprecipitated with anti-NEP in lysates of cultured HSF. Transfection of an NEP cDNA expression vector into COS-1 cells elicited the expression of HSF elastase and NEP activities in the transfected cells. These findings strongly suggest that HSF elastase is identical to NEP, which functions mainly in neuron-associated cells to degrade neuropeptides. Analysis of the expression pattern of NEP revealed that its expression was remarkably up-regulated at the gene, protein, and enzymatic activity levels during the replicative senescence of cultured HSF. Further, the activity of NEP was markedly enhanced in a pattern similar to elastase activity during the intrinsic aging of mouse skin, in UVA-exposed HSF as well as in HSF treated with conditioned medium from UVB-exposed human keratinocytes. Analysis of the cytokine profile for the stimulation of NEP and HSF elastase activities in HSF demonstrated that among the 11 cytokines tested, IL-1 alpha, IL-1 beta, IL-6, IL-8, and GM-CSF had the potential to significantly stimulate both activities similarly, again supporting the identity of HSF elastase and NEP.	[Imokawa, Genji] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo 1920982, Japan; [Morisaki, Naoko; Moriwaki, Shigeru; Sugiyama-Nakagiri, Yoriko; Haketa, Keiichi; Takema, Yoshinori] Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan	Tokyo University of Technology	Imokawa, G (corresponding author), Tokyo Univ Technol, Sch Biosci & Biotechnol, 1404-1 Katakura, Tokyo 1920982, Japan.	imokawag@dream.ocn.ne.jp						AGUAYO SM, 1994, AM J RESP CELL MOL, V10, P635, DOI 10.1165/ajrcmb.10.6.8003340; BERANGER JY, 1994, CELL BIOL INT, V18, P715, DOI 10.1006/cbir.1994.1100; BOLOGNIA JL, 1995, AM J MED, V98, pS99, DOI 10.1016/S0002-9343(99)80066-7; BOUDIER C, 1991, AM J RESP CELL MOL, V4, P497, DOI 10.1165/ajrcmb/4.6.497; CAMPBELL EJ, 1988, J CELL BIOL, V106, P667, DOI 10.1083/jcb.106.3.667; CASEY ML, 1991, J BIOL CHEM, V266, P23041; Cohen AJ, 1996, CANCER RES, V56, P831; CONSTAM DB, 1995, J BIOL CHEM, V270, P26930; DELOMBAERT S, 1994, J MED CHEM, V37, P498, DOI 10.1021/jm00030a009; GODEAU G, 1988, PATHOL BIOL, V36, P1133; Graf K, 1998, BASIC RES CARDIOL, V93, P11, DOI 10.1007/s003950050056; Habig J, 1996, HAUTARZT, V47, P515, DOI 10.1007/s001050050462; HOMSY R, 1988, J INVEST DERMATOL, V91, P472, DOI 10.1111/1523-1747.ep12476608; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; Kletsas D, 1998, MECH AGEING DEV, V102, P15, DOI 10.1016/S0047-6374(98)00003-7; KONDEPUDI A, 1993, AM J RESP CELL MOL, V8, P43, DOI 10.1165/ajrcmb/8.1.43; Kramer HH, 2005, EXP NEUROL, V195, P179, DOI 10.1016/j.expneurol.2005.04.015; LABATROBERT J, 1992, ANN NY ACAD SCI, V673, P16, DOI 10.1111/j.1749-6632.1992.tb27431.x; LEARN DB, 1991, PHOTODERMATOL PHOTO, V8, P195; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; LORKOWSKI G, 1987, BIOCHEM J, V248, P345, DOI 10.1042/bj2480345; Mari B, 1997, FASEB J, V11, P869, DOI 10.1096/fasebj.11.11.9285485; MCKENZIE RC, 1994, PHOTODERMATOL PHOTO, V10, P74; Misery L, 1996, PATHOL BIOL, V44, P867; NADEL JA, 1991, EUR RESPIR J, V4, P745; Nakagawa K, 1987, SKIN RES, V29, P793; NOZAKI S, 1991, J INVEST DERMATOL, V97, P10, DOI 10.1111/1523-1747.ep12477727; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oka T, 1993, Nihon Yakurigaku Zasshi, V101, P197; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; SCHWARTZ E, 1988, CLIN CHIM ACTA, V176, P219, DOI 10.1016/0009-8981(88)90211-2; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Solan NJ, 1998, INFLAMMATION, V22, P107, DOI 10.1023/A:1022304025789; Solmi R, 1996, MECH AGEING DEV, V92, P31, DOI 10.1016/S0047-6374(96)01800-3; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; STEFANO GB, 1992, J NEUROIMMUNOL, V41, P9, DOI 10.1016/0165-5728(92)90189-R; SUDA H, 1973, J ANTIBIOT, V26, P621, DOI 10.7164/antibiotics.26.621; TAKEMA Y, 1994, BRIT J DERMATOL, V131, P641, DOI 10.1111/j.1365-2133.1994.tb04975.x; Takema Y, 1998, DERMATOLOGY, V196, P397, DOI 10.1159/000017931; Toyoda M, 2005, BRIT J DERMATOL, V153, P13, DOI 10.1111/j.1365-2133.2005.06965.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150	47	41	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39819	39827		10.1074/jbc.M110.161547	http://dx.doi.org/10.1074/jbc.M110.161547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20876573	Green Published, hybrid			2022-12-25	WOS:000285185500026
J	Buosi, V; Placial, JP; Leroy, JL; Cherfils, J; Guittet, E; van Heijenoort, C				Buosi, Vanessa; Placial, Jean-Pierre; Leroy, Jean-Louis; Cherfils, Jacqueline; Guittet, Eric; van Heijenoort, Carine			Insight into the Role of Dynamics in the Conformational Switch of the Small GTP-binding Protein Arf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; TIME-SCALE DYNAMICS; BACKBONE DYNAMICS; SEQUENCE HOMOLOGY; RELAXATION; ACTIVATION; MECHANISM; N-15; GDP; MILLISECOND	Activation of the small GTP-binding protein Arf1, a major regulator of cellular traffic, follows an ordered sequence of structural events, which have been pictured by crystallographic snapshots. Combined with biochemical analysis, these data lead to a model of Arf1 activation, in which opening of its N-terminal helix first translocates Arf1-GDP to membranes, where it is then secured by a register shift of the interswitch beta-strands, before GDP is eventually exchanged for GTP. However, how Arf1 rearranges its central beta-sheet, an event that involves the loss and re-formation of H-bonds deep within the protein core, is not explained by available structural data. Here, we used Delta 17Arf1, in which the N-terminal helix has been deleted, to address this issue by NMR structural and dynamics analysis. We first completed the assignment of Delta 17Arf1 bound to GDP, GTP, and GTP gamma S and established that NMR data are fully consistent with the crystal structures of Arf1-GDP and Delta 17Arf1-GTP. Our assignments allowed us to analyze the kinetics of both protein conformational transitions and nucleotide exchange by real-time NMR. Analysis of the dynamics over a very large range of timescale by N-15 relaxation, CPMG relaxation dispersion and H/D exchange reveals that while Delta 17Arf1-GTP and full-length Arf1-GDP dynamics is restricted to localized fast motions, Delta 17Arf1-GDP features unique intermediate and slow motions in the interswitch region. Altogether, the NMR data bring insight into how that membrane-bound Arf1-GDP, which is mimicked by the truncation of the N-terminal helix, acquires internal motions that enable the toggle of the interswitch.	[van Heijenoort, Carine] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), CNRS, LEBS, Ctr Rech Gif, Lab Chim & Biol Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	jacqueline.cherfils@lebs.cnrs-gif.fr; eric.guittet@icsn.cnrs-gif.fr; carine@icsn.cnrs-gif.fr	van Heijenoort, Carine/AAX-1041-2021; VAN HEIJENOORT, Carine/N-1986-2016	van Heijenoort, Carine/0000-0002-2839-1037; VAN HEIJENOORT, Carine/0000-0002-2839-1037; Guittet, Eric/0000-0002-8368-6719	Association pour la Recherche contre le Cancer; CNRS; Ministere de la Recherche; Institut de Chimie des Substances Naturelles; TGE RMN THC [FR3050]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Institut de Chimie des Substances Naturelles; TGE RMN THC	This work was supported by grants from the Association pour la Recherche contre le Cancer (to V.B. and J.C.) by the CNRS, the Ministere de la Recherche, and the Institut de Chimie des Substances Naturelles (to V.B., E.G., and C.v.H.). This work was also supported by TGE RMN THC FR3050.	Adams PD, 2004, BIOCHEMISTRY-US, V43, P9968, DOI 10.1021/bi0490901; Amor JC, 2002, J BIOMOL NMR, V23, P253, DOI 10.1023/A:1019839607202; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bruschweiler S, 2009, J AM CHEM SOC, V131, P3063, DOI 10.1021/ja809947w; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Gruschus JM, 2009, STRUCTURE, V17, P2, DOI 10.1016/j.str.2008.12.002; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S., 2003, GDP GTP CYCLE ARF PR; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Seidel RD, 2004, J BIOL CHEM, V279, P48307, DOI 10.1074/jbc.M402109200; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; van Tilborg PJA, 1999, BIOCHEMISTRY-US, V38, P1951, DOI 10.1021/bi982526q; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104	36	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37987	37994		10.1074/jbc.M110.134445	http://dx.doi.org/10.1074/jbc.M110.134445			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861011	hybrid, Green Published			2022-12-25	WOS:000284625600006
J	Masuda, W; Betzenhauser, MJ; Yule, DI				Masuda, Wataru; Betzenhauser, Matthew J.; Yule, David I.			InsP(3)R-associated cGMP Kinase Substrate Determines Inositol 1,4,5-Trisphosphate Receptor Susceptibility to Phosphoregulation by Cyclic Nucleotide-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; CA2+ RELEASE; TRISPHOSPHATE RECEPTOR; MOLECULAR DETERMINANTS; RAT HEPATOCYTES; I-BETA; PHOSPHORYLATION; CAMP; TYPE-1	Ca2+ release through inositol 1,4,5-trisphosphate receptors (InsP(3)R) can be modulated by numerous factors, including input from other signal transduction cascades. These events shape the spatio-temporal characteristics of the Ca2+ signal and provide fidelity essential for the appropriate activation of effectors. In this study, we investigate the regulation of Ca2+ release via InsP(3)R following activation of cyclic nucleotide-dependent kinases in the presence and absence of expression of a binding partner InsP(3)R-associated cGMP kinase substrate (IRAG). cGMP-dependent kinase (PKG) phosphorylation of only the S2+ InsP(3)R-1 subtype resulted in enhanced Ca2+ release in the absence of IRAG expression. In contrast, IRAG bound to each InsP(3)R subtype, and phosphorylation of IRAG by PKG attenuated Ca2+ release through all InsP(3)R subtypes. Surprisingly, simply the expression of IRAG attenuated phosphorylation and inhibited the enhanced Ca2+ release through InsP(3)R-1 following cAMP-dependent protein kinase (PKA) activation. In contrast, IRAG expression did not influence the PKA-enhanced activity of the InsP(3)R-2. Phosphorylation of IRAG resulted in reduced Ca2+ release through all InsP(3)R subtypes during concurrent activation of PKA and PKG, indicating that IRAG modulation is dominant under these conditions. These studies yield mechanistic insight into how cells with various complements of proteins integrate and prioritize signals from ubiquitous signaling pathways.	[Yule, David I.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Betzenhauser, Matthew J.] Columbia Univ, Sch Med, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Masuda, Wataru] Kyushu Dent Coll, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	University of Rochester; Columbia University; Kyushu Dental University	Yule, DI (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [RO1-DK05458, RO1-DE14756]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK05458 and RO1-DE14756.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Desch M, 2010, CARDIOVASC RES, V86, P496, DOI 10.1093/cvr/cvq008; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Murthy KS, 2001, AM J PHYSIOL-GASTR L, V281, pG1238, DOI 10.1152/ajpgi.2001.281.5.G1238; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; Quinton TM, 1996, BIOCHEM BIOPH RES CO, V224, P740, DOI 10.1006/bbrc.1996.1093; Quinton TM, 1996, BIOCHEMISTRY-US, V35, P6865, DOI 10.1021/bi960128m; Rooney TA, 1996, J BIOL CHEM, V271, P19817, DOI 10.1074/jbc.271.33.19817; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; SILVER PJ, 1979, J BIOL CHEM, V254, P9951; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Soulsby MD, 2004, FEBS LETT, V557, P181, DOI 10.1016/S0014-5793(03)01487-X; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tasker PN, 2000, BIOCHEM BIOPH RES CO, V273, P907, DOI 10.1006/bbrc.2000.3036; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Yaroslavskiy BB, 2010, LAB INVEST, V90, P1533, DOI 10.1038/labinvest.2010.120; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37927	37938		10.1074/jbc.M110.168989	http://dx.doi.org/10.1074/jbc.M110.168989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876535	hybrid, Green Published			2022-12-25	WOS:000284424000082
J	Suptawiwat, O; Tantilipikorn, P; Boonarkart, C; Lumyongsatien, J; Uiprasertkul, M; Puthavathana, P; Auewarakul, P				Suptawiwat, Ornpreya; Tantilipikorn, Pongsakorn; Boonarkart, Chompunuch; Lumyongsatien, Jate; Uiprasertkul, Mongkol; Puthavathana, Pilaipan; Auewarakul, Prasert			Enhanced Susceptibility of Nasal Polyp Tissues to Avian and Human Influenza Viruses	PLOS ONE			English	Article							NF-KAPPA-B; A H5N1; ORGAN-CULTURES; EXPRESSION; SIALYLTRANSFERASES; TRANSMISSION; REPLICATION	Background: Influenza viruses bind and infect respiratory epithelial cells through sialic acid on cell surface. Differential preference to sialic acid types contributes to host-and tissue-tropism of avian and seasonal influenza viruses. Although the highly pathogenic avian influenza virus H5N1 can infect and cause severe diseases in humans, it is not efficient in infecting human upper respiratory tract. This is because of the scarcity of its receptor, alpha 2,3-linked sialic acid, in human upper airway. Expression of sialic acid can be influenced by various factors including inflammatory process. Allergic rhinitis and nasal polyp are common inflammatory conditions of nasal mucosa and may affect expression of the sialic acid and susceptibility to influenza infection. Methodology/Principal Finding: To test this hypothesis, we detected alpha 2,3- and alpha 2,6-linked sialic acid in human nasal polyp and normal nasal mucosal tissues by lectin staining and infected explants of those tissues with avian influenza viruses H5N1 and seasonal influenza viruses. We show here that mucosal surface of nasal polyp expressed higher level of alpha 2,3- and alpha 2,6-linked sialic acid than normal nasal mucosa. Accordingly, both H5N1 avian influenza viruses and seasonal influenza viruses replicated more efficiently in nasal polyp tissues explants. Conclusions/Significance: Our data suggest a role of nasal inflammatory conditions in susceptibility to influenza infection, especially by avian influenza viruses, which is generally inefficient in infecting human upper airway. The increased receptor expression may contribute to increased susceptibility in some individuals. This may contribute to the gradual adaptation of the virus to human population.	[Suptawiwat, Ornpreya; Boonarkart, Chompunuch; Puthavathana, Pilaipan; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Tantilipikorn, Pongsakorn; Lumyongsatien, Jate] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Otorhinolaryngol, Bangkok 10700, Thailand; [Uiprasertkul, Mongkol] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Suptawiwat, O (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	sipaw@mahidol.ac.th	Tantilipikorn, Pongsakorn/D-2797-2019; Auewarakul, Prasert/D-6015-2011	Tantilipikorn, Pongsakorn/0000-0003-1995-4798; Auewarakul, Prasert/0000-0002-4745-4291	Thailand Research Fund; Faculty of Medicine Siriraj Hospital	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Medicine Siriraj Hospital	This study was supported by Thailand Research Fund. O.S. and C. B. were supported by post-doctoral and research assistant grants of Faculty of Medicine Siriraj Hospital. The sponsors of the study had no role in study design, collection, analysis, or interpretation of data, or in the writing of the report.	Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; FASANO MB, CURR OPIN OTOLARYNGO, V18, P15; Fireman P, 1996, ALLERGY ASTHMA PROC, V17, P175, DOI 10.2500/108854196778996886; GINZBURG VP, 1985, ACTA VIROL, V29, P424; GINZBURG VP, 1982, ARCH VIROL, V74, P293, DOI 10.1007/BF01314162; JENSEN C, 1987, AGENTS ACTIONS, V20, P161, DOI 10.1007/BF02074657; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lopez Perez G, 2009, REV ALERG MEX, V56, P86; Miller EK, 2008, PEDIATRICS, V121, P1, DOI 10.1542/peds.2007-1053; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shimizu T, 2001, AM J RESP CRIT CARE, V164, P1077, DOI 10.1164/ajrccm.164.6.2012058; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Valera FCP, 2008, CLIN EXP ALLERGY, V38, P579, DOI 10.1111/j.1365-2222.2007.02929.x; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016	24	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12973	10.1371/journal.pone.0012973	http://dx.doi.org/10.1371/journal.pone.0012973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885984	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600012
J	Chang, JH; Cha, HR; Lee, DS; Seo, KY; Kweon, MN				Chang, Jae-Hoon; Cha, Hye-Ran; Lee, Dong-Sup; Seo, Kyoung Yul; Kweon, Mi-Na			1,25-Dihydroxyvitamin D-3 Inhibits the Differentiation and Migration of T(H)17 Cells to Protect against Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; VITAMIN-D; DENDRITIC CELLS; TH17 CELLS; IN-VITRO; TGF-BETA; TRANSCRIPTIONAL REPRESSION; PREFERENTIAL RECRUITMENT	Background: Vitamin D-3, the most physiologically relevant form of vitamin D, is an essential organic compound that has been shown to have a crucial effect on the immune responses. Vitamin D-3 ameliorates the onset of the experimental autoimmune encephalomyelitis (EAE); however, the direct effect of vitamin D-3 on T cells is largely unknown. Methodology/ Principal Findings: In an in vitro system using cells from mice, the active form of vitamin D-3 (1,25dihydroxyvitamin D-3) suppresses both interleukin (IL)-17-producing T cells (T(H)17) and regulatory T cells (Treg) differentiation via a vitamin D receptor signal. The ability of 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) to reduce the amount of IL-2 regulates the generation of Treg cells, but not T(H)17 cells. Under T(H)17-polarizing conditions, 1,25(OH)(2)D-3 helps to increase the numbers of IL-10-producing T cells, but 1,25(OH)(2)D-3' s negative regulation of T(H)17 development is still defined in the IL-10 2/ 2 T cells. Although the STAT1 signal reciprocally affects the secretion of IL-10 and IL-17, 1,25(OH)(2)D-3 inhibits IL-17 production in STAT1 2/ 2 T cells. Most interestingly, 1,25(OH)(2)D-3 negatively regulates CCR6 expression which might be essential for T(H)17 cells to enter the central nervous system and initiate EAE. Conclusions/ Significance: Our present results in an experimental murine model suggest that 1,25(OH)(2)D-3 can directly regulate T cell differentiation and could be applied in preventive and therapeutic strategies for T(H)17-mediated autoimmune diseases.	[Chang, Jae-Hoon; Cha, Hye-Ran; Seo, Kyoung Yul; Kweon, Mi-Na] Int Vaccine Inst, Mucosal Immunol Sect, Div Sci Lab, Seoul, South Korea; [Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Seo, Kyoung Yul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea	International Vaccine Institute; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Chang, JH (corresponding author), Int Vaccine Inst, Mucosal Immunol Sect, Div Sci Lab, Seoul, South Korea.	mnkweon@ivi.int	Lee, Dong-Sup/J-2777-2012; Seo, Kyoung Yul/I-5484-2019	Cha, Hye-Ran/0000-0001-7112-7525; Seo, Kyoung Yul/0000-0002-9855-1980	MEST [2007-04213]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Mid-Career Researcher Program through a NRF grant funded by the MEST (No. 2007-04213) http://www.nrf.go.kr/html/kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Issa LL, 1998, INFLAMM RES, V47, P451, DOI 10.1007/s000110050360; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; MEEHAN MA, 1992, CELL IMMUNOL, V140, P400, DOI 10.1016/0008-8749(92)90206-5; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Penna G, 2006, J IMMUNOL, V177, P8504, DOI 10.4049/jimmunol.177.12.8504; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	57	139	148	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12925	10.1371/journal.pone.0012925	http://dx.doi.org/10.1371/journal.pone.0012925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886077	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100029
J	Szereszewski, JM; Pampillo, M; Ahow, MR; Offermanns, S; Bhattacharya, M; Babwah, AV				Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Offermanns, Stefan; Bhattacharya, Moshmi; Babwah, Andy V.			GPR54 Regulates ERK1/2 Activity and Hypothalamic Gene Expression in a G alpha(q/11) and beta-Arrestin-Dependent Manner	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; KINASE ACTIVATION; BETA-ARRESTIN-1; PATHWAYS; MUTATION; LIGANDS; ROLES	G protein-coupled receptor 54 (GPR54) is a G(q/11)-coupled 7 transmembrane-spanning receptor (7TMR). Activation of GPR54 by kisspeptin (Kp) stimulates PIP2 hydrolysis, Ca2+ mobilization and ERK1/2 MAPK phosphorylation. Kp and GPR54 are established regulators of the hypothalamic-pituitary-gonadal (HPG) axis and loss-of-function mutations in GPR54 are associated with an absence of puberty and hypogonadotropic hypogonadism, thus defining an important role of the Kp/GPR54 signaling system in reproductive function. Given the tremendous physiological and clinical importance of the Kp/GPR54 signaling system, we explored the contributions of the GPR54-coupled G(q/11) and beta-arrestin pathways on the activation of a major downstream signaling molecule, ERK, using G(q/11) and beta-arrestin knockout mouse embryonic fibroblasts. Our study revealed that GPR54 employs the G(q/11) and beta-arrestin-2 pathways in a co-dependent and temporally overlapping manner to positively regulate ERK activity and pERK nuclear localization. We also show that while beta-arrestin-2 potentiates GPR54 signaling to ERK, beta-arrestin-1 inhibits it. Our data also revealed that diminished beta-arrestin-1 and -2 expression in the GT1-7 GnRH hypothalamic neuronal cell line triggered distinct patterns of gene expression following Kp10 treatment. Thus, beta-arrestin-1 and -2 also regulate distinct downstream responses in gene expression. Finally, we showed that GPR54, when uncoupled from the G(q/11) pathway, as is the case for several naturally occurring GPR54 mutants associated with hypogonadotropic hypogonadism, continues to regulate gene expression in a G protein-independent manner. These new and exciting findings add significantly to our mechanistic understanding of how this important receptor signals intracellularly in response to kisspeptin stimulation.	[Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Childrens Hlth Res Inst, London, ON, Canada; [Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Lawson Hlth Res Inst, London, ON, Canada; [Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Szereszewski, Jacob M.; Ahow, Maryse R.; Bhattacharya, Moshmi; Babwah, Andy V.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Max Planck Society	Szereszewski, JM (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	ababwah@uwo.ca	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Natural Sciences and Engineering Research Council of Canada (NSERC) [327334-2006]; Canadian Institute of Health Research (CIHR) [81383]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research reported in this study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) 327334-2006 (AVB) and the Canadian Institute of Health Research (CIHR, http://www.cihr-irsc.gc.ca) MOP#81383 (AVB). The following are recipients of a salary award and studentships: Andy Babwah: CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council New Investigator Award, Moshmi Bhattacharya: NSERC University Faculty Award and Jacob Szereszewski: Department of Obstetrics and Gynaecology, University of Western Ontario, Studentship and Frederick Banting and Charles Best Canada Graduate Scholarship-Master's Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Cerrato F, 2007, REV ENDOCR METAB DIS, V8, P47, DOI 10.1007/s11154-007-9027-3; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Luttrell LM, 2002, J CELL SCI, V115, P455; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Novaira HJ, 2009, MOL CELL ENDOCRINOL, V311, P126, DOI 10.1016/j.mce.2009.06.011; Pampillo M, 2009, MOL ENDOCRINOL, V23, P2060, DOI 10.1210/me.2009-0013; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	43	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12964	10.1371/journal.pone.0012964	http://dx.doi.org/10.1371/journal.pone.0012964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886089	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100055
J	Nalca, A; Livingston, VA; Garza, NL; Zumbrun, EE; Frick, OM; Chapman, JL; Hartings, JM				Nalca, Aysegul; Livingston, Virginia A.; Garza, Nicole L.; Zumbrun, Elizabeth E.; Frick, Ondraya M.; Chapman, Jennifer L.; Hartings, Justin M.			Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Aerosolized Monkeypox Virus	PLOS ONE			English	Article							VACCINIA VIRUS; SMALLPOX VACCINE; MODEL; PROTECTION; CHALLENGE; DISEASE; ST-246; CONGO	Monkeypox virus (MPXV) infection in humans results in clinical symptoms very similar to ordinary smallpox. Aerosol is a route of secondary transmission for monkeypox, and a primary route of smallpox transmission in humans. Therefore, an animal model for aerosol exposure to MPXV is needed to test medical countermeasures. To characterize the pathogenesis in cynomolgus macaques (Macaca fascicularis), groups of macaques were exposed to four different doses of aerosolized MPXV. Blood was collected the day before, and every other day after exposure and assessed for complete blood count (CBC), clinical chemistry analysis, and quantitative PCR. Macaques showed mild anorexia, depression, and fever on day 6 post-exposure. Lymphadenopathy, which differentiates monkeypox from smallpox, was observed in exposed macaques around day 6 post-exposure. CBC and clinical chemistries showed abnormalities similar to human monkeypox cases. Whole blood and throat swab viral loads peaked around day 10, and in survivors, gradually decreased until day 28 post-exposure. Survival was not dose dependent. As such, doses of 4 x 10(4) PFU, 1 x 10(5) PFU, or 1 x 10(6) PFU resulted in lethality for 70% of the animals, whereas a dose of 4 x 10(5) PFU resulted in 85% lethality. Overall, cynomolgus macaques exposed to aerosolized MPXV develop a clinical disease that resembles that of human monkeypox. These findings provide a strong foundation for the use of aerosolized MPXV exposure of cynomolgus macaques as an animal model to test medical countermeasures against orthopoxviruses.	[Nalca, Aysegul; Livingston, Virginia A.; Garza, Nicole L.; Zumbrun, Elizabeth E.; Frick, Ondraya M.; Hartings, Justin M.] USA, Med Res Inst Infect Dis, Ctr Aerobiol Sci, Ft Detrick, MD 21702 USA; [Chapman, Jennifer L.] USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA		Nalca, A (corresponding author), USA, Med Res Inst Infect Dis, Ctr Aerobiol Sci, Ft Detrick, MD 21702 USA.	aysegul.nalca@us.army.mil	Nalca, Aysegul/L-8149-2019	Nalca, Aysegul/0000-0001-8581-7535; Zumbrun, Elizabeth/0000-0002-9897-7201	Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID) [A120-B11]; USAMRIID	Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USAMRIID	This study was supported by an interagency agreement (IAA: A120-B11) between The Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID) and USAMRIID. The sponsors had input in study design and review of the manuscript, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2007, J VIROL, V81, P11084, DOI 10.1128/JVI.00423-07; Bauer KD, 2000, CLIN CANCER RES, V6, P3552; Besch TK, 1996, LAB ANIM SCI, V46, P539; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Garza NL, 2009, VACCINE, V27, P5496, DOI 10.1016/j.vaccine.2009.06.105; HAHON N, 1961, BACTERIOL REV, V25, P459, DOI 10.1128/MMBR.25.4.459-476.1961; HAHON N, 1961, J INFECT DIS, V109, P294, DOI 10.1093/infdis/109.3.294; Handley L, 2009, EXPERT REV VACCINES, V8, P841, DOI 10.1586/ERV.09.55; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson C. L., PLOS ONE, V5, pe8912; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jezek Z., 1988, MONOGRAPHS VIROLOGY; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; KRAMSKI M, PLOS ONE, V5; Marriott KA, 2008, VACCINE, V26, P581, DOI 10.1016/j.vaccine.2007.10.063; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Nigam P, 2007, VIROLOGY, V366, P73, DOI 10.1016/j.virol.2007.04.010; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Prophet E. B., 1992, LAB METHODS HISTOTEC; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Schriewer Jill, 2004, Methods Mol Biol, V269, P289; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; SWEARENGEN JR, 2006, BIODEFENSE RES METHO; Tesh RB, 2004, EMERG INFECT DIS, V10, P1563, DOI 10.3201/eid1009.040310; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	38	42	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12880	10.1371/journal.pone.0012880	http://dx.doi.org/10.1371/journal.pone.0012880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862223	Green Submitted, Green Published, gold			2022-12-25	WOS:000281963200023
J	Hedborg, F; Fischer-Colbrie, R; Ostlin, N; Sandstedt, B; Tran, MGB; Maxwell, PH				Hedborg, Fredrik; Fischer-Colbrie, Reiner; Ostlin, Nurtena; Sandstedt, Bengt; Tran, Maxine G. B.; Maxwell, Patrick H.			Differentiation in Neuroblastoma: Diffusion-Limited Hypoxia Induces Neuro-Endocrine Secretory Protein 55 and Other Markers of a Chromaffin Phenotype	PLOS ONE			English	Article							IGF2 EXPRESSION; GENE-EXPRESSION; ADRENAL-MEDULLA; NERVOUS-SYSTEM; CELLS; HIF-2-ALPHA; HIF-1-ALPHA; NESP55; GROWTH; TUMORS	Background: Neuroblastoma is a childhood malignancy of sympathetic embryonal origin. A high potential for differentiation is a hallmark of neuroblastoma cells. We have previously presented data to suggest that in situ differentiation in tumors frequently proceeds along the chromaffin lineage and that decreased oxygen ( hypoxia) plays a role in this. Here we explore the utility of Neuro-Endocrine Secretory Protein 55 ( NESP55), a novel member of the chromogranin family, as a marker for this process. Methodology/Principal Findings: Immunohistochemical analyses and in situ hybridizations were performed on human fetal tissues, mouse xenografts of human neuroblastoma cell lines, and on specimens of human neuroblastoma/ganglioneuroma. Effects of anaerobic exposure on gene expression by cultured neuroblastoma cells was analyzed with quantitative real-time PCR. Fetal sympathetic nervous system expression of NESP55 was shown to be specific for chromaffin cell types. In experimental and clinical neuroblastoma NESP55 immunoreactivity was specific for regions of chronic hypoxia. NESP55 expression also correlated strikingly with morphological evidence of differentiation and with other chromaffin-specific patterns of gene expression, including IGF2 and HIF2 alpha. Anaerobic culture of five neuroblastoma cell lines resulted in an 18.9-fold mean up-regulation of NESP55. Conclusions/Significance: The data confirms that chronic tumor hypoxia is a key microenvironmental factor for neuroblastoma cell differentiation, causing induction of chromaffin features and NESP55 provides a reliable marker for this neuronal to neuroendocrine transition. The hypoxia-induced phenotype is the predominant form of differentiation in stroma-poor tumors, while in stroma-rich tumors the chromaffin phenotype coexists with ganglion cell-like differentiation. The findings provide new insights into the biological diversity which is a striking feature of this group of tumors.	[Hedborg, Fredrik; Ostlin, Nurtena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hedborg, Fredrik] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fischer-Colbrie, Reiner] Innsbruck Med Univ, Dept Pharmacol, Innsbruck, Austria; [Sandstedt, Bengt] Karolinska Inst, Childhood Canc Res Unit, Stockholm, Sweden; [Tran, Maxine G. B.] Univ Cambridge, Li Ka Shing Ctr, Canc Res Inst, Canc Res UK, Cambridge, England; [Maxwell, Patrick H.] UCL, Div Med, London, England	Uppsala University; Uppsala University; Medical University of Innsbruck; Karolinska Institutet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London	Hedborg, F (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden.	fredrik.hedborg@genpat.uu.se	Tran, Maxine/ABF-4197-2021; Maxwell, Patrick H/C-5557-2008	Maxwell, Patrick H/0000-0002-0338-2679; Tran, Maxine Gia Binh/0000-0002-6034-4433	Lion's Cancer Fund of the Uppsala-Orebro Region; governmental and local funding via the regional health care organisation of Uppsala County; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Lion's Cancer Fund of the Uppsala-Orebro Region; governmental and local funding via the regional health care organisation of Uppsala County; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was supported by grants from Lion's Cancer Fund of the Uppsala-Orebro Region (http://www.lcff.se/), and by governmental and local funding via the regional health care organisation of Uppsala County (http://www.medfarm.uu.se/intranet/ALF/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; BRODEUR GM, 2000, NEUROBLASTOMA; Coupland RE., 1965, NATURAL HIST CHROMAF; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Feldman SA, 2003, ENDOCR PATHOL, V14, P3, DOI 10.1385/EP:14:1:3; Fischer-Colbrie R, 2002, ANN NY ACAD SCI, V971, P317, DOI 10.1111/j.1749-6632.2002.tb04486.x; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Gestblom C, 1997, AM J PATHOL, V150, P107; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HEDBORG F, 1995, AM J PATHOL, V146, P833; HEDBORG F, 1994, AM J PATHOL, V145, P802; Hedborg F, 2003, FASEB J, V17, P598, DOI 10.1096/fj.02-0390com; Hedborg F, 2001, MED PEDIATR ONCOL, V36, P149, DOI 10.1002/1096-911X(20010101)36:1<149::AID-MPO1036>3.0.CO;2-M; HERVONEN A, 1972, ACTA OBSTET GYN SCAN, V51, P17, DOI 10.3109/00016347209154963; Hoehner JC, 1998, LAB INVEST, V78, P29; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jakobsen AM, 2003, BRIT J CANCER, V88, P1746, DOI 10.1038/sj.bjc.6600924; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Li JY, 2002, NEUROSCIENCE, V110, P731, DOI 10.1016/S0306-4522(01)00465-1; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; LUNT SJ, 2008, TUMOR MICROENVIRONME; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Pahlman S, 2000, NEUROBLASTOMA, P9; Pahlman S, 2004, SEMIN CANCER BIOL, V14, P365, DOI 10.1016/j.semcancer.2004.04.016; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Siemann DW, 1998, INT J RADIAT ONCOL, V42, P697, DOI 10.1016/S0360-3016(98)00336-8; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Valentiner U, 2008, TUMOR BIOL, V29, P152, DOI 10.1159/000143401; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Weiss U, 2000, NEUROENDOCRINOLOGY, V71, P177, DOI 10.1159/000054535; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12825	10.1371/journal.pone.0012825	http://dx.doi.org/10.1371/journal.pone.0012825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862257	Green Submitted, Green Published, gold			2022-12-25	WOS:000281960800020
J	Lewis, TB; Glasgow, JN; Glandon, AM; Curiel, DT; Standaert, DG				Lewis, Travis B.; Glasgow, Joel N.; Glandon, Anya M.; Curiel, David T.; Standaert, David G.			Transduction of Brain Dopamine Neurons by Adenoviral Vectors Is Modulated by CAR Expression: Rationale for Tropism Modified Vectors in PD Gene Therapy	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; CHIMERIC FIBER; EXPANDED TROPISM; OPEN-LABEL; RECEPTOR; COXSACKIEVIRUS; CANCER; SAFETY; VIRUS	Background: Gene-based therapy is a new paradigm for the treatment of Parkinson disease (PD) and offers considerable promise for precise targeting and flexibility to impact multiple pathobiological processes for which small molecule agents are not available. Some success has been achieved utilizing adeno-associated virus for this approach, but it is likely that the characteristics of this vector system will ultimately create barriers to progress in clinical therapy. Adenovirus (Ad) vector overcomes limitations in payload size and targeting. The cellular tropism of Ad serotype 5 (Ad5)-based vectors is regulated by the Ad attachment protein binding to its primary cellular receptor, the coxsackie and adenovirus receptor (CAR). Many clinically relevant tissues are refractory to Ad5 infection due to negligible CAR levels but can be targeted by tropism-modified, CAR-independent forms of Ad. Our objective was to evaluate the role of CAR protein in transduction of dopamine (DA) neurons in vivo. Methodology/Principal Findings: Ad5 was delivered to the substantia nigra (SN) in wild type (wt) and CAR transgenic animals. Cellular tropism was assessed by immunohistochemistry (IHC) in the SN and striatal terminals. CAR expression was assessed by western blot and IHC. We found in wt animals, Ad5 results in robust transgene expression in astrocytes and other non-neuronal cells but poor infection of DA neurons. In contrast, in transgenic animals, Ad5 infects SNc neurons resulting in expression of transduced protein in their striatal terminals. Western blot showed low CAR expression in the ventral midbrain of wt animals compared to transgenic animals. Interestingly, hCAR protein localizes with markers of postsynaptic structures, suggesting synapses are the point of entry into dopaminergic neurons in transgenic animals. Conclusions/Significance: These findings demonstrate that CAR deficiency limits infection of wild type DA neurons by Ad5 and provide a rationale for the development of tropism-modified, CAR-independent Ad-vectors for use in gene therapy of human PD.	[Lewis, Travis B.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Glandon, Anya M.; Standaert, David G.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Glasgow, Joel N.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lewis, TB (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	dstandaert@uab.edu		Glasgow, Joel/0000-0002-2842-7917; Standaert, David/0000-0003-2921-8348	American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB); National Institutes of Health (NIH) [F30NS065661, R01CA122930]; NATIONAL CANCER INSTITUTE [R01CA122930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065661] Funding Source: NIH RePORTER	American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to acknowledge support by the American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB) and National Institutes of Health (NIH) grants F30NS065661 and R01CA122930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; *AM SOC GEN THER, 2009, MOL THER S1, V17, pS1; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bjorklund T, 2010, MOVEMENT DISORD, V25, pS161, DOI 10.1002/mds.22785; *CER, 2010, DOUBL BLIND MULT SHA; *CER, 2010, SAF CERE 120 AAV2 NT; *CER, 2010, SAF EFF CERE 120 SUB; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Cripe TP, 2001, CANCER RES, V61, P2953; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; FIELDS BN, 1996, FIELDS VIROLOGY, P1146; *GENZ, 2010, STUD AAV HAADC 2 SUB; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Glasgow JN, 2004, VIROLOGY, V324, P103, DOI 10.1016/j.virol.2004.03.028; GRAYBIEL AM, 1990, ADV NEUROL, V53, P17; Guse K, 2009, GENE THER, V16, P1009, DOI 10.1038/gt.2009.56; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Hotta Y, 2003, DEV BRAIN RES, V143, P1, DOI 10.1016/S0165-3806(03)00035-X; JIMENEZCASTELLANOS J, 1987, NEUROSCIENCE, V23, P223, DOI 10.1016/0306-4522(87)90285-5; Kanerva A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002917; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Lewis TB, 2008, EXP NEUROL, V209, P41, DOI 10.1016/j.expneurol.2007.08.012; Li HJ, 2007, CANCER RES, V67, P5354, DOI 10.1158/0008-5472.CAN-06-4679; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; *NEUR INC, 2010, STUD AAV GAD GEN TRA; *NEUR INC WEILL ME, 2010, SAF STUD SUBTHAL NUC; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; *OXF BIOMEDICA, 2010, PHAS 1 2 STUD SAF EF; Paul CPL, 2008, CANCER BIOL THER, V7, P786, DOI 10.4161/cbt.7.5.5421; Pesonen S, 2010, GENE THER, V17, P892, DOI 10.1038/gt.2010.17; Reynolds PN, 2001, NAT BIOTECHNOL, V19, P838, DOI 10.1038/nbt0901-838; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Stoff-Khalili MA, 2005, GENE THER, V12, P1696, DOI 10.1038/sj.gt.3302588; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tallone T, 2001, P NATL ACAD SCI USA, V98, P7910, DOI 10.1073/pnas.141223398; Tatarewicz SM, 2007, J CLIN IMMUNOL, V27, P620, DOI 10.1007/s10875-007-9117-8; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; *U AL BIRM NAT CAN, 2010, STUD INF ENH SUIC GE; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734	47	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12672	10.1371/journal.pone.0012672	http://dx.doi.org/10.1371/journal.pone.0012672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862245	Green Published, Green Submitted, gold			2022-12-25	WOS:000281960800005
J	Deans, MR; Peterson, JM; Wong, GW				Deans, Michael R.; Peterson, Jonathan M.; Wong, G. William			Mammalian Otolin: A Multimeric Glycoprotein Specific to the Inner Ear that Interacts with Otoconial Matrix Protein Otoconin-90 and Cerebellin-1	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACELLULAR MEMBRANES; STRUCTURAL PROTEIN; HUMAN ADIPONECTIN; SEVERE IMBALANCE; ADIPOSE-TISSUE; MAJOR PROTEIN; MUTANT MICE; FAMILY; GENE	Background: The mammalian otoconial membrane is a dense extracellular matrix containing bio-mineralized otoconia. This structure provides the mechanical stimulus necessary for hair cells of the vestibular maculae to respond to linear accelerations and gravity. In teleosts, Otolin is required for the proper anchoring of otolith crystals to the sensory maculae. Otoconia detachment and subsequent entrapment in the semicircular canals can result in benign paroxysmal positional vertigo (BPPV), a common form of vertigo for which the molecular basis is unknown. Several cDNAs encoding protein components of the mammalian otoconia and otoconial membrane have recently been identified, and mutations in these genes result in abnormal otoconia formation and balance deficits. Principal Findings: Here we describe the cloning and characterization of mammalian Otolin, a protein constituent of otoconia and the otoconial membrane. Otolin is a secreted glycoprotein of,70 kDa, with a C-terminal globular domain that is homologous to the immune complement C1q, and contains extensive posttranslational modifications including hydroxylated prolines and glycosylated lysines. Like all C1q/TNF family members, Otolin multimerizes into higher order oligomeric complexes. The expression of otolin mRNA is restricted to the inner ear, and immunohistochemical analysis identified Otolin protein in support cells of the vestibular maculae and semi-circular canal cristae. Additionally, Otolin forms protein complexes with Cerebellin-1 and Otoconin-90, two protein constituents of the otoconia, when expressed in vitro. Otolin was also found in subsets of support cells and non-sensory cells of the cochlea, suggesting that Otolin is also a component of the tectorial membrane. Conclusion: Given the importance of Otolin in lower organisms, the molecular cloning and biochemical characterization of the mammalian Otolin protein may lead to a better understanding of otoconial development and vestibular dysfunction.	[Deans, Michael R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Deans, Michael R.] Johns Hopkins Univ, Sch Med, Ctr Hearing & Balance, Baltimore, MD USA; [Deans, Michael R.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD USA; [Peterson, Jonathan M.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Deans, MR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506	National Institute on Deafness and Other Communication Disorders (NIDCD) [R03 DC009490]; National Organization for Hearing Research (NOHR); American Heart Association [SDG2260721]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; National Institutes of Health [DK084171]; National Institute of Diabetes and Digestive and Kidney Diseases [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P60DK079637, R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009490] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research (NOHR); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center (DRTC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	MRD is supported by National Institute on Deafness and Other Communication Disorders (NIDCD) R03 DC009490 and a research grant from National Organization for Hearing Research (NOHR). GWW is supported by research grants from the American Heart Association (SDG2260721), the Baltimore Diabetes Research and Training Center (DRTC; P60DK079637), and the National Institutes of Health (DK084171). JMP is supported by a National Research Service Award postdoctoral fellowship (F32DK084607) from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; ANNIKO M, 1988, ACTA OTO-LARYNGOL, V106, P208, DOI 10.3109/00016488809106427; Bao DS, 2006, MOL CELL BIOL, V26, P9327, DOI 10.1128/MCB.01161-06; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; DAVIS JG, 1995, SCIENCE, V267, P1031, DOI 10.1126/science.7863331; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; ERWAY LC, 1986, SCANNING MICROSCOPY, V1986, P1681; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; Jones SM, 1999, HEARING RES, V135, P56, DOI 10.1016/S0378-5955(99)00090-8; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KANG YJ, 2008, J ASS RES OTOLARYNGO; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kiss PJ, 2006, CURR BIOL, V16, P208, DOI 10.1016/j.cub.2005.12.025; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lim D J, 1973, Ann Otol Rhinol Laryngol, V82, P23; Lundberg YXW, 2006, BRAIN RES, V1091, P47, DOI 10.1016/j.brainres.2006.02.083; MELTON LJ, 1996, BONE S3, V18, P121; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Murayama E, 2004, HISTOCHEM CELL BIOL, V121, P155, DOI 10.1007/s00418-003-0605-5; Murayama E, 2002, EUR J BIOCHEM, V269, P688, DOI 10.1046/j.0014-2956.2001.02701.x; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Ornitz DM, 1998, HEARING RES, V122, P60, DOI 10.1016/S0378-5955(98)00080-X; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Petko JA, 2008, DEV NEUROBIOL, V68, P209, DOI 10.1002/dneu.20587; POTE KG, 1993, BIOCHEMISTRY-US, V32, P5017, DOI 10.1021/bi00070a007; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; Rau A, 1999, J COMP NEUROL, V405, P271; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; Salvinelli F, 2004, Clin Ter, V155, P395; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; Simmler MC, 2000, MAMM GENOME, V11, P961, DOI 10.1007/s003350010197; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Squires TM, 2004, J BIOMECH, V37, P1137, DOI 10.1016/j.jbiomech.2003.12.014; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thalmann I, 2001, DIS MARKERS, V17, P259, DOI 10.1155/2001/476738; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Tohse H, 2008, FEBS J, V275, P2512, DOI 10.1111/j.1742-4658.2008.06400.x; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Trune DR, 1983, J NEUROGENET, V1, P53, DOI 10.3109/01677068309107072; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhao X, 2008, NEUROSCIENCE, V153, P289, DOI 10.1016/j.neuroscience.2008.01.055; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	68	71	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12765	10.1371/journal.pone.0012765	http://dx.doi.org/10.1371/journal.pone.0012765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856818	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800027
J	Bailey, AL; Brewer, MS; Hendrixson, BE; Bond, JE				Bailey, Ashley L.; Brewer, Michael S.; Hendrixson, Brent E.; Bond, Jason E.			Phylogeny and Classification of the Trapdoor Spider Genus Myrmekiaphila: An Integrative Approach to Evaluating Taxonomic Hypotheses	PLOS ONE			English	Article							SPECIES DELIMITATION; CRYPTIC SPECIATION; MOLECULAR TAXONOMY; MITOCHONDRIAL-DNA; MALE GENITALIA; ARANEAE; MYGALOMORPHAE; POPULATION; COMPLEX; CYRTAUCHENIIDAE	Background: Revised by Bond and Platnick in 2007, the trapdoor spider genus Myrmekiaphila comprises 11 species. Species delimitation and placement within one of three species groups was based on modifications of the male copulatory device. Because a phylogeny of the group was not available these species groups might not represent monophyletic lineages; species definitions likewise were untested hypotheses. The purpose of this study is to reconstruct the phylogeny of Myrmekiaphila species using molecular data to formally test the delimitation of species and species-groups. We seek to refine a set of established systematic hypotheses by integrating across molecular and morphological data sets. Methods and Findings: Phylogenetic analyses comprising Bayesian searches were conducted for a mtDNA matrix composed of contiguous 12S rRNA, tRNA-val, and 16S rRNA genes and a nuclear DNA matrix comprising the glutamyl and prolyl tRNA synthetase gene each consisting of 1348 and 481 bp, respectively. Separate analyses of the mitochondrial and nuclear genome data and a concatenated data set yield M. torreya and M. millerae paraphyletic with respect to M. coreyi and M. howelli and polyphyletic fluviatilis and foliata species groups. Conclusions: Despite the perception that molecular data present a solution to a crisis in taxonomy, studies like this demonstrate the efficacy of an approach that considers data from multiple sources. A DNA barcoding approach during the species discovery process would fail to recognize at least two species M. coreyi and M. howelli) whereas a combined approach more accurately assesses species diversity and illuminates speciation pattern and process. Concomitantly these data also demonstrate that morphological characters likewise fail in their ability to recover monophyletic species groups and result in an unnatural classification. Optimizations of these characters demonstrate a pattern of "Dollo evolution'' wherein a complex character evolves only once but is lost multiple times throughout the group's history.	[Bailey, Ashley L.; Brewer, Michael S.; Bond, Jason E.] E Carolina Univ, N Carolina Ctr Biodivers, Greenville, NC 27858 USA; [Bailey, Ashley L.; Brewer, Michael S.; Bond, Jason E.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Hendrixson, Brent E.] Millsaps Coll, Dept Biol, Jackson, MS 39210 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Millsaps College	Bailey, AL (corresponding author), E Carolina Univ, N Carolina Ctr Biodivers, Greenville, NC 27858 USA.	bondja@ecu.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 0315160]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (http://www.nsf.gov) grant DEB 0315160 to J. Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; Albert EM, 2009, ZOOTAXA, P56, DOI 10.11646/zootaxa.2234.1.4; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Atkinson GF, 1886, ENTOMOLOGICA AM, V2, P109, DOI DOI 10.1371/JOURNAL.PONE.0012744; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bond JE, 2006, MOL PHYLOGENET EVOL, V41, P70, DOI 10.1016/j.ympev.2006.04.026; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, EVOLUTION, V56, P1123; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2004, INVERTEBR SYST, V18, P361, DOI 10.1071/IS04008; Bond JE, 2003, INVERTEBR SYST, V17, P711, DOI 10.1071/IS03026; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; BOND JE, 2007, TAXONOMIC REV TRAPDO, P1; BUTLIN RK, 1987, AM NAT, V130, P461, DOI 10.1086/284723; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Drummond A. J., 2009, TRACER MCMC TRACE AN; EBERHARD WG, 1987, NAT HIST, V96, P4; Eberhard WG, 1985, SEXUAL SELECTION ANI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Huang DW, 2009, MOL PHYLOGENET EVOL, V50, P102, DOI 10.1016/j.ympev.2008.10.012; Huber B.A., 2004, BIOSEMIOTIK PRAKTISC, V5, P89; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Kameda Y, 2009, AM NAT, V173, P689, DOI 10.1086/597607; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Korf RP, 2005, MYCOTAXON, V93, P407; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lou M, 2007, MOL ECOL NOTES, V7, P908, DOI 10.1111/j.1471-8286.2007.01904.x; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2009, MESQUITE MODULAR SYS; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Metzger GA, 2010, MOL PHYLOGENET EVOL, V54, P405, DOI 10.1016/j.ympev.2009.07.027; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; ROBINSON EA, 2009, PROSPECTS USING DNA, P27; Rodman JE, 2003, SYST BIOL, V52, P428, DOI 10.1080/10635150390197055; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song HJ, 2010, CLADISTICS, V26, P23, DOI 10.1111/j.1096-0031.2009.00273.x; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stockman AK, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1823.1.2; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tan DSH, 2010, ZOOL SCR, V39, P51, DOI 10.1111/j.1463-6409.2009.00408.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Tanabe T, 2008, AM NAT, V171, P692, DOI 10.1086/587075; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	74	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12744	10.1371/journal.pone.0012744	http://dx.doi.org/10.1371/journal.pone.0012744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856873	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815700024
J	Piekarski, DJ; Place, NJ; Zucker, I				Piekarski, David J.; Place, Ned J.; Zucker, Irving			Facilitation of Male Sexual Behavior in Syrian Hamsters by the Combined Action of Dihydrotestosterone and Testosterone	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; ANDROGEN-RECEPTOR; HORMONAL-REGULATION; BRAIN; RAT; 5-ALPHA-DIHYDROTESTOSTERONE; METABOLITES; EXPRESSION; INDUCTION; ESTRADIOL	Background: Testosterone (T) controls male Syrian hamster sexual behavior, however, neither of T's primary metabolites, dihydrotestosterone (DHT) and estradiol (E-2), even in highly supraphysiological doses, fully restores sexual behavior in castrated hamsters. DHT and T apparently interact with androgen receptors differentially to control male sexual behavior (MSB), but whether these two hormones act synergistically or antagonistically to control MSB has received scant experimental attention and is addressed in the present study. Methodology/Principal Findings: Sexually experienced male Syrian hamsters were gonadectomized and monitored 5 weeks later to confirm elimination of the ejaculatory reflex (week 0), at which time they received subcutaneous DHT-filled or empty capsules that remained in situ for the duration of the experiment. Daily injections of a physiological dose of 25 mu g T or vehicle commenced two weeks after capsule implantation. MSB was tested 2, 4 and 5 weeks after T treatment began. DHT capsules were no more effective than control treatment for long-term restoration of ejaculation. Combined DHT + T treatment, however, restored the ejaculatory reflex more effectively than T alone, as evidenced by more rapid recovery of ejaculatory behavior, shorter ejaculation latencies, and a greater number of ejaculations in 30 minute tests. Conclusions/Significance: DHT and T administered together restored sexual behavior to pre-castration levels more rapidly than did T alone, whereas DHT and vehicle were largely ineffective. The additive actions of DHT and T on MSB are discussed in relation to different effects of these androgens on androgen receptors in the male hamster brain mating circuit.	[Piekarski, David J.; Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Place, Ned J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University	Piekarski, DJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	piekarski@berkeley.edu		Piekarski, David/0000-0002-6055-2849	National Institute of Child Health and Human Development [HD 043098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043098] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant HD 043098 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga-Silva M, 2008, PHYSIOL BEHAV, V94, P412, DOI 10.1016/j.physbeh.2008.02.007; Arteaga-Silva M, 2005, PHYSIOL BEHAV, V85, P571, DOI 10.1016/j.physbeh.2005.06.004; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Ball GF, 2006, HORM BEHAV, V49, P1, DOI 10.1016/j.yhbeh.2005.07.008; Baum MJ, 2003, SCAND J PSYCHOL, V44, P213, DOI 10.1111/1467-9450.00338; BURGESS LH, 1993, MOL BRAIN RES, V19, P31, DOI 10.1016/0169-328X(93)90145-F; Cooper TT, 2000, HORM BEHAV, V37, P237, DOI 10.1006/hbeh.2000.1579; Crescioli C, 2004, EUR J ENDOCRINOL, V150, P591, DOI 10.1530/eje.0.1500591; DOHERTY PC, 1981, BRAIN RES, V219, P327, DOI 10.1016/0006-8993(81)90295-X; DOMINGUEZ P, 1994, MOL CELL ENDOCRINOL, V106, P81, DOI 10.1016/0303-7207(94)90189-9; Faruzzi AN, 2005, HORM BEHAV, V47, P569, DOI 10.1016/j.yhbeh.2004.11.023; Gutzler SJ, 2009, HORM BEHAV, V56, P481, DOI 10.1016/j.yhbeh.2009.08.007; Handa RJ, 1996, MOL BRAIN RES, V39, P57, DOI 10.1016/0169-328X(95)00353-T; Hsiao PW, 2000, MOL CELL BIOCHEM, V206, P169, DOI 10.1023/A:1007024726889; Hull E. M., 2002, HORMONES BRAIN BEHAV; Larsson K., 1979, Endocrine control of sexual behavior., P77; Lu SF, 1999, J NEUROBIOL, V41, P505, DOI 10.1002/(SICI)1097-4695(199912)41:4<505::AID-NEU6>3.0.CO;2-N; LUTTGE WG, 1973, HORM BEHAV, V4, P31, DOI 10.1016/0018-506X(73)90014-7; Lynch CS, 2000, PHYSIOL BEHAV, V69, P445, DOI 10.1016/S0031-9384(99)00257-7; MCGINNIS MY, 1989, ENDOCRINOLOGY, V124, P618, DOI 10.1210/endo-124-2-618; Meek LR, 1997, HORM BEHAV, V31, P75, DOI 10.1006/hbeh.1997.1371; MORALI G, 1994, BIOL REPROD, V51, P562, DOI 10.1095/biolreprod51.3.562; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Park JH, 2007, HORM BEHAV, V52, P169, DOI 10.1016/j.yhbeh.2007.03.008; Piekarski DJ, 2009, HORM BEHAV, V55, P182, DOI 10.1016/j.yhbeh.2008.10.003; Pieper DR, 2000, P SOC EXP BIOL MED, V224, P278, DOI 10.1046/j.1525-1373.2000.22432.x; POWERS JB, 1985, PHYSIOL BEHAV, V35, P607, DOI 10.1016/0031-9384(85)90149-0; Putnam SK, 2005, HORM BEHAV, V47, P513, DOI 10.1016/j.yhbeh.2005.01.007; Putnam SK, 2003, HORM BEHAV, V44, P419, DOI 10.1016/j.yhbeh.2003.06.006; ROSELLI CE, 1987, BIOL REPROD, V37, P628, DOI 10.1095/biolreprod37.3.628; Sachs B.D., 1988, P1393; SCHLEICHER G, 1989, J STEROID BIOCHEM, V33, P581, DOI 10.1016/0022-4731(89)90044-7; SHERIDAN PJ, 1991, MOL CELL ENDOCRINOL, V76, pC39, DOI 10.1016/0303-7207(91)90279-2; SHOLL SA, 1981, PSYCHONEUROENDOCRINO, V6, P105, DOI 10.1016/0306-4530(81)90002-0; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; WOOD RI, 1992, BRAIN RES, V596, P89, DOI 10.1016/0006-8993(92)91536-N; Wood RI, 1997, HORM BEHAV, V32, P40, DOI 10.1006/hbeh.1997.1403; YOUNG WC, 1961, SEX INTERNAL SECRETI, V2, P1173; ZAKAR T, 1980, J STEROID BIOCHEM, V13, P743, DOI 10.1016/0022-4731(80)90226-5; [No title captured]	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12749	10.1371/journal.pone.0012749	http://dx.doi.org/10.1371/journal.pone.0012749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856876	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815700025
J	Simba, DO; Warsame, M; Kakoko, D; Mrango, Z; Tomson, G; Premji, Z; Petzold, M				Simba, Daudi O.; Warsame, Marian; Kakoko, Deodatus; Mrango, Zakayo; Tomson, Goran; Premji, Zul; Petzold, Max			Who Gets Prompt Access to Artemisinin-Based Combination Therapy? A Prospective Community-Based Study in Children from Rural Kilosa, Tanzania	PLOS ONE			English	Article							FEBRILE CHILDREN; DRUG POLICY; MALARIA; MANAGEMENT; DETERMINANTS; SERVICES; SEEKING; DELAY	Background: Effective and timely case management remains one of the fundamental pillars for control of malaria. Tanzania introduced artemisinin-combination therapy [ACT] for uncomplicated malaria; however, the policy change is challenged by limited availability of ACTs due to high cost. This study aimed to determine factors influencing prompt access to ACTs among febrile children in rural Kilosa, Tanzania. Methods and Findings: In a community-based study, 1,235 randomly selected children under five were followed up weekly for six months, in 2008. Using a structured questionnaire, children's caretakers were asked about the child's febrile history in the last seven days, and treatment actions including timing, medicines used and source of care. Caretakers' knowledge about malaria and socioeconomic and demographic data were also obtained. About half of followed-up children had at least one episode of fever. Less than half (44.8%) of febrile children were taken to government facilities. Almost one-third (37.6%; 95% CI 33.1-42.1) of febrile children had prompt access to ACT. Care-seeking from a government facility was the overriding factor, increasing the likelihood of prompt access to an ACT 18 times (OR 17.7; 95% CI 10.55-29.54; adjusted OR 16.9; 95% CI 10.06-28.28). Caretakers from the better-off household (3rd-5th quintiles) were more likely to seek care from government facilities (OR 3.66; 95% CI 2.56-5.24; adjusted OR 1.80; 95% CI 1.18-2.76). The majority of antimalarials accessed by the poor were ineffective [86.0%; 295/343], however, they paid more for them (median Tsh 500) compared to the better-offs (median Tsh 0). Conclusions: Prompt access to ACT among febrile children was unacceptably low, due mainly to limited availability of subsidised ACT at the location where most caretakers sought care. There is urgent need to accelerate implementation of strategies that will ensure availability of ACT at an affordable price in remote rural areas, where the burden of malaria is	[Simba, Daudi O.] Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; [Simba, Daudi O.; Warsame, Marian; Tomson, Goran; Petzold, Max] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth IHCAR, Stockholm, Sweden; [Kakoko, Deodatus] Muhimbili Univ Hlth & Allied Sci, Dept Behav Sci, Dar Es Salaam, Tanzania; [Tomson, Goran] Karolinska Inst, Med Management Ctr, Stockholm, Sweden; [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dept Parasitol & Med Entomol, Dar Es Salaam, Tanzania; [Petzold, Max] Nord Sch Publ Hlth, Gothenburg, Sweden	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences	Simba, DO (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania.	dsimba@muhas.ac.tz		Tomson, Goran/0000-0001-9222-3604	Sida/SAREC Tanzania; Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project	Sida/SAREC Tanzania; Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project	This study was funded by the Sida/SAREC Tanzania and Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project [URL link http://www.sida.se.]. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; CHUMA J, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1243; DODOO A, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1182; Eriksen J, 2005, TROP MED INT HEALTH, V10, P1038, DOI 10.1111/j.1365-3156.2005.01486.x; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; GOODMAN C, 2007, HLTH POLICY PLANNING, V1, DOI DOI 10.1093/HEAPOL/CZM1033; Hart J.T., 1971, LANCET; HETZEL M, 2008, BMC PUBLIC HEALTH, V8, DOI DOI 10.1186/1471-2458-1188-1317; Hetzel MW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-7; Kalter HD, 2003, ACTA PAEDIATR, V92, P103; Malenga G, 2005, BMJ-BRIT MED J, V331, P706, DOI 10.1136/bmj.331.7519.706; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; Munguti KJ, 1998, E AFR MED J, V75, P687; *NBS TANZ MACR, 2005, TANZ DEM HLTH SURV 2; NJAU J, 2006, TROP MED INT HEALTH, V11, DOI DOI 10.1111/J.1365-3156..01569.X; Njogu J, 2008, East Afr Med J, V85, P213; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; *RBM PARTN, 2008, GLOB MAL ACT PLAN; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Sabot O, 2009, DISTRIBUTION ARTEMIS; TIPKE M, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1266; *WHO, 2009, WORLD MAL REP; Williams HA, 2004, HEALTH POLICY PLANN, V19, P356, DOI 10.1093/heapol/czh051; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; ZUROVAC D, 2005, BRIT MED J	29	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12104	10.1371/journal.pone.0012104	http://dx.doi.org/10.1371/journal.pone.0012104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856897	gold, Green Published			2022-12-25	WOS:000280811900037
J	Lee, W; Zeng, XC; Zhou, HX; Bennett, V; Yang, WT; Marszalek, PE				Lee, Whasil; Zeng, Xiancheng; Zhou, Huan-Xiang; Bennett, Vann; Yang, Weitao; Marszalek, Piotr E.			Full Reconstruction of a Vectorial Protein Folding Pathway by Atomic Force Microscopy and Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-REPEAT PROTEIN; TITIN IMMUNOGLOBULIN DOMAINS; SINGLE-MOLECULE; ENERGY LANDSCAPE; MECHANICAL-PROPERTIES; TRANSITION-STATE; UNFOLDING PATHWAYS; POLYPEPTIDE-CHAINS; IN-VITRO; TRANSLOCATION	During co-translational folding, the nascent polypeptide chain is extruded sequentially from the ribosome exit tunnel and, under severe conformational constraints, is dictated by its one-dimensional geometry. How do such vectorial constraints impact the folding pathway? Here, we combine single-molecule atomic force spectroscopy and steered molecular dynamics simulations to examine protein folding in the presence of one-dimensional constraints that are similar to those imposed on the nascent polypeptide chain. The simulations exquisitely reproduced the experimental unfolding and refolding force extension relationships and led to the full reconstruction of the vectorial folding pathway of a large polypeptide, the 253-residue consensus ankyrin repeat protein, NI6C. We show that fully stretched and then relaxed NI6C starts folding by the formation of local secondary structures, followed by the nucleation of three N-terminal repeats. This rate-limiting step is then followed by the vectorial and sequential folding of the remaining repeats. However, after partial unfolding, when allowed to refold, the C-terminal repeats successively regain structures without any nucleation step by using the intact N-terminal repeats as a template. These results suggest a pathway for the co-translational folding of repeat proteins and have implications for mechanotransduction.	[Yang, Weitao] Duke Univ, Dept Chem, French Family Sci Ctr 5310, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Ctr Biologically Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Bennett, Vann] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA; [Bennett, Vann] Duke Univ, Dept Cell Biol, Durham, NC 27708 USA; [Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Duke University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Yang, WT (corresponding author), Duke Univ, Dept Chem, French Family Sci Ctr 5310, Durham, NC 27708 USA.	weitao.yang@duke.edu; pemar@duke.edu	Zhou, Huan-Xiang/M-5170-2016; Yang, Weitao/C-1109-2008; zhou, huan/GYJ-4398-2022	Zhou, Huan-Xiang/0000-0001-9020-0302; Yang, Weitao/0000-0001-5576-2828; 	National Institutes of Health [GM079663, GM058187]; National Science Foundation [MCB-0717770]; Duke University Center of Theoretical and Mathematical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058187, R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Duke University Center of Theoretical and Mathematical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079663 (to P.E.M. and V.B.) and GM058187 (to H.-X.Z.). This work was also supported by National Science Foundation Grant MCB-0717770 (to P.E.M. and W.Y.) and a Duke University Center of Theoretical and Mathematical Sciences graduate fellowship (to X.Z.).	Ammenti A, 2009, J PHYS CHEM B, V113, P10348, DOI 10.1021/jp900947f; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Berezhkovskii A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139063; Berkovich R, 2010, BIOPHYS J, V98, P2692, DOI 10.1016/j.bpj.2010.02.053; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dougan L, 2008, P NATL ACAD SCI USA, V105, P3185, DOI 10.1073/pnas.0706075105; Dougan L, 2008, CHEMPHYSCHEM, V9, P2836, DOI 10.1002/cphc.200800572; Du DG, 2006, BIOCHEMISTRY-US, V45, P13131, DOI 10.1021/bi0615745; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Ferreiro DU, 2008, P NATL ACAD SCI USA, V105, P9853, DOI 10.1073/pnas.0805287105; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10540, DOI 10.1073/pnas.0902090106; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Huang F, 2009, P NATL ACAD SCI USA, V106, P16239, DOI 10.1073/pnas.0909126106; Hyeon C, 2006, STRUCTURE, V14, P1633, DOI 10.1016/j.str.2006.09.002; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kirmizialtin S, 2004, J CHEM PHYS, V121, P10268, DOI 10.1063/1.1807832; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li LW, 2006, BIOPHYS J, V90, pL30, DOI 10.1529/biophysj.105.078436; Li MS, 2006, P NATL ACAD SCI USA, V103, P93, DOI 10.1073/pnas.0503758103; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Makarov DE, 2009, ACCOUNTS CHEM RES, V42, P281, DOI 10.1021/ar800128x; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Mukherjee S, 2008, J PHYS CHEM B, V112, P9146, DOI 10.1021/jp801721p; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Schaeffer RD, 2008, CURR OPIN STRUC BIOL, V18, P4, DOI 10.1016/j.sbi.2007.11.007; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Serquera D, 2010, BIOPHYS J, V98, P1294, DOI 10.1016/j.bpj.2009.12.4287; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Sharma D, 2007, P NATL ACAD SCI USA, V104, P9278, DOI 10.1073/pnas.0700351104; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Tian P, 2005, J MOL BIOL, V350, P1017, DOI 10.1016/j.jmb.2005.05.035; Tinoco I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025006; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Walther KA, 2007, P NATL ACAD SCI USA, V104, P7916, DOI 10.1073/pnas.0702179104; Wang Y, 2007, BIOCHEMISTRY-US, V46, P10767, DOI 10.1021/bi700657d; Weikl TR, 2004, PROTEIN SCI, V13, P822, DOI 10.1110/ps.03403604; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Werbeck ND, 2008, P NATL ACAD SCI USA, V105, P9982, DOI 10.1073/pnas.0705300105; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104; West DK, 2006, BIOPHYS J, V91, pL51, DOI 10.1529/biophysj.106.089490; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100	90	32	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38167	38172		10.1074/jbc.M110.179697	http://dx.doi.org/10.1074/jbc.M110.179697			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870713	Green Published, hybrid			2022-12-25	WOS:000284625600024
J	Schuckmann, MM; Marchand, B; Hachiya, A; Kodama, EN; Kirby, KA; Singh, K; Sarafianos, SG				Schuckmann, Matthew M.; Marchand, Bruno; Hachiya, Atsuko; Kodama, Eiichi N.; Kirby, Karen A.; Singh, Kamalendra; Sarafianos, Stefan G.			The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT PRIMER UNBLOCKING; RNASE-H CLEAVAGE; NONNUCLEOSIDE INHIBITORS; DRUG-RESISTANCE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; TEMPLATE-PRIMER; 3'-AZIDO-3'-DEOXYTHYMIDINE RESISTANCE; CONFORMATIONAL-CHANGES	The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase (RT) confers clinically significant resistance to both nucleoside and non-nucleoside RT inhibitors (NNRTIs) by mechanisms that are not well understood. We used transient kinetics to characterize the enzymatic properties of N348I RT and determine the biochemical mechanism of resistance to the NNRTI nevirapine (NVP). We demonstrate that changes distant from the NNRTI binding pocket decrease inhibitor binding (increase Kd-NVP) by primarily decreasing the association rate of the inhibitor (k(on-NVP)). We characterized RTs mutated in either p66 (p66(N348I)/p51(WT)), p51 (p66(WT)/p51(N348I)), or both subunits (p66(N348I)/p51(N348I)). Mutation in either subunit caused NVP resistance during RNA-dependent and DNA-dependent DNA polymerization. Mutation in p66 alone (p66(N348I)/p51(WT)) caused NVP resistance without significantly affecting RNase H activity, whereas mutation in p51 caused NVP resistance and impaired RNase H, demonstrating that NVP resistance may occur independently from defects in RNase H function. Mutation in either subunit improved affinity for nucleic acid and enhanced processivity of DNA synthesis. Surprisingly, mutation in either subunit decreased catalytic rates (k(pol)) of p66(N348I)/p51(N348I), p66(N348I)/p51(WT), and p66(WT)/p51(N348I) without significantly affecting affinity for deoxynucleotide substrate (Kd-dNTP). Hence, in addition to providing structural integrity for the heterodimer, p51 is critical for fine tuning catalytic turnover, RNase H processing, and drug resistance. In conclusion, connection subdomain mutation N348I decreases catalytic efficiency and causes in vitro resistance to NVP by decreasing inhibitor binding.	[Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Hachiya, Atsuko] Natl Ctr Global Hlth & Med Int Med Ctr Japan, AIDS Clin Ctr, Shinjyuku Ku, Tokyo 1628655, Japan; [Kodama, Eiichi N.] Tohoku Univ, Div Emerging Infect Dis, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Missouri System; University of Missouri Columbia; Tohoku University	Sarafianos, SG (corresponding author), Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, 401 Bond Life Sci Ctr,1201 E Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X	National Institutes of Health [AI076119, AI074389, AI079801]; Korea Food and Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119 and AI074389 (to S. G. S.) and AI079801. This work was also supported by a grant from the Korea Food and Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea.; Recipient of the American Foundation for AIDS Research Mathilde Krim Fellowship.	Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; BOYER PL, 1994, ANTIMICROB AGENTS CH, V38, P1909, DOI 10.1128/AAC.38.9.1909; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Ghosh M, 1997, BIOCHEMISTRY-US, V36, P5758, DOI 10.1021/bi963045e; Ghosh M, 1996, BIOCHEMISTRY-US, V35, P8553, DOI 10.1021/bi952773j; Girouard M, 2003, J BIOL CHEM, V278, P34403, DOI 10.1074/jbc.M303528200; Gotte M, 2010, BBA-PROTEINS PROTEOM, V1804, P1202, DOI 10.1016/j.bbapap.2009.07.020; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACQUES PS, 1994, J BIOL CHEM, V269, P26472; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; MartinHernandez AM, 1996, EMBO J, V15, P4434, DOI 10.1002/j.1460-2075.1996.tb00816.x; Menendez MA, 2001, ENFERM INFEC MICR CL, V19, P287; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Parniak M A, 2000, Adv Pharmacol, V49, P67; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Powell MD, 1997, J BIOL CHEM, V272, P13262, DOI 10.1074/jbc.272.20.13262; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Ren J, 2004, J MOL BIOL, V336, P569, DOI 10.1016/j.jmb.2003.12.055; Ren J, 2001, J MOL BIOL, V312, P795, DOI 10.1006/jmbi.2001.4988; Ren JS, 2007, J MED CHEM, V50, P2301, DOI 10.1021/jm061117m; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2010, AIDS, V24, P317, DOI 10.1097/QAD.0b013e3283315697; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wisniewski M, 1999, J BIOL CHEM, V274, P28175, DOI 10.1074/jbc.274.40.28175; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	61	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38700	38709		10.1074/jbc.M110.153783	http://dx.doi.org/10.1074/jbc.M110.153783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876531	hybrid, Green Published			2022-12-25	WOS:000284625600075
J	Valnickova, Z; Sanglas, L; Arolas, JL; Petersen, SV; Schar, C; Otzen, D; Aviles, FX; Gomis-Ruth, FX; Enghild, JJ				Valnickova, Zuzana; Sanglas, Laura; Arolas, Joan L.; Petersen, Steen V.; Schar, Christine; Otzen, Daniel; Aviles, Francesc X.; Gomis-Rueth, F. Xavier; Enghild, Jan J.			Flexibility of the Thrombin-activatable Fibrinolysis Inhibitor Pro-domain Enables Productive Binding of Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; INTRINSIC ENZYMATIC-ACTIVITY; ACTIVABLE FIBRINOLYSIS; CARBOXYPEPTIDASE-B; 3-DIMENSIONAL STRUCTURE; MEDIATED ACTIVATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; U TAFI; MECHANISM	We have previously reported that thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits intrinsic proteolytic activity toward large peptides. The structural basis for this observation was clarified by the crystal structures of human and bovine TAFI. These structures evinced a significant rotation of the pro-domain away from the catalytic moiety when compared with other pro-carboxypeptidases, thus enabling access of large peptide substrates to the active site cleft. Here, we further investigated the flexible nature of the pro-domain and demonstrated that TAFI forms productive complexes with protein carboxypeptidase inhibitors from potato, leech, and tick (PCI, LCI, and TCI, respectively). We determined the crystal structure of the bovine TAFI-TCI complex, revealing that the pro-domain was completely displaced from the position observed in the TAFI structure. It protruded into the bulk solvent and was disordered, whereas TCI occupied the position previously held by the pro-domain. The authentic nature of the presently studied TAFI-inhibitor complexes was supported by the trimming of the C-terminal residues from the three inhibitors upon complex formation. This finding suggests that the inhibitors interact with the active site of TAFI in a substrate-like manner. Taken together, these data show for the first time that TAFI is able to form a bona fide complex with protein carboxypeptidase inhibitors. This underlines the unusually flexible nature of the pro-domain and implies a possible mechanism for regulation of TAFI intrinsic proteolytic activity in vivo.	[Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanglas, Laura; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Bellaterra, Spain; [Sanglas, Laura; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Bellaterra, Spain; [Arolas, Joan L.; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Spain; [Petersen, Steen V.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jje@mb.au.dk	Avilés, Francesc Xavier/A-2664-2015; Aviles, Francesc Xavier/F-3482-2019	Avilés, Francesc Xavier/0000-0002-1399-6789; Aviles, Francesc Xavier/0000-0002-1399-6789; Otzen, Daniel/0000-0002-2918-8989; Lopez Arolas, Joan/0000-0002-4198-5016; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Vang Petersen, Steen/0000-0002-9338-911X; Enghild, Jan Johannes/0000-0001-9292-9172	Danish Natural Science Research Council; Spanish agency [BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, CSD2006-00015]; Catalan agency [BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, CSD2006-00015]; European Union [FP7-HEALTH-F3-2009-223101, FP7-HEALTH-2010-261460]	Danish Natural Science Research Council(Danish Natural Science Research Council); Spanish agency; Catalan agency; European Union(European Commission)	This work was supported by grants from the Danish Natural Science Research Council and by Grants BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, and the CONSOLIDER-INGENIO 2010 Project "La Factor a de Cristalizacion" (CSD2006-00015) from Spanish and Catalan agencies, as well as FP7-HEALTH-F3-2009-223101 "AntiPathoGN" and FP7-HEALTH-2010-261460 "Gums&Joints" from the European Union.	Anand K, 2008, J BIOL CHEM, V283, P29416, DOI 10.1074/jbc.M804003200; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bedaiwy MA, 2006, OBSTET GYNECOL, V108, P162, DOI 10.1097/01.AOG.0000220517.53892.0a; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Buelens K, 2008, CIRC RES, V102, P295, DOI 10.1161/CIRCRESAHA.107.157099; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Carranza C., 1999, 9039 CNRSUPR, P89; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; COLL M, 1991, EMBO J, V10, P1; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; EATON DL, 1991, J BIOL CHEM, V266, P21833; Foley JH, 2008, J BIOL CHEM, V283, P8863, DOI 10.1074/jbc.M800127200; Fujimoto H, 2006, AM J PATHOL, V168, P1086, DOI 10.2353/ajpath.2006.050610; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; HENDRIKS D, 1990, BIOCHIM BIOPHYS ACTA, V1034, P86, DOI 10.1016/0304-4165(90)90157-R; HENDRIKS D, 1989, CLIN CHEM, V35, P177; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; LACKO AG, 1970, BIOCHEMISTRY-US, V9, P4680; Leung LLK, 2008, MOL IMMUNOL, V45, P4080, DOI 10.1016/j.molimm.2008.07.010; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Marx PF, 2002, BIOCHEMISTRY-US, V41, P6688, DOI 10.1021/bi015982e; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Redlitz A, 1996, CIRCULATION, V93, P1328, DOI 10.1161/01.CIR.93.7.1328; REECK GR, 1972, BIOCHEMISTRY-US, V11, P3947, DOI 10.1021/bi00771a018; Renckens R, 2005, J IMMUNOL, V175, P6764, DOI 10.4049/jimmunol.175.10.6764; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; Sanglas L, 2010, J THROMB HAEMOST, V8, P1056, DOI 10.1111/j.1538-7836.2010.03740.x; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Valnickova Z, 1996, J BIOL CHEM, V271, P12937, DOI 10.1074/jbc.271.22.12937; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; Valnickova Z, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-13; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x; Villanueva J, 1998, FEBS LETT, V440, P175, DOI 10.1016/S0014-5793(98)01447-1; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; Willemse JL, 2007, J THROMB HAEMOST, V5, P1334, DOI 10.1111/j.1538-7836.2007.02539.x; Willemse JL, 2006, ANAL BIOCHEM, V356, P157, DOI 10.1016/j.ab.2006.05.020; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	70	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38243	38250		10.1074/jbc.M110.150342	http://dx.doi.org/10.1074/jbc.M110.150342			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880845	Green Published, hybrid			2022-12-25	WOS:000284625600032
J	Ahn, J; Vu, T; Novince, Z; Guerrero-Santoro, J; Rapic-Otrin, V; Gronenborn, AM				Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Guerrero-Santoro, Jennifer; Rapic-Otrin, Vesna; Gronenborn, Angela M.			HIV-1 Vpr Loads Uracil DNA Glycosylase-2 onto DCAF1, a Substrate Recognition Subunit of a Cullin 4A-RING E3 Ubiquitin Ligase for Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-CYCLE ARREST; VIRAL-PROTEIN-R; TYPE-1 VPR; G(2) ARREST; BINDING-PROTEIN; V-PROTEIN; RECRUITING DCAF1/VPRBP; PREINTEGRATION COMPLEX; PRIMATE LENTIVIRUSES	The human immunodeficiency virus type 1 (HIV-1) accessory protein, Vpr, interacts with several host cellular proteins including uracil DNA glycosylase-2 (UNG2) and a cullin-RING E3 ubiquitin ligase assembly (CRL4(DCAF1)). The ligase is composed of cullin 4A (CUL4A), RING H2 finger protein (RBX1), DNA damage-binding protein 1 (DDB1), and a substrate recognition subunit, DDB1- and CUL4-associated factor 1 (DCAF1). Here we show that recombinant UNG2 specifically interacts with Vpr, but not with Vpx of simian immunodeficiency virus, forming a heterotrimeric complex with DCAF1 and Vpr in vitro as well as in vivo. Using reconstituted CRL4(DCAF1) and CRL4(DCAF1-Vpr) E3 ubiquitin ligases in vitro reveals that UNG2 ubiquitination (ubiquitylation) is facilitated by Vpr. Co-expression of DCAF1 and Vpr causes down-regulation of UNG2 in a proteasome-dependent manner, with Vpr mutants that are defective in UNG2 or DCAF1 binding abrogating this effect. Taken together, our results show that the CRL4(DCAF1) E3 ubiquitin ligase can be subverted by Vpr to target UNG2 for degradation.	[Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Guerrero-Santoro, Jennifer; Rapic-Otrin, Vesna] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; Inst Canc Res, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), 3501 5th Ave, Pittsburgh, PA 15260 USA.	jia12@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health through the NIGMS [P50GM082251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251 (to A.M.G.) through the NIGMS.	Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fenard D, 2009, NUCLEIC ACIDS RES, V37, P6008, DOI 10.1093/nar/gkp673; Goh WC, 2004, VIROLOGY, V318, P337, DOI 10.1016/j.virol.2003.10.007; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kamata M, 2008, J VIROL, V82, P5672, DOI 10.1128/JVI.01330-07; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Mansky LM, 2003, J VIROL, V77, P2071, DOI 10.1128/JVI.77.3.2071-2080.2003; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Stewart SA, 2000, J VIROL, V74, P3105, DOI 10.1128/JVI.74.7.3105-3111.2000; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Terada Y, 2006, MOL CELL BIOL, V26, P8149, DOI 10.1128/MCB.01170-06; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; WONGSTAAL F, 1987, AIDS RES HUM RETROV, V3, P33, DOI 10.1089/aid.1987.3.33; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	62	78	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37333	37341		10.1074/jbc.M110.133181	http://dx.doi.org/10.1074/jbc.M110.133181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870715	Green Published, hybrid			2022-12-25	WOS:000284424000026
J	Crowley, CS; Cascio, D; Sawaya, MR; Kopstein, JS; Bobik, TA; Yeates, TO				Crowley, Christopher S.; Cascio, Duilio; Sawaya, Michael R.; Kopstein, Jeffery S.; Bobik, Thomas A.; Yeates, Todd O.			Structural Insight into the Mechanisms of Transport across the Salmonella enterica Pdu Microcompartment Shell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; BACTERIAL MICROCOMPARTMENTS; PROTEIN STRUCTURES; DIFFRACTION DATA; TYPHIMURIUM; ORGANELLES; CARBOXYSOMES; GENE; SEQUENCE; CYANOBACTERIA	Bacterial microcompartments are a functionally diverse group of proteinaceous organelles that confine specific reaction pathways in the cell within a thin protein-based shell. The propanediol utilizing (Pdu) microcompartment contains the reactions for metabolizing 1,2-propanediol in certain enteric bacteria, including Salmonella. The Pdu shell is assembled from a few thousand protein subunits of several different types. Here we report the crystal structures of two key shell proteins, PduA and PduT. The crystal structures offer insights into the mechanisms of Pdu microcompartment assembly and molecular transport across the shell. PduA forms a symmetric homohexamer whose central pore appears tailored for facilitating transport of the 1,2-propanediol substrate. PduT is a novel, tandem domain shell protein that assembles as a pseudohexameric homotrimer. Its structure reveals an unexpected site for binding an [Fe-S] cluster at the center of the PduT pore. The location of a metal redox cofactor in the pore of a shell protein suggests a novel mechanism for either transferring redox equivalents across the shell or for regenerating luminal [Fe-S] clusters.	[Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Crowley, Christopher S.; Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Cascio, Duilio; Sawaya, Michael R.; Kopstein, Jeffery S.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Iowa State University	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	National Institutes of Health [AI081146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI081146.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bricogne G., 2009, BUSTER; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Mori K, 1997, J BIOL CHEM, V272, P32034, DOI 10.1074/jbc.272.51.32034; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Ponstingl H, 2000, PROTEINS, V41, P47; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Tsai YS, 2009, ACTA CRYSTALLOGR D, V65, P980, DOI 10.1107/S0907444909025153; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	49	100	105	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37838	37846		10.1074/jbc.M110.160580	http://dx.doi.org/10.1074/jbc.M110.160580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870711	hybrid, Green Published			2022-12-25	WOS:000284424000074
J	Saddic, LA; West, LE; Aslanian, A; Yates, JR; Rubin, SM; Gozani, O; Sage, J				Saddic, Louis A.; West, Lisandra E.; Aslanian, Aaron; Yates, John R., III; Rubin, Seth M.; Gozani, Or; Sage, Julien			Methylation of the Retinoblastoma Tumor Suppressor by SMYD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; HISTONE-METHYLATION; DNA-DAMAGE; TRANSCRIPTIONAL REPRESSION; RECEPTOR-ALPHA; P53 ACTIVITY; RB FAMILY; PROTEIN; ACETYLATION; GENE	The retinoblastoma tumor suppressor (RB) is a central cell cycle regulator and tumor suppressor. RB cellular functions are known to be regulated by a diversity of post-translational modifications such as phosphorylation and acetylation, raising the possibility that RB may also be methylated in cells. Here we demonstrate that RB can be methylated by SMYD2 at lysine 860, a highly conserved and novel site of modification. This methylation event occurs in vitro and in cells, and it is regulated during cell cycle progression, cellular differentiation, and in response to DNA damage. Furthermore, we show that RB monomethylation at lysine 860 provides a direct binding site for the methyl-binding domain of the transcriptional repressor L3MBTL1. These results support the idea that a code of post-translational modifications exists for RB and helps guide its functions in mammalian cells.	[Saddic, Louis A.; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Saddic, Louis A.; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [West, Lisandra E.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Rubin, Seth M.; Sage, Julien] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Aslanian, Aaron] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Aslanian, Aaron] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Yates, John R., III] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	Stanford University; Stanford University; Stanford University; Stanford University; Scripps Research Institute; Salk Institute; University of California System; University of California Santa Cruz	Sage, J (corresponding author), 269 Campus Dr,CCSR1215A, Stanford, CA 94305 USA.	julsage@stanford.edu	Gozani, Or P/I-6157-2013	Rubin, Seth/0000-0002-1670-4147; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [P41 RR011823, NCI T32 CA009523]; CIRM [RB1-01385, NIA F30 AG034741]; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA132685, T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported, in whole or in part, by National Institutes of Health Grants P41 RR011823 (to J. R. Y.), NCI T32 CA009523 (to A. A.), CIRM RB1-01385 (to J. S. and O. G.), and NIA F30 AG034741 (to L. A. S.).	Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, MOL CELL BIOL, V30, P1729, DOI 10.1128/MCB.00952-09; Carvalho PC, 2009, BIOINFORMATICS, V25, P2734, DOI 10.1093/bioinformatics/btp489; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Huq MDM, 2007, MOL CELL PROTEOMICS, V6, P677, DOI 10.1074/mcp.M600223-MCP200; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Leduc C, 2006, ONCOGENE, V25, P4147, DOI 10.1038/sj.onc.1209446; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Markham D, 2006, EMBO REP, V7, P192, DOI 10.1038/sj.embor.7400591; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wang YL, 2004, MOL CELL PROTEOMICS, V3, pS264; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	55	159	165	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37733	37740		10.1074/jbc.M110.137612	http://dx.doi.org/10.1074/jbc.M110.137612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870719	Green Published, hybrid			2022-12-25	WOS:000284424000065
J	Zhao, XL; Yamazaki, D; Park, KH; Komazaki, S; Tjondrokoesoemo, A; Nishi, M; Lin, PH; Hirata, Y; Brotto, M; Takeshima, H; Ma, JJ				Zhao, Xiaoli; Yamazaki, Daiju; Park, Ki Ho; Komazaki, Shinji; Tjondrokoesoemo, Andoria; Nishi, Miyuki; Lin, Peihui; Hirata, Yutaka; Brotto, Marco; Takeshima, Hiroshi; Ma, Jianjie			Ca2+ Overload and Sarcoplasmic Reticulum Instability in tric-a Null Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC ALTERNANS; CALCIUM; CHANNELS; RELEASE; MECHANISMS; RESPONSES; PROTEINS	The sarcoplasmic reticulum (SR) of skeletal muscle contains K+, Cl-, and H+ channels may facilitate charge neutralization during Ca2+ release. Our recent studies have identified trimeric intracellular cation (TRIC) channels on SR as an essential counter-ion permeability pathway associated with rapid Ca2+ release from intracellular stores. Skeletal muscle contains TRIC-A and TRIC-B isoforms as predominant and minor components, respectively. Here we test the physiological function of TRIC-A in skeletal muscle. Biochemical assay revealed abundant expression of TRIC-A relative to the skeletal muscle ryanodine receptor with a molar ratio of TRIC-A/ryanodine receptor similar to 5:1. Electron microscopy with the tric-a(-/-) skeletal muscle showed Ca2+ overload inside the SR with frequent formation of Ca2+ deposits compared with the wild type muscle. This elevated SR Ca2+ pool in the tric-a(-/-) muscle could be released by caffeine, whereas the elemental Ca2+ release events, e. g. osmotic stress-induced Ca2+ spark activities, were significantly reduced likely reflecting compromised counter-ion movement across the SR. Ex vivo physiological test identified the appearance of "alternan" behavior with isolated tric-a(-/-) skeletal muscle, i.e. transient and drastic increase in contractile force appeared within the decreasing force profile during repetitive fatigue stimulation. Inhibition of SR/endoplasmic reticulum Ca2+ ATPase function could lead to aggravation of the stress-induced alternans in the tric-a(-/-) muscle. Our data suggests that absence of TRIC-A may lead to Ca2+ overload in SR, which in combination with the reduced counter-ion movement may lead to instability of Ca2+ movement across the SR membrane. The observed alternan behavior with the tric-a(-/-) muscle may reflect a skeletal muscle version of store overload-induced Ca2+ release that has been reported in the cardiac muscle under stress conditions.	[Lin, Peihui; Hirata, Yutaka; Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Yamazaki, Daiju; Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Hirata, Yutaka] Hyogo Coll Med, Dept Physiol, Div Physiome, Nishinomiya, Hyogo 6638501, Japan; [Brotto, Marco] Univ Missouri, Dept Nursing & Med, Kansas City, MO 64108 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University; Saitama Medical University; Hyogo College of Medicine; University of Missouri System; University of Missouri Kansas City		zhaox1@umdnj.edu; maj2@umdnj.edu	Park, Ki Ho/E-8921-2011; Park, Ki Ho/N-8153-2017; Lin, Pei-Hui/I-3011-2015	Park, Ki Ho/0000-0002-6193-9826; Lin, Pei-Hui/0000-0002-3894-5099; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health [RO1-AG28856]; Takeda Science Foundation; American Heart Association; Nagai Foundation of Tokyo; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790209] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association); Nagai Foundation of Tokyo; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AG28856 (to J. M. and H. T.), grants from the Takeda Science Foundation (to H. T.), an American Heart Association National Scientist Development grant (to X. Z.), and the Nagai Foundation of Tokyo (to D. Y.).	CORONADO R, 1980, NATURE, V288, P495, DOI 10.1038/288495a0; Eisner DA, 2006, HEART RHYTHM, V3, P743, DOI 10.1016/j.hrthm.2005.12.020; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; HUCHET C, 1994, CAN J PHYSIOL PHARM, V72, P833, DOI 10.1139/y94-118; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Landeira-Fernandez AM, 2001, J EXP BIOL, V204, P909; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Li YT, 2009, J PHYSIOL-LONDON, V587, P1283, DOI 10.1113/jphysiol.2008.164368; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Pitt SJ, 2010, BIOPHYS J, V99, P417, DOI 10.1016/j.bpj.2010.04.051; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SURAWICZ B, 1992, J AM COLL CARDIOL, V20, P483, DOI 10.1016/0735-1097(92)90122-4; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Wilson LD, 2006, ANN NY ACAD SCI, V1080, P216, DOI 10.1196/annals.1380.018; Yamazaki D, 2009, DEVELOPMENT, V136, P2355, DOI 10.1242/dev.036798; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	26	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37370	37376		10.1074/jbc.M110.170084	http://dx.doi.org/10.1074/jbc.M110.170084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858894	Green Published, hybrid			2022-12-25	WOS:000284424000029
J	Dubey, S; Shine, R				Dubey, Sylvain; Shine, Richard			Evolutionary Diversification of the Lizard Genus Bassiana (Scincidae) across Southern Australia	PLOS ONE			English	Article							SOUTHEASTERN AUSTRALIA; PHYLOGENETIC-RELATIONSHIPS; COMPARATIVE PHYLOGEOGRAPHY; ENVIRONMENTAL EVOLUTION; MITOCHONDRIAL-DNA; DIVERGENCE; CLIMATE; COLONIZATION; BIOGEOGRAPHY; POPULATIONS	Background: Relatively recent (Plio-Pleistocene) climatic variations had strong impacts on the fauna and flora of temperate-zone North America and Europe; genetic analyses suggest that many lineages were restricted to unglaciated refuges during this time, and have expanded their ranges since then. Temperate-zone Australia experienced less severe glaciation, suggesting that patterns of genetic structure among species may reflect older (aridity-driven) divergence events rather than Plio-Pleistocene (thermally-mediated) divergences. The lizard genus Bassiana (Squamata, Scincidae) contains three species that occur across a wide area of southern Australia (including Tasmania), rendering them ideally-suited to studies on the impact of past climatic fluctuations. Methodology/Principal Findings: We performed molecular phylogenetic and dating analyses using two partial mitochondrial genes (ND2 and ND4) of 97 samples of Bassiana spp. Our results reveal a pattern of diversification beginning in the Middle Miocene, with intraspecific diversification arising from 5.7 to 1.7 million years ago in the Upper Miocene-Lower Pleistocene. Conclusions/Significance: In contrast to the temperate-zone Northern Hemisphere biota, patterns of evolutionary diversification within southern Australian taxa appear to reflect geologically ancient events, mostly relating to east-west discontinuities imposed by aridity rather than (as is the case in Europe and North America) relatively recent recolonisation of northern regions from unglaciated refugia to the south.	[Dubey, Sylvain; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Dubey, S (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	sylvain.dubey@bio.usyd.edu.au	Dubey, Sylvain/B-3662-2013		Australian Research Council	Australian Research Council(Australian Research Council)	The work was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert EM, 2009, GENE, V441, P12, DOI 10.1016/j.gene.2008.05.014; Alley N. F., 1995, GEOLOGICAL SURVEY S, V2, P151; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bowler Jim M., 2006, Proceedings of the Royal Society of Victoria, V118, P161; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; Brown RP, 2008, MOL PHYLOGENET EVOL, V48, P350, DOI 10.1016/j.ympev.2008.04.013; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Chapple DG, 2005, MOL ECOL, V14, P1279, DOI 10.1111/j.1365-294X.2005.02463.x; Cogger H, 2000, REPTILES AMPHIBIANS; Cogger H. G., 1983, REPTILES AMPHIBIANS; Colgan DJ, 2009, AUST J ZOOL, V57, P317, DOI 10.1071/ZO08088; Commonwealth of Australia, 2005, INT BIOG REG AUSTR V; Donnellan SC, 1999, AUST J ZOOL, V47, P275, DOI 10.1071/ZO99013; DRUMMOND AJ, 2006, BEAST V1 4; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Dubey S, 2011, BIOL LETTERS, V7, P96, DOI 10.1098/rsbl.2010.0557; Dubey S, 2010, J BIOGEOGR, V37, P902, DOI 10.1111/j.1365-2699.2009.02266.x; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Fairbairn J, 1998, MOL PHYLOGENET EVOL, V10, P95, DOI 10.1006/mpev.1997.0468; Frakes LA, 1987, FAUNA AUSTR A, P1; Gallagher SJ, 2003, PALAEOGEOGR PALAEOCL, V193, P349, DOI 10.1016/S0031-0182(03)00231-1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HARRIS PT, 2005, 200330 GEOSC AUSTR; Hewitt G.M., 2001, INTEGRATING ECOLOGY, P271; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Keogh JS, 2005, EVOLUTION, V59, P226; Kershaw A.P., 1994, AUSTR VEGETATION HIS; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P250, DOI 10.1006/mpev.1999.0615; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Martin JE, 2004, J HERPETOL, V38, P180, DOI 10.1670/25-03A; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; Melville J, 2007, CONSERV GENET, V8, P185, DOI 10.1007/s10592-006-9161-6; Oliver P, 2007, MOL PHYLOGENET EVOL, V44, P77, DOI 10.1016/j.ympev.2007.02.002; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, TRACER V1 6; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMITH MA, 1937, REC INDIAN MUS, V39, P213; Sniderman JMK, 2007, GEOLOGY, V35, P41, DOI 10.1130/G23247A.1; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Symula R, 2008, MOL PHYLOGENET EVOL, V47, P569, DOI 10.1016/j.ympev.2008.01.011; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Torres-Carvajal O, 2009, MOL PHYLOGENET EVOL, V50, P31, DOI 10.1016/j.ympev.2008.10.002; Veevers J.J, 2000, BILLION YEAR EARTH H, P45; Wells R.W., 1983, Australian Journal of Herpetology, V1, P73; Williams M., 1998, QUATERNARY ENV; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x	56	29	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12982	10.1371/journal.pone.0012982	http://dx.doi.org/10.1371/journal.pone.0012982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886050	Green Published, gold, Green Submitted			2022-12-25	WOS:000282122600017
J	Ichii, M; Oritani, K; Yokota, T; Zhang, QZ; Garrett, KP; Kanakura, Y; Kincade, PW				Ichii, Michiko; Oritani, Kenji; Yokota, Takafumi; Zhang, Qingzhao; Garrett, Karla P.; Kanakura, Yuzuru; Kincade, Paul W.			The Density of CD10 Corresponds to Commitment and Progression in the Human B Lymphoid Lineage	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW; CORD BLOOD; STEM-CELL; DENDRITIC CELLS; PROGENITOR; IL-7; LYMPHOPOIESIS; GROWTH; IDENTIFICATION	Background: Requirements for human B lymphopoiesis are still poorly understood, and that has hampered investigation of differentiation events. For example, there are few cell surface antigens that can be used as milestones of lineage progression. The CD10 ectoenzyme is one such marker and has been used to define CLP, but we found substantial tissue specific variations in CD10 levels, and there was no information about how that corresponded to differentiation options. Methodology/Principal Findings: The aim of the present study was to use recently developed culture methods to assess the nature and differentiation potential of progenitors sorted according to CD10 density from umbilical cord blood (CB), adult bone marrow (BM) or G-CSF mobilized peripheral blood (PB). Many CD34(+) cells in BM express high levels of CD10, while low or low/negative CD10 densities were found on CD34(+) cells in CB or G-CSF mobilized PB, respectively. The relative abundance of CD10(Lo) versus CD10 Hi cells only accounts for some CB versus BM differences. Almost all of the CD34(+) CD10(Hi) cells expressed CD19 and lymphocyte transcription factors and corresponded to loss of myeloid potential. A high degree of immunoglobulin DH-JH gene rearrangements was characteristic only of the CD10(Hi) subset. In contrast, the CD34(+) CD10(Lo) progenitors efficiently produced plasmacytoid and conventional dendritic cells as well as myeloid cells. These findings suggest a positive correlation between CD10 density and degree of differentiation. Although freshly isolated CD34(+) CD10(Hi) cells were in cycle, those from CB or BM expanded poorly in culture, suggesting regulators of populations remain to be discovered. Conclusions/Significance: Steps in human B lymphopoiesis have not been sufficiently studied, and we now show that increased CD10 expression corresponds to differentiation potential and stage. CD34(+) CD10(Hi) progenitors are obviously in the B lineage but may have progressed beyond the point where they can be expanded in culture.	[Ichii, Michiko; Zhang, Qingzhao; Garrett, Karla P.; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Oritani, Kenji; Yokota, Takafumi; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan	Oklahoma Medical Research Foundation; Osaka University	Ichii, M (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			National Institutes of Health [AI020069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI020069 (P.W.K.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P. W. K. holds the William H. and Rita Bell Endowed Chair in Biomedical Research.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; CROOKS GM, 2004, HDB STEM CELLS, P347; DITTEL BN, 1995, J IMMUNOL, V154, P58; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Harman BC, 2008, J IMMUNOL, V181, P7514, DOI 10.4049/jimmunol.181.11.7514; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Hou YH, 2005, BLOOD, V105, P3488, DOI 10.1182/blood-2004-07-2839; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Ichii M, 2008, EXP HEMATOL, V36, P587, DOI 10.1016/j.exphem.2007.12.013; Ichii M, 2010, J IMMUNOL METHODS, V359, P47, DOI 10.1016/j.jim.2010.06.002; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Iwata M, 2002, BLOOD, V100, P1318, DOI 10.1182/blood-2002-01-0062; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Johnson SE, 2008, J IMMUNOL, V180, P8109, DOI 10.4049/jimmunol.180.12.8109; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; KEE BL, 1992, INT IMMUNOL, V4, P1041, DOI 10.1093/intimm/4.9.1041; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lefranc Marie-Paule, 2005, In Silico Biology, V5, P45; Michonneau D, 2009, BRIT J HAEMATOL, V145, P107, DOI 10.1111/j.1365-2141.2008.07574.x; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Nishihara M, 1998, EUR J IMMUNOL, V28, P855, DOI 10.1002/(SICI)1521-4141(199803)28:03<855::AID-IMMU855>3.0.CO;2-X; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; Pribyl JAR, 1996, P NATL ACAD SCI USA, V93, P10348, DOI 10.1073/pnas.93.19.10348; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sanz E, 2003, BLOOD, V101, P3424, DOI 10.1182/blood-2002-07-2244; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; Schmitz N, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.29245; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Tomblyn MB, 2009, J CLIN ONCOL, V27, P3634, DOI 10.1200/JCO.2008.20.2960; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; WOLF ML, 1991, J IMMUNOL, V147, P3324	42	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12954	10.1371/journal.pone.0012954	http://dx.doi.org/10.1371/journal.pone.0012954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886092	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100049
J	Marre, ML; Petnicki-Ocwieja, T; DeFrancesco, AS; Darcy, CT; Hu, LT				Marre, Meghan L.; Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Darcy, Courtney T.; Hu, Linden T.			Human Integrin alpha(3)beta(1) Regulates TLR2 Recognition of Lipopeptides from Endosomal Compartments	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; FIBRONECTIN-BINDING PROTEIN; INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTOR-2; BORRELIA-BURGDORFERI; I INTERFERON; DENDRITIC CELLS; MATRIX METALLOPROTEINASES; INFLAMMATORY MEDIATORS; STAPHYLOCOCCUS-AUREUS	Background: Toll-like receptor (TLR)-2/TLR1 heterodimers recognize bacterial lipopeptides and initiate the production of inflammatory mediators. Adaptors and co-receptors that mediate this process, as well as the mechanisms by which these adaptors and co-receptors function, are still being discovered. Methodology/Principal Findings: Using shRNA, blocking antibodies, and fluorescent microscopy, we show that U937 macrophage responses to the TLR2/1 ligand, Pam(3)CSK(4), are dependent upon an integrin, alpha(3)beta(1). The mechanism for integrin alpha(3)beta(1) involvement in TLR2/1 signaling is through its role in endocytosis of lipopeptides. Using inhibitors of endosomal acidification/maturation and physical tethering of the ligand, we show that the endocytosis of Pam(3)CSK(4) is necessary for the complete TLR2/1-mediated pro-inflammatory cytokine response. We also show that TLR2/1 signaling from the endosome results in the induction of different inflammatory mediators than TLR2/1 signaling from the plasma membrane. Conclusion/Significance: Here we identify integrin alpha(3)beta(1) as a novel regulator for the recognition of bacterial lipopeptides. We demonstrate that induction of a specific subset of cytokines is dependent upon integrin alpha(3)beta(1)-mediated endocytosis of the ligand. In addition, we address an ongoing controversy regarding endosomal recognition of bacterial lipopeptides by demonstrating that TLR2/1 signals from within endosomal compartments as well as the plasma membrane, and that downstream responses may differ depending upon receptor localization. We propose that the regulation of endosomal TLR2/1 signaling by integrin alpha(3)beta(1) serves as a mechanism for modulating inflammatory responses.	[Marre, Meghan L.; Hu, Linden T.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Darcy, Courtney T.; Hu, Linden T.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	Tufts University; Tufts Medical Center	Marre, ML (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA.	lhu@tuftsmedicalcenter.org	Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558	U.S. National Institutes of Health [R56AI80846, R01-AI-50043, T32AI07077, T32AI007329]; National Institutes of Health [P30 NS047243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050043, R56AI080646, T32AI007077, T32AI007329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the U.S. National Institutes of Health (R56AI80846, R01-AI-50043 to L.T.H., T32AI07077 to M.L.M, and T32AI007329 to T.P.O.). The Tufts Center for Neuroscience Research microscopy core is funded by the National Institutes of Health (P30 NS047243 to F.Rob Jackson). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Behera AK, 2005, INFECT IMMUN, V73, P126, DOI 10.1128/IAI.73.1.126-134.2005; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Coburn Jenifer, 2001, Current Drug Targets - Infectious Disorders, V1, P171, DOI 10.2174/1568005014606062; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Ingalls RR, 1998, PROG CLIN BIOL RES, V397, P107; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Shin OS, 2009, J IMMUNOL, V183, P491, DOI 10.4049/jimmunol.0900724; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Somersan S, 2001, J CELL BIOL, V155, P501, DOI 10.1083/jcb.200110066; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; TAKADA Y, 1988, J CELL BIOCHEM, V37, P385, DOI 10.1002/jcb.240370406; TAKEMURA H, 1992, BIOCHEM PHARMACOL, V44, P1395, DOI 10.1016/0006-2952(92)90541-P; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Yamane I, 2005, INT J PHARMACEUT, V305, P145, DOI 10.1016/j.ijpharm.2005.08.020; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zullig S, 2004, SCIENCE, V304, P1123	65	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12871	10.1371/journal.pone.0012871	http://dx.doi.org/10.1371/journal.pone.0012871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877569	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100023
J	Tatarenkov, A; Ring, BC; Elder, JF; Bechler, DL; Avise, JC				Tatarenkov, Andrey; Ring, Brian C.; Elder, John F.; Bechler, David L.; Avise, John C.			Genetic Composition of Laboratory Stocks of the Self-Fertilizing Fish Kryptolebias marmoratus: A Valuable Resource for Experimental Research	PLOS ONE			English	Article							RIVULUS-OCELLATUS-MARMORATUS; HERMAPHRODITIC FISH; MANGROVE KILLIFISH; ONCOGENE EXPRESSION; SEQUENCE ALIGNMENT; MITOCHONDRIAL-DNA; HEPATIC NEOPLASMS; ACUTE TOXICITY; AIR-EXPOSURE; DIETHYLNITROSAMINE	The hermaphroditic Mangrove Killifish, Kryptolebias marmoratus, is the world's only vertebrate that routinely self-fertilizes. As such, highly inbred and presumably isogenic "clonal'' lineages of this androdioecious species have long been maintained in several laboratories and used in a wide variety of experiments that require genetically uniform vertebrate specimens. Here we conduct a genetic inventory of essentially all laboratory stocks of the Mangrove Killifish held worldwide. At 32 microsatellite loci, these stocks proved to show extensive interline differentiation as well as some intraline variation, much of which can be attributed to post-origin de novo mutations and/or to the segregation of polymorphisms from wild progenitors. Our genetic findings also document that many of the surveyed laboratory strains are not what they have been labeled, apparently due to the rather frequent mishandling or unintended mixing of various laboratory stocks over the years. Our genetic inventory should help to clarify much of this confusion about the clonal identities and genetic relationships of laboratory lines, and thereby help to rejuvenate interest in K. marmoratus as a reliable vertebrate model for experimental research that requires or can capitalize upon "clonal'' replicate specimens.	[Tatarenkov, Andrey; Avise, John C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Ring, Brian C.; Elder, John F.; Bechler, David L.] Valdosta State Univ, Dept Biol, Valdosta, GA USA	University of California System; University of California Irvine; University System of Georgia; Valdosta State University	Tatarenkov, A (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	tatarenk@uci.edu; bcring@valdosta.edu	Tatarenkov, Andrey/D-5228-2009	Tatarenkov, Andrey/0000-0002-0516-5862	Valdosta State University College of Arts & Science Center for Applied Research [2008-09]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [R15HD060017]; University of California-Irvine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060017] Funding Source: NIH RePORTER	Valdosta State University College of Arts & Science Center for Applied Research; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California-Irvine(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was fully supported by a Valdosta State University College of Arts & Science Center for Applied Research Grant Number 2008-09 to BCR, DLB, and JFE (URL: http://www.valdosta.edu/cas/car/), partially funded by Eunice Kennedy Shriver National Institute of Child Health & Human Development Award Number R15HD060017 to BCR (URL: http://www.nichd.nih.gov/), and fully supported by University of California-Irvine funds to JCA (URL: http://www.uci.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL DC, 1987, ENVIRON BIOL FISH, V18, P67, DOI 10.1007/BF00002329; ABEL DC, 1984, B ENVIRON CONTAM TOX, V33, P33, DOI 10.1007/BF01625508; ABEL DC, 1981, THESIS COLL CHARLEST; Atz J. W., 1964, INTERSEXUALITY VERTE, P145; Avise J., 2008, CLONALITY GENETICS E; AVISE JC, 2011, HERMAPHRODI IN PRESS; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bongers ABJ, 1998, LAB ANIM-UK, V32, P349, DOI 10.1258/002367798780599749; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROCKMANN F W, 1975, Florida Scientist, V38, P35; CARTER TC, 1952, CANCER RES, V12, P602; Cole KS, 1997, COPEIA, P596; Costa WJEM, 2010, BIOL J LINN SOC, V99, P344, DOI 10.1111/j.1095-8312.2009.01359.x; COUCH JA, 1995, CANCER RES, V55, P2438; COURTNEY LA, 1988, J FISH DIS, V14, P111; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DAVE G, 1993, SETAC SP P, P129; Davis W.P., 1990, Ichthyological Exploration of Freshwaters, V1, P123; DAVIS WP, 1988, ENVIRON BIOL FISH, V21, P81, DOI 10.1007/BF00004844; DAVIS WP, 1995, B MAR SCI, V57, P208; DAVIS WP, 1984, MAR ENVIRON RES, V14, P502, DOI 10.1016/0141-1136(84)90135-1; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Earley RL, 2000, ETHOLOGY, V106, P743, DOI 10.1046/j.1439-0310.2000.00586.x; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Frick NT, 2002, J EXP BIOL, V205, P91; Goldstein D, 1999, MICROSATELLITES EVOL; GOODWIN AE, 1994, CARCINOGENESIS, V15, P1993, DOI 10.1093/carcin/15.9.1993; GOODWIN AE, 1994, CARCINOGENESIS, V15, P1985, DOI 10.1093/carcin/15.9.1985; GOODWIN AE, 1994, J HISTOCHEM CYTOCHEM, V42, P109, DOI 10.1177/42.1.7505299; Grageda MVC, 2004, ICHTHYOL RES, V51, P309, DOI 10.1007/s10228-004-0235-5; GRIZZLE JM, 1988, DIS AQUAT ORGAN, V5, P39, DOI 10.3354/dao005039; GRIZZLE JM, 1987, COPEIA, P237, DOI 10.2307/1446065; HARRINGTON R, 1961, SCIENCE, V134, P1749, DOI 10.1126/science.134.3492.1749; Harrington R.W. Jr., 1975, P249; HARRINGTON RW, 1968, AM NAT, V102, P337, DOI 10.1086/282547; HARRINGTON RW, 1971, COPEIA, P389; HEATH AG, 1993, HYDROBIOLOGIA, V259, P47, DOI 10.1007/BF00005964; Hsu YY, 1999, ANIM BEHAV, V57, P903, DOI 10.1006/anbe.1998.1049; Hsu YY, 2001, ANIM BEHAV, V61, P777, DOI 10.1006/anbe.2000.1650; HUBER JH, 1986, J AM KILLIFISH ASS, V19, P81; HUEHNER M K, 1985, Florida Scientist, V48, P1; KALLMAN KD, 1964, BIOL BULL, V126, P101, DOI 10.2307/1539420; Koenig C C, 1984, Natl Cancer Inst Monogr, V65, P15; Koenig C. C., 1980, WATER CHLORINATION E, P827; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAUGHLIN TF, 1995, J HERED, V86, P399, DOI 10.1093/oxfordjournals.jhered.a111610; Lee JS, 2008, J FISH BIOL, V72, P1871, DOI 10.1111/j.1095-8649.2008.01818.x; LEE JS, 1995, BIOCHEM MOL BIOL INT, V35, P57; LEE JS, 2005, NIPPON GYORUI GAKKAI, V38, P27; LEE JS, 1995, BIOCHEM MOL BIOL INT, V35, P921; LEE JS, 1994, THESIS HANYANG U SEO; LIN HC, 1993, ARCH ENVIRON CON TOX, V25, P41; Litwiller SL, 2006, J EXP BIOL, V209, P1737, DOI 10.1242/jeb.02197; Lubinski BA, 1995, J HERED, V86, P469, DOI 10.1093/oxfordjournals.jhered.a111623; Luke KN, 2010, CURR ZOOL, V56, P6, DOI 10.1093/czoolo/56.1.6; MACKIEWICZ M, 2006, P ROY SOC LOND B BIO, V273, P2249; Mackiewicz M, 2006, J HERED, V97, P508, DOI 10.1093/jhered/esl017; Mackiewicz M, 2006, P NATL ACAD SCI USA, V103, P9924, DOI 10.1073/pnas.0603847103; Martin SB, 2007, J FISH BIOL, V71, P1383, DOI 10.1111/j.1095-8649.2007.01603.x; MCMILLAN CM, 1979, THESIS COLL CHARLEST; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V13, P289, DOI 10.1006/mpev.1999.0656; Nakamura Y, 2008, CAN J ZOOL, V86, P976, DOI 10.1139/Z08-075; Ong KJ, 2007, J EXP BIOL, V210, P1109, DOI 10.1242/jeb.002238; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park E. H., 1992, JPN J ICTHYOL, V34, P476; PARK EH, 1984, J NATL CANCER I, V73, P871; PARK EH, 1993, JPN J CANCER RES, V84, P608, DOI 10.1111/j.1349-7006.1993.tb02020.x; PARK EH, 1994, CAN J FISH AQUAT SCI, V51, P280, DOI 10.1139/f94-029; PARK EH, 1992, TERATOGEN CARCIN MUT, V12, P129, DOI 10.1002/tcm.1770120304; PARK EH, 1990, JPN J CANCER RES, V81, P738, DOI 10.1111/j.1349-7006.1990.tb02638.x; Sato A, 2002, GENETICS, V162, P1791; Silver L.M., 1995, MOUSE GENETICS CONCE; SOTO CG, 1992, CAN J ZOOL, V70, P2338, DOI 10.1139/z92-314; SOTO CG, 1988, THESIS U GUELPH GUEL; STAATS JOAN, 1966, P1; Taphorn D.C., 1980, Zoologische Mededelingen (Leiden), V55, P127; Tatarenkov A, 2007, MOL ECOL, V16, P2701, DOI 10.1111/j.1365-294X.2007.03349.x; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Tatarenkov A, 2009, P NATL ACAD SCI USA, V106, P14456, DOI 10.1073/pnas.0907852106; TAYLON D S, 1988, Northeast Gulf Science, V10, P63; Taylor DS, 2008, AM NAT, V171, P263, DOI 10.1086/524960; Taylor D. Scott, 2000, Florida Scientist, V63, P242; TAYLOR DS, 1995, B MAR SCI, V57, P202; THIYAGARAJAH A, 1995, MAR ENVIRON RES, V39, P279, DOI 10.1016/0141-1136(94)00073-X; THIYAGARAJAH A, 1986, J NATL CANCER I, V77, P141; THOMERSON JAIMtE E., 1966, J AMER KILUFISH ASS, V3, P48; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner B. J., 2003, P 9 S NAT HIST BAH, P91; TURNER BJ, 1990, P NATL ACAD SCI USA, V87, P5653, DOI 10.1073/pnas.87.15.5653; TURNER BJ, 1992, P NATL ACAD SCI USA, V89, P10643, DOI 10.1073/pnas.89.22.10643; TURNER BJ, 1992, J FISH BIOL, V40, P307, DOI 10.1111/j.1095-8649.1992.tb02576.x; Turner BJ, 2006, EVOL ECOL RES, V8, P1475; VOGELBEIN WK, 1987, J FISH BIOL, V31, P145, DOI 10.1111/j.1095-8649.1987.tb05306.x; VRIJENHOEK RC, 1985, J HERED, V76, P82, DOI 10.1093/oxfordjournals.jhered.a110050; Weibel AC, 1999, EVOLUTION, V53, P1217, DOI 10.1111/j.1558-5646.1999.tb04534.x	96	66	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12863	10.1371/journal.pone.0012863	http://dx.doi.org/10.1371/journal.pone.0012863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877576	gold, Green Published			2022-12-25	WOS:000282053100019
J	Fatti, G; Grimwood, A; Bock, P				Fatti, Geoffrey; Grimwood, Ashraf; Bock, Peter			Better Antiretroviral Therapy Outcomes at Primary Healthcare Facilities: An Evaluation of Three Tiers of ART Services in Four South African Provinces	PLOS ONE			English	Article							TREATMENT PROGRAM; FOLLOW-UP; MORTALITY; BARRIERS; CHILDREN; ACCESS; INCOME; ADULTS	Background: There are conflicting reports of antiretroviral therapy (ART) effectiveness comparisons between primary healthcare (PHC) facilities and hospitals in low-income settings. This comparison has not been evaluated on a broad scale in South Africa. Methodology/Principal Findings: A retrospective cohort study was conducted including ART-naive adults from 59 facilities in four provinces in South Africa, enrolled between 2004 and 2007. Kaplan-Meier estimates, competing-risks Cox regression, generalised estimating equation population-averaged models and logistic regression were used to compare death, loss to follow-up (LTFU) and virological suppression (VS) between PHC, district and regional hospitals. 29 203 adults from 47 PHC facilities, nine district hospitals and three regional hospitals were included. Patients at PHC facilities had more advanced WHO stage disease when starting ART. Retention in care was 80.1% (95% CI: 79.3%-80.8%), 71.5% (95% CI: 69.1%-73.8%) and 68.7% (95% CI: 67.0%-69.7%) at PHC, district and regional hospitals respectively, after 24 months of treatment (P<0.0001). In adjusted regression analyses, LTFU was independently increased at regional hospitals (aHR 2.19; 95% CI: 1.94-2.47) and mortality was independently elevated at district hospitals (aHR 1.60; 95% CI: 1.30-1.99) compared to PHC facilities after 12 months of ART. District and regional hospital patients had independently reduced probabilities of VS, aOR 0.76 (95% CI: 0.59-0.97) and 0.64 (95% CI: 0.56-0.75) respectively compared to PHC facilities over 24 months of treatment. Conclusions/Significance: ART outcomes were superior at PHC facilities, despite PHC patients having more advanced clinical stage disease when starting ART, suggesting that ART can be adequately provided at this level and supporting the South African government's call for rapid up-scaling of ART at the primary level of care. Further prospective research is required to determine the degree to which outcome differences are attributable to either facility level characteristics or patient co-morbidity at hospital level.	[Fatti, Geoffrey; Grimwood, Ashraf; Bock, Peter] Kheth Impilo, Cape Town, South Africa; [Fatti, Geoffrey] Univ Cape Town, Lung Inst, Lung Clin Res Unit, ZA-7925 Cape Town, South Africa; [Bock, Peter] Univ Cape Town, Primary Healthcare Directorate, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Fatti, G (corresponding author), Kheth Impilo, Cape Town, South Africa.	geoffrey.fatti@khethimpilo.org	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Bock, Peter/0000-0003-3211-6078				*ACT SOC S AFR, 2005, ASSA2003 AIDS DEM MO; Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], UNAIDS WHO AIDS EPID; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Bock P, 2008, T ROY SOC TROP MED H, V102, P905, DOI 10.1016/j.trstmh.2008.06.010; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Cornell M, 2009, SAMJ S AFR MED J, V99, P653; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2008, PLOS MED, V5, P1409, DOI 10.1371/journal.pmed.0050195; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; NACHEGA J, 2009, J ACQ IMMUN DEF SYND, V51, P61; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; *S AFR DEP HLTH, 2008, DEP REP; *S AFR NAT TREAS, 2008, 2008 NAT BUDG REV; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schaay N, 2008, S AFRICAN HLTH REV 2; South Sudan Ministry of Health, 2007, STRAT PLAN HUM RES H; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; UNAIDS WHO EPIDEMIOL	33	88	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12888	10.1371/journal.pone.0012888	http://dx.doi.org/10.1371/journal.pone.0012888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877631	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900019
J	Hall, HI; Espinoza, L; Benbow, N; Hu, YYW				Hall, H. Irene; Espinoza, Lorena; Benbow, Nanette; Hu, Yunyin W.		Urban Areas HIV Surveillance Workg	Epidemiology of HIV Infection in Large Urban Areas in the United States	PLOS ONE			English	Article							US METROPOLITAN-AREAS; PREVALENCE; RISK; TRANSMISSION	Background: While the U.S. HIV epidemic continues to be primarily concentrated in urban area, local epidemiologic profiles may differ and require different approaches in prevention and treatment efforts. We describe the epidemiology of HIV in large urban areas with the highest HIV burden. Methods/Principal Findings: We used data from national HIV surveillance for 12 metropolitan statistical areas (MSAs) to determine disparities in HIV diagnoses and prevalence and changes over time. Overall, 0.3% to 1% of the MSA populations were living with HIV at the end of 2007. In each MSA, prevalence was >1% among blacks; prevalence was >2% in Miami, New York, and Baltimore. Among Hispanics, prevalence was >1% in New York and Philadelphia. The relative percentage differences in 2007 HIV diagnosis rates, compared to whites, ranged from 239 (San Francisco) to 1239 (Baltimore) for blacks and from 15 (Miami) to 413 (Philadelphia) for Hispanics. The epidemic remains concentrated, with more than 50% of HIV diagnoses in 2007 attributed to male-to-male sexual contact in 7 of the 12 MSAs; heterosexual transmission surpassed or equaled male-to-male sexual transmission in Baltimore, Philadelphia, and Washington, DC. Yet in several MSAs, including Baltimore and Washington, DC, AIDS diagnoses increased among men-who-have sex with men in recent years. Conclusions/Significance: These data are useful to identify local drivers of the epidemic and to tailor public health efforts for treatment and prevention services for people living with HIV.	[Hall, H. Irene; Espinoza, Lorena] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Benbow, Nanette] Chicago Dept Publ Hlth, STI HIV Div, Chicago, IL USA; [Hu, Yunyin W.] Los Angeles Cty Dept Publ Hlth, HIV Epidemiol Program, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; Los Angeles County Department of Public Health	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ixh1@cdc.gov						Sifakis F., 2005, Morbidity and Mortality Weekly Report, V54, P597; [Anonymous], [No title captured]; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; *CDCP, 2009, HIV AIDS SURV REP, V19; *CDCP, 2010, CDC ANN MILL EXP SUC; *CDCP, 2006, MMWR SURVEILL SUMM, V55; Centers for Disease Control and Prevention, 2009, HIV AIDS PREV RES SY; Centers for Disease Control and Prevention, 2006, CAS HIV INF AIDS URB; Centers for Disease Control and Prevention, 1983, ACQ IMM SYNDR AIDS W; Centers for Disease Control and Prevention, 1982, MMWR-MORBID MORTAL W, V31, P507; Centers for Disease Control and Prevention, 2006, MMWR, V55; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; *DISTR COL DEP HLT, 2008, HIV AIDS EP UPD; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; *GOV DISTR COL DEP, 2009, HIV AIDS EP UDP 2008; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Holtgrave DR, 2009, JAIDS-J ACQ IMM DEF, V50, P236, DOI 10.1097/QAI.0b013e31819001be; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Office of management, 2000, FED REG, V65, P82228; Office of Management and Budget, 2008, OMB B; PURCELL DW, 2010, CALC HIV SYPH RAT RI; Rubin DB, 2004, MULTIPLE IMPUTATION; SHEDLIN MB, 2006, J URBAN HLTH B NEW Y, V83, P143; *US BUR CENS, 2008, ANN EST RES POP INC; *US BUR CENS, 2008, POP EST ENT DAR; WHO Joint United Nations Programme on HIV/AIDS, 2000, GUID 2 GEN HIV SURV; [No title captured]; 2009, PAN ANT GUID AD ADOL	32	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12756	10.1371/journal.pone.0012756	http://dx.doi.org/10.1371/journal.pone.0012756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856793	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800021
J	Benn, AR; Weaver, PP; Billet, DSM; van den Hove, S; Murdock, AP; Doneghan, GB; Le Bas, T				Benn, Angela R.; Weaver, Philip P.; Billet, David S. M.; van den Hove, Sybille; Murdock, Andrew P.; Doneghan, Gemma B.; Le Bas, Tim			Human Activities on the Deep Seafloor in the North East Atlantic: An Assessment of Spatial Extent	PLOS ONE			English	Article								Background: Environmental impacts of human activities on the deep seafloor are of increasing concern. While activities within waters shallower than 200 m have been the focus of previous assessments of anthropogenic impacts, no study has quantified the extent of individual activities or determined the relative severity of each type of impact in the deep sea. Methodology: The OSPAR maritime area of the North East Atlantic was chosen for the study because it is considered to be one of the most heavily impacted by human activities. In addition, it was assumed data would be accessible and comprehensive. Using the available data we map and estimate the spatial extent of five major human activities in the North East Atlantic that impact the deep seafloor: submarine communication cables, marine scientific research, oil and gas industry, bottom trawling and the historical dumping of radioactive waste, munitions and chemical weapons. It was not possible to map military activities. The extent of each activity has been quantified for a single year, 2005. Principal Findings: Human activities on the deep seafloor of the OSPAR area of the North Atlantic are significant but their footprints vary. Some activities have an immediate impact after which seafloor communities could re-establish, while others can continue to make an impact for many years and the impact could extend far beyond the physical disturbance. The spatial extent of waste disposal, telecommunication cables, the hydrocarbon industry and marine research activities is relatively small. The extent of bottom trawling is very significant and, even on the lowest possible estimates, is an order of magnitude greater than the total extent of all the other activities. Conclusions/Significance: To meet future ecosystem-based management and governance objectives for the deep sea significant improvements are required in data collection and availability as well as a greater awareness of the relative impact of each human activity.	[Benn, Angela R.; Billet, David S. M.] Natl Oceanog Ctr Southampton, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England; [Weaver, Philip P.; Le Bas, Tim] Natl Oceanog Ctr Southampton, Geol & Geophys Grp, Southampton, Hants, England; [van den Hove, Sybille] Median, Valldoreix, Spain; [van den Hove, Sybille] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Murdock, Andrew P.; Doneghan, Gemma B.] Univ Southampton, GeoData Inst, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre; University of Southampton; Autonomous University of Barcelona; University of Southampton	Benn, AR (corresponding author), Natl Oceanog Ctr Southampton, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England.	arb103@noc.soton.ac.uk	Le+Bas, Tim/AAP-9805-2020	Weaver, Philip/0000-0002-9541-3830; Gubbins, Gemma/0000-0002-0554-1856	Census of Marine Life; EC [GOCE-CT-2005-511234]; EU [226354]; Natural Environment Research Council [noc010004, noc010009, noc010011] Funding Source: researchfish; NERC [noc010004, noc010009, noc010011] Funding Source: UKRI	Census of Marine Life; EC(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB was supported by the Continental Margin Ecosystems (COMARGE) project of the Census of Marine Life initiated by the Alfred P. Sloan Foundation. This research was also supported by the HERMES project, EC contract no GOCE-CT-2005-511234, funded by the European Commission's Sixth Framework Programme under the priority "Sustainable Development, Global Change and Ecosystems"; the HERMIONE project (EU contract 226354 funded by the European Commission's Seventh Framework Programme under the priority 'Deep-Sea Ecosystems'). The publication reflects only the views of the authors and the EC is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSODIAS M, 2004, DEDICATED GIS ESTIMA, P323; BEDDINGTON J, MUNITIONS DUMPED SEA; Bensch A., 2008, WORLDWIDE REV BOTTOM; Breuer E, 2004, MAR POLLUT BULL, V48, P12, DOI 10.1016/j.marpolbul.2003.08.009; CALMET C, 1989, INT ATOMIC ENERGY AG, V4; Carter L., 2009, SUBMARINE CABLES OCE; Charmasson S., 1998, CYCLE COMBUSTIBLE NU; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; deGroot SJ, 1996, ICES J MAR SCI, V53, P1045, DOI 10.1006/jmsc.1996.0130; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; *EC, 2003, OFFICIAL J EUROPEAN, P26; European Commission, 2008, OFFICIAL J EUROPEAN, VL164, P19, DOI DOI 10.1016/J.MARENVRES.2012.03.003; European Union, 2003, OFFICIAL J EUROPEA L, V71, P17; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gianni M., 2004, HIGH SEAS BOTTOM TRA; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; *ICES, 2007, ICES ADV 2007 BOOK 9; IMO (International Maritime Organization), 1996, PROT CONV PREV MAR P; International Maritime Organisation IMO, 1972, CONV PREV MAR POLL D; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; LUMB CM, 2004, IRISH SEA PILOT REPO; *NEA, 1985, REV CONT SUIT DUMP S; *NEAFC, 2010, SCHEM CONTR ENF; *NPD, 2005, FACTS 2005 NORW PETR; *NPD, 2009, NPDS FACT PAG; *OLF, 2009, ANN ENV REP 2009; *OLF, 2006, ANN ENV REP 2006 NOR; *OSPAR, 2008, M OSPAR COMM BREST F; *OSPAR, 1995, 9581E OSPAR; *OSPAR, 2000, OSPAR QUAL STAT REP, pCH3; *OSPAR, 2005, OV PAST DUMP SEA CHE; *OSPAR, 2008, COD COND RESP MAR RE; *OSPAR, 2003, BIOD EC STRAT 2003 S; OSPAR, 2009, ASS IMP DUMP CONV CH; Thiel H, 2003, ECOSY WORLD, V28, P427; United Nations, 1992, CONV BIOL DIV; United Nations General Assembly, 2006, AGR IMPL PROV UN CON, V71, P1; Van den Hove S, 2007, ECOSYSTEMS BIODIVERS	40	99	99	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12730	10.1371/journal.pone.0012730	http://dx.doi.org/10.1371/journal.pone.0012730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856885	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000281735700025
J	Olcott, MH; Henkels, MD; Rosen, KL; Walker, FL; Sneh, B; Loper, JE; Taylor, BJ				Olcott, Marika H.; Henkels, Marcella D.; Rosen, Kise L.; Walker, Francesca L.; Sneh, Baruch; Loper, Joyce E.; Taylor, Barbara J.			Lethality and Developmental Delay in Drosophila melanogaster Larvae after Ingestion of Selected Pseudomonas fluorescens Strains	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; III SECRETION; HOST-DEFENSE; INFECTION; PATHWAY; GROWTH; GENE; REGULATOR; VIRULENCE; IMMUNITY	Background: The fruit fly, Drosophila melanogaster, is a well-established model organism for probing the molecular and cellular basis of physiological and immune system responses of adults or late stage larvae to bacterial challenge. However, very little is known about the consequences of bacterial infections that occur in earlier stages of development. We have infected mid-second instar larvae with strains of Pseudomonas fluorescens to determine how infection alters the ability of larvae to survive and complete development. Methodology/Principal Findings: We mimicked natural routes of infection using a non-invasive feeding procedure to study the toxicity of the three sequenced P. fluorescens strains (Pf0-1, SBW25, and Pf-5) to Drosophila melanogaster. Larvae fed with the three strains of P. fluorescens showed distinct differences in developmental trajectory and survival. Treatment with SBW25 caused a subset of insects to die concomitant with a systemic melanization reaction at larval, pupal or adult stages. Larvae fed with Pf-5 died in a dose-dependent manner with adult survivors showing eye and wing morphological defects. In addition, larvae in the Pf-5 treatment groups showed a dose-dependent delay in the onset of metamorphosis relative to control-, Pf0-1-, and SBW25-treated larvae. A functional gacA gene is required for the toxic properties of wild-type Pf-5 bacteria. Conclusions/Significance: These experiments are the first to demonstrate that ingestion of P. fluorescens bacteria by D. melanogaster larvae causes both lethal and non-lethal phenotypes, including delay in the onset of metamorphosis and morphological defects in surviving adult flies, which can be decoupled.	[Olcott, Marika H.; Rosen, Kise L.; Walker, Francesca L.; Taylor, Barbara J.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Henkels, Marcella D.; Loper, Joyce E.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA; [Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Sneh, Baruch] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; Tel Aviv University	Olcott, MH (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	taylorb@science.oregonstate.edu		Loper, Joyce/0000-0003-3501-5969	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35319-17427, 2008-35600-18770]; National Institutes of Health [9RO1 GM085818-14A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085818] Funding Source: NIH RePORTER	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Research Initiative Competitive Grants 2006-35319-17427 and 2008-35600-18770 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service to JEL and by National Institutes of Health Grant 9RO1 GM085818-14A2 to BJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MJ, 1995, MOL ECOL, V4, P755, DOI 10.1111/j.1365-294X.1995.tb00276.x; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Broderick KE, 2008, J INFECT DIS, V197, P457, DOI 10.1086/525282; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; CORBELL N, 1995, J BACTERIOL, V177, P6230, DOI 10.1128/jb.177.21.6230-6236.1995; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Fauvarque MO, 2002, MICROB PATHOGENESIS, V32, P287, DOI 10.1006/mpat.2002.0504; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; KING EO, 1954, J LAB CLIN MED, V44, P301; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Lutter EI, 2008, INFECT IMMUN, V76, P1877, DOI 10.1128/IAI.01165-07; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nijhout HF, 2003, DEVELOPMENT, V130, P5863, DOI 10.1242/dev.00902; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stein D, 1998, DEVELOPMENT, V125, P2159; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Stockwell VO, 2005, MICROBIOL-SGM, V151, P3001, DOI 10.1099/mic.0.28077-0; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Ye YXH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000385; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	52	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12504	10.1371/journal.pone.0012504	http://dx.doi.org/10.1371/journal.pone.0012504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856932	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700002
J	Dasgupta, S; Sirisha, PVS; Neelaveni, K; Anuradha, K; Reddy, AG; Thangaraj, K; Reddy, BM				Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Neelaveni, Kudugunti; Anuradha, Kathragadda; Reddy, Alla G.; Thangaraj, Kumarasamy; Reddy, B. Mohan			Androgen Receptor CAG Repeat Polymorphism and Epigenetic Influence among the South Indian Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; TRINUCLEOTIDE REPEATS; GENE; INFERTILITY; CRITERIA; LENGTH	The present study was carried out to assess the role of androgen receptor CAG repeat polymorphism and X chromosome inactivation (XCI) pattern among Indian PCOS women and controls which has not been hitherto explored and also to test the hypothesis that shorter CAG alleles would be preferentially activated in PCOS. CAG repeat polymorphism and X chromosome methylation patterns were compared between PCOS and non-PCOS women. 250 PCOS women and 299 controls were included for this study. Androgen receptor CAG repeat sizes, XCI percentages, and clinical and biochemical parameters were measured. The mean CAG repeat number is similar between the cases (18.74 +/- 0.13) and controls (18.73 +/- 0.12). The obese PCOS women were significantly more frequent in the 18 and 20 CAG repeat category than the lean PCOS women, yielding a highly significant odds (p = 0.001). Among the women with non-random X-inactivation, alleles with,19 repeats were more frequently activated among cases than controls (p = 0.33). CAG repeat polymorphism by itself cannot be considered as a useful marker for discriminating PCOS. We observed a trend of preferential activation of the shorter allele among the PCOS cases with non random XCI pattern. In the obese PCOS women, this microsatellite variation may account for the hyperandrogenicity to a larger extent than the lean PCOS women.	[Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Neelaveni, Kudugunti] Osmania Gen Hosp, Dept Endocrinol, Hyderabad, Andhra Pradesh, India; [Anuradha, Kathragadda] Anu Test Tube Baby Ctr, Hyderabad, Andhra Pradesh, India; [Reddy, Alla G.; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Dasgupta, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute, Kolkata	Indian Statistical Institute, Kolkata	The study was funded by the Indian Statistical Institute, Kolkata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cram DS, 2000, MOL HUM REPROD, V6, P861, DOI 10.1093/molehr/6.9.861; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferk P, 2008, FERTIL STERIL, V90, P860, DOI 10.1016/j.fertnstert.2007.07.1291; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Jaaskelainen J, 2005, FERTIL STERIL, V83, P1724, DOI 10.1016/j.fertnstert.2004.11.080; Kim JJ, 2008, FERTIL STERIL, V90, P2318, DOI 10.1016/j.fertnstert.2007.10.030; Liu QR, 2008, ENDOCRINE, V33, P165, DOI 10.1007/s12020-008-9069-7; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Mohlig M, 2006, EUR J ENDOCRINOL, V155, P127, DOI 10.1530/eje.1.02195; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; Sambrook J, 1989, MOL CLONING LABORATO; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382	21	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12401	10.1371/journal.pone.0012401	http://dx.doi.org/10.1371/journal.pone.0012401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865044	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100011
J	Del Debbio, CB; Balasubramanian, S; Parameswaran, S; Chaudhuri, A; Qiu, F; Ahmad, I				Del Debbio, Carolina Beltrame; Balasubramanian, Sudha; Parameswaran, Sowmya; Chaudhuri, Anathbandhu; Qiu, Fang; Ahmad, Iqbal			Notch and Wnt Signaling Mediated Rod Photoreceptor Regeneration by Muller Cells in Adult Mammalian Retina	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DIFFERENTIAL REGULATION; PROGENITOR CELLS; SIDE POPULATION; GANGLION-CELLS; GROWTH-FACTORS; RAT RETINA; DYE EFFLUX; NEURONS; GLIA	Background: Evidence emerging from a variety of approaches used in different species suggests that Muller cell function may extend beyond its role of maintaining retinal homeostasis to that of progenitors in the adult retina. Enriched Muller cells in vitro or those that re-enter cell cycle in response to neurotoxin-damage to retina in vivo display multipotential and self-renewing capacities, the cardinal features of stem cells. Methodology/Principal Findings: We demonstrate that Notch and Wnt signaling activate Muller cells through their canonical pathways and that a rare subset of activated Muller cells differentiates along rod photoreceptor lineage in the outer nuclear layer. The differentiation of activated Muller cells along photoreceptor lineage is confirmed by multiple approaches that included Hoechst dye efflux analysis, genetic analysis using retina from Nrl-GFP mice, and lineage tracing using GS-GFP lentivirus in wild type and rd mice in vitro and S334ter rats in vivo. Examination of S334ter rats for head-neck tracking of visual stimuli, a behavioral measure of light perception, demonstrates a significant improvement in light perception in animals treated to activate Muller cells. The number of activated Muller cells with rod photoreceptor phenotype in treated animals correlates with the improvement in their light perception. Conclusion/Significance: In summary, our results provide a proof of principle for non-neurotoxin-mediated activation of Muller cells through Notch and Wnt signaling toward the regeneration of rod photoreceptors.	[Del Debbio, Carolina Beltrame; Balasubramanian, Sudha; Parameswaran, Sowmya; Chaudhuri, Anathbandhu; Ahmad, Iqbal] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Qiu, Fang] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Del Debbio, CB (corresponding author), Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA.	iahmad@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017; Sowmya, Parameswaran/GZK-8635-2022	Chaudhuri, Anathbandhu/0000-0003-4833-3077; 	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Research to Prevent Blindness	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by Lincy Foundation, Pearson Foundation, Nebraska Department of Health and Human Services, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2004, SEMIN CELL DEV BIOL, V15, P53, DOI 10.1016/j.semcdb.2003.09.003; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bhattacharya S, 2003, INVEST OPHTH VIS SCI, V44, P2764, DOI 10.1167/iovs.02-0899; Bhattacharya S, 2008, STEM CELLS, V26, P2611, DOI 10.1634/stemcells.2008-0222; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fischer AJ, 2002, DEVELOPMENT, V129, P2283; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Geller SF, 2008, MOL VIS, V14, P691; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hulspas R, 2000, CYTOMETRY, V40, P245, DOI 10.1002/1097-0320(20000701)40:3<245::AID-CYTO10>3.3.CO;2-X; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; James J, 2004, J NEUROBIOL, V61, P359, DOI 10.1002/neu.20064; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Lamba DA, 2009, PROG BRAIN RES, V175, P23, DOI 10.1016/S0079-6123(09)17502-7; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Liu CD, 1999, J NEUROSCI, V19, P4778; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Parameswaran S, 2010, STEM CELLS, V28, P695, DOI 10.1002/stem.320; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Viti J, 2003, J NEUROSCI, V23, P5919; WATANABE T, 1992, DEVELOPMENT, V114, P899; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Zhao X, 2005, DEV DYNAM, V232, P349, DOI 10.1002/dvdy.20290; Zhao X, 2002, BIOCHEM BIOPH RES CO, V297, P177, DOI 10.1016/S0006-291X(02)02126-5; Zhao X, 2008, STEM CELLS, V26, P939, DOI 10.1634/stemcells.2007-0727; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	58	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12425	10.1371/journal.pone.0012425	http://dx.doi.org/10.1371/journal.pone.0012425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865053	Green Published, gold, Green Submitted			2022-12-25	WOS:000281292100020
J	Gollner, S; Riemer, B; Arbizu, PM; Le Bris, N; Bright, M				Gollner, Sabine; Riemer, Barbara; Arbizu, Pedro Martinez; Le Bris, Nadine; Bright, Monika			Diversity of Meiofauna from the 9 degrees 50 ' N East Pacific Rise across a Gradient of Hydrothermal Fluid Emissions	PLOS ONE			English	Article							VENT MUSSEL BEDS; DE-FUCA RIDGE; COMMUNITY STRUCTURE; ENVIRONMENTAL-STRESS; RIFTIA-PACHYPTILA; SEA; AGGREGATIONS; TUBEWORM; COPEPODA; SYMBIOSIS	Background: We studied the meiofauna community at deep-sea hydrothermal vents along a gradient of vent fluid emissions in the axial summit trought (AST) of the East Pacific Rise 9 degrees 50'N region. The gradient ranged from extreme high temperatures, high sulfide concentrations, and low pH at sulfide chimneys to ambient deep-sea water conditions on bare basalt. We explore meiofauna diversity and abundance, and discuss its possible underlying ecological and evolutionary processes. Methodology/Principal Findings: After sampling in five physico-chemically different habitats, the meiofauna was sorted, counted and classified. Abundances were low at all sites. A total of 52 species were identified at vent habitats. The vent community was dominated by hard substrate generalists that also lived on bare basalt at ambient deep-sea temperature in the axial summit trough (AST generalists). Some vent species were restricted to a specific vent habitat (vent specialists), but others occurred over a wide range of physico-chemical conditions (vent generalists). Additionally, 35 species were only found on cold bare basalt (basalt specialists). At vent sites, species richness and diversity clearly increased with decreasing influence of vent fluid emissions from extreme flow sulfide chimney (no fauna), high flow pompei worm (S: 4-7, H-loge': 0.11-0.45), vigorous flow tubeworm (S: 8-23; H-loge': 0.44-2.00) to low flow mussel habitats (S: 28-31; H-loge': 2.34-2.60). Conclusions/Significance: Our data suggest that with increasing temperature and toxic hydrogen sulfide concentrations and increasing amplitude of variation of these factors, fewer species are able to cope with these extreme conditions. This results in less diverse communities in more extreme habitats. The finding of many species being present at sites with and without vent fluid emissions points to a non endemic deep-sea hydrothermal vent meiofaunal community. This is in contrast to a mostly endemic macrofauna but similar to what is known for meiofauna from shallow-water vents.	[Gollner, Sabine; Riemer, Barbara; Bright, Monika] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Gollner, Sabine; Arbizu, Pedro Martinez] Forschungsinst Senckenberg, Deutsch Zentrum Marine Biodiversitatsforsch, Wilhelmshaven, Germany; [Le Bris, Nadine] IFREMER, Dept Environm Profond, Brest, France	University of Vienna; Senckenberg Gesellschaft fur Naturforschung (SGN); Ifremer	Gollner, S (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	sabine.gollner@senckenberg.de	Bright, Monika/AAA-7015-2021; Bright, Monika/I-5542-2012; Le Bris, Nadine/E-1381-2014	Bright, Monika/0000-0001-7066-1363; Le Bris, Nadine/0000-0002-0142-4847; Martinez-Arbizu, Pedro/0000-0002-0891-1154	Austrian Science Foundation [P16774-B03, P20190-B17]; National Science Foundation, USA [OCE-0002729]; ChEss	Austrian Science Foundation(Austrian Science Fund (FWF)); National Science Foundation, USA(National Science Foundation (NSF)); ChEss	This work was supported by the Austrian Science Foundation grant FWF (P16774-B03, P20190-B17 to MB), the National Science Foundation, USA (OCE-0002729 to CR Fisher), and ChEss. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M., 1996, ECOLOGY; Bertness M.D., 2001, MARINE COMMUNITY ECO; Bright M, 2005, SYMBIOSIS, V38, P1; Bright M, 2010, DEEP-SEA RES PT II, V57, P1982, DOI 10.1016/j.dsr2.2010.05.003; BRIGHT M, 2006, HDB HYDROTHERMAL VEN, P27; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Carbotte SM, 1994, J GEOPHYS RES, V97, P6959; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Clarke K., 2001, PRIMER V5 USER MANUA; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; Danovaro R, 2002, MAR ECOL PROG SER, V230, P159, DOI 10.3354/meps230159; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; Di Meo-Savoie CA, 2004, GEOCHIM COSMOCHIM AC, V68, P2055, DOI 10.1016/j.gca.2003.10.039; Dinet A, 1988, OCEANOL ACTA, V85, P7; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Flint HC, 2006, CAH BIOL MAR, V47, P365; Fornari DJ, 1998, J GEOPHYS RES-SOL EA, V103, P9827, DOI 10.1029/98JB00028; Galkin SV, 2008, OCEANOLOGY+, V48, P509, DOI 10.1134/S0001437008040061; Gheerardyn H, 2009, SCI MAR, V73, P747, DOI 10.3989/scimar.2009.73n4747; Giere, 2009, MEIOBENTHOLOGY THE M; GOLLNER S, PLOS ONE IN PRESS; Gollner S, 2008, ZOOTAXA, P323, DOI 10.11646/zootaxa.1866.1.16; Gollner S, 2006, CAH BIOL MAR, V47, P397; Gollner S, 2007, MAR ECOL PROG SER, V337, P39, DOI 10.3354/meps337039; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2007, MAR ECOL-EVOL PERSP, V28, P3, DOI 10.1111/j.1439-0485.2007.00148.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; Heptner M. V., 2002, Arthropoda Selecta, V11, P117; Hessler R., 1985, B BIOL SOC WASH, V6, P411; Hourdez S, 2000, BIOL BULL-US, V199, P95, DOI 10.2307/1542868; HUMES A G, 1989, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V11, P829; HUMES A G, 1990, Scientia Marina, V54, P145; HUMES AG, 1987, B MAR SCI, V41, P645; HUMES AG, 1989, ZOOL SCR, V18, P103, DOI 10.1111/j.1463-6409.1989.tb00125.x; HUMES AG, 1994, J CRUSTACEAN BIOL, V14, P337, DOI 10.2307/1548913; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Ivanenko VN, 2006, HDB HYDROTHERMAL VEN, P316; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; KAMENEV GM, 1993, NEW ZEAL J MAR FRESH, V27, P407, DOI 10.1080/00288330.1993.9516582; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; Katz S, 2006, MAR ECOL PROG SER, V320, P89, DOI 10.3354/meps320089; KIENEKE A, 2007, DESMODASYS ABYSSALIS, P1; Kornicker L. S., 1991, SMITHSONIAN CONTRIBU, V516, P1, DOI DOI 10.5479/SI.00810282.516; Kouris A, 2007, MAR ECOL-EVOL PERSP, V28, P63, DOI 10.1111/j.1439-0485.2006.00118.x; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Le Bris N, 2003, DEEP-SEA RES PT I, V50, P737, DOI 10.1016/S0967-0637(03)00051-7; Le Bris N, 2007, REV ENVIRON SCI BIO, V6, P167; Lee RW, 2003, BIOL BULL-US, V205, P98, DOI 10.2307/1543230; Limen H, 2007, MAR BIOL, V153, P129, DOI 10.1007/s00227-007-0790-1; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Matabos M, 2008, J MAR BIOL ASSOC UK, V88, P995, DOI 10.1017/S002531540800163X; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Micheli F, 2002, ECOL MONOGR, V72, P365, DOI 10.1890/0012-9615(2002)072[0365:PSCADS]2.0.CO;2; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mullineaux LS, 2003, ECOL MONOGR, V73, P523, DOI 10.1890/02-0674; Nees HA, 2008, J SHELLFISH RES, V27, P169, DOI 10.2983/0730-8000(2008)27[169:HVMHCP]2.0.CO;2; Nemeschkal HL, 1999, EVOLUTION, V53, P899, DOI 10.1111/j.1558-5646.1999.tb05384.x; Olafsson E, 2003, VIE MILIEU, V53, P249; Ott J, 2004, SYMBIOSIS, V36, P103; Ott J, 2004, OCEANOGR MAR BIOL, V42, P95; Panieri G, 2005, MAR GEOL, V218, P207, DOI 10.1016/j.margeo.2005.04.002; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Sell AF, 2000, P ROY SOC B-BIOL SCI, V267, P2323, DOI 10.1098/rspb.2000.1286; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; Soltwedel T, 2005, J MARINE SYST, V55, P271, DOI 10.1016/j.jmarsys.2004.09.001; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Thiermann F., 1994, Vie et Milieu, V44, P215; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Tsurumi M, 2003, DEEP-SEA RES PT I, V50, P611, DOI 10.1016/S0967-0637(03)00039-6; Tsurumi M, 2003, J MAR BIOL ASSOC UK, V83, P469, DOI 10.1017/S0025315403007367h; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, MAR ECOL PROG SER, V230, P137, DOI 10.3354/meps230137; Van Dover CL, 2000, ECOLOGY HYDROTHERMAL; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; VANREUSEL A, PLOS ONE IN PRESS; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zekely J, 2006, DEEP-SEA RES PT I, V53, P1363, DOI 10.1016/j.dsr.2006.05.010; Zekely J, 2006, CAH BIOL MAR, V47, P477; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140	97	52	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12321	10.1371/journal.pone.0012321	http://dx.doi.org/10.1371/journal.pone.0012321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856898	Green Published, gold, Green Submitted			2022-12-25	WOS:000280811900039
J	Nitta, RT; Del Vecchio, CA; Chu, AH; Mitra, SS; Godwin, AK; Wong, AJ				Nitta, R. T.; Del Vecchio, C. A.; Chu, A. H.; Mitra, S. S.; Godwin, A. K.; Wong, A. J.			The role of the c-Jun N-terminal kinase 2-alpha-isoform in non-small cell lung carcinoma tumorigenesis	ONCOGENE			English	Article						NSCLC; JNK; STAT3; MAPK	SERINE PHOSPHORYLATION; NH2-TERMINAL KINASE; SIGNAL TRANSDUCER; TUMOR-GROWTH; CANCER CELLS; STAT3; ACTIVATION; PATHWAY; ONCOGENE; JNK	The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase family and have been implicated in tumorigenesis. One isoform in particular, JNK2 alpha, has been shown to be frequently activated in primary brain tumors, to enhance several tumorigenic phenotypes and to increase tumor formation in mice. As JNK is frequently activated in non-small cell lung carcinoma (NSCLC), we investigated the role of the JNK2 alpha isoform in NSCLC formation by examining its expression in primary tumors and by modulating its expression in cultured cell lines. We discovered that 60% of the tested primary NSCLC tumors had three-fold higher JNK2 protein and two-to three-fold higher JNK2 alpha mRNA expression than normal lung control tissue. To determine the importance of JNK2 alpha in NSCLC progression, we reduced JNK2 alpha expression in multiple NSCLC cell lines using short hairpin RNA. Cell lines deficient in JNK2 alpha had decreased cellular growth and anchorage-independent growth, and the tumors were four-fold smaller in mass. To elucidate the mechanism by which JNK2 alpha induces NSCLC growth, we analyzed the JNK substrate, signal transducer and activator of transcription 3 (STAT3). Our data demonstrates for the first time that JNK2 alpha can regulate the transcriptional activity of STAT3 by phosphorylating the Ser727 residue, thereby regulating the expression of oncogenic genes, such as c-Myc. Furthermore, reintroduction of JNK2 alpha 2 or STAT3 restored the tumorigenicity of the NSCLC cells, demonstrating that JNK2 alpha is important for NSCLC progression. Our studies reveal a novel mechanism in which phosphorylation of STAT3 is mediated by a constitutively active JNK2 isoform, JNK2 alpha. Oncogene (2011) 30, 234-244; doi: 10.1038/onc.2010.414; published online 27 September 2010	[Wong, A. J.] Stanford Univ, Med Ctr, Dept Neurosurg, Canc Biol Program,Sch Med, Stanford, CA 94305 USA; [Del Vecchio, C. A.; Wong, A. J.] Stanford Univ, Sch Med, Canc Biol Grad Program, Stanford, CA 94305 USA; [Godwin, A. K.] Fox Chase Canc Ctr, Dept Med Oncol, Womens Canc Program, Philadelphia, PA 19111 USA	Stanford University; Stanford University; Fox Chase Cancer Center	Wong, AJ (corresponding author), Stanford Univ, Med Ctr, Dept Neurosurg, Canc Biol Program,Sch Med, 300 Pasteur Dr,Edwards R221, Stanford, CA 94305 USA.	ajwong@stanford.edu			Mark Linder/American Brain Tumor Association; NIH [CA69495, CA124832]; National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA096539, R01CA124832, R01CA069495, P30CA124435] Funding Source: NIH RePORTER	Mark Linder/American Brain Tumor Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Emily Piccione, Shawn Badal, Tiffany Lieu and Marina Holgado-Madruga for their useful discussions and critical review of the paper. This work was supported by the Mark Linder/American Brain Tumor Association Fellowship, NIH grants CA69495 and CA124832 and a research grant from the National Brain Tumor Foundation.	Achcar RDD, 2007, ARCH PATHOL LAB MED, V131, P1350; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Berner JM, 1999, GENE CHROMOSOME CANC, V26, P151, DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; BROERS JLV, 1993, AM J RESP CELL MOL, V9, P33, DOI 10.1165/ajrcmb/9.1.33; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chen NY, 2001, CANCER RES, V61, P3908; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; GAO SP, 2006, SCI STKE, pPE30; GAZZERI S, 1994, INT J CANCER, V58, P24, DOI 10.1002/ijc.2910580106; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Lee SO, 2004, PROSTATE, V60, P178, DOI 10.1002/pros.20045; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Onishi A, 2008, EXP CELL RES, V314, P377, DOI 10.1016/j.yexcr.2007.09.018; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Tang Gu-Sheng, 2006, Ai Zheng, V25, P269; Tsuiki H, 2003, CANCER RES, V63, P250; Weerasinghe P, 2007, INT J ONCOL, V31, P129; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xie W, 1997, ANTICANCER RES, V17, P2627; Xu X, 1996, ONCOGENE, V13, P135; Yakut T, 2003, LUNG, V181, P245, DOI 10.1007/s00408-003-1026-x; Yang YM, 2003, CLIN CANCER RES, V9, P391; YEAGER T, 1995, CANCER RES, V55, P493; Yeh HH, 2009, DNA CELL BIOL, V28, P131, DOI 10.1089/dna.2008.0762; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhang XL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-149	50	25	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					234	244		10.1038/onc.2010.414	http://dx.doi.org/10.1038/onc.2010.414			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20871632	Green Accepted			2022-12-25	WOS:000286438900011
J	Yan, CG; Cao, J; Wu, M; Zhang, W; Jiang, T; Yoshimura, A; Gao, HW				Yan, Chunguang; Cao, Jay; Wu, Min; Zhang, Wei; Jiang, Tao; Yoshimura, Aihiko; Gao, Hongwei			Suppressor of Cytokine Signaling 3 Inhibits LPS-induced IL-6 Expression in Osteoblasts by Suppressing CCAAT/Enhancer-binding Protein beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TOLL-LIKE RECEPTORS; C/EBP FAMILY; OSTEOCLAST DIFFERENTIATION; PROINFLAMMATORY CYTOKINES; INFLAMMATORY ARTHRITIS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNA	Suppressor of cytokine signaling 3 (SOCS3) is an important intracellular protein that inhibits cytokine signaling in numerous cell types and has been implicated in several inflammatory diseases. However, the expression and function of SOCS3 in osteoblasts are not known. In this study, we demonstrated that SOCS3 expression was transiently induced by LPS in osteoblasts, and apparently contributed to the inhibition of IL-6 induction by LPS treatment. We found that tyrosine 204 of the SOCS box, the SH2 domain, and the N-terminal kinase inhibitory region (KIR) of SOCS3 were all involved in its IL-6 inhibition. Furthermore, we demonstrated that CCAAT/enhancerbinding protein (C/EBP) beta was activated by LPS (increased DNA binding activity), and played a key role in LPS-induced IL-6 expression in osteoblasts. We further provided the evidence that SOCS3 functioned as a negative regulator for LPS response in osteoblasts by suppressing C/EBP beta DNA binding activity. In addition, tyrosine 204 of the SOCS box, the SH2 domain, and the N-terminal kinase inhibitory region (KIR) of SOCS3 were all required for its C/EBP beta inhibition. These findings suggest that SOCS3 by interfering with C/EBP beta activation may have an important regulatory role during bone-associated inflammatory responses.	[Yan, Chunguang; Zhang, Wei; Gao, Hongwei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, Boston, MA 02115 USA; [Yan, Chunguang; Wu, Min; Jiang, Tao; Gao, Hongwei] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA; [Cao, Jay] ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Yoshimura, Aihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yoshimura, Aihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks; United States Department of Agriculture (USDA); Keio University; Japan Science & Technology Agency (JST)	Gao, HW (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, 20 Shattuck St, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Yoshimura, Akihiko/K-5515-2013		North Dakota Experimental Program to Stimulate Competitive Research (NSF); National Institute of Biomedical Innovation (NIBIO)	North Dakota Experimental Program to Stimulate Competitive Research (NSF); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This study was supported by North Dakota Experimental Program to Stimulate Competitive Research (NSF, to H. G.) and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO, to A. Y.).	Akira S, 1995, ANN NY ACAD SCI, V762, P15; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Cao F, 2006, J NEUROCHEM, V98, P459, DOI 10.1111/j.1471-4159.2006.03890.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Hu HM, 1998, J IMMUNOL, V160, P2334; Jung WK, 2009, LIFE SCI, V85, P46, DOI 10.1016/j.lfs.2009.04.010; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kondo A, 2001, J INTERF CYTOK RES, V21, P943, DOI 10.1089/107999001753289550; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Liu X, 2008, MOL IMMUNOL, V45, P1405, DOI 10.1016/j.molimm.2007.08.018; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Matsuda K, 1997, DIABETES, V46, P354, DOI 10.2337/diabetes.46.3.354; Morales O, 2002, J BIOL CHEM, V277, P34879, DOI 10.1074/jbc.M204819200; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Park SH, 2003, DNA CELL BIOL, V22, P131, DOI 10.1089/104454903321515931; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI13568; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stoiber D, 1999, J IMMUNOL, V163, P2640; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yao CJ, 2008, BIOCHEM BIOPH RES CO, V371, P309, DOI 10.1016/j.bbrc.2008.04.065; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	44	34	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37227	37239		10.1074/jbc.M110.132084	http://dx.doi.org/10.1074/jbc.M110.132084			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876575	Green Published, hybrid			2022-12-25	WOS:000284424000016
J	Yoshida, H; Teraoka, M; Nishi, N; Nakakita, SI; Nakamura, T; Hirashima, M; Kamitori, S				Yoshida, Hiromi; Teraoka, Misa; Nishi, Nozomu; Nakakita, Shin-ichi; Nakamura, Takanori; Hirashima, Mitsuomi; Kamitori, Shigehiro			X-ray Structures of Human Galectin-9 C-terminal Domain in Complexes with a Biantennary Oligosaccharide and Sialyllactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; CRYSTAL-STRUCTURE; LECTIN; APOPTOSIS; FAMILY; ECALECTIN; INDUCTION; MECHANISM; REVEALS; PROGRAM	Galectin-9, a tandem-repeat-type beta-galactoside-specific animal lectin with two carbohydrate recognition domains (CRDs) at the N- and C-terminal ends, is involved in chemoattraction, apoptosis, and the regulation of cell differentiation and has anti-allergic effects. Its ability to recognize carbohydrates is essential for its biological functions. Human galectin-9 (hG9) has high affinity for branched N-glycan-type oligosaccharides (dissociation constants of 0.16-0.70 mu M) and linear beta 1-3-linked poly-N-acetyllactosamines (0.09-8.3 mu M) and significant affinity for the alpha 2-3-sialylated oligosaccharides (17-34 mu M). Further, its N-terminal CRD (hG9N) and C-terminal CRD (hG9C) differ in specificity. To elucidate this unique feature of hG9, x-ray structures of hG9C in the free form and in complexes with N-acetyllactosamine, the biantennary pyridylaminated oligosaccharide, and alpha 2-3-sialyllactose were determined. They are the first x-ray structural analysis of C-terminal CRD of the tandem-repeat-type galectin. The results clearly revealed the mechanism by which branched and alpha 2-3-sialylated oligosaccharides are recognized and explained the difference in specificity between hG9N and hG9C. Based on structural comparisons with other galectins, we propose that the wide entrance for ligand binding and the shallow binding site of hG9C are favorable for branched oligosaccharides and that Arg(221) is responsible for recognizing sialylated oligosaccharides.	[Yoshida, Hiromi; Teraoka, Misa; Nishi, Nozomu; Nakakita, Shin-ichi; Kamitori, Shigehiro] Kagawa Univ, Fac Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Nakamura, Takanori] Kagawa Univ, Fac Med, Dept Endocrinol, Miki, Kagawa 7610793, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University; Kagawa University	Kamitori, S (corresponding author), Kagawa Univ, Fac Med, Life Sci Res Ctr, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kamitori@med.kagawa-u.ac.jp		Kamitori, Shigehiro/0000-0002-3950-3372; Nishi, Nozomu/0000-0001-7050-3226; Yoshida, Hiromi/0000-0001-8333-8215	Kagawa University	Kagawa University	This work was supported in part by Kagawa University Characteristic Prior Research Fund 2009-2010.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; BRUNGER AT, 1993, X PLOR 3 1 SYSTEM X; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hirashima M, 1999, INT ARCH ALLERGY IMM, V120, P7, DOI 10.1159/000053584; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; LASKOWSKI RA, 1992, PROCHECK VERSION 2 P; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyanishi N, 2007, GLYCOBIOLOGY, V17, P423, DOI 10.1093/glycob/cwm001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2008, J MOL BIOL, V375, P119, DOI 10.1016/j.jmb.2007.09.060; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Nakakita SI, 2007, BIOCHEM BIOPH RES CO, V362, P639, DOI 10.1016/j.bbrc.2007.08.032; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	36	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36969	36976		10.1074/jbc.M110.163402	http://dx.doi.org/10.1074/jbc.M110.163402			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861009	hybrid, Green Published			2022-12-25	WOS:000284146100071
J	Suyemoto, MM; Spears, PA; Hamrick, TS; Barnes, JA; Havell, EA; Orndorff, PE				Suyemoto, M. Mitsu; Spears, Patricia A.; Hamrick, Terri S.; Barnes, Jill A.; Havell, Edward A.; Orndorff, Paul E.			Factors Associated with the Acquisition and Severity of Gestational Listeriosis	PLOS ONE			English	Article							FETOPLACENTAL LISTERIOSIS; MONOCYTOGENES INFECTION; GUINEA-PIG; PREGNANCY; MICE; PATHOGENESIS; HOST	Gravid mammals are more prone to listeriosis than their nongravid counterparts. However, many features of the disease in gravid animals are not well defined. We determined, in mice, that increased susceptibility to lethal infection following oral inoculation begins surprisingly early in pregnancy and extends through embryonic development. Pregnancy did not demonstrably increase the spread of listeriae from the intestine to the liver and spleen in the initial 96 h period post inoculation. Consequently, it appeared that gravid animals were competent to contain an enteric infection, but in those instances where escape did occur, a lethal outcome was more likely. Interestingly, colonic colonization level and prevalence, measured 96 h post inoculation, was significantly higher in gravid individuals. In terms of human risk factors for listeriosis, our results suggest that the window of listeriosis susceptibility afforded by pregnancy may be open longer than previously appreciated. Our results also suggest that while gravid animals are competent to contain an enteric infection, enteric carriage rate may be more of a factor in defining disease incidence than previously considered.	[Suyemoto, M. Mitsu; Spears, Patricia A.; Havell, Edward A.; Orndorff, Paul E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Hamrick, Terri S.] Campbell Univ, Sch Pharm, Dept Pharmaceut Sci, Buies Creek, NC 27506 USA; [Barnes, Jill A.] N Carolina State Univ, Coll Vet Med, Dept Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; Campbell University; University of North Carolina; North Carolina State University	Suyemoto, MM (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	paul_orndorff@ncsu.edu		Hamrick, Terri/0000-0003-0388-1256	National Institutes of Health [R03AI064217, R21AI064333, 1R21AI083838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083838, R03AI064217, R21AI064333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R03AI064217, R21AI064333 and 1R21AI083838 from the National Institutes of Health. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram M, 1997, FOLIA MICROBIOL, V42, P65, DOI 10.1007/BF02898648; ARMSTRONG D, 1995, PRINCIPLES PRACTICE; Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066; BORTOLUSSI R, 1984, SURV SYN PATHOL RES, V3, P311; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; CIESIELSKI CA, 1988, ARCH INTERN MED, V148, P1416, DOI 10.1001/archinte.148.6.1416; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; Hamrick TS, 2003, INFECT IMMUN, V71, P5202, DOI 10.1128/IAI.71.9.5202-5209.2003; Low JC, 1997, VET J, V153, P9, DOI 10.1016/S1090-0233(97)80005-6; NAKANE A, 1985, INFECT IMMUN, V50, P877, DOI 10.1128/IAI.50.3.877-880.1985; NODEN DM, 1985, EMBRYOLOGY DOMESTIC, P47; Orndorff PE, 2006, VET MICROBIOL, V114, P1, DOI 10.1016/j.vetmic.2005.12.003; PEZESHKIAN R, 1984, BRIT J OBSTET GYNAEC, V91, P85, DOI 10.1111/j.1471-0528.1984.tb05284.x; REDLINE RW, 1987, J CLIN INVEST, V79, P1234, DOI 10.1172/JCI112942; REED LJ, 1938, AM J HYG, V27, P293; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; WEINBERG ED, 1984, REV INFECT DIS, V6, P814	20	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13000	10.1371/journal.pone.0013000	http://dx.doi.org/10.1371/journal.pone.0013000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885996	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100009
J	Hackl, H; Rommer, A; Konrad, TA; Nassimbeni, C; Wieser, R				Hackl, Hubert; Rommer, Anna; Konrad, Torsten A.; Nassimbeni, Christine; Wieser, Rotraud			Tetracycline Regulator Expression Alters the Transcriptional Program of Mammalian Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH ARREST; DIFFERENTIATION; CYCLE	Background: Tetracycline regulated ectopic gene expression is a widely used tool to study gene function. However, the tetracycline regulator (tetR) itself has been reported to cause certain phenotypic changes in mammalian cells. We, therefore, asked whether human myeloid U937 cells expressing the tetR in an autoregulated manner would exhibit alterations in gene expression upon removal of tetracycline. Methodology/Principal Findings: Microarray analyses revealed that 172 and 774 unique genes were significantly differentially expressed by at least 2- or 1.5-fold, respectively, when tetR expressing U937 cells were maintained in media with or without the antibiotic. Conclusions/Significance: These alterations in gene expression are likely to contribute to the phenotypic consequences of tetR expression. In addition, they need to be taken into consideration when using the tetR system for the identification of target genes of transcription factors or other genes of interest.	[Hackl, Hubert] Innsbruck Med Univ, Sect Bioinformat, Bioctr, Innsbruck, Austria; [Rommer, Anna; Nassimbeni, Christine; Wieser, Rotraud] Med Univ Vienna, Med Clin 1, Vienna, Austria; [Rommer, Anna; Konrad, Torsten A.; Wieser, Rotraud] Med Univ Vienna, Inst Human Genet, Vienna, Austria	Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna	Hackl, H (corresponding author), Innsbruck Med Univ, Sect Bioinformat, Bioctr, Innsbruck, Austria.	rotraud.wieser@meduniwien.ac.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Wieser, Rotraud/0000-0003-4384-6658	Austrian Science Foundation (FWF) [P20920]; Austrian Science Fund (FWF) [P 20920] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Foundation (FWF), http://www.fwf.ac.at/, grant no P20920 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Caslini C, 2000, P NATL ACAD SCI USA, V97, P2797, DOI 10.1073/pnas.040574897; Caslini C, 2004, LEUKEMIA, V18, P1064, DOI 10.1038/sj.leu.2403321; FORNEROD M, 1995, ONCOGENE, V10, P1739; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; Hakansson P, 2004, LEUKEMIA, V18, P538, DOI 10.1038/sj.leu.2403255; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hultquist A, 2004, MOL CANCER RES, V2, P464; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097	22	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13013	10.1371/journal.pone.0013013	http://dx.doi.org/10.1371/journal.pone.0013013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886048	Green Published, gold			2022-12-25	WOS:000282122600025
J	Nalla, AK; Asuthkar, S; Bhoopathi, P; Gujrati, M; Dinh, DH; Rao, JS				Nalla, Arun Kumar; Asuthkar, Swapna; Bhoopathi, Praveen; Gujrati, Meena; Dinh, Dzung H.; Rao, Jasti S.			Suppression of uPAR Retards Radiation-Induced Invasion and Migration Mediated by Integrin beta 1/FAK Signaling in Medulloblastoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; EPITHELIAL-MESENCHYMAL TRANSITIONS; UROKINASE RECEPTOR; CELL-MIGRATION; PLASMINOGEN-ACTIVATOR; CANCER-CELLS; TUMOR-GROWTH; PROGNOSTIC-FACTORS; ADULT MEDULLOBLASTOMA; VINCULIN RECRUITMENT	Background: Despite effective radiotherapy for the initial stages of cancer, several studies have reported the recurrence of various cancers, including medulloblastoma. Here, we attempt to capitalize on the radiation-induced aggressive behavior of medulloblastoma cells by comparing the extracellular protease activity and the expression pattern of molecules, known to be involved in cell adhesion, migration and invasion, between non-irradiated and irradiated cells. Methodology/Principal Findings: We identified an increase in invasion and migration of irradiated compared to non-irradiated medulloblastoma cells. RT-PCR analysis confirmed increased expression of uPA, uPAR, focal adhesion kinase (FAK), N-Cadherin and integrin subunits (e. g., alpha 3, alpha 5 and beta 1) in irradiated cells. Furthermore, we noticed a similar to 2-fold increase in tyrosine phosphorylation of FAK in irradiated cells. Immunoprecipitation studies confirmed increased interaction of integrin beta 1 and FAK in irradiated cells. In addition, our results show that overexpression of uPAR in cancer cells can mimic radiation-induced activation of FAK signaling. Moreover, by inhibiting FAK phosphorylation, we were able to reduce the radiation-induced invasiveness of the cancer cells. In this vein, we studied the effect of siRNA-mediated knockdown of uPAR on cell migration and adhesion in irradiated and non-irradiated medulloblastoma cells. Downregulation of uPAR reduced the radiation-induced adhesion, migration and invasion of the irradiated cells, primarily by inhibiting phosphorylation of FAK, Paxillin and Rac-1/Cdc42. As observed from the immunoprecipitation studies, uPAR knockdown reduced interaction among the focal adhesion molecules, such as FAK, Paxillin and p130Cas, which are known to play key roles in cancer metastasis. Pretreatment with uPAR shRNA expressing construct reduced uPAR and phospho FAK expression levels in pre-established medulloblastoma in nude mice. Conclusion/Significance: Taken together, our results show that radiation enhances uPAR-mediated FAK signaling and by targeting uPAR we can inhibit radiation-activated cell adhesion and migration both in vitro and in vivo.	[Nalla, Arun Kumar; Asuthkar, Swapna; Bhoopathi, Praveen; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Nalla, AK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Nalla, Arun Kumar/D-1457-2012		National Institutes of Health [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health, CA138409 (to J.S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 1999, APMIS, V107, P96, DOI 10.1111/j.1699-0463.1999.tb01531.x; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Camphausen K, 2001, CANCER RES, V61, P2207; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casadei R, 2010, PANCREATOLOGY, V10, P33, DOI 10.1159/000217604; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan AW, 2000, NEUROSURGERY, V47, P623, DOI 10.1097/00006123-200009000-00018; Chan MY, 2007, ANN ACAD MED SINGAP, V36, P314; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feltbower R, 2004, PEDIATR HEMAT ONCOL, V21, P647, DOI 10.1080/08880010490501079; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; FU KK, 1991, HEMATOL ONCOL CLIN N, V5, P737, DOI 10.1016/S0889-8588(18)30413-1; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Grose R, 2002, DEVELOPMENT, V129, P2303; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hegedus B, 2004, J NEURO-ONCOL, V67, P147, DOI 10.1023/B:NEON.0000021826.73020.f3; Hehlgans S, 2007, INT J RADIAT BIOL, V83, P769, DOI 10.1080/09553000701694327; Howes TL, 2006, J NEURO-ONCOL, V80, P191, DOI 10.1007/s11060-006-9175-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kopac S, 2004, PEDIATR HEMAT ONCOL, V21, P17, DOI 10.1080/08880010490263344; Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Leo E, 1997, J NEURO-ONCOL, V32, P149, DOI 10.1023/A:1005721510659; LIOTTA LA, 1986, EUR J CANCER CLIN ON, V22, P345, DOI 10.1016/0277-5379(86)90403-7; LOWENFELS AB, 1989, GASTROENTEROLOGY, V96, P551, DOI 10.1016/S0016-5085(89)91616-8; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mazloom A, 2010, INT J RADIAT ONCOL, V78, P72, DOI 10.1016/j.ijrobp.2009.07.1729; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Ogata K, 2009, HEPATO-GASTROENTEROL, V56, P1760; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Painter KJ, 2010, J THEOR BIOL, V264, P1057, DOI 10.1016/j.jtbi.2010.03.033; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Qian LW, 2002, CLIN CANCER RES, V8, P1223; Ranger A, 2009, CAN J NEUROL SCI, V36, P631, DOI 10.1017/S0317167100008155; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rutkauskiene Giedre, 2006, Medicina (Kaunas), V42, P22; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun LM, 2002, J NEURO-ONCOL, V58, P77, DOI 10.1023/A:1015865614640; Tang CH, 2008, J CELL SCI, V121, P3747, DOI 10.1242/jcs.029769; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsutsumi K, 2009, CELL STRUCT FUNCT, V34, P89, DOI 10.1247/csf.09006; Uings IJ, 2000, J CLIN PATHOL-MOL PA, V53, P295; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wild-Bode C, 2001, CANCER RES, V61, P2744; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	78	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13006	10.1371/journal.pone.0013006	http://dx.doi.org/10.1371/journal.pone.0013006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886051	gold, Green Published, Green Submitted			2022-12-25	WOS:000282122600023
J	Bastianetto, S; Dumont, Y; Duranton, A; Vercauteren, F; Breton, L; Quirion, R				Bastianetto, Stephane; Dumont, Yvan; Duranton, Albert; Vercauteren, Freya; Breton, Lionel; Quirion, Remi			Protective Action of Resveratrol in Human Skin: Possible Involvement of Specific Receptor Binding Sites	PLOS ONE			English	Article							NITRIC-OXIDE; RED WINE; TRANS-RESVERATROL; POTENTIAL ROLE; APOPTOSIS; KERATINOCYTES; PEROXYNITRITE; AGGREGATION; POLYPHENOLS; CONSUMPTION	Background: Resveratrol is a plant-derived polyphenol with purported protecting action on various disorders associated with aging. It has been suggested that resveratrol could exert its protective action by acting on specific plasma membrane polyphenol binding sites (Han Y. S., et al. (2006) J Pharmacol Exp Ther 318: 238-245). The purpose of this study was to investigate, in human skin, the possible existence of specific binding sites that mediate the protective action of resveratrol. Methods and Findings: Using human skin tissue, we report here the presence of specific [H-3]-resveratrol binding sites (K-D = 180 nM) that are mainly located in the epidermis. Exposure of HaCaT cells to the nitric oxide free radical donor sodium nitroprusside (SNP; 0.3-3 mM) resulted in cell death which was reduced by resveratrol (EC50 = 14.7 mu M), and to a much lesser extent by the resveratrol analogue piceatannol (EC50 = 95 mu M) and epigallocatechin gallate (EC50 = 200 mu M), a green-tea derived polyphenol. The protective action of resveratrol likely relates to its anti-apoptotic effect since at the same range of concentration it was able to reduce both the number of apoptotic cells as well as mitochondrial apoptotic events triggered by SNP. Conclusion: Taken together, these findings suggest that resveratrol, by acting on specific polyphenol binding sites in epidermis, may be useful to prevent skin disorders associated with aging.	[Bastianetto, Stephane; Dumont, Yvan; Vercauteren, Freya; Quirion, Remi] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Duranton, Albert; Breton, Lionel] LOreal Rech, Clichy, France	McGill University; L'Oreal Group	Bastianetto, S (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada.	remi.quirion@douglas.mcgill.ca		Duranton, Albert/0000-0002-4057-7176	L'Oreal Research & Development, France	L'Oreal Research & Development, France	This work was supported by a research grant from L'Oreal Research & Development, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Bastianetto S, 2004, FRONT BIOSCI-LANDMRK, V9, P3447, DOI 10.2741/1493; Bastianetto S, 2002, NUTRITION, V18, P432, DOI 10.1016/S0899-9007(01)00745-6; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Baxter Richard A, 2008, J Cosmet Dermatol, V7, P2, DOI 10.1111/j.1473-2165.2008.00354.x; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; BOZYCZKOCOYNE D, 1993, J NEUROSCI METH, V50, P205, DOI 10.1016/0165-0270(93)90009-G; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Chen M, 2009, NEUROSIGNALS, V17, P162, DOI 10.1159/000205525; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; DELICONSTANTINOS G, 1995, BRIT J PHARMACOL, V114, P1257, DOI 10.1111/j.1476-5381.1995.tb13341.x; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; GOLDBERG DM, 1995, CLIN CHIM ACTA, V237, P155, DOI 10.1016/0009-8981(95)06069-P; Han YS, 2006, J PHARMACOL EXP THER, V318, P238, DOI 10.1124/jpet.106.102319; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Jung JY, 2007, NEUROSCI LETT, V411, P222, DOI 10.1016/j.neulet.2006.09.089; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; La Vecchia C, 2009, NUTR REV, V67, pS126, DOI 10.1111/j.1753-4887.2009.00174.x; Lee ER, 2005, J BIOL CHEM, V280, P31498, DOI 10.1074/jbc.M505537200; Lee SK, 2007, CANCER LETT, V249, P283, DOI 10.1016/j.canlet.2006.09.012; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Orallo F, 2008, CURR MED CHEM, V15, P1887, DOI 10.2174/092986708785132951; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Salvolini E, 2010, ARCH DERMATOL RES, V302, P367, DOI 10.1007/s00403-009-1018-7; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sparrow RL, 2005, J IMMUNOL METHODS, V305, P173, DOI 10.1016/j.jim.2005.07.017; VILLIOTOU V, 1995, ANTICANCER RES, V15, P931; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yu W, 2009, J CELL BIOCHEM, V107, P741, DOI 10.1002/jcb.22169	41	42	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12935	10.1371/journal.pone.0012935	http://dx.doi.org/10.1371/journal.pone.0012935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886076	gold, Green Submitted, Green Published			2022-12-25	WOS:000282091100034
J	Silk, JB; Strum, SC				Silk, Joan B.; Strum, Shirley C.			Maternal Condition Does Not Influence Birth Sex Ratios in Anubis Baboons (Papio anubis)	PLOS ONE			English	Article							REPRODUCTION; HYPOTHESIS; PREGNANCY; DOMINANCE; SELECTION; SUCCESS; RANK	Trivers and Willard predicted that when parental condition has differential effects on the fitness of male and female offspring, parents who are in good condition will bias investment toward the sex that benefits most from additional investment. Efforts to test predictions derived from Trivers and Willard's model have had mixed results, perhaps because most studies have relied on proxy measures of parental condition, such as dominance rank. Here, we examine the effects of female baboons condition on birth sex ratios and post-natal investment, based on visual assessments of maternal body condition. We find that local environmental conditions have significant effects on female condition, but maternal condition at conception has no consistent relationship with birth sex ratios. Mothers who are in poorer condition at the time of conception resume cycling significantly later than females who are in better condition, but the sex of their infants has no effect on the time to resumption of cycling. Thus, our findings provide strong evidence that maternal condition influences females' ability to reproduce, but females do not facultatively adjust the sex ratio of their offspring in relation to their dominance rank or current condition.	[Silk, Joan B.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Silk, Joan B.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90024 USA; [Strum, Shirley C.] Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA; [Strum, Shirley C.] Uaso Ngiro Baboon Project, Nairobi, Kenya	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Silk, JB (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	jsilk@anthro.ucla.edu			National Geographic Society; Wildlife Conservation Society; Conservation International; African Conservation Fund (ACF); Dutch Government (DGIS)	National Geographic Society(National Geographic Society); Wildlife Conservation Society; Conservation International; African Conservation Fund (ACF); Dutch Government (DGIS)	National Geographic Society, Wildlife Conservation Society, Conservation International, African Conservation Fund (ACF), and a grant from the Dutch Government (DGIS) provided funding for the research from 1984 to 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Altmann J, 2003, OFFSPRING, P140; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; BARTON RA, 1993, ANIM BEHAV, V46, P791, DOI 10.1006/anbe.1993.1256; BARTON RA, 1992, FOLIA PRIMATOL, V58, P56, DOI 10.1159/000156608; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; BERMAN CM, 1988, AM NAT, V131, P307, DOI 10.1086/284792; Brown GR, 2002, P NATL ACAD SCI USA, V99, P11252, DOI 10.1073/pnas.162360599; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; Dittus WPJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P149, DOI 10.1007/s002650050527; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; McNaughton SJ., 1979, SERENGETI DYNAMICS E, P46; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Schino G, 2004, BEHAV ECOL, V15, P850, DOI 10.1093/beheco/arh094; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SMUTS B, 1989, AM J PRIMATOL, V19, P229, DOI 10.1002/ajp.1350190405; Stearns S.C., 1992, pi; Strum S.C., 1982, International Journal of Primatology, V3, P175, DOI 10.1007/BF02693494; Strum SC, 2005, AM J PRIMATOL, V65, P117, DOI 10.1002/ajp.20103; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WESTNEY P, 1984, IRAL-INT REV APPL LI, V22, P229; [No title captured], DOI DOI 10.1371/JOURNAL.PONE.0012750	27	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12750	10.1371/journal.pone.0012750	http://dx.doi.org/10.1371/journal.pone.0012750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877648	Green Published, gold, Green Submitted			2022-12-25	WOS:000282053100006
J	Sun, QX; Jackson, RA; Ng, C; Guy, GR; Sivaraman, J				Sun, Qingxiang; Jackson, Rebecca A.; Ng, Cherlyn; Guy, Graeme R.; Sivaraman, J.			Additional Serine/Threonine Phosphorylation Reduces Binding Affinity but Preserves Interface Topography of Substrate Proteins to the c-Cbl TKB Domain	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; EGF RECEPTOR; TERMINAL DOMAIN; DOWN-REGULATION; SERINE; ACTIVATION; MUTATIONS; SPROUTY	The E3-ubiquitin ligase, c-Cbl, is a multi-functional scaffolding protein that plays a pivotal role in controlling cell phenotype. As part of the ubiquitination and downregulation process, c-Cbl recognizes targets, such as tyrosine kinases and the Sprouty proteins, by binding to a conserved (NX/R)pY(S/T) XXP motif via its uniquely embedded SH2 domain (TKB domain). We previously outlined the mode of binding between the TKB domain and various substrate peptide motifs, including epidermal growth factor receptor (EGFR) and Sprouty2 (Spry2), and demonstrated that an intrapetidyl hydrogen bond forms between the (pY-1) arginine or (pY-2) asparagine and the phosphorylated tyrosine, which is crucial for binding. Recent reports demonstrated that, under certain types of stimulation, the serine/threonine residues at the pY+1 and/or pY+2 positions within this recognition motif of EGFR and Sprouty2 may be endogenously phosphorylated. Using structural and binding studies, we sought to determine whether this additional phosphorylation could affect the binding of the TKB domain to these peptides and consequently, whether the type of stimulation can dictate the degree to which substrates bind to c-Cbl. Here, we show that additional phosphorylation significantly reduces the binding affinity between the TKB domain and its target proteins, EGFR and Sprouty2, as compared to peptides bearing a single tyrosine phosphorylation. The crystal structure indicates that this is accomplished with minimal changes to the essential intrapeptidyl bond and that the reduced strength of the interaction is due to the charge repulsion between c-Cbl and the additional phosphate group. This obvious reduction in binding affinity, however, indicates that Cbl's interactions with its TKB-centered binding partners may be more favorable in the absence of Ser/Thr phosphorylation, which is stimulation and context specific in vivo. These results demonstrate the importance of understanding the environment in which certain residues are phosphorylated, and the necessity of including this in structural investigations.	[Sun, Qingxiang; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Jackson, Rebecca A.; Ng, Cherlyn; Guy, Graeme R.] Biopolis, Inst Mol & Cell Biol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sun, QX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	mcbgg@imcb.a-star.edu.sg; dbsjayar@nus.edu.sg	Ng, Cherlyn/AAW-8058-2021; Sivaraman, J/H-8028-2012	Ng, Cherlyn/0000-0001-5816-8744; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council (BMRC) [BMRC 05/1/21/19/385]; Singapore Millennium Foundation (SMF)	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation)	This work was supported by the Biomedical Research Council (BMRC) grant (BMRC 05/1/21/19/385). Sun Qingxiang is a graduate student of the National University of Singapore, receiving a Singapore Millennium Foundation (SMF) scholarship (http://www.smf-scholar.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CARCINOGENESIS, V30, P1544, DOI 10.1093/carcin/bgp166; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; GAMOU S, 1994, J CELL PHYSIOL, V158, P151, DOI 10.1002/jcp.1041580119; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; KASHLES O, 1988, P NATL ACAD SCI USA, V85, P9567, DOI 10.1073/pnas.85.24.9567; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miin Wong Esther Sook, 2006, V327, P61; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Oksvold MP, 2004, RADIAT RES, V161, P685, DOI 10.1667/RR3185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sweet SMM, 2008, ANAL CHEM, V80, P6650, DOI 10.1021/ac800963a; THEROUX SJ, 1992, MOL ENDOCRINOL, V6, P1849, DOI 10.1210/me.6.11.1849; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	40	16	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12819	10.1371/journal.pone.0012819	http://dx.doi.org/10.1371/journal.pone.0012819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877636	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100012
J	Booker, KS; Schwarz, J; Garrett, MB; Jones, AM				Booker, Katherine S.; Schwarz, John; Garrett, Michelle B.; Jones, Alan M.			Glucose Attenuation of Auxin-Mediated Bimodality in Lateral Root Formation Is Partly Coupled by the Heterotrimeric G Protein Complex	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CELL ELONGATION; TRANSPORT; REGULATOR; SUGAR; ORGANOGENESIS; ORGANIZATION; INITIATION; INDUCTION; EMERGENCE	Background: Auxin and glucose are both essential elements in normal root development. The heterotrimeric G protein complex in Arabidopsis thaliana, defined as containing alpha (AtGPA1), beta (AGB1), and gamma (AGG) subunits and a GTPase accelerating protein called Regulator of G Signaling 1 protein (AtRGS1), are involved in glucose signaling and regulate auxin transport. Methodology/Principal Findings: A systems approach was used to show that formation of lateral roots, a process requiring coordinated cell division followed by targeted cell expansion, involves a signaling interaction between glucose and auxin. We dissected the relationship between auxin and glucose action using lateral root formation as the biological context. We found that auxin and glucose act synergistically to yield a complex output involving both stimulatory and antagonist glucose effects on auxin responsiveness. Auxin-induced, lateral-root formation becomes bimodal with regard to auxin dose in the presence of glucose. This bimodality is mediated, in part, by the G protein complex defined above. Conclusion/Significance: Auxin and glucose are essential signals controlling the rate of cell proliferation and expansion in roots. Auxin promotes the formation of lateral roots and is consequently essential for proper root architecture. Glucose affects the activation state of the heterotrimeric G protein complex which regulates auxin distribution in the root. The bimodality of auxin-induced, lateral-root formation becomes prominent in the presence of glucose and in roots lacking the G protein complex. Bimodality is apparent without added glucose in all loss-of-function mutants for these G protein components, suggesting that the heterotrimeric G protein complex attenuates the bimodality and that glucose inhibits this attenuation through the complex. The bimodality can be further resolved into the processes of lateral root primordia formation and lateral root emergence, from which a model integrating these signals is proposed.	[Booker, Katherine S.; Garrett, Michelle B.; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Schwarz, John] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Booker, KS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	alan_jones@unc.edu			NIGMS [R01GM065989]; DOE [DE-FG02-05er15671]; NSF [MCB-0723515, MCB-0718202]; UNC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIGMS (R01GM065989), DOE (DE-FG02-05er15671) and NSF (MCB-0723515 and MCB-0718202) to A.M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Friedman and the entire 2010 Biology 447 class for technical assistance and the UNC GRC program for support to J.S.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; DOLAN L, 1993, DEVELOPMENT, V119, P71; Enstone DE, 2001, TREES-STRUCT FUNCT, V15, P98, DOI 10.1007/s004680000079; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2003, PLANT PHYSIOL, V131, P1623, DOI 10.1104/pp.102.017624; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; JONES AM, 1990, PLANT PHYSIOL, V93, P1154, DOI 10.1104/pp.93.3.1154; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; MUDAY GK, 1994, PLANT PHYSIOL BIOCH, V32, P193; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; R Development Core Team, 2009, R FDN STAT COMP; RAYLE DL, 1970, P NATL ACAD SCI USA, V65, P184, DOI 10.1073/pnas.65.1.184; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sabina J, 2009, EUKARYOT CELL, V8, P1314, DOI 10.1128/EC.00138-09; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tian QY, 2009, NEW PHYTOL, V184, P918, DOI 10.1111/j.1469-8137.2009.03004.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; WILSON JW, 1978, PROC R SOC SER B-BIO, V203, P153, DOI 10.1098/rspb.1978.0098; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	41	39	43	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12833	10.1371/journal.pone.0012833	http://dx.doi.org/10.1371/journal.pone.0012833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862254	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800023
J	Becker, M; Siems, WE; Kluge, R; Gembardt, F; Schultheiss, HP; Schirner, M; Walther, T				Becker, Matthias; Siems, Wolf-Eberhard; Kluge, Reinhart; Gembardt, Florian; Schultheiss, Heinz-Peter; Schirner, Michael; Walther, Thomas			New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE INHIBITOR; NATRIURETIC PEPTIDE; FOOD-INTAKE; METABOLIC SYNDROME; PREVENTS OBESITY; CANDOXATRIL; KNOCKOUT; LEPTIN; ENERGY; MOUSE	Background: According to the World Health Organization (WHO) there is a pandemic of obesity with approximately 300 million people being obese. Typically, human obesity has a polygenetic causation. Neutral endopeptidase (NEP), also known as neprilysin, is considered to be one of the key enzymes in the metabolism of many active peptide hormones. Methodology/Principal Findings: An incidental observation in NEP-deficient mice was a late-onset excessive gain in body weight exclusively from a ubiquitous accumulation of fat tissue. In accord with polygenetic human obesity, mice were characterized by deregulation of lipid metabolism, higher blood glucose levels, with impaired glucose tolerance. The key role of NEP in determining body mass was confirmed by the use of the NEP inhibitor candoxatril in wild-type mice that increased body weight due to increased food intake. This is a peripheral and not a central NEP action on the switch for appetite control, since candoxatril cannot cross the blood-brain barrier. Furthermore, we demonstrated that inhibition of NEP in mice with cachexia delayed rapid body weight loss. Thus, lack in NEP activity, genetically or pharmacologically, leads to a gain in body fat. Conclusions/Significance: In the present study, we have identified NEP to be a crucial player in the development of obesity. NEP-deficient mice start to become obese under a normocaloric diet in an age of 6-7 months and thus are an ideal model for the typical human late-onset obesity. Therefore, the described obesity model is an ideal tool for research on development, molecular mechanisms, diagnosis, and therapy of the pandemic obesity.	[Becker, Matthias; Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmacol, Dept Biochem Neurobiol, Berlin, Germany; [Kluge, Reinhart] Deutsch Inst Ernahrungsforsch, Max Rubner Lab, Potsdam, Germany; [Gembardt, Florian] Univ Hull, Ctr Biomed Res, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Gembardt, Florian] Univ Giessen, Dept Expt Cardiol, Giessen, Germany; [Schultheiss, Heinz-Peter] Charite, Dept Cardiol, D-13353 Berlin, Germany; [Schirner, Michael] Mivenion GmbH, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Hull; University of York - UK; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Becker, M (corresponding author), Leibniz Inst Mol Pharmacol, Dept Biochem Neurobiol, Berlin, Germany.	thomas.walther@hyms.ac.uk	Gembardt, Florian/H-2360-2011	Gembardt, Florian/0000-0003-2739-345X; Becker, Matthias/0000-0001-9965-6648	Deutsche Forschungsgemeinschaft (DFG) [SI-483/8/1-2, SI-483/8/1-3, WA1441/18/1-2, WA1441/18/1-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant (SI-483/8/1-2 and -3, as well as WA1441/18/1-2 and -3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Aust L, 2001, EUR J NUTR, V40, P23, DOI 10.1007/PL00007382; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BEVAN EG, 1992, J HYPERTENS, V10, P607; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davidson E, 2009, EXP DIABETES RES, DOI 10.1155/2009/431980; Finer N, 2003, CLIN MED, V3, P23, DOI 10.7861/clinmedicine.3-1-23; Fischer HS, 2002, J MOL NEUROSCI, V18, P129, DOI 10.1385/JMN:18:1-2:129; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; Harris RBS, 2002, AM J PHYSIOL-REG I, V283, pR1094, DOI 10.1152/ajpregu.00339.2002; Inuzuka M, 2010, ENDOCRINOLOGY, V151, P3633, DOI 10.1210/en.2010-0141; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kaye B, 1997, XENOBIOTICA, V27, P1091, DOI 10.1080/004982597240046; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; McDowell G, 2000, CARDIOVASC DRUG REV, V18, P259; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; *NHS INF CTR, 2008, STAT OB PHYS ACT DIE; Pankow K, 2007, CIRC RES, V101, P875, DOI 10.1161/CIRCRESAHA.107.153585; Pankow K, 2009, J MOL BIOL, V393, P496, DOI 10.1016/j.jmb.2009.08.025; Poritsanos NJ, 2009, INT J OBESITY, V33, P1381, DOI 10.1038/ijo.2009.187; Powell DR, 2006, OBES REV, V7, P89, DOI 10.1111/j.1467-789X.2006.00220.x; RIVIERE PJM, 1987, LIFE SCI, V41, P333, DOI 10.1016/0024-3205(87)90157-3; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Scholzen TE, 2004, EXP DERMATOL, V13, P22, DOI 10.1111/j.1600-0625.2004.00260.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Siems WE, 2000, EUR J PHARMACOL, V397, P327, DOI 10.1016/S0014-2999(00)00222-3; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Walther T, 2004, BIOL CHEM, V385, P179, DOI 10.1515/BC.2004.036; Walther T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004590; Winkler A, 1998, BBA-MOL BASIS DIS, V1406, P219, DOI 10.1016/S0925-4439(97)00041-0; Zemel MB, 2000, NUTR REV, V58, P177, DOI 10.1111/j.1753-4887.2000.tb01857.x	38	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12793	10.1371/journal.pone.0012793	http://dx.doi.org/10.1371/journal.pone.0012793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862277	gold, Green Submitted, Green Published			2022-12-25	WOS:000281864100023
J	Christakis, NA; Fowler, JH				Christakis, Nicholas A.; Fowler, James H.			Social Network Sensors for Early Detection of Contagious Outbreaks	PLOS ONE			English	Article							INFLUENZA-A H1N1	Current methods for the detection of contagious outbreaks give contemporaneous information about the course of an epidemic at best. It is known that individuals near the center of a social network are likely to be infected sooner during the course of an outbreak, on average, than those at the periphery. Unfortunately, mapping a whole network to identify central individuals who might be monitored for infection is typically very difficult. We propose an alternative strategy that does not require ascertainment of global network structure, namely, simply monitoring the friends of randomly selected individuals. Such individuals are known to be more central. To evaluate whether such a friend group could indeed provide early detection, we studied a flu outbreak at Harvard College in late 2009. We followed 744 students who were either members of a group of randomly chosen individuals or a group of their friends. Based on clinical diagnoses, the progression of the epidemic in the friend group occurred 13.9 days (95% C. I. 9.9-16.6) in advance of the randomly chosen group (i.e., the population as a whole). The friend group also showed a significant lead time (p<0.05) on day 16 of the epidemic, a full 46 days before the peak in daily incidence in the population as a whole. This sensor method could provide significant additional time to react to epidemics in small or large populations under surveillance. The amount of lead time will depend on features of the outbreak and the network at hand. The method could in principle be generalized to other biological, psychological, informational, or behavioral contagions that spread in networks.	[Christakis, Nicholas A.] Harvard Univ, Fac Arts & Sci, Boston, MA 02115 USA; [Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fowler, James H.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Social Sci, La Jolla, CA 92093 USA	Harvard University; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Fac Arts & Sci, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	Office of the Provost, Harvard University; National Institute on Aging [P-01AG-031093]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	Office of the Provost, Harvard University; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the Office of the Provost, Harvard University (Steve Hyman). The analysis was partially supported by grants from the National Institute on Aging (P-01AG-031093) and by a Pioneer Grant from the Robert Wood Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACHA, 2010, AM COLL HLTH ASS INF; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; BATAGELJ V, 2006, PAJEK PROGRAM ANAL V; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Huet S., 2003, STAT TOOLS NONLINEAR; KAMADA T, 1989, INFORM PROCESSING LE, V31, P113; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; KITSAK M, 2010, 10015285V2 ARXIV; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2003, SOC NETWORKS, V25, P83, DOI 10.1016/S0378-8733(02)00039-4; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Rogers E. M., 1964, DIFFUSION INNOVATION; ROSENQUIST JN, 2010, MOL PSYCHIATR, V16, P273, DOI DOI 10.1038/MP.2010.13; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; Scott BA, 2009, J APPL PSYCHOL, V94, P20, DOI 10.1037/a0012951; Smith DMD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036112; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Zuckerman EW, 2001, SOC PSYCHOL QUART, V64, P207, DOI 10.2307/3090112; 2010, MORB MORTAL WEEKLY R, V59, P38	38	257	261	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12948	10.1371/journal.pone.0012948	http://dx.doi.org/10.1371/journal.pone.0012948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856792	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800033
J	Le Saout, C; Villard, M; Cabasse, C; Jacquet, C; Taylor, N; Hernandez, J				Le Saout, Cecile; Villard, Marine; Cabasse, Clemence; Jacquet, Chantal; Taylor, Naomi; Hernandez, Javier			IL-2 Mediates CD4(+) T Cell Help in the Breakdown of Memory-Like CD8(+) T Cell Tolerance under Lymphopenic Conditions	PLOS ONE			English	Article							HOMEOSTATIC PROLIFERATION; CUTTING EDGE; PERIPHERAL TOLERANCE; IN-VIVO; AUTOIMMUNE-DISEASE; TCR REPERTOIRE; INTERLEUKIN-2; LYMPHOCYTES; NAIVE; SELF	Background: Lymphopenia results in the proliferation and differentiation of naive T cells into memory-like cells in the apparent absence of antigenic stimulation. This response, at least in part due to a greater availability of cytokines, is thought to promote anti-self responses. Although potentially autoreactive memory-like CD8(+) T cells generated in a lymphopenic environment are subject to the mechanisms of peripheral tolerance, they can induce autoimmunity in the presence of antigen-specific memory-like CD4(+) T helper cells. Methodology/Principal Findings: Here, we studied the mechanisms underlying CD4 help under lymphopenic conditions in transgenic mice expressing a model antigen in the beta cells of the pancreas. Surprisingly, we found that the self-reactivity mediated by the cooperation of memory-like CD8(+) and CD4(+) T cells was not abrogated by CD40L blockade. In contrast, treatment with anti-IL-2 antibodies inhibited the onset of autoimmunity. IL-2 neutralization prevented the CD4-mediated differentiation of memory-like CD8(+) T cells into pathogenic effectors in response to self-antigen cross-presentation. Furthermore, in the absence of helper cells, induction of IL-2 signaling by an IL-2 immune complex was sufficient to promote memory-like CD8(+) T cell self-reactivity. Conclusions/Significance: IL-2 mediates the cooperation of memory-like CD4(+) and CD8(+) T cells in the breakdown of crosstolerance, resulting in effector cytotoxic T lymphocyte differentiation and the induction of autoimmune disease.	[Le Saout, Cecile] Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France; Univ Montpellier 1, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Le Saout, C (corresponding author), Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France.	javier.hernandez@igmm.cnrs.fr	Taylor, Naomi/H-4016-2014	Hernandez, Javier/0000-0002-7218-7519; VILLARD, Marine/0000-0002-3905-8993	European Community [SOE1/P1/E014, 2005-018914]	European Community(European Commission)	CL was supported by the Association pour la Recherche contre le Cancer and IMMUNONET. MV is supported by the Ministere de l'Enseignement Superieur et de la Recherche. NT is supported by Inserm and a Contrat d' interface with the Centre Hospitalier Universitaire (C.H.U.) d'Amiens. JH is supported by Inserm and a Contrat d'interface with the C. H. U. de Montellier. This work was supported by grants from the European Community SUDOE- FEDER (Contract # IMMUNONET SOE1/P1/E014), Association pour la Recherche contre le Cancer and the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques to JH and the European Community (contract LSHC-CT-2005-018914 ATTACK) to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cheung KP, 2009, J IMMUNOL, V183, P3364, DOI 10.4049/jimmunol.0900641; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; GUILLOUX Y, 1994, EUR J IMMUNOL, V24, P1966, DOI 10.1002/eji.1830240905; Hamilton SE, 2008, P NATL ACAD SCI USA, V105, P18484, DOI 10.1073/pnas.0806487105; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hernandez J, 2000, J IMMUNOL, V164, P596, DOI 10.4049/jimmunol.164.2.596; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Morgan DJ, 1996, J IMMUNOL, V157, P978; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Verdeil G, 2008, P NATL ACAD SCI USA, V105, P16683, DOI 10.1073/pnas.0805054105; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965	67	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12659	10.1371/journal.pone.0012659	http://dx.doi.org/10.1371/journal.pone.0012659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20856822	Green Published, Green Submitted, gold			2022-12-25	WOS:000281687300006
J	Briefer, E; Rybak, F; Aubin, T				Briefer, Elodie; Rybak, Fanny; Aubin, Thierry			Are Unfamiliar Neighbours Considered to Be Dear-Enemies?	PLOS ONE			English	Article							STRANGER DISCRIMINATION; SONG; RECOGNITION; SIGNATURE	Background: Discriminating threatening individuals from non-threatening ones allow territory owners to modulate their territorial responses according to the threat posed by each intruder. This ability reduces costs associated with territorial defence. Reduced aggression towards familiar adjacent neighbours, termed the dear-enemy effect, has been shown in numerous species. An important question that has never been investigated is whether territory owners perceive distant neighbours established in the same group as strangers because of their unfamiliarity, or as dear-enemies because of their group membership. Methodology/Principal Findings: To investigate this question, we played back to male skylarks (Alauda arvensis) songs of adjacent neighbours, distant neighbours established a few territories away in the same microdialect area and strangers. Additionally, we carried out a propagation experiment to investigate how far skylark songs are propagated in their natural habitat and we estimated repertoire similarity between adjacent neighbours, distant neighbours and strangers. We show that skylarks, in the field, respond less aggressively to songs of their distant and likely unfamiliar neighbours, as shown by the propagation experiment, compared to stranger songs. The song analysis revealed that individuals share a high amount of syllables and sequences with both their adjacent and distant neighbours, but only few syllables and no sequences with strangers. Conclusions: The observed reduction of aggression between distant neighbours thus probably results from their familiarity with the vocal group signature shared by all members of the neighbourhood. Therefore, in skylarks, dear-enemy-like relationships can be established between unfamiliar individuals who share a common acoustic code.	[Briefer, Elodie; Rybak, Fanny; Aubin, Thierry] Univ Paris 11, CNRS, UMR 8195, CNPS, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Briefer, E (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	e.briefer@qmul.ac.uk	Briefer, Elodie/A-3584-2010		Centre National de la Recherche Scientifique; Universite Paris Sud; French Minister of Research and Technology	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud; French Minister of Research and Technology	This study was supported by the Centre National de la Recherche Scientifique (http://www.cnrs.fr/index.php) - Universite Paris Sud (http://www.u-psud.fr/en/index.html). Elodie Briefer was funded by a French Minister of Research and Technology (http://www.enseignementsup-recherche.gouv.fr/) fellowship during the data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN T, 1983, Z TIERPSYCHOL, V61, P141; Baker MC, 2004, ETHOLOGY, V110, P21, DOI 10.1046/j.1439-0310.2003.00941.x; Botero CA, 2008, ETHOLOGY, V114, P1227, DOI 10.1111/j.1439-0310.2008.01576.x; Botero CA, 2007, ANIM BEHAV, V73, P661, DOI 10.1016/j.anbehav.2006.10.007; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Briefer E, 2010, J THEOR BIOL, V262, P151, DOI 10.1016/j.jtbi.2009.09.020; Briefer E, 2009, NATURWISSENSCHAFTEN, V96, P1067, DOI 10.1007/s00114-009-0567-0; BRINDLEY EL, 1991, ANIM BEHAV, V41, P503, DOI 10.1016/S0003-3472(05)80853-X; CRAIG C, 2000, GOLDWAVE V 5 11 GOLD; DONALD PF, 2004, SKYLARK, P72; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; HULTSCH H, 1981, BEHAV ECOL SOCIOBIOL, V8, P183, DOI 10.1007/BF00299828; Khanna H., 1997, Bioacoustics, V7, P209; Lambrechts Marcel M., 1995, Current Ornithology, V12, P115; Lehongre K, 2008, ETHOLOGY, V114, P425, DOI 10.1111/j.1439-0310.2008.01486.x; MAMMEN DL, 1981, BEHAV ECOL SOCIOBIOL, V9, P179, DOI 10.1007/BF00302935; MANTEL N, 1967, CANCER RES, V27, P209; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Mundinger P. C., 1982, ACOUSTIC COMMUNICATI, P147; Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246; Naguib M, 1998, J AVIAN BIOL, V29, P155, DOI 10.2307/3677193; Naguib Marc, 2006, P300; R- Development-Core-Team, 2009, R FDN STAT COMP; Radford AN, 2005, ANIM BEHAV, V70, P1227, DOI 10.1016/j.anbehav.2005.04.002; Skierczynski M, 2010, BEHAVIOUR, V147, P333, DOI 10.1163/000579509X12549112908535; Sokal R. R., 2012, BIOMETRY; SPECHT R, 2004, AVISOFT SASLAB PRO V; SPECHT R, 2001, AVISOFT CORRELATOR V; Stoddard Philip Kraft, 1996, P356; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; WEARY DM, 1992, ANIM BEHAV, V43, P283, DOI 10.1016/S0003-3472(05)80223-4; Wilson PL, 2001, ANIM BEHAV, V62, P1197, DOI 10.1006/anbe.2001.1863	37	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12428	10.1371/journal.pone.0012428	http://dx.doi.org/10.1371/journal.pone.0012428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865148	Green Submitted, Green Published, gold			2022-12-25	WOS:000281292100023
J	Wool, GD; Cabana, VG; Lukens, J; Shaw, PX; Binder, CJ; Witztum, JL; Reardon, CA; Getz, GS				Wool, Geoffrey D.; Cabana, Veneracion G.; Lukens, John; Shaw, Peter X.; Binder, Christoph J.; Witztum, Joseph L.; Reardon, Catherine A.; Getz, Godfrey S.			4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice	FASEB JOURNAL			English	Article						mimetic; apoA-I; oxidation; innate immunity; E06/T15	I-MIMETIC PEPTIDE; HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; OXIDATION-SPECIFIC EPITOPES; A-I; OXIDIZED LDL; APOA-I; DEFICIENT MICE; HDL; D-4F	Our objective was to contrast the effect of apolipoprotein (apo) A-I mimetic peptides, such as 4F and 4F-Pro-4F (Pro), on nascent and mature atherosclerotic lesions and on levels of antibodies against oxidation-specific epitopes. Chow-fed apoE(-/-) mice were injected intraperitoneally with either the 4F peptide or a tandem helix apoA-I mimetic peptide (Pro) every other day. Mice treated with 4F, but not Pro, for 4 wk starting at 10 wk of age showed a dramatic decrease in atherosclerosis at 2 arterial sites. However, neither peptide was effective in mice treated for 8 wk starting at 20 wk of age; lesions were larger and more mature at this time point. Peptide treatment caused increased production of antibodies against oxidation-specific epitopes, including a disproportionate induction of the IgM natural antibody (NAb) E06/T15 to oxidized phospholipids. In summary, 4F, but not the tandem peptide Pro, effectively inhibited early atherogenesis but was ineffective against more mature lesions. Two different apoA-I mimetic peptides increased titers of natural antibodies against oxidation-specific epitopes.-Wool, G. D., Cabana, V. G., Lukens, J., Shaw, P. X., Binder, C. J., Witztum, J. L., Reardon, C. A., Getz, G. S. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 25, 290-300 (2011). www.fasebj.org	[Wool, Geoffrey D.; Cabana, Veneracion G.; Lukens, John; Reardon, Catherine A.; Getz, Godfrey S.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Shaw, Peter X.; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Binder, Christoph J.] Austrian Acad Sci, CeMM, A-1010 Vienna, Austria; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria	University of Chicago; University of California System; University of California San Diego; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Getz, GS (corresponding author), 5841 S Maryland Ave,MC1089, Chicago, IL 60637 USA.	g-getz@uchicago.edu		Binder, Christoph J./0000-0001-8313-7050; Wool, Geoffrey/0000-0002-3335-2905	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL68661]; Foundation Leducq; National Institute of Child Health and Human Development [HD007009]; Francis L. Lederer Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068661] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation Leducq(Leducq Foundation); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Francis L. Lederer Foundation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (HL68661 to GSG) and the Foundation Leducq (to G.S.G., C.J.B., and J.L.W.). G.D.W. has received support from the National Institute of Child Health and Human Development (HD007009 Graduate Training in Growth and Development), the Francis L. Lederer Foundation Scholarship Fund, and an American Heart Association predoctoral fellowship. J.L.W. is named as inventor in patents and patent applications from the University of California-San Diego for the potential commercial use of antibodies to oxidized LDL.	Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Cabana VG, 1996, J LIPID RES, V37, P2662; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Carnemolla R, 2008, J BIOL CHEM, V283, P15779, DOI 10.1074/jbc.M710244200; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; DANNER D, 1985, P NATL ACAD SCI USA, V82, P8658, DOI 10.1073/pnas.82.24.8658; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Garber DW, 2001, J LIPID RES, V42, P545; Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Li XJ, 2004, CIRCULATION, V110, P1701, DOI 10.1161/01.CIR.0000142857.79401.69; Nanjee MN, 2001, J LIPID RES, V42, P1586; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2010, ARTERIOSCL THROM VAS, V30, P164, DOI 10.1161/ATVBAHA.109.187518; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Ross DA, 1998, IMMUNOL REV, V166, P143, DOI 10.1111/j.1600-065X.1998.tb01259.x; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Shao B, 2009, J LIPID RES, V50, P599, DOI 10.1194/jlr.E900001-JLR200; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tsimikas S, 2001, ARTERIOSCL THROM VAS, V21, P95, DOI 10.1161/01.ATV.21.1.95; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; Van Lenten BJ, 2007, J LIPID RES, V48, P2344, DOI 10.1194/jlr.M700138-JLR200; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; VanderLaan PA, 2007, AM J PATHOL, V170, P1100, DOI 10.2353/ajpath.2007.060188; Wool GD, 2008, J LIPID RES, V49, P1268, DOI 10.1194/jlr.M700552-JLR200; Wool GD, 2009, J LIPID RES, V50, P1889, DOI 10.1194/jlr.M900151-JLR200	40	33	33	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					290	300		10.1096/fj.10-165670	http://dx.doi.org/10.1096/fj.10-165670			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876212	Green Published			2022-12-25	WOS:000285869500026
J	Lee, M; Partridge, NC				Lee, Minnkyong; Partridge, Nicola C.			Parathyroid Hormone Activation of Matrix Metalloproteinase-13 Transcription Requires the Histone Acetyltransferase Activity of p300 and PCAF and p300-dependent Acetylation of PCAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT COLLAGENASE-3 PROMOTER; BONE-FORMATION; OSTEOBLASTIC CELLS; COACTIVATORS P300; GENE-EXPRESSION; IN-VIVO; P300/CBP-ASSOCIATED FACTOR; MUSCLE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MESSENGER-RNA	Parathyroid hormone (PTH) regulates the transcription of many genes involved in bone remodeling in osteoblasts. One of these genes is matrix metalloproteinase-13 (MMP-13), which is involved in bone remodeling and early stages of endochondral bone formation. We have previously shown that Mmp-13 gene expression is highly induced by PTH treatment in osteoblastic UMR106-01 cells, as well as primary osteoblasts. Here, we show that p300/CBP-associated factor (PCAF), in addition to p300 and Runx2, is required for PTH activation of Mmp-13 transcription. PCAF was increasingly recruited to the MMP-13 proximal promoter region after PTH treatment, and this was associated with an increase in RNA polymerase II recruitment and histone acetylation. In addition, PTH treatment increased the acetylation of PCAF, a process that required p300. Knockdown of PCAF, p300, or Runx2 by siRNA decreased Mmp-13 mRNA expression after PTH treatment in both UMR 106-01 cells and primary osteoblasts. We found that there is a mutual dependence between p300 and PCAF to be recruited to the Mmp-13 promoter after PTH treatment. In promoter-reporter assays, p300 and PCAF had an additive effect on PTH stimulation of MMP-13 promoter activity, and this required their histone acetyltransferase activity. Our findings demonstrate that PCAF acts downstream of PTH signaling as a transcriptional coactivator that is required for PTH stimulation of MMP-13 transcription. PCAF cooperates with p300 and Runx2 to mediate PTH activation of MMP-13 transcription.	[Lee, Minnkyong; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Lee, Minnkyong] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA	New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R56DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 ( to N.C.P.).	Ala-aho R, 2004, ONCOGENE, V23, P5111, DOI 10.1038/sj.onc.1207678; Andereya S, 2006, RHEUMATOL INT, V26, P432, DOI 10.1007/s00296-005-0006-2; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lanske B, 1998, ENDOCRINOLOGY, V139, P5194, DOI 10.1210/en.139.12.5194; Lee KC, 1996, AM J PHYSIOL-RENAL, V270, pF186, DOI 10.1152/ajprenal.1996.270.1.F186; Lee M, 2009, CURR OPIN NEPHROL HY, V18, P298, DOI 10.1097/MNH.0b013e32832c2264; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Uchida M, 2001, J BONE MINER METAB, V19, P207, DOI 10.1007/s007740170022; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38014	38022		10.1074/jbc.M110.142141	http://dx.doi.org/10.1074/jbc.M110.142141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870727	Green Published, hybrid			2022-12-25	WOS:000284625600009
J	Teutschbein, J; Gross, W; Nimtz, M; Milkowski, C; Hause, B; Strack, D				Teutschbein, Jenny; Gross, Wiltrud; Nimtz, Manfred; Milkowski, Carsten; Hause, Bettina; Strack, Dieter			Identification and Localization of a Lipase-like Acyltransferase in Phenylpropanoid Metabolism of Tomato (Solanum lycopersicum)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYCINNAMIC ACID-ESTERS; CHLOROGENIC ACID; GLUCARIC ACID; ENZYMATIC-SYNTHESIS; HYDROAROMATIC ACIDS; PROTEIN PREPARATION; GENE-EXPRESSION; COENZYME-A; CELL-WALL; PURIFICATION	We have isolated an enzyme classified as chlorogenate: glucarate caffeoyltransferase (CGT) from seedlings of tomato (Solanum lycopersicum) that catalyzes the formation of caffeoylglucarate and caffeoylgalactarate using chlorogenate (5-O-caffeoylquinate) as acyl donor. Peptide sequences obtained by trypsin digestion and spectrometric sequencing were used to isolate the SlCGT cDNA encoding a protein of 380 amino acids with a putative targeting signal of 24 amino acids indicating an entry of the SlCGT into the secretory pathway. Immunogold electron microscopy revealed the localization of the enzyme in the apoplastic space of tomato leaves. Southern blot analysis of genomic cDNA suggests that SlCGT is encoded by a single-copy gene. The SlCGT cDNA was functionally expressed in Nicotiana benthamiana leaves and proved to confer chlorogenate-dependent caffeoyltransferase activity in the presence of glucarate. Sequence comparison of the deduced amino acid sequence identified the protein unexpectedly as a GDSL lipase-like protein, representing a new member of the SGNH protein superfamily. Lipases of this family employ a catalytic triad of Ser-Asp-His with Ser as nucleophile of the GDSL motif. Site-directed mutagenesis of each residue of the assumed respective SlCGT catalytic triad, however, indicated that the catalytic triad of the GDSL lipase is not essential for SlCGT enzymatic activity. SlCGT is therefore the first example of a GDSL lipase-like protein that lost hydrolytic activity and has acquired a completely new function in plant metabolism, functioning in secondary metabolism as acyltransferase in synthesis of hydroxycinnamate esters by employing amino acid residues different from the lipase catalytic triad.	[Teutschbein, Jenny; Milkowski, Carsten; Hause, Bettina; Strack, Dieter] Leibniz Inst Plant Biochem, D-06120 Halle, Saale, Germany; [Gross, Wiltrud] Univ Cologne, Inst Bot, D-50674 Cologne, Germany; [Nimtz, Manfred] Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Cologne; German Center for Infection Research	Strack, D (corresponding author), POB 110432, D-06018 Halle, Germany.	dieter.strack@ipb-halle.de		Milkowski, Carsten/0000-0001-9758-6789	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (D. S. and B. H.).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; BARZ W, 1985, BIOCH PLANT PHENOLIC, P307; Baumert A, 2005, PHYTOCHEMISTRY, V66, P1334, DOI 10.1016/j.phytochem.2005.02.031; Beisson F, 1997, PLANT PHYSIOL BIOCH, V35, P761; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; CHEMINAT A, 1988, PHYTOCHEMISTRY, V27, P2787, DOI 10.1016/0031-9422(88)80664-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clauss K, 2008, PLANT J, V53, P802, DOI 10.1111/j.1365-313X.2007.03374.x; Cooper T., 1981, BIOCH ARBEITSMETHODE; Cummins I, 2004, PLANT J, V39, P894, DOI 10.1111/j.1365-313X.2004.02174.x; Dalrymple BP, 1997, MICROBIOL-SGM, V143, P2605, DOI 10.1099/00221287-143-8-2605; ELLIGER CA, 1981, PHYTOCHEMISTRY, V20, P1133, DOI 10.1016/0031-9422(81)83044-0; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Franke R, 1998, PLANT CELL REP, V17, P379, DOI 10.1007/s002990050410; FRY SC, 1995, ANNU REV PLANT PHYS, V46, P497, DOI 10.1146/annurev.pp.46.060195.002433; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; GROSS GG, 1974, EUR J BIOCHEM, V42, P453, DOI 10.1111/j.1432-1033.1974.tb03359.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Ling H, 2006, J BIOCHEM MOL BIOL, V39, P297; LIU ZB, 1994, PLANT CELL, V6, P645, DOI 10.1105/tpc.6.5.645; Lo M, 2004, PLANT PHYSIOL, V135, P947, DOI 10.1104/pp.103.036376; Maas M, 2009, MOLECULES, V14, P36, DOI 10.3390/molecules14010036; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; Milkowski C, 2004, PHYTOCHEMISTRY, V65, P517, DOI 10.1016/j.phytochem.2003.12.018; Milkowski C, 2010, PLANTA, V232, P19, DOI 10.1007/s00425-010-1168-z; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; PERKINS HJ, 1956, ARCH BIOCHEM BIOPHYS, V64, P506, DOI 10.1016/0003-9861(56)90293-4; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RAVN H, 1988, PHYTOCHEMISTRY, V27, P3433, DOI 10.1016/0031-9422(88)80744-1; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; RHODES MJC, 1973, PHYTOCHEMISTRY, V12, P2381, DOI 10.1016/0031-9422(73)80443-1; Ruiz C, 2004, BBA-GEN SUBJECTS, V1672, P184, DOI 10.1016/j.bbagen.2004.03.010; Ruppert M, 2005, PLANTA, V222, P888, DOI 10.1007/s00425-005-0031-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Steffens J C, 2000, Plant Cell, V12, P1253; Stehle F, 2008, PHYTOCHEMISTRY, V69, P1826, DOI 10.1016/j.phytochem.2008.03.021; Stehle F, 2006, FEBS LETT, V580, P6366, DOI 10.1016/j.febslet.2006.10.046; STOCKIGT J, 1974, FEBS LETT, V42, P131, DOI 10.1016/0014-5793(74)80769-6; STRACK D, 1987, J PLANT PHYSIOL, V131, P61, DOI 10.1016/S0176-1617(87)80268-7; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; STRACK D, 1987, PLANT PHYSIOL, V83, P475, DOI 10.1104/pp.83.3.475; STRACK D, 1988, Z NATURFORSCH C, V43, P32; Strack D., 1993, ENZYMES SECONDARY ME, P45; TEISSERE M, 1995, BBA-LIPID LIPID MET, V1255, P105, DOI 10.1016/0005-2760(94)00222-K; ULBRICH B, 1979, PHYTOCHEMISTRY, V18, P929, DOI 10.1016/S0031-9422(00)91451-1; VILLEGAS RJA, 1987, PHYTOCHEMISTRY, V26, P1577, DOI 10.1016/S0031-9422(00)82248-7	58	25	26	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38374	38381		10.1074/jbc.M110.171637	http://dx.doi.org/10.1074/jbc.M110.171637			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880851	Green Published, hybrid			2022-12-25	WOS:000284625600043
J	Iwawaki, T; Akai, R; Kohno, K				Iwawaki, Takao; Akai, Ryoko; Kohno, Kenji			IRE1 alpha Disruption Causes Histological Abnormality of Exocrine Tissues, Increase of Blood Glucose Level, and Decrease of Serum Immunoglobulin Level	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; ER STRESS; QUALITY-CONTROL; MESSENGER-RNA; IRE1; KINASE; REQUIRES	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress. As a cellular adaptive response to ER stress, unfolded protein response (UPR) activates molecules for the quality control of ER proteins. One enzyme that plays an important role in UPR is Inositol Requiring Enzyme-1 (IRE1), which is highly conserved from yeast to humans. In particular, mammalian IRE1 alpha activates X-box-binding protein 1 (XBP1) by unconventional splicing of XBP1 mRNA during ER stress. From analysis of knockout mice, both IRE1 alpha and XBP1 have been shown to be essential for development and that XBP1 is necessary for the secretory machinery of exocrine glands, plasma cell differentiation, and hepatic lipogenesis. However, the essentiality of IRE1 alpha in specific organs and tissues remains incompletely understood. Here, we analyzed the phenotype of IRE1 alpha conditional knockout mice and found that IRE1 alpha-deficient mice exhibit mild hypoinsulinemia, hyperglycemia, and a low-weight trend. Moreover, IRE1 alpha disruption causes histological abnormality of the pancreatic acinar and salivary serous tissues and decrease of serum level of immunoglobulin produced in the plasma cells, but not dysfunction of liver. Comparison of this report with previous reports regarding XBP1 conditional knockout mice might provide some clues for the discovery of the novel functions of IRE1 alpha and XBP1. (196 words)	[Iwawaki, Takao; Akai, Ryoko] RIKEN, Iwawaki Initiat Res Unit, Wako, Saitama, Japan; [Iwawaki, Takao] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Lab Mol & Cell Genet, Nara, Japan	RIKEN; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Iwawaki, T (corresponding author), RIKEN, Iwawaki Initiat Res Unit, Wako, Saitama, Japan.	iwawaki@riken.jp	Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Iwawaki, Takao/0000-0001-8753-1979	Institute of Physical and Chemical Research; Japan Science and Technology Agency; Mochida Memorial Foundation; Suzuken Memorial Foundation; Takeda Science Foundation; Naito Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology [21790218, 14037240]	Institute of Physical and Chemical Research; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Memorial Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Institute of Physical and Chemical Research (to T. I.), Japan Science and Technology Agency (to T.I.), the Mochida Memorial Foundation (to T.I.), the Suzuken Memorial Foundation (to T. I.), the Takeda Science Foundation (to T.I.), the Naito Memorial Foundation (to T.I.), and Ministry of Education, Culture, Sports, Science and Technology (No. 21790218 to T. I. and No. 14037240 to K.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MORI K, 1993, CELL, V74, P743; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	32	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13052	10.1371/journal.pone.0013052	http://dx.doi.org/10.1371/journal.pone.0013052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885949	Green Submitted, Green Published, gold			2022-12-25	WOS:000282167100031
J	Vinberg, F; Koskelainen, A				Vinberg, Frans; Koskelainen, Ari			Calcium Sets the Physiological Value of the Dominant Time Constant of Saturated Mouse Rod Photoresponse Recovery	PLOS ONE			English	Article							RETINAL RODS; GUANYLATE-CYCLASE; LIGHT ADAPTATION; EXCISED PATCHES; MODULATION; CGMP; PHOTORECEPTORS; DEPENDENCE; RESPONSES; CHANNEL	Background: The rate-limiting step that determines the dominant time constant (tau(D)) of mammalian rod photoresponse recovery is the deactivation of the active phosphodiesterase (PDE6). Physiologically relevant Ca2+-dependent mechanisms that would affect the PDE inactivation have not been identified. However, recently it has been shown that tD is modulated by background light in mouse rods. Methodology/Principal Findings: We used ex vivo ERG technique to record pharmacologically isolated photoreceptor responses (fast PIII component). We show a novel static effect of calcium on mouse rod phototransduction: Ca2+ shortens the dominant time constant (tau(D)) of saturated photoresponse recovery, i.e., when extracellular free Ca2+ is decreased from 1 mM to similar to 25 nM, the tau(D) is reversibly increased similar to 1.5-2-fold. Conclusions: We conclude that the increase in tau(D) during low Ca2+ treatment is not due to increased [cGMP], increased [Na+] or decreased [ATP] in rod outer segment (ROS). Also it cannot be due to protein translocation mechanisms. We suggest that a Ca2+-dependent mechanism controls the life time of active PDE.	[Vinberg, Frans; Koskelainen, Ari] Aalto Univ Sch Sci & Technol, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland	Aalto University	Vinberg, F (corresponding author), Aalto Univ Sch Sci & Technol, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	ari.koskelainen@tkk.fi	Vinberg, Frans/AAK-8615-2021	Vinberg, Frans/0000-0003-3439-4979	Academy of Finland [111866]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (http://www.aka.fi/en-gb/A/), grant 111866. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; DONNER K, 1988, ACTA PHYSIOL SCAND, V134, P535, DOI 10.1111/j.1365-201X.1988.tb10632.x; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; Heikkinen H, 2008, VISION RES, V48, P264, DOI 10.1016/j.visres.2007.11.005; HODGKIN AL, 1986, J PHYSIOL-LONDON, V372, pP54; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P863, DOI 10.1085/jgp.106.5.863; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2005, J GEN PHYSIOL, V126, P81, DOI 10.1085/jgp.200308994061405c; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Nymark S, 2006, INVEST OPHTH VIS SCI, V47, P2583, DOI 10.1167/iovs.05-1116; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PEPPERBERG DR, 1994, VISUAL NEUROSCI, V11, P53, DOI 10.1017/S095252380001110X; PORTZEHL H, 1964, BIOCHIM BIOPHYS ACTA, V79, P581, DOI 10.1016/0926-6577(64)90224-4; Rebrik TI, 2004, J GEN PHYSIOL, V123, P63, DOI 10.1085/jgp.200308952; STERN JH, 1987, SCIENCE, V236, P1674, DOI 10.1126/science.3037695; Vinberg FJ, 2009, J VISION, V9, DOI 10.1167/9.12.9; WINKLER BS, 1980, INVEST OPHTH VIS SCI, V19, P562; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P1151; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YAU KW, 1981, NATURE, V292, P502, DOI 10.1038/292502a0; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13025	10.1371/journal.pone.0013025	http://dx.doi.org/10.1371/journal.pone.0013025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885958	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100023
J	Liao, YL; Lonnerdal, B				Liao, Yalin; Loennerdal, Bo			Global MicroRNA Characterization Reveals That miR-103 Is Involved in IGF-1 Stimulated Mouse Intestinal Cell Proliferation	PLOS ONE			English	Article							CDNA MICROARRAY DATA; GROWTH-FACTOR-ALPHA; HUMAN CYCLIN-E; EPITHELIAL-CELLS; HUMAN COLOSTRUM; PROTEIN-KINASE; MINOR PROTEINS; STEM-CELLS; EXPRESSION; MILK	MicroRNAs play extensive roles in cellular development. Analysis of the microRNA expression pattern during intestinal cell proliferation in early life is likely to unravel molecular mechanisms behind intestinal development and have implications for therapeutic intervention. In this study, we isolated mouse intestinal crypt cells, examined the differences in microRNA expression upon IGF-1 stimulated proliferation and identified miR-103 as a one of the key regulators. Mouse intestinal crypt cells were cultured and treated with IGF-1 for 24 h. MicroRNA microarray showed that multiple microRNAs are regulated by IGF-1, and miR-103 was the most sharply down-regulated. Expression of miR-103 in mouse intestinal crypt cells was confirmed by real-time Q-PCR. Sequence analyses showed that, among the 1040 predicted miR-103 target genes, CCNE1, CDK2, and CREB1 contain complementary sequences to the miR-103 seed region that are conserved between human and mouse. We further demonstrated that miR-103 controls the expression level of these three genes in mouse crypt cells by luciferase assay and immunoblotting assay. Taken together, our data suggest that in mouse intestinal crypt cells, miR-103 is part of the G1/S transition regulatory network, which targets CCNE1, CDK2, and CREB1 during IGF-1 stimulated proliferation.	[Liao, Yalin; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis	Liao, YL (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu	Xie, Huangming/B-2260-2012		UC Davis Clinical Nutrition Research Unit (NIH) [DK 35747]; Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035747] Funding Source: NIH RePORTER	UC Davis Clinical Nutrition Research Unit (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Real-time Q-PCR analyses instrument is under the support of the UC Davis Clinical Nutrition Research Unit (NIH grant number DK 35747); this work was funded by Mead Johnson Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen K, 1999, JPEN-PARENTER ENTER, V23, pS89; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cummins AG, 2008, J PEDIATR GASTR NUTR, V47, P153, DOI 10.1097/MPG.0b013e3181604d27; DONOVAN SM, 1994, ANNU REV NUTR, V14, P147, DOI 10.1146/annurev.nu.14.070194.001051; Elmlinger MW, 1999, PEDIATR RES, V46, P76, DOI 10.1203/00006450-199907000-00013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hino Kimihiro, 2007, Nucleic Acids Symp Ser (Oxf), P415, DOI 10.1093/nass/nrm208; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Liao Y, 2010, CELL MOL LIFE SCI, V67, P2969, DOI 10.1007/s00018-010-0366-y; Liao Y, 2010, INT J BIOCHEM CELL B, V42, P1363, DOI 10.1016/j.biocel.2009.07.019; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; MACDONALD TT, 1992, ANN NY ACAD SCI, V664, P202, DOI 10.1111/j.1749-6632.1992.tb39761.x; Murakami K, 1998, ELECTROPHORESIS, V19, P2521, DOI 10.1002/elps.1150191427; Nishimura S, 1998, J GASTROENTEROL, V33, P172, DOI 10.1007/s005350050066; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OLIVER BL, 1995, P SOC EXP BIOL MED, V210, P162; OLIVER BL, 1994, BIOCHEM J, V303, P455, DOI 10.1042/bj3030455; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheng G, 2006, GASTROENTEROLOGY, V131, P153, DOI 10.1053/j.gastro.2006.05.007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Won YJ, 2009, BIOCHEM BIOPH RES CO, V380, P655, DOI 10.1016/j.bbrc.2009.01.159; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	41	30	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12976	10.1371/journal.pone.0012976	http://dx.doi.org/10.1371/journal.pone.0012976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886090	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100059
J	La Starza, R; Matteucci, C; Gorello, P; Brandimarte, L; Pierini, V; Crescenzi, B; Nofrini, V; Rosati, R; Gottardi, E; Saglio, G; Santucci, A; Berchicci, L; Arcioni, F; Falini, B; Martelli, MF; Sambani, C; Aventin, A; Mecucci, C				La Starza, Roberta; Matteucci, Caterina; Gorello, Paolo; Brandimarte, Lucia; Pierini, Valentina; Crescenzi, Barbara; Nofrini, Valeria; Rosati, Roberto; Gottardi, Enrico; Saglio, Giuseppe; Santucci, Antonella; Berchicci, Laura; Arcioni, Francesco; Falini, Brunangelo; Martelli, Massimo Fabrizio; Sambani, Constantina; Aventin, Anna; Mecucci, Cristina			NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; FUSION GENE TRANSCRIPTS; MYELODYSPLASTIC SYNDROME; DE-NOVO; NUCLEOPHOSMIN; DAMAGE; 5Q; DISORDERS	Background: NPM1 gene at chromosome 5q35 is involved in recurrent translocations in leukemia and lymphoma. It also undergoes mutations in 60% of adult acute myeloid leukemia (AML) cases with normal karyotype. The incidence and significance of NPM1 deletion in human leukemia have not been elucidated. Methodology and Principal Findings: Bone marrow samples from 145 patients with myelodysplastic syndromes (MDS) and AML were included in this study. Cytogenetically 43 cases had isolated 5q-, 84 cases had 5q- plus other changes and 18 cases had complex karyotype without 5q deletion. FISH and direct sequencing investigated the NPM1 gene. NPM1 deletion was an uncommon event in the "5q- syndrome'' but occurred in over 40% of cases with high risk MDS/AML with complex karyotypes and 5q loss. It originated from large 5q chromosome deletions. Simultaneous exon 12 mutations were never found. NPM1 gene status was related to the pattern of complex cytogenetic aberrations. NPM1 haploinsufficiency was significantly associated with monosomies (p<0.001) and gross chromosomal rearrangements, i.e., markers, rings, and double minutes (p<0.001), while NPM1 disomy was associated with structural changes (p = 0.013). Interestingly, in complex karyotypes with 5q- TP53 deletion and/or mutations are not specifically associated with NPM1 deletion. Conclusions and Significance: NPM1/5q35 deletion is a consistent event in MDS/AML with a 5q-/-5 in complex karyotypes. NPM1 deletion and NPM1 exon 12 mutations appear to be mutually exclusive and are associated with two distinct cytogenetic subsets of MDS and AML.	[La Starza, Roberta; Matteucci, Caterina; Gorello, Paolo; Brandimarte, Lucia; Pierini, Valentina; Crescenzi, Barbara; Nofrini, Valeria; Rosati, Roberto; Santucci, Antonella; Berchicci, Laura; Arcioni, Francesco; Falini, Brunangelo; Martelli, Massimo Fabrizio; Mecucci, Cristina] Univ Perugia, I-06100 Perugia, Italy; [Rosati, Roberto] Inst Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Parana, Brazil; [Gottardi, Enrico; Saglio, Giuseppe] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Sambani, Constantina] Demokritos Canc Ctr, Athens, Greece; [Aventin, Anna] Hosp De La Santa Creu I Sant Pau, Servei Hematol, Barcelona, Spain	University of Perugia; Hospital Pequeno Principe; University of Turin	La Starza, R (corresponding author), Univ Perugia, I-06100 Perugia, Italy.	crimecux@unipg.it	La Starza, Roberta/ABD-0836-2022; Rosati, Roberto/AAF-3708-2020	Rosati, Roberto/0000-0002-0475-3654; Saglio, Giuseppe/0000-0002-1046-3514; FALINI, Brunangelo/0000-0002-7198-5965	Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB); Associazione Italiana Ricerca sul Cancro (AIRC)	Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB, http://firb.miur.it/) and Associazione Italiana Ricerca sul Cancro ( AIRC, http://www.airc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Berger R, 2006, LEUKEMIA, V20, P319, DOI 10.1038/sj.leu.2404063; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Bowen D, 2009, LEUKEMIA, V23, P203, DOI 10.1038/leu.2008.173; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Crescenzi B, 2004, HAEMATOLOGICA, V89, P281; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Ebert BL, 2009, LEUKEMIA, V23, P1252, DOI 10.1038/leu.2009.53; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gjerset RA, 2006, J MOL HISTOL, V37, P239, DOI 10.1007/s10735-006-9040-y; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Kurki S, 2004, CELL CYCLE, V3, P976; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lessard M, 2007, CANCER GENET CYTOGEN, V176, P1, DOI 10.1016/j.cancergencyto.2007.01.013; Pedersen-Bjergaard J, 2006, LEUKEMIA, V20, P1943, DOI 10.1038/sj.leu.2404381; Royer-Pokora B, 2006, CANCER GENET CYTOGEN, V167, P66, DOI 10.1016/j.cancergencyto.2005.08.003; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0	26	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12855	10.1371/journal.pone.0012855	http://dx.doi.org/10.1371/journal.pone.0012855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877721	gold, Green Submitted, Green Published			2022-12-25	WOS:000282002900010
J	Wiese, M; Antebi, A; Zheng, H				Wiese, Mary; Antebi, Adam; Zheng, Hui			Intracellular Trafficking and Synaptic Function of APL-1 in Caenorhabditis elegans	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ANTEROGRADE AXONAL-TRANSPORT; CORE VESICLE MATURATION; C-ELEGANS; MICE LACKING; ALZHEIMERS-DISEASE; DEFICIENT MICE; GENE; PATHWAY; APP	Background: Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by the deposition of beta-amyloid plaques in the brain. Plaques are composed of the amyloid-beta peptide derived from cleavage of the amyloid precursor protein (APP). Mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), however, the normal function of this protein has proven elusive. The organism Caenorhabditis elegans is an attractive model as the amyloid precursor-like protein (APL-1) is the single ortholog of APP, and loss of apl-1 leads to a severe molting defect and early larval lethality. Methodology/Principal Findings: We report here that lethality and molting can be rescued by full length APL-1, C-terminal mutations as well as a C-terminal truncation, suggesting that the extracellular region of the protein is essential for viability. RNAi knock-down of apl-1 followed by drug testing on the acetylcholinesterase inhibitor aldicarb showed that loss of apl-1 leads to aldicarb hypersensitivity, indicating a defect in synaptic function. The aldicarb hypersensitivity can be rescued by full length APL-1 in a dose dependent fashion. At the cellular level, kinesins UNC-104/KIF-1A and UNC-116/kinesin-1 are positive regulators of APL-1 expression in the neurons. Knock-down of the small GTPase rab-5 also leads to a dramatic decrease in the amount of apl-1 expression in neurons, suggesting that trafficking from the plasma membrane to the early endosome is important for apl-1 function. Loss of function of a different small GTPase, UNC-108, on the contrary, leads to the retention of APL-1 in the cell body. Conclusions/Significance: Our results reveal novel insights into the intracellular trafficking of APL-1 and we report a functional role for APL-1 in synaptic transmission.	[Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Antebi, Adam] Max Planck Inst Biol Aging, Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Wiese, M (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	aantebi@bcm.edu; huiz@bcm.edu			National Institutes of Health [AG032051, AG033467, AG027498]; American Health and Assistance Foundation [A2008-052]; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG027498, R01AG033467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health and Assistance Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (AG032051 and AG033467 and AG027498) and the American Health and Assistance Foundation (A2008-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Heber S, 2000, J NEUROSCI, V20, P7951; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Phinney AL, 1999, NEUROSCIENCE, V90, P1207, DOI 10.1016/S0306-4522(98)00645-9; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; SCHINKMANN K, 1994, MOL BRAIN RES, V24, P238, DOI 10.1016/0169-328X(94)90137-6; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; Torroja L, 1999, J NEUROSCI, V19, P7793; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WOOD WB, 1988, NEMATODE CAENORHABDI, P167; Yochem J, 1999, DEVELOPMENT, V126, P597; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zambrano N, 2002, J CELL SCI, V115, P1411; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	56	36	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12790	10.1371/journal.pone.0012790	http://dx.doi.org/10.1371/journal.pone.0012790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862215	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200004
J	Fuss, J; Ben Abdallah, NMB; Hensley, FW; Weber, KJ; Hellweg, R; Gass, P				Fuss, Johannes; Ben Abdallah, Nada M. B.; Hensley, Frank W.; Weber, Klaus-Josef; Hellweg, Rainer; Gass, Peter			Deletion of Running-Induced Hippocampal Neurogenesis by Irradiation Prevents Development of an Anxious Phenotype in Mice	PLOS ONE			English	Article							DENTATE GYRUS; ADULT NEUROGENESIS; CELL-PROLIFERATION; FOS EXPRESSION; C-FOS; ANXIETY; BEHAVIOR; MEMORY; NEURONS; INTEGRATION	Recent evidence postulates a role of hippocampal neurogenesis in anxiety behavior. Here we report that elevated levels of neurogenesis elicit increased anxiety in rodents. Mice performing voluntary wheel running displayed both highly elevated levels of neurogenesis and increased anxiety in three different anxiety-like paradigms: the open field, elevated O-maze, and dark-light box. Reducing neurogenesis by focalized irradiation of the hippocampus abolished this exercise-induced increase of anxiety, suggesting a direct implication of hippocampal neurogenesis in this phenotype. On the other hand, irradiated mice explored less frequently the lit compartment of the dark-light box test irrespective of wheel running, suggesting that irradiation per se induced anxiety as well. Thus, our data suggest that intermediate levels of neurogenesis are related to the lowest levels of anxiety. Moreover, using c-Fos immunocytochemistry as cellular activity marker, we observed significantly different induction patterns between runners and sedentary controls when exposed to a strong anxiogenic stimulus. Again, this effect was altered by irradiation. In contrast, the well-known induction of brain-derived neurotrophic factor ( BDNF) by voluntary exercise was not disrupted by focal irradiation, indicating that hippocampal BDNF levels were not correlated with anxiety under our experimental conditions. In summary, our data demonstrate to our knowledge for the first time that increased neurogenesis has a causative implication in the induction of anxiety.	[Fuss, Johannes; Ben Abdallah, Nada M. B.; Gass, Peter] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth Mannheim ZI, D-6800 Mannheim, Germany; [Hensley, Frank W.; Weber, Klaus-Josef] Heidelberg Univ, Dept Radiooncol, Heidelberg, Germany; [Hellweg, Rainer] Univ Med Berlin, Dept Psychiat, Berlin, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fuss, J (corresponding author), Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth Mannheim ZI, D-6800 Mannheim, Germany.	johannes.fuss@zi-mannheim.de	Fuss, Johannes/AAI-6580-2021; Weber, Klaus/P-8241-2019	Weber, Klaus/0000-0002-2421-6178; Hellweg, Rainer/0000-0001-8033-389X	Deutsche Forschungsgemeinschaft [GA427/9-1, HE 1392/3-1, SFB636-B3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grant sponsor Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp), under grant numbers: GA427/9-1, HE 1392/3-1, SFB636-B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BELZUNG C, 2007, NEURAL PLAST; Ben Abdallah NMB, 2007, HIPPOCAMPUS, V17, P1230, DOI 10.1002/hipo.20358; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; Castro JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008618; Cazorla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009777; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CLARK PJ, 2010, BEHAV BRAIN RES; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Freud S, 1926, HEMMUNG SYMPTOM ANGS; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Gray JA, 2000, NEUROPSYCHOLOGY ANXI, pxvi; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; Heidegger M., 1949, SEIN ZEIT; Hellweg R, 2003, EXP NEUROL, V183, P346, DOI 10.1016/S0014-4886(03)00127-4; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Mizumatsu S, 2003, CANCER RES, V63, P4021; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	50	87	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12769	10.1371/journal.pone.0012769	http://dx.doi.org/10.1371/journal.pone.0012769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862278	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100014
J	Pericolini, E; Gabrielli, E; Bistoni, G; Cenci, E; Perito, S; Chow, SK; Riuzzi, F; Donato, R; Casadevall, A; Vecchiarelli, A				Pericolini, Eva; Gabrielli, Elena; Bistoni, Giovanni; Cenci, Elio; Perito, Stefano; Chow, Siu-Kei; Riuzzi, Francesca; Donato, Rosario; Casadevall, Arturo; Vecchiarelli, Anna			Role of CD45 Signaling Pathway in Galactoxylomannan-Induced T Cell Damage	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; NEGATIVE REGULATION; CDC25 PHOSPHATASES; INDUCED APOPTOSIS; TYROSINE KINASE; IMMUNE CELLS; ACTIVATION; DEATH; EXPRESSION; LCK	Previously, we reported that Galactoxylomannan (GalXM) activates the extrinsic and intrinsic apoptotic pathways through an interaction with the glycoreceptors on T cells. In this study we establish the role of the glycoreceptor CD45 in GalXM-induced T cell apoptosis, using CD45(+/+) and CD45(-/-) cell lines, derived from BW5147 murine T cell lymphoma. Our results show that whereas CD45 expression is not required for GalXM association by the cells, it is essential for apoptosis induction. In CD45(+/+) cells, CD45 triggering by GalXM reduces the activation of Lck, ZAP70 and Erk1/2. Conversely, in CD45(-/-) cells, Lck was hyperphosphorylated and did not show any modulation after GalXM stimulation. On the whole, our findings provide evidence that the negative regulation of Lck activation occurs via CD45 engagement. This appears to be related to the capacity of GalXM to antagonize T cell activation and induce T cell death. Overall this mechanism may be responsible for the immune paralysis that follows GalXM administration and could explain the powerful immunosuppression that accompanies cryptococcosis.	[Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Perito, Stefano; Riuzzi, Francesca; Donato, Rosario; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Perito, Stefano; Riuzzi, Francesca; Donato, Rosario; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Anat Sect, I-06100 Perugia, Italy; [Bistoni, Giovanni] Univ Roma La Sapienza, Sch Med, Dept Plast & Reconstruct Surg, Rome, Italy; [Chow, Siu-Kei; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA	University of Perugia; University of Perugia; Sapienza University Rome; Yeshiva University; Albert Einstein College of Medicine	Pericolini, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Donato, Rosario/I-3943-2019; Pericolini, Eva/AAZ-5848-2021	CENCI, ELIO/0000-0003-0752-7262; Pericolini, Eva/0000-0002-5299-8197; Vecchiarelli, Anna/0000-0002-3185-6720; Riuzzi, Francesca/0000-0001-7908-3379; PERITO, STEFANO/0000-0003-3181-523X	European Commission (FINSysB Marie Curie Initial Training Network) [PITN-GA-2008-214004]; Istituto Superiore di Sanita [A.DMSS.SEZ8.SPAL09AVEC]; National Institutes of Health [AI33774, AI33142, AI51519, HL59842-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, R01AI033142, R37AI033142, R01AI033774] Funding Source: NIH RePORTER	European Commission (FINSysB Marie Curie Initial Training Network)(European CommissionEuropean Commission Joint Research Centre); Istituto Superiore di Sanita; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is funded by the European Commission (FINSysB Marie Curie Initial Training Network, PITN-GA-2008-214004) and the Istituto Superiore di Sanita (Spallanzani Project, A.DMSS.SEZ8.SPAL09AVEC). AC is supported by National Institutes of Health Grants AI33774, AI33142, AI51519, and HL59842-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2008, INT J BIOCHEM CELL B, V40, P1654, DOI 10.1016/j.biocel.2007.05.016; Arimura Y, 2001, J BIOL CHEM, V276, P8550, DOI 10.1074/jbc.M009242200; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Brezak MC, 2004, CANCER RES, V64, P3320, DOI 10.1158/0008-5472.CAN-03-3984; Chaka W, 1997, INFECT IMMUN, V65, P272, DOI 10.1128/IAI.65.1.272-278.1997; Chou YK, 2004, J NEUROSCI RES, V77, P670, DOI 10.1002/jnr.20201; Contour-Galcera MO, 2004, BIOORG MED CHEM LETT, V14, P5809, DOI 10.1016/j.bmcl.2004.09.041; Dang AM, 1996, CELL IMMUNOL, V169, P196, DOI 10.1006/cimm.1996.0110; DE JESUS M, 2009, J IMMUNOL, V183, P3885; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DEJESUS M, EUKARYOT CELL; Doro U, 1996, MOL CELL BIOL, V16, P4996; Dupere-Minier G, 2010, APOPTOSIS, V15, P1, DOI 10.1007/s10495-009-0413-z; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Fukumori T, 2003, CANCER RES, V63, P8302; Haas A, 2008, CYTOM PART A, V73A, P799, DOI 10.1002/cyto.a.20598; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Hur YG, 2004, J IMMUNOL, V172, P79, DOI 10.4049/jimmunol.172.1.79; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Kirchberger S, 2008, BLOOD, V112, P1240, DOI 10.1182/blood-2008-02-138131; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kunte DP, 2005, FEBS LETT, V579, P3497, DOI 10.1016/j.febslet.2005.05.030; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; LIM TS, 1980, INFECT IMMUN, V30, P5, DOI 10.1128/IAI.30.1.5-11.1980; Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; MIGLIORATI G, 1993, BLOOD, V81, P1352; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Pajusto M, 2004, EUR J IMMUNOL, V34, P2771, DOI 10.1002/eji.200324761; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; SCHRAVEN B, 1995, FEBS LETT, V368, P491, DOI 10.1016/0014-5793(95)00720-T; Sharif-Askari E, 2007, J BIOL CHEM, V282, P36048, DOI 10.1074/jbc.M706007200; Steff AM, 2003, CRIT REV IMMUNOL, V23, P421, DOI 10.1615/CritRevImmunol.v23.i56.40; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; UITTENBOGAART CH, 1990, INT IMMUNOL, V2, P1180; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; WALLACE VA, 1992, J EXP MED, V176, P1657, DOI 10.1084/jem.176.6.1657; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang YN, 2005, J BIOL CHEM, V280, P14318, DOI 10.1074/jbc.M413265200; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	56	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12720	10.1371/journal.pone.0012720	http://dx.doi.org/10.1371/journal.pone.0012720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856869	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815700010
J	Hartbauer, M; Ofner, E; Grossauer, V; Siemers, BM				Hartbauer, Manfred; Ofner, Elisabeth; Grossauer, Viktoria; Siemers, Bjoern M.			The Cercal Organ May Provide Singing Tettigoniids a Backup Sensory System for the Detection of Eavesdropping Bats	PLOS ONE			English	Article							COCKROACH PERIPLANETA-AMERICANA; GIANT INTERNEURON SYSTEM; MOUSE-EARED BATS; PARASPHENDALE-AGRIONINA; TELEOGRYLLUS-OCEANICUS; ECHOLOCATION CALLS; AVOIDANCE-BEHAVIOR; FORAGING STRATEGY; FEEDING-BEHAVIOR; MYOTIS-MYOTIS	Conspicuous signals, such as the calling songs of tettigoniids, are intended to attract mates but may also unintentionally attract predators. Among them bats that listen to prey-generated sounds constitute a predation pressure for many acoustically communicating insects as well as frogs. As an adaptation to protect against bat predation many insect species evolved auditory sensitivity to bat-emitted echolocation signals. Recently, the European mouse-eared bat species Myotis myotis and M. blythii oxygnathus were found to eavesdrop on calling songs of the tettigoniid Tettigonia cantans. These gleaning bats emit rather faint echolocation signals when approaching prey and singing insects may have difficulty detecting acoustic predator-related signals. The aim of this study was to determine (1) if loud self-generated sound produced by European tettigoniids impairs the detection of pulsed ultrasound and (2) if wind-sensors on the cercal organ function as a sensory backup system for bat detection in tettigoniids. We addressed these questions by combining a behavioral approach to study the response of two European tettigoniid species to pulsed ultrasound, together with an electrophysiological approach to record the activity of wind-sensitive interneurons during real attacks of the European mouse-eared bat species Myotis myotis. Results showed that singing T. cantans males did not respond to sequences of ultrasound pulses, whereas singing T. viridissima did respond with predominantly brief song pauses when ultrasound pulses fell into silent intervals or were coincident with the production of soft hemi-syllables. This result, however, strongly depended on ambient temperature with a lower probability for song interruption observable at 21 degrees C compared to 28 degrees C. Using extracellular recordings, dorsal giant interneurons of tettigoniids were shown to fire regular bursts in response to attacking bats. Between the first response of wind-sensitive interneurons and contact, a mean time lag of 860 ms was found. This time interval corresponds to a bat-to-prey distance of ca. 72 cm. This result demonstrates the efficiency of the cercal system of tettigoniids in detecting attacking bats and suggests this sensory system to be particularly valuable for singing insects that are targeted by eavesdropping bats.	[Hartbauer, Manfred; Ofner, Elisabeth; Grossauer, Viktoria] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	University of Graz; Max Planck Society	Hartbauer, M (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Austria.	manfred.hartbauer@uni-graz.at			Austrian Science fund [P 21808-B09]; Max Planck Society; Austrian Science Fund (FWF) [P 21808] Funding Source: researchfish	Austrian Science fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Dr. Heinrich Joerg Stiftung (Graz, Austria) generously supported E. Ofner's visit to perform experiments at the Max Planck Institute for Ornithology in Seewiesen. This study was further funded by the Austrian Science fund project P 21808-B09 and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Andersson Malte, 1994; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Arlettaz R, 1995, SYM ZOOL S, P361; Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; Belwood J. J, 1990, TETTIGONIIDAE BIOL S, P8; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BOYAN GS, 1989, J COMP PHYSIOL A, V165, P523, DOI 10.1007/BF00611239; BOYAN GS, 1990, PROG NEUROBIOL, V35, P217, DOI 10.1016/0301-0082(90)90028-F; BOYAN GS, 1988, J NEUROSCI, V8, P2748; BUCHLER ER, 1981, ANIM BEHAV, V29, P428, DOI 10.1016/S0003-3472(81)80102-9; CAMHI JM, 1978, J COMP PHYSIOL, V128, P193, DOI 10.1007/BF00656852; EDWARDS JS, 1986, J COMP NEUROL, V243, P535, DOI 10.1002/cne.902430408; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; FAURE PA, 1993, J EXP BIOL, V178, P173; Faure PA, 2000, J COMP PHYSIOL A, V186, P129, DOI 10.1007/s003590050013; FULLARD JH, 1993, TRENDS ECOL EVOL, V8, P248, DOI 10.1016/0169-5347(93)90200-9; GANIHAR D, 1994, J COMP PHYSIOL A, V175, P49, DOI 10.1007/BF00217436; GNATZY W, 1990, J COMP PHYSIOL A, V167, P551, DOI 10.1007/BF00190826; GNATZY W, 1986, NATURWISSENSCHAFTEN, V73, P212, DOI 10.1007/BF00417728; Goerlitz HR, 2008, J EXP BIOL, V211, P2799, DOI 10.1242/jeb.019596; GRAS H, 1992, J EXP BIOL, V171, P189; Greenfield MD, 2003, ETHOLOGY, V109, P427, DOI 10.1046/j.1439-0310.2003.00886.x; Hartbauer M, 2010, J EXP BIOL, V213, P3036, DOI 10.1242/jeb.042432; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; HOY RR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P115; HOY RR, 1989, ANNU REV NEUROSCI, V12, P355, DOI 10.1146/annurev.ne.12.030189.002035; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; JATHO M, 1992, RHYTHMOGENESIS NEURO; JONES PL, 2010, BEHAV ECOL IN PRESS; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Land BR, 2001, J NEUROSCI METH, V106, P47, DOI 10.1016/S0165-0270(01)00328-4; Lehmann GUC, 1998, BEHAV ECOL SOCIOBIOL, V43, P239, DOI 10.1007/s002650050488; LIBERSAT F, 1991, J COMP PHYSIOL A, V169, P507, DOI 10.1007/BF00197663; Marsat G, 2006, J NEUROSCI, V26, P10542, DOI 10.1523/JNEUROSCI.2221-06.2006; Millar JS, 2001, BRIT J GEN PRACT, V51, P570; MILLER LA, 1979, J COMP PHYSIOL, V131, P113, DOI 10.1007/BF00619071; Miller Lee A., 1993, Bioacoustics, V5, P67; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Neuweiler G., 2000, BIOL BATS; NIELSEN E T, 1970, Behaviour, V37, P205, DOI 10.1163/156853970X00358; Norman AP, 1999, ANIM BEHAV, V57, P829, DOI 10.1006/anbe.1998.1028; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; RAMME W, 1920, ARCH NATURG A, V12, P123; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; RHEINLAENDER J, 1972, J COMP PHYSIOL, V77, P208, DOI 10.1007/BF00693607; RHEINLAENDER J, 1980, J COMP PHYSIOL, V140, P101, DOI 10.1007/BF00606302; RITZMANN RE, 1981, J COMP PHYSIOL, V143, P61, DOI 10.1007/BF00606069; RITZMANN RE, 1978, J COMP PHYSIOL, V125, P305, DOI 10.1007/BF00656865; RITZMANN RE, 1982, J COMP PHYSIOL, V147, P313, DOI 10.1007/BF00609665; Russo D, 2007, J EXP BIOL, V210, P166, DOI 10.1242/jeb.02644; RYAN MJ, 1987, J COMP PHYSIOL A, V161, P59, DOI 10.1007/BF00609455; SAKALUK SK, 1984, ANIM BEHAV, V32, P659, DOI 10.1016/S0003-3472(84)80141-4; Sales GD, 1974, ULTRASONIC COMMUNICA; Schul J, 1998, J COMP PHYSIOL A, V182, P687, DOI 10.1007/s003590050213; Schul J, 2000, P ROY SOC B-BIOL SCI, V267, P1711, DOI 10.1098/rspb.2000.1199; Schulze W, 2001, J EXP BIOL, V204, P733; Siemers BM, 2006, CURR BIOL, V16, pR157, DOI 10.1016/j.cub.2006.02.056; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; SPANGLER HG, 1984, SOUTHWEST NAT, V29, P481, DOI 10.2307/3671001; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; TER HOFSTEDE HM, 2009, J COMP PHYSIOL A, V195, P769; TER HOFSTEDE HM, 2010, J COMP PHYSIOL A, V196, P349; TER HOFSTEDE HM, 2008, J EXP BIOL, V211, P2431; TER HOFSTEDE HM, 2008, BEHAV ECOL SOCIOBIOL, V63, P217; TOBIAS M, 1979, J COMP PHYSIOL, V129, P51, DOI 10.1007/BF00679911; Triblehorn JD, 2008, J EXP BIOL, V211, P555, DOI 10.1242/jeb.005736; Triblehorn JD, 2006, J EXP BIOL, V209, P1430, DOI 10.1242/jeb.02132; TUTTLE MD, 1985, ANIM BEHAV, V33, P1369, DOI 10.1016/S0003-3472(85)80204-9; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Waters DA, 1996, J EXP BIOL, V199, P847; WATERS DA, 1995, J EXP BIOL, V198, P475; WERNER TK, 1981, CAN J ZOOL, V59, P525, DOI 10.1139/z81-076; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; YAGER DD, 1990, J EXP BIOL, V152, P17; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P; Zuk M, 1998, EVOLUTION, V52, P166, DOI 10.2307/2410931; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	84	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12698	10.1371/journal.pone.0012698	http://dx.doi.org/10.1371/journal.pone.0012698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856887	Green Published, gold, Green Submitted			2022-12-25	WOS:000281735700016
J	Nicastro, G; Todi, SV; Karaca, E; Bonvin, AMJJ; Paulson, HL; Pastore, A				Nicastro, Giuseppe; Todi, Sokol V.; Karaca, Ezgi; Bonvin, Alexandre M. J. J.; Paulson, Henry L.; Pastore, Annalisa			Understanding the Role of the Josephin Domain in the PolyUb Binding and Cleavage Properties of Ataxin-3	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; UBIQUITIN CHAINS; POLYUBIQUITIN CHAINS; STRUCTURAL DETERMINANTS; MEDIATED PROTEOLYSIS; TRANSGENIC MICE; IN-VITRO; PROTEASOME; PATHWAY; RECOGNITION	Ataxin-3, the disease protein in the neurodegenerative disorder Spinocerebellar Ataxia Type 3 or Machado Joseph disease, is a cysteine protease implicated in the ubiquitin proteasome pathway. It contains multiple ubiquitin binding sites through which it anchors polyubiquitin chains of different linkages that are then cleaved by the N-terminal catalytic (Josephin) domain. The properties of the ubiquitin interacting motifs (UIMs) in the C-terminus of ataxin-3 are well established. Very little is known, however, about how two recently identified ubiquitin-binding sites in the Josephin domain contribute to ubiquitin chain binding and cleavage. In the current study, we sought to define the specific contribution of the Josephin domain to the catalytic properties of ataxin-3 and assess how the topology and affinity of these binding sites modulate ataxin-3 activity. Using NMR we modeled the structure of diUb/Josephin complexes and showed that linkage preferences are imposed by the topology of the two binding sites. Enzymatic studies further helped us to determine a precise hierarchy between the sites. We establish that the structure of Josephin dictates specificity for K48-linked chains. Site 1, which is close to the active site, is indispensable for cleavage. Our studies open the way to understand better the cellular function of ataxin-3 and its link to pathology.	[Nicastro, Giuseppe; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Todi, Sokol V.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Karaca, Ezgi; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	MRC National Institute for Medical Research; University of Michigan System; University of Michigan; Utrecht University	Nicastro, G (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Karaca, Ezgi/0000-0002-4926-7991; TODI, SOKOL/0000-0003-4399-5549	Netherlands Organization for Scientific Research [700.56.442];  [1K99NS064097];  [R01 NS38712]; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064097, R01NS038712] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by 1K99NS064097 (SVT), R01 NS38712 (HLP) and a VICI grant (700.56.442) from the Netherlands Organization for Scientific Research (AMJJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gales L., 2005, J MOL BIOL, V26, P26; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Gould VFC, 2007, NEUROBIOL DIS, V27, P362, DOI 10.1016/j.nbd.2007.06.005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jung J, 2009, HUM MOL GENET, V18, P4843, DOI 10.1093/hmg/ddp456; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Maciejewski MW, 2000, J MOL BIOL, V296, P229, DOI 10.1006/jmbi.1999.3455; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2004, J BIOMOL NMR, V30, P457, DOI 10.1007/s10858-004-4343-3; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; RIESS O, 2007, CEREBELLUM, V30, P1; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	41	50	50	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12430	10.1371/journal.pone.0012430	http://dx.doi.org/10.1371/journal.pone.0012430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865150	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100025
J	Aker, M; Bomsztyk, K; Emery, DW				Aker, Mari; Bomsztyk, Karol; Emery, David W.			Poly(ADP-ribose) Polymerase-1 (PARP-1) Contributes to the Barrier Function of a Vertebrate Chromatin Insulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN INSULATOR; ENHANCER BLOCKING; DNA-BINDING; CTCF; TRANSCRIPTION; PROTEINS; VECTORS	The prototypic chromatin insulator cHS4 has proven effective in reducing silencing chromosomal position effects in a variety of settings. Most of this barrier insulator activity has been mapped to a 250-bp core region, as well as to several proteins that bind this region. However, recent studies from our laboratory demonstrated that an extended 400-bp core region of the cHS4 element is necessary to achieve full barrier insulator activity when used as a single copy in the context of recombinant gammaretroviral and lentiviral vectors. In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein binding activities associated with the distal portion of this extended core region. Affinity purification and tandem mass spectrometry studies led to the identification of one of these proteins as poly(ADP-ribose) polymerase-1 (PARP-1). The identity of this binding activity as PARP-1 was subsequently verified by a variety of biochemical studies in vitro and by chromatin immunoprecipitation studies in vivo. Functional studies with gammaretroviral reporter vectors in cell lines and primary mouse bone marrow progenitor cultures showed that cHS4 barrier activity was abrogated upon mutation of the putative PARP1-binding site or upon treatment with a PARP inhibitor, respectively. The barrier activity of the cHS4 element was also found to be abrogated in studies using bone marrow from Parp1-null mice. Taken together, this study demonstrates that binding of PARP-1 plays a key functional role in the barrier activity of the extended cHS4 insulator core element.	[Aker, Mari; Emery, David W.] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Bomsztyk, Karol; Emery, David W.] Univ Washington, UW Med Lake Union, Dept Med, Seattle, WA 98195 USA; [Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Emery, DW (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, 815 Mercer St,Box 358056, Seattle, WA 98109 USA.	demery@uw.edu			National Institutes of Health [HL75713, HL53750, DK-R37-45978, GM45134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750, R01HL075713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL75713 and HL53750 (to D. W. E.) and DK-R37-45978 and GM45134 (to K. B.).	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Emery DW, 2003, N COMP BIOC, V38, P381; Emery DW, 2000, GENE THER, V7, P359, DOI 10.1038/sj.gt.3301107; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37589	37597		10.1074/jbc.M110.174532	http://dx.doi.org/10.1074/jbc.M110.174532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876582	Green Published, hybrid			2022-12-25	WOS:000284424000051
J	Nishino, K; Toyoda, M; Yamazaki-Inoue, M; Makino, H; Fukawatase, Y; Chikazawa, E; Takahashi, Y; Miyagawa, Y; Okita, H; Kiyokawa, N; Akutsu, H; Umezawa, A				Nishino, Koichiro; Toyoda, Masashi; Yamazaki-Inoue, Mayu; Makino, Hatsune; Fukawatase, Yoshihiro; Chikazawa, Emi; Takahashi, Yoriko; Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka; Akutsu, Hidenori; Umezawa, Akihiro			Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; DNA METHYLATION; SOMATIC-CELLS; PLURIPOTENT; QUANTIFICATION; GENERATION; INDUCTION; LINKING; SYSTEM; LINES	Background: Human induced pluripotent stem (iPS) cells are currently used as powerful resources in regenerative medicine. During very early developmental stages, DNA methylation decreases to an overall low level at the blastocyst stage, from which embryonic stem cells are derived. Therefore, pluripotent stem cells, such as ES and iPS cells, are considered to have hypo-methylated status compared to differentiated cells. However, epigenetic mechanisms of "stemness'' remain unknown in iPS cells derived from extra-embryonic and embryonic cells. Methodology/Principal Findings: We examined genome-wide DNA methylation (24,949 CpG sites covering 1,3862 genes, mostly selected from promoter regions) with six human iPS cell lines derived from human amniotic cells and fetal lung fibroblasts as well as two human ES cell lines, and eight human differentiated cell lines using Illumina's Infinium HumanMethylation27. A considerable fraction (807 sites) exhibited a distinct difference in the methylation level between the iPS/ES cells and differentiated cells, with 87.6% hyper-methylation seen in iPS/ES cells. However, a limited fraction of CpG sites with hypo-methylation was found in promoters of genes encoding transcription factors. Thus, a group of genes becomes active through a decrease of methylation in their promoters. Twenty-three genes including SOX15, SALL4, TDGF1, PPP1R16B and SOX10 as well as POU5F1 were defined as genes with hypo-methylated SS-DMR (Stem cell-Specific Differentially Methylated Region) and highly expression in iPS/ES cells. Conclusions/Significance: We show that DNA methylation profile of human amniotic iPS cells as well as fibroblast iPS cells, and defined the SS-DMRs. Knowledge of epigenetic information across iPS cells derived from different cell types can be used as a signature for "stemness'' and may allow us to screen for optimum iPS/ES cells and to validate and monitor iPS/ES cell derivatives for human therapeutic applications.	[Nishino, Koichiro; Toyoda, Masashi; Yamazaki-Inoue, Mayu; Makino, Hatsune; Fukawatase, Yoshihiro; Chikazawa, Emi; Takahashi, Yoriko; Akutsu, Hidenori; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka] Natl Inst Child Hlth & Dev, Dept Dev Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nishino, K (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Miyagawa, Yoshitaka/0000-0003-2629-7503	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare Sciences (MHLW); Japan Health Science Foundation; Pharmaceuticals and Medical Devices Agency	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare Sciences (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Pharmaceuticals and Medical Devices Agency	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare Sciences (MHLW) research grants; by a Research Grant on Health Science focusing on Drug Innovation from the Japan Health Science Foundation; by the program for the promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a Research Grant for Cardiovascular Disease from the MHLW; and by a Grant for Child Health and Development from the MHLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brena RM, 2006, NAT PROTOC, V1, P52, DOI 10.1038/nprot.2006.8; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cui CH, 2007, MOL BIOL CELL, V18, P1586, DOI 10.1091/mbc.E06-09-0872; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; ZINGG JM, 1994, NUCLEIC ACIDS RES, V22, P2234, DOI 10.1093/nar/22.12.2234	43	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13017	10.1371/journal.pone.0013017	http://dx.doi.org/10.1371/journal.pone.0013017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885964	Green Submitted, Green Published, gold			2022-12-25	WOS:000282167100018
J	Papp, M; Norman, GL; Vitalis, Z; Tornai, I; Altorjay, I; Foldi, I; Udvardy, M; Shums, Z; Dinya, T; Orosz, P; Lombay, B; Par, G; Par, A; Veres, G; Csak, T; Osztovits, J; Szalay, F; Lakatos, PL				Papp, Maria; Norman, Gary L.; Vitalis, Zsuzsanna; Tornai, Istvan; Altorjay, Istvan; Foldi, Ildiko; Udvardy, Miklos; Shums, Zakera; Dinya, Tamas; Orosz, Peter; Lombay, Bela, Jr.; Par, Gabriella; Par, Alajos; Veres, Gabor; Csak, Timea; Osztovits, Janos; Szalay, Ferenc; Lakatos, Peter Laszlo			Presence of Anti-Microbial Antibodies in Liver Cirrhosis - A Tell-Tale Sign of Compromised Immunity?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE ANTIBODIES; SPONTANEOUS BACTERIAL PERITONITIS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PRIMARY SCLEROSING CHOLANGITIS; SMALL-BOWEL; ANTIBIOTIC-PROPHYLAXIS; ALCOHOLIC CIRRHOSIS; SEROLOGICAL MARKERS; MICROBIAL ANTIGENS; CELIAC-DISEASE	Background: Bacterial translocation plays important role in the complications of liver cirrhosis. Antibody formation against various microbial antigens is common in Crohn's disease and considered to be caused by sustained exposure to gut microflora constituents. We hypothesized that anti-microbial antibodies are present in patients with liver cirrhosis and may be associated with the development of bacterial infections. Methodology/Principal Findings: Sera of 676 patients with various chronic liver diseases (autoimmune diseases: 266, viral hepatitis C: 124, and liver cirrhosis of different etiology: 286) and 100 controls were assayed for antibodies to Saccharomyces cerevisiae(ASCA) and to antigens derived from two intestinal bacterial isolates (one gram positive, one gram negative, neither is Escherichia coli). In patients with liver cirrhosis, we also prospectively recorded the development of severe episodes of bacterial infection. ASCA and anti-OMP Plus (TM) antibodies were present in 38.5% and 62.6% of patients with cirrhosis and in 16% and 20% of controls, respectively (p<0.001). Occurrence of these antibodies was more frequent in cases of advanced cirrhosis (according to Child-Pugh and MELD score; p<0.001) or in the presence of ascites (p<0.001). During the median follow-up of 425 days, 81 patients (28.3%) presented with severe bacterial infections. Anti-microbial antibody titers (p = 0.003), as well as multiple seroreactivity (p = 0.036), was associated with infectious events. In logistic regression analysis, the presence of ascites (OR: 1.62, 95% CI: 1.16-2.25), co-morbidities (OR: 2.22, 95% CI: 1.27-3.86), and ASCA positivity (OR: 1.59, 95% CI: 1.07-2.36) were independent risk factors for severe infections. A shorter time period until the first infection was associated with the presence of ASCA (p = 0.03) and multiple seropositivity (p = 0.037) by Kaplan-Meier analysis, and with Child-Pugh stage (p = 0.018, OR: 1.85) and co-morbidities (p<0.001, OR: 2.02) by Cox-regression analysis. Conclusions/Significance: The present study suggests that systemic reactivity to microbial components reflects compromised mucosal immunity in patients with liver cirrhosis, further supporting the possible role of bacterial translocation in the formation of anti-microbial antibodies.	[Papp, Maria; Vitalis, Zsuzsanna; Tornai, Istvan; Altorjay, Istvan; Foldi, Ildiko; Udvardy, Miklos] Univ Debrecen, Dept Med 2, H-4012 Debrecen, Hungary; [Norman, Gary L.; Shums, Zakera] INOVA Diagnost Inc, San Diego, CA USA; [Dinya, Tamas] Univ Debrecen, Inst Surg, H-4012 Debrecen, Hungary; [Orosz, Peter] Borsod Abauj Zemplen Cty Hosp, Gastroenterol Dept Med, Miskolc, Hungary; [Lombay, Bela, Jr.] Szent Ferenc Hosp, Dept Med, Miskolc, Hungary; [Par, Gabriella; Par, Alajos] Univ Pecs, Dept Med 1, Pecs, Hungary; [Veres, Gabor] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Csak, Timea; Osztovits, Janos; Szalay, Ferenc; Lakatos, Peter Laszlo] Semmelweis Univ, Dept Med 1, H-1085 Budapest, Hungary	University of Debrecen; Inova Diagnostics, Inc.; University of Debrecen; University of Pecs; Semmelweis University; Semmelweis University	Papp, M (corresponding author), Univ Debrecen, Dept Med 2, H-4012 Debrecen, Hungary.	drpappm@yahoo.com	Lakatos, Peter L/B-2131-2008; Lakatos, Peter/Q-4797-2019	Lakatos, Peter L/0000-0002-3948-6488; Lakatos, Peter/0000-0002-3948-6488	Institute of Internal Medicine	Institute of Internal Medicine	Maria Papp was supported by the Research Development Grant (Institute of Internal Medicine). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gary L. Norman and Zakera Shums are employees of INOVA Diagnostics, Inc. and as such INOVA Diagnostics also played a role in the study design, data analysis and preparation of the manuscript.	Albillos A, 2004, LANCET, V363, P1608, DOI 10.1016/S0140-6736(04)16206-5; Albillos A, 2004, J HEPATOL, V40, P624, DOI 10.1016/j.jhep.2003.12.010; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; ALTORJAY I, 2010, J HEPATOL        JUN; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002907; Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Bauer TM, 2001, AM J GASTROENTEROL, V96, P2962, DOI 10.1111/j.1572-0241.2001.04668.x; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Bhonchal S, 2008, J GASTROEN HEPATOL, V23, pE43, DOI 10.1111/j.1440-1746.2007.05080.x; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; CALY WR, 1993, J HEPATOL, V18, P353, DOI 10.1016/S0168-8278(05)80280-6; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; De Palma GD, 2005, GASTROINTEST ENDOSC, V62, P529, DOI 10.1016/S0016-5107(05)01588-9; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; Fernandez J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065; Gaj P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-81; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; GARCIATSAO G, 1995, GASTROENTEROLOGY, V108, P1835, DOI 10.1016/0016-5085(95)90147-7; Granito A, 2006, GUT, V55, P296; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Gunnarsdottir SA, 2003, AM J GASTROENTEROL, V98, P1362, DOI 10.1016/S0002-9270(03)00250-8; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Hill PG, 2008, ALIMENT PHARM THER, V27, P572, DOI 10.1111/j.1365-2036.2008.03609.x; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; LAKATOS PL, 2004, Z GASTROENTEROL, V42, P423; Maria P, 2007, INFLAMM BOWEL DIS, V13, P984, DOI 10.1002/ibd.20146; MEHTA A, 2009, DISCOVERY ANTIBODY P; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Morencos FC, 1996, DIGEST DIS SCI, V41, P552, DOI 10.1007/BF02282340; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Muratori P, 2003, CLIN EXP IMMUNOL, V132, P473, DOI 10.1046/j.1365-2249.2003.02166.x; Norman K, 2008, CURR OPIN CLIN NUTR, V11, P613, DOI 10.1097/MCO.0b013e32830a70bc; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Papp M, 2007, WORLD J GASTROENTERO, V13, P2028, DOI 10.3748/wjg.v13.i14.2028; Papp M, 2009, WORLD J GASTROENTERO, V15, P3891, DOI 10.3748/wjg.15.3891; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Reddy KR, 2001, AM J GASTROENTEROL, V96, P252; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Saab S, 2009, AM J GASTROENTEROL, V104, P993, DOI 10.1038/ajg.2009.3; Saitoh O, 1999, WORLD J GASTROENTERO, V5, P391; Sakly W, 2008, DIGEST DIS SCI, V53, P1983, DOI 10.1007/s10620-007-0092-y; Singh N, 2003, CLIN MICROBIOL INFEC, V9, P531, DOI 10.1046/j.1469-0691.2003.00691.x; Tandon P, 2008, SEMIN LIVER DIS, V28, P26, DOI 10.1055/s-2008-1040319; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Toumi D, 2007, SCAND J GASTROENTERO, V42, P821, DOI 10.1080/00365520601154996; Vermeire S, 2008, GASTROENTEROL CLIN N, V37, P429, DOI 10.1016/j.gtc.2008.03.001; Weismueller TJ, 2008, J HEPATOL, V48, pS38, DOI 10.1016/j.jhep.2008.01.020; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yagmur E, 2006, DEUT MED WOCHENSCHR, V131, P1930, DOI 10.1055/s-2006-949189; YOSHIDA H, 1993, AM J GASTROENTEROL, V88, P2067; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	54	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12957	10.1371/journal.pone.0012957	http://dx.doi.org/10.1371/journal.pone.0012957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886039	Green Submitted, Green Published, gold			2022-12-25	WOS:000282091100052
J	Yamada, A; Ishimaru, N; Arakaki, R; Katunuma, N; Hayashi, Y				Yamada, Akiko; Ishimaru, Naozumi; Arakaki, Rieko; Katunuma, Nobuhiko; Hayashi, Yoshio			Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8(+) T Cell Activity	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-I; LYSOSOMAL CYSTEINE PROTEASES; ANTIGEN PRESENTATION; INVARIANT CHAIN; NOD MICE; VITRO; TOLERANCE; VIVO; CYCLOPHOSPHAMIDE; ACTIVATION	Background: Type 1 diabetes (T1D) is an autoimmune disease resulting from defects in central and peripheral tolerance and characterized by T cell-mediated destruction of islet beta cells. To determine whether specific lysosomal proteases might influence the outcome of a T cell-mediated autoimmune response, we examined the functional significance of cathepsin inhibition on autoimmune T1D-prone non-obese diabetic (NOD) mice. Methods and Findings: Here it was found that specific inhibition of cathepsin L affords strong protection from cyclophosphamide (CY)-induced insulitis and diabetes of NOD mice at the advanced stage of CD8(+) T cell infiltration via inhibiting granzyme activity. It was discovered that cathepsin L inhibition prevents cytotoxic activity of CD8(+) T cells in the pancreatic islets through controlling dipeptidyl peptidase I activity. Moreover, the gene targeting for cathepsin L with application of in vivo siRNA administration successfully prevented CY-induced diabetes of NOD mice. Finally, cathepsin L mRNA expression of peripheral CD8(+) T cells from NOD mice developing spontaneous T1D was significantly increased compared with that from control mice. Conclusions: Our results identified a novel function of cathepsin L as an enzyme whose activity is essential for the progression of CD8(+) T cell-mediated autoimmune diabetes, and inhibition of cathepsin L as a powerful therapeutic strategy for autoimmune diabetes.	[Yamada, Akiko; Ishimaru, Naozumi; Arakaki, Rieko; Hayashi, Yoshio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Katunuma, Nobuhiko] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan	Tokushima University; Tokushima Bunri University	Yamada, A (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	hayashi@dent.tokushima-u.ac.jp			Ministry of Education, Science, Sport, and Culture of Japan [17109016, 17689049]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported in part by a Grant-in-Aid for Scientific Research (nos. 17109016 and 17689049) from the Ministry of Education, Science, Sport, and Culture of Japan, from the Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bertolino P, 1996, CRIT REV IMMUNOL, V16, P359; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; BROWN GR, 1993, J IMMUNOL, V150, P4733; CHARLTON B, 1989, DIABETES, V38, P441, DOI 10.2337/diabetes.38.4.441; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; DiLorenzo TP, 2005, IMMUNOL REV, V204, P250, DOI 10.1111/j.0105-2896.2005.00244.x; GOLDBERG RB, 2009, J CLIN ENDOCR METAB, V94, P9172; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kreuwel HTC, 2001, J IMMUNOL, V167, P1112, DOI 10.4049/jimmunol.167.2.1112; Mabee CL, 1998, J IMMUNOL, V160, P5880; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Mao JN, 2008, J CELL BIOCHEM, V105, P1073, DOI 10.1002/jcb.21910; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Papaccio G, 2000, ENDOCRINOLOGY, V141, P1500, DOI 10.1210/en.141.4.1500; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Quinn A, 2001, J IMMUNOL, V167, P1748, DOI 10.4049/jimmunol.167.3.1748; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thiele DL, 1997, J IMMUNOL, V158, P5200; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Wu YL, 2003, DIABETES, V52, P2279, DOI 10.2337/diabetes.52.9.2279; Yang H, 2005, J IMMUNOL, V174, P1729, DOI 10.4049/jimmunol.174.3.1729; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Zhang TQ, 2001, BIOCHEM BIOPH RES CO, V283, P499, DOI 10.1006/bbrc.2001.4795	50	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12894	10.1371/journal.pone.0012894	http://dx.doi.org/10.1371/journal.pone.0012894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877570	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100028
J	Bader, HL; Ruhe, AL; Wang, LW; Wong, AK; Walsh, KF; Packer, RA; Mitelman, J; Robertson, KR; O'Brien, DP; Broman, KW; Shelton, GD; Apte, SS; Neff, MW				Bader, Hannah L.; Ruhe, Alison L.; Wang, Lauren W.; Wong, Aaron K.; Walsh, Kari F.; Packer, Rebecca A.; Mitelman, Jonathan; Robertson, Kathryn R.; O'Brien, Dennis P.; Broman, Karl W.; Shelton, G. Diane; Apte, Suneel S.; Neff, Mark W.			An ADAMTSL2 Founder Mutation Causes Musladin-Lueke Syndrome, a Heritable Disorder of Beagle Dogs, Featuring Stiff Skin and Joint Contractures	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; ECTOPIA LENTIS; MOUSE MODEL; FIBRILLIN; PROTEIN; DNA; MICROFIBRILS; PATHOGENESIS	Background: Musladin-Lueke Syndrome (MLS) is a hereditary disorder affecting Beagle dogs that manifests with extensive fibrosis of the skin and joints. In this respect, it resembles human stiff skin syndrome and the Tight skin mouse, each of which is caused by gene defects affecting fibrillin-1, a major component of tissue microfibrils. The objective of this work was to determine the genetic basis of MLS and the molecular consequence of the identified mutation. Methodology and Principal Findings: We mapped the locus for MLS by genome-wide association to a 3.05 Mb haplotype on canine chromosome 9 (CFA9 (50.11-54.26; p(raw) <10(-7))), which was homozygous and identical-by-descent among all affected dogs, consistent with recessive inheritance of a founder mutation. Sequence analysis of a candidate gene at this locus, ADAMTSL2, which is responsible for the human TGF beta dysregulation syndrome, Geleophysic Dysplasia (GD), uncovered a mutation in exon 7 (c.660C>T; p.R221C) perfectly associated with MLS (p-value = 10(-12)). Murine ADAMTSL2 containing the p.R221C mutation formed anomalous disulfide-bonded dimers when transiently expressed in COS-1, HEK293F and CHO cells, and was present in the medium of these cells at lower levels than wild-type ADAMTSL2 expressed in parallel. Conclusions/Significance: The genetic basis of MLS is a founder mutation in ADAMTSL2, previously shown to interact with latent TGF-beta binding protein, which binds fibrillin-1. The molecular effect of the founder mutation on ADAMTSL2 is formation of disulfide-bonded dimers. Although caused by a distinct mutation, and having a milder phenotype than human GD, MLS nevertheless offers a new animal model for study of GD, and for prospective insights on mechanisms and pathways of skin fibrosis and joint contractures.	[Bader, Hannah L.; Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Ruhe, Alison L.; Wong, Aaron K.; Walsh, Kari F.; Robertson, Kathryn R.; Neff, Mark W.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Packer, Rebecca A.] Purdue Univ, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Mitelman, Jonathan] Kingston Rd Anim Hosp, Toronto, ON, Canada; [O'Brien, Dennis P.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	Cleveland Clinic Foundation; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Bader, HL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA.	mark.neff@vai.org		Apte, Suneel/0000-0001-8441-1226; Wong, Aaron/0000-0002-7294-0646; Broman, Karl/0000-0002-4914-6671	Veterinary Genetics Laboratory of UC Davis; National Institutes of Health [AR53890, T32HL007914-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER	Veterinary Genetics Laboratory of UC Davis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by intramural funds from the Veterinary Genetics Laboratory of UC Davis and by National Institutes of Health award AR53890 (S. Apte) and T32HL007914-08 (Training Program in Vascular Biology and Pathology, Principal Investigator: Edward Plow) awarded to H. Bader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; KUTZ WE, 2008, HUM MUTAT; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Le Goff Carine, 2009, Pediatr Endocrinol Rev, V6, P418; LEGOFF C, 2008, NAT GENET; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Musladin JM, 1998, NEW BEAGLE DOG ALL S, Vsecond; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oberbauer AM, 2003, VET RES COMMUN, V27, P27, DOI 10.1023/A:1022006606796; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; SPRANGER J, 1984, AM J MED GENET, V19, P487, DOI 10.1002/ajmg.1320190310; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUTSUI K, 2009, J BIOL CHEM; Wong AK, 2009, ANIM GENET, V40, P569, DOI 10.1111/j.1365-2052.2009.01875.x	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12817	10.1371/journal.pone.0012817	http://dx.doi.org/10.1371/journal.pone.0012817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862248	Green Submitted, Green Published, gold			2022-12-25	WOS:000281960800018
J	Miquel, S; Peyretaillade, E; Claret, L; de Vallee, A; Dossat, C; Vacherie, B; Zineb, E; Segurens, B; Barbe, V; Sauvanet, P; Neut, C; Colombel, JF; Medigue, C; Mojica, FJM; Peyret, P; Bonnet, R; Darfeuille-Michaud, A				Miquel, Sylvie; Peyretaillade, Eric; Claret, Laurent; de Vallee, Amelie; Dossat, Carole; Vacherie, Benoit; Zineb, El Hajji; Segurens, Beatrice; Barbe, Valerie; Sauvanet, Pierre; Neut, Christel; Colombel, Jean-Frederic; Medigue, Claudine; Mojica, Francisco J. M.; Peyret, Pierre; Bonnet, Richard; Darfeuille-Michaud, Arlette			Complete Genome Sequence of Crohn's Disease-Associated Adherent-Invasive E. coli Strain LF82	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; INFLAMMATORY-BOWEL-DISEASE; PHYLOGENETIC GROUP; ILEAL MUCOSA; VI SECRETION; SALMONELLA-TYPHIMURIUM; FIMBRIAL OPERON; BINDING-PROTEIN; BACTERIAL-FLORA	Background: Ileal lesions of Crohn's disease (CD) patients are abnormally colonized by pathogenic adherent-invasive Escherichia coli (AIEC) able to invade and to replicate within intestinal epithelial cells and macrophages. Principal Findings: We report here the complete genome sequence of E. coli LF82, the reference strain of adherent-invasive E. coli associated with ileal Crohn's disease. The LF82 genome of 4,881,487 bp total size contains a circular chromosome with a size of 4,773,108 bp and a plasmid of 108,379 bp. The analysis of predicted coding sequences (CDSs) within the LF82 flexible genome indicated that this genome is close to the avian pathogenic strain APEC_01, meningitis-associated strain S88 and urinary-isolated strain UTI89 with regards to flexible genome and single nucleotide polymorphisms in various virulence factors. Interestingly, we observed that strains LF82 and UTI89 adhered at a similar level to Intestine-407 cells and that like LF82, APEC_01 and UTI89 were highly invasive. However, A1EC strain LF82 had an intermediate killer phenotype compared to APEC-01 and UTI89 and the LF82 genome does not harbour most of specific virulence genes from ExPEC. LF82 genome has evolved from those of ExPEC B2 strains by the acquisition of Salmonella and Yersinia isolated or clustered genes or CDSs located on pLF82 plasmid and at various loci on the chromosome. Conclusion: LF82 genome analysis indicated that a number of genes, gene clusters and pathoadaptative mutations which have been acquired may play a role in virulence of AIEC strain LF82.	[Miquel, Sylvie; Claret, Laurent; de Vallee, Amelie; Sauvanet, Pierre; Bonnet, Richard; Darfeuille-Michaud, Arlette] Univ Auvergne, Clermont Univ, JE2526, INRA,USC 2018, Clermont Ferrand, France; [Miquel, Sylvie; Peyretaillade, Eric; Claret, Laurent; de Vallee, Amelie; Peyret, Pierre; Darfeuille-Michaud, Arlette] Univ Auvergne, Inst Univ Technol, Aubiere, France; [Peyretaillade, Eric; Peyret, Pierre] Univ Clermont 2, Lab Microorganismes Genome & Environm, CNRS, UMR 6023, Aubiere, France; [Dossat, Carole; Vacherie, Benoit; Zineb, El Hajji; Segurens, Beatrice; Barbe, Valerie; Medigue, Claudine] Inst Genom, Direct Sci Vivant, CEA, Evry, France; [Sauvanet, Pierre] Ctr Hosp Univ, Clermont Ferrand, France; [Neut, Christel; Colombel, Jean-Frederic] INSERM, U995, F-59045 Lille, France; [Medigue, Claudine] CNRS, Lab Analyse Bioinformat Genom & Metab, UMR 8030, Evry, France; [Mojica, Francisco J. M.] Univ Alicante, Dept Fisiol, E-03080 Alicante, Spain; [Bonnet, Richard] Ctr Hosp Univ, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Universitat d'Alacant; CHU Clermont Ferrand	Miquel, S (corresponding author), Univ Auvergne, Clermont Univ, JE2526, INRA,USC 2018, Clermont Ferrand, France.	arlette.darfeuille-michaud@u-clermont1.fr	Neut, Christel/S-2521-2018; Neut, Christel/AAA-5153-2021; Bonnet, Richard/C-8544-2015; Mojica, Francisco/M-8478-2019; Mojica, Francisco J.M./K-2414-2014	Neut, Christel/0000-0002-2036-6152; Mojica, Francisco J.M./0000-0002-6660-4996; Miquel, Sylvie/0000-0001-8405-5073; Mangan, Rachel/0000-0002-2984-3699; Vacherie, Benoit/0000-0002-1564-0575; PEYRET, Pierre/0000-0003-3114-0586	Ministere de la Recherche et de la Technologie [JE2526]; Institut National de Recherche Agronomique [USC 2018]; Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough)	Ministere de la Recherche et de la Technologie; Institut National de Recherche Agronomique; Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough)	This study was supported by the Ministere de la Recherche et de la Technologie (JE2526), by the Institut National de Recherche Agronomique (USC 2018) and by grants from the Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Barrett B, 2002, CURR TOP MICROBIOL, V264, P137; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Baumler AJ, 1996, INFECT IMMUN, V64, P1862; Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; BURKE DA, 1988, BMJ-BRIT MED J, V297, P102, DOI 10.1136/bmj.297.6641.102; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; EAVESPYLES T, 2007, INT J MED MICROBIOL; Elson CO, 2000, GASTROENTEROLOGY, V119, P254, DOI 10.1053/gast.2000.9159; Flannery EL, 2009, INFECT IMMUN, V77, P4887, DOI 10.1128/IAI.00705-09; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gullberg E, 2006, ANN NY ACAD SCI, V1072, P218, DOI 10.1196/annals.1326.028; Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hommais F, 2003, INFECT IMMUN, V71, P3619, DOI 10.1128/IAI.71.6.3619-3622.2003; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huebner Claudia, 2009, BMC Res Notes, V2, P52, DOI 10.1186/1756-0500-2-52; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; La Ferla K, 2004, INT J COLORECTAL DIS, V19, P334, DOI 10.1007/s00384-004-0583-7; Lamps LW, 2003, ADV ANAT PATHOL, V10, P319, DOI 10.1097/00125480-200311000-00002; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lavigne JP, 2008, INFECT GENET EVOL, V8, P217, DOI 10.1016/j.meegid.2007.11.005; LIU CD, 1995, AM SURGEON, V61, P1054; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; MARTINEZMEDINA M, 2009, INFLAMM BOWEL DIS; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MORSON BC, 1972, NEW ENGL J MED, V287, P1337, DOI 10.1056/NEJM197212282872607; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sartor RB, 1996, GASTROENTEROLOGY, V110, P1467, DOI 10.1053/gast.1996.v110.pm8613052; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schneider G, 2004, INFECT IMMUN, V72, P5993, DOI 10.1128/IAI.72.10.5993-6001.2004; Schultsz C, 1997, J CLIN PATHOL, V50, P573, DOI 10.1136/jcp.50.7.573; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; Semiramoth N, 2009, J LEUKOCYTE BIOL, V85, P310, DOI 10.1189/jlb.0608350; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Shanahan F, 2002, EUR J SURG, V168, P47; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Subramanian S, 2008, ANTIMICROB AGENTS CH, V52, P427, DOI 10.1128/AAC.00375-07; Sutherland J, 2009, INT J FOOD SCI NUTR, V60, P717, DOI 10.3109/09637480802165650; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-180; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x	99	128	127	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12714	10.1371/journal.pone.0012714	http://dx.doi.org/10.1371/journal.pone.0012714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862302	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800007
J	Brown, JW; Sorhannus, U				Brown, Joseph W.; sorhannus, Ulf			A Molecular Genetic Timescale for the Diversification of Autotrophic Stramenopiles (Ochrophyta): Substantive Underestimation of Putative Fossil Ages	PLOS ONE			English	Article							DIVERGENCE TIMES; RIBOSOMAL-RNA; PHYLOGENETIC TREES; CRYPTIC SPECIATION; ECOLOGICAL LIMITS; SYNCHROMA-GRANDE; HETEROKONT ALGAE; MARINE DIATOMS; BROWN ALGA; EVOLUTION	Background: Stramenopiles constitute a large and diverse eukaryotic clade that is currently poorly characterized from both phylogenetic and temporal perspectives at deeper taxonomic levels. To better understand this group, and in particular the photosynthetic stramenopiles (Ochrophyta), we analyzed sequence data from 135 taxa representing most major lineages. Our analytical approach utilized several recently developed methods that more realistically model the temporal evolutionary process. Methodology/Principal Findings: Phylogenetic reconstruction employed a Bayesian joint rate-and pattern-heterogeneity model to reconstruct the evolutionary history of these taxa. Inferred phylogenetic resolution was generally high at all taxonomic levels, sister-class relationships in particular receiving good statistical support. A signal for heterotachy was detected in clustered portions of the tree, although this does not seem to have had a major influence on topological inference. Divergence time estimates, assuming a lognormally-distributed relaxed molecular clock while accommodating topological uncertainty, were broadly congruent over alternative temporal prior distributions. These data suggest that Ochrophyta originated near the Proterozoic-Phanerozoic boundary, diverging from their sister-taxon Oomycota. The evolution of the major ochrophyte lineages appears to have proceeded gradually thereafter, with most lineages coming into existence by,200 million years ago. Conclusions/Significance: The evolutionary timescale of the autotrophic stramenopiles reconstructed here is generally older than previously inferred from molecular clocks. However, this more ancient timescale nevertheless casts serious doubt on the taxonomic validity of putative xanthophyte/phaeophyte fossils from the Proterozoic, which predate by as much as a half billion years or more the age suggested by our molecular genetic data. If these fossils truly represent crown stramenopile lineages, then this would imply that molecular rate evolution in this group proceeds in a fashion that is fundamentally incompatible with the relaxed molecular clock model employed here. A more likely scenario is that there is considerable convergent morphological evolution within Heterokonta, and that these fossils have been taxonomically misdiagnosed.	[Brown, Joseph W.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; [Brown, Joseph W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [sorhannus, Ulf] Edinboro Univ Penn, Dept Biol & Hlth Serv, Edinboro, PA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania State System of Higher Education (PASSHE); Edinboro University	Brown, JW (corresponding author), Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA.	usorhannus@edinboro.edu	Brown, Joseph W/A-7713-2009	Brown, Joseph W/0000-0002-3835-8062	University of Michigan	University of Michigan(University of Michigan System)	JWB is funded through a Rackham Predoctoral Fellowship from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; ALLISON CW, 1986, J PALEONTOL, V60, P973, DOI 10.1017/S0022336000022538; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; ANDERSEN R.A, 2007, UNRAVELING ALGAE PRE, P283; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; ANDERSEN RA, 1992, BIODIVERS CONSERV, V1, P267, DOI 10.1007/BF00693765; ANDERSEN RA, 2009, INT M CONN COLL NEW, V160, P5; Ben Ali A, 2001, INT J SYST EVOL MICR, V51, P737, DOI 10.1099/00207713-51-3-737; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bown P., 1998, CALCAREOUS NANNOFOSS; BRITTON T, 2006, PATHD8 NEW METHOD ES; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; BROWN JW, 2011, EVOLUTIONAR IN PRESS; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; BUTTERFIELD N.J., 1994, LETHAIA, V27, P76; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Butterfield NJ, 2004, PALEOBIOLOGY, V30, P231, DOI 10.1666/0094-8373(2004)030<0231:AVAFTM>2.0.CO;2; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; CAVALIERSMITH T, 1986, PROGR PHYCOLOGICAL R, P309; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eikrem W, 2004, PHYCOLOGIA, V43, P658, DOI 10.2216/i0031-8884-43-6-658.1; GERMAN TN, 1990, ORGANIC WORLD ONE BI; Girard V, 2009, GEOLOGY, V37, P83, DOI 10.1130/G25009A.1; Goertzen LR, 2003, J PHYCOL, V39, P423, DOI 10.1046/j.1529-8817.2003.01238.x; Grant J, 2009, PROTIST, V160, P376, DOI 10.1016/j.protis.2009.01.001; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hackett Jeremiah D., 2007, P109; HARWOOD D. M., 2007, PALEONTOL SOC PAP, V13, P33, DOI DOI 10.1017/S1089332600001455; HARWOOD DM, 1990, P OCEAN DRILLING PRO, V13, P403; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Hiller N, 1996, REV PALAEOBOT PALYNO, V91, P143, DOI 10.1016/0034-6667(95)00062-3; Ho SYW, 2009, BIOL LETTERS, V5, P421, DOI 10.1098/rsbl.2008.0729; Horn S, 2007, PROTIST, V158, P277, DOI 10.1016/j.protis.2007.02.004; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; John U, 2003, MOL BIOL EVOL, V20, P1015, DOI 10.1093/molbev/msg105; Kai A, 2008, PROTIST, V159, P435, DOI 10.1016/j.protis.2007.12.003; Kato Mitsuru, 2005, Genome Inform, V16, P22; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; Leander BS, 2008, J EUKARYOT MICROBIOL, V55, P59, DOI 10.1111/j.1550-7408.2008.00308.x; LEARY RL, 1986, AM J BOT, V73, P369, DOI 10.2307/2444080; LIM BL, 1986, JPN J GENET, V61, P169, DOI 10.1266/jjg.61.169; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; LOEBLICH A R JR, 1974, Taxon, V23, P277, DOI 10.2307/1218707; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Medlin LK, 1997, PLANT SYST EVOL, P187; Negrisolo E, 2004, MOL PHYLOGENET EVOL, V33, P156, DOI 10.1016/j.ympev.2004.04.016; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Patil V, 2009, J EUKARYOT MICROBIOL, V56, P394, DOI 10.1111/j.1550-7408.2009.00389.x; PHILIPPE H, 1994, J EVOLUTION BIOL, V7, P247, DOI 10.1046/j.1420-9101.1994.7020247.x; Phillips N, 2008, J PHYCOL, V44, P15, DOI 10.1111/j.1529-8817.2007.00435.x; Porter S. M., 2004, PALEONTOL SOC PAP, V10, P35, DOI [DOI 10.1017/S1089332600002321, 10.1017/s1089332600002321]; Porter Susannah M., 2006, V27, P1; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; RAJANIKANTH A, 1989, CURR SCI INDIA, V58, P78; Rambaut A, 2013, TRACER VERSION 1 6; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Renner SS, 2008, SYST BIOL, V57, P795, DOI 10.1080/10635150802422282; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; ROTHPLETZ A., 1896, Z DTSCH GEOLOGISCHEN, V48, P854; Rothpletz A., 1900, Z DEUTSCH GEOLOGISCH, V52, P154; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SAUNDERS GW, 1995, P NATL ACAD SCI USA, V92, P244, DOI 10.1073/pnas.92.1.244; Schmid A. M.-M., 2000, ORIGIN EARLY EVOLUTI, P13; SIEMINSKA J, 2000, ORIGIN EARLY EVOLUTI, P117; Sieminska Jadwiga, 2002, Acta Palaeobotanica, V42, P3; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Siver PA, 2007, CAN J BOT, V85, P83, DOI 10.1139/B06-143; Sorhannus U, 2001, CLADISTICS, V17, P227, DOI 10.1111/j.1096-0031.2001.tb00119.x; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Sorhannus U, 2010, PROTIST, V161, P237, DOI 10.1016/j.protis.2009.10.003; STRELNIKOVA NI, 1975, NOVA HEDWIGIA S, V53, P311; Svennblad B, 2008, SYST BIOL, V57, P947, DOI 10.1080/10635150802562400; TAGGART RE, 1976, AM J BOT, V63, P1390, DOI 10.2307/2441848; TAPPAN HN, 1990, PALEOBIOLOGY PLANT P; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Woods K., 1998, GEOL SOC AM ABSTR, V30; XIA X, 2000, DATA ANAL MOL BIOL E; Xiao SH, 1998, J PALEONTOL, V72, P1072, DOI 10.1017/S0022336000027414; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	104	86	87	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12759	10.1371/journal.pone.0012759	http://dx.doi.org/10.1371/journal.pone.0012759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862282	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100011
J	Hagopian, K; Weber, KL; Hwee, DT; Van Eenennaam, AL; Lopez-Lluch, G; Villalba, JM; Buron, I; Navas, P; German, JB; Watkins, SM; Chen, YN; Wei, A; McDonald, RB; Ramsey, JJ				Hagopian, Kevork; Weber, Kristina L.; Hwee, Darren T.; Van Eenennaam, Alison L.; Lopez-Lluch, Guillermo; Villalba, Jose M.; Buron, Isabel; Navas, Placido; German, J. Bruce; Watkins, Steven M.; Chen, Yana; Wei, Alfreda; McDonald, Roger B.; Ramsey, Jon J.			Complex I-Associated Hydrogen Peroxide Production Is Decreased and Electron Transport Chain Enzyme Activities Are Altered in n-3 Enriched fat-1 Mice	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MAXIMUM LIFE-SPAN; DOCOSAHEXAENOIC ACID; H2O2 PRODUCTION; PROTON LEAK; CARDIOLIPIN REQUIREMENT; MITOCHONDRIAL-FUNCTION; CYTOCHROME-OXIDASE; RESPIRATORY-CHAIN; OXIDATIVE STRESS	The polyunsaturated nature of n-3 fatty acids makes them prone to oxidative damage. However, it is not clear if n-3 fatty acids are simply a passive site for oxidative attack or if they also modulate mitochondrial reactive oxygen species (ROS) production. The present study used fat-1 transgenic mice, that are capable of synthesizing n-3 fatty acids, to investigate the influence of increases in n-3 fatty acids and resultant decreases in the n-6: n-3 ratio on liver mitochondrial H2O2 production and electron transport chain (ETC) activity. There was an increase in n-3 fatty acids and a decrease in the n-6:n-3 ratio in liver mitochondria from the fat-1 compared to control mice. This change was largely due to alterations in the fatty acid composition of phosphatidylcholine and phosphatidylethanolamine, with only a small percentage of fatty acids in cardiolipin being altered in the fat-1 animals. The lipid changes in the fat-1 mice were associated with a decrease (p<0.05) in the activity of ETC complex I and increases (p<0.05) in the activities of complexes III and IV. Mitochondrial H2O2 production with either succinate or succinate/glutamate/malate substrates was also decreased (p<0.05) in the fat-1 mice. This change in H2O2 production was due to a decrease in ROS production from ETC complex I in the fat-1 animals. These results indicate that the fatty acid changes in fat-1 liver mitochondria may at least partially oppose oxidative stress by limiting ROS production from ETC complex I.	[Hagopian, Kevork; Chen, Yana; Wei, Alfreda; Ramsey, Jon J.] Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA; [Weber, Kristina L.; Van Eenennaam, Alison L.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hwee, Darren T.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Lopez-Lluch, Guillermo; Navas, Placido] Univ Pablo de Olavide, CSIC, CIBERER, Ctr Andaluz Biol Desarrollo,Inst Salud Carl III, Seville, Spain; [Villalba, Jose M.; Buron, Isabel] Univ Cordoba, Dept Biol Celular Fisiol & Immunol, Cordoba, Spain; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Watkins, Steven M.] Lip Technol, W Sacramento, CA USA; [McDonald, Roger B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad de Cordoba; University of California System; University of California Davis; University of California System; University of California Davis	Hagopian, K (corresponding author), Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA.	jjramsey@ucdavis.edu	Van Eenennaam, Alison L/G-3481-2011; Lopez-Lluch, Guillermo/N-4742-2014; NAVAS, PLACIDO/R-5943-2019	Van Eenennaam, Alison L/0000-0003-1562-162X; Lopez-Lluch, Guillermo/0000-0001-9830-8502; NAVAS, PLACIDO/0000-0002-4115-7966; Villalba Montoro, Jose Manuel/0000-0001-8554-3802	National Institutes of Health [RO1 AG-028125]; NATIONAL INSTITUTE ON AGING [R01AG028125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (www.nia.nih.gov) Grant RO1 AG-028125 (to J.J.R., K.H., J.M.V., P.N.). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. M. W. was an employee of Lipomics Technologies. Lipomics completed fatty analysis on the mitochondrial samples. This funder/company had no role in study design, decision to publish, or preparation of the manuscript.	Arroyo A, 1998, PROTOPLASMA, V205, P107, DOI 10.1007/BF01279300; Arvier M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1320, DOI 10.1152/ajpendo.00138.2007; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; BARZANTI V, 1994, BRIT J NUTR, V71, P193, DOI 10.1079/BJN19940126; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Berger A, 1993, Adv Food Nutr Res, V37, P259, DOI 10.1016/S1043-4526(08)60118-7; Bhattacharya A, 2006, BIOCHEM BIOPH RES CO, V349, P925, DOI 10.1016/j.bbrc.2006.08.093; Birch-Machin MA, 1993, METHODS TOXICOL, V2, P51; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brand M. D., 1995, BIOENERGETICS, V154, P62; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; CARO P, 2008, BIOGERONTOLOGY; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Cortes-Rojo C, 2009, J BIOENERG BIOMEMBR, V41, P15, DOI 10.1007/s10863-009-9200-3; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; DEMAISON L, 1994, BBA-MOL BASIS DIS, V1227, P53, DOI 10.1016/0925-4439(94)90106-6; Fernandez-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Grimm H, 2002, BRIT J NUTR, V87, pS59, DOI 10.1079/BJN2001457; Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Hong MY, 2002, CARCINOGENESIS, V23, P1919, DOI 10.1093/carcin/23.11.1919; Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kubo K, 1997, BRIT J NUTR, V78, P655, DOI 10.1079/BJN19970181; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lemieux H, 2008, COMP BIOCHEM PHYS A, V149, P20, DOI 10.1016/j.cbpa.2007.09.015; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; MALIS CD, 1990, P NATL ACAD SCI USA, V87, P8845, DOI 10.1073/pnas.87.22.8845; Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/0006-8993(96)00708-1; MCMILLIN JB, 1992, AM J PHYSIOL, V263, pH1479, DOI 10.1152/ajpheart.1992.263.5.H1479; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Pamplona R, 1998, J LIPID RES, V39, P1989; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; Rahman MM, 2009, OXID MED CELL LONGEV, V2, P307, DOI 10.4161/oxim.2.5.9579; Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016; Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Schultz JR, 1996, BIOCHEMISTRY-US, V35, P6595, DOI 10.1021/bi960245h; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Stillwell W, 1997, LIPIDS, V32, P497, DOI 10.1007/s11745-997-0064-6; SWANSON JE, 1986, J NUTR, V116, P514, DOI 10.1093/jn/116.4.514; Toroser D, 2007, BIOCHEM BIOPH RES CO, V363, P418, DOI 10.1016/j.bbrc.2007.08.193; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Valencak TG, 2007, AGING CELL, V6, P15, DOI 10.1111/j.1474-9726.2006.00257.x; Venditti P, 2004, FREE RADICAL BIO MED, V36, P348, DOI 10.1016/j.freeradbiomed.2003.11.012; Watkins SM, 1998, J LIPID RES, V39, P1583; Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8; YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290	68	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12696	10.1371/journal.pone.0012696	http://dx.doi.org/10.1371/journal.pone.0012696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856881	gold, Green Published, Green Submitted			2022-12-25	WOS:000281735700015
J	Gomez-Gardenes, J; Zamora-Lopez, G; Moreno, Y; Arenas, A				Gomez-Gardenes, Jesus; Zamora-Lopez, Gorka; Moreno, Yamir; Arenas, Alex			From Modular to Centralized Organization of Synchronization in Functional Areas of the Cat Cerebral Cortex	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; CORTICAL AREAS; CONNECTIVITY; INTEGRATION; CLUSTERS; KURAMOTO; MACAQUE	Recent studies have pointed out the importance of transient synchronization between widely distributed neural assemblies to understand conscious perception. These neural assemblies form intricate networks of neurons and synapses whose detailed map for mammals is still unknown and far from our experimental capabilities. Only in a few cases, for example the C. elegans, we know the complete mapping of the neuronal tissue or its mesoscopic level of description provided by cortical areas. Here we study the process of transient and global synchronization using a simple model of phase-coupled oscillators assigned to cortical areas in the cerebral cat cortex. Our results highlight the impact of the topological connectivity in the developing of synchronization, revealing a transition in the synchronization organization that goes from a modular decentralized coherence to a centralized synchronized regime controlled by a few cortical areas forming a Rich-Club connectivity pattern.	[Gomez-Gardenes, Jesus; Moreno, Yamir; Arenas, Alex] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Gomez-Gardenes, Jesus] Univ Rey Juan Carlos ESCET, Dept Matemat Aplicada, Mostoles, Madrid, Spain; [Zamora-Lopez, Gorka] Univ Potsdam, Interdisciplinary Ctr Dynam Complex Syst, Potsdam, Germany; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain	University of Zaragoza; Universidad Rey Juan Carlos; University of Potsdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza; Universitat Rovira i Virgili	Gomez-Gardenes, J (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	gardenes@gmail.com	Gomez-Gardenes, Jesus/M-9825-2019; Gomez-Gardenes, Jesus/A-3226-2009; Arenas, Alex/A-5216-2009; Zamora-López, Gorka/A-2648-2012; Gomez-Gardeñes, Jesus/B-5818-2009; Moreno, Yamir/A-1076-2009	Gomez-Gardenes, Jesus/0000-0001-5204-1937; Arenas, Alex/0000-0003-0937-0334; Zamora-López, Gorka/0000-0001-9361-9619; Gomez-Gardeñes, Jesus/0000-0001-5204-1937; Moreno, Yamir/0000-0002-0895-1893	Spanish Ministerio de Ciencia e Innovacion (MICINN) [FIS2008-01240, MTM2009-13848]; Deutsche Forschungsgemeinschaft [FOR 868, KU 837/23-1]; BioSim network of excellence [LSHB-CT-2004-005137]; Spanish MICINN [FIS2008-01240, FIS2009-13364-C02-01, FIS2009-13730-C02-02]; Office of Science, Computational and Technology Research, U.S. Department of Energy [DE-AC02-05CH11231]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioSim network of excellence(European Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Office of Science, Computational and Technology Research, U.S. Department of Energy(United States Department of Energy (DOE))	J.G.-G. is supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN) through projects FIS2008-01240 and MTM2009-13848. G.Z.-L. is supported by the Deutsche Forschungsgemeinschaft, research group FOR 868 (KU 837/23-1) and the BioSim network of excellence (LSHB-CT-2004-005137). Y.M. is supported by Spanish MICINN through projects FIS2008-01240 and FIS2009-13364-C02-01. A.A. acknowledges partial support by the Director, Office of Science, Computational and Technology Research, U.S. Department of Energy under Contract DE-AC02-05CH11231 and the Spanish MICINN through project FIS2009-13730-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Boccaletti S, 2009, HDB BIOL NETWORKS; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; FAHLE M, 1993, P ROY SOC B-BIOL SCI, V254, P199, DOI 10.1098/rspb.1993.0146; Gomez-Gardenes J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066106; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034101; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hilgetag CC, 2000, PHILOS T R SOC B, V355, P71, DOI 10.1098/rstb.2000.0550; Kuramoto Y., 1984, PROG THEOR PHYS SUPP, V79, P223, DOI DOI 10.1143/PTPS.79.223; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559; ZAMORALOPEZ G, 2010, FRONTIERS N IN PRESS; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhou CS, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/178; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	34	64	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12313	10.1371/journal.pone.0012313	http://dx.doi.org/10.1371/journal.pone.0012313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865046	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100006
J	Zykova, SN; Tveita, AA; Rekvig, OP				Zykova, Svetlana N.; Tveita, Anders A.; Rekvig, Ole Petter			Renal Dnase1 Enzyme Activity and Protein Expression Is Selectively Shut Down in Murine and Human Membranoproliferative Lupus Nephritis	PLOS ONE			English	Article							DEOXYRIBONUCLEASE I DNASE; APOPTOTIC CELLS; PLASMA-LEVELS; T-ANTIGEN; HUMAN SLE; ANTIBODIES; SERUM; ERYTHEMATOSUS; CHROMATIN; NUCLEOSOMES	Background: Deposition of chromatin-IgG complexes within glomerular membranes is a key event in the pathogenesis of lupus nephritis. We recently reported an acquired loss of renal Dnase1 expression linked to transformation from mild to severe membranoproliferative lupus nephritis in (NZBxNZW)F1 mice. As this may represent a basic mechanism in the progression of lupus nephritis, several aspects of Dnase1 expression in lupus nephritis were analyzed. Methodology/Principal Findings: Total nuclease activity and Dnase1 expression and activity was evaluated using in situ and in vitro analyses of kidneys and sera from (NZBxNZW) F1 mice of different ages, and from age-matched healthy controls. Immunofluorescence staining for Dnase1 was performed on kidney biopsies from (NZBxNZW) F1 mice as well as from human SLE patients and controls. Reduced serum Dnase1 activity was observed in both mesangial and end-stage lupus nephritis. A selective reduction in renal Dnase1 activity was seen in mice with massive deposition of chromatin-containing immune complexes in glomerular capillary walls. Mice with mild mesangial nephritis showed normal renal Dnase1 activity. Similar differences were seen when comparing human kidneys with severe and mild lupus nephritis. Dnase1 was diffusely expressed within the kidney in normal and mildly affected kidneys, whereas upon progression towards end-stage renal disease, Dnase1 was down-regulated in all renal compartments. This demonstrates that the changes associated with development of severe nephritis in the murine model are also relevant to human lupus nephritis. Conclusions/Significance: Reduction in renal Dnase1 expression and activity is limited to mice and SLE patients with signs of membranoproliferative nephritis, and may be a critical event in the development of severe forms of lupus nephritis. Reduced Dnase1 activity reflects loss in the expression of the protein and not inhibition of enzyme activity.	[Zykova, Svetlana N.; Tveita, Anders A.; Rekvig, Ole Petter] Univ Tromso, Inst Med Biol, Fac Med, Dept Biochem, Tromso, Norway; [Rekvig, Ole Petter] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Zykova, SN (corresponding author), Univ Tromso, Inst Med Biol, Fac Med, Dept Biochem, Tromso, Norway.	Ole.Petter.Rekvig@uit.no	Rekvig, Ole Petter/V-7113-2019	Tveita, Anders/0000-0002-0668-9262	Health and Rehabilitation organisation Norway; Northern Norway Regional Health Authority [SFP-100-04, SFP-101-04]; University of Tromsoe	Health and Rehabilitation organisation Norway; Northern Norway Regional Health Authority; University of Tromsoe	This study was supported by grants from The Health and Rehabilitation organisation Norway, The Northern Norway Regional Health Authority Medical Research Program (Grants SFP-100-04, SFP-101-04), and from University of Tromsoe as a Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Berden JHM, 2002, J NEPHROL, V15, pS1; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P55, DOI 10.1007/BF00541153; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P49, DOI 10.1007/BF00541152; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fenton KA, 2008, MOL IMMUNOL, V45, P3117, DOI 10.1016/j.molimm.2008.03.001; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gaipl US, 2004, ARTHRITIS RHEUM-US, V50, P640, DOI 10.1002/art.20034; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Holdenrieder S, 2008, ANN NY ACAD SCI, V1137, P180, DOI 10.1196/annals.1448.012; JOHNSON AJ, 1954, J CLIN INVEST, V33, P1670, DOI 10.1172/JCI103048; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, ARTHRITIS RHEUM-US, V54, P914, DOI 10.1002/art.21622; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Koizumi T, 1996, EXP ANIM TOKYO, V45, P245, DOI 10.1538/expanim.45.245; Kuenkele Susanne, 2003, Curr Rheumatol Rep, V5, P175, DOI 10.1007/s11926-003-0061-1; LACKS SA, 1981, J BIOL CHEM, V256, P2644; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Licht R, 2001, ARTHRITIS RHEUM-US, V44, P1320, DOI 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X; LINDBERG MU, 1966, J BIOL CHEM, V241, P1246; Lo YMD, 2000, CLIN CHEM, V46, P319; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; MALIDE D, 1993, AM J PATHOL, V143, P304; Manderson AP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1936; MIESCHER P, 1954, EXPERIENTIA, V10, P252, DOI 10.1007/BF02157392; Mizuta R, 2009, BIOMED RES-TOKYO, V30, P165, DOI 10.2220/biomedres.30.165; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Napirei M, 2006, INT J BIOCHEM CELL B, V38, P297, DOI 10.1016/j.biocel.2005.10.023; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; ORDONEZ NG, 1981, J PATHOL, V135, P259, DOI 10.1002/path.1711350403; RAPTIS L, 1980, J CLIN INVEST, V66, P1391, DOI 10.1172/JCI109992; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Sallai K, 2005, CLIN DIAGN LAB IMMUN, V12, P56, DOI 10.1128/CDLI.12.1.56-59.2005; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SBARRA AJ, 1963, NATURE, V198, P159, DOI 10.1038/198159a0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shiokawa D, 1997, BIOCHEM J, V326, P675, DOI 10.1042/bj3260675; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; Takeshita H, 2000, BIOCHEM BIOPH RES CO, V269, P481, DOI 10.1006/bbrc.2000.2300; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tew MB, 2001, ARTHRITIS RHEUM, V44, P2446, DOI 10.1002/1529-0131(200110)44:10<2446::AID-ART409>3.0.CO;2-U; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Wilber A, 2003, CLIN EXP IMMUNOL, V134, P46, DOI 10.1046/j.1365-2249.2003.02267.x; Williams RC, 2001, J RHEUMATOL, V28, P81; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276	58	46	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12096	10.1371/journal.pone.0012096	http://dx.doi.org/10.1371/journal.pone.0012096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856893	Green Published, gold			2022-12-25	WOS:000280811900033
J	Zhu, QS; Rosenblatt, K; Huang, KL; Lahat, G; Brobey, R; Bolshakov, S; Nguyen, T; Ding, Z; Belousov, R; Bill, K; Luo, X; Lazar, A; Dicker, A; Mills, GB; Hung, MC; Lev, D				Zhu, Q-S; Rosenblatt, K.; Huang, K-L; Lahat, G.; Brobey, R.; Bolshakov, S.; Nguyen, T.; Ding, Z.; Belousov, R.; Bill, K.; Luo, X.; Lazar, A.; Dicker, A.; Mills, G. B.; Hung, M-C; Lev, D.			Vimentin is a novel AKT1 target mediating motility and invasion	ONCOGENE			English	Article						soft-tissue sarcoma; AKT1; vimentin; phosphorylation; migration/invasion	EPITHELIAL-MESENCHYMAL TRANSITION; INTERMEDIATE FILAMENT PROTEINS; SOFT-TISSUE SARCOMA; CANCER CELLS; UP-REGULATION; HUMAN BREAST; EXPRESSION; KINASE; PHOSPHORYLATION; CARCINOMA	The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies. Oncogene (2011) 30, 457-470; doi: 10.1038/onc.2010.421; published online 20 September 2010	[Lev, D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhu, Q-S; Huang, K-L; Lahat, G.; Bolshakov, S.; Nguyen, T.; Belousov, R.; Bill, K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ding, Z.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Luo, X.] Univ Texas Med Branch, Mass Spectrometry Core Lab, Galveston, TX USA; [Lazar, A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Dicker, A.] Thomas Jefferson Univ, Dept Radiat Oncol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, M-C] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Hung, M-C] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center; Jefferson University; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lev, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 8515 Fannin,Unit 1104, Houston, TX 77030 USA.	dlev@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Lazar, Alexander J/A-3416-2008	Hung, Mien-Chie/0000-0003-4317-4740; Lazar, Alexander J/0000-0002-6395-4499; Huang, Kai-Lieh/0000-0001-5407-648X; Dicker, Adam/0000-0003-0733-3337	NIH/NHLBI [NO1-HV-28184]; NIH [CA138345]; RTOG; Welch Foundation Endowment [L-AU-0002]; NCI Cancer Center [16672]; NIH/NCI [CA138345]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA138345] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RTOG; Welch Foundation Endowment; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Giranda (Abbot Laboratories, Abbott Park, IL) for providing A674563 (A563), Dr Cryns (Division of Endocrinology, Northwestern University, Chicago, IL) for providing human Vim cDNA and Dr Fletcher (Brigham and Women's Hospital, Boston, MA) for the MPNST724 cell line. We thank the UTMB NHLBI Proteomic Center for assistance with mass spectrometry experiments. (The work was supported by the NIH/NHLBI proteomics Initiative NO1-HV-28184 (to KPR).) Vu is thanked for aid in figure preparation and Lo for her assistance with scientific editing. This paper was supported in part by NIH RO1 Grant CA138345 and a RTOG seed grant (to DL). Dr Rosenblatt is a recipient of a Welch Foundation Endowment in Chemistry and Related Science Fellowship award (Grant # L-AU-0002). All experiments conducted at UT-MDACC Core Facilities were further supported by an NCI Cancer Center Support Grant (CA#16672).; This paper was supported by NIH/NCI RO1 Grant CA138345 and an RTOG seed grant (to DL), and by NIH/NHLBI proteomics Initiative grant NO1-HV-28184 (to KPR).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Arboleda MJ, 2003, CANCER RES, V63, P196; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bodenstine TM, 2008, CANCER MICROENVIRON, V1, P1, DOI 10.1007/s12307-008-0001-8; BROERS JLV, 1989, DIFFERENTIATION, V40, P119, DOI 10.1111/j.1432-0436.1989.tb00821.x; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Eckes B, 1998, J CELL SCI, V111, P1897; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Grille SJ, 2003, CANCER RES, V63, P2172; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hernando E, 2007, NAT MED, V13, P748, DOI 10.1038/nm1560; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kanda S, 2004, J BIOL CHEM, V279, P4007, DOI 10.1074/jbc.M307569200; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Luo ML, 2007, ENDOCRINOLOGY, V148, P4895, DOI 10.1210/en.2007-0049; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Menet V, 2001, J NEUROSCI, V21, P6147; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Morishima N, 1999, GENES CELLS, V4, P401, DOI 10.1046/j.1365-2443.1999.00270.x; NELSON WJ, 1983, MOL CELL BIOL, V3, P1146, DOI 10.1128/MCB.3.6.1146; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Pittenger JT, 2008, BIOCHEMISTRY-US, V47, P10863, DOI 10.1021/bi801137m; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sumitani S, 2002, ENDOCRINOLOGY, V143, P820, DOI 10.1210/en.143.3.820; Tanno S, 2001, CANCER RES, V61, P589; Tomita Y, 2006, CLIN CANCER RES, V12, P3070, DOI 10.1158/1078-0432.CCR-05-1732; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhu QS, 2008, CANCER RES, V68, P2895, DOI 10.1158/0008-5472.CAN-07-6268	40	164	173	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					457	470		10.1038/onc.2010.421	http://dx.doi.org/10.1038/onc.2010.421			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20856200	Green Accepted, Green Submitted			2022-12-25	WOS:000286621600008
J	Sun, TT; Yang, XM; Wang, W; Zhang, XJ; Xu, QB; Zhu, SC; Kuchta, R; Chen, GJ; Liu, XD				Sun, Tingting; Yang, Xiaomei; Wang, Wei; Zhang, Xiaojuan; Xu, Quanbin; Zhu, Songcheng; Kuchta, Robert; Chen, Guanjun; Liu, Xuedong			Cellular Abundance of Mps1 and the Role of Its Carboxyl Terminal Tail in Substrate Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; DUPLICATION GENE MPS1; MITOTIC CHECKPOINT; PROTEIN-KINASE; CENTROSOME DUPLICATION; CANCER-CELLS; CHROMOSOMAL INSTABILITY; CRYSTAL-STRUCTURE; DROSOPHILA MPS1	Mps1 is a protein kinase that regulates normal mitotic progression and the spindle checkpoint in response to spindle damage. The levels of Mps1 are relatively low in cells during interphase but elevated in mitosis or upon activation of the spindle checkpoint, although the dynamic range of Mps1 expression and the Mps1 catalytic mechanism have not been carefully characterized. Our recent structural studies of the Mps1 kinase domain revealed that the carboxyl-terminal tail region of Mps1 is unstructured, raising the question of whether this region has any functional role in Mps1 catalysis. Here we first determined the cellular abundance of Mps1 during cell cycle progression and found that Mps1 levels vary between 60,000 per cell in early G(1) and 110,000 per cell during mitosis. We studied phosphorylation of a number of Mps1 substrates in vitro and in culture cells. Unexpectedly, we found that the unstructured carboxyl-terminal region of Mps1 plays an essential role in substrate recruitment. Kinetics studies using the purified recombinant wild type and mutant kinases indicate that the carboxyl-terminal tail is largely dispensable for autophosphorylation of Mps1 but critical for trans-phosphorylation of substrates in vitro and in cultured cells. Mps1 mutant without the unstructured tail region is defective in mediating spindle assembly checkpoint activation. Our results underscore the importance of the unstructured tail region of Mps1 in kinase activation.	[Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA; [Sun, Tingting; Chen, Guanjun] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Yang, Xiaomei] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Xu, Quanbin] Beijing Inst Biotechnol, Beijing 100850, Peoples R China	University of Colorado System; University of Colorado Boulder; Shandong University; Shandong University	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	liux@colorado.edu	Xu, Quanbin/K-1904-2019	LIU, XUEDONG/0000-0001-7209-4964; Xu, Quanbin/0000-0002-2833-9773	National Institutes of Health [R01CA107098]; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA107098 (to X. L.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Gilliland WD, 2005, CURR BIOL, V15, P672; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HOGG D, 1994, ONCOGENE, V9, P89; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; KOBAYASHI H, 1991, J CELL BIOL, V114, P755, DOI 10.1083/jcb.114.4.755; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LINDBERG RA, 1993, ONCOGENE, V8, P351; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmidt M, 2006, CELL CYCLE, V5, P159, DOI 10.4161/cc.5.2.2309; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xu NH, 2007, CELL CYCLE, V6, P1639, DOI 10.4161/cc.6.13.4385; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	53	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38730	38739		10.1074/jbc.M110.177642	http://dx.doi.org/10.1074/jbc.M110.177642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884615	Green Published, hybrid			2022-12-25	WOS:000284625600078
J	Tikhonov, A; Kazakov, T; Semenova, E; Serebryakova, M; Vondenhoff, G; Van Aerschot, A; Reader, JS; Govorun, VM; Severinov, K				Tikhonov, Anton; Kazakov, Teymur; Semenova, Ekaterina; Serebryakova, Marina; Vondenhoff, Gaston; Van Aerschot, Arthur; Reader, John S.; Govorun, Vadim M.; Severinov, Konstantin			The Mechanism of Microcin C Resistance Provided by the MccF Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; GENETIC-DETERMINANTS; ESCHERICHIA-COLI; AGROCIN 84; SPECIFICITY; IMMUNITY; CLONING; C51	The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. Inside a sensitive cell, McC is processed by aminopeptidases, which release a nonhydrolyzable aspartyl-adenylate, a strong inhibitor of aspartyl-tRNA synthetase. The mccABCDE operon is sufficient for McC production and resistance of the producing cell to McC. An additional gene, mccF, which is adjacent to but not part of the mccABCDE operon, also provides resistance to exogenous McC. MccF is similar to Escherichia coli LdcA, an L,D-carboxypeptidase whose substrate is monomeric murotetrapeptide L-Ala-D-Glu-meso-A(2)pm-D-Ala or its UDP-activated murein precursor. The mechanism by which MccF provides McC resistance remained unknown. Here, we show that MccF detoxifies both intact and processed McC by cleaving an amide bond between the C-terminal aspartate and the nucleotide moiety. MccF also cleaves the same bond in nonhydrolyzable aminoacyl sulfamoyl adenosines containing aspartyl, glutamyl, and, to a lesser extent, seryl aminoacyl moieties but is ineffective against other amino-acyl adenylates.	[Kazakov, Teymur; Semenova, Ekaterina; Govorun, Vadim M.; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Serebryakova, Marina; Govorun, Vadim M.] Fed Agcy Hlth Care & Social Dev, Inst Phys & Chem Med, Moscow, Russia; [Vondenhoff, Gaston; Van Aerschot, Arthur] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Vondenhoff, Gaston; Van Aerschot, Arthur] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Reader, John S.; Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; KU Leuven; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Serebryakova, Marina/E-2986-2012; Severinov, Konstantin/C-8545-2016; Govorun, Vadim M/A-9043-2018	Serebryakova, Marina/0000-0002-5402-8215; Van Aerschot, Arthur/0000-0003-3528-8588	National Institutes of Health [U54 AI057158]; Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; Rutgers University Technology Commercialization; Federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia [02.740.11.0771]; Russian Foundation for Basic Research [06-04-48865]; Dynasty Charitable Foundation; Belgian IWT [SB 81117]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); Rutgers University Technology Commercialization; Federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Dynasty Charitable Foundation; Belgian IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057158. This work was also supported by a Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology grant, a Rutgers University Technology Commercialization Fund grant, and federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia 2009-2013, State Contract 02.740.11.0771 (to K.S.), and Russian Foundation for Basic Research Grant 06-04-48865.; Supported in part by a scholarship from the Dynasty Charitable Foundation.; Recipient of Belgian IWT Fellowship SB 81117.	BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; BENZ G, 1982, ANGEW CHEM INT EDIT, V21, P527, DOI 10.1002/anie.198205271; Bloch A, 1971, Biochemistry, V10, P4395; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; GONZALEZPASTOR JE, 1995, J BACTERIOL, V177, P7131, DOI 10.1128/jb.177.24.7131-7140.1995; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; KUREPINA NE, 1993, MOL GEN GENET, V241, P700, DOI 10.1007/BF00279914; LEGUINA JI, 1994, FEBS LETT, V339, P249, DOI 10.1016/0014-5793(94)80425-7; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Murphy P. J., 1981, EUR J BIOCHEM, V11, P539; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; NOVOA MA, 1986, J BACTERIOL, V168, P1384, DOI 10.1128/jb.168.3.1384-1391.1986; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; ROBERTS WP, 1977, NATURE, V265, P379, DOI 10.1038/265379a0; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Tan D. S., 2006, U. S. Patent Application, Patent No. [11/ 911,525, 11911525]; TATE ME, 1979, NATURE, V280, P697, DOI 10.1038/280697a0; Van de Vijver P, 2009, J BACTERIOL, V191, P6273, DOI 10.1128/JB.00829-09	23	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37944	37952		10.1074/jbc.M110.179135	http://dx.doi.org/10.1074/jbc.M110.179135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876530	Green Published, hybrid			2022-12-25	WOS:000284625600002
J	Simon, F; Leiva-Salcedo, E; Armisen, R; Riveros, A; Cerda, O; Varela, D; Eguiguren, AL; Olivero, P; Stutzin, A				Simon, Felipe; Leiva-Salcedo, Elias; Armisen, Ricardo; Riveros, Ana; Cerda, Oscar; Varela, Diego; Luisa Eguiguren, Ana; Olivero, Pablo; Stutzin, Andres			Hydrogen Peroxide Removes TRPM4 Current Desensitization Conferring Increased Vulnerability to Necrotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; REGULATORY VOLUME DECREASE; PROTEIN-SULFENIC ACIDS; SMOOTH-MUSCLE-CELLS; MEMBRANE DEPOLARIZATION; OXIDATIVE STRESS; ACTIVATION; EXPRESSION; CA2+; NECROSIS	Necrosis is associated with an increase in plasma membrane permeability, cell swelling, and loss of membrane integrity with subsequent release of cytoplasmic constituents. Severe redox imbalance by overproduction of reactive oxygen species is one of the main causes of necrosis. Here we demonstrate that H2O2 induces a sustained activity of TRPM4, a Ca2+-activated, Ca2+-impermeant nonselective cation channel resulting in an increased vulnerability to cell death. In HEK 293 cells overexpressing TRPM4, H2O2 was found to eliminate in a dose-dependent manner TRPM4 desensitization. Site-directed mutagenesis experiments revealed that the Cys(1093) residue is crucial for the H2O2-mediated loss of desensitization. In HeLa cells, which endogenously express TRPM4, H2O2 elicited necrosis as well as apoptosis. H2O2-mediated necrosis but not apoptosis was abolished by replacement of external Na+ ions with sucrose or the non-permeant cation N-methyl-D-glucamine and by knocking down TRPM4 with a shRNA directed against TRPM4. Conversely, transient overexpression of TRPM4 in HeLa cells in which TRPM4 was previously silenced re-established vulnerability to H2O2-induced necrotic cell death. In addition, HeLa cells exposed to H2O2 displayed an irreversible loss of membrane potential, which was prevented by TRPM4 knockdown.	[Stutzin, Andres] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 7, Chile	Universidad de Chile; Universidad de Chile	Stutzin, A (corresponding author), Univ Chile, Fac Med, Ctr Estudios Mol Celula, Av Independencia 1027,Independencia 838-0543, Santiago 7, Chile.	astutzin@bitmed.med.uchile.cl	Varela, Diego/AAG-7489-2019; Cerda, Oscar/N-3895-2018; Stutzin, Andrés/I-7605-2013; Armisen, Ricardo/A-7409-2012; riveros, ana/AAD-2134-2020; Olivero, Pablo/AAS-5076-2021	Varela, Diego/0000-0002-9352-414X; Cerda, Oscar/0000-0003-2873-5722; Stutzin, Andrés/0000-0002-7264-066X; Armisen, Ricardo/0000-0003-2567-0521; Olivero, Pablo/0000-0001-8886-7706; Riveros, Ana Luisa/0000-0002-1926-4562; Simon, Felipe/0000-0002-2653-9798	FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile [15010006]	FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by Grant 15010006 from FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Barros LF, 2001, HEPATOLOGY, V33, P114, DOI 10.1053/jhep.2001.20530; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CROWE WE, 1995, NEUROSCIENCE, V69, P283, DOI 10.1016/0306-4522(95)00219-9; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Herson PS, 1997, J PHYSIOL-LONDON, V501, P59, DOI 10.1111/j.1469-7793.1997.059bo.x; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Inoue M, 1999, J PHYSIOL-LONDON, V519, P385, DOI 10.1111/j.1469-7793.1999.0385m.x; Jeulin C, 2002, PFLUG ARCH EUR J PHY, V443, P574, DOI 10.1007/s00424-001-0733-5; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Koliwad SK, 1996, J PHYSIOL-LONDON, V491, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Petersen OH, 2002, CURR BIOL, V12, pR520, DOI 10.1016/S0960-9822(02)01027-8; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schlenker T, 2000, GASTROENTEROLOGY, V118, P395, DOI 10.1016/S0016-5085(00)70222-8; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simon F, 2004, AM J PHYSIOL-CELL PH, V287, pC963, DOI 10.1152/ajpcell.00041.2004; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	42	52	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37150	37158		10.1074/jbc.M110.155390	http://dx.doi.org/10.1074/jbc.M110.155390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20884614	hybrid, Green Published			2022-12-25	WOS:000284424000008
J	Qiu, XX; Dul, BE; Walworth, NC				Qiu, Xinxing; Dul, Barbara E.; Walworth, Nancy C.			Activity of a C-terminal Plant Homeodomain (PHD) of Msc1 Is Essential for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; HISTONE-H3 LYSINE-4 METHYLATION; SISTER-CHROMATID SEPARATION; FISSION YEAST; H2A VARIANT; PROTEIN; FINGER; MICROTUBULE; DOMAIN; BINDING	Msc1, a member of the Jarid1 family of putative histone demethylases, is required for chromosome stability in fission yeast. Msc1 associates with the Swr1 complex that facilitates deposition of histone H2A.Z into chromatin. To assess the function of Msc1 in the Swr1 complex, domains of Msc1 necessary for interaction with Swr1 were identified. The C-terminal plant homeodomain (PHD) 2 and PHD3 of Msc1 are sufficient to confer association with Swr1 and allow Msc1 to function in the context of kinetochore mutants. On the other hand, a mutant with a single amino acid substitution in PHD2 within the full-length Msc1 protein retains the ability to bind to Swr1 but eliminates the function of Msc1 in combination with kinetochore mutants. Thus, Swr1 association is critical but not sufficient for Msc1 function. An activity of Msc1 that depends on the cysteine residue within PHD2 of Msc1 is likewise critical for function. On the basis of our observation that the PHDs of Msc1 act as E3 ubiquitin ligases and that mutations of cysteine residues within those domains abolish ligase activity, we speculate that the ability of Msc1 to facilitate ubiquitin transfer is critical for the function it mediates through its association with Swr1.	[Walworth, Nancy C.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Joint Grad Program Cellular & Mol Pharmacol, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA; Rutgers State Univ, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Walworth, NC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	walworna@umdnj.edu		Walworth, Nancy/0000-0001-5940-8236	NIGMS [GM53194]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053194] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM53194 from NIGMS, National Institutes of Health.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buchanan L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000726; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Hou HT, 2010, J BIOL CHEM, V285, P1909, DOI 10.1074/jbc.M109.058487; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Lawrence RJ, 2009, P NATL ACAD SCI USA, V106, P1163, DOI 10.1073/pnas.0811161106; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36828	36835		10.1074/jbc.M110.157792	http://dx.doi.org/10.1074/jbc.M110.157792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858896	Green Published, hybrid			2022-12-25	WOS:000284146100012
J	Boyd, LK; Mercer, B; Thompson, D; Main, E; Watts, FZ				Boyd, Lara K.; Mercer, Brenda; Thompson, Darren; Main, Ewan; Watts, Felicity Z.			Characterisation of the SUMO-Like Domains of Schizosaccharomyces pombe Rad60	PLOS ONE			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; RECOMBINATION REPAIR; CONJUGATING ENZYME; GENOME STABILITY; SMC5-6 COMPLEX; UBIQUITIN; PROTEIN; LIGASE	The S. pombe Rad60 protein is required for the repair of DNA double strand breaks, recovery from replication arrest, and is essential for cell viability. It has two SUMO-like domains (SLDs) at its C-terminus, an SXS motif and three sequences that have been proposed to be SUMO-binding motifs (SBMs). SMB1 is located in the middle of the protein, SBM2 is in SLD1 and SBM3 is at the C-terminus of SLD2. We have probed the functions of the two SUMO-like domains, SLD1 and SLD2, and the putative SBMs. SLD1 is essential for viability, while SLD2 is not. rad60-SLD2 Delta cells are sensitive to DNA damaging agents and hydroxyurea. Neither ubiquitin nor SUMO can replace SLD1 or SLD2. Cells in which either SBM1 or SBM2 has been mutated are viable and are wild type for response to MMS and HU. In contrast mutation of SBM3 results in significant sensitivity to MMS and HU. These results indicate that the lethality resulting from deletion of SLD1 is not due to loss of SBM2, but that mutation of SBM3 produces a more severe phenotype than does deletion of SLD2. Using chemical denaturation studies, FPLC and dynamic light scattering we show this is likely due to the destabilisation of SLD2. Thus we propose that the region corresponding to the putative SBM3 forms part of the hydrophobic core of SLD2 and is not a SUMO-interacting motif. Overexpression of Hus5, which is the SUMO conjugating enzyme and known to interact with Rad60, does not rescue rad60-SLD2 Delta, implying that as well as having a role in the sumoylation process as previously described [1], Rad60 has a Hus5-independent function.	[Boyd, Lara K.; Mercer, Brenda; Watts, Felicity Z.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Thompson, Darren] Univ Sussex, Sch Life Sci, Div Biochem & Biomed Sci, Brighton, E Sussex, England; [Main, Ewan] Univ Sussex, Sch Life Sci, Div Chem, Brighton, E Sussex, England	University of Sussex; University of Sussex; University of Sussex	Boyd, LK (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	f.z.watts@sussex.ac.uk		Main, Ewan/0000-0001-6087-9000	Biotechnology and Biological Sciences Research Council (BBSRC) [S03/G152, BB/D526861/1]; Leverhulme Trust [RFG/10839]; Medical Research Council [G0500308, G0801130B] Funding Source: researchfish; MRC [G0500308] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) S03/G152, http://www.bbsrc.ac.uk/; BBSRC BB/D526861/1; and Leverhulme Trust RFG/10839, http://www.leverhulme.ac.uk/. The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Cuperus G, 2002, GENETICS, V162, P633; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Laursen LV, 2003, MOL CELL BIOL, V23, P3692, DOI 10.1128/MCB.23.10.3692-3705.2003; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, MOL BIOL CELL, V19, P4099, DOI 10.1091/mbc.E08-02-0226; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Raffa GD, 2006, J BIOL CHEM, V281, P27973, DOI 10.1074/jbc.M601943200; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; SEKIYAMA N, PROTEINS, V78, P1491; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13009	10.1371/journal.pone.0013009	http://dx.doi.org/10.1371/journal.pone.0013009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885950	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000282167100013
J	Maupin, KA; Sinha, A; Eugster, E; Miller, J; Ross, J; Paulino, V; Keshamouni, VG; Tran, N; Berens, M; Webb, C; Haab, BB				Maupin, Kevin A.; Sinha, Arkadeep; Eugster, Emily; Miller, Jeremy; Ross, Julianna; Paulino, Vincent; Keshamouni, Venkateshwar G.; Tran, Nhan; Berens, Michael; Webb, Craig; Haab, Brian B.			Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems	PLOS ONE			English	Article							CELL-ADHESION; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES; CADHERIN EXPRESSION; CARCINOMA CELLS; GROWTH; TRANSFERASES; CLONING; GLYCANS; GLYCOSYLPHOSPHATIDYLINOSITOL	Background: The ability to selectively detect and target cancer cells that have undergone an epithelial-mesenchymal transition (EMT) may lead to improved methods to treat cancers such as pancreatic cancer. The remodeling of cellular glycosylation previously has been associated with cell differentiation and may represent a valuable class of molecular targets for EMT. Methodology/Principal Findings: As a first step toward investigating the nature of glycosylation alterations in EMT, we characterized the expression of glycan-related genes in three in-vitro model systems that each represented a complementary aspect of pancreatic cancer EMT. These models included: 1) TGF beta-induced EMT, which provided a look at the active transition between states; 2) a panel of 22 pancreatic cancer cell lines, which represented terminal differentiation states of either epithelial-like or mesenchymal-like; and 3) actively-migrating and stationary cells, which provided a look at the mechanism of migration. We analyzed expression data from a list of 587 genes involved in glycosylation (biosynthesis, sugar transport, glycan-binding, etc.) or EMT. Glycogenes were altered at a higher prevalence than all other genes in the first two models (p<0.05 and <0.005, respectively) but not in the migration model. Several functional themes were shared between the induced-EMT model and the cell line panel, including alterations to matrix components and proteoglycans, the sulfation of glycosaminoglycans; mannose receptor family members; initiation of O-glycosylation; and certain forms of sialylation. Protein-level changes were confirmed by Western blot for the mannose receptor MRC2 and the O-glycosylation enzyme GALNT3, and cell-surface sulfation changes were confirmed using Alcian Blue staining. Conclusions/Significance: Alterations to glycogenes are a major component of cancer EMT and are characterized by changes to matrix components, the sulfation of GAGs, mannose receptors, O-glycosylation, and specific sialylated structures. These results provide leads for targeting aggressive and drug resistant forms of pancreatic cancer cells.	[Maupin, Kevin A.; Sinha, Arkadeep; Eugster, Emily; Miller, Jeremy; Webb, Craig; Haab, Brian B.] Van Andel Res Inst, Grand Rapids, MI USA; [Ross, Julianna; Paulino, Vincent; Tran, Nhan; Berens, Michael] Translat Genom Res Inst, Phoenix, AZ USA; [Keshamouni, Venkateshwar G.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Van Andel Institute; Translational Genomics Research Institute; University of Michigan System; University of Michigan	Maupin, KA (corresponding author), Van Andel Res Inst, Grand Rapids, MI USA.	Brian.Haab@vai.org	Webb, Craig/I-8123-2012	sinha, arkadeep/0000-0002-9432-3956; Keshamouni, Venkateshwar/0000-0003-1947-791X	National Cancer Institute, National Institutes of Health [NIH] [R03CA139225, R01 CA132571, R01 CA130940 NT]; American Cancer Society [CSM-116801]; National Institute of Neurological Disorders and Stroke [NIH R01 NS042262]; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R03CA139225, R01CA130940, R01CA132571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042262] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute (www.cancer.gov) (R03CA139225 to B.H., National Institutes of Health [NIH] R01 CA132571 to V.K., and NIH R01 CA130940 NT), the American Cancer Society (www. cancer. org) (CSM-116801 to V.K.), The National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov) (NIH R01 NS042262 to M.B.) and the Van Andel Research Institute (www.vai.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; American Cancer Society, 2022, CANC FACTS FIGURES 2; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Berens ME, 2004, METH MOLEC MED, V88, P219; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; BUCK CA, 1971, SCIENCE, V172, P169, DOI 10.1126/science.172.3979.169; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; CHEN WC, BLOOD; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Goss PE, 1995, CLIN CANCER RES, V1, P935; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Harduin-Lepers A, 2000, BIOCHEM J, V352, P37, DOI 10.1042/0264-6021:3520037; Heiskanen A, 2009, GLYCOCONJUGATE J, V26, P367, DOI 10.1007/s10719-008-9217-6; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hruban RH, 2009, HUM PATHOL, V40, P612, DOI 10.1016/j.humpath.2009.01.008; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; IOZZO RV, 2007, PROTEOGLYCAN PROTOCO; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Julien S, 2005, BREAST CANCER RES TR, V90, P77, DOI 10.1007/s10549-004-3137-3; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kroes RA, 2007, J NEUROCHEM, V103, P14, DOI 10.1111/j.1471-4159.2007.04780.x; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Luttges J, 2000, J PATHOL, V191, P154; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Miyahara N, 2004, CLIN CANCER RES, V10, P2090, DOI 10.1158/1078-0432.CCR-1024-03; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mungul A, 2004, INT J ONCOL, V25, P937; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Nemoto-Sasaki Y, 2001, GLYCOCONJUGATE J, V18, P895, DOI 10.1023/A:1022252509765; Oida Y, 2006, ONCOL REP, V16, P457; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rosenberg L, 2000, DRUGS, V59, P1071, DOI 10.2165/00003495-200059050-00004; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Schreiber SC, 2008, GASTROENTEROLOGY, V134, P1555, DOI 10.1053/j.gastro.2008.02.023; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Skandalis SS, 2006, BBA-GEN SUBJECTS, V1760, P1217, DOI 10.1016/j.bbagen.2006.03.021; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Sutherlin ME, 1997, CANCER RES, V57, P4744; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Trombetta ES, 2002, ADV PROTEIN CHEM, V59, P303; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Varki A., 2009, ESSENTIALS GLYCOBIOL; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200	70	80	82	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13002	10.1371/journal.pone.0013002	http://dx.doi.org/10.1371/journal.pone.0013002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885998	gold, Green Published, Green Submitted			2022-12-25	WOS:000282167100010
J	Peltonen, K; Colis, L; Liu, H; Jaamaa, S; Moore, HM; Enback, J; Laakkonen, P; Vaahtokari, A; Jones, RJ; af Hallstrom, TM; Laiho, M				Peltonen, Karita; Colis, Laureen; Liu, Hester; Jaamaa, Sari; Moore, Henna M.; Enback, Juulia; Laakkonen, Pirjo; Vaahtokari, Anne; Jones, Richard J.; af Hallstrom, Taija M.; Laiho, Marikki			Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; DNA-DAMAGE; TARGETING DNA; CANCER; TUMORS; RESTORATION; BINDING; MECHANISM; DRUGS	Manipulation of the activity of the p53 tumor suppressor pathway has demonstrated potential benefit in preclinical mouse tumor models and has entered human clinical trials. We describe here an improved, extensive small-molecule chemical compound library screen for p53 pathway activation in a human cancer cell line devised to identify hits with potent antitumor activity. We uncover six novel small-molecule lead compounds, which activate p53 and repress the growth of human cancer cells. Two tested compounds suppress in vivo tumor growth in an orthotopic mouse model of human B-cell lymphoma. All compounds interact with DNA, and two activate p53 pathway in a DNA damage signaling-dependent manner. A further screen of a drug library of approved drugs for medicinal uses and analysis of gene-expression signatures of the novel compounds revealed similarities to known DNA intercalating and topoisomerase interfering agents and unexpected connectivities to known drugs without previously demonstrated anticancer activities. These included several neuroleptics, glycosides, antihistamines and adrenoreceptor antagonists. This unbiased screen pinpoints interference with the DNA topology as the predominant mean of pharmacological activation of the p53 pathway and identifies potential novel antitumor agents.	[Peltonen, Karita; Jaamaa, Sari; Moore, Henna M.; af Hallstrom, Taija M.; Laiho, Marikki] Univ Helsinki, Haartman Inst, Mol Canc Biol Program, Helsinki, Finland; [Peltonen, Karita; Jaamaa, Sari; Moore, Henna M.; af Hallstrom, Taija M.; Laiho, Marikki] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Colis, Laureen; Liu, Hester; Jones, Richard J.; Laiho, Marikki] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Jaamaa, Sari] Univ Helsinki, Lab Div, Helsinki, Finland; [Enback, Juulia; Laakkonen, Pirjo] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Vaahtokari, Anne; Laiho, Marikki] Univ Helsinki, Mol Imaging Unit, Helsinki, Finland	University of Helsinki; University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; University of Helsinki; University of Helsinki; University of Helsinki	Peltonen, K (corresponding author), Univ Helsinki, Haartman Inst, Mol Canc Biol Program, Helsinki, Finland.	mlaiho1@jhmi.edu		Peltonen, Karita Dolores/0000-0002-3063-451X; Laakkonen, Pirjo/0000-0002-9620-095X	Academy of Finland; Finnish Cancer Organization; Foundation for the Finnish Cancer Institute; Biocentrum Helsinki; Sigrid Juselius Foundation; Finnish Cultural Foundation; Biomedicum Helsinki Foundation; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Finnish Cancer Organization; Foundation for the Finnish Cancer Institute; Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biomedicum Helsinki Foundation; Helsinki Biomedical Graduate School	Funding for M.L. was from the Academy of Finland Center of Excellence Program, Finnish Cancer Organization, Foundation for the Finnish Cancer Institute, Biocentrum Helsinki and Sigrid Juselius Foundation. K.P. received support from the Finnish Cultural Foundation and the Biomedicum Helsinki Foundation. H.M.M. and J.E. were supported by the Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEDI A, 1994, CANCER RES, V54, P5535; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Dalton SO, 2006, BRIT J CANCER, V95, P934, DOI 10.1038/sj.bjc.6603259; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hallstrom TMKA, 2007, P NATL ACAD SCI USA, V104, P7211, DOI 10.1073/pnas.0609299104; Harris AM, 2007, J UROLOGY, V178, P2176, DOI 10.1016/j.juro.2007.06.043; Hendry LB, 2007, MUTAT RES-FUND MOL M, V623, P53, DOI 10.1016/j.mrfmmm.2007.03.009; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lin SC, 2007, NEOPLASIA, V9, P830, DOI 10.1593/neo.07475; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MALKIN D, 1994, ANNU REV GENET, V28, P443; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; Boer DR, 2009, DALTON T, P399, DOI 10.1039/b809873p; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sohn TA, 2002, CARCINOGENESIS, V23, P949, DOI 10.1093/carcin/23.6.949; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Webb MR, 2003, ANAL BIOCHEM, V321, P22, DOI 10.1016/S0003-2697(03)00459-7; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Ye RQ, 2004, DNA REPAIR, V3, P235, DOI 10.1016/j.dnarep.2003.10.014; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao RB, 2000, GENE DEV, V14, P981	49	72	77	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12996	10.1371/journal.pone.0012996	http://dx.doi.org/10.1371/journal.pone.0012996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885994	gold, Green Published, Green Submitted			2022-12-25	WOS:000282167100007
J	Shiller, DM; Gracco, VL; Rvachew, S				Shiller, Douglas M.; Gracco, Vincent L.; Rvachew, Susan			Auditory-Motor Learning during Speech Production in 9-11-Year-Old Children	PLOS ONE			English	Article							NEURAL-NETWORK MODEL; SENSORIMOTOR ADAPTATION; DEVELOPMENTAL-CHANGES; ACOUSTIC CHARACTERISTICS; TEMPORAL VARIABILITY; DYNAMIC MEASURES; VOCAL INTENSITY; FEEDBACK; JAW; PERCEPTION	Background: Hearing ability is essential for normal speech development, however the precise mechanisms linking auditory input and the improvement of speaking ability remain poorly understood. Auditory feedback during speech production is believed to play a critical role by providing the nervous system with information about speech outcomes that is used to learn and subsequently fine-tune speech motor output. Surprisingly, few studies have directly investigated such auditory-motor learning in the speech production of typically developing children. Methodology/Principal Findings: In the present study, we manipulated auditory feedback during speech production in a group of 9-11-year old children, as well as in adults. Following a period of speech practice under conditions of altered auditory feedback, compensatory changes in speech production and perception were examined. Consistent with prior studies, the adults exhibited compensatory changes in both their speech motor output and their perceptual representations of speech sound categories. The children exhibited compensatory changes in the motor domain, with a change in speech output that was similar in magnitude to that of the adults, however the children showed no reliable compensatory effect on their perceptual representations. Conclusions: The results indicate that 9-11-year-old children, whose speech motor and perceptual abilities are still not fully developed, are nonetheless capable of auditory-feedback-based sensorimotor adaptation, supporting a role for such learning processes in speech motor development. Auditory feedback may play a more limited role, however, in the fine-tuning of children's perceptual representations of speech sound categories.	[Shiller, Douglas M.] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Shiller, Douglas M.] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Shiller, Douglas M.; Gracco, Vincent L.; Rvachew, Susan] McGill Univ, Ctr Res Language Mind & Brain, Montreal, PQ, Canada; [Gracco, Vincent L.; Rvachew, Susan] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Gracco, Vincent L.] Haskins Labs Inc, New Haven, CT USA	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill University; Yale University; Haskins Laboratories	Shiller, DM (corresponding author), Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada.	douglas.shiller@umontreal.ca			Canadian Child Health Clinician Scientist Training Program; CHU Sainte-Justine Research Center	Canadian Child Health Clinician Scientist Training Program; CHU Sainte-Justine Research Center	Research funding was provided by the Canadian Child Health Clinician Scientist Training Program (http://cchcsp.ca/) and startup funds from the CHU Sainte-Justine Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport FH., 1924, SOC PSYCHOL-GERMANY; AMAZI DK, 1982, J SPEECH HEAR RES, V25, P581, DOI 10.1044/jshr.2504.581; ASLIN RN, 1980, CHILD PHONOLOGY, V2, P67; BAUM SR, 1988, J ACOUST SOC AM, V84, P1662, DOI 10.1121/1.397181; Baum SR, 1997, J ACOUST SOC AM, V102, P2353, DOI 10.1121/1.419619; Baum SR, 2000, J ACOUST SOC AM, V107, P3572, DOI 10.1121/1.429429; BEHRENS SJ, 1988, J PHONETICS, V16, P295, DOI 10.1016/S0095-4470(19)30504-2; BELMORE NF, 1973, J SPEECH HEAR RES, V16, P709, DOI 10.1044/jshr.1604.709; Callan DE, 2000, J SPEECH LANG HEAR R, V43, P721, DOI 10.1044/jslhr.4303.721; CHASE RA, 1961, J GENET PSYCHOL, V99, P101, DOI 10.1080/00221325.1961.10534396; Cheng HY, 2007, J SPEECH LANG HEAR R, V50, P352, DOI 10.1044/1092-4388(2007/025); COPLAN J, 1988, PEDIATRICS, V82, P447; DEJARNETTE G, 1988, PERCEPT MOTOR SKILL, V67, P963, DOI 10.2466/pms.1988.67.3.963; EDWARDS J, 1992, J PHONETICS, V20, P189, DOI 10.1016/S0095-4470(19)30622-9; Edwards J, 2002, J SPEECH LANG HEAR R, V45, P231, DOI 10.1044/1092-4388(2002/018); Eguchi S, 1969, Acta Otolaryngol Suppl, V257, P1; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Green JR, 2002, J SPEECH LANG HEAR R, V45, P66, DOI 10.1044/1092-4388(2002/005); GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Huber JE, 1999, J ACOUST SOC AM, V106, P1532, DOI 10.1121/1.427150; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Jongman A, 2000, J ACOUST SOC AM, V108, P1252, DOI 10.1121/1.1288413; Kawahara H., 1993, J ACOUST SOC AM, V94, P1883; KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; KENT RD, 1982, J ACOUST SOC AM, V72, P353, DOI 10.1121/1.388089; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Lane H, 2007, J SPEECH LANG HEAR R, V50, P2, DOI 10.1044/1092-4388(2007/001); Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Lombard E, 1911, ANN MALADIES OREILLE, P101; MACKAY DG, 1968, J ACOUST SOC AM, V43, P811, DOI 10.1121/1.1910900; Max L, 2003, P 15 INT C PHONETIC, P1053; Menard L, 2008, J ACOUST SOC AM, V124, P1192, DOI 10.1121/1.2945704; Mowrer OH, 1952, J SPEECH HEAR DISORD, V17, P263, DOI 10.1044/jshd.1703.263; Munson B, 2004, J SPEECH LANG HEAR R, V47, P58, DOI 10.1044/1092-4388(2004/006); Munson B, 2001, J ACOUST SOC AM, V110, P1203, DOI 10.1121/1.1387093; Oller D. Kimbrough, 1983, PRODUCTION SPEECH, P91; Orhan AE, 2010, J VISION, V10, DOI 10.1167/10.2.2; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; Perkell JS, 2000, J PHONETICS, V28, P233, DOI 10.1006/jpho.2000.0116; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; RATNER SC, 1964, PSYCHOL REC, V14, P47, DOI 10.1007/BF03393561; Sadagopan N, 2008, J SPEECH LANG HEAR R, V51, P1138, DOI 10.1044/1092-4388(2008/06-0222); SHARKEY SG, 1985, J SPEECH HEAR RES, V28, P8, DOI 10.1044/jshr.2801.08; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; SIEGEL GM, 1984, J SPEECH HEAR RES, V27, P56, DOI 10.1044/jshr.2701.56; SIEGEL GM, 1980, J SPEECH HEAR RES, V23, P802, DOI 10.1044/jshr.2304.802; SIEGEL GM, 1976, DEV PSYCHOL, V12, P255, DOI 10.1037/0012-1649.12.3.255; Smith A, 2004, DEV PSYCHOBIOL, V45, P22, DOI 10.1002/dev.20009; Smith A, 1998, J SPEECH LANG HEAR R, V41, P18, DOI 10.1044/jslhr.4101.18; Smith B.L., 1978, J PHON, V6, P37, DOI [10.1016/S0095-4470(19)31084-8, DOI 10.1016/S0095-4470(19)31084-8]; Smith BL, 1996, J ACOUST SOC AM, V99, P2344, DOI 10.1121/1.415421; Smith BL, 1999, PHONETICA, V56, P73, DOI 10.1159/000028442; SMITH BL, 1987, J ACOUST SOC AM, V81, P747, DOI 10.1121/1.394843; SMITH BL, 1994, J PHONETICS, V22, P155, DOI 10.1016/S0095-4470(19)30191-3; Stoel-Gammon C., 1985, NORMAL DISORDERED PH; Strange W., 1995, SPEECH PERCEPTION LI, P121; SUSSMAN JE, 1989, J SPEECH HEAR RES, V32, P151, DOI 10.1044/jshr.3201.151; SUSSMAN JE, 1993, J SPEECH HEAR RES, V36, P380, DOI 10.1044/jshr.3602.380; TINGLEY BM, 1975, CHILD DEV, V46, P186; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); Walsh B, 2006, DEV PSYCHOBIOL, V48, P660, DOI 10.1002/dev.20185; YENIKOMSHIAN G, 1968, J SPEECH HEAR RES, V11, P307, DOI 10.1044/jshr.1102.307; ZLATIN MA, 1976, J SPEECH HEAR RES, V19, P93, DOI 10.1044/jshr.1901.93	69	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12975	10.1371/journal.pone.0012975	http://dx.doi.org/10.1371/journal.pone.0012975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653UN	20886033	gold, Green Published			2022-12-25	WOS:000282122600013
J	Cleynen, I; John, JMM; Henckaerts, L; Van Moerkercke, W; Rutgeerts, P; Van Steen, K; Vermeire, S				Cleynen, Isabelle; John, Jestinah M. Mahachie; Henckaerts, Liesbet; Van Moerkercke, Wouter; Rutgeerts, Paul; Van Steen, Kristel; Vermeire, Severine			Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CLASSIFICATION; AUTOPHAGY; GENOTYPE; RISK	Background: Crohn's Disease (CD) has a heterogeneous presentation, and is typically classified according to extent and location of disease. The genetic susceptibility to CD is well known and genome-wide association scans (GWAS) and meta-analysis thereof have identified over 30 susceptibility loci. Except for the association between ileal CD and NOD2 mutations, efforts in trying to link CD genetics to clinical subphenotypes have not been very successful. We hypothesized that the large number of confirmed genetic variants enables (better) classification of CD patients. Methodology/Principal Findings: To look for genetic-based subgroups, genotyping results of 46 SNPs identified from CD GWAS were analyzed by Latent Class Analysis (LCA) in CD patients and in healthy controls. Six genetic-based subgroups were identified in CD patients, which were significantly different from the five subgroups found in healthy controls. The identified CD-specific clusters are therefore likely to contribute to disease behavior. We then looked at whether we could relate the genetic-based subgroups to the currently used clinical parameters. Although modest differences in prevalence of disease location and behavior could be observed among the CD clusters, Random Forest analysis showed that patients could not be allocated to one of the 6 genetic-based subgroups based on the typically used clinical parameters alone. This points to a poor relationship between the genetic-based subgroups and the used clinical subphenotypes. Conclusions/Significance: This approach serves as a first step to reclassify Crohn's disease. The used technique can be applied to other common complex diseases as well, and will help to complete patient characterization, in order to evolve towards personalized medicine.	[Cleynen, Isabelle; Van Moerkercke, Wouter; Rutgeerts, Paul; Vermeire, Severine] Katholieke Univ Leuven, Dept Gastroenterol, Louvain, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Dept Elect Engn & Comp Sci, Syst & Modeling Unit, Liege, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium; [Henckaerts, Liesbet] UZ Leuven, Dept Med, Louvain, Belgium	KU Leuven; University of Liege; University of Liege; KU Leuven; University Hospital Leuven	Cleynen, I (corresponding author), Katholieke Univ Leuven, Dept Gastroenterol, Louvain, Belgium.	isabelle.cleynen@med.kuleuven.be	Henckaerts, Liesbet/AAB-5706-2021	Van Steen, Kristel/0000-0001-9868-5033; Vermeire, Severine/0000-0001-9942-3019; Henckaerts, Liesbet/0000-0003-2880-1400	Fund for Scientific Research (FWO) Flanders, Belgium	Fund for Scientific Research (FWO) Flanders, Belgium(FWO)	This work was supported by the Fund for Scientific Research (FWO) Flanders, Belgium, to I. C. and S. V.; the Geconcerteerde Onderzoekacties (GOA) of the KU Leuven [grant number GOA/11/015]; the Belgian Network BioMAGNet (Bioinformatics and Modelling: from Genomes to Networks), funded by the Interuniversity Attraction Poles Programme (Phase VI/4) and initiated by the Belgian State, Science Policy Office to J.M.M.J. and K. V. S.; the IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning) [IST-2007-216886 to J.M.M.J. and K. V. S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; HENCKAERTS L, 2009, CLIN GASTROENTEROL H; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunt L, 2003, COMPUT STAT DATA AN, V41, P429, DOI 10.1016/S0167-9473(02)00190-1; Hunt L, 1999, AUST NZ J STAT, V41, P153; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weersma RK, 2009, GUT, V58, P388, DOI 10.1136/gut.2007.144865	21	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12952	10.1371/journal.pone.0012952	http://dx.doi.org/10.1371/journal.pone.0012952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886065	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100047
J	Greenough, TC; Campellone, SC; Brody, R; Jain, S; Sanchez-Merino, V; Somasundaran, M; Luzuriaga, K				Greenough, Thomas C.; Campellone, Shalyn C.; Brody, Robin; Jain, Surbhi; Sanchez-Merino, Victor; Somasundaran, Mohan; Luzuriaga, Katherine			Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; PD-1 EXPRESSION; HIV-INFECTION; EBV INFECTION; CD8(+); RESPONSES; EXHAUSTION; EVOLUTION; PROLIFERATION; MONONUCLEOSIS	Background: Programmed Death-1 (PD-1) is an inhibitory member of the CD28 family of molecules expressed on CD8+ T cells in response to antigenic stimulation. To better understand the role of PD-1 in antiviral immunity we examined the expression of PD-1 on Epstein-Barr virus (EBV) epitope-specific CD8+ T cells during acute infectious mononucleosis (AIM) and convalescence. Methodology/Principal Findings: Using flow cytometry, we observed higher frequencies of EBV-specific CD8+ T cells and higher intensity of PD-1 expression on EBV-specific CD8+ T cells during AIM than during convalescence. PD-1 expression during AIM directly correlated with viral load and with the subsequent degree of CD8+ T cell contraction in convalescence. Consistent differences in PD-1 expression were observed between CD8+ T cells with specificity for two different EBV lytic antigen epitopes. Similar differences were observed in the degree to which PD-1 was upregulated on these epitope-specific CD8+ T cells following peptide stimulation in vitro. EBV epitope-specific CD8+ T cell proliferative responses to peptide stimulation were diminished during AIM regardless of PD-1 expression and were unaffected by blocking PD-1 interactions with PD-L1. Significant variability in PD-1 expression was observed on EBV epitope-specific CD8+ T cell subsets defined by Vbeta usage. Conclusions/Significance: These observations suggest that PD-1 expression is not only dependent on the degree of antigen presentation, but also on undefined characteristics of the responding cell that segregate with epitope specificity and V-beta usage.	[Greenough, Thomas C.; Brody, Robin; Jain, Surbhi; Sanchez-Merino, Victor; Somasundaran, Mohan; Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Campellone, Shalyn C.] Medarex Inc, Bloomsbury, NJ USA	University of Massachusetts System; University of Massachusetts Worcester	Greenough, TC (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	thomas.greenough@umassmed.edu		Sanchez-Merino, Victor/0000-0001-9400-427X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI049320-08]; NIH/CFAR (Centers for AIDS Research) [P30-AI042845-10]; Medarex, Inc. Medarex, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, P01AI049320] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/CFAR (Centers for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medarex, Inc. Medarex, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grant P01 AI049320-08 with additional support from NIH/CFAR (Centers for AIDS Research) P30-AI042845-10 and Medarex, Inc. Medarex, Inc. provided reagents and salary support for one author (S.C.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Callan MFC, 2003, VIRAL IMMUNOL, V16, P3, DOI 10.1089/088282403763635401; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Catalina MD, 2002, J IMMUNOL, V168, P4184, DOI 10.4049/jimmunol.168.8.4184; Catalina MD, 2001, J IMMUNOL, V167, P4450, DOI 10.4049/jimmunol.167.8.4450; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Hadinoto V, 2008, BLOOD, V111, P1420, DOI 10.1182/blood-2007-06-093278; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Nakamura Masahiko, 2009, Ornithological Science, V8, P1, DOI 10.2326/048.008.0101; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Precopio ML, 2003, J IMMUNOL, V170, P2590, DOI 10.4049/jimmunol.170.5.2590; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauce D, 2007, J INFECT DIS, V195, P268, DOI 10.1086/510248; Sauce D, 2009, J VIROL, V83, P9068, DOI 10.1128/JVI.00141-09; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Vetsika Eleni-Kyriaki, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008440; Vollbrecht T, 2010, J MED VIROL, V82, P358, DOI 10.1002/jmv.21723; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037	39	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12926	10.1371/journal.pone.0012926	http://dx.doi.org/10.1371/journal.pone.0012926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886079	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100030
J	Vincent, M; Sayre, NL; Graham, MJ; Crooke, RM; Shealy, DJ; Liscum, L				Vincent, Melanie; Sayre, Naomi L.; Graham, Mark J.; Crooke, Rosanne M.; Shealy, David J.; Liscum, Laura			Evaluation of an Anti-Tumor Necrosis Factor Therapeutic in a Mouse Model of Niemann-Pick C Liver Disease	PLOS ONE			English	Article							CELL DEATH; CHOLESTEROL; MICE; APOPTOSIS; BRAIN	Background: Niemann-Pick type C (NPC) disease is a lysosomal storage disease characterized by the accumulation of cholesterol and glycosphingolipids. The majority of NPC patients die in their teen years due to progressive neurodegeneration; however, half of NPC patients also suffer from cholestasis, prolonged jaundice, and hepatosplenomegaly. We previously showed that a key mediator of NPC liver disease is tumor necrosis factor (TNF) alpha, which is involved in both proinflammatory and apoptotic signaling cascades. In this study, we tested the hypothesis that blocking TNF action with an anti-TNF monoclonal antibody (CNTO5048) will slow the progression of NPC liver disease. Methodology/Principal Findings: Treatment of wild-type C57BL/6 mice with NPC1-specific antisense oligonucleotides led to knockdown of NPC1 protein expression in the liver. This caused classical symptoms of NPC liver disease, including hepatic cholesterol accumulation, hepatomegaly, elevated serum liver enzymes, and lipid laden macrophage accumulation. In addition, there was a significant increase in the number of apoptotic cells and a proliferation of stellate cells. Concurrent treatment of NPC1 knockdown mice with anti-TNF had no effect on the primary lipid storage or accumulation of lipid-laden macrophages. However, anti-TNF treatment slightly blunted the increase in hepatic apoptosis and stellate cell activation that was seen with NPC1 knockdown. Conclusions/Significance: Current therapeutic options for NPC disease are limited. Our results provide proof of principle that pharmacologically blocking the TNF-alpha inflammatory cascade can slightly reduce certain markers of NPC disease. Small molecule inhibitors of TNF that penetrate tissues and cross the blood-brain barrier may prove even more beneficial.	[Vincent, Melanie; Sayre, Naomi L.; Liscum, Laura] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Graham, Mark J.; Crooke, Rosanne M.] Isis Pharmaceut Inc, Cardiovasc Dis Antisense Drug Discovery, Carlsbad, CA USA; [Shealy, David J.] Centocor Res & Dev Inc, Radnor, PA USA	Tufts University; Isis Pharmaceuticals Inc; Johnson & Johnson; Johnson & Johnson USA	Vincent, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	laura.liscum@tufts.edu		Liscum, Laura/0000-0002-8399-2222; Sayre, Naomi/0000-0002-6124-2535	National Institutes of Health [RO1 DK-49564, T32 DK-07542]; Tufts Center for Neurosciences Research [P30 NS047243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neurosciences Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1 DK-49564 and T32 DK-07542, and the Tufts Center for Neurosciences Research P30 NS047243. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJG and RMC are employees of Isis Pharmaceuticals. DJS is an employee of Centocor Research and Development, a subsidiary of Johnson & Johnson. They played a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Beltroy EP, 2007, J LIPID RES, V48, P869, DOI 10.1194/jlr.M600488-JLR200; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Erickson RP, 2005, AM J PHYSIOL-GASTR L, V289, pG300, DOI 10.1152/ajpgi.00568.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Kulinski A, 2007, J BIOL CHEM, V282, P1627, DOI 10.1074/jbc.M610001200; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; SAYRE NL, J LIPID RES IN PRESS; Shealy D. J., 2008, V181, P101; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011	23	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12941	10.1371/journal.pone.0012941	http://dx.doi.org/10.1371/journal.pone.0012941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886067	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100040
J	Khandelia, H; Duelund, L; Pakkanen, KI; Ipsen, JH				Khandelia, Himanshu; Duelund, Lars; Pakkanen, Kirsi I.; Ipsen, John H.			Triglyceride Blisters in Lipid Bilayers: Implications for Lipid Droplet Biogenesis and the Mobile Lipid Signal in Cancer Cell Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PLASMA-MEMBRANES; NEUTRAL LIPIDS; PHOSPHOLIPID MONOLAYER; BODY FORMATION; PHOSPHATIDYLCHOLINE; SOLUBILIZATION; CHOLESTEROL; MECHANISMS; CURVATURE	Triglycerides have a limited solubility, around 3%, in phosphatidylcholine lipid bilayers. Using millisecond-scale course grained molecular dynamics simulations, we show that the model lipid bilayer can accommodate a higher concentration of triolein (TO) than earlier anticipated, by sequestering triolein molecules to the bilayer center in the form of a disordered, isotropic, mobile neutral lipid aggregate, at least 17 nm in diameter, which forms spontaneously, and remains stable on at least the microsecond time scale. The results give credence to the hotly debated existence of mobile neutral lipid aggregates of unknown function present in malignant cells, and to the early biogenesis of lipid droplets accommodated between the two leaflets of the endoplasmic reticulum membrane. The TO aggregates give the bilayer a blister-like appearance, and will hinder the formation of multi-lamellar phases in model, and possibly living membranes. The blisters will result in anomalous membrane probe partitioning, which should be accounted for in the interpretation of probe-related measurements.	[Khandelia, Himanshu; Duelund, Lars; Pakkanen, Kirsi I.; Ipsen, John H.] Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark	University of Southern Denmark	Khandelia, H (corresponding author), Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	hkhandel@memphys.sdu.dk	Duelund, Lars/AHB-2952-2022; Duelund, Lars/AAC-7110-2019; Ipsen, John/X-3216-2019	Duelund, Lars/0000-0002-3786-2822; Pakkanen, Kirsi/0000-0002-3215-6937; Ipsen, John/0000-0002-1268-6180; Khandelia, Himanshu/0000-0001-9913-6394	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work is funded by The Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BROTHERUS J, 1977, J LIPID RES, V18, P191; CATES ME, 1988, LANGMUIR, V4, P802, DOI 10.1021/la00082a004; Daniels TF, 2009, INT J BIOL SCI, V5, P474; Ellena JF, 1999, DRUG DELIV, V6, P97, DOI 10.1080/107175499267011; Ferretti A, 1999, BBA-MOL CELL BIOL L, V1438, P329, DOI 10.1016/S1388-1981(99)00071-2; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; GIL J, 1973, J CELL BIOL, V58, P152, DOI 10.1083/jcb.58.1.152; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hall A, 2008, J PHYS CHEM B, V112, P13772, DOI 10.1021/jp803950w; HALLMAN M, 1976, J LIPID RES, V17, P257; HAMILTON JA, 1991, BIOCHEMISTRY-US, V30, P2894, DOI 10.1021/bi00225a024; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hennere G, 2009, CHEM PHYS LIPIDS, V157, P86, DOI 10.1016/j.chemphyslip.2008.10.002; Henriksen J, 2004, EUR BIOPHYS J BIOPHY, V33, P732, DOI 10.1007/s00249-004-0420-5; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HOLMES KT, 1990, MAGNET RESON MED, V16, P1, DOI 10.1002/mrm.1910160102; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Israelachvili J. N., 1991, INTERMOLECULAR SURFA, Vxxi; JACKSON RL, 1976, PHYSIOL REV, V56, P259, DOI 10.1152/physrev.1976.56.2.259; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Lee YC, 1996, BIOCHEMISTRY-US, V35, P3677, DOI 10.1021/bi9517502; LI KL, 1993, BIOCHEMISTRY-US, V32, P9926, DOI 10.1021/bi00089a008; Li R, 2003, J AGR FOOD CHEM, V51, P477, DOI 10.1021/jf025676n; MACKINNON WB, 1992, EUR J BIOCHEM, V205, P827, DOI 10.1111/j.1432-1033.1992.tb16847.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MAY GL, 1986, J BIOL CHEM, V261, P3048; May GL, 1997, J LIPID RES, V38, P1562; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MOUNTFORD CE, 1988, TRENDS BIOCHEM SCI, V13, P172, DOI 10.1016/0968-0004(88)90145-4; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakano M, 2009, J PHYS CHEM B, V113, P6745, DOI 10.1021/jp900913w; Napier JA, 1996, PLANT MOL BIOL, V31, P945, DOI 10.1007/BF00040714; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Pakkanen KI, 2010, CHEM PHYS LIPIDS, V163, P218, DOI 10.1016/j.chemphyslip.2009.11.007; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Prades J, 2003, J LIPID RES, V44, P1720, DOI 10.1194/jlr.M300092-JLR200; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Rosi A, 1999, MAGNET RESON MED, V42, P248, DOI 10.1002/(SICI)1522-2594(199908)42:2<248::AID-MRM6>3.0.CO;2-I; Ruiz JI, 1997, J LIPID RES, V38, P1482; SPOONER PJR, 1987, BIOCHEMISTRY-US, V26, P5820, DOI 10.1021/bi00392a036; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tulenko TN, 2002, J NUCL CARDIOL, V9, P638, DOI 10.1067/mnc.2002.128959; Veale MF, 1996, BBA-LIPID LIPID MET, V1303, P215, DOI 10.1016/0005-2760(96)00104-X; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; WANNER G, 1981, PLANTA, V151, P109, DOI 10.1007/BF00387812; YETUKURI L, 2010, J LIPID RES; ZACHOWSKI A, 1990, EXPERIENTIA, V46, P644, DOI 10.1007/BF01939703; Zanghellini J, 2010, J THEOR BIOL, V264, P952, DOI 10.1016/j.jtbi.2010.02.025	56	95	99	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12811	10.1371/journal.pone.0012811	http://dx.doi.org/10.1371/journal.pone.0012811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877640	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100010
J	Krall, P; Canales, CP; Kairath, P; Carmona-Mora, P; Molina, J; Carpio, JD; Ruiz, P; Mezzano, SA; Li, J; Wei, C; Reiser, J; Young, JI; Walz, K				Krall, Paola; Canales, Cesar P.; Kairath, Pamela; Carmona-Mora, Paulina; Molina, Jessica; Carpio, J. Daniel; Ruiz, Phillip; Mezzano, Sergio A.; Li, Jing; Wei, Changli; Reiser, Jochen; Young, Juan I.; Walz, Katherina			Podocyte-Specific Overexpression of Wild Type or Mutant Trpc6 in Mice Is Sufficient to Cause Glomerular Disease	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRANSIENT RECEPTOR; CRE RECOMBINASE; CATION CHANNEL; SLIT DIAPHRAGM; ANIMAL-MODELS; EXPRESSION; ACTIVATION; PROTEIN; GENE	Mutations in the TRPC6 calcium channel (Transient receptor potential channel 6) gene have been associated with familiar forms of Focal and Segmental Glomerulosclerosis (FSGS) affecting children and adults. In addition, acquired glomerular diseases are associated with increased expression levels of TRPC6. However, the exact role of TRPC6 in the pathogenesis of FSGS remains to be elucidated. In this work we describe the generation and phenotypic characterization of three different transgenic mouse lines with podocyte-specific overexpression of the wild type or any of two mutant forms of Trpc6 (P111Q and E896K) previously related to FSGS. Consistent with the human phenotype a non-nephrotic range of albuminuria was detectable in almost all transgenic lines. The histological analysis demonstrated that the transgenic mice developed a kidney disease similar to human FSGS. Differences of 2-3 folds in the presence of glomerular lesions were found between the non transgenic and transgenic mice expressing Trpc6 in its wild type or mutant forms specifically in podocytes. Electron microscopy of glomerulus from transgenic mice showed extensive podocyte foot process effacement. We conclude that overexpression of Trpc6 (wild type or mutated) in podocytes is sufficient to cause a kidney disease consistent with FSGS. Our results contribute to reinforce the central role of podocytes in the etiology of FSGS. These mice constitute an important new model in which to study future therapies and outcomes of this complex disease.	[Krall, Paola; Canales, Cesar P.; Kairath, Pamela; Carmona-Mora, Paulina; Molina, Jessica; Young, Juan I.; Walz, Katherina] Ctr Estudios Cient, Valdivia, Chile; [Krall, Paola; Kairath, Pamela] Univ Austral Chile, Valdivia, Chile; [Canales, Cesar P.; Carmona-Mora, Paulina; Young, Juan I.; Walz, Katherina] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Carpio, J. Daniel] Univ Austral Chile, Sch Med, Inst Anat Histol & Pathol, Valdivia, Chile; [Carpio, J. Daniel; Mezzano, Sergio A.] Univ Austral Chile, Sch Med, Nephrol Lab, Valdivia, Chile; [Ruiz, Phillip] Univ Miami, Leonard Miller Sch Med, Dept Pathol, Miami, FL USA; [Young, Juan I.] CIN Ctr Ingn Innovac CECS, Valdivia, Chile; [Li, Jing; Wei, Changli; Reiser, Jochen] Univ Miami, Leonard Miller Sch Med, Div Nephrol & Hypertens, Miami, FL USA	Universidad Austral de Chile; University of Miami; Universidad Austral de Chile; Universidad Austral de Chile; University of Miami; University of Miami	Krall, P (corresponding author), Ctr Estudios Cient, Valdivia, Chile.	kwalz@med.miami.edu	Carmona-Mora, Paulina/H-9055-2019	Carmona-Mora, Paulina/0000-0001-8560-1232	FONDECYT [1061067, 1051079]; FIC (Fogarty International Center) [R03 TW07536]; DID (Departamento de Investigacion y Desarrollo) [2007-10]; Chilean Government through the Millennium Science Initiative; Conicyt; NIH [DK073495]; FOGARTY INTERNATIONAL CENTER [R03TW007536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FIC (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); DID (Departamento de Investigacion y Desarrollo); Chilean Government through the Millennium Science Initiative; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by FONDECYT (grant 1061067, 1051079), FIC (Fogarty International Center; R03 TW07536) and DID (Departamento de Investigacion y Desarrollo; #2007-10. The Centro de Estudios Cienti-ficos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. CECS is also supported by a group of private companies, which at present includes Antofagasta Minerals, Arauco, Empresas CMPC, Indura, Naviera Ultragas and Telefonica del Sur. CIN (Centro de Ingenieria de la Innovacion) is funded by Conicyt and the Gobierno Regional de Los Rios. This work was also supported by NIH grants DK073495 (to J.R.). C. W. was the Halpin Scholar of the American Society of Nephrology 2007-2009. P. K acknowledges Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eder P, 2005, PFLUG ARCH EUR J PHY, V451, P99, DOI 10.1007/s00424-005-1434-2; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Juhila J, 2006, J AM SOC NEPHROL, V17, P648, DOI 10.1681/ASN.2005050547; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Monteiro EJB, 2006, J NEPHROL, V19, P366; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Thomas DB, 2009, ARCH PATHOL LAB MED, V133, P217, DOI 10.1043/1543-2165-133.2.217; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	44	97	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12859	10.1371/journal.pone.0012859	http://dx.doi.org/10.1371/journal.pone.0012859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877463	Green Published, gold, Green Submitted			2022-12-25	WOS:000281963200019
J	Nobrega, RH; Greebe, CD; van de Kant, H; Bogerd, J; de Franca, LR; Schulz, RW				Nobrega, Rafael Henrique; Greebe, Caaj Douwe; van de Kant, Henk; Bogerd, Jan; de Franca, Luiz Renato; Schulz, Rudiger W.			Spermatogonial Stem Cell Niche and Spermatogonial Stem Cell Transplantation in Zebrafish	PLOS ONE			English	Article							LABEL-RETAINING CELLS; GERM-CELLS; IN-VITRO; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; JAPANESE EEL; DANIO-RERIO; STEREOLOGICAL EVALUATION; EXPRESSION ANALYSIS; ANGUILLA-JAPONICA	Background: Spermatogonial stem cells (SSCs) are the foundation of spermatogenesis, and reside within a specific microenvironment in the testes called "niche'' which regulates stem cell properties, such as, self-renewal, pluripotency, quiescence and their ability to differentiate. Methodology/Principal Findings: Here, we introduce zebrafish as a new model for the study of SSCs in vertebrates. Using 59-bromo-29-deoxyuridine (BrdU), we identified long term BrdU-retaining germ cells, type A undifferentiated spermatogonia as putative stem cells in zebrafish testes. Similar to rodents, these cells were preferentially located near the interstitium, suggesting that the SSC niche is related to interstitial elements and might be conserved across vertebrates. This localization was also confirmed by analyzing the topographical distribution of type A undifferentiated spermatogonia in normal, vasa:: egfp and fli::egfp zebrafish testes. In the latter one, the topographical arrangement suggested that the vasculature is important for the SSC niche, perhaps as a supplier of nutrients, oxygen and/or signaling molecules. We also developed an SSC transplantation technique for both male and female recipients as an assay to evaluate the presence, biological activity, and plasticity of the SSC candidates in zebrafish. Conclusions/Significance: We demonstrated donor-derived spermato- and oogenesis in male and female recipients, respectively, indicating the stemness of type A undifferentiated spermatogonia and their plasticity when placed into an environment different from their original niche. Similar to other vertebrates, the transplantation efficiency was low. This might be attributed to the testicular microenvironment created after busulfan depletion in the recipients, which may have caused an imbalance between factors regulating self-renewal or differentiation of the transplanted SSCs.	[Nobrega, Rafael Henrique; Greebe, Caaj Douwe; van de Kant, Henk; Bogerd, Jan; Schulz, Rudiger W.] Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Utrecht, Netherlands; [Nobrega, Rafael Henrique; de Franca, Luiz Renato] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Schulz, Rudiger W.] Inst Marine Res, Res Grp Reprod & Growth Fish, N-5024 Bergen, Norway	Utrecht University; Universidade Federal de Minas Gerais; Institute of Marine Research - Norway	Nobrega, RH (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Utrecht, Netherlands.	lrfranca@icb.ufmg.br; r.w.schulz@uu.nl	Bogerd, Jan/B-8858-2011; Nóbrega, Rafael Henrique/C-3680-2015; Nóbrega, Rafael Henrique RHN/H-5976-2013; DE FRANCA, LUIZ/AAA-6923-2021; Schulz, Rüdiger Winfried/B-9046-2011	Bogerd, Jan/0000-0003-1120-7974; Nóbrega, Rafael Henrique/0000-0001-9796-5076; Schulz, Rüdiger Winfried/0000-0001-9115-669X	Norwegian Research Council; Utrecht University; National Council for Scientific and Technological Development (CNPq); Research Foundation of the State of Minas Gerais (FAPEMIG)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Utrecht University; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Norwegian Research Council, Utrecht University, the National Council for Scientific and Technological Development (CNPq), and Research Foundation of the State of Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braat AK, 2000, MECH DEVELOP, V95, P271, DOI 10.1016/S0925-4773(00)00344-0; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; de Rooij D. G., 2006, Animal Reproduction, V3, P130; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; de Waal PP, 2009, J ENDOCRINOL, V202, P287, DOI 10.1677/JOE-09-0050; Dobrinski I., 2006, Animal Reproduction, V3, P135; Garcia-Lopez A, 2009, ENDOCRINOLOGY, V150, P357, DOI 10.1210/en.2008-0447; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; GOMES WR, 1973, ENDOCRINOLOGY, V93, P800, DOI 10.1210/endo-93-4-800; Good-Avila SV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-293; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Kanatsu-Shinohara M, 2010, J REPROD DEVELOP, V56, P145, DOI 10.1262/jrd.09-153N; Krawetz SA, 2009, EMBO REP, V10, P1087, DOI 10.1038/embor.2009.211; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Lacerda SMSN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010740; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leal MC, 2009, BIOL REPROD, V81, P177, DOI 10.1095/biolreprod.109.076299; Leal MC, 2009, GEN COMP ENDOCR, V162, P134, DOI 10.1016/j.ygcen.2009.03.003; Li YW, 2008, GEN COMP ENDOCR, V159, P80, DOI 10.1016/j.ygcen.2008.07.023; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; McLean DJ, 2005, CELL TISSUE RES, V322, P21, DOI 10.1007/s00441-005-0009-z; Meistrich ML, 2003, INT J ANDROL, V26, P141, DOI 10.1046/j.1365-2605.2003.00400.x; Miura C, 2007, MOL REPROD DEV, V74, P420, DOI 10.1002/mrd.20653; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 1999, BIOCHEM BIOPH RES CO, V264, P230, DOI 10.1006/bbrc.1999.1494; Miura T, 2003, ENDOCRINOLOGY, V144, P5504, DOI 10.1210/en.2003-0800; Miura T, 2002, DEVELOPMENT, V129, P2689; MORRIS ID, 1987, INT J ANDROL, V10, P691, DOI 10.1111/j.1365-2605.1987.tb00371.x; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Neumann JC, 2009, ZEBRAFISH, V6, P319, DOI 10.1089/zeb.2009.0613; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Ohta T, 2007, BIOL REPROD, V77, P970, DOI 10.1095/biolreprod.107.062299; QUINTEROHUNTER I, 1991, BIOTECH HISTOCHEM, V66, P169, DOI 10.3109/10520299109109964; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rehbein H, 2007, J VERBRAUCH LEBENSM, V2, P122, DOI 10.1007/s00003-007-0179-6; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sakai N, 2006, METHODS, V39, P239, DOI 10.1016/j.ymeth.2005.12.008; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; SCHULZ RW, 1994, J ENDOCRINOL, V140, P265, DOI 10.1677/joe.0.1400265; SCHULZE C, 1988, CELL TISSUE RES, V251, P31, DOI 10.1007/BF00215444; SCHULZE C, 1979, CELL TISSUE RES, V198, P191; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; VANDEKANT HJG, 1992, HISTOCHEM J, V24, P170, DOI 10.1007/BF01047467; VANKEULEN CJ, 1974, CELL TISSUE KINET, V7, P549, DOI 10.1111/j.1365-2184.1974.tb00438.x; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhang Z, 2007, J CELL PHYSIOL, V211, P149, DOI 10.1002/jcp.20910; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	68	107	115	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12808	10.1371/journal.pone.0012808	http://dx.doi.org/10.1371/journal.pone.0012808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862221	gold, Green Published, Green Submitted			2022-12-25	WOS:000281963200008
J	Yap, LJ; Luo, DH; Chung, KY; Lim, SP; Bodenreider, C; Noble, C; Shi, PY; Lescar, J				Yap, Li Jian; Luo, Dahai; Chung, Ka Yan; Lim, Siew Pheng; Bodenreider, Christophe; Noble, Christian; Shi, Pei-Yong; Lescar, Julien			Crystal Structure of the Dengue Virus Methyltransferase Bound to a 5 '-Capped Octameric RNA	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; DE-NOVO SYNTHESIS; VIRAL-RNA; CATALYTIC DOMAIN; NTPASE ACTIVITY; POLYMERASE NS5; IN-VITRO; CAP; METHYLATION; SEQUENCE	The N-terminal domain of the flavivirus NS5 protein functions as a methyltransferase (MTase). It sequentially methylates the N7 and 2'-O positions of the viral RNA cap structure (GpppA ->(7me)GpppA ->(7me)GpppA(2'-O- me)). The same NS5 domain could also have a guanylyltransferase activity (GTP+ppA-RNA -> GpppA). The mechanism by which this protein domain catalyzes these three distinct functions is currently unknown. Here we report the crystallographic structure of DENV-3 MTase in complex with a 5'-capped RNA octamer (G(ppp)AGAACCUG) at a resolution of 2.9 angstrom. Two RNA octamers arranged as kissing loops are encircled by four MTase monomers around a 2-fold non-crystallography symmetry axis. Only two of the four monomers make direct contact with the 5' end of RNA. The RNA structure is stabilised by the formation of several intra and intermolecular base stacking and non- canonical base pairs. The structure may represent the product of guanylylation of the viral genome prior to the subsequent methylation events that require repositioning of the RNA substrate to reach to the methyl-donor sites. The crystal structure provides a structural explanation for the observed trans-complementation of MTases with different methylation defects.	[Yap, Li Jian; Luo, Dahai; Chung, Ka Yan; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Yap, Li Jian; Chung, Ka Yan; Lim, Siew Pheng; Bodenreider, Christophe; Noble, Christian; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore, Singapore; [Lescar, Julien] CNRS, AFMB, UMR6098, Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Novartis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Yap, LJ (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	pei_yong.shi@novartis.com; julien@ntu.edu.sg	Lim, Siew Pheng/P-8528-2016; Pheng, Lim Siew/AAG-4368-2021; Luo, Dahai/J-6022-2012	Pheng, Lim Siew/0000-0002-7377-5662; Luo, Dahai/0000-0001-7637-7275	BMRC [06/1/22/19/447]; ARC [ARC5/07]; CNRS	BMRC(Agency for Science Technology & Research (A*STAR)); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a BMRC grant (06/1/22/19/447) and an ARC grant ARC5/07 to the laboratory of JL. Support from an ATIP from the CNRS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Krissinel E., 2005, DETECTION PROTEIN AS, P163; Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE A, 1992, JOINT CCP4 ESF EAMCB, V4, P26; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; LINDENBACH BD, 2007, FIELDS VIROLOGY, V1, P991; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	42	34	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12836	10.1371/journal.pone.0012836	http://dx.doi.org/10.1371/journal.pone.0012836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862256	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800024
J	Yoneda, M; Guillaume, V; Sato, H; Fujita, K; Georges-Courbot, MC; Ikeda, F; Omi, M; Muto-Terao, Y; Wild, TF; Kai, C				Yoneda, Misako; Guillaume, Vanessa; Sato, Hiroki; Fujita, Kentaro; Georges-Courbot, Marie-Claude; Ikeda, Fusako; Omi, Mio; Muto-Terao, Yuri; Wild, T. Fabian; Kai, Chieko			The Nonstructural Proteins of Nipah Virus Play a Key Role in Pathogenicity in Experimentally Infected Animals	PLOS ONE			English	Article							NEWCASTLE-DISEASE-VIRUS; ACCESSORY C PROTEINS; VIRAL-RNA SYNTHESIS; V-PROTEIN; SENDAI-VIRUS; NUCLEAR ACCUMULATION; INTERFERON EVASION; PREVENTING STAT1; W-PROTEIN; PARAMYXOVIRUS	Nipah virus (NiV) P gene encodes P protein and three accessory proteins (V, C and W). It has been reported that all four P gene products have IFN antagonist activity when the proteins were transiently expressed. However, the role of those accessory proteins in natural infection with NiV remains unknown. We generated recombinant NiVs lacking V, C or W protein, rNiV(V-), rNiV(C-), and rNiV(W-), respectively, to analyze the functions of these proteins in infected cells and the implications in in vivo pathogenicity. All the recombinants grew well in cell culture, although the maximum titers of rNiV(V-) and rNiV(C-) were lower than the other recombinants. The rNiV(V-), rNiV(C-) and rNiV(W-) suppressed the IFN response as well as the parental rNiV, thereby indicating that the lack of each accessory protein does not significantly affect the inhibition of IFN signaling in infected cells. In experimentally infected golden hamsters, rNiV(V-) and rNiV(C-) but not the rNiV(W-) virus showed a significant reduction in virulence. These results suggest that V and C proteins play key roles in NiV pathogenicity, and the roles are independent of their IFN-antagonist activity. This is the first report that identifies the molecular determinants of NiV in pathogenicity in vivo.	[Yoneda, Misako; Sato, Hiroki; Ikeda, Fusako; Omi, Mio; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan; [Fujita, Kentaro; Muto-Terao, Yuri; Kai, Chieko] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; [Guillaume, Vanessa; Wild, T. Fabian] INSERM, U758, F-69008 Lyon, France; [Georges-Courbot, Marie-Claude] Lab P4 INSERM Jean Merieux, Lyon, France	University of Tokyo; University of Tokyo; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Yoneda, M (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 108, Japan.	yone@ims.u-tokyo.ac.jp; ckai@ims.u-tokyo.ac.jp			Ministry of Education, Science, Culture, and Sports of Japan	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants in aid from the Ministry of Education, Science, Culture, and Sports of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Butler D, 2004, NATURE, V429, P7, DOI 10.1038/429007b; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Enserink M, 2004, SCIENCE, V303, P1121; Epstein JH, 2006, EMERG INFECT DIS, V12, P1178, DOI 10.3201/eid1207.050799; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Horikami SM, 1997, VIROLOGY, V235, P261, DOI 10.1006/viro.1997.8702; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; *INT CTR DIARR DIS, 2005, HLTH SCI B, V3, P1; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Ludlow LE, 2008, J VIROL, V82, P6259, DOI 10.1128/JVI.00409-08; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Reutter GL, 2001, VIROLOGY, V285, P100, DOI 10.1006/viro.2001.0962; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103	47	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12709	10.1371/journal.pone.0012709	http://dx.doi.org/10.1371/journal.pone.0012709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856799	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815800009
J	Yue, GH; Chang, A				Yue, Gen Hua; Chang, Alex			Molecular Evidence for High Frequency of Multiple Paternity in a Freshwater Shrimp Species Caridina ensifera	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; MATING SYSTEMS; SPERM-STORAGE; NATURAL-POPULATIONS; GENETIC PARENTAGE; SEXUAL SELECTION; FIELD CRICKET; EVOLUTION; CRUSTACEA; DECAPODA	Background: Molecular genetic analyses of parentage provide insights into mating systems. Although there are 22,000 members in Malacostraca, not much has been known about mating systems in Malacostraca. The freshwater shrimp Caridina ensifera blue, is a new species belonging to Malacostraca which was discovered recently in Sulawesi, Indonesia. Due to its small body size and low fecundity, this species is an ideal species to study the occurrence and frequency of multiple paternity and to understand of how the low fecundity species persist and evolve. Methodology/Principal Findings: In this study, we developed four polymorphic microsatellites from C. ensifera and applied them to investigate the occurrence and frequency of multiple paternity in 20 C. ensifera broods caught from Lake Matano, Sulawesi. By genotyping the mother and all offspring from each brood we discovered multiple paternity in all 20 broods. In most of the 20 broods, fathers contributed skewed numbers of offspring and there was an apparent inverse correlation between reproductive success of sires and their relatedness to mothers. Conclusions/Significance: Our results in combination with recent reports on multiple paternity in crayfish, crab and lobster species suggests that multiple paternity is common in Malacostraca. Skewed contribution of fathers to the numbers of offspring and inverse correlation between reproductive success of sires and their relatedness to mothers suggest that sperm competition occurred and/or pre- and postcopulatory female choice happen, which may be important for avoiding the occurrence of inbreeding and optimize genetic variation in offspring and for persistence and evolution of low fecundity species.	[Yue, Gen Hua; Chang, Alex] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Chang, Alex] Qian Hu Fish Farm, R&D Dept, Singapore, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	Temasek Life Sciences Laboratory, Singapore	Temasek Life Sciences Laboratory, Singapore	This work was supported by the internal fund of the Temasek Life Sciences Laboratory, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2001, J HERED, V92, P99, DOI 10.1093/jhered/92.2.99; BAUER RT, 1991, CRUSLACEAN SEXUAL BI, P83; BERG ABV, 1984, J CRUSTACEAN BIOL, V4, P417, DOI 10.2307/1548041; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Buckland-Nicks J, 1998, MICRON, V29, P267, DOI 10.1016/S0968-4328(97)00064-4; Cai Y, 2007, RAFFLES B ZOOL, V55, P311; Calsbeek R, 2008, EVOLUTION, V62, P1137, DOI 10.1111/j.1558-5646.2008.00356.x; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Croshaw DA, 2009, GENET RES, V91, P313, DOI 10.1017/S0016672309990231; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Dick JTA, 2006, BIOL LETT-UK, V2, P501, DOI 10.1098/rsbl.2006.0512; Fischer D, 1998, BIOTECHNIQUES, V24, P796, DOI 10.2144/98245st03; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fretter V., 1994, BRIT PROSOBRANCH MOL; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Gosselin T, 2005, MOL ECOL, V14, P1517, DOI 10.1111/j.1365-294X.2005.02498.x; HAASE M, 1995, INVERTEBR REPROD DEV, V28, P33, DOI 10.1080/07924259.1995.9672461; Ilmonen P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-104; JAMES DF, 1974, P 2 INT CRAYF S, V2, P125; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jensen PC, 1996, BIOL BULL, V190, P336, DOI 10.2307/1543026; Johnson SL, 2007, MOL ECOL, V16, P3253, DOI 10.1111/j.1365-294X.2007.03366.x; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Lewis PO, 2000, GENETIC DATA ANAL; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Martinez JL, 2000, MOL ECOL, V9, P293, DOI 10.1046/j.1365-294x.2000.00857.x; Mathews D, 1956, PAC SCI, V10, P303; Mobley KB, 2007, MOL ECOL, V16, P2596, DOI 10.1111/j.1365-294X.2007.03337.x; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Salmon M., 1983, STUDIES ADAPTATION B; Schram F.R., 1986, CRUSTACEA; SCHRAM FR, 1974, SYST ZOOL, V23, P323, DOI 10.2307/2412539; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; Song SD, 2007, MOL ECOL, V16, P2353, DOI 10.1111/j.1365-294X.2007.03277.x; Streiff R, 2004, MAR BIOTECHNOL, V6, P60, DOI 10.1007/s10126-003-0015-7; Suzuki S, 2005, ARTHROPOD STRUCT DEV, V34, P441, DOI 10.1016/j.asd.2005.06.002; Thiel M, 2004, BEHAV ECOL SOCIOBIOL, V57, P62, DOI 10.1007/s00265-004-0828-z; Thomas ML, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-162; Toonen RJ, 2004, MAR ECOL PROG SER, V270, P259, DOI 10.3354/meps270259; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Villesen P, 1999, MOL ECOL, V8, P1819, DOI 10.1046/j.1365-294x.1999.00767.x; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Walker D, 2002, MOL ECOL, V11, P2115, DOI 10.1046/j.1365-294X.2002.01609.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; [王娟 Wang Juan], 2008, [分析仪器, Analytical Instrumentation], P21; Wilson AJ, 2002, CAN J FISH AQUAT SCI, V59, P1696, DOI [10.1139/f02-127, 10.1139/F02-127]; Yue GH, 2010, INT J BIOL SCI, V6, P107; Yue GH, 2000, MOL ECOL, V9, P1007, DOI 10.1046/j.1365-294x.2000.00939-10.x; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zitzler K, 2006, RAFFLES B ZOOL, V54, P271	66	28	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12721	10.1371/journal.pone.0012721	http://dx.doi.org/10.1371/journal.pone.0012721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856862	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815700011
J	Hauri, C; Fabricius, KE; Schaffelke, B; Humphrey, C				Hauri, Claudine; Fabricius, Katharina E.; Schaffelke, Britta; Humphrey, Craig			Chemical and Physical Environmental Conditions Underneath Mat- and Canopy-Forming Macroalgae, and Their Effects on Understorey Corals	PLOS ONE			English	Article							ORGANIC-CARBON; BENTHIC ALGAE; REEF; LIGHT; MICROENVIRONMENT; PHOTOSYNTHESIS; DISSOCIATION; COMPETITION; RESILIENCE; EXPRESSION	Disturbed coral reefs are often dominated by dense mat- or canopy-forming assemblages of macroalgae. This study investigated how such dense macroalgal assemblages change the chemical and physical microenvironment for understorey corals, and how the altered environmental conditions affect the physiological performance of corals. Field measurements were conducted on macroalgal-dominated inshore reefs in the Great Barrier Reef in quadrats with macroalgal biomass ranging from 235 to 1029 g DW m(-2) dry weight. Underneath mat- forming assemblages, the mean concentration of dissolved oxygen was reduced by 26% and irradiance by 96% compared with conditions above the mat, while concentrations of dissolved organic carbon and soluble reactive phosphorous increased by 26% and 267%, respectively. The difference was significant but less pronounced under canopy-forming assemblages. Dissolved oxygen declined and dissolved inorganic carbon and alkalinity increased with increasing algal biomass underneath mat- forming but not under canopy-forming assemblages. The responses of corals to conditions similar to those found underneath algal assemblages were investigated in an aquarium experiment. Coral nubbins of the species Acropora millepora showed reduced photosynthetic yields and increased RNA/DNA ratios when exposed to conditions simulating those underneath assemblages (pre-incubating seawater with macroalgae, and shading). The magnitude of these stress responses increased with increasing proportion of pre-incubated algal water. Our study shows that mat- forming and, to a lesser extent, canopy-forming macroalgal assemblages alter the physical and chemical microenvironment sufficiently to directly and detrimentally affect the metabolism of corals, potentially impeding reef recovery from algal to coral-dominated states after disturbance. Macroalgal dominance on coral reefs therefore simultaneously represents a consequence and cause of coral reef degradation.	[Hauri, Claudine] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Hauri, Claudine; Fabricius, Katharina E.; Schaffelke, Britta; Humphrey, Craig] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Australian Institute of Marine Science	Hauri, C (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	claudine.hauri@env.ethz.ch	Fabricius, Katharina E/F-1759-2010	Fabricius, Katharina E/0000-0001-7671-4358; Humphrey, Craig/0000-0002-1303-036X	Australian Institute of Marine Science; Sarasin Foundation; University of Basel; Mathieu Foundation; Josef and Olga Tomcsik Foundation	Australian Institute of Marine Science; Sarasin Foundation; University of Basel; Mathieu Foundation; Josef and Olga Tomcsik Foundation	This study was funded by the Australian Institute of Marine Science, the Sarasin Foundation, the University of Basel, the Mathieu Foundation and the Josef and Olga Tomcsik Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; DENYS R, 1991, MAR BIOL, V108, P315, DOI 10.1007/BF01344346; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; ESCARTIN J, 1995, ESTUAR COAST SHELF S, V40, P451, DOI 10.1006/ecss.1995.0031; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Gardella DJ, 1999, MAR BIOL, V135, P289, DOI 10.1007/s002270050626; Hendriks IE, 2010, MAR BIOL, V157, P473, DOI 10.1007/s00227-009-1333-8; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kyle M, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.1; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Lewis E., 1998, ORNLCDIAC105 US DEP; LITTLER DS, 2003, S PACIFIC PLANTS; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MILLER D, 1992, J THERM BIOL, V17, P217, DOI 10.1016/0306-4565(92)90058-N; MILLERO FJ, 1993, MAR CHEM, V44, P153, DOI 10.1016/0304-4203(93)90200-8; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; R Development Core Team, 2009, R FDN STAT COMP; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rossi S, 2006, HELGOLAND MAR RES, V60, P7, DOI 10.1007/s10152-005-0009-0; RYLE VD, 1981, OCEANOGRAPHY SERIES, V3; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Schaffelke B, 1999, MAR ECOL PROG SER, V182, P305, DOI 10.3354/meps182305; Schaffelke B, 1997, BOT MAR, V40, P373, DOI 10.1515/botm.1997.40.1-6.373; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Sebens KP, 2003, CORAL REEFS, V22, P35, DOI 10.1007/s00338-003-0277-6; SEGEL LA, 1982, B MAR SCI, V32, P919; Skelton PA, 2007, NOVA HEDWIGIA, P1; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SUNDBACK K, 1990, MAR ECOL PROG SER, V58, P261; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007	44	34	36	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12685	10.1371/journal.pone.0012685	http://dx.doi.org/10.1371/journal.pone.0012685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856882	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700011
J	He, X; Wang, J; Messing, EM; Wu, G				He, X.; Wang, J.; Messing, E. M.; Wu, G.			Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness	ONCOGENE			English	Article						VHL; RACK1; IGF-I; renal cell carcinoma	GROWTH-FACTOR RECEPTOR; ALVEOLAR EPITHELIAL-CELLS; BETA-SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; GENE-PRODUCT; INSULIN; RACK1; EXPRESSION; CANCER; IDENTIFICATION	von Hippel-Lindau (VHL) tumor suppressor loss is associated with renal cell carcinoma (RCC) pathogenesis. Meanwhile, aberrant activation of the insulin-like growth factor-I (IGF-I) signaling has been implicated in the development of highly invasive metastatic RCC. However, the link between VHL inactivation and RCC invasiveness is still unexplored. Here, we show that the receptor for activated C kinase 1 (RACK1) is a novel pVHLinteracting protein. pVHL competes with IGF-I receptor (IGF-IR) for binding to RACK1 thus potentially modulating the downstream IGF-I signal pathway. Upon IGFI stimulation, pVHL-deficient RCC cells exhibit increased RACK1/IGF-IR binding and increased IGF-IR tyrosine kinase activity. pVHL-deficient RCC cells also demonstrate elevated PI3K/Akt signaling and matrix metallo-proteinase-2 activity that culminates in enhanced cellular invasiveness, which can be partially suppressed by RACK1 small interfering RNA. Domain mapping analysis showed that the pVHL alpha-domain and the RACK1 WD 6-7 domains are critical for the interaction. Additionally, the RACK1 expression level is not regulated by pVHL expression status, suggesting that pVHL modifies RACK1 functions independent of the VHL/elongin E3 ubiquitin ligase complex. Our data indicate that RACK1 serves as a direct mediator between loss of pVHL function and enhanced IGF-IR signaling pathway in RCC. Oncogene (2011) 30, 535-547; doi: 10.1038/onc.2010.427; published online 27 September 2010	[He, X.; Messing, E. M.; Wu, G.] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Wang, J.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [He, X.; Messing, E. M.; Wu, G.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Wu, G (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave, Rochester, NY 14642 USA.	guan_wu@urmc.rochester.edu			James P Wilmot Cancer Center	James P Wilmot Cancer Center	Funding: This work was supported in part by the James P Wilmot Cancer Center grant to X He.	Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Brodt P, 2000, BIOCHEM PHARMACOL, V60, P1101, DOI 10.1016/S0006-2952(00)00422-6; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Datta K, 2000, J BIOL CHEM, V275, P20700, DOI 10.1074/jbc.M909970199; Dunn SE, 1998, CANCER RES, V58, P3353; Dupont J, 2003, HORM METAB RES, V35, P740; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Koochekpour S, 1999, MOL CELL BIOL, V19, P5902; Kugler A, 1998, J UROLOGY, V160, P1914, DOI 10.1016/S0022-5347(01)62443-1; Kugler A, 1999, ANTICANCER RES, V19, P1589; Li ZB, 2002, BIOCHEM BIOPH RES CO, V294, P700, DOI 10.1016/S0006-291X(02)00534-X; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Long L, 1998, CANCER RES, V58, P3243; Loughran G, 2005, ONCOGENE, V24, P6185, DOI 10.1038/sj.onc.1208772; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Min Y, 2005, GUT, V54, P591, DOI 10.1136/gut.2004.048926; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; O'Connor R, 2003, HORM METAB RES, V35, P771; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Rajala RVS, 2004, BIOCHEMISTRY-US, V43, P5637, DOI 10.1021/bi035913v; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Rosendahl A, 2004, INT J ONCOL, V25, P1327; Schips L, 2004, AM J CLIN PATHOL, V122, P931, DOI 10.1309/G7PY0RE7T86HQYV; Sekharam M, 2003, ANTICANCER RES, V23, P1517; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Stawowy P, 2004, BIOCHEM BIOPH RES CO, V321, P531, DOI 10.1016/j.bbrc.2004.07.001; Steele MR, 2001, CELL SIGNAL, V13, P507, DOI 10.1016/S0898-6568(01)00167-X; Tanno S, 2001, CANCER RES, V61, P589; Wang J, 2005, INFECT IMMUN, V73, P2766, DOI 10.1128/IAI.73.5.2766-2777.2005; Wang J, 2007, AM J PHYSIOL-LUNG C, V292, pL1495, DOI 10.1152/ajplung.00452.2006; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Yoon A, 2001, MOL CELL BIOCHEM, V223, P1, DOI 10.1023/A:1017549222677; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006; Zhou MI, 2004, CANCER RES, V64, P1278, DOI 10.1158/0008-5472.CAN-03-0884	52	25	27	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					535	547		10.1038/onc.2010.427	http://dx.doi.org/10.1038/onc.2010.427			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20871634				2022-12-25	WOS:000286922300003
J	Spevak, CC; Ivanov, IP; Sachs, MS				Spevak, Christina C.; Ivanov, Ivaylo P.; Sachs, Matthew S.			Sequence Requirements for Ribosome Stalling by the Arginine Attenuator Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; PROLYL-TRANSFER-RNA; NEUROSPORA-CRASSA; LEADER PEPTIDE; TRANSLATIONAL REGULATION; A-SITE; UPSTREAM; GENE; CPA1; MECHANISMS	The 5 ' regions of eukaryotic mRNAs often contain upstream open reading frames (uORFs). The Neurospora crassa arg-2 uORF encodes the 24-residue arginine attenuator peptide (AAP). This regulatory uORF-encoded peptide, which is evolutionarily conserved in fungal transcripts specifying an arginine biosynthetic enzyme, functions as a nascent peptide within the ribosomal tunnel and negatively regulates gene expression. The nascent AAP causes ribosomes to stall at the uORF stop codon in response to arginine, thus, blocking ribosomes from reaching the ARG-2 initiation codon. Here scanning mutagenesis with alanine and proline was performed to systematically determine which AAP residues were important for conferring regulation. Changing many of the most highly conserved residues (Asp-12, Tyr-13, Lys-14, and Trp-19) abolished regulatory function. The minimal functional domain of the AAP was determined by positioning AAP sequences internally within a large polypeptide. Pulse-chase analyses revealed that residues 9-20 of the AAP composed the minimal domain that was sufficient to confer regulatory function. An extensive analysis of predicted fungal AAPs revealed that the minimal functional domain of the N. crassa AAP corresponded closely to the region that was most highly conserved among the fungi. We also observed that the tripeptide RGD could function similarly to arginine in triggering AAP-mediated ribosome stalling. These studies provide a better understanding of the elements required for a nascent peptide and a small regulatory molecule to control translational processes.	[Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Ivanov, Ivaylo P.] Univ Coll Cork, BioSci Inst, Cork, Ireland; [Ivanov, Ivaylo P.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Texas A&M University System; Texas A&M University College Station; Scripps Research Institute; University College Cork; Utah System of Higher Education; University of Utah	Sachs, MS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	msachs@mail.bio.tamu.edu		Ivanov, Ivaylo/0000-0002-4793-5466; Ivanov, Ivaylo/0000-0002-6008-3261; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [R01GM47498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM47498 (to M. S. S.).	Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Delbecq P, 2000, CURR GENET, V38, P105, DOI 10.1007/s002940000140; DELBECQ P, 1994, MOL CELL BIOL, V14, P2378, DOI 10.1128/MCB.14.4.2378; Fang P, 2000, J BIOL CHEM, V275, P26710; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fang P, 2002, FUNGAL GENET BIOL, V36, P167, DOI 10.1016/S1087-1845(02)00014-2; Freitag M, 1996, GENETICS, V142, P117; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; HONG J, 1994, J MOL BIOL, V243, P131, DOI 10.1006/jmbi.1994.1638; Hood HM, 2007, FUNGAL GENET BIOL, V44, P93, DOI 10.1016/j.fgb.2006.07.009; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Luo ZL, 1996, J BACTERIOL, V178, P2172, DOI 10.1128/jb.178.8.2172-2177.1996; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Radford A, 2004, ADV GENET, V52, P165, DOI 10.1016/S0065-2660(04)52005-9; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Spevak CC, 2006, BIOCHEM BIOPH RES CO, V350, P834, DOI 10.1016/j.bbrc.2006.09.128; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; vandenHoff MJB, 1995, J MOL EVOL, V41, P813, DOI 10.1007/BF00173161; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1998, MOL CELL BIOL, V18, P7528, DOI 10.1128/MCB.18.12.7528; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wang Z, 1999, J BIOL CHEM, V274, P37565, DOI 10.1074/jbc.274.53.37565; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153	41	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40933	40942		10.1074/jbc.M110.164152	http://dx.doi.org/10.1074/jbc.M110.164152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20884617	hybrid, Green Published			2022-12-25	WOS:000285414400057
J	Bockelmann, S; Menche, D; Rudolph, S; Bender, T; Grond, S; von Zezschwitz, P; Muench, SP; Wieczorek, H; Huss, M				Bockelmann, Svenja; Menche, Dirk; Rudolph, Sven; Bender, Tobias; Grond, Stephanie; von Zezschwitz, Paultheo; Muench, Stephen P.; Wieczorek, Helmut; Huss, Markus			Archazolid A Binds to the Equatorial Region of the c-Ring of the Vacuolar H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASES; CONCANAMYCIN-A; SUBUNIT-C; P-TYPE; INHIBITORS; SITE; MYXOBACTERIA; PURIFICATION; ELUCIDATION; MEMBRANE	The macrolactone archazolid is a novel, highly specific V-ATPase inhibitor with an IC50 value in the low nanomolar range. The binding site of archazolid is presumed to overlap with the binding site of the established plecomacrolide V-ATPase inhibitors bafilomycin and concanamycin in subunit c of the membrane-integral V-O complex. Using a semi-synthetic derivative of archazolid for photoaffinity labeling of the V1VO holoenzyme we confirmed binding of archazolid to the V-O subunit c. For the plecomacrolide binding site a model has been published based on mutagenesis studies of the c subunit of Neurospora crassa, revealing 11 amino acids that are part of the binding pocket at the interface of two adjacent c subunits (Bowman, B. J., McCall, M. E., Baertsch, R., and Bowman, E. J. (2006) J. Biol. Chem. 281, 31885-31893). To investigate the contribution of these amino acids to the binding of archazolid, we established in Saccharomyces cerevisiae mutations that in N. crassa had changed the IC50 value for bafilomycin 10-fold or more and showed that out of the amino acids forming the plecomacrolide binding pocket only one amino acid (tyrosine 142) contributes to the binding of archazolid. Using a fluorescent derivative of N, N'-dicyclohexylcarbodiimide, we found that the binding site for archazolid comprises the essential glutamate within helix 4 of subunit c. In conclusion the archazolid binding site resides within the equatorial region of the V-O rotor subunit c. This hypothesis was supported by an additional subset of mutations within helix 4 that revealed that leucine 144 plays a role in archazolid binding.	[Wieczorek, Helmut; Huss, Markus] Univ Osnabruck, Fachbereich Biolo Chem, Abt Tierphysiol, D-49069 Osnabruck, Germany; [Menche, Dirk; Rudolph, Sven] Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany; [Bender, Tobias; von Zezschwitz, Paultheo] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany; [Grond, Stephanie] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; [Muench, Stephen P.] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University Osnabruck; Ruprecht Karls University Heidelberg; Philipps University Marburg; Eberhard Karls University of Tubingen; University of Leeds	Huss, M (corresponding author), Univ Osnabruck, Fachbereich Biolo Chem, Abt Tierphysiol, Barbarastr 11, D-49069 Osnabruck, Germany.	huss@biologie.uni-osnabrueck.de	Muench, Stephen/AAI-9529-2020	Muench, Stephen/0000-0001-6869-4414; Grond, Stephanie/0000-0002-7549-4936	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [SFB 431]; BMBF [0313105]; Medical Research Council; Medical Research Council [G1000567] Funding Source: researchfish; MRC [G1000567] Funding Source: UKRI	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants of the VolkswagenStiftung (Funding Initiative "Interplay between Molecular Conformations and Biological Function" (to D. M., H. W., and M. H.), Deutsche Forschungsgemeinschaft Grant SFB 431 (H. W. and M. H.) and BMBF MetabolitGenoMik Grant 0313105 (to S. G.).; Recipient of a Medical Research Council Career Development fellowship.	Bender T, 2007, EUR J ORG CHEM, V2007, P3870, DOI 10.1002/ejoc.200700194; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; CHADWICK CC, 1983, BIOCHIM BIOPHYS ACTA, V730, P201, DOI 10.1016/0005-2736(83)90334-6; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; FINBOW ME, 1992, PROTEIN ENG, V5, P7, DOI 10.1093/protein/5.1.7; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Harrison M, 2000, BIOCHEMISTRY-US, V39, P7531, DOI 10.1021/bi000159o; Hassfeld J, 2006, ORG LETT, V8, P4751, DOI 10.1021/ol061831y; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; Jansen R, 2000, EUR J ORG CHEM, V2000, P913, DOI 10.1002/(SICI)1099-0690(200003)2000:6<913::AID-EJOC913>3.0.CO;2-L; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Menche D, 2007, J AM CHEM SOC, V129, P6100, DOI 10.1021/ja071461o; Menche D, 2007, EUR J ORG CHEM, V2007, P1196, DOI 10.1002/ejoc.200600912; Menche D, 2007, BIOORG MED CHEM LETT, V17, P1732, DOI 10.1016/j.bmcl.2006.12.073; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; Pali T, 2004, BIOCHEMISTRY-US, V43, P12297, DOI 10.1021/bi0493867; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sasse F, 2003, J ANTIBIOT, V56, P520, DOI 10.7164/antibiotics.56.520; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608	33	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38304	38314		10.1074/jbc.M110.137539	http://dx.doi.org/10.1074/jbc.M110.137539			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884613	Green Published, hybrid			2022-12-25	WOS:000284625600037
J	Brailoiu, E; Rahman, T; Churamani, D; Prole, DL; Brailoiu, GC; Hooper, R; Taylor, CW; Patel, S				Brailoiu, Eugen; Rahman, Taufiq; Churamani, Dev; Prole, David L.; Brailoiu, G. Cristina; Hooper, Robert; Taylor, Colin W.; Patel, Sandip			An NAADP-gated Two-pore Channel Targeted to the Plasma Membrane Uncouples Triggering from Amplifying Ca2+ Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; RYANODINE RECEPTOR; ACIDIC ORGANELLES; PANCREATIC ACINAR; MOBILIZES CA2+; BETA-CELLS; CALCIUM; RELEASE; LYSOSOMES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a ubiquitous messenger proposed to stimulate Ca2+ release from acidic organelles via two-pore channels (TPCs). It has been difficult to resolve this trigger event from its amplification via endoplasmic reticulum Ca2+ stores, fuelling speculation that archetypal intracellular Ca2+ channels are the primary targets of NAADP. Here, we redirect TPC2 from lysosomes to the plasma membrane and show that NAADP evokes Ca2+ influx independent of ryanodine receptors and that it activates a Ca2+-permeable channel whose conductance is reduced by mutation of a residue within a putative pore. We there fore uncouple TPC2 from amplification pathways and prove that it is a pore-forming subunit of an NAADP-gated Ca2+ channel.	[Rahman, Taufiq; Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Brailoiu, Eugen; Brailoiu, G. Cristina] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Churamani, Dev; Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of London; University College London	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk; patel.s@ucl.ac.uk	rahman, taufiq/E-9806-2013; rahman, taufiq/GON-8210-2022; Taylor, Colin/G-2447-2010; Patel, Sandip/O-9591-2015	rahman, taufiq/0000-0003-3830-5160; rahman, taufiq/0000-0003-3830-5160; Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [HL90804]; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/H009736/1]; Wellcome Trust [085295]; Isaac Newton Trust, Cambridge; BBSRC [BB/H009736/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust, Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL90804 (to E. B.). This work was also supported by the Biotechnology and Biological Sciences Research Council Grants BB/G013721/1 (to S. P.) and BB/H009736/1 (to C. W. T.), the Wellcome Trust Grant 085295 (to C. W. T.), and an equipment grant from the Isaac Newton Trust, Cambridge (to C. W. T).	BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Galione A, 2000, Sci STKE, V2000, ppe1; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kusch J, 2004, J PHYSIOL-LONDON, V560, P605, DOI 10.1113/jphysiol.2004.070193; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Lu T, 2001, J GEN PHYSIOL, V118, P509, DOI 10.1085/jgp.118.5.509; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mojzisova A., 2001, PFLUGERS ARCH, V441, P674; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Pitt S. J., 2010, J BIOL CHEM IN PRESS, P285; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sakmann B., 1995, SINGLE CHANNEL RECOR; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	34	126	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38511	38516		10.1074/jbc.M110.162073	http://dx.doi.org/10.1074/jbc.M110.162073			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880839	hybrid, Green Published			2022-12-25	WOS:000284625600056
J	Pham, Y; Kuhlman, B; Butterfoss, GL; Hu, H; Weinreb, V; Carter, CW				Pham, Yen; Kuhlman, Brian; Butterfoss, Glenn L.; Hu, Hao; Weinreb, Violetta; Carter, Charles W., Jr.			Tryptophanyl-tRNA synthetase Urzyme: a model to recapitulate molecular evolution and investigate intramolecular complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; CLASS-I; CATALYTIC DOMAIN; GLUTAMATE-DEHYDROGENASE; GENETIC-CODE; ACTIVE-SITE; ATP-BINDING; AMINO-ACIDS; PROTEIN	We substantiate our preliminary description of the Class I tryptophanyl-tRNA synthetase minimal catalytic domain with details of its construction, structure, and steady-state kinetic parameters. Generating that active fragment involved deleting 65% of the contemporary enzyme, including the anticodon-binding domain and Connecting Peptide 1, CP1, a 74-residue internal segment from within the Rossmann fold. We used protein design (Rosetta), rather than phylogenetic sequence alignments, to identify mutations to compensate the severe loss of modularity, restoring stability, as evidenced by renaturation described previously and by 70 ns Molecular Dynamics simulations. Sufficient solubility to enable biochemical studies was achieved by expressing the redesigned Urzyme as a maltose-binding protein fusion. Michaelis-Menten kinetic parameters from amino acid activation assays show that, compared to the native full-length enzyme, TrpRS Urzyme binds ATP with similar affinity. This suggests that neither of the two deleted structural modules has a strong influence on ground-state ATP binding. However, tryptophan has 40-103 lower affinity, and the Urzyme has comparably reduced specificity relative to the related amino acid, tyrosine. MD simulations reveal how CP1 may contribute significantly to cognate amino acid specificity. As Class Ia editing domains are nested within the CP1, this finding suggests that this module enhanced amino acid specificity continuously, throughout their evolution. We call this type of reconstructed protein catalyst an Urzyme (Ur-: prefix for original, primitive, earliest). It establishes a model for recapitulating very early steps in molecular evolution in which fitness may have been enhanced by accumulating entire modules, rather than by discrete amino acid sequence changes.	[Pham, Yen; Kuhlman, Brian; Weinreb, Violetta; Carter, Charles W., Jr.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Butterfoss, Glenn L.] NYU, Biol & Courant Comp Sci Dept, New York, NY 10003 USA; [Hu, Hao] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; New York University; University of Hong Kong	Carter, CW (corresponding author), 3092 Genet Med,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			NIH [GM078227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant GM078227	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Benner Steven A., 2007, V75, P1; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CHUANG WJ, 1992, BIOCHEMISTRY-US, V31, P7915, DOI 10.1021/bi00149a024; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Hu H, 2008, J AM CHEM SOC, V130, P14493, DOI 10.1021/ja801202j; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JOSEPH DR, 1971, J BIOL CHEM, V246, P7610; JOSEPH DR, 1971, J BIOL CHEM, V246, P7602; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Lechler A, 1997, NUCLEIC ACIDS RES, V25, P2737, DOI 10.1093/nar/25.14.2737; LEJOHN HB, 1994, J BIOL CHEM, V269, P4523; LEJOHN HB, 1994, J BIOL CHEM, V269, P4513; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Niwa N, 2009, BIOORG MED CHEM LETT, V19, P3892, DOI 10.1016/j.bmcl.2009.03.114; Nixon AE, 1997, P NATL ACAD SCI USA, V94, P1069, DOI 10.1073/pnas.94.4.1069; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Rodin AS, 2009, J MOL EVOL, V69, P555, DOI 10.1007/s00239-009-9288-4; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; ROGERS MJ, 1992, P NATL ACAD SCI USA, V89, P3463, DOI 10.1073/pnas.89.8.3463; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; STARZYK RM, 1989, BIOCHEMISTRY-US, V28, P8479, DOI 10.1021/bi00447a031; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weinreb V, 2008, J AM CHEM SOC, V130, P1488, DOI 10.1021/ja076557x; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Williams TA, 2009, MOL BIOL EVOL, V26, P445, DOI 10.1093/molbev/msn267; Wolfson AD, 1998, RNA, V4, P1019, DOI 10.1017/S1355838298980700; YANG BH, 1994, J BIOL CHEM, V269, P4506; YANIV M, 1974, J MOL BIOL, V86, P245, DOI 10.1016/0022-2836(74)90016-3	64	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38590	38601		10.1074/jbc.M110.136911	http://dx.doi.org/10.1074/jbc.M110.136911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864539	Green Published, hybrid			2022-12-25	WOS:000284625600084
J	Ichihashi, N; Matsuura, T; Hosoda, K; Yomo, T				Ichihashi, Norikazu; Matsuura, Tomoaki; Hosoda, Kazufumi; Yomo, Tetsuya			Identification of Two Forms of Q beta Replicase with Different Thermal Stabilities but Identical RNA Replication Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ENCODED REPLICASE; CELL-FREE SYSTEM; ESCHERICHIA-COLI; KINETIC-ANALYSIS; INFECTION CYCLE; QBETA-REPLICASE; VIRAL RNA; PROTEIN; AMPLIFICATION; BACTERIOPHAGE	The enzyme Q beta replicase is an RNA-dependent RNA polymerase, which plays a central role in infection by the simple single-stranded RNA virus bacteriophage Q beta. This enzyme has been used in a number of applications because of its unique activity in amplifying RNA from an RNA template. Determination of the thermal stability of Q beta replicase is important to gain an understanding of its function and potential applications, but data reported to date have been contradictory. Here, we provide evidence that these previous inconsistencies were due to the heterogeneous forms of the replicase with different stabilities. We purified two forms of replicase expressed in Escherichia coli, which differed in their thermal stability but showed identical RNA replication activity. Furthermore, we found that the replicase undergoes conversion between these forms due to oxidation, and the Cys-533 residue in the catalytic beta subunit and Cys-82 residue in the EF-Tu subunit of the replicase are essential prerequisites for this conversion to occur. These results strongly suggest that the thermal stable replicase contains the intersubunit disulfide bond between these cysteines. The established strategies for isolating and purifying a thermally stable replicase should increase the usefulness of Q beta replicase in various applications, and the data regarding thermal stability obtained in this study may yield insight into the precise mechanism of infection by bacteriophage Q beta	[Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Ichihashi, Norikazu; Matsuura, Tomoaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Ichihashi, Norikazu/AAY-6897-2020; matsuura, tomoaki/O-7368-2018; Matsuura, Tomoaki/W-6086-2019	matsuura, tomoaki/0000-0003-1015-6781; Matsuura, Tomoaki/0000-0003-1015-6781	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Centers of Excellence Program and Special Coordination Funds for Promoting Science and Technology: Yuragi Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abramson Richard D., 1993, Current Opinion in Biotechnology, V4, P41, DOI 10.1016/0958-1669(93)90030-Z; BIEBRICHER CK, 1986, NATURE, V321, P89, DOI 10.1038/321089a0; BIEBRICHER CK, 1993, J MOL BIOL, V231, P175, DOI 10.1006/jmbi.1993.1271; BIEBRICHER CK, 1981, J MOL BIOL, V148, P391, DOI 10.1016/0022-2836(81)90183-2; Blumenthal T, 1979, Methods Enzymol, V60, P628; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Brown D, 1996, P NATL ACAD SCI USA, V93, P11558, DOI 10.1073/pnas.93.21.11558; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; EIGEN M, 1991, BIOCHEMISTRY-US, V30, P11005, DOI 10.1021/bi00110a001; Eoyang L., 1968, METHODS ENZYMOLOGY B, V12B, P530; HARUNA I, 1963, P NATL ACAD SCI USA, V50, P905, DOI 10.1073/pnas.50.5.905; HARUNA I, 1965, SCIENCE, V150, P884, DOI 10.1126/science.150.3698.884; Hosoda K, 2007, J BIOL CHEM, V282, P15516, DOI 10.1074/jbc.M700307200; Ichihashi N, 2008, CHEMBIOCHEM, V9, P3023, DOI 10.1002/cbic.200800518; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inokuchi Y, 1997, J BIOL CHEM, V272, P15339, DOI 10.1074/jbc.272.24.15339; Jacobson AB, 1998, J MOL BIOL, V275, P589, DOI 10.1006/jmbi.1997.1472; Johnson JL, 2001, PROTEIN SCI, V10, P2186, DOI 10.1110/ps.02401; KAMEN R, 1972, BIOCHIM BIOPHYS ACTA, V262, P88, DOI 10.1016/0005-2787(72)90221-3; Karlsson F, 2005, CAN J MICROBIOL, V51, P29, DOI 10.1139/W04-113; Karring H, 2004, J BIOL CHEM, V279, P1878, DOI 10.1074/jbc.M306605200; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Kim H, 2004, BIOTECHNOL BIOENG, V88, P148, DOI 10.1002/bit.20226; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Kita H, 2006, J BIOSCI BIOENG, V101, P421, DOI 10.1263/jbb.101.421; KOLAKOFS.D, 1971, BIOCHIM BIOPHYS ACTA, V246, P596, DOI 10.1016/0005-2787(71)90799-4; Kono M, 1998, BIOCHEMISTRY-US, V37, P1302, DOI 10.1021/bi9721445; Kopsidas G, 2006, IMMUNOL LETT, V107, P163, DOI 10.1016/j.imlet.2006.09.004; MILLS DR, 1979, P NATL ACAD SCI USA, V76, P2232, DOI 10.1073/pnas.76.5.2232; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; MOODY MD, 1994, BIOCHEMISTRY-US, V33, P13836, DOI 10.1021/bi00250a038; MOROZOV IY, 1993, P NATL ACAD SCI USA, V90, P9325, DOI 10.1073/pnas.90.20.9325; Nakaishi T, 2002, J BIOSCI BIOENG, V93, P322, DOI 10.1263/jbb.93.322; OBERHOLZER T, 1995, BIOCHEM BIOPH RES CO, V207, P250, DOI 10.1006/bbrc.1995.1180; Pace N. R., 1968, METHODS ENZYMOLOGY B, V12B, P540; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Schuppli D, 2000, J MOL BIOL, V295, P149, DOI 10.1006/jmbi.1999.3373; Spiegelman S., 1968, S Quant Biol, V33, P101; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tsukada K, 2009, BBA-GEN SUBJECTS, V1790, P65, DOI 10.1016/j.bbagen.2008.08.007; Tyagi S, 1996, P NATL ACAD SCI USA, V93, P5395, DOI 10.1073/pnas.93.11.5395; Ugarov VI, 2003, J BIOL CHEM, V278, P44139, DOI 10.1074/jbc.M305992200; Ugarov VI, 2008, J MOL BIOL, V379, P414, DOI 10.1016/j.jmb.2008.03.074; Urabe H, 2010, BIOCHEMISTRY-US, V49, P1809, DOI 10.1021/bi901805u; VANDUIN J, 1988, BACTERIOPHAGES; WEISSMANN C, 1973, ANNU REV BIOCHEM, V42, P303, DOI 10.1146/annurev.bi.42.070173.001511; WEISSMANN C, 1974, FEBS LETT, V43, pS10; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zinder ND, 1975, RNA PHAGES	50	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37210	37217		10.1074/jbc.M110.117846	http://dx.doi.org/10.1074/jbc.M110.117846			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858892	Green Published, hybrid			2022-12-25	WOS:000284424000014
J	Kim, JY; Song, EH; Lee, HJ; Oh, YK; Park, YS; Park, JW; Kim, BJ; Kim, DJ; Lee, I; Song, J; Kim, WH				Kim, Ji Yeon; Song, Eun Hyun; Lee, Hyun Jung; Oh, Yeo Kyoung; Park, Yoon Shin; Park, Joo-Won; Kim, Bong Jo; Kim, Dae Jin; Lee, Inkyu; Song, Jihyun; Kim, Won-Ho			Chronic Ethanol Consumption-induced Pancreatic beta-Cell Dysfunction and Apoptosis through Glucokinase Nitration and Its Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; CHRONIC HIGH GLUCOSE; ALCOHOL-CONSUMPTION; TYROSINE NITRATION; SUPEROXIDE-DISMUTASE; INSULIN-RESISTANCE; FASTING GLUCOSE; ROS PRODUCTION; FATTY LIVER; KAPPA-B	Chronic ethanol consumption is known as an independent risk factor for type 2 diabetes, which is characterized by impaired glucose homeostasis and insulin resistance; however, there is a great deal of controversy concerning the relationships between alcohol consumption and the development of type 2 diabetes. We investigated the effects of chronic ethanol consumption on pancreatic beta-cell dysfunction and whether generated peroxynitrite participates in the impaired glucose homeostasis. Here we show that chronic ethanol feeding decreases the ability of pancreatic beta-cells to mediate insulin secretion and ATP production in coordination with the decrease of glucokinase, Glut2, and insulin expression. Specific blockade of ATF3 using siRNA or C-terminally deleted ATF3(Delta C) attenuated ethanol-induced pancreatic beta-cell apoptosis or dysfunction and restored the down-regulation of glucokinase (GCK), insulin, and pancreatic duodenal homeobox-1 induced by ethanol. GCK inactivation and down-regulation were predominantly mediated by ethanol metabolism-generated peroxynitrite, which were suppressed by the peroxynitrite scavengers N-gamma-monomethyl-L-arginine, uric acid, and deferoxamine but not by the S-nitrosylation inhibitor DTT, indicating that tyrosine nitration is the predominant modification associated with GCK down-regulation and inactivation rather than S-nitrosylation of cysteine. Tyrosine nitration of GCK prevented its association with pBad, and GCK translocation into the mitochondria results in subsequent proteasomal degradation of GCK following ubiquitination. This study identified a novel and efficient pathway by which chronic ethanol consumption may induce GCK down-regulation and inactivation by inducing tyrosine nitration of GCK, resulting in pancreatic beta-cell apoptosis and dysfunction. Peroxynitrite-induced ATF3 may also serve as a potent upstream regulator of GCK down-regulation and beta-cell apoptosis.	[Kim, Ji Yeon; Song, Eun Hyun; Lee, Hyun Jung; Oh, Yeo Kyoung; Song, Jihyun; Kim, Won-Ho] Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, Seoul 122701, South Korea; [Park, Yoon Shin] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Seoul 122701, South Korea; [Park, Joo-Won] Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc Dis, Seoul 122701, South Korea; [Kim, Bong Jo] Natl Inst Hlth, Ctr Genome Sci, Seoul 122701, South Korea; [Kim, Dae Jin] Catholic Univ, Coll Med, Dept Psychiat, Seoul 122701, South Korea; [Lee, Inkyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Catholic University of Korea; Kyungpook National University	Kim, WH (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, 194 Tongillo, Seoul 122701, South Korea.	jhkwh@nih.go.kr	Lee, In-Kyu/AAR-6374-2021	Song, Eun Hyeon/0000-0001-9524-2595; Kim, Won-Ho/0000-0002-4849-472X	Korea Science and Engineering Foundation [R04-2002-000-20112-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R04-2002-000-20112-0.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Beck KF, 1999, J EXP BIOL, V202, P645; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Dembele K, 2009, CELL BIOL TOXICOL, V25, P141, DOI 10.1007/s10565-008-9067-9; Di Castelnuovo A, 2007, NUTR METAB CARDIOVAS, V17, P561, DOI 10.1016/j.numecd.2007.02.006; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; Djousse L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209; Elsner M, 2003, DIABETOLOGIA, V46, P1713, DOI 10.1007/s00125-003-1241-2; Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027; Furuya DT, 2005, LIFE SCI, V77, P1813, DOI 10.1016/j.lfs.2004.12.046; Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, p97A; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kim JY, 2009, CELL SIGNAL, V21, P1758, DOI 10.1016/j.cellsig.2009.07.011; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim SY, 2001, BIOCHIMIE, V83, P437, DOI 10.1016/S0300-9084(01)01258-5; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Knight TR, 2001, TOXICOL SCI, V62, P212, DOI 10.1093/toxsci/62.2.212; Lee HJ, 2007, J MOL BIOL, V369, P967, DOI 10.1016/j.jmb.2007.03.072; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Lee JR, 2009, ARCH PHARM RES, V32, P1109, DOI 10.1007/s12272-009-1802-0; Mishra DP, 2007, PROSTAG OTH LIPID M, V83, P75, DOI 10.1016/j.prostaglandins.2006.10.002; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Polikandriotis JA, 2007, ALCOHOL, V41, P309, DOI 10.1016/j.alcohol.2007.03.012; Roh WG, 2009, ALCOHOL, V43, P643, DOI 10.1016/j.alcohol.2009.10.005; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sebastian BM, 2005, AM J PHYSIOL-ENDOC M, V289, pE1077, DOI 10.1152/ajpendo.00296.2005; Shaper AG, 1998, NOVART FDN SYMP, V216, P173; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Strnad P, 2009, GASTROENTEROLOGY, V136, P1502, DOI 10.1053/j.gastro.2009.03.021; Tejedo JR, 2004, ENDOCRINOLOGY, V145, P2319, DOI 10.1210/en.2003-1489; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Walsh L, 2005, MUTAGENESIS, V20, P317, DOI 10.1093/mutage/gei044; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Yang ES, 2008, BIOCHIMIE, V90, P1316, DOI 10.1016/j.biochi.2008.03.001; Yang ES, 2009, BIOCHIMIE, V91, P1020, DOI 10.1016/j.biochi.2009.05.008	50	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37251	37262		10.1074/jbc.M110.142315	http://dx.doi.org/10.1074/jbc.M110.142315			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855893	hybrid, Green Published			2022-12-25	WOS:000284424000018
J	Chakraborty, M; Mangiamele, LA; Burmeister, SS				Chakraborty, Mukta; Mangiamele, Lisa A.; Burmeister, Sabrina S.			Neural Activity Patterns in Response to Interspecific and Intraspecific Variation in Mating Calls in the Tungara Frog	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; FEMALE MATE CHOICE; AUDITORY FOREBRAIN; RECEIVER PERMISSIVENESS; VENTRAL HYPOTHALAMUS; ACOUSTIC MODULATION; ADVERTISEMENT CALLS; SEX-DIFFERENCES; PREOPTIC AREA; RECOGNITION	Background: During mate choice, individuals must classify potential mates according to species identity and relative attractiveness. In many species, females do so by evaluating variation in the signals produced by males. Male tungara frogs (Physalaemus pustulosus) can produce single note calls (whines) and multi-note calls (whine-chucks). While the whine alone is sufficient for species recognition, females greatly prefer the whine-chuck when given a choice. Methodology/Principal Findings: To better understand how the brain responds to variation in male mating signals, we mapped neural activity patterns evoked by interspecific and intraspecific variation in mating calls in tungara frogs by measuring expression of egr-1. We predicted that egr-1 responses to conspecific calls would identify brain regions that are potentially important for species recognition and that at least some of those brain regions would vary in their egr-1 responses to mating calls that vary in attractiveness. We measured egr-1 in the auditory brainstem and its forebrain targets and found that conspecific whine-chucks elicited greater egr-1 expression than heterospecific whines in all but three regions. We found no evidence that preferred whine-chuck calls elicited greater egr-1 expression than conspecific whines in any of eleven brain regions examined, in contrast to predictions that mating preferences in tungara frogs emerge from greater responses in the auditory system. Conclusions: Although selectivity for species-specific signals is apparent throughout the tungara frog brain, further studies are necessary to elucidate how neural activity patterns vary with the attractiveness of conspecific mating calls.	[Chakraborty, Mukta; Mangiamele, Lisa A.; Burmeister, Sabrina S.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Burmeister, Sabrina S.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chakraborty, M (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	sburmeister@unc.edu		Burmeister, Sabrina/0000-0001-5612-692X	Smithsonian Tropical Research Institute; Friends of the Osa; Organization for Tropical Studies; NSF IOB [0445682]	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Friends of the Osa; Organization for Tropical Studies; NSF IOB(National Science Foundation (NSF))	We thank Christina Lebonville, Mihnea (Mike) Mangalea, Sera Haith, Stuart Jeckel, Joan Winter, and Rachel Glaeser for their contributions to data collection. We also thank Dr. Michael J. Ryan, the Smithsonian Tropical Research Institute, Friends of the Osa, and the Organization for Tropical Studies for research support and assistance in obtaining permits.; This research was supported by NSF IOB 0445682 to SSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON JD, 1992, J COMP PHYSIOL A, V171, P387; ALLISON JD, 1991, BRAIN BEHAV EVOLUT, V38, P322, DOI 10.1159/000114398; Andersson Malte, 1994; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Bernal XE, 2007, ANIM BEHAV, V73, P955, DOI 10.1016/j.anbehav.2006.10.018; Bernal XE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1269, DOI 10.1007/s00265-009-0795-5; Burmeister SS, 2008, BRAIN RES, V1190, P105, DOI 10.1016/j.brainres.2007.11.008; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hauber ME, 2007, J COMP PHYSIOL A, V193, P765, DOI 10.1007/s00359-007-0231-0; Hoke KL, 2008, BIOL LETTERS, V4, P518, DOI 10.1098/rsbl.2008.0192; Hoke KL, 2004, J NEUROSCI, V24, P11264, DOI 10.1523/JNEUROSCI.2079-04.2004; Leitner S, 2005, J NEUROBIOL, V64, P275, DOI 10.1002/neu.20135; Mangiamele LA, 2008, BRAIN BEHAV EVOLUT, V72, P239, DOI 10.1159/000171481; MANGIAMELE LM, 2010, DEV NEUROBI IN PRESS; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Michael J Ryan, 2003, [动物学报, Acta Zoologica Sinica], V49, P713; MUDRY KM, 1980, BRAIN RES, V182, P303, DOI 10.1016/0006-8993(80)91190-7; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; RAND AS, 1992, AM ZOOL, V32, P81; Ryan M. J., 1985, TUNGARA FROG STUDY S; Ryan MJ, 2000, BRAIN BEHAV EVOLUT, V56, P45, DOI 10.1159/000006677; Ryan MJ, 1999, ANIM BEHAV, V57, P945, DOI 10.1006/anbe.1998.1057; Ryan MJ, 2003, AM NAT, V161, P380, DOI 10.1086/367588; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Safi K, 2006, ETHOLOGY, V112, P1225, DOI 10.1111/j.1439-0310.2006.01282.x; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Walkowiak W, 1999, EUR J MORPHOL, V37, P177, DOI 10.1076/ejom.37.2.177.4740; WILCZYNSKI W, 1995, ANIM BEHAV, V49, P911, DOI 10.1006/anbe.1995.0123; Wilczynski W, 2001, BRAIN BEHAV EVOLUT, V58, P137, DOI 10.1159/000047268; WILCZYNSKI W, 2007, HEARING SOUND COMMUN; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	38	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12898	10.1371/journal.pone.0012898	http://dx.doi.org/10.1371/journal.pone.0012898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877560	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100030
J	Mahdy, MAK; Al-Mekhlafi, HM; Al-Mekhlafi, AM; Lim, YAL; Bin Shuaib, NOM; Azazy, AA; Mahmud, R				Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.; Lim, Yvonne A. L.; Bin Shuaib, Naemah O. M.; Azazy, Ahmed A.; Mahmud, Rohela			Molecular Characterization of Leishmania Species Isolated from Cutaneous Leishmaniasis in Yemen	PLOS ONE			English	Article							OPERATION-DESERT-STORM; VISCERAL INFECTION; SAUDI-ARABIA; TROPICA; IDENTIFICATION; DISEASE; KENYA; DIAGNOSIS; INFANTUM; FOCUS	Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in the tropics and subtropics with a global yearly incidence of 1.5 million. Although CL is the most common form of leishmaniasis, which is responsible for 60% of DALYs lost due to tropical-cluster diseases prevalent in Yemen, available information is very limited. Methodology/Principal Findings: This study was conducted to determine the molecular characterization of Leishmania species isolated from human cutaneous lesions in Yemen. Dermal scrapes were collected and examined for Leishmania amastigotes using the Giemsa staining technique. Amplification of the ribosomal internal transcribed spacer 1(ITS-1) gene was carried out using nested PCR and subsequent sequencing. The sequences from Leishmania isolates were subjected to phylogenetic analysis using the neighbor-joining and maximum parsimony methods. The trees identified Leishmania tropica from 16 isolates which were represented by two sequence types. Conclusions/Significance: The predominance of the anthroponotic species (i.e. L. tropica) indicates the probability of anthroponotic transmission of cutaneous leishmaniasis in Yemen. These findings will help public health authorities to build an effective control strategy taking into consideration person-to-person transmission as the main dynamic of transmission of CL.	[Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.; Lim, Yvonne A. L.; Mahmud, Rohela] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Bin Shuaib, Naemah O. M.] Cent Hlth Lab, Sanaa, Yemen; [Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Azazy, Ahmed A.] Sanaa Univ, Fac Med, Dept Parasitol, Sanaa, Yemen	Universiti Malaya	Mahdy, MAK (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	alsharaby9@yahoo.com	MAHMUD, ROHELA/B-9593-2010; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Mahdy, Mohammed A.K./C-1187-2010; LIM, YVONNE AL/B-5276-2010	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Mahdy, Mohammed A.K./0000-0002-8340-5219; LIM, YVONNE AL/0000-0003-4050-6332; kamal, amera/0000-0002-9154-9415				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; ALZAHRANI MA, 1988, T ROY SOC TROP MED H, V82, P416, DOI 10.1016/0035-9203(88)90142-3; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; BOZZA M, 1995, T ROY SOC TROP MED H, V89, P333, DOI 10.1016/0035-9203(95)90569-3; BRAY RS, 1973, T ROY SOC TROP MED H, V67, P345, DOI 10.1016/0035-9203(73)90111-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARIFALLOU A, 1984, ANN TROP MED PARASIT, V78, P369, DOI 10.1080/00034983.1984.11811834; GRAMICCIA M, 1987, T ROY SOC TROP MED H, V81, P235, DOI 10.1016/0035-9203(87)90225-2; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Karunaweera ND, 2003, T ROY SOC TROP MED H, V97, P380, DOI 10.1016/S0035-9203(03)90061-7; Khatri Mishri Lal, 2009, J Am Acad Dermatol, V61, pe15, DOI 10.1016/j.jaad.2009.04.047; Khatri ML, 2006, INT J DERMATOL, V45, P40, DOI 10.1111/j.1365-4632.2004.02588.x; Khatri ML, 1999, INT J DERMATOL, V38, P587, DOI 10.1046/j.1365-4362.1999.00756.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KREUTZER RD, 1993, AM J TROP MED HYG, V49, P357, DOI 10.4269/ajtmh.1993.49.357; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; MAGILL AJ, 1994, CLIN INFECT DIS, V19, P805, DOI 10.1093/clinids/19.4.805; MEBRAHTU YB, 1992, AM J TROP MED HYG, V47, P852, DOI 10.4269/ajtmh.1992.47.852; MEBRAHTU YB, 1992, T ROY SOC TROP MED H, V86, P381, DOI 10.1016/0035-9203(92)90230-A; Nei M., 2000, MOL EVOLUTION PHYLOG; PRATLONG F, 1995, T ROY SOC TROP MED H, V89, P398, DOI 10.1016/0035-9203(95)90025-X; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; RIOUX JA, 1989, B SOC PATHOL EXOT, V82, P658; SABROSKY CW, 1953, J WASHINGTON ACAD SC, V43, P119; Saliba EK, 1997, ANN TROP MED PARASIT, V91, P453, DOI 10.1080/00034989760815; SANG DK, 1994, T ROY SOC TROP MED H, V88, P35, DOI 10.1016/0035-9203(94)90486-3; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; *UNDP, 2007, YEM POV ASS REP UN D; *WHO, 1984, WHO TECH REP SER, V701; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wright JH, 1904, J MED RES, V10, P472; YAKIMOV W. L., 1914, Bulletin de la Societe de Pathologie Exotique, V7, P186	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12879	10.1371/journal.pone.0012879	http://dx.doi.org/10.1371/journal.pone.0012879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862227	Green Published, gold			2022-12-25	WOS:000281963200022
J	Schillaci, MA; Waitzkin, H; Carson, EA; Romain, SJ				Schillaci, Michael A.; Waitzkin, Howard; Carson, E. Ann; Romain, Sandra J.			Prenatal Care Utilization for Mothers from Low-Income Areas of New Mexico, 1989-1999	PLOS ONE			English	Article							MEDICAID MANAGED CARE; LOW-BIRTH-WEIGHT; HEALTH; PRETERM; MORBIDITY; INSURANCE; ADEQUACY; WOMEN; COST	Background: Prenatal care is considered to be an important component of primary health care. Our study compared prenatal care utilization and rates of adverse birth outcomes for mothers from low-and higher-income areas of New Mexico between 1989 and 1999. Methodology/Principal Findings: Prenatal care indicators included the number of prenatal care visits and the first month of prenatal care. Birth outcome indicators included low birth weight, premature birth, and births linked with death certificates. The results of our study indicated that mothers from low-income areas started their prenatal care significantly later in their pregnancies between 1989 and 1999, and had significantly fewer prenatal visits between 1989 and 1997. For the most part, there were not significant differences in birth outcome indicators between income groupings. Conclusions/Significance: These findings suggest that while mothers from low-income areas received lower levels of prenatal care, they did not experience a higher level of adverse birth outcomes.	[Schillaci, Michael A.] Univ Toronto, Dept Social Sci, Scarborough, ON M1C 1A4, Canada; [Waitzkin, Howard] Univ New Mexico, Dept Sociol, Albuquerque, NM 87131 USA; [Waitzkin, Howard] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Waitzkin, Howard] Univ New Mexico, Dept Family & Community Med, Albuquerque, NM 87131 USA; [Carson, E. Ann] Intellica Corp, San Antonio, TX USA; [Romain, Sandra J.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Scarborough; University of New Mexico; University of New Mexico; University of New Mexico; University of Toronto	Schillaci, MA (corresponding author), Univ Toronto, Dept Social Sci, Scarborough, ON M1C 1A4, Canada.	schillaci@utsc.utoronto.ca			Agency for Healthcare Research and Quality [R01 HS09703]; New Mexico Department of Health [98.665.42.194]; Hospital of the University of New Mexico; University of New Mexico School of Medicine; University of Toronto; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New Mexico Department of Health; Hospital of the University of New Mexico; University of New Mexico School of Medicine; University of Toronto(University of Toronto); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Partial funding for this research was provided by the Agency for Healthcare Research and Quality (R01 HS09703), the New Mexico Department of Health (98.665.42.194), the Hospital of the University of New Mexico, the Dedicated Health Research Funds of the University of New Mexico School of Medicine, and the University of Toronto. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini EA, 2001, PEDIATRICS, V107, P1335, DOI 10.1542/peds.107.6.1335; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Braveman P, 2000, OBSTET GYNECOL, V95, P874, DOI 10.1016/S0029-7844(00)00780-8; Conway KS, 2006, HEALTH ECON, V15, P461, DOI 10.1002/hec.1097; Dubay L, 2007, HEALTH AFFAIR, V26, pW22, DOI 10.1377/hlthaff.26.1.w22; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Goffinet F, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2005.00583.x; Herbst MA, 2003, AM J OBSTET GYNECOL, V189, P930, DOI 10.1067/S0002-9378(03)01055-X; Hueston WJ, 2003, J COMMUN HEALTH, V28, P199, DOI 10.1023/A:1022908307844; Kogan MD, 1998, PEDIATRICS, V102, P25, DOI 10.1542/peds.102.1.25; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Moos MK, 2006, JOGNN-J OBST GYN NEO, V35, P278, DOI 10.1111/J.1552-6909.2006.00039.x; Nothnagle M, 2000, Matern Child Health J, V4, P251; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schillaci MA, 2004, ANN FAM MED, V2, P13, DOI 10.1370/afm.100; Schillaci MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003953; Schmitt SK, 2006, PEDIATRICS, V117, P154, DOI 10.1542/peds.2005-0484; Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078; Stringer M, 2005, JOGNN-J OBST GYN NEO, V34, P551, DOI 10.1177/0884217505280276; Waitzkin H, 2002, AM J PUBLIC HEALTH, V92, P598, DOI 10.2105/AJPH.92.4.598; Waitzkin H, 2008, HEALTH SERV RES, V43, P1325, DOI 10.1111/j.1475-6773.2008.00842.x; *WHO, 2008, INT STAT DIS REL HLT; Willging CE, 2005, MED ANTHROPOL Q, V19, P84, DOI 10.1525/maq.2005.19.1.084	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12809	10.1371/journal.pone.0012809	http://dx.doi.org/10.1371/journal.pone.0012809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20862298	Green Submitted, gold, Green Published			2022-12-25	WOS:000281960800015
J	Khoshnevis, S; Neumann, P; Ficner, R				Khoshnevis, Sohail; Neumann, Piotr; Ficner, Ralf			Crystal Structure of the RNA Recognition Motif of Yeast Translation Initiation Factor eIF3bw Reveals Differences to Human eIF3b	PLOS ONE			English	Article							BINDING; DOMAIN; INSIGHTS; PRT1	Background: The multi-subunit eukaryotic initiation factor3 (eIF3) plays a central role in the initiation step of protein synthesis in eukaryotes. One of its large subunits, eIF3b, serves as a scaffold within eIF3 as it interacts with several other subunits. It harbors an RNA Recognition Motif (RRM), which is shown to be a non-canonical RRM in human as it is not capable to interact with oligonucleotides, but rather interacts with eIF3j, a sub-stoichiometric subunit of eIF3. Principal Finding: We have analyzed the high-resolution crystal structure of the eIF3b RRM domain from yeast. It exhibits the same fold as its human ortholog, with similar charge distribution on the surface interacting with the eIF3j in human. Thermodynamic analysis of the interaction between yeast eIF3b-RRM and eIF3j revealed the same range of enthalpy change and dissociation constant as for the human proteins, providing another line of evidence for the same mode of interaction between eIF3b and eIF3j in both organisms. However, analysis of the surface charge distribution of the putative RNA-binding beta-sheet suggested that in contrast to its human ortholog, it potentially could bind oligonucleotides. Three-dimensional positioning of the so called "RNP1" motif in this domain is similar to other canonical RRMs, suggesting that this domain might indeed be a canonical RRM, conferring oligonucleotide binding capability to eIF3 in yeast. Interaction studies with yeast total RNA extract confirmed the proposed RNA binding activity of yeast eIF3b-RRM. Conclusion: We showed that yeast eIF3b-RRM interacts with eIF3j in a manner similar to its human ortholog. However, it shows similarities in the oligonucleotide binding surface to canonical RRMs and interacts with yeast total RNA. The proposed RNA binding activity of eIF3b-RRM may help eIF3 to either bind to the ribosome or recruit the mRNA to the 43S pre-initiation complex.	[Khoshnevis, Sohail; Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Gottingen, Germany	University of Gottingen	Khoshnevis, S (corresponding author), Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Gottingen, Germany.	rficner@gwdg.de			State of Lower Saxony	State of Lower Saxony(European Commission)	S. K. was supported by a Georg-Christoph-Lichtenberg stipend granted by the State of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crowder SM, 1999, P NATL ACAD SCI USA, V96, P4892, DOI 10.1073/pnas.96.9.4892; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin-Tumasz S, 2010, RNA, V16, P792, DOI 10.1261/rna.1913310; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tsuda K, 2009, NUCLEIC ACIDS RES, V37, P5151, DOI 10.1093/nar/gkp546; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891	26	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12784	10.1371/journal.pone.0012784	http://dx.doi.org/10.1371/journal.pone.0012784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862284	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100019
J	Uhler, LM; Kumarasamy, N; Mayer, KH; Saxena, A; Losina, E; Muniyandi, M; Stoler, AW; Lu, ZG; Walensky, RP; Flanigan, TP; Bender, MA; Freedberg, KA; Swaminathan, S				Uhler, Lauren M.; Kumarasamy, Nagalingeswaran; Mayer, Kenneth H.; Saxena, Anjali; Losina, Elena; Muniyandi, Malaisamy; Stoler, Adam W.; Lu, Zhigang; Walensky, Rochelle P.; Flanigan, Timothy P.; Bender, Melissa A.; Freedberg, Kenneth A.; Swaminathan, Soumya		CEPAC Int Investigators	Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; COTRIMOXAZOLE PROPHYLAXIS; HIV-1-INFECTED ADULTS; COTE-DIVOIRE; VIRAL LOAD; IMPACT; RISK; PREVENTION; SEROPREVALENCE	Background: Indian guidelines recommend routine referral for HIV testing of all tuberculosis (TB) patients in the nine states with the highest HIV prevalence, and selective referral for testing elsewhere. We assessed the clinical impact and cost-effectiveness of alternative HIV testing referral strategies among TB patients in India. Methods and Findings: We utilized a computer model of HIV and TB disease to project outcomes for patients with active TB in India. We compared life expectancy, cost, and cost-effectiveness for three HIV testing referral strategies: 1) selective referral for HIV testing of those with increased HIV risk, 2) routine referral of patients in the nine highest HIV prevalence states with selective referral elsewhere (current standard), and 3) routine referral of all patients for HIV testing. TB-related data were from the World Health Organization. HIV prevalence among TB patients was 9.0% in the highest prevalence states, 2.9% in the other states, and 4.9% overall. The selective referral strategy, beginning from age 33.50 years, had a projected discounted life expectancy of 16.88 years and a mean lifetime HIV/TB treatment cost of US$ 100.The current standard increased mean life expectancy to 16.90 years with additional per-person cost of US$ 10; the incremental cost-effectiveness ratio was US$650/year of life saved (YLS) compared to selective referral. Routine referral of all patients for HIV testing increased life expectancy to 16.91 years, with an incremental cost-effectiveness ratio of US$730/YLS compared to the current standard. For HIV-infected patients cured of TB, receiving antiretroviral therapy increased survival from 4.71 to 13.87 years. Results were most sensitive to the HIV prevalence and the cost of second-line antiretroviral therapy. Conclusions: Referral of all patients with active TB in India for HIV testing will be both effective and cost-effective. While effective implementation of this strategy would require investment, routine, voluntary HIV testing of TB patients in India should be recommended.	[Uhler, Lauren M.; Saxena, Anjali; Stoler, Adam W.; Lu, Zhigang; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res CFAR, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Kumarasamy, Nagalingeswaran] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Mayer, Kenneth H.; Flanigan, Timothy P.] Brown Univ, Miriam Hosp, Providence, RI USA; [Muniyandi, Malaisamy; Swaminathan, Soumya] Indian Council Med Res, TB Res Ctr, Chennai, Tamil Nadu, India; [Bender, Melissa A.] NYU, Sch Med, Div Infect Dis, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); New York University	Uhler, LM (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.	luhler@partners.org; kfreedberg@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Muniyandi, Malaisamy/AAF-2076-2021	Lipsitch, Marc/0000-0003-1504-9213; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	U.S. National Institute of Allergy and Infectious Disease [R01 AI058736, K24 AI062476]; Doris Duke Charitable Foundation [2007015]; Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K24AI062476] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. National Institute of Allergy and Infectious Disease (R01 AI058736 and K24 AI062476), the Doris Duke Charitable Foundation (Operations Research on AIDS Care and Treatment in Africa (ORACTA) Award 2007015), and the Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2009, INT DRUG PRIC IND GU; BASSETT IV, AIDS S1, V24, pS37; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dewan PK, 2010, INT J TUBERC LUNG D, V14, P247; FREEDBERG KA, 2007, AIDS 21 S4, V4, pS117; Gold R, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Homan R, 2000, EC ANALYSES YRG CARE; IMF-International Monetary Fund, 2009, WORLD EC OUTL DAT; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Krishnan AKS, 2007, AIDS EDUC PREV, V19, P334, DOI 10.1521/aeap.2007.19.4.334; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liechty Cheryl A, 2005, Curr Infect Dis Rep, V7, P154, DOI 10.1007/s11908-005-0076-z; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MUNIYANDI M, 2006, INDIAN J TUBERC, P12; NACO, 2010, CAR SUPP TREATM NAT; *NACO, 2007, ANTIRETROVIRAL THERA; National AIDS Control Organization (NACO), 2010, NAT AIDS CONTR PROGR; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raizada N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005999; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Revised National Tuberculosis Control Programme (RNTCP), 2010, TB IND 2010 RNTCP ST; Sadacharam K, 2007, Indian J Tuberc, V54, P199; Sharma Aman, 2007, Indian J Pathol Microbiol, V50, P905; Sogarwal R., 2009, J INDIAN MED ASSOC, V107, P307; Sogarwal R, 2009, J INDIAN MED ASSOC, V107, P228; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Swaminathan S, 2008, NATL MED J INDIA, V21, P3; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; *UNAIDS WHO, 2007, 2007 AIDS EP UP; Vijay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007899; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wang B, 2006, 16 INT AIDS C TOR CA; WHO, 2010, ANT THER HIV INF AD; *WHO, 2009, WHO REP 2009 GLOB TU; WHO, 2008, EPI SEM 2008; *WHO, 2007, UGID PROV IN HIV TES; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, ANTIRETROVIRAL THERA; World Health Organization, 2001, MACR HLTH INV HLTH E; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12747	10.1371/journal.pone.0012747	http://dx.doi.org/10.1371/journal.pone.0012747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862279	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000281864100009
J	Prasad, BD; Goel, S; Krishna, P				Prasad, Bishun D.; Goel, Shilpi; Krishna, Priti			In Silico Identification of Carboxylate Clamp Type Tetratricopeptide Repeat Proteins in Arabidopsis and Rice As Putative Co-Chaperones of Hsp90/Hsp70	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; DOMAIN; RECEPTOR; IMMUNOPHILINS; ACCUMULATION; COCHAPERONE; INTERACTS; MECHANISM; RESPONSES; COMPLEX	The essential eukaryotic molecular chaperone Hsp90 operates with the help of different co-chaperones, which regulate its ATPase activity and serve as adaptors to recruit client proteins and other molecular chaperones, such as Hsp70, to the Hsp90 complex. Several Hsp90 and Hsp70 co-chaperones contain the tetratricopeptide repeat (TPR) domain, which interacts with the highly conserved EEVD motif at the C-terminal ends of Hsp90 and Hsp70. The acidic side chains in EEVD interact with a subset of basic residues in the TPR binding pocket called a 'carboxylate clamp'. Since the carboxylate clamp residues are conserved in the TPR domains of known Hsp90/Hsp70 co-chaperones, we carried out an in silico search for TPR proteins in Arabidopsis and rice comprising of at least one three-motif TPR domain with conserved amino acid residues required for Hsp90/Hsp70 binding. This approach identified in Arabidopsis a total of 36 carboxylate clamp (CC)-TPR proteins, including 24 novel proteins, with potential to interact with Hsp90/Hsp70. The newly identified CC-TPR proteins in Arabidopsis and rice contain additional protein domains such as ankyrin, SET, octicosapeptide/Phox/Bem1p (Phox/PB1), DnaJ-like, thioredoxin, FBD and F-box, and protein kinase and U-box, indicating varied functions for these proteins. To provide proof-of-concept of the newly identified CC-TPR proteins for interaction with Hsp90, we demonstrated interaction of AtTPR1 and AtTPR2 with AtHsp90 in yeast two-hybrid and in vitro pull down assays. These findings indicate that the in silico approach used here successfully identified in a genome-wide context CC-TPR proteins with potential to interact with Hsp90/Hsp70, and further suggest that the Hsp90/Hsp70 system relies on TPR co-chaperones more than it was previously realized.	[Prasad, Bishun D.; Goel, Shilpi; Krishna, Priti] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Prasad, BD (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	pkrishna@uwo.ca	Prasad, Bishun Deo/AAP-2957-2021	Krishna, Priti/0000-0001-6394-3012; Prasad, Bishun Deo/0000-0002-8037-8534	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a grant to P.K. from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Aviezer-Hagai K, 2007, PLANT MOL BIOL, V63, P237, DOI 10.1007/s11103-006-9085-z; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Krishna P, 1997, PLANT MOL BIOL, V33, P457, DOI 10.1023/A:1005709308096; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; KRISHNA P, 1995, PLANT PHYSIOL, V107, P915, DOI 10.1104/pp.107.3.915; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lin ZF, 2008, J EXP BOT, V59, P4271, DOI 10.1093/jxb/ern276; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reddy RK, 1998, PLANT PHYSIOL, V118, P1395, DOI 10.1104/pp.118.4.1395; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen GX, 2007, PLANT J, V49, P228, DOI 10.1111/j.1365-313X.2006.02963.x; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Stancato LF, 1996, BIOCHEMISTRY-US, V35, P554, DOI 10.1021/bi9511649; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; van Bentem SDF, 2005, PLANT J, V43, P284, DOI 10.1111/j.1365-313X.2005.02450.x; Verslues PE, 2005, BIOCHEM SOC T, V33, P375, DOI 10.1042/BST0330375; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang ZM, 2010, CELL STRESS CHAPERON, V15, P703, DOI 10.1007/s12192-010-0182-1; Zhang ZM, 2003, PLANT PHYSIOL, V131, P525, DOI 10.1104/pp.011940	55	68	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12761	10.1371/journal.pone.0012761	http://dx.doi.org/10.1371/journal.pone.0012761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856808	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800023
J	Campanella, GSV; Colvin, RA; Luster, AD				Campanella, Gabriele S. V.; Colvin, Richard A.; Luster, Andrew D.			CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; PLATELET FACTOR-IV; X-C-CHEMOKINE; GROWTH-FACTOR; MICE LACKING; RECEPTOR; IP-10; EXPRESSION; HEPARIN; BINDING	CXCL10 (or Interferon-inducible protein of 10 kDa, IP-10) is an interferon-inducible chemokine with potent chemotactic activity on activated effector T cells and other leukocytes expressing its high affinity G protein-coupled receptor CXCR3. CXCL10 is also active on other cell types, including endothelial cells and fibroblasts. The mechanisms through which CXCL10 mediates its effects on non-leukocytes is not fully understood. In this study, we focus on the anti-proliferative effect of CXCL10 on endothelial cells, and demonstrate that CXCL10 can inhibit endothelial cell proliferation in vitro independently of CXCR3. Four main findings support this conclusion. First, primary mouse endothelial cells isolated from CXCR3-deficient mice were inhibited by CXCL10 as efficiently as wildtype endothelial cells. We also note that the proposed alternative splice form CXCR3-B, which is thought to mediate CXCL10's angiostatic activity, does not exist in mice based on published mouse CXCR3 genomic sequences as an in-frame stop codon would terminate the proposed CXCR3-B splice variant in mice. Second, we demonstrate that human umbilical vein endothelial cells and human lung microvascular endothelial cells that were inhibited by CXL10 did not express CXCR3 by FACS analysis. Third, two different neutralizing CXCR3 antibodies did not inhibit the anti-proliferative effect of CXCL10. Finally, fourth, utilizing a panel of CXCL10 mutants, we show that the ability to inhibit endothelial cell proliferation correlates with CXCL10's glycosaminoglycan binding affinity and not with its CXCR3 binding and signaling. Thus, using a very defined system, we show that CXCL10 can inhibit endothelial cell proliferation through a CXCR3-independent mechanism.	[Campanella, Gabriele S. V.; Colvin, Richard A.; Luster, Andrew D.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis,Massachusetts Gen, Charlestown, MA USA	Harvard University	Campanella, GSV (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis,Massachusetts Gen, Charlestown, MA USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NIH [R01CA0169215, T32AR007258]; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA0169215 to ADL and T32AR007258 to GSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; Aksoy MO, 2006, AM J PHYSIOL-LUNG C, V290, pL909, DOI 10.1152/ajplung.00430.2005; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Charnaux N, 2005, FEBS J, V272, P1937, DOI 10.1111/j.1742-4658.2005.04624.x; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Giuliani N, 2006, HAEMATOLOGICA, V91, P1489; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; MAIONE TE, 1991, CANCER RES, V51, P2077; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; SATO Y, 1993, JPN J CANCER RES, V84, P485, DOI 10.1111/j.1349-7006.1993.tb00163.x; Schutyser E, 2007, EUR CYTOKINE NETW, V18, P59, DOI 10.1684/ecn.2007.0087; Sfriso P, 2006, J IMMUNOL, V176, P2581, DOI 10.4049/jimmunol.176.4.2581; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Sgadari C, 1996, P NATL ACAD SCI USA, V93, P13791, DOI 10.1073/pnas.93.24.13791; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; Sulpice E, 2004, EUR J BIOCHEM, V271, P3310, DOI 10.1111/j.1432-1033.2004.04263.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; TAUB DD, 1995, J IMMUNOL, V155, P3877; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Waeckel L, 2005, CIRC RES, V96, P576, DOI 10.1161/01.RES.0000159389.55544.20; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	48	69	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12700	10.1371/journal.pone.0012700	http://dx.doi.org/10.1371/journal.pone.0012700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856926	Green Submitted, Green Published, gold			2022-12-25	WOS:000281735700018
J	Dixit, A; Singh, PK; Sharma, GP; Malhotra, P; Sharma, P				Dixit, Aparna; Singh, Prashant K.; Sharma, Guru Prasad; Malhotra, Pawan; Sharma, Pushkar			PfSRPK1, a Novel Splicing-related Kinase from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SPECIFIC KINASES; B-LIKE ENZYME; SR PROTEINS; MALARIA PARASITES; SIGNALING PATHWAY; SEXUAL STAGE; RNA; PHOSPHORYLATION; INTERACTS; IDENTIFICATION	Even though it is increasingly evident that post-transcriptional events like mRNA processing and splicing may regulate gene expression and proteome diversity of malaria parasite Plasmodium, molecular mechanisms that regulate events like mRNA splicing in malaria parasite are poorly understood. Protein kinases control a wide variety of cellular events in almost all eukaryotes, including modulation of mRNA splicing, transport, and stability. We have identified a novel splicing-related protein kinase from Plasmodium falciparum, PfSRPK1. PfSRPK1 when incubated with parasite nuclear extracts inhibited RNA splicing, suggesting that it may control mRNA splicing in the parasite. PfSR1, a putative splicing factor from P. falciparum, was identified as a substrate of PfSRPK1. PfSR1 interacts with RNA and PfSRPK1 modulates its RNA binding. Early in the parasite development, PfSRPK1 and PfSR1 are present in the nucleus. These studies provide useful insights into the function of two potentially key components of P. falciparum mRNA splicing machinery.	Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Singh, Prashant K.; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi		pushkar@nii.ac.in	Sharma, Guruprasad/M-5256-2017	Sharma, Guruprasad/0000-0003-3197-4396	Department of Science and Technology, India; European Union; ICGEB; DBT	Department of Science and Technology, India(Department of Science & Technology (India)); European Union(European Commission); ICGEB; DBT(Department of Biotechnology (DBT) India)	This work was supported in part by a Swarnajayanti fellowship grant (to P. S.) by the Department of Science and Technology, India and in part by the MALSIG project, funded by the European Union under FP7. This work was also supported by ICGEB and DBT (to P. M.).	Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Breman JG, 2001, AM J TROP MED HYG, V64, pI; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; FU XD, 1995, RNA, V1, P663; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Iriko H, 2009, PARASITOL INT, V58, P196, DOI 10.1016/j.parint.2009.02.002; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANZER M, 1992, EMBO J, V11, P1949, DOI 10.1002/j.1460-2075.1992.tb05248.x; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Li JL, 2001, INT J PARASITOL, V31, P387, DOI 10.1016/S0020-7519(01)00126-6; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marshall AC, 2008, PRENATAL DIAG, V28, P1023, DOI 10.1002/pd.2114; McIntosh MT, 2007, J BIOL CHEM, V282, P11499, DOI 10.1074/jbc.M610974200; Militello KT, 2005, RNA, V11, P365, DOI 10.1261/rna.7940705; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P9, DOI 10.1016/S0166-6851(02)00299-2; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Saenz FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002287; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Sims JS, 2009, EUKARYOT CELL, V8, P327, DOI 10.1128/EC.00340-08; Singh N, 2004, J MOL BIOL, V343, P589, DOI 10.1016/j.jmb.2004.08.047; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sunil S, 2008, BIOCHEM BIOPH RES CO, V372, P373, DOI 10.1016/j.bbrc.2008.05.033; Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79	40	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38315	38323		10.1074/jbc.M110.119255	http://dx.doi.org/10.1074/jbc.M110.119255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870716	hybrid, Green Published			2022-12-25	WOS:000284625600038
J	Berlin, I; Higginbotham, KM; Dise, RS; Sierra, MI; Nash, PD				Berlin, Ilana; Higginbotham, Katherine M.; Dise, Rebecca S.; Sierra, Maria I.; Nash, Piers D.			The Deubiquitinating Enzyme USP8 Promotes Trafficking and Degradation of the Chemokine Receptor 4 at the Sorting Endosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-COUPLED RECEPTOR; DOWN-REGULATION; UBIQUITIN ISOPEPTIDASE; ESCRT MACHINERY; CXCR4; HRS; UBPY; LIGASE; INTERACTS	Reversible ubiquitination orchestrated by the opposition of ubiquitin ligases and deubiquitinating enzymes mediates endocytic trafficking of cell surface receptors for lysosomal degradation. Ubiquitin-specific protease 8 (USP8) has previously been implicated in endocytosis of several receptors by virtue of their deubiquitination. The present study explores an indirect role for USP8 in cargo trafficking through its regulation of the chemokine receptor 4 (CXCR4). Contrary to the effects of USP8 loss on enhanced green fluorescent protein, we find that USP8 depletion stabilizes CXCR4 on the cell surface and attenuates receptor degradation without affecting its ubiquitination status. In the presence of ligand, diminished CXCR4 turnover is accompanied by receptor accumulation on enlarged early endosomes and leads to enhancement of phospho-ERK signaling. Perturbation in CXCR4 trafficking, resulting from USP8 inactivation, occurs at the ESCRT-0 checkpoint, and catalytic mutation of USP8 specifically targeted to the ESCRT-0 complex impairs the spatial and temporal organization of the sorting endosome. USP8 functionally opposes the ubiquitin ligase AIP4 with respect to ESCRT-0 ubiquitination, thereby promoting trafficking of CXCR4. Collectively, our findings demonstrate a functional cooperation between USP8, AIP4, and the ESCRT-0 machinery at the early sorting phase of CXCR4 and underscore the versatility of USP8 in shaping trafficking events at the early-to-late endosome transition.	[Berlin, Ilana; Higginbotham, Katherine M.; Dise, Rebecca S.; Sierra, Maria I.; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	pdnash@uchicago.edu			American Cancer Society, Illinois Division; Concern Foundation; V Foundation; Department of Defense; National Research Service	American Cancer Society, Illinois Division(American Cancer Society); Concern Foundation; V Foundation; Department of Defense(United States Department of Defense); National Research Service	This work was suported in part by grants from the American Cancer Society, Illinois Division, the Concern Foundation, and the V Foundation Scholars Program (to P. N.).; Recipient of a Department of Defense (Congressionally Directed Medical Research Programs) Breast Cancer pre-doctoral fellowship.; Recipient of a National Research Service Award pre-doctoral fellowship.	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Berruti G, 2005, BIOL REPROD, V72, P14, DOI 10.1095/biolreprod.104.030866; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kucia M, 2004, J MOL HISTOL, V35, P233; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	58	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37895	37908		10.1074/jbc.M110.129411	http://dx.doi.org/10.1074/jbc.M110.129411			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876529	hybrid, Green Published			2022-12-25	WOS:000284424000079
J	Ogunrinu, TA; Sontheimer, H				Ogunrinu, Toyin Adeyemi; Sontheimer, Harald			Hypoxia Increases the Dependence of Glioma Cells on Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE; MITOCHONDRIAL COMPLEX-III; HYDROGEN DONOR SYSTEM; PRIMARY BRAIN-TUMORS; NITRIC-OXIDE; OXIDATIVE STRESS; IN-VIVO; KAPPA-B; CYSTINE; OXYGEN	Glutathione (GSH) is an essential antioxidant responsible for the maintenance of intracellular redox homeostasis. As tumors outgrow their blood supply and become hypoxic, their redox homeostasis is challenged by the production of nitric oxide and reactive oxygen species (ROS). In gliomas, the sustained import of L-cystine via the L-cystine/L-glutamate exchanger, system xc(-), is rate-limiting for the synthesis of GSH. We show that hypoxia causes a significant increase in NO and ROS but without affecting glioma cell growth. This is explained by a concomitant increase in the utilization of GSH, which is accompanied by an increase in the cell-surface expression of xCT, the catalytic subunit of system xc(-), and L-cystine uptake. Growth was inhibited when GSH synthesis was blocked by buthionine sulfoximine (BSO), an inhibitor of the enzyme required for GSH synthesis, or when cells were deprived of L-cystine. These findings suggest that glioma cells show an increased requirement for GSH to maintain growth under hypoxic conditions. Therefore, approaches that limit GSH synthesis such as blocking system xc(-) may be considered as an adjuvant to radiation or chemotherapy.	[Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, 1719 6th Ave S,CIRC 410, Birmingham, AL 35294 USA.	sontheimer@uab.edu		Sontheimer, Harald/0000-0002-5843-9871	National Institutes of Health [RO1 NS052634, T32MH18882]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS052634 and T32MH18882.	ANDERSON ME, 1989, FASEB J, V3, P2527, DOI 10.1096/fasebj.3.13.2572501; Anderson MF, 2004, NEUROCHEM INT, V44, P153, DOI 10.1016/S0197-0186(03)00133-5; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BUMP EA, 1990, PHARMACOL THERAPEUT, V47, P117, DOI 10.1016/0163-7258(90)90048-7; BURK RF, 1983, BIOCHEM J, V215, P441, DOI 10.1042/bj2150441; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; CHO ES, 1984, J NUTR, V114, P1853, DOI 10.1093/jn/114.10.1853; CHO Y, 1990, J NEUROCHEM, V55, P2091, DOI 10.1111/j.1471-4159.1990.tb05800.x; Choi CH, 2009, J MAGN RESON, V198, P160, DOI 10.1016/j.jmr.2009.02.002; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Davis GDJ, 2009, CELL BIOL TOXICOL, V25, P331, DOI 10.1007/s10565-008-9087-5; Dirven HAAM, 1996, CHEM RES TOXICOL, V9, P351, DOI 10.1021/tx950143c; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Flynn J, 2000, NEUROCHEM INT, V36, P513, DOI 10.1016/S0197-0186(99)00151-5; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; GRIFFITH OW, 1978, P NATL ACAD SCI USA, V75, P5405, DOI 10.1073/pnas.75.11.5405; Guan J, 2009, CANCER CHEMOTH PHARM, V64, P463, DOI 10.1007/s00280-008-0894-4; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; KATO S, 1992, NEUROSCIENCE, V48, P903, DOI 10.1016/0306-4522(92)90278-A; Lakshmi VM, 2003, CHEM RES TOXICOL, V16, P367, DOI 10.1021/tx0200966; Liu RM, 1998, AM J PHYSIOL-LUNG C, V274, pL330, DOI 10.1152/ajplung.1998.274.3.L330; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; McBean G. J., 2001, BIOCHEM SOC T, V29, P6; MEISTER A, 1976, ANNU REV BIOCHEM, V45, P559, DOI 10.1146/annurev.bi.45.070176.003015; Na N, 2010, FASEB J, V24, P799, DOI 10.1096/fj.08-128967; Narang VS, 2007, CHEMOTHERAPY, V53, P210, DOI 10.1159/000100812; NORDSMARK M, 1994, ACTA ONCOL, V33, P383, DOI 10.3109/02841869409098433; Papandreou I, 2005, MUTAT RES-FUND MOL M, V569, P87, DOI 10.1016/j.mrfmmm.2004.06.054; RADI R, 1991, J BIOL CHEM, V266, P4244; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Schafer C, 2001, ACTA ONCOL, V40, P529, DOI 10.1080/028418601750288271; Schmidt C L, 1940, Science, V91, P18, DOI 10.1126/science.91.2349.18; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Terpstra M, 2003, MAGN RESON MED, V50, P19, DOI 10.1002/mrm.10499; WANG GL, 1993, J BIOL CHEM, V268, P21513; Yamamoto Y, 2006, CELL TISSUE RES, V325, P3, DOI 10.1007/s00441-006-0178-4; Yang J, 2008, FREE RADICAL RES, V42, P1, DOI 10.1080/10715760701762407; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; YUAN F, 1994, CANCER RES, V54, P4564; Zhang W, 2005, CANCER RES, V65, P1554, DOI 10.1158/0008-5472.CAN-04-1554	51	66	68	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37716	37724		10.1074/jbc.M110.161190	http://dx.doi.org/10.1074/jbc.M110.161190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858898	Green Published, hybrid			2022-12-25	WOS:000284424000063
J	Sadykov, MR; Zhang, B; Halouska, S; Nelson, JL; Kreimer, LW; Zhu, YF; Powers, R; Somerville, GA				Sadykov, Marat R.; Zhang, Bo; Halouska, Steven; Nelson, Jennifer L.; Kreimer, Lauren W.; Zhu, Yefei; Powers, Robert; Somerville, Greg A.			Using NMR Metabolomics to Investigate Tricarboxylic Acid Cycle-dependent Signal Transduction in Staphylococcus epidermidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR ADHESIN PRODUCTION; CARBON CATABOLITE REPRESSION; VIRULENCE GENE-EXPRESSION; BIOFILM FORMATION; BACILLUS-SUBTILIS; SIGMA(B) REGULON; IRON LIMITATION; SIGB OPERON; AUREUS; GROWTH	Staphylococcus epidermidis is a skin-resident bacterium and a major cause of biomaterial-associated infections. The transition from residing on the skin to residing on an implanted biomaterial is accompanied by regulatory changes that facilitate bacterial survival in the new environment. These regulatory changes are dependent upon the ability of bacteria to "sense" environmental changes. In S. epidermidis, disparate environmental signals can affect synthesis of the biofilm matrix polysaccharide intercellular adhesin (PIA). Previously, we demonstrated that PIA biosynthesis is regulated by tricarboxylic acid (TCA) cycle activity. The observations that very different environmental signals result in a common phenotype (i.e. increased PIA synthesis) and that TCA cycle activity regulates PIA biosynthesis led us to hypothesize that S. epidermidis is "sensing" disparate environmental signals through the modulation of TCA cycle activity. In this study, we used NMR metabolomics to demonstrate that divergent environmental signals are transduced into common metabolomic changes that are "sensed" by metabolite-responsive regulators, such as CcpA, to affect PIA biosynthesis. These data clarify one mechanism by which very different environmental signals cause common phenotypic changes. In addition, due to the frequency of the TCA cycle in diverse genera of bacteria and the intrinsic properties of TCA cycle enzymes, it is likely the TCA cycle acts as a signal transduction pathway in many bacteria.	[Sadykov, Marat R.; Nelson, Jennifer L.; Zhu, Yefei; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Zhang, Bo; Halouska, Steven; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Kreimer, Lauren W.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Powers, R (corresponding author), 722 Hamilton Hall, Lincoln, NE 68588 USA.	rpowers3@unl.edu; gsomerville3@unl.edu	Zhu, Yefei/F-8940-2013; Sadykov, Marat/H-3147-2011; Somerville, Greg A/B-1326-2013; Powers, Robert/AAK-3431-2020	Sadykov, Marat/0000-0001-7090-1929; Somerville, Greg A/0000-0002-0991-8737; Powers, Robert/0000-0001-9948-6837; Zhang, Bo/0000-0001-8858-1425	Hatch Act; National Institutes of Health [AI087668]; American Heart Association [0860033Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087668] Funding Source: NIH RePORTER	Hatch Act(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This manuscript is a contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act and from National Institutes of Health Grant AI087668 (to G. A. S.) and the American Heart Association Grant 0860033Z (to R. P.).	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DEIGHTON M, 1993, INFECT IMMUN, V61, P4473, DOI 10.1128/IAI.61.10.4473-4479.1993; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forgue P, 2006, J PROTEOME RES, V5, P1916, DOI 10.1021/pr060114v; Goddard T.D., SPARKY 3; Halouska S, 2006, J MAGN RESON, V178, P88, DOI 10.1016/j.jmr.2005.08.016; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Korem M, 2007, FEMS MICROBIOL LETT, V269, P153, DOI 10.1111/j.1574-6968.2006.00625.x; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Matinaho S, 2001, FEMS MICROBIOL LETT, V196, P177, DOI 10.1016/S0378-1097(01)00065-9; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014; Otzen DE, 2007, BIOCHEMISTRY-US, V46, P4348, DOI 10.1021/bi700091r; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Presterl E, 2007, J ANTIMICROB CHEMOTH, V60, P417, DOI 10.1093/jac/dkm221; Retief J D, 2000, Methods Mol Biol, V132, P243; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379; Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	71	38	38	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36616	36624		10.1074/jbc.M110.152843	http://dx.doi.org/10.1074/jbc.M110.152843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861019	Green Published, hybrid			2022-12-25	WOS:000284146100050
J	Lahnalampi, M; Heinaniemi, M; Sinkkonen, L; Wabitsch, M; Carlberg, C				Lahnalampi, Mari; Heinaeniemi, Merja; Sinkkonen, Lasse; Wabitsch, Martin; Carlberg, Carsten			Time-Resolved Expression Profiling of the Nuclear Receptor Superfamily in Human Adipogenesis	PLOS ONE			English	Article							REV-ERB-ALPHA; PERIPHERAL CIRCADIAN CLOCKS; GLUCOCORTICOID-RECEPTOR; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR; GENE-EXPRESSION; INHIBITION; CELLS; IDENTIFICATION	Background: The differentiation of fibroblast-like pre-adipocytes to lipid-loaded adipocytes is regulated by a network of transcription factors, the most prominent one being the nuclear receptor peroxisome proliferator-activated receptor (PPAR) c. However, many of the other 47 members of the nuclear receptor superfamily have an impact on adipogenesis, which in human cells has not been investigated in detail. Methodology/Principal Findings: We analyzed by quantitative PCR all human nuclear receptors at multiple time points during differentiation of SGBS pre-adipocytes. The earliest effect was the down-regulation of the genes RARG, PPARD, REV-ERBA, REV-ERBB, VDR and GR followed by the up-regulation of PPARG, LXRA and AR. These observations are supported with data from 3T3-L1 mouse pre-adipocytes and primary human adipocytes. Investigation of the effects of the individual differentiation mix components in short-term treatments and of their omission from the full mix showed that the expression levels of the early-regulated nuclear receptor genes were most affected by the glucocorticoid receptor (GR) ligand cortisol and the phosophodiesterase inhibitor IBMX. Interestingly, the effects of both compounds converged to repress the genes PPARD, REV-ERBA, REV-ERBB, VDR and GR, whereas cortisol and IBMX showed antagonistic interaction for PPARG, LXRA and AR causing a time lag in their up-regulation. We hypothesize that the well-known auto-repression of GR fine-tunes the detected early responses. Consistently, chromatin immunoprecipitation experiments showed that GR association increased on the transcription start sites of the genes RARG, REV-ERBB, VDR and GR. Conclusions/Significance: Adipocyte differentiation is a process, in which many members of the nuclear receptor superfamily change their mRNA expression. The actions of cortisol and IBMX converged to repress several nuclear receptors early in differentiation, while up-regulation of other nuclear receptor genes showed a time lag due to antagonisms of the signals. Our results place GR and its ligand cortisol as central regulatory factors controlling early regulatory events in human adipogenesis that precedes the regulation of the later events by PPARG.	[Lahnalampi, Mari; Carlberg, Carsten] Univ Eastern Finland, Dept Biosci, Kuopio, Finland; [Heinaeniemi, Merja; Sinkkonen, Lasse; Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany	University of Eastern Finland; University of Luxembourg; Ulm University	Lahnalampi, M (corresponding author), Univ Eastern Finland, Dept Biosci, Kuopio, Finland.	carsten.carlberg@uni.lu	Sinkkonen, Lasse/AAL-7906-2021; Heinaniemi, Merja/AAS-4530-2020; Heinäniemi, Merja/C-5051-2014; Carlberg, Carsten/C-9075-2011	Sinkkonen, Lasse/0000-0002-4223-3027; Heinaniemi, Merja/0000-0001-6190-3439; Heinäniemi, Merja/0000-0001-6190-3439; Carlberg, Carsten/0000-0003-2633-0684	University of Luxembourg; Luxembourgish Research Foundation FNR; Academy of Finland; Juselius Foundation	University of Luxembourg; Luxembourgish Research Foundation FNR(Luxembourg National Research Fund); Academy of Finland(Academy of Finland); Juselius Foundation	Grants from the University of Luxembourg, the Luxembourgish Research Foundation FNR, the Academy of Finland and the Juselius Foundation supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Auwerx J, 1999, CELL, V97, P161; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Blouin K, 2009, MOL CELL ENDOCRINOL, V301, P97, DOI 10.1016/j.mce.2008.10.035; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRENTANI MM, 1986, HORM RES, V24, P9, DOI 10.1159/000180534; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cermakian N, 2009, OBES REV, V10, P25, DOI 10.1111/j.1467-789X.2009.00660.x; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CIDLOWSKI JA, 1981, ENDOCRINOLOGY, V109, P1975; Diamant M, 2003, DRUGS, V63, P1373, DOI 10.2165/00003495-200363130-00004; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elgadi A, 2010, BIOCHEM BIOPH RES CO, V393, P526, DOI 10.1016/j.bbrc.2010.02.042; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Fumoto T, 2007, J BIOCHEM, V141, P181, DOI 10.1093/jb/mvm018; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Maglich JM, 2001, GENOME BIOL, V2; Matsusue K, 2004, FASEB J, V18, P1477, DOI 10.1096/fj.04-1944fje; Mishra A, 2010, J MOL ENDOCRINOL, V44, P247, DOI 10.1677/JME-09-0137; Mohan R, 2003, CURR TOP MED CHEM, V3, P1637, DOI 10.2174/1568026033451709; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SCHLECHTE JA, 1982, J STEROID BIOCHEM, V16, P69, DOI 10.1016/0022-4731(82)90145-5; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12991	10.1371/journal.pone.0012991	http://dx.doi.org/10.1371/journal.pone.0012991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885999	Green Submitted, Green Published, gold			2022-12-25	WOS:000282167100006
J	James, MH; Charnley, JL; Jones, E; Levi, EM; Yeoh, JW; Flynn, JR; Smith, DW; Dayas, CV				James, Morgan H.; Charnley, Janine L.; Jones, Emma; Levi, Emily M.; Yeoh, Jiann Wei; Flynn, Jamie R.; Smith, Douglas W.; Dayas, Christopher V.			Cocaine- and Amphetamine-Regulated Transcript (CART) Signaling within the Paraventricular Thalamus Modulates Cocaine-Seeking Behaviour	PLOS ONE			English	Article							CONTEXT-INDUCED REINSTATEMENT; CONDITIONED PLACE PREFERENCE; INDUCED LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS SHELL; PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; HYPOTHALAMIC CART; REWARD SEEKING; PEPTIDE 55-102; RAT	Background: Cocaine- and amphetamine-regulated transcript (CART) has been demonstrated to play a role in regulating the rewarding and reinforcing effects of various drugs of abuse. A recent study demonstrated that i.c.v. administration of CART negatively modulates reinstatement of alcohol seeking, however, the site(s) of action remains unclear. We investigated the paraventricular thalamus (PVT) as a potential site of relapse-relevant CART signaling, as this region is known to receive dense innervation from CART-containing hypothalamic cells and to project to a number of regions known to be involved in mediating reinstatement, including the nucleus accumbens (NAC), medial prefrontal cortex (mPFC) and basolateral amygdala (BLA). Methodology/Principal Findings: Male rats were trained to self-administer cocaine before being extinguished to a set criterion. One day following extinction, animals received intra-PVT infusions of saline, tetrodotoxin (TTX; 2.5 ng), CART (0.625 mg or 2.5 mg) or no injection, followed by a cocaine prime (10 mg/kg, i.p.). Animals were then tested under extinction conditions for one hour. Treatment with either TTX or CART resulted in a significant attenuation of drug-seeking behaviour following cocaine-prime, with the 2.5 mg dose of CART having the greatest effect. This effect was specific to the PVT region, as misplaced injections of both TTX and CART resulted in responding that was identical to controls. Conclusions/Significance: We show for the first time that CART signaling within the PVT acts to inhibit drug-primed reinstatement of cocaine seeking behaviour, presumably by negatively modulating PVT efferents that are important for drug seeking, including the NAC, mPFC and BLA. In this way, we identify a possible target for future pharmacological interventions designed to suppress drug seeking.	[James, Morgan H.] Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2308, Australia; Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2308, Australia; Hunter Med Res Inst, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	James, MH (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2308, Australia.	Christopher.Dayas@newcastle.edu.au	Smith, Doug/ABC-3773-2021; Dayas, Chris/ABE-9173-2020; James, Morgan/AEM-8428-2022; Dayas, Chris/C-2158-2009	James, Morgan/0000-0001-9298-8607; Dayas, Christopher/0000-0002-9175-3854; Smith, Doug/0000-0002-4406-8061; Flynn, Jamie/0000-0002-3429-9421; Yeoh, Jiann Wei/0000-0001-8746-3769	National Health and Medical Research Council of Australia; Hunter Medical Research Institute	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute	This work was supported by project grants from the National Health and Medical Research Council of Australia and the Hunter Medical Research Institute to C. V. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P1452, DOI 10.1038/sj.npp.1300922; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; Bubser M, 1998, BRAIN RES, V787, P304, DOI 10.1016/S0006-8993(97)01373-5; CAINE B, 1992, BEHAV NEUROSCIENCE P, P117; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CORNWALL J, 1988, BRAIN RES BULL, V21, P147, DOI 10.1016/0361-9230(88)90227-4; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; Davidowa H, 2005, NEUROENDOCRINOL LETT, V26, P29; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; Dayas CV, 2007, BIOL PSYCHIAT, V61, P979, DOI 10.1016/j.biopsych.2006.07.034; DONG WK, 1978, J NEUROPHYSIOL, V41, P1592, DOI 10.1152/jn.1978.41.6.1592; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Fuchs RA, 2008, PSYCHOPHARMACOLOGY, V200, P545, DOI 10.1007/s00213-008-1234-4; Ghitza UE, 2003, J NEUROSCI, V23, P7239; GIESLER GJ, 1981, J COMP NEUROL, V195, P243, DOI 10.1002/cne.901950205; Hamlin AS, 2009, EUR J NEUROSCI, V29, P802, DOI 10.1111/j.1460-9568.2009.06623.x; Huang H, 2006, J NEUROPHYSIOL, V95, P1656, DOI 10.1152/jn.00927.2005; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; HUBERT GW, 2007, BIOCH PHARM; Jaworski JN, 2007, NEUROPEPTIDES, V41, P65, DOI 10.1016/j.npep.2006.12.003; Jaworski JN, 2003, J PHARMACOL EXP THER, V307, P1038, DOI 10.1124/jpet.103.052332; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kim JH, 2003, NEUROPEPTIDES, V37, P369, DOI 10.1016/j.npep.2003.10.001; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; King BJ, 2010, BEHAV NEUROSCI, V124, P423, DOI 10.1037/a0019540; Kirouac GJ, 2006, J COMP NEUROL, V497, P155, DOI 10.1002/cne.20971; Kirouac GJ, 2005, BRAIN RES, V1059, P179, DOI 10.1016/j.brainres.2005.08.035; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Nakahara K, 2004, J VET MED SCI, V66, P1297, DOI 10.1292/jvms.66.1297; Otake K, 1998, NEUROSCIENCE, V86, P635, DOI 10.1016/S0306-4522(98)00062-1; Parsons MP, 2007, J COMP NEUROL, V500, P1050, DOI 10.1002/cne.21224; Parsons MP, 2006, SYNAPSE, V59, P480, DOI 10.1002/syn.20264; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pinto A, 2003, J COMP NEUROL, V459, P142, DOI 10.1002/cne.10596; Rademacher DJ, 2010, PSYCHOPHARMACOLOGY, V208, P499, DOI 10.1007/s00213-009-1748-4; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Spencer SJ, 2004, BRAIN RES, V997, P234, DOI 10.1016/j.brainres.2003.10.054; Vertes RP, 2008, J COMP NEUROL, V508, P212, DOI 10.1002/cne.21679; Yoon HS, 2010, BEHAV BRAIN RES, V207, P169, DOI 10.1016/j.bbr.2009.10.003; Young CD, 1998, PHARMACOL BIOCHEM BE, V60, P753, DOI 10.1016/S0091-3057(98)00051-3	44	87	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12980	10.1371/journal.pone.0012980	http://dx.doi.org/10.1371/journal.pone.0012980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886038	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100061
J	Kil, DY; Boler, BMV; Apanavicius, CJ; Schook, LB; Swanson, KS				Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.			Gene Expression Profiles of Colonic Mucosa in Healthy Young Adult and Senior Dogs	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; GLUCAGON-LIKE PEPTIDE-1; NITRIC-OXIDE; MICROARRAY ANALYSIS; PROTEIN; DIET; AGE; METASTASIS; METABOLISM; PHOSPHORYLATION	Background: We have previously reported the effects of age and diet on nutrient digestibility, intestinal morphology, and large intestinal fermentation patterns in healthy young adult and senior dogs. However, a genome-wide molecular analysis of colonic mucosa as a function of age and diet has not yet been performed in dogs. Methodology/Principal Findings: Colonic mucosa samples were collected from six senior (12-year old) and six young adult (1-year old) female beagles fed one of two diets (animal protein-based vs. plant protein-based) for 12 months. Total RNA in colonic mucosa was extracted and hybridized to Affymetrix GeneChip (R) Canine Genome Arrays. Results indicated that the majority of gene expression changes were due to age (212 genes) rather than diet (66 genes). In particular, the colonic mucosa of senior dogs had increased expression of genes associated with cell proliferation, inflammation, stress response, and cellular metabolism, whereas the expression of genes associated with apoptosis and defensive mechanisms were decreased in senior vs. young adult dogs. No consistent diet-induced alterations in gene expression existed in both age groups, with the effects of diet being more pronounced in senior dogs than in young adult dogs. Conclusion: Our results provide molecular insight pertaining to the aged canine colon and its predisposition to dysfunction and disease. Therefore, our data may aid in future research pertaining to age-associated gastrointestinal physiological changes and highlight potential targets for dietary intervention to limit their progression.	[Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kil, DY (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Swanson, Kelly/0000-0001-5518-3076; Schook, Lawrence/0000-0002-6580-8364	Pyxis Genomics, Inc., Chicago, Illinois; National Center for Supercomputing Applications; University of Illinois under NCSA/UIUC	Pyxis Genomics, Inc., Chicago, Illinois; National Center for Supercomputing Applications; University of Illinois under NCSA/UIUC	This research was supported by Pyxis Genomics, Inc., Chicago, Illinois, and the National Center for Supercomputing Applications and the University of Illinois, under the auspices of the NCSA/UIUC Faculty Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAFCO, 2004, OFF PUBL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang WJ, 2009, INT J CANCER, V125, P2844, DOI 10.1002/ijc.24699; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206; Commane DM, 2009, WORLD J GASTROENTERO, V15, P2479, DOI 10.3748/wjg.15.2479; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Eklof V, 2008, SCAND J CLIN LAB INV, V68, P393, DOI 10.1080/00365510701805431; Fitch MD, 1999, AM J PHYSIOL-GASTR L, V277, pG31, DOI 10.1152/ajpgi.1999.277.1.G31; Gamlem H, 2008, APMIS, V116, P5, DOI 10.1111/j.1600-0463.2008.125m2.x; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; Hameed S, 2009, ORAL DIS, V15, P18, DOI 10.1111/j.1601-0825.2008.01492.x; Harding MA, 2007, UROL ONCOL-SEMIN ORI, V25, P401, DOI 10.1016/j.urolonc.2007.05.006; Henderson B, 2010, CELL BIOCHEM FUNCT, V28, P1, DOI 10.1002/cbf.1609; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoops TC, 1997, HEMATOL ONCOL CLIN N, V11, P609, DOI 10.1016/S0889-8588(05)70453-6; Hunt ND, 2006, AGEING RES REV, V5, P125, DOI 10.1016/j.arr.2006.03.006; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; JAMES SP, 1993, DIGEST DIS, V11, P146, DOI 10.1159/000171407; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; Keklikoglu N, 2008, DIGEST DIS SCI, V53, P1437, DOI 10.1007/s10620-007-0061-5; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kiyokawa N, 2004, MODERN PATHOL, V17, P423, DOI 10.1038/modpathol.3800079; Kleinschmidt S, 2008, RES VET SCI, V84, P41, DOI 10.1016/j.rvsc.2007.03.009; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee DM, 2009, ASIAN AUSTRAL J ANIM, V22, P1091, DOI 10.5713/ajas.2009.90009; Lee HM, 2001, MECH AGEING DEV, V122, P355, DOI 10.1016/S0047-6374(00)00254-2; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Lefevre M, 2008, METABOLISM, V57, pS52, DOI 10.1016/j.metabol.2008.03.005; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; LUK GD, 1990, BIOCHEM SOC T, V18, P1090, DOI 10.1042/bst0181090; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Middelbos IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004481; Mollenhauer J, 2002, CANCER DETECT PREV, V26, P266, DOI 10.1016/S0361-090X(02)00094-6; Mori M, 1999, BRIT J CANCER, V79, P211, DOI 10.1038/sj.bjc.6690035; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Notterman DA, 2001, CANCER RES, V61, P3124; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pool-Zobel B, 2005, MUTAT RES-FUND MOL M, V591, P74, DOI 10.1016/j.mrfmmm.2005.04.020; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263; Saksena S, 2009, AM J PHYSIOL-GASTR L, V297, pG878, DOI 10.1152/ajpgi.00283.2009; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; SCHJOLDAGER BTG, 1989, DIGEST DIS SCI, V34, P703, DOI 10.1007/BF01540341; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Smyth G., 2004, LINEAR MODELS EMPIRI; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Swanson KS, 2009, NEUROBIOL AGING, V30, P1314, DOI 10.1016/j.neurobiolaging.2007.10.017; Swanson KS, 2009, ARCH ANIM NUTR, V63, P160, DOI 10.1080/17450390902733934; Swanson KS, 2004, J ANIM SCI, V82, P1713; Swanson KS, 2003, J NUTR, V133, P3033, DOI 10.1093/jn/133.10.3033; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tulassay Z, 1998, SCAND J GASTROENTERO, V33, P115, DOI 10.1080/003655298750026642; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Vester BM, 2009, BRIT J NUTR, V102, P1136, DOI 10.1017/S0007114509371652; VOGEL VG, 1989, HEMATOL ONCOL CLIN N, V3, P35, DOI 10.1016/S0889-8588(18)30566-5; Voutsadakis IA, 2008, BBA-MOL BASIS DIS, V1782, P800, DOI 10.1016/j.bbadis.2008.06.007; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005; Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Wu CC, 2006, EUR J CANCER, V42, P557, DOI 10.1016/j.ejca.2005.11.015; Xie D, 2001, CANCER RES, V61, P8917; XU LL, 1995, J IMMUNOL, V155, P1184; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang GY, 2009, METHODS MOL BIOL, V512, P119, DOI 10.1007/978-1-60327-530-9_8; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	82	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12882	10.1371/journal.pone.0012882	http://dx.doi.org/10.1371/journal.pone.0012882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877568	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100027
J	Li, LC; Preuss, TM; Rilling, JK; Hopkins, WD; Glasser, MF; Kumar, B; Nana, R; Zhang, XD; Hu, XP				Li, Longchuan; Preuss, Todd M.; Rilling, James K.; Hopkins, William D.; Glasser, Matthew F.; Kumar, Bhargav; Nana, Roger; Zhang, Xiaodong; Hu, Xiaoping			Chimpanzee (Pan troglodytes) Precentral Corticospinal System Asymmetry and Handedness: A Diffusion Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; COORDINATED BIMANUAL TASK; ECHO-PLANAR IMAGES; WHITE-MATTER; TOOL-USE; HUMAN BRAIN; SPATIAL STATISTICS; WILD CHIMPANZEES; HAND PREFERENCES; STRUCTURAL ASYMMETRIES	Background: Most humans are right handed, and most humans exhibit left-right asymmetries of the precentral corticospinal system. Recent studies indicate that chimpanzees also show a population-level right-handed bias, although it is less strong than in humans. Methodology/Principal Findings: We used in vivo diffusion-weighted and T1-weighted magnetic resonance imaging (MRI) to study the relationship between the corticospinal tract (CST) and handedness in 36 adult female chimpanzees. Chimpanzees exhibited a hemispheric bias in fractional anisotropy (FA, left. right) and mean diffusivity (MD, right. left) of the CST, and the left CST was centered more posteriorly than the right. Handedness correlated with central sulcus depth, but not with FA or MD. Conclusions/Significance: These anatomical results are qualitatively similar to those reported in humans, despite the differences in handedness. The existence of a left. right FA, right. left MD bias in the corticospinal tract that does not correlate with handedness, a result also reported in some human studies, suggests that at least some of the structural asymmetries of the corticospinal system are not exclusively related to laterality of hand preference.	[Li, Longchuan; Hu, Xiaoping] Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA; [Preuss, Todd M.; Zhang, Xiaodong] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA USA; [Preuss, Todd M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Preuss, Todd M.; Rilling, James K.] Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Rilling, James K.; Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA; [Rilling, James K.; Glasser, Matthew F.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Rilling, James K.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Kumar, Bhargav; Nana, Roger; Hu, Xiaoping] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Li, LC (corresponding author), Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA.	xhu3@emory.edu	Preuss, Todd/GSI-6571-2022; Glasser, Matthew Frederick/AAE-7291-2019; Li, Longchuan/C-7619-2012	Li, Longchuan/0000-0002-0559-0754; Hu, Xiaoping/0000-0001-7014-5983	National Institutes of Health [5P01 AG026423-03, NS-42867, HD-56232]; Yerkes National Primate Research Center [RR-00165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056232] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was kindly supported by the National Institutes of Health (http://www.nih.gov/; 5P01 AG026423-03, NS-42867 and HD-56232) and Yerkes National Primate Research Center (http://www.yerkes.emory.edu/; RR-00165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, NMR BIOMED, V17, P411, DOI 10.1002/nbm.907; Alexander AL, 1997, MAGN RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Annett M, 2004, BRIT J PSYCHOL, V95, P339, DOI 10.1348/0007126041528130; Annett M, 1996, NEUROSCI BIOBEHAV R, V20, P631, DOI 10.1016/0149-7634(95)00076-3; Annett M, 2002, HANDEDNESS BRAIN ASY; Bailey P, 1950, ISOCORTEX CHIMPANZEE; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Bradshaw John., 1998, HUMAN EVOLUTION NEUR; Bril B, 2009, ANIM COGN, V12, P217, DOI 10.1007/s10071-008-0184-x; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; BYRNE RW, 1991, CORTEX, V27, P521, DOI 10.1016/S0010-9452(13)80003-2; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Corballis M. C, 1992, LOPSIDED BRAIN EVOLU; Corp N, 2004, AM J PHYS ANTHROPOL, V123, P62, DOI 10.1002/ajpa.10218; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Dubois J, 2010, NEUROIMAGE, V52, P32, DOI 10.1016/j.neuroimage.2010.03.054; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; EBELING U, 1992, ACTA NEUROCHIR, V118, P164, DOI 10.1007/BF01401303; Foundas AL, 1998, NEUROPSY NEUROPSY BE, V11, P65; Frey SH, 2005, J COGNITIVE NEUROSCI, V17, P262, DOI 10.1162/0898929053124974; Gong GL, 2005, NEUROREPORT, V16, P1701, DOI 10.1097/01.wnr.0000183327.98370.6a; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; Herve PY, 2009, HUM BRAIN MAPP, V30, P3151, DOI 10.1002/hbm.20734; Hopkins W. D., 2007, EVOLUTIONARY COGNITI, P99; Hopkins WD, 2005, LATERALITY, V10, P121, DOI 10.1080/13576500342000347; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P659, DOI 10.1037/0735-7044.118.3.659; Hopkins WD, 2003, AM J PHYS ANTHROPOL, V121, P378, DOI 10.1002/ajpa.10170; Hopkins WD, 2001, J COMP PSYCHOL, V115, P294, DOI 10.1037/0735-7036.115.3.294; HOPKINS WD, 1995, J COMP PSYCHOL, V109, P291, DOI 10.1037/0735-7036.109.3.291; Hopkins WD, 2007, PSYCHOL SCI, V18, P971, DOI 10.1111/j.1467-9280.2007.02011.x; Hopkins WD, 2007, EUR J NEUROSCI, V25, P2565, DOI 10.1111/j.1460-9568.2007.05502.x; Hopkins WD, 2006, PSYCHOL BULL, V132, P538, DOI 10.1037/0033-2909.132.4.538; Humle T, 2009, AM J PRIMATOL, V71, P40, DOI 10.1002/ajp.20616; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; KERTESZ A, 1971, ARCH NEUROL-CHICAGO, V24, P326, DOI 10.1001/archneur.1971.00480340058006; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Kumar A, 2009, AM J NEURORADIOL, V30, P1963, DOI 10.3174/ajnr.A1742; Li LC, 2009, HUM BRAIN MAPP, V30, P3265, DOI 10.1002/hbm.20747; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Marchant LF, 2007, PRIMATES, V48, P22, DOI 10.1007/s10329-006-0020-3; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; MCMANUS C, 2002, RIGHT HAND LEFT HAND; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; Nagae-Poetscher LM, 2004, AM J NEURORADIOL, V25, P1325; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenhuys R, 2007, HUMAN CENTRAL NERVOU; Okada T, 2006, RADIOLOGY, V240, P849, DOI 10.1148/radiol.2403050916; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Porac C, 1981, LATERAL PREFERENCES; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Rogers LJ., 2002, COMP VERTEBRATE LATE; Schmahmann JD, 2004, J COMP NEUROL, V478, P248, DOI 10.1002/cne.20286; Sherwood CC, 2003, ANAT REC PART A, V271A, P276, DOI 10.1002/ar.a.10046; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Taglialatela JP, 2006, NEUROREPORT, V17, P923, DOI 10.1097/01.wnr.0000221835.26093.5e; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; WARREN JM, 1980, PHYSIOL PSYCHOL, V8, P351, DOI 10.3758/BF03337470; Westerhausen R, 2007, NEUROIMAGE, V37, P379, DOI 10.1016/j.neuroimage.2007.05.047; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	99	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12886	10.1371/journal.pone.0012886	http://dx.doi.org/10.1371/journal.pone.0012886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877630	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900018
J	Lefevre, L; Gales, A; Olagnier, D; Bernad, J; Perez, L; Burcelin, R; Valentin, A; Auwerx, J; Pipy, B; Coste, A				Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Perez, Laurence; Burcelin, Remy; Valentin, Alexis; Auwerx, Johan; Pipy, Bernard; Coste, Agnes			PPAR gamma Ligands Switched High Fat Diet-Induced Macrophage M2b Polarization toward M2a Thereby Improving Intestinal Candida Elimination	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIABETIC-PATIENTS; GENE-EXPRESSION; OBESITY; TOLL-LIKE-RECEPTOR-4; INDUCTION; PHENOTYPE; IMMUNITY	Obesity is associated with a chronic low-grade inflammation that predisposes to insulin resistance and the development of type 2 diabetes. In this metabolic context, gastrointestinal (GI) candidiasis is common. We recently demonstrated that the PPAR gamma ligand rosiglitazone promotes the clearance of Candida albicans through the activation of alternative M2 macrophage polarization. Here, we evaluated the impact of high fat diet (HFD)-induced obesity and the effect of rosiglitazone (PPAR gamma ligand) or WY14643 (PPAR alpha ligand) both on the phenotypic M1/M2 polarization of peritoneal and cecal tissue macrophages and on the outcome of GI candidiasis. We demonstrated that the peritoneal macrophages and the cell types present in the cecal tissue from HF fed mice present a M2b polarization (TNF-alpha(high), IL-10(high), MR, Dectin-1). Interestingly, rosiglitazone induces a phenotypic M2b-to-M2a (TNF-alpha(low), IL-10(low), MRhigh, Dectin-1(high)) switch of peritoneal macrophages and of the cells present in the cecal tissue. The incapacity of WY14643 to switch this polarization toward M2a state, strongly suggests the specific involvement of PPAR gamma in this mechanism. We showed that in insulin resistant mice, M2b polarization of macrophages present on the site of infection is associated with an increased susceptibility to GI candidiasis, whereas M2a polarization after rosiglitazone treatment favours the GI fungal elimination independently of reduced blood glucose. In conclusion, our data demonstrate a dual benefit of PPAR gamma ligands because they promote mucosal defence mechanisms against GI candidiasis through M2a macrophage polarization while regulating blood glucose level.	[Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Valentin, Alexis; Pipy, Bernard; Coste, Agnes] Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Pathol In, UMR MD3, EA2405, F-31062 Toulouse, France; [Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Valentin, Alexis; Pipy, Bernard; Coste, Agnes] Univ Mediterranee, Minist Defense, UMR MD3, RH2PT, Marseille, France; [Perez, Laurence; Burcelin, Remy] Rangueil Inst Mol Med, INSERM, U858, IFR31,I2MR, Toulouse, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol LISP, Lausanne, Switzerland	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lefevre, L (corresponding author), Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Pathol In, UMR MD3, EA2405, F-31062 Toulouse, France.	agnes.coste@cict.fr	Agnès, Coste/AAK-9408-2020; Galès, Amandine/M-9066-2014; è-, ä/F-9947-2012; Valentin, Alexis/I-6821-2015; Auwerx, Johan/ABE-9307-2021; burcelin, remy/M-6013-2014	Valentin, Alexis/0000-0002-2133-112X; Pipy, Bernard/0000-0001-8060-7029; Auwerx, Johan/0000-0002-5065-5393; Lefevre, Lise/0000-0003-0237-6696; Coste, Agnes/0000-0001-7781-3323; Olagnier, David/0000-0001-6912-0674	Region Midi-Pyrenees [07005642]; Paul Sabatier Toulouse 3 University	Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Paul Sabatier Toulouse 3 University	This work was supported by the Region Midi-Pyrenees grants (number: 07005642) and by Paul Sabatier Toulouse 3 University institutional funds (URL: http://www.ups-tlse.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no financial interest in this manuscript.	Aleshin S, 2009, MOL PHARMACOL, V76, P414, DOI 10.1124/mol.109.056010; Belazi M, 2005, MYCOSES, V48, P192, DOI 10.1111/j.1439-0507.2005.01124.x; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Caimi G, 2003, ACTA DIABETOL, V40, P14, DOI 10.1007/s005920300003; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; Cho HY, 2010, AM J RESP CRIT CARE, V181; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; Coste A, 2002, J ANTIMICROB CHEMOTH, V49, P731, DOI 10.1093/jac/dkf011; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Fernandes-Santos C, 2009, NUTRITION, V25, P818, DOI 10.1016/j.nut.2008.12.010; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Greenfield JR, 2006, CURR DIABETES REV, V2, P195, DOI 10.2174/157339906776818532; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Khovidhunkit Siribang-on Piboonniyom, 2009, Journal of the Medical Association of Thailand, V92, P1220; Kim H, 2004, DIABETOLOGIA, V47, P2215, DOI 10.1007/s00125-004-1581-6; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Ma XW, 2009, CHINESE MED J-PEKING, V122, P2123, DOI 10.3760/cma.j.issn.0366-6999.2009.18.009; MACEDO DP, 2010, MED MYCOL, P1; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Soysa NS, 2006, DIABETIC MED, V23, P455, DOI 10.1111/j.1464-5491.2005.01701.x; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Viswanathan V, 2002, J Assoc Physicians India, V50, P1013; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632; Zhou JM, 2002, BIOCHEM BIOPH RES CO, V293, P274, DOI 10.1016/S0006-291X(02)00138-9; Zhou M, 2008, AM J PHYSIOL-REG I, V294, pR84, DOI 10.1152/ajpregu.00340.2007	39	60	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12828	10.1371/journal.pone.0012828	http://dx.doi.org/10.1371/journal.pone.0012828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877467	Green Published, gold, Green Submitted			2022-12-25	WOS:000281963200010
J	Thaker, M; Vanak, AT; Owen, CR; Ogden, MB; Slotow, R				Thaker, Maria; Vanak, Abi T.; Owen, Cailey R.; Ogden, Monika B.; Slotow, Rob			Group Dynamics of Zebra and Wildebeest in a Woodland Savanna: Effects of Predation Risk and Habitat Density	PLOS ONE			English	Article							LIONS PANTHERA-LEO; GROUP-SIZE; MAMMALIAN HERBIVORES; HUNTING SUCCESS; PREY; MECHANISMS; SELECTION; BEHAVIOR; CHOICE	Background: Group dynamics of gregarious ungulates in the grasslands of the African savanna have been well studied, but the trade-offs that affect grouping of these ungulates in woodland habitats or dense vegetation are less well understood. We examined the landscape-level distribution of groups of blue wildebeest, Connochaetes taurinus, and Burchell's zebra, Equus burchelli, in a predominantly woodland area (Karongwe Game Reserve, South Africa; KGR) to test the hypothesis that group dynamics are a function of minimizing predation risk from their primary predator, lion, Panthera leo. Methodology/Principal Findings: Using generalized linear models, we examined the relative importance of habitat type (differing in vegetation density), probability of encountering lion (based on utilization distribution of all individual lions in the reserve), and season in predicting group size and composition. We found that only in open scrub habitat, group size for both ungulate species increased with the probability of encountering lion. Group composition differed between the two species and was driven by habitat selection as well as predation risk. For both species, composition of groups was, however, dominated by males in open scrub habitats, irrespective of the probability of encountering lion. Conclusions/Significance: Distribution patterns of wildebeest and zebra groups at the landscape level directly support the theoretical and empirical evidence from a range of taxa predicting that grouping is favored in open habitats and when predation risk is high. Group composition reflected species-specific social, physiological and foraging constraints, as well as the importance of predation risk. Avoidance of high resource open scrub habitat by females can lead to loss of foraging opportunities, which can be particularly costly in areas such as KGR, where this resource is limited. Thus, landscape-level grouping dynamics are species specific and particular to the composition of the group, arising from a tradeoff between maximizing resource selection and minimizing predation risk.	[Thaker, Maria; Vanak, Abi T.; Owen, Cailey R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa; [Owen, Cailey R.; Ogden, Monika B.] Karongwe Ecol Res Inst, Schagen, South Africa	University of Kwazulu Natal	Thaker, M (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa.	thaker@ukzn.ac.za	Slotow, Rob/AAM-9053-2020; Vanak, Abi/F-8519-2010	Vanak, Abi/0000-0003-2435-4260; Slotow, Rob/0000-0001-9469-1508; Thaker, Maria/0000-0001-6019-2639	Landowners of Karongwe Game Reserve; Global Vision International, University of KwaZulu-Natal (UKZN); National Research Foundation [2069358]; University of KwaZulu-Natal (UKZN)	Landowners of Karongwe Game Reserve; Global Vision International, University of KwaZulu-Natal (UKZN); National Research Foundation; University of KwaZulu-Natal (UKZN)	This project was funded by the landowners of Karongwe Game Reserve, and grants from Global Vision International, University of KwaZulu-Natal (UKZN), and the National Research Foundation (to RS, 2069358). ATV and MT were supported by postdoctoral fellowships from UKZN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Cherry S, 1996, J WILDLIFE MANAGE, V60, P653, DOI 10.2307/3802084; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Cresswell W, 2004, OIKOS, V104, P71, DOI 10.1111/j.0030-1299.2004.12814.x; Ebensperger LA, 2002, OIKOS, V98, P491, DOI 10.1034/j.1600-0706.2002.980313.x; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fernandez-Juricic E, 2006, ANIM BEHAV, V71, P901, DOI 10.1016/j.anbehav.2005.09.008; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; FRYXELL JM, 1995, SERENGETI, V2, P257; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; HIRST SM, 1969, J WILDLIFE MANAGE, V33, P40, DOI 10.2307/3799648; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Krause J, 2000, P ROY SOC B-BIOL SCI, V267, P2011, DOI 10.1098/rspb.2000.1243; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; Krause J, 2002, LIVING GROUPS; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Lehmann MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003998; Lett C, 2004, THEOR POPUL BIOL, V65, P263, DOI 10.1016/j.tpb.2003.10.005; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Molinari-Jobin A, 2004, ECOGRAPHY, V27, P323, DOI 10.1111/j.0906-7590.2004.03862.x; Mucina L., 2006, VEGETATION S AFRICA; Neuhaus P, 2002, CAN J ZOOL, V80, P1437, DOI 10.1139/Z02-126; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; PARRISH JK, 1993, ETHOLOGY, V95, P233; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Ranta Esa, 1994, Ecoscience, V1, P99; Redfern JV, 2006, OECOLOGIA, V146, P632, DOI 10.1007/s00442-005-0235-9; RODGERS AR, 2007, HRT HOME RANGE TOOLS; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Spieler M, 2003, ANIM BEHAV, V65, P179, DOI 10.1006/anbe.2002.2030; THAKER M, ECOLOGY IN PRESS, DOI DOI 10.1890/1810-0126.1891; Valeix M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1483, DOI 10.1007/s00265-009-0760-3	45	39	39	5	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12758	10.1371/journal.pone.0012758	http://dx.doi.org/10.1371/journal.pone.0012758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862216	gold, Green Submitted, Green Published			2022-12-25	WOS:000281963200003
J	Schulz, E; Frechero, M; Appignanesi, G; Fernandez, A				Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo; Fernandez, Ariel			Sub-Nanoscale Surface Ruggedness Provides a Water-Tight Seal for Exposed Regions in Soluble Protein Structure	PLOS ONE			English	Article							HYDROPHOBICITY; DYNAMICS	Soluble proteins must maintain backbone hydrogen bonds (BHBs) water-tight to ensure structural integrity. This protection is often achieved by burying the BHBs or wrapping them through intermolecular associations. On the other hand, water has low coordination resilience, with loss of hydrogen-bonding partnerships carrying significant thermodynamic cost. Thus, a core problem in structural biology is whether natural design actually exploits the water coordination stiffness to seal the backbone in regions that are exposed to the solvent. This work explores the molecular design features that make this type of seal operative, focusing on the side-chain arrangements that shield the protein backbone. We show that an efficient sealing is achieved by adapting the sub-nanoscale surface topography to the stringency of water coordination: an exposed BHB may be kept dry if the local concave curvature is small enough to impede formation of the coordination shell of a penetrating water molecule. Examination of an exhaustive database of uncomplexed proteins reveals that exposed BHBs invariably occur within such sub-nanoscale cavities in native folds, while this level of local ruggedness is absent in other regions. By contrast, BHB exposure in misfolded proteins occurs with larger local curvature promoting backbone hydration and consequently, structure disruption. These findings unravel physical constraints fitting a spatially dependent least-action for water coordination, introduce a molecular design concept, and herald the advent of water-tight peptide-based materials with sufficient backbone exposure to remain flexible.	[Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo] Univ Nacl Sur, Secc Fisicoquim, Inst Quim Sur, Consejo Nacl Invest Cientif & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo] Univ Nacl Sur, Dept Quim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Fernandez, Ariel] Rice Univ, Dept Bioengn, Houston, TX USA; [Fernandez, Ariel] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South; Rice University; University of Chicago	Schulz, E (corresponding author), Univ Nacl Sur, Secc Fisicoquim, Inst Quim Sur, Consejo Nacl Invest Cientif & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	arifer@rice.edu	Frechero, Marisa A./B-8286-2011; Fernandez, Ariel/I-7925-2016	Fernandez, Ariel/0000-0002-5102-4294	NIH [R01GM072614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research of Ariel Fernandez is supported by NIH grant R01GM072614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 2003, J BIOL CHEM, V278, P17581, DOI 10.1074/jbc.X200009200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fernandez A, 2004, NAT BIOTECHNOL, V22, P1081, DOI 10.1038/nbt0904-1081; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez A, 2010, TRANSFORMATIVE CONCEPTS FOR DRUG DESIGN: TARGET WRAPPING, P1, DOI 10.1007/978-3-642-11792-3_1; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Giovambattista N, 2008, P NATL ACAD SCI USA, V105, P2274, DOI 10.1073/pnas.0708088105; Giovambattista N, 2009, P NATL ACAD SCI USA, V106, P15181, DOI 10.1073/pnas.0905468106; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; Malaspina DC, 2010, EUR PHYS J E, V32, P35, DOI 10.1140/epje/i2010-10594-2; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; POWERS ET, 2006, ADV PROTEIN CHEM, V72, P40; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Stokely K, 2010, P NATL ACAD SCI USA, V107, P1301, DOI 10.1073/pnas.0912756107; Street AG, 1998, FOLD DES, V3, P253, DOI 10.1016/S1359-0278(98)00036-4; Zhang NG, 2004, PROTEINS, V57, P565, DOI 10.1002/prot.20191	23	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12844	10.1371/journal.pone.0012844	http://dx.doi.org/10.1371/journal.pone.0012844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862253	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800029
J	Govindaraj, RG; Manavalan, B; Lee, G; Choi, S				Govindaraj, Rajiv Gandhi; Manavalan, Balachandran; Lee, Gwang; Choi, Sangdun			Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling	PLOS ONE			English	Article							LEUCINE-RICH REPEATS; PATHOGEN RECOGNITION; GLYCOSYLATION SITES; STRUCTURAL BASIS; PROTEIN-DOCKING; SERVER; SIMULATIONS; EXPRESSION; BINDING; CELLS	Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogens based on distinct molecular signatures. The human (h) TLR1, 2, 6 and 10 belong to the hTLR1 subfamilies, which are localized in the extracellular regions and activated in response to diverse ligand molecules. Due to the unavailability of the hTLR10 crystal structure, the understanding of its homo and heterodimerization with hTLR2 and hTLR1 and the ligand responsible for its activation is limited. To improve our understanding of the TLR10 receptor-ligand interaction, we used homology modeling to construct a three dimensional (3D) structure of hTLR10 and refined the model through molecular dynamics (MD) simulations. We utilized the optimized structures for the molecular docking in order to identify the potential site of interactions between the homo and heterodimer (hTLR10/2 and hTLR10/1). The docked complexes were then used for interaction with ligands (Pam3CSK4 and PamCysPamSK(4)) using MOE-Dock and ASEDock. Our docking studies have shown the binding orientations of hTLR10 heterodimer to be similar with other TLR2 family members. However, the binding orientation of hTLR10 homodimer is different from the heterodimer due to the presence of negative charged surfaces at the LRR11-14, thereby providing a specific cavity for ligand binding. Moreover, the multiple protein-ligand docking approach revealed that Pam3CSK4 might be the ligand for the hTLR10/2 complex and PamCysPamSK(4), a di-acylated peptide, might activate hTLR10/1 hetero and hTLR10 homodimer. Therefore, the current modeled complexes can be a useful tool for further experimental studies on TLR biology.	[Govindaraj, Rajiv Gandhi; Manavalan, Balachandran; Lee, Gwang; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University	Govindaraj, RG (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Govindaraj, Rajiv Gandhi/X-1809-2019; Manavalan, Balachandran/Q-8279-2019	Govindaraj, Rajiv Gandhi/0000-0003-2364-5429; Manavalan, Balachandran/0000-0003-0697-9419	Ministry of Education, Science, and Technology [2010-0016256]; Korea Food and Drug Administration [10182KFDA992]; Ajou University; NRF [2009-0093826]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Ajou University; NRF	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0016256). This work was also partly supported by a grant (10182KFDA992) from the Korea Food and Drug Administration, the Ajou University Research Fellowship and the Priority Research Centers Program through the NRF (2009-0093826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; GONG J, 2007, P 2 IAPR INT WORKSH; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hasan UA, 2004, BIOCHEM BIOPH RES CO, V321, P124, DOI 10.1016/j.bbrc.2004.06.134; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KORTEMME T, 2004, SCI STKE, P12, DOI DOI 10.1126/STKE.2192004P12; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SHUICHI M, 1992, J COMPUT CHEM, V13, P952; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Wei T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-47; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186	41	61	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12713	10.1371/journal.pone.0012713	http://dx.doi.org/10.1371/journal.pone.0012713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20877634	Green Published, Green Submitted, gold			2022-12-25	WOS:000281864100006
J	Ball, SK; Field, MC; Tippins, JR				Ball, Stephen K.; Field, Mark C.; Tippins, John R.			Regulation of Thromboxane Receptor Signaling at Multiple Levels by Oxidative Stress-Induced Stabilization, Relocation and Enhanced Responsiveness	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEIN-KINASE; BETA-ISOFORM; EXPRESSION; ISOPROSTANE; ALPHA; CELLS; PHOSPHORYLATION; TRAFFICKING; GENERATION	Background: Thromboxane A(2) (TxA(2)) is a major, unstable arachidonic acid metabolite, and plays a key role in normal physiology and control of vascular tone. The human thromboxane receptor (TP beta), expressed in COS-7 cells, is located predominantly in the endoplasmic reticulum (ER). Brief hydrogen peroxide exposure increases the efficiency of translocation of TP beta from the ER into the Golgi complex, inducing maturation and stabilization of TP beta. However, the ultimate fate of this post-ER TP beta pool is not known, nor is its capacity to initiate signal transduction. Here we specifically assessed if functional TP beta was transported to the plasma membrane following H2O2 exposure. Results: We demonstrate, by biotinylation and confocal microscopy, that exposure to H2O2 results in rapid delivery of a cohort of TP beta to the cell surface, which is stable for at least eight hours. Surface delivery is brefeldin A-sensitive, indicating that translocation of this receptor cohort is from internal pools and via the Golgi complex. H2O2 treatment results in potentiation of the increase to intracellular calcium concentrations in response to TP beta agonists U46619 and 8-iso PGF(2 alpha) and also in the loss of ligand-dependent receptor internalization. Further there is increased responsiveness to a second application of the agonist. Finally we demonstrate that the effect of H2O2 on stimulating surface delivery is shared with the FP prostanoid receptor but not the EP3 or EP4 receptors. Conclusions/Significance: In summary, brief exposure to H2O2 results in an immediate and sustained increase in the surface pool of thromboxane receptor that is capable of mediating a persistent hyper-responsiveness of the cell and suggests a highly sophisticated mechanism for rapidly regulating thromboxane signaling.	[Ball, Stephen K.; Tippins, John R.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Ball, Stephen K.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Imperial College London; University of Cambridge	Ball, SK (corresponding author), UCL, Inst Urol, London, England.	mcf34@cam.ac.uk	Field, Mark/AAD-6455-2021	Field, Mark/0000-0002-4866-2885	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cipollone F, 2000, CIRCULATION, V102, P1007, DOI 10.1161/01.CIR.102.9.1007; DAngelo DD, 1996, J BIOL CHEM, V271, P6233, DOI 10.1074/jbc.271.11.6233; DORN GW, 1990, CIRCULATION, V81, P212, DOI 10.1161/01.CIR.81.1.212; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Habib A, 1997, J BIOL CHEM, V272, P7191, DOI 10.1074/jbc.272.11.7191; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hu QH, 1998, CIRCULATION, V97, P268, DOI 10.1161/01.CIR.97.3.268; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; KRIPPEITDREWS P, 1995, BIOCHEM BIOPH RES CO, V209, P139, DOI 10.1006/bbrc.1995.1481; Kromer BM, 1999, BRIT J PHARMACOL, V126, P1171, DOI 10.1038/sj.bjp.0702433; Kromer BM, 1996, BRIT J PHARMACOL, V119, P1276, DOI 10.1111/j.1476-5381.1996.tb16033.x; Laroche G, 2005, CELL SIGNAL, V17, P1373, DOI 10.1016/j.cellsig.2005.02.008; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Mehrabi MR, 1999, CARDIOVASC RES, V43, P492; Molavi B, 2004, CURR OPIN CARDIOL, V19, P488, DOI 10.1097/01.hco.0000133657.77024.bd; MONCADA S, 1978, PHARMACOL REV, V30, P293; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; Nakagawa H, 2004, CARCINOGENESIS, V25, P1567, DOI 10.1093/carcin/bgh168; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nie DT, 2008, CANCER RES, V68, P115, DOI 10.1158/0008-5472.CAN-07-1018; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Reznikov K, 2000, FASEB J, V14, P1754, DOI 10.1096/fj.99-0890com; ROBERTS LJ, 1977, J BIOL CHEM, V252, P7415; Sasaki M, 2007, PROSTAG OTH LIPID M, V83, P237, DOI 10.1016/j.prostaglandins.2006.12.001; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Valentin F, 2005, BIOCHEM BIOPH RES CO, V329, P898, DOI 10.1016/j.bbrc.2005.02.058; Valentin FO, 2004, J BIOL CHEM, V279, P8316, DOI 10.1074/jbc.M306761200; Wilson SJ, 2007, BIOCHEM BIOPH RES CO, V352, P397, DOI 10.1016/j.bbrc.2006.11.040; Wilson SJ, 2009, J LIPID RES, V50, P1047, DOI 10.1194/jlr.M800447-JLR200; Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Yin W, 2008, INT J BIOCHEM CELL B, V40, P942, DOI 10.1016/j.biocel.2007.10.036; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12798	10.1371/journal.pone.0012798	http://dx.doi.org/10.1371/journal.pone.0012798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856817	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815800032
J	Fadok, JP; Darvas, M; Dickerson, TMK; Palmiter, RD				Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.			Long-Term Memory for Pavlovian Fear Conditioning Requires Dopamine in the Nucleus Accumbens and Basolateral Amygdala	PLOS ONE			English	Article							DEFICIENT MICE; NEURONS; CONSOLIDATION; INHIBITION; MODULATION; STRESS; BRAIN; SHELL; NEUROBIOLOGY; FACILITATION	The neurotransmitter dopamine (DA) is essential for learning in a Pavlovian fear conditioning paradigm known as fear-potentiated startle (FPS). Mice lacking the ability to synthesize DA fail to learn the association between the conditioned stimulus and the fear-inducing footshock. Previously, we demonstrated that restoration of DA synthesis to neurons of the ventral tegmental area (VTA) was sufficient to restore FPS. Here, we used a target-selective viral restoration approach to determine which mesocorticolimbic brain regions receiving DA signaling from the VTA require DA for FPS. We demonstrate that restoration of DA synthesis to both the basolateral amygdala (BLA) and nucleus accumbens (NAc) is required for long-term memory of FPS. These data provide crucial insight into the dopamine-dependent circuitry involved in the formation of fear-related memory.	[Fadok, Jonathan P.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fadok, JP (corresponding author), Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA.	palmiter@u.washington.edu	Darvas, Martin/E-2935-2015; Fadok, Jonathan/AAX-2999-2020	Darvas, Martin/0000-0002-7942-2526; Fadok, Jonathan/0000-0002-0608-5151	Howard Hughes Medical Institute; Public Health Service; National Research Service; National Institute of General Medical Sciences [T32 GM07270]; NIH National Institutes of General Medical Science [4 R25 GM 058501-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R25GM058501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Research Service; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institutes of General Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported in part by the Howard Hughes Medical Institute, Public Health Service, National Research Service Award, T32 GM07270, from the National Institute of General Medical Sciences and NIH National Institutes of General Medical Sciences' Grant 4 R25 GM 058501-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; de Oliveira AR, 2006, PHARMACOL BIOCHEM BE, V84, P102, DOI 10.1016/j.pbb.2006.04.012; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; LaLumiere RT, 2005, LEARN MEMORY, V12, P296, DOI 10.1101/lm.93205; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Manago F, 2009, LEARN MEMORY, V16, P46, DOI 10.1101/lm.1177509; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pezze MA, 2001, NEUROSCIENCE, V108, P91, DOI 10.1016/S0306-4522(01)00403-1; Ponnusamy R, 2005, LEARN MEMORY, V12, P399, DOI 10.1101/lm.96605; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	36	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12751	10.1371/journal.pone.0012751	http://dx.doi.org/10.1371/journal.pone.0012751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856811	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815800018
J	Jogi, A; Rono, B; Lund, IK; Nielsen, BS; Ploug, M; Hoyer-Hansen, G; Romer, J; Lund, LR				Jogi, Annika; Rono, Birgitte; Lund, Ida K.; Nielsen, Boye S.; Ploug, Michael; Hoyer-Hansen, Gunilla; Romer, John; Lund, Leif R.			Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice	PLOS ONE			English	Article							UROKINASE-TYPE; MATRIX METALLOPROTEINASES; FUNCTIONAL OVERLAP; ACTIVATOR; CANCER; RECEPTOR; GENE; KERATINOCYTES; EXPRESSION; SYSTEMS	Background: Proteolytic degradation by plasmin and metalloproteinases is essential for epidermal regeneration in skin wound healing. Plasminogen deficient mice have severely delayed wound closure as have mice simultaneously lacking the two plasminogen activators, urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA). In contrast, individual genetic deficiencies in either uPA or tPA lead to wound healing kinetics with no or only slightly delayed closure of skin wounds. Methodology/Principal Findings: To evaluate the therapeutic potential in vivo of a murine neutralizing antibody directed against mouse uPA we investigated the efficacy in skin wound healing of tPA-deficient mice. Systemic administration of the anti-mouse uPA monoclonal antibody, mU1, to tPA-deficient mice caused a dose-dependent delay of skin wound closure almost similar to the delayed kinetics observed in uPA; tPA double-deficient mice. Analysis of wound extracts showed diminished levels of plasmin in the mU1-treated tPA-deficent mice. Immunohistochemistry revealed that fibrin accumulated in the wounds of such mU1-treated tPA-deficent mice and that keratinocyte tongues were aberrant. Together these abnormalities lead to compromised epidermal closure. Conclusions/Significance: Our findings demonstrate that inhibition of uPA activity with a monoclonal antibody in adult tPA-deficient mice mimics the effect of simultaneous genetic ablation of uPA and tPA. Thus, application of the murine inhibitory mU1 antibody provides a new and highly versatile tool to interfere with uPA-activity in vivo in mouse models of disease.	[Jogi, Annika; Rono, Birgitte; Lund, Ida K.; Nielsen, Boye S.; Ploug, Michael; Hoyer-Hansen, Gunilla; Romer, John; Lund, Leif R.] Copenhagen Univ Hosp, Copenhagen Bioctr, Finsen Lab, Copenhagen, Denmark	University of Copenhagen	Jogi, A (corresponding author), Lund Univ, Ctr Mol Pathol, Skane Univ Hosp Malmo, Malmo, Sweden.	lrlund@sund.ku.dk		Jogi, Annika/0000-0003-1697-8030; Ploug, Michael/0000-0003-2215-4265	Swedish Cancer Society; Svenska Medicinsk Forskning; European Union [201279]; MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation"; Agnes og Poul Friis Foundation; Lundbeck Foundation	Swedish Cancer Society(Swedish Cancer Society); Svenska Medicinsk Forskning; European Union(European Commission); MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation"; Agnes og Poul Friis Foundation; Lundbeck Foundation(Lundbeckfonden)	Research grants supporting this work: Swedish Cancer Society and Svenska Medicinsk Forskning (Fellowship to A.J.), European Union Grant 201279, MICROENVIMET, Aage Bangs Foundation, "Grosserer Alfred Nielsen og Hustrus Foundation, Danish Cancer Society, the Danish Cancer Research Foundation," Agnes og Poul Friis Foundation, and the Lundbeck Foundation. The funders, had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript. There is no restriction in the authors' right to follow all PLoS ONE policies on sharing data and materials.	Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Collen D, 2005, THROMB HAEMOSTASIS, V93, P627, DOI 10.1160/TH04-11-0724; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; GRONDAHLHANSEN J, 1988, J INVEST DERMATOL, V90, P790, DOI 10.1111/1523-1747.ep12461511; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harbeck Nadia, 2004, Clin Breast Cancer, V5, P348, DOI 10.3816/CBC.2004.n.040; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Lund LR, 2000, DEVELOPMENT, V127, P4481; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Mingers AM, 1997, SEMIN THROMB HEMOST, V23, P259, DOI 10.1055/s-2007-996099; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; ROMER J, 1994, J INVEST DERMATOL, V102, P519, DOI 10.1111/1523-1747.ep12373187; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; ROMER J, 1991, J INVEST DERMATOL, V97, P803, DOI 10.1111/1523-1747.ep12486833; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Scott KA, 2003, MOL CANCER THER, V2, P445; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; Weinberg RA, 2007, BIOL CANC	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12746	10.1371/journal.pone.0012746	http://dx.doi.org/10.1371/journal.pone.0012746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856796	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815800017
J	Gong, Y; Bourhis, E; Chiu, C; Stawicki, S; DeAlmeida, VI; Liu, BY; Phamluong, K; Cao, TC; Carano, RAD; Ernst, JA; Solloway, M; Rubinfeld, B; Hannoush, RN; Wu, Y; Polakis, P; Costa, M				Gong, Yan; Bourhis, Eric; Chiu, Cecilia; Stawicki, Scott; DeAlmeida, Venita I.; Liu, Bob Y.; Phamluong, Khanhky; Cao, Tim C.; Carano, Richard A. D.; Ernst, James A.; Solloway, Mark; Rubinfeld, Bonnee; Hannoush, Rami N.; Wu, Yan; Polakis, Paul; Costa, Mike			Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies	PLOS ONE			English	Article							BETA-CATENIN; DOMAIN; ACTIVATION; MECHANISM; PATHWAY; LIGAND; GROWTH; AXIN; PHOSPHORYLATION; OSTEOBLASTS	beta-catenin-dependent Wnt signaling is initiated as Wnt binds to both the receptor FZD and coreceptor LRP5/6, which then assembles a multimeric complex at the cytoplasmic membrane face to recruit and inactivate the kinase GSK3. The large number and sequence diversity of Wnt isoforms suggest the possibility of domain-specific ligand-coreceptor interactions, and distinct binding sites on LRP6 for Wnt3a and Wnt9b have recently been identified in vitro. Whether mechanistically different interactions between Wnts and coreceptors might mediate signaling remains to be determined. It is also not clear whether coreceptor homodimerization induced extracellularly can activate Wnt signaling, as is the case for receptor tyrosine kinases. We generated monoclonal antibodies against LRP6 with the unexpected ability to inhibit signaling by some Wnt isoforms and potentiate signaling by other isoforms. In cell culture, two antibodies characterized further show reciprocal activities on most Wnts, with one antibody antagonizing and the other potentiating. We demonstrate that these antibodies bind to different regions of LRP6 protein, and inhibition of signaling results from blocking Wnt binding. Antibody-mediated dimerization of LRP6 can potentiate signaling only when a Wnt isoform is also able to bind the complex, presumably recruiting FZD. Endogenous autocrine Wnt signaling in different tumor cell lines can be either antagonized or enhanced by the LRP6 antibodies, indicating expression of different Wnt isoforms. As anticipated from the roles of Wnt signaling in cancer and bone development, antibody activities can also be observed in mice for inhibition of tumor growth and in organ culture for enhancement of bone mineral density. Collectively, our results indicate that separate binding sites for different subsets of Wnt isoforms determine the inhibition or potentiation of signaling conferred by LRP6 antibodies. This complexity of coreceptor-ligand interactions may allow for differential regulation of signaling by Wnt isoforms during development, and can be exploited with antibodies to differentially manipulate Wnt signaling in specific tissues or disease states.	[Gong, Yan; DeAlmeida, Venita I.; Liu, Bob Y.; Rubinfeld, Bonnee; Polakis, Paul; Costa, Mike] Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA; [Bourhis, Eric; Ernst, James A.; Hannoush, Rami N.] Genentech Res & Early Dev, Dept Prot Engn, San Francisco, CA USA; [Chiu, Cecilia; Stawicki, Scott; Wu, Yan] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA USA; [Phamluong, Khanhky; Solloway, Mark] Genentech Res & Early Dev, Dept Mol Biol, San Francisco, CA USA; [Cao, Tim C.; Carano, Richard A. D.] Genentech Res & Early Dev, Dept Tumor Biol & Angiogenesis, San Francisco, CA USA; [Ernst, James A.] Genentech Res & Early Dev, Dept Prot Chem, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Gong, Y (corresponding author), Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA.	mcosta@gene.com		Rubinfeld, Bonnee/0000-0001-9861-6775	Genentech Research & Early Development	Genentech Research & Early Development	This work was supported by Genentech Research & Early Development. The funder did have roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Binnerts ME, 2009, MOL BIOL CELL, V20, P3552, DOI 10.1091/mbc.E08-12-1252; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V231, P596, DOI 10.1006/bbrc.1997.6156; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liu BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008611; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; QUARTO N, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091116; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VAN AMERONGEN R, 2009, DEVELOPMENT, V136, P3205; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yasui N, 2010, J IMMUNOL METHODS, V352, P153, DOI 10.1016/j.jim.2009.11.016; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhou H, 2009, DEVELOPMENT, V136, P427, DOI 10.1242/dev.027706; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	40	90	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12682	10.1371/journal.pone.0012682	http://dx.doi.org/10.1371/journal.pone.0012682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856934	Green Submitted, Green Published, gold			2022-12-25	WOS:000281735700009
J	Fureix, C; Menguy, H; Hausberger, M				Fureix, Carole; Menguy, Herve; Hausberger, Martine			Partners with Bad Temper: Reject or Cure? A Study of Chronic Pain and Aggression in Horses	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; BACK-PAIN; BEHAVIOR; MANIPULATION; HUMANS; WORK; PERFORMANCE; TRAIT; TIME	Background: Experiencing acute pain can affect the social behaviour of both humans and animals and can increase the risk that they exhibit aggressive or violent behaviour. However, studies have focused mainly on the impact of acute rather than chronic painful experiences. As recent results suggest that chronic pain or chronic discomfort could increase aggressiveness in humans and other mammals, we tested here the hypothesis that, in horses, aggression towards humans (a common source of accidents for professionals) could be linked to regularly reported vertebral problems of riding horses. Methodology/Principal Findings: Vertebral examination and standardized behavioural tests were made independently on the same horses. Here we showed that most horses severely affected by vertebral problems were prone to react aggressively towards humans (33/43 horses, chi-square test, df = 1, chi(2) = 12.30, p 0.001), which was not the case for unaffected or slightly affected horses (9/16 horses, chi-square test, df = 1, chi(2) = 0.25, p > 0.05). The more affected they were, the fewer positive reactions they exhibited (rs = -0.31, p = 0.02). Conclusions/Significance: This is to our knowledge the first experimental evidence of such a link between chronic discomfort/potential pain (inferred from the presence of vertebral problems) and aggression, suggesting that chronic painful experiences may act in ways similar to those of acute experiences. Chronic discomfort or pain may often be overlooked when facing "bad tempered'' individuals, whether humans or animals. This experimental study confirms the importance of including chronic discomfort or pain as a major factor in interpersonal relations and models of aggression.	[Fureix, Carole; Hausberger, Martine] Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Fureix, C (corresponding author), Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, UMR 6552, Rennes, France.	carole.fureix@univ-rennes1.fr			Caisse Centrale de la Mutualite Sociale Agricole (MSA); CNRS; French Ministry of Research	Caisse Centrale de la Mutualite Sociale Agricole (MSA); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole (MSA), the CNRS and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Anderson KB, 1998, AGGRESSIVE BEHAV, V24, P161, DOI 10.1002/(SICI)1098-2337(1998)24:3<161::AID-AB1>3.0.CO;2-O; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; BERKOWITZ L, 1981, J PERS SOC PSYCHOL, V40, P687, DOI 10.1037/0022-3514.40.4.687; Bruns Daniel, 2003, Curr Pain Headache Rep, V7, P127, DOI 10.1007/s11916-003-0022-4; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cauvin E, 1997, IN PRACTICE, V19, P522; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Day JEL, 2008, APPL ANIM BEHAV SCI, V109, P249, DOI 10.1016/j.applanim.2007.02.006; Dionne CE, 2005, CAN MED ASSOC J, V172, P1559, DOI 10.1503/cmaj.1041159; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Hansen B, 1997, SEMIN VET MED SURG, V12, P61, DOI 10.1016/S1096-2867(97)80003-5; Hansen BD, 2003, ILAR J, V44, P197, DOI 10.1093/ilar.44.3.197; Hardie EM, 1997, APPL ANIM BEHAV SCI, V51, P111, DOI 10.1016/S0168-1591(96)01078-7; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Henry S, 2005, APPL ANIM BEHAV SCI, V93, P341, DOI 10.1016/j.applanim.2005.01.008; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Izard C.E., 1991, PSYCHOL EMOTION; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Lloyd AS, 2008, APPL ANIM BEHAV SCI, V112, P369, DOI 10.1016/j.applanim.2007.08.010; MCDONNELL SM, 1995, APPL ANIM BEHAV SCI, V43, P147, DOI 10.1016/0168-1591(94)00550-X; *NAT I OCC SAF HLT, 1996, VIOL WORKPL RISK FAC; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Sondergaard E, 2003, APPL ANIM BEHAV SCI, V84, P265, DOI 10.1016/j.applanim.2003.08.011; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Vieira ER, 2004, J OCCUP REHABIL, V14, P143, DOI 10.1023/B:JOOR.0000018330.46029.05; Waring G.H., 2003, HORSE BEHAV, V2; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	57	61	60	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12434	10.1371/journal.pone.0012434	http://dx.doi.org/10.1371/journal.pone.0012434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865160	Green Published, gold			2022-12-25	WOS:000281292100027
J	Chakravarthy, H; Ormsbee, BD; Mallanna, SK; Rizzino, A				Chakravarthy, Harini; Ormsbee, Briana D.; Mallanna, Sunil K.; Rizzino, Angie			Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery	FASEB JOURNAL			English	Article						H3K4me3; H3K27me3; PRC; HDAC; Sox2	EMBRYONIC STEM-CELLS; POLYCOMB-REPRESSIVE COMPLEX-2; SOX2-OCT-3/4 TARGET GENES; RNA-POLYMERASE-II; GROUP PROTEIN EED; HISTONE H3; TRANSCRIPTIONAL REPRESSION; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; CARCINOMA-CELLS	The rapid formation of numerous tissues during development is highly dependent on the swift activation of key developmental regulators. Recent studies indicate that many key regulatory genes are repressed in embryonic stem cells (ESCs), yet poised for rapid activation due to the presence of both activating (H3K4 trimethylation) and repressive (H3K27 trimethylation) histone modifications (bivalent genes). However, little is known about bivalent gene regulation. In this study, we investigated the regulation of the bivalent gene Sox21, which is activated rapidly when ESCs differentiate in response to increases in Sox2. Chromatin immunoprecipitation demonstrated that prior to differentiation, the Sox21 gene is bound by a complex array of repressive and activating transcriptional machinery. Upon activation, all identified repressive machinery and histone modifications associated with the gene are lost, but the activating modifications and transcriptional machinery are retained. Notably, these changes do not occur when ESCs differentiate in response to retinoic acid. Moreover, ESCs lacking a functional PRC2 complex fail to activate this gene, apparently due to its association with other repressive complexes. Together, these findings suggest that bivalent genes, such as Sox21, are silenced by a complex set of redundant repressive machinery, which exit rapidly in response to appropriate differentiation signals.-Chakravarthy, H., Ormsbee, B. D., Mallanna, S. K., Rizzino, A. Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery. FASEB J. 25, 206-218 (2011). www.fasebj.org	[Chakravarthy, Harini; Ormsbee, Briana D.; Mallanna, Sunil K.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Chakravarthy, Harini; Rizzino, Angie] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Canc Inst, Omaha, NE 68198 USA.	arizzino@unmc.edu			National Institute of General Medicinal Sciences [GM 080751]; National Cancer Institute [CA009476, CA36727]; NATIONAL CANCER INSTITUTE [T32CA009476, P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institute of General Medicinal Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Terry Magnuson (University of North Carolina, Chapel Hill, NC, USA) for the gift of Eed-null ESCs, and Heather Rizzino for editorial assistance. This work was supported by a grant from the National Institute of General Medicinal Sciences (GM 080751). B.D.O. was supported in part by a Cancer Biology Training Grant from the National Cancer Institute (CA009476). Core facilities of the University of Nebraska Medical Center Eppley Cancer Center were supported in part by a Cancer Center Support Grant from the National Cancer Institute (CA36727).	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bernadt CT, 2005, GENE EXPRESSION, V12, P193, DOI 10.3727/000000005783992052; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boer B, 2006, J CELL PHYSIOL, V208, P97, DOI 10.1002/jcp.20635; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chakravarthy H., 2010, TFE; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mallanna SK, 2008, MOL REPROD DEV, V75, P1247, DOI 10.1002/mrd.20871; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Montgomery ND, 2007, J MOL BIOL, V374, P1145, DOI 10.1016/j.jmb.2007.10.040; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	48	19	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					206	218		10.1096/fj.10-166926	http://dx.doi.org/10.1096/fj.10-166926			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876214	Green Published			2022-12-25	WOS:000285869500019
J	Pardali, E; van der Schaft, DWJ; Wiercinska, E; Gorter, A; Hogendoorn, PCW; Griffioen, AW; ten Dijke, P				Pardali, E.; van der Schaft, D. W. J.; Wiercinska, E.; Gorter, A.; Hogendoorn, P. C. W.; Griffioen, A. W.; ten Dijke, P.			Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma	ONCOGENE			English	Article						endoglin; tumor cell plasticity; transforming growth factor-beta; bone morphogenetic proteins; Ewing sarcoma; melanoma	VASCULOGENIC MIMICRY; MOLECULAR DETERMINANTS; OSTEOPONTIN EXPRESSION; UVEAL MELANOMA; ANGIOGENESIS; INVASION; PROMOTES; IDENTIFICATION; PROLIFERATION; PROTEIN	Tumor cell plasticity enables certain types of highly malignant tumor cells to dedifferentiate and engage a plastic multipotent embryonic-like phenotype, which enables them to 'adapt' during tumor progression and escape conventional therapeutic strategies. This plastic phenotype of aggressive cancer cells enables them to express endothelial cell-specific markers and form tubelike structures, a phenotype that has been linked to aggressive behavior and poor prognosis. We demonstrate here that the transforming growth factor (TGF)-beta co-receptor endoglin, an endothelial cell marker, is expressed by tumor cells and its expression correlates with tumor cell plasticity in two types of human cancer, Ewing sarcoma and melanoma. Moreover, endoglin expression was significantly associated with worse survival of Ewing sarcoma patients. Endoglin knockdown in tumor cells interferes with tumor cell plasticity and reduces invasiveness and anchorage-independent growth in vitro. Ewing sarcoma and melanoma cells with reduced endoglin levels showed reduced tumor growth in vivo. Mechanistically, we provide evidence that endoglin, while interfering with TGF-beta signaling, is required for efficient bone morphogenetic protein, integrin, focal adhesion kinase and phosphoinositide-3-kinase signaling in order to maintain tumor cell plasticity. The present study delineates an important role of endoglin in tumor cell plasticity and progression of aggressive tumors. Oncogene (2011) 30, 334-345; doi:10.1038/onc.2010.418; published online 20 September 2010	[Pardali, E.; Wiercinska, E.; ten Dijke, P.] Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [van der Schaft, D. W. J.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, NL-5600 MB Eindhoven, Netherlands; [Gorter, A.; Hogendoorn, P. C. W.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Griffioen, A. W.] Vrije Univ Amsterdam Med Ctr, Angiogenesis Lab, Dept Med Oncol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eindhoven University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Pardali, E (corresponding author), Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol, Bldg 2,Room R-02-024,Postzone S-1-P,Postbus 9600, NL-2300 RC Leiden, Netherlands.	E.Pardali@lumc.nl; p.ten_dijke@lumc.nl	Hogendoorn, Pancras C.W./H-5859-2015; Hogendoorn, Pancras/O-6494-2019; Dijke, Peter ten/AAG-4660-2021	Hogendoorn, Pancras C.W./0000-0002-1513-8104; Hogendoorn, Pancras/0000-0002-1513-8104; Dijke, Peter ten/0000-0002-7234-342X; Wiercinska, Eliza/0000-0002-8434-6492	Centre of Biomedical Genetics, Dutch Cancer Society [RUL 2005-3371]; Ludwig Institute for Cancer Research; EC [504743, 518198, 018814]	Centre of Biomedical Genetics, Dutch Cancer Society(KWF Kankerbestrijding); Ludwig Institute for Cancer Research; EC(European CommissionEuropean Commission Joint Research Centre)	We thank the members of our research groups for help and suggestions during the course of this work. We are grateful to Margriet Ouwens for assistance with PI3K activity assays, Inge Briaire-de Bruijn for excellent technical assistance with the TMA histochemical analysis, Dagmar Berghuis for help with the patient's clinical characteristics, and David de Gorter for critical reading of the paper. This study was supported by grants from the Centre of Biomedical Genetics, Dutch Cancer Society (RUL 2005-3371), the Ludwig Institute for Cancer Research, and FP6 EC Integrated Projects: Angiotargeting (504743), EC STREP Tumor-Host-Genomics (518198) and EuroBoNeT (018814).	Altomonte M, 1996, BRIT J CANCER, V74, P1586, DOI 10.1038/bjc.1996.593; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Dome B, 2005, INT J CANCER, V116, P27, DOI 10.1002/ijc.20991; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2002, CANCER RES, V62, P665; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Hess AR, 2003, CANCER RES, V63, P4757; Hess AR, 2001, CANCER RES, V61, P3250; Hillen F, 2008, BIOCHEM BIOPH RES CO, V368, P364, DOI 10.1016/j.bbrc.2008.01.080; Kadkol SS, 2006, INVEST OPHTH VIS SCI, V47, P802, DOI 10.1167/iovs.05-0422; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Mueller AJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P31, DOI 10.1001/archopht.116.1.31; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Oxmann D, 2008, ONCOGENE, V27, P3567, DOI 10.1038/sj.onc.1211025; Perez-Gomez E, 2007, CANCER RES, V67, P10268, DOI 10.1158/0008-5472.CAN-07-1348; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Rothhammer T, 2005, CANCER RES, V65, P448; Scavelli C, 2008, ONCOGENE, V27, P663, DOI 10.1038/sj.onc.1210691; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Seon BK, 1997, CLIN CANCER RES, V3, P1031; Sharma N, 2002, PROSTATE, V50, P189, DOI 10.1002/pros.10048; Shirakawa K, 2002, INT J CANCER, V99, P821, DOI 10.1002/ijc.10423; Sood AK, 2001, AM J PATHOL, V158, P1279, DOI 10.1016/S0002-9440(10)64079-5; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Sun BC, 2007, J CANCER RES CLIN, V133, P979, DOI 10.1007/s00432-007-0245-6; Szuhai K, 2006, CANCER GENET CYTOGEN, V166, P173, DOI 10.1016/j.cancergencyto.2005.11.006; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wong VCL, 2008, INT J CANCER, V123, P2816, DOI 10.1002/ijc.23882; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x	44	56	59	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					334	345		10.1038/onc.2010.418	http://dx.doi.org/10.1038/onc.2010.418			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20856203	Green Published			2022-12-25	WOS:000286418800008
J	Xia, M; Knezevic, D; Vassilev, LT				Xia, M.; Knezevic, D.; Vassilev, L. T.			p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation	ONCOGENE			English	Article						p53; MDM2; p21; apoptosis; cell cycle	GROWTH ARREST; TRANSCRIPTIONAL ACTIVATION; INHIBITORY-ACTIVITY; SPINDLE CHECKPOINT; SURVIVIN; PATHWAY; MDM2; THERAPY; GENE; PHOSPHORYLATION	p21(Waf1/Cip1) is a p53 transcription target implicated in both major functions of the tumor suppressor-cell cycle arrest and apoptosis. It is a potent inhibitor of the key cyclin-dependent kinases (CDK1-4), and has been thought to be the main mediator of p53-dependent G1 and G2 arrest. However, an increasing body of information suggests that in addition to its cell-cycle inhibitory activity, p21 can affect p53-dependent apoptosis. These data have been obtained from experiments in which p53 is activated primarily by genotoxic stress. In this study, we use the selective MDM2 antagonist, nutlin-3a, as a nongenotoxic p53 activator and show that the cell-cycle arrest function of p21 is dependent on the cellular context. In most cancer cell lines, p53-dependent p21 induction is essential for cell-cycle arrest, but in some, p21 is dispensable. Depletion of p21 did not increase the apoptotic response to nutlin-3a in all seven cancer cell lines tested and p21 overexpression did not protect apoptosis-sensitive lines from death. p21 was found to mediate nutlin-induced p53-dependent downregulation of another antiapoptotic protein, survivin, without significantly affecting the apoptotic outcome. Taken together our results suggest that p21 induction does not affect the apoptotic response to nongenotoxic p53 activation. Oncogene (2011) 30, 346-355; doi:10.1038/onc.2010.413; published online 27 September 2010	[Xia, M.; Knezevic, D.; Vassilev, L. T.] Hoffmann La Roche Inc, Discovery Oncol, Roche Res Ctr, Nutley, NJ 07110 USA	Roche Holding	Vassilev, LT (corresponding author), Hoffmann La Roche Inc, Discovery Oncol, Roche Res Ctr, 340 Kingsland St, Nutley, NJ 07110 USA.	lyubomir.vassilev@roche.com						Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bissonnette N, 1998, ONCOGENE, V16, P3461, DOI 10.1038/sj.onc.1201899; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chan TA, 2000, GENE DEV, V14, P1584; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Ferrandiz N, 2009, DNA REPAIR, V8, P390, DOI 10.1016/j.dnarep.2008.12.001; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; HARPER JW, 1993, CELL, V75, P805; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Janicke RU, 2007, CELL CYCLE, V6, P407; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu YJ, 1998, ONCOGENE, V16, P705, DOI 10.1038/sj.onc.1201585; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Tian H, 2000, CANCER RES, V60, P679; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Xia MX, 2008, CELL CYCLE, V7, P1604, DOI 10.4161/cc.7.11.5929; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang H, 2003, MOL CANCER THER, V2, P1023; Zhang YK, 1999, ONCOGENE, V18, P1131, DOI 10.1038/sj.onc.1202426	44	48	48	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					346	355		10.1038/onc.2010.413	http://dx.doi.org/10.1038/onc.2010.413			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20871630				2022-12-25	WOS:000286418800009
J	Guitart, T; Bernardo, TL; Sagales, J; Stratmann, T; Bernues, J; de Pouplana, LR				Guitart, Tanit; Leon Bernardo, Teresa; Sagales, Jessica; Stratmann, Thomas; Bernues, Jordi; Ribas de Pouplana, Lluis			New Aminoacyl-tRNA Synthetase-like Protein in Insecta with an Essential Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE GAMMA; ACCESSORY SUBUNIT; DROSOPHILA; GENE; SEQUENCES; IDENTIFICATION; RECOGNITION; PHYLOGENIES; EXPRESSION; MUTATION	Aminoacyl-tRNA synthetases (ARS) are modular enzymes that aminoacylate transfer RNAs (tRNA) for their use by the ribosome during protein synthesis. ARS are essential and universal components of the genetic code that were almost completely established before the appearance of the last common ancestor of all living species. This long evolutionary history explains the growing number of functions being discovered for ARS, and for ARS homologues, beyond their canonical role in gene translation. Here we present a previously uncharacterized paralogue of seryl-tRNA synthetase named SLIMP (seryl-tRNA synthetase-like insect mitochondrial protein). SLIMP is the result of a duplication of a mitochondrial seryl-tRNA synthetase (SRS) gene that took place in early metazoans and was fixed in Insecta. Here we show that SLIMP is localized in the mitochondria, where it carries out an essential function that is unrelated to the aminoacylation of tRNA. The knockdown of SLIMP by RNA interference (RNAi) causes a decrease in respiration capacity and an increase in mitochondrial mass in the form of aberrant mitochondria.	[Ribas de Pouplana, Lluis] IRB, Barcelona 08028, Spain; [Stratmann, Thomas] Univ Barcelona Biol, Dept Physiol, Barcelona 08028, Spain; [Bernues, Jordi] CSIC, Inst Biol Mol Barcelona, Barcelona 08028, Spain; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA	de Pouplana, LR (corresponding author), IRB, C Baldiri Reixac 12, Barcelona 08028, Spain.	lluis.ribas@irbbarcelona.org	Bernues, Jordi/ABE-8360-2021; Guitart, Tanit/G-9772-2015; de Pouplana, Lluis Ribas/AAA-4738-2019; SEGALES, J/H-6434-2014	Bernues, Jordi/0000-0001-6218-8254; Guitart, Tanit/0000-0003-2992-9895; de Pouplana, Lluis Ribas/0000-0002-2087-0359; SEGALES, J/0000-0003-3565-0014; Stratmann, Thomas/0000-0001-6196-1487	Spanish Ministry of Science and Education [BIO2006-01558]; ICREA Funding Source: Custom	Spanish Ministry of Science and Education(Spanish Government); ICREA(ICREA)	This work was supported by Grant BIO2006-01558 from the Spanish Ministry of Science and Education.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrus AM, 2009, GENETICS, V183, P79, DOI 10.1534/genetics.109.104661; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herzog W, 2009, CIRC RES, V104, P1260, DOI 10.1161/CIRCRESAHA.108.191718; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jaric J, 2009, J BIOL CHEM, V284, P30643, DOI 10.1074/jbc.M109.044099; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sambrook J, 1989, MOL CLONING LAB MANU, V1 and 3; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	46	17	18	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38157	38166		10.1074/jbc.M110.167486	http://dx.doi.org/10.1074/jbc.M110.167486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870726	Green Published, hybrid			2022-12-25	WOS:000284625600023
J	Ishida, H; Vogel, HJ				Ishida, Hiroaki; Vogel, Hans J.			The Solution Structure of a Plant Calmodulin and the CaM-binding Domain of the Vacuolar Calcium-ATPase BCA1 Reveals a New Binding and Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; LIGHT-CHAIN KINASE; TARGET RECOGNITION; RELAXATION MEASUREMENTS; N-TERMINUS; NMR; ISOFORMS; PROTEINS; DYNAMICS; PEPTIDE	The type IIb class of plant Ca2+-ATPases contains a unique N-terminal extension that encompasses a calmodulin (CaM) binding domain and an auto-inhibitory domain. Binding of Ca2+-CaM to this region can release auto-inhibition and activates the calcium pump. Using multidimensional NMR spectroscopy, we have determined the solution structure of the complex of a plant CaM isoform with the CaM-binding domain of the well characterized Ca2+-ATPase BCA1 from cauliflower. The complex has a rather elongated structure in which the two lobes of CaM do not contact each other. The anchor residues Trp-23 and Ile-40 form a 1-8-18 interaction motif. Binding of Ca2+-CaM gives rise to the induction of two helical parts in this unique target peptide. The two helical portions are connected by a highly positively charged bend region, which represents a relatively fixed angle and positions the two lobes of CaM in an orientation that has not been seen before in any complex structure of calmodulin. The behavior of the complex was further characterized by heteronuclear NMR dynamics measurements of the isotope-labeled protein and peptide. These data suggest a unique calcium-driven activation mechanism for BCA1 and other plant Ca2+-ATPases that may also explain the action of calcium-CaM on some other target enzymes. Moreover, CaM activation of plant Ca2+-ATPases seems to occur in an organelle-specific manner.	[Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Natural Science and Engineering Research Council of Canada.	Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bolte S, 2004, J CELL SCI, V117, P943, DOI 10.1242/jcs.00920; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P1640, DOI 10.1021/bi701987n; Boursiac Y, 2007, J BIOENERG BIOMEMBR, V39, P409, DOI 10.1007/s10863-007-9104-z; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evans DE, 1998, BBA-REV BIOMEMBRANES, V1376, P1, DOI 10.1016/S0304-4157(97)00009-9; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kabala K, 2005, ACTA PHYSIOL PLANT, V27, P559, DOI 10.1007/s11738-005-0062-y; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Malmstrom S, 2000, PLANT PHYSIOL, V122, P517, DOI 10.1104/pp.122.2.517; Malmstrom S, 1997, FEBS LETT, V400, P324, DOI 10.1016/S0014-5793(96)01448-2; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Ryabov Y, 2006, MAGN RESON CHEM, V44, pS143, DOI 10.1002/mrc.1822; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHANG MJ, 1993, PROTEIN SCI, V2, P1931, DOI 10.1002/pro.5560021114; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	58	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38502	38510		10.1074/jbc.M110.131201	http://dx.doi.org/10.1074/jbc.M110.131201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880850	Green Published, hybrid			2022-12-25	WOS:000284625600055
J	Lyons, PJ; Fricker, LD				Lyons, Peter J.; Fricker, Lloyd D.			Substrate Specificity of Human Carboxypeptidase A6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-ACTIVATABLE FIBRINOLYSIS; REGULATED SECRETORY PATHWAY; RAT CARBOXYPEPTIDASE; GENE FAMILY; EXTRACELLULAR-MATRIX; CRYSTAL-STRUCTURES; U TAFIA; METALLOCARBOXYPEPTIDASE; PEPTIDES; CLONING	Carboxypeptidase A6 (CPA6) is an extracellular matrix-bound metallocarboxypeptidase (CP) that has been implicated in Duane syndrome, a neurodevelopmental disorder in which the lateral rectus extraocular muscle is not properly innervated. Consistent with a role in Duane syndrome, CPA6 is expressed in a number of chondrocytic and nervous tissues during embryogenesis. To better characterize the enzymatic function and specificity of CPA6 and to compare this with other CPs, CPA6 was expressed in HEK293 cells and purified. Kinetic parameters were determined using a panel of synthetic carboxypeptidase substrates, indicating a preference of CPA6 for large hydrophobic C-terminal amino acids and only very weak activity toward small amino acids and histidine. A quantitative peptidomics approach using a mixture of peptides representative of the neuropeptidome allowed the characterization of CPA6 preferences at the P1 substrate position and suggested that small and acidic P1 residues significantly inhibit CPA6 cleavage. Finally, a comparison of available kinetic data for CPA enzymes shows a gradient of specificity across the subfamily, from the very restricted specificity of CPA2 to the very broad activity of CPA4. Structural data and modeling for all CPA/B subfamily members suggests the structural basis for the unique specificities observed for each member of the CPA/B subfamily of metallocarboxypeptidases.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	Natural Sciences and Engineering Research Council of Canada [DA-004494]; NEI [EY-194332]; NATIONAL EYE INSTITUTE [F32EY019433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-004494 (to L. D. F.) and postdoctoral fellowships (to P.J.L.) from the Natural Sciences and Engineering Research Council of Canada and the National Eye Institute of the National Institutes of Health Grant EY-194332 from the NEI.	Adler M, 2005, BIOCHEMISTRY-US, V44, P9339, DOI 10.1021/bi0501941; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; CHRISTIANSON DW, 1986, P NATL ACAD SCI USA, V83, P7568, DOI 10.1073/pnas.83.20.7568; CLAUSER E, 1988, J BIOL CHEM, V263, P17837; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Deiteren K, 2007, BBA-PROTEINS PROTEOM, V1774, P267, DOI 10.1016/j.bbapap.2006.11.017; DILLEN L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P105, DOI 10.1016/0167-4838(92)90430-L; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; Geetha-Loganathan P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-32; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; Gutowski NJ, 2000, EUR J NEUROL, V7, P145, DOI 10.1046/j.1468-1331.2000.00029.x; HARTSUCK JA, 1965, P NATL ACAD SCI USA, V53, P396, DOI 10.1073/pnas.53.2.396; Helle KB, 2010, RESULTS PROBL CELL D, V50, P21, DOI 10.1007/400_2009_26; Huang HJ, 1999, CANCER RES, V59, P2981; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MORGAN BA, 1976, J PHARM PHARMACOL, V28, P660, DOI 10.1111/j.2042-7158.1976.tb02827.x; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; NATSUAKI M, 1992, J INVEST DERMATOL, V99, P138, DOI 10.1111/1523-1747.ep12616776; Novikova EG, 1999, BIOCHEM BIOPH RES CO, V256, P564, DOI 10.1006/bbrc.1999.0378; Novikova EG, 2000, J BIOL CHEM, V275, P4865, DOI 10.1074/jbc.275.7.4865; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; PETERSON LM, 1982, ANAL BIOCHEM, V125, P420, DOI 10.1016/0003-2697(82)90024-0; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; RUPLEY JA, 1960, J BIOL CHEM, V235, P609; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Schmidt C, 2004, DEV BIOL, V271, P198, DOI 10.1016/j.ydbio.2004.03.016; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Song LX, 1997, J BIOL CHEM, V272, P10543; SPRINGMAN EB, 1995, J BIOL CHEM, V270, P1300, DOI 10.1074/jbc.270.3.1300; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Ventura S, 1999, J BIOL CHEM, V274, P19925, DOI 10.1074/jbc.274.28.19925; Ventura S, 1997, BIOL CHEM, V378, P161; Wang L, 2009, J BONE MINER RES, V24, P265, DOI [10.1359/jbmr.081014, 10.1359/JBMR.081014]; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Willemse J, 2005, ANAL BIOCHEM, V340, P106, DOI 10.1016/j.ab.2005.01.039; Willemse JL, 2009, J THROMB HAEMOST, V7, P1962, DOI 10.1111/j.1538-7836.2009.03596.x; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	55	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38234	38242		10.1074/jbc.M110.158626	http://dx.doi.org/10.1074/jbc.M110.158626			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855895	Green Published, hybrid			2022-12-25	WOS:000284625600031
J	Herrera, F; Chen, Q; Schubert, D				Herrera, Federico; Chen, Qi; Schubert, David			Synergistic Effect of Retinoic Acid and Cytokines on the Regulation of Glial Fibrillary Acidic Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL PROGENITOR CELLS; HUMAN GLIOBLASTOMA T98G; EMBRYONIC STEM-CELLS; ASTROCYTIC DIFFERENTIATION; SUBVENTRICULAR ZONE; SIGNALING PATHWAY; REACTIVE GLIOSIS; DOWN-SYNDROME; U87MG CELLS; BRAIN	Glial fibrillary acidic protein (GFAP) is the main astroglial marker during astrogliogenesis, but it is also expressed in other cell types, including neural stem cells and old neurons. Activation of the JAK/STAT pathway by the IL-6 family of cytokines is the canonical pathway regulating GFAP expression, whereas retinoic acid is thought to be the only inducer of GFAP to operate independently of this pathway. Here, we show that retinoic acid receptor alpha not only links retinoic acid signaling to the canonical cytokine-stimulated pathway leading to GFAP expression but that it also plays a key role in the synergistic actions of retinoic acid and cytokines on this pathway. Cytokines both potentiate retinoic acid receptor alpha expression and enhance its binding to DNA and to the Stat3-p300/CBP-Smad transcriptional complex, the cornerstone of the canonical pathway. PI3K is upstream to all the key events leading to the expression of GFAP. Our results give new insights about the role of retinoic acid signaling in GFAP expression.	[Herrera, Federico; Chen, Qi; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Schubert, D (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schubert@salk.edu	Herrera, Federico/F-2261-2011	Herrera, Federico/0000-0002-9596-9353				Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bouterfa H, 2000, NEUROSURGERY, V46, P419, DOI 10.1097/00006123-200002000-00029; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Das A, 2008, J NEURO-ONCOL, V87, P9, DOI 10.1007/s11060-007-9485-1; Das A, 2009, NEUROCHEM RES, V34, P87, DOI 10.1007/s11064-008-9669-x; Faigle R, 2008, J NEUROCHEM, V106, P1681, DOI 10.1111/j.1471-4159.2008.05525.x; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Goncalves MBC, 2005, DEV BIOL, V278, P60, DOI 10.1016/j.ydbio.2004.10.015; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Jang YK, 2004, J NEUROSCI RES, V75, P573, DOI 10.1002/jnr.10789; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; Liang XY, 2010, CHINESE MED J-PEKING, V123, P949, DOI 10.3760/cma.j.issn.0366-6999.2010.07.033; Martin-Ibanez R, 2007, J NEUROSCI RES, V85, P2686, DOI 10.1002/jnr.21228; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; MITO T, 1993, EXP NEUROL, V120, P170, DOI 10.1006/exnr.1993.1052; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prestegarden L, 2010, CANCER RES, V70, P4274, DOI 10.1158/0008-5472.CAN-09-3904; Rajan P, 1998, J NEUROSCI, V18, P3620; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Schubert D, 2006, J NEUROCHEM, V96, P444, DOI 10.1111/j.1471-4159.2005.03563.x; Silbereis J, 2010, MOL CELL NEUROSCI, V44, P362, DOI 10.1016/j.mcn.2010.05.001; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Yanagisawa M, 2001, FEBS LETT, V489, P139, DOI 10.1016/S0014-5793(01)02095-6; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yung WKA, 1996, CLIN CANCER RES, V2, P1931	40	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38915	38922		10.1074/jbc.M110.170274	http://dx.doi.org/10.1074/jbc.M110.170274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876578	hybrid, Green Published			2022-12-25	WOS:000284941300021
J	Federici, L; Arcovito, A; Scaglione, GL; Scaloni, F; Lo Sterzo, C; Di Matteo, A; Falini, B; Giardina, B; Brunori, M				Federici, Luca; Arcovito, Alessandro; Scaglione, Giovanni L.; Scaloni, Flavio; Lo Sterzo, Carlo; Di Matteo, Adele; Falini, Brunangelo; Giardina, Bruno; Brunori, Maurizio			Nucleophosmin C-terminal Leukemia-associated Domain Interacts with G-rich Quadruplex Forming DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEOLAR PROTEIN B23; CATIONIC PORPHYRIN; DENATURED STATE; NUCLEIC-ACIDS; NPMC(+) AML; MYC; PROMOTER; ARF	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling phosphoprotein, mainly localized at nucleoli, that plays a key role in ribogenesis, centrosome duplication, and response to stress stimuli. Mutations at the C-terminal domain of NPM1 are the most frequent genetic lesion in acute myeloid leukemia and cause the aberrant and stable translocation of the protein in the cytoplasm. The NPM1 C-terminal domain was previously shown to bind nucleic acids. Here we further investigate the DNA binding properties of the NPM1 C-terminal domain both at the protein and nucleic acid levels; we investigate the domain boundaries and identify key residues for high affinity recognition. Furthermore, we demonstrate that the NPM1 C-terminal domain has a preference for G-quadruplex forming DNA regions and induces the formation of G-quadruplex structures in vitro. Finally we show that a specific sequence found at the SOD2 gene promoter, which was previously shown to be a target of NPM1 in vivo, is indeed folded as a G-quadruplex in vitro under physiological conditions. Our data extend considerably present knowledge on the DNA binding properties of NPM1 and suggest a general role in the transcription of genes characterized by the presence of G-quadruplex forming regions at their promoters.	Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; Univ G dAnnunzio, Ce SI Ctr Excellence Aging, I-66013 Chieti, Italy; [Arcovito, Alessandro; Scaglione, Giovanni L.; Giardina, Bruno] Univ Cattolica Sacro Cuore, Haemostasis Res Ctr, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Scaglione, Giovanni L.] Univ Cattolica Sacro Cuore, Haemostasis Res Ctr, Dept Internal Med, I-00168 Rome, Italy; [Scaloni, Flavio; Lo Sterzo, Carlo; Brunori, Maurizio] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Scaloni, Flavio; Lo Sterzo, Carlo; Brunori, Maurizio] Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Di Matteo, Adele] CNR, Inst Biol & Mol Pathol, I-00185 Rome, Italy; [Falini, Brunangelo] Univ Perugia, Inst Hematol, I-06100 Perugia, Italy; [Giardina, Bruno] CNR, Inst Chem Mol Recognit, I-00168 Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)		lfederici@unich.it	Di Matteo, Adele/AAC-8338-2019; Scaglione, Giovanni Luca/ABD-6776-2020; Arcovito, Alessandro/I-5552-2012	Di Matteo, Adele/0000-0002-5921-7365; Scaglione, Giovanni Luca/0000-0001-5622-7843; Arcovito, Alessandro/0000-0002-8384-4844; FALINI, Brunangelo/0000-0002-7198-5965; Brunori, Maurizio/0000-0002-7795-1635	Associazione Italiana Ricerca sul Cancro (AIRC); Universita Cattolica del Sacro Cuore; University of Chieti "G. D'Annunzio"	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Universita Cattolica del Sacro Cuore; University of Chieti "G. D'Annunzio"	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) (to M. B. and B. F.), Research Programs D.1 2009-2010 "Kinetic Study of Nucleophosmin by Surface Plasmon Resonance" and D.2.2 2008-2009 "SPR of Biological Macromolecules" from the Universita Cattolica del Sacro Cuore (to A. A.) and grants from the University of Chieti "G. D'Annunzio" (to L. F.).	Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Szebeni A, 1999, PROTEIN SCI, V8, P905; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2010, BIOPHYS CHEM, V148, P51, DOI 10.1016/j.bpc.2010.02.009; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8	37	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37138	37149		10.1074/jbc.M110.166736	http://dx.doi.org/10.1074/jbc.M110.166736			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858903	Green Published, hybrid			2022-12-25	WOS:000284424000007
J	Mathews, JA; Gibb, DR; Chen, BH; Scherle, P; Conrad, DH				Mathews, Joel A.; Gibb, David R.; Chen, Bing-Hung; Scherle, Peggy; Conrad, Daniel H.			CD23 Sheddase A Disintegrin and Metalloproteinase 10 (ADAM10) Is Also Required for CD23 Sorting into B Cell-derived Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-CD23 MONOCLONAL-ANTIBODY; IGE-BINDING FACTORS; IN-VIVO; ECTODOMAIN CLEAVAGE; MEMBRANE-PROTEINS; RECEPTOR CD23; LIGAND; FC-EPSILON-RII/CD23; BIOGENESIS; COMPONENTS	The low affinity receptor for IgE, CD23, is the natural regulator of IgE synthesis, and understanding both the synthesis and the catabolism of CD23 are, thus, important issues. Membrane CD23 is cleaved by a disintegrin and metalloproteinase 10 (ADAM10) and this cleavage influences the ability of CD23 to regulate IgE. In contrast to the belief that cleavage is a cell surface event, endosomal neutralization with NH4Cl was found to dramatically reduce CD23 cleavage, suggesting that the majority of CD23 cleavage occurred subsequent to internalization in the endosomal pathway and not at the cell surface. In line with this, full-length CD23 was shown to be sorted in an ADAM10-dependent manner into exosomes. Greatly increased ADAM10-mediated CD23 cleavage was seen at endosomal pH. Additionally, the stalk region of CD23 was found to interact with ADAM10 and ADAM10 binding of CD23 was found to be protease independent. SPR analysis of the interaction indicated about a 10-fold increase in the R-max at endosomal pH (pH 5.8) compared with pH 7.4, whereas the affinity of the interaction was not significantly changed. The R-max change, combined with the increased cleavage at endosomal pH, indicates greater accessibility of the CD23 stalk region for ADAM10 at the lower pH. These results indicate a model where CD23 internalization results in ADAM10-dependent incorporation into exosomes, followed by partial cleavage of CD23 by ADAM10 prior to being released from the cell. The increased cleavage at endosomal pH also has implications for other ADAM10 substrates.	[Mathews, Joel A.; Gibb, David R.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Chen, Bing-Hung] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung 807, Taiwan; [Scherle, Peggy] Incyte Corp, Wilmington, DE 19880 USA	Virginia Commonwealth University; Kaohsiung Medical University; Incyte	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, POB 980678, Richmond, VA 23298 USA.	dconrad@vcu.edu	Chen, Bing-Hung/F-4451-2010	Chen, Bing-Hung/0000-0001-5960-5176	National Institutes of Health [RO1AI18697, 1U19AI077435];  [P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI018697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI18697 and 1U19AI077435 and imaging cytometry supported by Grant P30 CA16059.	BANSAL AS, 1993, IMMUNOLOGY, V79, P285; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BONNEFOY JY, 1995, INT ARCH ALLERGY IMM, V107, P40, DOI 10.1159/000236924; Chen BH, 2002, IMMUNOLOGY, V107, P373, DOI 10.1046/j.1365-2567.2002.01512.x; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; FLORESROMO L, 1993, SCIENCE, V261, P1038, DOI 10.1126/science.8351517; Ford JW, 2006, CELL IMMUNOL, V243, P107, DOI 10.1016/j.cellimm.2007.01.004; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Gauvreau ME, 2009, TRAFFIC, V10, P1518, DOI 10.1111/j.1600-0854.2009.00948.x; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson L, 2009, J IMMUNOL, V183, P2585, DOI 10.4049/jimmunol.0803660; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Karagiannis SN, 2001, IMMUNOLOGY, V103, P319, DOI 10.1046/j.1365-2567.2001.01238.x; KEEGAN AD, 1987, J IMMUNOL, V139, P1199; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kelly AE, 1998, J IMMUNOL, V161, P6696; Kilmon MA, 2004, J IMMUNOL, V172, P1065, DOI 10.4049/jimmunol.172.2.1065; Kilmon MA, 2001, J IMMUNOL, V167, P3139, DOI 10.4049/jimmunol.167.6.3139; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; LETELLIER M, 1989, MOL IMMUNOL, V26, P1105, DOI 10.1016/0161-5890(89)90054-0; LIU FT, 1980, J IMMUNOL, V124, P2728; Liu YL, 2009, AM J PATHOL, V174, P1415, DOI 10.2353/ajpath.2009.080861; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Munoz O, 1998, J BIOL CHEM, V273, P31795, DOI 10.1074/jbc.273.48.31795; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; SARFATI M, 1988, BLOOD, V71, P94; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Savina A, 2002, J CELL SCI, V115, P2505; Schwartz W., 2004, BIOPROCESSING J, V3, P53; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	50	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37531	37541		10.1074/jbc.M110.141556	http://dx.doi.org/10.1074/jbc.M110.141556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876574	hybrid, Green Published			2022-12-25	WOS:000284424000045
J	van der Weerden, NL; Hancock, REW; Anderson, MA				van der Weerden, Nicole L.; Hancock, Robert E. W.; Anderson, Marilyn A.			Permeabilization of Fungal Hyphae by the Plant Defensin NaD1 Occurs through a Cell Wall-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; CANDIDA-ALBICANS; ANTIFUNGAL ACTIVITY; GAMMA-PUROTHIONINS; PROTEIN; BACTERIA; LL-37; INHIBITORS; ENDOSPERM; MEMBRANE	The antifungal activity of the plant defensin NaD1 involves specific interaction with the fungal cell wall, followed by permeabilization of the plasma membrane and entry of NaD1 into the cytoplasm. Prior to this study, the role of membrane permeabilization in the activity of NaD1, as well as the relevance of cell wall binding, had not been investigated. To address this, the permeabilization of Fusarium oxysporum f. sp. vasinfectum hyphae by NaD1 was investigated and compared with that by other antimicrobial peptides, including the cecropin-melittin hybrid peptide CP-29, the bovine peptide BMAP-28, and the human peptide LL-37, which are believed to act largely through membrane disruption. NaD1 appeared to permeabilize cells via a novel mechanism that required the presence of the fungal cell wall. NaD1 and Bac2A, a linear variant of the bovine peptide bactenecin, were able to enter the cytoplasm of treated hyphae, indicating that cell death is accelerated by interaction with intracellular targets.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	La Trobe University; University of British Columbia		m.anderson@latrobe.edu.au	Anderson, Marilyn A/A-4259-2012; Hancock, Robert E. W./E-1145-2013; van der Weerden, Nicole L/C-3705-2014	Anderson, Marilyn A/0000-0002-8257-5128; Hancock, Robert E. W./0000-0001-5989-8503; 	Australian Research Council; Victoria fellowship; Canadian Institutes of Health Research	Australian Research Council(Australian Research Council); Victoria fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by an Australian Research Council grant (to M. A. A.).; Supported by a Victoria fellowship.; Supported by a grant from the Canadian Institutes of Health Research. Holds a Canada Research Chair.	Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chen GH, 2005, J AGR FOOD CHEM, V53, P982, DOI 10.1021/jf0402227; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; den Hertog AL, 2006, BIOL CHEM, V387, P1495, DOI 10.1515/BC.2006.187; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lee DG, 2001, BIOCHEM BIOPH RES CO, V282, P570, DOI 10.1006/bbrc.2001.4602; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Lopez-Garcia B, 2005, J INVEST DERMATOL, V125, P108, DOI 10.1111/j.0022-202X.2005.23713.x; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Oren Z, 1998, BIOPOLYMERS, V47, P451; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Zhang Y, 1997, FEMS MICROBIOL LETT, V149, P59, DOI 10.1111/j.1574-6968.1997.tb10308.x	36	122	125	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37513	37520		10.1074/jbc.M110.134882	http://dx.doi.org/10.1074/jbc.M110.134882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861017	hybrid, Green Published			2022-12-25	WOS:000284424000043
J	Webb, KJ; Zurita-Lopez, CI; Al-Hadid, Q; Laganowsky, A; Young, BD; Lipson, RS; Souda, P; Faull, KF; Whitelegge, JP; Clarke, SG				Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Souda, Puneet; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.			A Novel 3-Methylhistidine Modification of Yeast Ribosomal Protein Rpl3 Is Dependent upon the YIL110W Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; AMINO-ACID-SEQUENCE; ARGININE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MUTANT LACKING; METHYL-ESTER; IDENTIFICATION; ACTIN	We have shown that Rpl3, a protein of the large ribosomal subunit from baker's yeast (Saccharomyces cerevisiae), is stoichiometrically monomethylated at position 243, producing a 3-methylhistidine residue. This conclusion is supported by top-down and bottom-up mass spectrometry of Rpl3, as well as by biochemical analysis of Rpl3 radiolabeled in vivo with S-adenosyl-L-[methyl-H-3] methionine. The results show that a + 14-Da modification occurs within the GTKKLPRKTHRGLRKVAC sequence of Rpl3. Using high-resolution cation-exchange chromatography and thin layer chromatography, we demonstrate that neither lysine nor arginine residues are methylated and that a 3-methylhistidine residue is present. Analysis of 37 deletion strains of known and putative methyltransferases revealed that only the deletion of the YIL110W gene, encoding a seven + -strand methyltransferase, results in the loss of the + 14-Da modification of Rpl3. We suggest that YIL110W encodes a protein histidine methyltransferase responsible for the modification of Rpl3 and potentially other yeast proteins, and now designate it Hpm1 (Histidine protein methyltransferase 1). Deletion of the YIL110W/HPM1 gene results in numerous phenotypes including some that may result from abnormal interactions between Rpl3 and the 25 S ribosomal RNA. This is the first report of a methylated histidine residue in yeast cells, and the first example	[Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Souda, Puneet; Faull, Kym F.; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Laganowsky, Arthur/0000-0001-5012-5547; Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM026020 from the National Institutes of Health.	Arnold RJ, 1999, J BIOL CHEM, V274, P37035, DOI 10.1074/jbc.274.52.37035; BAUER K, 1994, EUR J BIOCHEM, V219, P43, DOI 10.1111/j.1432-1033.1994.tb19912.x; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bengtsson O, 2008, YEAST, V25, P835, DOI 10.1002/yea.1638; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; CLARKE S, 1984, METHOD ENZYMOL, V106, P330; Clarke SG, 2006, ENZYMES, V24, P1; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; ELZINGA M, 1971, BIOCHEMISTRY-US, V10, P224, DOI 10.1021/bi00778a005; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Hirs C. H. W., 1970, HDB BIOCH SELECTED D, pC; HORAKOVA M, 1978, J CHROMATOGR, V159, P227, DOI 10.1016/S0021-9673(00)93923-2; HUSZAR G, 1971, BIOCHEMISTRY-US, V10, P229, DOI 10.1021/bi00778a006; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; LHOEST J, 1981, EUR J BIOCHEM, V121, P33, DOI 10.1111/j.1432-1033.1981.tb06425.x; LHOEST J, 1977, MOL GEN GENET, V154, P175, DOI 10.1007/BF00330833; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Lipson RS, 2010, BIOCHEM BIOPH RES CO, V391, P1658, DOI 10.1016/j.bbrc.2009.12.112; MAITA T, 1991, J BIOCHEM-TOKYO, V110, P68, DOI 10.1093/oxfordjournals.jbchem.a123545; Meskauskas A, 2005, MOL CELL BIOL, V25, P10863, DOI 10.1128/MCB.25.24.10863-10874.2005; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P6175, DOI 10.1093/nar/gkn642; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; MEYER HE, 1987, BIOL CHEM H-S, V368, P1607, DOI 10.1515/bchm3.1987.368.2.1607; Miranda TB, 2004, FEBS LETT, V577, P181, DOI 10.1016/j.febslet.2004.09.080; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; NAKAYAMA S, 1994, J BIOCHEM-TOKYO, V115, P909, DOI 10.1093/oxfordjournals.jbchem.a124439; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; PAIVA ACM, 1976, J AM CHEM SOC, V98, P7645, DOI 10.1021/ja00440a033; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Raftery MJ, 1996, BIOCHEM J, V316, P285, DOI 10.1042/bj3160285; RAGHAVAN M, 1992, EUR J BIOCHEM, V210, P311, DOI 10.1111/j.1432-1033.1992.tb17423.x; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Smith I., 1960, CHROMATOGR ELECTROPH, VI, P212; SUSSMAN DJ, 1984, J BIOL CHEM, V259, P7349; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; VIJAYASARATHY C, 1987, BIOCHIM BIOPHYS ACTA, V923, P156, DOI 10.1016/0304-4165(87)90139-5; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	64	52	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37598	37606		10.1074/jbc.M110.170787	http://dx.doi.org/10.1074/jbc.M110.170787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864530	Green Published, hybrid			2022-12-25	WOS:000284424000052
J	Perreault, ML; Hasbi, A; Alijaniaram, M; Fan, T; Varghese, G; Fletcher, PJ; Seeman, P; O'Dowd, BF; George, SR				Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Fletcher, Paul J.; Seeman, Philip; O'Dowd, Brian F.; George, Susan R.			The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons INCREASED HIGH AFFINITY STATE FOLLOWING AMPHETAMINE AND IN SCHIZOPHRENIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; COCAINE-SEEKING; AMPA RECEPTORS; RAT STRIATUM; SUBSTANCE-P; D1; PHOSPHORYLATION; ACTIVATION	The distribution and function of neurons coexpressing the dopamine D1 and D2 receptors in the basal ganglia and mesolimbic system are unknown. We found a subset of medium spiny neurons coexpressing D1 and D2 receptors in varying densities throughout the basal ganglia, with the highest incidence in nucleus accumbens and globus pallidus and the lowest incidence in caudate putamen. These receptors formed D1-D2 receptor heteromers that were localized to cell bodies and presynaptic terminals. In rats, selective activation of D1-D2 heteromers increased grooming behavior and attenuated AMPA receptor GluR1 phosphorylation by calcium/calmodulin kinase II alpha in nucleus accumbens, implying a role in reward pathways. D1-D2 heteromer sensitivity and functional activity was up-regulated in rat striatum by chronic amphetamine treatment and in globus pallidus from schizophrenia patients, indicating that the dopamine D1-D2 heteromer may contribute to psychopathologies of drug abuse, schizophrenia, or other disorders involving elevated dopamine transmission.	[Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Seeman, Philip; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Fletcher, Paul J.] Univ Toronto, Dept Psychiat & Psychol, Toronto, ON M5S 1A8, Canada; [Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Fletcher, Paul J.; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	George, SR (corresponding author), Univ Toronto, Dept Pharmacol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	s.george@utoronto.ca	Perreault, Melissa L/N-2867-2017; George, Susan R/P-9669-2018; George, Susan/W-7494-2019	Perreault, Melissa L/0000-0002-5775-8950; Fletcher, Paul/0000-0001-8906-2280	National Institute on Drug Abuse [DA007223]; Ontario Mental Health Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ontario Mental Health Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse DA007223 (to S. R. G., B. F. O., and P. S.) and an Ontario Mental Health Foundation postdoctoral fellowship (to M. L. P.).	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Aubert I, 2000, J COMP NEUROL, V418, P22; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Chen Y., 2005, MOL IMAGING FRET MIC, P126; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Crombag HS, 2008, BEHAV BRAIN RES, V191, P178, DOI 10.1016/j.bbr.2008.03.026; Culver KE, 2000, PSYCHOPHARMACOLOGY, V151, P202, DOI 10.1007/s002139900346; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Geldwert D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-53; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kegeles LS, 2008, NEUROPSYCHOPHARMACOL, V33, P3111, DOI 10.1038/npp.2008.33; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lidow MS, 2003, BRAIN RES REV, V43, P70, DOI 10.1016/S0165-0173(03)00203-0; Mizuno Takeo, 2007, BMC Neurosci, V8, P8, DOI 10.1186/1471-2202-8-8; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Ping AS, 2008, BRAIN RES, V1215, P173, DOI 10.1016/j.brainres.2008.03.088; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Reiner A, 1999, NEUROSCIENCE, V88, P775, DOI 10.1016/S0306-4522(98)00254-1; Seeman P, 2008, SYNAPSE, V62, P819, DOI 10.1002/syn.20561; Seeman P, 2009, SYNAPSE, V63, P935, DOI 10.1002/syn.20704; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Wang HB, 2006, J CHEM NEUROANAT, V31, P178, DOI 10.1016/j.jchemneu.2006.01.003; Wang JQ, 2006, J NEUROSCI RES, V84, P1621, DOI 10.1002/jnr.21050	32	135	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36625	36634		10.1074/jbc.M110.159954	http://dx.doi.org/10.1074/jbc.M110.159954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864528	Green Published, hybrid			2022-12-25	WOS:000284146100067
J	Haeusler, RA; Kaestner, KH; Accili, D				Haeusler, Rebecca A.; Kaestner, Klaus H.; Accili, Domenico			FoxOs Function Synergistically to Promote Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; MOLECULAR PHYSIOLOGY; HOMEOSTASIS; MICE; LIVER; GLUCONEOGENESIS; PHOSPHORYLATION; GLUCOKINASE; METABOLISM; GROWTH	Hepatic glucose production (HGP) plays a vital role in maintaining the supply of glucose to the body, and transcription factor FoxO1 is known to confer hormone responsiveness onto HGP. Mice with a liver-specific FoxO1 deletion (L-FoxO1) show reduced HGP and reduced expression of glucose production genes. To determine the contribution of additional transcription factors to HGP, we created double and triple liver-specific knock-outs lacking FoxO1, FoxO3, and FoxO4 or the related protein FoxA2. We show that, when compared with single knock-out of FoxO1, triple ablation of FoxO genes causes more pronounced fasting hypoglycemia, increased glucose tolerance, and enhanced insulin sensitivity, with decreased plasma insulin levels. In contrast, combined ablation of FoxO1 and FoxA2 phenocopied the single knock-out of FoxO1. These data indicate that FoxOs work in concert to regulate multiple aspects of hepatic glucose metabolism.	Columbia Univ, Dept Med, New York, NY 10032 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Haeusler, Rebecca/0000-0002-6973-9845	National Institutes of Health [P01HL87123, R01DK57539, P30DK63608, T32DK07328]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL87123, R01DK57539, and P30DK63608 (to D.A.), and T32DK07328 (to R.A.H.).	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Barrett EJ, 2003, J CLIN INVEST, V111, P434, DOI 10.1172/JCI200317881; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hume R, 2005, EARLY HUM DEV, V81, P95, DOI 10.1016/j.earlhumdev.2004.10.005; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Wang JC, 2000, J BIOL CHEM, V275, P14717, DOI 10.1074/jbc.275.19.14717; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	34	132	142	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35245	35248		10.1074/jbc.C110.175851	http://dx.doi.org/10.1074/jbc.C110.175851			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20880840	hybrid, Green Published			2022-12-25	WOS:000283845300001
J	Olivares-Hernandez, R; Sunner, H; Frisvad, JC; Olsson, L; Nielsen, J; Panagiotou, G				Olivares-Hernandez, Roberto; Sunner, Hampus; Frisvad, Jens C.; Olsson, Lisbeth; Nielsen, Jens; Panagiotou, Gianni			Combining Substrate Specificity Analysis with Support Vector Classifiers Reveals Feruloyl Esterase as a Phylogenetically Informative Protein Group	PLOS ONE			English	Article							CLASSIFICATION	Background: Our understanding of how fungi evolved to develop a variety of ecological niches, is limited but of fundamental biological importance. Specifically, the evolution of enzymes affects how well species can adapt to new environmental conditions. Feruloyl esterases (FAEs) are enzymes able to hydrolyze the ester bonds linking ferulic acid to plant cell wall polysaccharides. The diversity of substrate specificities found in the FAE family shows that this family is old enough to have experienced the emergence and loss of many activities. Methodology/Principal Findings: In this study we evaluate the relative activity of FAEs against a variety of model substrates as a novel predictive tool for Ascomycota taxonomic classification. Our approach consists of two analytical steps; (1) an initial unsupervised analysis to cluster the FAEs substrate specificity data which were generated by cultivation of 34 Ascomycota strains and then an analysis of the produced enzyme cocktail against 10 substituted cinnamate and phenylalkanoate methyl esters, (2) a second, supervised analysis for training a predictor built on these substrate activities. By applying both linear and non-linear models we were able to correctly predict the taxonomic Class (similar to 86% correct classification), Order (similar to 88% correct classification) and Family (similar to 88% correct classification) that the 34 Ascomycota belong to, using the activity profiles of the FAEs. Conclusion/Significance: The good correlation with the FAEs substrate specificities that we have defined via our phylogenetic analysis not only suggests that FAEs are phylogenetically informative proteins but it is also a considerable step towards improved FAEs functional prediction.	[Frisvad, Jens C.; Panagiotou, Gianni] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Olivares-Hernandez, Roberto; Sunner, Hampus; Olsson, Lisbeth; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Chalmers University of Technology	Olivares-Hernandez, R (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Frisvad, Jens C/K-2818-2017; Nielsen, Jens/Q-1347-2017	Frisvad, Jens C/0000-0002-0573-4340; /0000-0002-0827-5442; Olivares-Hernandez, Roberto/0000-0002-8431-4052; Nielsen, Jens/0000-0002-9955-6003	Danish Research Council for Technology and Production Sciences; Wallenberg Wood Science Center; CONACYT-Mexico; Chalmers Foundation	Danish Research Council for Technology and Production Sciences; Wallenberg Wood Science Center; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Chalmers Foundation	GPA would like to thank the Danish Research Council for Technology and Production Sciences for financial support. HS and LO thank Wallenberg Wood Science Center for financial support. ROH would like to thank the CONACYT-Mexico and the Chalmers Foundation for scholarship to support doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1996, INTRODUCTORY MYCOLOG; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARR ME, 1990, MYCOTAXON, V39, P43; Benoit I, 2008, BIOTECHNOL LETT, V30, P387, DOI 10.1007/s10529-007-9564-6; CHRISTENSEN M, 1962, MYCOLOGIA, V54, P573, DOI 10.2307/3756326; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson O., 1993, SYSTEMA ASCOMYCETUM, V12, P1; Fausset L, 1994, FUNDAMENTALS NEURAL; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.pp.42.060191.003005; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; KIRK PM, DICT FUNGI; Kroon PA, 1997, EUR J BIOCHEM, V248, P245, DOI 10.1111/j.1432-1033.1997.00245.x; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; LOBUGLIO KF, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P115; McCullagh P, 1989, GEN LINEAR MODELS; PETERSON SW, 2000, INTEGRATION MODERN T, P163; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Topakas E, 2005, J BIOTECHNOL, V115, P355, DOI 10.1016/j.jbiotec.2004.10.001; Vafiadi C, 2008, J BIOTECHNOL, V133, P497, DOI 10.1016/j.jbiotec.2007.11.004; Vafiadi C, 2007, BIOTECHNOL LETT, V29, P1771, DOI 10.1007/s10529-007-9440-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Witten I. H., 2005, DATA MINING PRACTICA; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	33	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12781	10.1371/journal.pone.0012781	http://dx.doi.org/10.1371/journal.pone.0012781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877647	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100008
J	Richmond, OMW; McEntee, JP; Hijmans, RJ; Brashares, JS				Richmond, Orien M. W.; McEntee, Jay P.; Hijmans, Robert J.; Brashares, Justin S.			Is the Climate Right for Pleistocene Rewilding? Using Species Distribution Models to Extrapolate Climatic Suitability for Mammals across Continents	PLOS ONE			English	Article							HABITAT DISTRIBUTION MODELS; SAMPLE-SIZE; POTENTIAL DISTRIBUTION; ASSISTED MIGRATION; CHANGE PROJECTIONS; ENVELOPE MODELS; ROC CURVE; CONSERVATION; PERFORMANCE; PREDICTION	Species distribution models (SDMs) are increasingly used for extrapolation, or predicting suitable regions for species under new geographic or temporal scenarios. However, SDM predictions may be prone to errors if species are not at equilibrium with climatic conditions in the current range and if training samples are not representative. Here the controversial "Pleistocene rewilding" proposal was used as a novel example to address some of the challenges of extrapolating modeled species-climate relationships outside of current ranges. Climatic suitability for three proposed proxy species (Asian elephant, African cheetah and African lion) was extrapolated to the American southwest and Great Plains using Maxent, a machine-learning species distribution model. Similar models were fit for Oryx gazella, a species native to Africa that has naturalized in North America, to test model predictions. To overcome biases introduced by contracted modern ranges and limited occurrence data, random pseudo-presence points generated from modern and historical ranges were used for model training. For all species except the oryx, models of climatic suitability fit to training data from historical ranges produced larger areas of predicted suitability in North America than models fit to training data from modern ranges. Four naturalized oryx populations in the American southwest were correctly predicted with a generous model threshold, but none of these locations were predicted with a more stringent threshold. In general, the northern Great Plains had low climatic suitability for all focal species and scenarios considered, while portions of the southern Great Plains and American southwest had low to intermediate suitability for some species in some scenarios. The results suggest that the use of historical, in addition to modern, range information and randomly sampled pseudo-presence points may improve model accuracy. This has implications for modeling range shifts of organisms in response to climate change.	[Richmond, Orien M. W.; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [McEntee, Jay P.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis	Richmond, OMW (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	orien.richmond@gmail.com	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872	National Science Foundation-Integrative Organismal Systems [0818185]; United States Department of Agriculture-National Research Initiative [2008-03116]	National Science Foundation-Integrative Organismal Systems; United States Department of Agriculture-National Research Initiative(United States Department of Agriculture (USDA))	This work was supported in part by the following grants: National Science Foundation-Integrative Organismal Systems 0818185 and United States Department of Agriculture-National Research Initiative 2008-03116 to JSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WORLDCLIM INTERPOLAT; [Anonymous], [No title captured]; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bar-David S, 2006, ECOLOGY, V87, P1215, DOI 10.1890/0012-9658(2006)87[1215:DAMOID]2.0.CO;2; BAUER H, 2008, IUCN 2009 RED LIST T; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Brito JC, 2009, BIOL CONSERV, V142, P3020, DOI 10.1016/j.biocon.2009.08.001; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Early R, 2008, J APPL ECOL, V45, P228, DOI 10.1111/j.1365-2664.2007.01424.x; EAST R, 1989, ANTELOPES GLOBAL S 2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *ENV SYST RES I, 2009, ARCMAP VERS 9 3 1; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN SSC Antelope Specialist Group, 2008, IUCN 2010 IUCN RED L; Jackson P., 1996, BIOL CONSERVATION; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mackey BG, 2001, J BIOGEOGR, V28, P1147, DOI 10.1046/j.1365-2699.2001.00626.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Masembe C, 2006, CONSERV GENET, V7, P551, DOI 10.1007/s10592-005-9066-9; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Mueller JM, 2008, CONSERV BIOL, V22, P562, DOI 10.1111/j.1523-1739.2008.00952.x; Olivier R., 1978, Oryx, V14, P379, DOI 10.1017/S003060530001601X; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; REID WH, 1983, SOUTHWEST NAT, V28, P97, DOI 10.2307/3670599; Santiapillai C., 1990, ASIAN ELEPHANT ACTIO; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Steig EJ, 1999, SCIENCE, V286, P1485, DOI 10.1126/science.286.5444.1485; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson Robert S., 1993, P468; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Varela S, 2009, J BIOGEOGR, V36, P1645, DOI 10.1111/j.1365-2699.2009.02125.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; WEB T, 1993, GLOBAL CLIMATES SINC, P415; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wrogemann N., 1975, CHEETAH SUN; Yunsheng Wang, 2007, Shengwu Duoyangxing, V15, P365, DOI 10.1360/biodiv.060280; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x; [No title captured]	81	34	34	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12899	10.1371/journal.pone.0012899	http://dx.doi.org/10.1371/journal.pone.0012899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877563	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100031
J	Sheldon, IM; Roberts, MH				Sheldon, Iain Martin; Roberts, Mark H.			Toll-Like Receptor 4 Mediates the Response of Epithelial and Stromal Cells to Lipopolysaccharide in the Endometrium	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; FEMALE REPRODUCTIVE-TRACT; INDUCED PRETERM BIRTH; CUTTING EDGE; EXPRESSION; IMMUNITY; CULTURE; GENE; MICE; RESPONSIVENESS	Background: Ascending infections of the female genital tract with bacteria causes pelvic inflammatory disease (PID), preterm labour and infertility. Lipopolysaccharide (LPS) is the main component of the cell wall of Gram-negative bacteria. Innate immunity relies on the detection of LPS by Toll-like receptor 4 (TLR4) on host cells. Binding of LPS to TLR4 on immune cells stimulates secretion of pro-inflammatory cytokines such as IL-6, chemokines such as CXCL1 and CCL20, and prostaglandin E(2). The present study tested the hypothesis that TLR4 on endometrial epithelial and stromal cells is essential for the innate immune response to LPS in the female genital tract. Methodology/Principal Findings: Wild type (WT) mice expressed TLR4 in the endometrium. Intrauterine infusion of purified LPS caused pelvic inflammatory disease, with accumulation of granulocytes throughout the endometrium of WT but not Tlr4(-/-) mice. Intra-peritoneal infusion of LPS did not cause PID in WT or Tlr4(-/-) mice, indicating the importance of TLR4 in the endometrium for the detection of LPS in the female genital tract. Stromal and epithelial cells isolated from the endometrium of WT but not Tlr4(-/-) mice, secreted IL-6, CXCL1, CCL20 and prostaglandin E(2) in response to LPS, in a concentration and time dependent manner. Co-culture of combinations of stromal and epithelial cells from WT and Tlr4(-/-) mice provided little evidence of stromal-epithelial interactions in the response to LPS. Conclusions/Significance: The innate immune response to LPS in the female genital tract is dependent on TLR4 on the epithelial and stromal cells of the endometrium.	[Sheldon, Iain Martin; Roberts, Mark H.] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales	Swansea University	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	I.M.Sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013	Sheldon, I Martin/0000-0001-7902-5558	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D02028X/1]; BBSRC [BB/D02028X/1, BB/D02028X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D02028X/1, BB/D02028X/2] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) through the award of a Research Development Fellowship (Grant No. BB/D02028X/1) to IMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; COOKE PS, 1986, P NATL ACAD SCI USA, V83, P2109, DOI 10.1073/pnas.83.7.2109; Davies D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-53; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Hirata T, 2005, J CLIN ENDOCR METAB, V90, P548, DOI 10.1210/jc.2004-0241; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; *NIAID, 2008, PELV INFL DIS; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POYSER NL, 1987, J REPROD FERTIL, V81, P269, DOI 10.1530/jrf.0.0810269; Reznikov LL, 1999, BIOL REPROD, V60, P1231, DOI 10.1095/biolreprod60.5.1231; Ross JDC, 2002, SEX TRANSM INFECT, V78, P18, DOI 10.1136/sti.78.1.18; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Soboll G, 2006, BIOL REPROD, V75, P131, DOI 10.1095/biolreprod.106.050690; Soboll G, 2006, IMMUNOLOGY, V118, P185, DOI 10.1111/j.1365-2567.2006.02353.x; Sweet R. L., 2009, INFECT DIS FEMALE GE; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Young SL, 2004, AM J REPROD IMMUNOL, V52, P67, DOI 10.1111/j.1600-0897.2004.00189.x; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	35	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12906	10.1371/journal.pone.0012906	http://dx.doi.org/10.1371/journal.pone.0012906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877575	Green Published, gold, Green Submitted			2022-12-25	WOS:000282053100032
J	Rabinovich, MI; Muezzinoglu, MK; Strigo, I; Bystritsky, A				Rabinovich, Mikhail I.; Muezzinoglu, Mehmet K.; Strigo, Irina; Bystritsky, Alexander			Dynamical Principles of Emotion-Cognition Interaction: Mathematical Images of Mental Disorders	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; NEURAL MASS MODEL; FUNCTIONAL CONNECTIVITY; TRANSIENT DYNAMICS; WORKING-MEMORY; BRAIN NETWORKS; STATES; NEUROSCIENCE; ANXIETY; NEURONS	The key contribution of this work is to introduce a mathematical framework to understand self-organized dynamics in the brain that can explain certain aspects of itinerant behavior. Specifically, we introduce a model based upon the coupling of generalized Lotka-Volterra systems. This coupling is based upon competition for common resources. The system can be regarded as a normal or canonical form for any distributed system that shows self-organized dynamics that entail winnerless competition. Crucially, we will show that some of the fundamental instabilities that arise in these coupled systems are remarkably similar to endogenous activity seen in the brain (using EEG and fMRI). Furthermore, by changing a small subset of the system's parameters we can produce bifurcations and metastable sequential dynamics changing, which bear a remarkable similarity to pathological brain states seen in psychiatry. In what follows, we will consider the coupling of two macroscopic modes of brain activity, which, in a purely descriptive fashion, we will label as cognitive and emotional modes. Our aim is to examine the dynamical structures that emerge when coupling these two modes and relate them tentatively to brain activity in normal and non-normal states.	[Rabinovich, Mikhail I.; Muezzinoglu, Mehmet K.; Strigo, Irina] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Strigo, Irina] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Bystritsky, Alexander] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Rabinovich, MI (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	mrabinovich@ucsd.edu	strigo, irina A/L-9882-2016	strigo, irina A/0000-0002-8799-716X; Rabinovich, Mikhail I./0000-0003-4499-5348	ONR [N00014-07-1-0741]; Jet Propulsion Laboratory [1396686]; National Institutes of Health (NIH) [NH080003]; Saban Family Foundation	ONR(Office of Naval Research); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saban Family Foundation	M.I.R. and M. K. M. acknowledge the support from ONR grant N00014-07-1-0741. M. K. M. acknowledges the support from the Jet Propulsion Laboratory (1396686). I. S. is supported by the National Institutes of Health (NIH) grant NH080003. A. B. is partially supported by Saban Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Afraimovich V, 2008, CHAOS, V18, DOI 10.1063/1.2991108; Afraimovich VS, 2004, CHAOS, V14, P1123, DOI 10.1063/1.1819625; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2010, P NATL ACAD SCI USA, V107, P10769, DOI 10.1073/pnas.1005987107; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; CALLAHAN J, 1990, BEHAV SCI, V35, P60, DOI 10.1002/bs.3830350107; CHEN Y, 2009, COMPUT MATH IN PRESS; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; CURETON RD, 1994, J LITERARY SEMANTICS, V23, P220, DOI 10.1515/jlse.1994.23.3.220; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Fingelkurts Andrew A, 2006, Cogn Process, V7, P135, DOI 10.1007/s10339-006-0035-0; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K, 2000, PHILOS T ROY SOC B, V355, P135, DOI 10.1098/rstb.2000.0554; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Globerson A, 2009, P NATL ACAD SCI USA, V106, P3490, DOI 10.1073/pnas.0806782106; Gros C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/109; GUSTAFSON JP, 2004, PSYCHODYNAMIC PRACTI, V10, P470; Hollander E, 2007, CNS SPECTRUMS, V12, P12, DOI 10.1017/S1092852900020447; Hollnagel E., 2003, HDB COGNITIVE TASK D; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huber MT, 1999, BIOL PSYCHIAT, V46, P256, DOI 10.1016/S0006-3223(98)00311-4; Huber MT, 2000, BIOL PSYCHIAT, V47, P634, DOI 10.1016/S0006-3223(99)00174-2; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Huppert Jonathan D, 2005, Curr Psychiatry Rep, V7, P268, DOI 10.1007/s11920-005-0080-x; Ito J, 2007, HUM BRAIN MAPP, V28, P904, DOI 10.1002/hbm.20316; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; James W., 1890, PRINCIPLES PSYCHOL; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Katerndahl David, 2007, Prim Care Companion J Clin Psychiatry, V9, P183; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kiebel SJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000464; Koenig T, 2001, NEUROIMAGE, V14, P383, DOI 10.1006/nimg.2001.0825; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Kubota S, 2002, MED HYPOTHESES, V59, P16, DOI 10.1016/S0306-9877(02)00196-2; Landau L.D., 1959, FLUID MECH COURSE TH, V6; LANE RD, 2002, WISDOM FEELING PSYCH; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lee JH, 1999, J EXP EDUC, V67, P218, DOI 10.1080/00220979909598354; Lotka A. J., 1956, ELEMENTS MATH BIOL, DOI DOI 10.2307/1909476; MAGOR L, 2009, PLOS ONE, V4, pE4447; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Masterpasqua F, 1997, PSYCHOL MEANING CHAO; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MCCLURE SM, 2007, HDB EMOTION REGULATI, V32, P204; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Moran A. P., 2004, SPORT EXERCISE PSYCH; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; MUEZZINOGLU MK, 2009, INT J BIFUR IN PRESS; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Ott E., 1993, CHAOS DYNAMICAL SYST; Oullier O, 2006, TRENDS COGN SCI, V10, P353, DOI 10.1016/j.tics.2006.06.009; Pariitt C.G., 1990, STRESS PERFORMANCE S, P43; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Poincare H., 1958, VALUE SCI; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; Port R., 1995, MIND MOTION EXPLORAT; PRICE DD, 1985, MOTIV EMOTION, V9, P19, DOI 10.1007/BF00991548; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; SABELLI HC, 1995, CHAOS THEORY PSYCHOL, P65; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; SCHERER KR, 1993, COGNITION EMOTION, V7, P1, DOI 10.1080/02699939308409174; Schraagen J.M., 2000, COGNITIVE TASK ANAL; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Temam R., 1988, INFINITE DIMENSIONAL, DOI DOI 10.1007/978-1-4684-0313-8; Thagard P, 2008, CONSCIOUS COGN, V17, P811, DOI 10.1016/j.concog.2007.05.014; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Varona P, 2004, NEUROCOMPUTING, V58, P549, DOI 10.1016/j.neucom.2004.01.093; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; Zavaglia M, 2006, J NEUROSCI METH, V157, P317, DOI 10.1016/j.jneumeth.2006.04.022; ZOR R, 2007, WORLD J BIOL PSYCHIA, P1	88	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12547	10.1371/journal.pone.0012547	http://dx.doi.org/10.1371/journal.pone.0012547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877723	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900001
J	Kraatz, BP; Meng, J; Weksler, M; Li, CK				Kraatz, Brian P.; Meng, Jin; Weksler, Marcelo; Li, Chuankui			Evolutionary Patterns in the Dentition of Duplicidentata (Mammalia) and a Novel Trend in the Molarization of Premolars	PLOS ONE			English	Article							TEETH; MODEL; LAGOMORPHS; PHYLOGENY; GLIRES	Background: The cusp homology of Lagomorpha has long been problematic largely because their teeth are highly derived relative to their more typically tribosphenic ancestors. Within this context, the lagomorph central cusp has been particularly difficult to homologize with other tribosphenic cusps; authors have previously considered it the paracone, protocone, metacone, amphicone, or an entirely new cusp. Methodology/Principal Findings: Here we present newly described fossil duplicidentates (Lagomorpha and Mimotonidae) in the context of a well-constrained phylogeny to establish a nomenclatural system for cusps based on the tribosphenic pattern. We show that the central cusp of lagomorphs is homologous with the metaconule of other mammals. We also show that the buccal acquisition of a second cusp on the premolars (molarization) within duplicidentates is atypical with respect to other mammalian lineages; within the earliest lagomorphs, a second buccal cusp is added mesially to an isolated buccal cusp. Conclusions/Significance: The distal shift of the 'ancestral' paracone within early duplicidentates amounts to the changing of a paracone into a metacone in these lineages. For this reason, we support a strictly topological approach to cusp names, and suggest a discontinuity in nomenclature to capture the complexity of the interplay between evolutionary history and the developmental process that have produced cusp patterns in duplicidentates.	[Kraatz, Brian P.] Western Univ Hlth Sci, Dept Anat, Pomona, CA USA; [Kraatz, Brian P.; Meng, Jin; Weksler, Marcelo] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Li, Chuankui] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Dept Vertebrate Paleontol, Beijing, Peoples R China	Western University of Health Sciences; American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Kraatz, BP (corresponding author), Western Univ Hlth Sci, Dept Anat, Pomona, CA USA.	bkraatz@westernu.edu	Weksler, Marcelo/A-7420-2010	Weksler, Marcelo/0000-0001-8111-4779	American Museum of Natural History; National Science Foundation (NSF) [EAR-0120727, BCS-0309800]; MST of China [2006CB806400]	American Museum of Natural History; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); MST of China(Ministry of Science and Technology, China)	BPK was supported by a research fellowship at the American Museum of Natural History. Funding was provided via National Science Foundation (NSF) grants EAR-0120727, BCS-0309800 and Major Basic Research Projects of MST of China (2006CB806400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Aversa S, 1998, QUAL LIFE RES, V7, P205, DOI 10.1023/A:1008869829358; Bair AR, 2007, PALEOBIOLOGY, V33, P53, DOI 10.1666/06044.1; Bohlin B., 1942, Paleont sinica NSO, V8a, P1; Bohlin B, 1937, PALAEONTOLOGIA SIN C, V3, P1; Bown T.M., 1979, P172; Burke J J, 1936, ANN CARNEGIE MUS, V25, P135; Burke J.T., 1934, Annals of the Carnegie Museum, V23, P399; Butler PM., 1985, EVOLUTIONARY RELATIO, P381; BUTLER PM, 1952, P ZOOL SOC LOND, V121, P810; COPE ED, 1875, P ACAD NAT SCI PHILA, V27, P20; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Dawson M.R., 1967, ESSAYS PALEONTOLOGY, V2, P287; de Chardin P. Teilhard, 1926, ANN PALEONTOL, V15, P1; DICE LEER, 1929, JOUR MAMMALOGY, V10, P340, DOI 10.2307/1374124; EHIK J, 1926, ANN MUSEI NATL HUNGA, V22, P178; Forsyth Major CI., 1899, T LINN SOC LOND, V7, P433, DOI 10.1111/j.1096-3642.1899.tb002021.x.; Hall B. K., 1994, HOMOLOGY HIERARCHICA; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall J, 2008, DEV PRIMATOL-PROG PR, P335, DOI 10.1007/978-0-387-73896-3_22; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Li Chuankui, 2007, Bulletin of Carnegie Museum of Natural History, V39, P97, DOI 10.2992/0145-9058(2007)39[97:DAAPLF]2.0.CO;2; Lopez-Martinez Nieves, 2008, P27, DOI 10.1007/978-3-540-72446-9_3; LOPEZMARTINEZ N, 1985, EVOLUTIONARY RELATIO, P151; Major C. I. F., 1873, PALAEONTOGRAPHICA, V22, P75; MAJOR CJF, 1893, P ZOOLOGICAL SOC, V10, P179; MATHEW WD, 1923, AM MUS NOVIT, P10; MCKENNA MC, 1982, GEOBIOS MEM SPEC, V6, P213; Meng J, 2003, B AM MUS NAT HIST, P1; MENG J, 2004, AM MUS NOVIT, P24; MENG J, 2009, AM MUS NOVIT, P11; Meng Jin, 2004, Vertebrata Palasiatica, V42, P261; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Osborn HF, 1904, AM J SCI, V17, P321; OSBORN HF, 2007, EVOLUTION MAMMALIAN; OSBORN HF, 1895, INT DENT J, V7, P1; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; RUSSELL LS, 1958, NAT MUS CANADA, V166, P41; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; SIMPSON GG, 1936, DENT COSMOS, P1; SYCH L, 1975, Palaeontologia Polonica, V33, P183; SYCH L, 1977, Acta Zoologica Cracoviensia, V22, P1; SYCH L, 1976, Acta Zoologica Cracoviensia, V21, P33; SYCH L, 1967, ACTA ZOOLOGICA CRACO, V12, P1; Tobien H., 1975, Notizblatt Hess Landesamt Bodenforsch Wiesbaden, V103, P103; Tobien H., 1974, Mainzer geowiss. Mitt., V3, P95; TONG YS, 1987, VERTEBRAT PALASIATIC, V25, P208; Van Valen Leigh, 2002, Evolutionary Theory & Review, V12, P101; VANVALEN L, 1964, EVOLUTION, V18, P484, DOI 10.1111/j.1558-5646.1964.tb01624.x; VANVALEN LM, 1982, J MORPHOL, V173, P305, DOI 10.1002/jmor.1051730307; White J.A., 1991, Journal of Vertebrate Paleontology, V11, P67; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wible John R., 2007, Bulletin of Carnegie Museum of Natural History, V39, P213, DOI 10.2992/0145-9058(2007)39[213:OTCOOT]2.0.CO;2; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wood A. E., 1940, Transactions of the American Philosophical Society Philadelphia NS, V28, P271; WOOD AE, 1957, EVOLUTION, V11, P417, DOI 10.2307/2406062	57	79	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12838	10.1371/journal.pone.0012838	http://dx.doi.org/10.1371/journal.pone.0012838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877465	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200014
J	VanDalen, KK; Franklin, AB; Mooers, NL; Sullivan, HJ; Shriner, SA				VanDalen, Kaci K.; Franklin, Alan B.; Mooers, Nicole L.; Sullivan, Heather J.; Shriner, Susan A.			Shedding Light on Avian Influenza H4N6 Infection in Mallards: Modes of Transmission and Implications for Surveillance	PLOS ONE			English	Article							WILD BIRDS; A VIRUS; RT-PCR; PREVALENCE; PERSISTENCE; EVOLUTION; DIAGNOSIS	Background: Wild mallards (Anas platyrhychos) are considered one of the primary reservoir species for avian influenza viruses (AIV). Because AIV circulating in wild birds pose an indirect threat to agriculture and human health, understanding the ecology of AIV and developing risk assessments and surveillance systems for prevention of disease is critical. Methodology/Principal Findings: In this study, mallards were experimentally infected with an H4N6 subtype of AIV by oral inoculation or contact with an H4N6 contaminated water source. Cloacal swabs, oropharyngeal swabs, fecal samples, and water samples were collected daily and tested by real-time RT-PCR (RRT-PCR) for estimation of viral shedding. Fecal samples had significantly higher virus concentrations than oropharyngeal or cloacal swabs and 6 month old ducks shed significantly more viral RNA than 3 month old ducks regardless of sample type. Use of a water source contaminated by AIV infected mallards, was sufficient to transmit virus to naive mallards, which shed AIV at higher or similar levels as orally-inoculated ducks. Conclusions: Bodies of water could serve as a transmission pathway for AIV in waterfowl. For AIV surveillance purposes, water samples and fecal samples appear to be excellent alternatives or additions to cloacal and oropharyngeal swabbing. Furthermore, duck age (even within hatch-year birds) may be important when interpreting viral shedding results from experimental infections or surveillance. Differential shedding among hatch-year mallards could affect prevalence estimates, modeling of AIV spread, and subsequent risk assessments.	[VanDalen, Kaci K.; Franklin, Alan B.; Mooers, Nicole L.; Sullivan, Heather J.; Shriner, Susan A.] USDA, Natl Wildlife Res Ctr, Wildlife Serv, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA)	VanDalen, KK (corresponding author), USDA, Natl Wildlife Res Ctr, Wildlife Serv, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA.	Kaci.vandalen@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2007, AVIAN DIS, V51, P235, DOI 10.1637/7634-042806R1.1; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cattoli G, 2007, AVIAN DIS, V51, P414, DOI 10.1637/7562-033106R.1; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Ferro PJ, 2010, AVIAN DIS, V54, P655, DOI 10.1637/8810-040109-ResNote.1; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Halvorson DA, 2003, AVIAN DIS, V47, P36; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; KIDA H, 1980, INFECT IMMUN, V30, P547; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lira J, 2010, AVIAN DIS, V54, P606, DOI 10.1637/8838-040309-Reg.1; MCLEAN R., 2007, P 12 WILDL DAM MAN C, P87; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Pasick J, 2008, TRANSBOUND EMERG DIS, V55, P329, DOI 10.1111/j.1865-1682.2008.01047.x; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; SLEMONS RD, 1977, J AM VET MED ASSOC, V171, P947; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Sullivan HJ, 2009, J VIROL METHODS, V161, P141, DOI 10.1016/j.jviromet.2009.06.001; SZRETTER KJ, 2006, CUR PROTOC MICROBI S, V3; *USDA, 2008, EARL DET SYST HIGHL; Vandekerckhove C, 2009, J SCI COMPUT, V39, P167, DOI 10.1007/s10915-008-9256-y; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325	36	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12851	10.1371/journal.pone.0012851	http://dx.doi.org/10.1371/journal.pone.0012851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877466	gold, Green Published, Green Submitted			2022-12-25	WOS:000281963200017
J	Mayorek, N; Naftali-Shani, N; Grunewald, M				Mayorek, Nina; Naftali-Shani, Nili; Grunewald, Myriam			Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SUPPRESSOR-CELLS; IN-VIVO; INDUCED ANGIOGENESIS; COLORECTAL-CANCER; CYCLOOXYGENASE-2; ARGININE; MACROPHAGES; PROGRESSION; PREVENTION	Background: Diclofenac is one of the oldest anti-inflammatory drugs in use. In addition to its inhibition of cyclooxygenases (COX), diclofenac potently inhibits phospholipase A(2) (PLA(2)), thus yielding a broad anti-inflammatory effect. Since inflammation is an important factor in the development of pancreatic tumors we explored the potential of diclofenac to inhibit tumor growth in mice inoculated with PANCO2 cells orthotopically. Methodology/Principal Findings: We found that diclofenac treatment (30 mg/kg/bw for 11 days) of mice inoculated with PANC02 cells, reduced the tumor weight by 60%, correlating with increased apoptosis of tumor cells. Since this effect was not observed in vitro on cultured PANCO2 cells, we theorized that diclofenac beneficial treatment involved other mediators present in vivo. Indeed, diclofenac drastically decreased tumor vascularization by downregulating VEGF in the tumor and in abdominal cavity fluid. Furthermore, diclofenac directly inhibited vascular sprouting ex vivo. Surprisingly, in contrast to other COX-2 inhibitors, diclofenac increased arginase activity/arginase 1 protein content in tumor stroma cells, peritoneal macrophages and white blood cells by 2.4, 4.8 and 2 fold, respectively. We propose that the subsequent arginine depletion and decrease in NO levels, both in serum and peritoneal cavity, adds to tumor growth inhibition by malnourishment and poor vasculature development. Conclusion/Significance: In conclusion, diclofenac shows pronounced antitumoral properties in pancreatic cancer model that can contribute to further treatment development. The ability of diclofenac to induce arginase activity in tumor stroma, peritoneal macrophages and white blood cells provides a tool to study a controversial issue of pro-and antitumoral effects of arginine depletion.	[Mayorek, Nina; Naftali-Shani, Nili; Grunewald, Myriam] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Mayorek, N (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel.	ninam@ekmd.huji.ac.il		Mayorek, Nina/0000-0002-5989-4884	Hebrew University-Hadassah Medical School [0463435]	Hebrew University-Hadassah Medical School	This work was supported by the Hebrew University-Hadassah Medical School (grant # 0463435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beloussow K, 2002, CANCER LETT, V183, P155, DOI 10.1016/S0304-3835(01)00793-5; BENSASSON SA, 1995, METHOD CELL BIOL, V46, P29; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Caso G, 2004, CLIN SCI, V107, P371, DOI 10.1042/CS20040096; Chang CI, 2001, CANCER RES, V61, P1100; Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945; Chiang CS, 2008, INT IMMUNOL, V20, P215, DOI 10.1093/intimm/dxm137; Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; CURRIE GA, 1978, NATURE, V273, P758, DOI 10.1038/273758a0; Davel LE, 2002, FEBS LETT, V532, P216, DOI 10.1016/S0014-5793(02)03682-7; Davies NM, 1997, CLIN PHARMACOKINET, V33, P184, DOI 10.2165/00003088-199733030-00003; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; GONZALEZ GG, 1991, CANCER RES, V51, P2932; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; HARTVEIT F, 1966, NATURE, V210, P1123, DOI 10.1038/2101123a0; Jackson PG, 2000, J SURG ONCOL, V75, P146, DOI 10.1002/1096-9098(200010)75:2<146::AID-JSO14>3.0.CO;2-1; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lagas JS, 2010, MOL PHARMACOL, V77, P687, DOI 10.1124/mol.109.062364; LAM TL, 2009, CANC LETT; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587; Michaud D S, 2004, Minerva Chir, V59, P99; Muller-Decker K, 2006, GASTROENTEROLOGY, V130, P2165, DOI 10.1053/j.gastro.2006.03.053; Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6; MURTHY SM, 1989, CANCER, V64, P2035, DOI 10.1002/1097-0142(19891115)64:10<2035::AID-CNCR2820641012>3.0.CO;2-L; Nachtsheim R, 2006, J SURG RES, V134, P28, DOI 10.1016/j.jss.2006.03.008; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Reymond MA, 1998, DIGEST SURG, V15, P105, DOI 10.1159/000018602; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Seed MP, 1997, CANCER RES, V57, P1625; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; von Rahden BHA, 2005, CANCER RES, V65, P5038, DOI 10.1158/0008-5472.CAN-04-1107	41	52	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12715	10.1371/journal.pone.0012715	http://dx.doi.org/10.1371/journal.pone.0012715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856806	Green Submitted, gold, Green Published			2022-12-25	WOS:000281815800011
J	Yan, J; Jin, SQ; Li, J; Zhan, QM				Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin			Aurora B Interaction of Centrosomal Nlp Regulates Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; CELL-DIVISION; ANIMAL CYTOKINESIS; GAMMA-TUBULIN; PROTEIN; PHOSPHORYLATION; MIDBODY; CANCER; SPINDLE; SEGREGATION	Cytokinesis is a fundamental cellular process, which ensures equal abscission and fosters diploid progenies. Aberrant cytokinesis may result in genomic instability and cell transformation. However, the underlying regulatory machinery of cytokinesis is largely undefined. Here, we demonstrate that Nlp (Ninein-like protein), a recently identified BRCA1-associated centrosomal protein that is required for centrosomes maturation at interphase and spindle formation in mitosis, also contributes to the accomplishment of cytokinesis. Through immunofluorescent analysis, Nlp is found to localize at midbody during cytokinesis. Depletion of endogenous Nlp triggers aborted division and subsequently leads to multinucleated phenotypes. Nlp can be recruited by Aurora B to the midbody apparatus via their physical association at the late stage of mitosis. Disruption of their interaction induces aborted cytokinesis. Importantly, Nlp is characterized as a novel substrate of Aurora B and can be phosphorylated by Aurora B. The specific phosphorylation sites are mapped at Ser-185, Ser-448, and Ser-585. The phosphorylation at Ser-448 and Ser-585 is likely required for Nlp association with Aurora B and localization at midbody. Meanwhile, the phosphorylation at Ser-185 is vital to Nlp protein stability. Disruptions of these phosphorylation sites abolish cytokinesis and lead to chromosomal instability. Collectively, these observations demonstrate that regulation of Nlp by Aurora B is critical for the completion of cytokinesis, providing novel insights into understanding the machinery of cell cycle progression.	[Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jin, Shunqian] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	Zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [30730046, 30721001]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grant 2009CB521801 and National Natural Science Foundation of China Grants 30730046 and 30721001.	Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Jin SQ, 2009, J BIOL CHEM, V284, P22970, DOI 10.1074/jbc.M109.009134; JULIAN M, 1993, J CELL SCI, V105, P145; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qu D, 2008, GYNECOL ONCOL, V110, P230, DOI 10.1016/j.ygyno.2008.04.015; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Shao SJ, 2010, J CLIN INVEST, V120, P498, DOI 10.1172/JCI39447; SHU HB, 1995, J CELL SCI, V108, P2955; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vernos I, 2004, DEV CELL, V7, P145, DOI 10.1016/j.devcel.2004.07.016; Yu LL, 2009, ONCOL REP, V22, P789, DOI 10.3892/or_00000501; ZHAO X, 2010, CANC BIOL T IN PRESS; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097	32	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40230	40239		10.1074/jbc.M110.140541	http://dx.doi.org/10.1074/jbc.M110.140541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20864540	hybrid, Green Published			2022-12-25	WOS:000285185500067
J	Petit, D; Mir, AM; Petit, JM; Thisse, C; Delannoy, P; Oriol, R; Thisse, B; Harduin-Lepers, A				Petit, Daniel; Mir, Anne-Marie; Petit, Jean-Michel; Thisse, Christine; Delannoy, Philippe; Oriol, Rafael; Thisse, Bernard; Harduin-Lepers, Anne			Molecular Phylogeny and Functional Genomics of beta-Galactoside alpha 2,6-Sialyltransferases That Explain Ubiquitous Expression of st6gal1 Gene in Amniotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; IN-SITU HYBRIDIZATION; SIALIC ACIDS; N-GLYCANS; CATALYTIC-ACTIVITY; NERVOUS-SYSTEM; SIALYLTRANSFERASE; EVOLUTION; GOLGI; IDENTIFICATION	Sialyltransferases are key enzymes in the biosynthesis of sialoglycoconjugates that catalyze the transfer of sialic residue from its activated form to an oligosaccharidic acceptor. beta-Galactoside alpha 2,6-sialyltransferases ST6Gal I and ST6Gal II are the two unique members of the ST6Gal family described in higher vertebrates. The availability of genome sequences enabled the identification of more distantly related invertebrates' st6gal gene sequences and allowed us to propose a scenario of their evolution. Using a phylogenomic approach, we present further evidence of an accelerated evolution of the st6gal1 genes both in their genomic regulatory sequences and in their coding sequence in reptiles, birds, and mammals known as amniotes, whereas st6gal2 genes conserve an ancestral profile of expression throughout vertebrate evolution.	[Mir, Anne-Marie; Delannoy, Philippe; Harduin-Lepers, Anne] Univ Lille 1, CNRS UMR 8576, IFR 147, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Petit, Daniel; Petit, Jean-Michel] Univ Limoges, Fac Sci & Tech, INRA UMR 1061, Unite Genet Mol Anim, F-87060 Limoges, France; [Thisse, Christine; Thisse, Bernard] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Oriol, Rafael] Univ Paris 11, INSERM, U1004, Unite Microenvironm & Physiol Differenciat, F-94807 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; INRAE; Universite de Limoges; University of Virginia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Harduin-Lepers, A (corresponding author), Univ Lille 1, CNRS UMR 8576, IFR 147, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France.	anne.harduin@univ-lille1.fr	Anne, Harduin-Lepers/O-7503-2017	Anne, Harduin-Lepers/0000-0002-1233-3799; Delannoy, Philippe/0000-0001-6467-7553; THISSE, Christine/0000-0002-8684-1681	CNRS; Institut National de la Recherche Agronomique (INRA); INSERM; PPF-Bioinformatique de Lille	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PPF-Bioinformatique de Lille	This work was supported in part by CNRS, Institut National de la Recherche Agronomique (INRA), INSERM, and the PPF-Bioinformatique de Lille.	Altheide TK, 2006, J BIOL CHEM, V281, P25689, DOI 10.1074/jbc.M604221200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aparicio S, 2000, TRENDS GENET, V16, P54, DOI 10.1016/S0168-9525(99)01934-4; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; BAUM LG, 1990, ACTA HISTOCHEM, P35; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chang LY, 2009, GLYCOCONJUGATE J, V26, P263, DOI 10.1007/s10719-008-9165-1; Chen TLL, 2003, GLYCOBIOLOGY, V13, P109, DOI 10.1093/glycob/cwg015; Chiricolo M, 2006, GLYCOBIOLOGY, V16, P146, DOI 10.1093/glycob/cwj045; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio F, 2000, INT J CANCER, V88, P58, DOI 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; Danchin EGJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-5; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; Datta AK, 2009, CURR DRUG TARGETS, V10, P483, DOI 10.2174/138945009788488422; Ding GH, 2008, NUCLEIC ACIDS RES, V36, pD255, DOI 10.1093/nar/gkm924; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Ehrlich J, 1997, GENETICS, V147, P289; Ermonval M, 2009, GLYCOCONJUGATE J, V26, P477, DOI 10.1007/s10719-008-9198-5; Felsenstein J., 2002, PHYLIP PHYLOGENY INF; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Force A, 1999, GENETICS, V151, P1531; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hardham AR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-63; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers A., 2010, GLYCOBIOL INSIGHTS, V2, P29, DOI [10.4137/GBI.S3123, DOI 10.4137/GBI.S3123, 10.4137/gbi.s3123]; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JAMIESON JC, 1993, COMP BIOCHEM PHYS B, V105, P29, DOI 10.1016/0305-0491(93)90165-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2002, SEIKAGAKU, V74, P1180; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Koles K, 2009, GLYCOCONJUGATE J, V26, P313, DOI 10.1007/s10719-008-9154-4; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUROSAWA N, 1994, EUR J BIOCHEM, V219, P375, DOI 10.1111/j.1432-1033.1994.tb19949.x; Laporte B, 2009, GLYCOBIOLOGY, V19, P1082, DOI 10.1093/glycob/cwp094; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Lo NW, 1999, GLYCOBIOLOGY, V9, P907, DOI 10.1093/glycob/9.9.907; Ma JY, 1997, J BIOL CHEM, V272, P672; Ma JY, 1999, J BIOL CHEM, V274, P8046, DOI 10.1074/jbc.274.12.8046; Mannherz O, 2006, GENOMICS, V87, P665, DOI 10.1016/j.ygeno.2005.12.009; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Martin Renaud, 2009, Recent Pat DNA Gene Seq, V3, P63; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mercier D, 1999, GLYCOBIOLOGY, V9, P851, DOI 10.1093/glycob/9.9.851; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; MULLER WEG, 1977, J BIOL CHEM, V252, P3836; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; OHANLON TP, 1989, J BIOL CHEM, V264, P17389; Ohno S., 1970, EVOLUTION GENE DUPLI; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Patel RY, 2007, PROTEIN PEPTIDE LETT, V14, P601; Patel RY, 2006, GLYCOBIOLOGY, V16, P108, DOI 10.1093/glycob/cwj046; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; Rohfritsch PF, 2006, BBA-GEN SUBJECTS, V1760, P685, DOI 10.1016/j.bbagen.2005.12.012; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Takashima S, 2003, J BIOCHEM, V134, P287, DOI 10.1093/jb/mvg142; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; Taylor JS, 2001, CURR BIOL, V11, pR1005, DOI 10.1016/S0960-9822(01)00610-8; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C., 1998, ZEBRAFISH SCI MON, V5, P8; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; WANG XC, 1993, J BIOL CHEM, V268, P4355; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; Wang Z, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-2; WEN DX, 1992, J BIOL CHEM, V267, P2512; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385	123	19	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38399	38414		10.1074/jbc.M110.163931	http://dx.doi.org/10.1074/jbc.M110.163931			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855889	Green Published, hybrid			2022-12-25	WOS:000284625600046
J	Du, W; Li, J; Sipple, J; Chen, JJ; Pang, QS				Du, Wei; Li, Jie; Sipple, Jared; Chen, Jianjun; Pang, Qishen			Cytoplasmic FANCA-FANCC Complex Interacts and Stabilizes the Cytoplasm-dislocalized Leukemic Nucleophosmin Protein (NPMc)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; E3 UBIQUITIN LIGASE; ANEMIA PROTEIN; MUTATED NUCLEOPHOSMIN; NES MOTIF; CELLS; GENE; DEGRADATION; PATHWAY	Eight of the Fanconi anemia (FA) proteins form a core complex that activates the FA pathway. Some core complex components also form subcomplexes for yet-to-be-elucidated functions. Here, we have analyzed the interaction between a cytoplasmic FA subcomplex and the leukemic nucleophosmin (NPMc). Exogenous NPMc was degraded rapidly in FA acute myeloid leukemia bone marrow cells. Knockdown of FANCA or FANCC in leukemic OCI/AML3 cells induced rapid degradation of endogenous NPMc. NPMc degradation was mediated by the ubiquitin-proteasome pathway involving the IBR-type RING-finger E3 ubiquitin ligase IBRDC2, and genetic correction of FA-A or FA-C lymphoblasts prevented NPMc ubiquitination. Moreover, cytoplasmic FANCA and FANCC formed a cytoplasmic complex and interacted with NPMc. Using a patient-derived FANCC mutant and a nuclearized FANCC, we demonstrated that the cytoplasmic FANCA-FANCC complex was essential for NPMc stability. Finally, depletion of FANCA and FANCC in NPMc-positive leukemic cells significantly increased inflammation and chemoresistance through NF-kappa B activation. Our findings not only reveal the molecular mechanism involving cytoplasmic retention of NPMc but also suggest cytoplasmic function of FANCA and FANCC in NPMc-related leukemogenesis.	[Du, Wei; Li, Jie; Sipple, Jared; Pang, Qishen] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Chen, Jianjun] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Pang, Qishen] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Chicago; University System of Ohio; University of Cincinnati	Du, W (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	wei.du@cchmc.org	Du, Wei/AAW-7158-2021; chen, JJ/HGB-6029-2022; Li, Jie/L-1737-2015; Du, Wei/ABD-4748-2020	Du, Wei/0000-0003-3669-537X; Li, Jie/0000-0002-0590-9817; Du, Wei/0000-0003-3669-537X	National Institutes of Health [R01 CA109641, R01 HL076712]; Fanconi Anemia Research Fund; Leukemia and Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [R01CA109641] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA109641 and R01 HL076712.; Supported by a Fanconi Anemia Research Fund grant. To whom correspondence should be addressed: Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229. Tel.: 513-636-9222; Fax: 513-636-3768; E-mail: wei.du@cchmc.org.; Supported by a Leukemia and Lymphoma Scholar award.	Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Cilloni D, 2008, LEUKEMIA, V22, P1234, DOI 10.1038/leu.2008.68; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Du W, 2008, ANTIOXID REDOX SIGN, V10, P1909, DOI 10.1089/ars.2008.2129; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, LEUKEMIA, V21, P2052, DOI 10.1038/sj.leu.2404839; Falini B, 2008, HAEMATOLOGICA, V93, P775, DOI 10.3324/haematol.12225; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; GAVISH H, 1993, HUM MOL GENET, V2, P123, DOI 10.1093/hmg/2.2.123; Gordon SM, 2005, J BIOL CHEM, V280, P36118, DOI 10.1074/jbc.M507758200; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hussain S, 2003, HUM MOL GENET, V12, P2503, DOI 10.1093/hmg/ddg266; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Lensch MW, 1999, LEUKEMIA, V13, P1784, DOI 10.1038/sj.leu.2401586; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Meani N, 2009, EXPERT REV ANTICANC, V9, P1283, DOI 10.1586/ERA.09.84; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Pasqualucci L, 2006, BLOOD, V108, P4146, DOI 10.1182/blood-2006-06-026716; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhou Y, 2008, BLOOD, V112, P2474, DOI 10.1182/blood-2007-12-130211	35	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37436	37444		10.1074/jbc.M110.113209	http://dx.doi.org/10.1074/jbc.M110.113209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864535	hybrid, Green Published			2022-12-25	WOS:000284424000036
J	Khan, S; Nagarajan, SN; Parikh, A; Samantaray, S; Singh, A; Kumar, D; Roy, RP; Bhatt, A; Nandicoori, VK				Khan, Shazia; Nagarajan, Sathya Narayanan; Parikh, Amit; Samantaray, Sharmishtha; Singh, Albel; Kumar, Devanand; Roy, Rajendra P.; Bhatt, Apoorva; Nandicoori, Vinay Kumar			Phosphorylation of Enoyl-Acyl Carrier Protein Reductase InhA Impacts Mycobacterial Growth and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; SER/THR KINASE; SERINE/THREONINE KINASES; MYCOLIC ACIDS; TUBERCULOSIS; SUBSTRATE; IDENTIFICATION; BIOSYNTHESIS; SYSTEM; TARGET	InhA, the primary target for the first line anti-tuberculosis drug isoniazid, is a key enzyme of the fatty-acid synthase II system involved in mycolic acid biosynthesis in Mycobacterium tuberculosis. In this study, we show that InhA is a substrate for mycobacterial serine/threonine protein kinases. Using a novel approach to validate phosphorylation of a substrate by multiple kinases in a surrogate host (Escherichia coli), we have demonstrated efficient phosphorylation of InhA by PknA, PknB, and PknH, and to a lower extent by PknF. Additionally, the sites targeted by PknA/PknB have been identified and shown to be predominantly located at the C terminus of InhA. Results demonstrate in vivo phosphorylation of InhA in mycobacteria and validate Thr-266 as one of the key sites of phosphorylation. Significantly, our studies reveal that the phosphorylation of InhA by kinases modulates its biochemical activity, with phosphorylation resulting in decreased enzymatic activity. Co-expression of kinase and InhA alters the growth dynamics of Mycobacterium smegmatis, suggesting that InhA phosphorylation in vivo is an important event in regulating its activity. An InhA-T266E mutant, which mimics constitutive phosphorylation, is unable to rescue an M. smegmatis conditional inhA gene replacement mutant, emphasizing the critical role of Thr-266 in mediating post-translational regulation of InhA activity. The involvement of various serine/threonine kinases in modulating the activity of a number of enzymes of the mycolic acid synthesis pathway, including InhA, accentuates the intricacies of mycobacterial signaling networks in parallel with the changing environment.	[Khan, Shazia; Nagarajan, Sathya Narayanan; Parikh, Amit; Samantaray, Sharmishtha; Roy, Rajendra P.; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Kumar, Devanand] Univ Delhi S Campus, Dept Microbiol, New Delhi 110021, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Birmingham; University of Delhi	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in		Nandicoori, Vinay/0000-0002-5682-4178; NAGARAJAN, Sathya Narayanan/0000-0002-3902-3678	Department of Biotechnology, India; Medical Research Council, United Kingdom; MRC [G0600105] Funding Source: UKRI; Medical Research Council [G0600105] Funding Source: researchfish	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Department of Biotechnology, India (to V. K. N. and R. P. R.).; Supported by a career development award from the Medical Research Council, United Kingdom.	Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; ASSELINEAU J, 1950, NATURE, V166, P782, DOI 10.1038/166782a0; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; DeLano W. L., 2002, PYMOL MOL GRAPHIES S; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384	44	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37860	37871		10.1074/jbc.M110.143131	http://dx.doi.org/10.1074/jbc.M110.143131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864541	Green Published, hybrid			2022-12-25	WOS:000284424000076
J	Varma, H; Yamamoto, A; Sarantos, MR; Hughes, RE; Stockwell, BR				Varma, Hemant; Yamamoto, Ai; Sarantos, Melissa R.; Hughes, Robert E.; Stockwell, Brent R.			Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRIATAL SPINY NEURONS; FAST AXONAL-TRANSPORT; MITOTIC SPINDLE; GENE-EXPRESSION; WILD-TYPE; DISEASE; SURVIVAL; PROTEIN; DEATH; RHO	Cellular responses to drug treatment show tremendous variations. Elucidating mechanisms underlying these variations is critical for predicting therapeutic responses and developing personalized therapeutics. Using a small molecule screening approach, we discovered how a disease causing allele leads to opposing cell fates upon pharmacological perturbation. Diverse microtubule-depolymerizing agents protected mutant huntingtin-expressing cells from cell death, while being toxic to cells lacking mutant huntingtin or those expressing wild-type huntingtin. Additional neuronal cell lines and primary neurons from Huntington disease mice also showed altered survival upon microtubule depolymerization. Transcription profiling revealed that microtubule depolymerization induced the auto-crine growth factor connective tissue growth factor and activated ERK survival signaling. The genotype-selective rescue was dependent upon increased RhoA protein levels in mutant huntingtin-expressing cells, because inhibition of RhoA, its downstream effector, Rho-associated kinase ( ROCK), or a microtubule-associated RhoA activator, guanine nucleotide exchange factor-H1 (GEF-H1), all attenuated the rescue. Conversely, RhoA overexpression in cells lacking mutant huntingtin conferred resistance to microtubule-depolymerizer toxicity. This study elucidates a novel pathway linking microtubule stability to cell survival and provides insight into how genetic context can dramatically alter cellular responses to pharmacological interventions.	Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, Fairchild Ctr 614, New York, NY 10027 USA; [Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Sarantos, Melissa R.; Hughes, Robert E.] Buck Inst Age Res, Novato, CA 94945 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Buck Institute for Research on Aging	Stockwell, BR (corresponding author), Columbia Univ, Dept Chem, Fairchild Ctr 614, MC 2406,1212 Amsterdam Ave, New York, NY 10027 USA.	bstockwell@columbia.edu	Stockwell, Brent R/AAE-7200-2019; Yamamoto, Ai/D-1100-2011	Stockwell, Brent R/0000-0002-3532-3868; 	National Institutes of Health [5R01GM085081, RO1NS050199, R01NS055247, T32 AG000266-10]; Parkinson's Disease Foundation; High Q Foundation; Arnold and Mabel Beckman Foundation; Cure Huntington Disease Initiative, Inc.; Hereditary Disease Foundation; Burroughs Wellcome Fund; Buck Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055247, R01NS050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; High Q Foundation; Arnold and Mabel Beckman Foundation; Cure Huntington Disease Initiative, Inc.; Hereditary Disease Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Buck Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM085081 (to B. R. S.), RO1NS050199 (to A. Y.), R01NS055247, and Training Grant T32 AG000266-10 (to M. R. S.), grants from the Parkinson's Disease Foundation (to A. Y.), the High Q Foundation (to H. V.), a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation, Cure Huntington Disease Initiative, Inc., Hereditary Disease Foundation, a Burroughs Wellcome Fund Career Award at the Scientific Interface (to B. R. S.), and the Buck Trust (to R. E. H.).	Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bell J, 2004, NATURE, V429, P453, DOI 10.1038/nature02624; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chatterjee K, 2007, J MOL CELL CARDIOL, V43, P327, DOI 10.1016/j.yjmcc.2007.06.005; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Chowdhury I, 2004, EUR J BIOCHEM, V271, P4436, DOI 10.1111/j.1432-1033.2004.04382.x; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Feng GP, 2000, J CLIN INVEST, V105, P329, DOI 10.1172/JCI7398; Ferrante R. J., 2009, J BIOCHIM BIOPHYS AC, P506; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Makaryus JN, 2007, HEMATOLOGY, V12, P349, DOI 10.1080/10245330701255254; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakamura K, 2001, J CEREBR BLOOD F MET, V21, P876, DOI 10.1097/00004647-200107000-00013; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Ogawa M, 2007, P NATL ACAD SCI USA, V104, P14789, DOI 10.1073/pnas.0706945104; Orso G, 2005, J CLIN INVEST, V115, P3026, DOI 10.1172/JCI24694; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Picard C, 2006, CURR OPIN IMMUNOL, V18, P383, DOI 10.1016/j.coi.2006.05.005; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Ross CA, 2004, CELL, V118, P4, DOI 10.1016/j.cell.2004.06.022; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Saji K, 2007, TOHOKU J EXP MED, V213, P139, DOI 10.1620/tjem.213.139; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; STAHELIN HF, 1991, CANCER RES, V51, P5; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TOBEY RA, 1972, EXP CELL RES, V75, P460, DOI 10.1016/0014-4827(72)90453-3; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Varani K, 2007, NEUROBIOL DIS, V27, P36, DOI 10.1016/j.nbd.2007.03.011; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Varma H, 2007, NAT CHEM BIOL, V3, P99, DOI 10.1038/nchembio852; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zuchner T, 2008, CELL DEATH DIFFER, V15, P435, DOI 10.1038/sj.cdd.4402261	81	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37445	37457		10.1074/jbc.M110.125542	http://dx.doi.org/10.1074/jbc.M110.125542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858895	Green Published, hybrid			2022-12-25	WOS:000284424000037
J	Belch, Y; Yang, JY; Liu, Y; Malkaram, SA; Liu, R; Riethoven, JJM; Ladunga, I				Belch, Yaakov; Yang, Jingyi; Liu, Yang; Malkaram, Sridhar A.; Liu, Rong; Riethoven, Jean-Jack M.; Ladunga, Istvan			Weakly Positioned Nucleosomes Enhance the Transcriptional Competency of Chromatin	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; HISTONE EVICTION; DNA INTERACTIONS; CORE PARTICLE; GENOMIC CODE; CHIP-SEQ; ELONGATION	Background: Transcription is affected by nucleosomal resistance against polymerase passage. In turn, nucleosomal resistance is determined by DNA sequence, histone chaperones and remodeling enzymes. The contributions of these factors are widely debated: one recent title claims "... DNA-encoded nucleosome organization..." while another title states that "histone-DNA interactions are not the major determinant of nucleosome positions." These opposing conclusions were drawn from similar experiments analyzed by idealized methods. We attempt to resolve this controversy to reveal nucleosomal competency for transcription. Methodology/Principal Findings: To this end, we analyzed 26 in vivo, nonlinked, and in vitro genome-wide nucleosome maps/replicates by new, rigorous methods. Individual H2A nucleosomes are reconstituted inaccurately by transcription, chaperones and remodeling enzymes. At gene centers, weakly positioned nucleosome arrays facilitate rapid histone eviction and remodeling, easing polymerase passage. Fuzzy positioning is not due to artefacts. At the regional level, transcriptional competency is strongly influenced by intrinsic histone-DNA affinities. This is confirmed by reproducing the high in vivo occupancy of translated regions and the low occupancy of intergenic regions in reconstitutions from purified DNA and histones. Regional level occupancy patterns are protected from invading histones by nucleosome excluding sequences and barrier nucleosomes at gene boundaries and within genes. Conclusions/Significance: Dense arrays of weakly positioned nucleosomes appear to be necessary for transcription. Weak positioning at exons facilitates temporary remodeling, polymerase passage and hence the competency for transcription. At regional levels, the DNA sequence plays a major role in determining these features but positions of individual nucleosomes are typically modified by transcription, chaperones and enzymes. This competency is reduced at intergenic regions by sequence features, barrier nucleosomes, and proteins, preventing accessibility regulation of untargeted genes. This combination of DNA-and protein-influenced positioning regulates DNA accessibility and competence for regulatory protein binding and transcription. Interactive nucleosome displays are offered at http://chromatin.unl.edu/cgi-bin/skyline.cgi.	[Belch, Yaakov; Liu, Yang] Univ Nebraska Lincoln, Dept Stat, Lincoln, NE USA; [Yang, Jingyi] Univ Nebraska Lincoln, Dept Comp Sci & Engn, Lincoln, NE USA; [Malkaram, Sridhar A.; Liu, Rong; Riethoven, Jean-Jack M.] Univ Nebraska Lincoln, Ctr Biotechnol, Lincoln, NE USA; [Riethoven, Jean-Jack M.; Ladunga, Istvan] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Belch, Y (corresponding author), LINUX Consulting, Karmiel, Israel.	sladunga@unl.edu		Riethoven, Jean-Jack/0000-0002-2709-7880	National Science Foundation (NSF) [EPS-0701892]; University of Nebraska-Lincoln	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Nebraska-Lincoln	The study was supported by National Science Foundation (NSF) grant EPS-0701892 and grants from the University of Nebraska-Lincoln to IL. Funding for the Open Access Charge was obtained by NSF grant EPS-0701892 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fraser RM, 2006, J MOL BIOL, V364, P582, DOI 10.1016/j.jmb.2006.08.092; Fraser RM, 2009, J MOL BIOL, V390, P292, DOI 10.1016/j.jmb.2009.04.079; Gencheva M, 2006, J MOL BIOL, V361, P216, DOI 10.1016/j.jmb.2006.06.039; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pugh BF, 2010, NAT STRUCT MOL BIOL, V17, P923, DOI 10.1038/nsmb0810-923; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Studitsky VM, 2004, TRENDS BIOCHEM SCI, V29, P127, DOI 10.1016/j.tibs.2004.01.003; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yin SY, 2009, BIOCHEM BIOPH RES CO, V385, P363, DOI 10.1016/j.bbrc.2009.05.072; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2010, NAT STRUCT MOL BIOL, V17, P920, DOI 10.1038/nsmb0810-920; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12984	10.1371/journal.pone.0012984	http://dx.doi.org/10.1371/journal.pone.0012984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886052	Green Published, gold			2022-12-25	WOS:000282122600018
J	Hernandez-Martinez, P; Navarro-Cerrillo, G; Caccia, S; de Maagd, RA; Moar, WJ; Ferre, J; Escriche, B; Herrero, S				Hernandez-Martinez, Patricia; Navarro-Cerrillo, Gloria; Caccia, Silvia; de Maagd, Ruud A.; Moar, William J.; Ferre, Juan; Escriche, Baltasar; Herrero, Salvador			Constitutive Activation of the Midgut Response to Bacillus thuringiensis in Bt-Resistant Spodoptera exigua	PLOS ONE			English	Article							MEDIATED INSECT RESISTANCE; POSTERIOR MIDGUT; AMINOPEPTIDASE-N; KINASE PATHWAYS; MANDUCA-SEXTA; TOXIN; DROSOPHILA; CRY1AC; PROTEIN; LEPIDOPTERA	Bacillus thuringiensis is the most effective microbial control agent for controlling numerous species from different insect orders. The main threat for the long term use of B. thuringiensis in pest control is the ability of insects to develop resistance. Thus, the identification of insect genes involved in conferring resistance is of paramount importance. A colony of Spodoptera exigua (Lepidoptera: Noctuidae) was selected for 15 years in the laboratory for resistance to Xentari (TM), a B. thuringiensis-based insecticide, reaching a final resistance level of greater than 1,000-fold. Around 600 midgut ESTs were analyzed by DNA-macroarray in order to find differences in midgut gene expression between susceptible and resistant insects. Among the differentially expressed genes, repat and arylphorin were identified and their increased expression was correlated with B. thuringiensis resistance. We also found overlap among genes that were constitutively over-expressed in resistant insects with genes that were up-regulated in susceptible insects after exposure to Xentari (TM), suggesting a permanent activation of the response to Xentari (TM) in resistant insects. Increased aminopeptidase activity in the lumen of resistant insects in the absence of exposure to Xentari (TM) corroborated the hypothesis of permanent activation of response genes. Increase in midgut proliferation has been proposed as a mechanism of response to pathogens in the adult from several insect species. Analysis of S. exigua larvae revealed that midgut proliferation was neither increased in resistant insects nor induced by exposure of susceptible larvae to Xentari (TM), suggesting that mechanisms other than midgut proliferation are involved in the response to B. thuringiensis by S. exigua larvae.	[Hernandez-Martinez, Patricia; Navarro-Cerrillo, Gloria; Caccia, Silvia; Ferre, Juan; Escriche, Baltasar; Herrero, Salvador] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [de Maagd, Ruud A.] Univ Wageningen & Res Ctr, Plant Res Int BV, Wageningen, Netherlands; [Moar, William J.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	University of Valencia; Plant Research International; Wageningen University & Research; Auburn University System; Auburn University	Hernandez-Martinez, P (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	sherrero@uv.es	Patricia, Hernandez-Martinez/Q-3082-2019; Herrero, Salva/ABE-5123-2020; Herrero, Salvador/J-5767-2013; Escriche, Baltasar/N-5136-2014; de Maagd, Ruud A/A-5859-2012; Ferré, Juan/L-9426-2014	Patricia, Hernandez-Martinez/0000-0002-3263-5786; Herrero, Salva/0000-0001-5690-2108; Herrero, Salvador/0000-0001-5690-2108; Escriche, Baltasar/0000-0003-4889-793X; de Maagd, Ruud A/0000-0001-7049-2029; Ferré, Juan/0000-0001-5535-0612; CACCIA, Silvia/0000-0003-1954-7180	Spanish Ministry of Science and Innovation [AGL2008-05456-C03-03, AGL2006-11914, BES-2006-13999]; European FEDER; EU [PIEF-GA-2008-219993]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European FEDER(European Commission); EU(European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors want to thank COST 862 Action from the EU for facilitating the interaction of different groups. This research was supported by the Spanish Ministry of Science and Innovation (AGL2008-05456-C03-03, AGL2006-11914 and grant BES-2006-13999 for GNC) and European FEDER funds. SC was supported by a Marie Curie fellowship PIEF-GA-2008-219993 from the EU.	Anilkumar KJ, 2009, J CHEM ECOL, V35, P785, DOI 10.1007/s10886-009-9665-x; BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Baton LA, 2007, J INVERTEBR PATHOL, V96, P244, DOI 10.1016/j.jip.2007.05.005; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; BENZ G, 1967, EXPERIENTIA, V23, P871, DOI 10.1007/BF02146902; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; de Maagd RA, 1999, TRENDS PLANT SCI, V4, P9, DOI 10.1016/S1360-1385(98)01356-9; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferre Juan, 2008, V5, P41; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hakim RS, 2007, ARCH INSECT BIOCHEM, V64, P63, DOI 10.1002/arch.20155; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herfs W., 1965, Zeitschrift fur Pflanzenkrankheiten, Pflanzenpathologie und Pflanzenschutz, V72, P584; Hernandez-Martinez P, 2008, J INVERTEBR PATHOL, V97, P245, DOI 10.1016/j.jip.2007.11.001; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Herrero S, 2007, INSECT BIOCHEM MOLEC, V37, P1109, DOI 10.1016/j.ibmb.2007.06.007; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Loeb MJ, 2001, J INSECT PHYSIOL, V47, P599, DOI 10.1016/S0022-1910(00)00150-5; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; MCGAUGHEY WH, 1985, SCIENCE, V229, P193, DOI 10.1126/science.229.4709.193; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rodrigo-Simon A, 2008, APPL ENVIRON MICROB, V74, P1710, DOI 10.1128/AEM.02827-07; Rodriguez-Cabrera L, 2008, TOXICON, V51, P681, DOI 10.1016/j.toxicon.2007.12.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1993, APPL ENVIRON MICROB, V59, P1332, DOI 10.1128/AEM.59.5.1332-1335.1993; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valaitis AP, 2008, INSECT BIOCHEM MOLEC, V38, P611, DOI 10.1016/j.ibmb.2008.03.003; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; Zhang XP, 2009, J IND MICROBIOL BIOT, V36, P815, DOI 10.1007/s10295-009-0556-5	58	58	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12792	10.1371/journal.pone.0012795	http://dx.doi.org/10.1371/journal.pone.0012795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862260	Green Published, Green Submitted, gold			2022-12-25	WOS:000281960800012
J	Martin, J; Anamika, K; Srinivasan, N				Martin, Juliette; Anamika, Krishanpal; Srinivasan, Narayanaswamy			Classification of Protein Kinases on the Basis of Both Kinase and Non-Kinase Regions	PLOS ONE			English	Article							DATABASE; KINOME; SEQUENCE; PHOSPHORYLATION; DIVERSITY; GENOMICS; FAMILY; ARABIDOPSIS; ALIGNMENTS; EXPRESSION	Background: Protein phosphorylation is a generic way to regulate signal transduction pathways in all kingdoms of life. In many organisms, it is achieved by the large family of Ser/Thr/Tyr protein kinases which are traditionally classified into groups and subfamilies on the basis of the amino acid sequence of their catalytic domains. Many protein kinases are multidomain in nature but the diversity of the accessory domains and their organization are usually not taken into account while classifying kinases into groups or subfamilies. Methodology: Here, we present an approach which considers amino acid sequences of complete gene products, in order to suggest refinements in sets of pre-classified sequences. The strategy is based on alignment-free similarity scores and iterative Area Under the Curve (AUC) computation. Similarity scores are computed by detecting common patterns between two sequences and scoring them using a substitution matrix, with a consistent normalization scheme. This allows us to handle full-length sequences, and implicitly takes into account domain diversity and domain shuffling. We quantitatively validate our approach on a subset of 212 human protein kinases. We then employ it on the complete repertoire of human protein kinases and suggest few qualitative refinements in the subfamily assignment stored in the KinG database, which is based on catalytic domains only. Based on our new measure, we delineate 37 cases of potential hybrid kinases: sequences for which classical classification based entirely on catalytic domains is inconsistent with the full-length similarity scores computed here, which implicitly consider multi-domain nature and regions outside the catalytic kinase domain. We also provide some examples of hybrid kinases of the protozoan parasite Entamoeba histolytica. Conclusions: The implicit consideration of multi-domain architectures is a valuable inclusion to complement other classification schemes. The proposed algorithm may also be employed to classify other families of enzymes with multidomain architecture.	[Martin, Juliette; Anamika, Krishanpal; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Martin, Juliette] INRA, UR1077, Unite Math Informat & Genome, Jouy En Josas, France	Indian Institute of Science (IISC) - Bangalore; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Martin, J (corresponding author), Univ Lyon, Lyon, France.	martin@ibcp.fr	Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016	Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885	Department of Science and Technology, New Delhi under the Mathematical Biology initiative; Department of Biotechnology, New Delhi; INRA, France	Department of Science and Technology, New Delhi under the Mathematical Biology initiative(Department of Science & Technology (India)); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); INRA, France	This research is supported by Department of Science and Technology, New Delhi under the Mathematical Biology initiative and also by the Department of Biotechnology, New Delhi. JM had a fellowship from INRA, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Anamika K, 2007, PROTEIN PEPTIDE LETT, V14, P509; Anamika K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-622; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; DESHMUKH K, 2009, PROG BIOPHYS MOL BIO; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gribskov M, 2001, NUCLEIC ACIDS RES, V29, P111, DOI 10.1093/nar/29.1.111; Han EKH, 2007, ANTI-CANCER AGENT ME, V7, P681, DOI 10.2174/187152007784111296; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kostich M, 2002, GENOME BIOL, V3; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2002, GENOME BIOL, V3; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Krupa A, 2006, GENE, V380, P1, DOI 10.1016/j.gene.2006.05.016; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; R Development Core Team, 2007, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Smith CM, 1997, TRENDS BIOCHEM SCI, V22, P444, DOI 10.1016/S0968-0004(97)01131-6; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tchieu JH, 2003, NUCLEIC ACIDS RES, V31, P342, DOI 10.1093/nar/gkg025; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	52	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12460	10.1371/journal.pone.0012460	http://dx.doi.org/10.1371/journal.pone.0012460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856812	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815800002
J	Stridh, P; Hedreul, MT; Beyeen, AD; Adzemovic, MZ; Laaksonen, H; Gillett, A; Ockinger, J; Marta, M; Lassmann, H; Becanovic, K; Jagodic, M; Olsson, T				Stridh, Pernilla; Hedreul, Melanie Thessen; Beyeen, Amennai Daniel; Adzemovic, Milena Z.; Laaksonen, Hannes; Gillett, Alan; Ockinger, Johan; Marta, Monica; Lassmann, Hans; Becanovic, Kristina; Jagodic, Maja; Olsson, Tomas			Fine-Mapping Resolves Eae23 into Two QTLs and Implicates ZEB1 as a Candidate Gene Regulating Experimental Neuroinflammation in Rat	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; QUANTITATIVE TRAIT LOCI; MULTIPLE-SCLEROSIS; LINKAGE ANALYSIS; T-CELLS; INTERLEUKIN-7 RECEPTOR; CONFIDENCE-INTERVALS; MILK PROTEIN	Background: To elucidate mechanisms involved in multiple sclerosis (MS), we studied genetic regulation of experimental autoimmune encephalomyelitis (EAE) in rats, assuming a conservation of pathogenic pathways. In this study, we focused on Eae23, originally identified to regulate EAE in a (LEW. 1AV1xPVG. 1AV1) F2 cross. Our aim was to determine whether one or more genes within the 67 Mb region regulate EAE and to define candidate risk genes. Methodology/Principal Findings: We used high resolution quantitative trait loci (QTL) analysis in the 10th generation (G10) of an advanced intercross line (AIL) to resolve Eae23 into two QTLs that independently regulate EAE, namely Eae23a and Eae23b. We established a congenic strain to validate the effect of this region on disease. PVG alleles in Eae23 resulted in significant protection from EAE and attenuated CNS inflammation/demyelination. Disease amelioration was accompanied with increased levels of Foxp3(+) cells in the CNS of the congenic strain compared to DA. We then focused on candidate gene investigation in Eae23b, a 9 Mb region linked to all clinical phenotypes. Affymetrix exon arrays were used to study expression of the genes in Eae23b in the parental strains, where none showed differential expression. However, we found lower expression of exon 4 of ZEB1, which is specific for splice-variant Zfhep1. ZEB1 is an interleukin 2 (IL2) repressor involved in T cell development. The splice-specific variance prompted us to next analyze the expression of ZEB1 and its two splice variants, Zfhep1 and Zfhep2, in both lymph node and spleen. We demonstrated that ZEB1 splice-variants are differentially expressed; severity of EAE and higher IL2 levels were associated with down-regulation of Zfhep1 and up-regulation of Zfhep2. Conclusions/Significance: We speculate that the balance between splice-variants of ZEB1 could influence the regulation of EAE. Further functional studies of ZEB1 and the splice-variants may unravel novel pathways contributing to MS pathogenesis and inflammation in general.	[Stridh, Pernilla; Hedreul, Melanie Thessen; Beyeen, Amennai Daniel; Laaksonen, Hannes; Gillett, Alan; Ockinger, Johan; Marta, Monica; Becanovic, Kristina; Jagodic, Maja; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Adzemovic, Milena Z.; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Karolinska Institutet; Medical University of Vienna	Stridh, P (corresponding author), Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden.	pernilla.strid@ki.se	Lassmann, Hans/Z-2269-2019; Marta, Monica/H-5804-2019; Becanovic, Kristina/A-4479-2016; Stridh, Pernilla/J-2918-2012; Öckinger, Johan/F-4543-2010; Marta, Monica/H-3376-2019	Lassmann, Hans/0000-0001-8617-5052; Marta, Monica/0000-0002-5464-9070; Stridh, Pernilla/0000-0003-4855-0039; Öckinger, Johan/0000-0003-4300-3415; Marta, Monica/0000-0002-5464-9070; Lindahl, Hannes/0000-0002-4447-9426; Olsson, Tomas/0000-0002-2938-1877	Swedish Research Council; Wadsworth Foundation; Soderbergs Foundation; Petrus and Augusta Hedlunds Foundation; Bibbi and Niels Jensens Foundation; Montel Williams Foundation; Ake-Wibergs Stiftelse; Swedish Foundation for Neurologically Disabled; EU [LSHG-CT-2005-019015, LSHM-CT-2005-018637]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wadsworth Foundation; Soderbergs Foundation; Petrus and Augusta Hedlunds Foundation; Bibbi and Niels Jensens Foundation; Montel Williams Foundation; Ake-Wibergs Stiftelse; Swedish Foundation for Neurologically Disabled; EU(European Commission)	This study was supported by grants from the Swedish Research Council, The Wadsworth Foundation, Soderbergs Foundation, Petrus and Augusta Hedlunds Foundation, Bibbi and Niels Jensens Foundation, Montel Williams Foundation, Ake-Wibergs Stiftelse, the Swedish Foundation for Neurologically Disabled and the EU 6TH Framework EURATools (LSHG-CT-2005-019015) and Neuropromise (LSHM-CT-2005-018637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; AMOR S, 1994, J IMMUNOL, V153, P4349; Becanovic K, 2003, J IMMUNOL, V170, P1062, DOI 10.4049/jimmunol.170.2.1062; Becanovic K, 2006, J IMMUNOL, V176, P6055, DOI 10.4049/jimmunol.176.10.6055; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cabanillas AM, 1996, DNA CELL BIOL, V15, P643, DOI 10.1089/dna.1996.15.643; CHURCHILL GA, 1994, GENETICS, V138, P963; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; Dahlman I, 1999, HUM MOL GENET, V8, P2183, DOI 10.1093/hmg/8.12.2183; Dahlman I, 1999, J IMMUNOL, V162, P2581; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Foxwell BMJ, 2001, ANN RHEUM DIS, V60, pIII13; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; GREENBERG SJ, 1988, NEW ENGL J MED, V319, P1019; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; HILLERT J, 1993, NEUROLOGY, V43, P163, DOI 10.1212/WNL.43.1_Part_1.163; HOPPENBROUWERS IA, 2009, J HUM GENET; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Jagodic M, 2005, J IMMUNOL, V174, P918, DOI 10.4049/jimmunol.174.2.918; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Jagodic M, 2001, IMMUNOGENETICS, V53, P410, DOI 10.1007/s002510100342; JERSILD C, 1972, LANCET, V1, P1240; JERSILD C, 1973, LANCET, V2, P1221; Jin P, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2447; Klein AP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S73; Kouki T, 2002, J ENDOCRINOL INVEST, V25, P208, DOI 10.1007/BF03343992; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Mana P, 2004, INT IMMUNOL, V16, P489, DOI 10.1093/intimm/dxh049; Manavella PA, 2007, BIOCHEM BIOPH RES CO, V360, P621, DOI 10.1016/j.bbrc.2007.06.088; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; MARTA M, 2009, GENES IMMUN; Martino G, 2002, LANCET NEUROL, V1, P499, DOI 10.1016/S1474-4422(02)00223-5; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; OCKINGER J, 2009, GENES IMMUN; Ockinger J, 2006, GENETICS, V173, P1539, DOI 10.1534/genetics.106.057406; Paleolog EM, 1996, BRIT J RHEUMATOL, V35, P917; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Teuscher C, 2006, GENETICS, V172, P1147, DOI 10.1534/genetics.105.049049; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Visscher PM, 1996, GENETICS, V143, P1013; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Wenz HM, 1998, GENOME RES, V8, P69, DOI 10.1101/gr.8.1.69; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yasui DH, 1998, J IMMUNOL, V160, P4433; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	88	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12716	10.1371/journal.pone.0012716	http://dx.doi.org/10.1371/journal.pone.0012716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856809	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815800012
J	Friis, C; Wassenaar, TM; Javed, MA; Snipen, L; Lagesen, K; Hallin, PF; Newell, DG; Toszeghy, M; Ridley, A; Manning, G; Ussery, DW				Friis, Carsten; Wassenaar, Trudy M.; Javed, Muhammad A.; Snipen, Lars; Lagesen, Karin; Hallin, Peter F.; Newell, Diane G.; Toszeghy, Monique; Ridley, Anne; Manning, Georgina; Ussery, David W.			Genomic Characterization of Campylobacter jejuni Strain M1	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; CLINICAL ISOLATE; SEQUENCE; PROTEIN; IDENTIFICATION; COLONIZATION; POULTRY; FIBRONECTIN; INFECTION; CHICKEN	Campylobacter jejuni strain M1 (laboratory designation 99/308) is a rarely documented case of direct transmission of C. jejuni from chicken to a person, resulting in enteritis. We have sequenced the genome of C. jejuni strain M1, and compared this to 12 other C. jejuni sequenced genomes currently publicly available. Compared to these, M1 is closest to strain 81116. Based on the 13 genome sequences, we have identified the C. jejuni pan-genome, as well as the core genome, the auxiliary genes, and genes unique between strains M1 and 81116. The pan-genome contains 2,427 gene families, whilst the core genome comprised 1,295 gene families, or about two-thirds of the gene content of the average of the sequenced C. jejuni genomes. Various comparison and visualization tools were applied to the 13 C. jejuni genome sequences, including a species pan- and core genome plot, a BLAST Matrix and a BLAST Atlas. Trees based on 16S rRNA sequences and on the total gene families in each genome are presented. The findings are discussed in the background of the proven virulence potential of M1.	[Friis, Carsten; Snipen, Lars; Lagesen, Karin; Hallin, Peter F.; Ussery, David W.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Wassenaar, Trudy M.] Mol Microbiol & Genom Consultants, Zotzenheim, Germany; [Javed, Muhammad A.; Manning, Georgina] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Lagesen, Karin] Oslo Univ Hosp, Inst Med Microbiol, Oslo, Norway; [Lagesen, Karin] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Newell, Diane G.; Toszeghy, Monique; Ridley, Anne] Vet Labs Agencies, Addlestone, Surrey, England; [Newell, Diane G.] Food Borne Zoonoses Consultancy, Andover, England	Technical University of Denmark; Nottingham Trent University; Norwegian University of Life Sciences; University of Oslo; University of Oslo; Veterinary Laboratories Agency	Friis, C (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	carsten@cbs.dtu.dk	Ussery, David/J-2026-2019; Ridley, Anne M/E-2294-2011; Ridley, Anne/AAH-5205-2019	Ussery, David/0000-0003-3632-5512; Wassenaar, Trudy/0000-0002-7024-1139; Manning, Georgina/0000-0003-2198-0880; Lagesen, Karin/0000-0003-1329-9032	Danish Center for Scientific Computing (DCSC); Danish Natural Science Research Council [26-06-0349]; Defra, Great Britain; The Technical University of Denmark; Molecular Microbiology and Genomics Consultants MMGC	Danish Center for Scientific Computing (DCSC); Danish Natural Science Research Council(Danish Natural Science Research Council); Defra, Great Britain(Department for Environment, Food & Rural Affairs (DEFRA)); The Technical University of Denmark; Molecular Microbiology and Genomics Consultants MMGC	Danish Center for Scientific Computing (DCSC) http://www.dcsc.dk/; Danish Natural Science Research Council (FNU grant 26-06-0349) http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research; Defra, Great Britain, funded the work leading to the isolation and characterization of C. jejuni 99/308 http://www.defra.gov.uk/. Dr. Wassenaar's salary was co-financed between The Technical University of Denmark and by Molecular Microbiology and Genomics Consultants MMGC (http://www.mmgc.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuOun M, 2005, INFECT IMMUN, V73, P3053, DOI 10.1128/IAI.73.5.3053-3062.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Ayling RD, 1996, RES VET SCI, V60, P168, DOI 10.1016/S0034-5288(96)90013-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Binnewies TT, 2005, MICROBIOL-SGM, V151, P1, DOI 10.1099/mic.0.27760-0; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHRISTENSEN JE, 2009, MOL MICROBIOL; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; Fearnley C, 2008, J MED MICROBIOL, V57, P570, DOI 10.1099/jmm.0.47803-0; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; FRIIS C, 2009, SUPPLEMENTARY SECTIO; Frost JA, 1998, J CLIN MICROBIOL, V36, P335, DOI 10.1128/JCM.36.2.335-339.1998; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gibson J, 1997, J MED MICROBIOL, V46, P157, DOI 10.1099/00222615-46-2-157; Hallin PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/b717118h; *HLTH PROT AG, CELL LIN WER OBT EUR; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; HUMPHREY T, 1995, INT J FOOD MICROBIOL, V26, P295, DOI 10.1016/0168-1605(94)00135-S; Jacobs-Reitsma W., 2000, CAMPYLOBACTER, P467; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; KERVELLA M, 1993, INFECT IMMUN, V61, P3440, DOI 10.1128/IAI.61.8.3440-3448.1993; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Little CL, 2008, INT J ENVIRON HEAL R, V18, P403, DOI 10.1080/09603120802100220; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Miller WG, 2008, FOODBORNE PATHOG DIS, V5, P371, DOI 10.1089/fpd.2008.0101; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001; Newell D. G., 2001, Society for Applied Microbiology Symposium Series, p57S; Newell DG, 2001, APPL ENVIRON MICROB, V67, P2636, DOI 10.1128/AEM.67.6.2636-2640.2001; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-50; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raphael BH, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P397; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; SIMONSEN B, 1971, METHODS DETERMINING, P27; Sinden RR, 1999, ANN NY ACAD SCI, V870, P173, DOI 10.1111/j.1749-6632.1999.tb08878.x; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Ussery DW, 2009, COMPUTING COMP MICRO; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; WASSENAAR TM, 2009, LETT APPL MICROBIOL; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	79	70	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12253	10.1371/journal.pone.0012253	http://dx.doi.org/10.1371/journal.pone.0012253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865039	Green Published, gold			2022-12-25	WOS:000281292100001
J	Mazuet, C; Dano, J; Popoff, MR; Creminon, C; Volland, H				Mazuet, Christelle; Dano, Julie; Popoff, Michel R.; Creminon, Christophe; Volland, Herve			Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity	PLOS ONE			English	Article							BINDING DOMAIN; FRAGMENTS; IGG; PHARMACOKINETICS; F(AB')(2); GENE	Botulinum toxins, i.e. BoNT/A to/G, include the most toxic substances known. Since botulism is a potentially fatal neuroparalytic disease with possible use as a biowarfare weapon (Centers for Disease Control and Prevention category A bioterrorism agent), intensive efforts are being made to develop vaccines or neutralizing antibodies. The use of active fragments from non-human immunoglobulins (F(ab')(2), Fab', scFv), chemically modified or not, may avoid side effects, but also largely modify the in vivo half-life and effectiveness of these reagents. We evaluated the neutralizing activity of several monoclonal anti-BoNT/A antibodies (mAbs). F(ab')(2) fragments, native or treated with polyethyleneglycol (PEG), were prepared from selected mAbs to determine their half-life and neutralizing activity as compared with the initial mAbs. We compared the protective efficiency of the different biochemical forms of anti-toxin mAbs providing the same neutralizing activity. Among fourteen tested mAbs, twelve exhibited neutralizing activity. Fragments from two of the best mAbs (TA12 and TA17), recognizing different epitopes, were produced. These two mAbs neutralized the A1 subtype of the toxin more efficiently than the A2 or A3 subtypes. Since mAb TA12 and its fragments both exhibited the greatest neutralizing activity, they were further evaluated in the therapeutic experiments. These showed that, in a mouse model, a 2- to 4-h interval between toxin and antitoxin injection allows the treatment to remain effective, but also suggested an absence of correlation between the half-life of the antitoxins and the length of time before treatment after botulinum toxin A contamination. These experiments demonstrate that PEG treatment has a strong impact on the half-life of the fragments, without affecting the effectiveness of neutralization, which was maintained after preparation of the fragments. These reagents may be useful for rapid treatment after botulinum toxin A contamination.	[Mazuet, Christelle; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Dano, Julie; Creminon, Christophe; Volland, Herve] CEA, iBiTecS, Serv Pharmacol & Immunoanal, Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay	Mazuet, C (corresponding author), Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France.	herve.volland@cea.fr	Popoff, Michel/O-7719-2016; Mazuet, Christelle/O-7731-2016	Popoff, Michel/0000-0001-9305-8989; Mazuet, Christelle/0000-0001-7619-9050	Institut de Aerospatiale du service de sante des armees (IMASSA)	Institut de Aerospatiale du service de sante des armees (IMASSA)	This work was supported by grants from Institut de Aerospatiale du service de sante des armees (IMASSA) (contrat de recherche #2 BIS IMASSA/TOXBOT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; ARNON SS, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P477; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; CLAYTON MA, 1995, INFECT IMMUN, V63, P2738, DOI 10.1128/IAI.63.7.2738-2742.1995; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; HATHEWAY CL, 1994, IMMUNOGENICITY NEURO, P93; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Jones RGA, 2006, TOXICON, V48, P246, DOI 10.1016/j.toxicon.2006.05.007; KNAUF MJ, 1988, J BIOL CHEM, V263, P15064; Koumenis IL, 2000, INT J PHARM, V198, P83, DOI 10.1016/S0378-5173(99)00458-5; LAMOYI E, 1983, J IMMUNOL METHODS, V56, P235, DOI 10.1016/0022-1759(83)90415-5; Leong SR, 2001, CYTOKINE, V16, P106, DOI 10.1006/cyto.2001.0936; Liu W, 2003, P NATL ACAD SCI USA, V100, P13621, DOI 10.1073/pnas.2233819100; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mayers CN, 2003, IMMUNOPHARM IMMUNOT, V25, P397, DOI 10.1081/IPH-120024507; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Sheridan RE, 2001, TOXICON, V39, P651, DOI 10.1016/S0041-0101(00)00189-6; Shone CC, 1995, CURR TOP MICROBIOL, V195, P143; Smith LA, 1998, TOXICON, V36, P1539, DOI 10.1016/S0041-0101(98)00146-9; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; SMITH TW, 1979, CLIN EXP IMMUNOL, V36, P384; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Torii Y, 2002, VACCINE, V20, P2556, DOI 10.1016/S0264-410X(02)00157-3; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; Wheeler MW, 1923, J IMMUNOL, V8, P501; Wu HC, 2001, APPL ENVIRON MICROB, V67, P3201, DOI 10.1128/AEM.67.7.3201-3207.2001	34	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12416	10.1371/journal.pone.0012416	http://dx.doi.org/10.1371/journal.pone.0012416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865035	gold, Green Submitted, Green Published			2022-12-25	WOS:000281292100016
J	Verhoeven, KJF; Casella, G; McIntyre, LM				Verhoeven, Koen J. F.; Casella, George; McIntyre, Lauren M.			Epistasis: Obstacle or Advantage for Mapping Complex Traits?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; MULTIPLE LOCI; MODEL SELECTION; HIGH-RESOLUTION; SNP DISCOVERY; IDENTIFICATION; RECOMBINATION; MARKERS	Identification of genetic loci in complex traits has focused largely on one-dimensional genome scans to search for associations between single markers and the phenotype. There is mounting evidence that locus interactions, or epistasis, are a crucial component of the genetic architecture of biologically relevant traits. However, epistasis is often viewed as a nuisance factor that reduces power for locus detection. Counter to expectations, recent work shows that fitting full models, instead of testing marker main effect and interaction components separately, in exhaustive multi-locus genome scans can have higher power to detect loci when epistasis is present than single-locus scans, and improvement that comes despite a much larger multiple testing alpha-adjustment in such searches. We demonstrate, both theoretically and via simulation, that the expected power to detect loci when fitting full models is often larger when these loci act epistatically than when they act additively. Additionally, we show that the power for single locus detection may be improved in cases of epistasis compared to the additive model. Our exploration of a two step model selection procedure shows that identifying the true model is difficult. However, this difficulty is certainly not exacerbated by the presence of epistasis, on the contrary, in some cases the presence of epistasis can aid in model selection. The impact of allele frequencies on both power and model selection is dramatic.	[Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Heteren, Netherlands; [Casella, George; McIntyre, Lauren M.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [McIntyre, Lauren M.] Univ Florida, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Verhoeven, KJF (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Heteren, Netherlands.	mcintyre@ufl.edu	McIntyre, Lauren/J-8414-2012; Verhoeven, Koen JF/C-9920-2010	McIntyre, Lauren/0000-0002-0077-3359; Verhoeven, Koen JF/0000-0003-3002-4102	National Science Foundation Division of Biological Sciences [0821954]; National Institutes of Health (NIH) [1R01GM077618, NIH 1R01GM081704]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077618, R01GM081704] Funding Source: NIH RePORTER	National Science Foundation Division of Biological Sciences; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support from National Science Foundation Division of Biological Sciences 0821954, National Institutes of Health (NIH) 1R01GM077618 and NIH 1R01GM081704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2005, MAMM GENOME, V16, P481, DOI 10.1007/s00335-004-2425-4; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Coffman CJ, 2005, GENETICS, V170, P1281, DOI 10.1534/genetics.104.033910; Cohen J., 1990, STAT POWER ANAL BEHA; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Duran C, 2009, NUCLEIC ACIDS RES, V37, pD951, DOI 10.1093/nar/gkn650; EAVES LJ, 1994, HEREDITY, V72, P175, DOI 10.1038/hdy.1994.25; Ehrenreich IM, 2007, GENETICS, V176, P1223, DOI 10.1534/genetics.107.071928; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Ewens WJ, 2001, THEOR POPUL BIOL, V60, P135, DOI 10.1006/tpbi.2001.1547; Gurganus MC, 1999, GENETICS, V152, P1585; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HARTL DL, 2004, GENETICS ANAL GENES; Holland JB, 1997, CROP SCI, V37, P1306, DOI 10.2135/cropsci1997.0011183X003700040047x; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Jannink JL, 2001, GENETICS, V157, P445; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1989, GENETICS, V121, P185; Lehmann E.L., 2006, TESTING STAT HYPOTHE, V3rd ed; Li ZK, 1997, GENETICS, V145, P453; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Neter J., 1996, APPL LINEAR STAT MOD; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Park M, 2007, COMPUT STAT DATA AN, V51, P3145, DOI 10.1016/j.csda.2006.09.002; Peripato AC, 2002, GENETICS, V162, P1341; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Routman EJ, 1997, EVOLUTION, V51, P1654, DOI 10.1111/j.1558-5646.1997.tb01488.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simonsen KL, 1997, THEOR POPUL BIOL, V52, P43, DOI 10.1006/tpbi.1997.1307; Strahs A, 2000, AM J HUM GENET, V67, P316; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Verhoeven KJF, 2005, MOL BIOL EVOL, V22, P735, DOI 10.1093/molbev/msi058; Wade MJ, 2001, GENETICA, V112, P59, DOI 10.1023/A:1013316611768; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; XU SH, 1995, GENETICS, V141, P1189; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng MX, 2007, AM J HUM GENET, V80, P112, DOI 10.1086/510685	65	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12264	10.1371/journal.pone.0012264	http://dx.doi.org/10.1371/journal.pone.0012264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865037	Green Submitted, Green Published, gold			2022-12-25	WOS:000281292100003
J	Weingartner, A; Drobot, B; Herrmann, A; Sanchez-Canete, MP; Gamarro, F; Castanys, S; Pomorski, TG				Weingaertner, Adrien; Drobot, Bjoern; Herrmann, Andreas; Sanchez-Canete, Maria P.; Gamarro, Francisco; Castanys, Santiago; Pomorski, Thomas Gunther			Disruption of the Lipid-Transporting LdMT-LdRos3 Complex in Leishmania donovani Affects Membrane Lipid Asymmetry but Not Host Cell Invasion	PLOS ONE			English	Article							P-TYPE ATPASE; PLASMA-MEMBRANE; MILTEFOSINE TRANSPORTER; PHOSPHOLIPID TRANSLOCATION; APOPTOTIC MIMICRY; DRUG-RESISTANCE; PROTEIN; YEAST; EXPRESSION; PHOSPHATIDYLETHANOLAMINE	Maintenance and regulation of the asymmetric lipid distribution across eukaryotic plasma membranes is governed by the concerted action of specific membrane proteins controlling lipid movement across the bilayer. Here, we show that the miltefosine transporter (LdMT), a member of the P4-ATPase subfamily in Leishmania donovani, and the Cdc50-like protein LdRos3 form a stable complex that plays an essential role in maintaining phospholipid asymmetry in the parasite plasma membrane. Loss of either LdMT or LdRos3 abolishes ATP-dependent transport of NBD-labelled phosphatidylethanolamine (PE) and phosphatidylcholine from the outer to the inner plasma membrane leaflet and results in an increased cell surface exposure of endogenous PE. We also find that promastigotes of L. donovani lack any detectable amount of phosphatidylserine (PS) but retain their infectivity in THP-1-derived macrophages. Likewise, infectivity was unchanged for parasites without LdMT-LdRos3 complexes. We conclude that exposure of PS and PE to the exoplasmic leaflet is not crucial for the infectivity of L. donovani promastigotes.	[Weingaertner, Adrien; Drobot, Bjoern; Herrmann, Andreas] Humboldt Univ, Inst Biol & Biophys, Berlin, Germany; [Sanchez-Canete, Maria P.; Gamarro, Francisco; Castanys, Santiago] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Pomorski, Thomas Gunther] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen, Denmark	Humboldt University of Berlin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Copenhagen	Weingartner, A (corresponding author), Humboldt Univ, Inst Biol & Biophys, Berlin, Germany.	tgp@life.ku.dk	Castanys, Santiago/Y-3981-2019; Pomorski, Thomas Günther/G-4804-2014; Drobot, Björn/AAZ-3694-2021	Castanys, Santiago/0000-0002-3460-844X; Pomorski, Thomas Günther/0000-0002-4889-0829; Drobot, Björn/0000-0003-1245-0466; Sanchez-Canete, Maria P./0000-0002-9418-8942; Gamarro, Francisco/0000-0003-1347-3440	German Research Foundation; ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) [RD06/0021/0002]; Plan Andaluz de Investigacion [Cod. BIO130]; Marie Curie Flippase Network; FAZIT; Carlsberg Foundation; Deutsche Forschungsgemeinschaft [PO748/9];  [SAF2005-01639]	German Research Foundation(German Research Foundation (DFG)); ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)(Instituto de Salud Carlos III); Plan Andaluz de Investigacion; Marie Curie Flippase Network; FAZIT; Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Research Training Group 1121 of the German Research Foundation (AW, AH and TGP), the Spanish grants SAF2005-01639 (SC), the ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) RD06/0021/0002 (FG) and by the Plan Andaluz de Investigacion (Cod. BIO130), the Marie Curie Flippase Network (AW, AH and FG), FAZIT (AW), the Carlsberg Foundation (TGP) and the Deutsche Forschungsgemeinschaft (TGP, grant PO748/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTTILA HSI, 1992, CLIN EXP IMMUNOL, V89, P509; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; COLEMAN JA, 2009, J BIOL CHEM; Dasgupta B, 2003, SCAND J IMMUNOL, V57, P366, DOI 10.1046/j.1365-3083.2003.01227.x; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Guenther UP, 2009, J MOL MED, V87, P31, DOI 10.1007/s00109-008-0402-7; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sanchez-Canete MP, 2009, ANTIMICROB AGENTS CH, V53, P1305, DOI 10.1128/AAC.01694-08; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	39	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12443	10.1371/journal.pone.0012443	http://dx.doi.org/10.1371/journal.pone.0012443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865154	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100031
J	Kim, J; Thorne, SH; Sun, L; Huang, B; Mochly-Rosen, D				Kim, J.; Thorne, S. H.; Sun, L.; Huang, B.; Mochly-Rosen, D.			Sustained inhibition of PKC alpha reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model	ONCOGENE			English	Article						bioluminescence; mammary cancer; metastasis; protein kinase C	PROTEIN-KINASE-C; BREAST-CANCER METASTASIS; MATRIX METALLOPROTEINASES; EPITHELIAL-CELLS; BETA-II; EXPRESSION; ACTIVATION; PEPTIDES; INVASION; THERAPY	Metastasis is the major reason for breast cancer-related deaths. Although there is a host of indirect evidence for a role of protein kinase C (PKC) alpha in primary breast cancer growth, its role in the molecular pathways leading to metastasis has not been studied comprehensively. By treating mice with alpha V5-3, a novel peptide inhibitor selective for PKC alpha, we were able to determine how PKC alpha regulates metastasis of mammary cancer cells using a syngeneic and orthotopic model. The primary tumor growth was not affected by alpha V5-3 treatment. However, the mortality rate was reduced and metastasis in the lung decreased by more than 90% in the alpha V5-3-treated mice relative to the control-treated mice. alpha V5-3 treatment reduced intravasation by reducing matrix metalloproteinase-9 activities. alpha V5-3 treatment also reduced lung seeding of tumor cells and decreased cell migration, effects that were accompanied by a reduction in nuclear factor kappa B activity and cell surface levels of the CXCL12 receptor, CXCR4. alpha V5-3 treatment caused no apparent toxicity in non-tumor-bearing naive mice. Rather, inhibiting PKC alpha protected against liver damage and increased the number of immune cells in tumor-bearing mice. Importantly, alpha V5-3 showed superior efficacy relative to anti-CXCR4 antibody in reducing metastasis in vivo. Together, these data show that pharmacological inhibition of PKC alpha effectively reduces mammary cancer metastasis by targeting intravasation and lung seeding steps in the metastatic process and suggest that PKC alpha-specific inhibitors, such as alpha V5-3, can be used to study the mechanistic roles of PKC alpha specifically and may provide a safe and effective treatment for the prevention of lung metastasis of breast cancer patients. Oncogene (2011) 30, 323-333; doi:10.1038/onc.2010.415; published online 20 September 2010	[Kim, J.; Sun, L.; Mochly-Rosen, D.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Thorne, S. H.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Thorne, S. H.; Huang, B.] Univ Pittsburgh, Div Surg Oncol, Inst Canc, Pittsburgh, PA USA	Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Room 3145-A,269 Campus Dr, Stanford, CA 94305 USA.	mochly@stanford.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; Kim, Jeewon/0000-0002-1063-0239	National Cancer Institute, DHHS [CA09151]; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER	National Cancer Institute, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Erinn Bruno Rankin in Dr Amato Giaccia's lab at the Department of Radiation Oncology at Stanford University for generous technical support and Dr Adrienne Gordon for critical reading of the paper. This work was supported in part by PHS Grant Number CA09151, awarded by the National Cancer Institute, DHHS (to JK).	Affara NI, 2007, CELL, V129, P25, DOI 10.1016/j.cell.2007.03.029; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Assender JW, 2007, J CLIN PATHOL, V60, P1216, DOI 10.1136/jcp.2006.041616; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; BORNER C, 1987, INT J CANCER, V40, P344, DOI 10.1002/ijc.2910400310; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Christofori G, 2007, NATURE, V446, P735, DOI 10.1038/446735a; Cindoruk M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-44; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Frankel LB, 2007, BREAST CANCER RES TR, V104, P165, DOI 10.1007/s10549-006-9399-1; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Kawakami A, 2007, ARTERIOSCL THROM VAS, V27, P219, DOI 10.1161/01.ATV.0000249620.68705.0d; Ke ZJ, 2006, INT J CANCER, V119, P8, DOI 10.1002/ijc.21769; Kim JW, 2008, CANCER RES, V68, P6831, DOI 10.1158/0008-5472.CAN-07-6195; Kim YM, 2000, CANCER RES, V60, P5410; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Mimeault M, 2007, CANCER METAST REV, V26, P203, DOI 10.1007/s10555-007-9052-4; Mochly-Rosen D, 1998, FASEB J, V12, P35; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; OBRIAN CA, 1989, CANCER RES, V49, P3215; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Shin Y, 2007, EXP MOL MED, V39, P97, DOI 10.1038/emm.2007.11; Sledge GW, 2006, SEMIN ONCOL, V33, pS15, DOI 10.1016/j.seminoncol.2006.03.019; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Taichman RS, 2002, CANCER RES, V62, P1832; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Thorne SH, 2005, P IEEE, V93, P750, DOI 10.1109/JPROC.2005.844261; Tonetti DA, 2003, BRIT J CANCER, V88, P1400, DOI 10.1038/sj.bjc.6600923; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197; Zorzi D, 2007, BRIT J SURG, V94, P274, DOI 10.1002/bjs.5719; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	48	52	54	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					323	333		10.1038/onc.2010.415	http://dx.doi.org/10.1038/onc.2010.415			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20856202	Green Accepted			2022-12-25	WOS:000286418800007
J	Ding, Y; Kim, JK; Kim, SI; Na, HJ; Jun, SY; Lee, SJ; Choi, ME				Ding, Yan; Kim, Jin Kuk; Kim, Sung Il; Na, Hee-Jun; Jun, Soo Young; Lee, Seon Jin; Choi, Mary E.			TGF-beta 1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; I-KAPPA-B; DEPENDENT-KINASE; TRANSFORMING GROWTH-FACTOR-BETA-1; SMAD PATHWAYS; BETA; ACTIVATION; DEATH; INHIBITION; TAK1	Autophagy can lead to cell death in response to stress, but it can also act as a protective mechanism for cell survival. We show that TGF-beta 1 induces autophagy and protects glomerular mesangial cells from undergoing apoptosis during serum deprivation. Serum withdrawal rapidly induced autophagy within 1 h in mouse mesangial cells (MMC) as determined by increased microtubule-associated protein 1 light chain 3 (LC3) levels and punctate distribution of the autophagic vesicle-associated-form LC3-II. We demonstrate that after 1 h there was a time-dependent decrease in LC3 levels that was accompanied by induction of apoptosis, evidenced by increases in cleaved caspase 3. However, treatment with TGF-beta 1 resulted in induction of the autophagy protein LC3 while suppressing caspase 3 activation. TGF-beta 1 failed to rescue MMC from serum deprivation-induced apoptosis upon knockdown of LC3 by siRNA and in MMC from LC3 null (LC3(-/-)) mice. We show that TGF-beta 1 induced autophagy through TAK1 and Akt activation, and inhibition of PI3K-Akt pathway by LY294002 or dominant-negative Akt suppressed LC3 levels and enhanced caspase 3 activation. TGF-beta 1 also up-regulated cyclin D1 and E protein levels while down-regulating p27, thus stimulating cell cycle progression. Bafilomycin A1, but not MG132, blocked TGF-beta 1 down-regulation of p27, suggesting that p27 levels were regulated through autophagy. Taken together, our data indicate that TGF-beta 1 rescues MMC from serum deprivation-induced apoptosis via induction of autophagy through activation of the Akt pathway. The autophagic process may constitute an adaptive mechanism to glomerular injury by inhibiting apoptosis and promoting mesangial cell survival.	[Ding, Yan; Kim, Jin Kuk; Kim, Sung Il; Na, Hee-Jun; Jun, Soo Young; Choi, Mary E.] Harvard Univ, Sch Med, Dept Med, Div Renal,Brigham & Womens Hosp, 4 Black Fan Circle,HIM-5, Boston, MA 02115 USA; [Ding, Yan] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin 150001, Peoples R China; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harbin Medical University; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Renal,Brigham & Womens Hosp, 4 Black Fan Circle,HIM-5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu	Lee, Seon-Jin/AAJ-8258-2020	JUN, SOO YOUNG`/0000-0001-6516-3140; Lee, Seon-Jin/0000-0001-7214-7536	National Institutes of Health [R01 DK57661 (NIDDK)]; American Heart Association [0665379U]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK57661 (NIDDK; to M. E. C.). This work was also supported by American Heart Association Beginning Grant-in-aid 0665379U and by the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to S. I. K.).	Andjelic S, 1997, J IMMUNOL, V158, P2527; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brown TL, 1999, J BIOL CHEM, V274, P23256, DOI 10.1074/jbc.274.33.23256; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen HH, 2003, CELL DEATH DIFFER, V10, P516, DOI 10.1038/sj.cdd.4401171; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Huang Y, 2000, J BIOL CHEM, V275, P18234, DOI 10.1074/jbc.M909431199; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim G, 2002, ARTHRITIS RHEUM-US, V46, P1504, DOI 10.1002/art.10314; Kim SM, 2007, AM J PHYSIOL-RENAL, V292, pF415, DOI 10.1152/ajprenal.00317.2006; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; LOTEM J, 1992, BLOOD, V80, P1750; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Narita Y, 2002, CANCER RES, V62, P6764; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; Roberts A.B., 2001, SCI STKE, V113, ppe43, DOI [10.1126/stke.2001.113.pe43, DOI 10.1126/STKE.2001.113.PE43]; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schoecklmann HO, 1997, KIDNEY INT, V51, P1228, DOI 10.1038/ki.1997.168; Shankland SJ, 1996, KIDNEY INT, V50, P1230, DOI 10.1038/ki.1996.432; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zeng XH, 2008, CANCER RES, V68, P2384, DOI 10.1158/0008-5472.CAN-07-6163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	82	114	123	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37909	37919		10.1074/jbc.M109.093724	http://dx.doi.org/10.1074/jbc.M109.093724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876581	hybrid, Green Published			2022-12-25	WOS:000284424000080
J	Frijns, E; Sachs, N; Kreft, M; Wilhelmsen, K; Sonnenberg, A				Frijns, Evelyne; Sachs, Norman; Kreft, Maaike; Wilhelmsen, Kevin; Sonnenberg, Arnoud			EGF-induced MAPK Signaling Inhibits Hemidesmosome Formation through Phosphorylation of the Integrin beta 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH; ALPHA-6-BETA-4 INTEGRIN; EPIDERMOLYSIS-BULLOSA; S6 KINASE; IN-VITRO; SUBUNIT; PLECTIN; DOMAIN; ADHESION	Migration of keratinocytes requires a regulated and dynamic turnover of hemidesmosomes (HDs). We and others have previously identified three serine residues on the integrin beta 4 cytoplasmic domain that play a critical role in the regulation of HD disassembly. In this study we show that only two of these residues (Ser-1356 and Ser-1364) are phosphorylated in keratinocytes after stimulation with either PMA or EGF. Furthermore, in direct contrast to previous studies performed in vitro, we found that the PMA- and EGF-stimulated phosphorylation of beta 4 is not mediated by PKC, but by ERK1/2 and its downstream effector kinase p90RSK1/2. EGF-stimulated phosphorylation of beta 4 increased keratinocyte migration, and reduced the number of stable HDs. Furthermore, mutation of the two serines in beta 4 to phospho-mimicking aspartic acid decreased its interaction with the cytoskeletal linker protein plectin, as well as the strength of alpha 6 beta 4-mediated adhesion to laminin-332. During mitotic cell rounding, when the overall cell-substrate area is decreased and the number of HDs is reduced, beta 4 was only phosphorylated on Ser-1356 by a distinct, yet unidentified, kinase. Collectively, these data demonstrate an important role of beta 4 phosphorylation on residues Ser-1356 and Ser-1364 in the formation and/or stability of HDs.	[Frijns, Evelyne; Sachs, Norman; Kreft, Maaike; Wilhelmsen, Kevin; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.sonnenberg@nki.nl		Sachs, Norman/0000-0002-5467-7151	Dutch Cancer Society; Netherlands Science Organization (NWO/ALW)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Science Organization (NWO/ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Cancer Society and the Netherlands Science Organization (NWO/ALW).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BUTT E, 1994, J BIOL CHEM, V269, P14509; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chung HJ, 2010, DERMATOL CLIN, V28, P43, DOI 10.1016/j.det.2009.10.005; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2001, J INVEST DERMATOL, V117, P1405, DOI 10.1046/j.0022-202x.2001.01567.x; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Malecz N, 1996, J BIOL CHEM, V271, P8203, DOI 10.1074/jbc.271.14.8203; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Niessen CM, 1997, J CELL SCI, V110, P1705; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; OrianRousseau V, 1996, DEV DYNAM, V206, P12, DOI 10.1002/(SICI)1097-0177(199605)206:1<12::AID-AJA2>3.0.CO;2-3; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shah BH, 2005, MOL PHARMACOL, V67, P184, DOI 10.1124/mol.104.003533; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; UEMATSU J, 1994, J BIOCHEM-TOKYO, V115, P469, DOI 10.1093/oxfordjournals.jbchem.a124361; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	42	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37650	37662		10.1074/jbc.M110.138818	http://dx.doi.org/10.1074/jbc.M110.138818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870721	Green Published, hybrid			2022-12-25	WOS:000284424000057
J	Mao, P; Smerdon, MJ				Mao, Peng; Smerdon, Michael J.			Yeast Deubiquitinase Ubp3 Interacts with the 26 S Proteasome to Facilitate Rad4 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UV-INDUCED UBIQUITYLATION; UBIQUITIN LIGASE COMPLEX; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN; DAMAGE; RECOGNITION; PATHWAY; ENZYME	Deubiquitinating enzymes (DUBs) function in a variety of cellular processes by removing ubiquitin moieties from substrates, but their role in DNA repair has not been elucidated. Yeast Rad4-Rad23 heterodimer is responsible for recognizing DNA damage in nucleotide excision repair (NER). Rad4 binds to UV damage directly while Rad23 stabilizes Rad4 from proteasomal degradation. Here, we show that disruption of yeast deubiquitinase UBP3 leads to enhanced UV resistance, increased repair of UV damage and Rad4 levels in rad23 Delta cells, and elevated Rad4 stability. A catalytically inactive Ubp3 (Ubp3-C469A), however, is unable to affect NER or Rad4. Consistent with its role in down-regulating Rad4, Ubp3 physically interacts with Rad4 and the proteasome, both in vivo and in vitro, suggesting that Ubp3 associates with the proteasome to facilitate Rad4 degradation and thus suppresses NER.	[Mao, Peng; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			NIEHS [ES002614]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES002614 from NIEHS.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; den Dulk B, 2008, DNA REPAIR, V7, P858, DOI 10.1016/j.dnarep.2008.02.004; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P317; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mueller JP, 1996, MOL CELL BIOL, V16, P2361; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Xie ZW, 2004, NUCLEIC ACIDS RES, V32, P5981, DOI 10.1093/nar/gkh934; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	34	26	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37542	37550		10.1074/jbc.M110.170175	http://dx.doi.org/10.1074/jbc.M110.170175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876584	Green Published, hybrid			2022-12-25	WOS:000284424000046
J	Vyas, AK; Koster, JC; Tzekov, A; Hruz, PW				Vyas, Arpita Kalla; Koster, Joseph C.; Tzekov, Anatoly; Hruz, Paul W.			Effects of the HIV Protease Inhibitor Ritonavir on GLUT4 Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; CELLULAR MECHANISMS; RAT ADIPOCYTES; BETA-CELLS; SECRETION; INDINAVIR; HEALTHY; EXPRESSION; DIFFERENTIATION	HIV protease inhibitors acutely block glucose transporters (GLUTs) in vitro, and this may contribute to altered glucose homeostasis in vivo. However, several GLUT-independent mechanisms have been postulated. To determine the contribution of GLUT blockade to protease inhibitor-mediated glucose dysregulation, the effects of ritonavir were investigated in mice lacking the insulin-sensitive glucose transporter GLUT4 (G4KO). G4KO and control C57BL/6J mice were administered ritonavir or vehicle at the start of an intraperitoneal glucose tolerance test and during hyperinsulinemic-euglycemic clamps. G4KO mice exhibited elevated fasting blood glucose compared with C57BL/6J mice. Ritonavir impaired glucose tolerance in control mice but did not exacerbate glucose intolerance in G4KO mice. Similarly, ritonavir reduced peripheral insulin sensitivity in control mice but not in G4KO mice. Serum insulin levels were reduced in vivo in ritonavir-treated mice. Ritonavir reduced serum leptin levels in C57BL/6J mice but had no effect on serum adiponectin. No change in these adipokines was observed following ritonavir treatment of G4KO mice. These data confirm that a primary effect of ritonavir on peripheral glucose disposal is mediated through direct inhibition of GLUT4 activity in vivo. The ability of GLUT4 blockade to contribute to derangements in the other molecular pathways that influence insulin sensitivity remains to be determined.	[Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Koster, Joseph C.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hruz, PW (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064572 and HL092798.	Ben-Romano R, 2003, AIDS, V17, P23, DOI 10.1097/00002030-200301030-00005; Carper MJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE558, DOI 10.1152/ajpendo.00167.2007; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dube MP, 2001, J ACQ IMMUN DEF SYND, V27, P130, DOI 10.1097/00126334-200106010-00006; Evans SA, 2009, ENDOCRINOLOGY, V150, P5302, DOI 10.1210/en.2009-0747; Flint OP, 2009, TOXICOL PATHOL, V37, P65, DOI 10.1177/0192623308327119; Foisy ML, 1999, J CHROMATOGR B, V721, P239, DOI 10.1016/S0378-4347(98)00451-4; Grunfeld Carl, 2008, Circulation, V118, pe20, DOI 10.1161/CIRCULATIONAHA.107.189623; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2008, CURR OPIN HIV AIDS, V3, P660, DOI 10.1097/COH.0b013e3283139134; Hruz PW, 2002, DIABETES, V51, P937, DOI 10.2337/diabetes.51.4.937; Jones SP, 2008, AIDS, V22, P1293, DOI 10.1097/QAD.0b013e3283021a4f; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim RJ, 2006, OBESITY, V14, P994, DOI 10.1038/oby.2006.114; Koster JC, 2003, DIABETES, V52, P1695, DOI 10.2337/diabetes.52.7.1695; Lagathu C, 2005, BIOCHIMIE, V87, P65, DOI 10.1016/j.biochi.2004.12.007; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lee GA, 2006, CLIN INFECT DIS, V43, P658, DOI 10.1086/505974; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Neye Y, 2006, J PHARMACOL EXP THER, V316, P106, DOI 10.1124/jpet.105.090589; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; NOOR M, 2000, ANTIVIR THER S, V5, P8; Noor Mustafa A, 2007, Curr HIV/AIDS Rep, V4, P126, DOI 10.1007/s11904-007-0019-4; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pao VY, 2010, AIDS, V24, P265, DOI 10.1097/QAD.0b013e328333af1c; PAQUET MR, 1992, MOL CELL BIOCHEM, V109, P149; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Schuit FC, 1997, DIABETOLOGIA, V40, P104, DOI 10.1007/s001250050651; Schutt M, 2004, J ENDOCRINOL, V183, P445, DOI 10.1677/joe.1.05620; Schwarz JM, 2004, AIDS, V18, P1852, DOI 10.1097/00002030-200409030-00017; Shulman GI, 1999, AM J CARDIOL, V84, p3J; Tan QY, 2005, JAIDS-J ACQ IMM DEF, V40, P398, DOI 10.1097/01.qai.0000176654.97392.c7; *THOMS PDR, 2008, PHYS DESK REF, P479; Tomaka F, 2009, HIV MED, V10, P318, DOI 10.1111/j.1468-1293.2008.00690.x; Woerle H, 2003, DIABETES, V52, pA351; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005	42	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36395	36400		10.1074/jbc.M110.176321	http://dx.doi.org/10.1074/jbc.M110.176321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864532	Green Published, hybrid			2022-12-25	WOS:000284146100049
J	Andereck, JW; King, JG; Hillyer, JF				Andereck, Jonathan W.; King, Jonas G.; Hillyer, Julian F.			Contraction of the Ventral Abdomen Potentiates Extracardiac Retrograde Hemolymph Propulsion in the Mosquito Hemocoel	PLOS ONE			English	Article							ACCESSORY PULSATILE ORGANS; HEARTBEAT REVERSAL; ACTIVE REGULATION; INSECT; CIRCULATION; MOVEMENTS; PRESSURE; MELANIZATION; PHAGOCYTOSIS; NEUROPEPTIDE	Background: Hemolymph circulation in mosquitoes is primarily controlled by the contractile action of a dorsal vessel that runs underneath the dorsal midline and is subdivided into a thoracic aorta and an abdominal heart. Wave-like peristaltic contractions of the heart alternate in propelling hemolymph in anterograde and retrograde directions, where it empties into the hemocoel at the terminal ends of the insect. During our analyses of hemolymph propulsion in Anopheles gambiae, we observed periodic ventral abdominal contractions and hypothesized that they promote extracardiac hemolymph circulation in the abdominal hemocoel. Methodology/Principal Findings: We devised methods to simultaneously analyze both heart and abdominal contractions, as well as to measure hemolymph flow in the abdominal hemocoel. Qualitative and quantitative analyses revealed that ventral abdominal contractions occur as series of bursts that propagate in the retrograde direction. Periods of ventral abdominal contraction begin only during periods of anterograde heart contraction and end immediately following a heartbeat directional reversal, suggesting that ventral abdominal contractions function to propel extracardiac hemolymph in the retrograde direction. To test this functional role, fluorescent microspheres were intrathoracically injected and their trajectory tracked throughout the hemocoel. Quantitative measurements of microsphere movement in extracardiac regions of the abdominal cavity showed that during periods of abdominal contractions hemolymph flows in dorsal and retrograde directions at a higher velocity and with greater acceleration than during periods of abdominal rest. Histochemical staining of the abdominal musculature then revealed that ventral abdominal contractions result from the contraction of intrasegmental lateral muscle fibers, intersegmental ventral muscle bands, and the ventral transverse muscles that form the ventral diaphragm. Conclusions/Significance: These data show that abdominal contractions potentiate extracardiac retrograde hemolymph propulsion in the abdominal hemocoel during periods of anterograde heart flow.	[Andereck, Jonathan W.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Andereck, JW (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	julian.hillyer@vanderbilt.edu		King, Jonas/0000-0003-2270-4212; Hillyer, Julian/0000-0002-3178-0201	National Science Foundation [IOS-0817644]; Vanderbilt University	National Science Foundation(National Science Foundation (NSF)); Vanderbilt University	This work was funded by National Science Foundation Grant IOS-0817644 to JFH and a fellowship from the Vanderbilt University Summer Research Program (VUSRP) to JWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Dulcis D, 2001, J COMP PHYSIOL A, V187, P837, DOI 10.1007/s00359-001-0254-x; Duttlinger A, 2003, NEUROPEPTIDES, V37, P120, DOI 10.1016/S0143-4179(03)00023-4; Ejaz A, 2008, PEPTIDES, V29, P214, DOI 10.1016/j.peptides.2007.07.036; Gerould JH, 1933, BIOL BULL-US, V64, P424, DOI 10.2307/1537208; GILLETT JD, 1982, PROC R SOC SER B-BIO, V215, P127, DOI 10.1098/rspb.1982.0032; Glenn JD, 2010, J EXP BIOL, V213, P541, DOI 10.1242/jeb.035014; HEINRICH B, 1976, J EXP BIOL, V64, P561; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; Hillyer JF, 2010, INVERTEBRATE IMMUNIT; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Ichikawa T, 2008, COMP BIOCHEM PHYS A, V150, P8, DOI 10.1016/j.cbpa.2008.02.012; Jones J. C., 1977, CIRCULATORY SYSTEM I; Klowden Marc J., 2007, P357; Koladich PM, 2002, J EXP BIOL, V205, P3123; Kuusik A, 2004, PHYSIOL ENTOMOL, V29, P152, DOI 10.1111/j.0307-6962.2004.00379.x; Kuusik A, 1996, EUR J ENTOMOL, V93, P23; NATION JL, 2008, INSECT PHYSL BIOCH, P339; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Pass G, 2000, ANNU REV ENTOMOL, V45, P495, DOI 10.1146/annurev.ento.45.1.495; PEDIGO LP, 2002, ENTOMOLOGY PEST MANA, P381; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1979, J INSECT PHYSIOL, V25, P825, DOI 10.1016/0022-1910(79)90085-4; SLAMA K, 1984, J COMP PHYSIOL, V154, P635, DOI 10.1007/BF00684418; SLAMA K, 1976, ACTA ENTOMOL BOHEMOS, V73, P65; Slama K, 2001, J INSECT PHYSIOL, V47, P1321, DOI 10.1016/S0022-1910(01)00122-6; Slama Karel, 2008, Terrestrial Arthropod Reviews, V1, P39, DOI 10.1163/187498308X345433; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; WASSERTHAL LT, 1980, J COMP PHYSIOL, V139, P145, DOI 10.1007/BF00691029; WASSERTHAL LT, 1976, EXPERIENTIA, V32, P577, DOI 10.1007/BF01990172; Wasserthal LT, 2007, J EXP BIOL, V210, P3707, DOI 10.1242/jeb.007864; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008	37	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12943	10.1371/journal.pone.0012943	http://dx.doi.org/10.1371/journal.pone.0012943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886066	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100041
J	Drury, LJ; Wendt, MK; Dwinell, MB				Drury, Luke J.; Wendt, Michael K.; Dwinell, Michael B.			CXCL12 Chemokine Expression and Secretion Regulates Colorectal Carcinoma Cell Anoikis through Bim-Mediated Intrinsic Apoptosis	PLOS ONE			English	Article							MCL-1; ACTIVATION; RECEPTORS; SURVIVAL; CXCR4; BCL-2; BAK; RESISTANCE; RELEVANCE; MIGRATION	Background: Resistance to anoikis, apoptosis triggered by a loss of cellular adhesion to the underlying extracellular matrix, is a hallmark of metastatic cancer. Previously we have shown re-establishment of CXCL12 expression in colorectal carcinoma cells inhibits metastasis by enhancing anoikis sensitivity. The objective of these studies was to define the signaling mechanisms regulating CXCL12-mediated anoikis. Methodology/Principal Findings: Adhesion, examined by crystal violet staining, immunofluorescence microscopy, and immunoblot analysis indicated decreased focal adhesion signaling corresponding with loss of adhesion in cells constitutively simulated by CXCL12. Loss of adhesion was inhibited by pertussis toxin treatment, indicating CXCL12 regulating anoikis through G(alpha i)-protein coupled receptors. Non-adherent HCT116 and HT29 colorectal carcinoma cells expressing CXCL12 exhibited enhanced anoikis sensitivity by propidium iodide staining, caspase activity assays, and immunoblot compared to GFP control cells. CXCL12 producing carcinomas cultured on poly-HEMA displayed heightened Bim and loss of Mcl-1 and Bcl-2 preceding cytochrome c release, and caspase-9 activation. RNAi knockdown of Bim reversed anoikis sensitivity of CXCL12-expressing cells and fostered increased soft-agar foci formation and hepatic tumors in an orthotopic mouse model of metastasis. Conclusions/Significance: These data indicate CXCL12 provides a barrier to metastasis by increasing anoikis via activation of a Bim-mediated intrinsic apoptotic pathway. These results underscore the importance of retaining CXCL12 expression to sensitize colorectal carcinomas to anoikis and minimize tumor progression.	[Drury, Luke J.; Wendt, Michael K.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Drury, LJ (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu		Wendt, Mike/0000-0002-3665-7413	Medical College of Wisconsin Cancer Center [NIDDK 062066]; Bobbie Nick Voss Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062066] Funding Source: NIH RePORTER	Medical College of Wisconsin Cancer Center; Bobbie Nick Voss Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Medical College of Wisconsin Cancer Center, NIDDK 062066 and the Bobbie Nick Voss Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cao YN, 2006, SURGERY, V140, P322, DOI 10.1016/j.surg.2006.05.006; Colamussi ML, 2001, J LEUKOCYTE BIOL, V69, P263; Duckworth CA, 2009, GASTROENTEROLOGY, V136, P943, DOI 10.1053/j.gastro.2008.11.036; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KOCHETKOVA M, 2009, CELL DEATH DIFFER; Krajewska M, 1996, CANCER RES, V56, P2422; Krajewski S, 1996, CANCER RES, V56, P2849; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Shanmugathasan M, 2000, PATHOL INT, V50, P273, DOI 10.1046/j.1440-1827.2000.01047.x; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	37	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12895	10.1371/journal.pone.0012895	http://dx.doi.org/10.1371/journal.pone.0012895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877573	Green Submitted, Green Published, gold			2022-12-25	WOS:000282053100029
J	Liebl, FLW; McKeown, C; Yao, Y; Hing, HK				Liebl, Faith L. W.; McKeown, Cassandra; Yao, Ying; Hing, Huey K.			Mutations in Wnt2 Alter Presynaptic Motor Neuron Morphology and Presynaptic Protein Localization at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							SYNAPTIC VESICLE CYCLE; ACTIVE ZONE; SIGNALING PATHWAY; FUNCTIONAL COMPONENTS; REGULATES DEVELOPMENT; ADHESION MOLECULES; GENETIC DISSECTION; MULTIPLE FUNCTIONS; CELL-ADHESION; AXON GUIDANCE	Wnt proteins are secreted proteins involved in a number of developmental processes including neural development and synaptogenesis. We sought to determine the role of the Drosophila Wnt7b ortholog, Wnt2, using the neuromuscular junction (NMJ). Mutations in wnt2 produce an increase in the number of presynaptic branches and a reduction in immunolabeling of the active zone proteins, Bruchpilot and synaptobrevin, at the NMJ. There was no change, however, in immunolabeling for the presynaptic proteins cysteine-string protein (CSP) and synaptotagmin, nor the postsynaptic proteins GluRIIA and DLG at the NMJ. Consistent with the presynaptic defects, wnt2 mutants exhibit approximately a 50% reduction in evoked excitatory junctional currents. Rescue, RNAi, and tissue-specific qRT-PCR experiments indicate that Wnt2 is expressed by the postsynaptic cell where it may serve as a retrograde signal that regulates presynaptic morphology and the localization of presynaptic proteins.	[Liebl, Faith L. W.; McKeown, Cassandra] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA; [Yao, Ying] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hing, Huey K.] SUNY Coll Brockport, Dept Biol, Brockport, NY 14420 USA	Southern Illinois University System; Southern Illinois University Edwardsville; University of Washington; University of Washington Seattle; State University of New York (SUNY) System	Liebl, FLW (corresponding author), So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA.	fliebl@siue.edu			NIH NRSA (NIH/NIDCD) [1 F32 DC08443-01]; NIH [1R15NS063315-01]; NIH/NIDCD [DC5408-01]; Roy J. Carver Charitable Trust [03-27]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS063315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005408] Funding Source: NIH RePORTER	NIH NRSA (NIH/NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Roy J. Carver Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH NRSA (NIH/NIDCD, 1 F32 DC08443-01 to F. L.), http://grants.nih.gov/training/nrsa.htm; NIH Academic Research Enhancement Award (1R15NS063315-01 to F. L.), http://grants.nih.gov/grants/funding/area.htm; NIH/NIDCD (DC5408-01 to H. H.), http://www.nidcd.nih.gov/funding/foa/; Roy J. Carver Charitable Trust (#03-27 to H. H.), https://www.carvertrust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Burden SJ, 2000, CELL, V100, P495, DOI 10.1016/S0092-8674(00)80685-6; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Deguchi-Tawarada M, 2004, GENES CELLS, V9, P15, DOI 10.1111/j.1356-9597.2004.00697.x; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kidokoro Y, 2003, NEUROSIGNALS, V12, P13, DOI 10.1159/000068912; Kirikoshi H, 2001, INT J ONCOL, V19, P779; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Lang Thorsten, 2008, V184, P107; Liebl FLW, 2008, DEV NEUROBIOL, V68, P152, DOI 10.1002/dneu.20562; Liebl FLW, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-27; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; MINAMI Y, 2009, DEV DYN; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Sakurai M, 2009, J NEUROSCI, V29, P4972, DOI 10.1523/JNEUROSCI.2821-08.2009; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; Sato A, 1999, DEVELOPMENT, V126, P4421; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yao Y, 2007, NAT NEUROSCI, V10, P1423, DOI 10.1038/nn1993; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	82	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12778	10.1371/journal.pone.0012778	http://dx.doi.org/10.1371/journal.pone.0012778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856675	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800031
J	Saisongkorh, W; Robert, C; La Scola, B; Raoult, D; Rolain, JM				Saisongkorh, Watcharee; Robert, Catherine; La Scola, Bernard; Raoult, Didier; Rolain, Jean-Marc			Evidence of Transfer by Conjugation of Type IV Secretion System Genes between Bartonella Species and Rhizobium radiobacter in Amoeba	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; GENOMIC SEQUENCE; HENSELAE; IMMUNOFLUORESCENCE; RESISTANCE; EVOLUTION; QUINTANA; BACTERIA; INVASION; BINDING	Background: Bartonella species cospeciate with mammals and live within erythrocytes. Even in these specific niches, it has been recently suggested by bioinformatic analysis of full genome sequences that Lateral Gene Transfer (LGT) may occur but this has never been demonstrated biologically. Here we describe the sequence of the B. rattaustraliani (AUST/NH4 T) circular plasmid (pNH4) that encodes the tra cluster of the Type IV secretion system (T4SS) and we eventually provide evidence that Bartonella species may conjugate and exchange this plasmid inside amoeba. Principal Findings: The T4SS of pNH4 is critical for intracellular viability of bacterial pathogens, exhibits bioinformatic evidence of LGT among bacteria living in phagocytic protists. For instance, 3 out of 4 T4SS encoding genes from pNH4 appear to be closely related to Rhizobiales, suggesting that gene exchange occurs between intracellular bacteria from mammals (bartonellae) and plants (Rhizobiales). We show that B. rattaustraliani and Rhizobium radiobacter both survived within the amoeba Acanthamoeba polyphaga and can conjugate together. Our findings further support the hypothesis that tra genes might also move into and out of bacterial communities by conjugation, which might be the primary means of genomic evolution for intracellular adaptation by cross-talk of interchangeable genes between Bartonella species and plant pathogens. Conclusions: Based on this, we speculate that amoeba favor the transfer of genes as phagocytic protists, which allows for intraphagocytic survival and, as a consequence, promotes the creation of potential pathogenic organisms.	[Saisongkorh, Watcharee; Robert, Catherine; La Scola, Bernard; Raoult, Didier; Rolain, Jean-Marc] Univ Mediterranee, URMITE, CNRS, Fac Med & Pharm,IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Saisongkorh, W (corresponding author), Univ Mediterranee, URMITE, CNRS, Fac Med & Pharm,IRD UMR 6236, Marseille, France.	didier.raoult@gmail.com; jean-marc.rolain@univmed.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; Rolain, Jean-Marc/Y-3788-2019	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Rolain, Jean-Marc/0000-0002-2402-4467	Centre National de la Recherche Scientifique France (CNRS)	Centre National de la Recherche Scientifique France (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique France (CNRS, credits recurrents). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Angelakis E, 2008, J ANTIMICROB CHEMOTH, V61, P1252, DOI 10.1093/jac/dkn094; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Beranek A, 2004, J BACTERIOL, V186, P6999, DOI 10.1128/JB.186.20.6999-7006.2004; Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546; Biswas S, 2006, ANTIMICROB AGENTS CH, V50, P3192, DOI 10.1128/AAC.00263-06; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fournier PE, 2007, EMERG INFECT DIS, V13, P1961, DOI 10.3201/eid1312.060559; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Guglielmini J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-104; Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; JEON KW, 1976, J CELL PHYSIOL, V89, P337, DOI 10.1002/jcp.1040890216; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11; LA SCOLA B, 2003, SCIENCE, V299, P2033; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; MAURIN M, 1994, J CLIN MICROBIOL, V32, P1166, DOI 10.1128/JCM.32.5.1166-1171.1994; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; MOLINER C, 2010, FEMS MICROBIOL REV, DOI DOI 10.1111/J.1574-6976.00209.X; Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ohnishi H, 2004, INFECT IMMUN, V72, P3592, DOI 10.1128/IAI.72.6.3592-3603.2004; Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Rolain JM, 2003, CLIN DIAGN LAB IMMUN, V10, P686, DOI 10.1128/CDLI.10.4.686-691.2003; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; SCHANDEL KA, 1992, J BACTERIOL, V174, P3800, DOI 10.1128/JB.174.11.3800-3806.1992; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528; Schroder G, 2003, J BACTERIOL, V185, P4371, DOI 10.1128/JB.185.15.4371-4381.2003; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004; THOMAS V, 2010, INTEROVIROL IN PRESS; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528	53	30	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12666	10.1371/journal.pone.0012666	http://dx.doi.org/10.1371/journal.pone.0012666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856925	Green Published, gold, Green Submitted			2022-12-25	WOS:000281735700006
J	Youssef, NH; Couger, MB; Elshahed, MS				Youssef, Noha H.; Couger, M. B.; Elshahed, Mostafa S.			Fine-Scale Bacterial Beta Diversity within a Complex Ecosystem (Zodletone Spring, OK, USA): The Role of the Rare Biosphere	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; SPECIES RICHNESS; SEASONAL-CHANGES; ARCTIC-OCEAN; SOIL; COMMUNITY; TIME; DNA; PHYLLOSPHERE; SIMILARITY	Background: The adaptation of pyrosequencing technologies for use in culture-independent diversity surveys allowed for deeper sampling of ecosystems of interest. One extremely well suited area of interest for pyrosequencing-based diversity surveys that has received surprisingly little attention so far, is examining fine scale (e.g. micrometer to millimeter) beta diversity in complex microbial ecosystems. Methodology/Principal Findings: We examined the patterns of fine scale Beta diversity in four adjacent sediment samples (1mm apart) from the source of an anaerobic sulfide and sulfur rich spring (Zodletone spring) in southwestern Oklahoma, USA. Using pyrosequencing, a total of 292,130 16S rRNA gene sequences were obtained. The beta diversity patterns within the four datasets were examined using various qualitative and quantitative similarity indices. Low levels of Beta diversity (high similarity indices) were observed between the four samples at the phylum-level. However, at a putative species (OTU(0.03)) level, higher levels of beta diversity (lower similarity indices) were observed. Further examination of beta diversity patterns within dominant and rare members of the community indicated that at the putative species level, beta diversity is much higher within rare members of the community. Finally, sub-classification of rare members of Zodletone spring community based on patterns of novelty and uniqueness, and further examination of fine scale beta diversity of each of these subgroups indicated that members of the community that are unique, but non novel showed the highest beta diversity within these subgroups of the rare biosphere. Conclusions/Significance: The results demonstrate the occurrence of high inter-sample diversity within seemingly identical samples from a complex habitat. We reason that such unexpected diversity should be taken into consideration when exploring gamma diversity of various ecosystems, as well as planning for sequencing-intensive metagenomic surveys of highly complex ecosystems.	[Youssef, Noha H.; Couger, M. B.; Elshahed, Mostafa S.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Youssef, NH (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Mostafa@Okstate.edu	Youssef, Noha H./T-5198-2019	Youssef, Noha H./0000-0001-9159-3785; Couger, Matthew/0000-0003-3692-1613	National Science Foundation [EF0801858]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Microbial Observatories Program (Grant EF0801858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anderberg M. R., 1973, CLUSTER ANAL APPL; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; BUHRING SI, 2010, GEOBIOL UNPUB; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Jaccard P., 1901, B SOCIT VAUDOISE SCI, V37, P547, DOI DOI 10.5169/SEALS-266450; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; LEGARD DE, 1994, AGR ECOSYST ENVIRON, V50, P87, DOI 10.1016/0167-8809(94)90128-7; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Levin I. P., 1999, QUANTITATIVE APPL SO, V125; LIGGENSTOFFER AS, 2010, ISME J IN PRESS, DOI DOI 10.1038/ISMEJ.2010.1049; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; OCHIAI AKIRA, 1957, BULL JAPANESE SOC SCI FISH, V22, P526; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; R Development Core Team, 2009, R FDN STAT COMP; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Savage KN, 2010, FEMS MICROBIOL ECOL, V72, P485, DOI 10.1111/j.1574-6941.2010.00866.x; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Senko JM, 2004, GEOCHIM COSMOCHIM AC, V68, P773, DOI 10.1016/j.gca.2003.07.008; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Smith W, 1996, BIOMETRICS, V52, P1472, DOI 10.2307/2532861; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sorensen T, 1948, BIOL SKRIFTER, V5, P1; THOMPSON IP, 1993, PLANT SOIL, V150, P177, DOI 10.1007/BF00013015; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Youssef NH, 2008, J MICROBIOL METH, V75, P86, DOI 10.1016/j.mimet.2008.05.009; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; ZHU W, 2010, NUCLEIC ACIDS RES	57	50	50	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12414	10.1371/journal.pone.0012414	http://dx.doi.org/10.1371/journal.pone.0012414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865128	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100014
J	Kamata, T; Handa, M; Ito, S; Sato, Y; Ohtani, T; Kawai, Y; Ikeda, Y; Aiso, S				Kamata, Tetsuji; Handa, Makoto; Ito, Sonomi; Sato, Yukiko; Ohtani, Toshimitsu; Kawai, Yohko; Ikeda, Yasuo; Aiso, Sadakazu			Structural Requirements for Activation in alpha IIb beta 3 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PLATELET GPIIB-IIIA; LIGAND-BINDING; ELECTRON-MICROSCOPY; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; COMPLEX; AFFINITY; ALPHA(IIB)BETA(3); ALPHA-V-BETA-3	Integrins are postulated to undergo structural rearrangement from a low affinity bent conformer to a high affinity extended conformer upon activation. However, some reports have shown that a bent conformer is capable of binding a ligand, whereas another report has shown that integrin extension does not absolutely lead to activation. To clarify whether integrin affinity is indeed regulated by the so-called switchblade-like movement, we have engineered a series of mutant alpha IIb beta 3 integrins that are constrained specifically in either a bent or an extended conformation. These mutant alpha IIb beta 3 integrins were expressed in mammalian cells, and fibrinogen binding to these cells was examined. The bent integrins were created through the introduction of artificial disulfide bridges in the beta-head/beta-tail interface. Cells expressing bent integrins all failed to bind fibrinogen unless pretreated with DTT to disrupt the disulfide bridges. The extended integrins were created by introducing N-glycosylation sites in amino acid residues located close to the alpha-genu, where the integrin legs fold backward. Among these mutants, activation was maximized in one integrin with an N-glycosylation site located behind the alpha-genu. This extension-induced activation was completely blocked when the swing-out of the hybrid domain was prevented. These results suggest that the bent and extended conformers represent low affinity and high affinity conformers, respectively, and that extension-induced activation depends on the swing-out of the hybrid domain. Taken together, these results are consistent with the current hypothesis that integrin affinity is regulated by the switchblade-like movement of the integrin legs.	[Kamata, Tetsuji; Ito, Sonomi; Sato, Yukiko; Ohtani, Toshimitsu; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; [Handa, Makoto] Keio Univ, Sch Med, Dept Transfus Med & Cell Therapy, Shinjuku Ku, Tokyo 1608582, Japan; [Kawai, Yohko] Int Univ Hlth & Welf, Prevent Hlth Examinat Ctr, Minato Ku, Tokyo 1070052, Japan; [Ikeda, Yasuo] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Keio University; Keio University; International University of Health & Welfare; Waseda University	Kamata, T (corresponding author), Keio Univ, Sch Med, Dept Anat 3S1, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kamata@sc.itc.keio.ac.jp	Handa, Makoto/B-1121-2014		Ministry of Health, Labour and Welfare; Fukuzawa Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fukuzawa Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Labor Sciences research grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare (to T. K. and M. H.), a grant from the Fukuzawa Memorial Foundation (to T. K.), and a grant-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (to S. A.).	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Adair BD, 2007, METHOD ENZYMOL, V426, P337, DOI 10.1016/S0076-6879(07)26015-X; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Matsumoto A, 2008, BIOPHYS J, V95, P2895, DOI 10.1529/biophysj.108.131045; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; TOMIYAMA Y, 1992, J BIOL CHEM, V267, P18085; TOMIYAMA Y, 1992, BLOOD, V79, P2303; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; YLANNE J, 1988, BLOOD, V72, P1478; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	33	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38428	38437		10.1074/jbc.M110.139667	http://dx.doi.org/10.1074/jbc.M110.139667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884611	hybrid, Green Published			2022-12-25	WOS:000284625600048
J	Choi, YJ; Im, E; Chung, HK; Pothoulakis, C; Rhee, SH				Choi, Yoon Jeong; Im, Eunok; Chung, Hyo Kyun; Pothoulakis, Charalabos; Rhee, Sang Hoon			TRIF Mediates Toll-like Receptor 5-induced Signaling in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINFLAMMATORY GENE-EXPRESSION; BACTERIAL FLAGELLIN; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; ACTIVATION; RECOGNITION; IMMUNITY; DISEASE; MOUSE; IPAF; TLR5	Toll-like receptors (TLRs) associate with adaptor molecules (MyD88, Mal/TIRAP, TRAM, and TRIF) to mediate signaling of host-microbial interaction. For instance, TLR4 utilizes the combination of both Mal/TIRAP-MyD88 (MyD88-dependent pathway) and TRAM-TRIF (MyD88-independent pathway). However, TLR5, the specific receptor for flagellin, is known to utilize only MyD88 to elicit inflammatory responses, and an involvement of other adaptor molecules has not been suggested in TLR5-dependent signaling. Here, we found that TRIF is involved in mediating TLR5-induced nuclear factor kappa B (NF kappa B) and mitogen-activated protein kinases (MAPKs), specifically JNK1/2 and ERK1/2, activation in intestinal epithelial cells. TLR5 activation by flagellin permits the physical interaction between TLR5 and TRIF in human colonic epithelial cells (NCM460), whereas TLR5 does not interact with TRAM upon flagellin stimulation. Both primary intestinal epithelial cells from TRIF-KO mice and TRIF-silenced NCM460 cells significantly reduced flagellin-induced NF kappa B (p105 and p65), JNK1/2, and ERK1/2 activation compared with control cells. However, p38 activation by flagellin was preserved in these TRIF-deficient cells. TRIF-KO intestinal epithelial cells exhibited substantially reduced inflammatory cytokine (keratinocyte-derived cytokine, macrophage inflammatory protein 3 alpha, and IL-6) expression upon flagellin, whereas control cells from TRIF-WT mice showed robust cytokine expression by flagellin. Compare with TRIF-WT mice, TRIF-KO mice were resistant to in vivo intestinal inflammatory responses: flagellin-mediated exacerbation of colonic inflammation and dextran sulfate sodium-induced experimental colitis. We conclude that in addition to MyD88, TRIF mediates TLR5-dependent responses and, thereby regulates inflammatory responses elicited by flagellin/TLR5 engagement. Our findings suggest an important role of TRIF in regulating host-microbial communication via TLR5 in the gut epithelium.	[Choi, Yoon Jeong; Im, Eunok; Chung, Hyo Kyun; Pothoulakis, Charalabos; Rhee, Sang Hoon] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rhee, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, MRL1240,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shrhee@mednet.ucla.edu	Lee, Kee-Joon/AAA-4090-2022		National Institutes of Health [DK072471, DK083336, DK079015]; Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079015, K01DK083336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health signaling. Grants DK072471 (to C. P.), DK083336 (to E. I.), and DK079015 (S. H. R.). This work was also supported by a Young Clinical Scientist Award (to S. H. R. and E. I.) from the Flight Attendant Medical Research Institute, Inc.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; EVANS GS, 1992, J CELL SCI, V101, P219; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Im E, 2009, J NUTR, V139, P1848, DOI 10.3945/jn.109.108613; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanaya T, 2008, AM J PHYSIOL-GASTR L, V295, pG273, DOI 10.1152/ajpgi.00378.2007; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kitajima S, 1999, J VET MED SCI, V61, P67, DOI 10.1292/jvms.61.67; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622	32	64	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37570	37578		10.1074/jbc.M110.158394	http://dx.doi.org/10.1074/jbc.M110.158394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855887	Green Published, hybrid			2022-12-25	WOS:000284424000049
J	Yagi, H; Yanagisawa, M; Suzuki, Y; Nakatani, Y; Ariga, T; Kato, K; Yu, RK				Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Kato, Koichi; Yu, Robert K.			HNK-1 Epitope-carrying Tenascin-C Spliced Variant Regulates the Proliferation of Mouse Embryonic Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BINDING-PROTEIN; MICE DEFICIENT; UP-REGULATION; CARBOHYDRATE; EXPRESSION; GLYCOLIPIDS; GENERATION; MOLECULE; ISOFORMS	Neural stem cells (NSCs) possess high proliferative potential and the capacity for self-renewal with retention of multipotency to differentiate into neuronal and glial cells. NSCs are the source for neurogenesis during central nervous system development from fetal and adult stages. Although the human natural killer-1 (HNK-1) carbohydrate epitope is expressed predominantly in the nervous system and involved in intercellular adhesion, cell migration, and synaptic plasticity, the expression patterns and functional roles of HNK-1-containing glycoconjugates in NSCs have not been fully recognized. We found that HNK-1 was expressed in embryonic mouse NSCs and that this expression was lost during the process of differentiation. Based on proteomics analysis, it was revealed that the HNK-1 epitopes were almost exclusively displayed on an extracellular matrix protein, tenascin-C (TNC), in the mouse embryonic NSCs. Furthermore, the HNK-1 epitope was found to be present only on the largest isoform of the TNC molecules. In addition, the expression of HNK-1 was dependent on expression of the largest TNC variant but not by enzymes involved in the biosynthesis of HNK-1. By knocking down HNK-1 sulfotransferase or TNC by small interfering RNA, we further demonstrated that HNK-1 on TNC was involved in the proliferation of NSCs via modulation of the expression level of the epidermal growth factor receptor. Our finding provides insights into the function of HNK-1 carbohydrate epitopes in NSCs to maintain stemness during neural development.	[Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Yu, Robert K.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Yu, Robert K.] Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Yu, RK (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.	ryu@mcg.edu	Yagi, Hirokazu/ABH-6151-2020	Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	U. S. Public Health Service [NS11853-34, NS26994-20]; Childrens' Medical Research Foundation, Chicago, IL; Medical College of Georgia; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22790076]; Japan Society; Naito Foundation, Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853, R01NS026994] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Childrens' Medical Research Foundation, Chicago, IL; Medical College of Georgia; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation, Japan(Naito Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by U. S. Public Health Service Grants NS11853-34 and NS26994-20. This work was also supported by a grant from the Childrens' Medical Research Foundation, Chicago, IL (to R. K. Y.), a start-up fund from Medical College of Georgia (to M. Y.), and Grant-in-aid for Young Scientists B 22790076 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. Y.).; Supported by the Japan Society for the Japan-United States Brain Research Cooperative Program and the Naito Foundation, Japan.	ABO T, 1981, J IMMUNOL, V127, P1024; ARIGA T, 1987, J BIOL CHEM, V262, P848; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chou DKH, 2001, J NEUROCHEM, V77, P120, DOI 10.1046/j.1471-4159.2001.t01-1-00209.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; DORRIES U, 1994, J NEUROSCI RES, V37, P336, DOI 10.1002/jnr.490370306; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Gurevicius K, 2007, MOL CELL NEUROSCI, V34, P189, DOI 10.1016/j.mcn.2006.10.014; HALL H, 1995, EUR NEUROPSYCHOPHARM, V5, P19, DOI 10.1016/0924-977X(94)00127-W; Hamanoue M, 2009, J NEUROCHEM, V110, P1575, DOI 10.1111/j.1471-4159.2009.06256.x; Joester A, 1999, J BIOL CHEM, V274, P17144, DOI 10.1074/jbc.274.24.17144; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Learish RD, 2000, DEV BRAIN RES, V122, P97; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Miura R, 2001, J NEUROCHEM, V76, P413, DOI 10.1046/j.1471-4159.2001.00042.x; Moritz S, 2008, STEM CELLS, V26, P2321, DOI 10.1634/stemcells.2007-1095; Nagase T, 2001, DEV GROWTH DIFFER, V43, P683; Nair SM, 1998, NEUROSCIENCE, V85, P759, DOI 10.1016/S0306-4522(97)00666-0; Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Suzuki Y, 2010, J BIOL CHEM, V285, P18443, DOI 10.1074/jbc.M110.114645; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tokuda A, 1998, J CARBOHYD CHEM, V17, P535, DOI 10.1080/07328309808002335; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; VINCENT M, 1984, DEV BIOL, V103, P468, DOI 10.1016/0012-1606(84)90334-8; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yagi H, 2008, GLYCOBIOLOGY, V18, P145, DOI 10.1093/glycob/cwm128; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamawaki M, 1996, J NEUROSCI RES, V44, P586, DOI 10.1002/(SICI)1097-4547(19960615)44:6<586::AID-JNR9>3.0.CO;2-7; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 1999, MOL BIOCHEM PARASIT, V102, P225, DOI 10.1016/S0166-6851(99)00102-4; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2010, ASN NEURO, V2, DOI 10.1042/AN20090063; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170	49	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37293	37301		10.1074/jbc.M110.157081	http://dx.doi.org/10.1074/jbc.M110.157081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855890	Green Published, hybrid			2022-12-25	WOS:000284424000022
J	Salameh, MA; Soares, AS; Navaneetham, D; Sinha, D; Walsh, PN; Radisky, ES				Salameh, Moh'd A.; Soares, Alexei S.; Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.; Radisky, Evette S.			Determinants of Affinity and Proteolytic Stability in Interactions of Kunitz Family Protease Inhibitors with Mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR-XIA; HUMAN BRAIN TRYPSIN; SERINE PROTEINASES; PLASMINOGEN-ACTIVATOR; INTERSCAFFOLDING ADDITIVITY; GEL-ELECTROPHORESIS; NEUTROPHIL ELASTASE; CRYSTAL-STRUCTURES	An important functional property of protein protease inhibitors is their stability to proteolysis. Mesotrypsin is a human trypsin that has been implicated in the proteolytic inactivation of several protein protease inhibitors. We have found that bovine pancreatic trypsin inhibitor (BPTI), a Kunitz protease inhibitor, inhibits mesotrypsin very weakly and is slowly proteolyzed, whereas, despite close sequence and structural homology, the Kunitz protease inhibitor domain of the amyloid precursor protein (APPI) binds to mesotrypsin 100 times more tightly and is cleaved 300 times more rapidly. To define features responsible for these differences, we have assessed the binding and cleavage by mesotrypsin of APPI and BPTI reciprocally mutated at two nonidentical residues that make direct contact with the enzyme. We find that Arg at P-1 (versus Lys) favors both tighter binding and more rapid cleavage, whereas Met (versus Arg) at P'(2) favors tighter binding but has minimal effect on cleavage. Surprisingly, we find that the APPI scaffold greatly enhances proteolytic cleavage rates, independently of the binding loop. We draw thermodynamic additivity cycles analyzing the interdependence of P-1 and P'(2) substitutions and scaffold differences, finding multiple instances in which the contributions of these features are nonadditive. We also report the crystal structure of the mesotrypsin.APPI complex, in which we find that the binding loop of APPI displays evidence of increased mobility compared with BPTI. Our data suggest that the enhanced vulnerability of APPI to mesotrypsin cleavage may derive from sequence differences in the scaffold that propagate increased flexibility and mobility to the binding loop.	[Salameh, Moh'd A.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Paditz, Ekkehart/F-5351-2015; Radisky, Evette S/C-8526-2012; Soares, Alexei S/F-4800-2014	Radisky, Evette S/0000-0003-3121-109X; Soares, Alexei S/0000-0002-6565-8503	National Institutes of Health [P50 CA091956-08, HL74124, HL46213]; Bankhead-Coley Florida Biomedical Research Program [07BN-07]; Department of Defense [PC094054]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL046213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Biomedical Research Program; Department of Defense(United States Department of Defense); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA091956-08 (to E. S. R.) and HL74124 and HL46213 (to P. N. W.). This work was also supported by Bankhead-Coley Florida Biomedical Research Program Grant 07BN-07 (to E. S. R.) and Department of Defense Grant PC094054 (to E. S. R.). Diffraction data were measured at beamlines X12-B, X12-C, and X25 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER, V42; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Devy L, 2007, NEOPLASIA, V9, P927, DOI 10.1593/neo.07544; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; EVNIN LB, 1990, P NATL ACAD SCI USA, V87, P6659, DOI 10.1073/pnas.87.17.6659; Frank BT, 2001, J IMMUNOL, V166, P2783, DOI 10.4049/jimmunol.166.4.2783; Gallagher S. R., 2001, CURRENT PROTOCOLS MO; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Kantyka T, 2009, BIOL CHEM, V390, P1313, DOI 10.1515/BC.2009.136; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koistinen H, 2009, NEUROSCIENCE, V160, P97, DOI 10.1016/j.neuroscience.2009.02.042; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; LASKOWSKI M, 1971, ENZYMES, V3, P375; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Nyberg P, 2006, EXP CELL RES, V312, P1219, DOI 10.1016/j.yexcr.2005.12.024; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Qasim MA, 1999, BIOCHEMISTRY-US, V38, P7142, DOI 10.1021/bi990265u; Qasim MA, 1997, BIOCHEMISTRY-US, V36, P1598, DOI 10.1021/bi9620870; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Travis J, 2000, BBA-PROTEIN STRUCT M, V1477, P35, DOI 10.1016/S0167-4838(99)00278-2; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vindigni A, 1998, PROTEIN SCI, V7, P1728, DOI 10.1002/pro.5560070807; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Yang L, 2008, J BIOL CHEM, V283, P35295, DOI 10.1074/jbc.M806965200; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	93	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36884	36896		10.1074/jbc.M110.171348	http://dx.doi.org/10.1074/jbc.M110.171348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861008	Green Published, hybrid			2022-12-25	WOS:000284146100026
J	Grunewald, A; Voges, L; Rakovic, A; Kasten, M; Vandebona, H; Hemmelmann, C; Lohmann, K; Orolicki, S; Ramirez, A; Schapira, AHV; Pramstaller, PP; Sue, CM; Klein, C				Gruenewald, Anne; Voges, Lisa; Rakovic, Aleksandar; Kasten, Meike; Vandebona, Himesha; Hemmelmann, Claudia; Lohmann, Katja; Orolicki, Slobodanka; Ramirez, Alfredo; Schapira, Anthony H. V.; Pramstaller, Peter P.; Sue, Carolyn M.; Klein, Christine			Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; PINK1; DISEASE; PATHOGENESIS; DYSFUNCTION; MUTATIONS; PATHOLOGY; DOMAIN; MICE	Background: Mutations in Parkin are the most common cause of autosomal recessive Parkinson disease (PD). The mitochondrially localized E3 ubiquitin-protein ligase Parkin has been reported to be involved in respiratory chain function and mitochondrial dynamics. More recent publications also described a link between Parkin and mitophagy. Methodology/Principal Findings: In this study, we investigated the impact of Parkin mutations on mitochondrial function and morphology in a human cellular model. Fibroblasts were obtained from three members of an Italian PD family with two mutations in Parkin (homozygous c.1072delT, homozygous delEx7, compound-heterozygous c.1072delT/delEx7), as well as from two relatives without mutations. Furthermore, three unrelated compound-heterozygous patients (delEx3-4/duplEx7-12, delEx4/c.924C>T and delEx1/c.924C>T) and three unrelated age-matched controls were included. Fibroblasts were cultured under basal or paraquat-induced oxidative stress conditions. ATP synthesis rates and cellular levels were detected luminometrically. Activities of complexes I-IV and citrate synthase were measured spectrophotometrically in mitochondrial preparations or cell lysates. The mitochondrial membrane potential was measured with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide. Oxidative stress levels were investigated with the OxyBlot technique. The mitochondrial network was investigated immunocytochemically and the degree of branching was determined with image processing methods. We observed a decrease in the production and overall concentration of ATP coinciding with increased mitochondrial mass in Parkin-mutant fibroblasts. After an oxidative insult, the membrane potential decreased in patient cells but not in controls. We further determined higher levels of oxidized proteins in the mutants both under basal and stress conditions. The degree of mitochondrial network branching was comparable in mutants and controls under basal conditions and decreased to a similar extent under paraquat-induced stress. Conclusions: Our results indicate that Parkin mutations cause abnormal mitochondrial function and morphology in non-neuronal human cells.	[Gruenewald, Anne; Voges, Lisa; Rakovic, Aleksandar; Kasten, Meike; Lohmann, Katja; Orolicki, Slobodanka; Ramirez, Alfredo; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany; [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia; [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia; [Hemmelmann, Claudia] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany; [Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy	University of Lubeck; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Lubeck; University of London; University College London; European Academy of Bozen-Bolzano	Grunewald, A (corresponding author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Schapira, Anthony H V/A-1245-2010; Pramstaller, Peter P/C-2357-2008; Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Ramirez, Alfredo/S-5126-2019	Schapira, Anthony H V/0000-0002-3018-3966; Grünewald, Anne/0000-0002-4179-2994; Ramirez, Alfredo/0000-0003-4991-763X; Klein, Christine/0000-0003-2102-3431; Pramstaller, Peter P/0000-0002-9831-8302; Kasten, Meike/0000-0003-1910-6035	German Research Foundation [GR 3731/1-1]; Fritz Thyssen Foundation; Boehringer Ingelheim Foundation; German Academic Exchange Service; EU [EU-LSHB-CT-2006-037544]; Deutsches Bundesministerium fur Bildung und Forschung [PNP-01GS08135-3]; Volkswagen Foundation; Hermann and Lilly Schilling Foundation; Hilde Ulrichs Foundation for Parkinson Disease Research; Australian Brain Foundation; University of Lubeck; Kattan Trust; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0601943] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); EU(European Commission); Deutsches Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen); Hermann and Lilly Schilling Foundation; Hilde Ulrichs Foundation for Parkinson Disease Research; Australian Brain Foundation; University of Lubeck; Kattan Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the German Research Foundation (GR 3731/1-1), the Fritz Thyssen Foundation, the Boehringer Ingelheim Foundation, the German Academic Exchange Service, the EU Grant GENEPARK (EU-LSHB-CT-2006-037544), the Deutsches Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz plus, PNP-01GS08135-3), the Volkswagen Foundation, the Hermann and Lilly Schilling Foundation, the Hilde Ulrichs Foundation for Parkinson Disease Research, the Australian Brain Foundation and the Medical Faculty of the University of Lubeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Schapira is a board member of the Royal Free Hospital trust, served as a consultant for BI, GSK, Teva-Lundbeck, Orion-Novartis and EMD Serono, and received research support from the Kattan Trust. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	32	104	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12962	10.1371/journal.pone.0012962	http://dx.doi.org/10.1371/journal.pone.0012962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885945	Green Published, Green Submitted, gold			2022-12-25	WOS:000282167100003
J	Mesure, L; De Visscher, G; Vranken, I; Lebacq, A; Flameng, W				Mesure, Lindsay; De Visscher, Geofrey; Vranken, Ilse; Lebacq, An; Flameng, Willem			Gene Expression Study of Monocytes/Macrophages during Early Foreign Body Reaction and Identification of Potential Precursors of Myofibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CIRCULATING FIBROCYTES; CELLS; DIFFERENTIATION; MACROPHAGES; RESPONSES	Foreign body reaction (FBR), initiated by adherence of macrophages to biomaterials, is associated with several complications. Searching for mechanisms potentially useful to overcome these complications, we have established the signaling role of monocytes/macrophages in the development of FBR and the presence of CD34(+) cells that potentially differentiate into myofibroblasts. Therefore, CD68(+) cells were in vitro activated with fibrinogen and also purified from the FBR after 3 days of implantation in rats. Gene expression profiles showed a switch from monocytes and macrophages attracted by fibrinogen to activated macrophages and eventually wound-healing macrophages. The immature FBR also contained a subpopulation of CD34(+) cells, which could be differentiated into myofibroblasts. This study showed that macrophages are the clear driving force of FBR, dependent on milieu, and myofibroblast deposition and differentiation.	[Mesure, Lindsay; De Visscher, Geofrey; Vranken, Ilse; Lebacq, An; Flameng, Willem] KULeuven, Dept Cardiovasc Dis, Lab Expt Cardiac Surg, Louvain, Belgium	KU Leuven	Mesure, L (corresponding author), KULeuven, Dept Cardiovasc Dis, Lab Expt Cardiac Surg, Louvain, Belgium.	geofrey.devisscher@hotmail.com	De Visscher, geofrey/B-9318-2012; De Visscher, Geofrey/ABH-8607-2020	De Visscher, Geofrey/0000-0002-2317-392X	National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen) [G.0549.06]	National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen)(FWO)	This project was partially funded by the National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen); Grant No. G.0549.06. Additional funding was provided by the Catholic University of Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bahnelli C, 2007, IMMUNOBIOLOGY, V212, P693, DOI 10.1016/j.imbio.2007.09.009; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Butler KR, 2001, J INVEST SURG, V14, P139, DOI 10.1080/089419301300343291; Campbell JH, 2000, J VASC RES, V37, P364, DOI 10.1159/000025752; CAMPBELL JH, 2006, VASCUL PHARM, V45, pE33; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; De Visscher G, 2008, J THORAC CARDIOV SUR, V135, P395, DOI 10.1016/j.jtcvs.2007.09.016; De Visscher G, 2010, BIOMATERIALS, V31, P20, DOI 10.1016/j.biomaterials.2009.09.016; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Klinge U, 1999, EUR J SURG, V165, P665; Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da; Krauter J, 2001, J HEMATOTH STEM CELL, V10, P863, DOI 10.1089/152581601317210953; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ninomiya K, 2006, HYPERTENS RES, V29, P269, DOI 10.1291/hypres.29.269; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Subramanian R, 2003, CATHETER CARDIO INTE, V59, P205, DOI 10.1002/ccd.10468; TANG LP, 1995, AM J CLIN PATHOL, V103, P466; Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9	36	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12949	10.1371/journal.pone.0012949	http://dx.doi.org/10.1371/journal.pone.0012949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886081	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100044
J	Dayan, J; Creveuil, C; Dreyfus, M; Herlicoviez, M; Baleyte, JM; O'Keane, V				Dayan, Jacques; Creveuil, Christian; Dreyfus, Michel; Herlicoviez, Michel; Baleyte, Jean-Marc; O'Keane, Veronica			Developmental Model of Depression Applied to Prenatal Depression: Role of Present and Past Life Events, Past Emotional Disorders and Pregnancy Stress	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; NATIONAL SWEDISH SAMPLE; POSTNATAL DEPRESSION; ANTENATAL DEPRESSION; MENTAL-HEALTH; SCALE EPDS; PROSPECTIVE COHORT; MAJOR DEPRESSION; SOUTH-AUSTRALIA; ETIOLOGIC MODEL	Background: Several risk factors for depression during pregnancy have already been established. However, very few studies have conducted a multivariate analysis incorporating both the major predictors of depression in women, in accordance with comprehensive developmental models of depression, and specific stressors associated with the biological and psychosocial state of the mother-to-be. Methodology/Principal Findings: We used a cross-sectional cohort design to analyze the associations between prenatal depression and potential risk factors. 693 French-speaking women with singleton pregnancies at 20-28 weeks' gestation were consecutively recruited at Caen University Hospital. Fifty women with missing values were subsequently excluded from the analysis. Depressive symptoms were assessed on the Edinburgh Postnatal Depression Scale. Risk factors were either extracted from the computerized obstetric records or assessed by means of self-administered questionnaires. The associations between prenatal depression and the potential risk factors were assessed using log-binomial regression models to obtain a direct estimate of relative risk (RR). The following factors were found to be significant in the multivariate analysis: level of education (p<0.001), past psychiatric history (adjusted RR = 1.8, 95% confidence interval (CI): 1.1;2.8, p = 0.014), stress related to the health and viability of the fetus (adjusted RR = 2.6, 95% CI: 1.6;4.1, p<0.001), and stress related to severe marital conflicts (adjusted RR = 2.4, 95% CI: 1.5;3.9, p<0.001) or to serious difficulties at work (adjusted RR = 1.6, 95% CI : 1.04;2.4, p = 0.031). An association was also found with the previous delivery of a child with a major or minor birth defect (adjusted RR = 2.0, 95% CI: 1.04;4.0, p = 0.038). Univariate analyses revealed a strong association with childhood adversity (parental rejection: RR = 1.8, 95% CI: 1.2;2.8, p = 0.0055 and family secrets: RR = 2.0, 95% CI: 1.2;3.1, p = 0.0046) and with lack of partner support (RR = 0.50, 95% CI: 0.30;0.84, p = 0.0086). Conclusions/Significance: Our study identifies several risk factors that could easily be assessed in clinical practice. It draws attention to the impact of previously delivering a child with a birth defect. The association with childhood adversity warrants further study.	[Dayan, Jacques; Baleyte, Jean-Marc] Caen Univ Hosp, INSERM, U923, Dept Child Psychiat, Caen, France; [Creveuil, Christian] Caen Univ Hosp, Biostat & Clin Res Unit, Caen, France; [Dreyfus, Michel; Herlicoviez, Michel] Caen Univ Hosp, Dept Obstet & Gynecol, Caen, France; [O'Keane, Veronica] St James Hosp, Jonathan Swift Unit, Dept Psychiat, Dublin, Ireland	CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Trinity College Dublin	Dayan, J (corresponding author), Caen Univ Hosp, INSERM, U923, Dept Child Psychiat, Caen, France.	jcdayan@gmail.com	Dayan, Jacques/G-3371-2013; CREVEUIL, Christian/L-7215-2015	CREVEUIL, Christian/0000-0002-5506-5296; o'keane, veronica/0000-0002-1519-099X	French Ministry of Social Affairs [ORS 617136]; University Hospital of Caen [AOI 97-101]	French Ministry of Social Affairs; University Hospital of Caen	This work was supported by grants from the French Ministry of Social Affairs (ORS 617136) and the University Hospital of Caen (AOI 97-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; AKISKAL HS, 1973, SCIENCE, V182, P20, DOI 10.1126/science.182.4107.20; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Andersson L, 2004, OBSTET GYNECOL, V104, P467, DOI 10.1097/01.AOG.0000135277.04565.e9; Andersson L, 2006, ACTA OBSTET GYN SCAN, V85, P937, DOI 10.1080/00016340600697652; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bilszta JLC, 2008, AUST NZ J PSYCHIAT, V42, P56, DOI 10.1080/00048670701732731; Bolton HL, 1998, J PSYCHOSOM OBST GYN, V19, P202, DOI 10.3109/01674829809025698; Bowen A, 2009, J EPIDEMIOL COMMUN H, V63, P414, DOI 10.1136/jech.2008.078832; Broen AN, 2006, ACTA OBSTET GYN SCAN, V85, P317, DOI 10.1080/00016340500438116; BROWN GW, 1987, BRIT J PSYCHIAT, V150, P30, DOI 10.1192/bjp.150.1.30; Bunevicius R, 2009, ACTA OBSTET GYN SCAN, V88, P599, DOI 10.1080/00016340902846049; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Dayan J, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P530; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dieter J N, 2001, J Obstet Gynaecol, V21, P468; Edwards B, 2008, AUST NZ J PSYCHIAT, V42, P45, DOI 10.1080/00048670701732673; Edwards B, 2008, AUST NZ J PSYCHIAT, V42, P51, DOI 10.1080/00048670701739629; Faisal-Cury A, 2007, ARCH WOMEN MENT HLTH, V10, P25, DOI 10.1007/s00737-006-0164-6; Faisal-Cury A, 2009, ARCH WOMEN MENT HLTH, V12, P335, DOI 10.1007/s00737-009-0081-6; Fanos JH, 2009, J PEDIATR-US, V154, P849, DOI 10.1016/j.jpeds.2008.11.053; Fergusson DM, 2008, BRIT J PSYCHIAT, V193, P444, DOI 10.1192/bjp.bp.108.056499; Field T, 2003, DEPRESS ANXIETY, V17, P140, DOI 10.1002/da.10071; Florio P, 2002, ENDOCRINE, V19, P91, DOI 10.1385/ENDO:19:1:91; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gotzmann L, 2002, ULTRASCHALL MED, V23, P33, DOI 10.1055/s-2002-20073; Groves BM, 1999, FUTURE CHILD, V9, P122, DOI 10.2307/1602786; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lau Y, 2008, JOGNN-J OBST GYN NEO, V37, P556, DOI 10.1111/j.1552-6909.2008.00273.x; Lau Y, 2007, SOC SCI MED, V64, P1802, DOI 10.1016/j.socscimed.2007.01.001; Le HN, 2004, HISPANIC J BEHAV SCI, V26, P463, DOI 10.1177/0739986304269165; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Leithner K, 2004, ULTRASOUND OBST GYN, V23, P240, DOI 10.1002/uog.978; Li D, 2009, HUM REPROD, V24, P146, DOI 10.1093/humrep/den342; Limlomwongse N, 2006, ARCH WOMEN MENT HLTH, V9, P131, DOI 10.1007/s00737-005-0115-7; Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Misri S, 2004, CAN J PSYCHIAT, V49, P684, DOI 10.1177/070674370404901006; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Oates MR, 2004, BRIT J PSYCHIAT, V184, pS10, DOI 10.1192/bjp.184.46.s10; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Orr ST, 2007, J WOMENS HEALTH, V16, P535, DOI 10.1089/jwh.2006.0116; PARKER G, 1992, PSYCHOL MED, V22, P657, DOI 10.1017/S0033291700038101; Parker G, 1998, AUST NZ J PSYCHIAT, V32, P104, DOI 10.3109/00048679809062716; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Rodgers CS, 2003, J WOMENS HEALTH, V12, P961, DOI 10.1089/154099903322643884; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Rubertsson C, 2003, J REPROD INFANT PSYC, V21, P113, DOI 10.1080/0264683031000124073; Rubin DC, 2009, MEM COGNITION, V37, P679, DOI 10.3758/37.5.679; Wallis AB, 2009, AM J HYPERTENS, V22, P345, DOI 10.1038/ajh.2009.28; WOODSIDE M, 1988, PUBLIC HEALTH REP, V103, P643; Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	68	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12942	10.1371/journal.pone.0012942	http://dx.doi.org/10.1371/journal.pone.0012942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653AC	20877652	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100036
J	Ramos-Cabrer, P; Justicia, C; Wiedermann, D; Hoehn, M				Ramos-Cabrer, Pedro; Justicia, Carles; Wiedermann, Dirk; Hoehn, Mathias			Stem Cell Mediation of Functional Recovery after Stroke in the Rat	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; BONE-MARROW; IN-VIVO; INTRACEREBRAL TRANSPLANTATION; NEURONAL DIFFERENTIATION; MOTOR FUNCTION; STROMAL CELLS; BRAIN; MIGRATION; DEFICITS	Background: Regenerative strategies of stem cell grafting have been demonstrated to be effective in animal models of stroke. In those studies, the effectiveness of stem cells promoting functional recovery was assessed by behavioral testing. These behavioral studies do, however, not provide access to the understanding of the mechanisms underlying the observed functional outcome improvement. Methodology/Principal Findings: In order to address the underlying mechanisms of stem cell mediated functional improvement, this functional improvement after stroke in the rat was investigated for six months after stroke by use of fMRI, somatosensory evoked potentials by electrophysiology, and sensorimotor behavior testing. Stem cells were grafted ipsilateral to the ischemic lesion. Rigorous exclusion of spontaneous recovery as confounding factor permitted to observe graft-related functional improvement beginning after 7 weeks and continuously increasing during the 6-month observation period. The major findings were i) functional improvement causally related to the stem cells grafting; ii) tissue replacement can be excluded as dominant factor for stem cell mediated functional improvement; iii) functional improvement occurs by exclusive restitution of the function in the original representation field, without clear contributions from reorganization processes, and iv) stem cells were not detectable any longer after six months. Conclusions/Significance: A delayed functional improvement due to stem cell implantation has been documented by electrophysiology, fMRI and behavioral testing. This functional improvement occurred without cells acting as a tissue replacement for the necrotic tissue after the ischemic event. Combination of disappearance of grafted cells after six months on histological sections with persistent functional recovery was interpreted as paracrine effects by the grafted stem cells being the dominant mechanism of cell activity underlying the observed functional restitution of the original activation sites. Future studies will have to investigate whether the stem cell mediated improvement reactivates the original representation target field by using original connectivity pathways or by generating/activating new ones for the stimulus.	[Ramos-Cabrer, Pedro; Justicia, Carles; Wiedermann, Dirk; Hoehn, Mathias] Max Planck Inst Neurol Res, In vivo NMR Lab, Cologne, Germany	Max Planck Society	Ramos-Cabrer, P (corresponding author), Univ Santiago de Compostela, Univ Clin Hosp Santiago, Dept Neurol, Clin Neurosci Res Lab, Santiago De Compostela, Spain.	mathias@nf.mpg.de	Ramos-Cabrer, Pedro/J-5306-2014; Ramos-Cabrer, Pedro/AAF-1467-2020; Justicia, Carles/H-7762-2015	Ramos-Cabrer, Pedro/0000-0003-0368-7031; Ramos-Cabrer, Pedro/0000-0003-0368-7031; Justicia, Carles/0000-0003-0969-6158	Hertie Foundation (Germany); EU [LSHB-CT-2005-512146, LSHC-CT-2004-503569, LSHB-CT-2006-037526]	Hertie Foundation (Germany); EU(European Commission)	Financial support from the Hertie Foundation (Germany), and EU grants of the FP-6: DiMI (LSHB-CT-2005-512146), EMIL (LSHC-CT-2004-503569) and Stem Stroke (LSHB-CT-2006-037526) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Helene J, 2003, BEHAV BRAIN RES, V143, P177, DOI 10.1016/S0166-4328(03)00032-9; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2009, NEUROIMAGE, V47, pT133, DOI 10.1016/j.neuroimage.2008.06.017; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rasband W., 2006, IMAGEJ; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Roitberg B, 2004, NEUROL RES, V26, P256, DOI 10.1179/016164104225014076; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Strupp JP, 1996, NEUROIMAGE, V3, pS607; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Wu WF, 2010, J CLIN NEUROSCI, V17, P92, DOI 10.1016/j.jocn.2009.03.039; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	45	59	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12779	10.1371/journal.pone.0012779	http://dx.doi.org/10.1371/journal.pone.0012779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877642	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100007
J	Burgess, GC; Braver, TS				Burgess, Gregory C.; Braver, Todd S.			Neural Mechanisms of Interference Control in Working Memory: Effects of Interference Expectancy and Fluid Intelligence	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; PROACTIVE-INTERFERENCE; COGNITIVE CONTROL; BRAIN MECHANISMS; CONFLICT; ATTENTION; CAPACITY; MIND	Background: A critical aspect of executive control is the ability to limit the adverse effects of interference. Previous studies have shown activation of left ventrolateral prefrontal cortex after the onset of interference, suggesting that interference may be resolved in a reactive manner. However, we suggest that interference control may also operate in a proactive manner to prevent effects of interference. The current study investigated the temporal dynamics of interference control by varying two factors - interference expectancy and fluid intelligence (gF) - that could influence whether interference control operates proactively versus reactively. Methodology/Principal Findings: A modified version of the recent negatives task was utilized. Interference expectancy was manipulated across task blocks by changing the proportion of recent negative (interference) trials versus recent positive (facilitation) trials. Furthermore, we explored whether gF affected the tendency to utilize specific interference control mechanisms. When interference expectancy was low, activity in lateral prefrontal cortex replicated prior results showing a reactive control pattern (i.e., interference-sensitivity during probe period). In contrast, when interference expectancy was high, bilateral prefrontal cortex activation was more indicative of proactive control mechanisms (interference-related effects prior to the probe period). Additional results suggested that the proactive control pattern was more evident in high gF individuals, whereas the reactive control pattern was more evident in low gF individuals. Conclusions/Significance: The results suggest the presence of two neural mechanisms of interference control, with the differential expression of these mechanisms modulated by both experimental (e. g., expectancy effects) and individual difference (e. g., gF) factors.	[Burgess, Gregory C.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; Washington University (WUSTL)	Burgess, GC (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	greg.burgess@colorado.edu		Braver, Todd/0000-0002-2631-3393	National Institute of Mental Health [RO1 MH66078]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health grant (RO1 MH66078) to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bunting M, 2006, J EXP PSYCHOL LEARN, V32, P183, DOI 10.1037/0278-7393.32.2.183; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diamond A, 2009, DEV PSYCHOL, V45, P130, DOI 10.1037/a0014025; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hasher L., 2008, VARIATION WORKING ME, P227, DOI [10.1093/acprof:oso/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.003.0009]; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Mecklinger A, 2003, COGNITIVE BRAIN RES, V18, P26, DOI 10.1016/j.cogbrainres.2003.08.008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Raven J.C., 1998, ADV PROGR MATRICES; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P155, DOI 10.3758/CABN.3.3.155; Thompson-Schill SL, 2006, PSYCHON B REV, V13, P402, DOI 10.3758/BF03193860; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Whitney P, 2001, BRAIN COGNITION, V45, P1, DOI 10.1006/brcg.2000.1243	37	85	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12861	10.1371/journal.pone.0012861	http://dx.doi.org/10.1371/journal.pone.0012861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651YH	20877464	Green Published, gold			2022-12-25	WOS:000281963200021
J	Ma, T; Hoeffer, CA; Capetillo-Zarate, E; Yu, FM; Wong, H; Lin, MT; Tampellini, D; Klann, E; Blitzer, RD; Gouras, GK				Ma, Tao; Hoeffer, Charles A.; Capetillo-Zarate, Estibaliz; Yu, Fangmin; Wong, Helen; Lin, Michael T.; Tampellini, Davide; Klann, Eric; Blitzer, Robert D.; Gouras, Gunnar K.			Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; A-BETA; PROTEIN-SYNTHESIS; UP-REGULATION; S6 KINASE; LIFE-SPAN; MEMORY; INHIBITION; INDUCTION; DEFICITS	Background: The mammalian target of rapamycin (mTOR) is an evolutionarily conserved Ser/Thr protein kinase that plays a pivotal role in multiple fundamental biological processes, including synaptic plasticity. We explored the relationship between the mTOR pathway and beta-amyloid (A beta)-induced synaptic dysfunction, which is considered to be critical in the pathogenesis of Alzheimer's disease (AD). Methodology/Principal Findings: We provide evidence that inhibition of mTOR signaling correlates with impairment in synaptic plasticity in hippocampal slices from an AD mouse model and in wild-type slices exposed to exogenous A beta 1-42. Importantly, by up-regulating mTOR signaling, glycogen synthase kinase 3 (GSK3) inhibitors rescued LTP in the AD mouse model, and genetic deletion of FK506-binding protein 12 (FKBP12) prevented A beta-induced impairment in long-term potentiation (LTP). In addition, confocal microscopy demonstrated co-localization of intraneuronal A beta 42 with mTOR. Conclusions/Significance: These data support the notion that the mTOR pathway modulates A beta-related synaptic dysfunction in AD.	[Ma, Tao; Capetillo-Zarate, Estibaliz; Yu, Fangmin; Lin, Michael T.; Tampellini, Davide; Gouras, Gunnar K.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Hoeffer, Charles A.; Wong, Helen; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Blitzer, Robert D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Gouras, Gunnar K.] Rockefeller Univ, New York, NY 10021 USA	Cornell University; New York University; Icahn School of Medicine at Mount Sinai; Rockefeller University	Ma, T (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA.	gkgouras@med.cornell.edu	Capetillo-Zarate, Estibaliz/Z-5772-2019; Gouras, Gunnar/B-3021-2010	Capetillo-Zarate, Estibaliz/0000-0002-8416-0495; Gouras, Gunnar/0000-0002-5500-6325; Tampellini, Davide/0000-0003-3188-0293	National Institutes of Health [NS034007, GM054508, AG027140, AG28174, AG09464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034007, R29NS034007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464, R01AG027140, K02AG028174, R01AG020729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants NS034007 (EK), GM054508 (RDB), AG027140, AG28174, and AG09464 (GKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Choo AY, 2006, CELL, V126, P834, DOI 10.1016/j.cell.2006.08.025; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	49	181	189	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12845	10.1371/journal.pone.0012845	http://dx.doi.org/10.1371/journal.pone.0012845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862226	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200015
J	Boue, S; Paramonov, I; Barrero, MJ; Belmonte, JCI				Boue, Stephanie; Paramonov, Ida; Jose Barrero, Maria; Izpisua Belmonte, Juan Carlos			Analysis of Human and Mouse Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells. What Is in the Plate?	PLOS ONE			English	Article							GENE-EXPRESSION; IPS CELLS; CHROMATIN-STRUCTURE; DEFINED FACTORS; GENERATION; FIBROBLASTS; INDUCTION; MURINE; MICE; DIFFERENTIATION	After the hope and controversy brought by embryonic stem cells two decades ago for regenerative medicine, a new turn has been taken in pluripotent cells research when, in 2006, Yamanaka's group reported the reprogramming of fibroblasts to pluripotent cells with the transfection of only four transcription factors. Since then many researchers have managed to reprogram somatic cells from diverse origins into pluripotent cells, though the cellular and genetic consequences of reprogramming remain largely unknown. Furthermore, it is still unclear whether induced pluripotent stem cells (iPSCs) are truly functionally equivalent to embryonic stem cells (ESCs) and if they demonstrate the same differentiation potential as ESCs. There are a large number of reprogramming experiments published so far encompassing genome-wide transcriptional profiling of the cells of origin, the iPSCs and ESCs, which are used as standards of pluripotent cells and allow us to provide here an in-depth analysis of transcriptional profiles of human and mouse cells before and after reprogramming. When compared to ESCs, iPSCs, as expected, share a common pluripotency/self-renewal network. Perhaps more importantly, they also show differences in the expression of some genes. We concentrated our efforts on the study of bivalent domain-containing genes (in ESCs) which are not expressed in ESCs, as they are supposedly important for differentiation and should possess a poised status in pluripotent cells, i.e. be ready to but not yet be expressed. We studied each iPSC line separately to estimate the quality of the reprogramming and saw a correlation of the lowest number of such genes expressed in each respective iPSC line with the stringency of the pluripotency test achieved by the line. We propose that the study of expression of bivalent domain-containing genes, which are normally silenced in ESCs, gives a valuable indication of the quality of the iPSC line, and could be used to select the best iPSC lines out of a large number of lines generated in each reprogramming experiment.	[Boue, Stephanie; Paramonov, Ida; Jose Barrero, Maria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona CMRB, Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Salk Institute	Boue, S (corresponding author), Ctr Regenerat Med Barcelona CMRB, Barcelona, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Boue, Stephanie/0000-0003-0680-4168	G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Fundacion Cellex; Networking Center of Biomedical Research (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)	G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Fundacion Cellex(Foundation CELLEX); Networking Center of Biomedical Research (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by The G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Fundacion Cellex, Networking Center of Biomedical Research (CIBER), Terapia Celular (TERCEL) and Ministerio de Ciencia e Innovacion (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; DIMOS JT, 2008, SCIENCE; EBERT AD, 2008, NATURE; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; HENG JC, CELL STEM CELL, V6, P167; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; HONG H, 2009, NATURE; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L., 2009, CELL STEM CELL; KAWAMURA T, 2009, NATURE; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LEE G, 2009, NATURE; LI H, 2009, NATURE; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; MARION RM, 2009, NATURE; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIKKELSEN TS, 2008, NATURE; MIURA K, 2009, NAT BIOTECHNOL; MULLER FJ, 2008, NATURE; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schulz TC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-478; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; SOMMER CA, 2008, STEM CELLS; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tsai KN, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/917084; UTIKAL J, 2009, NATURE; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; YU J, 2007, SCIENCE; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	83	48	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12664	10.1371/journal.pone.0012664	http://dx.doi.org/10.1371/journal.pone.0012664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862250	Green Published, Green Submitted, gold			2022-12-25	WOS:000281960800004
J	Song, MJ; Dean, D; Tate, MLK				Song, Min Jae; Dean, David; Tate, Melissa L. Knothe			In Situ Spatiotemporal Mapping of Flow Fields around Seeded Stem Cells at the Subcellular Length Scale	PLOS ONE			English	Article							MARROW STROMAL CELLS; FLUID SHEAR-STRESS; GENE-EXPRESSION; MECHANICAL MODULATION; EXTRACELLULAR-MATRIX; HYDROSTATIC-PRESSURE; BONE-CELLS; DIFFERENTIATION; CHONDROGENESIS; MECHANOTRANSDUCTION	A major hurdle to understanding and exploiting interactions between the stem cell and its environment is the lack of a tool for precise delivery of mechanical cues concomitant to observing sub-cellular adaptation of structure. These studies demonstrate the use of microscale particle image velocimetry (mu-PIV) for in situ spatiotemporal mapping of flow fields around mesenchymal stem cells, i.e. murine embryonic multipotent cell line C3H10T1/2, at the subcellular length scale, providing a tool for real time observation and analysis of stem cell adaptation to the prevailing mechanical milieu. In the absence of cells, computational fluid dynamics (CFD) predicts flow regimes within 12% of m-PIV measures, achieving the technical specifications of the chamber and the flow rates necessary to deliver target shear stresses at a particular height from the base of the flow chamber. However, our mu-PIV studies show that the presence of cells per se as well as the density at which cells are seeded significantly influences local flow fields. Furthermore, for any given cell or cell seeding density, flow regimes vary significantly along the vertical profile of the cell. Hence, the mechanical milieu of the stem cell exposed to shape changing shear stresses, induced by fluid drag, varies with respect to proximity of surrounding cells as well as with respect to apical height. The current study addresses a previously unmet need to predict and observe both flow regimes as well as mechanoadaptation of cells in flow chambers designed to deliver precisely controlled mechanical signals to live cells. An understanding of interactions and adaptation in response to forces at the interface between the surface of the cell and its immediate local environment may be key for de novo engineering of functional tissues from stem cell templates as well as for unraveling the mechanisms underlying multiscale development, growth and adaptation of organisms.	[Song, Min Jae] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Biomed Engn, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Song, MJ (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Dean, David/F-9605-2017; Knothe Tate, Melissa L./O-2086-2015	Dean, David/0000-0002-1217-3764; Knothe Tate, Melissa L./0000-0002-3552-2525	National Institutes of Health [R01-DE013740]; National Science Foundation [CMMI-0826435]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013740] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [0826435] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	National Institutes of Health grant (NIDCR, R01-DE013740) (http://www.nih.gov/), National Science Foundation Grant # CMMI-0826435 (Nano/Bio Mechanics Program) (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Anderson EJ, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-46; Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443; Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518; Billotte W G, 2001, Biomed Sci Instrum, V37, P1; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; CARTER DR, 1988, J ORTHOPAED RES, V6, P148, DOI 10.1002/jor.1100060120; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Christ KV, 2010, BIOMED MICRODEVICES, V12, P443, DOI 10.1007/s10544-010-9401-x; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Derfoul A, 2004, DIFFERENTIATION, V72, P209, DOI 10.1111/j.1432-0436.2004.07205003.x; Elder SH, 2005, BIOMECH MODEL MECHAN, V3, P141, DOI 10.1007/s10237-004-0058-3; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; FALLS TD, 2007, THESIS CASE W RESERV; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; HANACHANG, 2010, 722 ORS; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; KURPINSKI K, 2010, STEM CELLS, P9999, DOI DOI 10.1002/STEM.319; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; MELISSA L, 2010, ENG ECOSYSTEM TAKING, P57; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; OSTER GF, 1985, J EMBRYOL EXP MORPH, V89, P93; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Salek MM, 2009, BIOFOULING, V25, P711, DOI 10.1080/08927010903114603; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x; Sorkin AM, 2004, AM J PHYSIOL-CELL PH, V287, pC1527, DOI 10.1152/ajpcell.00059.2004; Stops AJF, 2010, J BIOMECH, V43, P618, DOI 10.1016/j.jbiomech.2009.10.037; Takahashi I, 1998, J CELL SCI, V111, P2067; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8	48	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12796	10.1371/journal.pone.0012796	http://dx.doi.org/10.1371/journal.pone.0012796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862249	gold, Green Submitted, Green Published			2022-12-25	WOS:000281960800013
J	Karlsson, K; Eroukhmanoff, F; Svensson, EI				Karlsson, Kristina; Eroukhmanoff, Fabrice; Svensson, Erik I.			Phenotypic Plasticity in Response to the Social Environment: Effects of Density and Sex Ratio on Mating Behaviour Following Ecotype Divergence	PLOS ONE			English	Article							ASELLUS-AQUATICUS L; MALE-MALE COMPETITION; FRESH-WATER ISOPOD; FEMALE RESISTANCE; MATE CHOICE; ADAPTIVE PLASTICITY; LIFE-HISTORY; EVOLUTION; INVESTMENT; SELECTION	The ability to express phenotypically plastic responses to environmental cues might be adaptive in changing environments. We studied phenotypic plasticity in mating behaviour as a response to population density and adult sex ratio in a freshwater isopod (Asellus aquaticus). A. aquaticus has recently diverged into two distinct ecotypes, inhabiting different lake habitats (reed Phragmites australis and stonewort Chara tomentosa, respectively). In field surveys, we found that these habitats differ markedly in isopod population densities and adult sex ratios. These spatially and temporally demographic differences are likely to affect mating behaviour. We performed behavioural experiments using animals from both the ancestral ecotype ("reed" isopods) and from the novel ecotype ("stonewort" isopods) population. We found that neither ecotype adjusted their behaviour in response to population density. However, the reed ecotype had a higher intrinsic mating propensity across densities. In contrast to the effects of density, we found ecotype differences in plasticity in response to sex ratio. The stonewort ecotype show pronounced phenotypic plasticity in mating propensity to adult sex ratio, whereas the reed ecotype showed a more canalised behaviour with respect to this demographic factor. We suggest that the lower overall mating propensity and the phenotypic plasticity in response to sex ratio have evolved in the novel stonewort ecotype following invasion of the novel habitat. Plasticity in mating behaviour may in turn have effects on the direction and intensity of sexual selection in the stonewort habitat, which may fuel further ecotype divergence.	[Karlsson, Kristina; Eroukhmanoff, Fabrice; Svensson, Erik I.] Lund Univ, Sect Anim Ecol, Dept Biol, Lund, Sweden	Lund University	Karlsson, K (corresponding author), Lund Univ, Sect Anim Ecol, Dept Biol, Lund, Sweden.	kristina.karlsson@zooekol.lu.se	Eroukhmanoff, Fabrice/F-8319-2010; Svensson, Erik/E-8324-2010; eroukhmanoff, fabrice/D-1414-2015	Svensson, Erik/0000-0001-9006-016X; 	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by grants from the Swedish Research Council (VR) http://www.vr.se/ and FORMAS http://www.formas.se/ to E.I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Bonduriansky R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000255; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Duckworth RA, 2009, EVOL ECOL, V23, P513, DOI 10.1007/s10682-008-9252-6; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Eroukhmanoff F, 2009, J EVOLUTION BIOL, V22, P1098, DOI 10.1111/j.1420-9101.2009.01723.x; EROUKHMANOFF F, 2009, THESIS LUND U LUND, P241; Eroukhmanoff F, 2009, MOL ECOL, V18, P4912, DOI 10.1111/j.1365-294X.2009.04408.x; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gosden TP, 2009, AM NAT, V173, P709, DOI 10.1086/598491; Hargeby A, 2005, J EVOLUTION BIOL, V18, P713, DOI 10.1111/j.1420-9101.2004.00837.x; Hargeby A, 2004, EVOLUTION, V58, P81; Hargeby A, 2007, ECOSYSTEMS, V10, P29, DOI 10.1007/s10021-006-9008-5; Harris S, 2010, THESIS LUND U LUND; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; JORMALAINEN V, 1994, ETHOLOGY, V96, P46; JORMALAINEN V, 1994, BEHAV PROCESS, V32, P265, DOI 10.1016/0376-6357(94)90047-7; JORMALAINEN V, 1995, BIOL J LINN SOC, V55, P45, DOI 10.1111/j.1095-8312.1995.tb01049.x; JORMALAINEN V, 1995, BEHAV ECOL SOCIOBIOL, V36, P43; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; JORMALAINEN V, 1993, BEHAVIOUR, V125, P219, DOI 10.1163/156853993X00254; JORMALAINEN V, 1992, ANN ZOOL FENN, V29, P161; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; KRUPA JJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P107, DOI 10.1007/BF00171662; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; MANNING JT, 1975, BEHAVIOUR, V55, P1, DOI 10.1163/156853975X00380; MANNING JT, 1980, BEHAVIOUR, V74, P264, DOI 10.1163/156853980X00483; OKLAND KA, 1978, HYDROBIOLOGIA, V59, P243, DOI 10.1007/BF00036504; PARKER GA, 1974, BEHAVIOUR, V48, P157, DOI 10.1163/156853974X00327; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RIDLEY M, 1979, Z TIERPSYCHOL, V51, P380; Sparkes TC, 2000, BEHAV ECOL SOCIOBIOL, V47, P145, DOI 10.1007/s002650050005; Svensson E, 2001, EVOLUTION, V55, P2053; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; TULSA L, 2004, STATISTICA 7 STATSOF; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Wagner BMA, 1998, HYDROBIOLOGIA, V368, P75, DOI 10.1023/A:1003213224327; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x	55	19	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12755	10.1371/journal.pone.0012755	http://dx.doi.org/10.1371/journal.pone.0012755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862332	Green Published, Green Submitted, gold			2022-12-25	WOS:000281864100010
J	Dawes, FE; Kuzevski, A; Bettelheim, KA; Hornitzky, MA; Djordjevic, SP; Walker, MJ				Dawes, Fay E.; Kuzevski, Alexander; Bettelheim, Karl A.; Hornitzky, Michael A.; Djordjevic, Steven P.; Walker, Mark J.			Distribution of Class 1 Integrons with IS26-Mediated Deletions in Their 3 '-Conserved Segments in Escherichia coli of Human and Animal Origin	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; CLASS-I INTEGRONS; ANTIBIOTIC-RESISTANCE; GENE CASSETTES; MULTIDRUG-RESISTANCE; SITE; ENTEROBACTERIACEAE; ELEMENTS	Class 1 integrons play a role in the emergence of multi-resistant bacteria by facilitating the recruitment of gene cassettes encoding antibiotic resistance genes. 512 E. coli strains sourced from humans (n = 202), animals (n = 304) and the environment (n = 6) were screened for the presence of the intl1 gene. In 31/79 integron positive E. coli strains, the gene cassette regions could not be PCR amplified using standard primers. DNA sequence analysis of 6 serologically diverse strains revealed atypical integrons harboured the dfrA5 cassette gene and only 24 bp of the integron 3'-conserved segment (CS) remained, due to the insertion of IS26. PCR targeting intl1 and IS26 followed by restriction fragment length polymorphism (RFLP) analysis identified the integron-dfrA5-IS26 element in 27 E. coli strains of bovine origin and 4 strains of human origin. Southern hybridization and transformation studies revealed the integron-dfrA5-IS26 gene arrangement was either chromosomally located or plasmid borne. Plasmid location in 4/9 E. coli strains and PCR linkage of Tn21 transposition genes with the intl1 gene in 20/31 strains, suggests this element is readily disseminated by horizontal transfer.	[Dawes, Fay E.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Kuzevski, Alexander; Bettelheim, Karl A.] Univ Melbourne, Dept Microbiol & Immunol, Microbiol Diagnost Unit, Parkville, Vic 3052, Australia; [Hornitzky, Michael A.; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, Microbiol & Immunol Sect, Menangle, NSW, Australia; [Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Wollongong; University of Melbourne; University of Technology Sydney; University of Queensland	Dawes, FE (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mark.walker@uq.edu.au	Djordjevic, Steven/A-2024-2013; djordjevic, steven/GNP-4000-2022; Walker, Mark J./F-6940-2011	Djordjevic, Steven/0000-0001-9301-5372; djordjevic, steven/0000-0001-9301-5372; Walker, Mark/0000-0001-7423-2769	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Linkage grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelheim KA, 2003, J MED MICROBIOL, V52, P155, DOI 10.1099/jmm.0.04903-0; Chen J, 1998, LETT APPL MICROBIOL, V27, P369, DOI 10.1046/j.1472-765X.1998.00445.x; COLLIS CM, 1993, MOL MICROBIOL, V9, P41, DOI 10.1111/j.1365-2958.1993.tb01667.x; Dichi I, 2009, FASEB J, V23; Gallego L, 2001, J MED MICROBIOL, V50, P71, DOI 10.1099/0022-1317-50-1-71; Goldmann DA, 1999, ECOSYST HEALTH, V5, P158, DOI 10.1046/j.1526-0992.1999.09925.x; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Maguire AJ, 2001, ANTIMICROB AGENTS CH, V45, P1022, DOI 10.1128/AAC.45.4.1022-1029.2001; MOLLET B, 1985, MOL GEN GENET, V201, P198, DOI 10.1007/BF00425660; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitz FJ, 2001, J CLIN MICROBIOL, V39, P3724, DOI 10.1128/JCM.39.10.3724-3726.2001; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; SUNDSTROM L, 1988, MOL GEN GENET, V213, P191, DOI 10.1007/BF00339581; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001	22	71	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12754	10.1371/journal.pone.0012754	http://dx.doi.org/10.1371/journal.pone.0012754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856797	Green Published, gold			2022-12-25	WOS:000281815800020
J	Hong, S; Chung, T; Kim, D				Hong, Seungpyo; Chung, Taesu; Kim, Dongsup			SH3 Domain-Peptide Binding Energy Calculations Based on Structural Ensemble and Multiple Peptide Templates	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SPOT-SYNTHESIS; FORCE-FIELD; PREDICTION; PARALLEL; RECOGNITION; SIMULATIONS; PROTEINS; SUPPORT; ARRAYS	SH3 domains mediate signal transduction by recognizing short peptides. Understanding of the driving forces in peptide recognitions will help us to predict the binding specificity of the domain-peptide recognition and to understand the molecular interaction networks of cells. However, accurate calculation of the binding energy is a tough challenge. In this study, we propose three ideas for improving our ability to predict the binding energy between SH3 domains and peptides: (1) utilizing the structural ensembles sampled from a molecular dynamics simulation trajectory, (2) utilizing multiple peptide templates, and (3) optimizing the sequence-structure mapping. We tested these three ideas on ten previously studied SH3 domains for which SPOT analysis data were available. The results indicate that calculating binding energy using the structural ensemble was most effective, clearly increasing the prediction accuracy, while the second and third ideas tended to give better binding energy predictions. We applied our method to the five SH3 targets in DREAM4 Challenge and selected the best performing method.	[Hong, Seungpyo; Chung, Taesu; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Hong, S (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	kds@kaist.ac.kr	Kim, Dongsup/C-1612-2011; Hong, Seungpyo/ABA-4461-2021	Hong, Seungpyo/0000-0003-1273-0740	Ministry of Education, Science and Technology [2008-2000220]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2008-2000220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brannetti B, 2000, J MOL BIOL, V298, P313, DOI 10.1006/jmbi.2000.3670; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fernandez-Ballester G, 2009, J MOL BIOL, V388, P902, DOI 10.1016/j.jmb.2009.03.038; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2006, PLOS COMPUT BIOL, V2, P46, DOI 10.1371/journal.pcbi.0020001; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lehrach WP, 2006, BIOINFORMATICS, V22, P532, DOI 10.1093/bioinformatics/bti804; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reiss DJ, 2004, BIOINFORMATICS, V20, P274, DOI 10.1093/bioinformatics/bth922; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Suenaga A, 2003, BIOCHEMISTRY-US, V42, P5195, DOI 10.1021/bi034113h; Wunderlich Z, 2009, NUCLEIC ACIDS RES, V37, P4629, DOI 10.1093/nar/gkp394; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12654	10.1371/journal.pone.0012654	http://dx.doi.org/10.1371/journal.pone.0012654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856816	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815800004
J	Deruy, E; Gosselin, K; Vercamer, C; Martien, S; Bouali, F; Slomianny, C; Bertout, J; Bernard, D; Pourtier, A; Abbadie, C				Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Bernard, David; Pourtier, Albin; Abbadie, Corinne			MnSOD Upregulation Induces Autophagic Programmed Cell Death in Senescent Keratinocytes	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PIECEMEAL MICROAUTOPHAGY; REPLICATIVE SENESCENCE; POLYETHYLENE-GLYCOL; IN-VITRO; PROTEIN; MITOCHONDRIA; NUCLEUS; DIE	Senescence is a state of growth arrest resulting mainly from telomere attrition and oxidative stress. It ultimately leads to cell death. We have previously shown that, in keratinocytes, senescence is induced by NF-kappaB activation, MnSOD upregulation and H2O2 overproduction. We have also shown that senescent keratinocytes do not die by apoptosis but as a result of high macroautophagic activity that targets the primary vital cell components. Here, we investigated the mechanisms that activate this autophagic cell death program. We show that corpses occurring at the senescence plateau display oxidatively-damaged mitochondria and nucleus that colocalize with autophagic vacuoles. The occurrence of such corpses was decreased by specifically reducing the H2O2 level with catalase, and, conversely, reproduced by overexpressing MnSOD or applying subtoxic doses of H2O2. This H2O2-induced cell death did occur through autophagy since it was accompanied by an accumulation of autophagic vesicles as evidenced by Lysotracker staining, LC3 vesiculation and transmission electron microscopy. Most importantly, it was partly abolished by 3-methyladenine, the specific inhibitor of autophagosome formation, and by anti-Atg5 siRNAs. Taken together these results suggest that autophagic cell death is activated in senescent keratinocytes because of the upregulation of MnSOD and the resulting accumulation of oxidative damages to nucleus and mitochondria.	[Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Univ Lille Nord France, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Inst Biol Lille, CNRS, UMR8161, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] USTL, Villeneuve Dascq, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] UDSL, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Inst Pasteur, F-59019 Lille, France; [Slomianny, Christian] INSERM, Lab Physiol Cellulaire, U600, Villeneuve Dascq, France; [Bernard, David] Ctr Leon Berard, CNRS, UMR5238, F-69373 Lyon, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard	Deruy, E (corresponding author), Univ Lille Nord France, Lille, France.	corinne.abbadie@ibl.fr	Slomianny, Christian/L-8285-2018; POURTIER, ALBIN/G-7401-2012; ABBADIE, Corinne/F-4949-2018; Bernard, David/D-6265-2018	POURTIER, ALBIN/0000-0002-1576-3946; ABBADIE, Corinne/0000-0002-8174-2393; Bernard, David/0000-0002-1557-2074	Centre National de la Recherche Scientifique; Universite Lille 1; Ligue contre le Cancer (Comites du Nord et de l Aisne); Institut Pasteur de Lille; Region Nord/Pas-de-Calais; Societe Francaise du Cancer; French Research Ministry; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lille 1; Ligue contre le Cancer (Comites du Nord et de l Aisne); Institut Pasteur de Lille; Region Nord/Pas-de-Calais(Region Hauts-de-France); Societe Francaise du Cancer; French Research Ministry(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique, the Universite Lille 1, the Ligue contre le Cancer (Comites du Nord et de l Aisne), the Institut Pasteur de Lille. E. D. has a fellowship from the Institut Pasteur de Lille and the Region Nord/Pas-de-Calais. K. G. had a fellowship from the Institut Pasteur de Lille and the Region Nord/Pas-de-Calais and from the Societe Francaise du Cancer. S. M. had a fellowship from the French Research Ministry and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Bernard D, 2001, CANCER RES, V61, P2656; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding GH, 2001, EXP MOL PATHOL, V70, P43, DOI 10.1006/exmp.2000.2346; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim EH, 2008, AUTOPHAGY, V4, P76, DOI 10.4161/auto.5119; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; MARTINON O, 1994, BIOCHEM MOL BIOL INT, V34, P135; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; SASAKI M, 2010, LAB INVEST; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	58	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12712	10.1371/journal.pone.0012712	http://dx.doi.org/10.1371/journal.pone.0012712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856861	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815700008
J	Stevenson, IH; Cronin, B; Sur, M; Kording, KP				Stevenson, Ian H.; Cronin, Beau; Sur, Mriganka; Kording, Konrad P.			Sensory Adaptation and Short Term Plasticity as Bayesian Correction for a Changing Brain	PLOS ONE			English	Article							VISUAL-CORTEX; MOTION; STATISTICS; EXCITABILITY; DYNAMICS; DEPRESSION; INVARIANCE; REDUCTION; CONTRAST; NOISE	Neurons in the sensory system exhibit changes in excitability that unfold over many time scales. These fluctuations produce noise and could potentially lead to perceptual errors. However, to prevent such errors, postsynaptic neurons and synapses can adapt and counteract changes in the excitability of presynaptic neurons. Here we ask how neurons could optimally adapt to minimize the influence of changing presynaptic neural properties on their outputs. The resulting model, based on Bayesian inference, explains a range of physiological results from experiments which have measured the overall properties and detailed time-course of sensory tuning curve adaptation in the early visual cortex. We show how several experimentally measured short term plasticity phenomena can be understood as near-optimal solutions to this adaptation problem. This framework provides a link between high level computational problems, the properties of cortical neurons, and synaptic physiology.	[Stevenson, Ian H.; Kording, Konrad P.] Northwestern Univ, Dept Physiol, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Cronin, Beau; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Northwestern University; Shirley Ryan AbilityLab; Massachusetts Institute of Technology (MIT); Northwell Health	Stevenson, IH (corresponding author), Northwestern Univ, Dept Physiol, Rehabil Inst Chicago, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	National Eye Institute [EY-07023]; Chicago Community Trust; National Institutes of Health (NIH) [1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007023, F32EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, P01NS044393] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BC and MS were supported by National Eye Institute Grant EY-07023. IHS and KPK were supported by the Chicago Community Trust and National Institutes of Health (NIH) grants 1R01NS063399 and 2P01NS044393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Azouz R, 1999, J NEUROSCI, V19, P2209; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Carandini M, 2002, J NEUROSCI, V22, P10053; Chance FS, 2001, NEUROCOMPUTING, V38, P141, DOI 10.1016/S0925-2312(01)00550-1; Chance FS, 1998, J NEUROSCI, V18, P4785; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Dittman JS, 2000, J NEUROSCI, V20, P1374; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Duke PA, 2006, VISION RES, V46, P228, DOI 10.1016/j.visres.2005.09.004; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Hoyer PO, 2003, ADV NEUR INF PROC SY; Huang CQ, 1998, HEARING RES, V116, P55, DOI 10.1016/S0378-5955(97)00196-2; JIANG C, 1994, P NATL ACAD SCI USA, V91, P7198, DOI 10.1073/pnas.91.15.7198; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; Mather G, 1998, MOTION AFTEREFFECT M, P220; Minka Thomas P., 2001, P 17 C UNC ART INT; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; PFISTER JP, 2009, ADV NEURAL INFORM PR, V22; Schrater PR, 1998, VISION RES, V38, P3899, DOI 10.1016/S0042-6989(98)00088-1; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STOCKER AA, 2006, ADV NEURAL INFORM PR, P1291; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turner R, 2007, NEURAL COMPUT, V19, P1022, DOI 10.1162/neco.2007.19.4.1022; ULLMAN S, 1982, PROC R SOC SER B-BIO, V216, P299, DOI 10.1098/rspb.1982.0076; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Xu H, 2008, J NEUROSCI, V28, P3374, DOI 10.1523/JNEUROSCI.0182-08.2008	53	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12436	10.1371/journal.pone.0012436	http://dx.doi.org/10.1371/journal.pone.0012436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865056	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100029
J	van der Aa, LM; Chadzinska, M; Tijhaar, E; Boudinot, P; Verburg-van Kemenade, BML				van der Aa, Lieke M.; Chadzinska, Magdalena; Tijhaar, Edwin; Boudinot, Pierre; Verburg-van Kemenade, B. M. Lidy			CXCL8 Chemokines in Teleost Fish: Two Lineages with Distinct Expression Profiles during Early Phases of Inflammation	PLOS ONE			English	Article							NEUTROPHIL-ACTIVATING FACTOR; TROUT ONCORHYNCHUS-MYKISS; CYPRINUS-CARPIO L.; INTERLEUKIN-8 RECEPTORS; MOLECULAR EVOLUTION; CHEMOTACTIC FACTOR; ESCHERICHIA-COLI; GENE-EXPRESSION; GRO-ALPHA; TNF-ALPHA	Background: During the inflammatory process, chemokine CXCL8 plays a pivotal role in recruitment of human neutrophilic granulocytes. A diversity of sequences similar to CXCL8 was reported in fish, but their evolutionary relationships and functional homology with their human homolog remain unclear. Principal Findings: We screened fish genomes to seek for sequences related to CXCL8. A first lineage was retrieved in all teleosts, while a second CXCL8 lineage was found in zebrafish and carp only. An early inflammatory function for both lineages was indicated by several lines of evidence. The induction of carp CXCL8s, CXCb, and CXC receptor-1 and -2 was analyzed after in vitro stimulation of leukocyte subpopulations and in two in vivo inflammation models. Recombinant proteins of carp CXCL8 proteins were produced and showed significant chemotactic activity for carp leukocytes. Conclusions: While both carp CXCL8s appear to be functional homologs of mammalian CXCL8, their different induction requirements and kinetics evoke a gene-specific sub-functionalization.	[van der Aa, Lieke M.; Chadzinska, Magdalena; Tijhaar, Edwin; Verburg-van Kemenade, B. M. Lidy] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [van der Aa, Lieke M.; Boudinot, Pierre] INRA, Virol & Immunol Mol, Jouy En Josas, France; [Chadzinska, Magdalena] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunobiol, PL-30060 Krakow, Poland	Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Jagiellonian University	van der Aa, LM (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	Lidy.vanKemenade@wur.nl	boudinot, pierre/L-4246-2016	van Kemenade, Lidy/0000-0002-5031-7335; boudinot, pierre/0000-0002-7490-9677	 [FP7-People-ERG-2008-228583];  [MNiSW/999/7.PR/UE/2009/7]	; 	This work was supported by FP7-People-ERG-2008-228583 and MNiSW/999/7.PR/UE/2009/7 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek NK, 2009, FISH SHELLFISH IMMUN, V27, P763, DOI 10.1016/j.fsi.2009.08.004; Arts JAJ, 2010, FISH SHELLFISH IMMUN, V29, P793, DOI 10.1016/j.fsi.2010.07.010; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Cai ZH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-66; Chadzinska M, 2009, DEV COMP IMMUNOL, V33, P88, DOI 10.1016/j.dci.2008.07.004; Chadzinska M, 2008, DEV COMP IMMUNOL, V32, P509, DOI 10.1016/j.dci.2007.08.008; Chen LQ, 2005, DEV COMP IMMUNOL, V29, P135, DOI 10.1016/j.dci.2004.06.011; Corripio-Miyar Y, 2007, MOL IMMUNOL, V44, P1361, DOI 10.1016/j.molimm.2006.05.010; Covello JM, 2009, FISH SHELLFISH IMMUN, V26, P773, DOI 10.1016/j.fsi.2009.03.012; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; FANGE R, 1986, VET IMMUNOL IMMUNOP, V12, P153, DOI 10.1016/0165-2427(86)90119-4; FREVERT CW, 1995, J IMMUNOL, V154, P335; GEISER T, 1993, J BIOL CHEM, V268, P15419; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harun NO, 2008, DEV COMP IMMUNOL, V32, P673, DOI 10.1016/j.dci.2007.10.005; Huising MO, 2004, EUR J BIOCHEM, V271, P4094, DOI 10.1111/j.1432-1033.2004.04347.x; Huising MO, 2003, VACCINE, V21, P4178, DOI 10.1016/S0264-410X(03)00497-3; Huising MO, 2003, DEV COMP IMMUNOL, V27, P875, DOI 10.1016/S0145-305X(03)00082-X; Huising MO, 2003, TRENDS IMMUNOL, V24, P307, DOI 10.1016/S1471-4906(03)00120-0; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; KAATTARI SL, 1985, DEV COMP IMMUNOL, V9, P433, DOI 10.1016/0145-305X(85)90006-0; Kaiser P, 1999, IMMUNOGENETICS, V49, P673, DOI 10.1007/s002510050664; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kemenade B, 1994, J EXP BIOL, V187, P143; Laing KJ, 2002, DEV COMP IMMUNOL, V26, P433, DOI 10.1016/S0145-305X(01)00092-1; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; Lee EY, 2001, GENE, V274, P237, DOI 10.1016/S0378-1119(01)00600-X; LEE J, 1992, J BIOL CHEM, V267, P16283; LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Montero J, 2008, DEV COMP IMMUNOL, V32, P1374, DOI 10.1016/j.dci.2008.05.004; MOSER B, 1993, BIOCHEM J, V294, P285, DOI 10.1042/bj2940285; Najakshin AM, 1999, EUR J IMMUNOL, V29, P375, DOI 10.1002/(SICI)1521-4141(199902)29:02<375::AID-IMMU375>3.3.CO;2-Y; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; Saha NR, 2007, FISH SHELLFISH IMMUN, V23, P1324, DOI 10.1016/j.fsi.2007.06.008; Sanchez X, 1998, J IMMUNOL, V160, P906; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; SHIBATA F, 1995, EUR J BIOCHEM, V231, P306, DOI 10.1111/j.1432-1033.1995.tb20701.x; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; WATANABE K, 1989, J BIOL CHEM, V264, P19559; WATANABE K, 1991, EXP MOL PATHOL, V55, P30, DOI 10.1016/0014-4800(91)90016-Q; Wiens GD, 2006, IMMUNOGENETICS, V58, P308, DOI 10.1007/s00251-006-0084-7; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	60	86	89	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12384	10.1371/journal.pone.0012384	http://dx.doi.org/10.1371/journal.pone.0012384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865040	Green Published, gold			2022-12-25	WOS:000281292100010
J	van Lummel, M; van Blitterswijk, WJ; Vink, SR; Veldman, RJ; van der Valk, MA; Schipper, D; Dicheva, BM; Eggermont, AMM; ten Hagen, TLM; Verheij, M; Koning, GA				van Lummel, Menno; van Blitterswijk, Wim J.; Vink, Stefan R.; Veldman, Robert Jan; van der Valk, Martin A.; Schipper, Debby; Dicheva, Bilyana M.; Eggermont, Alexander M. M.; ten Hagen, Timo L. M.; Verheij, Marcel; Koning, Gerben A.			Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors	FASEB JOURNAL			English	Article						chemotherapy; liposome; nanomedicine; short-chain sphingolipid; cell membrane permeability	PEGYLATED LIPOSOMAL DOXORUBICIN; MURINE BREAST-CANCER; STEALTH LIPOSOMES; MICROVASCULAR PERMEABILITY; ANTHRACYCLINES; CYTOTOXICITY; CERAMIDE; THERAPY; PHARMACOKINETICS; IMMUNOLIPOSOMES	For amphiphilic anticancer drugs, such as the anthracyclin doxorubicin (Dox), uptake by tumor cells involves slow diffusion across the plasma membrane, a limiting factor in clinical oncology. Previously, we discovered that preinsertion of short-chain sphingolipids such as N-octanoyl-glucosylceramide (GC) in the tumor cell membrane enhances cellular Dox uptake. In the present study, we apply this strategy in vitro and in vivo by coadministering GC and Dox in a lipid nanovesicle (LNV). GC enrichment of Dox-LNVs strongly enhanced in vitro cytotoxicity toward B16 melanoma and A431 carcinoma, as evidenced by 6-fold decreased IC50 values compared with Dox-LNVs. This correlated with enhanced cellular Dox uptake observed by confocal microscopy. Intravital optical imaging in window chamber-bearing mice with orthotopically implanted B16 melanoma demonstrated enhanced GC-mediated Dox delivery to tumor cells. Treatment of nude mice bearing human A431 xenografts with 6 mg/kg GC-Dox-LNVs almost doubled the tumor growth delay compared with Dox-LNVs. A second administration of 5 mg/kg after 3 d induced even 3-fold delay in tumor growth, while no systemic toxicity was found. GC-enriched Dox-LNVs displayed superior in vitro and in vivo antitumor activity, without systemic toxicity. This new drug delivery concept, aiming at increased membrane permeability for amphiphilic drugs, provides an opportunity to improve cancer chemotherapy.-Van Lummel, M., van Blitterswijk, W. J., Vink, S. R., Veldman, R. J., van der Valk, M. A., Schipper, D., Dicheva, B. M., Eggermont, A. M. M., ten Hagen, T. L. M., Verheij, M., Koning, G. A. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. FASEB J. 25, 280-289 (2011). www.fasebj.org	[Schipper, Debby; Dicheva, Bilyana M.; Eggermont, Alexander M. M.; ten Hagen, Timo L. M.; Koning, Gerben A.] Erasmus MC, Lab Expt Surg Oncol, Sect Surg Oncol, Dept Surg, NL-3000 CA Rotterdam, Netherlands; [van Lummel, Menno; van Blitterswijk, Wim J.; Vink, Stefan R.; Veldman, Robert Jan; Verheij, Marcel] Antoni Van Leeuwenhoek Hosp, Dept Cellular Biochem, Amsterdam, Netherlands; [van der Valk, Martin A.] Antoni Van Leeuwenhoek Hosp, Lab Expt Anim Pathol, Amsterdam, Netherlands; [Verheij, Marcel] Antoni Van Leeuwenhoek Hosp, Dept Radiat Oncol, Netherlands Canc Inst, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute	Koning, GA (corresponding author), Erasmus MC, Lab Expt Surg Oncol, Sect Surg Oncol, Dept Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.verheij@nki.nl; g.koning@erasmusmc.nl	Koning, Gerben A/K-2326-2012; Verheij, Marcel/O-9652-2018	Koning, Gerben A/0000-0003-3090-2403; 				Alberts DS, 2004, SEMIN ONCOL, V31, P53, DOI 10.1053/j.seminoncol.2004.08.010; Allen TM, 2004, SEMIN ONCOL, V31, P5, DOI 10.1053/j.seminoncol.2004.08.001; Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; DVORAK HF, 1988, AM J PATHOL, V133, P95; Elrick MJ, 2006, BIOPHYS J, V91, P1749, DOI 10.1529/biophysj.106.088443; Ewer MS, 2004, SEMIN ONCOL, V31, P161, DOI 10.1053/j.seminoncol.2004.08.006; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Gabizon AA, 2001, CLIN CANCER RES, V7, P223; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Harrington KJ, 2000, CLIN ONCOL-UK, V12, P2, DOI 10.1007/s001740050002; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Hussein MA, 2004, SEMIN ONCOL, V31, P147, DOI 10.1053/j.seminoncol.2004.08.005; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364; Koning GA, 1999, BBA-BIOMEMBRANES, V1420, P153, DOI 10.1016/S0005-2736(99)00091-7; Koning GA, 1999, BRIT J CANCER, V80, P1718, DOI 10.1038/sj.bjc.6690588; Koning GA, 2007, ANTI-CANCER AGENT ME, V7, P425; Krown SE, 2004, SEMIN ONCOL, V31, P36, DOI 10.1053/j.seminoncol.2004.08.003; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Mulder WJM, 2007, FASEB J, V21, P378, DOI 10.1096/fj.06-6791com; Mulder WJM, 2005, FASEB J, V19, P2008, DOI 10.1096/fj.05-4145fje; Osheroff N, 1994, Adv Pharmacol, V29B, P105; Robert NJ, 2004, SEMIN ONCOL, V31, P106, DOI 10.1053/j.seminoncol.2004.09.018; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Seynhaeve ALB, 2007, CANCER RES, V67, P9455, DOI 10.1158/0008-5472.CAN-07-1599; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Van der Graaf PH, 1999, J PHARMACOL TOXICOL, V41, P107, DOI 10.1016/S1056-8719(99)00026-X; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veldman RJ, 2005, J PHARMACOL EXP THER, V315, P704, DOI 10.1124/jpet.105.087486; Veldman RJ, 2004, BRIT J CANCER, V90, P917, DOI 10.1038/sj.bjc.6601581; Verhaar-Langereis M, 2006, INT J GYNECOL CANCER, V16, P65, DOI 10.1111/j.1525-1438.2006.00298.x; WU NZ, 1993, CANCER RES, V53, P3765; YUAN F, 1994, CANCER RES, V54, P3352	41	47	48	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					280	289		10.1096/fj.10-163709	http://dx.doi.org/10.1096/fj.10-163709			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876209				2022-12-25	WOS:000285869500025
J	Su, YC; Hong, JR				Su, Yu-Chin; Hong, Jiann-Ruey			Betanodavirus B2 Causes ATP Depletion-induced Cell Death via Mitochondrial Targeting and Complex II Inhibition in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-NECROSIS-VIRUS; CYTOCHROME-C RELEASE; ALZHEIMERS-DISEASE; FISH CELLS; PROTEIN TRANSLOCATION; EMBRYONIC-DEVELOPMENT; MARINE FISH; APOPTOSIS; MEMBRANE; INDUCTION	The betanodavirus non-structural protein B2 is a newly discovered necrotic death factor with a still unknown role in regulation of mitochondrial function. In the present study, we examined protein B2-mediated inhibition of mitochondrial complex II activity, which results in ATP depletion and thereby in a bioenergetic crisis in vitro and in vivo. Expression of protein B2 was detected early at 24 h postinfection with red-spotted grouper nervous necrosis virus in the cytoplasm. Later B2 was found in mitochondria using enhanced yellow fluorescent protein (EYFP) and immuno-EM analysis. Furthermore, the B2 mitochondrial targeting signal peptide was analyzed by serial deletion and specific point mutation. The sequence of the B2 targeting signal peptide ((41)RTFVISAHAA(50)) was identified and its presence correlated with loss of mitochondrial membrane potential in fish cells. Protein B2 also was found to dramatically inhibit complex II (succinate dehydrogenase) activity, which impairs ATP synthesis in fish GF-1 cells as well as human embryonic kidney 293T cells. Furthermore, when B2 was injected into zebrafish embryos at the one-cell stage to determine its cytotoxicity and ability to inhibit ATP synthesis, we found that B2 caused massive embryonic cell death and depleted ATP resulting in further embryonic death at 10 and 24 h post-fertilization. Taken together, our results indicate that betanodavirus protein B2-induced cell death is due to direct targeting of the mitochondrial matrix by a specific signal peptide that targets mitochondria and inhibits mitochondrial complex II activity thereby reducing ATP synthesis.	[Su, Yu-Chin; Hong, Jiann-Ruey] Natl Cheng Kung Univ, Lab Mol Virol & Biotechnol, Inst Biotechnol, Tainan 701, Taiwan	National Cheng Kung University	Hong, JR (corresponding author), Natl Cheng Kung Univ, Lab Mol Virol & Biotechnol, Inst Biotechnol, Tainan 701, Taiwan.	jrhong@mail.ncku.edu.tw			National Science Council, Taiwan, Republic of China [NSC 98-2313-B-006-004-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC 98-2313-B-006-004-MY3 (to J.-R. H.) from the National Science Council, Taiwan, Republic of China.	Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Chen LJ, 2009, VIROLOGY, V385, P444, DOI 10.1016/j.virol.2008.11.048; Chen SP, 2007, APOPTOSIS, V12, P1043, DOI 10.1007/s10495-006-0032-x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Fenner BJ, 2006, J VIROL, V80, P6822, DOI 10.1128/JVI.00079-06; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GREEN JD, 1980, J HISTOCHEM CYTOCHEM, V28, P408, DOI 10.1177/28.5.6966645; Guo YX, 2003, VIROLOGY, V308, P74, DOI 10.1016/S0042-6822(02)00098-3; Higuchi Y, 2004, J CELL MOL MED, V8, P455, DOI 10.1111/j.1582-4934.2004.tb00470.x; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; JONES DP, 1982, AM J PHYSIOL, V243, pC247, DOI 10.1152/ajpcell.1982.243.5.C247; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Kroemer G, 2007, PLOS BIOL, V5, P1409, DOI 10.1371/journal.pbio.0050206; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuczynski B, 2006, NEUROCHEM RES, V31, P639, DOI 10.1007/s11064-006-9061-7; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neve EPA, 2001, J BIOL CHEM, V276, P11317, DOI 10.1074/jbc.M008640200; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Roise D, 1997, J BIOENERG BIOMEMBR, V29, P19, DOI 10.1023/A:1022403604273; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Su YC, 2009, VIROLOGY, V385, P143, DOI 10.1016/j.virol.2008.11.036; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tan C, 2001, J GEN VIROL, V82, P647, DOI 10.1099/0022-1317-82-3-647; Tanaka S, 2003, J FISH DIS, V26, P109, DOI 10.1046/j.1365-2761.2003.00440.x; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Valmas N, 2008, TOXICOLOGY, V252, P33, DOI 10.1016/j.tox.2008.07.060; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Wu HC, 2008, FISH SHELLFISH IMMUN, V24, P436, DOI 10.1016/j.fsi.2008.01.001; Wu HC, 2010, FISH SHELLFISH IMMUN, V29, P451, DOI 10.1016/j.fsi.2010.05.003; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	59	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39801	39810		10.1074/jbc.M110.164988	http://dx.doi.org/10.1074/jbc.M110.164988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20870718	hybrid, Green Published			2022-12-25	WOS:000285185500024
J	Lotz, GP; Legleiter, J; Aron, R; Mitchell, EJ; Huang, SY; Ng, CP; Glabe, C; Thompson, LM; Muchowski, PJ				Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Mitchell, Emily J.; Huang, Shao-Yi; Ng, Cheping; Glabe, Charles; Thompson, Leslie M.; Muchowski, Paul J.			Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; MOUSE MODEL; EXPANSION PROTEINS; CELLULAR TOXICITY; AMYLOID OLIGOMERS; IN-VITRO; POLYGLUTAMINE; DISEASE; AGGREGATION; MECHANISM	Inclusion bodies of aggregated mutant huntingtin (htt) fragments are a neuropathological hallmark of Huntington disease (HD). The molecular chaperones Hsp70 and Hsp40 colocalize to inclusion bodies and are neuroprotective in HD animal models. How these chaperones suppress mutant htt toxicity is unclear but might involve direct effects on mutant htt misfolding and aggregation. Using size exclusion chromatography and atomic force microscopy, we found that mutant htt fragments assemble into soluble oligomeric species with a broad size distribution, some of which reacted with the conformation-specific antibody A11. Hsp70 associated with A11-reactive oligomers in an Hsp40- and ATP-dependent manner and inhibited their formation coincident with suppression of caspase 3 activity in PC12 cells. Thus, Hsp70 and Hsp40 (DNAJB1) dynamically target specific subsets of soluble oligomers in a classic ATP-dependent reaction cycle, supporting a pathogenic role for these structures in HD.	[Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Huang, Shao-Yi; Ng, Cheping; Muchowski, Paul J.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Muchowski, PJ (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019	Sontag, Emily/0000-0003-3068-6253; Legleiter, Justin/0000-0002-5262-1867; Lotz, Gregor/0000-0002-0231-5503	National Institutes of Health [R01NS054753, R01NS047237]; HighQ Foundation; Deutsche Forschungsgemeinschaft; Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237, R01NS054753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HighQ Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054753 and R01NS047237. This work was also supported by the HighQ Foundation.; Supported by a research fellowship from the Deutsche Forschungsgemeinschaft.; Supported by a postdoctoral fellowship from the Hereditary Disease Foundation.	Adachi H, 2003, J NEUROSCI, V23, P2203; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Gekko K., 1979, J PHYS CHEM, V83; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; Miller J, 2009, STRUCTURE, V17, P1151, DOI 10.1016/j.str.2009.08.004; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	48	57	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38183	38193		10.1074/jbc.M110.160218	http://dx.doi.org/10.1074/jbc.M110.160218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864533	hybrid, Green Published			2022-12-25	WOS:000284625600026
J	Miserez, A; Rubin, D; Waite, JH				Miserez, Ali; Rubin, Daniel; Waite, J. Herbert			Cross-linking Chemistry of Squid Beak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; CUTICLE; QUINONE; SHELL; TRANSITION; MORPHOLOGY; ADHESION; DESIGN; NEREIS; CHITIN	In stark contrast to most aggressive predators, Dosidicus gigas (jumbo squids) do not use minerals in their powerful mouthparts known as beaks. Their beaks instead consist of a highly sclerotized chitinous composite with incremental hydration from the tip to the base. We previously reported L-3,4-dihydroxyphenylalanine (dopa)-histidine (dopa-His) as an important covalent cross-link providing mechanical strengthening to the beak material. Here, we present a more complete characterization of the sclerotization chemistry and describe additional cross-links from D. gigas beak. All cross-links presented in this report share common building blocks, a family of di-, tri-, and tetra-histidine-catecholic adducts, that were separated by affinity chromatography and high performance liquid chromatography (HPLC) and identified by tandem mass spectroscopy and proton nuclear magnetic resonance (H-1 NMR). The data provide additional insights into the unusually high cross-link density found in mature beaks. Furthermore, we propose both a low molecular weight catechol, and peptidyl-dopa, to be sclerotization agents of squid beak. This appears to represent a new strategy for forming hard tissue in animals. The interplay between covalent cross-linking and dehydration on the graded properties of the beaks is discussed.	[Waite, J. Herbert] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Rubin, Daniel; Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA; [Miserez, Ali; Rubin, Daniel; Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Miserez, A (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	ali.miserez@ntu.edu.sg	Miserez, Ali/CAF-2662-2022; Miserez, Ali/D-1074-2010	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170	National Institutes of Health [R01DE018468]; Nanyang Technological University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nanyang Technological University(Nanyang Technological University); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE018468. This work was also supported by a Nanyang Technological University start-up grant (to A.M.).	ANDERSEN SO, 1981, J INSECT PHYSIOL, V27, P393, DOI 10.1016/0022-1910(81)90017-2; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Barnes HH, 1999, BIOMETALS, V12, P83, DOI 10.1023/A:1009223615607; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Birkedal H, 2006, CHEMBIOCHEM, V7, P1392, DOI 10.1002/cbic.200600160; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; FETTERER RH, 1994, J PARASITOL, V80, P952, DOI 10.2307/3283445; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; Hernandez-Garcia V., 2003, COLEID CEPHALOPODS T; Hopkins Theodore L., 1991, P213; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; KEAR AJ, 1994, J MAR BIOL ASSOC UK, V74, P801, DOI 10.1017/S0025315400090068; Kerwin JL, 1999, ANAL BIOCHEM, V268, P229, DOI 10.1006/abio.1998.3069; Khan RK, 2006, LANGMUIR, V22, P8465, DOI 10.1021/la061027k; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H; Paris O, 2010, MRS BULL, V35, P219, DOI 10.1557/mrs2010.655; Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332; Pryor M.G.M., 1962, COMP BIOCHEM PHYSIOL, V4, P371; Pryor MGM, 1940, PROC R SOC SER B-BIO, V128, P393, DOI 10.1098/rspb.1940.0018; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rubin DJ, 2010, ADV INSECT PHYSIOL, V38, P75, DOI 10.1016/S0065-2806(10)38003-9; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; SUGUMARAN M, 1992, J BIOL CHEM, V267, P10355; Sugumaran Manickam, 1991, P141; Uyeno TA, 2005, J MORPHOL, V264, P211, DOI 10.1002/jmor.10330; Vincent J. F. V., 2001, ENCY MAT SCI TECHNOL, P1924; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; VINCENT JFV, 1987, J INSECT PHYSIOL, V33, P973, DOI 10.1016/0022-1910(87)90010-2; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1981, ANAL BIOCHEM, V111, P131, DOI 10.1016/0003-2697(81)90240-2; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; Wu LQ, 2006, ADV FUNCT MATER, V16, P1967, DOI 10.1002/adfm.200500792; Wu LQ, 2005, ADV FUNCT MATER, V15, P189, DOI 10.1002/adfm.200400279; Xu RD, 1996, ARCH BIOCHEM BIOPHYS, V329, P56, DOI 10.1006/abbi.1996.0191; Yamauchi A, 2009, MACROMOL BIOSCI, V9, P875, DOI 10.1002/mabi.200900032; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhao H, 2005, BIOCHEMISTRY-US, V44, P15915, DOI 10.1021/bi051530g; [No title captured]	48	74	78	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38115	38124		10.1074/jbc.M110.161174	http://dx.doi.org/10.1074/jbc.M110.161174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870720	Green Published, hybrid			2022-12-25	WOS:000284625600019
J	Jules, J; Shi, ZQ; Liu, JZ; Xu, DR; Wang, SQ; Feng, X				Jules, Joel; Shi, Zhenqi; Liu, Jianzhong; Xu, Duorong; Wang, Shunqing; Feng, Xu			Receptor Activator of NF-kappa B (RANK) Cytoplasmic IVVY535-538 Motif Plays an Essential Role in Tumor Necrosis Factor-alpha (TNF)-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; T-CELLS; ESTROGEN DEFICIENCY; FAMILY-MEMBERS; KEY REGULATOR; STROMAL CELLS; TNF RECEPTOR; IN-VIVO; DIFFERENTIATION	Tumor necrosis factor-alpha (TNF) enhances osteoclast formation and activity leading to bone loss in various pathological conditions, but its precise role in osteoclastogenesis remains controversial. Although several groups showed that TNF can promote osteoclastogenesis independently of the receptor activator of NF-kappa B (RANK) ligand (RANKL), others demonstrated that TNF-mediated osteoclastogenesis needs permissive levels of RANKL. Here, we independently reveal that although TNF cannot stimulate osteoclastogenesis on bone slices, it can induce the formation of functional osteoclasts on bone slices in the presence of permissive levels of RANKL or from bone marrow macrophages (BMMs) pretreated by RANKL. TNF can still promote the formation of functional osteoclasts 2 days after transient RANKL pretreatment. These data have confirmed that TNF-mediated osteoclastogenesis requires priming of BMMs by RANKL. Moreover, we investigated the molecular mechanism underlying the dependence of TNF-mediated osteoclastogenesis on RANKL. RANK, the receptor for RANKL, contains an IVVY535-538 motif that has been shown to play a vital role in osteoclastogenesis by committing BMMs to the osteoclast lineage. We show that TNF-induced osteoclastogenesis depends on RANKL to commit BMMs to the osteoclast lineage and RANKL regulates the lineage commitment through the IVVY motif. Mechanistically, the IVVY motif controls the lineage commitment by reprogramming osteoclast genes into an inducible state in which they can be activated by TNF. Our findings not only provide important mechanistic insights into the action of RANKL in TNF-mediated osteoclastogenesis but also establish that the IVVY motif may serve as an attractive therapeutic target for bone loss in various bone disorders.	[Jules, Joel; Shi, Zhenqi; Liu, Jianzhong; Xu, Duorong; Wang, Shunqing; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wang, Shunqing] Guangzhou Med Univ, Municipal Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; Guangzhou Medical University	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	xufeng@uab.edu			National Institutes of Health through the NIAMS [AR47830]; Research and Education Foundation of American College of Rheumatology; National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR) [5P30 AR046031]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Research and Education Foundation of American College of Rheumatology; National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant AR47830 through the NIAMS (to X. F.). This work was also supported by a National Institutes of Health/NIAMS graduate research supplement to AR47830 (to J. J.), a Within Our Reach innovative basic research grant from Research and Education Foundation of American College of Rheumatology (to X. F.), and National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR) Grant 5P30 AR046031.	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Fouque-Aubert A, 2008, JOINT BONE SPINE, V75, P5, DOI 10.1016/j.jbspin.2007.05.004; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Quinn JMW, 2000, J BONE MINER RES, V15, P1459, DOI 10.1359/jbmr.2000.15.8.1459; Rho J, 2002, DNA CELL BIOL, V21, P541, DOI 10.1089/104454902320308915; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; THOMSON BM, 1987, J IMMUNOL, V138, P775; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	49	32	35	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37427	37435		10.1074/jbc.M110.149484	http://dx.doi.org/10.1074/jbc.M110.149484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870724	hybrid, Green Published			2022-12-25	WOS:000284424000035
J	Fan, QP; He, MA; Sheng, T; Zhang, XL; Sinha, M; Luxon, B; Zhao, XB; Xie, JW				Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Sinha, Mala; Luxon, Bruce; Zhao, Xingbo; Xie, Jingwu			Requirement of TGF beta Signaling for SMO-mediated Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; MOUSE MODEL; IN-VITRO; ACTIVATION; PATHWAY; CANCER; DIFFERENTIATION; EXPRESSION; GENES	Hedgehog (Hh) signaling, via the key signal transducer Smoothened (SMO) and Gli transcription factors, is essential for embryonic development and carcinogenesis. At present, the molecular mechanism of Hh signaling-mediated carcinogenesis is not completely understood. Using a mouse model (K14cre/R26SmoM2) of SMO-mediated basal cell carcinoma development, we identified TGF beta 2 as a major Hh-regulated gene. TGF beta 2 expression was high in the keratinocytes, with activated TGF beta signaling (indicated by elevated expression of phosphorylated SMAD2/3) detected in both tumor and stroma. The significance of TGF beta signaling for SMO function was demonstrated in two assays. Down-regulation of TGF beta 2 expression prevented Hh signaling-dependent osteoblast differentiation and motor neuron differentiation. Furthermore, inhibition of TGF beta signaling by TGF beta receptor I inhibitor SD208 significantly reduced tumor area in K14cre/R26SmoM2 mice. Tumor shrinkage in mice was associated with an increased number of lymphocytes, suggesting an immune suppression role of TGF beta signaling. The relevance of our results to human cancer is reflected by the fact that human basal cell carcinomas, which almost always harbor activated Hh signaling, have activated TGF beta signaling, as indicated by high levels of phosphorylated SMAD2 and SMAD3 in tumor and stroma. Together, our data indicate that TGF beta signaling is critical for Hh signaling-mediated carcinogenesis.	China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Xie, Jingwu] Indiana Univ, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Xie, Jingwu] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA; [He, Miao] Wuhan Univ, Sch Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China; [He, Miao] Wuhan Univ, Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	China Agricultural University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Wuhan University; Wuhan University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston		zhxb@cau.edu.cn; jinxie@iupui.edu	He, Miao/AAK-8617-2020; Luxon, Bruce A/C-9140-2012	He, Miao/0000-0001-8255-8072; Zhao, Xingbo/0000-0002-5576-349X	National Institutes of Health [R01-CA94160]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA094160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA94160 (to J.X.) and by a grant from the China Scholarship Council.	Alvarez J, 2002, DEVELOPMENT, V129, P1913; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Chen YG, 2009, CELL RES, V19, P1, DOI 10.1038/cr.2009.3; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Owens P, 2008, J INVEST DERMATOL, V128, P783, DOI 10.1038/sj.jid.5700969; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; XIE J, 2009, Patent No. 2009000737; Xie JW, 2008, ACTA BIOCH BIOPH SIN, V40, P670, DOI 10.1111/j.1745-7270.2008.00431.x; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	28	49	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36570	36576		10.1074/jbc.C110.164442	http://dx.doi.org/10.1074/jbc.C110.164442			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858897	hybrid, Green Published			2022-12-25	WOS:000284146100082
J	Inderjit; Bajpai, D; Rajeswari, MS				Inderjit; Bajpai, Devika; Rajeswari, M. S.			Interaction of 8-Hydroxyquinoline with Soil Environment Mediates Its Ecological Function	PLOS ONE			English	Article							GLORY SEEDLING BIOMASS; P-COUMARIC ACID; MICROBIAL-METABOLISM; CENTAUREA-DIFFUSA; QUINOLINE; DEGRADATION; ROOT; ALLELOCHEMICALS; CHEMISTRY; BACTERIUM	Background: Allelopathic functions of plant-released chemicals are often studied through growth bioassays assuming that these chemicals will directly impact plant growth. This overlooks the role of soil factors in mediating allelopathic activities of chemicals, particularly non-volatiles. Here we examined the allelopathic potential of 8-hydroxyquinoline (HQ), a chemical reported to be exuded from the roots of Centaurea diffusa. Methodology/Principal Findings: Growth bioassays and HQ recovery experiments were performed in HQ-treated soils (non-sterile, sterile, organic matter-enriched and glucose-amended) and untreated control soil. Root growth of either Brassica campestris or Phalaris minor was not affected in HQ-treated non-sterile soil. Soil modifications (organic matter and glucose amendments) could not enhance the recovery of HQ in soil, which further supports the observation that HQ is not likely to be an allelopathic compound. Hydroxyquinoline-treated soil had lower values for the CO2 release compared to untreated non-sterile soil. Soil sterilization significantly influenced the organic matter content, PO4-P and total organic nitrogen levels. Conclusion/Significance: Here, we concluded that evaluation of the effect of a chemical on plant growth is not enough in evaluating the ecological role of a chemical in plant-plant interactions. Interaction of the chemical with soil factors largely determines the impact of HQ on plant growth.	[Inderjit] Univ Delhi, Dept Environm Biol, Delhi 110007, India; [Inderjit; Bajpai, Devika] Univ Delhi, CEMDE, Delhi 110007, India; [Rajeswari, M. S.] Univ Delhi, Dept Bot, Acharya Narendra Dev Coll, Delhi 110007, India	University of Delhi; University of Delhi; University of Delhi	Inderjit (corresponding author), Univ Delhi, Dept Environm Biol, Delhi 110007, India.	inderjit@cemde.du.ac.in			University of Delhi; Department of Science and Technology	University of Delhi(University of Delhi); Department of Science and Technology(Department of Science & Technology (India))	This research was funded by the University of Delhi and the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SE, 1989, CHEM ANAL ECOLOGICAL; Anderson J. P. E., 1982, METHODS SOIL ANAL 2; [Anonymous], 1944, SOIL PLANT ANAL; Appel HM, 2001, J CHEM ECOL, V27, P761, DOI 10.1023/A:1010306103643; Bai YH, 2010, BIODEGRADATION, V21, P335, DOI 10.1007/s10532-009-9304-9; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; BLUM U, 1993, J CHEM ECOL, V19, P2791, DOI 10.1007/BF00980584; BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2; Chobot V, 2009, J CHEM ECOL, V35, P980, DOI 10.1007/s10886-009-9681-x; Chon SU, 2004, J AGRON CROP SCI, V190, P145, DOI 10.1111/j.1439-037X.2004.00088.x; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Erdem B, 2010, APPL SURF SCI, V256, P5422, DOI 10.1016/j.apsusc.2009.12.126; GRANT DJW, 1976, MICROBIOS, V15, P177; Huang PM, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P287; Inderjit, 2006, SOIL BIOL BIOCHEM, V38, P256, DOI 10.1016/j.soilbio.2005.05.004; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Kaiser JP, 1996, MICROBIOL REV, V60, P483, DOI 10.1128/MMBR.60.3.483-498.1996; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Kilbane JJ, 2000, APPL ENVIRON MICROB, V66, P688, DOI 10.1128/AEM.66.2.688-693.2000; KUITERS AT, 1986, SOIL BIOL BIOCHEM, V18, P475, DOI 10.1016/0038-0717(86)90003-9; Lan Y, 2002, ARCH ENVIRON CON TOX, V43, P168, DOI 10.1007/s00244-002-1178-3; Norton AP, 2008, BIOL INVASIONS, V10, P79, DOI 10.1007/s10530-007-9111-3; Oliva A, 1999, J CHEM ECOL, V25, P519, DOI 10.1023/A:1020949703205; PUE KJ, 1995, J CHEM ECOL, V21, P833, DOI 10.1007/BF02033464; Schmidt IK, 1997, OECOLOGIA, V112, P557, DOI 10.1007/s004420050345; SCHWARZ G, 1988, SYST APPL MICROBIOL, V10, P185, DOI 10.1016/S0723-2020(88)80035-3; SHUKLA OP, 1986, APPL ENVIRON MICROB, V51, P1332, DOI 10.1128/AEM.51.6.1332-1342.1986; Suding KN, 2004, OECOLOGIA, V141, P526, DOI 10.1007/s00442-004-1678-0; Sutton SD, 1996, APPL ENVIRON MICROB, V62, P2910, DOI 10.1128/AEM.62.8.2910-2914.1996; Tharayil N, 2009, NEW PHYTOL, V181, P424, DOI 10.1111/j.1469-8137.2008.02647.x; Troelstra SR, 2001, NEW PHYTOL, V150, P697, DOI 10.1046/j.1469-8137.2001.00133.x; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Watkins AJ, 2009, SOIL BIOL BIOCHEM, V41, P580, DOI 10.1016/j.soilbio.2008.12.019; Weidenhamer JD, 2004, J CHEM ECOL, V30, P1067, DOI 10.1023/B:JOEC.0000028468.97851.7a; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; Weidenhamer JD, 2009, PLANT SOIL, V322, P177, DOI 10.1007/s11104-009-9905-4; Zhu SN, 2008, J HAZARD MATER, V160, P289, DOI 10.1016/j.jhazmat.2008.02.112	38	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12852	10.1371/journal.pone.0012852	http://dx.doi.org/10.1371/journal.pone.0012852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877629	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900009
J	Kuffner, R; Petri, T; Windhager, L; Zimmer, R				Kueffner, Robert; Petri, Tobias; Windhager, Lukas; Zimmer, Ralf			Petri Nets with Fuzzy Logic (PNFL): Reverse Engineering and Parametrization	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; SYSTEMS; RECONSTRUCTION; SIMULATION; INFERENCE; ALGORITHM; MODELS	Background: The recent DREAM4 blind assessment provided a particularly realistic and challenging setting for network reverse engineering methods. The in silico part of DREAM4 solicited the inference of cycle-rich gene regulatory networks from heterogeneous, noisy expression data including time courses as well as knockout, knockdown and multifactorial perturbations. Methodology and Principal Findings: We inferred and parametrized simulation models based on Petri Nets with Fuzzy Logic (PNFL). This completely automated approach correctly reconstructed networks with cycles as well as oscillating network motifs. PNFL was evaluated as the best performer on DREAM4 in silico networks of size 10 with an area under the precision-recall curve (AUPR) of 81%. Besides topology, we inferred a range of additional mechanistic details with good reliability, e. g. distinguishing activation from inhibition as well as dependent from independent regulation. Our models also performed well on new experimental conditions such as double knockout mutations that were not included in the provided datasets. Conclusions: The inference of biological networks substantially benefits from methods that are expressive enough to deal with diverse datasets in a unified way. At the same time, overly complex approaches could generate multiple different models that explain the data equally well. PNFL appears to strike the balance between expressive power and complexity. This also applies to the intuitive representation of PNFL models combining a straightforward graphical notation with colloquial fuzzy parameters.	[Kueffner, Robert; Petri, Tobias; Windhager, Lukas; Zimmer, Ralf] Univ Munich, Inst Informat, D-8000 Munich, Germany	University of Munich	Kuffner, R (corresponding author), Univ Munich, Inst Informat, D-8000 Munich, Germany.	Robert.Kueffner@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019		Helmholtz Alliance on Systems Biology	Helmholtz Alliance on Systems Biology	This work was supported by Helmholtz Alliance on Systems Biology, Project CoReNe (http://www.helmholtz.de/en/joint_initiative_for_innovation_and_research/initiating_and_networking/helmholtz_alliances/systembiologie/helmholtz_alliance_on_systems_biology/networks_in_detail/corene_control_of_regulatory_networks_with_focus_on_non_coding_rna/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Li C, 2007, J BIOSCIENCES, V32, P113; Li H, 2008, FRONT BIOSCI-LANDMRK, V13, P263, DOI 10.2741/2677; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Marwan W, 2008, MATH METHOD OPER RES, V67, P117, DOI 10.1007/s00186-007-0178-5; Matsuno Hiroshi, 2003, In Silico Biology, V3, P389; MENDEL JM, 1995, P IEEE, V83, P345, DOI 10.1109/5.364485; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; WINDHAGER L, 2008, LECT NOTES INFORMA P, V136, P106; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	31	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12807	10.1371/journal.pone.0012807	http://dx.doi.org/10.1371/journal.pone.0012807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862218	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200007
J	Mallet, C; Barriere, DA; Ermund, A; Jonsson, BAG; Eschalier, A; Zygmunt, PM; Hogestatt, ED				Mallet, Christophe; Barriere, David A.; Ermund, Anna; Jonsson, Bo A. G.; Eschalier, Alain; Zygmunt, Peter M.; Hogestatt, Edward D.			TRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; TRANSPORT INHIBITOR AM404; CANNABINOID CB1 RECEPTOR; ANANDAMIDE TRANSPORT; INFLAMMATORY PAIN; SEROTONERGIC SYSTEMS; PARACETAMOL EXERTS; MICE LACKING; RAT; MODEL	Background: Acetaminophen, the major active metabolite of acetanilide in man, has become one of the most popular overthe- counter analgesic and antipyretic agents, consumed by millions of people daily. However, its mechanism of action is still a matter of debate. We have previously shown that acetaminophen is further metabolized to N-(4-hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide (AM404) by fatty acid amide hydrolase (FAAH) in the rat and mouse brain and that this metabolite is a potent activator of transient receptor potential vanilloid 1 (TRPV1) in vitro. Pharmacological activation of TRPV1 in the midbrain periaqueductal gray elicits antinociception in rats. It is therefore possible that activation of TRPV1 in the brain contributes to the analgesic effect of acetaminophen. Methodology/Principal Findings: Here we show that the antinociceptive effect of acetaminophen at an oral dose lacking hypolocomotor activity is absent in FAAH and TRPV1 knockout mice in the formalin, tail immersion and von Frey tests. This dose of acetaminophen did not affect the global brain contents of prostaglandin E-2 (PGE(2)) and endocannabinoids. Intracerebroventricular injection of AM404 produced a TRPV1-mediated antinociceptive effect in the mouse formalin test. Pharmacological inhibition of TRPV1 in the brain by intracerebroventricular capsazepine injection abolished the antinociceptive effect of oral acetaminophen in the same test. Conclusions: This study shows that TRPV1 in brain is involved in the antinociceptive action of acetaminophen and provides a strategy for developing central nervous system active oral analgesics based on the coexpression of FAAH and TRPV1 in the brain.	[Mallet, Christophe; Barriere, David A.; Eschalier, Alain] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Mallet, Christophe; Barriere, David A.; Eschalier, Alain] INSERM, U766, Clermont Ferrand, France; [Jonsson, Bo A. G.] Lund Univ, Dept Occupat & Environm Med, Lund, Sweden; [Ermund, Anna; Zygmunt, Peter M.; Hogestatt, Edward D.] Lund Univ, Dept Clin Chem, Lund, Sweden; [Ermund, Anna; Zygmunt, Peter M.; Hogestatt, Edward D.] Lund Univ, Pain Res Ctr, Lund, Sweden	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Lund University; Lund University; Lund University	Mallet, C (corresponding author), Univ Auvergne, Clermont Univ, Clermont Ferrand, France.	peter.zygmunt@med.lu.se	ESCHALIER, Alain/L-9957-2015; Nada, Aly/H-4219-2015; Ermund, Anna/AAG-3160-2020; Barrière, David André/ABC-3925-2021; Mallet, Christophe/K-2918-2015	Nada, Aly/0000-0003-4628-3475; Barrière, David André/0000-0003-4355-3329; Zygmunt, Peter/0000-0002-5102-8199; Ermund, Anna/0000-0002-3233-043X; Mallet, Christophe/0000-0002-0873-6763; Jonsson, Bo/0000-0002-8767-0589	INSERM; Universite d'Auvergne-Clermont1; Swedish Medical Research Council [2007-3095]; Medical Faculty of Lund; School of Pharmaceutical Sciences at Lund University; Association Nationale de la Recherche Technique; University of Auvergne; Bristol-Myers-Squibb	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Auvergne-Clermont1; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty of Lund; School of Pharmaceutical Sciences at Lund University; Association Nationale de la Recherche Technique; University of Auvergne; Bristol-Myers-Squibb(Bristol-Myers Squibb)	This work was supported by fundings from INSERM, Universite d'Auvergne-Clermont1, the Swedish Medical Research Council (2007-3095), the Medical Faculty of Lund and the School of Pharmaceutical Sciences at Lund University. CM and DB have received a PhD grant ("Bourse Cifre") funded by Association Nationale de la Recherche Technique, the University of Auvergne, INSERM and Bristol-Myers-Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloui A, 2002, EUR J PHARMACOL, V443, P71, DOI 10.1016/S0014-2999(02)01578-9; Alloui A, 1996, FUNDAM CLIN PHARM, V10, P406, DOI 10.1111/j.1472-8206.1996.tb00593.x; Ayoub SS, 2006, EUR J PHARMACOL, V538, P57, DOI 10.1016/j.ejphar.2006.03.061; Ballou LR, 2000, P NATL ACAD SCI USA, V97, P10272, DOI 10.1073/pnas.180319297; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BJORKMAN R, 1994, PAIN, V57, P259, DOI 10.1016/0304-3959(94)90001-9; BJORKMAN R, 1995, ACTA ANAESTH SCAND, V39, P3; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019; Borsani E, 2007, BRAIN RES, V1152, P87, DOI 10.1016/j.brainres.2007.03.071; BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P29; Bujalska M, 2001, POL J PHARMACOL, V53, P341; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Choi SS, 2001, BRAIN RES, V921, P233, DOI 10.1016/S0006-8993(01)03126-2; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Fowler CJ, 1997, PHARMACOL TOXICOL, V80, P103, DOI 10.1111/j.1600-0773.1997.tb00291.x; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Hasanein P, 2009, CLIN EXP PHARMACOL P, V36, P1127, DOI 10.1111/j.1440-1681.2009.05197.x; Hermann H, 2003, CELL MOL LIFE SCI, V60, P607, DOI 10.1007/s000180300052; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jung J, 1999, J NEUROSCI, V19, P529; Khanolkar AD, 1996, J MED CHEM, V39, P4515, DOI 10.1021/jm960152y; Knotkova H, 2008, CLIN J PAIN, V24, P142, DOI 10.1097/AJP.0b013e318158ed9e; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; McPartland JM, 2004, BRAIN RES REV, V45, P18, DOI 10.1016/j.brainresrev.2003.11.005; Mitchell VA, 2007, CLIN EXP PHARMACOL P, V34, P1186, DOI 10.1111/j.1440-1681.2007.04692.x; Ong CKS, 2010, ANESTH ANALG, V110, P1170, DOI 10.1213/ANE.0b013e3181cf9281; Ottani A, 2006, EUR J PHARMACOL, V531, P280, DOI 10.1016/j.ejphar.2005.12.015; Palazzo E, 2002, EUR J PHARMACOL, V439, P69, DOI 10.1016/S0014-2999(02)01367-5; Palazzo E, 2006, EUR J NEUROSCI, V24, P2011, DOI 10.1111/j.1460-9568.2006.05086.x; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pelissier T, 1996, J PHARMACOL EXP THER, V278, P8; Pickering G, 2006, CLIN PHARMACOL THER, V79, P371, DOI 10.1016/j.clpt.2005.12.307; PILETTA P, 1991, CLIN PHARMACOL THER, V49, P350, DOI 10.1038/clpt.1991.40; Pini LA, 1996, EUR J PHARMACOL, V308, P31, DOI 10.1016/0014-2999(96)00261-0; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Ruggieri V, 2008, N-S ARCH PHARMACOL, V377, P219, DOI 10.1007/s00210-008-0284-9; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	54	105	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12748	10.1371/journal.pone.0012748	http://dx.doi.org/10.1371/journal.pone.0012748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862299	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800008
J	Nettle, D; Cockerill, M				Nettle, Daniel; Cockerill, Maria			Development of Social Variation in Reproductive Schedules: A Study from an English Urban Area	PLOS ONE			English	Article							LIFE-HISTORY; FATHER ABSENCE; FAMILY ENVIRONMENT; TEENAGE PREGNANCY; NATURAL-SELECTION; EARLY STRESS; CHILD; MENARCHE; BIRTH; SEX	Background: There is striking social variation in the timing of the onset of childbearing in contemporary England, with the mean age at first motherhood about 8 years earlier in the most deprived compared to the least deprived neighbourhoods. However, relatively little is known about how these social differences in reproductive schedule develop in childhood. Methodology/Principal Findings: We studied the development of differences in reproductive schedules, using a cross-sectional survey over 1000 school students aged 9-15 in the metropolitan borough of North Tyneside. Students from more deprived neighbourhoods had earlier ideal ages for parenthood than those from more affluent ones, and these differences were fully apparent by age 11. We found evidence consistent with three mechanisms playing a role in maintaining the socioeconomic gradient. These were: vertical intergenerational transmission (students whose own parents were younger at their birth wanted children younger); oblique intergenerational transmission (students in neighbourhoods where parents were younger in general wanted children earlier); and low parental investment (students who did not feel emotionally supported by their own parents wanted children at a younger age). Conclusions/Significance: Our results shed some light on the proximate factors which may be involved in maintaining early childbearing in disadvantaged communities. They help understand why educational initiatives aimed at adolescents tend to have no effect, whereas improving the well-being of poor families with young children may do so. Our results also suggest that there will be considerable intergenerational inertia in the response of reproductive schedules to changing socioecological conditions.	[Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cockerill, Maria] N Tyneside Council, Sch Improvement Serv, Wallsend, Tyne & Wear, England	Newcastle University - UK	Nettle, D (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Cockerill, Maria/HCH-1489-2022; Nettle, Daniel/B-2259-2008	Nettle, Daniel/0000-0001-9089-2599; Cockerill, Maria/0000-0002-9780-3859	North Tyneside Council [KH092651]	North Tyneside Council	This work was partially supported by North Tyneside Council (http://www.northtyneside.gov.uk/) under grant KH092651 to Daniel Nettle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvergne A, 2008, PHYSIOL BEHAV, V95, P625, DOI 10.1016/j.physbeh.2008.09.005; Arai L, 2009, TEENAGE PREGNANCY: THE MAKING AND UNMAKING OF A PROBLEM, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 2007, CHILD DEV, V78, P1302, DOI 10.1111/j.1467-8624.2007.01067.x; Bereczkei T, 2001, INT J BEHAV DEV, V25, P501, DOI 10.1080/01650250042000573; Bogaert AF, 2008, J BIOSOC SCI, V40, P623, DOI 10.1017/S0021932007002386; Boyd R., 1985, CULTURE EVOLUTIONARY; BROOKSGUNN J, 1993, AM J SOCIOL, V99, P353, DOI 10.1086/230268; Burton L M, 1990, Hum Nat, V1, P123, DOI 10.1007/BF02692149; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Chisholm JS, 1999, HUM NATURE-INT BIOS, V10, P51, DOI 10.1007/s12110-999-1001-1; Chisholm JS, 2005, HUM NATURE-INT BIOS, V16, P233, DOI 10.1007/s12110-005-1009-0; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Cohan CL, 2002, J FAM PSYCHOL, V16, P14, DOI 10.1037//0893-3200.16.1.14; Davis J, 2007, EVOL HUM BEHAV, V28, P228, DOI 10.1016/j.evolhumbehav.2007.02.003; *DCLG, 2010, IND DEPR 2007; Duncan S, 2007, CRIT SOC POLICY, V27, P307, DOI 10.1177/0261018307078845; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Gaudie J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-63; Geronimus AT, 1996, HUM NATURE-INT BIOS, V7, P323, DOI 10.1007/BF02732898; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Henderson M, 2007, BMJ-BRIT MED J, V334, P133, DOI 10.1136/bmj.39014.503692.55; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Jewell D, 2000, FAM PRACT, V17, P522, DOI 10.1093/fampra/17.6.522; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Lawson DW, 2009, EVOL HUM BEHAV, V30, P170, DOI 10.1016/j.evolhumbehav.2008.12.001; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Mathews P., 2008, J EVOLUTIONARY PSYCH, V6, P155, DOI [10.1556/JEP.6.2008.3.1, DOI 10.1556/JEP.6.2008.3.1]; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McElreath R, 2008, CURR ANTHROPOL, V49, P307, DOI 10.1086/524364; Meade CS, 2008, HEALTH PSYCHOL, V27, P419, DOI 10.1037/0278-6133.27.4.419; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; NETTLE D, P ROYAL S B IN PRESS; Nettle D., PHILOS T B IN PRESS; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; *ONS, 2010, IND MULT DEPR WARDS; Pesonen AK, 2008, AM J HUM BIOL, V20, P345, DOI 10.1002/ajhb.20735; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Rasbash J., 2010, USERS GUIDE MLWIN VE; RASBASH J, 2010, MLWIN VERSION 2 19; Rodgers JL, 2005, DEMOGRAPHY, V42, P675, DOI 10.1353/dem.2005.0034; Smith Debbie M, 2006, Psychol Health Med, V11, P399, DOI 10.1080/13548500500429353; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; Tither JM, 2008, DEV PSYCHOL, V44, P1409, DOI 10.1037/a0013065; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Zhou XY, 2009, ASIAN J SOC PSYCHOL, V12, P40, DOI 10.1111/j.1467-839X.2008.01268.x	51	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12690	10.1371/journal.pone.0012690	http://dx.doi.org/10.1371/journal.pone.0012690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856795	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815800005
J	Egusa, H; Okita, K; Kayashima, H; Yu, GN; Fukuyasu, S; Saeki, M; Matsumoto, T; Yamanaka, S; Yatani, H				Egusa, Hiroshi; Okita, Keisuke; Kayashima, Hiroki; Yu, Guannan; Fukuyasu, Sho; Saeki, Makio; Matsumoto, Takuya; Yamanaka, Shinya; Yatani, Hirofumi			Gingival Fibroblasts as a Promising Source of Induced Pluripotent Stem Cells	PLOS ONE			English	Article							BONE-MARROW; GENERATION; MOUSE; DIFFERENTIATION; AUGMENTATION; REGENERATION; SUPPRESSION; TELOMERASE; EXPRESSION; INDUCTION	Background: Induced pluripotent stem (iPS) cells efficiently generated from accessible tissues have the potential for clinical applications. Oral gingiva, which is often resected during general dental treatments and treated as biomedical waste, is an easily obtainable tissue, and cells can be isolated from patients with minimal discomfort. Methodology/Principal Findings: We herein demonstrate iPS cell generation from adult wild-type mouse gingival fibroblasts (GFs) via introduction of four factors (Oct3/4, Sox2, Klf4 and c-Myc; GF-iPS-4F cells) or three factors (the same as GF-iPS-4F cells, but without the c-Myc oncogene; GF-iPS-3F cells) without drug selection. iPS cells were also generated from primary human gingival fibroblasts via four-factor transduction. These cells exhibited the morphology and growth properties of embryonic stem (ES) cells and expressed ES cell marker genes, with a decreased CpG methylation ratio in promoter regions of Nanog and Oct3/4. Additionally, teratoma formation assays showed ES cell-like derivation of cells and tissues representative of all three germ layers. In comparison to mouse GF-iPS-4F cells, GF-iPS-3F cells showed consistently more ES cell-like characteristics in terms of DNA methylation status and gene expression, although the reprogramming process was substantially delayed and the overall efficiency was also reduced. When transplanted into blastocysts, GF-iPS-3F cells gave rise to chimeras and contributed to the development of the germline. Notably, the four-factor reprogramming efficiency of mouse GFs was more than 7-fold higher than that of fibroblasts from tail-tips, possibly because of their high proliferative capacity. Conclusions/Significance: These results suggest that GFs from the easily obtainable gingival tissues can be readily reprogrammed into iPS cells, thus making them a promising cell source for investigating the basis of cellular reprogramming and pluripotency for future clinical applications. In addition, high-quality iPS cells were generated from mouse GFs without Myc transduction or a specific system for reprogrammed cell selection.	[Egusa, Hiroshi; Kayashima, Hiroki; Yu, Guannan; Fukuyasu, Sho; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka, Japan; [Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Saeki, Makio] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Osaka, Japan; [Matsumoto, Takuya] Osaka Univ, Grad Sch Dent, Dept Oromaxillofacial Regenerat, Osaka, Japan	Osaka University; Kyoto University; Osaka University; Osaka University	Egusa, H (corresponding author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka, Japan.	egu@dent.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132; Okita, Keisuke/0000-0001-5806-1090	Ministry of Education, Culture, Sports, Science and Technology, Japan [A: 22689049]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This investigation was supported by a Grant-in-Aid for Young Scientists (A: 22689049, H. E.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Egusa H, 2010, J ORAL BIOSCI, V52, P107, DOI 10.2330/joralbiosci.52.107; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Giannopoulou C, 1996, J DENT RES, V75, P895, DOI 10.1177/00220345960750030601; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nikawa H, 2006, MYCOSES, V49, P14, DOI 10.1111/j.1439-0507.2005.01176.x; ODA Y, J BIOL CHEM IN PRESS; Ohnuki M, 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Ueda M, 2008, IMPLANT DENT, V17, P82, DOI 10.1097/ID.0b013e31815cd591; Walsh LJ, 1996, AUST DENT J, V41, P75, DOI 10.1111/j.1834-7819.1996.tb05916.x; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189; Yamada Y, 2006, INT J PERIODONT REST, V26, P363; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926; Zeuschner D, 2010, STEM CELLS DEV, V19, P615, DOI 10.1089/scd.2009.0159	50	114	117	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12743	10.1371/journal.pone.0012743	http://dx.doi.org/10.1371/journal.pone.0012743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856871	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815700023
J	Delaney, A; Keighren, M; Fleetwood-Walker, SM; Jackson, IJ				Delaney, Ada; Keighren, Margaret; Fleetwood-Walker, Susan M.; Jackson, Ian J.			Involvement of the Melanocortin-1 Receptor in Acute Pain and Pain of Inflammatory but Not Neuropathic Origin	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEX-DIFFERENCES; FORMALIN TEST; PROOPIOMELANOCORTIN DEFICIENCY; MORPHINE ANTINOCICEPTION; DIFFERENTIAL EXPRESSION; THERMAL NOCICEPTION; HAIR PIGMENTATION; OPIOID ANALGESIA; SENSORY NEURONS	Background: Response to painful stimuli is susceptible to genetic variation. Numerous loci have been identified which contribute to this variation, one of which, MC1R, is better known as a gene involved in mammalian hair colour. MC1R is a G protein-coupled receptor expressed in melanocytes and elsewhere and mice lacking MC1R have yellow hair, whilst humans with variant MC1R protein have red hair. Previous work has found differences in acute pain perception, and response to analgesia in mice and humans with mutations or variants in MC1R. Methodology and Principal Findings: We have tested responses to noxious and non-noxious stimuli in mutant mice which lack MC1R, or which overexpress an endogenous antagonist of the receptor, as well as controls. We have also examined the response of these mice to inflammatory pain, assessing the hyperalgesia and allodynia associated with persistent inflammation, and their response to neuropathic pain. Finally we tested by a paired preference paradigm their aversion to oral administration of capsaicin, which activates the noxious heat receptor TRPV1. Female mice lacking MC1R showed increased tolerance to noxious heat and no alteration in their response to non-noxious mechanical stimuli. MC1R mutant females, and females overexpressing the endogenous MC1R antagonist, agouti signalling protein, had a reduced formalin-induced inflammatory pain response, and a delayed development of inflammation-induced hyperalgesia and allodynia. In addition they had a decreased aversion to capsaicin at moderate concentrations. Male mutant mice showed no difference from their respective controls. Mice of either sex did not show any effect of mutant genotype on neuropathic pain. Conclusions: We demonstrate a sex-specific role for MC1R in acute noxious thermal responses and pain of inflammatory origin.	[Delaney, Ada; Keighren, Margaret; Jackson, Ian J.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med,Western Gen Hosp, Edinburgh EH8 9YL, Midlothian, Scotland; [Delaney, Ada; Fleetwood-Walker, Susan M.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Delaney, A (corresponding author), Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med,Western Gen Hosp, Edinburgh EH8 9YL, Midlothian, Scotland.	Ian.Jackson@hgu.mrc.ac.uk		delaney, ada/0000-0003-4040-1186; Jackson, Ian/0000-0001-6526-0688	Medical Research Council, UK; Medical Research Council [MC_U127527200] Funding Source: researchfish; MRC [MC_U127527200] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Bellasio S, 2003, EUR J PHARMACOL, V482, P127, DOI 10.1016/j.ejphar.2003.09.017; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bergeson SE, 2001, MAMM GENOME, V12, P546, DOI 10.1007/s003350020022; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Bertorelli R, 2005, BEHAV BRAIN RES, V157, P55, DOI 10.1016/j.bbr.2004.06.008; Bhardwaj R, 1997, J IMMUNOL, V158, P3378; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Craft RM, 2003, CLIN J PAIN, V19, P175, DOI 10.1097/00002508-200305000-00005; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Elitt CM, 2008, BRAIN RES, V1230, P80, DOI 10.1016/j.brainres.2008.06.119; Furuse T, 2003, PAIN, V105, P169, DOI 10.1016/S0304-3959(03)00178-7; GIROS B, 1995, LIFE SCI, V56, pPL369, DOI 10.1016/0024-3205(95)00119-Q; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kavaliers M, 1997, BRAIN RES, V768, P30, DOI 10.1016/S0006-8993(97)00569-6; Kest B, 1999, J PHARMACOL EXP THER, V289, P1370; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Liem EB, 2005, ANESTHESIOLOGY, V102, P509, DOI 10.1097/00000542-200503000-00006; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Mogil JS, 2006, PAIN, V126, P24, DOI 10.1016/j.pain.2006.06.004; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; Mogil JS, 1997, PAIN, V70, P267, DOI 10.1016/S0304-3959(97)03333-2; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Simons CT, 2001, CHEM SENSES, V26, P491, DOI 10.1093/chemse/26.5.491; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Starowicz K, 2009, PHARMACOL REP, V61, P1086, DOI 10.1016/S1734-1140(09)70171-9; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tanabe K, 2007, J NEUROCHEM, V101, P1145, DOI 10.1111/j.1471-4159.2006.04432.x; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vrinten DH, 2000, J NEUROSCI, V20, P8131; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Wilson SG, 2002, PAIN, V96, P385, DOI 10.1016/S0304-3959(01)00489-4; XIA Y, 1995, NEUROREPORT, V6, P2193, DOI 10.1097/00001756-199511000-00022; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Zvejniece L, 2006, PHARMACOL BIOCHEM BE, V85, P287, DOI 10.1016/j.pbb.2006.08.001	52	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12498	10.1371/journal.pone.0012498	http://dx.doi.org/10.1371/journal.pone.0012498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856883	Green Submitted, Green Published, gold			2022-12-25	WOS:000281735700001
J	Huo, LF; Yao, H; Wang, XC; Wong, GW; Kung, HF; Lin, MC				Huo, Longfei; Yao, Hong; Wang, Xicai; Wong, Gee Wan; Kung, Hsiang-fu; Lin, Marie C.			Inhibition of Melanoma Growth by Subcutaneous Administration of hTERTC27 Viral Cocktail in C57BL/6 Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TELOMERASE REVERSE-TRANSCRIPTASE; RECOMBINANT ADENOASSOCIATED VIRUS; TRYPANOSOMA-CRUZI INFECTION; CYTOTOXIC T-LYMPHOCYTES; CANCER GENE-THERAPY; METASTATIC MELANOMA; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; ANTITUMOR-ACTIVITY	Background: hTERTC27 is a 27 kDa C-terminal polypeptide of human telomerase reverse transcriptase that has previously been shown to reduce tumorigenicity of HeLa cells and suppress growth of xenografted glioblastoma in nude mice. Although ectopic expression of hTERTC27 upregulated genes that are involved in apoptosis, cell cycle, and immune response, the mechanism for hTERTC27-induced tumor suppression has not been completely elucidated. Since hTERT was identified as a universal tumor-associated antigen, we hypothesize that hTERTC27 inhibits tumor growth in vivo through activation of anti-tumor immune response. Methodology/Principal Finding: Immunocopetent C57BL/6 mice were used for mouse B16 melanoma model. Mice bearing B16 melanoma were administered rAAV-/rAdv viral cocktail expressing hTERTC27, and tumor growth was monitored after viral cocktail treatment. Blood and splenocytes were used to determine the level of cytokines and the activity of immune cells, respectively. B16 tumor growth was significantly inhibited by subcutaneous administration of a single dose of 1.5x10(11) vg rAAV-hTERTC27 and 2.5x10(9) pfu rAdv-hTERTC27 viral cocktail (rAAV-/rAdv-hTERTC27). The population and cytotoxicity of NK cells in the mice were significantly augmented by rAAV-/rAdv-hTERTC27 treatment, and selective depletion of the NK cell population in mice by intraperitoneal injection of anti-GM1 antibody abrogated the growth suppression of melanoma induced by rAAV-/rAdv-hTERTC27 administration. Conclusion: Activation of NK cells by administration of rAAV-/rAdv-hTERTC27 is critical for growth suppression of melanoma in mouse model.	[Huo, Longfei; Yao, Hong; Wong, Gee Wan; Lin, Marie C.] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol, Dept Chem, Pokfulam, Hong Kong, Peoples R China; [Yao, Hong] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Yao, Hong] Third Mil Med Univ, SW Canc Ctr, SW Hosp, Chongqing, Peoples R China; [Wong, Gee Wan; Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Lin, Marie C.] Chinese Univ Hong Kong, Prince Wales Hosp, Brain Tumor Ctr, Fac Med, Shatin, Hong Kong, Peoples R China; [Wang, Xicai] Kunming Med Coll, Tumor Hosp Yunnan Prov, Tumor Inst Yunnan Prov, Canc Res Dept,Biomed Engn Res Ctr, Kunming, Peoples R China	University of Hong Kong; Army Medical University; Army Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Kunming Medical University	Huo, LF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mcllin@surgery.cuhk.edu.hk	Huo, Longfei/F-9233-2010		Innovation and Technology Fund [ITS/105/02, ITS/173/08]	Innovation and Technology Fund	The work was supported by grants from the Innovation and Technology Fund (ITS/105/02 and ITS/173/08 to M.C.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Blesa JMG, 2009, CANC THERAPY, V7, P188; Brockstedt DG, 1999, CLIN IMMUNOL, V92, P67, DOI 10.1006/clim.1999.4724; Brown CK, 2003, SURG CLIN N AM, V83, P283, DOI 10.1016/S0039-6109(02)00187-1; Chen Y, 2004, BIOCHEM BIOPH RES CO, V317, P675, DOI 10.1016/j.bbrc.2004.03.098; Clark PR, 2000, CELL IMMUNOL, V204, P96, DOI 10.1006/cimm.2000.1699; Duthie MS, 2006, IMMUNOLOGY, V119, P355, DOI 10.1111/j.1365-2567.2006.02439.x; Eckert A, 2009, DERMATOLOGY, V218, P69, DOI 10.1159/000161122; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Fadel F, 2009, NEW ENGL J MED, V361, P211, DOI 10.1056/NEJMc0904283; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Flaherty LE, 2001, J CLIN ONCOL, V19, P3194, DOI 10.1200/JCO.2001.19.13.3194; Gao Y, 2008, CANCER GENE THER, V15, P723, DOI 10.1038/cgt.2008.33; Huang JJ, 2002, CANCER RES, V62, P3226; Huncharek M, 2001, MELANOMA RES, V11, P75, DOI 10.1097/00008390-200102000-00009; Huo LF, 2006, CELL MOL IMMUNOL, V3, P1; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kijima M, 2005, INT J ONCOL, V26, P679; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, EUR J CANCER, V33, P781, DOI 10.1016/S0959-8049(97)00057-9; KUROSAWA S, 1995, IMMUNOLOGY, V85, P338; Lens M, 2008, RECENT PAT ANTI-CANC, V3, P105, DOI 10.2174/157489208784638767; Linn YC, 2003, LEUKEMIA LYMPHOMA, V44, P1457, DOI 10.1080/1042819031000083082; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; Misawa E, 2003, J IMMUNOTHER, V26, P21, DOI 10.1097/00002371-200301000-00003; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Ng SSM, 2007, CANCER GENE THER, V14, P561, DOI 10.1038/sj.cgt.7701038; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Pawlik TM, 2003, CRIT REV ONCOL HEMAT, V45, P245, DOI 10.1016/S1040-8428(02)00080-X; Pilla L, 2006, EXPERT REV ANTICANC, V6, P1305, DOI 10.1586/14737140.6.8.1305; Pilla L, 2009, EXPERT OPIN BIOL TH, V9, P1043, DOI 10.1517/14712590903085109; Queirolo P, 2005, MELANOMA RES, V15, P471, DOI 10.1097/00008390-200510000-00018; Ramakrishnan S, 1998, CANCER RES, V58, P622; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; ROTTENBERG M, 1988, SCAND J IMMUNOL, V28, P573, DOI 10.1111/j.1365-3083.1988.tb01489.x; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Scardino A, 2002, J IMMUNOL, V168, P5900, DOI 10.4049/jimmunol.168.11.5900; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Schroers R, 2002, CANCER RES, V62, P2600; Schroers R, 2003, CLIN CANCER RES, V9, P4743; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Smyth MJ, 2005, J EXP MED, V201, P1973, DOI 10.1084/jem.20042280; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; TALMADGE JE, 1987, CANCER RES, V47, P5725; TALMADGE JE, 1987, CANCER RES, V47, P2563; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Thompson JF, 2009, LANCET, V374, P362, DOI 10.1016/S0140-6736(09)61397-0; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Vonderheide RH, 2001, CLIN CANCER RES, V7, P3343; Vonderheide RH, 1999, IMMUNITY, V10, P673, DOI 10.1016/S1074-7613(00)80066-7; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang G, 2003, CANCER RES, V63, P9016; Yajima T, 2002, INT J CANCER, V99, P573, DOI 10.1002/ijc.10395; YE JP, 1995, J LEUKOCYTE BIOL, V58, P225, DOI 10.1002/jlb.58.2.225; Zimmermann S, 2007, CELL MOL LIFE SCI, V64, P906, DOI 10.1007/s00018-007-6481-8	57	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12705	10.1371/journal.pone.0012705	http://dx.doi.org/10.1371/journal.pone.0012705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856939	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700020
J	Jamali, Y; Azimi, M; Mofrad, MRK				Jamali, Yousef; Azimi, Mohammad; Mofrad, Mohammad R. K.			A Sub-Cellular Viscoelastic Model for Cell Population Mechanics	PLOS ONE			English	Article							SHAPE	Understanding the biomechanical properties and the effect of biomechanical force on epithelial cells is key to understanding how epithelial cells form uniquely shaped structures in two or three-dimensional space. Nevertheless, with the limitations and challenges posed by biological experiments at this scale, it becomes advantageous to use mathematical and 'in silico' (computational) models as an alternate solution. This paper introduces a single-cell-based model representing the cross section of a typical tissue. Each cell in this model is an individual unit containing several sub-cellular elements, such as the elastic plasma membrane, enclosed viscoelastic elements that play the role of cytoskeleton, and the viscoelastic elements of the cell nucleus. The cell membrane is divided into segments where each segment (or point) incorporates the cell's interaction and communication with other cells and its environment. The model is capable of simulating how cells cooperate and contribute to the overall structure and function of a particular tissue; it mimics many aspects of cellular behavior such as cell growth, division, apoptosis and polarization. The model allows for investigation of the biomechanical properties of cells, cell-cell interactions, effect of environment on cellular clusters, and how individual cells work together and contribute to the structure and function of a particular tissue. To evaluate the current approach in modeling different topologies of growing tissues in distinct biochemical conditions of the surrounding media, we model several key cellular phenomena, namely monolayer cell culture, effects of adhesion intensity, growth of epithelial cell through interaction with extra-cellular matrix (ECM), effects of a gap in the ECM, tensegrity and tissue morphogenesis and formation of hollow epithelial acini. The proposed computational model enables one to isolate the effects of biomechanical properties of individual cells and the communication between cells and their microenvironment while simultaneously allowing for the formation of clusters or sheets of cells that act together as one complex tissue.	[Jamali, Yousef; Azimi, Mohammad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Jamali, Y (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	Jamali, Yousef/V-5156-2019; /R-6010-2019	Jamali, Yousef/0000-0002-5709-3821; /0000-0001-7004-4859	National Science Foundation; Institute for Research in Fundamental Sciences	National Science Foundation(National Science Foundation (NSF)); Institute for Research in Fundamental Sciences	Financial support by National Science Foundation is gratefully acknowledged. Dr. Jamali was supported by a generous fellowship support from the Institute for Research in Fundamental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; ALBER M, 2003, MATH SYSTEMS THEORY; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Anderson ARA, 2003, MATH BIOSCI INTERAC, P261; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; BEREITERHAHN J, 1985, ACTA BIOTHEOR, V34, P139, DOI 10.1007/BF00046779; Bottino D, 2002, J CELL SCI, V115, P367; Bray D, 2001, CELL MOVEMENTS MOL M; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; BUCK CA, 1993, CR ACAD SCI III-VIE, V316, P849; CANADAS P, 2002, J THEOR BIOL, V218, P19; CASTANO E, 2010, HISTOCHEM CELL BIOL; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CHEN CS, 1999, OSTEOARTHR CARTILAGE, V7, P14; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COSKUNA H, 2007, J THEOR BIOL, V244, P11; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DEBNATH J, 2005, NATURE REV CANC, V5, P14; DORMANN S, 2002, IN SILICO BIOL, V2, P14; DRASDO D, 1995, PHYS REV E, V52, P6635, DOI 10.1103/PhysRevE.52.6635; Drasdo D, 2007, J STAT PHYS, V128, P287, DOI 10.1007/s10955-007-9289-x; DUCHTING W, 1996, EUR J CANCER, V32, P10; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P37; ETTINGER L, 1992, BIOL REV, V67, P459, DOI 10.1111/j.1469-185X.1992.tb01190.x; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Flaherty B, 2007, CELL BIOCHEM BIOPHYS, V49, P14, DOI 10.1007/s12013-007-0045-2; Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GALLI C, 2005, ACTA BIOL MED GER, V76, P8; Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1; GUMBINER BM, 2005, NATURE REV MOL CELL, V6, P13; GUNST SJ, 2003, AM PHYSL SOC, P413; HAGIOS C, 1998, PHILTRANS R SOC LO B, V353, P4; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; HOCHMUTH RM, 1993, BIOPHYS J, V64, P5; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOWARD J, 2009, ANN REV BIOPHYSICS, V38; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; INGBER DE, 2003, J CELL SCI, V116, P12; INGBER DE, 2003, J CELL SCI, V116, P17; INGBER DE, 2000, J APPL PHYSIOL, V89, P8; KAMM RD, 2004, MCB, V1, P10; KANSAL AR, 2000, J THEOR BIOL, V203, P16; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; LECUIT T, 2007, NATURE REV MOL CELL, V8, P12; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; LODISH H, 2003, MOL CELL BIOL; Mofrad M.R.K., 2006, CYTOSKELETAL MECH; Mofrad M.R.K., 2009, CELLULAR MECHANOTRAN; Mogilner A, 2003, J STAT PHYS, V110, P1169, DOI 10.1023/A:1022153028488; NEWMAN TJ, 2005, MATH BIOSCI ENG, V2, P11; OBRIEN LE, 2002, NATURE REV MOL CELL, V3, P7; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; OJAKIAN GK, 2001, INTEGRIN REGULATION; PALSSON E, 2001, FUTURE GENER COMP SY, V17, P18; PALSSON E, 2000, PNAS, V97, P6; REJNIAK KA, 2007, COMP MATH MATH PHYS, V8, P9; REJNIAK KA, 2007, B MATH BIOL; REJNIAK KA, 2007, J THEOR BIOL, V247, P19; REJNIAK KA, 2004, B MATH BIOL; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; SULTAN C, 2004, ANN BIOMED ENG, V32, P11; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRANSONTAY R, 1987, BIOPHYS J, V51, P10; TURNER S, 2002, J THEOR BIOL, V216, P16; VOGEL V, 2009, CURRENT OPINION CELL; WANG AZ, 1990, STEPS MORPHOGENESIS; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WEI C, 2003, J THEOR BIOL, V224, P8; YEUNG A, 1989, BIOPHYS J, P56; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	81	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12097	10.1371/journal.pone.0012097	http://dx.doi.org/10.1371/journal.pone.0012097			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856895	gold, Green Published, Green Submitted			2022-12-25	WOS:000280811900034
J	Lin, W; Chai, J; Love, J; Fu, D				Lin, Wei; Chai, Jin; Love, James; Fu, Dax			Selective Electrodiffusion of Zinc Ions in a Zrt-, Irt-like Protein, ZIPB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL TRANSPORTER YIIP; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; BINDING; CELLS; FAMILY; TRAFFICKING; HOMEOSTASIS; PHYSIOLOGY; MECHANISM	All living cells need zinc ions to support cell growth. Zrt-, Irt-like proteins (ZIPs) represent a major route for entry of zinc ions into cells, but how ZIPs promote zinc uptake has been unclear. Here we report the molecular characterization of ZIPB from Bordetella bronchiseptica, the first ZIP homolog to be purified and functionally reconstituted into proteoliposomes. Zinc flux through ZIPB was found to be nonsaturable and electrogenic, yielding membrane potentials as predicted by the Nernst equation. Conversely, membrane potentials drove zinc fluxes with a linear voltage-flux relationship. Direct measurements of metal uptake by inductively coupled plasma mass spectroscopy demonstrated that ZIPB is selective for two group 12 transition metal ions, Zn2+ and Cd2+, whereas rejecting transition metal ions in groups 7 through 11. Our results provide the molecular basis for cellular zinc acquisition by a zinc-selective channel that exploits in vivo zinc concentration gradients to move zinc ions into the cytoplasm.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Love, James] New York Struct Biol Ctr, New York, NY 10027 USA	United States Department of Energy (DOE); Brookhaven National Laboratory		dax@bnl.gov	Lin, Wei/M-6202-2013	Fu, Dax/0000-0002-2663-1316; chai, jin/0000-0002-4760-5811	National Institutes of Health [R01 GM065137, 5U54GM075026]; Office of Basic Energy Sciences, United States Department of Energy [DOE KC0304000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065137 (to D. F.) and by the Office of Basic Energy Sciences, United States Department of Energy, Grant DOE KC0304000 (to D. F.).; We thank Bill Studier for comments, Marco Punta for bioinformatics support, Renato Bruni for cloning and expression of ZIPB homologs, and Babak Andi for proofreading of the manuscript. NYCOMPS is supported by the National Institutes of Health (Grant 5U54GM075026 to W. Hendrickson). Brookhaven National Laboratory (BNL) is managed by Brookhaven Science Associates for the United States Department of Energy.	APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Elias CL, 2001, AM J PHYSIOL-CELL PH, V281, pC993, DOI 10.1152/ajpcell.2001.281.3.C993; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Hille B, 2001, ION CHANNELS EXCITAB, V3rd, P445; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; King J. C., 2005, NUTR HLTH, P271; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Mancia F, 2010, J STRUCT BIOL, V172, P85, DOI 10.1016/j.jsb.2010.03.021; NEGULESCU PA, 1990, METHOD ENZYMOL, V192, P38; Nies DH, 2007, SCIENCE, V317, P1695, DOI 10.1126/science.1149048; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; PRESSMAN BC, 1967, P NATL ACAD SCI USA, V58, P1949, DOI 10.1073/pnas.58.5.1949; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Schmitt BM, 2005, J BIOL CHEM, V280, P24481, DOI 10.1074/jbc.M414550200; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	45	77	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39013	39020		10.1074/jbc.M110.180620	http://dx.doi.org/10.1074/jbc.M110.180620			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876577	Green Published, hybrid			2022-12-25	WOS:000284941300031
J	Brailoiu, GC; Gurzu, B; Gao, X; Parkesh, R; Aley, PK; Trifa, DI; Galione, A; Dun, NJ; Madesh, M; Patel, S; Churchill, GC; Brailoiu, E				Brailoiu, G. Cristina; Gurzu, Bogdan; Gao, Xin; Parkesh, Raman; Aley, Parvinder K.; Trifa, Diana I.; Galione, Antony; Dun, Nae J.; Madesh, Muniswamy; Patel, Sandip; Churchill, Grant C.; Brailoiu, Eugen			Acidic NAADP-sensitive Calcium Stores in the Endothelium AGONIST-SPECIFIC RECRUITMENT AND ROLE IN REGULATING BLOOD PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; MOBILIZES CALCIUM; PANCREATIC ACINAR; ANGIOTENSIN-II; SMOOTH-MUSCLE; CA2+ SIGNALS; NITRIC-OXIDE; RECEPTORS; RELEASE; CELLS	Accumulating evidence implicates nicotinic acid adenine dinucleotide phosphate (NAADP) in the control of Ca2+-dependent functions. Little, however, is known concerning its role in the vascular endothelium, a major regulator of blood pressure. Here, we show that NAADP acetoxymethyl ester (NAADP-AM), a cell-permeant NAADP analog, increases cytosolic Ca2+ concentration in aortic endothelial cells. We demonstrate that these signals and those evoked by acetylcholine are blocked by disrupting acidic organelles with bafilomycin A1. In contrast, Ca2+ signals in response to thrombin are only partially inhibited by bafilomycin A1 treatment, and those to ATP were insensitive, suggesting that recruitment of acidic stores is agonist-specific. We further show that NAADP-evoked Ca2+ signals hyperpolarize endothelial cells and generate NO. Additionally, we demonstrate that NAADP dilates aortic rings in an endothelium- and NO-dependent manner. Finally, we show that intravenous administration of NAADP-AM into anesthetized rats decreases mean arterial pressure. Our data extend the actions of NAADP to the endothelium both in vitro and in vivo, pointing to a previously unrecognized role for this messenger in controlling blood pressure.	[Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, G. Cristina; Gurzu, Bogdan; Gao, Xin; Dun, Nae J.; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Parkesh, Raman; Aley, Parvinder K.; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Trifa, Diana I.] Coney Isl Hosp, Dept Internal Med, Brooklyn, NY 11235 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oxford	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; grant.churchill@pharm.ox.ac.uk; ebrailou@temple.edu	Galione, Antony/E-5884-2011; Patel, Sandip/O-9591-2015	Aley, Parvinder/0000-0002-0749-8329; Galione, Antony/0000-0002-4132-7646; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [HL90804, HL51314, HL086699]; Biotechnology and Biological Sciences Research Council [BB/D012694/1, BB/G013721/1]; BBSRC [BB/G013721/1, BB/G008523/1, BB/D012694/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804, R01HL086699, R01HL051314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL90804 (to E. B.), HL51314 (to N. J. D.), and HL086699 (to M. M.). This work was also supported by the Biotechnology and Biological Sciences Research Council Grants BB/D012694/1 (to G. C. C.) and BB/G013721/1 (to S. P.).	Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E, 1999, BRIT J PHARMACOL, V126, P1133, DOI 10.1038/sj.bjp.0702421; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2008, NEUROSCIENCE, V151, P701, DOI 10.1016/j.neuroscience.2007.11.031; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Leikert JF, 2001, FEBS LETT, V506, P131, DOI 10.1016/S0014-5793(01)02901-5; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	38	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37133	37137		10.1074/jbc.C110.169763	http://dx.doi.org/10.1074/jbc.C110.169763			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876534	hybrid, Green Published			2022-12-25	WOS:000284424000006
J	Carra, S; Boncoraglio, A; Kanon, B; Brunsting, JF; Minoia, M; Rana, A; Vos, MJ; Seidel, K; Sibon, OCM; Kampinga, HH				Carra, Serena; Boncoraglio, Alessandra; Kanon, Bart; Brunsting, Jeanette F.; Minoia, Melania; Rana, Anil; Vos, Michel J.; Seidel, Kay; Sibon, Ody C. M.; Kampinga, Harm H.			Identification of the Drosophila Ortholog of HSPB8 IMPLICATION OF HSPB8 LOSS OF FUNCTION IN PROTEIN FOLDING DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; HEAT-SHOCK-PROTEIN; NEURODEGENERATIVE DISEASE; CHAPERONE ACTIVITY; MISSENSE MUTATION; OXIDATIVE STRESS; MOTOR NEUROPATHY; GENE-EXPRESSION; MELANOGASTER; AUTOPHAGY	Protein aggregation is a hallmark of many neuronal disorders, including the polyglutamine disorder spinocerebellar ataxia 3 and peripheral neuropathies associated with the K141E and K141N mutations in the small heat shock protein HSPB8. In cells, HSPB8 cooperates with BAG3 to stimulate autophagy in an eIF2 alpha-dependent manner and facilitates the clearance of aggregate-prone proteins (Carra, S., Seguin, S. J., Lambert, H., and Landry, J. (2008) J. Biol. Chem. 283, 1437-1444; Carra, S., Brunsting, J. F., Lambert, H., Landry, J., and Kampinga, H. H. (2009) J. Biol. Chem. 284, 5523-5532). Here, we first identified Drosophila melanogaster HSP67Bc (Dm-HSP67Bc) as the closest functional ortholog of human HSPB8 and demonstrated that, like human HSPB8, Dm-HSP67Bc induces autophagy via the eIF2 alpha pathway. In vitro, both Dm-HSP67Bc and human HSPB8 protected against mutated ataxin-3-mediated toxicity and decreased the aggregation of a mutated form of HSPB1 (P182L-HSPB1) associated with peripheral neuropathy. Upregulation of both Dm-HSP67Bc and human HSPB8 protected and down-regulation of endogenous Dm-HSP67Bc significantly worsened SCA3-mediated eye degeneration in flies. The K141E and K141N mutated forms of human HSPB8 that are associated with peripheral neuropathy were significantly less efficient than wild-type HSPB8 in decreasing the aggregation of both mutated ataxin 3 and P182L-HSPB1. Our current data further support the link between the HSPB8-BAG3 complex, autophagy, and folding diseases and demonstrate that impairment or loss of function of HSPB8 might accelerate the progression and/or severity of folding diseases.	[Carra, Serena; Boncoraglio, Alessandra; Kanon, Bart; Brunsting, Jeanette F.; Minoia, Melania; Rana, Anil; Vos, Michel J.; Sibon, Ody C. M.; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, NL-9713 AV Groningen, Netherlands; [Seidel, Kay] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 RB Groningen, Netherlands	University of Groningen; University of Groningen	Carra, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	s.carra@med.umcg.nl	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Sibon, Ody/0000-0002-6836-6063; Kampinga, Harm/0000-0002-8966-8466; Vos, Michel/0000-0001-9379-2219	National Ataxia Foundation; Marie Curie International Reintegration; Prinses Beatrix Foundation/Dutch Huntington Association [WAR09-23]; Netherlands Organisation for Scientific Research NWO [917-36-400]; NWO [911-06-001]; Senter (IOP Genomics) [IGE03018]; Prinses Beatrix Foundation [WAR05-0129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R56AI079705, R01AI079705, T32AI060573, R01AI045011] Funding Source: NIH RePORTER	National Ataxia Foundation; Marie Curie International Reintegration(European Commission); Prinses Beatrix Foundation/Dutch Huntington Association; Netherlands Organisation for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Senter (IOP Genomics); Prinses Beatrix Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Ataxia Foundation Young Investigator Award, by the Marie Curie International Reintegration and the Prinses Beatrix Foundation/Dutch Huntington Association WAR09-23 (to S. C.), by a VIDI grant from the Netherlands Organisation for Scientific Research NWO (917-36-400), by NWO Middelgroot Grant 911-06-001 (to O. C. M. S.), by Senter (IOP Genomics Grant IGE03018), and by the Prinses Beatrix Foundation WAR05-0129 (to H. H. K.).	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fortun J, 2006, NEUROBIOL DIS, V22, P153, DOI 10.1016/j.nbd.2005.10.010; Fortun J, 2003, J NEUROSCI, V23, P10672; Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Irobi J, 2006, NEUROMOL MED, V8, P131, DOI 10.1385/NMM:8:1:131; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Marin R, 1996, CHROMOSOMA, V105, P142, DOI 10.1007/s004120050169; Michaud S, 1997, J CELL SCI, V110, P1989; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow G, 2003, SEMIN CELL DEV BIOL, V14, P291, DOI 10.1016/j.semcdb.2003.09.023; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Sharma MC, 2005, NEUROL INDIA, V53, P273; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vos M. J., 2010, HUM MOL GEN IN PRESS; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	63	65	67	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37811	37822		10.1074/jbc.M110.127498	http://dx.doi.org/10.1074/jbc.M110.127498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858900	Green Published, hybrid			2022-12-25	WOS:000284424000072
J	Lee, GE; Kim, JH; Taylor, M; Muller, MT				Lee, Gun E.; Kim, Joo Hee; Taylor, Michael; Muller, Mark T.			DNA Methyltransferase 1-associated Protein (DMAP1) Is a Co-repressor That Stimulates DNA Methylation Globally and Locally at Sites of Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC REGULATION; X-CHROMOSOME; SRA DOMAIN; DE-NOVO; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; CELLS; DNMT1; REPLICATION; INSTABILITY	Correction of double strand DNA breaks proceeds in an error-free pathway of homologous recombination (HR), which can result in gene silencing of half of the DNA molecules caused by action by DNA methyltransferase 1 (DNMT1) (Cuozzo, C., Porcellini, A., Angrisano, T., Morano, A., Lee, B., Di Pardo, A., Messina, S., Iuliano, R., Fusco, A., Santillo, M. R., Muller, M. T., Chiariotti, L., Gottesman, M. E., and Avvedimento, E. V. (2007) PLoS Genet. 3, e110). To explore the mechanism that leads to HR-induced silencing, a genetic screen was carried out based on the silencing of a GFP reporter to identify potential partners. DMAP1, a DNMT1 interacting protein, was identified as a mediator of this process. DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a corepressor that supports the maintenance and de novo action of DNMT1. To examine critical roles for DMAP1 in vivo, lentiviral shRNA was used to conditionally reduce cellular DMAP1 levels. The shRNA transduced cells grew poorly and eventually ceased their growth. Analysis of the tumor suppressor gene p16 methylation status revealed a clear reduction in methylated CpGs in the shRNA cells, suggesting that reactivation of a tumor suppressor gene pathway caused the slow growth phenotype. Analysis of HR, using a fluorescence-based reporter, revealed that knocking down DMAP1 also caused hypomethylation of the DNA repair products following gene conversion. DMAP1 was selectively enriched in recombinant GFP chromatin based on chromatin immunoprecipitation analysis. The picture that emerges is that DMAP1 activates DNMT1 preferentially at sites of HR repair. Because DMAP1 depleted cells display enhanced HR, we conclude that it has additional roles in genomic stability.	[Lee, Gun E.; Kim, Joo Hee; Taylor, Michael; Muller, Mark T.] Univ Cent Florida, Dept Mol Biol & Microbiol, Coll Med, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Muller, MT (corresponding author), 12722 Res Pkwy, Orlando, FL 32826 USA.	mtmuller@mail.ucf.edu			National Institutes of Health [CA098214, CA127416]; NATIONAL CANCER INSTITUTE [R21CA127416, R01CA098214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098214 and CA127416 (to M. T. M.).	Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bender CM, 1998, CANCER RES, V58, P95; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Haruki M, 1997, J BIOL CHEM, V272, P22015, DOI 10.1074/jbc.272.35.22015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Luo W, 2010, CANCER RES, V70, P5953, DOI 10.1158/0008-5472.CAN-10-0617; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Negishi M, 2009, GENES CELLS, V14, P1347, DOI 10.1111/j.1365-2443.2009.01352.x; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Palii SS, 2007, CRIT REV EUKAR GENE, V17, P295; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Renodon-Corniere A, 2002, BIOCHEMISTRY-US, V41, P13395, DOI 10.1021/bi0263614; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970	43	51	53	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37630	37640		10.1074/jbc.M110.148536	http://dx.doi.org/10.1074/jbc.M110.148536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864525	Green Published, hybrid			2022-12-25	WOS:000284424000055
J	Tiffin, N; Meintjes, A; Ramesar, R; Bajic, VB; Rayner, B				Tiffin, Nicki; Meintjes, Ayton; Ramesar, Rajkumar; Bajic, Vladimir B.; Rayner, Brian			Computational Analysis of Candidate Disease Genes and Variants for Salt-Sensitive Hypertension in Indigenous Southern Africans	PLOS ONE			English	Article							BLOOD-PRESSURE; PARATHYROID-HORMONE; SIGNALING SYSTEMS; URINARY CALCIUM; SODIUM; ANGIOTENSIN; ALDOSTERONE; RECEPTOR; DATABASE; INSULIN	Multiple factors underlie susceptibility to essential hypertension, including a significant genetic and ethnic component, and environmental effects. Blood pressure response of hypertensive individuals to salt is heterogeneous, but salt sensitivity appears more prevalent in people of indigenous African origin. The underlying genetics of salt-sensitive hypertension, however, are poorly understood. In this study, computational methods including text-and data-mining have been used to select and prioritize candidate aetiological genes for salt-sensitive hypertension. Additionally, we have compared allele frequencies and copy number variation for single nucleotide polymorphisms in candidate genes between indigenous Southern African and Caucasian populations, with the aim of identifying candidate genes with significant variability between the population groups: identifying genetic variability between population groups can exploit ethnic differences in disease prevalence to aid with prioritisation of good candidate genes. Our top-ranking candidate genes include parathyroid hormone precursor (PTH) and type-1angiotensin II receptor (AGTR1). We propose that the candidate genes identified in this study warrant further investigation as potential aetiological genes for salt-sensitive hypertension.	[Tiffin, Nicki; Rayner, Brian] Univ Cape Town, Groote Schuur Hosp, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa; [Ramesar, Rajkumar] Univ Cape Town, Inst Infect Dis & Mol Med, Div Human Genet, Med Res Council MRC Res Unit Human Genet, ZA-7925 Cape Town, South Africa; [Bajic, Vladimir B.] KAUST, CBRC, Thuwal, Saudi Arabia	University of Cape Town; University of Cape Town; King Abdullah University of Science & Technology	Tiffin, N (corresponding author), Univ Cape Town, Groote Schuur Hosp, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa.	nickitiffin@imaginet.co.za	Tiffin, Nicki/ABA-9391-2020; Ramesar, Raj S/I-6941-2015; Tiffin, Nicki/A-5914-2013; Rayner, Brian/AAA-3174-2021; Bajic, Vladimir/D-2810-2009	Tiffin, Nicki/0000-0001-5083-2735; Ramesar, Raj S/0000-0001-5688-1634; Rayner, Brian/0000-0002-0167-9591; Bajic, Vladimir/0000-0001-5435-4750	National Research Foundation of South Africa; Medical Research Council of South Africa; Affymetrix (USA); Centre for Proteomic and Genomic Research at the University of Cape Town	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa(South African Medical Research Council); Affymetrix (USA); Centre for Proteomic and Genomic Research at the University of Cape Town	Funding for this study was provided by the National Research Foundation of South Africa (http://www.nrf.ac.za/) through the rated researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Medical Research Council of South Africa, Affymetrix (USA), and the Centre for Proteomic and Genomic Research (notably Dr Reinhard Hiller) at the University of Cape Town, are acknowledged for their support of the generation of the SNP6 data on the indigenous Southern African populations.	Aloia John F, 2006, Endocr Pract, V12, P137; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anan F, 2008, HYPERTENS RES, V31, P1913, DOI 10.1291/hypres.31.1913; Bajic VB, 2005, PLANT PHYSIOL, V138, P1914, DOI 10.1104/pp.105.060863; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; ERNE P, 1984, NEW ENGL J MED, V310, P1084, DOI 10.1056/NEJM198404263101705; Essack M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-219; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fliser D, 1997, NEPHROL DIAL TRANSPL, V12, P933, DOI 10.1093/ndt/12.5.933; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris SS, 2006, J NUTR, V136, P1126, DOI 10.1093/jn/136.4.1126; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; HULTER H N, 1986, Journal of Clinical Hypertension, V2, P360; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KURTZ TW, 1990, AM J HYPERTENS, V3, pS152, DOI 10.1093/ajh/3.8.152; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lombard Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-389; MACGREGOR GA, 1993, J HYPERTENS, V11, P781, DOI 10.1097/00004872-199308000-00003; MCCARRON DA, 1980, HYPERTENSION, V2, P162, DOI 10.1161/01.HYP.2.2.162; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Muscogiuri G, 2008, CURR VASC PHARMACOL, V6, P301, DOI 10.2174/157016108785909715; NYBY MD, 1995, ENDOCRINOLOGY, V136, P2497, DOI 10.1210/en.136.6.2497; Pan H, 2004, NUCLEIC ACIDS RES, V32, pW230, DOI 10.1093/nar/gkh484; Puddu P, 2007, ACTA CARDIOL, V62, P281, DOI 10.2143/AC.62.3.2020818; Rayner BL, 2003, J HYPERTENS, V21, P921, DOI 10.1097/00004872-200305000-00016; Rayner BL, 2001, S AFR MED J, V91, P594; RESNICK LM, 1994, J CLIN INVEST, V94, P1269, DOI 10.1172/JCI117445; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Rodriguez-Iturbe B, 2007, NEPHROL DIAL TRANSPL, V22, P992, DOI 10.1093/ndt/gfl757; Rothermund L, 2001, HYPERTENSION, V37, P275, DOI 10.1161/01.HYP.37.2.275; Sagar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-622; Seedat YK, 2009, CARDIOVASC J AFR, V20, P39; Shih PAB, 2008, HYPERTENSION, V51, P1456, DOI 10.1161/HYPERTENSIONAHA.107.090480; Strazzullo P, 2003, HYPERTENSION, V41, P1000, DOI 10.1161/01.HYP.0000066844.63035.3A; Strazzullo P, 2007, CURR HYPERTENS REP, V9, P25, DOI 10.1007/s11906-007-0006-6; SULLIVAN JM, 1988, AM J MED SCI, V295, P370, DOI 10.1097/00000441-198804000-00025; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Tiffin N, 2008, PHYSIOL GENOMICS, V35, P55, DOI 10.1152/physiolgenomics.90247.2008; VANHOOFT IMS, 1993, HYPERTENSION, V21, P267, DOI 10.1161/01.HYP.21.3.267; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Weder AB, 2009, HYPERTENSION, V53, P715, DOI 10.1161/HYPERTENSIONAHA.108.121665; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Yancy CW, 2008, CURR HYPERTENS REP, V10, P276, DOI 10.1007/s11906-008-0052-8; Zhang KX, 2010, J HYPERTENS, V28, P1115, DOI 10.1097/HJH.0b013e328337f6bc; Zhao XY, 2003, HYPERTENSION, V42, P775, DOI [10.1161/01.HYP.0000085649.28268.DF, 10.1161/01.HYP.000008549.28268.DF]; AFFYMETRIX POWER TOO	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12989	10.1371/journal.pone.0012989	http://dx.doi.org/10.1371/journal.pone.0012989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886000	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100005
J	Amico, P; Aran, C; Avila, C				Amico, Peter; Aran, Christian; Avila, Carlos			HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country Study	PLOS ONE			English	Article								Background: HIV has devastated numerous countries in sub-Saharan Africa and is a dominant health force in many other parts of the world. Its undeniable importance is reflected in the establishment of Millennium Development Goal No. 6. Unprecedented amounts of funding have been committed and disbursed over the past two decades. Many have argued that this enormous influx of funding has been detrimental to building stronger health systems in recipient countries. This paper examines the funding share for HIV measured against the total funding for health. Methodology/Principal Findings: A descriptive analysis of HIV and health expenditures in 2007 from 65 countries was conducted. Comparable data from individual countries was used by applying a consistent definition for HIV expenditures and total health expenditures from NHAs to align them with National AIDS Assessment Reports. In 2007, the total public and international expenditure in LMICs for HIV was 1.6 percent of the total spending on health, while the share in SSA was 19.4 percent. HIV prevalence was six-fold higher in SSA than the next highest region and it is the only region whose share of HIV spending exceeded the burden of HIV DALYs. Conclusions/Significance: The share of HIV spending across the 65 countries was quite moderate considering that the estimated share of deaths attributable to HIV stood at 3.8 percent and DALYs at 4.4 percent. Several high spending countries are using a large share of their total health spending for HIV health, but these countries are the exception rather than representative of the average SSA country. There is wide variation between regions, but the burden of disease also varies significantly. The percentage of HIV spending is a useful indicator for better understanding health care resources and their allocation patterns.	[Amico, Peter] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA; [Aran, Christian; Avila, Carlos] UNAIDS, AIDS Financing & Econ Div, Geneva, Switzerland	Brandeis University; UNAIDS	Amico, P (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.	avilac@unaids.org						ATUM R, 2008, DO VERTICAL STAND AL; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; BUSE K, 2006, SCAL UP HIV AIDS RES; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; DUGGER C, 2010, S AFRICA REDOUBLES E; Farag M, 2009, HEALTH AFFAIR, V28, P1045, DOI 10.1377/hlthaff.28.4.1045; *GLOB FUND, 2008, COUNTR REQ HIGH EV A; *HLTH SYST 20 20 P, 2009, LINK NASA NHA CONC M; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Marchal B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000059; MATHERS C, 2005, UPD PROJ GLOB MORT B; Ooms G, 2008, GLOBAL HLTH, V4; *PEPFAR, 2009, CEL LIF 5 ANN REP C; *PEPFAR, 2009, EX SUMM PEPFARS STRA; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Shiffman J, 2009, JAIDS-J ACQ IMM DEF, V52, pS45, DOI 10.1097/QAI.0b013e3181bbcb45; The Global Fund, 2008, GLOB FUND SUPP PROGR; UN, 2004, IMP AIDS; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2009, NAT AIDS SPEND ASS N; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, 2010, UNAIDS OUTL REP 2010; UNAIDS, 2006, REP GLOB AIDS EP; UNAIDS & World Bank, 2009, GLOB EC CRIS HIV PRE; United Nations Development Programme, 2005, HUM DEV REP; United Nations Development Programme, 2010, WHAT AR MILL DEV GOA; *WORLD BANK, 2007, WORLD BANK EMP TAIL; *WORLD BANK, 2008, DATASTATISTICS; World Bank WHO and The United States Agency for International Development, 2003, GUID PROD NAT HLTH A; World Health Organization, 2008, GLOB BURD DIS 2004 U	33	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12997	10.1371/journal.pone.0012997	http://dx.doi.org/10.1371/journal.pone.0012997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885986	gold, Green Published, Green Submitted			2022-12-25	WOS:000282122600021
J	Mittag, J; Behrends, T; Hoefig, CS; Vennstrom, B; Schomburg, L				Mittag, Jens; Behrends, Thomas; Hoefig, Carolin S.; Vennstrom, Bjorn; Schomburg, Lutz			Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice	PLOS ONE			English	Article							NONTHYROIDAL ILLNESS SYNDROME; ACUTE-PHASE RESPONSE; IODOTHYRONINE DEIODINASE; IMMUNE-RESPONSE; 5-DEIODINASE; METABOLISM; ACTIVATION; KIDNEY; BRAIN; RAT	Impaired expression of selenium-containing proteins leads to perturbed thyroid hormone (TH) levels, indicating the central importance of selenium for TH homeostasis. Moreover, critically ill patients with declining serum selenium develop a syndrome of low circulating TH and a central downregulation of the hypothalamus-pituitary-thyroid axis. This prompted us to test the reciprocal effect, i.e., if TH status would also regulate selenoprotein expression and selenium levels. To investigate the TH dependency of selenium metabolism, we analyzed mice expressing a mutant TH receptor alpha 1 (TR alpha 1+m) that confers a receptor-mediated hypothyroidism. Serum selenium was reduced in these animals, which was a direct consequence of the mutant TR alpha 1 and not related to their metabolic alterations. Accordingly, hyperthyroidism, genetically caused by the inactivation of TR beta or by oral TH treatment of adult mice, increased serum selenium levels in TR alpha 1+m and controls, thus demonstrating a novel and specific role for TR alpha 1 in selenium metabolism. Furthermore, TH affected the mRNA levels for several enzymes involved in selenoprotein biosynthesis as well as serum selenoprotein P concentrations and the expression of other antioxidative selenoproteins. Taken together, our results show that TH positively affects the serum selenium status and regulates the expression of several selenoproteins. This demonstrates that selenium and TH metabolism are interconnected through a feed-forward regulation, which can in part explain the rapid parallel downregulation of both systems in critical illness.	[Mittag, Jens; Vennstrom, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Behrends, Thomas; Hoefig, Carolin S.; Schomburg, Lutz] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mittag, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Bjorn.Vennstrom@ki.se; lutz.schomburg@charite.de	Schomburg, Lutz/D-8096-2013; Mittag, Jens/ABE-7875-2020; Mittag, Jens/A-1387-2009	Schomburg, Lutz/0000-0001-9445-1555; Mittag, Jens/0000-0001-7778-5158; Mittag, Jens/0000-0001-7778-5158	Deutsche Forschungsgemeinschaft [Mi1242/1-1, Scho849/2-2, GraKo1208]; Swedish Research Council; Swedish Cancer Society; Soderberg Stiftelse; KaroBio AB stiftelse; Karolinska Institutet Funds; Deutsche Krebshilfe [10-1792 SchoII]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Soderberg Stiftelse; KaroBio AB stiftelse; Karolinska Institutet Funds; Deutsche Krebshilfe(Deutsche Krebshilfe)	The authors received funding from Deutsche Forschungsgemeinschaft (Mi1242/1-1, Scho849/2-2, GraKo1208; www.dfg.de), the Swedish Research Council (BV; www.vr.se), the Swedish Cancer Society (BV; www.cancerfonden.se), the Soderberg Stiftelse (BV; www.soderbergsstiftelser.se), KaroBio AB stiftelse (BV, JM; www.karobio.se), Karolinska Institutet Funds (BV, JM; www.ki.se), and the Deutsche Krebshilfe (10-1792 SchoII; www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Angstwurm MWA, 2004, EUR J ENDOCRINOL, V151, P47, DOI 10.1530/eje.0.1510047; Arthur JR, 1999, NUTR RES REV, V12, P55, DOI 10.1079/095442299108728910; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Bellastella A, 1998, HORM RES, V49, P153, DOI 10.1159/000023163; Bello G, 2009, CURR DRUG TARGETS, V10, P778, DOI 10.2174/138945009788982414; Bernal J, 2005, VITAM HORM, V71, P95, DOI 10.1016/S0083-6729(05)71004-9; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Boelen A, 2008, THYROID, V18, P123, DOI 10.1089/thy.2007.0253; BURK RF, 2009, BIOCH BIOPHYS ACTA; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHANOINE JP, 1992, ENDOCRINOLOGY, V131, P479, DOI 10.1210/en.131.1.479; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Combs GF, 2009, AM J CLIN NUTR, V89, P1808, DOI 10.3945/ajcn.2008.27356; Farwell Alan P, 2008, Endocr Pract, V14, P1180; Fekete C, 2004, ENDOCRINOLOGY, V145, P1649, DOI 10.1210/en.2003-1439; Fliers E, 2006, PROG BRAIN RES, V153, P189, DOI 10.1016/S0079-6123(06)53011-0; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Gartner R, 2009, J TRACE ELEM MED BIO, V23, P71, DOI 10.1016/j.jtemb.2009.01.001; Geoghegan M, 2006, CURR OPIN CRIT CARE, V12, P136, DOI 10.1097/01.ccx.0000216581.80051.d6; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Golombek SG, 2008, SEMIN PERINATOL, V32, P413, DOI 10.1053/j.semperi.2008.09.010; Gromadzinska J, 2008, EUR J NUTR, V47, P29, DOI 10.1007/s00394-008-2005-z; Holzer R, 2004, PEDIATR CARDIOL, V25, P522, DOI 10.1007/s00246-004-0659-8; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Kohrle J, 2005, THYROID, V15, P841, DOI 10.1089/thy.2005.15.841; KOHRLE J, 1995, MOL CELL ENDOCRINOL, V108, P17, DOI 10.1016/0303-7207(95)92574-8; Liu YY, 2007, ENDOCRINOLOGY, V148, P1206, DOI 10.1210/en.2006-0836; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; OLSON GE, 2008, J BIOL CHEM; Peeters RP, 2007, ANN ENDOCRINOL-PARIS, V68, P224, DOI 10.1016/j.ando.2007.06.01; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 1999, GASTROENTEROLOGY, V116, P1367, DOI 10.1016/S0016-5085(99)70501-9; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Rayman MP, 2008, AM J CLIN NUTR, V87, P370, DOI 10.1093/ajcn/87.2.370; RAYMAN MP, 2009, BIOCH BIOPHYS ACTA; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SCHOMBURG L, 2009, SHOCK IN PRESS; SCHOMBURG L, 2009, BIOCH BIOPHYS ACTA, V25; Schomburg L, 2008, MOL NUTR FOOD RES, V52, P1235, DOI 10.1002/mnfr.200700465; Schomburg L, 2007, CRIT CARE MED, V35, P995, DOI 10.1097/01.CCM.0000257479.88792.A5; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Schweizer U, 2008, MOL CELL ENDOCRINOL, V289, P1, DOI 10.1016/j.mce.2008.04.007; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; STGERMAIN DL, 1988, J CLIN INVEST, V81, P1476, DOI 10.1172/JCI113479; Stoedter M, 2010, BIOCHEM J, V429, P43, DOI 10.1042/BJ20091868; Stosnach H, 2005, ANAL SCI, V21, P873, DOI 10.2116/analsci.21.873; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Thomson CD, 2005, BRIT J NUTR, V94, P962, DOI 10.1079/BJN20051564; Tinnikov A, 2002, EMBO J, V21, P5079, DOI 10.1093/emboj/cdf523; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vennstrom B, 2008, ACTA PAEDIATR, V97, P1605, DOI 10.1111/j.1651-2227.2008.01031.x; Vincent JL, 2008, CURR OPIN ANESTHESIO, V21, P148, DOI 10.1097/ACO.0b013e3282f49afe; Wallis K, 2008, J NEUROSCI, V28, P1904, DOI 10.1523/JNEUROSCI.5163-07.2008; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Wyne KL, 2005, CRIT CARE, V9, P333, DOI 10.1186/cc3738; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392	68	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12931	10.1371/journal.pone.0012931	http://dx.doi.org/10.1371/journal.pone.0012931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877559	Green Submitted, Green Published, gold			2022-12-25	WOS:000282053100035
J	Charles, N; Thomas, B; Watson, B; Sakthivel, RM; Chandrasekeran, V; Wares, F				Charles, Niruparani; Thomas, Beena; Watson, Basilea; Sakthivel, Raja M.; Chandrasekeran, V.; Wares, Fraser			Care Seeking Behavior of Chest Symptomatics: A Community Based Study Done in South India after the Implementation of the RNTCP	PLOS ONE			English	Article							SYSTEM DELAYS; TAMIL-NADU; TUBERCULOSIS; DIAGNOSIS; PATIENT	Introduction: With the creation of the Revised National TB Control Programme (RNTCP), tuberculosis services have become decentralized and more accessible. A 1997 study prior to RNTCP implementation reported that most chest symptomatics accessed first private health care facilities and a general dissatisfaction with government health facilities. The study was repeated post-RNTCP implementation to gain insight into the current care seeking behavior of chest symptomatics. Methodology: A cross-sectional community-based study carried out between March-August 2008 in 4 sites (2 rural [R] and 2 urban [U]) from the same two districts of Chennai and Madurai, southern India, as in the 1997 study. Six hundred and forty chest symptomatics were identified (R 314; U 326), and detailed interviews were done for 606 (R311; U295). Results: Prevalence of chest symptomatics in the urban and rural areas were 2.7% and 4.9% respectively (p < 0.01), and was found to increase with age (Chi-square for trend, p < 0.01). Longer delays in seeking care were seen amongst symptomatics above 45 years of age (p 0.01), and those who had taken previous TB treatment (p = 0.05). Overall, 50% (222/444) of the chest symptomatics approached a government health care facility first (R 142 (61%); U 80 (38%), p = < 0.001). This was significantly (p < 0.001) more than were observed in the 1997 study, where only 38.4% approached a government facility first. Sixty two (28%) of the 222 made a second visit to a government facility (R26%; U31%), while 17% shifted to a private facility (R14%; U21%). Dissatisfaction with the health care facility was one of the major reasons expressed. Conclusions: It appears that the RNTCP has had an impact in the community with regard to the availability and accessibility of TB services in government health facilities. However the relatively high levels of subsequent shifting to private health facilities calls for urgent action to make government facilities more patients friendly with quality care facilities in the delivery of RNTCP services.	[Charles, Niruparani; Thomas, Beena; Watson, Basilea; Sakthivel, Raja M.; Chandrasekeran, V.] Indian Council Med Res, TB Res Ctr, Madras, Tamil Nadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Charles, N (corresponding author), Indian Council Med Res, TB Res Ctr, Madras, Tamil Nadu, India.	niru_charles@hotmail.com	Watson, Basilea/AGH-6965-2022		World Health Organization (WHO); United States Agency for International Development (USAID); Medical and Rural Health Services; District TB Officers of Chennai and Madurai Corporation	World Health Organization (WHO)(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Medical and Rural Health Services; District TB Officers of Chennai and Madurai Corporation	The study was supported in part by the World Health Organization (WHO), with financial assistance provided by the United States Agency for International Development (USAID) under the Model DOTS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Additional Director of Medical and Rural Health Services, and the District TB Officers of Chennai and Madurai Corporation for providing the necessary support for the successful conduct of the study. We especially thank all the respondents and their family members without whose co-operation this study would not have been possible.	Ahsan Giasuddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P126; *GOV IND MIN HLTH, TB IND 2006 RNTCP ST; Grover A, 2006, INDIAN J COMMUNITY M, V31, P145; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; UPLEKAR MW, 1996, TACKLING TB SEARCH S	8	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12379	10.1371/journal.pone.0012379	http://dx.doi.org/10.1371/journal.pone.0012379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862219	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000281963200001
J	Bakszt, R; Wernimont, A; Allali-Hassani, A; Mok, MW; Hills, T; Hui, R; Pizarro, JC				Bakszt, Rebecca; Wernimont, Amy; Allali-Hassani, Abdellah; Mok, Man Wai; Hills, Tanya; Hui, Raymond; Pizarro, Juan C.			The Crystal Structure of Toxoplasma gondii Pyruvate Kinase 1	PLOS ONE			English	Article							ALLOSTERIC REGULATION; CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; MOLECULAR-BASIS; RABBIT MUSCLE; M2; EXPRESSION; RESOLUTION; PROTEINS; BINDING	Background: Pyruvate kinase (PK), which catalyzes the final step in glycolysis converting phosphoenolpyruvate to pyruvate, is a central metabolic regulator in most organisms. Consequently PK represents an attractive therapeutic target in cancer and human pathogens, like Apicomplexans. The phylum Aplicomplexa, a group of exclusively parasitic organisms, includes the genera Plasmodium, Cryptosporidium and Toxoplasma, the etiological agents of malaria, cryptosporidiosis and toxoplasmosis respectively. Toxoplasma gondii infection causes a mild illness and is a very common infection affecting nearly one third of the world's population. Methodology/Principal Findings: We have determined the crystal structure of the PK1 enzyme from T. gondii, with the B domain in the open and closed conformations. We have also characterized its enzymatic activity and confirmed glucose-6-phosphate as its allosteric activator. This is the first description of a PK enzyme in a closed inactive conformation without any bound substrate. Comparison of the two tetrameric TgPK1 structures indicates a reorientation of the monomers with a concomitant change in the buried surface among adjacent monomers. The change in the buried surface was associated with significant B domain movements in one of the interacting monomers. Conclusions: We hypothesize that a loop in the interface between the A and B domains plays an important role linking the position of the B domain to the buried surface among monomers through two a-helices. The proposed model links the catalytic cycle of the enzyme with its domain movements and highlights the contribution of the interface between adjacent subunits. In addition, an unusual ordered conformation was observed in one of the allosteric binding domains and it is related to a specific apicomplexan insertion. The sequence and structural particularity would explain the atypical activation by a mono-phosphorylated sugar. The sum of peculiarities raises this enzyme as an emerging target for drug discovery.	[Bakszt, Rebecca; Wernimont, Amy; Allali-Hassani, Abdellah; Mok, Man Wai; Hills, Tanya; Hui, Raymond; Pizarro, Juan C.] Univ Toronto, SGC, Toronto, ON, Canada; [Bakszt, Rebecca] Linkoping Univ, Dept Phys & Measurement Technol, Biol & Chem IFM, Linkoping, Sweden	University of Toronto; Linkoping University	Bakszt, R (corresponding author), Univ Toronto, SGC, Toronto, ON, Canada.	juan.pizarro@utoronto.ca			Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co. Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co. Inc.(Merck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium (SGC) is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co. Inc., the Novartis Research Foundation, the Petrus and Augusta Hedlund's Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SC, 1996, ACTA CRYSTALLOGR D, V52, P499, DOI 10.1107/S0907444995016040; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CJ, 2000, BIOCHEMISTRY-US, V39, P15333, DOI 10.1021/bi001443i; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denton H, 1996, MOL BIOCHEM PARASIT, V76, P23, DOI 10.1016/0166-6851(95)02527-8; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Friesen RHE, 1998, BIOCHEMISTRY-US, V37, P2949, DOI 10.1021/bi971990c; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAHN A, 1982, METHOD ENZYMOL, V90, P131; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Larsen TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P199, DOI 10.1006/abbi.1997.0257; LEBRAS G, 1993, BIOCHIMIE, V75, P797, DOI 10.1016/0300-9084(93)90130-K; Lee JC, 2008, ACTA BIOCH BIOPH SIN, V40, P663, DOI 10.1111/j.1745-7270.2008.00445.x; LEVINE M, 1978, NATURE, V271, P626, DOI 10.1038/271626a0; Maeda T, 2003, PARASITOL RES, V89, P259, DOI 10.1007/s00436-002-0739-8; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; Suzuki K, 2008, J BIOCHEM, V144, P305, DOI 10.1093/jb/mvn069; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x	41	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12736	10.1371/journal.pone.0012736	http://dx.doi.org/10.1371/journal.pone.0012736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856875	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815700020
J	Rosen, S; Larson, B; Brennan, A; Long, L; Fox, M; Mongwenyana, C; Ketlhapile, M; Sanne, I				Rosen, Sydney; Larson, Bruce; Brennan, Alana; Long, Lawrence; Fox, Matthew; Mongwenyana, Constance; Ketlhapile, Mpefe; Sanne, Ian			Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment	PLOS ONE			English	Article							QUALITY-OF-LIFE; TREATMENT PROGRAM; COUNTRIES; ADULTS; HIV	Background: Although the medical outcomes of antiretroviral therapy (ART) for HIV/AIDS are well described, less is known about how ART affects patients' economic activities and quality of life, especially after the first year on ART. We assessed symptom prevalence, general health, ability to perform normal activities, and employment status among adult antiretroviral therapy patients in South Africa over three full years following ART initiation. Methodology/Principal Findings: A cohort of 855 adult pre-ART patients and patients on ART for <6 months was enrolled and interviewed an average of 4.4 times each during routine clinic visits for up to three years after treatment initiation using an instrument designed for the study. The probability of pain in the previous week fell from 74% before ART initiation to 32% after three years on ART, fatigue from 66% to 12%, nausea from 28% to 4%, and skin problems from 55% to 10%. The probability of not feeling well physically yesterday fell from 46% to 23%. Before starting ART, 39% of subjects reported not being able to perform their normal activities sometime during the previous week; after three years, this proportion fell to 10%. Employment rose from 27% to 42% of the cohort. Improvement in all outcomes was sustained over 3 years and for some outcomes increased in the second and third year. Conclusions/Significance: Improvements in adult ART patients' symptom prevalence, general health, ability to perform normal activities, and employment status were large and were sustained through the first three years on treatment. These results suggest that some of the positive economic and social externalities anticipated as a result of large-scale treatment provision, such as increases in workforce participation and productivity and the ability of patients to carry on normal lives, may indeed be accruing.	[Rosen, Sydney; Larson, Bruce; Brennan, Alana; Fox, Matthew] Boston Univ Ctr Global Hlth & Dev, Boston, MA USA; [Rosen, Sydney; Brennan, Alana; Long, Lawrence; Fox, Matthew; Mongwenyana, Constance; Ketlhapile, Mpefe; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa	Boston University; University of Witwatersrand; University of Witwatersrand	Rosen, S (corresponding author), Boston Univ Ctr Global Hlth & Dev, Boston, MA USA.	sbrosen@bu.edu	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019	Brennan, Alana/0000-0002-7746-0668; Rosen, Sydney/0000-0002-6560-2964; Larson, Bruce/0000-0002-9322-2387; Long, Lawrence/0000-0003-4986-4988	U.S. Agency for International Development GHSA-00-00020-00; NATIONAL CANCER INSTITUTE [R01CA122930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065661, P30NS057098] Funding Source: NIH RePORTER	U.S. Agency for International Development GHSA-00-00020-00(United States Agency for International Development (USAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by the South Africa Mission of the U.S. Agency for International Development through Cooperative Agreement GHSA-00-00020-00, Country Research Activity (G/PHN/HN/CS) to Boston University, Associate Cooperative Agreement 674-A-00-09-00018-00 to Boston University, Cooperative Agreement 674-A-00-02-00018 to Right to Care, and by the US National Institutes of Health through National Institute of Allergies and Infectious Diseases Grant PEPFAR 13 to the Wits Health Consortium. The authors thank Melinda Wilson and Clint Cavanaugh of USAID/South Africa for their unwavering support for this study. The authors wish to acknowledge support by the APDA Advanced Center for Parkinson Research at UAB, NIH F30NS065661, NIH R01CA122930, and by NIH Neuroscience Blueprint Core Grant NS057098 to the University of Alabama at Birmingham. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Fox was supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases. The content does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; BOCK N, 2008, 15 C RETR OPP INF BO; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fox MP, 2010, AIDS CARE, V22, P137, DOI 10.1080/09540120903038366; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Rosen S, 2008, AIDS, V22, pS131, DOI 10.1097/01.aids.0000327634.92844.91; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Rosen Sydney, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P200, DOI 10.1177/1545109708320684; Stangl AL, 2007, AIDS CARE, V19, P626, DOI 10.1080/09540120701203915; *STAT S AFR, 2009, LAB MARK DYN S AFR; Statistics South Africa, 2010, Q LAB FORC SURV QUAR, V3; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO INT CLASS FUNCT	18	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12731	10.1371/journal.pone.0012731	http://dx.doi.org/10.1371/journal.pone.0012731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZO	20856821	Green Published, gold			2022-12-25	WOS:000281815700017
J	Sun, XA; He, Y; Hou, L; Yang, WX				Sun, Xiao; He, Ying; Hou, Lin; Yang, Wan-Xi			Myosin Va Participates in Acrosomal Formation and Nuclear Morphogenesis during Spermatogenesis of Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ACTIN-FILAMENTS; AMPA RECEPTORS; MESSENGER-RNA; KINESIN MOTOR; WILD-TYPE; TRANSPORT; PROTEIN; VESICLES	Background: The Chinese mitten crab Eriocheir sinensis belongs to the Class Crustacea, Decapoda, Brachyura. The spermatozoon of this species is of aflagellated type, it has a spherical acrosome surrounded by the cup-shaped nucleus, which are unique to brachyurans. For the past several decades, studies on the spermatogenesis of the mitten crab mainly focus on the morphology. Compared with the extensive study of molecular mechanism of spermatogenesis in mammals, relatively less information is available in crustacean species. Myosin Va, a member of Class V myosin, has been implicated in acrosome biogenesis and vesicle transport during spermatogenesis in mammals. In the present study we demonstrate the expression and cellular localization of myosin Va during spermatogenesis in E. sinensis. Methodology/Principal Findings: Western blot demonstrated that myosin Va is expressed during spermatogenesis. Immunocytochemical and ultrastructural analyses showed that myosin Va mainly localizes in the cytoplasm in spermatocytes. At the early stage of spermiogenesis, myosin Va binds to the endoplasmic reticulum vesicle (EV) and proacrosomal granule (PG). Subsequently, myosin Va localizes within the proacrosomal vesicle (PV) formed by PG and EV fusion and locates in the membrane complex (MC) at the mid spermatid stage. At the late spermatid stage, myosin Va is associated with the shaping nucleus and mitochondria. In mature spermatozoon, myosin Va predominates in acrosomal tubule (AT) and nucleus. Conclusions/Significance: Our study demonstrates that myosin Va may be involved in acrosome biogenesis and nuclear morphogenesis during spermatogenesis in E. sinensis. Considering the distribution and molecular characteristics of myosin Va, we also propose a hypothesis of AT formation in this species. It is the first time to uncover the role of myosin Va in crustacean spermatogenesis.	[Sun, Xiao; He, Ying; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China; [He, Ying; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China	Zhejiang University; Liaoning Normal University	Sun, XA (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [40776079, 31072198]; National Basic Research Program of China (973 Program) [2007CB948104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported in part by the following projects: National Natural Science Foundation of China (http://www.nsfc.gov.cn)(No. 40776079 and 31072198) and National Basic Research Program of China (973 Program) (Grant No 2007CB948104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Bittins CM, 2009, CELL MOL NEUROBIOL, V29, P597, DOI 10.1007/s10571-009-9352-z; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Du NS, 1998, FISHERIES SCI TECHNO, V25, P9; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Espindola FS, 2008, CELL TISSUE RES, V333, P263, DOI 10.1007/s00441-008-0630-8; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Kurtz K, 2008, J CELL BIOCHEM, V105, P574, DOI 10.1002/jcb.21857; LI Z, 2010, INVERTEBR R IN PRESS; Mermall V, 2005, DEV BIOL, V286, P238, DOI 10.1016/j.ydbio.2005.07.028; Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Perlson E, 2008, CELL, V135, P414, DOI 10.1016/j.cell.2008.10.013; Pranchevicius MCS, 2008, CELL MOTIL CYTOSKEL, V65, P441, DOI 10.1002/cm.20269; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Simeo CG, 2010, J MORPHOL, V271, P394, DOI 10.1002/jmor.10805; Sotelo-Silveira JR, 2004, J NEUROBIOL, V60, P187, DOI 10.1002/neu.20015; Stafford P, 2000, BIOL BULL-US, V199, P203, DOI 10.2307/1542899; Tabb JS, 1998, J CELL SCI, V111, P3221; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wollert T, 2002, J CELL BIOL, V159, P571, DOI 10.1083/jcb.200204065; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Yang Wan-Xi, 1998, Acta Zoologica Sinica, V44, P377; Yang Wan-Xi, 1999, Acta Zoologica Sinica, V45, P178; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12738	10.1371/journal.pone.0012738	http://dx.doi.org/10.1371/journal.pone.0012738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856877	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815700021
J	Sughra, K; Birbach, A; de Martin, R; Schmid, JA				Sughra, Kalsoom; Birbach, Andreas; de Martin, Rainer; Schmid, Johannes A.			Interaction of the TNFR-Receptor Associated Factor TRAF1 with I-Kappa B Kinase-2 and TRAF2 Indicates a Regulatory Function for NF-Kappa B Signaling	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; FACTOR (TRAF)-1; ACTIVATION; PROTEIN; BETA; IKK; MOLECULES; PATHWAYS; COMPLEX; FAMILY	Background: I-kappa B kinase 2 (IKK2 or IKK-beta) is one of the most crucial signaling kinases for activation of NF-kappa B, a transcription factor that is important for inflammation, cell survival and differentiation. Since many NF-kappa B activating pathways converge at the level of IKK2, molecular interactions of this kinase are pivotal for regulation of NF-kappa B signaling. Methodology/Principal Findings: We searched for proteins interacting with IKK2 using the C-terminal part (amino acids 466-756) as bait in a yeast two-hybrid system and identified the N-terminal part (amino acids 1-228) of the TNF-receptor associated factor TRAF1 as putative interaction partner. The interaction was confirmed in human cells by mammalian two-hybrid and coimmunoprecipitation experiments. The IKK2/TRAF1 interaction seemed weaker than the interaction between TRAF1 and TRAF2, an important activating adapter molecule of NF-kappa B signaling. Reporter gene and kinase assays using ectopic expression of TRAF1 indicated that it can both activate and inhibit IKK2 and NF-kappa B. Co-expression of fluorescently tagged TRAF1 and TRAF2 at different ratios implied that TRAF1 can affect clustering and presumably the activating function of TRAF2 in a dose dependent manner. Conclusions/Significance: The observation that TRAF1 can either activate or inhibit the NF-kappa B pathway and the fact that it influences the oligomerization of TRAF2 indicates that relative levels of IKK2, TRAF1 and TRAF2 may be important for regulation of NF-kappa B activity. Since TRAF1 is an NF-kappa B induced gene, it might act as a feedback effector molecule.	[Sughra, Kalsoom; Birbach, Andreas; de Martin, Rainer; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Sughra, K (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	Johannes.Schmid@meduniwien.ac.at	Schmid, Johannes A./C-7659-2009	Schmid, Johannes A./0000-0002-6586-3507	Medical University Vienna; Competence Center Bio-Molecular Therapeutics; Austrian Science Foundation (FWF) [P19217-B13, P21919]; Austrian Science Fund (FWF) [P 21919] Funding Source: researchfish	Medical University Vienna; Competence Center Bio-Molecular Therapeutics; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Medical University Vienna and the Competence Center Bio-Molecular Therapeutics and in part by the Austrian Science Foundation (FWF, Project P19217-B13 to R. dM. and FWF, Project P21919 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; DEVIN A, 2001, ALPHA BETA SUBUNITS, P3986; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Henkler F, 2003, J BIOL CHEM, V278, P29216, DOI 10.1074/jbc.M211090200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1999, MOL CELL BIOL, V19, P4547	22	21	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12683	10.1371/journal.pone.0012683	http://dx.doi.org/10.1371/journal.pone.0012683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856938	gold, Green Submitted, Green Published			2022-12-25	WOS:000281735700010
J	Sjoholm, LK; Backlund, L; Cheteh, EH; Ek, IR; Frisen, L; Schalling, M; Osby, U; Lavebratt, C; Nikamo, P				Sjoholm, Louise K.; Backlund, Lena; Cheteh, Emarndeena Haji; Ek, Inger Romer; Frisen, Louise; Schalling, Martin; Osby, Urban; Lavebratt, Catharina; Nikamo, Pernilla			CRY2 Is Associated with Rapid Cycling in Bipolar Disorder Patients	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; SEASONAL AFFECTIVE-DISORDER; SINGLE-NUCLEOTIDE POLYMORPHISMS; NEUROTROPHIC FACTOR BDNF; CIRCADIAN GENES; MOOD DISORDERS; CANDIDATE GENES; CLOCK GENES; I-DISORDER; DEPRESSION	Background: Bipolar disorder patients often display abnormalities in circadian rhythm, and they are sensitive to irregular diurnal rhythms. CRY2 participates in the core clock that generates circadian rhythms. CRY2 mRNA expression in blood mononuclear cells was recently shown to display a marked diurnal variation and to respond to total sleep deprivation in healthy human volunteers. It was also shown that bipolar patients in a depressive state had lower CRY2 mRNA levels, nonresponsive to total sleep deprivation, compared to healthy controls, and that CRY2 gene variation was associated with winter depression in both Swedish and Finnish cohorts. Principal Findings: Four CRY2 SNPs spanning from intron 2 to downstream 3'UTR were analyzed for association to bipolar disorder type 1 (n = 497), bipolar disorder type 2 (n = 60) and bipolar disorder with the feature rapid cycling (n = 155) versus blood donors (n = 1044) in Sweden. Also, the rapid cycling cases were compared with bipolar disorder cases without rapid cycling (n = 422). The haplotype GGAC was underrepresented among rapid cycling cases versus controls and versus bipolar disorder cases without rapid cycling (OR = 0.7, P = 0.006-0.02), whereas overrepresentation among rapid cycling cases was seen for AAAC (OR = 1.3-1.4, P = 0.03-0.04) and AGGA (OR = 1.5, P = 0.05). The risk and protective CRY2 haplotypes and their effect sizes were similar to those recently suggested to be associated with winter depression in Swedes. Conclusions: We propose that the circadian gene CRY2 is associated with rapid cycling in bipolar disorder. This is the first time a clock gene is implicated in rapid cycling, and one of few findings showing a molecular discrimination between rapid cycling and other forms of bipolar disorder.	[Sjoholm, Louise K.; Cheteh, Emarndeena Haji; Frisen, Louise; Schalling, Martin; Osby, Urban; Lavebratt, Catharina; Nikamo, Pernilla] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Backlund, Lena; Ek, Inger Romer; Frisen, Louise; Osby, Urban] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Sjoholm, LK (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.	catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; H. Cheteh, Emarndeena/0000-0002-9216-6942; Backlund, Lena/0000-0001-9399-5024; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Research Council [2002-6602, 2005-6245, 2008-3307]; Stockholm County Council (ALF); Karolinska Institutet Foundations; Soderstromska Foundation; Fredrik and Ingrid Thuring Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Soderstromska Foundation; Fredrik and Ingrid Thuring Foundation; Royal Physiographic Society in Lund	This study was supported in part by grants from the Swedish Research Council (2002-6602, 2005-6245, 2008-3307, www.vr.se), the Stockholm County Council (ALF, www.forskningsstod.sll.se), the Karolinska Institutet Foundations (www.ki.se), the Soderstromska Foundation, the Fredrik and Ingrid Thuring Foundation, and the Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, BIPOLAR DISORD, V10, P153, DOI 10.1111/j.1399-5618.2007.00560.x; Colom F, 2003, J CLIN PSYCHIAT, V64, P1101, DOI 10.4088/JCP.v64n0917; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Cusin C, 2001, J PSYCHIAT RES, V35, P217, DOI 10.1016/S0022-3956(01)00026-7; CZEISLER CA, 1987, PSYCHIAT CLIN N AM, V10, P687; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; ELSASS P, 1979, ACTA PSYCHIAT SCAND, V60, P263, DOI 10.1111/j.1600-0447.1979.tb00274.x; Frye MA, 2000, J CLIN PSYCHIAT, V61, P9, DOI 10.4088/JCP.v61n0104; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Kishi T, 2008, NEUROSCI RES, V62, P211, DOI 10.1016/j.neures.2008.08.008; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kupka RW, 2005, AM J PSYCHIAT, V162, P1273, DOI 10.1176/appi.ajp.162.7.1273; Kupka RW, 2003, J CLIN PSYCHIAT, V64, P1483, DOI 10.4088/JCP.v64n1213; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lewy A.J., 1983, PINEAL GLAND, P77; Lincoln GA, 2003, J NEUROENDOCRINOL, V15, P390, DOI 10.1046/j.1365-2826.2003.00990.x; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; Muller DJ, 2006, BRIT J PSYCHIAT, V189, P317, DOI 10.1192/bjp.bp.105.010587; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nurnberger JI, 2000, ARCH GEN PSYCHIAT, V57, P572, DOI 10.1001/archpsyc.57.6.572; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Ozgur S, 2003, BIOCHEMISTRY-US, V42, P2926, DOI 10.1021/bi026963n; Patel SD, 2010, AM J MED GENET B, V153B, P850, DOI 10.1002/ajmg.b.31087; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Rousseva A, 2003, PHARMACOGENOMICS J, V3, P101, DOI 10.1038/sj.tpj.6500156; Salvatore P, 2008, BIPOLAR DISORD, V10, P256, DOI 10.1111/j.1399-5618.2007.00505.x; Schneck CD, 2006, J CLIN PSYCHIAT, V67, P22; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Solomon DA, 2008, BIPOLAR DISORD, V10, P798, DOI 10.1111/j.1399-5618.2008.00624.x; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spoelstra K, 2008, J COMP PHYSIOL A, V194, P235, DOI 10.1007/s00359-007-0301-3; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Teicher MH, 1997, ARCH GEN PSYCHIAT, V54, P124; Thompson C, 1997, BRIT J PSYCHIAT, V170, P431, DOI 10.1192/bjp.170.5.431; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	53	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12632	10.1371/journal.pone.0012632	http://dx.doi.org/10.1371/journal.pone.0012632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20856823	Green Submitted, Green Published, gold			2022-12-25	WOS:000281687200003
J	Shuvaev, VV; Han, JY; Yu, KJ; Huang, SH; Hawkins, BJ; Madesh, M; Nakada, M; Muzykantov, VR				Shuvaev, Vladimir V.; Han, Jingyan; Yu, Kevin J.; Huang, Shaohui; Hawkins, Brian J.; Madesh, Muniswamy; Nakada, Marian; Muzykantov, Vladimir R.			PECAM-targeted delivery of SOD inhibits endothelial inflammatory response	FASEB JOURNAL			English	Article						drug delivery; oxidative stress; superoxide anion; endocytosis	ALLEVIATES OXIDATIVE STRESS; CELL-ADHESION MOLECULE-1; SUPEROXIDE-DISMUTASE; NADPH OXIDASE; GENE-THERAPY; INTRACELLULAR SUPEROXIDE; SIGNAL-TRANSDUCTION; ANGIOTENSIN-II; IN-VITRO; MNSOD-PL	Elevated generation of reactive oxygen species (ROS) by endothelial enzymes, including NADPH-oxidase, is implicated in vascular oxidative stress and endothelial proinflammatory activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1). Catalase and superoxide dismutase (SOD) conjugated with antibodies to platelet/endothelial cell adhesion molecule 1 (PECAM-1) bind specifically to endothelium and inhibit effects of corresponding ROS, H2O2, and superoxide anion. In this study, anti-PECAM/SOD, but not anti-PECAM/catalase or nontargeted enzymes, including polyethylene glycol (PEG)-SOD, inhibited 2- to 3-fold VCAM expression caused by tumor necrosis factor (TNF), interleukin-1 beta, and lipopolysaccharide. Anti-PECAM/SOD, but not nontargeted counterparts, accumulated in vascular endothelium after intravenous injection, localized in endothelial endosomes, and inhibited by 70% lipopolysaccharide-caused VCAM-1 expression in mice. Anti-PECAM/SOD colocalized with EEA-1-positive endothelial vesicles and quenched ROS produced in response to TNF. Inhibitors of NADPH oxidase and anion channel ClC3 blocked TNF-induced VCAM expression, affirming that superoxide produced and transported by these proteins, respectively, mediates inflammatory signaling. Anti-PECAM/SOD abolished VCAM expression caused by poly(I:C)-induced activation of toll-like receptor 3 localized in intracellular vesicles. These results directly implicate endosomal influx of superoxide in endothelial inflammatory response and suggest that site-specific interception of this signal attained by targeted delivery of anti-PECAM/SOD into endothelial endosomes may have anti-inflammatory effects.-Shuvaev, V. V., Han, J., Yu, K. J., Huang, S., Hawkins, B. J., Madesh, M., Nakada, M., and Muzykantov, V. R. PECAM-targeted delivery of SOD inhibits endothelial inflammatory response. FASEB J. 25, 348-357 (2011). www.fasebj.org	[Shuvaev, Vladimir V.; Han, Jingyan; Yu, Kevin J.; Huang, Shaohui; Hawkins, Brian J.; Madesh, Muniswamy; Muzykantov, Vladimir R.] Univ Penn, Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Han, Jingyan; Muzykantov, Vladimir R.] Univ Penn, Sch Med, Dept Pharmacol, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Hawkins, Brian J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19122 USA; [Nakada, Marian] Centocor Inc, Malvern, PA 19355 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Muzykantov, VR (corresponding author), Univ Penn, Sch Med, Inst Environm Med, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	Shuvaev, Vladimir/O-1719-2014; Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021		U.S. National Institutes of Health [RO1 HL073940, HL087036, PO1 HL079063, K99HL094536, HL086699, 1S10RR022511]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022511] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL094536, R00HL094536, P01HL079063, R01HL073940, R01HL087036, R01HL086699] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Drs. T. Dziubla and E. Simone for experiments with isotope-labeled PEG enzymes, Dr. M. Christofidou-Solomidou for help in visualization of SOD conjugates in mice, and E. Arguiri for technical assistance in animal studies. The authors thank Drs. A. Fisher, S. Albelda, and H. Ischiropoulos for their expert advice and stimulating discussions. This work was supported, in whole or in part, by U.S. National Institutes of Health grants RO1 HL073940 and HL087036 and Project 4 of PO1 HL079063 (to V.R.M.), K99HL094536 (to B.G.H.), and HL086699 and 1S10RR022511 (to M.M.).	BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Cook-Mills JM, 2006, CELL MOL BIOL, V52, P8, DOI 10.1170/T721; Ding BS, 2006, MOL INTERV, V6, P98, DOI 10.1124/mi.6.2.7; Epperly MW, 2008, RADIAT RES, V170, P437, DOI 10.1667/RR1286.1; Epperly MW, 2003, GENE THER, V10, P163, DOI 10.1038/sj.gt.3301852; Epperly MW, 2002, BIOL BLOOD MARROW TR, V8, P175, DOI 10.1053/bbmt.2002.v8.pm12014807; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gao BF, 2003, AM J PHYSIOL-LUNG C, V284, pL917, DOI 10.1152/ajplung.00374.2002; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Hagiwara S, 2010, SHOCK, V33, P282, DOI 10.1097/SHK.0b013e3181b0ef7b; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kim DW, 2008, BMB REP, V41, P170, DOI 10.5483/BMBRep.2008.41.2.170; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Lin SJ, 2007, ATHEROSCLEROSIS, V190, P124, DOI 10.1016/j.atherosclerosis.2006.02.044; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Matsui T, 2007, J INT MED RES, V35, P886, DOI 10.1177/147323000703500617; McCord J M, 1985, Adv Myocardiol, V5, P183; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro Silvia, 2004, V283, P21; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Pratico D, 2005, ATHEROSCLEROSIS, V181, P215, DOI 10.1016/j.atherosclerosis.2005.03.005; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; Shuvaev VV, 2007, J PHARMACOL EXP THER, V323, P450, DOI 10.1124/jpet.107.127126; Shuvaev VV, 2009, J PHARMACOL EXP THER, V331, P404, DOI 10.1124/jpet.109.156877; Supinski GS, 2006, AM J RESP CRIT CARE, V173, P1240, DOI 10.1164/rccm.200410-1346OC; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Wang ZJ, 2009, ACS NANO, V3, P4110, DOI 10.1021/nn9012274; Watanabe N, 2003, BIOCHEM BIOPH RES CO, V303, P287, DOI 10.1016/S0006-291X(03)00335-8; WHITE CW, 1989, J APPL PHYSIOL, V66, P584, DOI 10.1152/jappl.1989.66.2.584; Yamagishi S, 2008, CURR MED CHEM, V15, P172, DOI 10.2174/092986708783330557; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; Yi XA, 2010, FREE RADICAL BIO MED, V49, P548, DOI 10.1016/j.freeradbiomed.2010.04.039; Yun J, 2009, ANTIOXID REDOX SIGN, V11, P1961, DOI 10.1089/ARS.2009.2476; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9	55	77	78	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2011	25	1					348	357		10.1096/fj.10-169789	http://dx.doi.org/10.1096/fj.10-169789			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876216	Green Published			2022-12-25	WOS:000285869500031
J	Presley, T; Vedam, K; Druhan, LJ; Ilangovan, G				Presley, Tennille; Vedam, Kaushik; Druhan, Lawrence J.; Ilangovan, Govindasamy			Hyperthermia-induced Hsp90.eNOS Preserves Mitochondrial Respiration in Hyperglycemic Endothelial Cells by Down-regulating Glut-1 and Up-regulating G6PD Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NATURAL PROTECTIVE MECHANISM; SMOOTH-MUSCLE-CELLS; HIGH-GLUCOSE; HEAT-SHOCK; OXIDATIVE STRESS; NAD(P)H OXIDASE; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; NO SYNTHASE	Uncoupling of NO production from NADPH oxidation by endothelial nitric-oxide synthase (eNOS) is enhanced in hyperglycemic endothelium, potentially due to dissociation of heat shock proteins 90 (Hsp90), and cellular glucose homeostasis is enhanced by a ROS-induced positive feed back mechanism. In this study we investigated how such an uncoupling impacts oxygen metabolism and how the oxidative phosphorylation can be preserved by heat shock (42 degrees C for 2 h, hyperthermia) in bovine aortic endothelial cells. Normal and heat-shocked bovine aortic endothelial cells were exposed to normoglycemia (NG, 5.0 mM) or hyperglycemia (30 mM). With hyperglycemia treatment, O-2 consumption rate was reduced (from V-O2max = 7.51 +/- 0.54 to 2.35 +/- 0.27 mm Hg/min/10(6) cells), whereas in heat-shocked cells, O-2 consumption rate remained unaltered (8.19 +/- 1.01 mm Hg/min/10 x 10(6) cells). Heat shock was found to enhance Hsp90/endothelial NOS interactions and produce higher NO. Moreover, ROS generation in the hyperglycemic condition was also reduced in heat-shocked cells. Interestingly, glucose uptake was reduced in heat-shocked cells as a result of decrease in Glut-1 protein level. Glucose phosphate dehydrogenase activity that gives rise to NADPH generation was increased by hyperthermia, and mitochondrial oxidative metabolism was preserved. In conclusion, the present study provides a novel mechanism wherein the reduced oxidative stress in heat-shocked hyperglycemic cells down-regulates Glut-1 and glucose uptake, and fine-tuning of this pathway may be a potential approach to use for therapeutic benefit of diabetes mellitus.	[Presley, Tennille; Ilangovan, Govindasamy] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Vedam, Kaushik; Ilangovan, Govindasamy] Ohio State Univ, Div Cardiovasc Med, Dept Internal Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Druhan, Lawrence J.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Ilangovan, G (corresponding author), Rm 392,Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Govindasamy.Ilangovan@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [R21 EB004658, R01 HL078796, F31 GM078772-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM078772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 EB004658, R01 HL078796 (to G. I.), and F31 GM078772-01 (to T. P.).	Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Alpert E, 2004, BIOCHEM PHARMACOL, V67, P1985, DOI 10.1016/j.bcp.2004.02.005; Averna M, 2008, J BIOL CHEM, V283, P29069, DOI 10.1074/jbc.M803638200; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; BELT JA, 1979, BIOCHEMISTRY-US, V18, P3506, DOI 10.1021/bi00583a011; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen Y, 2004, AM J PHYSIOL-HEART C, V287, pH1104, DOI 10.1152/ajpheart.00102.2004; Cohen G., 2007, Archives of Physiology and Biochemistry, V113, P259, DOI 10.1080/13813450701783513; Cosentino F, 1997, CIRCULATION, V96, P25; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Harris MB, 2003, AM J PHYSIOL-HEART C, V285, pH333, DOI 10.1152/ajpheart.00726.2002; Hink U, 2001, CIRC RES, V88, pE14; Ilangovan G, 2004, AM J PHYSIOL-CELL PH, V287, pC1472, DOI 10.1152/ajpcell.00103.2004; Ilangovan G, 2004, METHOD ENZYMOL, V381, P747; Jones CI, 2008, AM J PHYSIOL-CELL PH, V295, pC180, DOI 10.1152/ajpcell.00549.2007; Konduri GG, 2003, AM J PHYSIOL-HEART C, V285, pH204, DOI 10.1152/ajpheart.00837.2002; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Lin LY, 2005, J CELL BIOCHEM, V94, P194, DOI 10.1002/jcb.20195; Mohan S, 2009, AM J PHYSIOL-CELL PH, V296, pC182, DOI 10.1152/ajpcell.00575.2007; Oishi PE, 2008, AM J PHYSIOL-LUNG C, V295, pL756, DOI 10.1152/ajplung.00146.2007; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Presley T, 2009, CELL STRESS CHAPERON, V14, P611, DOI 10.1007/s12192-009-0114-0; Presley T, 2008, AM J PHYSIOL-CELL PH, V295, pC1281, DOI 10.1152/ajpcell.00550.2007; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, pH153, DOI 10.1152/ajpheart.01142.2008; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Srinivasan S, 2004, DIABETOLOGIA, V47, P1727, DOI 10.1007/s00125-004-1525-1; Sweet IR, 2009, DIABETOLOGIA, V52, P921, DOI 10.1007/s00125-009-1272-4; Totary-Jain H, 2005, CIRC RES, V97, P1001, DOI 10.1161/01.RES.0000189260.46084.e5; Wang H, 2009, MOL ENDOCRINOL, V23, P1613, DOI 10.1210/me.2009-0115; White RL, 2000, AM J PHYSIOL-HEART C, V279, pH1849, DOI 10.1152/ajpheart.2000.279.4.H1849; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572	53	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38194	38203		10.1074/jbc.M110.147728	http://dx.doi.org/10.1074/jbc.M110.147728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861020	hybrid, Green Published			2022-12-25	WOS:000284625600027
J	Sims, K; Haynes, CA; Kelly, S; Allegood, JC; Wang, E; Momin, A; Leipelt, M; Reichart, D; Glass, CK; Sullards, MC; Merrill, AH				Sims, Kacee; Haynes, Christopher A.; Kelly, Samuel; Allegood, Jeremy C.; Wang, Elaine; Momin, Amin; Leipelt, Martina; Reichart, Donna; Glass, Christopher K.; Sullards, M. Cameron; Merrill, Alfred H., Jr.			Kdo(2)-Lipid A, a TLR4-specific Agonist, Induces de Novo Sphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; TOLL-LIKE RECEPTORS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; GLYCOSPHINGOLIPID METABOLISM; SERINE PALMITOYLTRANSFERASE; MURINE MACROPHAGES; MEMBRANE-STRUCTURE; GOLGI-COMPLEX; CANCER-CELLS	Activation of RAW264.7 cells with a lipopolysaccharide specific for the TLR4 receptor, Kdo(2)-lipid A (KLA), causes a large increase in cellular sphingolipids, from 1.5 to 2.6 x 10(9) molecules per cell in 24 h, based on the sum of subspecies analyzed by "lipidomic" mass spectrometry. Thus, this study asked the following question. What is the cause of this increase and is there a cell function connected with it? The sphingolipids arise primarily from de novo biosynthesis based on [U-C-13] palmitate labeling, inhibition by ISP1 (myriocin), and an apparent induction of many steps of the pathway (according to the distribution of metabolites and microarray analysis), with the exception of ceramide, which is also produced from pre-existing sources. Nonetheless, the activated RAW264.7 cells have a higher number of sphingolipids per cell because KLA inhibits cell division; thus, the cells are larger and contain increased numbers of membrane vacuoles termed autophagosomes, which were detected by the protein marker GFP-LC3. Indeed, de novo biosynthesis of sphingolipids performs an essential structural and/or signaling function in autophagy because autophagosome formation was eliminated by ISP1 in KLA-stimulated RAW264.7 cells (and mutation of serine palmitoyltransferase in CHO-LYB cells); furthermore, an anti-ceramide antibody co-localizes with autophagosomes in activated RAW264.7 cells versus the Golgi in unstimulated or ISP1-inhibited cells. These findings establish that KLA induces profound changes in sphingolipid metabolism and content in this macrophage-like cell line, apparently to produce sphingolipids that are necessary for formation of autophagosomes, which are thought to play important roles in the mechanisms of innate immunity.	[Haynes, Christopher A.; Kelly, Samuel; Wang, Elaine; Momin, Amin; Leipelt, Martina; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sims, Kacee; Allegood, Jeremy C.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Haynes, Christopher A.; Kelly, Samuel; Wang, Elaine; Momin, Amin; Leipelt, Martina; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Reichart, Donna; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego	Merrill, AH (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	al.merrill@biology.gatech.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069338 (to LIPID MAPS).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Berenson CS, 2002, J LEUKOCYTE BIOL, V72, P492; Blom T, 2010, CIRC RES, V106, P720, DOI 10.1161/CIRCRESAHA.109.204396; Cho JY, 2007, BIOL PHARM BULL, V30, P2105, DOI 10.1248/bpb.30.2105; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Emoto M, 2010, INFECT IMMUN, V78, P2667, DOI 10.1128/IAI.01441-09; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; Fazi B, 2008, AUTOPHAGY, V4, P435, DOI 10.4161/auto.5669; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; GAL D, 1981, CANCER RES, V41, P473; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Grabowski Gregory A, 2006, Expert Opin Drug Deliv, V3, P771, DOI 10.1517/17425247.3.6.771; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hamasaki M, 2010, FEBS LETT, V584, P1296, DOI 10.1016/j.febslet.2010.02.061; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HOFFMANN PM, 1993, EUR J CELL BIOL, V60, P371; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Knapp KM, 2000, J LEUKOCYTE BIOL, V67, P735, DOI 10.1002/jlb.67.5.735; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Memon RA, 1999, J BIOL CHEM, V274, P19707, DOI 10.1074/jbc.274.28.19707; Memon RA, 2001, J LIPID RES, V42, P452; MERRILL AH, 1988, BIOCHEMISTRY-US, V27, P340, DOI 10.1021/bi00401a051; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mijaljica D, 2006, TRAFFIC, V7, P1590, DOI 10.1111/j.1600-0854.2006.00495.x; Momin AA, 2009, LIPIDS, V44, P725, DOI 10.1007/s11745-009-3316-4; Monick MM, 2004, J IMMUNOL, V173, P123, DOI 10.4049/jimmunol.173.1.123; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Saxena RK, 2003, J BIOSCIENCES, V28, P129, DOI 10.1007/BF02970143; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schaade L, 1999, IUBMB LIFE, V48, P353, DOI 10.1080/713803512; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Xu KD, 2010, J LIPID RES, V51, P2581, DOI 10.1194/jlr.M005702; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	75	89	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38568	38579		10.1074/jbc.M110.170621	http://dx.doi.org/10.1074/jbc.M110.170621			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876532	Green Published, hybrid			2022-12-25	WOS:000284625600062
J	Benedix, J; Lajoie, P; Jaiswal, H; Burgard, C; Greiner, M; Zimmermann, R; Rospert, S; Snapp, EL; Dudek, J				Benedix, Julia; Lajoie, Patrick; Jaiswal, Himjyot; Burgard, Carsten; Greiner, Markus; Zimmermann, Richard; Rospert, Sabine; Snapp, Erik L.; Dudek, Johanna			BiP Modulates the Affinity of Its Co-chaperone ERj1 for Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; ATP-BINDING; YEAST; MEMBRANE; COMPLEX; SEC63P; MECHANISMS; TRANSPORT; HOMOLOGS	Ribosomes synthesizing secretory and membrane proteins are bound to the endoplasmic reticulum (ER) membrane and attach to ribosome-associated membrane proteins such as the Sec61 complex, which forms the protein-conducting channel in the membrane. The ER membrane-resident Hsp40 protein ERj1 was characterized as being able to recruit BiP to ribosomes in solution and to regulate protein synthesis in a BiP-dependent manner. Here, we show that ERj1 and Sec61 are associated with ribosomes at the ER of human cells and that the binding of ERj1 to ribosomes occurs with a binding constant in the picomolar range and is prevented by pretreatment of ribosomes with RNase. However, the affinity of ERj1 for ribosomes dramatically changes upon binding of BiP. This modulation by BiP may be responsible for the dual role of ERj1 at the ribosome, i.e. acting as a recruiting factor for BiP and regulating translation.	[Dudek, Johanna] Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Lajoie, Patrick; Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Jaiswal, Himjyot; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Jaiswal, Himjyot; Rospert, Sabine] Univ Freiburg, Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	Saarland University; Yeshiva University; Albert Einstein College of Medicine; University of Freiburg; University of Freiburg	Dudek, J (corresponding author), Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany.	johanna.dudek@uks.eu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Rospert, Sabine/0000-0002-3089-9614; Lajoie, Patrick/0000-0002-1614-176X	Homburger Forschungsfor-derungsprogramm (HOMFOR); Deutsche Forschungsgemein-schaft [FOR 967, SFB530]; BiP expression plasmids; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	Homburger Forschungsfor-derungsprogramm (HOMFOR); Deutsche Forschungsgemein-schaft(German Research Foundation (DFG)); BiP expression plasmids; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from Homburger Forschungsfor-derungsprogramm (HOMFOR) and the Deutsche Forschungsgemein-schaft (FOR 967 and SFB530).; We are grateful to Linda Hendershot for the kind gift of the BiP expression plasmids. We thank A. Muller, S. Amann, and M. Lerner for expert technical assistance.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Dierks T, 1996, EMBO J, V15, P6931, DOI 10.1002/j.1460-2075.1996.tb01085.x; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kroczynska B, 2004, J BIOL CHEM, V279, P11432, DOI 10.1074/jbc.M310903200; MATSUMOTOTANIUR.N, 1996, J M MOL BIOL CELL, V7, P1455; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Tyedmers J, 2003, EMBO REP, V4, P505, DOI 10.1038/sj.embor.embor826; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 2006, TRENDS MOL MED, V12, P567, DOI 10.1016/j.molmed.2006.10.004	30	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36427	36433		10.1074/jbc.M110.143263	http://dx.doi.org/10.1074/jbc.M110.143263			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864538	Green Published, hybrid			2022-12-25	WOS:000284146100007
J	Kartberg, F; Asp, L; Dejgaard, SY; Smedh, M; Fernandez-Rodriguez, J; Nilsson, T; Presley, JF				Kartberg, Fredrik; Asp, Lennart; Dejgaard, Selma Y.; Smedh, Maria; Fernandez-Rodriguez, Julia; Nilsson, Tommy; Presley, John F.			ARFGAP2 and ARFGAP3 Are Essential for COPI Coat Assembly on the Golgi Membrane of Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; BREFELDIN-A; BINDING-PROTEIN; ARF GAPS; VESICLES; TRANSPORT; APPARATUS; DYNAMICS; HYDROLYSIS	Coat protein complex I (COPI) vesicles play a central role in the recycling of proteins in the early secretory pathway and transport of proteins within the Golgi stack. Vesicle formation is initiated by the exchange of GDP for GTP on ARF1 (ADP-ribosylation factor 1), which, in turn, recruits the coat protein coatomer to the membrane for selection of cargo and membrane deformation. ARFGAP1 (ARF1 GTPase-activating protein 1) regulates the dynamic cycling of ARF1 on the membrane that results in both cargo concentration and uncoating for the generation of a fusion-competent vesicle. Two human orthologues of the yeast ARFGAP Glo3p, termed ARFGAP2 and ARFGAP3, have been demonstrated to be present on COPI vesicles generated in vitro in the presence of guanosine 5'-3-O-(thio) triphosphate. Here, we investigate the function of these two proteins in living cells and compare it with that of ARFGAP1. We find that ARFGAP2 and ARFGAP3 follow the dynamic behavior of coatomer upon stimulation of vesicle budding in vivo more closely than does ARFGAP1. Electron microscopy of ARFGAP2 and ARFGAP3 knockdowns indicated Golgi unstacking and cisternal shortening similarly to conditions where vesicle uncoating was blocked. Furthermore, the knockdown of both ARFGAP2 and ARFGAP3 prevents proper assembly of the COPI coat lattice for which ARFGAP1 does not seem to play a major role. This suggests that ARFGAP2 and ARFGAP3 are key components of the COPI coat lattice and are necessary for proper vesicle formation.	[Nilsson, Tommy] Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, S-40530 Gothenburg, Sweden; [Smedh, Maria; Fernandez-Rodriguez, Julia; Nilsson, Tommy] Univ Gothenburg, Ctr Cellular Imaging, S-40530 Gothenburg, Sweden; [Nilsson, Tommy] McGill Univ, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada; [Nilsson, Tommy] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Dejgaard, Selma Y.; Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	University of Gothenburg; University of Gothenburg; McGill University; McGill University; McGill University	Presley, JF (corresponding author), 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	john.presley@mcgill.ca		Fernandez-Rodriguez, Julia/0000-0003-4522-0966	Swedish Research Council; Canadian Institutes for Health Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Swedish Research Council and by the Canadian Institutes for Health Research.	ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeRegis CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-3; Dogic D, 1999, EUR J CELL BIOL, V78, P305, DOI 10.1016/S0171-9335(99)80064-8; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kartberg F, 2005, BBA-MOL CELL RES, V1744, P351, DOI 10.1016/j.bbamcr.2005.05.003; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.e04-04-0316; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Pepperkok R, 2000, J CELL SCI, V113, P135; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SIMIONESCU N, 1976, J CELL BIOL, V70, pA186; Singh J, 2001, J BIOL CHEM, V276, P11852, DOI 10.1074/jbc.M006931200; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	61	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36709	36720		10.1074/jbc.M110.180380	http://dx.doi.org/10.1074/jbc.M110.180380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858901	Green Published, hybrid			2022-12-25	WOS:000284146100010
J	Kim, S; Jho, EH				Kim, Sewoon; Jho, Eek-hoon			The Protein Stability of Axin, a Negative Regulator of Wnt Signaling, Is Regulated by Smad Ubiquitination Regulatory Factor 2 (Smurf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; DEGRADATION; PATHWAY; CANCER; LIGASE; COMPLEX; INHIBITION; ACTIVATION; TARGETS; KINASE	Axin is a negative regulator of Wnt/beta-catenin signaling via regulating the level of beta-catenin, which is a key effector molecule. Therefore, controlling the level of Axin is a critical step for the regulation of Wnt/beta-catenin signaling. It has been shown that ubiquitination-mediated proteasomal degradation may play a critical role in the regulation of Axin; however, the E3 ubiquitin ligase(s), which attaches ubiquitin to a target protein in combination with an E2 ubiquitin-conjugating enzyme, for Axin has not yet been identified. Here, we show that Smurf2 is an E3 ubiquitin ligase for Axin. Transient expression of Smurf2 down-regulated the level of Axin and increased the ubiquitination of Axin. Conversely, shRNA specific to Smurf2 blocked Axin ubiquitination. Essential domains of Axin responsible for Smurf2 interaction as well as Smurf2-mediated down-regulation and ubiquitination were identified. In vitro ubiquitination assays followed by analysis using mass spectroscopy revealed that Smurf2 specifically ubiquitinylated Lys(505) of Axin and that the Axin(K505R) mutant resisted degradation. Knockdown of endogenous Smurf2 increased the level of endogenous Axin and resulted in reduced beta-catenin/Tcf reporter activity. Overall, our data strongly suggest that Smurf2 is a genuine E3 ligase for Axin.	[Kim, Sewoon; Jho, Eek-hoon] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Jho, EH (corresponding author), Univ Seoul, Dept Life Sci, 90 Jeonnong Dong, Seoul 130743, South Korea.	ej70@uos.ac.kr		Jho, Eek-hoon/0000-0003-2414-6234	Ministry of Education, Science, and Technology; Brain Korea 21 Program; Seoul Science Fellowship	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science Fellowship	This work was supported in part by Grants 2006-2004046 and R01-2007-000-20944-0 from the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology.; Supported by the Brain Korea 21 Program and a Seoul Science Fellowship.	Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu QQ, 2009, EXP CELL RES, V315, P2386, DOI 10.1016/j.yexcr.2009.05.019; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	27	62	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36420	36426		10.1074/jbc.M110.137471	http://dx.doi.org/10.1074/jbc.M110.137471			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858899	hybrid, Green Published			2022-12-25	WOS:000284146100081
J	Bruant, G; Levesque, MJ; Peter, C; Guiot, SR; Masson, L				Bruant, Guillaume; Levesque, Marie-Josee; Peter, Chardeen; Guiot, Serge R.; Masson, Luke			Genomic Analysis of Carbon Monoxide Utilization and Butanol Production by Clostridium carboxidivorans Strain P7(T)	PLOS ONE			English	Article							ACETOBUTYLICUM ATCC 824; WOOD-LJUNGDAHL PATHWAY; SP-NOV; SOLVENT PRODUCTION; MOLECULAR CHARACTERIZATION; BEIJERINCKII; GENES; FERMENTATION; ETHANOL; DEHYDROGENASE	Increasing demand for the production of renewable fuels has recently generated a particular interest in microbial production of butanol. Anaerobic bacteria, such as Clostridium spp., can naturally convert carbohydrates into a variety of primary products, including alcohols like butanol. The genetics of microorganisms like Clostridium acetobutylicum have been well studied and their solvent-producing metabolic pathways characterized. In contrast, less is known about the genetics of Clostridium spp. capable of converting syngas or its individual components into solvents. In this study, the type of strain of a new solventogenic Clostridium species, C. carboxidivorans, was genetically characterized by genome sequencing. C. carboxidivorans strain P7(T) possessed a complete Wood-Ljungdahl pathway gene cluster, involving CO and CO2 fixation and conversion to acetyl-CoA. Moreover, with the exception of an acetone production pathway, all the genetic determinants of canonical ABE metabolic pathways for acetate, butyrate, ethanol and butanol production were present in the P7T chromosome. The functionality of these pathways was also confirmed by growth of P7(T) on CO and production of CO2 as well as volatile fatty acids (acetate and butyrate) and solvents (ethanol and butanol). P7(T) was also found to harbour a 19 Kbp plasmid, which did not include essential or butanol production related genes. This study has generated in depth knowledge of the P7(T) genome, which will be helpful in developing metabolic engineering strategies to improve C. carboxidivorans's natural capacity to produce potential biofuels from syngas.	[Bruant, Guillaume; Levesque, Marie-Josee; Peter, Chardeen; Guiot, Serge R.; Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Guiot, Serge R.; Masson, Luke] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	National Research Council Canada; Universite de Montreal	Bruant, G (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	luke.masson@cnrc-nrc.gc.ca		Guiot, Serge R/0000-0002-2532-0620	ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan)	ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan)	This research was partly supported by the ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINI J, 1994, ARCH MICROBIOL, V161, P345, DOI 10.1007/BF00303591; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berezina OV, 2009, SYST APPL MICROBIOL, V32, P449, DOI 10.1016/j.syapm.2009.07.005; Boynton ZL, 1996, APPL ENVIRON MICROB, V62, P2758, DOI 10.1128/AEM.62.8.2758-2766.1996; Chen CK, 1999, APPL ENVIRON MICROB, V65, P499; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornillot E, 1997, J BACTERIOL, V179, P5442, DOI 10.1128/jb.179.17.5442-5447.1997; Cotter JL, 2009, BIOPROC BIOSYST ENG, V32, P369, DOI 10.1007/s00449-008-0256-y; DABROCK B, 1992, APPL ENVIRON MICROB, V58, P1233, DOI 10.1128/AEM.58.4.1233-1239.1992; Datar RP, 2004, BIOTECHNOL BIOENG, V86, P587, DOI 10.1002/bit.20071; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desai RP, 1999, METAB ENG, V1, P206, DOI 10.1006/mben.1999.0118; DURRE P, 1995, FEMS MICROBIOL REV, V17, P251; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Fontaine L, 2002, J BACTERIOL, V184, P821, DOI 10.1128/JB.184.3.821-830.2002; GEORGE HA, 1983, APPL ENVIRON MICROB, V46, P321, DOI 10.1128/AEM.46.2.321-327.1983; GEORGE HA, 1983, APPL ENVIRON MICROB, V45, P1160, DOI 10.1128/AEM.45.3.1160-1163.1983; Gheshlaghi R, 2009, BIOTECHNOL ADV, V27, P764, DOI 10.1016/j.biotechadv.2009.06.002; GOTTWALD M, 1984, APPL ENVIRON MICROB, V48, P573, DOI 10.1128/AEM.48.3.573-576.1984; GRETHLEIN AJ, 1991, J FERMENT BIOENG, V72, P58, DOI 10.1016/0922-338X(91)90147-9; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Jones D. T., 1989, CLOSTRIDIA, P105; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095, DOI 10.1099/00207713-51-6-2095; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Liou JSC, 2005, INT J SYST EVOL MICR, V55, P2085, DOI 10.1099/ijs.0.63482-0; Munasinghe PC, 2010, BIORESOURCE TECHNOL, V101, P5013, DOI 10.1016/j.biortech.2009.12.098; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rajagopalan S, 2002, BIOMASS BIOENERG, V23, P487, DOI 10.1016/S0961-9534(02)00071-5; SCHWARZ WH, 2006, BUTANOL REDISCOVERIN, P16; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; TANNER RS, 1993, INT J SYST BACTERIOL, V43, P232, DOI 10.1099/00207713-43-2-232; Toth J, 1999, APPL ENVIRON MICROB, V65, P4973; VASCONCELOS I, 1994, J BACTERIOL, V176, P1443, DOI 10.1128/jb.176.5.1443-1450.1994; WALTER KA, 1993, GENE, V134, P107, DOI 10.1016/0378-1119(93)90182-3; YAN RT, 1988, APPL ENVIRON MICROB, V54, P642, DOI 10.1128/AEM.54.3.642-648.1988; Zheng YN, 2009, J IND MICROBIOL BIOT, V36, P1127, DOI 10.1007/s10295-009-0609-9	44	110	117	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13033	10.1371/journal.pone.0013033	http://dx.doi.org/10.1371/journal.pone.0013033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885952	gold, Green Submitted, Green Published			2022-12-25	WOS:000282167100026
J	de Wit, J; Souwer, Y; Jorritsma, T; Bos, HK; ten Brinke, A; Neefjes, J; van Ham, SM				de Wit, Jelle; Souwer, Yuri; Jorritsma, Tineke; Bos, Hanny Klaasse; ten Brinke, Anja; Neefjes, Jacques; van Ham, S. Marieke			Antigen-Specific B Cells Reactivate an Effective Cytotoxic T Cell Response against Phagocytosed Salmonella through Cross-Presentation	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; GUT EPITHELIAL MONOLAYERS; IMMUNE-RESPONSES; INFECTIOUS ENTEROCOLITIS; PATHOGENICITY ISLAND-2; BACTERIAL-GROWTH; HOST-CELLS; VIRULENCE; PROTEINS	Background: The eradication of facultative intracellular bacterial pathogens, like Salmonella typhi, requires the concerted action of both the humoral immune response and the cytotoxic CD8(+) T cell response. Dendritic cells (DCs) are considered to orchestrate the cytotoxic CD8(+) T cell response via cross-presentation of bacterial antigens onto MHC class I molecules. Cross-presentation of Salmonella by DCs however, is accompanied by the induction of apoptosis in the DCs. Besides antibody production, B cells are required to clear Salmonella infection for other unknown reasons. Methodology/Principal Findings: Here we show that Salmonella-specific B cells that phagocytose Salmonella upon BCR-ligation reactivate human memory CD8(+) T cells via cross-presentation yielding a Salmonella-specific cytotoxic T cell response. The reactivation of CD8(+) T cells is dependent on CD4(+) T cell help. Unlike the DCs, B cell-mediated cross-presentation of Salmonella does not coincide with apoptosis. Conclusions/Significance: B cells form a new player in the activation of the cytotoxic effector arm of the immune response and the generation of effective adaptive immunity in Salmonella infection.	[de Wit, Jelle; Souwer, Yuri; Jorritsma, Tineke; Bos, Hanny Klaasse; ten Brinke, Anja; van Ham, S. Marieke] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	de Wit, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.vanham@sanquin.nl	Neefjes, Jacques J.C./H-8780-2017; de Wit, Jelle/W-7035-2019	Neefjes, Jacques J.C./0000-0001-6763-2211; de Wit, Jelle/0000-0003-2444-6050; ten Brinke, Anja/0000-0002-0135-7496	Landsteiner Foundation for Blood Research [0533]	Landsteiner Foundation for Blood Research	This work was supported by a grant from the Landsteiner Foundation for Blood Research (Grant 0533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Harty JT, 1999, CURR OPIN IMMUNOL, V11, P89, DOI 10.1016/S0952-7915(99)80016-8; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Russmann H, 2003, INT J MED MICROBIOL, V293, P107, DOI 10.1078/1438-4221-00249; Salerno-Goncalves R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005879; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang SP, 2003, INFECT IMMUN, V71, P4795, DOI 10.1128/IAI.71.8.4795-4803.2003; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	33	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13016	10.1371/journal.pone.0013016	http://dx.doi.org/10.1371/journal.pone.0013016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885961	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100017
J	Schindler, R; Nilsson, E; Skinner, MK				Schindler, Ryan; Nilsson, Eric; Skinner, Michael K.			Induction of Ovarian Primordial Follicle Assembly by Connective Tissue Growth Factor CTGF	PLOS ONE			English	Article							MESSENGER RIBONUCLEIC-ACIDS; RAT GRANULOSA-CELLS; GERM-CELLS; INITIATES FOLLICULOGENESIS; CCN FAMILY; OOCYTE; APOPTOSIS; FETAL; TRANSITION; EXPRESSION	Primordial follicle assembly is a process that occurs when oocyte nests break down to form individual primordial follicles. The size of this initial pool of primordial follicles in part determines the reproductive lifespan of the female. Connective tissue growth factor (CTGF) was identified as a potential regulatory candidate for this process in a previous microarray analysis of follicle development. The current study examines the effects of CTGF and associated transforming growth factor beta 1 (TGF beta-1) on follicle assembly. Ovaries were removed from newborn rat pups and placed in an organ culture system. The ovaries treated with CTGF for two days were found to have an increased proportion of assembled follicles. CTGF was found to regulate the ovarian transcriptome during primordial follicle assembly and an integrative network of genes was identified. TGF beta-1 had no effect on primordial follicle assembly and in combination with CTGF decreased oocyte number in the ovary after two days of culture. Over ten days of treatment only the combined treatment of CTGF and TGF beta-1 was found to cause an increase in the proportion of assembled follicles. Interestingly, treatment with TGF beta-1 alone resulted in fewer total oocytes in the ovary and decreased the primordial follicle pool size after ten days of culture. Observations indicate that CTGF alone or in combination with TGF beta-1 stimulates primordial follicle assembly and TGF beta-1 can decrease the primordial follicle pool size. These observations suggest the possibility of manipulating primordial follicle pool size and influencing female reproductive lifespan.	[Schindler, Ryan; Nilsson, Eric; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Schindler, R (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020		NIH [NIH R01 HD043093-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an NIH grant to MKS (NIH R01 HD043093-01 "Ovarian Primordial Follicle Development.") The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; BYSKOV AG, 1977, J ANAT, V123, P77; CRAN DG, 1980, SCI PROG, V66, P371; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Fan WH, 2000, EUR J CELL BIOL, V79, P915, DOI 10.1078/0171-9335-00122; FENG P, 1988, ENDOCRINOLOGY, V122, P181, DOI 10.1210/endo-122-1-181; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Juengel JL, 2002, MOL CELL ENDOCRINOL, V191, P1, DOI 10.1016/S0303-7207(02)00045-X; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Levacher C, 1996, DIFFERENTIATION, V61, P45, DOI 10.1046/j.1432-0436.1996.6110045.x; Lovasco LA, 2010, BIOL REPROD, V82, P23, DOI 10.1095/biolreprod.109.077495; McNatty KP, 2000, MOL CELL ENDOCRINOL, V163, P11, DOI 10.1016/S0303-7207(99)00235-X; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson EE, 2006, REPRODUCTION, V132, P877, DOI 10.1530/REP-06-0045; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Rajareddy S, 2007, MOL ENDOCRINOL, V21, P2189, DOI 10.1210/me.2007-0172; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schilling B, 1999, FERTIL STERIL, V72, P147, DOI 10.1016/S0015-0282(99)00182-X; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Slee RB, 2001, ENDOCRINOLOGY, V142, P1082, DOI 10.1210/en.142.3.1082; Tilly JL, 1998, TOXICOL LETT, V103, P497, DOI 10.1016/S0378-4274(98)00240-9; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Wandji SA, 2000, ENDOCRINOLOGY, V141, P2648, DOI 10.1210/en.141.7.2648; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	50	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12979	10.1371/journal.pone.0012979	http://dx.doi.org/10.1371/journal.pone.0012979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886044	Green Submitted, Green Published, gold			2022-12-25	WOS:000282122600015
J	Jann, K; Kottlow, M; Dierks, T; Boesch, C; Koenig, T				Jann, Kay; Kottlow, Mara; Dierks, Thomas; Boesch, Chris; Koenig, Thomas			Topographic Electrophysiological Signatures of fMRI Resting State Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; BRAIN OSCILLATIONS; EEG TOPOGRAPHY; ALPHA; THETA; SYNCHRONIZATION; CLASSIFICATION; TOMOGRAPHY	Background: fMRI Resting State Networks (RSNs) have gained importance in the present fMRI literature. Although their functional role is unquestioned and their physiological origin is nowadays widely accepted, little is known about their relationship to neuronal activity. The combined recording of EEG and fMRI allows the temporal correlation between fluctuations of the RSNs and the dynamics of EEG spectral amplitudes. So far, only relationships between several EEG frequency bands and some RSNs could be demonstrated, but no study accounted for the spatial distribution of frequency domain EEG. Methodology/Principal Findings: In the present study we report on the topographic association of EEG spectral fluctuations and RSN dynamics using EEG covariance mapping. All RSNs displayed significant covariance maps across a broad EEG frequency range. Cluster analysis of the found covariance maps revealed the common standard EEG frequency bands. We found significant differences between covariance maps of the different RSNs and these differences depended on the frequency band. Conclusions/Significance: Our data supports the physiological and neuronal origin of the RSNs and substantiates the assumption that the standard EEG frequency bands and their topographies can be seen as electrophysiological signatures of underlying distributed neuronal networks.	[Jann, Kay; Kottlow, Mara; Dierks, Thomas; Koenig, Thomas] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Jann, Kay; Kottlow, Mara; Dierks, Thomas; Boesch, Chris; Koenig, Thomas] Univ Bern, Bern, Switzerland; [Boesch, Chris] Univ Bern, Inselspital, Dept Clin Res, AMSM, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Jann, K (corresponding author), Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	jann@puk.unibe.ch	Boesch, Chris/F-2577-2010; Jann, Kay/AAF-2154-2020; Dierks, Thomas/B-7092-2012; Jann, Kay/E-8343-2010; Koenig, Thomas/F-6454-2010; Koenig, Thomas/ABD-2278-2020	Boesch, Chris/0000-0001-8498-8543; Dierks, Thomas/0000-0002-4173-5308; Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Jann, Kay/0000-0003-3574-0538	Swiss National Science Foundation [320000-108321/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed by the Swiss National Science Foundation grant 320000-108321/1 ( http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELSEOUD A, HUM BRAIN MAPP; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRITZ J, NEUROIMAGE; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; GASTAUT MH, 1952, REV NEUROL, V87, P176; GIBBS FA, 1949, ELECTROEN CLIN NEURO, V1, P223, DOI 10.1016/0013-4694(49)90026-7; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jann K, 2008, NEUROIMAGE, V42, P635, DOI 10.1016/j.neuroimage.2008.05.001; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; John ER, 2001, CONSCIOUS COGN, V10, P184, DOI 10.1006/ccog.2001.0508; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; Koenig T., 2009, ELECT NEUROIMAGING, P169, DOI DOI 10.1017/CBO9780511596889; Koenig T, 2008, CLIN NEUROPHYSIOL, V119, P1262, DOI 10.1016/j.clinph.2007.12.023; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McKeown MJ, 1997, NEUROLOGY, V48, P6056; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; MICHEL CM, 1992, ELECTROEN CLIN NEURO, V82, P38, DOI 10.1016/0013-4694(92)90180-P; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Saletu B, 2006, CLIN EEG NEUROSCI, V37, P66, DOI 10.1177/155005940603700205; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Strik WK, 1998, EVOKED POTENTIAL, V108, P406, DOI 10.1016/S0168-5597(98)00021-5; TALAIRACH J, 1988, REFERENTIALLY ORIENT; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; VOLKOW ND, 1987, BIOL PSYCHIAT, V22, P199, DOI 10.1016/0006-3223(87)90231-9; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	57	118	121	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12945	10.1371/journal.pone.0012945	http://dx.doi.org/10.1371/journal.pone.0012945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877577	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100037
J	Vivithanaporn, P; Maingat, F; Lin, LT; Na, H; Richardson, CD; Agrawal, B; Cohen, EA; Jhamandas, JH; Power, C				Vivithanaporn, Pornpun; Maingat, Ferdinand; Lin, Liang-Tzung; Na, Hong; Richardson, Christopher D.; Agrawal, Babita; Cohen, Eric A.; Jhamandas, Jack H.; Power, Christopher			Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity	PLOS ONE			English	Article							LENTIVIRUS INFECTION; ALZHEIMERS-DISEASE; NEURONAL AUTOPHAGY; HIV-1; EXPRESSION; BRAIN; COINFECTION; MICROGLIA; CELLS; REPLICATION	Background: Hepatitis C virus (HCV) genomes and proteins are present in human brain tissues although the impact of HIV/ HCV co-infection on neuropathogenesis remains unclear. Herein, we investigate HCV infectivity and effects on neuronal survival and neuroinflammation in conjunction with HIV infection. Methodology: Human microglia, astrocyte and neuron cultures were infected with cell culture-derived HCV or exposed to HCV core protein with or without HIV-1 infection or HIV-1 Viral Protein R (Vpr) exposure. Host immune gene expression and cell viability were measured. Patch-clamp studies of human neurons were performed in the presence or absence of HCV core protein. Neurobehavioral performance and neuropathology were examined in HIV-1 Vpr-transgenic mice in which stereotaxic intrastriatal implants of HCV core protein were performed. Principal Findings: HCV-encoded RNA as well as HCV core and non-structural 3 (NS3) proteins were detectable in human microglia and astrocytes infected with HCV. HCV core protein exposure induced expression of pro-inflammatory cytokines including interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in microglia (p<0.05) but not in astrocytes while increased chemokine (e. g. CXCL10 and interleukin-8) expression was observed in both microglia and astrocytes (p<0.05). HCV core protein modulated neuronal membrane currents and reduced both beta-III-tubulin and lipidated LC3-II expression (p<0.05). Neurons exposed to supernatants from HCV core-activated microglia exhibited reduced b-III-tubulin expression (p<0.05). HCV core protein neurotoxicity and interleukin-6 induction were potentiated by HIV-1 Vpr protein (p<0.05). HIV-1 Vpr transgenic mice implanted with HCV core protein showed gliosis, reduced neuronal counts together with diminished LC3 immunoreactivity. HCV core-implanted animals displayed neurobehavioral deficits at days 7 and 14 post-implantation (p<0.05). Conclusions: HCV core protein exposure caused neuronal injury through suppression of neuronal autophagy in addition to neuroimmune activation. The additive neurotoxic effects of HCV- and HIV-encoded proteins highlight extrahepatic mechanisms by which HCV infection worsens the disease course of HIV infection.	[Vivithanaporn, Pornpun; Maingat, Ferdinand; Na, Hong; Jhamandas, Jack H.; Power, Christopher] Univ Alberta, Div Neurol, Edmonton, AB, Canada; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Lin, Liang-Tzung; Richardson, Christopher D.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Agrawal, Babita] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Cohen, Eric A.] Univ Montreal, IRCM, Montreal, PQ, Canada	University of Alberta; Mahidol University; Dalhousie University; University of Alberta; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Vivithanaporn, P (corresponding author), Univ Alberta, Div Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013	Lin, Liang-Tzung/0000-0001-7374-7234; Power, Christopher/0000-0002-5131-9711	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR) [HET-85517]	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	PV holds a fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR). CP holds a Canada Research Chair (CRC) (Tier 1) in Neurological Infection and Immunity and an AHFMR Senior Scholarship. BA holds an AHFMR Senior Scholarship. This study was supported by an Emerging Team Grant (HET-85517) from the Canadian Institutes of Health Research (CIHR). The authors have no financial interests. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afkhami-Goli A, 2009, J NEUROVIROL, V15, P139, DOI 10.1080/13550280802534763; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Anthony IC, 2008, FRONT BIOSCI-LANDMRK, V13, P1294, DOI 10.2741/2762; Apolinario A, 2005, J VIRAL HEPATITIS, V12, P27, DOI 10.1111/j.1365-2893.2005.00540.x; Barbasz A, 2008, INT IMMUNOPHARMACOL, V8, P211, DOI 10.1016/j.intimp.2007.08.002; Boddi M, 2010, J CLIN VIROL, V47, P72, DOI 10.1016/j.jcv.2009.10.005; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Clifford DB, 2005, J NEUROVIROL, V11, P67, DOI 10.1080/13550280500513762; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; Dijkstra S, 2000, J COMP NEUROL, V428, P266, DOI 10.1002/1096-9861(20001211)428:2<266::AID-CNE6>3.0.CO;2-0; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Duffy HS, 2000, J NEUROSCI, V20; Eisen-Vandervelde AL, 2004, CLIN IMMUNOL, V111, P16, DOI 10.1016/j.clim.2003.12.003; Fernando LP, 2003, THROMB HAEMOSTASIS, V90, P787, DOI 10.1160/TH03-04-0231; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2008, J HEPATOL, V49, P316, DOI 10.1016/j.jhep.2008.03.022; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hilsabeck RC, 2005, CLIN INFECT DIS, V41, pS38, DOI 10.1086/429494; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2001, ANN NEUROL, V49, P230, DOI 10.1002/1531-8249(20010201)49:2<230::AID-ANA43>3.0.CO;2-O; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Jones R, 2005, INT J CLIN PRACT, V59, P1082, DOI 10.1111/j.1742-1241.2005.00596.x; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Klein RS, 2004, J CELL BIOCHEM, V92, P213, DOI 10.1002/jcb.20052; Laskus T, 2005, AIDS, V19, pS140, DOI 10.1097/01.aids.0000192083.41561.00; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Moorman JP, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-105; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Mukaida N, 2000, INT J HEMATOL, V72, P391; Murray J, 2008, J NEUROVIROL, V14, P17, DOI 10.1080/13550280701708427; NOORBAKHSH F, FASEB J; Orvedahl A, 2008, CELL MICROBIOL, V10, P1747, DOI 10.1111/j.1462-5822.2008.01175.x; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Power C, 1995, CURR TOP MICROBIOL, V202, P89; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Radkowski M, 2004, J GEN VIROL, V85, P47, DOI 10.1099/vir.0.19491-0; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; REFAELI Y, 1995, P NATL ACAD SCI USA, V92, P3621, DOI 10.1073/pnas.92.8.3621; Romanitan MO, 2007, J CELL MOL MED, V11, P569, DOI 10.1111/j.1582-4934.2007.00047.x; Ruggieri A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-21; Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C; Sanchez MJ, 2008, MED SCI MONITOR, V14, pRA55; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Soffredini R, 2004, AM J GASTROENTEROL, V99, P1738, DOI 10.1111/j.1572-0241.2004.30396.x; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Yuki N, 2006, J HEPATOL, V44, P302, DOI 10.1016/j.jhep.2005.10.014; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	73	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12856	10.1371/journal.pone.0012856	http://dx.doi.org/10.1371/journal.pone.0012856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877724	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900011
J	de Sousa, BC; Cunha, C				de Sousa, Bruno C.; Cunha, Celso			Development of Mathematical Models for the Analysis of Hepatitis Delta Virus Viral Dynamics	PLOS ONE			English	Article							B-VIRUS; COMBINATION THERAPY; REPLICATION; INFECTION; INTERFERON; LIVER; LAMIVUDINE; KINETICS; HBV; ANTIGEN	Background: Mathematical models have shown to be extremely helpful in understanding the dynamics of different virus diseases, including hepatitis B. Hepatitis D virus (HDV) is a satellite virus of the hepatitis B virus (HBV). In the liver, production of new HDV virions depends on the presence of HBV. There are two ways in which HDV can occur in an individual: coinfection and super-infection. Co-infection occurs when an individual is simultaneously infected by HBV and HDV, while super-infection occurs in persons with an existing chronic HBV infection. Methodology/Principal Findings: In this work a mathematical model based on differential equations is proposed for the viral dynamics of the hepatitis D virus (HDV) across different scenarios. This model takes into consideration the knowledge of the biology of the virus and its interaction with the host. In this work we will present the results of a simulation study where two scenarios were considered, co-infection and super-infection, together with different antiviral therapies. Although, in general the predicted course of HDV infection is similar to that observed for HBV, we observe a faster increase in the number of HBV infected cells and viral load. In most tested scenarios, the number of HDV infected cells and viral load values remain below corresponding predicted values for HBV. Conclusions/Significance: The simulation study shows that, under the most commonly used and generally accepted therapy approaches for HDV infection, such as lamivudine (LMV) or ribavirine, peggylated alpha-interferon (IFN) or a combination of both, LMV monotherapy and combination therapy of LMV and IFN were predicted to more effectively reduce the HBV and HDV viral loads in the case of super-infection scenarios when compared with the co-infection. In contrast, IFN monotherapy was found to reduce the HDV viral load more efficiently in the case of super-infection while the effect on the HBV viral load was more pronounced during co-infection. The results suggest that there is a need for development of high efficacy therapeutic approaches towards the specific inhibition of HDV replication. These approaches may additionally be directed to the reduction of the half-life of infected cells and life-span of newly produced circulating virions.	[de Sousa, Bruno C.] Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Unit Epidemiol & Biostat,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Cunha, Celso] Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Mol Biol Unit,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	de Sousa, BC (corresponding author), Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Unit Epidemiol & Biostat,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	bruno.desousa@ihmt.unl.pt	de Sousa, Bruno/S-2600-2019; Cunha, Celso/I-2371-2012; de Sousa, Bruno/A-1654-2012	Cunha, Celso/0000-0003-4745-3819; de Sousa, Bruno/0000-0001-9918-8100	MCI [MTM2008-01603]	MCI	This work was supported in part by MCI grant MTM2008-01603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI L, 1980, VIRUS LIVER; BLIKKENDAALLIEFTINCK LF, 1977, EXP MOL PATHOL, V26, P184, DOI 10.1016/0014-4800(77)90048-X; Brunetto MR, 2009, WORLD J GASTROENTERO, V15, P531, DOI 10.3748/wjg.15.531; Casey J, 2005, ANTIMICROB AGENTS CH, V49, P4396, DOI 10.1128/AAC.49.10.4396-4399.2005; Chien RN, 2008, HEPATOL INT, V2, P296, DOI 10.1007/s12072-008-9066-1; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Colombatto P, 2006, ANTIVIR THER, V11, P197; D'Ugo E, 2008, ARCH VIROL, V153, P2069, DOI 10.1007/s00705-008-0236-1; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; GOVINDARAJAN J, 1993, PROG CLIN BIOL, V382, P139; GOVINDARAJAN S, 2005, HEPATOLOGY, V11, P703; Gozlan J, 2009, J HEPATOL, V50, P432, DOI 10.1016/j.jhep.2008.05.029; GRISHAM JW, 1962, CANCER RES, V22, P842; Gudima S, 2002, J VIROL, V76, P3709, DOI 10.1128/JVI.76.8.3709-3719.2002; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; HADZIYANNIS SJ, 1985, HEPATOLOGY, V5, P544, DOI 10.1002/hep.1840050404; HANSSON BG, 1982, J INFECT DIS, V146, P472, DOI 10.1093/infdis/146.4.472; HOOFNAGLE J, 1987, HEPATITIS DELTA VIRU; Hsieh TH, 2006, J FORMOS MED ASSOC, V105, P869, DOI 10.1016/S0929-6646(09)60172-8; JACOBSON IM, 1985, HEPATOLOGY, V5, P188, DOI 10.1002/hep.1840050205; KROGSGAARD K, 1987, HEPATOLOGY, V7, P42, DOI 10.1002/hep.1840070110; Lau DTY, 1999, GASTROENTEROLOGY, V117, P1229, DOI 10.1016/S0016-5085(99)70409-9; Lau DTY, 1999, HEPATOLOGY, V30, P546, DOI 10.1002/hep.510300217; Lewin SR, 2001, HEPATOLOGY, V34, P1012, DOI 10.1053/jhep.2001.28509; LIANJIE H, 1990, J HUAZHONG U SCI TEC, V10, P65; Mathurin P, 2000, J VIRAL HEPATITIS, V7, P15; Niro GA, 2005, J VIRAL HEPATITIS, V12, P2, DOI 10.1111/j.1365-2893.2005.00601.x; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P1107, DOI 10.1590/S0100-879X1999000900009; PONZETTO A, 1985, European Journal of Epidemiology, V1, P257, DOI 10.1007/BF00237100; Ribeiro RM, 2002, MICROBES INFECT, V4, P829, DOI 10.1016/S1286-4579(02)01603-9; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakugawa H, 2001, J MED VIROL, V65, P478, DOI 10.1002/jmv.2061; Schaper M, 2010, J HEPATOL, V52, P658, DOI 10.1016/j.jhep.2009.10.036; SMEDILE A, 1991, HEPATOLOGY, V13, P413; Su CW, 2006, GASTROENTEROLOGY, V130, P1625, DOI 10.1053/j.gastro.2006.01.035; Taylor JM, 2006, CURR TOP MICROBIOL, V307, P1; Taylor JM, 2003, TRENDS MICROBIOL, V11, P185, DOI 10.1016/S0966-842X(03)00045-3; THOMAS HC, 1987, HEPATITIS DELTA VIRU; Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626; TSIANG M, 2004, METHODS MOL MED HEPA, V2, P361; Wolters LMM, 2000, J VIRAL HEPATITIS, V7, P428, DOI 10.1046/j.1365-2893.2000.00254.x; WU JC, 1995, LANCET, V346, P939, DOI 10.1016/S0140-6736(95)91558-3; Xiridou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005247; Yamashiro T, 2004, J INFECT DIS, V189, P1151, DOI 10.1086/382133; Yurdaydin C, 2002, J HEPATOL, V37, P266, DOI 10.1016/S0168-8278(02)00162-9	49	11	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12512	10.1371/journal.pone.0012512	http://dx.doi.org/10.1371/journal.pone.0012512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862328	gold, Green Published, Green Submitted			2022-12-25	WOS:000281864100002
J	Goncalves, MD; Pistilli, EE; Balduzzi, A; Birnbaum, MJ; Lachey, J; Khurana, TS; Ahima, RS				Goncalves, Marcus D.; Pistilli, Emidio E.; Balduzzi, Anthony; Birnbaum, Morris J.; Lachey, Jennifer; Khurana, Tejvir S.; Ahima, Rexford S.			Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition	PLOS ONE			English	Article							MICE LACKING; MYOTUBE HYPERTROPHY; MYOSTATIN; KINASE; GROWTH; MASS; TRANSCRIPTION; ACTIVATION; ATROPHY; DIFFERENTIATION	Background: Akt is a critical mediator of developmental skeletal muscle growth. Treatment with a soluble ActRIIB fusion protein (ActRIIB-mFc) increases skeletal muscle mass and strength by inhibiting myostatin and related peptides. Recent in vitro studies have suggested that Akt signaling is necessary for the ability of ActRIIB inhibition to induce muscle hypertrophy. Thus, we hypothesized that mice deficient in either Akt1 or Akt2 would not respond to in vivo inhibition of ActRIIB with ActRIIB-mFc treatment. Methodology and Principal Findings: We analyzed body composition and muscle parameters in wild-type C57BL/6J and Akt1 and Akt2 knockout mice, and compared the responses to blockade of ActRIIB signaling via ActRIIB-mFc treatment. Mice lacking Akt1 or Akt2 had reduced muscle mass, grip strength and contractile force. However, deficiency of Akt1 or Akt2 did not prevent the ability of ActRIIB-mFc treatment to induce muscle hypertrophy, or increase grip strength and contractile force. Akt1 and Akt2 deficient mice responded similarly as wild type mice to ActRIIB-mFc treatment by increasing fiber size. Conclusions and Significance: Akt1 and Akt2 are important for the regulation of skeletal muscle mass and function. However, these Akt isoforms are not essential for the ability of ActRIIB inhibition to regulate muscle size, fiber type, strength or contractile force.	[Goncalves, Marcus D.; Balduzzi, Anthony; Birnbaum, Morris J.; Ahima, Rexford S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Pistilli, Emidio E.; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Pistilli, Emidio E.; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Goncalves, Marcus D.; Birnbaum, Morris J.; Ahima, Rexford S.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lachey, Jennifer] Acceleron Pharma, Cambridge, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Acceleron Pharma	Goncalves, MD (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	ahima@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Goncalves, Marcus/L-6073-2019	Goncalves, Marcus/0000-0002-0784-9248; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [RO1-DK062348, PO1-DK-049210]; World Anti-Doping Agency Institution [801619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK062348, P01DK049210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Anti-Doping Agency Institution; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants: RO1-DK062348 and PO1-DK-049210 to R.S.A. and M.J.B., and the World Anti-Doping Agency Institution grant No: 801619 to T.S.K. Neither organization had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Body composition was assessed by the Penn Diabetes and Endocrinology Research Center (DERC) Mouse Metabolic Phenotyping Core (P30-DK50306). Acceleron Pharma was responsibile for the initial characterization of ActRIIB-mFc and reviewed the manuscript prior to submission.	AKPAN I, 2009, INT J OBES LOND; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Asmussen G, 2003, EXP NEUROL, V184, P758, DOI 10.1016/S0014-4886(03)00294-2; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; CADENA SM, J APPL PHYSL; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; Coffer PJ, 1998, BIOCHEM J, V335, P1; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hornberger TA, 2007, FEBS LETT, V581, P4562, DOI 10.1016/j.febslet.2007.08.045; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; NEMETH P, 1981, J PHYSIOL-LONDON, V320, P73, DOI 10.1113/jphysiol.1981.sp013935; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Sumitani S, 2002, ENDOCRINOLOGY, V143, P820, DOI 10.1210/en.143.3.820; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	41	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12707	10.1371/journal.pone.0012707	http://dx.doi.org/10.1371/journal.pone.0012707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856813	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800007
J	Spade, DJ; Griffitt, RJ; Liu, L; Brown-Peterson, NJ; Kroll, KJ; Feswick, A; Glazer, RA; Barber, DS; Denslow, ND				Spade, Daniel J.; Griffitt, Robert J.; Liu, Li; Brown-Peterson, Nancy J.; Kroll, Kevin J.; Feswick, April; Glazer, Robert A.; Barber, David S.; Denslow, Nancy D.			Queen Conch (Strombus gigas) Testis Regresses during the Reproductive Season at Nearshore Sites in the Florida Keys	PLOS ONE			English	Article							STUDYING ENDOCRINE DISRUPTION; GENE-EXPRESSION; REVERSE TRANSCRIPTION; SCHISTOSOMA-MANSONI; MESSENGER-RNA; HELIX-ASPERSA; MOLECULAR-CLONING; MICROARRAY DATA; STEM-CELL; DROSOPHILA	Background: Queen conch (Strombus gigas) reproduction is inhibited in nearshore areas of the Florida Keys, relative to the offshore environment where conchs reproduce successfully. Nearshore reproductive failure is possibly a result of exposure to environmental factors, including heavy metals, which are likely to accumulate close to shore. Metals such as Cu and Zn are detrimental to reproduction in many mollusks. Methodology/Principal Findings: Histology shows gonadal atrophy in nearshore conchs as compared to reproductively healthy offshore conchs. In order to determine molecular mechanisms leading to tissue changes and reproductive failure, a microarray was developed. A normalized cDNA library for queen conch was constructed and sequenced using the 454 Life Sciences GS-FLX pyrosequencer, producing 27,723 assembled contigs and 7,740 annotated transcript sequences. The resulting sequences were used to design the microarray. Microarray analysis of conch testis indicated differential regulation of 255 genes (p<0.01) in nearshore conch, relative to offshore. Changes in expression for three of four transcripts of interest were confirmed using real-time reverse transcription polymerase chain reaction. Gene Ontology enrichment analysis indicated changes in biological processes: respiratory chain (GO:0015992), spermatogenesis (GO:0007283), small GTPase-mediated signal transduction (GO:0007264), and others. Inductively coupled plasma-mass spectrometry analysis indicated that Zn and possibly Cu were elevated in some nearshore conch tissues. Conclusions/Significance: Congruence between testis histology and microarray data suggests that nearshore conch testes regress during the reproductive season, while offshore conch testes develop normally. Possible mechanisms underlying the testis regression observed in queen conch in the nearshore Florida Keys include a disruption of small GTPase (Ras)-mediated signaling in testis development. Additionally, elevated tissue levels of Cu (34.77 ng/mg in testis) and Zn (831.85 ng/mg in digestive gland, 83.96 ng/mg in testis) nearshore are similar to reported levels resulting in reproductive inhibition in other gastropods, indicating that these metals possibly contribute to NS conch reproductive failure.	[Spade, Daniel J.; Griffitt, Robert J.; Kroll, Kevin J.; Feswick, April; Barber, David S.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Spade, Daniel J.; Griffitt, Robert J.; Kroll, Kevin J.; Feswick, April; Barber, David S.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Liu, Li] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Brown-Peterson, Nancy J.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA; [Glazer, Robert A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Southern Mississippi; Florida Fish & Wildlife Conservation Commission	Spade, DJ (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.	ndenslow@ufl.edu		Spade, Daniel/0000-0002-4694-8724; kroll, kevin j/0000-0002-5374-6733	United States Environmental Protection Agency [X7974799-03]; Florida Fish and Wildlife Conservation Commission [F2410, NG06-106]; University of Florida College of Veterinary Medicine; University of Florida	United States Environmental Protection Agency(United States Environmental Protection Agency); Florida Fish and Wildlife Conservation Commission; University of Florida College of Veterinary Medicine(University of Florida); University of Florida(University of Florida)	This project was funded by the following sources: The United States Environmental Protection Agency (www.epa.gov; # X7974799-03), Florida Fish and Wildlife Conservation Commission (www.myfwc.com; # F2410 and # NG06-106) and the University of Florida College of Veterinary Medicine (www.vetmed.ufl.edu). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Aldana-Aranda, 2003, CARACOL STROMBUS GIG, P73; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BUCHARDT B, 1978, SCIENCE, V199, P291, DOI 10.1126/science.199.4326.291; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Carnahan EA, 2008, J COASTAL RES, V24, P159, DOI 10.2112/06-0666.1; CHAKALALL B, 2007, WORLD MARKETS IND SE; Coeurdassier M, 2005, ENVIRON TOXICOL CHEM, V24, P198, DOI 10.1897/03-505.1; DAVIS M, 2000, RECENT ADV MARINE BI, V4, P27; Delgado GA, 2004, FISH B-NOAA, V102, P278; Desouky MMA, 2006, AQUAT TOXICOL, V77, P143, DOI 10.1016/j.aquatox.2005.11.009; Dillon GP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000240; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Ducrot V, 2007, ENVIRON TOXICOL CHEM, V26, P1774, DOI 10.1897/06-556R.1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erkan M, 2002, TISSUE CELL, V34, P262, DOI 10.1016/S0040-8166(02)00016-2; Farmerie WG, 2005, DATA KNOWL ENG, V53, P75, DOI 10.1016/j.datak.2004.06.014; Fitzpatrick JM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000323; Garcia-Reyero N, 2008, J FISH BIOL, V72, P2354, DOI 10.1111/j.1095-8649.2008.01904.x; Gimbert F, 2008, ENVIRON TOXICOL CHEM, V27, P1284, DOI 10.1897/07-503; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; GROPPE JC, 1993, ANAL BIOCHEM, V210, P337, DOI 10.1006/abio.1993.1205; Gros O, 2009, J MOLLUS STUD, V75, P59, DOI 10.1093/mollus/eyn041; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Guiller A, 2006, GENET RES, V88, P27, DOI 10.1017/S0016672306008305; Iguchi T, 2007, GEN COMP ENDOCR, V153, P25, DOI 10.1016/j.ygcen.2007.01.013; Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061; ISHIKAWA H, 1977, COMP BIOCHEM PHYS B, V58, P1, DOI 10.1016/0305-0491(77)90116-X; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; KOFOED TMN, 2010, 4 WORKSH GON HIST FI, P83; KRUCZYNSKI WL, 1999, WATER QUALITY CONCER; Laskowski R, 1996, ECOTOX ENVIRON SAFE, V34, P59, DOI 10.1006/eesa.1996.0045; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lee YS, 2008, P NATL ACAD SCI USA, V105, P18602, DOI 10.1073/pnas.0808893105; Lewis MA, 2007, ENVIRON POLLUT, V146, P206, DOI 10.1016/j.envpol.2006.04.041; Li L, 2009, MOL BIOL REP, V36, P1023, DOI 10.1007/s11033-008-9276-6; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Nishida H, 2002, BIOESSAYS, V24, P613, DOI 10.1002/bies.10099; NOTT JA, 1990, J MAR BIOL ASSOC UK, V70, P905, DOI 10.1017/S0025315400059130; O'Keefe DD, 2009, DEV BIOL, V333, P143, DOI 10.1016/j.ydbio.2009.06.032; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Reeve S, 2007, GENESIS, V45, P66, DOI 10.1002/dvg.20265; Rogevich EC, 2009, ARCH ENVIRON CON TOX, V56, P450, DOI 10.1007/s00244-008-9231-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Singh Shree Ram, 2008, V450, P45, DOI 10.1007/978-1-60327-214-8_3; Snyman RG, 2004, B ENVIRON CONTAM TOX, V73, P398, DOI 10.1007/s00128-004-0442-9; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Rensburg MJ, 2009, FISH SHELLFISH IMMUN, V26, P171, DOI 10.1016/j.fsi.2008.09.016; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Waisberg M, 2008, EXP PARASITOL, V120, P357, DOI 10.1016/j.exppara.2008.09.005; Yaffe MP, 1997, CURR BIOL, V7, pR782, DOI 10.1016/S0960-9822(06)00404-0; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Yang HM, 2005, DNA SEQUENCE, V16, P166, DOI 10.1080/10425170500129736	63	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12737	10.1371/journal.pone.0012737	http://dx.doi.org/10.1371/journal.pone.0012737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856805	Green Submitted, gold, Green Published			2022-12-25	WOS:000281815800016
J	Edwards, RD; Roff, J				Edwards, Ryan D.; Roff, Jennifer			Negative Effects of Paternal Age on Children's Neurocognitive Outcomes Can Be Explained by Maternal Education and Number of Siblings	PLOS ONE			English	Article							SCHIZOPHRENIA; ACHIEVEMENT; FAMILY; MATTER; TIME	Background: Recent findings suggest advanced paternal age may be associated with impaired child outcomes, in particular, neurocognitive skills. Such patterns are worrisome given relatively universal trends in advanced countries toward delayed nuptiality and fertility. But nature and nurture are both important for child outcomes, and it is important to control for both when drawing inferences about either pathway. Methods and Findings: We examined cross-sectional patterns in six developmental outcome measures among children in the U. S. Collaborative Perinatal Project (n = 31,346). Many of these outcomes at 8 mo, 4 y, and 7 y of age (Bayley scales, Stanford Binet Intelligence Scale, Graham-Ernhart Block Sort Test, Wechsler Intelligence Scale for Children, Wide Range Achievement Test) are negatively correlated with paternal age when important family characteristics such as maternal education and number of siblings are not included as covariates. But controlling for family characteristics in general and mother's education in particular renders the effect of paternal age statistically insignificant for most developmental measures. Conclusions: Assortative mating produces interesting relationships between maternal and paternal characteristics that can inject spurious correlation into observational studies via omitted variable bias. Controlling for both nature and nurture reveals little residual evidence of a link between child neurocognitive outcomes and paternal age in these data. Results suggest that benefits associated with the upward trend in maternal education may offset any negative effects of advancing paternal age.	[Edwards, Ryan D.; Roff, Jennifer] CUNY, Queens Coll, Dept Econ, Flushing, NY USA; [Edwards, Ryan D.; Roff, Jennifer] CUNY, Grad Ctr, Flushing, NY USA; [Edwards, Ryan D.] Natl Bur Econ Res, Cambridge, MA 02138 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; National Bureau of Economic Research	Edwards, RD (corresponding author), CUNY, Queens Coll, Dept Econ, Flushing, NY USA.	redwards@qc.cuny.edu			Queens College, City University of New York	Queens College, City University of New York	The authors are supported as instructional research faculty of Queens College, City University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P693; Bianchi SM, 1997, J MARRIAGE FAM, V59, P332, DOI 10.2307/353474; Cannon M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000042; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; Fischer CS., 2006, CENTURY DIFFERENCE; Goldin C, 2006, AM ECON REV, V96, P1, DOI 10.1257/000282806777212350; Hamilton BE, 2006, INT J ANDROL, V29, P34, DOI 10.1111/j.1365-2605.2005.00638.x; Hardy JB, 2003, ANN EPIDEMIOL, V13, P303, DOI 10.1016/S1047-2797(02)00479-9; Hsin A, 2009, SOC INDIC RES, V93, P123, DOI 10.1007/s11205-008-9413-6; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; LEIBOWITZ A, 1977, J HUM RESOUR, V12, P242, DOI 10.2307/145387; LEIBOWITZ A, 1974, J POLITICAL EC, V82, P111, DOI DOI 10.1086/260295; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; *NAT CTR HLTH STAT, 2006, DAT FIL DOC NAT DAT; Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Pencavel J, 1998, AM ECON REV, V88, P326; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; White KM, 2002, POPUL DEV REV, V28, P59, DOI 10.1111/j.1728-4457.2002.00059.x	21	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12157	10.1371/journal.pone.0012157	http://dx.doi.org/10.1371/journal.pone.0012157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZO	20856853	Green Published, gold			2022-12-25	WOS:000281815700001
J	Godmann, M; May, E; Kimmins, S				Godmann, Maren; May, Erin; Kimmins, Sarah			Epigenetic Mechanisms Regulate Stem Cell Expressed Genes Pou5f1 and Gfra1 in a Male Germ Cell Line	PLOS ONE			English	Article							HISTONE H3 METHYLTRANSFERASE; INHIBITOR TRICHOSTATIN-A; CONTROLS DNA METHYLATION; SELF-RENEWAL; C-KIT; TRANSCRIPTION FACTOR; DEMETHYLASE LSD1; MOUSE SPERMATOGENESIS; CONTAINING COMPLEXES; MEIOTIC PROPHASE	Male fertility is declining and an underlying cause may be due to environment-epigenetic interactions in developing sperm, yet nothing is known of how the epigenome controls gene expression in sperm development. Histone methylation and acetylation are dynamically regulated in spermatogenesis and are sensitive to the environment. Our objectives were to determine how histone H3 methylation and acetylation contribute to the regulation of key genes in spermatogenesis. A germ cell line, GC-1, was exposed to either the control, or the chromatin modifying drugs tranylcypromine (T), an inhibitor of the histone H3 demethylase KDM1 (lysine specific demethylase 1), or trichostatin (TSA), an inhibitor of histone deacetylases, (HDAC). Quantitative PCR (qPCR) was used to identify genes that were sensitive to treatment. As a control for specificity the Myod1 (myogenic differentiation 1) gene was analyzed. Chromatin immunoprecipitation (ChIP) followed by qPCR was used to measure histone H3 methylation and acetylation at the promoters of target genes and the control, Myod1. Remarkably, the chromatin modifying treatment specifically induced the expression of spermatogonia expressed genes Pou5f1 and Gfra1. ChIP-qPCR revealed that induction of gene expression was associated with a gain in gene activating histone H3 methylation and acetylation in Pou5f1 and Gfra1 promoters, whereas CpG DNA methylation was not affected. Our data implicate a critical role for histone H3 methylation and acetylation in the regulation of genes expressed by spermatogonia - here, predominantly mediated by HDAC-containing protein complexes.	[Godmann, Maren; May, Erin; Kimmins, Sarah] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Kimmins, Sarah] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University	Godmann, M (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada.	sarah.kimmins@mcgill.ca	Godmann, Maren/B-5899-2016	Godmann, Maren/0000-0002-0214-8012; Kimmins, Sarah/0000-0002-0168-7233	Canadian Institutes of Health Research [82820]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research (SK grant # 82820). MG is supported by a post-doctoral fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 1996, INT J DEV BIOL, V40, P345; Behr R, 2002, MECH DEVELOP, V115, P167, DOI 10.1016/S0925-4773(02)00127-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DE ROOIJ DG, 2001, REPRODUCTION, V121, P347; DE ROOIJ DG, 2000, J ANDROL, V21, P776; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fenic I, 2004, J ANDROL, V25, P811; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GODMANN M, 2009, MICROSC RES TECH; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2009, MECH DEVELOP, V126, P650, DOI 10.1016/j.mod.2009.06.1081; GRIMES SR, 1984, EXP CELL RES, V152, P91, DOI 10.1016/0014-4827(84)90232-5; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; HINTZ M, 1977, DEV BIOL, V57, P375, DOI 10.1016/0012-1606(77)90222-6; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; MANOVA K, 1990, DEVELOPMENT, V110, P1057; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Medina V, 1997, CANCER RES, V57, P3697; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ohmura M, 2004, ARCH HISTOL CYTOL, V67, P285, DOI 10.1679/aohc.67.285; Ohta H, 2000, DEVELOPMENT, V127, P2125; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schmittwolf C, 2005, EMBO J, V24, P554, DOI 10.1038/sj.emboj.7600546; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SORRENTINO V, 1991, ONCOGENE, V6, P149; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Svechnikova I, 2008, INT J ONCOL, V32, P821; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Taylor SJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-5; Vincent S, 1998, DEVELOPMENT, V125, P4585; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Yeom YI, 1996, DEVELOPMENT, V122, P881; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	91	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12727	10.1371/journal.pone.0012727	http://dx.doi.org/10.1371/journal.pone.0012727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856864	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815700014
J	Jelsbak, L; Ingmer, H; Valihrach, L; Cohn, MT; Christiansen, MHG; Kallipolitis, BH; Frees, D				Jelsbak, Lotte; Ingmer, Hanne; Valihrach, Lukas; Cohn, Marianne Thorup; Christiansen, Mie H. G.; Kallipolitis, Birgitte H.; Frees, Dorte			The Chaperone ClpX Stimulates Expression of Staphylococcus aureus Protein A by Rot Dependent and Independent Pathways	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIRULENCE FACTOR; SPECIFICITY COMPONENT; GLOBAL REGULATOR; BINDING-PROTEIN; GENE-EXPRESSION; RNA; AGR; ROLES; IDENTIFICATION	The Clp ATPases (Hsp100) constitute a family of closely related proteins that have protein reactivating and remodelling activities typical of molecular chaperones. In Staphylococcus aureus the ClpX chaperone is essential for virulence and for transcription of spa encoding Protein A. The present study was undertaken to elucidate the mechanism by which ClpX stimulates expression of Protein A. For this purpose, we prepared antibodies directed against Rot, an activator of spa transcription, and demonstrated that cells devoid of ClpX contain three-fold less Rot than wild-type cells. By varying Rot expression from an inducible promoter we showed that expression of Protein A requires a threshold level of Rot. In the absence of ClpX the Rot content is reduced below this threshold level, hence, explaining the substantially reduced Protein A expression in the clpX mutant. Experiments addressed at pinpointing the role of ClpX in Rot synthesis revealed that ClpX is required for translation of Rot. Interestingly, translation of the spa mRNA was, like the rot mRNA, enhanced by ClpX. These data demonstrate that ClpX performs dual roles in regulating Protein A expression, as ClpX stimulates transcription of spa by enhancing translation of Rot, and that ClpX additionally is required for full translation of the spa mRNA. The current findings emphasize that ClpX has a central role in fine-tuning virulence regulation in S. aureus.	[Jelsbak, Lotte; Ingmer, Hanne; Valihrach, Lukas; Cohn, Marianne Thorup; Frees, Dorte] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Christiansen, Mie H. G.; Kallipolitis, Birgitte H.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Copenhagen; University of Southern Denmark	Jelsbak, L (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	df@life.ku.dk	Valihrach, Lukas/H-4368-2014	Valihrach, Lukas/0000-0002-6704-4337; Jelsbak, Lotte/0000-0002-6642-7424; Ingmer, Hanne/0000-0002-8350-5631; Kallipolitis, Birgitte H./0000-0003-1233-9776; Frees, Dorte/0000-0003-4946-2890	Danish Research Council on Technology and Production	Danish Research Council on Technology and Production	This work was supported by grants from the Danish Research Council on Technology and Production to Hanne Ingmer and Dorte Frees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Hartleib J, 2000, BLOOD, V96, P2149; Hsieh HY, 2008, J BACTERIOL, V190, P546, DOI 10.1128/JB.00536-07; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jelsbak L, 2005, J BACTERIOL, V187, P2105, DOI 10.1128/JB.187.6.2105-2112.2005; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; Kornblum J., 1990, MOL BIOL STAPHYLOCOC, P373; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 2006, STAPHYLOCOCCUS PATHO, P496; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wells DR, 1998, GENE DEV, V12, P3236, DOI 10.1101/gad.12.20.3236; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	47	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12752	10.1371/journal.pone.0012752	http://dx.doi.org/10.1371/journal.pone.0012752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856878	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815700026
J	Brisbin, A; Weissman, MM; Fyer, AJ; Hamilton, SP; Knowles, JA; Bustamante, CD; Mezey, JG				Brisbin, Abra; Weissman, Myrna M.; Fyer, Abby J.; Hamilton, Steven P.; Knowles, James A.; Bustamante, Carlos D.; Mezey, Jason G.			Bayesian Linkage Analysis of Categorical Traits for Arbitrary Pedigree Designs	PLOS ONE			English	Article							CHAIN MONTE-CARLO; ORDINAL TRAITS; GENERAL PEDIGREES; LOCI; ASSOCIATION; STRATEGIES; INFERENCE; FAMILIES; CROSSES; MODELS	Background: Pedigree studies of complex heritable diseases often feature nominal or ordinal phenotypic measurements and missing genetic marker or phenotype data. Methodology: We have developed a Bayesian method for Linkage analysis of Ordinal and Categorical traits (LOCate) that can analyze complex genealogical structure for family groups and incorporate missing data. LOCate uses a Gibbs sampling approach to assess linkage, incorporating a simulated tempering algorithm for fast mixing. While our treatment is Bayesian, we develop a LOD (log of odds) score estimator for assessing linkage from Gibbs sampling that is highly accurate for simulated data. LOCate is applicable to linkage analysis for ordinal or nominal traits, a versatility which we demonstrate by analyzing simulated data with a nominal trait, on which LOCate outperforms LOT, an existing method which is designed for ordinal traits. We additionally demonstrate our method's versatility by analyzing a candidate locus (D2S1788) for panic disorder in humans, in a dataset with a large amount of missing data, which LOT was unable to handle. Conclusion: LOCate's accuracy and applicability to both ordinal and nominal traits will prove useful to researchers interested in mapping loci for categorical traits.	[Brisbin, Abra; Bustamante, Carlos D.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Weissman, Myrna M.; Fyer, Abby J.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Weissman, Myrna M.; Fyer, Abby J.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Hamilton, Steven P.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Knowles, James A.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Mezey, Jason G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Cornell University; Columbia University; New York State Psychiatry Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; Stanford University; Cornell University	Brisbin, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	agb36@cornell.edu		Weissman, Myrna/0000-0003-3490-3075; Hamilton, Steven/0000-0001-8106-6260; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health (NIH) [R01 GM083606, N01-HG-65403]; National Institute of Mental Health (NIMH) [MH28274, MH37592, MH30906, MH48858]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030906, R01MH048858, R37MH028274, P50MH030906, R01MH028274, P01MH037592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by National Institutes of Health (NIH), www.nih.gov, grant R01 GM083606 and National Institute of Mental Health (NIMH), www.nimh.nih.gov, grants MH28274 (to MMW), MH37592 (to AJF), MH30906 (to DFK and AJF), and MH48858 (to SEH). Genotyping services were provided to JAK by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to Johns Hopkins University, contract number N01-HG-65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; *AM, 2010, AM EL COMP CLOUD; CHURCHILL GA, 1994, GENETICS, V138, P963; Corbett J, 2004, HUM HERED, V57, P21, DOI 10.1159/000077386; Diao G, 2010, GENET EPIDEMIOL, V34, P232, DOI 10.1002/gepi.20453; Dupuis J, 2009, GENET EPIDEMIOL, V33, P617, DOI 10.1002/gepi.20413; Feng R, 2004, P NATL ACAD SCI USA, V101, P16739, DOI 10.1073/pnas.0404623101; Fishelson M., 2002, BIOINFORMATICS, V18, pS189, DOI [10.1093/bioinformatics/18.suppl_1.S189, DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S189]; Fyer AJ, 2006, BIOL PSYCHIAT, V60, P388, DOI 10.1016/j.biopsych.2006.04.018; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; GEYER CJ, 1991, 568 U MINN SCH STAT; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; Hayashi T, 2006, HEREDITY, V96, P185, DOI 10.1038/sj.hdy.6800783; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Jordan MI, 2004, STAT SCI, V19, P140, DOI 10.1214/088342304000000026; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li J, 2006, GENETICS, V173, P1649, DOI 10.1534/genetics.105.054619; Mackay DJC, 1998, NATO ADV SCI I D-BEH, V89, P175; Pritchard JK, 2000, GENETICS, V155, P945; Rao SQ, 1998, HEREDITY, V81, P214, DOI 10.1038/sj.hdy.6883780; Rao SQ, 2000, GENETICA, V109, P183, DOI 10.1023/A:1017507624695; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.1093/biomet/77.3.663; THOMAS A, 1994, IMA J MATH APPL MED, V11, P79; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; THOMAS DC, 1996, MARKOV CHAIN MONTE C, P419; Wang XQ, 2006, GENET EPIDEMIOL, V30, P728, DOI 10.1002/gepi.20184; Xu C, 2005, HEREDITY, V94, P119, DOI 10.1038/sj.hdy.6800583; Xu S, 2006, HEREDITY, V97, P409, DOI 10.1038/sj.hdy.6800885; Yandell BS, 2007, BIOINFORMATICS, V23, P641, DOI 10.1093/bioinformatics/btm011; Yi NJ, 2007, GENETICS, V176, P1855, DOI 10.1534/genetics.107.071142; Yi NJ, 2004, BEHAV GENET, V34, P3, DOI 10.1023/B:BEGE.0000009473.43185.43; Zhang HP, 2006, GENETICS, V172, P693, DOI 10.1534/genetics.105.049122; Zhang MZ, 2008, BIOINFORMATICS, V24, P1737, DOI 10.1093/bioinformatics/btn258	38	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12307	10.1371/journal.pone.0012307	http://dx.doi.org/10.1371/journal.pone.0012307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865038	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100005
J	Khandelwal, G; Bhyravabhotla, J				Khandelwal, Garima; Bhyravabhotla, Jayaram			A Phenomenological Model for Predicting Melting Temperatures of DNA Sequences	PLOS ONE			English	Article							HELIX-COIL TRANSITION; THERMAL-DENATURATION; BASE-PAIRS; STABILITY; DUPLEX; STACKING; DYNAMICS; THERMODYNAMICS; RECOGNITION; OLIGOMERS	We report here a novel method for predicting melting temperatures of DNA sequences based on a molecular-level hypothesis on the phenomena underlying the thermal denaturation of DNA. The model presented here attempts to quantify the energetic components stabilizing the structure of DNA such as base pairing, stacking, and ionic environment which are partially disrupted during the process of thermal denaturation. The model gives a Pearson product-moment correlation coefficient (r) of similar to 0.98 between experimental and predicted melting temperatures for over 300 sequences of varying lengths ranging from 15-mers to genomic level and at different salt concentrations. The approach is implemented as a web tool (www.scfbio-iitd.res.in/chemgenome/Tm_predictor.jsp) for the prediction of melting temperatures of DNA sequences.	[Khandelwal, Garima; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Khandelwal, Garima; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India; [Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Khandelwal, G (corresponding author), Indian Inst Technol Delhi, Dept Chem, New Delhi, India.	bjayaram@chemistry.iitd.ac.in	Jayaram, B/G-9130-2011	Jayaram, B/0000-0002-5495-2213	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	The funding for the work has been provided by the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN SOFTW LTD, AN IT MICR EXC VERS; Arora N, 1998, J PHYS CHEM B, V102, P6139, DOI 10.1021/jp9813692; Barbi M, 1999, PHYS LETT A, V253, P358, DOI 10.1016/S0375-9601(99)00059-6; Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; BLAKE RD, 1987, BIOPOLYMERS, V26, P1063, DOI 10.1002/bip.360260706; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Campa A, 1998, PHYS REV E, V58, P3585, DOI 10.1103/PhysRevE.58.3585; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; DAUXOIS T, 1993, PHYS REV E, V47, pR44, DOI 10.1103/PhysRevE.47.R44; DELCOURT SG, 1991, J BIOL CHEM, V266, P15160; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; DOKTYCZ MJ, 1995, J BIOL CHEM, V270, P8439, DOI 10.1074/jbc.270.15.8439; Dutta S, 2006, J CHEM INF MODEL, V46, P78, DOI 10.1021/ci050119x; Eldrup AB, 2002, J AM CHEM SOC, V124, P3254, DOI 10.1021/ja0117027; FRANKKAMENETSKII M, 1987, NATURE, V328, P17, DOI 10.1038/328017a0; Grigoryan AV, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2727456; Guckian KM, 1996, J AM CHEM SOC, V118, P8182, DOI 10.1021/ja961733f; Haaima G, 1997, NUCLEIC ACIDS RES, V25, P4639, DOI 10.1093/nar/25.22.4639; JAYARAM B, 1990, J PHYS CHEM-US, V94, P4666, DOI 10.1021/j100374a055; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; Jayaram B, 1997, J MOL EVOL, V45, P704, DOI 10.1007/PL00013144; Jiranusornkul S, 2008, J R SOC INTERFACE, V5, pS191, DOI 10.1098/rsif.2008.0304.focus; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kim JY, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2827471; Kohandel M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011905; Lafontaine I, 2000, BIOPHYS J, V79, P680, DOI 10.1016/S0006-3495(00)76326-0; Lewin B, 2004, GENE 8, VVIII; Licinio P, 2007, BIOPHYS J, V92, P2000, DOI 10.1529/biophysj.106.095059; LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MANDEL M, 1970, J BACTERIOL, V101, P333, DOI 10.1128/JB.101.2.333-338.1970; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Movileanu L, 2002, NUCLEIC ACIDS RES, V30, P3767, DOI 10.1093/nar/gkf471; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; OWEN RJ, 1982, J GEN MICROBIOL, V128, P2945; Panjkovich A, 2005, BIOINFORMATICS, V21, P711, DOI 10.1093/bioinformatics/bti066; PETRUSKA J, 1995, J BIOL CHEM, V270, P746, DOI 10.1074/jbc.270.2.746; PEYRARD M, 1993, PHYSICA D, V68, P104, DOI 10.1016/0167-2789(93)90035-Y; PORSCHKE D, 1971, BIOPOLYMERS, V10, P1989, DOI 10.1002/bip.360101016; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; PULLMAN B, 1966, J MOL BIOL, V22, P373, DOI 10.1016/0022-2836(66)90141-0; Rezac J, 2007, CHEM-EUR J, V13, P2983, DOI 10.1002/chem.200601120; Sandman K, 2000, ARCH MICROBIOL, V173, P165, DOI 10.1007/s002039900122; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Shaikh SA, 2007, J MED CHEM, V50, P2240, DOI 10.1021/jm060542c; SINDEN RR, 1997, CELL, V89, P999; Singhal P, 2008, BIOPHYS J, V94, P4173, DOI 10.1529/biophysj.107.116392; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Sundaralingam M, 2004, BIOCHEMISTRY-US, V43, P16467, DOI 10.1021/bi048158+; USSERY DW, 2001, DNA DENATURATION; Vamosi G, 2008, J PHYS CHEM B, V112, P13136, DOI 10.1021/jp8034055; WADA A, 1980, CRC CR REV BIOCH MOL, V9, P87, DOI 10.3109/10409238009105432; WADA A, 1986, PROG BIOPHYS MOL BIO, V47, P113, DOI 10.1016/0079-6107(86)90012-X; WARTELL RM, 1985, PHYS REP, V126, P67, DOI 10.1016/0370-1573(85)90060-2; Weber G, 2006, NAT PHYS, V2, P55, DOI 10.1038/nphys189; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zhang YL, 1997, PHYS REV E, V56, P7100, DOI 10.1103/PhysRevE.56.7100; ZIMM BH, 1960, J CHEM PHYS, V33, P1349, DOI 10.1063/1.1731411	59	40	42	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12433	10.1371/journal.pone.0012433	http://dx.doi.org/10.1371/journal.pone.0012433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865157	Green Submitted, Green Published, gold			2022-12-25	WOS:000281292100026
J	Sawesi, O; Spillmann, D; Lunden, A; Wernersson, S; Abrink, M				Sawesi, Osama; Spillmann, Dorothe; Lunden, Anna; Wernersson, Sara; Abrink, Magnus			Serglycin-independent Release of Active Mast Cell Proteases in Response to Toxoplasma gondii Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULE; CARBOXYPEPTIDASE-A; TRICHINELLA-SPIRALIS; TRYPTASE MMCP-6; INNATE IMMUNITY; MICE LACKING; IN-VITRO; HEPARIN; PROTEOGLYCAN; MOUSE	Earlier studies identified serglycin proteoglycan and its heparin chains to be important for storage and activity of mast cell proteases. However, the importance of serglycin for secretion and activity of mast cell proteases in response to parasite infection has been poorly investigated. To address this issue, we studied the effects on mast cell proteases in serglycin-deficient and wild type mice after peritoneal infection with the obligate intracellular parasite Toxoplasma gondii. In line with previous results, we found severely reduced levels of cell-bound mast cell proteases in both noninfected and infected serglycin-deficient mice. However, serglycin-deficient mice secreted mast cell proteases at wild type levels at the site of infection, and enzymatic activities associated with mast cell proteases were equally up-regulated in wild type and serglycin-deficient mice 48 h after infection. In both wild type and serglycin-deficient mice, parasite infection resulted in highly increased extracellular levels of glycosaminoglycans, including hyaluronan and chondroitin sulfate A, suggesting a role of these substances in the general defense mechanism. In contrast, heparan sulfate/heparin was almost undetectable in serglycin-deficient mice, and in wild type mice, it was mainly confined to the cellular fraction and was not increased upon infection. Furthermore, the heparan sulfate/heparin population was less sulfated in serglycin-deficient than in wild type mice indicative for the absence of heparin, which supports that heparin production is dependent on the serglycin core protein. Together, our results suggest that serglycin proteoglycan is dispensable for normal secretion and activity of mast cell proteases in response to peritoneal infection with T. gondii.	[Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, SE-75123 Uppsala, Sweden; [Lunden, Anna] Sect Parasitol SWEPAR, Dept Biomed Sci & Vet Publ Hlth, SE-75189 Uppsala, Sweden; [Sawesi, Osama; Wernersson, Sara] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Abrink, M (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC, Box 582, SE-75123 Uppsala, Sweden.	Magnus.Abrink@imbim.uu.se	Wernersson, Sara/D-4580-2011; Lunden, Anna/H-3778-2012; Wernersson, Sara/N-8830-2019; Åbrink, Magnus/AAK-8346-2020	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Abrink, Magnus/0000-0002-1335-3927	FORMAS; Goran Gustafsson Foundation; Medical Research Council; Ivar and Elsa Sandberg Foundation; Polysackaridforskning AB; Vardal Foundation; Libyan Higher Education Board	FORMAS(Swedish Research Council Formas); Goran Gustafsson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ivar and Elsa Sandberg Foundation; Polysackaridforskning AB(HOGANAS ABStatisticon AB); Vardal Foundation; Libyan Higher Education Board	This work was supported by FORMAS (to M.A.), the Goran Gustafsson Foundation (to M.A.), the Medical Research Council (to M.A.), the Ivar and Elsa Sandberg Foundation (to A.L.), Polysackaridforskning AB (to D.S.), and the Vardal Foundation (to S.W.).; Supported by the Libyan Higher Education Board.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Bjorkman C, 1998, INT J PARASITOL, V28, P187, DOI 10.1016/S0020-7519(97)00174-4; Bliss SK, 1999, J IMMUNOL, V163, P2081; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Ferreira GLS, 2004, MICROBES INFECT, V6, P172, DOI 10.1016/j.micinf.2003.11.007; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hallgren J, 2001, BIOCHEMISTRY-US, V40, P7342, DOI 10.1021/bi001988c; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Lawrence CE, 2004, GASTROENTEROLOGY, V127, P155, DOI 10.1053/j.gastro.2004.04.004; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LeDoux JM, 1996, J VIROL, V70, P6468, DOI 10.1128/JVI.70.9.6468-6473.1996; Lunden A, 1998, PARASITE IMMUNOL, V20, P519, DOI 10.1046/j.1365-3024.1998.00184.x; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Muramatsu T, 2008, PROTEOMICS, V8, P3350, DOI 10.1002/pmic.200800042; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; PEJLER G, 1994, J BIOL CHEM, V269, P14451; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Raja SM, 2005, J BIOL CHEM, V280, P20752, DOI 10.1074/jbc.M501181200; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Sayles PC, 1997, NAT IMMUN, V15, P249; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Srinoulprasert Y, 2006, MICROB PATHOGENESIS, V40, P126, DOI 10.1016/j.micpath.2005.12.001; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; TANTRAVAHI RV, 1986, P NATL ACAD SCI USA, V83, P9207, DOI 10.1073/pnas.83.23.9207; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Wernersson S., 2008, J LEUKOC BIOL; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	45	11	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38005	38013		10.1074/jbc.M110.118471	http://dx.doi.org/10.1074/jbc.M110.118471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864536	Green Published, hybrid			2022-12-25	WOS:000284625600008
J	Oberoi, J; Richards, MW; Crumpler, S; Brown, N; Blagg, J; Bayliss, R				Oberoi, Jasmeen; Richards, Mark W.; Crumpler, Simon; Brown, Nathan; Blagg, Julian; Bayliss, Richard			Structural Basis of Poly(ADP-ribose) Recognition by the Multizinc Binding Domain of Checkpoint with Forkhead-associated and RING Domains (CHFR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER DOMAIN; PROTEIN; ENTRY; IDENTIFICATION; TANKYRASE-1; MITOSIS; LIGASE; MOTIFS; DELAYS; APLF	Cellular stress in early mitosis activates the antephase checkpoint, resulting in the decondensation of chromosomes and delayed mitotic progression. Checkpoint with forkhead-associated and RING domains (CHFR) is central to this checkpoint, and its activity is ablated in many tumors and cancer cell lines through promoter hypermethylation or mutation. The interaction between the PAR-binding zinc finger (PBZ) of CHFR and poly(ADP-ribose) (PAR) is crucial for a functional antephase checkpoint. We determined the crystal structure of the cysteine-rich region of human CHFR (amino acids 425-664) to 1.9 angstrom resolution, which revealed a multizinc binding domain of elaborate topology within which the PBZ is embedded. The PBZ of CHFR closely resembles the analogous motifs from aprataxin-like factor and CG1218-PA, which lie within unstructured regions of their respective proteins. Based on co-crystal structures of CHFR bound to several different PAR-like ligands (adenosine 5'-diphosphoribose, adenosine monophosphate, and (PP2)-P-1-diadenosine 5'-pyrophosphate), we made a model of the CHFR-PAR interaction, which we validated using site-specific mutagenesis and surface plasmon resonance. The PBZ motif of CHFR recognizes two adenine-containing subunits of PAR and the phosphate backbone that connects them. More generally, PBZ motifs may recognize different numbers of PAR subunits as required to carry out their functions.	[Oberoi, Jasmeen; Richards, Mark W.; Bayliss, Richard] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Crumpler, Simon; Brown, Nathan; Blagg, Julian] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.bayliss@icr.ac.uk	Brown, Nathan/I-7711-2016	Brown, Nathan/0000-0001-9243-8699; Oberoi, Jasmeen/0000-0001-8216-3898; Bayliss, Richard/0000-0003-0604-2773; Richards, Mark/0000-0003-1108-2825	Cancer Research UK [C24461/A9549, C309/A8274]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Project Grant C24461/A9549 (to R. B.) and Cancer Research UK Centre Grant C309/A8274.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chaturvedi P, 2002, CANCER RES, V62, P1797; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Isogai S, 2010, GENES CELLS, V15, P101, DOI 10.1111/j.1365-2443.2009.01369.x; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Maddika S, 2009, J BIOL CHEM, V284, P12998, DOI 10.1074/jbc.M900333200; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millo E, 2008, SYNTHETIC COMMUN, V38, P3260, DOI 10.1080/00397910802116583; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	32	50	51	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39348	39358		10.1074/jbc.M110.159855	http://dx.doi.org/10.1074/jbc.M110.159855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20880844	hybrid, Green Published			2022-12-25	WOS:000284941300062
J	Cheung, MY; Xue, Y; Zhou, LA; Li, MW; Sun, SSM; Lam, HM				Cheung, Ming-Yan; Xue, Yan; Zhou, Liang; Li, Man-Wah; Sun, Samuel Sai-Ming; Lam, Hon-Ming			An Ancient P-Loop GTPase in Rice Is Regulated by a Higher Plant-specific Regulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBG-LIKE ATPASE; DISEASE RESISTANCE; BINDING; DOMAIN; EXPRESSION; EVOLUTION; REVEALS; DEFINES; SYSTEM; YCHF	YchF is a subfamily of the Obg family in the TRAFAC class of P-loop GTPases. The wide distribution of YchF homologues in both eukarya and bacteria suggests that they are descendents of an ancient protein, yet their physiological roles remain unclear. Using the OsYchF1-OsGAP1 pair from rice as the prototype, we provide evidence for the regulation of GTPase/ATPase activities and RNA binding capacity of a plant YchF (OsYchF1) by its regulatory protein (OsGAP1). The effects of OsGAP1 on the subcellular localization/cycling and physiological functions of OsYchF1 are also discussed. The finding that OsYchF1 and OsGAP1 are involved in plant defense response might shed light on the functional roles of YchF homologues in plants. This work suggests that during evolution, an ancestral P-loop GTPase/ATPase may acquire new regulation and function(s) by the evolution of a lineage-specific regulatory protein.	[Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Lam, Hon-Ming/A-9866-2008; Li, Man-Wah/AAZ-5631-2021; Zhou, Liang/P-4174-2015	Lam, Hon-Ming/0000-0002-6673-8740; Li, Man-Wah/0000-0003-4859-5683; Zhou, Liang/0000-0001-5973-7873	Hong Kong Research Grants Council [467608]; Hong Kong University Grants Committee Area of Excellence [AoE-B-07/09]; Shanghai-Hong Kong-Anson Research Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong University Grants Committee Area of Excellence; Shanghai-Hong Kong-Anson Research Foundation	This work was supported by Hong Kong Research Grants Council General Research Fund Grant 467608 (to H.-M. L.), Hong Kong University Grants Committee Area of Excellence Plant and Agricultural Biotechnology Project AoE-B-07/09, and the Shanghai-Hong Kong-Anson Research Foundation Grant (to H.-M. L. and S. S.-M. S.).	Bechtold N, 1998, METH MOL B, V82, P259; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Hitchcock C., 1971, PLANT LIPID BIOCH, P279; Jensen RB, 2000, PLANT MOL BIOL, V44, P799, DOI 10.1023/A:1026509002161; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Katagiri F., 2002, ARABIDOPSIS BOOK, P28; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Koonin EV, 2000, ADV PROTEIN CHEM, V54, P245, DOI 10.1016/S0065-3233(00)54008-X; Kopka J, 1998, PLANT MOL BIOL, V36, P627, DOI 10.1023/A:1005915020760; Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Ma L, 2008, PLANT PHYSIOL, V148, P223, DOI 10.1104/pp.108.120527; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P21; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rohn TT, 1999, FREE RADICAL BIO MED, V26, P1321, DOI 10.1016/S0891-5849(98)00332-3; Scamardella J M, 1999, Int Microbiol, V2, P207; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Spangler C, 2009, ANAL BIOANAL CHEM, V394, P989, DOI 10.1007/s00216-008-2517-7; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Suzuma S, 1999, FEMS MICROBIOL LETT, V180, P271, DOI 10.1016/S0378-1097(99)00498-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Wolf YI, 1999, GENOME RES, V9, P689; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106; Zhang Qi, 1996, Acta Agronomica Sinica, V22, P135; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x; Zhu Q, 1996, CURR OPIN GENET DEV, V6, P624, DOI 10.1016/S0959-437X(96)80093-1	45	25	28	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37359	37369		10.1074/jbc.M110.172080	http://dx.doi.org/10.1074/jbc.M110.172080			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876569	Green Published, hybrid			2022-12-25	WOS:000284424000028
J	Cenik, C; Wakeley, J				Cenik, Can; Wakeley, John			Pacific Salmon and the Coalescent Effective Population Size	PLOS ONE			English	Article							GEOGRAPHICALLY STRUCTURED POPULATIONS; STRONG-MIGRATION LIMIT; OVERLAPPING GENERATIONS; CONSERVATION GENETICS; GENEALOGICAL PROCESS; MULTIPLE COLLISIONS; ALLELE FREQUENCY; TEMPORAL CHANGES; DNA-SEQUENCES; VARYING SIZE	Pacific salmon include several species that are both commercially important and endangered. Understanding the causes of loss in genetic variation is essential for designing better conservation strategies. Here we use a coalescent approach to analyze a model of the complex life history of salmon, and derive the coalescent effective population (CES). With the aid of Kronecker products and a convergence theorem for Markov chains with two time scales, we derive a simple formula for the CES and thereby establish its existence. Our results may be used to address important questions regarding salmon biology, in particular about the loss of genetic variation. To illustrate the utility of our approach, we consider the effects of fluctuations in population size over time. Our analysis enables the application of several tools of coalescent theory to the case of salmon.	[Cenik, Can; Wakeley, John] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Cenik, C (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA.	wakeley@fas.harvard.edu		Cenik, Can/0000-0001-6370-0889				[Anonymous], 2002, MODERN DEV THEORETIC; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; BEAMSDERFER RC, 1998, SPAWNER RECRUIT DATA, P1; Birkner M, 2008, J MATH BIOL, V57, P435, DOI 10.1007/s00285-008-0170-6; Cederholm C. J., 2000, PACIFIC SALMON WILDL; Crow J.F., 1954, STAT MATH BIOL, P543; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Efremov V.V., 2005, Genetika, V41, P680; Efremov V. V., 2004, Genetika, V40, P538; Eldon B, 2006, GENETICS, V172, P2621, DOI 10.1534/genetics.105.052175; EMIGH TH, 1979, GENETICS, V92, P323; Ewens W. J., 1979, MATH POPULATION GENE; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; FELSENSTEIN J, 1971, GENETICS, V68, P581; Fernandez J, 2001, CONSERV GENET, V2, P121, DOI 10.1023/A:1011830703723; Fisher R.A., 1930, GENETICAL THEORY NAT; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hartl D., 2007, PRINCIPLES POPULATIO; HEIN J, 2004, SEQUENCE VARIATION G; Hey J, 1997, GENETICS, V145, P833; HILL WG, 1979, GENETICS, V92, P317; HILL WG, 1972, THEOR POPUL BIOL, V3, P27, DOI 10.1016/0040-5809(72)90032-9; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; Jagers P, 2004, J APPL PROBAB, V41, P368, DOI 10.1239/jap/1082999072; Jones J. W., 1959, THE SALMON; Kaj I, 2003, J APPL PROBAB, V40, P33, DOI 10.1017/S0021900200022257; Kaj I, 2001, J APPL PROBAB, V38, P285, DOI 10.1017/S0021900200019860; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kingman JFC, 2000, GENETICS, V156, P1461; Kobayashi Y, 2007, THEOR POPUL BIOL, V71, P174, DOI 10.1016/j.tpb.2006.12.001; Krone SM, 1997, THEOR POPUL BIOL, V51, P210, DOI 10.1006/tpbi.1997.1299; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Matsen FA, 2006, GENETICS, V172, P701, DOI 10.1534/genetics.105.047597; Mohle M, 1998, ADV APPL PROBAB, V30, P493, DOI 10.1239/aap/1035228080; Mohle M, 2001, ANN PROBAB, V29, P1547; Mohle M, 1998, ADV APPL PROBAB, V30, P513, DOI 10.1239/aap/1035228081; Moran P., 1962, STAT PROCESSES EVOLU; Moran P. A. P., 1958, P CAMB PHILOS SOC, V54, P60, DOI DOI 10.1017/S0305004100033193); Myers RA, 2004, SCIENCE, V303, P1980, DOI 10.1126/science.1095410; NAGYLAKI T, 1980, J MATH BIOL, V9, P101, DOI 10.1007/BF00275916; Neuhauser C, 1997, GENETICS, V145, P519; Nomura T, 2005, CONSERV GENET, V6, P655, DOI 10.1007/s10592-005-9025-5; Nordborg M, 1997, GENETICS, V146, P1185; NORDBORG M, 2001, COALESCENT THEORY, P179; NOTOHARA M, 1993, J MATH BIOL, V31, P115; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Pitman J, 1999, ANN PROBAB, V27, P1870, DOI 10.1214/aop/1022677552; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sagitov S, 2005, ANN APPL PROBAB, V15, P1778, DOI 10.1214/105051605000000223; Sagitov S, 1999, J APPL PROBAB, V36, P1116, DOI 10.1239/jap/1032374759; Sano A, 2004, THEOR POPUL BIOL, V65, P39, DOI 10.1016/j.tpb.2003.09.001; Sjodin P, 2005, GENETICS, V169, P1061, DOI 10.1534/genetics.104.026799; TAJIMA F, 1992, J HERED, V83, P309, DOI 10.1093/oxfordjournals.jhered.a111219; TAJIMA F, 1983, GENETICS, V105, P437; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; Wakeley J, 2004, THEOR POPUL BIOL, V66, P83, DOI 10.1016/j.tpb.2004.04.005; Wakeley J., 2008, COALESCENT THEORY IN; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; Waples RS, 2006, AM NAT, V167, P118, DOI 10.1086/498584; WAPLES RS, 1990, J HERED, V81, P277, DOI 10.1093/oxfordjournals.jhered.a110990; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WAPLES RS, 1989, GENETICS, V121, P379; Waples RS, 2002, GENETICS, V161, P783; WAPLES RS, 1990, J HERED, V81, P267, DOI 10.1093/oxfordjournals.jhered.a110989; Wilkins JF, 2002, GENETICS, V161, P873; Wilkinson-Herbots HM, 1998, J MATH BIOL, V37, P535, DOI 10.1007/s002850050140; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1931, GENETICS, V16, P0097	73	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13019	10.1371/journal.pone.0013019	http://dx.doi.org/10.1371/journal.pone.0013019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885947	Green Submitted, gold, Green Published			2022-12-25	WOS:000282167100020
J	Rayavarapu, S; Van der Meulen, JH; Gordish-Dressman, H; Hoffman, EP; Nagaraju, K; Knoblach, SM				Rayavarapu, Sree; Van der Meulen, Jack H.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.			Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLES; T-CELLS; KAPPA-B; MODEL; EXPRESSION; MYOPATHY; INFLAMMATION; ACTIVATION	The dysferlin deficient SJL/J mouse strain is commonly used to study dysferlin deficient myopathies. Therefore, we systematically evaluated behavior in relatively young (9-25 weeks) SJL/J mice and compared them to C57BL6 mice to determine which functional end points may be the most effective to use for preclinical studies in the SJL/J strain. SJL/J mice had reduced body weight, lower open field scores, higher creatine kinase levels, and less muscle force than did C57BL6 mice. Power calculations for expected effect sizes indicated that grip strength normalized to body weight and open field activity were the most sensitive indicators of functional status in SJL/J mice. Weight and open field scores of SJL/J mice deteriorated over the course of the study, indicating that progressive myopathy was ongoing even in relatively young (<6 months old) SJL/J mice. To further characterize SJL/J mice within the context of treatment, we assessed the effect of fasudil, a rho-kinase inhibitor, on disease phenotype. Fasudil was evaluated based on previous observations that Rho signaling may be overly activated as part of the inflammatory cascade in SJL/J mice. Fasudil treated SJL/J mice showed increased body weight, but decreased grip strength, horizontal activity, and soleus muscle force, compared to untreated SJL/J controls. Fasudil either improved or had no effect on these outcomes in C57BL6 mice. Fasudil also reduced the number of infiltrating macrophages/monocytes in SJL/J muscle tissue, but had no effect on muscle fiber degeneration/regeneration. These studies provide a basis for standardization of preclinical drug testing trials in the dysferlin deficient SJL/J mice, and identify measures of functional status that are potentially translatable to clinical trial outcomes. In addition, the data provide pharmacological evidence suggesting that activation of rho-kinase, at least in part, may represent a beneficial compensatory response in dysferlin deficient myopathies.	[Rayavarapu, Sree; Van der Meulen, Jack H.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Rayavarapu, Sree] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA	Children's National Health System; George Washington University; George Washington University	Rayavarapu, S (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	KNagaraju@cnmcresearch.org; sknoblach@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Rayavarapu, Sree/0000-0002-5833-4711; Hoffman, Eric/0000-0001-6470-5139; Gordish-Dressman, Heather/0000-0002-2330-5427	Cecil B. Day Foundation (UMASS Medical School); Department of Defense (Mouse Drug Screening Core) [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne Inc; NIH [R01-AR050478, 1U54HD053177-01A1]; Wellstone Muscular Dystrophy Center; NIH IDDRC (Intellectual and Developmental Disabilities Research Center) [P30HD40677]; NIH NCMRR/NINDS (Integrated Molecular Core for Rehabilitation Medicine) [5R24 HD050846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	Cecil B. Day Foundation (UMASS Medical School); Department of Defense (Mouse Drug Screening Core)(United States Department of Defense); Foundation to Eradicate Duchenne Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellstone Muscular Dystrophy Center; NIH IDDRC (Intellectual and Developmental Disabilities Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCMRR/NINDS (Integrated Molecular Core for Rehabilitation Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by Cecil B. Day Foundation to Dr. Robert H. Brown JR (UMASS Medical School) and by the Department of Defense USAMRAA grant W81XWH-05-1-0616 (Mouse Drug Screening Core), Foundation to Eradicate Duchenne Inc, and NIH grant R01-AR050478 (K. Nagaraju), NIH grant 1U54HD053177-01A1, Wellstone Muscular Dystrophy Center (EP Hoffman) and Wellstone Muscular Dystrophy Center pilot project funding (SM Knoblach). The work was also partially supported by the NIH IDDRC P30HD40677 (Intellectual and Developmental Disabilities Research Center) and the NIH NCMRR/NINDS 5R24 HD050846 (Integrated Molecular Core for Rehabilitation Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley J, 2003, EXP NEUROL, V180, P14, DOI 10.1016/S0014-4886(02)00054-7; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chase TH, 2009, AM J PATHOL, V175, P2299, DOI 10.2353/ajpath.2009.080930; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Confalonieri P, 2003, J NEUROIMMUNOL, V142, P130, DOI 10.1016/S0165-5728(03)00255-8; De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136; Gerhauser I, 2007, J NEUROPATH EXP NEUR, V66, P809, DOI 10.1097/nen.0b013e3181461f31; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Han GM, 2009, CELL IMMUNOL, V258, P188, DOI 10.1016/j.cellimm.2009.05.003; He Y, 2008, ARTHRITIS RHEUM-US, V58, P3366, DOI 10.1002/art.23986; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hidaka T, 2008, AM J PATHOL, V172, P603, DOI 10.2353/ajpath.2008.070196; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; LI Y, MED SCI MONIT, V16, pBR112; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Nagaraju K, 2002, RHEUM DIS CLIN N AM, V28, P917, DOI 10.1016/S0889-857X(02)00026-1; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Nemoto H, 2007, EUR NEUROL, V57, P19, DOI 10.1159/000097005; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Spurney CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008976; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Sun XJ, 2006, J NEUROIMMUNOL, V180, P126, DOI 10.1016/j.jneuroim.2006.06.027; SUZUKI K, 2005, NIPPON RINSHO S, V10, P608; Suzuki N, 2005, NEUROSCI RES, V52, P47, DOI 10.1016/j.neures.2005.01.006; Tawara S, 2007, J CARDIOVASC PHARM, V50, P195, DOI 10.1097/FJC.0b013e31806befe6; Tharaux PL, 2003, J IMMUNOL, V171, P96, DOI 10.4049/jimmunol.171.1.96; TIETZ NW, 1982, FUNDAMENTALS CLIN CH; Vafiadaki E, 2001, NEUROREPORT, V12, P625, DOI 10.1097/00001756-200103050-00039; Weller AH, 1997, MUSCLE NERVE, V20, P72, DOI 10.1002/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu JZ, 2010, J NEUROSCI RES, V88, P1664, DOI 10.1002/jnr.22339; Zhang J, 2009, CLIN CHIM ACTA, V401, P76, DOI 10.1016/j.cca.2008.11.016	48	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12981	10.1371/journal.pone.0012981	http://dx.doi.org/10.1371/journal.pone.0012981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886045	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600016
J	Jin, L; Gan, QO; Zieba, BJ; Goicoechea, SM; Owens, GK; Otey, CA; Somlyo, AV				Jin, Li; Gan, Qiong; Zieba, Bartosz J.; Goicoechea, Silvia M.; Owens, Gary K.; Otey, Carol A.; Somlyo, Avril V.			The Actin Associated Protein Palladin Is Important for the Early Smooth Muscle Cell Differentiation	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; BINDING PARTNER; HISTONE DEACETYLASES; ANGIOTENSIN-II; MARKER GENES; STEM-CELLS; MYOCARDIN; FAMILY; CYTOSKELETON	Palladin, an actin associated protein, plays a significant role in regulating cell adhesion and cell motility. Palladin is important for development, as knockdown in mice is embryonic lethal, yet its role in the development of the vasculature is unknown. We have shown that palladin is essential for the expression of smooth muscle cells (SMC) marker genes and force development in response to agonist stimulation in palladin deficient SMCs. The goal of the study was to determine the molecular mechanisms underlying palladin's ability to regulate the expression of SMC marker genes. Results showed that palladin expression was rapidly induced in an A404 cell line upon retinoic acid (RA) induced differentiation. Suppression of palladin expression with siRNAs inhibited the expression of RA induced SMC differentiation genes, SM alpha-actin (SMA) and SM22, whereas over-expression of palladin induced SMC gene expression. Chromatin immunoprecipitation assays provided evidence that palladin bound to SMC genes, whereas co-immunoprecipitation assays also showed binding of palladin to myocardin related transcription factors (MRTFs). Endogenous palladin was imaged in the nucleus, increased with leptomycin treatment and the carboxyl-termini of palladin co-localized with MRTFs in the nucleus. Results support a model wherein palladin contributes to SMC differentiation through regulation of CArG-SRF-MRTF dependent transcription of SMC marker genes and as previously published, also through actin dynamics. Finally, in E11.5 palladin null mouse embryos, the expression of SMA and SM22 mRNA and protein is decreased in the vessel wall. Taken together, our findings suggest that palladin plays a key role in the differentiation of SMCs in the developing vasculature.	[Jin, Li; Gan, Qiong; Zieba, Bartosz J.; Owens, Gary K.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA; [Goicoechea, Silvia M.; Otey, Carol A.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Jin, L (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	avs5u@virginia.edu		Goicoechea, Silvia/0000-0003-1107-389X	National Institutes of Health [PO1 HL48807, PO1 HL 19242, AHA 0635025N, GM081505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, P01HL019242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807 (to A.V.S.), PO1 HL 19242 (to A.V.S. and G.K.O.), AHA 0635025N (to S.G.), and GM081505 (to C.O.).	Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; GAMEZ J, 2008, J NEUROL SCI; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Gorenne I, 2003, AM J PHYSIOL-CELL PH, V285, pC674, DOI 10.1152/ajpcell.00608.2002; Hwang SJ, 2001, J COMP NEUROL, V436, P211, DOI 10.1002/cne.1062.abs; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Jin L, 2009, J MUSCLE RES CELL M, V30, P41, DOI 10.1007/s10974-009-9173-1; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008	45	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12823	10.1371/journal.pone.0012823	http://dx.doi.org/10.1371/journal.pone.0012823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877641	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100013
J	Johnson, PJ; Kansky, R; Loveridge, AJ; Macdonald, DW				Johnson, Paul J.; Kansky, Ruth; Loveridge, Andrew J.; Macdonald, David W.			Size, Rarity and Charisma: Valuing African Wildlife Trophies	PLOS ONE			English	Article							CONSERVATION; EXTINCTION	We explore variation in the prices paid by recreational hunters of trophy animals in Africa and its possible causes, including perceived rarity. Previous work has raised the possibility that extinction can result if demand rises fast enough as a species becomes rarer. We attempt to disentangle this from other inter-correlated influences affecting price. Species with larger body sizes and larger trophies were more valuable. Value increased less steeply as a function of size for bovids than for felids and the effect was consistent across countries. Power laws, ubiquitous in physical and social systems, described the trends. The exponent was approximately 0.4 for bovids, compared with approximately 1.0 for felids. Rarity (as indexed by IUCN score) influenced the value of bovid trophies - price was higher for species in categories denoting higher global threat. There was substantial variation in price among and within families not explained by either size or rarity. This may be attributable to a 'charisma' effect, which seems likely to be a general attribute of human perceptions of wildlife. Species where prices were higher than predicted by size or rarity are ranked high in published accounts of desirability by hunters. We conclude that the valuation of these species is explicable to a large extent by body size and perceived rarity, and that differences in valuation between taxonomic groups are related to less easily quantified 'charisma' effects. These findings are relevant for conservationists considering the threat status of species exploited in open access markets, and where license quotas are adjusted in response to changes in perceived rarity.	[Johnson, Paul J.; Kansky, Ruth; Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford OX1 3PS, England	University of Oxford	Johnson, PJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, S Parks Rd, Oxford OX1 3PS, England.	paul.johnson@zoo.ox.ac.uk			Panthera Foundation; Whitley Trust	Panthera Foundation; Whitley Trust	The work was partly funded by the Panthera Foundation and the Whitley Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 2008, MODEL BASED INFERENC, pxxiv; Angulo E, 2009, P ROY SOC B-BIOL SCI, V276, P1331, DOI 10.1098/rspb.2008.1475; Batt S., 2009, BIOSCIENCE HORIZONS, V2, P180, DOI [https://doi.org/10.1093/biohorizons/hzp021, DOI 10.1093/BIOHORIZONS/HZP021]; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Gault A, 2008, CONSERV LETT, V1, P199, DOI 10.1111/j.1755-263X.2008.00038.x; Grafen A., 2002, MODERN STAT LIFE SCI, p[XV, 351]; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; KINGDON J, 2003, KINGDON FIELD GUIDE, pR18; KRUUK H, 2002, HUNTER HUNTED RELATI, pR12; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; Macdonald DW, 2010, BIOL CONSERVATION WI; MACDONALD DW, 2006, ENCY MAMMALS, pR41; Milner-Gulland E. J., 2009, RECREATIONAL HUNTING; PACKER C, 2009, PLOS ONE, P4; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; 2005, SAFARI CLUB INT RECO	22	43	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12866	10.1371/journal.pone.0012866	http://dx.doi.org/10.1371/journal.pone.0012866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877564	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100021
J	O'Rourke, CT; Hall, MI; Pitlik, T; Fernandez-Juricic, E				O'Rourke, Colleen T.; Hall, Margaret I.; Pitlik, Todd; Fernandez-Juricic, Esteban			Hawk Eyes I: Diurnal Raptors Differ in Visual Fields and Degree of Eye Movement	PLOS ONE			English	Article							OWL TYTO-ALBA; STRIX-ALUCO L; HEAD MOVEMENTS; EVOLUTIONARY HISTORY; ORBIT ORIENTATION; PANORAMIC VISION; HUNTING BEHAVIOR; BINOCULAR VISION; SCHEMATIC OPTICS; BIRDS	Background: Different strategies to search and detect prey may place specific demands on sensory modalities. We studied visual field configuration, degree of eye movement, and orbit orientation in three diurnal raptors belonging to the Accipitridae and Falconidae families. Methodology/Principal Findings: We used an ophthalmoscopic reflex technique and an integrated 3D digitizer system. We found inter-specific variation in visual field configuration and degree of eye movement, but not in orbit orientation. Red-tailed Hawks have relatively small binocular areas (similar to 33 degrees) and wide blind areas (similar to 82 degrees), but intermediate degree of eye movement (similar to 5 degrees), which underscores the importance of lateral vision rather than binocular vision to scan for distant prey in open areas. Cooper's Hawks' have relatively wide binocular fields (similar to 36 degrees), small blind areas (similar to 60 degrees), and high degree of eye movement (similar to 8 degrees), which may increase visual coverage and enhance prey detection in closed habitats. Additionally, we found that Cooper's Hawks can visually inspect the items held in the tip of the bill, which may facilitate food handling. American Kestrels have intermediate-sized binocular and lateral areas that may be used in prey detection at different distances through stereopsis and motion parallax; whereas the low degree eye movement (similar to 1 degrees) may help stabilize the image when hovering above prey before an attack. Conclusions: We conclude that: (a) there are between-species differences in visual field configuration in these diurnal raptors; (b) these differences are consistent with prey searching strategies and degree of visual obstruction in the environment (e. g., open and closed habitats); (c) variations in the degree of eye movement between species appear associated with foraging strategies; and (d) the size of the binocular and blind areas in hawks can vary substantially due to eye movements. Inter-specific variation in visual fields and eye movements can influence behavioral strategies to visually search for and track prey while perching.	[O'Rourke, Colleen T.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Hall, Margaret I.] Midwestern Univ, Dept Physiol, Glendale, AZ USA; [Pitlik, Todd] Wildlife Serv, Dept Agr, Anim & Plant Hlth Inspect Serv, Los Angeles, CA USA; [Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	California State University System; California State University Long Beach; Midwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Rourke, CT (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	efernan@purdue.edu			National Science Foundation [DBI-0641550]; California State University, Long Beach	National Science Foundation(National Science Foundation (NSF)); California State University, Long Beach	This study was funded by National Science Foundation DBI-0641550 (www.nsf.org). CTO received funding from the 2008 California State University, Long Beach, Provost's Graduate Student Summer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2009, FUNCT ECOL, V23, P373, DOI 10.1111/j.1365-2435.2008.01512.x; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; BEYER WH, 1979, STANDARD MATH TABLES; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Brown L.H., 1982, BIRDS AFRICA, V1; Changizi MA, 2008, J THEOR BIOL, V254, P756, DOI 10.1016/j.jtbi.2008.07.011; CLARK W. S., 2001, HAWKS N AM; CLAY WILLIAM M., 1953, WILSON BULL, V65, P129; Curtis O. E., 2006, BIRDS N AM ONLINE; Duijni M., 1959, Archives Neerlandaises de Zoologie, V13, P128; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Fernandez-Juricic E, 2008, IBIS, V150, P779, DOI 10.1111/j.1474-919X.2008.00860.x; Ferry-Graham LA, 2002, INTEGR COMP BIOL, V42, P265, DOI 10.1093/icb/42.2.265; FOX R, 1977, SCIENCE, V197, P79, DOI 10.1126/science.867054; FROST BJ, 1990, VISUAL NEUROSCI, V5, P231, DOI 10.1017/S0952523800000304; GALL MD, 2009, J COMP PHYS IN PRESS; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Heesy C.P., 2003, THESIS STONY BROOK U; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; KATZIR G, 1994, NATURWISSENSCHAFTEN, V81, P182, DOI 10.1007/BF01134539; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kral K, 2003, BEHAV PROCESS, V64, P21, DOI 10.1016/S0376-6357(03)00057-3; Land MF, 1999, J COMP PHYSIOL A, V184, P265, DOI 10.1007/s003590050324; Leyhe JE, 2004, J RAPTOR RES, V38, P19; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; MARTIN GR, 1986, VISION RES, V26, P1303, DOI 10.1016/0042-6989(86)90112-4; Martin GR, 2004, IBIS, V146, P18, DOI 10.1111/j.1474-919X.2004.00211.x; Martin GR, 2000, BRAIN BEHAV EVOLUT, V56, P340, DOI 10.1159/000047218; MARTIN GR, 1982, J COMP PHYSIOL, V145, P341, DOI 10.1007/BF00619338; Martin GR, 1999, BRAIN BEHAV EVOLUT, V53, P55, DOI 10.1159/000006582; MARTIN GR, 1984, VISION RES, V24, P1739, DOI 10.1016/0042-6989(84)90005-1; Martin GR, 2008, VISION I, P25; Martin GR, 2008, IBIS, V150, P485, DOI 10.1111/j.1474-919X.2008.00808.x; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Martin GR, 2009, P ROY SOC B-BIOL SCI, V276, P437, DOI 10.1098/rspb.2008.1110; MARTIN TE, 1990, STUDIES AVIAN BIOL, V0013, P00353; Meyer D.B., 1977, HDB SENSORY PHYSL, V7/5, P549; O'Rourke CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012169; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Peeters H, 2005, RAPTORS CALIFORNIA; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; Preston C. R., 2009, BIRDS N AM; Remsen J.V. Jr, 1990, Studies in Avian Biology, P144; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Roth TC, 2003, CONDOR, V105, P474, DOI 10.1650/7219; SHERROD SK, 1978, RAPTOR RES, V12, P49; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Smallwood JA, 2002, BIRDS N AM ONLINE; STEINBACH MJ, 1974, VISION RES, V14, P745, DOI 10.1016/0042-6989(74)90075-3; Tucker VA, 2000, J EXP BIOL, V203, P3745; Tucker VA, 2000, J EXP BIOL, V203, P3733; van der Willigen RF, 1998, NEUROREPORT, V9, P1233, DOI 10.1097/00001756-199804200-00050; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; WALLMAN J, 1985, J NEUROSCI, V5, P1418; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936	64	41	45	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12802	10.1371/journal.pone.0012802	http://dx.doi.org/10.1371/journal.pone.0012802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877645	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100009
J	Reitzel, AM; Behrendt, L; Tarrant, AM				Reitzel, Adam M.; Behrendt, Lars; Tarrant, Ann M.			Light Entrained Rhythmic Gene Expression in the Sea Anemone Nematostella vectensis: The Evolution of the Animal Circadian Clock	PLOS ONE			English	Article							CORAL ACROPORA-MILLEPORA; PHYLOGENETIC ANALYSES; MOLECULAR-COMPONENTS; MAMMALIAN TIMELESS; PERIOD GENE; DROSOPHILA; TIM; CRYPTOCHROMES; DUPLICATION; PROMOTER	Background: Circadian rhythms in behavior and physiology are the observable phenotypes from cycles in expression of, interactions between, and degradation of the underlying molecular components. In bilaterian animals, the core molecular components include Timeless-Timeout, photoreceptive cryptochromes, and several members of the basic-loop-helix-Per-ARNT-Sim (bHLH-PAS) family. While many of core circadian genes are conserved throughout the Bilateria, their specific roles vary among species. Here, we identify and experimentally study the rhythmic gene expression of conserved circadian clock members in a sea anemone in order to characterize this gene network in a member of the phylum Cnidaria and to infer critical components of the clockwork used in the last common ancestor of cnidarians and bilaterians. Methodology/Principal Findings: We identified homologs of circadian regulatory genes in the sea anemone Nematostella vectensis, including a gene most similar to Timeout, three cryptochromes, and several key bHLH-PAS transcription factors. We then maintained N. vectensis either in complete darkness or in a 12 hour light: 12 hour dark cycle in three different light treatments (blue only, full spectrum, blue-depleted). Gene expression varied in response to light cycle and light treatment, with a particularly strong pattern observed for NvClock. The cryptochromes more closely related to the light-sensitive clade of cryptochromes were upregulated in light treatments that included blue wavelengths. With co-immunoprecipitation, we determined that heterodimerization between CLOCK and CYCLE is conserved within N. vectensis. Additionally, we identified E-box motifs, DNA sequences recognized by the CLOCK: CYCLE heterodimer, upstream of genes showing rhythmic expression. Conclusions/Significance: This study reveals conserved molecular and functional components of the circadian clock that were in place at the divergence of the Cnidaria and Bilateria, suggesting the animal circadian clockwork is more ancient than previous data suggest. Characterizing circadian regulation in a cnidarian provides insight into the early origins of animal circadian rhythms and molecular regulation of environmentally cued behaviors.	[Reitzel, Adam M.; Behrendt, Lars; Tarrant, Ann M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Reitzel, AM (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	atarrant@whoi.edu	Tarrant, Ann/AAU-8263-2021; Behrendt, Lars/M-5218-2014; Reitzel, Adam M/A-9129-2017	Tarrant, Ann/0000-0002-1909-7899; Behrendt, Lars/0000-0002-8988-2032; Reitzel, Adam M/0000-0001-5734-7118	Eunice Kennedy Shriver National Institute of Child Health and Human Development [F32HD062178]; Tropical Research Initiative of the Woods Hole Oceanographic Institution; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062178] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Tropical Research Initiative of the Woods Hole Oceanographic Institution; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by Award Number F32HD062178 to AMR from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Tropical Research Initiative of the Woods Hole Oceanographic Institution. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AMANO S, 1988, BIOL BULL, V175, P181, DOI 10.2307/1541557; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; ILER WEG, 2010, FEBS J, V277, P1182; Iwai S, 2006, J INSECT PHYSIOL, V52, P625, DOI 10.1016/j.jinsphys.2006.03.001; Kaniewska P, 2009, J EXP BIOL, V212, P662, DOI 10.1242/jeb.022624; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Looby P, 2005, TRENDS GENET, V21, P46, DOI 10.1016/j.tig.2004.11.012; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; SALICHOS L, 2009, MYCOLOGIA, P9; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vize PD, 2009, BIOL BULL-US, V216, P131; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	51	54	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12805	10.1371/journal.pone.0012805	http://dx.doi.org/10.1371/journal.pone.0012805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877728	Green Published, gold			2022-12-25	WOS:000282002900005
J	Vagenas, P; Aravantinou, M; Williams, VG; Jasny, E; Piatak, M; Lifson, JD; Salazar, AM; Blanchard, JL; Gettie, A; Robbiani, M				Vagenas, Panagiotis; Aravantinou, Meropi; Williams, Vennansha G.; Jasny, Edith; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Salazar, Andres M.; Blanchard, James L.; Gettie, Agegnehu; Robbiani, Melissa			A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE RESPONSES; DENDRITIC-CELL VACCINE; RHESUS MACAQUES; DISEASE PROGRESSION; INFECTED MACAQUES; SIVMAC251 INFECTION; ANTIBODY-RESPONSES; PARTIAL PROTECTION; IMMUNE-RESPONSES	Background: HIV-infected individuals rely on antiretroviral therapy (ART) to control viral replication. Despite abundant demonstrable benefits, the multiple limitations of ART point to the potential advantages of therapeutic vaccination approaches that could provide sustained host control of viral replication after discontinuation of ART. We provide evidence from a non-human primate model that a therapeutic vaccine applied to the tonsils can maintain low viral loads after cessation of ART. Methodology/Principal Findings: Animals received 40 weeks of ART initiated 9 weeks after rectal SIVmac239 infection. During ART, animals were vaccinated (or not) with AT-2 inactivated SIVmac239 using CpG-C ISS-ODN (C274) or polyICLC as adjuvants. PolyICLC/AT-2 SIV vaccinated animals maintained viral loads <3x10(3) copies/ml for up to 16 weeks post-ART, whereas the C274/AT-2 SIV vaccinated and non-vaccinated animals' viremia ranged between 1x10(4)-4x10(5) copies/ml (p<0.03). Neutralizing Ab activity in plasma was increased by polyICLC/AT-2 tonsillar vaccination under ART, compared to controls (p<0.03). Subsequent vaccination of all animals with polyICLC/AT-2 SIV in the absence of ART did not alter viral loads. Other immune parameters measured in blood and tissues were comparable between groups. Conclusions/Significance: These results provide support for the potential benefit of mucosally delivered vaccines in therapeutic immunization strategies for control of AIDS virus infection.	[Vagenas, Panagiotis; Aravantinou, Meropi; Williams, Vennansha G.; Jasny, Edith; Robbiani, Melissa] Populat Council, Ctr Biomed Res, HIV AIDS Program, New York, NY 10021 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Blanchard, James L.] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Vagenas, P (corresponding author), Populat Council, Ctr Biomed Res, HIV AIDS Program, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org	Vagenas, Panagiotis/H-7850-2013	Vagenas, Panagiotis/0000-0003-2107-0377	National Institutes of Health [R01 DE016256, RR00164]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funded by the National Institutes of Health grant R01 DE016256, the base grant RR00164, and in part with Federal Funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. MR was a 2002 Elizabeth Glaser Scientist. Oncovir Inc. provided the PolyICLC (Hiltonol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Butowski N, 2009, J NEURO-ONCOL, V91, P175, DOI 10.1007/s11060-008-9693-3; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chertova E, 2003, CURR MOL MED, V3, P265, DOI 10.2174/1566524033479889; Cline AN, 2005, J MED PRIMATOL, V34, P303; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2006, BMJ-BRIT MED J, V332, P1489, DOI 10.1136/bmj.332.7556.1489; Earl PL, 2007, VIROLOGY, V366, P84, DOI 10.1016/j.virol.2007.02.041; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Gauduin MC, 2006, METHODS, V38, P263, DOI 10.1016/j.ymeth.2005.12.004; Hardy Gareth Ad, 2007, J Immune Based Ther Vaccines, V5, P6, DOI 10.1186/1476-8518-5-6; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kader M, 2008, J VIROL, V82, P11467, DOI 10.1128/JVI.01143-08; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kinloch-de Loes S, 2005, J INFECT DIS, V192, P607, DOI 10.1086/432002; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lifson JD, 2002, J MED PRIMATOL, V31, P205, DOI 10.1034/j.1600-0684.2002.02007.x; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Markowitz M, 2002, J INFECT DIS, V186, P634, DOI 10.1086/342559; Marshall JD, 2003, J LEUKOCYTE BIOL, V73, P781, DOI 10.1189/jlb.1202630; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauermann U, 2000, J INFECT DIS, V182, P716, DOI 10.1086/315800; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Stahl-Hennig C, 2007, FRONT BIOSCI, V12, P2107, DOI 10.2741/2215; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Teleshova N, 2006, J LEUKOCYTE BIOL, V79, P257, DOI 10.1189/jlb.0205084; Teleshova N, 2004, J IMMUNOL, V173, P1647, DOI 10.4049/jimmunol.173.3.1647; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; *UDOHAHS, 1985, GUID CAR US LAB AN, P1; Vagenas P, 2009, JAIDS-J ACQ IMM DEF, V52, P433, DOI 10.1097/QAI.0b013e3181b880f3; Valentin A, 2010, VACCINE, V28, P1962, DOI 10.1016/j.vaccine.2009.10.099; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wang Y, 2009, CLIN VACCINE IMMUNOL, V16, P499, DOI 10.1128/CVI.00471-08; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; zur Megede J, 2008, AIDS RES HUM RETROV, V24, P1103, DOI 10.1089/aid.2008.0055	66	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12891	10.1371/journal.pone.0012891	http://dx.doi.org/10.1371/journal.pone.0012891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877632	Green Published, Green Submitted, gold			2022-12-25	WOS:000282002900020
J	Brichacek, B; Vanpouille, C; Kiselyeva, Y; Biancotto, A; Merbah, M; Hirsch, I; Lisco, A; Grivel, JC; Margolis, L				Brichacek, Beda; Vanpouille, Christophe; Kiselyeva, Yana; Biancotto, Angelique; Merbah, Melanie; Hirsch, Ivan; Lisco, Andrea; Grivel, Jean Charles; Margolis, Leonid			Contrasting Roles for TLR Ligands in HIV-1 Pathogenesis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; HUMAN LYMPHOID-TISSUE; TROPICAL INFECTIOUS-DISEASES; MEROZOITE SURFACE PROTEIN-1; X-C-CHEMOKINE; INNATE IMMUNITY; CXCR4-TROPIC HIV-1; EX-VIVO	The first line of a host's response to various pathogens is triggered by their engagement of cellular pattern recognition receptors (PRRs). Binding of microbial ligands to these receptors leads to the induction of a variety of cellular factors that alter intracellular and extracellular environment and interfere directly or indirectly with the life cycle of the triggering pathogen. Such changes may also affect any coinfecting microbe. Using ligands to Toll-like receptors (TLRs) 5 and 9, we examined their effect on human immunodeficiency virus (HIV)-1 replication in lymphoid tissue ex vivo. We found marked differences in the outcomes of such treatment. While flagellin (TLR5 agonist) treatment enhanced replication of CC chemokine receptor 5 (CCR 5)-tropic and CXC chemokine receptor 4 (CXCR4)-tropic HIV-1, treatment with oligodeoxynucleotide (ODN) M362 (TLR9 agonist) suppressed both viral variants. The differential effects of these TLR ligands on HIV-1 replication correlated with changes in production of CC chemokines CCL3, CCL4, CCL5, and of CXC chemokines CXCL10, and CXCL12 in the ligand-treated HIV-1-infected tissues. The nature and/or magnitude of these changes were dependent on the ligand as well as on the HIV-1 viral strain. Moreover, the tested ligands differed in their ability to induce cellular activation as evaluated by the expression of the cluster of differentiation markers (CD) 25, CD38, CD39, CD69, CD154, and human leukocyte antigen D related (HLA)-DR as well as of a cell proliferation marker, Ki67, and of CCR5. No significant effect of the ligand treatment was observed on apoptosis and cell death/loss in the treated lymphoid tissue ex vivo. Our results suggest that binding of microbial ligands to TLRs is one of the mechanisms that mediate interactions between coinfected microbes and HIV-1 in human tissues. Thus, the engagement of appropriate TLRs by microbial molecules or their mimetic might become a new strategy for HIV therapy or prevention.	[Brichacek, Beda; Vanpouille, Christophe; Kiselyeva, Yana; Biancotto, Angelique; Merbah, Melanie; Lisco, Andrea; Grivel, Jean Charles; Margolis, Leonid] NICHHD, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Hirsch, Ivan] Univ Mediterrane, Inst Paoli Calmettes, INSERM, Ctr Rech Cancerol Marseille,UMR 891, Marseille, France	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Brichacek, B (corresponding author), NICHHD, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	bricbeda@mail.nih.gov	biancotto, angelique/C-4632-2011; Kiseleva, Yana/AAB-5083-2020; Hirsch, Ivan/J-7726-2015; Lisco, Andrea/L-2105-2019	biancotto, angelique/0000-0003-2271-009X; Kiseleva, Yana/0000-0002-8352-4787; Hirsch, Ivan/0000-0003-1701-1438; Lisco, Andrea/0000-0002-1475-356X; Grivel, Jean-Charles/0000-0003-0365-3181; Merbah, Melanie/0000-0002-5641-8612	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alfano M, 2005, AIDS, V19, P1007, DOI 10.1097/01.aids.0000174446.40379.3b; Ashkar AA, 2003, J VIROL, V77, P8948, DOI 10.1128/JVI.77.16.8948-8956.2003; Bafica A, 2004, J LEUKOCYTE BIOL, V75, P460, DOI 10.1189/jlb.0803388; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Beilke MA, 2004, CLIN INFECT DIS, V39, P256, DOI 10.1086/422146; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bergler W, 1999, CLIN EXP IMMUNOL, V116, P9; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Blanchard A, 1997, TRENDS MICROBIOL, V5, P326, DOI 10.1016/S0966-842X(97)01089-5; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9; Borkow G, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000160; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Casoli C, 2007, AIDS REV, V9, P140; Chang Q, 2007, J GEN VIROL, V88, P3341, DOI 10.1099/vir.0.83198-0; Chen F, 2010, J HUAZHONG U SCI-MED, V30, P278, DOI 10.1007/s11596-010-0343-6; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Claeys S, 2003, ALLERGY, V58, P748, DOI 10.1034/j.1398-9995.2003.00180.x; Cohen OJ, 1997, SPRINGER SEMIN IMMUN, V18, P305, DOI 10.1007/BF00813500; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gaeta GB, 2006, J HEPATOL, V44, pS108, DOI 10.1016/j.jhep.2005.11.023; Ghassemi M, 2003, J MED MICROBIOL, V52, P877, DOI 10.1099/jmm.0.05231-0; Giacaman RA, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-29; Giger B, 2004, J IMMUNOL METHODS, V289, P179, DOI 10.1016/j.jim.2004.04.015; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; HOOD JD, 2010, HUM VACCIN, V6; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Kannangara S, 2005, J INFECT DIS, V192, P1003, DOI 10.1086/432767; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KOELLE DM, 1994, J VIROL, V68, P2803, DOI 10.1128/JVI.68.5.2803-2810.1994; Krishnamachari Y, 2009, ADV DRUG DELIVER REV, V61, P205, DOI 10.1016/j.addr.2008.12.013; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Lisco A, 2009, CELL HOST MICROBE, V6, P403, DOI 10.1016/j.chom.2009.10.010; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Margolis L, 2003, NAT BIOTECHNOL, V21, P15, DOI 10.1038/nbt0103-15; Marshall JD, 2003, J LEUKOCYTE BIOL, V73, P781, DOI 10.1189/jlb.1202630; Moss WJ, 2002, J INFECT DIS, V185, P1035, DOI 10.1086/340027; Murad YM, 2009, BIODRUGS, V23, P361, DOI 10.2165/11316930-000000000-00000; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; Ramaswamy M, 2007, EXPERT REV ANTI-INFE, V5, P231, DOI 10.1586/14787210.5.2.231; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RICHARDTPARGMAN.D, 2010, IMMUNOBIOLOGY; Rottembourg D, 2010, J IMMUNOL, V184, P7100, DOI 10.4049/jimmunol.0803935; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schlaepfer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001999; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; Vanpouille C, 2007, J VIROL, V81, P12458, DOI 10.1128/JVI.00326-07; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002580; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	96	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12831	10.1371/journal.pone.0012831	http://dx.doi.org/10.1371/journal.pone.0012831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862220	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200013
J	Sun, CM; Pager, CT; Luo, GX; Sarnow, P; Cate, JHD				Sun, Chaomin; Pager, Cara T.; Luo, Guangxiang; Sarnow, Peter; Cate, Jamie H. D.			Hepatitis C Virus Core-Derived Peptides Inhibit Genotype 1b Viral Genome Replication via Interaction with DDX3X	PLOS ONE			English	Article							BOX RNA HELICASE; PROTEIN INTERACTS; TRANSLATION; REQUIREMENT	The protein DDX3X is a DEAD-box RNA helicase that is essential for the hepatitis C virus (HCV) life cycle. The HCV core protein has been shown to bind to DDX3X both in vitro and in vivo. However, the specific interactions between these two proteins and the functional importance of these interactions for the HCV viral life cycle remain unclear. We show that amino acids 16-36 near the N-terminus of the HCV core protein interact specifically with DDX3X both in vitro and in vivo. Replication of HCV replicon NNeo/C-5B RNA (genotype 1b) is significantly suppressed in HuH-7-derived cells expressing green fluorescent protein (GFP) fusions to HCV core protein residues 16-36, but not by GFP fusions to core protein residues 16-35 or 16-34. Notably, the inhibition of HCV replication due to expression of the GFP fusion to HCV core protein residues 16-36 can be reversed by overexpression of DDX3X. These results suggest that the protein interface on DDX3X that binds the HCV core protein is important for replicon maintenance. However, infection of HuH-7 cells by HCV viruses of genotype 2a (JFH1) was not affected by expression of the GFP fusion protein. These results suggest that the role of DDX3X in HCV infection involves aspects of the viral life cycle that vary in importance between HCV genotypes.	[Sun, Chaomin] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Pager, Cara T.; Sarnow, Peter] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Luo, Guangxiang] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of Kentucky; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sun, CM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.			Sun, Chaomin/0000-0003-4802-184X; Sarnow, Peter/0000-0002-2043-2770	National Institutes of Health (NIH) [GM073732]; Damon Runyon Cancer Research Foundation [DRG1954-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM073732 to J.H.D.C. and P. S. (www.nih.gov). C.T.P. is supported by the Damon Runyon Cancer Research Foundation (DRG1954-07, http://www.damonrunyon.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Asselah T, 2009, LIVER INT, V29, P57, DOI 10.1111/j.1478-3231.2008.01928.x; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; He YP, 2007, DRUG DISCOV TODAY, V12, P209, DOI 10.1016/j.drudis.2007.01.009; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kim YS, 2001, MOL CELLS, V12, P209; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Perard J, 2009, FEBS LETT, V583, P70, DOI 10.1016/j.febslet.2008.11.025; Purcell R, 1997, HEPATOLOGY, V26, pS11, DOI 10.1002/hep.510260702; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Sekiguchi T, 2007, BIOCHEM BIOPH RES CO, V356, P668, DOI 10.1016/j.bbrc.2007.03.038; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Trahtenherts A, 2008, ANTIVIR RES, V77, P195, DOI 10.1016/j.antiviral.2007.12.013; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	37	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12826	10.1371/journal.pone.0012826	http://dx.doi.org/10.1371/journal.pone.0012826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862261	gold, Green Published, Green Submitted			2022-12-25	WOS:000281960800021
J	Hilimire, MR; Mounts, JRW; Parks, NA; Corballis, PM				Hilimire, Matthew R.; Mounts, Jeffrey R. W.; Parks, Nathan A.; Corballis, Paul M.			Event-Related Potentials Dissociate Effects of Salience and Space in Biased Competition for Visual Representation	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTION; MECHANISMS; CAPTURE; SUPPRESSION; CORTEX; TARGET	Background: Selective visual attention is the process by which the visual system enhances behaviorally relevant stimuli and filters out others. Visual attention is thought to operate through a cortical mechanism known as biased competition. Representations of stimuli within cortical visual areas compete such that they mutually suppress each others' neural response. Competition increases with stimulus proximity and can be biased in favor of one stimulus (over another) as a function of stimulus significance, salience, or expectancy. Though there is considerable evidence of biased competition within the human visual system, the dynamics of the process remain unknown. Methodology/Principal Findings: Here, we used scalp-recorded electroencephalography (EEG) to examine neural correlates of biased competition in the human visual system. In two experiments, subjects performed a task requiring them to either simultaneously identify two targets (Experiment 1) or discriminate one target while ignoring a decoy (Experiment 2). Competition was manipulated by altering the spatial separation between target(s) and/or decoy. Both experimental tasks should induce competition between stimuli. However, only the task of Experiment 2 should invoke a strong bias in favor of the target (over the decoy). The amplitude of two lateralized components of the event-related potential, the N2pc and Ptc, mirrored these predictions. N2pc amplitude increased with increasing stimulus separation in Experiments 1 and 2. However, Ptc amplitude varied only in Experiment 2, becoming more positive with decreased spatial separation. Conclusions/Significance: These results suggest that N2pc and Ptc components may index distinct processes of biased competition-N2pc reflecting visual competitive interactions and Ptc reflecting a bias in processing necessary to individuate task-relevant stimuli.	[Hilimire, Matthew R.; Corballis, Paul M.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA; [Mounts, Jeffrey R. W.] SUNY Coll Geneseo, Dept Psychol, Geneseo, NY 14454 USA; [Parks, Nathan A.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University System of Georgia; Georgia Institute of Technology; State University of New York (SUNY) System; SUNY Geneseo; University of Illinois System; University of Illinois Urbana-Champaign	Hilimire, MR (corresponding author), Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA.	gth828b@mail.gatech.edu	Corballis, Paul M/G-3995-2011	Corballis, Paul/0000-0001-9699-3999				Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bles M, 2006, NEUROIMAGE, V30, P506, DOI 10.1016/j.neuroimage.2005.09.042; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hilimire MR, 2009, PSYCHOPHYSIOLOGY, V46, P1080, DOI 10.1111/j.1469-8986.2009.00846.x; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McCarley JS, 2007, ACTA PSYCHOL, V126, P98, DOI 10.1016/j.actpsy.2006.11.004; Mounts JRW, 2007, PERCEPT PSYCHOPHYS, V69, P209, DOI 10.3758/BF03193743; Reddy L, 2007, J VISION, V7, DOI 10.1167/7.2.3; Sawaki R, 2010, ATTEN PERCEPT PSYCHO, V72, P1455, DOI 10.3758/APP.72.6.1455; Scalf PE, 2010, J NEUROSCI, V30, P161, DOI 10.1523/JNEUROSCI.4207-09.2010; Schubo A, 2009, PSYCHOL RES-PSYCH FO, V73, P233, DOI 10.1007/s00426-008-0215-x; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 2010, ACTA PSYCHO IN PRESS; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4	24	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12677	10.1371/journal.pone.0012677	http://dx.doi.org/10.1371/journal.pone.0012677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	650QH	20862327	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100004
J	Moisenovich, MM; Ol'shevskaya, VA; Rokitskaya, TI; Ramonova, AA; Nikitina, RG; Savchenko, AN; Tatarskiy, VV; Kaplan, MA; Kalinin, VN; Kotova, EA; Uvarov, OV; Agapov, II; Antonenko, YN; Shtil, AA				Moisenovich, Mikhail M.; Ol'shevskaya, Valentina A.; Rokitskaya, Tatyana I.; Ramonova, Alla A.; Nikitina, Roza G.; Savchenko, Arina N.; Tatarskiy, Victor V., Jr.; Kaplan, Mikhail A.; Kalinin, Valery N.; Kotova, Elena A.; Uvarov, Oleg V.; Agapov, Igor I.; Antonenko, Yuri N.; Shtil, Alexander A.			Novel Photosensitizers Trigger Rapid Death of Malignant Human Cells and Rodent Tumor Transplants via Lipid Photodamage and Membrane Permeabilization	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; ROS RELEASE; DERIVATIVES; PORPHYRIN; OXIDATION; APOPTOSIS; PHTHALOCYANINES; MITOCHONDRIA; ANTIOXIDANTS; CHLORINS	Background: Apoptotic cascades may frequently be impaired in tumor cells; therefore, the approaches to circumvent these obstacles emerge as important therapeutic modalities. Methodology/Principal Findings: Our novel derivatives of chlorin e(6), that is, its amide (compound 2) and boronated amide (compound 5) evoked no dark toxicity and demonstrated a significantly higher photosensitizing efficacy than chlorin e(6) against transplanted aggressive tumors such as B16 melanoma and M-1 sarcoma. Compound 5 showed superior therapeutic potency. Illumination with red light of mammalian tumor cells loaded with 0.1 mu M of 5 caused rapid (within the initial minutes) necrosis as determined by propidium iodide staining. The laser confocal microscopy-assisted analysis of cell death revealed the following order of events: prior to illumination, 5 accumulated in Golgi cysternae, endoplasmic reticulum and in some (but not all) lysosomes. In response to light, the reactive oxygen species burst was concomitant with the drop of mitochondrial transmembrane electric potential, the dramatic changes of mitochondrial shape and the loss of integrity of mitochondria and lysosomes. Within 3-4 min post illumination, the plasma membrane became permeable for propidium iodide. Compounds 2 and 5 were one order of magnitude more potent than chlorin e(6) in photodamage of artificial liposomes monitored in a dye release assay. The latter effect depended on the content of non-saturated lipids; in liposomes consisting of saturated lipids no photodamage was detectable. The increased therapeutic efficacy of 5 compared with 2 was attributed to a striking difference in the ability of these photosensitizers to permeate through hydrophobic membrane interior as evidenced by measurements of voltage jump-induced relaxation of transmembrane current on planar lipid bilayers. Conclusions/Significance: The multimembrane photodestruction and cell necrosis induced by photoactivation of 2 and 5 are directly associated with membrane permeabilization caused by lipid photodamage.	[Moisenovich, Mikhail M.; Ramonova, Alla A.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Ol'shevskaya, Valentina A.; Savchenko, Arina N.; Kalinin, Valery N.] AN Nesmeyanov Organoelement Cpds Inst, Moscow, Russia; [Rokitskaya, Tatyana I.; Kotova, Elena A.; Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physico Chem Biol, Moscow, Russia; [Nikitina, Roza G.; Kaplan, Mikhail A.] Med Radiol Res Ctr, Obninsk, Russia; [Tatarskiy, Victor V., Jr.; Shtil, Alexander A.] Blokhin Canc Ctr, Moscow, Russia; [Uvarov, Oleg V.] Prokhorov Inst Gen Phys, Moscow, Russia; [Agapov, Igor I.] Shumakov Res Ctr Transplantol & Artificial Organs, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs	Moisenovich, MM (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.	antonen@genebee.msu.su; shtilaa@yahoo.com	Rokitskaya, Tatyana/J-3541-2013; Ol'shevskaya, Valentina/ABA-9045-2020; Ramonova, Alena/U-2713-2017; Kotova, Elena/A-6214-2012; Tatarskiy, Victor V/K-1224-2017; Moisenovich, Michael/D-9428-2014; Shtil, Alexander A./K-1568-2017; Antonenko, Yuri N/K-1323-2013; Tatarskiy, Victor/T-1156-2019; Agapov, Igor/D-9450-2014; Uvarov, Oleg/I-1793-2018	Ramonova, Alena/0000-0003-0838-5454; Tatarskiy, Victor V/0000-0002-9080-5683; Shtil, Alexander A./0000-0001-6469-0221; Agapov, Igor/0000-0002-0273-4601; Uvarov, Oleg/0000-0001-9033-4802; Rokitskaya, Tatyana/0000-0002-7719-1875	Russian Foundation for Basic Research [09-04-97511-r-centre-a, 08-03-99084-r-ofi, 10-04-01518]; Ministry of Education and Science of Russian Federation [P2460, P2087]; Government of Sverdlovsk Region	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Government of Sverdlovsk Region	This work was supported by grants of Russian Foundation for Basic Research 09-04-97511-r-centre-a 08-03-99084-r-ofi, 10-04-01518, Federal Program 'Scientific and Scientific-Pedagogical Personnel of Innovative Russia for 2009-2013' of Ministry of Education and Science of Russian Federation (P2460 and P2087) and Government of Sverdlovsk Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCLAY LRC, 1994, FREE RADICAL BIO MED, V16, P779, DOI 10.1016/0891-5849(94)90193-7; BENHUR E, 1995, TRANSFUSION, V35, P401, DOI 10.1046/j.1537-2995.1995.35595259150.x; Bourre L, 2003, J PHOTOCH PHOTOBIO B, V69, P179, DOI 10.1016/S1011-1344(03)00020-4; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bronshtein I, 2004, BIOPHYS J, V87, P1155, DOI 10.1529/biophysj.104.041434; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Caruso JA, 2005, BIOCHEM J, V392, P325, DOI 10.1042/BJ20050313; DROR SB, 2009, PHOTOCHEM PHOTOBIOL, V8, P354, DOI DOI 10.1039/B814970D; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Floreani AA, 2007, CELL CYCLE, V6, P2835, DOI 10.4161/cc.6.22.4899; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Hao E, 2008, ORG BIOMOL CHEM, V6, P3732, DOI 10.1039/b807836j; Hargus JA, 2007, PHOTOCHEM PHOTOBIOL, V83, P1006, DOI 10.1111/j.1751-1097.2007.00092.x; KETTERER B, 1971, J MEMBRANE BIOL, V5, P225, DOI 10.1007/BF01870551; Koudinova NV, 2003, INT J CANCER, V104, P782, DOI 10.1002/ijc.11002; Kuchin RAV, 2006, DOKL CHEM, V409, P135, DOI 10.1134/S0012500806080039; Kuznetsova NA, 2003, J PORPHYR PHTHALOCYA, V7, P147, DOI 10.1142/S1088424603000203; Lam M, 2001, J BIOL CHEM, V276, P47379, DOI 10.1074/jbc.M107678200; Lavi A, 2002, BIOPHYS J, V82, P2101, DOI 10.1016/S0006-3495(02)75557-4; Liu C, 2008, J AM CHEM SOC, V130, P14311, DOI 10.1021/ja8050298; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Melnikova VO, 2000, INT J CANCER, V88, P798, DOI 10.1002/1097-0215(20001201)88:5<798::AID-IJC18>3.0.CO;2-8; Mojzisova H, 2007, EUR BIOPHYS J BIOPHY, V36, P943, DOI 10.1007/s00249-007-0204-9; Mojzisova H, 2009, PHOTOCH PHOTOBIO SCI, V8, P778, DOI 10.1039/b822269j; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nieminen AL, 2003, INT REV CYTOL, V224, P29, DOI 10.1016/S0074-7696(05)24002-0; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Ohara K, 2009, J PHOTOCH PHOTOBIO B, V97, P132, DOI 10.1016/j.jphotobiol.2009.08.010; Ol'shevskaya VA, 2006, ORG BIOMOL CHEM, V4, P3815, DOI 10.1039/b607766h; Ol'shevskaya VA, 2007, B KOREAN CHEM SOC, V28, P1910; Ol'shevskaya VA, 2009, J ORGANOMET CHEM, V694, P1632, DOI 10.1016/j.jorganchem.2008.11.013; Ol'shevskaya VA, 2009, BIOORGAN MED CHEM, V17, P1297, DOI 10.1016/j.bmc.2008.12.016; Palma M, 2008, J PHYS CHEM A, V112, P13574, DOI 10.1021/jp804350n; Pandey RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P194, DOI 10.1111/j.1751-1097.1996.tb02442.x; Pashkovskaya A, 2010, LANGMUIR, V26, P5726, DOI 10.1021/la903867a; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Renner M. W., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P145, DOI 10.2174/187152006776119135; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Rokitskaya TI, 2008, J MEMBRANE BIOL, V224, P9, DOI 10.1007/s00232-008-9124-6; Sakharov DV, 2005, FEBS LETT, V579, P1255, DOI 10.1016/j.febslet.2005.01.024; Shchekotikhin AE, 2009, BIOORGAN MED CHEM, V17, P1861, DOI 10.1016/j.bmc.2009.01.047; Sholto A, 2008, PHOTOCH PHOTOBIO SCI, V7, P344, DOI 10.1039/b716377k; SMITH KM, 1985, J AM CHEM SOC, V107, P4946, DOI 10.1021/ja00303a021; Stein WD, 2004, CURR DRUG TARGETS, V5, P333, DOI 10.2174/1389450043345489; van den Heever SC, 2006, J ATMOS SCI, V63, P1752, DOI 10.1175/JAS3713.1; Wu YX, 2006, CELL CYCLE, V5, P729, DOI 10.4161/cc.5.7.2630; Ytzhak S, 2010, J PHYS CHEM B, V114, P10097, DOI 10.1021/jp103355m; Zhivotovsky B, 2004, CELL CYCLE, V3, P64; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	51	29	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12717	10.1371/journal.pone.0012717	http://dx.doi.org/10.1371/journal.pone.0012717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856679	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800013
J	Wang, QH; Chen, K; Liu, R; Zhao, F; Gupta, S; Zhang, NN; Prud'homme, GJ				Wang, Qinghua; Chen, Kui; Liu, Rui; Zhao, Fang; Gupta, Sandeep; Zhang, Nina; Prud'homme, Gerald J.			Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; IN-VIVO; GLUCOSE-HOMEOSTASIS; INSULIN-SECRETION; DIABETES-MELLITUS; INCRETIN HORMONES; DB/DB MICE; CELL MASS; IGG-FC; GENE	GLP-1 has a variety of anti-diabetic effects. However, native GLP-1 is not suitable for therapy of diabetes due to its short half-life (t1/2<2 min). To circumvent this, we developed a long-lasting GLP-1 receptor agonist by the fusion of GLP-1 with human IgG2 Fc (GLP-1/hlgG2). ELISA-based receptor binding assay demonstrated that GLP-1/hlgG2 had high binding affinity to the GLP-1R in INS-1 cells (Kd = 13.90 +/- 1.52 nM). Upon binding, GLP-1/hlgG2 was rapidly internalized by INS-1 cells in a dynamin-dependent manner. Insulin RIA showed that GLP-1/IgG2 dose-dependently stimulated insulin secretion from INS-1 cells. Pharmacokinetic studies in CD1 mice showed that with intraperitoneal injection (i.p.), the GLP-1/hlgG2 peaked at 30 minutes in circulation and maintained a plateau for >168 h. Intraperitoneal glucose tolerance test (IPGTT) in mice showed that GLP-1/hlgG2 significantly decreased glucose excursion. Furthermore, IPGTT performed on mice one week after a single drug-injection also displayed significantly reduced glucose excursion, indicating that GLP-1/hlgG2 fusion protein has long-lasting effects on the modulation of glucose homeostasis. GLP-1/hlgG2 was found to be effective in reducing the incidence of diabetes in multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Together, the long-lasting bioactive GLP-1/hlgG2 retains native GLP-1 activities and thus may serve as a potent GLP-1 receptor agonist.	[Wang, Qinghua; Chen, Kui; Liu, Rui; Zhao, Fang; Gupta, Sandeep; Zhang, Nina] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Wang, Qinghua] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Qinghua] Univ Toronto, Dept Med, Toronto, ON, Canada; [Prud'homme, Gerald J.] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wang, QH (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Div Endocrinol & Metab, 30 Bond St, Toronto, ON M5B 1W8, Canada.	qinghua.wang@utoronto.ca	Wang, Qinghua/GVT-3252-2022; zhang, nina/GXH-0962-2022		Juvenile Diabetes Research Foundation; St Michael's Hospital; Canadian Institute for Health Research (CIHR); Canadian Diabetes association	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); St Michael's Hospital(University of Toronto); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes association	This work was supported by grants from the Juvenile Diabetes Research Foundation (PI: Q Wang; Co-PI: G Prud'homme) and St Michael's Hospital. Research in the Wang lab was supported by Canadian Institute for Health Research (CIHR) and Canadian Diabetes association. Q Wang is supported by CIHR New Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangari G, 2004, INT J IMMUNOPATH PH, V17, P33, DOI 10.1177/039463200401700105; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; HUPESODMANN K, 1995, REGUL PEPTIDES, V58, P149, DOI 10.1016/0167-0115(95)00063-H; Irwin DM, 1997, P NATL ACAD SCI USA, V94, P7915, DOI 10.1073/pnas.94.15.7915; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Jorgensen R, 2005, MOL ENDOCRINOL, V19, P812, DOI 10.1210/me.2004-0312; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; King LB, 2000, IMMUNOL REV, V176, P86; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; Kumpel BM, 2002, TRANSFUS CLIN BIOL, V9, P9, DOI 10.1016/S1246-7820(01)00209-9; Larrick J W, 1991, Hum Antibodies Hybridomas, V2, P172; Larsen J, 2001, DIABETES CARE, V24, P1416, DOI 10.2337/diacare.24.8.1416; Lee AY, 2002, ACTA DERM-VENEREOL, V82, P114, DOI 10.1080/00015550252948149; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Melo MEF, 2002, J IMMUNOL, V168, P4788, DOI 10.4049/jimmunol.168.9.4788; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; MURPHY K, 2008, JANEWAYS IMMUNOBIOLO, P409; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; Picha KM, 2008, DIABETES, V57, P1926, DOI 10.2337/db07-1775; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Prislovsky A, 2008, EXP HEMATOL, V36, P609, DOI 10.1016/j.exphem.2007.12.019; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Soltani N, 2007, GENE THER, V14, P981, DOI 10.1038/sj.gt.3302944; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; THORENS B, 1993, DIABETES, V42, P1219, DOI 10.2337/diabetes.42.9.1219; Todd JF, 1997, EUR J CLIN INVEST, V27, P533, DOI 10.1046/j.1365-2362.1997.1490691.x; Uray K, 2004, J MOL RECOGNIT, V17, P95, DOI 10.1002/jmr.652; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Weir ANC, 2002, BIOCHEM SOC T, V30, P512, DOI 10.1042/bst0300512; Widmann C, 1997, MOL ENDOCRINOL, V11, P1094, DOI 10.1210/me.11.8.1094; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; YU SS, 1993, J BIOL CHEM, V268, P337; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	46	32	40	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12734	10.1371/journal.pone.0012734	http://dx.doi.org/10.1371/journal.pone.0012734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856794	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815800015
J	Lavergne, E; Hendaoui, I; Coulouarn, C; Ribault, C; Leseur, J; Eliat, PA; Mebarki, S; Corlu, A; Clement, B; Musso, O				Lavergne, E.; Hendaoui, I.; Coulouarn, C.; Ribault, C.; Leseur, J.; Eliat, P-A; Mebarki, S.; Corlu, A.; Clement, B.; Musso, O.			Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active beta-catenin	ONCOGENE			English	Article						frizzled; collagen XVIII; Wnt; beta-catenin; colorectal cancer; secreted frizzled-related proteins	HUMAN COLORECTAL-CANCER; BASEMENT-MEMBRANE ZONES; COLON-CANCER; XVIII COLLAGEN; EXPRESSION; GENE; PATHWAY; CARCINOMA; MOUSE; ACTIVATION	Constitutive activation of Wnt/beta-catenin signaling in cancer results from mutations in pathway components, which frequently coexist with autocrine Wnt signaling or epigenetic silencing of extracellular Wnt antagonists. Among the extracellular Wnt inhibitors, the secreted frizzled-related proteins (SFRPs) are decoy receptors that contain soluble Wnt-binding frizzled domains. In addition to SFRPs, other endogenous molecules harboring frizzled motifs bind to and inhibit Wnt signaling. One of such molecules is V3Nter, a soluble SFRP-like frizzled polypeptide that binds to Wnt3a and inhibits Wnt signaling and expression of the beta-catenin target genes cyclin D1 and c-myc. V3Nter is derived from the cell surface extracellular matrix component collagen XVIII. Here, we used HCT116 human colon cancer cells carrying the Delta S45 activating mutation in one of the alleles of beta-catenin to show that V3Nter and SFRP-1 decrease baseline and Wnt3a-induced beta-catenin stabilization. Consequently, V3Nter reduces the growth of human colorectal cancer xenografts by specifically controlling cell proliferation and cell cycle progression, without affecting angiogenesis or apoptosis, as shown by decreased [H-3]-thymidine (in vitro) or BrdU (in vivo) incorporation, clonogenesis assays, cell cycle analysis and magnetic resonance imaging in living mice. Additionally, V3Nter switches off the beta-catenin target gene expression signature in vivo. Moreover, experiments with b-catenin allele-targeted cells showed that the DS45 beta-catenin allele hampers, but does not abrogate, inhibition of Wnt signaling by SFRP-1 or by the SFRP-like frizzled domain. Finally, neither SFRP-1 nor V3Nter affect beta-catenin signaling in SW480 cells carrying nonfunctional Adenomatous polyposis coli. Thus, SFRP-1 and the SFRP-like molecule V3Nter can inhibit tumor growth of beta-catenin-activated tumor cells in vivo. Oncogene (2011) 30, 423-433; doi: 10.1038/onc.2010.432; published online 20 September 2010	[Musso, O.] Univ Rennes, INSERM, UMR991, Hop Pontchaillou, F-35033 Rennes, France; [Lavergne, E.; Hendaoui, I.; Coulouarn, C.; Ribault, C.; Leseur, J.; Eliat, P-A; Mebarki, S.; Corlu, A.; Clement, B.; Musso, O.] Univ Rennes 1, Rennes, France; [Leseur, J.] Ctr Reg Lutte Canc, Rennes, France; [Eliat, P-A] PRISM, IFR 140, Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes	Musso, O (corresponding author), Univ Rennes, INSERM, UMR991, Hop Pontchaillou, Rue Henri le Guilloux, F-35033 Rennes, France.	orlando.musso@inserm.fr	Clement, Bruno/E-5546-2016; Eliat, Pierre-Antoine/AAL-2600-2020; Coulouarn, Cedric/E-5472-2011; Musso, Orlando/N-5756-2017; Corlu, Anne/U-8030-2018	Clement, Bruno/0000-0001-8827-146X; Eliat, Pierre-Antoine/0000-0002-8082-4477; Coulouarn, Cedric/0000-0002-5692-9586; Corlu, Anne/0000-0002-7370-0564; Musso, Orlando/0000-0001-8881-6925	Institut National de la Sante et de la Recherche Medicale; Institut National du Cancer; Agence Nationale de la Recherche; Universite de Rennes 1; Region Bretagne	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite de Rennes 1; Region Bretagne(Region Bretagne)	We thank technical assistance from C Rocher at the Small Animal Imaging Platform, A Fautrel and P Bellaud at the Core HistoPathology Platform, R Le Guevel at the ImpactCell Platform, D Le Quilleuc and B Turlin at the Center for Biological Ressources and the animal husbandry group. We are indebted to B Vogelstein, S Bayling and H Suzuki, R Moon, R Nusse, T Pihlajaniemi and J Pouyssegur for generously providing cells, cDNAs or antibodies and to Christine Perret (Institut Cochin, Department Endocrinology, Metabolism and Cancer, Paris, France) for critical reading of the paper. This study was supported by Institut National de la Sante et de la Recherche Medicale, Institut National du Cancer, Agence Nationale de la Recherche (Emergence-BIO Program 2008), Universite de Rennes 1, Region Bretagne.	Ahmed N, 2003, PROTEOMICS, V3, P288, DOI 10.1002/pmic.200390042; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dimitriadis A, 2001, CANCER LETT, V166, P185, DOI 10.1016/S0304-3835(01)00428-1; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kenny PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-3; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kyle AH, 2003, CANCER RES, V63, P5707; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Ramanujan S, 2000, CANCER RES, V60, P1442; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; Takeuchi T, 2004, CLIN CANCER RES, V10, P5572, DOI 10.1158/1078-0432.CCR-03-0656; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Treanor D, 2007, CLIN ONCOL-UK, V19, P769, DOI 10.1016/j.clon.2007.08.012; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Vider BZ, 1996, ONCOGENE, V12, P153; Wang ZH, 2003, CANCER RES, V63, P5234; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200	53	63	67	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	4					423	433		10.1038/onc.2010.432	http://dx.doi.org/10.1038/onc.2010.432			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20856206	Green Submitted, Green Accepted			2022-12-25	WOS:000286621600005
J	Steinberg, GR; O'Neill, HM; Dzamko, NL; Galic, S; Naim, T; Koopman, R; Jorgensen, SB; Honeyman, J; Hewitt, K; Chen, ZP; Schertzer, JD; Scott, JW; Koentgen, F; Lynch, GS; Watt, MJ; van Denderen, BJW; Campbell, DJ; Kemp, BE				Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Naim, Tim; Koopman, Rene; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Schertzer, Jonathan D.; Scott, John W.; Koentgen, Frank; Lynch, Gordon S.; Watt, Matthew J.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.			Whole Body Deletion of AMP-activated Protein Kinase beta 2 Reduces Muscle AMPK Activity and Exercise Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; HUMAN SKELETAL-MUSCLE; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; LIFE-STYLE; ISOFORM; CONTRACTION; TRANSPORT; PHOSPHORYLATION	AMP-activated protein kinase (AMPK) beta subunits (beta 1 and beta 2) provide scaffolds for binding alpha and gamma subunits and contain a carbohydrate-binding module important for regulating enzyme activity. We generated C57Bl/6 mice with germline deletion of AMPK beta 2 (beta 2 KO) and examined AMPK expression and activity, exercise capacity, metabolic control during muscle contractions, aminoimidazole carboxamide ribonucleotide (AICAR) sensitivity, and susceptibility to obesity-induced insulin resistance. We find that beta 2 KO mice are viable and breed normally. beta 2 KO mice had a reduction in skeletal muscle AMPK alpha 1 and alpha 2 expression despite up-regulation of the beta 1 isoform. Heart AMPK alpha 2 expression was also reduced but this did not affect resting AMPK alpha 1 or alpha 2 activities. AMPK alpha 1 and alpha 2 activities were not changed in liver, fat, or hypothalamus. AICAR-stimulated glucose uptake but not fatty acid oxidation was impaired in beta 2 KO mice. During treadmill running beta 2 KO mice had reduced maximal and endurance exercise capacity, which was associated with lower muscle and heart AMPK activity and reduced levels of muscle and liver glycogen. Reductions in exercise capacity of beta 2 KO mice were not due to lower muscle mitochondrial content or defects in contraction-stimulated glucose uptake or fatty acid oxidation. When challenged with a high-fat diet beta 2 KO mice gained more weight and were more susceptible to the development of hyperinsulinemia and glucose intolerance. In summary these data show that deletion of AMPK beta 2 reduces AMPK activity in skeletal muscle resulting in impaired exercise capacity and the worsening of diet-induced obesity and glucose intolerance.	[Schertzer, Jonathan D.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Scott, John W.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Scott, John W.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Naim, Tim; Koopman, Rene; Schertzer, Jonathan D.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Jorgensen, Sebastian B.] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark; [Koentgen, Frank] Ozgene Pty Ltd, Perth, WA, Australia; Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	McMaster University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of Melbourne; Novo Nordisk; Monash University	Steinberg, GR (corresponding author), 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gsteinberg@mcmaster.ca	Kemp, Bruce E/L-2633-2014; Galic, Sandra/C-6098-2014; Scott, John W/P-1170-2018; van Denderen, Bryce/AAW-5454-2021; Scott, John W/AAA-2676-2021; Dzamko, Nicolas/AAD-6922-2019; Lynch, Gordon/G-9553-2015; Kemp, Bruce/G-9602-2019; Watt, Matthew J/B-2089-2014; Schertzer, Jonathan/P-3395-2017	Kemp, Bruce E/0000-0001-6735-5082; Galic, Sandra/0000-0002-7611-5619; Scott, John W/0000-0002-1896-9798; Scott, John W/0000-0002-1896-9798; Lynch, Gordon/0000-0001-9220-9810; Kemp, Bruce/0000-0001-6735-5082; Dzamko, Nicolas/0000-0002-9121-0294; O'Neill, Hayley/0000-0001-6812-6580; Schertzer, Jonathan/0000-0002-1547-5856; Steinberg, Gregory/0000-0001-5425-8275	Australian Research Council; National Health and Medical Research Council; Natural Science and Engineering Research Council of Canada; Diabetes Australia Research Trust; National Heart Foundation of Australia; National Heart Foundation; Danish Medical Research Council [271-05-0697]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Diabetes Australia Research Trust; National Heart Foundation of Australia(National Heart Foundation of Australia); National Heart Foundation(National Heart Foundation of Australia); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Australian Research Council (to B. E. K.), National Health and Medical Research Council (to D. J. C., B. E. K., G. R. S., and M. J. W.), Natural Science and Engineering Research Council of Canada (to G. R. S.), Diabetes Australia Research Trust (to G. R. S.), and the National Heart Foundation of Australia (to B. E. K. and D. J. C.).; Supported by a scholarship from the National Heart Foundation.; Supported by Research Fellowship 271-05-0697 from the Danish Medical Research Council.; Supported by research fellowships from the National Health and Medical Research Council of Australia.	Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Dean DJ, 2000, DIABETES, V49, pA11; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Hayashi T, 1998, DIABETES, V47, pA3; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V282, pE593, DOI 10.1152/ajpendo.00303.2001; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x	63	122	122	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37198	37209		10.1074/jbc.M110.102434	http://dx.doi.org/10.1074/jbc.M110.102434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855892	Green Published, hybrid			2022-12-25	WOS:000284424000013
J	Bonivento, D; Milczek, EM; McDonald, GR; Binda, C; Holt, A; Edmondson, DE; Mattevi, A				Bonivento, Daniele; Milczek, Erika M.; McDonald, G. Reid; Binda, Claudia; Holt, Andrew; Edmondson, Dale E.; Mattevi, Andrea			Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; PICHIA-PASTORIS; IMIDAZOLINE LIGANDS; HUMAN BRAIN; RAT-LIVER; HUMAN-MAO; SITES; TRANYLCYPROMINE; INHIBITION; BFI	Crystallographic and biochemical studies have been employed to identify the binding site and mechanism for potentiation of imidazoline binding in human monoamine oxidase B (MAO B). 2-(2-Benzofuranyl)-2-imidazoline (2-BFI) inhibits recombinant human MAO B with a K-i of 8.3 +/- 0.6 mu M, whereas tranylcypromine-inhibited MAO B binds 2-BFI with a K-d of 9 +/- 2 nM, representing an increase in binding energy Delta(Delta G) of -3.9 kcal/mol. Crystal structures show the imidazoline ligand bound in a site that is distinct from the substrate-binding cavity. Contributions to account for the increase in binding affinity upon tranylcypromine inhibition include a conformational change in the side chain of Gln(206) and a "closed conformation" of the side chain of Ile(199), forming a hydrophobic "sandwich" with the side chain of Ile(316) on each face of the benzofuran ring of 2-BFI. Data with the I199A mutant of human MAO B and failure to observe a similar binding potentiation with rat MAO B, where Ile316 is replaced with a Val residue, support an allosteric mechanism where the increased binding affinity of 2-BFI results from a cooperative increase in H-bond strength through formation of a more hydrophobic milieu. These insights should prove valuable in the design of high affinity and specific reversible MAO B inhibitors.	[McDonald, G. Reid; Holt, Andrew] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, PV, Italy; [Milczek, Erika M.; Edmondson, Dale E.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Milczek, Erika M.; Edmondson, Dale E.] Emory Univ, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA	University of Alberta; University of Pavia; Emory University; Emory University	Holt, A (corresponding author), Univ Alberta, Dept Pharmacol, 9-58 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	aholt@pmcol.ualberta.ca; deedmon@emory.edu; andrea.mattevi@unipv.it	mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019	mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Binda, Claudia/0000-0003-2038-9845	National Institutes of Health [GM 29433]; National Institutes of Health through NINDS [F31NS063648]; Fondazione Cariplo; MIUR-PRIN09; Fondazone Bussolera; Canadian Institutes of Health Research [MOP77529]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fondazione Cariplo(Fondazione Cariplo); MIUR-PRIN09; Fondazone Bussolera; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 29433 (to D. E. E.) and a predoctoral fellowship from the National Institutes of Health through NINDS Award F31NS063648 (to E. M. M.). This work was also supported by grants from the Fondazione Cariplo (to D. E. E. and A. M.), MIUR-PRIN09 and Fondazone Bussolera (to A. M.), and Canadian Institutes of Health Research (Grant MOP77529) to A. H.	ALEMANY R, 1995, BRIT J PHARMACOL, V114, P837, DOI 10.1111/j.1476-5381.1995.tb13280.x; Anderson NJ, 2006, J NEUROCHEM, V96, P1551, DOI 10.1111/j.1471-4159.2006.03662.x; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; DUNN SMJ, 1993, BIOCHEMISTRY-US, V32, P8608, DOI 10.1021/bi00084a031; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Hubalek F, 2005, J BIOL CHEM, V280, P15761, DOI 10.1074/jbc.M500949200; Imbrici P, 2009, CHANNELS, V3, P39, DOI 10.4161/chan.3.1.7548; Jones TZE, 2007, FEBS J, V274, P1567, DOI 10.1111/j.1742-4658.2007.05704.x; Lanier S M, 1995, Ann N Y Acad Sci, V763, P106, DOI 10.1111/j.1749-6632.1995.tb32395.x; Li M, 2002, PROTEIN EXPRES PURIF, V24, P152, DOI 10.1006/prep.2001.1546; Muley L, 2010, J MED CHEM, V53, P2126, DOI 10.1021/jm9016416; Newton-Vinson P, 2000, PROTEIN EXPRES PURIF, V20, P334, DOI 10.1006/prep.2000.1309; Ozaita A, 1997, BRIT J PHARMACOL, V121, P901, DOI 10.1038/sj.bjp.0701214; Parini A, 1996, TRENDS PHARMACOL SCI, V17, P13, DOI 10.1016/0165-6147(96)81564-1; Raddatz R, 1997, MOL PHARMACOL, V52, P549, DOI 10.1124/mol.52.4.549; Raddatz R, 2000, J PHARMACOL EXP THER, V292, P1135; RADDATZ R, 1995, J BIOL CHEM, V270, P27961, DOI 10.1074/jbc.270.46.27961; Remaury A, 2000, MOL PHARMACOL, V58, P1085, DOI 10.1124/mol.58.5.1085; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Steinberg MI, 1999, ANN NY ACAD SCI, V881, P193, DOI 10.1111/j.1749-6632.1999.tb09359.x; TESSON F, 1995, J BIOL CHEM, V270, P9856, DOI 10.1074/jbc.270.17.9856; Upadhyay AK, 2008, PROTEIN EXPRES PURIF, V59, P349, DOI 10.1016/j.pep.2008.03.002; VOET DG, 2004, BIOCHEMISTRY-US, P1303; Wang J, 2010, PROTEIN EXPRES PURIF, V70, P211, DOI 10.1016/j.pep.2009.10.013; Wiest SA, 1999, N-S ARCH PHARMACOL, V360, P209, DOI 10.1007/s002109900065; Wiest SA, 1997, LIFE SCI, V60, P605, DOI 10.1016/S0024-3205(96)00639-X; Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392	29	84	83	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36849	36856		10.1074/jbc.M110.169482	http://dx.doi.org/10.1074/jbc.M110.169482			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855894	hybrid, Green Published			2022-12-25	WOS:000284146100025
J	Liu, J; Sandoval, J; Doh, ST; Cai, L; Lopez-Rodas, G; Casaccia, P				Liu, Jia; Sandoval, Juan; Doh, Sung Tae; Cai, Li; Lopez-Rodas, Gerardo; Casaccia, Patrizia			Epigenetic Modifiers Are Necessary but Not Sufficient for Reprogramming Non-Myelinating Cells into Myelin Gene-Expressing Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OLIGODENDROCYTE PROGENITOR DIFFERENTIATION; SMALL-MOLECULE COMPOUNDS; DNA METHYLATION; BASIC-PROTEIN; TRANSCRIPTION FACTOR; HISTONE METHYLATION; DEFINED FACTORS; FIBROBLASTS; INDUCTION	Background: Modifications on specific histone residues and DNA methylation play an essential role in lineage choice and cellular reprogramming. We have previously shown that histone modifications or combinatorial codes of transcription factors (TFs) are critical for the differentiation of multipotential progenitors into myelinating oligodendrocytes. In this study we asked whether combining global manipulation of DNA methylation and histone acetylation together with the expression of oligodendrocyte-specific TFs, was sufficient to switch the identity of fibroblasts into myelin gene-expressing cells. Methodology/Principal Findings: Transfection of six oligodendrocyte-specific TFs (Olig1, Olig2, Sox10, Mash1, E47 and Nkx2.2) into NIH3T3 fibroblasts was capable of inducing expression of myelin gene promoter-driven reporters, but did not activate endogenous myelin gene expression. These results suggested the existence of a transcriptionally incompetent chromatin conformation in NIH3T3 fibroblasts. Using chromatin immunoprecipitation (ChIP) analysis, we compared the histone code on the conserved regions of myelin genes (i.e. Mbp and Mag) in differentiating oligodendrocyte progenitors and NIH3T3 fibroblasts. Chromatin at myelin gene loci was characterized by the presence of repressive histone modifications (me3K9H3 and me3K27H3) in NIH3T3 fibroblasts and active histone marks (me3K4H3 and AcH3) in oligodendrocyte lineage cells. To induce a transcriptionally competent chromatin signature, NIH3T3 fibroblasts were treated with 5-azadeoxy-citidine (5-AzaC) to decrease DNA methylation, and trichostatin A (TSA) or sirtinol, to favor histone acetylation. Treatment with 5-AzaC/TSA but not sirtinol, resulted in the detection of endogenous myelin gene transcripts in fibroblasts, although not to the levels detected in myelinating cells. Transfection of oligodendrocyte-specific TFs after 5AzaC/TSA treatment did not further increase myelin gene expression, nor did it reprogram the transcriptional network of NIH3T3 fibroblasts into that of oligodendrocytes. Conclusions/Significance: These results suggest that reprogramming of fibroblasts into myelin gene-expressing cells not only requires transcriptional activation, but also chromatin manipulations that go beyond histone acetylation and DNA methylation.	[Liu, Jia; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sandoval, Juan; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Doh, Sung Tae; Cai, Li] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Icahn School of Medicine at Mount Sinai; University of Valencia; Rutgers State University New Brunswick	Liu, J (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu	Liu, Jia/AAN-2112-2020; sandoval, juan/M-4593-2015; LOPEZ-RODAS, GERARDO/I-1349-2015	Liu, Jia/0000-0001-6274-2710; sandoval, juan/0000-0002-5100-973X; Cai, Li/0000-0003-3344-337X; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X	Winston Foundation [NMSS FG1874-A1]; Ministerio de Ciencia y Tecnologia [CSD2006-00049, PR2008-0243]; National Institutes of Health (NIH) [R21-EY018738]; New Jersey Commission on Spinal Cord Research [08-3074-SCR-E-0];  [NS-R01-42925-08];  [NS-R01-42925-08-S1];  [NMSS-RG3957]; NATIONAL EYE INSTITUTE [R21EY018738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925] Funding Source: NIH RePORTER	Winston Foundation; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord Research; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a fellowship to Dr. Liu (NMSS FG1874-A1, sponsored by the Winston Foundation) and by grants to: Dr. Casaccia (NS-R01-42925-08; NS-R01-42925-08-S1 ARRA supplement; NMSS-RG3957), Dr. Lopez-Rodas (Ministerio de Ciencia y Tecnologia CSD2006-00049 and PR2008-0243) and to Dr. Cai (National Institutes of Health (NIH) R21-EY018738 and New Jersey Commission on Spinal Cord Research 08-3074-SCR-E-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Doh ST, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-94; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Farhadi HF, 2003, J NEUROSCI, V23, P10214; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; MIKOSHIBA K, 1991, ANNU REV NEUROSCI, V14, P201, DOI 10.1146/annurev.ne.14.030191.001221; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wei Q, 2005, J BIOL CHEM, V280, P16284, DOI 10.1074/jbc.M500491200; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; ZHANG XM, 2009, MOL BIOL REP; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	39	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13023	10.1371/journal.pone.0013023	http://dx.doi.org/10.1371/journal.pone.0013023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885955	gold, Green Submitted, Green Published			2022-12-25	WOS:000282167100022
J	Sarkari, F; Sheng, Y; Frappier, L				Sarkari, Feroz; Sheng, Yi; Frappier, Lori			USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; TUMOR-SUPPRESSOR P53; C-TERMINAL DOMAIN; HUMAN CANCER; CONFORMATION; ACETYLATION; ACTIVATION; HAUSP/USP7; PHOSPHORYLATION; IDENTIFICATION	The p53 tumor suppressor invokes cellular responses to stressful stimuli by coordinating distinct gene expression programs. This function relies heavily on the ability of p53 to function as a transcription factor by binding promoters of target genes in a sequence specific manner. The DNA binding activity of the core domain of p53 is subject to regulation via post-translational modifications of the C-terminal region. Here we show that the ubiquitin specific protease, USP7 or HAUSP, known to stabilize p53, also regulates the sequence-specific DNA binding mediated by the core domain of p53 in vitro. This regulation is contingent upon interaction between USP7 and the C-terminal regulatory region of p53. However, our data suggest that this effect is not mediated through the N-terminal domain of USP7 previously shown to bind p53, but rather involves the USP7 C-terminal domain and is independent of the deubiquitylation activity of USP7. Consistent with our in vitro observations, we found that overexpression of catalytically inactive USP7 in cells promotes p53 binding to its target sequences and p21 expression, without increasing the levels of p53 protein. We also found that the USP7 C-terminal domain was sufficient for p21 induction. Our results suggest a novel mode of regulation of p53 function by USP7, which is independent of USP7 deubiquitylating activity.	[Sarkari, Feroz; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Sarkari, F (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca			Canadian Cancer Society Research; National Cancer Institute of Canada	Canadian Cancer Society Research(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by a Canadian Cancer Society Research Grant to L. F. and a National Cancer Institute of Canada studentship to F.S.L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SARKARI F, 2010, HERPESVIRUS AS UNPUB; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Shan J, 2008, Ernst Schering Found Symp Proc, P127; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 2009, J VIROL, V83, P11704, DOI 10.1128/JVI.00931-09; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0	41	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13040	10.1371/journal.pone.0013040	http://dx.doi.org/10.1371/journal.pone.0013040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885946	gold, Green Published, Green Submitted			2022-12-25	WOS:000282167100028
J	Kim, S; Selote, DS; Vatamaniuk, OK				Kim, Sungjin; Selote, Devarshi S.; Vatamaniuk, Olena K.			The N-Terminal Extension Domain of the C. elegans Half-Molecule ABC Transporter, HMT-1, Is Required for Protein-Protein Interactions and Function	PLOS ONE			English	Article							MEMBRANE-SPANNING DOMAIN; CAENORHABDITIS-ELEGANS; HEAVY-METALS; BINDING; TRANSFORMATION; TRAFFICKING; TOLERANCE; SYSTEM; LOCALIZATION; SUPERFAMILY	Background: Members of the HMT-1 (heavy metal tolerance factor 1) subfamily of the ATP-binding cassette (ABC) transporter superfamily detoxify heavy metals and have unique topology: they are half-molecule ABC transporters that, in addition to a single transmembrane domain (TMD1) and a single nucleotide-binding domain (NBD1), possess a hydrophobic NH2-terminal extension (NTE). These structural features distinguish HMTs from other ABC transporters in different species including Drosophila and humans. Functional ABC transporters, however, are comprised of at least four-domains (two TMDs and two NDBs) formed from either a single polypeptide or by the association of two or four separate subunits. Whether HMTs act as oligomers and what role the NTE domain plays in their function have not been determined. Methodology/Principal Findings: In this study, we examined the oligomeric status of Caenorhabditis elegans HMT-1 and the functional significance of its NTE using gel-filtration chromatography in combination with the mating-based split-ubiquitin yeast two-hybrid system (mbSUS) and functional in vivo assays. We found that HMT-1 exists in a protein complex in C. elegans. Studies in S. cerevisiae showed that HMT-1 at a minimum homodimerizes and that oligomerization is essential for HMT-1 to confer cadmium tolerance. We also established that the NTE domain plays an important structural and functional role: it is essential for HMT-1 oligomerization and Cd-detoxification function. However, the NTE itself was not sufficient for oligomerization suggesting that multiple structural features of HMT-1 must associate to form a functional transporter. Conclusions: The prominence of heavy metals as environmental toxins and the remarkable conservation of HMT-1 structural architecture and function in different species reinforce the value of continued studies of HMT-1 in model systems for identifying functional domains in HMT1 of humans.	[Kim, Sungjin; Selote, Devarshi S.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Kim, S (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Selote, Devarshi/F-1560-2015		National Science Foundation (NSF) [MCB-0923731]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the National Science Foundation (NSF) MCB-0923731 grant awarded to O.K.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; Chloupkova M, 2004, FEBS LETT, V569, P65, DOI 10.1016/j.febslet.2004.05.051; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; MADURO M, 1995, GENETICS, V141, P977; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mello C, 1995, METHOD CELL BIOL, V48, P451; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PARRY RV, 1989, J BIOL CHEM, V264, P20025; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schwartz MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009564; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Taylor JC, 2001, J BIOL CHEM, V276, P36075, DOI 10.1074/jbc.C100345200; Tian CX, 2010, DEVELOPMENT, V137, P2375, DOI 10.1242/dev.051615; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200	40	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12938	10.1371/journal.pone.0012938	http://dx.doi.org/10.1371/journal.pone.0012938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886084	Green Submitted, Green Published, gold			2022-12-25	WOS:000282091100037
J	Varian, A; Nichols, KM				Varian, Anna; Nichols, Krista M.			Heritability of Morphology in Brook Trout with Variable Life Histories	PLOS ONE			English	Article							CHARR SALVELINUS-FONTINALIS; SALMON ONCORHYNCHUS-KISUTCH; JUVENILE COHO SALMON; LAKE-SUPERIOR; PHENOTYPIC PLASTICITY; ATLANTIC SALMON; CHINOOK SALMON; GENETIC ARCHITECTURE; ADAPTIVE RADIATION; SPECIES COMPLEX	Distinct morphological variation is often associated with variation in life histories within and among populations of both plants and animals. In this study, we examined the heritability of morphology in three hatchery strains of brook trout (Salvelinus fontinalis), which were historically or are currently used for stocking and supplementation of both migratory and resident ecotypes in the upper Great Lakes region. In a common garden experiment, significant variation in body morphology was observed within and across populations sampled at three time periods. The most notable differences among strains were differences in dorso-ventral body depth and the shape of the caudal peduncle, with some differences in the anterior-posterior placement of the dorsal and ventral fins. Variation with and among 70 half-sib families indicates that heritabilities of morphology and body size were significant at most developmental time points both within and across strains. Heritabilities for morphological characters within strains ranged from 0 to 0.95 across time points. Significant within-strain heritabilities for length ranged from 0 to 0.93 across time points and for weight ranged from 0 to 0.88. Significant additive genetic variation exists within and across hatchery brook trout strains for morphology and size, indicating that these traits are capable of responding to natural or artificial selection.	[Varian, Anna; Nichols, Krista M.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Nichols, Krista M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Varian, A (corresponding author), Minnesota Dept Nat Resources, Aitkan, MN USA.	kmnichol@purdue.edu			Purdue University Agriculture; United States Department of Agriculture-National Research Initiative (USDA-NRI) [2006-04796]	Purdue University Agriculture; United States Department of Agriculture-National Research Initiative (USDA-NRI)(United States Department of Agriculture (USDA))	This work was supported in part by a Purdue University Agriculture Research Program Fellowship and a grant from the United States Department of Agriculture-National Research Initiative (USDA-NRI) [grant number 2006-04796]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Alfonso NR, 2004, ENVIRON BIOL FISH, V71, P21, DOI 10.1023/B:EBFI.0000043176.61258.3d; Anderson Richard O., 1996, P447; BEEMAN JW, 1994, CAN J FISH AQUAT SCI, V51, P836, DOI 10.1139/f94-082; Bhagat Y, 2006, J FISH BIOL, V69, P79, DOI 10.1111/j.1095-8649.2006.01267.x; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Boily P, 2002, J EXP BIOL, V205, P1031; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Chernoff E, 2007, J FISH BIOL, V70, P334, DOI 10.1111/j.1095-8649.2007.01328.x; CHEVERUD JM, 1983, GENET RES, V42, P65, DOI 10.1017/S0016672300021492; COOPER AM, 2009, CONSERVATION GENETIC; D'Amelio S, 2008, T AM FISH SOC, V137, P1213, DOI 10.1577/T05-275.1; Dahl J, 2006, ECOL FRESHW FISH, V15, P388, DOI 10.1111/j.1600-0633.2006.00150.x; Dickerson BR, 2005, T AM FISH SOC, V134, P1323, DOI 10.1577/T04-006.1; DuBois R.B., 1996, STATUS BROOK TROUT L; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; FLEMING IA, 1989, EVOLUTION, V43, P141, DOI 10.1111/j.1558-5646.1989.tb04213.x; FLICK WA, 1977, NAT CAN, V104, P353; Funk WC, 2005, J HERED, V96, P24, DOI 10.1093/jhered/esi009; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hard JJ, 1999, J HERED, V90, P597, DOI 10.1093/jhered/90.6.597; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; Huckins CJ, 2008, T AM FISH SOC, V137, P1229, DOI 10.1577/T05-274.1; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Imre I, 2002, J FISH BIOL, V61, P1171, DOI 10.1006/jfbi.2002.2131; Keeley ER, 2005, CAN J FISH AQUAT SCI, V62, P1523, DOI 10.1139/F05-062; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Letcher BH, 2003, OECOLOGIA, V137, P533, DOI 10.1007/s00442-003-1387-0; Lynch M., 1998, GENETICS ANAL QUANTI; MACCRIMM.HR, 1969, J FISH RES BOARD CAN, V26, P1699, DOI 10.1139/f69-159; Marcil J, 2006, BIOL J LINN SOC, V88, P351, DOI 10.1111/j.1095-8312.2006.00656.x; Moore SA, 2001, T AM FISH SOC, V130, P1233, DOI 10.1577/1548-8659(2001)130<1233:DOSMOL>2.0.CO;2; Morinville GR, 2008, ENVIRON BIOL FISH, V81, P171, DOI 10.1007/s10641-007-9186-9; Morinville GR, 2006, J ANIM ECOL, V75, P693, DOI 10.1111/j.1365-2656.2006.01090.x; Morinville GR, 2003, CAN J FISH AQUAT SCI, V60, P401, DOI [10.1139/f03-036, 10.1139/F03-036]; NEWMAN LE, 2003, GREAT LAKES FISHERIE; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Nichols KM, 2007, GENETICS, V175, P335, DOI 10.1534/genetics.106.064311; NICIEZA AG, 1995, FUNCT ECOL, V9, P448, DOI 10.2307/2390008; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Pakkasmaa S, 2001, BIOL J LINN SOC, V72, P231, DOI 10.1111/j.1095-8312.2001.tb01313.x; Parsons KJ, 2003, ENVIRON BIOL FISH, V67, P417, DOI 10.1023/A:1025895317253; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Perry GML, 2005, J EVOLUTION BIOL, V18, P1348, DOI 10.1111/j.1420-9101.2005.00954.x; Perry GML, 2004, EVOLUTION, V58, P2002, DOI 10.1111/j.0014-3820.2004.tb00485.x; Proulx R, 2004, EVOL ECOL RES, V6, P503; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; RIDDELL BE, 1981, CAN J FISH AQUAT SCI, V38, P308, DOI 10.1139/f81-042; Rincon PA, 2007, OECOLOGIA, V152, P345, DOI 10.1007/s00442-006-0651-5; Robison BD, 1999, AQUACULTURE, V173, P131, DOI 10.1016/S0044-8486(98)00481-5; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ., 2006, TPSDIG DIGITIZE LAND; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schreiner DR, 2008, N AM J FISH MANAGE, V28, P1350, DOI 10.1577/M05-173.1; Seiler SM, 2007, CAN J FISH AQUAT SCI, V64, P127, DOI 10.1139/F06-175; SO M, 2009, FISH STOCKING DATABA; Sutton TM, 2002, N AM J AQUACULT, V64, P188, DOI 10.1577/1548-8454(2002)064&lt;0188:HPAONA&gt;2.0.CO;2; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; TAYLOR EB, 1986, PROG FISH CULT, V48, P171, DOI 10.1577/1548-8640(1986)48<171:DIMBWA>2.0.CO;2; Theriault V, 2007, J EVOLUTION BIOL, V20, P2266, DOI 10.1111/j.1420-9101.2007.01417.x; Theriault V, 2003, J FISH BIOL, V63, P1144, DOI 10.1046/j.1095-8649.2003.00233.x; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Vamosi SM, 2004, EVOLUTION, V58, P376, DOI 10.1111/j.0014-3820.2004.tb01653.x; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Van Offelen Henry K., 1993, North American Journal of Fisheries Management, V13, P86, DOI 10.1577/1548-8675(1993)013<0086:SGMADO>2.3.CO;2; WEBB PW, 1984, AM ZOOL, V24, P107; Wessel ML, 2006, T AM FISH SOC, V135, P333, DOI 10.1577/T04-078.1; WILAND L., 2006, COASTER CHALLENGE RE; WILLIS JH, 1993, EVOLUTION, V47, P949, DOI 10.1111/j.1558-5646.1993.tb01249.x; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; WINANS GA, 1984, CAN J FISH AQUAT SCI, V41, P1150, DOI 10.1139/f84-136; Zimmerman MS, 2006, T AM FISH SOC, V135, P1056, DOI 10.1577/T05-237.1; [No title captured]	83	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12950	10.1371/journal.pone.0012950	http://dx.doi.org/10.1371/journal.pone.0012950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886080	Green Published, Green Submitted, gold			2022-12-25	WOS:000282091100045
J	Garcia-Gonzalez, MA; Outeda, P; Zhou, Q; Zhou, F; Menezes, LF; Qian, F; Huso, DL; Germino, GG; Piontek, KB; Watnick, T				Garcia-Gonzalez, Miguel A.; Outeda, Patricia; Zhou, Qin; Zhou, Fang; Menezes, Luis F.; Qian, Feng; Huso, David L.; Germino, Gregory G.; Piontek, Klaus B.; Watnick, Terry			Pkd1 and Pkd2 Are Required for Normal Placental Development	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; ENDOTHELIAL-CELLS; CYST FORMATION; IN-VIVO; MICE; MOUSE; EXPRESSION; DEFECTS; GENE; MUTATIONS	Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of inherited renal failure that results from mutations in PKD1 and PKD2. The disorder is characterized by focal cyst formation that involves somatic mutation of the wild type allele in a large fraction of cysts. Consistent with a two-hit mechanism, mice that are homozygous for inactivating mutations of either Pkd1 or Pkd2 develop cystic kidneys, edema and hemorrhage and typically die in midgestation. Cystic kidney disease is unlikely to be the cause of fetal loss since renal function is not required to complete gestation. One hypothesis is that embryonic demise is due to leaky vessels or cardiac pathology. Methodology/Principal Findings: In these studies we used a series of genetically modified Pkd1 and Pkd2 murine models to investigate the cause of embryonic lethality in mutant embryos. Since placental defects are a frequent cause of fetal loss, we conducted histopathologic analyses of placentas from Pkd1 null mice and detected abnormalities of the labyrinth layer beginning at E12.5. We performed placental rescue experiments using tetraploid aggregation and conditional inactivation of Pkd1 with the Meox2 Cre recombinase. We found that both strategies improved the viability of Pkd1 null embryos. Selective inactivation of Pkd1 and Pkd2 in endothelial cells resulted in polyhydramnios and abnormalities similar to those observed in Pkd1(-/-) placentas. However, endothelial cell specific deletion of Pkd1 or Pkd2 did not yield the dramatic vascular phenotypes observed in null animals. Conclusions/Significance: Placental abnormalities contribute to the fetal demise of Pkd(-/-) embryos. Endothelial cell specific deletion of Pkd1 or Pkd2 recapitulates a subset of findings seen in Pkd null animals. Our studies reveal a complex role for polycystins in maintaining vascular integrity.	[Garcia-Gonzalez, Miguel A.; Outeda, Patricia; Zhou, Qin; Zhou, Fang; Menezes, Luis F.; Qian, Feng; Germino, Gregory G.; Piontek, Klaus B.; Watnick, Terry] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Garcia-Gonzalez, MA (corresponding author), Hosp Clin Univ Santiago, Inst Invest Sanitaria, Lab Nephrol 11, Genet & Dev Biol Renal Dis Lab, Santiago De Compostela, Galicia, Spain.	kpiontek@jhmi.edu; twatnick@jhmi.edu	Garcia-Gonzalez, Miguel A/G-6920-2011; Menezes, Luis Fernando/C-7286-2015; Gonzalez, Miguel Garcia/ABF-9880-2020	Gonzalez, Miguel Garcia/0000-0002-4330-7200; Germino, Gregory/0000-0002-3609-5588	NIH [DK48006, P50 DK57325, RR00171, DK076017]; Satellite Foundation; National Kidney Foundation of Maryland; European Molecular Biology Organization (EMBO) [ALTF99-2008]; Parga Pondal Xunta de Galicia; National Kidney Foundation fellowship award; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076017, P50DK057325, ZIADK075042, R01DK048006, P30DK090868, R37DK048006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Foundation; National Kidney Foundation of Maryland; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Parga Pondal Xunta de Galicia(Xunta de Galicia); National Kidney Foundation fellowship award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH: DK48006 and P50 DK57325 (GGG), RR00171 (DLH), DK076017 (TW), Satellite Foundation Research Award (TW), National Kidney Foundation of Maryland Professional Development Award (TW), European Molecular Biology Organization (EMBO) Fellowship, ALTF99-2008 (MAGG) and Parga Pondal Xunta de Galicia (MAGG). PO was supported by a National Kidney Foundation fellowship award. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; AHRABI AK, NEPHROL DIAL TRANSPL, V25, P1067; Allen E, 2006, HUM MOL GENET, V15, P11, DOI 10.1093/hmg/ddi421; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75; Beall MH, 2007, PLACENTA, V28, P824, DOI 10.1016/j.placenta.2006.12.004; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GALLAGHER AR, ADV CHRONIC KIDNEY D, V17, P118; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Ohlsson R, 1999, DEV BIOL, V212, P124, DOI 10.1006/dbio.1999.9306; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Paterson AD, 2002, AM J KIDNEY DIS, V40, P16, DOI 10.1053/ajkd.2002.33908; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; PIRSON Y, ADV CHRONIC KIDNEY D, V17, P173; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; ZAMBONI L, 1981, ANAT REC, V201, P641, DOI 10.1002/ar.1092010408	47	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12821	10.1371/journal.pone.0012821	http://dx.doi.org/10.1371/journal.pone.0012821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862291	Green Published, gold			2022-12-25	WOS:000281864100028
J	Saragosti, E; Tchernov, D; Katsir, A; Shaked, Y				Saragosti, Eldad; Tchernov, Dan; Katsir, Adi; Shaked, Yeala			Extracellular Production and Degradation of Superoxide in the Coral Stylophora pistillata and Cultured Symbiodinium	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; OXIDATIVE STRESS; THERMAL-STRESS; MOLECULAR CHARACTERIZATION; ANTHOPLEURA-ELEGANTISSIMA; ENDOSYMBIOTIC ALGAE; RADICAL PRODUCTION; AQUEOUS-SOLUTION; HEAT-STRESS; TEMPERATURE	Background: Reactive oxygen species (ROS) are thought to play a major role in cell death pathways and bleaching in scleractinian corals. Direct measurements of ROS in corals are conspicuously in short supply, partly due to inherent problems with ROS quantification in cellular systems. Methodology/Principal Findings: In this study we characterized the dynamics of the reactive oxygen species superoxide anion radical (O(2)(-)) in the external milieu of the coral Stylophora pistillata. Using a sensitive, rapid and selective chemiluminesence-based technique, we measured extracellular superoxide production and detoxification activity of symbiont (non-bleached) and aposymbiont (bleached) corals, and of cultured Symbiodinium (from clades A and C). Bleached and non-bleached Stylophora fragments were found to produce superoxide at comparable rates of 10(-11) -10(-9) mol O(2)(-) mg protein(-1) min(-1) in the dark. In the light, a two-fold enhancement in O(2)(-) production rates was observed in non-bleached corals, but not in bleached corals. Cultured Symbiodinium produced superoxide in the dark at a rate of 10(-18)-10(-16) mol O(2)(-) cell(-1) min(-1). Light was found to markedly enhance O(2)(-) production. The NADPH Oxidase inhibitor Diphenyleneiodonium chloride (DPI) strongly inhibited O(2)(-) production by corals (and more moderately by algae), possibly suggesting an involvement of NADPH Oxidase in the process. An extracellular O(2)(-) detoxifying activity was found for bleached and non-bleached Stylophora but not for Symbiodinium. The O(2)(-)detoxifying activity was partially characterized and found to resemble that of the enzyme superoxide dismutase (SOD). Conclusions/Significance: The findings of substantial extracellular O(2)(-) production as well as extracellular O(2)(-) detoxifying activity may shed light on the chemical interactions between the symbiont and its host and between the coral and its environment. Superoxide production by Symbiodinium possibly implies that algal bearing corals are more susceptible to an internal build-up of O(2)(-), which may in turn be linked to oxidative stress mediated bleaching.	[Saragosti, Eldad; Tchernov, Dan; Shaked, Yeala] Interuniv Inst Marine Sci, Elat, Israel; [Saragosti, Eldad; Tchernov, Dan] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, Elat, Israel; [Katsir, Adi] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Shaked, Yeala] Hebrew Univ Jerusalem, Fredy & Nadine Herrmann Inst Earth Sci, Elat, Israel	Hebrew University of Jerusalem; Ben Gurion University; Hebrew University of Jerusalem	Saragosti, E (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	yshaked@vms.huji.ac.il	Shaked, Yeala/AAH-7956-2021; Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270; Shaked, Yeala/0000-0002-7831-8313	Israel Science Foundation [933/07, 981/05]; Moshe Shilo Minerva Center for Marine Biogeochemistry	Israel Science Foundation(Israel Science Foundation); Moshe Shilo Minerva Center for Marine Biogeochemistry	This work was supported in part by the Israel Science Foundation grant 933/07 and 981/05 (www.isf.org.il), and the Moshe Shilo Minerva Center for Marine Biogeochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Bartosz G, 2006, CLIN CHIM ACTA, V368, P53, DOI 10.1016/j.cca.2005.12.039; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BIELSKI BHJ, 1978, PHOTOCHEM PHOTOBIOL, V28, P645, DOI 10.1111/j.1751-1097.1978.tb06986.x; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BYCZKOWSKI JZ, 1988, INT J BIOCHEM, V20, P569, DOI 10.1016/0020-711X(88)90095-X; Chignell CF, 2003, FREE RADICAL BIO MED, V34, P1029, DOI 10.1016/S0891-5849(03)00022-4; Dash B, 2007, GENE, V387, P93, DOI 10.1016/j.gene.2006.08.020; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; DUNLAP WC, 1995, COMP BIOCHEM PHYS B, V112, P105, DOI 10.1016/0305-0491(95)00086-N; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; DYKENS JA, 1992, J EXP BIOL, V168, P219; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Flores-Ramirez LA, 2007, COMP BIOCHEM PHYS C, V146, P194, DOI 10.1016/j.cbpc.2006.09.008; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goldstone JV, 2000, ENVIRON SCI TECHNOL, V34, P1043, DOI 10.1021/es9905445; Heyno E, 2008, NEW PHYTOL, V179, P687, DOI 10.1111/j.1469-8137.2008.02512.x; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; MCDOWELL MS, 1983, INORG CHEM, V22, P847, DOI 10.1021/ic00147a033; Milne A, 2009, LIMNOL OCEANOGR-METH, V7, P706, DOI 10.4319/lom.2009.7.706; Munn CB, 2008, FEMS MICROBIOL LETT, V281, P58, DOI 10.1111/j.1574-6968.2008.01073.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Plantivaux A, 2004, FREE RADICAL BIO MED, V37, P1170, DOI 10.1016/j.freeradbiomed.2004.06.043; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Richier S, 2008, COMP BIOCHEM PHYS D, V3, P283, DOI 10.1016/j.cbd.2008.08.001; Rose AL, 2008, ENVIRON SCI TECHNOL, V42, P2387, DOI 10.1021/es7024609; Rose AL, 2008, ANAL CHEM, V80, P1215, DOI 10.1021/ac7018975; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; RUSH JD, 1985, J PHYS CHEM-US, V89, P5062, DOI 10.1021/j100269a035; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Shaked Y, 2010, ENVIRON SCI TECHNOL, V44, P3238, DOI 10.1021/es902343y; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Sumimoto H, 2008, FEBS J, V275, P3984; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Whitehead K, 2005, J PHOTOCH PHOTOBIO B, V80, P115, DOI 10.1016/j.jphotobiol.2005.03.008; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036	53	80	80	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12508	10.1371/journal.pone.0012508	http://dx.doi.org/10.1371/journal.pone.0012508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856857	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815700004
J	Milano, F; Guarriera, M; Rygiel, AM; Krishnadath, KK				Milano, Francesca; Guarriera, Mirta; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.			Trastuzumab Mediated T-Cell Response against HER-2/Neu Overexpressing Esophageal Adenocarcinoma Depends on Intact Antigen Processing Machinery	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; IN-VITRO; MONOCLONAL-ANTIBODY; CERVICAL-CARCINOMA; DENDRITIC CELLS; GASTRIC-CANCER; TUMOR-CELLS; CYTOTOXICITY; COMPONENTS; EXPRESSION	Background: Esophageal adenocarcinoma (EAC) is a highly aggressive disease with poor prognosis, which frequently exhibits HER-2 gene amplification. Trastuzumab, the humanized antibody against HER-2, has potent growth inhibitory effects on HER-2 overexpressing cancers. One effect of trastuzumab is that it causes HER-2 receptor internalization and degradation, enhancing presentation of HER-2 epitopes on MHC-Class I molecules. This enhances the ability of HER-2 specific cytotoxic T lymphocytes (CTLs) to recognize and kill cancer cells. Novel strategies targeting the HER-2 receptor either directly by trastuzumab and/or indirectly by inducing a CTL response against HER-2 epitopes with, for instance, DC immunotherapy and consequently combining these strategies might prove to be very effective. Methodology/Principal Findings: In this study we report that trastuzumab has potent growth inhibitory effects on two HER-2 overexpressing EAC cell lines OE33 and OE19. However, we found that trastuzumab and HER-2 specific CTLs act synergistically in inducing tumor lysis in OE33 but not in OE19. We discovered that in OE19 this deficient response is due to a down-regulation of the Transporter Associated with Antigen Processing-2 (TAP-2). TAP-2 is an important member of the Antigen Processing Machinery (APM), and is one of the essential elements for loading antigens on MHC class I molecules. Importantly, we demonstrated that by inducing re-expression of TAP-2 in OE19 with INF-gamma treatment or by incubating the cells with INF-gamma producing CTLs, the specific anti HER-2 CTL tumor lysis response and synergistic effect with trastuzumab can be restored. Conclusion: An inefficient response of HER-2 overexpressing EAC to trastuzumab and/or DC immunotherapy can be due to a down-regulated TAP-2 expression and thus a deficient APM. Future studies combining trastuzumab with IFN-gamma and/or immune-therapies inducing potent anti HER-2 CTL responses could lead to an effective combinatorial strategy for successful treatment of HER-2 overexpressing but APM defective cancers.	[Milano, Francesca; Guarriera, Mirta; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Milano, Francesca; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Milano, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	F.Milano@amc.uva.nl; K.K.Krishnadath@amc.uva.nl	Milano, Francesca/AAJ-7120-2021	Milano, Francesca/0000-0001-7579-6769; Rygiel, Agnieszka/0000-0002-3838-2900	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	Academic Medical Center, Amsterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; BOONSTRA JJ, J NATL CANC I, V102, P271; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Bubenik J, 2004, INT J ONCOL, V25, P487; Clemenceau B, 2006, J IMMUNOTHER, V29, P53; Dahlberg PS, 2004, ANN THORAC SURG, V78, P1790, DOI 10.1016/j.athoracsur.2004.05.037; Donington JS, 2004, ANN THORAC SURG, V77, P1193, DOI 10.1016/j.athoracsur.2003.09.029; Gamliel Z, 2000, Chest Surg Clin N Am, V10, P441; Geddert H, 2002, AM J CLIN PATHOL, V118, P60; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hung MC, 1999, SEMIN ONCOL, V26, P51; HURWITZ E, 1995, P NATL ACAD SCI USA, V92, P3353, DOI 10.1073/pnas.92.8.3353; Kimura K, 2006, CLIN CANCER RES, V12, P4925, DOI 10.1158/1078-0432.CCR-06-0544; Kono K, 2002, CANCER RES, V62, P5813; Kono K, 2004, CLIN CANCER RES, V10, P2538, DOI 10.1158/1078-0432.CCR-03-0424; Kono K, 2002, CLIN CANCER RES, V8, P3394; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Lopez-Albaitero A, 2006, J IMMUNOL, V176, P3402, DOI 10.4049/jimmunol.176.6.3402; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Milano F, 2007, J IMMUNOL METHODS, V321, P94, DOI 10.1016/j.jim.2007.01.004; Milano F, 2007, CANCER IMMUNOL IMMUN, V56, P1967, DOI 10.1007/s00262-007-0341-0; Mimura K, 2005, CLIN CANCER RES, V11, P4898, DOI 10.1158/1078-0432.CCR-04-2476; Muller MR, 2003, CLIN CANCER RES, V9, P3448; Murray JL, 2002, CLIN CANCER RES, V8, P3407; Pera M, 2003, WORLD J SURG, V27, P999, DOI 10.1007/s00268-003-7052-2; Perez SA, 2002, CANCER IMMUNOL IMMUN, V50, P615, DOI 10.1007/s002620100225; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Ritz U, 2001, INT J ONCOL, V19, P1211; Rygiel AM, 2007, CANCER-AM CANCER SOC, V109, P1980, DOI 10.1002/cncr.22643; Safran H, 2007, INT J RADIAT ONCOL, V67, P405, DOI 10.1016/j.ijrobp.2006.08.076; Seliger B, 2001, CANCER RES, V61, P8647; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; Walch A, 2000, ANAL CELL PATHOL, V20, P25, DOI 10.1155/2000/947249; Wu AH, 2004, J NEURO-ONCOL, V66, P1, DOI 10.1023/B:NEON.0000013460.53527.28; YAMANAKA Y, 1993, HUM PATHOL, V24, P1127, DOI 10.1016/0046-8177(93)90194-L; zum Buschenfelde CM, 2002, CANCER RES, V62, P2244	39	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12424	10.1371/journal.pone.0012424	http://dx.doi.org/10.1371/journal.pone.0012424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865050	gold, Green Published, Green Submitted			2022-12-25	WOS:000281292100019
J	Maretzky, T; Zhou, W; Huang, XY; Blobel, CP				Maretzky, T.; Zhou, W.; Huang, X-Y; Blobel, C. P.			A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17	ONCOGENE			English	Article						ADAM17; Src; EGF receptor; EGF-receptor ligands; protein ectodomain shedding; ERK	NECROSIS-FACTOR-ALPHA; UP-REGULATED EXPRESSION; GROWTH-FACTOR-ALPHA; CONVERTING-ENZYME; DISINTEGRIN; CLEAVAGE; TRANSACTIVATION; INACTIVATION; COEXPRESSION; ACTIVATION	ADAM17 (a disintegrin and metalloproteinase 17, also referred to as TNF alpha converting enzyme or TACE) is a cell-surface metalloproteinase that regulates signaling via the epidermal growth factor receptor (EGFR) and has important roles in diseases such as cancer and rheumatoid arthritis. ADAM17 can be activated by stimulation of several tyrosine kinase receptors, raising questions about whether oncogenic tyrosine kinases could also enhance EGFR signaling and activation of extracellular signal-regulated kinase (ERK) via stimulation of ADAM17. The main goal of this study was to evaluate the role of Src in activating ADAM17. We provide evidence that a constitutively active transforming form of Src, the E378G mutant, as well as v-Src enhance ADAM17-mediated shedding of the EGFR ligand TGF alpha. Moreover, we demonstrate that constitutive shedding of TGF alpha can be reduced by inhibition of Src in several cell lines, including COS7, MCF7 (the human breast cancer cell line), PAE (a pig aortic endothelial cell line) and HaCaT (the human keratinocyte cell line) cells. Src(E378G)-stimulated shedding of TGF alpha is abolished in Adam17(-/-) cells, but can be rescued by wild-type (wt) ADAM17 and a mutant ADAM17 lacking its cytoplasmic domain. These findings demonstrate that ADAM17 is the principal TGF alpha sheddase that is activated by Src in a manner that does not require the cytoplasmic domain of ADAM17. Finally, we show that stimulation of ADAM17 by Src(E378G) leads to enhanced paracrine signaling via release of EGFR ligands into the culture supernatant. These results raise the possibility that activation of ADAM17 by oncogenic forms of Src can aid in promoting tumorigenesis by enhancing signaling via the EGFR and ERK in an autocrine and paracrine manner. Enhanced autocrine signaling could further activate tumor cells expressing oncogenic mutants of Src, whereas paracrine signaling could stimulate EGFR and ERK signaling in surrounding non-transformed cells such as stromal cells, thereby contributing to crosstalk between tumor cells and stromal cells. Oncogene (2011) 30, 611-618; doi: 10.1038/onc.2010.443; published online 27 September 2010	[Maretzky, T.; Zhou, W.; Blobel, C. P.] Cornell Univ, Hosp Special Surg, Weill Med Coll, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Huang, X-Y] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University; Cornell University	Blobel, CP (corresponding author), Cornell Univ, Hosp Special Surg, Weill Med Coll, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.	blobelc@hss.edu	Maretzky, Thorsten/GSN-2981-2022; Maretzky, Thorsten/AEN-1915-2022	Maretzky, Thorsten/0000-0003-1282-6080; Zhou, Wenhui/0000-0002-3857-8567	NIH [R01 GM64750]; Emerald Foundation; Tri-Institutional MD/PhD Program Gateway Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; Tri-Institutional MD/PhD Program Gateway Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH R01 GM64750, and TM was supported by the Emerald Foundation. WZ was supported by the Tri-Institutional MD/PhD Program Gateway Program. We are grateful to Drs Daniel Lundell and Xioada Niu from the Schering Plough Research Institute in Kenilworth, NJ, for providing SP26, and to Dr Robert Waltermire from Bristol-Myers Squibb for DPC333, and to Andreas Ludwig at the University of Aachen, Germany, for providing GI254023X.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; COOPER JA, 1983, J VIROL, V48, P752, DOI 10.1128/JVI.48.3.752-764.1983; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Mazzola RD, 2008, BIOORG MED CHEM LETT, V18, P5809, DOI 10.1016/j.bmcl.2008.09.045; McGowan PM, 2008, ANN ONCOL, V19, P1075, DOI 10.1093/annonc/mdm609; Merchant NB, 2008, CLIN CANCER RES, V14, P1182, DOI 10.1158/1078-0432.CCR-07-1216; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Qian MX, 2007, DRUG METAB DISPOS, V35, P1916, DOI 10.1124/dmd.107.015933; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Van Schaeybroeck S, 2008, CANCER RES, V68, P8312, DOI 10.1158/0008-5472.CAN-07-6736; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	36	48	49	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					611	618		10.1038/onc.2010.443	http://dx.doi.org/10.1038/onc.2010.443			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20871631	Green Accepted			2022-12-25	WOS:000286922300009
J	Delgado, VMC; Nugnes, LG; Colombo, LL; Troncoso, MF; Fernandez, MM; Malchiodi, EL; Frahm, I; Croci, DO; Compagno, D; Rabinovich, GA; Wolfenstein-Todel, C; Elola, MT				Cardenas Delgado, Victor M.; Nugnes, Lorena G.; Colombo, Lucas L.; Troncoso, Maria F.; Fernandez, Marisa M.; Malchiodi, Emilio L.; Frahm, Isabel; Croci, Diego O.; Compagno, Daniel; Rabinovich, Gabriel A.; Wolfenstein-Todel, Carlota; Elola, Maria T.			Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8	FASEB JOURNAL			English	Article						glycan-binding proteins; capillary formation; invasion	CARBOHYDRATE-RECOGNITION; ADHESION MOLECULE; PROSTATE-CANCER; IN-VITRO; EXPRESSION; BINDING; AFFINITY; MORPHOGENESIS; INFLAMMATION; INTEGRINS	Angiogenesis, the growth OF new capillaries from preexisting blood vessels, is a complex process involving endothelial cell (EC) activation, disruption of vascular basement membranes, and migration and proliferation of ECs. Glycan-mediated recognition has been proposed to play an instrumental role in mediating cell-cell and cell-matrix interactions. Galectins (Gal), a family of glycan-binding proteins with affinity for beta-galactosides and a conserved sequence motif, can decipher glycan-containing information and mediate cell-cell communication. Galectin-8 (Gal-8), a member of this family, is a bivalent "tandem-repeat"-type galectin, which possesses 2 CRDs connected by a linker peptide. Here, we show that Gal-8 is endowed with proangiogeneic properties. Functional assays revealed a critical role for this lectin in the regulation of capillary-tube formation and EC migration. Moreover, Matrigel, either supplemented with Gal-8 or vascular endothelial growth factor (VEGF), injected in mice resulted in induction of in vivo angiogenesis. Remarkably, Gal-8 was expressed both in the cytoplasm and nucleus in ECs of normal and tumor vessels. Furthermore, CD166 [activated leukocyte cell adhesion molecule (ALCAM)] was identified as a specific Gal-8-binding partner in normal vascular ECs. Collectively, these data provide the first evidence demonstrating an essential role for Gal-8 in the regulation of angiogenesis with critical implications in tumor biology.-Cardenas Delgado, V. M., Nugnes, L. G., Colombo, L. L., Troncoso, M. F., Fernandez, M. M., Malchiodi, E. L., Frahm, I., Croci, D. O., Compagno, D., Rabinovich, G. A., Wolfenstein-Todel, C., Elola, M. T. Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8. FASEB J. 25, 242-254 (2011). www.fasebj.org	[Cardenas Delgado, Victor M.; Nugnes, Lorena G.; Troncoso, Maria F.; Wolfenstein-Todel, Carlota; Elola, Maria T.] Univ Buenos Aires, Inst Quim & Fis Quim Biol, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn UBA CONICET, Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Catedra Inmunol, Fac Farm & Bioquim,Inst Estudios Inmunidad Humora, Consejo Nacl Invest Cient & Tecn UBA CONICET, Buenos Aires, DF, Argentina; [Colombo, Lucas L.] Univ Buenos Aires, Area Invest, Inst Oncolo AH Roffo, Buenos Aires, DF, Argentina; [Compagno, Daniel; Rabinovich, Gabriel A.] Univ Buenos Aires, Lab Modulac Genet & Inmunol, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Frahm, Isabel] Sanatorio Mater Dei, Dept Patol, Buenos Aires, DF, Argentina; [Croci, Diego O.; Rabinovich, Gabriel A.] Inst Biol & Med Expt IBYME CONICET, Lab Inmunopatol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Elola, MT (corresponding author), Univ Buenos Aires, Inst Quim & Fis Quim Biol UBA CONICET, Fac Farm & Bioquim, Junin 956,C1113, Buenos Aires, DF, Argentina.	mt_elola@yahoo.com	Croci, Diego/AAJ-5709-2021; Cárdenas Delgado, Víctor Manuel/GRY-5060-2022	Croci, Diego/0000-0002-8623-0645; Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907; Troncoso, Maria Fernanda/0000-0002-4919-9976; Compagno, Daniel/0000-0002-7589-7217	Argentinean National Agency for Promotion of Science and Technology; University of Buenos Aires; Argentinean National Research Council (CONICET); Sales Foundation	Argentinean National Agency for Promotion of Science and Technology; University of Buenos Aires(University of Buenos Aires); Argentinean National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sales Foundation	The authors thank Guillermo Peluffo (Instituto Roffo, Buenos Aires, Argentina) who provided BAECs. This work was supported by grants from the Argentinean National Agency for Promotion of Science and Technology, the University of Buenos Aires, the Argentinean National Research Council (CONICET), and the Sales Foundation.	Ahmed H, 2007, BIOCHEM BIOPH RES CO, V358, P241, DOI 10.1016/j.bbrc.2007.04.114; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bidon N, 2001, INT J MOL MED, V8, P245; Bidon-Wagner N, 2002, GLYCOCONJUGATE J, V19, P557, DOI 10.1023/B:GLYC.0000014086.38343.98; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camby I, 2001, BRAIN PATHOL, V11, P12; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Elola MT, 2005, J BIOMED SCI, V12, P13, DOI 10.1007/s11373-004-8169-5; Fernandez MM, 2007, PROTEINS, V68, P389, DOI 10.1002/prot.21388; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Hadari YR, 2000, J CELL SCI, V113, P2385; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Ikeda K, 2004, J BIOL CHEM, V279, P55315, DOI 10.1074/jbc.M407776200; Institute of Laboratory Animal Resources CoLSNRC, 1996, GUID CAR US LAB AN; Le Mercier M, 2008, J NEUROPATH EXP NEUR, V67, P456, DOI 10.1097/NEN.0b013e318170f892; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Masedunskas A, 2006, FEBS LETT, V580, P2637, DOI 10.1016/j.febslet.2006.04.013; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2000, CANCER METAST REV, V19, P51, DOI 10.1023/A:1026540129688; Nguyen M, 1996, BIOCHEM BIOPH RES CO, V228, P716, DOI 10.1006/bbrc.1996.1722; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Rabinovich GA, 2006, GLYCOBIOLOGY, V16, P210, DOI 10.1093/glycob/cwj056; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tribulatti M. V., 2009, J LEUKOCYTE BIOL, V86, P1; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	46	105	110	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					242	254		10.1096/fj.09-144907	http://dx.doi.org/10.1096/fj.09-144907			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876211				2022-12-25	WOS:000285869500022
J	Simonin, A; Fuster, D				Simonin, Alexandre; Fuster, Daniel			Nedd4-1 and beta-Arrestin-1 Are Key Regulators of Na+/H+ Exchanger 1 Ubiquitylation, Endocytosis, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE NEDD4-1; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; TRAFFICKING; NHE1; DEGRADATION; INTERNALIZATION; ACTIVATION; TRANSLOCATION; SUFFICIENT	The ubiquitously expressed mammalian Na+/H+ exchanger 1 (NHE1) controls cell volume and pH but is also critically involved in complex biological processes like cell adhesion, cell migration, cell proliferation, and mechanosensation. Pathways controlling NHE1 turnover at the plasma membrane, however, are currently unclear. Here, we demonstrate that NHE1 undergoes ubiquitylation at the plasma membrane by a process that is unprecedented for a mammalian ion transport protein. This process requires the adapter protein beta-arrestin-1 that interacts with both the E3 ubiquitin ligase Nedd4-1 and the NHE1 C terminus. Truncation of NHE1 C terminus to amino acid 550 abolishes binding to beta-arrestin-1 and NHE1 ubiquitylation. Overexpression of beta-arrestin-1 or of wild type but not ligase-dead Nedd4-1 increases NHE1 ubiquitylation. siRNA-mediated knockdown of Nedd4-1 or beta-arrestin-1 reduces NHE1 ubiquitylation and endocytosis leading to increased NHE1 surface levels. Fibroblasts derived from beta-arrestin-1 and Nedd4-1 knock-out mice show loss of NHE1 ubiquitylation, increased plasmalemmal NHE1 levels and greatly enhanced NHE1 transport compared with wild-type fibroblasts. These findings reveal Nedd4-1 and beta-arrestin-1 as key regulators of NHE1 ubiquitylation, endocytosis, and function. Our data suggest a broader role for beta-arrestins in the regulation of membrane ion transport proteins than currently known.	Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Simonin, Alexandre; Fuster, Daniel] Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern; University Hospital of Bern	Fuster, D (corresponding author), Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	Daniel.Fuster@mci.unibe.ch	Fuster, Daniel G/AAA-7079-2021	Fuster, Daniel G/0000-0001-7220-1803	European Union [41400]; Swiss National Science Foundation [3100A0-117732]; Foundation Prof. Dr. Max Cloetta	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Prof. Dr. Max Cloetta	This work was supported in part by a European Union Intra-European Marie-Curie Fellowship (Grant 41400, to D. F.), the Swiss National Science Foundation (Grant 3100A0-117732, to D. F.), and by a Medical Research Position Award of the Foundation Prof. Dr. Max Cloetta (to D. F.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ALPERN RJ, 1985, J GEN PHYSIOL, V86, P613, DOI 10.1085/jgp.86.5.613; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; BAUM M, 1993, AM J PHYSIOL, V264, pF1027, DOI 10.1152/ajprenal.1993.264.6.F1027; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lagana A, 2000, J CELL SCI, V113, P3649; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	47	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38293	38303		10.1074/jbc.M110.115089	http://dx.doi.org/10.1074/jbc.M110.115089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855896	Green Published, hybrid			2022-12-25	WOS:000284625600036
J	Tsai, MF; Jih, KY; Shimizu, H; Li, M; Hwang, TC				Tsai, Ming-Feng; Jih, Kang-Yang; Shimizu, Hiroyasu; Li, Min; Hwang, Tzyh-Chang			Optimization of the Degenerated Interfacial ATP Binding Site Improves the Function of Disease-related Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC-TRANSPORTERS; CHLORIDE CHANNELS; NUCLEOTIDE; DOMAIN; DIMER; POTENTIATION; MECHANISM; MUTATION; ANALOGS	The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, an ATP binding cassette (ABC) protein whose defects cause the deadly genetic disease cystic fibrosis (CF), encompasses two nucleotide binding domains (NBD1 and NBD2). Recent studies indicate that in the presence of ATP, the two NBDs coalesce into a dimer, trapping an ATP molecule in each of the two interfacial composite ATP binding sites (site 1 and site 2). Experimental evidence also suggests that CFTR gating is mainly controlled by ATP binding and hydrolysis in site 2, whereas site 1, which harbors several non-canonical substitutions in ATP-interacting motifs, is considered degenerated. The CF-associated mutation G551D, by introducing a bulky and negatively charged side chain into site 2, completely abolishes ATP-induced openings of CFTR. Here, we report a strategy to optimize site 1 for ATP binding by converting two amino acid residues to ABC consensus (i.e. H1348G) or more commonly seen residues in other ABC proteins (i.e. W401Y, W401F). Introducing either one or both of these mutations into G551D-CFTR confers ATP responsiveness for this disease-associated mutant channel. We further showed that the same maneuver also improved the function of WT-CFTR and the most common CF-associated Delta F508 channels, both of which rely on site 2 for gating control. Thus, our results demonstrated that the degenerated site 1 can be rebuilt to complement or support site 2 for CFTR function. Possible approaches for developing CFTR potentiators targeting site 1 will be discussed.	[Tsai, Ming-Feng; Jih, Kang-Yang; Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Tsai, Ming-Feng; Jih, Kang-Yang; Li, Min; Hwang, Tzyh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Shimizu, Hiroyasu] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka 5698686, Japan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Osaka Medical College	Hwang, TC (corresponding author), 134 Res Pk Dr, Columbia, MO 65211 USA.	hwangt@health.missouri.edu		TSAI, MING-FENG/0000-0003-4277-1885	National Center for Research Resources, National Institutes of Health [C06 RR-016489-01]; National Institutes of Health [R01-HL53445, R01-DK55835]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shenghui Hu and Cindy Chu for technical assistance. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR-016489-01) from the National Center for Research Resources, National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL53445 and R01-DK55835 (to T.-C. H.).	Aleksandrov L, 2008, BIOCHEM J, V416, P129, DOI 10.1042/BJ20081068; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Tsai MF, 2009, J GEN PHYSIOL, V133, P405, DOI 10.1085/jgp.200810186; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	31	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37663	37671		10.1074/jbc.M110.172817	http://dx.doi.org/10.1074/jbc.M110.172817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861014	Green Published, hybrid			2022-12-25	WOS:000284424000058
J	Wahl, B; Reichmann, D; Niks, D; Krompholz, N; Havemeyer, A; Clement, B; Messerschmidt, T; Rothkegel, M; Biester, H; Hille, R; Mendel, RR; Bittner, F				Wahl, Bettina; Reichmann, Debora; Niks, Dimitri; Krompholz, Nina; Havemeyer, Antje; Clement, Bernd; Messerschmidt, Tania; Rothkegel, Martin; Biester, Harald; Hille, Russ; Mendel, Ralf R.; Bittner, Florian			Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in Eukaryotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALIANA PROVIDES INSIGHT; HYDROXYLATED BASE ANALOGS; COFACTOR SULFURASE GENE; XANTHINURIA TYPE-II; NITRATE REDUCTASE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; ALDEHYDE OXIDASE; SULFITE OXIDASE; MECHANISM	The mitochondrial amidoxime reducing componentm ARC is a newly discovered molybdenum enzyme that is presumed to form the catalytical part of a three-component enzyme system, consisting of mARC, heme/cytochrome b(5), and NADH/FAD-dependent cytochrome b5 reductase. mARC proteins share a significant degree of homology to the molybdenum cofactor-binding domain of eukaryotic molybdenum cofactor sulfurase proteins, the latter catalyzing the post-translational activation of aldehyde oxidase and xanthine oxidoreductase. The human genome harbors two mARC genes, referred to as hmARC-1/MOSC-1 and hmARC-2/MOSC-2, which are organized in a tandem arrangement on chromosome 1. Recombinant expression of hmARC-1 and hmARC-2 proteins in Escherichia coli reveals that both proteins are monomeric in their active forms, which is in contrast to all other eukaryotic molybdenum enzymes that act as homo-or heterodimers. Both hmARC-1 and hmARC-2 catalyze the N-reduction of a variety of N-hydroxylated substrates such as N-hydroxy-cytosine, albeit with different specificities. Reconstitution of active molybdenum cofactor onto recombinant hmARC-1 and hmARC-2 proteins in the absence of sulfur indicates that mARC proteins do not belong to the xanthine oxidase family of molybdenum enzymes. Moreover, they also appear to be different from the sulfite oxidase family, because no cysteine residue could be identified as a putative ligand of the molybdenum atom. This suggests that the hmARC proteins and sulfurase represent members of a new family of molybdenum enzymes.	[Wahl, Bettina; Reichmann, Debora; Mendel, Ralf R.; Bittner, Florian] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38023 Braunschweig, Germany; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Krompholz, Nina; Havemeyer, Antje; Clement, Bernd] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany; [Messerschmidt, Tania; Rothkegel, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Dept Cellular Neurobiol, D-38023 Braunschweig, Germany; [Biester, Harald] Tech Univ Carolo Wilhelmina Braunschweig, Dept Environm Geol, D-38023 Braunschweig, Germany	Braunschweig University of Technology; University of California System; University of California Riverside; University of Kiel; Braunschweig University of Technology; Braunschweig University of Technology	Mendel, RR (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Humboldtstr 1, D-38023 Braunschweig, Germany.	r.mendel@tu-bs.de		, Martin/0000-0001-5041-4429	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Estabrook R W, 1978, Methods Enzymol, V52, P212; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; George GN, 2004, INORG CHEM, V43, P8456, DOI 10.1021/ic0489847; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; GUTTERIDGE S, 1983, BIOCHEM J, V213, P137, DOI 10.1042/bj2130137; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Kotthaus J., BIOCH J IN PRESS; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Kozmin SG, 2007, MUTAT RES-FUND MOL M, V619, P9, DOI 10.1016/j.mrfmmm.2006.12.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMY MT, 1980, BIOCHEM J, V185, P397, DOI 10.1042/bj1850397; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Mihara K, 1978, Methods Enzymol, V52, P102; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STRITTMATTER P, 1956, J BIOL CHEM, V221, P253; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	42	83	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37847	37859		10.1074/jbc.M110.169532	http://dx.doi.org/10.1074/jbc.M110.169532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861021	Green Published, hybrid			2022-12-25	WOS:000284424000075
J	Seebacher, F; Glanville, EJ				Seebacher, Frank; Glanville, Elsa J.			Low Levels of Physical Activity Increase Metabolic Responsiveness to Cold in a Rat (Rattus fuscipes)	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; BODY-TEMPERATURE; CHRONIC DISEASE; EXERCISE	Background: Physical activity modulates expression of metabolic genes and may therefore be a prerequisite for metabolic responses to environmental stimuli. However, the extent to which exercise interacts with environmental conditions to modulate metabolism is unresolved. Hence, we tested the hypothesis that even low levels of physical activity are beneficial by improving metabolic responsiveness to temperatures below the thermal neutral zone, thereby increasing the capacity for substrate oxidation and energy expenditure. Methodology/Principal Findings: We used wild rats (Rattus fuscipes) to avoid potential effects of breeding on physiological phenotypes. Exercise acclimation (for 30 min/day on 5 days/week for 30 days at 60% of maximal performance) at 22 degrees C increased mRNA concentrations of PGC1 alpha, PPAR delta, and NRF-1 in skeletal muscle and brown adipose tissue compared to sedentary animals. Lowering ambient temperature to 12 degrees C caused further increases in relative expression of NRF-1 in skeletal muscle, and of PPARd of brown adipose tissue. Surprisingly, relative expression of UCP1 increased only when both exercise and cold stimuli were present. Importantly, in sedentary animals cold acclimation (12 degrees C) alone did not change any of the above variables. Similarly, cold alone did not increase maximum capacity for substrate oxidation in mitochondria (cytochrome c oxidase and citrate synthase activities) of either muscle or brown adipose tissue. Animals that exercised regularly had higher exercise induced metabolic rates in colder environments than sedentary rats, and temperature induced metabolic scope was greater in exercised rats. Conclusions/Significance: Physical activity is a necessary prerequisite for the expression of transcriptional regulators that influence a broad range of physiological functions from energy metabolism to cardiovascular function and nutrient uptake. A sedentary lifestyle leads to decreased daily energy expenditure because of a lack of direct use of energy and a muted metabolic response to ambient temperature, which can be reversed even by low levels of physical activity.	[Seebacher, Frank; Glanville, Elsa J.] Univ Sydney, Sch Biol Sci, Integrat Physiol Res Grp, Sydney, NSW 2006, Australia	University of Sydney	Seebacher, F (corresponding author), Univ Sydney, Sch Biol Sci, Integrat Physiol Res Grp, Sydney, NSW 2006, Australia.	frank.seebacher@sydney.edu.au		Seebacher, Frank/0000-0002-2281-9311	Australian Research Council [DP0772438]	Australian Research Council(Australian Research Council)	This work was partly funded by the Australian Research Council (grant DP0772438; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507; Booth FW, 2008, BRIT J SPORT MED, V42, P950, DOI 10.1136/bjsm.2008.052589; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chappell MA, 2004, J EXP BIOL, V207, P3839, DOI 10.1242/jeb.01213; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Gillis LJ, 2002, INT J OBESITY, V26, P458, DOI 10.1038/sj.ijo.0801967; GLANVILLE EJ, 2010, J MAMMAL IN PRESS; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Grundy SM, 2008, EUR HEART J SUPPL, V10, pB16, DOI 10.1093/eurheartj/sum044; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mekjavic IB, 2006, J APPL PHYSIOL, V100, P2065, DOI 10.1152/japplphysiol.01118.2005; Moyes CD, 2003, J EXP BIOL, V206, P4385, DOI 10.1242/jeb.00699; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nunn AVW, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-16; O'Gorman DJ, 2008, ENDOCRIN METAB CLIN, V37, P887, DOI 10.1016/j.ecl.2008.07.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Redinger RN, 2009, TRANSL RES, V154, P52, DOI 10.1016/j.trsl.2009.05.003; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Seebacher F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000281; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	55	34	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13022	10.1371/journal.pone.0013022	http://dx.doi.org/10.1371/journal.pone.0013022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885954	Green Published, gold, Green Submitted			2022-12-25	WOS:000282167100021
J	Xavier, S; Gilbert, V; Rastaldi, MP; Krick, S; Kollins, D; Reddy, A; Bottinger, E; Cohen, CD; Schlondorff, D				Xavier, Sandhya; Gilbert, Victoria; Rastaldi, Maria Pia; Krick, Stefanie; Kollins, Dmitrij; Reddy, Anand; Bottinger, Erwin; Cohen, Clemens D.; Schlondorff, Detlef			BAMBI Is Expressed in Endothelial Cells and Is Regulated by Lysosomal/Autolysosomal Degradation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MEMBRANE-BOUND INHIBITOR; ISOLATED RAT HEPATOCYTES; TGF-BETA; GENE-EXPRESSION; PSEUDORECEPTOR BAMBI; PROTEIN-DEGRADATION; COLORECTAL-CANCER; MESANGIAL CELLS; AUTOPHAGY	Background: BAMBI (BMP and Activin Membrane Bound Inhibitor) is considered to influence TGF beta and Wnt signaling, and thereby fibrosis. Surprisingly data on cell type-specific expression of BAMBI are not available. We therefore examined the localization, gene regulation, and protein turnover of BAMBI in kidneys. Methodology/Principal Findings: By immunofluorescence microscopy and by mRNA expression, BAMBI is restricted to endothelial cells of the glomerular and some peritubular capillaries and of arteries and veins in both murine and human kidneys. TGF beta upregulated mRNA of BAMBI in murine glomerular endothelial cells (mGEC). LPS did not downregulate mRNA for BAMBI in mGEC or in HUVECs. BAMBI mRNA had a half-life of only 60 minutes and was stabilized by cycloheximide, indicating post-transcriptional regulation due to AU-rich elements, which we identified in the 3' untranslated sequence of both the human and murine BAMBI gene. BAMBI protein turnover was studied in HUVECs with BAMBI overexpression using a lentiviral system. Serum starvation as an inducer of autophagy caused marked BAMBI degradation, which could be totally prevented by inhibition of lysosomal and autolysosomal degradation with bafilomycin, and partially by inhibition of autophagy with 3-methyladenine, but not by proteasomal inhibitors. Rapamycin activates autophagy by inhibiting TOR, and resulted in BAMBI protein degradation. Both serum starvation and rapamycin increased the conversion of the autophagy marker LC3 from LC3-I to LC3-II and also enhanced co-staining for BAMBI and LC3 in autolysosomal vesicles. Conclusions/Significance: 1. BAMBI localizes to endothelial cells in the kidney and to HUVECs. 2. BAMBI mRNA is regulated by post-transcriptional mechanisms. 3. BAMBI protein is regulated by lysosomal and autolysosomal degradation. The endothelial localization and the quick turnover of BAMBI may indicate novel, yet to be defined functions of this modulator for TGF beta and Wnt protein actions in the renal vascular endothelium in health and disease.	[Xavier, Sandhya; Gilbert, Victoria; Krick, Stefanie; Kollins, Dmitrij; Reddy, Anand; Bottinger, Erwin; Schlondorff, Detlef] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Cohen, Clemens D.] Univ Hosp, Div Nephrol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Hosp, Inst Physiol, Ctr Integrat Human Physiol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich, Zurich, Switzerland; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Renal Immunopathol Lab, Milan, Italy	Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Xavier, S (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	detlef.schlondorff@mssm.edu			National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK081420-01]; Else Kroener-Fresenius Foundation [A62/04]; Swiss National Science Foundation [32-122439/1]; Fondazione IRCCS Policlinico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081420, R01DK056077, R01DK060043] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Else Kroener-Fresenius Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione IRCCS Policlinico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health ( National Institute of Diabetes and Digestive and Kidney Diseases R01-DK081420-01 to D. S.) and in part by the Else Kroener-Fresenius Foundation (A62/04 to C. D. C.) and the Swiss National Science Foundation (32-122439/1 to C. D. C.), and Progetto a concorso 2009/2010 Fondazione IRCCS Policlinico to M. P. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bedford JJ, 2003, J AM SOC NEPHROL, V14, P2581, DOI 10.1097/01.ASN.0000089566.28106.F6; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Knight C, 2001, J DENT RES, V80, P1895, DOI 10.1177/00220345010800100701; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; O'Connor MN, 2009, BLOOD, V113, P4754, DOI 10.1182/blood-2008-06-162693; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Satriano JA, 1997, J AM SOC NEPHROL, V8, P596; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Togo N, 2008, WORLD J GASTROENTERO, V14, P4880, DOI 10.3748/wjg.14.4880; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; WOODWARD TL, 1995, J CELL PHYSIOL, V165, P339, DOI 10.1002/jcp.1041650215; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YAMAWAKI M, 1993, J HISTOCHEM CYTOCHEM, V41, P105, DOI 10.1177/41.1.8417105; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	55	36	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12995	10.1371/journal.pone.0012995	http://dx.doi.org/10.1371/journal.pone.0012995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886049	Green Published, Green Submitted, gold			2022-12-25	WOS:000282122600020
J	Chang, JW; Hsu, HS; Ni, HJ; Chuang, CT; Hsiung, CH; Huang, TH; Wang, YC				Chang, Jer-Wei; Hsu, Han-Shui; Ni, Huey-Juin; Chuang, Ching-Ting; Hsiung, Chi-Hui; Huang, Tim H.; Wang, Yi-Ching			Distinct Epigenetic Domains Separated by a CTCF Bound Insulator between the Tandem Genes, BLU and RASSF1A	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CELL LUNG-CANCER; DNA METHYLATION; NASOPHARYNGEAL CARCINOMA; MOLECULAR PATHOGENESIS; REGULATORY ELEMENTS; BREAST-CANCER; PROTEIN CTCF; ALLELE LOSS; INACTIVATION	Background: Tumor suppressor gene (TSG) RASSF1A and candidate TSG BLU are two tandem head-to-tail genes located at 3p21.3. We hypothesized that there may be a concordance on their gene expression and promoter methylation status. If not, then there may be an insulator located between RASSF1A and BLU genes that provides a barrier activity. Methodology/Principal Findings: We first identified potential transcriptionally important CpG sites using the methylation-specific oligonucleotide array in relation to mRNA expression of RASSF1A and BLU genes in primary lung tumors. We demonstrated that E2F1 bound to the potential transcriptionally important CpG sites in RASSF1A gene of a normal lung cell line expressing RASSF1A transcripts, whereas loss of E2F1 binding to RASSF1A in A549 cancer cell line was the result of DNA methylation. Both RASSF1A and BLU genes had their own potential transcriptionally important CpG regions. However, there was no correlation of methylation status between RASSF1A and BLU. Using gel shift assay and chromatin immunoprecipitation-PCR (ChIP-PCR), we found that CCCTC-binding factor (CTCF) bound to insulator sequences located between these two genes. Bisulfite sequencing and ChIP-PCR revealed distinct methylation and chromatin boundaries separated by the CTCF binding domains in normal cells, whereas such distinct epigenetic domains were not observed in cancer cells. Note that demethylation reagent and histone deacetylase inhibitor treatments led to CTCF binding and recovery of barrier effect for RASSF1A and BLU genes in cancer cells. Conclusions/Significance: Our study dissects the potential transcriptionally important CpG sites for RASSF1A and BLU genes at the sequence level and demonstrates that CTCF binding to the insulator of BLU gene provides a barrier activity within separate epigenetic domains of the juxtaposed BLU and RASSF1A loci in the 3p21.3 gene cluster region.	[Chang, Jer-Wei; Hsiung, Chi-Hui; Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Hsu, Han-Shui] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei Vet Gen Hosp, Div Thorac Surg, Taipei 112, Taiwan; [Ni, Huey-Juin; Chuang, Ching-Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Huang, Tim H.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Cheng Kung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan Normal University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chang, JW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019	Wang, Yi-Ching/0000-0002-7694-2067	National Science Council [NSC96-2628-B-006-048-MY3]; Department of Health (The Executive Yuan, Republic of China) [DOH98-TD-G-111-024]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health (The Executive Yuan, Republic of China)	This work was supported in part by grant NSC96-2628-B-006-048-MY3 from the National Science Council and grant DOH98-TD-G-111-024 from the Department of Health (The Executive Yuan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2003, ONCOGENE, V22, P1580, DOI 10.1038/sj.onc.1206243; Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Dallol A, 2005, CANCER RES, V65, P7653, DOI 10.1158/0008-5472.CAN-05-0247; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Fong KM, 1999, J THORAC CARDIOV SUR, V118, P1136, DOI 10.1016/S0022-5223(99)70121-2; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hesson L, 2004, ONCOGENE, V23, P2408, DOI 10.1038/sj.onc.1207407; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Kim DH, 2003, CANCER RES, V63, P3743; Liu L, 2007, CELL CYCLE, V6, P1663, DOI 10.4161/cc.6.13.4435; Marsit CJ, 2005, INT J CANCER, V114, P219, DOI 10.1002/ijc.20714; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Riquelme E, 2007, CANCER LETT, V250, P100, DOI 10.1016/j.canlet.2006.09.019; Sekido Y, 1998, BBA-REV CANCER, V1378, pF21, DOI 10.1016/S0304-419X(98)00010-9; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang YC, 1998, CANCER RES, V58, P328; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yan Pearlly S, 2004, Methods Mol Biol, V287, P251; Yan PS, 2003, CANCER RES, V63, P6178; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232; Zhang B, 2009, ONCOGENE, V28, P651, DOI 10.1038/onc.2008.419; Zhang DD, 2006, ANAL BIOCHEM, V355, P117, DOI 10.1016/j.ab.2006.04.048	43	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12847	10.1371/journal.pone.0012847	http://dx.doi.org/10.1371/journal.pone.0012847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877461	Green Published, gold, Green Submitted			2022-12-25	WOS:000281963200016
J	Johnson, EC; Kazgan, N; Bretz, CA; Forsberg, LJ; Hector, CE; Worthen, RJ; Onyenwoke, R; Brenman, JE				Johnson, Erik C.; Kazgan, Nevzat; Bretz, Colin A.; Forsberg, Lawrence J.; Hector, Clare E.; Worthen, Ryan J.; Onyenwoke, Rob; Brenman, Jay E.			Altered Metabolism and Persistent Starvation Behaviors Caused by Reduced AMPK Function in Drosophila	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY RESTRICTION; LIFE-SPAN; ABLATION; STRESS; DOMAIN; CELLS; INHIBITION; RESISTANCE; EXERCISE	Organisms must utilize multiple mechanisms to maintain energetic homeostasis in the face of limited nutrient availability. One mechanism involves activation of the heterotrimeric AMP-activated protein kinase (AMPK), a cell-autonomous sensor to energetic changes regulated by ATP to AMP ratios. We examined the phenotypic consequences of reduced AMPK function, both through RNAi knockdown of the gamma subunit (AMPK gamma) and through expression of a dominant negative alpha (AMPK alpha) variant in Drosophila melanogaster. Reduced AMPK signaling leads to hypersensitivity to starvation conditions as measured by lifespan and locomotor activity. Locomotor levels in flies with reduced AMPK function were lower during unstressed conditions, but starvation-induced hyperactivity, an adaptive response to encourage foraging, was significantly higher than in wild type. Unexpectedly, total dietary intake was greater in animals with reduced AMPK function yet total triglyceride levels were lower. AMPK mutant animals displayed starvation-like lipid accumulation patterns in metabolically key liver-like cells, oenocytes, even under fed conditions, consistent with a persistent starved state. Measurements of O-2 consumption reveal that metabolic rates are greater in animals with reduced AMPK function. Lastly, rapamycin treatment tempers the starvation sensitivity and lethality associated with reduced AMPK function. Collectively, these results are consistent with models that AMPK shifts energy usage away from expenditures into a conservation mode during nutrient-limited conditions at a cellular level. The highly conserved AMPK subunits throughout the Metazoa, suggest such findings may provide significant insight for pharmaceutical strategies to manipulate AMPK function in humans.	[Johnson, Erik C.; Bretz, Colin A.; Hector, Clare E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Johnson, Erik C.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Kazgan, Nevzat; Forsberg, Lawrence J.; Worthen, Ryan J.; Onyenwoke, Rob; Brenman, Jay E.] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA; [Brenman, Jay E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Johnson, EC (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	johnsoec@wfu.edu; brenman@med.unc.edu		Worthen, Ryan Joseph/0000-0002-2010-5876	Wake Forest University; National Science Foundation (NSF) Integrative Organismal Systems (IOS) [092931]; National Institutes of Health (NIH) [MH073155]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080108] Funding Source: NIH RePORTER	Wake Forest University; National Science Foundation (NSF) Integrative Organismal Systems (IOS)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Science Research Fund of Wake Forest University and National Science Foundation (NSF) Integrative Organismal Systems (IOS) grant 092931 to ECJ and National Institutes of Health (NIH) grant MH073155 to JEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BLAND ML, 2010, DEV BIOL IN PRESS; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Deshmukh AS, 2008, MOL ENDOCRINOL, V22, P1105, DOI 10.1210/me.2007-0448; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1069; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Williams T, 2009, AUTOPHAGY, V5, P1155, DOI 10.4161/auto.5.8.10090; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	44	64	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12799	10.1371/journal.pone.0012799	http://dx.doi.org/10.1371/journal.pone.0012799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862213	gold, Green Published, Green Submitted			2022-12-25	WOS:000281963200005
J	Moore, ME; Goetz, FA; Van Doornik, DM; Tezak, EP; Quinn, TP; Reyes-Tomassini, JJ; Berejikian, BA				Moore, Megan E.; Goetz, Fred A.; Van Doornik, Donald M.; Tezak, Eugene P.; Quinn, Thomas P.; Reyes-Tomassini, Jose J.; Berejikian, Barry A.			Early Marine Migration Patterns of Wild Coastal Cutthroat Trout (Oncorhynchus clarki clarki), Steelhead Trout (Oncorhynchus mykiss), and Their Hybrids	PLOS ONE			English	Article							NATURAL HYBRIDIZATION; JUVENILE STEELHEAD; RAINBOW-TROUT; COHO SALMON; INTROGRESSION; RIVER; SURVIVAL; BEHAVIOR; IRIDEUS; SMOLTS	Background: Hybridization between coastal cutthroat trout (Oncorhynchus clarki clarki) and steelhead or rainbow trout (Oncorhynchus mykiss) has been documented in several streams along the North American west coast. The two species occupy similar freshwater habitats but the anadromous forms differ greatly in the duration of marine residence and migration patterns at sea. Intermediate morphological, physiological, and performance traits have been reported for hybrids but little information has been published comparing the behavior of hybrids to the pure species. Methodology/Principal Findings: This study used acoustic telemetry to record the movements of 52 cutthroat, 42 steelhead x cutthroat hybrids, and 89 steelhead smolts, all wild, that migrated from Big Beef Creek into Hood Canal (Puget Sound, Washington). Various spatial and temporal metrics were used to compare the behavior of the pure species to their hybrids. Median hybrid residence time, estuary time, and tortuosity values were intermediate compared to the pure species. The median total track distance was greater for hybrids than for either cutthroat or steelhead. At the end of each track, most steelhead (80%) were located near or north of the Hood Canal, as expected for this seaward migrating species, whereas most cutthroat (89%) were within 8 kilometers of the estuary. Most hybrids (70%) were detected leaving Hood Canal, though a substantial percentage (20%) remained near the Big Beef Creek estuary. More hybrids (7.5%) than pure cutthroat (4.5%) or steelhead (0.0%) were last detected in the southern reaches of Hood Canal. Conclusions/Significance: Given the similarity in freshwater ecology between the species, differences in marine ecology may play an important role in maintaining species integrity in areas of sympatry.	[Moore, Megan E.; Tezak, Eugene P.; Reyes-Tomassini, Jose J.; Berejikian, Barry A.] NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Technol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA; [Goetz, Fred A.; Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Van Doornik, Donald M.] NW Fisheries Sci Ctr, Conservat Biol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Moore, ME (corresponding author), NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Technol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA.	megan.moore@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	National Oceanic and Atmospheric Administration (NOAA)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was primarily funded by the National Oceanic and Atmospheric Administration (NOAA), with some acoustic tags provided by the Army Corps of Engineers. Those who determine fund allocation within NOAA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; ANDERSON BW, 1971, CONDOR, V73, P342, DOI 10.2307/1365761; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Baker J, 2002, T AM FISH SOC, V131, P404, DOI 10.1577/1548-8659(2002)131&lt;0404:MMDCCT&gt;2.0.CO;2; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Baumsteiger J, 2005, T AM FISH SOC, V134, P829, DOI 10.1577/T04-114.1; Behnke R.J., 1992, AM FISHERIES SOC AM, V6, P275; Bettles CM, 2005, J EVOLUTION BIOL, V18, P1220, DOI 10.1111/j.1420-9101.2005.00935.x; BETTLES CM, 2004, THESIS U WINDSOR WIN; BISSON PA, 1988, T AM FISH SOC, V117, P262, DOI 10.1577/1548-8659(1988)117<0262:CHHUAB>2.3.CO;2; BUCHHOLZ WS, 1999, SUMMARY PCR PRIMERS, P99; Burgner R. L., 1992, INT N PACIFIC FISHER, V51; BUSACK CA, 1981, CAN J FISH AQUAT SCI, V38, P939, DOI 10.1139/f81-127; Busby P. J. T. C., 1996, NMFSNWFSC27 NOAA US; CAMPTON DE, 1985, CAN J FISH AQUAT SCI, V42, P110, DOI 10.1139/f85-014; CANDOLIN U, 2006, EVOL BIOL, V20, P233; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Gargett AE, 1997, FISH OCEANOGR, V6, P109, DOI 10.1046/j.1365-2419.1997.00033.x; GIGER RD, 1972, 6 OR STAT GAM COMM; GOETZ FA, HOOD CANAL UNPUB; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Goodman SJ, 1999, GENETICS, V152, P355; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Hawkins DK, 1998, CAN J FISH AQUAT SCI, V55, P2097, DOI 10.1139/cjfas-55-9-2097; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; HAWKINS DK, 1997, THESIS U WASHINGTON; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Johnson O.W., 1999, NOAA TECHNICAL MEMOR; Kennedy BM, 2009, MAR COAST FISH, V1, P45, DOI 10.1577/C08-006.1; KOKKO H, 2008, PHILOS T R SOC B, V361, P319; LEARY RF, 1995, AM FISH S S, V15, P91; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MCCONNELL RJ, 1972, KEY FIELD IDENTIFICA; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Ostberg CO, 2004, MOL ECOL, V13, P2773, DOI 10.1111/j.1365-294X.2004.02268.x; Ostberg CO, 2004, MOL ECOL NOTES, V4, P26, DOI 10.1046/j.1471-8286.2003.00554.x; QUINN TP, 2005, FISCH OCEANOGR, V6, P109; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; TROTTER PC, 1989, T AM FISH SOC, V118, P463, DOI 10.1577/1548-8659(1989)118<0463:CCTALH>2.3.CO;2; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Wenburg JK, 1998, MOL ECOL, V7, P733, DOI 10.1046/j.1365-294x.1998.00386.x; Williams I, 2007, T AM FISH SOC, V136, P926, DOI 10.1577/T06-214.1; Young WP, 2001, MOL ECOL, V10, P921, DOI 10.1046/j.1365-294X.2001.01247.x	54	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12881	10.1371/journal.pone.0012881	http://dx.doi.org/10.1371/journal.pone.0012881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862225	gold, Green Published, Green Submitted			2022-12-25	WOS:000281963200024
J	Fuller, K; Ross, JL; Szewczyk, KA; Moss, R; Chambers, TJ				Fuller, Karen; Ross, Jade L.; Szewczyk, Kinga A.; Moss, Raymond; Chambers, Tim J.			Bone Is Not Essential for Osteoclast Activation	PLOS ONE			English	Article							ISOLATED RABBIT OSTEOCLASTS; VITRONECTIN RECEPTOR; SEALING ZONE; IN-VITRO; CYTOSKELETAL ORGANIZATION; ALPHA(V)BETA(3) INTEGRIN; RESORBING OSTEOCLASTS; CULTURED OSTEOCLASTS; EXTRACELLULAR-MATRIX; PARATHYROID-HORMONE	Background: The mechanism whereby bone activates resorptive behavior in osteoclasts, the cells that resorb bone, is unknown. It is known that alpha(v)beta(3) ligands are important, because blockade of alpha(v)beta(3) receptor signaling inhibits bone resorption, but this might be through inhibition of adhesion or migration rather than resorption itself. Nor is it known whether alpha(v)beta(3) ligands are sufficient for resorption the consensus is that bone mineral is essential for the recognition of bone as the substrate appropriate for resorption. Methodology/Principal Findings: Vitronectin-but not fibronectin-coated coverslips induced murine osteoclasts to secrete tartrate-resistant acid phosphatase, as they do on bone. Osteoclasts incubated on vitronectin, unlike fibronectin, formed podosome belts on glass coverslips, and these were modulated by resorption-regulating cytokines. Podosome belts formed on vitronectin-coated surfaces whether the substrates were rough or smooth, rigid or flexible. We developed a novel approach whereby the substrate-apposed surface of cells can be visualized in the scanning electron microscope. With this approach, supported by transmission electron microscopy, we found that osteoclasts on vitronectin-coated surfaces show ruffled borders and clear zones characteristic of resorbing osteoclasts. Ruffles were obscured by a film if cells were incubated in the cathepsin inhibitor E64, suggesting that removal of the film represents substrate-degrading behavior. Analogously, osteoclasts formed resorption-like trails on vitronectin-coated substrates. Like bone resorption, these trails were dependent upon resorbogenic cytokines and were inhibited by E64. Bone mineral induced actin rings and surface excavation only if first coated with vitronectin. Fibronectin could not substitute in any of these activities, despite enabling adhesion and cell spreading. Conclusions/Significance: Our results show that ligands alpha(v)beta(3) are not only necessary but sufficient for the induction of resorptive behavior in osteoclasts; and suggest that bone is recognized through its affinity for these ligands, rather than by its mechanical or topographical attributes, or through a putative 'mineral receptor'.	[Fuller, Karen; Ross, Jade L.; Szewczyk, Kinga A.; Moss, Raymond; Chambers, Tim J.] St Georges Univ London, Div Basic Med Sci, London, England	St Georges University London	Fuller, K (corresponding author), St Georges Univ London, Div Basic Med Sci, London, England.	tchamber@sgul.ac.uk			St George's, University of London	St George's, University of London	This work was supported by St George's, University of London (www.sgul.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1995, J BONE MINER RES, V10, P1209; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; BOYD NAM, 1993, J CLIN PATHOL, V46, P1042, DOI 10.1136/jcp.46.11.1042; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; CHAMBERS TJ, 1991, VITAM HORM, V46, P41; CHAMBERS TJ, 1984, J CELL SCI, V66, P383; CHAMBERS TJ, 1984, J CELL SCI, V70, P61; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; Chambers TJ, 2000, J PATHOL, V192, P4; CHAMBERS TJ, 1986, BONE MINER, V1, P127; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; DODDS RA, 1995, J BONE MINER RES, V10, P1666; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Engelman VW, 1997, J CLIN INVEST, V99, P2284, DOI 10.1172/JCI119404; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; GEBLINGER D, 2010, J CELL SCI; Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053; HOLTROP ME, 1974, J CELL BIOL, V60, P346, DOI 10.1083/jcb.60.2.346; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001; HUGHES DE, 1993, J BONE MINER RES, V8, P527; Huq NL, 2000, J MOL MODEL, V6, P35; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179; LAKKAKORPI PT, 1990, J HISTOCHEM CYTOCHEM, V38, P1487, DOI 10.1177/38.10.2169493; LAKKAKORPI PT, 1993, J CELL SCI, V104, P663; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V118, P824, DOI 10.1210/endo-118-2-824; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 2002, J IMMUNOL, V168, P5103, DOI 10.4049/jimmunol.168.10.5103; Nakamura I, 1996, J BONE MINER RES, V11, P1873; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; ROBEY PG, 1989, J CELL BIOL, V108, P719, DOI 10.1083/jcb.108.2.719; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; SHAFFER MC, 1984, J LAB CLIN MED, V103, P783; Shyu JF, 2007, BONE, V40, P1329, DOI 10.1016/j.bone.2007.01.014; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; TEZUKA K, 1992, J BONE MINER RES, V7, pS130; TURKSEN K, 1988, J BONE MINER RES, V3, P389; Vaananen HK, 2000, J CELL SCI, V113, P377	57	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12837	10.1371/journal.pone.0012837	http://dx.doi.org/10.1371/journal.pone.0012837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862258	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800025
J	Halton, KA; Cook, D; Paterson, DL; Safdar, N; Graves, N				Halton, Kate A.; Cook, David; Paterson, David L.; Safdar, Nasia; Graves, Nicholas			Cost-Effectiveness of a Central Venous Catheter Care Bundle	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; QUALITY-OF-LIFE; AUSTRALIA; ECONOMICS	Background: A bundled approach to central venous catheter care is currently being promoted as an effective way of preventing catheter-related bloodstream infection (CR-BSI). Consumables used in the bundled approach are relatively inexpensive which may lead to the conclusion that the bundle is cost-effective. However, this fails to consider the nontrivial costs of the monitoring and education activities required to implement the bundle, or that alternative strategies are available to prevent CR-BSI. We evaluated the cost-effectiveness of a bundle to prevent CR-BSI in Australian intensive care patients. Methods and Findings: A Markov decision model was used to evaluate the cost-effectiveness of the bundle relative to remaining with current practice (a non-bundled approach to catheter care and uncoated catheters), or use of antimicrobial catheters. We assumed the bundle reduced relative risk of CR-BSI to 0.34. Given uncertainty about the cost of the bundle, threshold analyses were used to determine the maximum cost at which the bundle remained cost-effective relative to the other approaches to infection control. Sensitivity analyses explored how this threshold alters under different assumptions about the economic value placed on bed-days and health benefits gained by preventing infection. If clinicians are prepared to use antimicrobial catheters, the bundle is cost-effective if national 18-month implementation costs are below $1.1 million. If antimicrobial catheters are not an option the bundle must cost less than $4.3 million. If decision makers are only interested in obtaining cash-savings for the unit, and place no economic value on either the bed-days or the health benefits gained through preventing infection, these cost thresholds are reduced by two-thirds. Conclusions: A catheter care bundle has the potential to be cost-effective in the Australian intensive care setting. Rather than anticipating cash-savings from this intervention, decision makers must be prepared to invest resources in infection control to see efficiency improvements.	[Halton, Kate A.; Paterson, David L.; Graves, Nicholas] Ctr Healthcare Related Infect Surveillance & Prev, Brisbane, Qld, Australia; [Halton, Kate A.; Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cook, David] Princess Alexandra Hosp, Intens Care Unit, Brisbane, Qld 4102, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Safdar, Nasia] Univ Wisconsin, Dept Med, Infect Dis Sect, Sch Med & Publ Hlth, Madison, WI USA	Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital; University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Halton, KA (corresponding author), Ctr Healthcare Related Infect Surveillance & Prev, Brisbane, Qld, Australia.	k.halton@qut.edu.au	Cook, David/D-7318-2013; Graves, Nicholas/A-3052-2011; Paterson, David L/A-9258-2010; Halton, Kate/I-9964-2012	Graves, Nicholas/0000-0002-5559-3267; Paterson, David/0000-0003-2079-4437; Halton, Kate/0000-0001-9785-1458	Queensland Health Quality and Safety Programme; National Health and Medical Research Council	Queensland Health Quality and Safety Programme; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Queensland Health Quality and Safety Programme and a National Health and Medical Research Council project grant provided support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; *AUST I HLTH WELF, 2006, AUST HLTH 2006; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Blot SI, 2005, CLIN INFECT DIS, V41, P1591, DOI 10.1086/497833; *BUR LAB STAT, BUR LAB STAT CONS PR; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Drummond MF, 2005, METHODS EC EVALUATIO, P27; Gastmeier P, 2006, J HOSP INFECT, V64, P326, DOI 10.1016/j.jhin.2006.07.005; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 1996, COST EFFECTIVENESS H; Graves N, 2005, WOUND REPAIR REGEN, V13, P462, DOI 10.1111/j.1067-1927.2005.00066.x; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N., 2008, HEALTHCARE INFECT, V13, P48; GRAVES N, 2008, REDUCING HARM PATIEN; Graves N, 2008, JAMA-J AM MED ASSOC, V300, P1577, DOI 10.1001/jama.300.13.1577; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048; Halton KA, 2009, CRIT CARE, V13, DOI 10.1186/cc7744; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; MARTIN J, 2006, INTENSIVE CARE RESOU; McConnell SA, 2003, CLIN INFECT DIS, V37, P65, DOI 10.1086/375227; McLaws ML, 2005, INFECT CONT HOSP EP, V26, P715, DOI 10.1086/502608; Morton AP, 2008, INFECT CONT HOSP EP, V29, P695, DOI 10.1086/589904; Oda T, 1997, ANESTHESIOLOGY, V87, P1242, DOI 10.1097/00000542-199711000-00031; Pronovost P, 2003, J CRIT CARE, V18, P71, DOI 10.1053/jcrc.2003.50008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost Peter J, 2004, Jt Comm J Qual Saf, V30, P59; PRONOVOST PJ, 2005, HLTH EXEC, V20, P15; PRONOVOST PJ, 2005, J PATIENT SAF, V1, P33; Ramritu P, 2008, AM J INFECT CONTROL, V36, P104, DOI 10.1016/j.ajic.2007.02.012; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rechner IJ, 2005, ANAESTH INTENS CARE, V33, P477, DOI 10.1177/0310057X0503300409; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; SHIROIWA T, 2009, HLTH EC; Ward William J Jr, 2006, Healthc Financ Manage, V60, P92; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D; Williams TA, 2006, ANAESTH INTENS CARE, V34, P307, DOI 10.1177/0310057X0603400316; 2008, FED REG, V73, P48434; 2005, MMWR MORBIDITY MORTA, V54, P1013	45	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12815	10.1371/journal.pone.0012815	http://dx.doi.org/10.1371/journal.pone.0012815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20862246	gold, Green Submitted, Green Published			2022-12-25	WOS:000281960800016
J	Yang, FK; Ke, YH; Tan, YF; Bi, YJ; Shi, QH; Yang, HY; Qiu, JF; Wang, XY; Guo, ZB; Ling, H; Yang, RF; Du, ZM				Yang, Fengkun; Ke, Yuehua; Tan, Yafang; Bi, Yujing; Shi, Qinghai; Yang, Huiying; Qiu, Jinfu; Wang, Xiaoyi; Guo, Zhaobiao; Ling, Hong; Yang, Ruifu; Du, Zongmin			Cell Membrane Is Impaired, Accompanied by Enhanced Type III Secretion System Expression in Yersinia pestis Deficient in RovA Regulator	PLOS ONE			English	Article							ESCHERICHIA-COLI; H-NS; TRANSCRIPTIONAL REGULATOR; GENOME SEQUENCE; VIRULENCE; ENTEROCOLITICA; PROTEIN; PSEUDOTUBERCULOSIS; TRANSLOCATION; ACTIVATOR	Background: In the enteropathogenic Yersinia species, RovA regulates the expression of invasin, which is important for enteropathogenic pathogenesis but is inactivated in Yersinia pestis. Investigation of the RovA regulon in Y. pestis at 26 degrees C has revealed that RovA is a global regulator that contributes to virulence in part by the direct regulation of psaEFABC. However, the regulatory roles of RovA in Y. pestis at 37 degrees C, which allows most virulence factors in mammalian hosts to be expressed, are still poorly understood. Methodology/Principal Findings: The transcriptional profile of an in-frame rovA mutant of Y. pestis biovar Microtus strain 201 was analyzed under type III secretion system (T3SS) induction conditions using microarray techniques, and it was revealed that many cell-envelope and transport/binding proteins were differentially expressed in the Delta rovA mutant. Most noticeably, many of the T3SS genes, including operons encoding the translocon, needle and Yop (Yersinia outer protein) effectors, were significantly up-regulated. Analysis of Yop proteins confirmed that YopE and YopJ were also expressed in greater amounts in the mutant. However, electrophoresis mobility shift assay results demonstrated that the His-RovA protein could not bind to the promoter sequences of the T3SS genes, suggesting that an indirect regulatory mechanism is involved. Transmission electron microscopy analysis indicated that there are small loose electron dense particle-like structures that surround the outer membrane of the mutant cells. The bacterial membrane permeability to CFSE (carboxyfluorescein diacetate succinimidyl ester) was significantly decreased in the Delta rovA mutant compared to the wild-type strain. Taken together, these results revealed the improper construction and dysfunction of the membrane in the Delta rovA mutant. Conclusions/Significance: We demonstrated that the RovA regulator plays critical roles in the construction and functioning of the bacterial membrane, which sheds considerable light on the regulatory functions of RovA in antibiotic resistance and environmental adaptation. The expression of T3SS was upregulated in the Delta rovA mutant through an indirect regulatory mechanism, which is possibly related to the altered membrane construction in the mutant.	[Yang, Fengkun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Yang, Fengkun; Ke, Yuehua; Tan, Yafang; Bi, Yujing; Shi, Qinghai; Yang, Huiying; Qiu, Jinfu; Wang, Xiaoyi; Guo, Zhaobiao; Yang, Ruifu; Du, Zongmin] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Harbin Medical University; Academy of Military Medical Sciences - China	Ling, H (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	Profling2003@yahoo.com; ruifuyang@gmail.com; zongmindu@gmail.com		ling, hong/0000-0002-1886-1242	National Natural Science Foundation of China [30970121, 30430620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this work came from the National Natural Science Foundation of China (No. 30970121, No. 30430620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN WF, 1964, AM J HYG, V79, P37, DOI 10.1093/oxfordjournals.aje.a120362; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 2000, PHILOS T R SOC B, V355, P681, DOI 10.1098/rstb.2000.0608; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2004, TRENDS MICROBIOL, V12, P296, DOI 10.1016/j.tim.2004.04.006; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12840	10.1371/journal.pone.0012840	http://dx.doi.org/10.1371/journal.pone.0012840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862262	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800026
J	Gowen, BB; Wong, MH; Larson, D; Ye, W; Jung, KH; Sefing, EJ; Skirpstunas, R; Smee, DF; Morrey, JD; Schneller, SW				Gowen, Brian B.; Wong, Min-Hui; Larson, Deanna; Ye, Wei; Jung, Kie-Hoon; Sefing, Eric J.; Skirpstunas, Ramona; Smee, Donald F.; Morrey, John D.; Schneller, Stewart W.			Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin Analog	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; S-ADENOSYLHOMOCYSTEINE HYDROLASE; CARBOCYCLIC ADENOSINE-ANALOGS; GAMMA-INTERFERONS; VIRUS-INFECTION; LASSA FEVER; GUINEA-PIGS; RIBAVIRIN; DISEASE; INHIBITION	Background: A growing number of arenaviruses can cause a devastating viral hemorrhagic fever (VHF) syndrome. They pose a public health threat as emerging viruses and because of their potential use as bioterror agents. All of the highly pathogenic New World arenaviruses (NWA) phylogenetically segregate into clade B and require maximum biosafety containment facilities for their study. Tacaribe virus (TCRV) is a nonpathogenic member of clade B that is closely related to the VHF arenaviruses at the amino acid level. Despite this relatedness, TCRV lacks the ability to antagonize the host interferon (IFN) response, which likely contributes to its inability to cause disease in animals other than newborn mice. Methodology/Principal Findings: Here we describe a new mouse model based on TCRV challenge of AG129 IFN-a/b and -gamma receptor-deficient mice. Titration of the virus by intraperitoneal (i.p.) challenge of AG129 mice resulted in an LD(50) of similar to 100 fifty percent cell culture infectious doses. Virus replication was evident in the serum, liver, lung, spleen, and brain 4-8 days after inoculation. MY-24, an aristeromycin derivative active against TCRV in cell culture at 0.9 mu M, administered i.p. once daily for 7 days, offered highly significant (P<0.001) protection against mortality in the AG129 mouse TCRV infection model, without appreciably reducing viral burden. In contrast, in a hamster model of arenaviral hemorrhagic fever based on challenge with clade A Pichinde arenavirus, MY-24 did not offer significant protection against mortality. Conclusions/Significance: MY-24 is believed to act as an inhibitor of S-adenosyl-L-homocysteine hydrolase, but our findings suggest that it may ameliorate disease by blunting the effects of the host response that play a role in disease pathogenesis. The new AG129 mouse TCRV infection model provides a safe and cost-effective means to conduct early-stage pre-clinical evaluations of candidate antiviral therapies that target clade B arenaviruses.	[Gowen, Brian B.; Wong, Min-Hui; Larson, Deanna; Jung, Kie-Hoon; Sefing, Eric J.; Skirpstunas, Ramona; Smee, Donald F.; Morrey, John D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA; [Ye, Wei; Schneller, Stewart W.] Auburn Univ, Molette Lab Drug Discovery Res, Dept Chem & Biochem, Auburn, AL 36849 USA; [Skirpstunas, Ramona] Dept Agr & Food, Logan, UT USA	Utah System of Higher Education; Utah State University; Auburn University System; Auburn University	Gowen, BB (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	brian.gowen@usu.edu			Virology Branch, NIAID, NIH [N01-AI-30048, N01-AI-15435, N01-AI-30063, U19-AI-56540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048, U19AI056540, N01AI015435, R29AI030063] Funding Source: NIH RePORTER	Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by contract/grant N01-AI-30048, N01-AI-15435, N01-AI-30063 (awarded to Southern Research Institute), and U19-AI-56540, Virology Branch, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asper M, 2004, J VIROL, V78, P3162, DOI 10.1128/JVI.78.6.3162-3169.2004; BENNETT LL, 1985, MOL PHARMACOL, V27, P666; BENNETT LL, 1986, MOL PHARMACOL, V29, P383; BENNETT LL, 1986, BIOCHEM PHARMACOL, V35, P4106, DOI 10.1016/0006-2952(86)90036-5; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; COOLS M, 1990, BIOCHEM PHARMACOL, V40, P2259, DOI 10.1016/0006-2952(90)90720-6; De Clercq E, 2005, NUCLEOS NUCLEOT NUCL, V24, P1395, DOI 10.1080/15257770500265638; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; ENRIA DA, 1987, ANTIVIR RES, V7, P353, DOI 10.1016/0166-3542(87)90017-9; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Grajkowski A, 2005, NUCLEIC ACIDS RES, V33, P3550, DOI 10.1093/nar/gki657; Hall WC, 1996, AM J TROP MED HYG, V55, P81, DOI 10.4269/ajtmh.1996.55.81; HILL DL, 1971, MOL PHARMACOL, V7, P375; JAHRLING PB, 1982, INFECT IMMUN, V37, P771, DOI 10.1128/IAI.37.2.771-778.1982; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; KISHI T, 1972, CHEM PHARM BULL, V20, P940; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MONTGOMERY JA, 1982, J MED CHEM, V25, P626, DOI 10.1021/jm00348a004; OUBINA JR, 1984, AM J TROP MED HYG, V33, P1251, DOI 10.4269/ajtmh.1984.33.1251; PETERS CJ, 1989, REV INFECT DIS, V11, pS743; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez JB, 2003, MINI-REV MED CHEM, V3, P95, DOI 10.2174/1389557033405331; Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039; Schneller Stewart W., 2002, Current Topics in Medicinal Chemistry, V2, P1087, DOI 10.2174/1568026023393228; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Xiao SY, 2001, AM J TROP MED HYG, V64, P111, DOI 10.4269/ajtmh.2001.64.111; Yang MM, 2005, BIOORG MED CHEM LETT, V15, P149, DOI 10.1016/j.bmcl.2004.10.019	42	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12760	10.1371/journal.pone.0012760	http://dx.doi.org/10.1371/journal.pone.0012760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862280	gold, Green Published			2022-12-25	WOS:000281864100012
J	Murdoch, BM; Clawson, ML; Yue, S; Basu, U; McKay, S; Settles, M; Capoferri, R; Laegreid, WW; Williams, JL; Moore, SS				Murdoch, Brenda M.; Clawson, Michael L.; Yue, Samuel; Basu, Urmila; McKay, Stephanie; Settles, Matthew; Capoferri, Rossana; Laegreid, William W.; Williams, John L.; Moore, Stephen S.			PRNP Haplotype Associated with Classical BSE Incidence in European Holstein Cattle	PLOS ONE			English	Article							NF-KAPPA-B; PRION PROTEIN; VARIANT; MICE; CJD	Background: Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease of cattle. The bovine prion gene (PRNP) contains regions of both high and low linkage disequilibrium (LD) that appear to be conserved across Bos taurus populations. The region of high LD, which spans the promoter and part of intron 2, contains polymorphic loci that have been associated with classical BSE status. However, the complex genetic architecture of PRNP has not been systematically tested for an association with classical BSE. Methodology/Principal Findings: In this study, haplotype tagging single nucleotide polymorphisms (htSNPs) within PRNP were used to test for association between PRNP haplotypes and BSE disease. A combination of Illumina goldengate assay, sequencing and PCR amplification was used to genotype 18 htSNPs and 2 indels in 95 BSE case and 134 control animals. A haplotype within the region of high LD was found to be associated with BSE unaffected animals (p-value = 0.000114). Conclusion/Significance: A PRNP haplotype association with classical BSE incidence has been identified. This result suggests that a genetic determinant in or near PRNP may influence classical BSE incidence in cattle.	[Murdoch, Brenda M.; Yue, Samuel; Basu, Urmila; McKay, Stephanie; Moore, Stephen S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Clawson, Michael L.] ARS, Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [Laegreid, William W.] Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA; [McKay, Stephanie] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Settles, Matthew] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Capoferri, Rossana] Ist Sperimentale Italiano, IDRA Lab, Lodi, Italy; [Williams, John L.] Polo Univ, Lodi, Italy	University of Alberta; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; Idaho; University of Idaho	Murdoch, BM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	bmurdoch@ualberta.ca	Settles, Matthew L/F-2031-2011; Moore, Stephen S/F-5285-2013	Settles, Matthew L/0000-0002-3424-1086; Moore, Stephen/0000-0002-9758-166X; Clawson, Michael/0000-0002-3355-5390; Laegreid, William/0000-0002-8694-5229; Williams, John/0000-0001-5188-7957; Murdoch, Brenda M/0000-0001-8675-3473; McKay, Stephanie/0000-0003-1434-3111	PrioNet Canada; Alberta Prion Research Institute [200500696]; USDA; Cariplo Foundation	PrioNet Canada; Alberta Prion Research Institute; USDA(United States Department of Agriculture (USDA)); Cariplo Foundation(Fondazione Cariplo)	The authors would like to thank the PrioNet Canada and Alberta Prion Research Institute (200500696) for their funding and support of this work. JLW would like to thank the USDA and the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2006, J ANIM SCI, V84, P259, DOI 10.2527/2006.842259x; Blanchong JA, 2009, INFECT GENET EVOL, V9, P1329, DOI 10.1016/j.meegid.2009.08.010; Bourteele S, 2007, CELL MICROBIOL, V9, P2202, DOI 10.1111/j.1462-5822.2007.00950.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Clawson Michael L, 2008, BMC Res Notes, V1, P32, DOI 10.1186/1756-0500-1-32; Clawson ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001830; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Julius C, 2008, J GEN VIROL, V89, P1545, DOI 10.1099/vir.0.83622-0; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sanderson K, 2004, CHEM WORLD-UK, V1, P19; Sherman EL, 2008, ANIM GENET, V39, P225, DOI 10.1111/j.1365-2052.2008.01704.x; Stack MJ, 2009, VET REC, V165, P605, DOI 10.1136/vr.165.20.605-c; Strom A, 2006, PROTEOMICS, V6, P26, DOI 10.1002/pmic.200500066; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264; XUE G, 2008, BIOCHEM BIOPH RES CO, V4, P530; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08	39	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12786	10.1371/journal.pone.0012786	http://dx.doi.org/10.1371/journal.pone.0012786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862290	Green Published, gold			2022-12-25	WOS:000281864100021
J	Benardais, K; Kasem, B; Couegnas, A; Samama, B; Fernandez, S; Schaeffer, C; Antal, MC; Job, D; Schweitzer, A; Andrieux, A; Giersch, A; Nehlig, A; Boehm, N				Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Fernandez, Sebastien; Schaeffer, Christiane; Antal, Maria-Cristina; Job, Didier; Schweitzer, Annie; Andrieux, Annie; Giersch, Anne; Nehlig, Astrid; Boehm, Nelly			Loss of STOP Protein Impairs Peripheral Olfactory Neurogenesis	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; COLD-STABLE MICROTUBULES; CELL-DEATH; VOMERONASAL EPITHELIUM; SENSORY NEURONS; ADULT MICE; NULL MICE; SCHIZOPHRENIA; MOUSE; EXPRESSION	Background: STOP (Stable Tubulin-Only Polypeptide) null mice show behavioral deficits, impaired synaptic plasticity, decrease in synaptic vesicular pools and disturbances in dopaminergic transmission, and are considered a neurodevelopmental model of schizophrenia. Olfactory neurons highly express STOP protein and are continually generated throughout life. Experimentally-induced loss of olfactory neurons leads to epithelial regeneration within two months, providing a useful model to evaluate the role played by STOP protein in adult olfactory neurogenesis. Methodology/Principal Findings: Immunocytochemistry and electron microscopy were used to study the structure of the glomerulus in the main olfactory bulb and neurogenesis in the neurosensorial epithelia. In STOP null mice, olfactory neurons showed presynaptic swellings with tubulovesicular profiles and autophagic-like structures. In olfactory and vomeronasal epithelia, there was an increase in neurons turnover, as shown by the increase in number of proliferating, apoptotic and immature cells with no changes in the number of mature neurons. Similar alterations in peripheral olfactory neurogenesis have been previously described in schizophrenia patients. In STOP null mice, regeneration of the olfactory epithelium did not modify these anomalies; moreover, regeneration resulted in abnormal organisation of olfactory terminals within the olfactory glomeruli in STOP null mice. Conclusions/Significance: In conclusion, STOP protein seems to be involved in the establishment of synapses in the olfactory glomerulus. Our results indicate that the olfactory system of STOP null mice is a well-suited experimental model (1) for the study of the mechanism of action of STOP protein in synaptic function/plasticity and (2) for pathophysiological studies of the mechanisms of altered neuronal connections in schizophrenia.	[Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Schaeffer, Christiane; Antal, Maria-Cristina; Giersch, Anne; Nehlig, Astrid; Boehm, Nelly] INSERM, U666, Strasbourg, France; [Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Fernandez, Sebastien; Schaeffer, Christiane; Antal, Maria-Cristina; Boehm, Nelly] Univ Strasbourg, Fac Med, Hist Inst, Strasbourg, France; [Samama, Brigitte; Schaeffer, Christiane; Antal, Maria-Cristina; Boehm, Nelly] Hop Univ Strasbourg, Strasbourg, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] Grenoble Inst Neurosci, INSERM, U836, Grenoble, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] CEA Grenoble, IRTSV GPC, Grenoble, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] Univ Grenoble 1, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Benardais, K (corresponding author), INSERM, U666, Strasbourg, France.	Brigitte.Samama@medecine.u-strasbg.fr	Giersch, Anne/H-6444-2016; ANDRIEUX, ANNIE/B-2134-2017	Giersch, Anne/0000-0002-8577-6021; ANDRIEUX, ANNIE/0000-0002-4022-6405	INSERM (Institut National de la Sante et de la Recherche Medicale)	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Source of funding: INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Arnold SE, 2001, ARCH GEN PSYCHIAT, V58, P829, DOI 10.1001/archpsyc.58.9.829; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; BARBER PC, 1978, BRAIN RES, V141, P57, DOI 10.1016/0006-8993(78)90616-9; Begou M, 2007, SYNAPSE, V61, P689, DOI 10.1002/syn.20409; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; BOEHM N, 1991, PHYSIOL BEHAV, V50, P1001, DOI 10.1016/0031-9384(91)90428-Q; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bouvrais-Veret C, 2008, J NEUROCHEM, V104, P745, DOI 10.1111/j.1471-4159.2007.05025.x; Bouvrais-Veret C, 2007, NEUROPHARMACOLOGY, V52, P1691, DOI 10.1016/j.neuropharm.2007.03.015; Brenner E, 2007, J NEUROSCI RES, V85, P3487, DOI 10.1002/jnr.21200; Brun P, 2005, J NEUROCHEM, V94, P63, DOI 10.1111/j.1471-4159.2005.03166.x; Calof AL, 1996, J NEUROBIOL, V30, P67; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Cascella NG, 2007, J NEUROCHEM, V102, P587, DOI 10.1111/j.1471-4159.2007.04628.x; Couegnas A, 2007, J NEUROSCI RES, V85, P1515, DOI 10.1002/jnr.21278; Cowan CM, 2002, MICROSC RES TECHNIQ, V58, P204, DOI 10.1002/jemt.10150; Cowan CM, 2001, J NEUROSCI, V21, P7099, DOI 10.1523/JNEUROSCI.21-18-07099.2001; DELA ROSAPRIETO, 2009, J COMP NEUROL, V517, P723; Delotterie D, 2010, PSYCHOPHARMACOLOGY, V208, P131, DOI 10.1007/s00213-009-1712-3; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Ducray A, 2002, EUR J NEUROSCI, V15, P1907, DOI 10.1046/j.1460-9568.2002.02044.x; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Fradley RL, 2005, BEHAV BRAIN RES, V163, P257, DOI 10.1016/j.bbr.2005.05.012; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fung KM, 1997, BRAIN RES, V761, P347, DOI 10.1016/S0006-8993(97)00467-8; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Hanaya R, 2008, NEUROBIOL DIS, V31, P451, DOI 10.1016/j.nbd.2008.06.006; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; Martinez-Marcos A, 2005, J NEUROBIOL, V63, P173, DOI 10.1002/neu.20128; Martinez-Marcos A, 2000, J NEUROBIOL, V44, P423, DOI 10.1002/1097-4695(20000915)44:4<423::AID-NEU5>3.0.CO;2-H; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; Murdoch B, 2007, J MOL HISTOL, V38, P581, DOI 10.1007/s10735-007-9141-2; Powell KJ, 2007, BEHAV NEUROSCI, V121, P826, DOI 10.1037/0735-7044.121.5.826; Rheuben MB, 2004, TOXICOL APPL PHARM, V196, P266, DOI 10.1016/j.taap.2004.01.004; Richard M, 2009, MOL CELL NEUROSCI, V41, P120, DOI 10.1016/j.mcn.2009.02.004; Robertson GS, 2006, J PSYCHIATR NEUROSCI, V31, P157; Rossler W, 2002, CHEM SENSES, V27, P803, DOI 10.1093/chemse/27.9.803; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Sultan-Styne K, 2009, J COMP NEUROL, V515, P696, DOI 10.1002/cne.22084; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; Weiler E, 2005, J NEUROCYTOL, V34, P217, DOI 10.1007/s11068-005-8355-z	51	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12753	10.1371/journal.pone.0012753	http://dx.doi.org/10.1371/journal.pone.0012753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856814	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800019
J	Danzer, KM; Ruf, WP; Putcha, P; Joyner, D; Hashimoto, T; Glabe, C; Hyman, BT; McLean, PJ				Danzer, Karin M.; Ruf, Wolfgang P.; Putcha, Preeti; Joyner, Daniel; Hashimoto, Tadafumi; Glabe, Charles; Hyman, Bradley T.; McLean, Pamela J.			Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity	FASEB JOURNAL			English	Article						Parkinson's disease; aggregation; microfluidic culture system; protein complementation	PARKINSONS-DISEASE; INCLUSION FORMATION; MAMMALIAN-CELLS; LEWY BODIES; PROTEIN; HSP70; STRESS; RELEASE; PATHOLOGY; GLIA	The paradoxical appearance of aggregated alpha-synuclein (alpha syn) in naive transplanted embryonic stem cells in Parkinson's disease (PD) brains has recently been reported, highlighting the possibility of neuron to neuron transmission of alpha syn in PD. Here, we demonstrate in a cellular model the presence of alpha syn oligomers in the extracellular space, their uptake by neurons, retrograde axonal transport to cell soma, and detrimental effects on neighboring cells. Moreover, we demonstrate that Hsp70 chaperones alpha syn in the extracellular space and reduces extracellular alpha syn oligomer formation and related toxicity. These novel findings provide evidence that extracellular alpha syn oligomers may represent a crucial player in the propagation of pathology in PD, with their modulation by Hsp70 representing a potential new target for therapeutic interventions.-Danzer, K. M., Ruf, W. P., Putcha, P., Joyner, D., Hashimoto, T., Glabe, C., Hyman, B. T., McLean, P. J. Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326-336 (2011). www.fasebj.org	[Danzer, Karin M.; Ruf, Wolfgang P.; Putcha, Preeti; Joyner, Daniel; Hashimoto, Tadafumi; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis,Med Sch, Charlestown, MA 02129 USA; [Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine	McLean, PJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis,Med Sch, 114 16th St, Charlestown, MA 02129 USA.	pmclean@partners.org	Hashimoto, Tadafumi/A-7723-2013	Hashimoto, Tadafumi/0000-0001-5442-4800; Ruf, Wolfgang/0000-0002-8105-6123; McLean, Pamela/0000-0003-4870-5715	U.S. National Institutes of Health (NIH) [NS063963]; BioMEMS Resource Center [P41 EB002503]; Massachusetts General Hospital-Massachusetts Institute of Technology Udall Center for Excellence in Parkinson Disease Research [NIH NS038372]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372, R01NS063963] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMEMS Resource Center; Massachusetts General Hospital-Massachusetts Institute of Technology Udall Center for Excellence in Parkinson Disease Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Jon Edd and Daniel Irima for help and advice on the microfluid chamber production. This work was supported by the U.S. National Institutes of Health (NIH; NS063963 to P.J.M.), the BioMEMS Resource Center (P41 EB002503 to J.E. and D.I.), and the Massachusetts General Hospital-Massachusetts Institute of Technology Udall Center for Excellence in Parkinson Disease Research (NIH NS038372).	Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Febbraio MA, 2002, J PHYSIOL-LONDON, V544, P957, DOI 10.1113/jphysiol.2002.025148; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Putcha P., 2009, J PHARMACOL EXP THER, V332, P847; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; TYTELL M, 1986, BRAIN RES, V363, P161, DOI 10.1016/0006-8993(86)90671-2; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398	56	231	235	2	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					326	336		10.1096/fj.10-164624	http://dx.doi.org/10.1096/fj.10-164624			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876215	Green Published			2022-12-25	WOS:000285869500029
J	Ding, B; Gibbs, PEM; Brookes, PS; Maines, MD				Ding, Bo; Gibbs, Peter E. M.; Brookes, Paul S.; Maines, Mahin D.			The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters beta-adrenergic receptor ligand-mediated cardiac dysfunction	FASEB JOURNAL			English	Article						apoptosis; antioxidants; heart failure	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; EARLY REPRESSOR ICER; CARBON-MONOXIDE; HEART-FAILURE; RAT-BRAIN; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-DISEASE; REGULATORY MOTIFS; MESSENGER-RNA	HO-2 oxidizes heme to CO and biliverdin; the latter is reduced to bilirubin by biliverdin reductase (BVR). In addition, HO-2 is a redox-sensitive K/Ca-2-associated protein, and BVR is an S/T/Y kinase. The two enzymes are components of cellular defense mechanisms. This is the first reporting of regulation of HO-2 by BVR and that their coordinated increase in isolated myocytes and intact heart protects against cardiotoxicity of beta-adrenergic receptor activation by isoproterenol (ISO). The induction of BVR mRNA, protein, and activity and HO-2 protein was maintained for >= 96 h; increase in HO-1 was modest and transient. In isolated cardiomyocytes, experiments with cycloheximide, proteasome inhibitor MG-132, and siBVR suggested BVR-mediated stabilization of HO-2. In both models, activation of BVR offered protection against the ligand's stimulation of apoptosis. Two human BVR-based peptides known to inhibit and activate the reductase, KKRILHC281 and KYCCSRK296, respectively, were tested in the intact heart. Perfusion of the heart with the inhibitory peptide blocked ISO-mediated BVR activation and augmented apoptosis; conversely, perfusion with the activating peptide inhibited apoptosis. At the functional level, peptide-mediated inhibition of BVR was accompanied by dysfunction of the left ventricle and decrease in HO-2 protein levels. Perfusion of the organ with the activating peptide preserved the left ventricular contractile function and was accompanied by increased levels of HO-2 protein. Finding that BVR and HO-2 levels, myocyte apoptosis, and contractile function of the heart can be modulated by small human BVR-based peptides offers a promising therapeutic approach for treatment of cardiac dysfunctions.-Ding, B., Gibbs, P. E. M., Brookes, P. S., Maines, M. D. The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival; a reductase-based peptide counters beta-adrenergic receptor ligand-mediated cardiac dysfunction. FASEB J. 25, 301-313 (2011). www.fasebj.org	[Ding, Bo; Gibbs, Peter E. M.; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Brookes, Paul S.] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu		Brookes, Paul/0000-0002-8639-8413	National Institute of Environmental Health Sciences [ES04066, ES012187]; American Heart Association [AHA0635312N]; National Institutes of Health [RO1-HL071158]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066, R01ES012187] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences grants ES04066 and ES012187 and American Heart Association grant AHA0635312N. Work in the laboratory of P.S.B. is supported by National Institutes of Health grant RO1-HL071158. The assistance and advice of Dr. Sergiy Nadtochiy in setting up the heart perfusion experiments are gratefully acknowledged.	Abuarqoub H, 2007, EXP MOL MED, V39, P139, DOI 10.1038/emm.2007.16; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bolognesi M, 2007, J PHARMACOL EXP THER, V321, P187, DOI 10.1124/jpet.106.116665; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Brunt KR, 2009, EXP BIOL MED, V234, P582, DOI 10.3181/0810-RM-312; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Choi AMK, 2001, CIRC RES, V89, P105, DOI 10.1161/res.89.2.105; Chung HT, 2008, METHOD ENZYMOL, V441, P329, DOI 10.1016/S0076-6879(08)01218-4; Das DK, 2006, CARDIOVASC RES, V70, P254, DOI 10.1016/j.cardiores.2006.02.023; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; Ding B, 2005, P NATL ACAD SCI USA, V102, P14771, DOI 10.1073/pnas.0506489102; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Ding Y, 1999, EUR J BIOCHEM, V264, P854, DOI 10.1046/j.1432-1327.1999.00677.x; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; EWING JF, 1994, J PHARMACOL EXP THER, V271, P408; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; Ferreira AJ, 2007, LIFE SCI, V81, P916, DOI 10.1016/j.lfs.2007.07.022; Florczyk UM, 2008, PHARMACOL REP, V60, P38; Giannini L, 2005, CELL MOL BIOL, V51, P393, DOI 10.1170/T643; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grimm D, 1998, CARDIOVASC RES, V37, P91, DOI 10.1016/S0008-6363(97)00212-5; HAYES JS, 1986, J PHARMACOL EXP THER, V237, P757; Hu AH, 2006, J PHARMACOL EXP THER, V318, P469, DOI 10.1124/jpet.106.102160; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; HUANG TJ, 1989, J BIOL CHEM, V264, P7844; Immenschuh S, 2006, HISTOL HISTOPATHOL, V21, P679, DOI 10.14670/HH-21.679; Jadhav A, 2008, HYPERTENSION, V52, P910, DOI 10.1161/HYPERTENSIONAHA.108.114801; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kemp PJ, 2005, BIOCHEM BIOPH RES CO, V338, P648, DOI 10.1016/j.bbrc.2005.08.110; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kinobe RT, 2008, CAN J PHYSIOL PHARM, V86, P577, DOI 10.1139/y08-066; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Li Volti G, 2006, NEPHRON EXP NEPHROL, V104, pE135, DOI 10.1159/000094964; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marshall D, 2000, HEART, V84, P355, DOI 10.1136/heart.84.4.355; Masini E, 2003, EXP BIOL MED, V228, P546, DOI 10.1177/15353702-0322805-25; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Miller SM, 1998, GASTROENTEROLOGY, V114, P239, DOI 10.1016/S0016-5085(98)70473-1; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Pachori AS, 2004, P NATL ACAD SCI USA, V101, P12282, DOI 10.1073/pnas.0404616101; Panahian N, 2001, J NEUROCHEM, V76, P539, DOI 10.1046/j.1471-4159.2001.00023.x; PRABHAKAR NR, 1995, P NATL ACAD SCI USA, V92, P1994, DOI 10.1073/pnas.92.6.1994; Prabhakar NR, 1999, RESP PHYSIOL, V115, P161, DOI 10.1016/S0034-5687(99)00019-5; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; RUBLEVSKAYA I, 1994, J BIOL CHEM, V269, P26390; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Sethi R, 1995, J Card Fail, V1, P391, DOI 10.1016/S1071-9164(05)80008-9; Slebos DJ, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-7; Steinberg SF, 1999, CIRC RES, V85, P1101; Tomita H, 2003, CIRC RES, V93, P12, DOI 10.1161/01.RES.0000079794.57578.F1; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; van Empel VPM, 2004, CARDIOVASC RES, V63, P487, DOI 10.1016/j.cardiores.2004.02.013; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Volti GL, 2007, TRANSPL P, V39, P2986, DOI 10.1016/j.transproceed.2007.09.047; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Yamashita K, 2006, FASEB J, V20, P776, DOI 10.1096/fj.05-4791fje; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Yeh CH, 2009, J SURG RES, V155, P147, DOI 10.1016/j.jss.2008.07.044; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Zaugg M, 2000, CIRCULATION, V102, P344	81	25	26	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					301	313		10.1096/fj.10-166454	http://dx.doi.org/10.1096/fj.10-166454			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20876213	Green Published			2022-12-25	WOS:000285869500027
J	Gaiser, AM; Kretzschmar, A; Richter, K				Gaiser, Andreas M.; Kretzschmar, Anja; Richter, Klaus			Cdc37-Hsp90 Complexes Are Responsive to Nucleotide-induced Conformational Changes and Binding of Further Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; HEAT-SHOCK PROTEINS; ATPASE ACTIVITY; PROGESTERONE-RECEPTOR; CRYSTAL-STRUCTURE; COCHAPERONE AHA1; TERMINAL DOMAIN; CLIENT PROTEIN; CO-CHAPERONES; IN-VIVO	Hsp90 is an ATP-dependent molecular chaperone, which facilitates the activation and stabilization of hundreds of client proteins in cooperation with a defined set of cofactors. Many client proteins are protein kinases, which are activated and stabilized by Hsp90 in cooperation with the kinase-specific co-chaperone Cdc37. Other Hsp90 co-chaperones, like the ATPase activator Aha1, also are implicated in kinase activation, and it is not yet clear how Cdc37 is integrated into Hsp90 co-chaperone complexes. Here, we studied the interaction between Cdc37, Hsp90, and other Hsp90 co-chaperones from the nematode Caenorhabditis elegans. Nematode Cdc37 binds with high affinity to Hsp90 and strongly inhibits the ATPase activity. In contrast to the human Hsp90 system, we observed binding of Cdc37 to open and closed Hsp90 conformations, potentially reflecting two different binding modes. Using a novel ultracentrifugation setup, which allows accurate analysis of multifactorial protein complexes, we show that cooperative and competitive interactions exist between other co-chaperones and Cdc37-Hsp90 complexes in the C. elegans system. We observed strong competitive interactions between Cdc37 and the co-chaperones p23 and Sti1, whereas the binding of the phosphatase Pph5 and the ATPase activator Aha1 to Cdc37-Hsp90 complexes is possible. The ternary Aha1-Cdc37Hsp90 complex is disrupted by the nucleotide-induced closing reaction at the N terminus of Hsp90. This implies a carefully regulated exchange process of cofactors during the chaperoning of kinase clients by Hsp90.	Ctr Integrated Prot Sci Munchen, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich	Richter, K (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	klaus.richter@ch.tum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642	Deutsche Forschungsgemeinschaft [RI1873/1-1]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant RI1873/1-1 (to K. R.) and a grant from the Fonds der Chemischen Industrie (to K. R.).	Abbas-Terki T, 2002, BIOL CHEM, V383, P1335, DOI 10.1515/BC.2002.152; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; HARTSON SD, 1994, BIOCHEMISTRY-US, V33, P8912, DOI 10.1021/bi00196a008; Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pashtan I, 2008, CELL CYCLE, V7, P2936, DOI 10.4161/cc.7.18.6701; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SMITH DF, 1992, J STEROID BIOCHEM, V41, P201, DOI 10.1016/0960-0760(92)90345-J; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	63	31	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40921	40932		10.1074/jbc.M110.131086	http://dx.doi.org/10.1074/jbc.M110.131086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20880838	Green Published, hybrid			2022-12-25	WOS:000285414400056
J	Tran, K; Gralla, JD				Tran, Khiem; Gralla, Jay D.			The TFIIB Tip Domain Couples Transcription Initiation to Events Involved in RNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE SELECTION; CARBOXYL-TERMINAL DOMAIN; POLYMERASE-II; PROMOTER ESCAPE; HYDROGEN-PEROXIDE; STRUCTURAL BASIS; GENE-EXPRESSION; CAPPING ENZYME; ACTIVE-CENTER; IN-VITRO	TFIIB is the only factor within the multimegadalton transcription complex that is obligatorily required to undergo dissociation and re-association with each round of mRNA transcription. Here we show that a six-amino acid human TFIIB tip region is needed for appropriate levels of serine 5 C-terminal domain phosphorylation and mRNA capping and for retention of the required elongation factor TFIIF. We suggest that the broad functions of this tiny region are used to suppress transcription noise by restricting functional RNA synthesis from non-promoter sites on the genome, which will not contain TFIIB.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gralla, JD (corresponding author), 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	gralla@chem.ucla.edu			National Institutes of Health [GM49048]; UCLA Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49048. This work was also supported by a grant from the UCLA Academic Senate.	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CHAFIN DR, 1991, J BIOL CHEM, V266, P9256; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; CHANDLER DW, 1981, NUCLEIC ACIDS RES, V9, P6031, DOI 10.1093/nar/9.22.6031; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Choi WS, 2004, J MOL BIOL, V340, P981, DOI 10.1016/j.jmb.2004.04.075; Choi WS, 2002, J MOL BIOL, V319, P1005, DOI 10.1016/S0022-2836(02)00329-7; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Mutoh N, 2005, J BIOCHEM, V138, P797, DOI 10.1093/jb/mvi179; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Szekvolgyi L, 2007, P NATL ACAD SCI USA, V104, P14964, DOI 10.1073/pnas.0702269104; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100	55	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39580	39587		10.1074/jbc.M110.171850	http://dx.doi.org/10.1074/jbc.M110.171850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20880846	Green Published, hybrid			2022-12-25	WOS:000285185500002
J	Wang, HC; Robinson, H; Ke, HM				Wang, Huanchen; Robinson, Howard; Ke, Hengming			Conformation Changes, N-terminal Involvement, and cGMP Signal Relay in the Phosphodiesterase-5 GAF Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; REGULATORY DOMAIN; CRYSTAL-STRUCTURE; A DOMAIN; BINDING; DIMERIZATION; LIGAND; 2A; PHOSPHORYLATION; DETERMINANTS	The activity of phosphodiesterase-5 (PDE5) is specific for cGMP and is regulated by cGMP binding to GAF-A in its regulatory domain. To better understand the regulatory mechanism, x-ray crystallographic and biochemical studies were performed on constructs of human PDE5A1 containing the N-terminal phosphorylation segment, GAF-A, and GAF-B. Superposition of this unliganded GAF-A with the previously reported NMR structure of cGMP-bound PDE5 revealed dramatic conformational differences and suggested that helix H4 and strand B3 probably serve as two lids to gate the cGMP-binding pocket in GAF-A. The structure also identified an interfacial region among GAF-A, GAF-B, and the N-terminal loop, which may serve as a relay of the cGMP signal from GAF-A to GAF-B. N-terminal loop 98-147 was physically associated with GAF-B domains of the dimer. Biochemical analyses showed an inhibitory effect of this loop on cGMP binding and its involvement in the cGMP-induced conformation changes.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Brookhaven National Laboratory		hke@med.unc.edu	, PEP-MX Core/AGV-4051-2022	Wang, Huanchen/0000-0003-2701-7155	National Institutes of Health [GM59791]; Office of Biological and Environmental Research; Office of Basic Energy Sciences, United States Department of Energy; National Center for Research Resources, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59791 (to H.K.). This work was also supported by the Office of Biological and Environmental Research and the Office of Basic Energy Sciences, United States Department of Energy, and by the National Center for Research Resources, National Institutes of Health (to H.R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Hofbauer K, 2008, J BIOL CHEM, V283, P25164, DOI 10.1074/jbc.M800230200; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu L, 2002, CELL SIGNAL, V14, P45, DOI 10.1016/S0898-6568(01)00216-9; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Turko IV, 1998, BIOCHEM J, V329, P505; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	35	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38149	38156		10.1074/jbc.M110.141614	http://dx.doi.org/10.1074/jbc.M110.141614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861010	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000284625600022
J	Diani-Moore, S; Ram, P; Li, XT; Mondal, P; Youn, DY; Sauve, AA; Rifkind, AB				Diani-Moore, Silvia; Ram, Payal; Li, Xintian; Mondal, Prosenjit; Youn, Dou Yeon; Sauve, Anthony A.; Rifkind, Arleen B.			Identification of the Aryl Hydrocarbon Receptor Target Gene TiPARP as a Mediator of Suppression of Hepatic Gluconeogenesis by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and of Nicotinamide as a Corrective Agent for This Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; MAMMALIAN-CELLS; ACUTE TOXICITY; TCDD; METABOLISM; ACTIVATION; EXPRESSION; ENZYMES; ALPHA; PGC-1	The environmental toxin TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, dioxin) produces diverse toxic effects including a lethal wasting syndrome whose hallmark is suppressed hepatic gluconeogenesis. All TCDD toxicities require activation of the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor. Whereas the mechanism for AHR induction of target genes is well understood, it is not known how AHR activation produces any TCDD toxicity. This report identifies for the first time an AHR target gene, TiPARP (TCDD-inducible poly(ADPribose) polymerase, PARP7) that can mediate a TCDD toxicity, i.e. suppression of hepatic gluconeogenesis. TCDD suppressed hepatic glucose production, expression of key gluconeogenic genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase), and NAD(+) levels, and increased PARP activity and TiPARP expression. TCDD also increased acetylation and ubiquitin-dependent proteosomal degradation of the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1 alpha), a coactivator of PEPCK and G6Pase transcription. TiPARP overexpression reproduced TCDD effects on glucose output and NAD(+) levels whereas TiPARP silencing diminished them. TiPARP overexpression also increased PGC1 alpha acetylation and decreased PGC1 alpha levels. In contrast, silencing of cytochromes P450 (CYP) 1A, main AHR-induced genes, did not alter TCDD suppression of gluconeogenesis. The vitamin B3 constituent, nicotinamide (NAM), prevented TCDD suppression of glucose output, NAD(+), and gluconeogenic genes and stabilized PGC1 alpha. The corrective effects of NAM could be attributed to increased NAD(+) levels and suppression of AHR target gene induction. The results reveal that TiPARP can mediate a TCDD effect, that the AHR is linked to PGC1 alpha function and stability and that NAM has novel AHR antagonist activity.	[Diani-Moore, Silvia; Ram, Payal; Li, Xintian; Mondal, Prosenjit; Youn, Dou Yeon; Sauve, Anthony A.; Rifkind, Arleen B.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Rifkind, AB (corresponding author), 1300 York Ave, New York, NY 10065 USA.	arifkind@med.cornell.edu	Li, Xintian/HGA-0346-2022	MONDAL, PROSENJIT/0000-0001-8566-249X	National Institutes of Health [R01-ES03606, T32-CA062948, R01-DK73466]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01-ES03606 (to A.B.R.), T32-CA062948 (to S.D.-M.), R01-DK73466 (to A.A.S.), a gift from the Winston Foundation (to A.B.R.), and a New Scholar in Aging Award from the Ellison Medical Foundation (to A.A.S.).	Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; CANGA L, 1993, MOL PHARMACOL, V44, P1142; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Dolle C, 2009, ANAL BIOCHEM, V385, P377, DOI 10.1016/j.ab.2008.10.033; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; FAN F, 1994, ARCH TOXICOL, V69, P73, DOI 10.1007/s002040050140; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; HSIA MTS, 1985, TOXICOL LETT, V25, P247, DOI 10.1016/0378-4274(85)90204-8; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kitamura N, 2006, J BIOCHEM MOL TOXIC, V20, P151, DOI 10.1002/jbt.20131; Lee JS, 2009, TOXICOL APPL PHARM, V234, P1, DOI 10.1016/j.taap.2008.09.007; LENTNEK M, 1991, BIOCHEM BIOPH RES CO, V174, P1267, DOI 10.1016/0006-291X(91)91558-T; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin PH, 2007, TOXICOL LETT, V172, P146, DOI 10.1016/j.toxlet.2007.06.003; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2002, ARCH BIOCHEM BIOPHYS, V404, P309, DOI 10.1016/S0003-9861(02)00339-9; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Stahl B U, 1992, Arch Toxicol Suppl, V15, P151; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	83	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38801	38810		10.1074/jbc.M110.131573	http://dx.doi.org/10.1074/jbc.M110.131573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876576	Green Published, hybrid			2022-12-25	WOS:000284941300009
J	Borst, JP; Taatgen, NA; Stocco, A; van Rijn, H				Borst, Jelmer P.; Taatgen, Niels A.; Stocco, Andrea; van Rijn, Hedderik			The Neural Correlates of Problem States: Testing fMRI Predictions of a Computational Model of Multitasking	PLOS ONE			English	Article							INFORMATION-PROCESSING MODEL; 3 CORTICAL REGIONS; WORKING-MEMORY; SENTENCE COMPREHENSION; SYMBOL MANIPULATION; INTEGRATED THEORY; BRAIN ACTIVATION; FRONTAL-CORTEX; FUNCTIONAL MRI; BOLD RESPONSE	Background: It has been shown that people can only maintain one problem state, or intermediate mental representation, at a time. When more than one problem state is required, for example in multitasking, performance decreases considerably. This effect has been explained in terms of a problem state bottleneck. Methodology: In the current study we use the complimentary methodologies of computational cognitive modeling and neuroimaging to investigate the neural correlates of this problem state bottleneck. In particular, an existing computational cognitive model was used to generate a priori fMRI predictions for a multitasking experiment in which the problem state bottleneck plays a major role. Hemodynamic responses were predicted for five brain regions, corresponding to five cognitive resources in the model. Most importantly, we predicted the intraparietal sulcus to show a strong effect of the problem state manipulations. Conclusions: Some of the predictions were confirmed by a subsequent fMRI experiment, while others were not matched by the data. The experiment supported the hypothesis that the problem state bottleneck is a plausible cause of the interference in the experiment and that it could be located in the intraparietal sulcus.	[Borst, Jelmer P.; Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Stocco, Andrea] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Washington; University of Washington Seattle; University of Groningen	Borst, JP (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	jpborst@ai.rug.nl	Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014; Stocco, Andrea/A-2159-2013; Borst, Jelmer/C-4666-2008	van Rijn, Hedderik/0000-0002-0461-9850; Stocco, Andrea/0000-0001-8919-3934; Borst, Jelmer/0000-0002-4493-8223; Taatgen, Niels/0000-0001-7286-3460	Office of Naval Research [N00014-08-10541]	Office of Naval Research(Office of Naval Research)	This study was supported by the Office of Naval Research (http://www.onr.navy.mil/) grant N00014-08-10541 awarded to Niels A. Taatgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Anderson J.R., 1998, ATOMIC COMPONENTS TH; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Anderson JR, 2007, COGNITIVE PSYCHOL, V54, P185, DOI 10.1016/j.cogpsych.2006.06.003; Anderson JR, 2005, J COGNITIVE NEUROSCI, V17, P1261, DOI 10.1162/0898929055002427; Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2004, J COGNITIVE NEUROSCI, V16, P637, DOI 10.1162/089892904323057353; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Bandettini PA, 2001, NAT NEUROSCI, V4, P864, DOI 10.1038/nn0901-864; Borst J., 2007, P 8 INT C COGNITIVE, P133; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Brett M, 2002, NEUROIMAGE, V16; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Byrne MD, 2001, PSYCHOL REV, V108, P847, DOI 10.1037/0033-295X.108.4.847; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friston K. J., 2003, HUMAN BRAIN FUNCTION, P599; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hendriks P, 2007, LINGUA, V117, P1879, DOI 10.1016/j.lingua.2006.11.008; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lewis RL, 2006, TRENDS COGN SCI, V10, P447, DOI 10.1016/j.tics.2006.08.007; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Myung IJ, 2000, J MATH PSYCHOL, V44, P190, DOI 10.1006/jmps.1999.1283; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Salvucci D.D., 2002, COGN SYST RES, V3, P95, DOI [10.1016/S1389-0417(01)00048-1, DOI 10.1016/S1389-0417(01)00048-1, DOI 10.1016/]; Salvucci D. D, 2010, MULTITASKING MIND; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; SALVUCCI DD, 2009, HUM FACT COMP SYST C, P1819; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Sohn MH, 2005, NEUROIMAGE, V25, P21, DOI 10.1016/j.neuroimage.2004.11.001; SPELKE E, 1976, COGNITION, V4, P215, DOI 10.1016/0010-0277(76)90018-4; Stocco A, 2008, J COGNITIVE NEUROSCI, V20, P1300, DOI 10.1162/jocn.2008.20089; TAATGEN NA, 2008, HDB COGNITIVE MODELI, P170; TAATGEN NA, 2009, COGNITIVE PSYCHOL; Taatgen NA, 2007, PSYCHOL REV, V114, P577, DOI 10.1037/0033-295X.114.3.577; van Rij J, 2010, J CHILD LANG, V37, P731, DOI 10.1017/S0305000909990560; Vazquez AL, 1998, NEUROIMAGE, V7, P108, DOI 10.1006/nimg.1997.0316; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]	51	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12966	10.1371/journal.pone.0012966	http://dx.doi.org/10.1371/journal.pone.0012966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886034	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100056
J	Rando, JC; Alcover, JA; Illera, JC				Carlos Rando, Juan; Antoni Alcover, Josep; Carlos Illera, Juan			Disentangling Ancient Interactions: A New Extinct Passerine Provides Insights on Character Displacement among Extinct and Extant Island Finches	PLOS ONE			English	Article							FRINGILLA-COELEBS; K-AR; CHAFFINCHES; EVOLUTION; COLONIZATION; VARIABILITY; POPULATIONS; INFERENCE; AVIFAUNA; MRBAYES	Background: Evolutionary studies of insular biotas are based mainly on extant taxa, although such biotas represent artificial subsets of original faunas because of human-caused extinctions of indigenous species augmented by introduced exotic taxa. This makes it difficult to obtain a full understanding of the history of ecological interactions between extant sympatric species. Morphological bill variation of Fringilla coelebs and F. teydea (common and blue chaffinches) has been previously studied in the North Atlantic Macaronesian archipelagos. Character displacement between both species has been argued to explain bill sizes in sympatry. However, this explanation is incomplete, as similar patterns of bill size have been recorded in F. coelebs populations from islands with and without F. teydea. Methodology/Principal Findings: The discovery of a new extinct species in Tenerife (Canary Islands), here named Carduelis aurelioi n. sp. (slender-billed greenfinch), provides the opportunity to study ancient ecological interactions among Macaronesian finches. To help understand the evolutionary histories of forest granivores in space and time, we have performed a multidisciplinary study combining: (1) morphological analyses and radiocarbon dating (11,460 +/- 60 yr BP) of the new taxon and, (2) molecular divergence among the extant finch species and populations in order to infer colonization times (1.99 and 1.09 My for F. teydea and F. coelebs respectively). Conclusion/Significance: C. aurelioi, F. coelebs and F. teydea co-habited in Tenerife for at least one million years. The unique anatomical trends of the new species, namely chaffinch-like beak and modified hind and forelimbs, reveal that there was a process of divergence of resource competition traits among the three sympatric finches. The results of our study, combined with the presence of more extinct greenfinches in other Macaronesian islands with significant variation in their beak sizes, suggests that the character displacement has influenced patterns of divergence in bill size and shape on other Macaronesian islands as well.	[Carlos Rando, Juan] Univ La Laguna, Dept Biol Anim, Tenerife, Spain; [Antoni Alcover, Josep] CSIC UIB, Inst Mediterrani Estudis Avancats, Esporles, Mallorca, Spain; [Carlos Illera, Juan] IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Spain; [Carlos Illera, Juan] CSIC UO PA, Inst Cantabr Biodiversidad, Oviedo, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Consejo Superior de Investigaciones Cientificas (CSIC)	Rando, JC (corresponding author), Univ La Laguna, Dept Biol Anim, Tenerife, Spain.	canariomys@yahoo.es	Illera, Juan Carlos/C-6583-2014; Alcover, Josep Antoni/Y-3796-2018	Illera, Juan Carlos/0000-0002-4389-0264; Rando, Juan Carlos/0000-0001-7397-869X; Alcover, Josep Antoni/0000-0001-9905-2588	Spanish Direccion General de Investigacion Cientifica y Tecnica Research [CGL2007-62047/BTE]; Spanish Ministry of Education	Spanish Direccion General de Investigacion Cientifica y Tecnica Research; Spanish Ministry of Education(Spanish Government)	JAA and JCR were partially supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Research Project CGL2007-62047/BTE. JCI was supported by a postdoctoral contract (Juan de La Cierva) from the Spanish Ministry of Education. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcover J.A., 1987, Vieraea, V17, P75; Alcover JA, 2001, ENDINS, V24, P5; Alonso MR, 2006, J CONCHOL, V39, P41; ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; BAKER AJ, 1990, EVOLUTION, V44, P981, DOI 10.1111/j.1558-5646.1990.tb03819.x; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Bover P, 2003, J BIOGEOGR, V30, P771, DOI 10.1046/j.1365-2699.2003.00872.x; Boyer AG, 2008, DIVERS DISTRIB, V14, P509, DOI 10.1111/j.1472-4642.2007.00459.x; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Illera JC, 2008, MOL PHYLOGENET EVOL, V48, P1145, DOI 10.1016/j.ympev.2008.05.016; Cramp S.E., 1994, HDB BIRDS EUROPE MID; DENNISON MD, 1991, EVOLUTION, V45, P29, DOI 10.1111/j.1558-5646.1991.tb05263.x; DIAZ M, 1994, OECOLOGIA, V99, P1, DOI 10.1007/BF00317076; Diaz M, 1996, COMP BIOCHEM PHYS A, V113, P239, DOI 10.1016/0300-9629(95)02093-4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Garcia-Alonso MD, 2005, SCOT J POLIT ECON, V52, P305; GRANT P R, 1980, Bonner Zoologische Beitraege, V31, P311; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1979, BIOL J LINN SOC, V11, P301, DOI 10.1111/j.1095-8312.1979.tb00042.x; Guillou H, 2001, J VOLCANOL GEOTH RES, V106, P175, DOI 10.1016/S0377-0273(00)00294-8; Guillou H, 1996, J VOLCANOL GEOTH RES, V73, P141, DOI 10.1016/0377-0273(96)00021-2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HERNANDEZ JJ, 1995, CATALOGO ESPELEOLOGI; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James HF, 2004, ZOOL J LINN SOC-LOND, V141, P207, DOI 10.1111/j.1096-3642.2004.00117.x; JauMe d., 1993, BOL MUS MUNIC FUNCHA, P147; Marshall HD, 1999, MOL PHYLOGENET EVOL, V11, P201, DOI 10.1006/mpev.1998.0552; Martin A., 2001, AVES ARCHIPIELAGO CA; Martuin A., 2000, PALOMAS ENDEMICAS CA; MILLENER P R, 1989, Notornis, V36, P280; MILLENER PR, 1991, J ROY SOC NEW ZEAL, V21, P179; Moreno E., 1985, Ardeola, V32, P295; Olmos M, 1996, ANN SCI NAT ZOOL, V17, P39; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; PENNYCUICK DJ, 1972, STUDIES BIOL, V33; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; PIEPER H, 1985, BOCAGIANA, V88, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinn GP, 2002, EXPT DESIGN DATA ANA, DOI DOI 10.1017/CBO9780511806384; Ramis D., 2002, J MEDITERR ARCHAEOL, V15, DOI [DOI 10.1558/jmea.v15i1.3, 10.1558/jmea.v15i1.3, DOI 10.1558/JMEA.V15I1.3]; RAMOS JA, 1995, BIOL CONSERV, V71, P237, DOI 10.1016/0006-3207(94)00033-M; RAMOS JA, 2008, EQUIPAATLAS, P492; Rando JC, 1999, CONDOR, V101, P1, DOI 10.2307/1370440; RANDO JC, 1996, 7 INT S VULC, V1, P171; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Scheiner Samuel M., 1993, P94; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SNOW DW, 1998, BIRDS W PALEARCTIC C, V2; Steadman David W., 2006, P1; Suarez NM, 2009, MOL PHYLOGENET EVOL, V53, P556, DOI 10.1016/j.ympev.2009.07.018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUGGLE HD, 2000, ASIAN PERSPECT, V39, P165; Valido Alfredo, 1994, Ardeola, V41, P29; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; Vanhooydonck B, 2009, BIOL J LINN SOC, V98, P129, DOI 10.1111/j.1095-8312.2009.01269.x; Worthy TH, 2002, PREHISTORIC LIFE NZ; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898	60	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12956	10.1371/journal.pone.0012956	http://dx.doi.org/10.1371/journal.pone.0012956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886036	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100051
J	O'Rourke, CT; Pitlik, T; Hoover, M; Fernandez-Juricic, E				O'Rourke, Colleen T.; Pitlik, Todd; Hoover, Melissa; Fernandez-Juricic, Esteban			Hawk Eyes II: Diurnal Raptors Differ in Head Movement Strategies When Scanning from Perches	PLOS ONE			English	Article							SPATIAL VISUAL-ACUITY; MOTION PARALLAX; GAZE DIRECTION; DEEP FOVEA; DEPTH; VISION; PREDATOR; SEARCH; PERCEPTION; VIGILANCE	Background: Relatively little is known about the degree of inter-specific variability in visual scanning strategies in species with laterally placed eyes (e. g., birds). This is relevant because many species detect prey while perching; therefore, head movement behavior may be an indicator of prey detection rate, a central parameter in foraging models. We studied head movement strategies in three diurnal raptors belonging to the Accipitridae and Falconidae families. Methodology/Principal Findings: We used behavioral recording of individuals under field and captive conditions to calculate the rate of two types of head movements and the interval between consecutive head movements. Cooper's Hawks had the highest rate of regular head movements, which can facilitate tracking prey items in the visually cluttered environment they inhabit (e. g., forested habitats). On the other hand, Red-tailed Hawks showed long intervals between consecutive head movements, which is consistent with prey searching in less visually obstructed environments (e. g., open habitats) and with detecting prey movement from a distance with their central foveae. Finally, American Kestrels have the highest rates of translational head movements (vertical or frontal displacements of the head keeping the bill in the same direction), which have been associated with depth perception through motion parallax. Higher translational head movement rates may be a strategy to compensate for the reduced degree of eye movement of this species. Conclusions: Cooper's Hawks, Red-tailed Hawks, and American Kestrels use both regular and translational head movements, but to different extents. We conclude that these diurnal raptors have species-specific strategies to gather visual information while perching. These strategies may optimize prey search and detection with different visual systems in habitat types with different degrees of visual obstruction.	[O'Rourke, Colleen T.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Pitlik, Todd] Wildlife Serv, Dept Agr, Anim & Plant Hlth Inspect Serv, Los Angeles, CA USA; [Hoover, Melissa; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	California State University System; California State University Long Beach; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Rourke, CT (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	efernan@purdue.edu			National Science Foundation [DBI-0641550]; California State University, Long Beach	National Science Foundation(National Science Foundation (NSF)); California State University, Long Beach	This study was funded by National Science Foundation DBI-0641550. CTO received funding from the 2008 California State University, Long Beach, Provost's Graduate Student Summer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1981, THEOR POPUL BIOL, V19, P58, DOI 10.1016/0040-5809(81)90035-6; Andersson M, 2009, FUNCT ECOL, V23, P373, DOI 10.1111/j.1365-2435.2008.01512.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bradbury Jack W., 1998, pi; Casperson Lee W., 1999, Bird Behavior, V13, P31; Curtis O. E., 2006, BIRDS N AM ONLINE; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; FITE KV, 1975, BRAIN BEHAV EVOLUT, V12, P97, DOI 10.1159/000124142; FOX R, 1977, SCIENCE, V197, P79, DOI 10.1126/science.867054; FROST BJ, 1990, VISUAL NEUROSCI, V5, P231, DOI 10.1017/S0952523800000304; Fujita M, 2004, COMP BIOCHEM PHYS A, V139, P117, DOI 10.1016/j.cbpb.2004.07.005; Fux M, 2009, PHYSIOL BEHAV, V98, P359, DOI 10.1016/j.physbeh.2009.06.016; Gall MD, 2010, J COMP PHYSIOL A, V196, P15, DOI 10.1007/s00359-009-0488-6; Gall MD, 2009, CONDOR, V111, P150, DOI 10.1525/cond.2009.080016; Gibson JJ, 1950, PERCEPTION VISUAL WO; Griesser M, 2003, BEHAV ECOL, V14, P246, DOI 10.1093/beheco/14.2.246; HARKNESS L, 1978, NATURE, V272, P814, DOI 10.1038/272814a0; Ilany A, 2008, BEHAV ECOL SOCIOBIOL, V62, P923, DOI 10.1007/s00265-007-0516-x; Jones KA, 2007, ANIM BEHAV, V74, P1181, DOI 10.1016/j.anbehav.2006.09.029; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; Kjaersgaard A, 2008, J AVIAN BIOL, V39, P466, DOI 10.1111/j.2008.0908-8857.04288.x; Kral K, 2003, BEHAV PROCESS, V64, P21, DOI 10.1016/S0376-6357(03)00057-3; Kral K, 1998, BEHAV PROCESS, V43, P71, DOI 10.1016/S0376-6357(98)00007-2; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Land MF, 1999, J COMP PHYSIOL A, V184, P265, DOI 10.1007/s003590050324; Leyhe JE, 2004, J RAPTOR RES, V38, P19; MARTIN GR, 1986, NATURE, V319, P357, DOI 10.1038/319357a0; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Meyer D.B., 1977, HDB SENSORY PHYSL, V7/5, P549; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Nadler JW, 2008, NATURE, V452, P642, DOI 10.1038/nature06814; Nadler JW, 2009, NEURON, V63, P523, DOI 10.1016/j.neuron.2009.07.029; Nawrot M, 2003, J VISION, V3, P841, DOI 10.1167/3.11.17; Nawrot M, 2003, VISION RES, V43, P1553, DOI 10.1016/S0042-6989(03)00144-5; O'Rourke CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012802; Ohayon S, 2008, BIOL CYBERN, V98, P115, DOI 10.1007/s00422-007-0199-4; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; Preston C. R., 2009, BIRDS N AM; PUMPHREY RJ, 1948, J EXP BIOL, V25, P299; REYMOND L, 1987, VISION RES, V27, P1859, DOI 10.1016/0042-6989(87)90114-3; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Smallwood JA, 2002, BIRDS N AM ONLINE; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Stevens D., 1986, FORAGING THEORY; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Tucker VA, 2000, J EXP BIOL, V203, P3745; Tucker VA, 2000, J EXP BIOL, V203, P3733; van der Willigen RF, 2002, J COMP PHYSIOL A, V187, P997, DOI 10.1007/s00359-001-0271-9; van der Willigen RF, 1998, NEUROREPORT, V9, P1233, DOI 10.1097/00001756-199804200-00050; Wallman Josh, 1993, P245; Walls G. L., 1942, B CRANBROOK I SCI, V19; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936; Wolfe JM, 2000, SEEING, P335, DOI DOI 10.1016/B978-012443760-9/50010-6	61	20	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12169	10.1371/journal.pone.0012169	http://dx.doi.org/10.1371/journal.pone.0012169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877650	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100001
J	Prieto-Godino, LL; de Polavieja, GG				Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.			Brain Activity at 70-80 Hz Changes during Olfactory Stimulation Protocols in Drosophila	PLOS ONE			English	Article							ODOR REPRESENTATIONS; OSCILLATIONS; SYNCHRONIZATION; MEMORY; DISCRIMINATION; DISHABITUATION; SENSITIZATION; LOCALIZATION	Oscillatory and synchronized activities in the mammalian brain have been correlated with the execution of complex cognitive tasks. Similar oscillations have been observed in local field potentials (LFPs) in flies, in this case correlated with different attentional states. To further test the significance of these oscillations we recorded LFPs from the brain of Drosophila melanogaster as it responded to the presentation of olfactory stimuli. We find that responses in the 70-80 Hz range increase during olfactory stimulation. Recurrent stimulation specifically decreased the power of LFPs in this frequency range. Delivery of electric shocks before olfactory stimulation modulated LFPs in the 70-80 Hz range by evoking a transient increase. These results suggest that these signals are a simple neuronal correlate of higher-order olfactory processing in flies.	[Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid	Prieto-Godino, LL (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	llp23@cam.ac.uk; gonzalo.polavieja@cajal.csic.es		Prieto-Godino, Lucia L/0000-0002-2980-362X; de Polavieja, Gonzalo/0000-0001-5359-3426	Ministerio de Ciencia e Innovacion (MICINN); CAM	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM	GGP acknowledges grants from Ministerio de Ciencia e Innovacion (MICINN) and the CAM Biociencia program. LPG acknowledges fellowship 'de aprovechamiento academico excelente' from CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos Z, 2007, J NEUROGENET, V21, P59, DOI 10.1080/01677060701249488; Asztalos Z, 2007, J NEUROGENET, V21, P1, DOI 10.1080/01677060701247508; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BRAGIN A, 1995, J NEUROSCI, V15, P47; Christensen TA, 2003, P NATL ACAD SCI USA, V100, P11076, DOI 10.1073/pnas.1934001100; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Yarali A, 2009, P R SOC B, V276, P3413, DOI 10.1098/rspb.2009.0705; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZILBERGA.NF, 1974, COMP BIOCHEM PHYSIOL, V49, P441, DOI 10.1016/0300-9629(74)90560-X	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12867	10.1371/journal.pone.0012867	http://dx.doi.org/10.1371/journal.pone.0012867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877566	Green Submitted, gold, Green Published			2022-12-25	WOS:000282053100022
J	Sampson, SD; Loewen, MA; Farke, AA; Roberts, EM; Forster, CA; Smith, JA; Titus, AL				Sampson, Scott D.; Loewen, Mark A.; Farke, Andrew A.; Roberts, Eric M.; Forster, Catherine A.; Smith, Joshua A.; Titus, Alan L.			New Horned Dinosaurs from Utah Provide Evidence for Intracontinental Dinosaur Endemism	PLOS ONE			English	Article							1ST CERATOPSID DINOSAUR; KAIPAROWITS FORMATION; WESTERN INTERIOR; 40AR/39AR AGE; SOUTHERN UTAH; BODY-SIZE; EVOLUTION; FACIES	Background: During much of the Late Cretaceous, a shallow, epeiric sea divided North America into eastern and western landmasses. The western landmass, known as Laramidia, although diminutive in size, witnessed a major evolutionary radiation of dinosaurs. Other than hadrosaurs (duck-billed dinosaurs), the most common dinosaurs were ceratopsids (large-bodied horned dinosaurs), currently known only from Laramidia and Asia. Remarkably, previous studies have postulated the occurrence of latitudinally arrayed dinosaur "provinces,'' or "biomes,'' on Laramidia. Yet this hypothesis has been challenged on multiple fronts and has remained poorly tested. Methodology/Principal Findings: Here we describe two new, co-occurring ceratopsids from the Upper Cretaceous Kaiparowits Formation of Utah that provide the strongest support to date for the dinosaur provincialism hypothesis. Both pertain to the clade of ceratopsids known as Chasmosaurinae, dramatically increasing representation of this group from the southern portion of the Western Interior Basin of North America. Utahceratops gettyi gen. et sp. nov.-characterized by short, rounded, laterally projecting supraorbital horncores and an elongate frill with a deep median embayment-is recovered as the sister taxon to Pentaceratops sternbergii from the late Campanian of New Mexico. Kosmoceratops richardsoni gen. et sp. nov.-characterized by elongate, laterally projecting supraorbital horncores and a short, broad frill adorned with ten well developed hooks-has the most ornate skull of any known dinosaur and is closely allied to Chasmosaurus irvinensis from the late Campanian of Alberta. Conclusions/Significance: Considered in unison, the phylogenetic, stratigraphic, and biogeographic evidence documents distinct, co-occurring chasmosaurine taxa north and south on the diminutive landmass of Laramidia. The famous Triceratops and all other, more nested chasmosaurines are postulated as descendants of forms previously restricted to the southern portion of Laramidia. Results further suggest the presence of latitudinally arrayed evolutionary centers of endemism within chasmosaurine ceratopsids during the late Campanian, the first documented occurrence of intracontinental endemism within dinosaurs.	[Sampson, Scott D.; Loewen, Mark A.; Smith, Joshua A.] Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Sampson, Scott D.; Loewen, Mark A.; Smith, Joshua A.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld, Australia; [Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Titus, Alan L.] Bur Land Management, Grand Staircase Escalante Natl Monument, Kanab, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; James Cook University; George Washington University	Sampson, SD (corresponding author), Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA.	ssampson@umnh.utah.edu	Roberts, Eric/J-1836-2014	Roberts, Eric/0000-0002-8583-7437; Farke, Andrew/0000-0002-6930-2002	National Science Foundation [0745454, 0819953]; Division Of Earth Sciences [0819953, 0745454] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation (EAR 0745454, 0819953; http://www.nsf.gov/funding/), Bureau of Land Management ( GSENM; http://www.blm.gov), Discovery Quest (http://www.discovery.com), and the University of Utah (http://www.utah.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Befus KS, 2008, J VOLCANOL GEOTH RES, V173, P245, DOI 10.1016/j.jvolgeores.2008.01.021; Blakey R. C., 2009, REGIONAL PALEOGEOGRA; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; FASSETT JE, 1997, NEW MEXICO GEOLOGICA, V48, P29; Forster Catherine A., 1993, Journal of Vertebrate Paleontology, V13, P161; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff P, 2008, CLADISTICS, V24, P91; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Horner JR, 1984, FIELD C GUIDEBOOK, P299; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Lehman T. M., 1997, DINOFEST INT, P223; Lehman Thomas M., 2001, P310; LEHMAN TM, 1993, J PALEONTOL, V67, P279, DOI 10.1017/S0022336000032200; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Longrich NR, 2010, J PALEONTOL, V84, P681, DOI 10.1666/09-114.1; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V35, P367; Maddison W, MESQUITE MODULAR SYS; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; RUSSELL D., 1967, NAT MUS CAN NATUR HIST PAP, V36, P1; Ryan MJ, 2005, LIFE O PAST, P312; Sampson Scott D., 2010, P405; SAMPSON SD, LEARN LAND IN PRESS; SEELEY HG, 1887, P ROY SOC LONDON, V43, P165, DOI DOI 10.1098/RSPL.1887.0117; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sues HD, 2009, NATURWISSENSCHAFTEN, V96, P645, DOI 10.1007/s00114-009-0518-9; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P7; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; VANDEGRAFF FR, 1972, J SEDIMENT PETROL, V42, P558; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2	49	124	127	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12292	10.1371/journal.pone.0012292	http://dx.doi.org/10.1371/journal.pone.0012292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877459	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000282053100002
J	van der Poorten, D; Shahidi, M; Tay, E; Sesha, J; Tran, K; McLeod, D; Milliken, JS; Ho, V; Hebbard, LW; Douglas, MW; George, J				van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Tran, Kayla; McLeod, Duncan; Milliken, Jane S.; Ho, Vikki; Hebbard, Lionel W.; Douglas, Mark W.; George, Jacob			Hepatitis C Virus Induces the Cannabinoid Receptor 1	PLOS ONE			English	Article							CORE PROTEIN; RISK-FACTOR; CB1 RECEPTORS; STEATOSIS; FIBROSIS; ENDOCANNABINOIDS; ACTIVATION; MECHANISMS; LOCALIZATION; HEPATOCYTES	Background: Activation of hepatic CB1 receptors (CB1) is associated with steatosis and fibrosis in experimental forms of liver disease. However, CB1 expression has not been assessed in patients with chronic hepatitis C (CHC), a disease associated with insulin resistance, steatosis and metabolic disturbance. We aimed to determine the importance and explore the associations of CB1 expression in CHC. Methods: CB1 receptor mRNA was measured by real time quantitative PCR on extracted liver tissue from 88 patients with CHC (genotypes 1 and 3), 12 controls and 10 patients with chronic hepatitis B (CHB). The Huh7/JFH1 Hepatitis C virus (HCV) cell culture model was used to validate results. Principal Findings: CB1 was expressed in all patients with CHC and levels were 6-fold higher than in controls (P<0.001). CB1 expression increased with fibrosis stage, with cirrhotics having up to a 2 fold up-regulation compared to those with low fibrosis stage (p<0.05). Even in mild CHC with no steatosis (F0-1), CB1 levels remained substantially greater than in controls (p<0.001) and in those with mild CHB (F0-1; p<0.001). Huh7 cells infected with JFH-1 HCV showed an 8-fold up-regulation of CB1, and CB1 expression directly correlated with the percentage of cells infected over time, suggesting that CB1 is an HCV inducible gene. While HCV structural proteins appear essential for CB1 induction, there was no core genotype specific difference in CB1 expression. CB1 significantly increased with steatosis grade, primarily driven by patients with genotype 3 CHC. In genotype 3 patients, CB1 correlated with SREBP-1c and its downstream target FASN (SREBP-1c; R = 0.37, FASN; R = 0.39, p<0.05 for both). Conclusions/Significance: CB1 is up-regulated in CHC and is associated with increased steatosis in genotype 3. It is induced by the hepatitis C virus.	[van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Ho, Vikki; Hebbard, Lionel W.; Douglas, Mark W.; George, Jacob] Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Tran, Kayla; McLeod, Duncan; Milliken, Jane S.] Westmead Hosp, Dept Anat Pathol, Inst Clin Pathol & Med Res ICPMR, Sydney, NSW, Australia; [Douglas, Mark W.] Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	van der Poorten, D (corresponding author), Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jacob.george@sydney.edu.au	George, jacob/P-1496-2014; Hebbard, Lionel w/F-7272-2014; Douglas, Mark/D-5513-2011; Hebbard, Lionel/W-4057-2019; Hebbard, Lionel/O-1489-2017	Douglas, Mark/0000-0003-4621-3485; Hebbard, Lionel/0000-0002-7094-9065	Gastroenterological Society of Australia (GESA); Australian National Health and Medical Research Council [402577, 219282]; CJ Martin Fellowship; Robert W. Storr Bequest	Gastroenterological Society of Australia (GESA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest	This work was funded by the Gastroenterological Society of Australia (GESA) Postgraduate Medical Scholarship (DVDP), Australian National Health and Medical Research Council #402577, #219282 (JG), CJ Martin Fellowship (MD) and the Robert W. Storr Bequest to the University of Sydney (JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; *EUR MED AG, 2008, EMEACHMP537777532008; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Hui JM, 2002, J GASTROEN HEPATOL, V17, P873, DOI 10.1046/j.1440-1746.2002.02813.x; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; McCaughan GW, 2004, GUT, V53, P318, DOI 10.1136/gut.2003.026393; Munoz-Luque J, 2008, J PHARMACOL EXP THER, V324, P475, DOI 10.1124/jpet.107.131896; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parfieniuk A, 2008, WORLD J GASTROENTERO, V14, P6109, DOI 10.3748/wjg.14.6109; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Rasband WS, 1997, IMAGEJ; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Shaw ML, 2003, J MED VIROL, V70, P361, DOI 10.1002/jmv.10404; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Smart RG, 2000, ADDICT BEHAV, V25, P455, DOI 10.1016/S0306-4603(99)00013-1; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; van der Poorten D, 2008, CLIN LIVER DIS, V12, P805, DOI 10.1016/j.cld.2008.07.003; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; *WHO, WHO IN VACC RES IVR; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	42	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12841	10.1371/journal.pone.0012841	http://dx.doi.org/10.1371/journal.pone.0012841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862263	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000281960800027
J	Reece, JC; Loh, L; Alcantara, S; Fernandez, CS; Stambas, J; Sexton, A; De Rose, R; Petravic, J; Davenport, MP; Kent, SJ				Reece, Jeanette C.; Loh, Liyen; Alcantara, Sheilajen; Fernandez, Caroline S.; Stambas, John; Sexton, Amy; De Rose, Robert; Petravic, Janka; Davenport, Miles P.; Kent, Stephen J.			Timing of Immune Escape Linked to Success or Failure of Vaccination	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTE; CLASS-I ALLELE; ACUTE SIV INFECTION; IMMUNODEFICIENCY-VIRUS; SIMIAN-HUMAN; PIGTAIL MACAQUES; KILLING KINETICS; HIV-1 VACCINE; VIRAL LOAD; REVERSION	Successful vaccination against HIV should limit viral replication sufficiently to prevent the emergence of viral immune escape mutations. Broadly directed immunity is likely to be required to limit opportunities for immune escape variants to flourish. We studied the emergence of an SIV Gag cytotoxic T cell immune escape variant in pigtail macaques expressing the Mane-A* 10 MHC I allele using a quantitative RT-PCR to measure viral loads of escape and wild type variants. Animals receiving whole Gag expressing vaccines completely controlled an SIVmac251 challenge, had broader CTL responses and exhibited minimal CTL escape. In contrast, animals vaccinated with only a single CTL epitope and challenged with the same SIVmac251 stock had high levels of viral replication and rapid CTL escape. Unvaccinated naive animals exhibited a slower emergence of immune escape variants. Thus narrowly directed vaccination against a single epitope resulted in rapid immune escape and viral levels equivalent to that of naive unvaccinated animals. These results emphasize the importance of inducing broadly directed HIV-specific immunity that effectively quashes early viral replication and limits the generation of immune escape variants. This has important implications for the selection of HIV vaccines for expanded human trials.	[Reece, Jeanette C.; Loh, Liyen; Alcantara, Sheilajen; Fernandez, Caroline S.; Stambas, John; Sexton, Amy; De Rose, Robert; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	University of Melbourne; University of New South Wales Sydney	Reece, JC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	skent@unimelb.edu.au	Kent, Stephen/AAL-5101-2020; Petravic, Janka/AAD-9192-2020	Kent, Stephen/0000-0002-8539-4891; Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831; Reece, Jeanette/0000-0003-2897-0271; Stambas, John/0000-0002-5690-2551; De Rose, Robert/0000-0003-4316-3910; Loh, Liyen/0000-0002-1676-0579	NHMRC [508902, 454553]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Supported by NHMRC awards 508902 and 454553 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002; Batten CJ, 2006, AIDS RES HUM RETROV, V22, P580, DOI 10.1089/aid.2006.22.580; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; De Rose R, 2008, VIROLOGY, V378, P201, DOI 10.1016/j.virol.2008.06.006; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; De Rose R, 2007, J VIROL, V81, P292, DOI 10.1128/JVI.01727-06; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; KENT SJ, 2008, VIROLOGY, V347, P538; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Loh L, 2007, J VIROL, V81, P5418, DOI 10.1128/JVI.02763-06; Loh L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000378; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Mankowski JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003603; Mason RD, 2009, VIROLOGY, V388, P315, DOI 10.1016/j.virol.2009.03.020; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; OLEARY CE, 2009, IMMUNOGENETICS; Petravic J, 2008, J VIROL, V82, P4091, DOI 10.1128/JVI.02552-07; Pratt BF, 2006, IMMUNOGENETICS, V58, P995, DOI 10.1007/s00251-006-0164-8; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Rollman E, 2007, J IMMUNOL, V179, P4571, DOI 10.4049/jimmunol.179.7.4571; Rollman E, 2008, J MED PRIMATOL, V37, P24, DOI 10.1111/j.1600-0684.2008.00326.x; Sexton A, 2009, J VIROL, V83, P7619, DOI 10.1128/JVI.00470-09; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Smith MZ, 2005, J MED PRIMATOL, V34, P282, DOI 10.1111/j.1600-0684.2005.00126.x	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12774	10.1371/journal.pone.0012774	http://dx.doi.org/10.1371/journal.pone.0012774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862289	Green Published, gold			2022-12-25	WOS:000281864100017
J	Cai, YD; Huang, T; Feng, KY; Hu, LL; Xie, L				Cai, Yu-Dong; Huang, Tao; Feng, Kai-Yan; Hu, Lele; Xie, Lu			A Unified 35-Gene Signature for both Subtype Classification and Survival Prediction in Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							GRADE FIBROMYXOID SARCOMA; GENE-EXPRESSION PROFILES; PROSTATE-CANCER; HISTONE DEACETYLASE-1; KINASE; IMMUNOPHENOTYPE; TRANSCRIPTION; INDUCTION; CARCINOMA; MOTILITY	Cancer subtype classification and survival prediction both relate directly to patients' specific treatment plans, making them fundamental medical issues. Although the two factors are interrelated learning problems, most studies tackle each separately. In this paper, expression levels of genes are used for both cancer subtype classification and survival prediction. We considered 350 diffuse large B-cell lymphoma (DLBCL) subjects, taken from four groups of patients (activated B-cell-like subtype dead, activated B-cell-like subtype alive, germinal center B-cell-like subtype dead, and germinal center B-cell-like subtype alive). As classification features, we used 11,271 gene expression levels of each subject. The features were first ranked by mRMR (Maximum Relevance Minimum Redundancy) principle and further selected by IFS (Incremental Feature Selection) procedure. Thirty-five gene signatures were selected after the IFS procedure, and the patients were divided into the above mentioned four groups. These four groups were combined in different ways for subtype prediction and survival prediction, specifically, the activated versus the germinal center and the alive versus the dead. Subtype prediction accuracy of the 35-gene signature was 98.6%. We calculated cumulative survival time of high-risk group and low-risk groups by the Kaplan-Meier method. The log-rank test p-value was 5.98e-08. Our methodology provides a way to study subtype classification and survival prediction simultaneously. Our results suggest that for some diseases, especially cancer, subtype classification may be used to predict survival, and, conversely, survival prediction features may shed light on subtype features.	[Cai, Yu-Dong; Hu, Lele] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan; Xie, Lu] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Fudan University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xielu@scbit.org		cai, yudong/0000-0001-5664-7979	National High-Tech RD Program [2006AA02Z334, 2007DFA31040]; China National Key Projects for Infectious Disease [2008ZX10002-021]; National Basic Research Program of China [2006CB910700]; National Natural Science Foundation of China [31070752]; CAS [KSCX2-YW-R-112]	National High-Tech RD Program(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by grants from National High-Tech R&D Program (863) (2006AA02Z334, 2007DFA31040), China National Key Projects for Infectious Disease (2008ZX10002-021), National Basic Research Program of China (2006CB910700), National Natural Science Foundation of China (Grant No. 31070752) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baytel D, 1998, BBA-GENE STRUCT EXPR, V1442, P274, DOI 10.1016/S0167-4781(98)00185-7; Berglund M, 2005, MODERN PATHOL, V18, P1113, DOI 10.1038/modpathol.3800396; Chan WC, 1997, BLOOD, V89, P3909; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gong JP, 2009, J SURG RES, V153, P17, DOI 10.1016/j.jss.2008.03.033; Goytain A, 2008, AM J PHYSIOL-CELL PH, V295, pC944, DOI 10.1152/ajpcell.00091.2008; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Koch JG, 2007, MAMM GENOME, V18, P300, DOI 10.1007/s00335-007-9028-2; Lacoste J, 2005, MOL CELL ENDOCRINOL, V235, P51, DOI 10.1016/j.mce.2004.06.014; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lossos IS, 2003, INT J HEMATOL, V77, P321, DOI 10.1007/BF02982638; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Marinkovic D, 2004, NUCLEIC ACIDS RES, V32, P5368, DOI 10.1093/nar/gkh877; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Panagopoulos L, 2004, GENE CHROMOSOME CANC, V40, P218, DOI 10.1002/gcc.20037; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Senga T, 2002, ONCOGENE, V21, P8186, DOI 10.1038/sj.onc.1205918; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shim H, 2006, BIOTECHNOL LETT, V28, P2057, DOI 10.1007/s10529-006-9190-8; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Toh Y, 2003, ONCOL REP, V10, P333; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Veelken H, 2007, ANN ONCOL, V18, P931, DOI 10.1093/annonc/mdm012; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1	46	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12726	10.1371/journal.pone.0012726	http://dx.doi.org/10.1371/journal.pone.0012726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856936	gold, Green Published, Green Submitted			2022-12-25	WOS:000281735700024
J	Rolli, J; Rosenblatt-Velin, N; Li, JH; Loukili, N; Levrand, S; Pacher, P; Waeber, B; Feihl, F; Ruchat, P; Liaudet, L				Rolli, Joelle; Rosenblatt-Velin, Nathalie; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Pacher, Pal; Waeber, Bernard; Feihl, Francois; Ruchat, Patrick; Liaudet, Lucas			Bacterial Flagellin Triggers Cardiac Innate Immune Responses and Acute Contractile Dysfunction	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; MYOCARDIAL INFLAMMATION; SIGNALING PATHWAY; SEPTIC SHOCK; CUTTING EDGE; SEPSIS; PEROXYNITRITE; EXPRESSION; HEART; LIPOPOLYSACCHARIDE	Background: Myocardial contractile failure in septic shock may develop following direct interactions, within the heart itself, between molecular motifs released by pathogens and their specific receptors, notably those belonging to the toll-like receptor (TLR) family. Here, we determined the ability of bacterial flagellin, the ligand of mammalian TLR5, to trigger myocardial inflammation and contractile dysfunction. Methodology/Principal Findings: TLR5 expression was determined in H9c2 cardiac myoblasts, in primary rat cardiomyocytes, and in whole heart extracts from rodents and humans. The ability of flagellin to activate pro-inflammatory signaling pathways (NF-kappaB and MAP kinases) and the expression of inflammatory cytokines was investigated in H9c2 cells, and, in part, in primary cardiomyocytes, as well as in the mouse myocardium in vivo. The influence of flagellin on left ventricular function was evaluated in mice by a conductance pressure-volume catheter. Cardiomyoyctes and intact myocardium disclosed significant TLR5 expression. In vitro, flagellin activated NF-kappaB, MAP kinases, and the transcription of inflammatory genes. In vivo, flagellin induced cardiac activation of NF-kappaB, expression of inflammatory cytokines (TNF alpha, IL-1 beta, IL-6, MIP-2 and MCP-1), and provoked a state of reversible myocardial dysfunction, characterized by cardiac dilation, reduced ejection fraction, and decreased end-systolic elastance. Conclusion/Significance: These results are the first to indicate that flagellin has the ability to trigger cardiac innate immune responses and to acutely depress myocardial contractility.	[Rolli, Joelle; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland; [Rolli, Joelle; Rosenblatt-Velin, Nathalie; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Waeber, Bernard; Feihl, Francois; Ruchat, Patrick; Liaudet, Lucas] Fac Biol & Med, Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Levrand, Sandra; Waeber, Bernard; Feihl, Francois; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Div Pathophysiol, Lausanne, Switzerland; [Ruchat, Patrick] Univ Lausanne Hosp, Med Ctr, Dept Cardiovasc Surg, Lausanne, Switzerland; [Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA; [Li, Jianhui] Zhejiang Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Zhejiang University	Rolli, J (corresponding author), Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Pacher, Pal/B-6378-2008; Liaudet, Lucas/E-1322-2017	Pacher, Pal/0000-0001-7036-8108; Liaudet, Lucas/0000-0003-2670-4930; Rosenblatt, Nathalie/0000-0003-2011-2862	Swiss National Fund for Scientific Research [PP00B-68882/1, 320000-118174/1]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the Swiss National Fund for Scientific Research (PP00B-68882/1 and 320000-118174/1) to Lucas Liaudet. URL: www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Constable PD, 1999, SHOCK, V12, P391, DOI 10.1097/00024382-199911000-00008; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Levrand S, 2005, J BIOL CHEM, V280, P34878, DOI 10.1074/jbc.M501977200; Levrand S, 2007, BIOCHEM BIOPH RES CO, V359, P445, DOI 10.1016/j.bbrc.2007.05.147; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; NATANSON C, 1986, J CLIN INVEST, V78, P259, DOI 10.1172/JCI112559; Nemoto S, 2002, AM J PHYSIOL-HEART C, V282, pH2316, DOI 10.1152/ajpheart.00763.2001; Neviere RR, 1999, AM J PHYSIOL-HEART C, V277, pH885, DOI 10.1152/ajpheart.1999.277.3.H885; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; Pinsky MR, 2000, AM J RESP CRIT CARE, V161, P1087, DOI 10.1164/ajrccm.161.4.9904033; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Waeckel L, 2006, ARTERIOSCL THROM VAS, V26, P773, DOI 10.1161/01.ATV.0000203510.96492.14; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006; Zhang Z, 2007, INFECT IMMUN, V75, P5985, DOI 10.1128/IAI.00678-07	38	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12687	10.1371/journal.pone.0012687	http://dx.doi.org/10.1371/journal.pone.0012687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856884	Green Submitted, Green Published, gold			2022-12-25	WOS:000281735700012
J	Behnke, MS; Wootton, JC; Lehmann, MM; Radke, JB; Lucas, O; Nawas, J; Sibley, LD; White, MW				Behnke, Michael S.; Wootton, John C.; Lehmann, Margaret M.; Radke, Josh B.; Lucas, Olivier; Nawas, Julie; Sibley, L. David; White, Michael W.			Coordinated Progression through Two Subtranscriptomes Underlies the Tachyzoite Cycle of Toxoplasma gondii	PLOS ONE			English	Article							CELL-NUCLEAR-ANTIGENS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; BRADYZOITE DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; COMPARATIVE GENOMICS; REGULATED GENES; DNA-BINDING; IDENTIFICATION; PROTEIN	Background: Apicomplexan parasites replicate by varied and unusual processes where the typically eukaryotic expansion of cellular components and chromosome cycle are coordinated with the biosynthesis of parasite-specific structures essential for transmission. Methodology/Principal Findings: Here we describe the global cell cycle transcriptome of the tachyzoite stage of Toxoplasma gondii. In dividing tachyzoites, more than a third of the mRNAs exhibit significant cyclical profiles whose timing correlates with biosynthetic events that unfold during daughter parasite formation. These 2,833 mRNAs have a bimodal organization with peak expression occurring in one of two transcriptional waves that are bounded by the transition into S phase and cell cycle exit following cytokinesis. The G1-subtranscriptome is enriched for genes required for basal biosynthetic and metabolic functions, similar to most eukaryotes, while the S/M-subtranscriptome is characterized by the uniquely apicomplexan requirements of parasite maturation, development of specialized organelles, and egress of infectious daughter cells. Two dozen AP2 transcription factors form a series through the tachyzoite cycle with successive sharp peaks of protein expression in the same timeframes as their mRNA patterns, indicating that the mechanisms responsible for the timing of protein delivery might be mediated by AP2 domains with different promoter recognition specificities. Conclusion/Significance: Underlying each of the major events in apicomplexan cell cycles, and many more subordinate actions, are dynamic changes in parasite gene expression. The mechanisms responsible for cyclical gene expression timing are likely crucial to the efficiency of parasite replication and may provide new avenues for interfering with parasite growth.	[Behnke, Michael S.; Lehmann, Margaret M.; Radke, Josh B.; White, Michael W.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Radke, Josh B.; Lucas, Olivier; White, Michael W.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Radke, Josh B.; Lucas, Olivier; White, Michael W.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Wootton, John C.] Natl Lib Med, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Behnke, Michael S.; Nawas, Julie; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL)	Behnke, MS (corresponding author), Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA.	mwhite.usf@gmail.com	White, Michael/A-4978-2012; Behnke, Michael S/R-8839-2016	Behnke, Michael S/0000-0002-4668-8109	National Institutes of Health [AI 48390, AI077662, AI072739, AI034036]; NCBI, National Library of Medicine, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036, R21AI072739, R01AI048390, R01AI077662, R01AI059176, R01AI036629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCBI, National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health to MWW (AI 48390, AI077662, and AI072739) and LDS (AI034036). JCW is supported by the Intramural program of NCBI, National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Billups SC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-96; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Coleman BI, 2008, CELL MICROBIOL, V10, P1935, DOI 10.1111/j.1462-5822.2008.01203.x; Cooper Stephen, 2003, Cell Chromosome, V2, P1, DOI 10.1186/1475-9268-2-1; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; DARZYNKIEWICZ Z, 1980, P NATL ACAD SCI-BIOL, V77, P6696, DOI 10.1073/pnas.77.11.6696; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; de Felipe MMC, 2008, MOL BIOCHEM PARASIT, V157, P22, DOI 10.1016/j.molbiopara.2007.09.003; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; DEROJAS MO, 1985, T ROY SOC TROP MED H, V79, P792, DOI 10.1016/0035-9203(85)90119-1; DIXON SE, MOL BIOCH PARASITOL; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guerini MN, 2000, MOL BIOCHEM PARASIT, V109, P121, DOI 10.1016/S0166-6851(00)00240-1; Guerini MN, 2005, MOL BIOCHEM PARASIT, V142, P56, DOI 10.1016/j.molbiopara.2005.03.020; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jensen LJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-403; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; KHAN A, 2009, EUKARYOT CELL; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kovacs LAS, 2008, CELL CYCLE, V7, P2626, DOI 10.4161/cc.7.17.6515; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Ma YF, 2004, INT J PARASITOL, V34, P333, DOI 10.1016/j.ijpara.2003.11.020; Matrajt M, 2004, MOL BIOCHEM PARASIT, V137, P229, DOI 10.1016/j.molbiopara.2003.12.015; MCDONALD V, 1986, EXP PARASITOL, V61, P192, DOI 10.1016/0014-4894(86)90152-9; MCDONALD V, 1987, J PARASITOL, V73, P993, DOI 10.2307/3282523; MEISSNER M, 2005, MICROBES INFECT; Mercier C, 1996, MOL MICROBIOL, V21, P421, DOI 10.1046/j.1365-2958.1996.6501361.x; MOORE SA, 1988, J BIOL CHEM, V263, P9674; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; MURRAY A, 1993, CELL CYCLE; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; SENAUD J, 1966, CR ACAD SCI D NAT, V262, P119; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Van Poppel NFJ, 2006, PARASITOLOGY, V133, P19, DOI 10.1017/S0031182006009954; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; White MW, 2007, CELL CYCLE CONTROL P; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; YUDA M, 2009, MOL MICROBIOL; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	87	180	181	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12354	10.1371/journal.pone.0012354	http://dx.doi.org/10.1371/journal.pone.0012354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865045	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100008
J	Kapun, M; Nolte, V; Flatt, T; Schlotterer, C				Kapun, Martin; Nolte, Viola; Flatt, Thomas; Schloetterer, Christian			Host Range and Specificity of the Drosophila C Virus	PLOS ONE			English	Article							MUTATION-RATES; MELANOGASTER; RECOMBINATION; POPULATION; EVOLUTION	Background: The Drosophila C virus (DCV) is a common and well-studied Drosophila pathogen. Although natural infections are known from Drosophila melanogaster and D. simulans, and artificial infections have been reported from several Drosophila species and other insects, it remains unclear to date whether DCV infections also occur naturally in other Drosophila species. Methods/Principal Findings: Using reverse transcription PCR, we detected natural infections in six Drosophila species, which have not been previously known as natural hosts. By subsequent Sanger sequencing we compared DCV haplotypes among eight Drosophila host species. Our data suggest that cross-infections might be frequent both within and among species within the laboratory environment. Moreover, we find that some lines exhibit multiple infections with distinct DCV haplotypes. Conclusions: Our results suggest that the natural host range of DCV is much broader than previously assumed and that cross-infections might be a common phenomenon in the laboratory, even among different Drosophila hosts.	[Kapun, Martin; Nolte, Viola; Flatt, Thomas; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	University of Veterinary Medicine Vienna	Kapun, M (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Flatt, Thomas/AAE-7329-2019; Flatt, Thomas/A-7384-2009; Schlötterer, Christian/Q-5264-2019; Kapun, Martin/GVT-4278-2022; Kapun, Martin/GLU-9265-2022; Kapun, Martin/I-3536-2019	Schlötterer, Christian/0000-0003-4710-6526; Flatt, Thomas/0000-0002-5990-1503; Schlötterer, Christian/0000-0003-4710-6526; Kapun, Martin/0000-0002-3810-0504; Kapun, Martin/0000-0002-3810-0504; Kapun, Martin/0000-0002-3810-0504	Austrian Academy of Sciences; Austrian Science Fund (FWF) [P19467-B11]; Austrian Science Fund (FWF) [P 19467] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded through a DOC fellowship of the Austrian Academy of Sciences (http://stipendien.oeaw.ac.at/doc-doktorandinnenprogrammder-oesterreichischen-akademie-der-wissenschaften) to MK. CS is supported through the Austrian Science Fund (FWF) by grant P19467-B11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBURNER M, 2007, MAINTENANCE DROSOPHI; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BRUN G, 1980, BIOL GENETICS DROSOP, P625; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Christian PD, 1998, VIRUSES, P301; CLEWLEY JP, 1983, J GEN VIROL, V64, P503, DOI 10.1099/0022-1317-64-2-503; COMENDADOR MA, 1986, GENET SEL EVOL, V18, P131, DOI 10.1186/1297-9686-18-2-131; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Filipe D, 1998, ENDOCYTOBIOSIS CELL, V12, P163; GOMARIZZILBER E, 1995, J INVERTEBR PATHOL, V65, P243, DOI 10.1006/jipa.1995.1037; Gravot E, 2000, J INVERTEBR PATHOL, V75, P144, DOI 10.1006/jipa.1999.4913; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; JOUSSET FX, 1976, ANN INST PASTEUR MIC, VA127, P529; JOUSSET FX, 1972, CR ACAD SCI D NAT, P3043; KING LA, 1994, ADV INSECT PHYSL, V25; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; MOORE NF, 1991, VIRUSES INVERTEBRATE; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; PLUS N, 1978, J INVERTEBR PATHOL, V31, P296, DOI 10.1016/0022-2011(78)90219-7; PLUS N, 1975, ANN INST PASTEUR MIC, VA126, P107; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; THOMASORILLARD M, 1984, GENETICS, V107, P635; TULLY T, 2008, DCV PROTOCOLS; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	33	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12421	10.1371/journal.pone.0012421	http://dx.doi.org/10.1371/journal.pone.0012421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865043	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100017
J	Foretz, M; Hebrard, S; Guihard, S; Leclerc, J; Do Cruzeiro, M; Hamard, G; Niedergang, F; Gaudry, M; Viollet, B				Foretz, Marc; Hebrard, Sophie; Guihard, Soizic; Leclerc, Jocelyne; Do Cruzeiro, Marcio; Hamard, Ghislaine; Niedergang, Florence; Gaudry, Muriel; Viollet, Benoit			The AMPK gamma 1 subunit plays an essential role in erythrocyte membrane elasticity, and its genetic inactivation induces splenomegaly and anemia	FASEB JOURNAL			English	Article						knockout mice; protein kinase; RBC; membrane deformability; osmotic resistance	ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; UPSTREAM KINASE; DISEASE; CELLS; MUTATION; GAMMA-3; BINDING; DEFORMABILITY; GENERATION	AMP-activated protein kinase (AMPK) is an alpha beta gamma heterotrimer conserved throughout evolution and important for energy sensing in all eukaryote cells. AMPK controls metabolism and various cellular events in response to both hormones and changes in cellular energy status. The gamma subunit senses intracellular energy status through the competitive binding of AMP and ATP. We show here that targeted disruption of the mouse AMPK gamma 1 gene (Prkag1) causes regenerative hemolytic anemia by increasing the sequestration of abnormal erythrocytes. Prkag1(-/-) mice displayed splenomegaly and iron accumulation due to compensatory splenic erythropoiesis and erythrophagocytosis. Moreover, AMPK gamma 1-deficient erythrocytes were highly resistant to osmotic hemolysis and poorly deformable in response to increasing shear stress, consistent with greater membrane rigidity. No change in cytoskeletal protein composition was observed; however, the phosphorylation level of adducin, a protein promoting the binding of spectrin to actin, was higher in AMPK gamma 1-deficient erythrocytes. Together, these results demonstrate that AMPK gamma 1 subunit is required for the maintenance of erythrocyte membrane elasticity.-Foretz, M., Hebrard, S., Guihard, S., Leclerc, J., Do Cruzeiro, M., Hamard, G., Niedergang, F., Gaudry, M., Viollet, B. The AMPK gamma 1 subunit plays an essential role in erythrocyte membrane elasticity, and its genetic inactivation induces splenomegaly and anemia. FASEB J. 25, 337-347 (2011). www.fasebj.org	[Foretz, Marc] Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS,UMR 8104, F-75014 Paris, France; [Foretz, Marc; Hebrard, Sophie; Guihard, Soizic; Leclerc, Jocelyne; Do Cruzeiro, Marcio; Hamard, Ghislaine; Niedergang, Florence; Gaudry, Muriel; Viollet, Benoit] INSERM, U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Foretz, M (corresponding author), Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS,UMR 8104, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	marc.foretz@inserm.fr	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Gaudry, Murielle/N-5934-2018; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Gaudry, Murielle/0000-0002-9281-2334; Niedergang, Florence/0000-0002-7064-830X	European Commission [LSHM-CT-2004-005272]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a European Commission integrated project (LSHM-CT-2004-005272). The authors thank Pierre Billuart (Institut Cochin, Paris, France) and Grahame Hardie (University of Dundee, Dundee, UK) for providing reagents. The authors also thank Virginie Siguret (Hopital Charles Foix, Ivry-sur-Seine, France) and Pierre Buffet (Institut Pasteur, Paris, France) for access to the Advia and the LORCA, respectively. The authors are grateful to Marc Uldry for critical reading of the manuscript.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; LIPOWSKY HH, 1986, AM J PHYSIOL, V250, pH908, DOI 10.1152/ajpheart.1986.250.6.H908; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; REINHART WH, 1990, EUR J CLIN INVEST, V20, P458, DOI 10.1111/j.1365-2362.1990.tb01884.x; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; Torrance JD, 1980, IRON, P90; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yu HY, 2004, AM J PHYSIOL-CELL PH, V286, pC283, DOI 10.1152/ajpcell.00319.2003	38	30	30	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					337	347		10.1096/fj.10-169383	http://dx.doi.org/10.1096/fj.10-169383			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20881209				2022-12-25	WOS:000285869500030
J	Sengupta, S; Mantha, AK; Mitra, S; Bhakat, KK				Sengupta, S.; Mantha, A. K.; Mitra, S.; Bhakat, K. K.			Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1	ONCOGENE			English	Article						APE1; acetylation; YB-1/p300; RNA pol II; MDR1	BASE EXCISION-REPAIR; DNA-BINDING ACTIVITY; KINASE-C-ALPHA; APURINIC/APYRIMIDINIC ENDONUCLEASE; OXIDATIVE STRESS; P-GLYCOPROTEIN; HUMAN AP-ENDONUCLEASE-1; ANTICANCER AGENTS; ALTERED EXPRESSION; ELECTRON-TRANSFER	The overexpression of human apurinic/apyrimidinic (AP) endonuclease 1 (APE1/Ref-1), a key enzyme in the DNA base excision repair (BER) pathway, is often associated with tumor cell resistance to various anticancer drugs. In this study, we examined the molecular basis of transcriptional regulatory (nonrepair) function of APE1 in promoting resistance to certain types of drugs. We have recently shown that APE1 stably interacts with Y-box-binding protein 1 (YB-1), and acts as its coactivator for the expression of multidrug resistance gene MDR1, thereby causing drug resistance. In this study, we show, to the best of our knowledge, for the first time that APE1 is stably associated with the basic transcription factor RNA polymerase II (RNA pol II) and the coactivator p300 on the endogenous MDR1 promoter. The depletion of APE1 significantly reduces YB-1-p300 recruitment to the promoter, resulting in reduced RNA pol II loading. Drug-induced APE1 acetylation, which is mediated by p300, enhances formation of acetylated APE1 (AcAPE1)-YB-1-p300 complex on the MDR1 promoter. Enhanced recruitment of this complex increases MDR1 promoter-dependent luciferase activity and its endogenous expression. Using APE1-downregulated cells and cells overexpressing wild-type APE1 or its nonacetylable mutant, we have demonstrated that the loss of APE1's acetylation impaired MDR1 activation and sensitizes the cells to cisplatin or etoposide. We have thus established the basis for APE1's acetylation-dependent regulatory function in inducing MDR1-mediated drug resistance. Oncogene (2011) 30, 482-493; doi: 10.1038/onc.2010.435; published online 20 September 2010	[Sengupta, S.; Mantha, A. K.; Mitra, S.; Bhakat, K. K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Mitra, S.; Bhakat, K. K.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bhakat, KK (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 6-136 Med Res Bldg, Galveston, TX 77555 USA.	kkbhakat@utmb.edu	Sengupta, Shiladitya/L-5951-2015; Mantha, Anil/AAM-5035-2021; Bhakat, Kishor/C-8072-2012	Sengupta, Shiladitya/0000-0001-9558-2741	 [RO1 ESO8457];  [RO1 CA53791];  [P50 ES66076]; NATIONAL CANCER INSTITUTE [R01CA053791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008457] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge the help of Dr Gianluca Tell, University of Udine, Italy for the APE1 siRNA construct, Larry J Bellot, University of Texas Medical Branch, Galveston and Dr Ranajay Chattopadhyay, University of Virginia, Charlottesville in this study. This study was supported by Grants: RO1 ESO8457, RO1 CA53791 and P50 ES66076 to SM.	AHMAD S, 1993, MOL PHARMACOL, V43, P858; AHMAD S, 1994, BIOCHEMISTRY-US, V33, P10313, DOI 10.1021/bi00200a011; Ambudkar SV, 2005, TRENDS PHARMACOL SCI, V26, P385, DOI 10.1016/j.tips.2005.06.001; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2003, METHOD ENZYMOL, V371, P292; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Bhakat KK, 2000, J BIOL CHEM, V275, P34197, DOI 10.1074/jbc.M005447200; Bhattacharyya A, 2009, GASTROENTEROLOGY, V136, P2258, DOI 10.1053/j.gastro.2009.02.014; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bobola MS, 2005, CLIN CANCER RES, V11, P7405, DOI 10.1158/1078-0432.CCR-05-1068; Busso CS, 2009, ONCOGENE, V28, P1616, DOI 10.1038/onc.2009.5; Chattopadhyay R, 2008, MOL CELL BIOL, V28, P7066, DOI 10.1128/MCB.00244-08; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fuchs S, 2003, J HYPERTENS, V21, P327, DOI 10.1097/00004872-200302000-00024; Germann UA, 1998, CYTOTECHNOLOGY, V27, P31, DOI 10.1023/A:1008023629269; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Kaina B, 2002, INT J CLIN PHARM TH, V40, P354; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kelley MR, 2001, CLIN CANCER RES, V7, P824; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; KOHNO K, 1989, BIOCHEM BIOPH RES CO, V165, P1415, DOI 10.1016/0006-291X(89)92761-7; KOHNO K, 1994, J BIOL CHEM, V269, P20503; Kovacic P, 2000, CURR PHARM DESIGN, V6, P277, DOI 10.2174/1381612003401046; Kovacic P, 2007, MED HYPOTHESES, V69, P510, DOI 10.1016/j.mehy.2006.08.046; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Mantha AK, 2008, J MOL BIOL, V379, P28, DOI 10.1016/j.jmb.2008.03.052; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McNeill DR, 2009, MOL CANCER RES, V7, P897, DOI 10.1158/1541-7786.MCR-08-0519; Mitra S, 2002, FREE RADICAL BIO MED, V33, P15, DOI 10.1016/S0891-5849(02)00819-5; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Okamura H, 2004, INT J ONCOL, V25, P1031; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; Ordway JM, 2003, MOL CELL BIOL, V23, P4257, DOI 10.1128/MCB.23.12.4257-4266.2003; Pajic M, 2009, CANCER RES, V69, P6396, DOI 10.1158/0008-5472.CAN-09-0041; Rahman I, 2002, BIOCHEM PHARMACOL, V64, P935, DOI 10.1016/S0006-2952(02)01153-X; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Robertson KA, 1997, CELL GROWTH DIFFER, V8, P443; Robertson KA, 2001, CANCER RES, V61, P2220; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Wang D, 2004, MOL CANCER THER, V3, P679; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xu Y, 1997, ANTICANCER RES, V17, P3713; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; YU G, 1991, CANCER COMMUN, V3, P181, DOI 10.3727/095535491820873263	73	95	97	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2011	30	4					482	493		10.1038/onc.2010.435	http://dx.doi.org/10.1038/onc.2010.435			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	711WH	20856196	Green Accepted			2022-12-25	WOS:000286621600010
J	Cosker, F; Cheviron, N; Yamasaki, M; Menteyne, A; Lund, FE; Moutin, MJ; Galione, A; Cancela, JM				Cosker, Francois; Cheviron, Nathalie; Yamasaki, Michiko; Menteyne, Alexis; Lund, Frances E.; Moutin, Marie-Jo; Galione, Antony; Cancela, Jose-Manuel			The Ecto-enzyme CD38 Is a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Synthase That Couples Receptor Activation to Ca2+ Mobilization from Lysosomes in Pancreatic Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; MESSENGER PATHWAYS; BETA-CELLS; IN-VIVO; CALCIUM; RELEASE; 2ND-MESSENGER; STORES; GENERATION	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca2+-mobilizing intracellular messenger and is linked to a variety of stimuli and cell surface receptors. However, the enzyme responsible for endogenous NAADP synthesis in vivo is unknown, and it has been proposed that another enzyme differing from ADP-ribosyl cyclase family members may exist. The ectoenzyme CD38, involved in many functions as diverse as cell proliferation and social behavior, represents an important alternative. In pancreatic acinar cells, the hormone cholecystokinin (CCK) stimulates NAADP production evoking Ca2+ signals by discharging acidic Ca2+ stores and leading to digestive enzyme secretion. From cells derived from CD38(-/-) mice, we provide the first physiological evidence that CD38 is required for endogenous NAADP generation in response to CCK stimulation. Furthermore, CD38 expression in CD38-deficient pancreatic AR42J cells remodels Ca2+-signaling pathways in these cells by restoring Ca2+ mobilization from lysosomes during CCK-induced Ca2+ signaling. In agreement with an intracellular site for messenger synthesis, we found that CD38 is expressed in endosomes. These CD38-containing vesicles, likely of endosomal origin, appear to be proximal to lysosomes but not colocalized with them. We propose that CD38 is an NAADP synthase required for coupling receptor activation to NAADP-mediated Ca2+ release from lysosomal stores in pancreatic acinar cells.	[Cosker, Francois; Cheviron, Nathalie; Menteyne, Alexis; Cancela, Jose-Manuel] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Mol,UPR9040, F-91198 Gif Sur Yvette, France; [Lund, Frances E.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Moutin, Marie-Jo] Univ Grenoble 1, CEA CHU, Ctr Rech INSERM 836, Grenoble Inst Neurosci Equipe 1,Grp Physiopathol, F-38042 Grenoble, France; [Yamasaki, Michiko; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Rochester; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Oxford	Cancela, JM (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Mol,UPR9040, F-91198 Gif Sur Yvette, France.	jose.cancela@nbcm.cnrs-gif.fr	Moutin, Marie-Jo/P-7518-2017; Galione, Antony/E-5884-2011	Moutin, Marie-Jo/0000-0003-2681-9818; Cancela, Jose-Manuel/0000-0002-6234-1500; Galione, Antony/0000-0002-4132-7646	CNRS; Association pour la Recherche sur le Cancer (ARC); Fondation de la Recherche Medicale (FRM); Association Francaise contre les Myopathies (AFM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by an ATIP program grant from the CNRS, by the Association pour la Recherche sur le Cancer (ARC), Fondation de la Recherche Medicale (FRM), and the Association Francaise contre les Myopathies (AFM) (to J.-M.C.).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Burdakov D, 2000, CURR BIOL, V10, P993, DOI 10.1016/S0960-9822(00)00649-7; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2002, DIABETES, V51, pS349, DOI 10.2337/diabetes.51.2007.S349; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Morgan AJ, 2007, J BIOL CHEM, V282, P37730, DOI 10.1074/jbc.M704630200; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; THORN P, 1994, EMBO J, V13, P2038, DOI 10.1002/j.1460-2075.1994.tb06478.x; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	41	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38251	38259		10.1074/jbc.M110.125864	http://dx.doi.org/10.1074/jbc.M110.125864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870729	Green Published, hybrid			2022-12-25	WOS:000284625600033
J	Schubert, S; Knoch, KP; Ouwendijk, J; Mohammed, S; Bodrov, Y; Jager, M; Altkruger, A; Wegbrod, C; Adams, ME; Kim, Y; Froehner, SC; Jensen, ON; Kalaidzidis, Y; Solimena, M				Schubert, Sandra; Knoch, Klaus-Peter; Ouwendijk, Joke; Mohammed, Shabaz; Bodrov, Yury; Jaeger, Melanie; Altkrueger, Anke; Wegbrod, Carolin; Adams, Marvin E.; Kim, Yong; Froehner, Stanley C.; Jensen, Ole N.; Kalaidzidis, Yannis; Solimena, Michele			beta 2-Syntrophin Is a Cdk5 Substrate That Restrains the Motility of Insulin Secretory Granules	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; SITE-SPECIFIC PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC VESICLE ENDOCYTOSIS; PANCREATIC BETA-CELLS; NITRIC-OXIDE SYNTHASE; MYOSIN-VA; PLASMA-MEMBRANE; F-ACTIN; SODIUM-CHANNELS	The molecular basis for the interaction of insulin granules with the cortical cytoskeleton of pancreatic beta-cells remains unknown. We have proposed that binding of the granule protein ICA512 to the PDZ domain of beta 2-syntrophin anchors granules to actin filaments and that the phosphorylation/dephosphorylation of beta 2-syntrophin regulates this association. Here we tested this hypothesis by analyzing INS-1 cells expressing GFP-beta 2-syntrophin through the combined use of biochemical approaches, imaging studies by confocal and total internal reflection fluorescence microscopy as well as electron microscopy. Our results support the notion that beta 2-syntrophin restrains the mobility of cortical granules in insulinoma INS-1 cells, thereby reducing insulin secretion and increasing insulin stores in resting cells, while increasing insulin release upon stimulation. Using mass spectrometry, in vitro phosphorylation assays and beta 2-syntrophin phosphomutants we found that phosphorylation of beta 2-syntrophin on S75 near the PDZ domain decreases its binding to ICA512 and correlates with increased granule motility, while phosphorylation of S90 has opposite effects. We further show that Cdk5, which regulates insulin secretion, phosphorylates S75. These findings provide mechanistic insight into how stimulation displaces insulin granules from cortical actin, thus promoting their motility and exocytosis.	[Schubert, Sandra; Knoch, Klaus-Peter; Ouwendijk, Joke; Jaeger, Melanie; Altkrueger, Anke; Wegbrod, Carolin; Solimena, Michele] Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-8027 Dresden, Germany; [Schubert, Sandra; Bodrov, Yury; Wegbrod, Carolin; Kalaidzidis, Yannis; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Mohammed, Shabaz; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Adams, Marvin E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Kim, Yong] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	Technische Universitat Dresden; Max Planck Society; University of Southern Denmark; University of Washington; University of Washington Seattle; Rockefeller University; Lomonosov Moscow State University	Schubert, S (corresponding author), Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-8027 Dresden, Germany.	michele.solimena@tu-dresden.de	Jensen, Ole N/J-1763-2012; Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020; Kalaidzidis, Yannis/H-3094-2016	Jensen, Ole N/0000-0003-1862-8528; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Kalaidzidis, Yannis/0000-0002-6137-1193; Kim, Yong/0000-0002-1387-2962	Humboldt Foundation; Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.); Deutsche Forschungsgemeinschaft [SFB 655, SO 818/1-1]; Medical School of Dresden University of Technology; National Institutes of Health [NS33145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	Humboldt Foundation(Alexander von Humboldt Foundation); Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical School of Dresden University of Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the Paul Award from the Humboldt Foundation, the Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.) the Deutsche Forschungsgemeinschaft (SFB 655 and SO 818/1-1) to M. S., a MedDrive Grant from the Medical School of Dresden University of Technology to S. S., and by National Institutes of Health grant NS33145 to S. C. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bergert H, 2005, CELL TRANSPLANT, V14, P441, DOI 10.3727/000000005783982873; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Eichler TW, 2006, BIOCHEM SOC T, V34, P671, DOI 10.1042/BST0340671; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Gee SH, 1998, J NEUROSCI, V18, P128; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hashida-Okumura A, 1999, J BIOL CHEM, V274, P11736, DOI 10.1074/jbc.274.17.11736; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kaksonen M, 2000, J CELL SCI, V113, P4421; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; KRAMARCY NR, 1994, J BIOL CHEM, V269, P2870; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Lahtinen U, 2003, FEBS LETT, V538, P85, DOI 10.1016/S0014-5793(03)00135-2; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; LU J, 1994, BIOCHEM BIOPH RES CO, V204, P930, DOI 10.1006/bbrc.1994.2549; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Moores CA, 2000, CELL MOTIL CYTOSKEL, V46, P116, DOI 10.1002/1097-0169(200006)46:2<116::AID-CM4>3.0.CO;2-L; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; RABIN DU, 1992, DIABETES, V41, P183, DOI 10.2337/diabetes.41.2.183; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Rutter GA, 2004, CELL BIOCHEM BIOPHYS, P179; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sekine N, 1997, DIABETES, V46, P1424, DOI 10.2337/diabetes.46.9.1424; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Solimena M, 2003, TRENDS CELL BIOL, V13, P399, DOI 10.1016/S0962-8924(03)00150-8; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yokota T, 2000, P JPN ACAD B-PHYS, V76, P22, DOI 10.2183/pjab.76.22	78	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12929	10.1371/journal.pone.0012929	http://dx.doi.org/10.1371/journal.pone.0012929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886068	gold, Green Submitted, Green Published			2022-12-25	WOS:000282091100032
J	Bai, M; Jarvis, K; Wang, SY; Song, KQ; Wang, YP; Wang, ZL; Li, WZ; Wang, W; Yang, XK				Bai, Ming; Jarvis, Karl; Wang, Shu-Yong; Song, Ke-Qing; Wang, Yan-Ping; Wang, Zhi-Liang; Li, Wen-Zhu; Wang, Wei; Yang, Xing-Ke			A Second New Species of Ice Crawlers from China (Insecta: Grylloblattodea), with Thorax Evolution and the Prediction of Potential Distribution	PLOS ONE			English	Article							PHYLOGENY; ORDER; FLIGHTLESSNESS; PERSISTENCE; TAXONOMY	Modern grylloblattids are one of the least diverse of the modern insect orders. The thorax changes in morphology might be associated with the changes of the function of the forelegs, wing loss, changes in behavior and adaptation to habitat. As temperature is the main barrier for migration of modern grylloblattids, the range of each species is extremely limited. The potential distribution areas of grylloblattids remain unclear. A second new species of ice crawlers (Insecta: Grylloblattodea), Grylloblattella cheni Bai, Wang et Yang sp. nov., is described from China. The distribution map and key to species of Grylloblattella are given. A comparison of the thorax of extant and extinct Grylloblattodea is presented, with an emphasis on the pronotum using geometric morphometric analysis, which may reflect thorax adaptation and the evolution of Grylloblattodea. Potential global distribution of grylloblattids is inferred. Highly diversified pronota of extinct Grylloblattodea may reflect diverse habitats and niches. The relatively homogeneous pronota of modern grylloblattids might be explained by two hypotheses: synapomorphy or convergent evolution. Most fossils of Grylloblattodea contain an obviously longer meso-and metathorax than prothorax. The length of the meso- and metathorax of modern grylloblattids is normally shorter than the prothorax. This may be associated with the wing loss, which is accompanied by muscle reduction and changes to the thoracic skeleton system. Threats to grylloblattids and several conservation comments are also provided.	[Bai, Ming; Wang, Shu-Yong; Song, Ke-Qing; Wang, Yan-Ping; Wang, Zhi-Liang; Li, Wen-Zhu; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Jarvis, Karl] No Arizona Univ, Flagstaff, AZ 86011 USA; [Wang, Wei] Minist Environm Protect, Foreign Econ Cooperat Off, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Northern Arizona University	Bai, M (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn	Yuan, Ningyi/HDO-3272-2022; Jarvis, Karl J./M-6537-2015	Jarvis, Karl J./0000-0002-9658-6872	Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0630964/J0109, J0930004]	Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research	This research was partly supported by grants from the Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105), and the National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0630964/J0109, J0930004). Discovery of the unique specimen resulted from the North Xinjiang Environment Exploration Program presided by Dr. Run-Zhi Zhang, Professor of the Institute of Zoology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristov DS, 2006, PALEONTOL J+, V40, P79, DOI 10.1134/S0031030106010096; Aristov Danil, 2009, Virgo, V12, P30; Aristov DS, 2004, PALEONTOL J+, V38, pS80; Asahina S., 1961, Kontyu Tokyo, V29, P85; Asahina S., 1959, Kontyu Tokyo, V27, P249; Bei-Bienko G. Ya., 1951, Entomologicheskoe Obozrenie, V31, P506; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BYERS GW, 1969, EVOLUTION, V23, P346, DOI 10.1111/j.1558-5646.1969.tb03517.x; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Caudell A. N., 1924, Proceedings of the Entomological Society of Washington, V26, P53; Caudell A. N., 1924, Journal of the Washington Academy of Sciences, V14, P369; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; Denno RF, 2001, ECOL ENTOMOL, V26, P25, DOI 10.1046/j.1365-2311.2001.00293.x; Goodall C., 1987, Computer Science and Statistics: Proceedings of the 19th Symposium on the Interface, P86; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Grimaldi D, 2001, J PALEONTOL, V75, P1152, DOI 10.1666/0022-3360(2001)075<1152:IEHFHT>2.0.CO;2; Grimaldi David, 2005, pi; Gurney A. B., 1937, Pan-Pacific Entomologist, V13, P159; GURNEY ASHLEY B., 1961, PROC BIOL SOC WASHINGTON, V74, P67; Haeberli W, 1999, GEOGR ANN A, V81A, P585, DOI 10.1111/1468-0459.00086; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huang DY, 2008, ZOOL J LINN SOC-LOND, V152, P17, DOI 10.1111/j.1096-3642.2007.00351.x; Jarvis KJ, 2006, MOL PHYLOGENET EVOL, V41, P222, DOI 10.1016/j.ympev.2006.04.013; KAMP J. W., 1963, ANN ENTOMOL SOC AMER, V56, P53; KAMP JW, 1979, CAN ENTOMOL, V111, P27, DOI 10.4039/Ent11127-1; Kim BW, 2007, ZOOL SCI, V24, P733, DOI 10.2108/zsj.24.733; Levine RS, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-7; MARCUS LF, 1993, CONTRIHUTIONS MORPHO; NAMKUNG J, 1974, Korean Journal of Entomology, V4, P1; Namkung J., 1974, Korean J Ent, V4, P91; Novokshonov VG, 1999, NEUES JAHRB GEOL P M, P193; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; PRAVDIN F N, 1977, Entomologicheskoe Obozrenie, V56, P352; Pretorius E, 2001, BIOL J LINN SOC, V74, P35, DOI 10.1111/j.1095-8312.2001.tb01375.x; PRITCHARD G, 1978, CAN ENTOMOL, V110, P205, DOI 10.4039/Ent110205-2; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V175, P150; RASNITSYN AP, 1976, DOKL AKAD NAUK SSSR+, V228, P502; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Rohlf, 2007, NTSYS PC NUMERICAL T; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rohlf F.J., 2003, TPS SMALL VERSION 1; Rohlf F. J., 2018, TPSUTIL VERSION 1 76; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf F.J., 2006, TPS UTIL FILE UTILIT; Rohlf FJ, 2006, TPS RELW RELATIVE WA; ROHLF FJ, 1990, ORDINATIONS STUDY MO; Rohlf FJ, 2004, TPS SPLIN THIN PLATE; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Storozhenko S., 1988, Articulata, V3, P167; Storozhenko S. Y., 1996, ZOOSYSTEMATICA ROSSI, V4, P320; Storozhenko S.Yu., 1996, Chteniya Pamyati Alekseya Ivanovicha Kurentsova, V6, P13; Storozhenko S.Yu., 1984, Entomologicheskoe Obozrenie, V63, P729; Storozhenko S.Yu., 2002, Far Eastern Entomologist, V114, P18; Storozhenko S. Yu., 1997, Far Eastern Entomologist, V42, P1; Storozhenko S.Yu., 1992, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, V41, P122; STOROZHENKO SY, 1988, PALEONTOL ZH, P48; SYu Storozhenko, 1996, RUSSIAN ENTOMOLOGICA, V19, P115; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; *U CFIESINCC, 2005, GRIDD POP WORLD FUT; *U CFIESINCC CIAT, 2005, GRIDD POP WORLD VERS; Vrsansky P, 2001, ANN ENTOMOL SOC AM, V94, P179, DOI 10.1603/0013-8746(2001)094[0179:GOSNGG]2.0.CO;2; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Walker E. M., 1914, Canadian Entomologist, V46; WANG SY, 1987, ACTA ENTOMOL SINICA, V30, P423; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Winkler S, 2010, GEOMORPHOLOGY, V116, P87, DOI 10.1016/j.geomorph.2009.10.011; Zalessky G., 1938, Annales de la Societe Geologique du Nord, V63, P62; Zemp M., 2008, GLOBAL GLACIER CHANG; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	73	23	34	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12850	10.1371/journal.pone.0012850	http://dx.doi.org/10.1371/journal.pone.0012850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877572	Green Published, Green Submitted, gold			2022-12-25	WOS:000282053100017
J	Doherty, HE; Kim, HS; Hiller, S; Sulik, KK; Maeda, N				Doherty, Heather E.; Kim, Hyung-Suk; Hiller, Sylvia; Sulik, Kathleen K.; Maeda, Nobuyo			A Mouse Strain Where Basal Connective Tissue Growth Factor Gene Expression Can Be Switched from Low to High	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; EMBRYOS LACKING; LIVER FIBROSIS; BLOOD-PRESSURE; TGF-BETA; MICE; CELLS; OVEREXPRESSION; REPAIR; CTGF	Connective tissue growth factor (CTGF) is a signaling molecule that primarily functions in extracellular matrix maintenance and repair. Increased Ctgf expression is associated with fibrosis in chronic organ injury. Studying the role of CTGF in fibrotic disease in vivo, however, has been hampered by perinatal lethality of the Ctgf null mice as well as the limited scope of previous mouse models of Ctgf overproduction. Here, we devised a new approach and engineered a single mutant mouse strain where the endogenous Ctgf-3' untranslated region (3'UTR) was replaced with a cassette containing two 3'UTR sequences arranged in tandem. The modified Ctgf allele uses a 3'UTR from the mouse FBJ osteosarcoma oncogene (c-Fos) and produces an unstable mRNA, resulting in 60% of normal Ctgf expression (Lo allele). Upon Cre-expression, excision of the c-Fos-3'UTR creates a transcript utilizing the more stable bovine growth hormone (bGH) 3'UTR, resulting in increased Ctgf expression (Hi allele). Using the Ctgf Lo and Hi mutants, and crosses to a Ctgf knockout or Cre-expressing mice, we have generated a series of strains with a 30-fold range of Ctgf expression. Mice with the lowest Ctgf expression, 30% of normal, appear healthy, while a global nine-fold overexpression of Ctgf causes abnormalities, including developmental delay and craniofacial defects, and embryonic death at E10-12. Overexpression of Ctgf by tamoxifen-inducible Cre in the postnatal life, on the other hand, is compatible with life. The Ctgf Lo-Hi mutant mice should prove useful in further understanding the function of CTGF in fibrotic diseases. Additionally, this method can be used for the production of mouse lines with quantitative variations in other genes, particularly with genes that are broadly expressed, have distinct functions in different tissues, or where altered gene expression is not compatible with normal development.	[Doherty, Heather E.; Maeda, Nobuyo] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Doherty, Heather E.; Kim, Hyung-Suk; Hiller, Sylvia; Maeda, Nobuyo] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Sulik, Kathleen K.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Sulik, Kathleen K.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Doherty, HE (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	nobuyo@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Doherty, Heather/D-8199-2011		National Institutes of Health [HL042630, HL077145]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042630, R01HL042630, R01HL077145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge funding from the National Institutes of Health (www.nih.gov), grant numbers HL042630 and HL077145. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cheng O, 2006, AM J TRANSPLANT, V6, P2292, DOI 10.1111/j.1600-6143.2006.01493.x; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gonzalez A, 2002, EUR HEART J SUPPL, V4, pD18, DOI 10.1016/S1520-765X(02)90156-2; Gordois A, 2004, J DIABETES COMPLICAT, V18, P18, DOI 10.1016/S1056-8727(03)00035-7; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gupta AK, 2008, ENT-EAR NOSE THROAT, V87, P291, DOI 10.1177/014556130808700514; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEFFNER C, 2010, STRAIN NAME FVB N TG; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jacobsson C, 1997, SCAND J PLAST RECONS, V31, P125, DOI 10.3109/02844319709085479; Kakoki M, 2004, DEV CELL, V6, P597, DOI 10.1016/S1534-5807(04)00094-2; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Kwon S, 2007, INT J ONCOL, V31, P693; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leamy LJ, 2005, GENET SEL EVOL, V37, P151, DOI 10.1051/gse:2004042; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Ren SY, 2009, KIDNEY INT, V76, P857, DOI 10.1038/ki.2009.297; Riser BL, 2003, KIDNEY INT, V64, P451, DOI 10.1046/j.1523-1755.2003.00130.x; RYSECK RP, 1991, CELL GROWTH DIFFER, V2, P225; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Smerdel-Ramoya' A, 2008, ENDOCRINOLOGY, V149, P4374, DOI 10.1210/en.2008-0254; SONNYLAL S, ARTHRITIS RHEUM, V62, P1523; SULIK KK, 1982, SCAN ELECTRON MICROS, P309; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tikellis C, 2004, ENDOCRINOLOGY, V145, P860, DOI 10.1210/en.2003-0967; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Tsai YS, 2009, P NATL ACAD SCI USA, V106, P19084, DOI 10.1073/pnas.0909657106; Tsai YS, 2009, MOL ENDOCRINOL, V23, P1787, DOI 10.1210/me.2009-0073; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Williams EJ, 1998, POSTGRAD MED J, V74, P193, DOI 10.1136/pgmj.74.870.193; WU S, AM J RESP CELL MOL B, V42, P552; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12909	10.1371/journal.pone.0012909	http://dx.doi.org/10.1371/journal.pone.0012909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877562	Green Published, gold, Green Submitted			2022-12-25	WOS:000282053100033
J	Radulescu, AR				Radulescu, Anca R.			Mechanisms Explaining Transitions between Tonic and Phasic Firing in Neuronal Populations as Predicted by a Low Dimensional Firing Rate Model	PLOS ONE			English	Article							NIGRAL DOPAMINERGIC-NEURONS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; EXTRACELLULAR ELECTROPHYSIOLOGY; BIOPHYSICAL MODEL; SPIKING NEURONS; NEURAL-NETWORKS; ANTENNAL LOBES; SINGLE NEURON; ANIMAL-MODEL; AREA NEURONS	Several firing patterns experimentally observed in neural populations have been successfully correlated to animal behavior. Population bursting, hereby regarded as a period of high firing rate followed by a period of quiescence, is typically observed in groups of neurons during behavior. Biophysical membrane-potential models of single cell bursting involve at least three equations. Extending such models to study the collective behavior of neural populations involves thousands of equations and can be very expensive computationally. For this reason, low dimensional population models that capture biophysical aspects of networks are needed. The present paper uses a firing-rate model to study mechanisms that trigger and stop transitions between tonic and phasic population firing. These mechanisms are captured through a two-dimensional system, which can potentially be extended to include interactions between different areas of the nervous system with a small number of equations. The typical behavior of midbrain dopaminergic neurons in the rodent is used as an example to illustrate and interpret our results. The model presented here can be used as a building block to study interactions between networks of neurons. This theoretical approach may help contextualize and understand the factors involved in regulating burst firing in populations and how it may modulate distinct aspects of behavior.	[Radulescu, Anca R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Radulescu, Anca R.] SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Radulescu, AR (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80309 USA.	radulesc@colorado.edu	Radulescu, Anca/GYR-1316-2022	Radulescu, Anca/0000-0002-2681-7233				AVRON E, 1993, BIOL CYBERN, V69, P87, DOI 10.1007/BF00201411; AVRON E, 1991, BIOL CYBERN, V65, P487, DOI 10.1007/BF00204662; Bailey EF, 2001, J PHYSIOL-LONDON, V532, P525, DOI 10.1111/j.1469-7793.2001.0525f.x; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Brozovic M, 2008, J COMPUT NEUROSCI, V25, P158, DOI 10.1007/s10827-007-0070-6; BUCHANAN JT, 1992, BIOL CYBERN, V66, P367, DOI 10.1007/BF00203673; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cateau H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058101; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; Gonon F, 1997, J NEUROSCI, V17, P5972; GRACE AA, 1983, NEUROSCIENCE, V10, P317, DOI 10.1016/0306-4522(83)90136-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Guckenheimer J., 1990, NONLINEAR OSCILLATIO; He JF, 2002, J NEUROPHYSIOL, V88, P2152, DOI 10.1152/jn.2002.88.4.2152; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Heinz A, 2009, BIOL PSYCHIAT, V65, P101, DOI 10.1016/j.biopsych.2008.11.003; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; IZHIKEVICH E, 2006, DYNAMICAL SYSTEMS NE, P267; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kauffman S.A., 1993, ORIGINS ORDER; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Knight BW, 2000, NEURAL COMPUT, V12, P1045, DOI 10.1162/089976600300015493; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P767, DOI 10.1085/jgp.59.6.767; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Komendantov AO, 2002, J NEUROPHYSIOL, V87, P1526, DOI 10.1152/jn.00255.2001; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; KUZNETSOV Y, 1995, APPL MATH SCI, V112, P295; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lodge DJ, 2007, J NEUROSCI, V27, P11424, DOI 10.1523/JNEUROSCI.2847-07.2007; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Lokwan SJA, 1999, NEUROSCIENCE, V92, P245, DOI 10.1016/S0306-4522(98)00748-9; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; McCrimmon DR, 1997, RESP PHYSIOL, V110, P161, DOI 10.1016/S0034-5687(97)00081-9; MEADORWOODRUFF JH, 1994, P NATL ACAD SCI USA, V91, P8297, DOI 10.1073/pnas.91.17.8297; Medvedev GS, 2001, SIAM J APPL MATH, V61, P1762, DOI 10.1137/S0036139900368807; Meller R, 2003, CELL DEATH DIFFER, V10, P539, DOI 10.1038/sj.cdd.4401206; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nykamp DQ, 2000, J COMPUT NEUROSCI, V8, P19, DOI 10.1023/A:1008912914816; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Plenz D., 2009, ARXIV09125369; PULVER SR, 2009, NAT NEUROSCI, V13, P53; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Rozental R, 1998, J NEUROSCI, V18, P1753; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schumann D, 1998, RADIOCHIM ACTA, V80, P1; Sil'kis I G, 2008, Neurosci Behav Physiol, V38, P399, DOI 10.1007/s11055-008-0057-4; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; SQALLIHOUSSAINI Y, 1993, J NEUROPHYSIOL, V70, P803, DOI 10.1152/jn.1993.70.2.803; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Terada K, 2000, ELECTRON COMM JPN 3, V83, P86, DOI 10.1002/(SICI)1520-6440(200006)83:6<86::AID-ECJC10>3.0.CO;2-C; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Toyoizumi T, 2009, NEURAL COMPUT, V21, P1203, DOI 10.1162/neco.2008.04-08-757; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Vandecasteele M, 2005, J NEUROSCI, V25, P291, DOI 10.1523/JNEUROSCI.4167-04.2005; Varkonyi PL, 2008, J COMPUT NEUROSCI, V25, P245, DOI 10.1007/s10827-008-0076-8; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; WILLIAMS TL, 1992, SCIENCE, V258, P662, DOI 10.1126/science.1411575; Wilson CJ, 2004, J NEUROPHYSIOL, V91, P1963, DOI 10.1152/jn.00924.2003; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008; Zhang X, 2002, J NEUROSCI, V22, P6052; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106; [No title captured]	87	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12695	10.1371/journal.pone.0012695	http://dx.doi.org/10.1371/journal.pone.0012695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877649	Green Submitted, Green Published, gold			2022-12-25	WOS:000282053100004
J	Hendrickson, SL; Lautenberger, JA; Chinn, LW; Malasky, M; Sezgin, E; Kingsley, LA; Goedert, JJ; Kirk, GD; Gomperts, ED; Buchbinder, SP; Troyer, JL; O'Brien, SJ				Hendrickson, Sher L.; Lautenberger, James A.; Chinn, Leslie Wei; Malasky, Michael; Sezgin, Efe; Kingsley, Lawrence A.; Goedert, James J.; Kirk, Gregory D.; Gomperts, Edward D.; Buchbinder, Susan P.; Troyer, Jennifer L.; O'Brien, Stephen J.			Genetic Variants in Nuclear-Encoded Mitochondrial Genes Influence AIDS Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HIV-1 INFECTION; EXPRESSION; DNA; IDENTIFICATION; ASSOCIATION; HEMOPHILIA; CARCINOMA; ISOMERASE	Background: The human mitochondrial genome includes only 13 coding genes while nuclear-encoded genes account for 99% of proteins responsible for mitochondrial morphology, redox regulation, and energetics. Mitochondrial pathogenesis occurs in HIV patients and genetically, mitochondrial DNA haplogroups with presumed functional differences have been associated with differential AIDS progression. Methodology/Principal Findings: Here we explore whether single nucleotide polymorphisms (SNPs) within 904 of the estimated 1,500 genes that specify nuclear-encoded mitochondrial proteins (NEMPs) influence AIDS progression among HIV-1 infected patients. We examined NEMPs for association with the rate of AIDS progression using genotypes generated by an Affymetrix 6.0 genotyping array of 1,455 European American patients from five US AIDS cohorts. Successfully genotyped SNPs gave 50% or better haplotype coverage for 679 of known NEMP genes. With a Bonferroni adjustment for the number of genes and tests examined, multiple SNPs within two NEMP genes showed significant association with AIDS progression: acyl-CoA synthetase medium-chain family member 4 (ACSM4) on chromosome 12 and peroxisomal D3, D2-enoyl-CoA isomerase (PECI) on chromosome 6. Conclusions: Our previous studies on mitochondrial DNA showed that European haplogroups with presumed functional differences were associated with AIDS progression and HAART mediated adverse events. The modest influences of nuclear-encoded mitochondrial genes found in the current study add support to the idea that mitochondrial function plays a role in AIDS pathogenesis.	[Hendrickson, Sher L.; Lautenberger, James A.; Chinn, Leslie Wei; Sezgin, Efe; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Malasky, Michael; Troyer, Jennifer L.] SAIC Frederick Inc, Lab Genom Divers, Frederick, MD USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Bethesda, MD 20892 USA; [Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gomperts, Edward D.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Buchbinder, Susan P.] San Francisco City Clin, Dept Publ Hlth, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Children's Hospital Los Angeles	Hendrickson, SL (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21701 USA.	hendricksons@mail.nih.gov	Sezgin, Efe/B-8418-2012; Troyer, Jennifer/B-8415-2012; OBRIEN, STEPHEN/ABD-1346-2020	Sezgin, Efe/0000-0002-8000-7485; Chinn, Leslie/0000-0003-3127-6758; OBRIEN, STEPHEN/0000-0001-7857-0757; Kingsley, Lawrence/0000-0002-7000-8556	National Cancer Institute [N02-CP-55504, UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; National Institutes of Health [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041, HHSN261200800001E, N01-CO-12400, R01-DA-04334, R01-DA-12568, M01 RR00425]; National Center for Research Resources at Harbor-UCLA Research and Education Institute; National Institute of Child Health; Human Development [1 R01 HD41224]; NATIONAL CANCER INSTITUTE [ZIABC010317] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at Harbor-UCLA Research and Education Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (contract HHSN261200800001E). ALIVE was supported by NIH grants R01-DA-04334 and R01-DA-12568. MACS work was supported by NIH grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041 and M01 RR00425 (National Center for Research Resources grant awarded to the GCRC at Harbor-UCLA Research and Education Institute). The MHCS is supported by National Cancer Institute contract N02-CP-55504 with RTI International. The HGDS is funded by the National Institutes of Health, National Institute of Child Health and Human Development, 1 R01 HD41224. National Cancer Institute contracts include: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V21, p1S; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; CHAN EY, DYNAMIC HOST ENERGET; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; COX DR, 1972, J R STAT SOC B, V34, P187; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Geisbrecht BV, 1999, J BIOL CHEM, V274, P21797, DOI 10.1074/jbc.274.31.21797; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Imbeault M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-5; Janssen U, 2002, J BIOL CHEM, V277, P19579, DOI 10.1074/jbc.M110993200; Jaruga P, 2002, FREE RADICAL BIO MED, V32, P414, DOI 10.1016/S0891-5849(01)00821-8; KAMEOKA M, 1993, FEBS LETT, V331, P182, DOI 10.1016/0014-5793(93)80322-L; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Olinski R, 2002, FREE RADICAL BIO MED, V33, P192, DOI 10.1016/S0891-5849(02)00878-X; Oosthuizen W, 2006, AM J CLIN NUTR, V83, P1193, DOI 10.1093/ajcn/83.5.1193; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; Scanlan M J, 2001, Cancer Immun, V1, P4; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Shedlock DJ, 2008, APOPTOSIS, V13, P1088, DOI 10.1007/s10495-008-0239-0; Suk K, 1999, BBA-MOL BASIS DIS, V1454, P126, DOI 10.1016/S0925-4439(99)00033-2; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; TROYER JL, LANCET UNPUB; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wen WR, 2005, VIRUS RES, V113, P26, DOI 10.1016/j.virusres.2005.04.002; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	42	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12862	10.1371/journal.pone.0012862	http://dx.doi.org/10.1371/journal.pone.0012862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877624	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000282002900012
J	Mulrennan, S; Tempone, SS; Ling, ITW; Williams, SH; Gan, GC; Murray, RJ; Speers, DJ				Mulrennan, Siobhain; Tempone, Simone Sara; Ling, Ivan Thian Wai; Williams, Simon Hedley; Gan, Gek-Choo; Murray, Ronan John; Speers, David John			Pandemic Influenza (H1N1) 2009 Pneumonia: CURB-65 Score for Predicting Severity and Nasopharyngeal Sampling for Diagnosis Are Unreliable	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RAPID-TEST SENSITIVITY; A H1N1; UNITED-STATES; VIRUS; HUMANS	Background: From the first case reports of pandemic influenza (H1N1) 2009 it was clear that a significant proportion of infected individuals suffered a primary viral pneumonia. The objective of this study was twofold; to assess the utility of the CURB-65 community acquired pneumonia (CAP) severity index in predicting pneumonia severity and ICU admission, and to assess the relative sensitivity of nasopharyngeal versus lower respiratory tract sampling for the detection of pandemic influenza (H1N1) CAP. Methods: A retrospective cohort study of 70 patients hospitalised for pandemic influenza (H1N1) 2009 in an adult tertiary referral hospital. Characteristics evaluated included age, pregnancy status, sex, respiratory signs and symptoms, smoking and alcohol history, CURB-65 score, co-morbidities, disabling sequelae, length of stay and in-hospital mortality outcomes. Laboratory features evaluated included lymphocyte count, C-reactive protein (CRP), nasopharyngeal and lower respiratory tract pandemic influenza (H1N1) 2009 PCR results. Results: Patients with pandemic (H1N1) 2009 influenza CAP differed significantly from those without pneumonia regarding length of stay, need for ICU admission, CRP and the likelihood of disabling sequelae. The CURB-65 score did not predict CAP severity or the need for ICU admission (only 2/11 patients admitted to ICU had CURB-65 scores of 2 or 3). Nasopharyngeal specimens for PCR were only 62.9% sensitive in CAP patients compared to 97.8% sensitivity for lower respiratory tract specimens. Conclusions: The CURB-65 score does not predict severe pandemic influenza (H1N1) 2009 CAP or need for ICU admission. Lower respiratory tract specimens should be collected when pandemic (H1N1) 2009 influenza CAP is suspected.	[Mulrennan, Siobhain; Ling, Ivan Thian Wai] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Tempone, Simone Sara; Williams, Simon Hedley; Murray, Ronan John; Speers, David John] PathWest Lab Med Western Australia, Dept Microbiol, Nedlands, WA, Australia; [Gan, Gek-Choo] Sir Charles Gairdner Hosp, Dept Radiol, Nedlands, WA 6009, Australia; [Murray, Ronan John] Sir Charles Gairdner Hosp, Dept Infect Dis, Nedlands, WA 6009, Australia; [Speers, David John] Univ Western Australia, Dept Med & Pharmacol, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Mulrennan, S (corresponding author), Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia.	Siobhain.Mulrennan@health.wa.gov.au		Ling, Ivan/0000-0003-1429-3476; Williams, Simon/0000-0002-6276-4685				*AUSTR GOV DEP HLT, 2009, 24 AUSTR GOV DEP HLT; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; *NAT HLTH MED RES, 2003, DOES QUAL ASS HEALTH; NHMRC, 2018, NAT STAT ETH COND HU; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Whiley DM, 2005, DIAGN MICR INFEC DIS, V53, P335, DOI 10.1016/j.diagmicrobio.2005.08.002; 2009, MMWR MORB MORTAL WKL, V58, P497	15	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12849	10.1371/journal.pone.0012849	http://dx.doi.org/10.1371/journal.pone.0012849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877727	Green Published, gold, Green Submitted			2022-12-25	WOS:000282002900008
J	Agnarsson, I; Kuntner, M; Blackledge, TA				Agnarsson, Ingi; Kuntner, Matjaz; Blackledge, Todd A.			Bioprospecting Finds the Toughest Biological Material: Extraordinary Silk from a Giant Riverine Orb Spider	PLOS ONE			English	Article							WEAVING SPIDERS; MECHANICAL-PROPERTIES; DRAGLINE SILK; CAPTURE THREADS; FORCED SILKING; EVOLUTION; WEB; PERFORMANCE; BIOMATERIAL; PREY	Background: Combining high strength and elasticity, spider silks are exceptionally tough, i.e., able to absorb massive kinetic energy before breaking. Spider silk is therefore a model polymer for development of high performance biomimetic fibers. There are over 41.000 described species of spiders, most spinning multiple types of silk. Thus we have available some 200.000+ unique silks that may cover an amazing breadth of material properties. To date, however, silks from only a few tens of species have been characterized, most chosen haphazardly as model organisms (Nephila) or simply from researchers' backyards. Are we limited to 'blindly fishing' in efforts to discover extraordinary silks? Or, could scientists use ecology to predict which species are likely to spin silks exhibiting exceptional performance properties? Methodology: We examined the biomechanical properties of silk produced by the remarkable Malagasy 'Darwin's bark spider' (Caerostris darwini), which we predicted would produce exceptional silk based upon its amazing web. The spider constructs its giant orb web (up to 2.8 m(2)) suspended above streams, rivers, and lakes. It attaches the web to substrates on each riverbank by anchor threads as long as 25 meters. Dragline silk from both Caerostris webs and forcibly pulled silk, exhibits an extraordinary combination of high tensile strength and elasticity previously unknown for spider silk. The toughness of forcibly silked fibers averages 350 MJ/m(3), with some samples reaching 520 MJ/m3. Thus, C. darwini silk is more than twice tougher than any previously described silk, and over 10 times better than Kevlar (R). Caerostris capture spiral silk is similarly exceptionally tough. Conclusions: Caerostris darwini produces the toughest known biomaterial. We hypothesize that this extraordinary toughness coevolved with the unusual ecology and web architecture of these spiders, decreasing the likelihood of bridgelines breaking and collapsing the web into the river. This hypothesis predicts that rapid change in material properties of silk co-occurred with ecological shifts within the genus, and can thus be tested by combining material science, behavioral observations, and phylogenetics. Our findings highlight the potential benefits of natural history-informed bioprospecting to discover silks, as well as other materials, with novel and exceptional properties to serve as models in biomimicry.	[Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA; [Agnarsson, Ingi; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); University System of Ohio; University of Akron; University System of Ohio; University of Akron	Agnarsson, I (corresponding author), Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA.	iagnarsson@gmail.com	Kuntner, Matjaz/AAE-2195-2020		Slovenian Research Agency [Z1-9799-0618-07]; National Geographic Society [8655-09]; National Science Foundation [DBI-0521261, DEB-0516038, IOS-0745379]; European Community [MIRG-CT-2005 036536]; Sallee Charitable Trust; United States National Science Foundation [DEB-9712353]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); European Community(European Commission); Sallee Charitable Trust; United States National Science Foundation(National Science Foundation (NSF))	Primary funding for this work came from the Slovenian Research Agency (grant Z1-9799-0618-07 to I. Agnarsson), the National Geographic Society (grant 8655-09 to the authors), and the National Science Foundation (grants DBI-0521261, DEB-0516038 and IOS-0745379 to T. Blackledge). Additional funding came from the European Community 6th Framework Programme (a Marie Curie International Reintegration Grant MIRG-CT-2005 036536 to M. Kuntner). The 2001 field work was supported by the Sallee Charitable Trust grant to I. Agnarsson and M. Kuntner and by a United States National Science Foundation grant (DEB-9712353) to G. Hormiga and J. A. Coddington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x; Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480; Agnarsson I, 2009, J EXP BIOL, V212, P1989, DOI 10.1242/jeb.028282; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597; Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; BOOTH C, 1989, COMPREHENSIVE POLYM; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003; EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013; Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c; Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245; Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1; Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162; Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1111/j.1095-8312.2000.tb00203.x; OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115; Opell BD, 2001, EVOL ECOL RES, V3, P567; Opell BD, 2006, ZOOLOGY, V109, P339, DOI 10.1016/j.zool.2006.04.002; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3; Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038; SENSENIG A, 2010, J EVOLUTION IN PRESS, V23; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420; Swanson BO, 2006, EVOLUTION, V60, P2539; Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013; Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068	39	174	180	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e11234	10.1371/journal.pone.0011234	http://dx.doi.org/10.1371/journal.pone.0011234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20856804	Green Published, gold, Green Submitted			2022-12-25	WOS:000281864100001
J	Delaney, KS; Riley, SPD; Fisher, RN				Delaney, Kathleen Semple; Riley, Seth P. D.; Fisher, Robert N.			A Rapid, Strong, and Convergent Genetic Response to Urban Habitat Fragmentation in Four Divergent and Widespread Vertebrates	PLOS ONE			English	Article							JERUSALEM CRICKET ORTHOPTERA; SKINKS EGERNIA-CUNNINGHAMI; MICROSATELLITE LOCI; POPULATION-STRUCTURE; DISPERSAL; EXTINCTION; ROADS; DIVERSITY; DIFFERENTIATION; PATTERNS	Background: Urbanization is a major cause of habitat fragmentation worldwide. Ecological and conservation theory predicts many potential impacts of habitat fragmentation on natural populations, including genetic impacts. Habitat fragmentation by urbanization causes populations of animals and plants to be isolated in patches of suitable habitat that are surrounded by non-native vegetation or severely altered vegetation, asphalt, concrete, and human structures. This can lead to genetic divergence between patches and in turn to decreased genetic diversity within patches through genetic drift and inbreeding. Methodology/Principal Findings: We examined population genetic patterns using microsatellites in four common vertebrate species, three lizards and one bird, in highly fragmented urban southern California. Despite significant phylogenetic, ecological, and mobility differences between these species, all four showed similar and significant reductions in gene flow over relatively short geographic and temporal scales. For all four species, the greatest genetic divergence was found where development was oldest and most intensive. All four animals also showed significant reduction in gene flow associated with intervening roads and freeways, the degree of patch isolation, and the time since isolation. Conclusions/Significance: Despite wide acceptance of the idea in principle, evidence of significant population genetic changes associated with fragmentation at small spatial and temporal scales has been rare, even in smaller terrestrial vertebrates, and especially for birds. Given the striking pattern of similar and rapid effects across four common and widespread species, including a volant bird, intense urbanization may represent the most severe form of fragmentation, with minimal effective movement through the urban matrix.	[Delaney, Kathleen Semple] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Delaney, Kathleen Semple; Riley, Seth P. D.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA; [Fisher, Robert N.] US Geol Survey, San Diego Field Stn, San Diego, CA USA	University of California System; University of California Los Angeles; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Delaney, KS (corresponding author), Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA.	Katy_Delaney@nps.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240	Western office of the National Resources	Western office of the National Resources	The source of funding was a USGS grant from the Western office of the National Resources Preservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1995, CONDOR, V97, P663, DOI 10.2307/1369175; Barnett JR, 2008, CONSERV GENET, V9, P1403, DOI 10.1007/s10592-007-9463-3; Bjorklund M, 2010, BIOL J LINN SOC, V99, P9, DOI 10.1111/j.1095-8312.2009.01335.x; BOLGER DT, 1991, AM NAT, V137, P155, DOI 10.1086/285151; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Busteed GT, 2003, EFFECTS HABITAT FRAG; CAMPBELL HW, 1982, 13 US DEP INT FISH W, P193; Case TJ, 2001, SPATIAL UNCERTAINTY IN ECOLOGY, P47; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Coughlan JP, 2004, MOL ECOL NOTES, V4, P678, DOI 10.1111/j.1471-8286.2004.00782.x; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Donnelly M. A., 1994, MEASURING MONITORING, P277; DOUGHTY P, 1994, J HERPETOL, V28, P485, DOI 10.2307/1564962; DOUGHTY P, 1994, ANIM BEHAV, V47, P227, DOI 10.1006/anbe.1994.1029; Fisher RN, 2002, CONSERV BIOL, V16, P205, DOI 10.1046/j.1523-1739.2002.00326.x; FITCH HS, 1977, HERPETOLOGICA, V33, P303; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R., 2006, CONNECTIVITY CONSERV, P72; GEUPEL GR, WRENTIT CHAMAEA FASC; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; GOUDET J, 2002, FSTAT SOFTWARE ESTIM; *GOV EX LAND US DA, 2005, LAND US DAT COUNT IM; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Howes BJ, 2004, MOL ECOL NOTES, V4, P237, DOI 10.1111/j.1471-8286.2004.00628.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Koenig J, 2001, WILDLIFE RES, V28, P215, DOI 10.1071/WR00068; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lynch M, 1999, GENETICS, V152, P1753; Magle SB, 2010, J MAMMAL, V91, P326, DOI 10.1644/09-MAMM-A-019.1; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Massot M, 2003, BEHAV ECOL, V14, P650, DOI 10.1093/beheco/arg056; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Moore JA, 2008, MOL ECOL, V17, P4630, DOI 10.1111/j.1365-294X.2008.03951.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Mylecraine KA, 2008, CONSERV GENET, V9, P1633, DOI 10.1007/s10592-008-9518-0; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Noel S, 2007, CONSERV GENET, V8, P599, DOI 10.1007/s10592-006-9202-1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Redeker S, 2006, MAMM BIOL, V71, P144, DOI 10.1016/j.mambio.2005.12.003; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2002, CONSERV GENET, V3, P301, DOI 10.1023/A:1019948130263; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2000, MOL ECOL, V9, P2226; RICHMOND JQ, 2008, CONSERV GENET, V10, P1291; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwacke L, 2005, RERAT RELATEDNESS ES; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sinervo B, 2006, AM NAT, V168, P88, DOI 10.1086/505765; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Stebbins R. C., 1954, AMPHIBIANS REPTILES; Stow AJ, 2004, MOL ECOL, V13, P419, DOI 10.1046/j.1365-294X.2003.02061.x; Stow AJ, 2004, MOL ECOL, V13, P443, DOI 10.1046/j.1365-294X.2003.02060.x; Sumner J, 2005, CONSERV GENET, V6, P333, DOI 10.1007/s10592-005-4959-1; Sumner J, 2004, MOL ECOL, V13, P259, DOI 10.1046/j.1365-294X.2003.02056.x; Syphard AD, 2005, ECOL COMPLEX, V2, P185, DOI 10.1016/j.ecocom.2004.11.003; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Veit ML, 2005, CONSERV GENET, V6, P159, DOI 10.1007/s10592-004-7831-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	85	147	149	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12767	10.1371/journal.pone.0012767	http://dx.doi.org/10.1371/journal.pone.0012767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862274	Green Submitted, Green Published, gold			2022-12-25	WOS:000281864100013
J	Shin, YJ; Bleris, L				Shin, Yong-Jun; Bleris, Leonidas			Linear Control Theory for Gene Network Modeling	PLOS ONE			English	Article							REGULATORY NETWORKS; SYNTHETIC BIOLOGY; EXPRESSION; CIRCUIT; NOISE; SYSTEMS; ROBUST; MOTIFS	Systems biology is an interdisciplinary field that aims at understanding complex interactions in cells. Here we demonstrate that linear control theory can provide valuable insight and practical tools for the characterization of complex biological networks. We provide the foundation for such analyses through the study of several case studies including cascade and parallel forms, feedback and feedforward loops. We reproduce experimental results and provide rational analysis of the observed behavior. We demonstrate that methods such as the transfer function (frequency domain) and linear state-space (time domain) can be used to predict reliably the properties and transient behavior of complex network topologies and point to specific design strategies for synthetic networks.	[Shin, Yong-Jun; Bleris, Leonidas] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA; [Bleris, Leonidas] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Shin, YJ (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA.	yshin@cornell.edu; bleris@utdallas.edu						Alberts B, 2002, MOL BIOL CELL; Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anderson BDO., 1990, OPTIMAL CONTROL LINE; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BLERIS LG, 2009, SYSTEMS BIOL HUMAN D; Bolouri H, 2008, COMPUTATIONAL MODELI; Brogan W. L., 1991, MODERN CONTROL THEOR; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; DASGUPTA B, 2010, ALGORITHMS COMPUTATI; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Iglesias PA, 2009, CONTROL THEORY SYSTE; Iglesias PA., 2010, CONTROL THEORY SYSTE; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOHANE IS, 2005, MICROARRAYS INTEGRAT; Lathi B.P., 2002, LINEAR SYSTEMS SIGNA; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nise NS, 2000, CONTROL SYSTEMS ENG; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schilstra MJ, 2008, ARTIF LIFE, V14, P121, DOI 10.1162/artl.2008.14.1.121; SCHWEICKHARDT T, 2004, QUANTITATIVE NONLINE; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009376; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Simon D., 2006, OPTIMAL STATE ESTIMA; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Skogestad S, 1996, MULTIVARIABLE FEEDBA; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Steggles LJ, 2007, BIOINFORMATICS, V23, P336, DOI 10.1093/bioinformatics/btl596; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Strang G., 2007, COMPUTATIONAL SCI EN; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Yuh Chiou-Hwa, 2001, P73	58	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12785	10.1371/journal.pone.0012785	http://dx.doi.org/10.1371/journal.pone.0012785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862288	Green Published, Green Submitted, gold			2022-12-25	WOS:000281864100020
J	Bentley, JP; Asselbergs, FW; Coffey, CS; Hebert, PR; Moore, JH; Hillege, HL; van Gilst, WH				Bentley, John P.; Asselbergs, Folkert W.; Coffey, Christopher S.; Hebert, Patricia R.; Moore, Jason H.; Hillege, Hans L.; van Gilst, Wiek H.			Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CONVERTING-ENZYME GENE; MULTIFACTOR-DIMENSIONALITY REDUCTION; PLASMA T-PA; URINARY ALBUMIN EXCRETION; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; INSERTION/DELETION POLYMORPHISM; VENOUS THROMBOEMBOLISM; DELETION POLYMORPHISM	Background: Vascular fibrinolytic balance is maintained primarily by interplay of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1). Previous research has shown that polymorphisms in genes from the reninangiotensin (RA), bradykinin, and fibrinolytic systems affect plasma concentrations of both t-PA and PAI-1 through a set of gene-gene interactions. In the present study, we extend this finding by exploring the effects of polymorphisms in genes from these systems on incident cardiovascular disease, explicitly examining two-way interactions in a large population-based study. Methodology/Principal Findings: Data from the population-based PREVEND study in Groningen, The Netherlands (n = 8,138) were analyzed. The effects of the polymorphisms and their interactions on cardiovascular events were analyzed via Cox proportional hazards models. There was no association between five of the six polymorphisms singly and risk of cardiovascular disease. There was a significant main effect for the ACE I/D polymorphism for both dominant and additive coding schemes. There were significant interactions between the following polymorphism pairs even after adjustment for known risk factors: ACE I/D & PAI-1 4G/5G (p = 0.012), BDKRB2 C181T & ACE I/D (p = 0.016), BDKRB2 C58T & ACE I/D (p = 0.025), BDKRB2 exon 1 I/D & AT1R A1166C (p = 0.017), and BDKRB2 C58T & AT1R A1166C (p = 0.015). Conclusions/Significance: This study suggests possible interactions between genes from the RA, bradykinin, and fibrinolytic systems on the risk of cardiovascular disease, extending previous research that has demonstrated that interactions among genes from these systems influence plasma concentrations of both t-PA and PAI-1. Further explorations of these interactions are needed.	[Bentley, John P.] Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Coffey, Christopher S.] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Hebert, Patricia R.] Florida Atlantic Univ, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Asselbergs, Folkert W.; Hillege, Hans L.] Univ Groningen, Dept Cardiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Gilst, Wiek H.] Univ Groningen, Dept Expt Cardiol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Mississippi; Utrecht University; Utrecht University Medical Center; University of Iowa; State University System of Florida; Florida Atlantic University; Dartmouth College; Dartmouth College; University of Groningen; University of Groningen	Bentley, JP (corresponding author), Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA.	f.w.asselbergs@umcutrecht.nl	van Gilst, Wiek H/C-3828-2008; Moore, Jason H./AAV-9645-2021; van Gilst, Wiek/R-1806-2019; Asselbergs, Folkert W./ABD-6752-2021	Moore, Jason H./0000-0002-5015-1099; van Gilst, Wiek/0000-0003-2968-8585; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health (NIH) [HL65234, HL67466, RR018787, LM010098]; Netherlands Kidney Foundation [E. 013]; ZonMW Clinical Fellowship [90700342]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234, R01HL067466] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Kidney Foundation; ZonMW Clinical Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health (NIH) grant HL65234, HL67466, RR018787, LM010098, and by grant E. 013 of Netherlands Kidney Foundation. Dr. F.W. Asselbergs is supported by a ZonMW Clinical Fellowship (grant 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, J THROMB HAEMOST, V5, P313, DOI 10.1111/j.1538-7836.2007.02311.x; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Borggreve SE, 2006, J CLIN ENDOCR METAB, V91, P3382, DOI 10.1210/jc.2005-2322; Brown NJ, 2000, CIRCULATION, V102, P2190; Brown NJ, 1999, HYPERTENSION, V34, P285, DOI 10.1161/01.HYP.34.2.285; Brown NJ, 2002, CIRCULATION, V105, P304, DOI 10.1161/hc0302.102570; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Geluk CA, 2008, ATHEROSCLEROSIS, V196, P372, DOI 10.1016/j.atherosclerosis.2006.11.013; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Kim DK, 1997, ARTERIOSCL THROM VAS, V17, P3242, DOI 10.1161/01.ATV.17.11.3242; Labinjoh C, 2001, J AM COLL CARDIOL, V38, P1402, DOI 10.1016/S0735-1097(01)01562-5; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P152, DOI 10.1161/01.ATV.18.2.152; Minai K, 2001, J AM COLL CARDIOL, V37, P1565, DOI 10.1016/S0735-1097(01)01202-5; Moore JH, 2002, CLIN GENET, V62, P53, DOI 10.1034/j.1399-0004.2002.620107.x; Ordonez AJG, 2000, BLOOD COAGUL FIBRIN, V11, P485; Pankow JS, 2000, BLOOD COAGUL FIBRIN, V11, P551, DOI 10.1097/00001721-200009000-00007; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; RUIZ J, 1994, P NATL ACAD SCI USA, V91, P3662, DOI 10.1073/pnas.91.9.3662; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Vaughan DE, 1997, CIRCULATION, V96, P442; Verhave JC, 2004, J INTERN MED, V256, P324, DOI 10.1111/j.1365-2796.2004.01390.x; Wells PS, 2003, THROMB HAEMOSTASIS, V90, P829, DOI 10.1160/TH03-03-0170; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12757	10.1371/journal.pone.0012757	http://dx.doi.org/10.1371/journal.pone.0012757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856803	gold, Green Published, Green Submitted			2022-12-25	WOS:000281815800022
J	Seimon, TA; Kim, MJ; Blumenthal, A; Koo, J; Ehrt, S; Wainwright, H; Bekker, LG; Kaplan, G; Nathan, C; Tabas, I; Russell, DG				Seimon, Tracie A.; Kim, Mi-Jeong; Blumenthal, Antje; Koo, Jovanka; Ehrt, Sabine; Wainwright, Helen; Bekker, Linda-Gail; Kaplan, Gilla; Nathan, Carl; Tabas, Ira; Russell, David G.			Induction of ER Stress in Macrophages of Tuberculosis Granulomas	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ADVANCED ATHEROSCLEROTIC LESIONS; OXIDATIVE STRESS; INNATE IMMUNITY; CELL-DEATH; APOPTOSIS; HOST; CHOLESTEROL; RECEPTORS	Background: The endoplasmic reticulum (ER) stress pathway known as the Unfolded Protein Response (UPR) is an adaptive survival pathway that protects cells from the buildup of misfolded proteins, but under certain circumstances it can lead to apoptosis. ER stress has been causally associated with macrophage apoptosis in advanced atherosclerosis of mice and humans. Because atherosclerosis shares certain features with tuberculosis (TB) with regard to lesional macrophage accumulation, foam cell formation, and apoptosis, we investigated if the ER stress pathway is activated during TB infection. Principal Findings: Here we show that ER stress markers such as C/EBP homologous protein (CHOP; also known as GADD153), phosphorylated inositol-requiring enzyme 1 alpha (Ire1 alpha) and eukaryotic initiation factor 2 alpha (eIF2 alpha), and activating transcription factor 3 (ATF3) are expressed in macrophage-rich areas of granulomas in lungs of mice infected with virulent Mycobacterium tuberculosis (Mtb). These areas were also positive for numerous apoptotic cells as assayed by TUNEL. Microarray analysis of human caseous TB granulomas isolated by laser capture microdissection reveal that 73% of genes involved in the UPR are upregulated at the mRNA transcript level. The expression of two ER stress markers, ATF3 and CHOP, were also increased in macrophages of human TB granulomas when assayed by immunohistochemistry. CHOP has been causally associated with ER stress-induced macrophage apoptosis. We found that apoptosis was more abundant in granulomas as compared to non-granulomatous tissue isolated from patients with pulmonary TB, and apoptosis correlated with CHOP expression in areas surrounding the centralized areas of caseation. Conclusions: In summary, ER stress is induced in macrophages of TB granulomas in areas where apoptotic cells accumulate in mice and humans. Although macrophage apoptosis is generally thought to be beneficial in initially protecting the host from Mtb infection, death of infected macrophages in advanced granulomas might favor dissemination of the bacteria. Therefore future work is needed to determine if ER-stress is causative for apoptosis and plays a role in the host response to infection.	[Seimon, Tracie A.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10027 USA; [Kim, Mi-Jeong; Russell, David G.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Blumenthal, Antje; Koo, Jovanka; Ehrt, Sabine; Nathan, Carl] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med Coll, New York, NY 10021 USA; [Wainwright, Helen] UCT Fac Hlth Sci, Div Anat Pathol, Cape Town, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Dept Med, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kaplan, Gilla] Univ Med & Dent New Jersey, PHRI Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Tabas, Ira] Columbia Univ, Dept Med, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Cornell University; Cornell University; University of Cape Town; University of Cape Town; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University	Seimon, TA (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10027 USA.	tseimon@wcs.org	Bekker, Linda-Gail/AAZ-8929-2020; Russell, David G/D-4533-2009; Blumenthal, Antje/A-3608-2011; Ehrt, Sabine/AAU-6449-2020; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Blumenthal, Antje/0000-0003-3673-7015; Russell, David G/0000-0002-9748-750X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institutes of Health [NHLBI 055936, NIAID 057086, RO1AI05338, NHLBI 075662]; American Heart Association [0735594T]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institutes of Health NHLBI 055936 and NIAID 057086 to DGR, RO1AI05338 to GK, and NHLBI 075662 to IT, and an American Heart Association Scientist Development Grant 0735594T (TAS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Cruz D, 2008, J CLIN INVEST, V118, P2917, DOI 10.1172/JCI34189; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fayyazi A, 2000, J PATHOL, V191, P417, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH664&gt;3.0.CO;2-R; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Gartner T, 2008, VACCINE, V26, P1458, DOI 10.1016/j.vaccine.2007.12.056; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Heldwein KA, 2003, J LEUKOCYTE BIOL, V74, P277, DOI 10.1189/jlb.0103026; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hunter RL, 2007, TUBERCULOSIS, V87, P267, DOI 10.1016/j.tube.2006.11.003; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; KONDO E, 1971, JPN J MED SCI BIOL, V24, P345, DOI 10.7883/yoken1952.24.345; KONDO E, 1976, JPN J MED SCI BIOL, V29, P123, DOI 10.7883/yoken1952.29.123; Kornfeld H, 1999, CELL DEATH DIFFER, V6, P71, DOI 10.1038/sj.cdd.4400454; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lee SH, 2009, INT ECON REV, V50, P1, DOI 10.1111/j.1468-2354.2008.00522.x; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SEIMON T, 2010, CELL METABO IN PRESS; SEIMON T, 2009, J CLIN INVEST, V119; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; TABAS I, 2002, BIOCH LIPIDS LIPOPRO, P573; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	56	93	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12772	10.1371/journal.pone.0012772	http://dx.doi.org/10.1371/journal.pone.0012772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856677	Green Published, gold, Green Submitted			2022-12-25	WOS:000281815800030
J	Negro, SS; Caudron, AK; Dubois, M; Delahaut, P; Gemmell, NJ				Negro, Sandra S.; Caudron, Abigail K.; Dubois, Michel; Delahaut, Philippe; Gemmell, Neil J.			Correlation between Male Social Status, Testosterone Levels, and Parasitism in a Dimorphic Polygynous Mammal	PLOS ONE			English	Article							ZEALAND FUR-SEAL; MALE MATING SUCCESS; HISTORY TRADE-OFFS; ARCTOCEPHALUS-FORSTERI; SPECIES RICHNESS; SEASONAL-CHANGES; BEHAVIOR; MODULATION; SIZE; EVOLUTION	Life history trade-offs have often been assumed to be the consequence of restrictions in the availability of critical resources such as energy and nutrients, which necessitate the differential allocation of resources to costly traits. Here, we examined endocrine (testosterone) and health (parasite burdens) parameters in territorial and non-territorial New Zealand fur seal males. We documented intra-sexual differences in sexual behaviours, testosterone levels, and parasitism that suggest a trade-off exists between reproductive success and physical health, particularly susceptibility to helminths and acanthocephalans, in males displaying different mating tactics (i.e., territorial and non-territorial tactics). Levels of testosterone were higher in territorial males and correlated positively with reproductive effort (i.e., intra-and inter-sexual interactions). However, these territorial males also exhibited high levels of parasitic infection, which may impair survival in the long-term. Our study, while limited in sample size, provides preliminary evidence for a link between male mating tactics, testosterone levels and parasite loads, and potential effects on reproductive success and life history that should be explored further.	[Negro, Sandra S.; Caudron, Abigail K.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Negro, Sandra S.] Univ Liege, BiopTis S A, Sart Tilman Par Liege, Belgium; [Caudron, Abigail K.] Univ Liege, Inst Zool, Liege, Belgium; [Dubois, Michel; Delahaut, Philippe] Ctr Economie Rurale, Marloie, Belgium; [Gemmell, Neil J.] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand	University of Canterbury; University of Liege; University of Liege; University of Otago	Negro, SS (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	sandras.negro@gmail.com	Delahaut, Philippe/ABC-8350-2021; Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637; Delahaut, Philippe/0000-0003-2328-3042	University of Canterbury; New Zealand International Doctoral Research (NZIDR); University of California Santa Cruz (UCSC) National Institutes of Health	University of Canterbury; New Zealand International Doctoral Research (NZIDR); University of California Santa Cruz (UCSC) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SSN was funded by University of Canterbury and New Zealand International Doctoral Research (NZIDR). Research support for this project was obtained from the University of California Santa Cruz (UCSC) National Institutes of Health Minority International Research Training scheme and University of Canterbury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AMOS W, 1993, P ROY SOC B-BIOL SCI, V252, P199, DOI 10.1098/rspb.1993.0066; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; ATKINSON S, 1992, J REPROD FERTIL, V96, P35; BARTHOLOMEW GA, 1970, EVOLUTION, V24, P546, DOI 10.1111/j.1558-5646.1970.tb01790.x; BARTSH SS, 1992, CAN J ZOOL, V70, P680, DOI 10.1139/z92-102; Boren LJ, 2006, WILDLIFE RES, V33, P497, DOI 10.1071/WR05092; Bradshaw CJA, 2000, J ZOOL, V252, P41, DOI 10.1111/j.1469-7998.2000.tb00818.x; CAREY PW, 1989, THESIS U CANTERBURY; Caudron AK, 2009, AUST J ZOOL, V57, P409, DOI 10.1071/ZO09024; Clutton-Brock T.H., 1988, P325; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Dailey MD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P357; DEMAS GE, 2006, HDB NEUROCHEMISTRY M; Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x; Fauquier D, 2004, J WILDLIFE DIS, V40, P816, DOI 10.7589/0090-3558-40.4.816; FLETCHER D, 1998, INT ASS AQ AN MED 29; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GALES NJ, 1994, J ZOOL, V234, P353, DOI 10.1111/j.1469-7998.1994.tb04853.x; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; GOLDSWORTHY SD, 1994, WILDLIFE RES, V21, P365, DOI 10.1071/WR9940365; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gulland FMD, 1997, MAR MAMMAL SCI, V13, P446, DOI 10.1111/j.1748-7692.1997.tb00651.x; HARDING CF, 1981, AM ZOOL, V21, P223; Hughes J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-227; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ionita M, 2008, PARASITOL RES, V103, P1025, DOI 10.1007/s00436-008-1087-0; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Knapp R, 2003, INTEGR COMP BIOL, V43, P658, DOI 10.1093/icb/43.5.658; KREBS JR, 1983, INTRO BEHAV ECOLOGY; Kunc HP, 2008, ETHOLOGY, V114, P381, DOI 10.1111/j.1439-0310.2008.01484.x; LAUCKNER G, 1985, DIS MARINE ANIMALS 2, V4, P683; le Boeuf B.J., 1988, P344; Lidgard DC, 2008, HORM BEHAV, V53, P241, DOI 10.1016/j.yhbeh.2007.10.003; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Mattlin RH, 1978, THESIS U CANTERBURY; Mcglothlin JW, 2008, J EVOLUTION BIOL, V21, P39, DOI 10.1111/j.1420-9101.2007.01471.x; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; NEGRO SS, 2008, THESIS U CANTERBURY; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; RIDGWAY S H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P327; SAPOLSKY RM, 1986, ENDOCRINOLOGY, V118, P1630, DOI 10.1210/endo-118-4-1630; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; Simkova A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-29; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; Statsoft Inc., 2007, STAT DAT AN SOFTW SY; Stevenson IR, 1995, P ROY SOC B-BIOL SCI, V262, P267, DOI 10.1098/rspb.1995.0205; STIRLING I, 1970, J MAMMAL, V51, P766, DOI 10.2307/1378300; Thienpont D., 1979, DIAGNOSTIC VERMINOSE; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; YOUNG PC, 1969, J COMP PATHOL, V79, P301, DOI 10.1016/0021-9975(69)90043-7; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4; [No title captured]	64	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12507	10.1371/journal.pone.0012507	http://dx.doi.org/10.1371/journal.pone.0012507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856933	Green Published, Green Submitted, gold			2022-12-25	WOS:000281735700004
J	Nowak, I; Majorczyk, E; Wisniewski, A; Pawlik, A; Magott-Procelewska, M; Passowicz-Muszynska, E; Malejczyk, J; Ploski, R; Giebel, S; Barcz, E; Zon-Giebel, A; Malinowski, A; Tchorzewski, H; Chlebicki, A; Luszczek, W; Kurpisz, M; Grybos, M; Wilczynski, J; Wiland, P; Senitzer, D; Sun, JY; Jankowska, R; Klinger, M; Kusnierczyk, P				Nowak, Izabela; Majorczyk, Edyta; Wisniewski, Andrzej; Pawlik, Andrzej; Magott-Procelewska, Maria; Passowicz-Muszynska, Ewa; Malejczyk, Jacek; Ploski, Rafal; Giebel, Sebastian; Barcz, Ewa; Zon-Giebel, Aleksandra; Malinowski, Andrzej; Tchorzewski, Henryk; Chlebicki, Arkadiusz; Luszczek, Wioleta; Kurpisz, Maciej; Grybos, Marian; Wilczynski, Jacek; Wiland, Piotr; Senitzer, David; Sun, Ji-Yao; Jankowska, Renata; Klinger, Marian; Kusnierczyk, Piotr			Does the KIR2DS5 Gene Protect from Some Human Diseases?	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY; RECEPTOR; KIR; TRANSPLANTATION; CLASSIFICATION; ENDOMETRIOSIS; ASSOCIATION; DIVERSITY	Background: KIR2DS5 gene encodes an activating natural killer cell receptor whose ligand is not known. It was recently reported to affect the outcome of hematopoietic stem cell transplantation. Methodology/Principal Findings: In our studies on KIR2DS5 gene associations with human diseases, we compared the frequencies of this gene in patients and relevant controls. Typing for KIR2DS5 gene was performed by either individual or multiplex polymerase chain reactions which, when compared in the same samples, gave concordant results. We noted an apparently protective effect of KIR2DS5 gene presence in several clinical conditions, but not in others. Namely, this effect was observed in ankylosing spondylitis (p = 0.003, odds ratio [OR] = 0.47, confidence interval [CI] = 0.28-0.79), endometriosis (p = 0.03, OR = 0.25, CI = 0.07-0.82) and acute rejection of kidney graft (p = 0.0056, OR = 0.44, CI = 0.24-0.80), but not in non-small-cell lung carcinoma, rheumatoid arthritis, spontaneous abortion, or leukemia (all p>0.05). In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p = 0.0003, OR = 0.35, CI = 0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p = 0.0017, OR = 1.92, CI = 1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p = 0.005, OR = 1.47, CI = 1.13-1.92). The presence of both KIR2DS5 and C1 seemed to protect from acute kidney graft rejection (p = 0.017, OR = 0.47, CI = 0.25-0.89), whereas lack of KIR2DS5 and presence of C2 seemed to favor rejection (p = 0.0015, OR = 2.13, CI = 1.34-3.37). Conclusions/Significance: Our results suggest that KIR2DS5 may protect from endometriosis, ankylosing spondylitis, and acute rejection of kidney graft.	[Nowak, Izabela; Majorczyk, Edyta; Wisniewski, Andrzej; Luszczek, Wioleta; Kusnierczyk, Piotr] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Clin Immunol, PL-53114 Wroclaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Pharmacokinet & Therapeut Drug Monitoring, Szczecin, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Wroclaw Med Univ, Fac Med, Dept Nephrol & Transplantat Med, Wroclaw, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Wroclaw Med Univ, Fac Med, Clin Nephrol & Transplantat Med, Wroclaw, Poland; [Passowicz-Muszynska, Ewa; Jankowska, Renata] Wroclaw Med Univ, Dept Pulmonol & Lung Canc, Wroclaw, Poland; [Malejczyk, Jacek] Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct Res, Warsaw, Poland; [Ploski, Rafal] Warsaw Med Univ, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Giebel, Sebastian] Maria Sklodowska Curie Mem Inst Oncol, Dept Clin & Expt Oncol, Ctr Comprehens Canc, Branch Gliwice, Gliwice, Poland; [Giebel, Sebastian] Silesian Med Univ, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair Obstet & Gynecol 1, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Clin Obstet & Gynecol, Warsaw, Poland; [Zon-Giebel, Aleksandra] Silesian Hosp Rheumatol & Rehabil, Ustron, Poland; [Malinowski, Andrzej] Polish Mothers Mem Hosp, Res Inst, Dept Surg & Endoscop Gynecol, Lodz, Poland; [Tchorzewski, Henryk] Polish Mothers Mem Hosp, Res Inst, Dept Clin Immunol, Lodz, Poland; [Chlebicki, Arkadiusz; Wiland, Piotr] Wroclaw Med Univ, Chair Rheumatol & Internal Dis, Wroclaw, Poland; [Chlebicki, Arkadiusz; Wiland, Piotr] Wroclaw Med Univ, Clin Rheumatol & Internal Dis, Wroclaw, Poland; [Kurpisz, Maciej] Polish Acad Sci, Dept Reprod Biol & Stem Cells, Inst Human Genet, PL-53114 Wroclaw, Poland; [Grybos, Marian] Med Univ Wroclaw, Dept Obstet & Gynecol 1, Wroclaw, Poland; [Wilczynski, Jacek] Polish Mothers Mem Hosp, Res Inst, Dept Gynecol Surg, Lodz, Poland; [Senitzer, David; Sun, Ji-Yao] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Kusnierczyk, Piotr] Jan Dlugosz Pedag Univ, Czestochowa, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Pomeranian Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Medical University of Warsaw; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University Silesia; Medical University of Warsaw; Medical University of Warsaw; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Wroclaw Medical University; Wroclaw Medical University; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Wroclaw Medical University; Polish Mother's Memorial Hospital - Research Institute; City of Hope; Jan Dlugosz University	Nowak, I (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Clin Immunol, PL-53114 Wroclaw, Poland.	pkusnier@iitd.pan.wroc.pl	Kusnierczyk, Piotr/ABB-6734-2020; Pawlik, Andrzej/A-9052-2015; Majorczyk, Edyta/P-3066-2019; Wilczyński, Jacek R/M-7134-2014; Barcz, Ewa/AAS-7533-2020; Malinowski, Andrzej/O-8796-2014	Majorczyk, Edyta/0000-0001-7248-9544; Pawlik, Andrzej/0000-0001-6557-1208; Nowak, Izabela/0000-0002-9127-1089; Malejczyk, Jacek/0000-0002-5371-8476; Wisniewski, Andrzej/0000-0002-1919-2298; Kurpisz, Maciej/0000-0003-3275-3245; Giebel, Sebastian/0000-0002-4827-4401; Ploski, Rafal/0000-0001-6286-5526; Wiland, Piotr/0000-0001-9999-0267	Polish Ministry of Science and Higher Education [N402 078 31/2416, N401 077 31/1819, 2P05A 069 28, 2 PO5B 155 28]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants N402 078 31/2416, N401 077 31/1819, 2P05A 069 28, and 2 PO5B 155 28 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Beilke JN, 2007, J AM SOC NEPHROL, V18, P2262, DOI 10.1681/ASN.2007040423; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Canis M, 1997, FERTIL STERIL, V67, P817; Cheent K, 2009, IMMUNOLOGY, V126, P449, DOI 10.1111/j.1365-2567.2009.03045.x; Diaz-Pena R, 2008, HUM IMMUNOL, V69, P437, DOI 10.1016/j.humimm.2008.04.012; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Frohn C, 1998, J IMMUNOL METHODS, V218, P155, DOI 10.1016/S0022-1759(98)00126-4; Giebel S, 2009, EUR J HAEMATOL, V83, P343, DOI 10.1111/j.1600-0609.2009.01280.x; Jiao YL, 2008, J CLIN IMMUNOL, V28, P343, DOI 10.1007/s10875-008-9183-6; Kollnberger S, 2007, EUR J IMMUNOL, V37, P1313, DOI 10.1002/eji.200635997; de Castro JAL, 2010, TISSUE ANTIGENS, V75, P9, DOI 10.1111/j.1399-0039.2009.01405.x; Lopez-Larrea C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1988; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; McCappin J, 2010, TISSUE ANTIGENS, V75, P68, DOI 10.1111/j.1399-0039.2009.01392.x; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Nowak I, 2009, J APPL GENET, V50, P391, DOI 10.1007/BF03195699; Ploski R, 2006, HUM IMMUNOL, V67, P521, DOI 10.1016/j.humimm.2006.04.001; Ploski R, 2009, J REPROD IMMUNOL, V79, P196, DOI 10.1016/j.jri.2008.11.004; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reveille John D, 2009, Curr Rheumatol Rep, V11, P340, DOI 10.1007/s11926-009-0049-6; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Sun JY, 2004, TISSUE ANTIGENS, V64, P462, DOI 10.1111/j.1399-0039.2004.00303.x; Ulukus M, 2005, Minerva Ginecol, V57, P237; van der Meer A, 2008, MOL IMMUNOL, V45, P3631, DOI 10.1016/j.molimm.2008.04.016; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; *WHO, 1981, HIST TYP LUNG CANC T; Zenhaeusern G, 2009, AM J TRANSPLANT, V9, P2624, DOI 10.1111/j.1600-6143.2009.02808.x	31	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12381	10.1371/journal.pone.0012381	http://dx.doi.org/10.1371/journal.pone.0012381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865034	Green Published, Green Submitted, gold			2022-12-25	WOS:000281292100009
J	Wippel, K; Wittek, A; Hedrich, R; Sauer, N				Wippel, Kathrin; Wittek, Anke; Hedrich, Rainer; Sauer, Norbert			Inverse pH Regulation of Plant and Fungal Sucrose Transporters: A Mechanism to Regulate Competition for Sucrose at the Host/Pathogen Interface?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; APOPLASTIC PH; YEAST-CELLS; GUARD-CELL; COMPARTMENTATION; TRANSFORMATION; EXPRESSION; PROTEINS; SIGNAL	Background: Plant sucrose transporter activities were shown to respond to changes in the extracellular pH and redox status, and oxidizing compounds like glutathione (GSSG) or H(2)O(2) were reported to effect the subcellular targeting of these proteins. We hypothesized that changes in both parameters might be used to modulate the activities of competing sucrose transporters at a plant/pathogen interface. We, therefore, compared the effects of redox-active compounds and of extracellular pH on the sucrose transporters UmSRT1 and ZmSUT1 known to compete for extracellular sucrose in the Ustilago maydis (corn smut)/Zea mays (maize) pathosystem. Methodology/Principal Findings: We present functional analyses of the U. maydis sucrose transporter UmSRT1 and of the plant sucrose transporters ZmSUT1 and StSUT1 in Saccharomyces cerevisiae or in Xenopus laevis oocytes in the presence of different extracellular pH-values and redox systems, and study the possible effects of these treatments on the subcellular targeting. We observed an inverse regulation of host and pathogen sucrose transporters by changes in the apoplastic pH. Under none of the conditions analyzed, we could confirm the reported effects of redox-active compounds. Conclusions/Significance: Our data suggest that changes in the extracellular pH but not of the extracellular redox status might be used to oppositely adjust the transport activities of plant and fungal sucrose transporters at the host/pathogen interface.	[Wippel, Kathrin; Sauer, Norbert] Univ Erlangen Nurnberg, Erlangen, Germany; [Wittek, Anke; Hedrich, Rainer] Univ Wurzburg, Julius von Sachs Inst, Biozentrum, Wurzburg, Germany	University of Erlangen Nuremberg; University of Wurzburg	Wippel, K (corresponding author), Univ Erlangen Nurnberg, Erlangen, Germany.	nsauer@biologie.uni-erlangen.de	Hedrich, Rainer/G-8771-2011	Hedrich, Rainer/0000-0003-3224-1362	Deutsche Forschungsgemeinschaft [SA382/16-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (http://www.DFG.de) SA382/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Felle HH, 1998, J EXP BOT, V49, P987, DOI 10.1093/jexbot/49.323.987; Felle HH, 2002, J EXP BOT, V53, P73, DOI 10.1093/jexbot/53.366.73; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hartung W, 1998, J EXP BOT, V49, P361, DOI 10.1093/jexbot/49.suppl_1.361; Krugel U, 2008, PLANT CELL, V20, P2497, DOI 10.1105/tpc.108.058271; Krugel U, 2009, PLANT CELL, V21, P4059, DOI 10.1105/tpc.109.211260; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schmitt B, 2008, PLANT PHYSIOL, V148, P187, DOI 10.1104/pp.108.120410; Sun Y, 2010, PLANT CELL PHYSIOL, V51, P114, DOI 10.1093/pcp/pcp172; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wilkinson S, 1999, PLANT GROWTH REGUL, V29, P87, DOI 10.1023/A:1006203715640; Yu Q., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P242	27	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12429	10.1371/journal.pone.0012429	http://dx.doi.org/10.1371/journal.pone.0012429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865151	Green Published, gold, Green Submitted			2022-12-25	WOS:000281292100024
J	Burkart, A; Shi, XR; Chouinard, M; Corvera, S				Burkart, Alison; Shi, Xiarong; Chouinard, My; Corvera, Silvia			Adenylate Kinase 2 Links Mitochondrial Energy Metabolism to the Induction of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL DIFFERENTIATION; RESPIRATORY-CHAIN; CDNA CLONING; INSULIN; GENE; EXPRESSION; ADIPONECTIN; ADIPOCYTES; DISEASE	The unfolded protein response (UPR) is a homeostatic signaling mechanism that balances the protein folding capacity of the endoplasmic reticulum (ER) with the secretory protein load of the cell. ER protein folding capacity is dependent on the abundance of chaperones, which is increased in response to UPR signaling, and on a sufficient ATP supply for their activity. An essential branch of the UPR entails the splicing of XBP1 mRNA to form the XBP1 transcription factor. XBP1 has been shown to be required during adipocyte differentiation, enabling mature adipocytes to secrete adiponectin, and during differentiation of B cells into antibody-secreting plasma cells. Here we find that adenylate kinase 2 (AK2), a mitochondrial enzyme that regulates adenine nucleotide interconversion within the intermembrane space, is markedly induced during adipocyte and B cell differentiation. Depletion of AK2 by RNAi impairs adiponectin secretion in 3T3-L1 adipocytes, IgM secretion in BCL1 cells, and the induction of the UPR during differentiation of both cell types. These results reveal a new mechanism by which mitochondria support ER function and suggest that specific mitochondrial defects may give rise to impaired UPR signaling. The requirement for AK2 for UPR induction may explain the pathogenesis of the profound hematopoietic defects of reticular dysgenesis, a disease associated with mutations of the AK2 gene in humans.	[Burkart, Alison; Shi, Xiarong; Chouinard, My; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu			National Institutes of Health [DK60837]; National Institutes of Health Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK089101, R01DK060837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60837 (to S.C.) and core services supported by the National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Counago R, 2005, EXTREMOPHILES, V9, P135, DOI 10.1007/s00792-004-0428-x; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; FukamiKobayashi K, 1996, FEBS LETT, V385, P214, DOI 10.1016/0014-5793(96)00367-5; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2003, J BIOL CHEM, V278, P12937, DOI 10.1074/jbc.M211465200; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; KONRAD M, 1993, J BIOL CHEM, V268, P11326; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miron S, 2004, BIOCHEMISTRY-US, V43, P67, DOI 10.1021/bi0355995; Morimoto N, 2007, NEUROSCIENCE, V147, P957, DOI 10.1016/j.neuroscience.2007.04.017; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Van Rompay AR, 1999, EUR J BIOCHEM, V261, P509, DOI 10.1046/j.1432-1327.1999.00294.x; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	49	39	41	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4081	4089		10.1074/jbc.M110.134106	http://dx.doi.org/10.1074/jbc.M110.134106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20876536	Green Published, hybrid			2022-12-25	WOS:000286975700006
J	Zhang, H; Pradhan, P; Kaur, P				Zhang, Han; Pradhan, Prajakta; Kaur, Parjit			The Extreme C Terminus of the ABC Protein DrrA Contains Unique Motifs Involved in Function and Assembly of the DrrAB Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING CASSETTE; ESCHERICHIA-COLI; STREPTOMYCES-PEUCETIUS; MALTOSE TRANSPORTER; EFFLUX PUMP; INDUCER EXCLUSION; CRYSTAL-STRUCTURE; DOXORUBICIN; EXPRESSION; DOMAINS	Two novel regulatory motifs, LDEVFL and C-terminal regulatory Glu (E)-rich motif (CREEM), are identified in the extreme C terminus of the ABC protein DrrA, which is involved in direct interaction with the N-terminal cytoplasmic tail of the membrane protein DrrB and in homodimerization of DrrA. Disulfide cross-linking analysis showed that the CREEM and the region immediately upstream of CREEM participate directly in forming an interaction interface with the N terminus of DrrB. A series of mutations created in the LDEVFL and CREEM motifs drastically affected overall function of the DrrAB transporter. Mutations in the LDEVFL motif also significantly impaired interaction between the C terminus of DrrA and the N terminus of DrrB as well as the ability of DrrA and DrrB to co-purify, therefore suggesting that the LDEVFL motif regulates CREEM-mediated interaction between DrrA and DrrB and plays a key role in biogenesis of the DrrAB complex. Modeling analysis indicated that the LDEVFL motif is critical for conformational integrity of the C-terminal domain of DrrA and confirmed that the C terminus of DrrA forms an independent domain. This is the first report which describes the presence of an assembly domain in an ABC protein and uncovers a novel mechanism whereby the ABC component facilitates the assembly of the membrane component. Homology sequence comparisons showed the presence of the LDEVFL and CREEM motifs in close prokaryotic and eukaryotic homologs of DrrA, suggesting that these motifs may play a similar role in other homologous drug and lipid export systems.	[Zhang, Han; Pradhan, Prajakta; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [RO1 GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51981-09 (to P. K.).	Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; ANGOV E, 1988, J BACTERIOL, V170, P459, DOI 10.1128/jb.170.1.459-462.1988; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; BUKAU B, 1986, J BACTERIOL, V166, P884, DOI 10.1128/jb.166.3.884-891.1986; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; GUILFOILE PG, 1991, P NATL ACAD SCI USA, V88, P8553, DOI 10.1073/pnas.88.19.8553; Harrison RW, 1995, PROTEINS, V23, P463, DOI 10.1002/prot.340230402; Holland I.B., 2003, ABC PROTEINS BACTERI, P3; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kaur P, 2005, BIOCHEMISTRY-US, V44, P2661, DOI 10.1021/bi048959c; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mace S, 2005, NEUROBIOL DIS, V18, P119, DOI 10.1016/j.nbd.2004.09.011; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Nehme D, 2004, J BACTERIOL, V186, P2973, DOI 10.1128/JB.186.10.2973-2983.2004; Nsahlai CJ, 2003, FEMS MICROBIOL LETT, V224, P113, DOI 10.1016/S0378-1097(03)00428-2; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Panagiotidis CH, 1998, MOL MICROBIOL, V30, P535, DOI 10.1046/j.1365-2958.1998.01084.x; Pradhan P, 2009, J MOL BIOL, V385, P831, DOI 10.1016/j.jmb.2008.11.027; Rao DK, 2008, BIOCHEMISTRY-US, V47, P3038, DOI 10.1021/bi701699a; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	42	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38324	38336		10.1074/jbc.M110.131540	http://dx.doi.org/10.1074/jbc.M110.131540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876527	hybrid, Green Published			2022-12-25	WOS:000284625600039
J	Di, L; Srivastava, S; Zhdanova, O; Sun, Y; Li, Z; Skolnik, EY				Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.			Nucleoside Diphosphate Kinase B Knock-out Mice Have Impaired Activation of the K+ Channel KCa3.1, Resulting in Defective T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; NM23/NDP KINASE; NM23-H1; GENE; METASTASIS; PHOSPHORYLATION; MECHANISM; COLITIS; TARGETS; IKCA1	Nucleoside diphosphate kinases (NDPKs) are encoded by the Nme (non-metastatic cell) gene family. Although they comprise a family of 10 genes, NDPK-A and -B are ubiquitously expressed and account for most of the NDPK activity. We previously showed that NDPK-B activates the K+ channel KCa3.1 via histidine phosphorylation of the C terminus of KCa3.1, which is required for T cell receptor-stimulated Ca2+ flux and proliferation of activated naive human CD4 T cells. We now report the phenotype of NDPK-B-/- mice. NDPK-B-/- mice are phenotypically normal at birth with a normal life span. Although T and B cell development is normal in NDPK-B-/- mice, KCa3.1 channel activity and cytokine production are markedly defective in T helper 1 (Th1) and Th2 cells, whereas Th17 function is normal. These findings phenocopy studies in the same cells isolated from KCa3.1(-/-) mice and thereby support genetically that NDPK-B functions upstream of KCa3.1. NDPK-A and -B have been linked to an astonishing array of disparate cellular and biochemical functions, few of which have been confirmed in vivo in physiological relevant systems. NDPK-B-/- mice will be an essential tool with which to definitively address the biological functions of NDPK-B. Our finding that NDPK-B is required for activation of Th1 and Th2 CD4 T cells, together with the normal overall phenotype of NDPK-B-/- mice, suggests that specific pharmacological inhibitors of NDPK-B may provide new opportunities to treat Th1- and Th2-mediated autoimmune diseases.	[Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.] NYU, Langone Med Ctr, Dept Internal Med, New York, NY 10016 USA; [Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.] NYU, Langone Med Ctr, Dept Pharmacol, New York, NY 10016 USA; [Srivastava, Shekhar; Zhdanova, Olga; Skolnik, Edward Y.] NYU, Langone Med Ctr, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Div Nephrol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Skolnik, EY (corresponding author), NYU, Langone Med Ctr, Dept Internal Med, 550 1St Ave, New York, NY 10016 USA.	skolnik@nyumc.org		Srivastava, Shekhar/0000-0001-5165-7385	National Institutes of Health [RO1GM084195, RO1AI052459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health Grants RO1GM084195 and RO1AI052459. To whom correspondence should be addressed. Tel.: 212-263-7458; Fax: 212-263-3110; E-mail: edward.skolnik@nyumc.org.	Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Fournier E, 2003, CURR BIOL, V13, P1858, DOI 10.1016/j.cub.2003.09.034; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Hippe HJ, 2003, J BIOL CHEM, V278, P7227, DOI 10.1074/jbc.M210305200; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kaetzel DM, 2006, J BIOENERG BIOMEMBR, V38, P163, DOI 10.1007/s10863-006-9040-3; Klumpp S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe13; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lee JH, 2009, MOL CELL BIOCHEM, V329, P141, DOI 10.1007/s11010-009-0124-3; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Murakami M, 2009, MOL CELL BIOCHEM, V329, P131, DOI 10.1007/s11010-009-0123-4; Nallamothu G, 2009, MOL CELL BIOCHEM, V329, P35, DOI 10.1007/s11010-009-0112-7; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Postel EH, 2009, DEV DYNAM, V238, P775, DOI 10.1002/dvdy.21887; Postel EH, 2009, MOL CELL BIOCHEM, V329, P45, DOI 10.1007/s11010-009-0110-9; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983	33	65	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38765	38771		10.1074/jbc.M110.168070	http://dx.doi.org/10.1074/jbc.M110.168070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20884616	Green Published, hybrid			2022-12-25	WOS:000284941300005
J	Liu, XY; Ruan, LF; Hu, ZF; Peng, DH; Cao, SY; Yu, ZN; Liu, Y; Zheng, JS; Sun, M				Liu, Xiao-Yan; Ruan, Li-Fang; Hu, Zhen-Fei; Peng, Dong-Hai; Cao, Shi-Yun; Yu, Zi-Niu; Liu, Yao; Zheng, Jin-Shui; Sun, Ming			Genome-wide Screening Reveals the Genetic Determinants of an Antibiotic Insecticide in Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL PROTEIN GENES; BETA-EXOTOXIN; STRAINS; PLASMIDS; IDENTIFICATION; PURIFICATION; LEPIDOPTERAN; EVOLUTION; CLONING	Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects. Until now, the regulatory mechanisms and genetic determinants involved in thuringiensin production have remained unclear. Here, we successfully used heterologous expression-guided screening in an Escherichia coli-Bacillus thuringiensis shuttle bacterial artificial chromosome library, to clone the intact thuringiensin synthesis (thu) cluster. Then the thu cluster was located on a 110-kb endogenous plasmid bearing insecticide crystal protein gene cry1Ba in strain CT-43. Furthermore, the plasmid, named pBMB0558, was indirectly cloned and sequenced. The gene functions on pBMB0558 were annotated by BLAST based on the GenBank (TM) and KEGG databases. The genes on pBMB0558 could be classified into three functional modules: a thuringiensin synthesis cluster, a type IV secretion system-like module, and mobile genetic elements. By HPLC coupling mass spectrometer, atmospheric pressure ionization with ion trap, and TOF technologies, biosynthetic intermediates of thuringiensin were detected. The thuE gene is proved to be responsible for the phosphorylation of thuringiensin at the last step by vivo and vitro activity assays. The thuringiensin biosynthesis pathway was deduced and clarified. We propose that thuringiensin is an adenine nucleoside oligosaccharide rather than an adenine nucleotide analog, as is traditionally believed, based on the predicted functions of the key enzymes, glycosyltransferase (ThuF) and exopolysaccharide polymerization protein (Thu1).	[Liu, Xiao-Yan; Ruan, Li-Fang; Hu, Zhen-Fei; Peng, Dong-Hai; Cao, Shi-Yun; Yu, Zi-Niu; Liu, Yao; Zheng, Jin-Shui; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Sun, M (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	National Basic Research Program (973 Program) of China [2009CB118902]; National Natural Science Foundation of China [30400003, 30970037]; National High Technology Research and Development Program (863 Program) of China [2006AA02Z174, 2006AA10A212]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Forestry Project (948 Program) of China [2006-4-41]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Forestry Project (948 Program) of China	This work was supported by National Basic Research Program (973 Program) of China Grant 2009CB118902, National Natural Science Foundation of China Grants 30400003 and 30970037, National High Technology Research and Development Program (863 Program) of China Grants 2006AA02Z174 and 2006AA10A212, Genetically Modified Organisms Breeding Major Projects of China Grant 2009ZX08009-032B, and Ministry of Forestry Project (948 Program) of China Grant 2006-4-41.	ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; ARONSON AI, 1986, MICROBIOL REV, V50, P1; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cheng WC, 2005, J BACTERIOL, V187, P8156, DOI 10.1128/JB.187.23.8156-8163.2005; COHEN SS, 1951, J BIOL CHEM, V189, P617; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Donovan WP, 2006, APPL MICROBIOL BIOT, V72, P713, DOI 10.1007/s00253-006-0332-7; Draper O, 2006, J BIOL CHEM, V281, P37628, DOI 10.1074/jbc.M606403200; ENGEL HJ, 1969, BIOCHIM BIOPHYS ACTA, V191, P509, DOI 10.1016/0005-2744(69)90344-1; Espinasse S, 2002, J BACTERIOL, V184, P5848, DOI 10.1128/JB.184.21.5848-5854.2002; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; GLASER L, 1955, J BIOL CHEM, V216, P67; GONZALEZ JM, 1982, P NATL ACAD SCI-BIOL, V79, P6951, DOI 10.1073/pnas.79.22.6951; Grynberg M, 2007, TRENDS MICROBIOL, V15, P191, DOI 10.1016/j.tim.2007.03.002; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; HOFTE H, 1989, MICROBIOL REV, V53, P242; Ji F, 2009, FEMS MICROBIOL LETT, V300, P11, DOI 10.1111/j.1574-6968.2009.01743.x; KALVODA L, 1973, TETRAHEDRON LETT, P4671; LEVINSON BL, 1990, J BACTERIOL, V172, P3172, DOI 10.1128/jb.172.6.3172-3179.1990; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; Liu ZY, 2008, RAPID COMMUN MASS SP, V22, P1009, DOI 10.1002/rcm.3422; LOBNEROLESEN A, 1992, J BACTERIOL, V174, P525, DOI 10.1128/jb.174.2.525-529.1992; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MAXWELL ES, 1956, ARCH BIOCHEM BIOPHYS, V65, P2, DOI 10.1016/0003-9861(56)90171-0; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; Ohba M, 2009, ANTICANCER RES, V29, P427; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; SABLE HZ, 1952, J BIOL CHEM, V196, P395; Sambrook J., 1989, MOL CLONING LAB MANU, P474; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SEBESTA K, 1970, BIOCHIM BIOPHYS ACTA, V209, P357, DOI 10.1016/0005-2787(70)90734-3; Song LL, 2008, J INVERTEBR PATHOL, V98, P169, DOI 10.1016/j.jip.2008.02.006; STABB EV, 1994, APPL ENVIRON MICROB, V60, P4404, DOI 10.1128/AEM.60.12.4404-4412.1994; STROMINGER JL, 1957, J BIOL CHEM, V224, P79; Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003; Tamez-Guerra P, 2004, J INVERTEBR PATHOL, V86, P7, DOI 10.1016/j.jip.2004.02.009; Toledo J, 1999, J ECON ENTOMOL, V92, P1052, DOI 10.1093/jee/92.5.1052; Tsai SF, 2006, TOXICOL APPL PHARM, V216, P347, DOI 10.1016/j.taap.2006.05.013; Tsai SF, 2004, TOXICOL APPL PHARM, V194, P34, DOI 10.1016/j.taap.2003.08.015; Tsuchiya S, 2002, J INVERTEBR PATHOL, V81, P122, DOI 10.1016/S0022-2011(02)00148-9; WAALWIJK C, 1985, NUCLEIC ACIDS RES, V13, P8207, DOI 10.1093/nar/13.22.8207; Wirth MC, 2010, ENVIRON MICROBIOL, V12, P1154, DOI 10.1111/j.1462-2920.2010.02156.x	48	38	43	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39191	39200		10.1074/jbc.M110.148387	http://dx.doi.org/10.1074/jbc.M110.148387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20864531	Green Published, hybrid			2022-12-25	WOS:000284941300049
J	Wiethaus, J; Busch, AWU; Kock, K; Leichert, LI; Herrmann, C; Frankenberg-Dinkel, N				Wiethaus, Jessica; Busch, Andrea W. U.; Kock, Klaus; Leichert, Lars I.; Herrmann, Christian; Frankenberg-Dinkel, Nicole			CpeS Is a Lyase Specific for Attachment of 3Z-PEB to Cys(82) of beta-phycoerythrin from Prochlorococcus marinus MED4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; BILIN BINDING-PROTEIN; ANABAENA SP PCC-7120; CHROMOPHORE ATTACHMENT; C-PHYCOCYANIN; FERREDOXIN OXIDOREDUCTASE; PHOTOSYNTHETIC PROKARYOTE; PHYCOBILIPROTEIN LYASE; CRYPTOPHYCEAN ALGAE; GENE ENCODES	In contrast to the majority of cyanobacteria, the unicellular marine cyanobacterium Prochlorococcus marinus MED4 uses an intrinsic divinyl-chlorophyll-dependent light-harvesting system for photosynthesis. Despite the absence of phycobilisomes, this high-light adapted strain possesses beta-phycoerythrin (CpeB), an S-type lyase (CpeS), and enzymes for the biosynthesis of phycoerythrobilin (PEB) and phycocyanobilin. Of all linear tetrapyrroles synthesized by Prochlorococcus including their 3Z-and 3E-isomers, CpeS binds both isomers of PEB and its biosynthetic precursor 15,16-dihydrobiliverdin (DHBV). However, dimerization of CpeS is independent of bilins, which are tightly bound in a complex at a ratio of 1:1. Although bilin binding by CpeS is fast, transfer to CpeB is rather slow. CpeS is able to attach 3E-PEB and 3Z-PEB to dimeric CpeB but not DHBV. CpeS transfer of 3Z-PEB exclusively yields correctly bound beta Cys(82)-PEB, whereas beta Cys(82)-DHBV is a side product of 3E-PEB transfer. Spontaneous 3E- and 3Z-PEB addition to CpeB is faulty, and products are in both cases beta Cys(82)-DHBV and likely a PEB bound at beta Cys(82) in a non-native configuration. Our data indicate that CpeS is specific for 3Z-PEB transfer to beta Cys(82) of phycoerythrin and essential for the correct configuration of the attachment product.	[Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Dept Physiol Microorganisms, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Kock, Klaus] Ruhr Univ Bochum, Fac Chem & Biochem, D-44780 Bochum, Germany; [Leichert, Lars I.] Ruhr Univ Bochum, Med Proteome Ctr, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Dept Physiol Microorganisms, Fac Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Leichert, Lars I./B-4762-2009; Frankenberg-Dinkel, Nicole/C-1058-2011	Leichert, Lars I./0000-0002-5666-9681; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839	Deutsche Forschungsgemeinschaft; German-Israeli Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Deutsche Forschungsgemeinschaft and a German-Israeli Foundation Young Investigator grant (to N. F.-D.).	Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2007, FEMS MICROBIOL LETT, V271, P251, DOI 10.1111/j.1574-6968.2007.00715.x; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg N., 2003, PORPHYRIN HDB, P211; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; GOSSAUER A, 1978, J AM CHEM SOC, V100, P5928, DOI 10.1021/ja00486a053; Grzenclowski M, 2010, NEURO-ONCOLOGY, V12, P243, DOI 10.1093/neuonc/nop025; HEIRWEGH KPM, 1991, ANAL BIOCHEM, V195, P273, DOI 10.1016/0003-2697(91)90329-R; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; HUBER R, 1987, J MOL BIOL, V195, P423, DOI 10.1016/0022-2836(87)90661-9; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; SCHARNAGL C, 1983, Z NATURFORSCH C, V38, P951; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Stec B, 1999, BIOPHYS J, V76, P2912, DOI 10.1016/S0006-3495(99)77446-1; Steglich C, 2003, ENVIRON MICROBIOL, V5, P681, DOI 10.1046/j.1462-2920.2003.00456.x; Steglich C, 2003, FEBS LETT, V553, P79, DOI 10.1016/S0014-5793(03)00971-2; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Ting CS, 2001, MICROBIOL-SGM, V147, P3171, DOI 10.1099/00221287-147-11-3171; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; WAHLEITHNER JA, 1991, P NATL ACAD SCI USA, V88, P10387, DOI 10.1073/pnas.88.23.10387; WEDEMAYER GJ, 1992, J BIOL CHEM, V267, P7315; WEMMER DE, 1993, J BIOL CHEM, V268, P1658; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	63	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37561	37569		10.1074/jbc.M110.172619	http://dx.doi.org/10.1074/jbc.M110.172619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876568	Green Published, hybrid			2022-12-25	WOS:000284424000048
J	Eichelsdoerfer, JL; Evans, JA; Slaugenhaupt, SA; Cuajungco, MP				Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Slaugenhaupt, Susan A.; Cuajungco, Math P.			Zinc Dyshomeostasis Is Linked with the Loss of Mucolipidosis IV-associated TRPML1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; ENDOGENOUS ZINC; ENHANCED ZINC; CELL-CULTURE; BRAIN; AUTOPHAGY; MUTATION; RELEASE; NEURONS; INJURY	Chelatable zinc is important in brain function, and its homeostasis is maintained to prevent cytotoxic overload. However, certain pathologic events result in intracellular zinc accumulation in lysosomes and mitochondria. Abnormal lysosomes and mitochondria are common features of the human lysosomal storage disorder known as mucolipidosis IV (MLIV). MLIV is caused by the loss of TRPML1 ion channel function. MLIV cells develop large hyperacidic lysosomes, membranous vacuoles, mitochondrial fragmentation, and autophagic dysfunction. Here, we observed that RNA interference of mucolipin-1 gene (TRPML1) in HEK-293 cells mimics the MLIV cell phenotype consisting of large lysosomes and membranous vacuoles that accumulate chelatable zinc. To show that abnormal chelatable zinc levels are indeed correlated with MLIV pathology, we quantified its concentration in cultured MLIV patient fibroblast and control cells with a spectrofluorometer using N-(6-methoxy-8-quinolyl)-p-toluene sulfonamide fluorochrome. We found a significant increase of chelatable zinc levels in MLIV cells but not in control cells. Furthermore, we quantified various metal isotopes in whole brain tissue of TRPML1(-/-) null mice and wild-type littermates using inductively coupled plasma mass spectrometry and observed that the zinc-66 isotope is markedly elevated in the brain of TRPML1(-/-) mice when compared with controls. In conclusion, we show for the first time that the loss of TRPML1 function results in intracellular chelatable zinc dyshomeostasis. We propose that chelatable zinc accumulation in large lysosomes and membranous vacuoles may contribute to the pathogenesis of the disease and progressive cell degeneration in MLIV patients.	[Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Cuajungco, Math P.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92831 USA; [Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Cuajungco, Math P.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Fullerton, CA 92831 USA; [Slaugenhaupt, Susan A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Slaugenhaupt, Susan A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cuajungco, Math P.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia	California State University System; California State University Fullerton; California State University System; California State University Fullerton; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Florey Institute of Neuroscience & Mental Health	Cuajungco, MP (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, 800 N State Coll Blvd, Fullerton, CA 92831 USA.	mcuajungco@fullerton.edu	Cuajungco, Math/B-2647-2008	Cuajungco, Math/0000-0003-0749-9564	National Institutes of Health [R01 NS39995]; Doris Howell-CSUPERB research scholarships; Howard Hughes Medical Institute; National Science Foundation [MCB 920127]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Howell-CSUPERB research scholarships; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS39995 (to S. A. S.). This work was also partially supported by Doris Howell-CSUPERB research scholarships (to J.L.E. and J.A.E.), the Howard Hughes Medical Institute undergraduate research program, and National Science Foundation Grant MCB 920127 (to M. P. C.). A preliminary account of this work was presented in the Experimental Biology 2010 meeting on April 26, 2010 in Anaheim, CA.	AMIR N, 1987, PEDIATRICS, V79, P953; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Chung H, 2009, TOXICOL APPL PHARM, V235, P163, DOI 10.1016/j.taap.2008.11.006; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; FALCO N, 2007, EXP CELL RES */* E C, V313, P1473; Flinn JM, 2005, PHYSIOL BEHAV, V83, P793, DOI 10.1016/j.physbeh.2004.10.009; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hirose K, 2004, J COMP NEUROL, V470, P164, DOI 10.1002/cne.11046; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Jiang PJ, 2004, COORDIN CHEM REV, V248, P205, DOI 10.1016/j.cct.2003.10.013; Kogot-Levin A, 2009, PEDIATR RES, V65, P686, DOI 10.1203/PDR.0b013e3181a1681a; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Linkous DH, 2009, J ALZHEIMERS DIS, V18, P565, DOI 10.3233/JAD-2009-1162; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yanagisawa H, 2009, TOXICOL LETT, V191, P15, DOI 10.1016/j.toxlet.2009.07.024; Yoon YH, 2000, TOXICOL APPL PHARM, V162, P107, DOI 10.1006/taap.1999.8846; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587	34	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34304	34308		10.1074/jbc.C110.165480	http://dx.doi.org/10.1074/jbc.C110.165480			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20864526	Green Published, hybrid			2022-12-25	WOS:000283659100003
J	Lyons, PJ; Ma, LH; Baker, R; Fricker, LD				Lyons, Peter J.; Ma, Leung-hang; Baker, Robert; Fricker, Lloyd D.			Carboxypeptidase A6 in Zebrafish Development and Implications for VIth Cranial Nerve Pathfinding	PLOS ONE			English	Article							DUANE-SYNDROME; EMBRYONIC-DEVELOPMENT; GENE; IDENTIFICATION; DELETION; REGION; ALPHA-2-CHIMAERIN; HYBRIDIZATION; INHIBITION; MUTATIONS	Carboxypeptidase A6 (CPA6) is an extracellular protease that cleaves carboxy-terminal hydrophobic amino acids and has been implicated in the defective innervation of the lateral rectus muscle by the VIth cranial nerve in Duane syndrome. In order to investigate the role of CPA6 in development, in particular its potential role in axon guidance, the zebrafish ortholog was identified and cloned. Zebrafish CPA6 was secreted and interacted with the extracellular matrix where it had a neutral pH optimum and specificity for C-terminal hydrophobic amino acids. Transient mRNA expression was found in newly formed somites, pectoral fin buds, the stomodeum and a conspicuous condensation posterior to the eye. Markers showed this tissue was not myogenic in nature. Rather, the CPA6 localization overlapped with a chondrogenic site which subsequently forms the walls of a myodome surrounding the lateral rectus muscle. No other zebrafish CPA gene exhibited a similar expression profile. Morpholino-mediated knockdown of CPA6 combined with retrograde labeling and horizontal eye movement analyses demonstrated that deficiency of CPA6 alone did not affect either VIth nerve development or function in the zebrafish. We suggest that mutations in other genes and/or enhancer elements, together with defective CPA6 expression, may be required for altered VIth nerve pathfinding. If mutations in CPA6 contribute to Duane syndrome, our results also suggest that Duane syndrome can be a chondrogenic rather than a myogenic or neurogenic developmental disorder.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Ma, Leung-hang; Baker, Robert] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; New York University	Lyons, PJ (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	peter.lyons@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445; Baker, Robert/0000-0001-7920-1769	Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health (NIH NRSA) [EY19433]; Grass Foundation; National Institutes of Health (NIH) [DA004494, EY002007]; NATIONAL EYE INSTITUTE [R01EY002007, F32EY019433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grass Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by fellowships from the Natural Sciences and Engineering Research Council of Canada (NSERC), National Institutes of Health (NIH NRSA EY19433) and the Grass Foundation to P.J.L., as well as National Institutes of Health (NIH) Grants DA004494 (L. D. F.) and EY002007 (R. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Allis EP, 1918, P NATL ACAD SCI USA, V4, P241, DOI 10.1073/pnas.4.8.241; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Barry JS, 2008, OPHTHALMIC GENET, V29, P177, DOI 10.1080/13816810802354224; Beck JC, 2004, METHOD CELL BIOL, V76, P385; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; Bosley TM, 2007, NEUROLOGY, V69, P1245, DOI 10.1212/01.wnl.0000276947.59704.cf; Calabrese G, 1998, EUR J HUM GENET, V6, P187, DOI 10.1038/sj.ejhg.5200173; COULY GF, 1992, DEVELOPMENT, V114, P1; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dobson JT, 2008, BLOOD, V112, P2969, DOI 10.1182/blood-2008-03-145011; Easter SS, 1996, DEV BIOL, V180, P646; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Geerinckx T, 2005, J MORPHOL, V266, P331, DOI 10.1002/jmor.10381; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Gutowski NJ, 2000, EUR J NEUROL, V7, P145, DOI 10.1046/j.1468-1331.2000.00029.x; Huang HJ, 1999, CANCER RES, V59, P2981; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lehman AM, 2009, EUR J MED GENET, V52, P436, DOI 10.1016/j.ejmg.2009.09.006; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Monfort S, 2008, J MED GENET, V45, P432, DOI 10.1136/jmg.2008.057596; Mootoosamy RC, 2002, DEVELOPMENT, V129, P573; Murillo-Correa CE, 2009, J AAPOS, V13, P245, DOI 10.1016/j.jaapos.2009.03.007; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rickard S, 2001, HUM GENET, V108, P398, DOI 10.1007/s004390100495; Row RH, 2009, DEV BIOL, V329, P55, DOI 10.1016/j.ydbio.2009.02.016; Starks EC, 1905, SCIENCE, V21, P0754, DOI 10.1126/science.21.541.754; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009	41	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12967	10.1371/journal.pone.0012967	http://dx.doi.org/10.1371/journal.pone.0012967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885977	Green Published, gold, Green Submitted			2022-12-25	WOS:000282122600007
J	Song, WB; Wang, YY; Meng, FS; Zhang, QH; Zeng, JY; Xiao, LP; Yu, XP; Peng, DD; Su, L; Xiao, B; Zhang, ZS				Song, Wei-Bing; Wang, Yuan-Yuan; Meng, Fan-Su; Zhang, Qing-Hua; Zeng, Jian-Ying; Xiao, Li-Ping; Yu, Xin-Pei; Peng, Dan-dan; Su, Lei; Xiao, Bing; Zhang, Zhen-Shu			Curcumin Protects Intestinal Mucosal Barrier Function of Rat Enteritis via Activation of MKP-1 and Attenuation of p38 and NF-kappa B Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; EPITHELIAL-CELLS; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; NEUTROPHIL INFILTRATION; ALVEOLAR MACROPHAGES; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; REPERFUSION INJURY	Background: Intestinal mucosa barrier (IMB) dysfunction results in many notorious diseases for which there are currently few effective treatments. We studied curcumin's protective effect on IMB and examined its mechanism by using methotrexate (MTX) induced rat enteritis model and lipopolysaccharide (LPS) treated cell death model. Methodology/Principal Findings: Curcumin was intragastrically administrated from the first day, models were made for 7 days. Cells were treated with curcumin for 30 min before exposure to LPS. Rat intestinal mucosa was collected for evaluation of pathological changes. We detected the activities of D-lactate and diamine oxidase (DAO) according to previous research and measured the levels of myeloperoxidase (MPO) and superoxide dismutase (SOD) by colorimetric method. Intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) were determined by RT-PCR and IL-10 production was determined by ELISA. We found Curcumin decreased the levels of D-lactate, DAO, MPO, ICAM-1, IL-1 beta and TNF-alpha, but increased the levels of IL-10 and SOD in rat models. We further confirmed mitogen-activated protein kinase phosphatase-1 (MKP-1) was activated but phospho-p38 was inhibited by curcumin by western blot assay. Finally, NF-kappa B translocation was monitored by immunofluorescent staining. We showed that curcumin repressed I-kappa B and interfered with the translocation of NF-kappa B into nucleus. Conclusions/Significance: The effect of curcumin is mediated by the MKP-1-dependent inactivation of p38 and inhibition of NF-kappa B-mediated transcription. Curcumin, with anti-inflammatory and anti-oxidant activities may be used as an effective reagent for protecting intestinal mucosa barrier and other related intestinal diseases.	[Song, Wei-Bing; Zeng, Jian-Ying; Xiao, Li-Ping; Yu, Xin-Pei; Peng, Dan-dan; Su, Lei] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China; [Wang, Yuan-Yuan; Xiao, Bing; Zhang, Zhen-Shu] So Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Meng, Fan-Su] Tradit Chinese Med Hosp ZhongSan City, Dept Intens Care Unit, Zhongshan, Peoples R China; [Zhang, Qing-Hua] 458 Hosp Peoples Liberat Army, Dept Gerontol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Song, WB (corresponding author), Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China.	songweibing@yahoo.com			General Hospital of Guangzhou Military Command of People's Liberation Army of Medical Technology; Guangdong Provincial Key Laboratory of Gastroenterology	General Hospital of Guangzhou Military Command of People's Liberation Army of Medical Technology; Guangdong Provincial Key Laboratory of Gastroenterology	This work was supported by the research fund of General Hospital of Guangzhou Military Command of People's Liberation Army of Medical & Technology and the research fund of Guangdong Provincial Key Laboratory of Gastroenterology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aranow JS, 1996, BRIT J ANAESTH, V77, P71, DOI 10.1093/bja/77.1.71; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Chretien A, 2008, FREE RADICAL BIO MED, V44, P1732, DOI 10.1016/j.freeradbiomed.2008.01.026; De Plaen IG, 2000, BRIT J PHARMACOL, V129, P307, DOI 10.1038/sj.bjp.0703055; Dinarello CA, 2005, CRIT CARE MED, V33, pS460, DOI 10.1097/01.CCM.0000185500.11080.91; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Gong JP, 2002, WORLD J GASTROENTERO, V8, P923, DOI 10.3748/wjg.v8.i5.923; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177; Howarth GS, 1996, J NUTR, V126, P2519, DOI 10.1093/jn/126.10.2519; Iles KE, 2002, FREE RADICAL BIO MED, V32, P1304, DOI 10.1016/S0891-5849(02)00840-7; Jang BC, 2007, FEMS IMMUNOL MED MIC, V51, P171, DOI 10.1111/j.1574-695X.2007.00293.x; Jeong HJ, 2002, CYTOKINE, V18, P252, DOI 10.1006/cyto.2002.0894; Jobin C, 1999, J IMMUNOL, V163, P3474; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kalff JC, 1999, ARCH ORTHOP TRAUM SU, V119, P89, DOI 10.1007/s004020050363; Kim BH, 2008, MOL PHARMACOL, V73, P1309, DOI 10.1124/mol.107.041251; Kimura T, 1998, EUR J GASTROEN HEPAT, V10, P659; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Laharie D, 2007, DIGEST DIS SCI, V52, P84, DOI 10.1007/s10620-006-9183-4; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nieto N, 2000, DIGEST DIS SCI, V45, P1820, DOI 10.1023/A:1005565708038; Olanders K, 2002, SHOCK, V18, P86, DOI 10.1097/00024382-200207000-00016; PATEL RT, 1995, DIS COLON RECTUM, V38, P831, DOI 10.1007/BF02049839; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Roozendaal C, 1998, CLIN EXP IMMUNOL, V112, P10; Ruh J, 2000, MICROVASC RES, V59, P329, DOI 10.1006/mvre.1999.2201; Sandborn WJ, 2003, BEST PRACT RES CL GA, V17, P105, DOI 10.1053/bega.2002.0345; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Tanaka T, 2008, NEUROSCI LETT, V431, P262, DOI 10.1016/j.neulet.2007.11.051; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; Van't Land B, 2004, DIGEST DIS SCI, V49, P425, DOI 10.1023/B:DDAS.0000020497.35250.93; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wang KJ, 2008, PROD PLAN CONTROL, V19, P475, DOI 10.1080/09537280802088659; Weaver SA, 2001, GASTROENTEROLOGY, V120, P1117, DOI 10.1053/gast.2001.23257; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xian CJ, 2000, BRIT J CANCER, V82, P945, DOI 10.1054/bjoc.1999.1023; Yagci G, 2004, J GASTROENTEROL, V39, P268, DOI 10.1007/s00535-003-1287-4; Ye JP, 2000, ANN CLIN LAB SCI, V30, P65; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zingarelli B, 2001, GUT, V48, P610, DOI 10.1136/gut.48.5.610	58	72	76	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12969	10.1371/journal.pone.0012969	http://dx.doi.org/10.1371/journal.pone.0012969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885979	gold, Green Published, Green Submitted			2022-12-25	WOS:000282122600008
J	Desikan, RS; Sabuncu, MR; Schmansky, NJ; Reuter, M; Cabral, HJ; Hess, CP; Weiner, MW; Biffi, A; Anderson, CD; Rosand, J; Salat, DH; Kemper, TL; Dale, AM; Sperling, RA; Fischl, B				Desikan, Rahul S.; Sabuncu, Mert R.; Schmansky, Nicholas J.; Reuter, Martin; Cabral, Howard J.; Hess, Christopher P.; Weiner, Michael W.; Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan; Salat, David H.; Kemper, Thomas L.; Dale, Anders M.; Sperling, Reisa A.; Fischl, Bruce		Alzheimer's Dis Neuroimaging Initi	Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SURFACE-BASED ANALYSIS; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; AMYLOID DEPOSITION; CORTICAL SURFACE; COORDINATE SYSTEM; APOLIPOPROTEIN-E; ELDERLY SUBJECTS; PRODROMAL AD	Background: Alzheimer's disease (AD) and its transitional state mild cognitive impairment (MCI) are characterized by amyloid plaque and tau neurofibrillary tangle (NFT) deposition within the cerebral neocortex and neuronal loss within the hippocampal formation. However, the precise relationship between pathologic changes in neocortical regions and hippocampal atrophy is largely unknown. Methodology/Principal Findings: In this study, combining structural MRI scans and automated image analysis tools with reduced cerebrospinal fluid (CSF) A beta levels, a surrogate for intra-cranial amyloid plaques and elevated CSF phosphorylated tau (p-tau) levels, a surrogate for neocortical NFTs, we examined the relationship between the presence of Alzheimer's pathology, gray matter thickness of select neocortical regions, and hippocampal volume in cognitively normal older participants and individuals with MCI and AD (n = 724). Amongst all 3 groups, only select heteromodal cortical regions significantly correlated with hippocampal volume. Amongst MCI and AD individuals, gray matter thickness of the entorhinal cortex and inferior temporal gyrus significantly predicted longitudinal hippocampal volume loss in both amyloid positive and p-tau positive individuals. Amongst cognitively normal older adults, thinning only within the medial portion of the orbital frontal cortex significantly differentiated amyloid positive from amyloid negative individuals whereas thinning only within the entorhinal cortex significantly discriminated p-tau positive from p-tau negative individuals. Conclusions/Significance: Cortical Ab and tau pathology affects gray matter thinning within select neocortical regions and potentially contributes to downstream hippocampal degeneration. Neocortical Alzheimer's pathology is evident even amongst older asymptomatic individuals suggesting the existence of a preclinical phase of dementia.	[Desikan, Rahul S.; Sabuncu, Mert R.; Schmansky, Nicholas J.; Reuter, Martin; Salat, David H.; Sperling, Reisa A.; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hess, Christopher P.; Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Weiner, Michael W.] Dept Vet Affairs, San Francisco, CA USA; [Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Kemper, Thomas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Sperling, Reisa A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, Boston, MA 02115 USA; [Sabuncu, Mert R.; Fischl, Bruce] Massachusetts Gen Hosp, Comp Sci & Artificial Intelligence Lab, Cambridge, MA USA; [Sabuncu, Mert R.; Fischl, Bruce] Massachusetts Gen Hosp, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; Boston University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Desikan, RS (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	rahul@nmr.mgh.harvard.edu	Sabuncu, Mert Rory/ABE-2284-2021; Reuter, Martin/B-3456-2010	Reuter, Martin/0000-0002-2665-9693; Hess, Christopher/0000-0002-5132-5302; Anderson, Christopher/0000-0002-0053-2002; Sabuncu, Mert/0000-0002-7068-719X; Cabral, Howard/0000-0002-1185-8331; Kemper, Thomas/0000-0002-4623-4094	National Center for Research Resources [P41-RR14075, R01 RR 16594-01A1, BIRN002, U24 RR021382]; National Institute for Biomedical Imaging and Bioengineering [R01 EB001550, R01EB006758]; National Institute for Neurological Disorders and Stroke [R01 NS052585-01]; Mental Illness and Neuroscience Discovery (MIND) Institute; National Institute on Aging [P50 AG05681, P01 AG03991, AG02238, AG021910]; Ellison Medical Foundation; NIH [P30 AG010129, K01 AG030514]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382, P41RR014075, R01RR016594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001550, R01EB006758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, U01AG024904, R01AG021910, P30AG010129, K01AG030514, P01AG003991] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mental Illness and Neuroscience Discovery (MIND) Institute; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the National Center for Research Resources (P41-RR14075, R01 RR 16594-01A1 and the NCRR BIRN Morphometric Project BIRN002, U24 RR021382), the National Institute for Biomedical Imaging and Bioengineering (R01 EB001550, R01EB006758), National Institute for Neurological Disorders and Stroke (R01 NS052585-01), the Mental Illness and Neuroscience Discovery (MIND) Institute, and the National Institute on Aging (P50 AG05681, P01 AG03991, AG02238 and AG021910). Additional support was provided by The Autism & Dyslexia Project funded by the Ellison Medical Foundation. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2009, NEUROLOGY, V72, P1504, DOI 10.1212/WNL.0b013e3181a2e896; Gomez-Isla Teresa, 2008, Handb Clin Neurol, V89, P233, DOI 10.1016/S0072-9752(07)01222-5; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jones E. G., 1985, CEREB CORTEX, V4, P3; Kemper T. L., 1994, CLIN NEUROLOGY AGING, V2nd, P3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Pandya D.N., 1990, NEUROBIOLOGY HIGHER, P53; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; REUTER M, 2010, NEUROIMAGE      0713; SANIDES F, 1969, ANN NY ACAD SCI, V167, P404, DOI 10.1111/j.1749-6632.1969.tb20459.x; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Thompson PM, 2003, J NEUROSCI, V23, P994; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107; YAKOVLEV PI, 1948, J NERV MENT DIS, V107, P313, DOI 10.1097/00005053-194810740-00001	60	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12853	10.1371/journal.pone.0012853	http://dx.doi.org/10.1371/journal.pone.0012853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886094	gold, Green Published			2022-12-25	WOS:000282091100002
J	Mo, KG; Razak, Z; Rao, PC; Yu, ZG; Adachi, H; Katsuno, M; Sobue, G; Lieberman, AP; Westwood, JT; Monks, DA				Mo, Kaiguo; Razak, Zak; Rao, Pengcheng; Yu, Zhigang; Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen; Lieberman, Andrew P.; Westwood, J. Timothy; Monks, D. Ashley			Microarray Analysis of Gene Expression by Skeletal Muscle of Three Mouse Models of Kennedy Disease/Spinal Bulbar Muscular Atrophy	PLOS ONE			English	Article							ANDROGEN RECEPTOR PROTEIN; HEAT-SHOCK PROTEINS; AMELIORATES PHENOTYPES; BODY-COMPOSITION; AGGREGATION; TOXICITY; BINDING; OVEREXPRESSION; ABNORMALITIES; MITOCHONDRIAL	Background: Emerging evidence implicates altered gene expression within skeletal muscle in the pathogenesis of Kennedy disease/spinal bulbar muscular atrophy (KD/SBMA). We therefore broadly characterized gene expression in skeletal muscle of three independently generated mouse models of this disease. The mouse models included a polyglutamine expanded (polyQ) AR knock-in model (AR113Q), a polyQ AR transgenic model (AR97Q), and a transgenic mouse that overexpresses wild type AR solely in skeletal muscle (HSA-AR). HSA-AR mice were included because they substantially reproduce the KD/SBMA phenotype despite the absence of polyQ AR. Methodology/Principal Findings: We performed microarray analysis of lower hindlimb muscles taken from these three models relative to wild type controls using high density oligonucleotide arrays. All microarray comparisons were made with at least 3 animals in each condition, and only those genes having at least 2-fold difference and whose coefficient of variance was less than 100% were considered to be differentially expressed. When considered globally, there was a similar overlap in gene changes between the 3 models: 19% between HSA-AR and AR97Q, 21% between AR97Q and AR113Q, and 17% between HSA-AR and AR113Q, with 8% shared by all models. Several patterns of gene expression relevant to the disease process were observed. Notably, patterns of gene expression typical of loss of AR function were observed in all three models, as were alterations in genes involved in cell adhesion, energy balance, muscle atrophy and myogenesis. We additionally measured changes similar to those observed in skeletal muscle of a mouse model of Huntington's Disease, and to those common to muscle atrophy from diverse causes. Conclusions/Significance: By comparing patterns of gene expression in three independent models of KD/SBMA, we have been able to identify candidate genes that might mediate the core myogenic features of KD/SBMA.	[Mo, Kaiguo; Rao, Pengcheng; Monks, D. Ashley] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Mo, Kaiguo; Razak, Zak; Westwood, J. Timothy] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Yu, Zhigang; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Katsuno, Masahisa] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Monks, D. Ashley] Univ Toronto, Inst Med Sci, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga; University of Michigan System; University of Michigan; Nagoya University; Nagoya University; University of Toronto; University Toronto Mississauga	Mo, KG (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	ashley.monks@utoronto.ca	Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014; Yu, Zhigang/A-6893-2009	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; 	National Institutes of Health [R01-NS51257, R01-NS055746]; Natural Sciences and Research Council of Canada [138234-06, 326916-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055746, R01NS051257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work reported in this manuscript received financial support from the National Institutes of Health [(http://www.nih.gov/) R01-NS51257 to DAM, R01-NS055746 to APL]; Natural Sciences and Research Council of Canada [(http://www.nserc-crsng.gc.ca/) 138234-06, 326916-06 to JTW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2007, NEUROPATH APPL NEURO, V33, P135, DOI 10.1111/j.1365-2990.2007.00830.x; Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Eigenthaler M, 2003, AM J PHYSIOL-HEART C, V285, pH2471, DOI 10.1152/ajpheart.00362.2003; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fayazi Z, 2006, NEUROBIOL DIS, V24, P226, DOI 10.1016/j.nbd.2006.06.015; Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; JOHANSEN JA, 2008, NEUROBIOL DIS; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KATSUNO M, 2003, ACNR, V3, P8; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li J, 2003, DEV BIOL, V261, P209, DOI 10.1016/S0012-1606(03)00304-X; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Mandrusiak LM, 2003, HUM MOL GENET, V12, P1497, DOI 10.1093/hmg/ddg161; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; MINAMIYAMA M, 2004, HUM MOL GENET; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Monks DA, 2008, HORM BEHAV, V53, P729, DOI 10.1016/j.yhbeh.2007.12.009; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Orngreen MC, 2008, NEUROLOGY, V70, P1876, DOI 10.1212/01.wnl.0000289190.66955.67; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pires-Oliveira M, 2010, J APPL PHYSIOL, V108, P266, DOI 10.1152/japplphysiol.00490.2009; Pisani DF, 2005, BIOCHEM BIOPH RES CO, V326, P788, DOI 10.1016/j.bbrc.2004.11.111; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Tong JF, 2009, J CELL BIOCHEM, V108, P458, DOI 10.1002/jcb.22272; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wootton PTE, 2007, NUTR METAB CARDIOVAS, V17, P24, DOI 10.1016/j.numecd.2005.11.008; Wuyts W, 2005, AM J MED GENET A, V133A, P82, DOI 10.1002/ajmg.a.30517; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12922	10.1371/journal.pone.0012922	http://dx.doi.org/10.1371/journal.pone.0012922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886071	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000282091100026
J	Lyons, JA; Haring, JS; Biga, PR				Lyons, Jeri-Anne; Haring, Jodie S.; Biga, Peggy R.			Myostatin Expression, Lymphocyte Population, and Potential Cytokine Production Correlate with Predisposition to High-Fat Diet Induced Obesity in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INNATE IMMUNE PROTECTION; BETA SUPERFAMILY MEMBER; INBRED MOUSE STRAINS; SKELETAL-MUSCLE MASS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; LISTERIA-MONOCYTOGENES; TRANSGENIC MICE; GLUCOSE-UPTAKE	A strong relationship exists between increased inflammatory cytokines and muscle insulin resistance in obesity. This study focused on identifying a relationship between metabolic propensity and myostatin expression in muscle and spleen cells in response to high-fat diet intake. Using a comparative approach, we analyzed the effects of high-fat diet intake on myostatin and follistatin expression, spleen cell composition, and potential cytokine expression in high-fat diet induced obesity (HFDIO) resistant (SWR/J) and susceptible (C57BL/6) mice models. Results demonstrated overall increased myostatin expression in muscle following high-fat diet intake in HFDIO-susceptible mice, while myostatin expression levels decreased initially in muscle from high-fat diet fed resistant mice. In HFDIO-resistant mice, myostatin expression decreased in spleen, while myostatin increased in spleen tissue from HFDIO-susceptible mice. Proinflammatory cytokine (IL-17, IL-1 beta, and IFN gamma) potential increased in splenocytes from HFDIO-susceptible mice. In comparison, C57BL/6 mice fed a high-fat diet exhibited higher frequencies of CD4(+)/CD44(hi) and CD8(+)/CD44(hi) cells in the spleen compared to control fed mice. Together, these results suggest that susceptibility to high-fat diet induced obesity could be influenced by local myostatin activity in a tissue-specific manner and that splenocytes exhibit differential cytokine production in a strain-dependent manner. This study sets the stage for future investigations into the interactions between growth, inflammation, and metabolism.	[Lyons, Jeri-Anne] Univ Wisconsin, Dept Clin Hlth Sci, Milwaukee, WI 53201 USA; [Haring, Jodie S.] N Dakota State Univ, Dept Chem & Mol Biol, Fargo, ND 58105 USA; [Biga, Peggy R.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA	University of Wisconsin System; University of Wisconsin Milwaukee; North Dakota State University Fargo; North Dakota State University Fargo	Lyons, JA (corresponding author), Univ Wisconsin, Dept Clin Hlth Sci, Milwaukee, WI 53201 USA.	peggy.biga@ndsu.edu		Biga, Peggy/0000-0002-0540-291X	NIH NCRR COBRE, Center for Protease Research [2P20RR015566]; NSF [EPS-00447679]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER	NIH NCRR COBRE, Center for Protease Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds to PRB by NIH NCRR COBRE, Center for Protease Research Grant # 2P20RR015566 and ND EPSCoR Grant # EPS-00447679 from NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Biga PR, 2004, GEN COMP ENDOCR, V138, P32, DOI 10.1016/j.ygcen.2004.05.001; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Carey AL, 2004, DIABETOLOGIA, V47, P1029, DOI 10.1007/s00125-004-1403-x; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; GOTTSCHLICH MM, 1993, J AM DIET ASSOC, V93, P1261, DOI 10.1016/0002-8223(93)91952-M; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; KRISHNAN EC, 1982, J SURG RES, V33, P89, DOI 10.1016/0022-4804(82)90012-9; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OH IS, AM J PHYSL ENDOCRINO, V299, pE47; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rodgers BD, 2003, AM J PHYSIOL-REG I, V284, pR1277, DOI 10.1152/ajpregu.00644.2002; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; White LJ, 2006, METABOLISM, V55, P128, DOI 10.1016/j.metabol.2005.08.026; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P574, DOI 10.1249/01.MSS.0000121952.71533.EA; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	54	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12928	10.1371/journal.pone.0012928	http://dx.doi.org/10.1371/journal.pone.0012928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877574	Green Submitted, Green Published, gold			2022-12-25	WOS:000282053100034
J	Rujoi, M; Pipalia, NH; Maxfield, FR				Rujoi, Madalina; Pipalia, Nina H.; Maxfield, Frederick R.			Cholesterol Pathways Affected by Small Molecules That Decrease Sterol Levels in Niemann-Pick Type C Mutant Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; COENZYME-A REDUCTASE; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; CULTURED FIBROBLASTS; ACYL-COENZYME; PROTEIN; DISEASE; RECEPTOR	Background: Niemann-Pick type C (NPC) disease is a genetically inherited multi-lipid storage disorder with impaired efflux of cholesterol from lysosomal storage organelles. Methodology/Principal Findings: The effect of screen-selected cholesterol lowering compounds on the major sterol pathways was studied in CT60 mutant CHO cells lacking NPC1 protein. Each of the selected chemicals decreases cholesterol in the lysosomal storage organelles of NPC1 mutant cells through one or more of the following mechanisms: increased cholesterol efflux from the cell, decreased uptake of low-density lipoproteins, and/or increased levels of cholesteryl esters. Several chemicals promote efflux of cholesterol to extracellular acceptors in both non-NPC and NPC1 mutant cells. The uptake of low-density lipoprotein-derived cholesterol is inhibited by some of the studied compounds. Conclusions/Significance: Results herein provide the information for prioritized further studies in identifying molecular targets of the chemicals. This approach proved successful in the identification of seven chemicals as novel inhibitors of lysosomal acid lipase (Rosenbaum et al, Biochim. Biophys. Acta. 2009, 1791:1155-1165).	[Rujoi, Madalina; Pipalia, Nina H.; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Cornell University	Rujoi, M (corresponding author), Depaul Univ, Dept Chem, Chicago, IL 60604 USA.	frmaxfie@med.cornell.edu	Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NIH [R37-DK27083]; Ara Parseghian Medical Research Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R37-DK27083 (http://www.nih.gov/) and a grant from the Ara Parseghian Medical Research Foundation (http:// www.parseghian.org/). MR was supported in part by a grant from the W.M. Keck Foundation (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Cosner CC, 2009, J MED CHEM, V52, P6494, DOI 10.1021/jm900707n; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LEFEVRE M, 1988, J LIPID RES, V29, P815; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Morris JA, 1998, MOL MED TODAY, V4, P525, DOI 10.1016/S1357-4310(98)01374-4; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pipalia NH, 2006, J LIPID RES, V47, P284, DOI 10.1194/jlr.M500388-JLR200; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Reid PC, 2008, J NEUROSCI METH, V168, P15, DOI 10.1016/j.jneumeth.2007.09.002; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; SOKOL J, 1988, J BIOL CHEM, V263, P3411; SPILLANE DM, 1995, BBA-LIPID LIPID MET, V1254, P283, DOI 10.1016/0005-2760(94)00190-A; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; WILLINGHAM MC, 1979, J CELL BIOL, V82, P614, DOI 10.1083/jcb.82.3.614; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang M, 2003, ACTA PAEDIATR, V92, P63, DOI 10.1080/08035320310021958	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12788	10.1371/journal.pone.0012788	http://dx.doi.org/10.1371/journal.pone.0012788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877719	Green Submitted, Green Published, gold			2022-12-25	WOS:000282002900002
J	Edwards, TE; Phan, I; Abendroth, J; Dieterich, SH; Masoudi, A; Guo, W; Hewitt, SN; Kelley, A; Leibly, D; Brittnacher, MJ; Staker, BL; Miller, SI; Van Voorhis, WC; Myler, PJ; Stewart, LJ				Edwards, Thomas E.; Phan, Isabelle; Abendroth, Jan; Dieterich, Shellie H.; Masoudi, Amir; Guo, Wenjin; Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Brittnacher, Mitch J.; Staker, Bart L.; Miller, Samuel I.; Van Voorhis, Wesley C.; Myler, Peter J.; Stewart, Lance J.			Structure of a Burkholderia pseudomallei Trimeric Autotransporter Adhesin Head	PLOS ONE			English	Article							PROTEIN; DOMAIN; MODEL; YADA; PREDICTION; ALIGNMENT; TOOLS; BINDS; DNA	Background: Pathogenic bacteria adhere to the host cell surface using a family of outer membrane proteins called Trimeric Autotransporter Adhesins (TAAs). Although TAAs are highly divergent in sequence and domain structure, they are all conceptually comprised of a C-terminal membrane anchoring domain and an N-terminal passenger domain. Passenger domains consist of a secretion sequence, a head region that facilitates binding to the host cell surface, and a stalk region. Methodology/Principal Findings: Pathogenic species of Burkholderia contain an overabundance of TAAs, some of which have been shown to elicit an immune response in the host. To understand the structural basis for host cell adhesion, we solved a 1.35 angstrom resolution crystal structure of a BpaA TAA head domain from Burkholderia pseudomallei, the pathogen that causes melioidosis. The structure reveals a novel fold of an intricately intertwined trimer. The BpaA head is composed of structural elements that have been observed in other TAA head structures as well as several elements of previously unknown structure predicted from low sequence homology between TAAs. These elements are typically up to 40 amino acids long and are not domains, but rather modular structural elements that may be duplicated or omitted through evolution, creating molecular diversity among TAAs. Conclusions/Significance: The modular nature of BpaA, as demonstrated by its head domain crystal structure, and of TAAs in general provides insights into evolution of pathogen-host adhesion and may provide an avenue for diagnostics.	[Edwards, Thomas E.; Phan, Isabelle; Abendroth, Jan; Dieterich, Shellie H.; Masoudi, Amir; Guo, Wenjin; Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Staker, Bart L.; Van Voorhis, Wesley C.; Myler, Peter J.; Stewart, Lance J.] Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA; [Edwards, Thomas E.; Abendroth, Jan; Dieterich, Shellie H.; Staker, Bart L.; Stewart, Lance J.] Emerald BioStruct, Bainbridge Isl, WA USA; [Phan, Isabelle; Masoudi, Amir; Guo, Wenjin; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Van Voorhis, Wesley C.] Univ Washington, Sch Med, Seattle, WA USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Edwards, TE (corresponding author), Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA.	tedwards@embios.com	Myler, Peter John/AAR-9535-2021	Staker, Bart/0000-0001-9570-5086; Myler, Peter/0000-0002-0056-0513; Edwards, Thomas/0000-0002-0474-8003	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded under federal contract number HHSN272200700057C from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez BH, 2010, J STRUCT BIOL, V170, P236, DOI 10.1016/j.jsb.2010.02.009; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dauter Miroslawa, 2007, Methods Mol Biol, V364, P149; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen JA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000224; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leo JC, 2008, PROTEIN ENG DES SEL, V21, P475, DOI 10.1093/protein/gzn025; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Mil-Homens D, 2010, MICROBIOL-SGM, V156, P1084, DOI 10.1099/mic.0.032623-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142; Yogavel M, 2007, ACTA CRYSTALLOGR D, V63, P931, DOI 10.1107/S0907444907029174; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049	49	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12803	10.1371/journal.pone.0012803	http://dx.doi.org/10.1371/journal.pone.0012803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862217	gold, Green Published, Green Submitted			2022-12-25	WOS:000281963200006
J	Factor, VM; Seo, D; Ishikawa, T; Kaposi-Novak, P; Marquardt, JU; Andersen, JB; Conner, EA; Thorgeirsson, SS				Factor, Valentina M.; Seo, Daekwan; Ishikawa, Tsuyoshi; Kaposi-Novak, Pal; Marquardt, Jens U.; Andersen, Jesper B.; Conner, Elizabeth A.; Thorgeirsson, Snorri S.			Loss of c-Met Disrupts Gene Expression Program Required for G2/M Progression during Liver Regeneration in Mice	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MITOTIC CHROMOSOME CONDENSATION; SIGNAL-REGULATED KINASE; CELL-CYCLE PROGRESSION; EGF RECEPTOR; HISTONE H3; PATHWAY; PHOSPHORYLATION; MITOSIS; ACTIVATION	Background: Previous work has established that HGF/c-Met signaling plays a pivotal role in regulating the onset of S phase following partial hepatectomy (PH). In this study, we used Met(fl/fl); Alb-Cre(+/-) conditional knockout mice to determine the effects of c-Met dysfunction in hepatocytes on kinetics of liver regeneration. Methodology/Principal Finding: The priming events appeared to be intact in Met(fl/fl); Alb-Cre(+/-) livers. Up-regulation of stress response (MAFK, IKBZ, SOCS3) and early growth response (c-Myc, c-Jun, c-Fos, DUSP1 and 6) genes as assessed by RT-qPCR and/or microarray profiling was unchanged. This was consistent with an early induction of MAPK/Erk and STAT3. However, after a successful completion of the first round of DNA replication, c-Met deficient hepatocytes were blocked in early/mid G2 phase as shown by staining with phosphorylated form of histone H3. Furthermore, loss of c-Met in hepatocytes diminished the subsequent G1/S progression and delayed liver recovery after partial hepatectomy. Upstream signaling pathways involved in the blockage of G2/M transition included lack of persistent Erk1/2 activation and inability to up-regulate the levels of Cdk1, Plk1, Aurora A and B, and Mad2 along with a defective histone 3 phosphorylation and lack of chromatin condensation. Continuous supplementation with EGF in vitro increased proliferation of Met(fl/fl); Alb-Cre(+/-) primary hepatocytes and partially restored expression levels of mitotic cell cycle regulators albeit to a lesser degree as compared to control cultures. Conclusion/Significance: In conclusion, our results assign a novel non-redundant function for HGF/c-Met signaling in regulation of G2/M gene expression program via maintaining a persistent Erk1/2 activation throughout liver regeneration.	[Factor, Valentina M.; Seo, Daekwan; Ishikawa, Tsuyoshi; Kaposi-Novak, Pal; Marquardt, Jens U.; Andersen, Jesper B.; Conner, Elizabeth A.; Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Factor, VM (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov		Marquardt, Jens/0000-0002-8314-2682; Andersen, Jesper B/0000-0003-1760-5244	NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; MATSUMOTO K, 1991, J GASTROEN HEPATOL, V6, P509, DOI 10.1111/j.1440-1746.1991.tb00897.x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Neuhauser Markus, 2006, Appl Bioinformatics, V5, P173, DOI 10.2165/00822942-200605030-00005; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Scheving LA, 2002, BIOCHEM BIOPH RES CO, V290, P197, DOI 10.1006/bbrc.2001.6157; Shiota G, 1998, INT J EXP PATHOL, V79, P267, DOI 10.1046/j.1365-2613.1998.730403.x; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; THROWER DA, 1995, EMBO J, V14, P918, DOI 10.1002/j.1460-2075.1995.tb07073.x; Vande Woude GF, 1997, CIBA F SYMP, V212, P119; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	46	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12739	10.1371/journal.pone.0012739	http://dx.doi.org/10.1371/journal.pone.0012739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862286	Green Published, Green Submitted, gold			2022-12-25	WOS:000281864100007
J	Stiebler, R; Hoang, AN; Egan, TJ; Wright, DW; Oliveira, MF				Stiebler, Renata; Hoang, Anh N.; Egan, Timothy J.; Wright, David W.; Oliveira, Marcus F.			Increase on the Initial Soluble Heme Levels in Acidic Conditions Is an Important Mechanism for Spontaneous Heme Crystallization In Vitro	PLOS ONE			English	Article							BETA-HEMATIN FORMATION; PLASMODIUM-FALCIPARUM; MALARIA PIGMENT; SCHISTOSOMA-MANSONI; HEMOZOIN FORMATION; POLYMERIZATION; DEGRADATION; MEMBRANE; PROLIXUS; MIDGUT	Background: Hemozoin (Hz) is a heme crystal that represents a vital pathway for heme disposal in several blood-feeding organisms. Recent evidence demonstrated that beta-hematin (beta H) (the synthetic counterpart of Hz) formation occurs under physiological conditions near synthetic or biological hydrophilic-hydrophobic interfaces. This seems to require a heme dimer acting as a precursor of Hz crystals that would be formed spontaneously in the absence of the competing water molecules bound to the heme iron. Here, we aimed to investigate the role of medium polarity on spontaneous beta H formation in vitro. Methodology/Principal Findings: We assessed the effect of water content on spontaneous beta H formation by using the aprotic solvent dimethylsulfoxide (DMSO) and a series of polyethyleneglycols (PEGs). We observed that both DMSO and PEGs (3.350, 6.000, 8.000, and 22.000) increased the levels of soluble heme under acidic conditions. These compounds were able to stimulate the production of beta H crystals in the absence of any biological sample. Interestingly, the effects of DMSO and PEGs on beta H formation were positively correlated with their capacity to promote previous heme solubilization in acidic conditions. Curiously, a short chain polyethyleneglycol (PEG 300) caused a significant reduction in both soluble heme levels and beta H formation. Finally, both heme solubilization and beta H rmation strongly correlated with reduced medium water activity provided by increased DMSO concentrations. Conclusions: The data presented here support the notion that reduction of the water activity is an important mechanism to support spontaneous heme crystallization, which depends on the previous increase of soluble heme levels.	[Stiebler, Renata; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Redox, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Hoang, Anh N.; Wright, David W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Egan, Timothy J.] Univ Cape Town, Dept Chem, ZA-7700 Rondebosch, South Africa	Universidade Federal do Rio de Janeiro; Vanderbilt University; University of Cape Town	Stiebler, R (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Redox, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	timothy.egan@uct.ac.za; david.w.wright@vanderbilt.edu; maroli@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425	International Centre for Genetic Engineering and Biotechnology (ICGEB); CNPq; FAPERJ (Jovens Cientistas do Nosso Estado); CAPES; NIH [1R01AI083145-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083145] Funding Source: NIH RePORTER	International Centre for Genetic Engineering and Biotechnology (ICGEB); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Jovens Cientistas do Nosso Estado)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation received financial support from the International Centre for Genetic Engineering and Biotechnology (ICGEB), CNPq, FAPERJ (Jovens Cientistas do Nosso Estado) and CAPES. MFO is a research scholar from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TJE and DWW acknowledge support from the NIH (1R01AI083145-01) for their contributions to this study.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; BERGER BJ, 1995, ANAL BIOCHEM, V231, P151, DOI 10.1006/abio.1995.1514; Blauer G, 2002, ARCH BIOCHEM BIOPHYS, V398, P7, DOI 10.1006/abbi.2001.2638; BOGITSH BJ, 1991, J PARASITOL, V77, P187, DOI 10.2307/3283078; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; Bohle DS, 2002, ACTA CRYSTALLOGR D, V58, P1752, DOI 10.1107/S0907444902014294; BROWN WH, 1911, J EXP MED, V15, P579; Carter MD, 2007, BIOCHEM BIOPH RES CO, V363, P867, DOI 10.1016/j.bbrc.2007.09.051; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; Soares JBR, 2007, FEBS LETT, V581, P1742, DOI 10.1016/j.febslet.2007.03.054; DE VILLIERS KA, 2007, J BIOL INORG CHEM, V12, P101; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P737, DOI 10.1016/S0006-2952(97)00509-1; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; Egan TJ, 2006, DALTON T, P5024, DOI 10.1039/b610866k; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501; Falk J.E, 1964, PORPHYRINS METALLOPO, P181, DOI [10.1002/jobm.19640040512, DOI 10.1002/JOBM.19640040512]; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hempelmann E, 2003, TRENDS PARASITOL, V19, P23, DOI 10.1016/S1471-4922(02)00011-9; Hoang AN, 2010, DALTON T, V39, P1235, DOI 10.1039/b914359a; Huy NT, 2007, ACTA TROP, V101, P130, DOI 10.1016/j.actatropica.2007.01.001; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kiss G., 2004, ATMOS CHEM PHYS DISC, V4, P7667, DOI DOI 10.5194/ACPD-4-7667-2004; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Mury FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006966; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Terra W. R., 1996, P206; TERRA WR, 1988, BRAZ J MED BIOL RES, V21, P675; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001	46	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12694	10.1371/journal.pone.0012694	http://dx.doi.org/10.1371/journal.pone.0012694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856937	gold, Green Published, Green Submitted			2022-12-25	WOS:000281735700014
J	Lugada, E; Millar, D; Haskew, J; Grabowsky, M; Garg, N; Vestergaard, M; Kahn, J; Muraguri, N; Mermin, J				Lugada, Eric; Millar, Debra; Haskew, John; Grabowsky, Mark; Garg, Navneet; Vestergaard, Mikkel; Kahn, James; Muraguri, Nicholas; Mermin, Jonathan			Rapid Implementation of an Integrated Large-Scale HIV Counseling and Testing, Malaria, and Diarrhea Prevention Campaign in Rural Kenya	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; INSECTICIDE-TREATED BEDNETS; RISK-FACTORS; COTRIMOXAZOLE PROPHYLAXIS; UGANDAN COMMUNITY; WESTERN KENYA; BED NETS; INFECTION; MORTALITY; ADULTS	Background: Integrated disease prevention in low resource settings can increase coverage, equity and efficiency in controlling high burden infectious diseases. A public-private partnership with the Ministry of Health, CDC, Vestergaard Frandsen and CHF International implemented a one-week integrated multi-disease prevention campaign. Method: Residents of Lurambi, Western Kenya were eligible for participation. The aim was to offer services to at least 80% of those aged 15-49. 31 temporary sites in strategically dispersed locations offered: HIV counseling and testing, 60 male condoms, an insecticide-treated bednet, a household water filter for women or an individual filter for men, and for those testing positive, a 3-month supply of cotrimoxazole and referral for follow-up care and treatment. Findings: Over 7 days, 47,311 people attended the campaign with a 96% uptake of the multi-disease preventive package. Of these, 99.7% were tested for HIV (87% in the target 15-49 age group); 80% had previously never tested. 4% of those tested were positive, 61% were women (5% of women and 3% of men), 6% had median CD4 counts of 541 cell/mL (IQR; 356, 754). 386 certified counselors attended to an average 17 participants per day, consistent with recommended national figures for mass campaigns. Among women, HIV infection varied by age, and was more likely with an ended marriage (e. g. widowed vs. never married, OR. 3.91; 95% CI. 2.87-5.34), and lack of occupation. In men, quantitatively stronger relationships were found (e. g. widowed vs. never married, OR. 7.0; 95% CI. 3.5-13.9). Always using condoms with a non-steady partner was more common among HIV-infected women participants who knew their status compared to those who did not (OR. 5.4 95% CI. 2.3-12.8). Conclusion: Through integrated campaigns it is feasible to efficiently cover large proportions of eligible adults in rural underserved communities with multiple disease preventive services simultaneously achieving various national and international health development goals.	[Lugada, Eric] CHF Int, Nairobi, Kenya; [Millar, Debra] CHF Int, Silver Spring, MD USA; [Haskew, John] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Grabowsky, Mark] ESP UN Fdn, Washington, DC USA; [Garg, Navneet; Vestergaard, Mikkel] Vestergaard Frandsen Inc, Lausanne, Switzerland; [Kahn, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Muraguri, Nicholas] Natl AIDS STI Control Program NASCOP, Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Mermin, Jonathan] Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; University of California System; University of California San Francisco	Lugada, E (corresponding author), CHF Int, Nairobi, Kenya.	ericlugada@yahoo.com	Mermin, Jonathan/J-9847-2012		Vestergaard Frandsen company	Vestergaard Frandsen company	Vestergaard Frandsen company provided a grant to CHF International Kenya to implement this integrated disease prevention program in Lurambi Division Western Kenya in conjunction with the Ministry of Public Health and Sanitation Kenya. In addition, the company manufactured and donated the long lasting insecticide treated bed nets (LLIN) and water filters used in this campaign. The funders had no role in study design, data collection and analysis, decision to publish, but two of their employees contributed as co-authors in the preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], KENYA DEMOGRAPHIC HL; *CDCP, CDC ACT KEN; CLASEN T, 2008, INTERVENTIONS IMPROV; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; KIMAIYO SWK, 2008, 17 INT AIDS C AUG 20; Kitua AY, 2008, SCIENCE, V319, P900, DOI 10.1126/science.319.5865.900c; LAWN SD, LANCET INFECT DIS, V10, P489; MALAMBA SS, 1994, AIDS, V8, P253, DOI 10.1097/00002030-199402000-00014; Matovu JKB, 2002, TROP MED INT HEALTH, V7, P1064, DOI 10.1046/j.1365-3156.2002.00964.x; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; *NAT GUID HIV TEST, 2008, NAT AIDS STD CONTR P; NUNN AJ, 1994, AIDS, V8, P81, DOI 10.1097/00002030-199401000-00012; Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Quick R, 2003, INT J ENVIRON HEAL R, V13, pS115, DOI 10.1080/0960312031000102877; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; *WHO, EPIDEMIOLOGICAL PROF; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; World Health Organization, COUNTR PROF ENV BURD; World Health Organization, 2008, GLOB BURD DIS 2004 U; 2004, MMWR WEEKLY      DEC; 2007, KENYA AIDS INDICTOR; TOWARDS UNIVERSAL AC	33	58	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12435	10.1371/journal.pone.0012435	http://dx.doi.org/10.1371/journal.pone.0012435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	643JL	20865049	Green Submitted, Green Published, gold			2022-12-25	WOS:000281292100028
J	Toussaint, J; Durbecq, V; Altintas, S; Doriath, V; Rouas, G; Paesmans, M; Bedard, P; Haibe-Kains, B; Tjalma, WA; Larsimont, D; Piccart, M; Sotiriou, C				Toussaint, Jerome; Durbecq, Virginie; Altintas, Sevilay; Doriath, Valerie; Rouas, Ghizlane; Paesmans, Marianne; Bedard, Philippe; Haibe-Kains, Benjamin; Tjalma, Wiebren A.; Larsimont, Denis; Piccart, Martine; Sotiriou, Christos			Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)	PLOS ONE			English	Article							BREAST-CONSERVING TREATMENT; MYOEPITHELIAL CELLS; RADIATION-THERAPY; PROGNOSTIC INDEX; YOUNG AGE; CANCER; INVASION	Purpose: Optimal management of breast ductal carcinoma in situ (DCIS) is controversial, and many patients are still overtreated. The local death of myoepithelial cells (MECs) is believed to be a pre-requisite to tumor invasion. We thus hypothesized that loss of CD10 expression, a MEC surface peptidase, would signify basement membrane disruption and confer increased risk of relapse in DCIS. The aim of our study was to retrospectively evaluate the prognostic value of CD10 in DCIS. Experimental Design: CD10 expression was evaluated by quantitative RT-PCR and immunohistochemistry using paraffin-embedded samples of normal breast tissue (n = 11); of morphologically normal ducts associated with DCIS (n = 10); and of DCIS without an invasive component (n = 154). Results: CD10 immunostaining was only observed in MECs in normal tissue and in DCIS. Normal tissue showed high mRNA expression levels of CD10, whereas DCIS showed a variable range. After a median follow-up of 6 years, DCIS with CD10 expression below the levels observed in normal tissue (71%) demonstrated a higher risk of local relapse (HR = 1.88; [95CI: 1.30-2.70], p = 0.001) in univariate analysis. No relapse was observed in patients expressing high CD10 mRNA levels (29%) similar to the ones observed in normal tissue. In multivariate analysis including known prognostic factors, low CD10 mRNA expression remained significant (HR = 2.25; [95% CI: 1.24-4.09], p = 0.008), as did the recently revised Van Nuys Prognostic Index (VNPI) score (HR = 2.03; [95% CI: 1.23-3.35], p = 0.006). Conclusion: The decrease of CD10 expression in MECs is associated with a higher risk of relapse in DCIS; this knowledge has the potential to improve DCIS management.	[Toussaint, Jerome; Durbecq, Virginie; Rouas, Ghizlane; Paesmans, Marianne; Bedard, Philippe; Haibe-Kains, Benjamin; Larsimont, Denis; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Breast Canc Translat Res Lab JC Heuson, B-1000 Brussels, Belgium; [Doriath, Valerie; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium; [Altintas, Sevilay; Tjalma, Wiebren A.] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium	Institut Jules Bordet; Institut Jules Bordet; University of Antwerp	Toussaint, J (corresponding author), Inst Jules Bordet, Breast Canc Translat Res Lab JC Heuson, B-1000 Brussels, Belgium.	christos.sotiriou@bordet.be	Haibe-Kains, Benjamin/D-3702-2011; Altintas, Sevilay/D-2129-2014	Haibe-Kains, Benjamin/0000-0002-7684-0079; Bedard, Philippe/0000-0002-6771-2999	Breast Cancer Research Foundation (BCRF); Swiss MEDIC Foundation; Fonds National de la Recherche Scientifique (FNRS); FNRS (FRIA)	Breast Cancer Research Foundation (BCRF); Swiss MEDIC Foundation; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS (FRIA)(Fonds de la Recherche Scientifique - FNRS)	The Breast Cancer Research Foundation (BCRF - http://www.cancer.be/), the Swiss MEDIC Foundation, the Fonds National de la Recherche Scientifique (FNRS - http://www2.frs-fnrs.be/) have supported the work. Jerome Toussaint was supported by a grant from the FNRS (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bijker N, 2001, EUR J SURG ONCOL, V27, P135, DOI 10.1053/ejso.2000.1062; Boughey JC, 2007, ONCOLOGIST, V12, P1276, DOI 10.1634/theoncologist.12-11-1276; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Goldstein NS, 2000, CANCER, V88, P2553, DOI 10.1002/1097-0142(20000601)88:11<2553::AID-CNCR18>3.0.CO;2-V; Hilson JB, 2009, AM J SURG PATHOL, V33, P227, DOI 10.1097/PAS.0b013e318180431d; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Kalof AN, 2004, J CLIN PATHOL, V57, P625, DOI 10.1136/jcp.2003.013227; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Polyak K, 2005, J MAMMARY GLAND BIOL, V10, P231, DOI 10.1007/s10911-005-9584-6; Silverstein MJ, 2003, AM J SURG, V186, P337, DOI 10.1016/S0002-9610(03)00265-4; Silverstein MJ, 1996, CANCER-AM CANCER SOC, V77, P2267, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Szelei-Stevens KA, 2000, INT J RADIAT ONCOL, V48, P943, DOI 10.1016/S0360-3016(00)00715-X; Vicini FA, 2000, J CLIN ONCOL, V18, P296, DOI 10.1200/JCO.2000.18.2.296	18	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12100	10.1371/journal.pone.0012100	http://dx.doi.org/10.1371/journal.pone.0012100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856894	Green Published, Green Submitted, gold			2022-12-25	WOS:000280811900036
J	Delston, RB; Matatall, KA; Sun, Y; Onken, MD; Harbour, JW				Delston, R. B.; Matatall, K. A.; Sun, Y.; Onken, M. D.; Harbour, J. W.			p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis	ONCOGENE			English	Article						apoptosis; p38; phosphorylation; retinoblastoma protein; Hdm2	S-PHASE ENTRY; RETINOBLASTOMA GENE-PRODUCT; TUMOR-SUPPRESSOR; E2F1-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; DIFFERENTIAL REGULATION; NEURONAL APOPTOSIS; MULTIPLE SITES; FAMILY-MEMBERS; PROTEIN PRB	The retinoblastoma protein (Rb) inhibits both cell division and apoptosis, but the mechanism by which Rb alternatively regulates these divergent outcomes remains poorly understood. Cyclin-dependent kinases (Cdks) promote cell division by phosphorylating and reversibly inactivating Rb by a hierarchical series of phosphorylation events and sequential conformational changes. The stress-regulated mitogen-activated protein kinase p38 also phosphorylates Rb, but it does so in a cell cycle-independent manner that is associated with apoptosis rather than with cell division. Here, we show that p38 phosphorylates Rb by a novel mechanism that is distinct from that of Cdks. p38 bypasses the cell cycle-associated hierarchical phosphorylation and directly phosphorylates Rb on Ser567, which is not phosphorylated during the normal cell cycle. Phosphorylation by p38, but not Cdks, triggers an interaction between Rb and the human homolog of murine double minute 2 (Hdm2), leading to degradation of Rb, release of E2F1 and cell death. These findings provide a mechanistic explanation as to how Rb regulates cell division and apoptosis through different kinases, and reveal how Hdm2 may functionally link the tumor suppressors Rb and p53. Oncogene (2011) 30, 588-599; doi: 10.1038/onc.2010.442; published online 27 September 2010	[Delston, R. B.; Matatall, K. A.; Sun, Y.; Onken, M. D.; Harbour, J. W.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL)	Harbour, JW (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	harbour@wustl.edu	Onken, Michael D/H-5620-2013; Harbour, J. William/B-1448-2015	Onken, Michael D/0000-0003-4082-1105; Harbour, J. William/0000-0002-1104-9809	Vision Training Grant [5T32EY013360-09]; NIH [EY013169-09, P30 EY 02687]; Barnes-Jewish Hospital Foundation; Horncrest Foundation; Kling Family Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [T32EY013360, P30EY002687, R01EY013169] Funding Source: NIH RePORTER	Vision Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Horncrest Foundation; Kling Family Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Doug Dean and members of the Harbour Lab for helpful discussions. This work was supported by the Vision Training Grant 5T32EY013360-09, and grants from the NIH (EY013169-09), the Barnes-Jewish Hospital Foundation, the Horncrest Foundation, The Kling Family Foundation and a Research to Prevent Blindness David F Weeks Professorship. This work was also supported by awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness Inc. Unrestricted grant, and the NIH Vision Core Grant P30 EY 02687.	ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bowen C, 2002, J BIOL CHEM, V277, P44969, DOI 10.1074/jbc.M202000200; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Chau BN, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000082; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Fattman CL, 1998, CANCER LETT, V130, P103, DOI 10.1016/S0304-3835(98)00121-9; Fattman CL, 2001, ONCOGENE, V20, P2918, DOI 10.1038/sj.onc.1204414; Fattman CL, 1997, J CELL BIOCHEM, V67, P399; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hauck L, 2002, CIRC RES, V91, P782, DOI 10.1161/01.RES.0000041030.98642.41; Hayashi T, 2000, NEUROPATH APPL NEURO, V26, P390, DOI 10.1046/j.1365-2990.2000.00264.x; Heidkamp MC, 2005, AM J PHYSIOL-CELL PH, V289, pC471, DOI 10.1152/ajpcell.00130.2005; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kitagawa M, 2008, ONCOGENE, V27, P5303, DOI 10.1038/onc.2008.164; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee EJ, 2003, INT J ONCOL, V23, P503; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Lemaire C, 2005, ONCOGENE, V24, P3297, DOI 10.1038/sj.onc.1208493; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma DD, 2003, J BIOL CHEM, V278, P19358, DOI 10.1074/jbc.M301761200; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Nath N, 2003, ONCOGENE, V22, P5986, DOI 10.1038/sj.onc.1206843; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Proctor BM, 2008, CIRCULATION, V118, P658, DOI 10.1161/CIRCULATIONAHA.107.734848; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Strobeck MW, 2000, ONCOGENE, V19, P1857, DOI 10.1038/sj.onc.1203510; Sun BH, 2010, CELL CYCLE, V9, P1122, DOI 10.4161/cc.9.6.10990; Sun Y, 2005, INVEST OPHTH VIS SCI, V46, P1561, DOI 10.1167/iovs.04-1362; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; Thakur A, 2008, INT J CLIN EXP PATHO, V1, P134; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Valentini A, 2007, CANCER BIOL THER, V6, P185, DOI 10.4161/cbt.6.2.3578; von Willebrand M, 2003, CANCER RES, V63, P1420; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Weber HO, 2005, ONCOGENE, V24, P1965, DOI 10.1038/sj.onc.1208389; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yap DBS, 1999, ONCOGENE, V18, P7681, DOI 10.1038/sj.onc.1202954; Yeste-Velasco M, 2009, NEUROCHEM INT, V54, P99, DOI 10.1016/j.neuint.2008.10.004; Yilmaz S, 1998, Hum Mutat, V12, P434, DOI 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU16>3.3.CO;2-Z; Young AP, 2003, ONCOGENE, V22, P7209, DOI 10.1038/sj.onc.1206804; Young AP, 2004, ONCOGENE, V23, P2587, DOI 10.1038/sj.onc.1207330; Yu BD, 2003, P NATL ACAD SCI USA, V100, P14881, DOI 10.1073/pnas.2431391100; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	95	32	33	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2011	30	5					588	599		10.1038/onc.2010.442	http://dx.doi.org/10.1038/onc.2010.442			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	715WG	20871633	Green Accepted			2022-12-25	WOS:000286922300007
J	Ward, SM; Fernando, SJ; Hou, TY; Duffield, GE				Ward, Sarah M.; Fernando, Shanik J.; Hou, Tim Y.; Duffield, Giles E.			The Transcriptional Repressor ID2 Can Interact with the Canonical Clock Components CLOCK and BMAL1 and Mediate Inhibitory Effects on mPer1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN GENE-EXPRESSION; CULTURED RAT-1 FIBROBLASTS; LOOP-HELIX PROTEINS; SUPRACHIASMATIC NUCLEUS; CELL-PROLIFERATION; PERIPHERAL-TISSUES; RESPONSE ELEMENT; FEEDBACK LOOP; PHASE-SHIFTS; IN-VIVO	ID2 is a rhythmically expressed HLH transcriptional repressor. Deletion of Id2 in mice results in circadian phenotypes, highlighted by disrupted locomotor activity rhythms and an enhanced photoentrainment response. ID2 can suppress the transactivation potential of the positive elements of the clock, CLOCK-BMAL1, on mPer1 and clock-controlled gene ( CCG) activity. Misregulation of CCGs is observed in Id2(-/-) liver, and mutant mice exhibit associated alterations in lipid homeostasis. These data suggest that ID2 contributes to both input and output components of the clock and that this may be via interaction with the bHLH clock proteins CLOCK and BMAL1. The aim of the present study was to explore this potential interaction. Coimmunoprecipitation analysis revealed the capability of ID2 to complex with both CLOCK and BMAL1, and mammalian two-hybrid analysis revealed direct interactions of ID2, ID1 and ID3 with CLOCK and BMAL1. Deletion of the ID2 HLH domain rendered ID2 ineffective at inhibiting CLOCK-BMAL1 transactivation, suggesting that interaction between the proteins is via the HLH region. Immunofluorescence analysis revealed overlapping localization of ID2 with CLOCK and BMAL1 in the cytoplasm. Overexpression of CLOCK and BMAL1 in the presence of ID2 resulted in a significant reduction in their nuclear localization, revealing that ID2 can sequester CLOCK and BMAL1 to the cytoplasm. Serum stimulation of Id2(-/-) mouse embryonic fibroblasts resulted in an enhanced induction of mPer1 expression. These data provide the basis for a molecular mechanism through which ID2 could regulate aspects of both clock input and output through a time-of-day specific interaction with CLOCK and BMAL1.	[Ward, Sarah M.; Fernando, Shanik J.; Hou, Tim Y.; Duffield, Giles E.] Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Duffield, GE (corresponding author), Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu			NIGMS, National Institutes of Health [GM087508]; University of Notre Dame; University Research fellowship; Royal Society; University of Notre Dame Fisher Research fellowship; National Science Foundation Research Experience for Undergraduate (REU) [0453325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Notre Dame; University Research fellowship; Royal Society(Royal Society of London); University of Notre Dame Fisher Research fellowship; National Science Foundation Research Experience for Undergraduate (REU); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant GM087508 (to G. E. D.). This work was also supported by a grant from the University of Notre Dame (to G. E. D.), a University Research fellowship and grant from the Royal Society (to G. E. D.), a University of Notre Dame Fisher Research fellowship (to S. M. W.), and National Science Foundation Research Experience for Undergraduate (REU) Summer Research Fellowship Award 0453325 (to S. J. F.).	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1; Chen BB, 1997, NUCLEIC ACIDS RES, V25, P423, DOI 10.1093/nar/25.2.423; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; FINKEL T, 1993, J BIOL CHEM, V268, P5; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Jung HS, 2003, NEUROREPORT, V14, P15, DOI 10.1097/00001756-200301200-00003; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McNulty S, 1998, EUR J NEUROSCI, V10, P1063, DOI 10.1046/j.1460-9568.1998.00114.x; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Norton JD, 2000, J CELL SCI, V113, P3897; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; von Gall C, 1998, J NEUROSCI, V18, P10389; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	62	20	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38987	39000		10.1074/jbc.M110.175182	http://dx.doi.org/10.1074/jbc.M110.175182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20861012	Green Published, hybrid			2022-12-25	WOS:000284941300029
J	Rodriguez, C; Tejera, P; Medina, B; Guillen, R; Dominguez, A; Ramos, J; Siverio, JM				Rodriguez, Celia; Tejera, Paula; Medina, Braulio; Guillen, Rosa; Dominguez, Angel; Ramos, Jose; Siverio, Jose M.			Ure2 Is Involved in Nitrogen Catabolite Repression and Salt Tolerance via Ca2+ Homeostasis and Calcineurin Activation in the Yeast Hansenula polymorpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UREIDOSUCCINIC ACID UPTAKE; GLUTATHIONE-S-TRANSFERASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PLASMA-MEMBRANE; PHOSPHATASE CALCINEURIN; METABOLITE REPRESSION; TRANSCRIPTION FACTORS; ASPERGILLUS-NIDULANS; NUCLEAR-LOCALIZATION	Disruption of HpURE2 resulted in a low expression of genes encoding nitrate-assimilatory proteins; sensitivity to Li+, Na+, and Cd2+; no induction of ENA1; low levels of the GATA-type transcription factor Gat1; and low intracellular Ca2+ levels. Gat1 levels were also very low in a Delta cnb1 mutant lacking the regulatory subunit of calcineurin. The strain Delta ure2 was very sensitive to the calcineurin inhibitor FK506 and displayed several phenotypes reminiscent of Delta cnb1. The reporter 4xCDRE-lacZ, containing calcineurin-dependent response elements in its promoter, revealed that calcineurin activation was reduced in Hp Delta ure2. Expression of ScURE2 in Delta ure2 rescued nitrogen catabolite repression and Cd2+ tolerance but not those phenotypes depending on calcineurin activation, such as salt tolerance and nitrate assimilation gene derepression. Hp Delta ure2 showed an increased expression of the gene PMR1 encoding the Golgi Ca2+-ATPase, whereas that of PMC1 encoding the vacuolar Ca2+-ATPase remained unaltered. PMR1 up-regulation was abolished by deletion of the GATA-type transcription factor GAT2 in a Hp Delta ure2 genetic background, and normal Ca2+ levels were recovered. Moreover, overexpression of GAT2 or PMR1 yielded strains mimicking the phenotype of the Hp Delta ure2. This suggests that the low Ca2+ levels in the Hp Delta ure2 mutant are due to the high levels of Pmr1 that replenish the Golgi Ca2+ content, thus acting as a negative signal for Ca2+ entry into the cell. We conclude that HpUre2 is involved in salt tolerance and also in nitrate assimilation gene derepression via Ca2+ homeostasis regulation and calcineurin activation, which control the levels of Gat1.	[Rodriguez, Celia; Tejera, Paula; Medina, Braulio; Guillen, Rosa; Siverio, Jose M.] Univ La Laguna, Dept Biochem & Mol Biol, Inst Biomed Technol, Nitrogen Metab Grp, E-38206 Tenerife, Canarias, Spain; [Dominguez, Angel] Univ Salamanca, IMB CSIC, CIETUS, Dpto Microbiol & Genet, E-37007 Salamanca, Spain; [Ramos, Jose] Univ Cordoba, Dept Microbiol, Lab Microbiol Agr, E-14071 Cordoba, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Universidad de Cordoba	Siverio, JM (corresponding author), Univ La Laguna, Dept Biochem & Mol Biol, Inst Biomed Technol, Nitrogen Metab Grp, Av Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es	IBSAL, Secretaría/H-3719-2011; Rodríguez, Celia/HDL-7429-2022; Ramos, Jose/K-4307-2014; Siverio, José Manuel/K-7136-2014	Ramos, Jose/0000-0002-9797-1561; Siverio, José Manuel/0000-0001-9404-2655; Tejera, Paula/0000-0002-0317-890X	Ministerio de Ciencia e Innovacion, Spain [BFU2007-60172/BMC, BFU2008-04188-C03-03]; Junta de Castilla y Leon, Spain [GEN2006-27775-C2-E/PAT, SA141A08]; CajaCanarias; Ministerio de Educacion y Ciencia, Spain; Agencia Espanola de Cooperacion Iberoamericana; ACIISI from Gobierno de Canarias	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); CajaCanarias; Ministerio de Educacion y Ciencia, Spain(Spanish Government); Agencia Espanola de Cooperacion Iberoamericana; ACIISI from Gobierno de Canarias	This work was supported by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2007-60172/BMC (to J. M. S.) and BFU2008-04188-C03-03 (to J. R.), and by Junta de Castilla y Leon, Spain, Grants GEN2006-27775-C2-E/PAT and (SA141A08) (to A. D.).; Recipient of predoctoral fellowships from CajaCanarias and the ACIISI from Gobierno de Canarias.; Recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia, Spain. Present address: Dept. of Environmental Health, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115. 3; Recipient of a predoctoral fellowship from the Agencia Espanola de Cooperacion Iberoamericana. Present address: Dpto. de Biologia Molecular y Genetica, Instituto de Investigaciones en Ciencia de la Salud, Universidad Nacional de Asuncion, Rio de la Plata y Lagerenza E-2511 Asuncion, Paraguay.	ABERG B, 1947, KUNGL LANTBRUKSHOGSK, V15, P37; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brito N, 1999, APPL MICROBIOL BIOT, V53, P23, DOI 10.1007/s002530051609; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Devasahayam G, 2007, GENETICS, V177, P231, DOI 10.1534/genetics.107.073577; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; HEITMAN J, 1994, TRANSPLANT P, V26, P2833; Jiang B, 1999, J BIOL CHEM, V274, P18543, DOI 10.1074/jbc.274.26.18543; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Leao-Helder AN, 2003, J BIOL CHEM, V278, P40749, DOI 10.1074/jbc.M304029200; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Pan H, 1997, MOL MICROBIOL, V26, P721, DOI 10.1046/j.1365-2958.1997.6041979.x; Park SY, 2001, J BIOL CHEM, V276, P28694, DOI 10.1074/jbc.M101185200; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; RAMOS J, 1990, BIOCHIM BIOPHYS ACTA, V1029, P211, DOI 10.1016/0005-2736(90)90156-I; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sambrook J, 2001, MOL CLONING LAB MANU; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Withee JL, 1998, GENETICS, V149, P865; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038	66	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37551	37560		10.1074/jbc.M110.146902	http://dx.doi.org/10.1074/jbc.M110.146902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20880842	Green Published, hybrid			2022-12-25	WOS:000284424000047
J	Ribeiro, CMS; Pontes, MJSL; Bird, S; Chadzinska, M; Scheer, M; Verburg-van Kemenade, BML; Savelkoul, HFJ; Wiegertjes, GF				Ribeiro, Carla M. S.; Pontes, Maria J. S. L.; Bird, Steve; Chadzinska, Magdalena; Scheer, Marleen; Verburg-van Kemenade, B. M. Lidy; Savelkoul, Huub F. J.; Wiegertjes, Geert F.			Trypanosomiasis-Induced Th17-Like Immune Responses in Carp	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; TOXOPLASMA-GONDII INFECTION; IL-12 P40 HOMODIMER; FRESH-WATER FISH; CYPRINUS-CARPIO; TH17 CELLS; PLASMODIUM-FALCIPARUM; DENDRITIC CELLS; NK CELLS; SIGNALING PATHWAY	Background: In mammalian vertebrates, the cytokine interleukin (IL)-12 consists of a heterodimer between p35 and p40 subunits whereas interleukin-23 is formed by a heterodimer between p19 and p40 subunits. During an immune response, the balance between IL-12 and IL-23 can depend on the nature of the pathogen associated molecular pattern (PAMP) recognized by, for example TLR2, leading to a preferential production of IL-23. IL-23 production promotes a Th17-mediated immune response characterized by the production of IL-17A/F and several chemokines, important for neutrophil recruitment and activation. For the cold blooded vertebrate common carp, only the IL-12 subunits have been described so far. Methodology/Principal Findings: Common carp is the natural host of two protozoan parasites: Trypanoplasma borreli and Trypanosoma carassii. We found that these parasites negatively affect p35 and p40a gene expression in carp. Transfection studies of HEK293 and carp macrophages show that T. carassii-derived PAMPs are agonists of carp TLR2, promoting p19 and p40c gene expression. The two protozoan parasites induce different immune responses as assessed by gene expression and histological studies. During T. carassii infections, in particular, we observed a propensity to induce p19 and p40c gene expression, suggestive of the formation of IL-23. Infections with T. borreli and T. carassii lead to an increase of IFN-gamma 2 gene expression whereas IL-17A/F2 gene expression was only observed during T. carasssii infections. The moderate increase in the number of splenic macrophages during T. borreli infection contrasts the marked increase in the number of splenic neutrophilic granulocytes during T. carassii infection, along with an increased gene expression of metalloproteinase-9 and chemokines. Conclusion/Significance: This is the first study that provides evidence for a Th17-like immune response in fish in response to infection with a protozoan parasite.	[Ribeiro, Carla M. S.; Pontes, Maria J. S. L.; Scheer, Marleen; Verburg-van Kemenade, B. M. Lidy; Savelkoul, Huub F. J.; Wiegertjes, Geert F.] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Bird, Steve] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Sch Biol Sci, Aberdeen, Scotland; [Chadzinska, Magdalena] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunobiol, PL-30060 Krakow, Poland	Wageningen University & Research; University of Aberdeen; Jagiellonian University	Ribeiro, CMS (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	geert.wiegertjes@wur.nl	Bird, Steve/K-4822-2014; Savelkoul, Huub FJ/F-6026-2012; Wiegertjes, Geert F/E-3330-2012	Bird, Steve/0000-0003-2937-8579; wiegertjes, geert/0000-0001-9265-3436; van Kemenade, Lidy/0000-0002-5031-7335; Ribeiro, Carla/0000-0002-5682-4143	Portuguese foundation Fundacao para a Ciencia e Tecnologia [SFR/BD/21522/2005]; European Commission [FP6007103]	Portuguese foundation Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Portuguese foundation Fundacao para a Ciencia e Tecnologia under grant agreement number SFR/BD/21522/2005 and the European Commission through contract FP6007103 (Improved Immunity of Aquacultured Animals, IMAQUANIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author has any financial, personal, or professional interest that could be construed to have influenced the paper.	Abdelkhalek NK, 2009, FISH SHELLFISH IMMUN, V27, P763, DOI 10.1016/j.fsi.2009.08.004; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chin AC, 2009, J IMMUNOL, V183, P5957, DOI 10.4049/jimmunol.0900789; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; FEDELE G, PLOS ONE, V5, pE8734; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; Forlenza M, 2009, J IMMUNOL, V183, P5319, DOI 10.4049/jimmunol.0901780; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Gazzinelli RT, 2004, IMMUNOL REV, V201, P9, DOI 10.1111/j.0105-2896.2004.00174.x; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; HOLT A, 2010, DISCOVERY ZEBR UNPUB; Huising MO, 2006, MOL IMMUNOL, V43, P1519, DOI 10.1016/j.molimm.2005.10.010; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1; Joerink M, 2006, J IMMUNOL, V177, P61, DOI 10.4049/jimmunol.177.1.61; Joerink M, 2006, FISH SHELLFISH IMMUN, V21, P561, DOI 10.1016/j.fsi.2006.03.006; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kemenade B, 1994, J EXP BIOL, V187, P143; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; LING P, 1995, J IMMUNOL, V154, P116; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nishimura K, 2008, J PARASITOL, V94, P99, DOI 10.1645/GE-1322.1; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Overath P, 1998, PARASITOL RES, V84, P343, DOI 10.1007/s004360050408; Overath P, 1999, PARASITOLOGY, V119, P591, DOI 10.1017/S0031182099005089; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Ribeiro CMS, 2010, J IMMUNOL, V184, P2355, DOI 10.4049/jimmunol.0900990; Romano N, 1998, ANAT EMBRYOL, V198, P31, DOI 10.1007/s004290050162; Saeij JPJ, 2002, PARASITOLOGY, V124, P77, DOI 10.1017/S0031182001008915; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Stafford JL, 2001, DEV COMP IMMUNOL, V25, P447, DOI 10.1016/S0145-305X(01)00015-5; STEINHAGEN D, 1989, J PARASITOL, V75, P685, DOI 10.2307/3283050; Steinhagen D, 2000, DIS AQUAT ORGAN, V41, P195, DOI 10.3354/dao041195; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Weyts FAA, 1997, FISH SHELLFISH IMMUN, V7, P123, DOI 10.1006/fsim.1996.0069; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x	66	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13012	10.1371/journal.pone.0013012	http://dx.doi.org/10.1371/journal.pone.0013012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885956	gold, Green Submitted, Green Published			2022-12-25	WOS:000282167100015
J	Chen, SJ; Chen, GH; Chen, YH; Liu, CY; Chang, KP; Chang, YS; Chen, HC				Chen, Shu-Jen; Chen, Gian-Hung; Chen, Yi-Hsuan; Liu, Cheng-Yuan; Chang, Kai-Ping; Chang, Yu-Sun; Chen, Hua-Chien			Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; MIR-200 FAMILY; PROTEIN EXPRESSION; LUNG-CANCER; IDENTIFICATION; ZEB1; MODULATION; LEUKEMIA; TARGETS; GENES	Virus-encoded microRNAs (miRNAs) have been shown to regulate a variety of biological processes involved in viral infection and viral-associated pathogenesis. Epstein-Barr virus (EBV) is a herpesvirus implicated in nasopharyngeal carcinoma (NPC) and other human malignancies. EBV-encoded miRNAs were among the first group of viral miRNAs identified. To understand the roles of EBV miRNAs in the pathogenesis of NPC, we utilized deep sequencing technology to characterize the EBV miRNA transcriptome in clinical NPC tissues. We obtained more than 110,000 sequence reads in NPC samples and identified 44 EBV BART miRNAs, including four new mature miRNAs derived from previously identified BART miRNA precursor hairpins. Further analysis revealed extensive sequence variations (isomiRs) of EBV miRNAs, including terminal isomiRs at both the 59 and 39 ends and nucleotide variants. Analysis of EBV genomic sequences indicated that the majority of EBV miRNA nucleotide variants resulted from post-transcriptional modifications. Read counts of individual EBV miRNA in NPC tissue spanned from a few reads to approximately 18,000 reads, confirming the wide expression range of EBV miRNAs. Several EBV miRNAs were expressed at levels similar to highly abundant human miRNAs. Sequence analysis revealed that most of the highly abundant EBV miRNAs share their seed sequences (nucleotides 2-7) with human miRNAs, suggesting that seed sequence content may be an important factor underlying the differential accumulation of BART miRNAs. Interestingly, many of these human miRNAs have been found to be dysregulated in human malignancies, including NPC. These observations not only provide a potential linkage between EBV miRNAs and human malignancy but also suggest a highly coordinated mechanism through which EBV miRNAs may mimic or compete with human miRNAs to affect cellular functions.	[Chen, Shu-Jen; Chen, Gian-Hung; Chen, Yi-Hsuan; Chen, Hua-Chien] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Chen, Shu-Jen; Liu, Cheng-Yuan; Chang, Yu-Sun; Chen, Hua-Chien] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, SJ (corresponding author), Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan.	hcchen@mail.cgu.edu.tw	Chang, Kai-Ping/B-5135-2011	Chang, Yu-Sun/0000-0002-6457-3890	Ministry of Education	Ministry of Education	This work was supported by grants from the Ministry of Education to Chang Gung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankier A T, 1983, Mol Biol Med, V1, P21; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Burgos JS, 2005, MED ONCOL, V22, P113, DOI 10.1385/MO:22:2:113; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Middeldorp JM, 2008, SEMIN CANCER BIOL, V18, P388, DOI 10.1016/j.semcancer.2008.10.004; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yoshizaki T, 2002, HISTOL HISTOPATHOL, V17, P845, DOI 10.14670/HH-17.845; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	56	106	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12745	10.1371/journal.pone.0012745	http://dx.doi.org/10.1371/journal.pone.0012745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862214	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200002
J	Stelzer, CP; Schmidt, J; Wiedlroither, A; Riss, S				Stelzer, Claus-Peter; Schmidt, Johanna; Wiedlroither, Anneliese; Riss, Simone			Loss of Sexual Reproduction and Dwarfing in a Small Metazoan	PLOS ONE			English	Article							BRACHIONUS-CALYCIFLORUS; DAPHNIA-PULEX; ROTIFER; PARTHENOGENESIS; CULTURE; INDUCTION; EVOLUTION; DYNAMICS; STRAIN	Background: Asexuality has major theoretical advantages over sexual reproduction, yet newly formed asexual lineages rarely endure. The success, or failure, of such lineages is affected by their mechanism of origin, because it determines their initial genetic makeup and variability. Most previously described mechanisms imply that asexual lineages are randomly frozen subsamples of a sexual population. Methodology/Principal Findings: We found that transitions to obligate parthenogenesis (OP) in the rotifer Brachionus calyciflorus, a small freshwater invertebrate which normally reproduces by cyclical parthenogenesis, were controlled by a simple Mendelian inheritance. Pedigree analysis suggested that obligate parthenogens were homozygous for a recessive allele, which caused inability to respond to the chemical signals that normally induce sexual reproduction in this species. Alternative mechanisms, such as ploidy changes, could be ruled out on the basis of flow cytometric measurements and genetic marker analysis. Interestingly, obligate parthenogens were also dwarfs (approximately 50% smaller than cyclical parthenogens), indicating pleiotropy or linkage with genes that strongly affect body size. We found no adverse effects of OP on survival or fecundity. Conclusions/Significance: This mechanism of inheritance implies that genes causing OP may evolve within sexual populations and remain undetected in the heterozygous state long before they get frequent enough to actually cause a transition to asexual reproduction. In this process, genetic variation at other loci might become linked to OP genes, leading to non-random associations between asexuality and other phenotypic traits.	[Stelzer, Claus-Peter; Schmidt, Johanna; Wiedlroither, Anneliese; Riss, Simone] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria	Austrian Academy of Sciences	Stelzer, CP (corresponding author), Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria.	claus-peter.stelzer@oeaw.ac.at	Stelzer, Claus-Peter/F-3789-2018	Stelzer, Claus-Peter/0000-0002-6682-0904	FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [P20735-B17]; Austrian Science Fund (FWF) [P 20735] Funding Source: researchfish	FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding was provided by a FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) Grant P20735-B17 to CPS (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; BENNETT WN, 1988, AQUACULTURE, V73, P27, DOI 10.1016/0044-8486(88)90038-5; BENNETT WN, 1989, OIKOS, V55, P365, DOI 10.2307/3565596; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; BORAAS ME, 1983, LIMNOL OCEANOGR, V28, P546, DOI 10.4319/lo.1983.28.3.0546; BUCHNER H, 1987, ARCH HYDROBIOL, V109, P333; Carmona MJ, 2009, J EVOLUTION BIOL, V22, P1975, DOI 10.1111/j.1420-9101.2009.01811.x; Fussmann GF, 2003, P ROY SOC B-BIOL SCI, V270, P1015, DOI 10.1098/rspb.2003.2335; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gilbert John J., 2004, Journal of Limnology, V63, P32; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Jokela J, 1997, ECOLOGY, V78, P452; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Kubanek J, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P453; Lattorff HMG, 2005, HEREDITY, V94, P533, DOI 10.1038/sj.hdy.6800654; Lynch M, 2008, GENETICS, V180, P317, DOI 10.1534/genetics.107.084657; Nogrady T., 1993, ROTIFERA BIOL ECOLOG, P137; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Ruttner-Kolisko A., 1977, ARCH HYDROBIOL, V8, P71; Serra M, 1999, J EVOLUTION BIOL, V12, P263; Serra Manuel, 2004, P135; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; SMITH JM, 1978, EVOLUTION SEX; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; Stelzer CP, 2008, J EVOLUTION BIOL, V21, P287, DOI 10.1111/j.1420-9101.2007.01437.x; Stelzer CP, 2005, HYDROBIOLOGIA, V546, P335, DOI 10.1007/s10750-005-4243-x; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; SUOMALAINEN E, 1950, ADV GENET, V3, P193, DOI 10.1016/S0065-2660(08)60086-3; Timmermeyer N, 2006, J PLANKTON RES, V28, P1233, DOI 10.1093/plankt/fbl052; VRIJENHOEK RC, 2009, GEOGRAPHICAL PARTHEN, P99	33	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12854	10.1371/journal.pone.0012854	http://dx.doi.org/10.1371/journal.pone.0012854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862222	Green Submitted, gold, Green Published			2022-12-25	WOS:000281963200018
J	Schuchmann, M; Siemers, BM				Schuchmann, Maike; Siemers, Bjoern M.			Variability in Echolocation Call Intensity in a Community of Horseshoe Bats: A Role for Resource Partitioning or Communication?	PLOS ONE			English	Article							BIG BROWN BATS; RHINOLOPHUS-FERRUMEQUINUM; MEHELYI CHIROPTERA; INSECTIVOROUS BATS; FORAGING BEHAVIOR; EPTESICUS-FUSCUS; DAUBENTONS BATS; PREY SELECTION; BODY-SIZE; SEX	Background: Only recently data on bat echolocation call intensities is starting to accumulate. Yet, intensity is an ecologically crucial parameter, as it determines the extent of the bats' perceptual space and, specifically, prey detection distance. Interspecifically, we thus asked whether sympatric, congeneric bat species differ in call intensities and whether differences play a role for niche differentiation. Specifically, we investigated whether R. mehelyi that calls at a frequency clearly above what is predicted by allometry, compensates for frequency-dependent loss in detection distance by using elevated call intensity. Maximum echolocation call intensities might depend on body size or condition and thus be used as an honest signal of quality for intraspecific communication. We for the first time investigated whether a size-intensity relation is present in echolocating bats. Methodology/Principal Findings: We measured maximum call intensities and frequencies for all five European horseshoe bat species. Maximum intensity differed among species largely due to R. euryale. Furthermore, we found no compensation for frequency-dependent loss in detection distance in R. mehelyi. Intraspecifically, there is a negative correlation between forearm lengths and intensity in R. euryale and a trend for a negative correlation between body condition index and intensity in R. ferrumequinum. In R. hipposideros, females had 8 dB higher intensities than males. There were no correlations with body size or sex differences and intensity for the other species. Conclusions/Significance: Based on call intensity and frequency measurements, we estimated echolocation ranges for our study community. These suggest that intensity differences result in different prey detection distances and thus likely play some role for resource access. It is interesting and at first glance counter-intuitive that, where a correlation was found, smaller bats called louder than large individuals. Such negative relationship between size or condition and vocal amplitude may indicate an as yet unknown physiological or sexual selection pressure.	[Schuchmann, Maike; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	Max Planck Society	Schuchmann, M (corresponding author), Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany.	schuchmann@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ivailo Borissov, Stefan Greif, Markus Schuller and Daniela Schmieder for invaluable help during fieldwork; as well as the Directorate of the Rusenski Lom Nature Park (director Milko Belberov), the Bulgarian Bat Research and Conservation Group, and Christiana Popova for cooperation and support. Henrik Brumm and Matthais Ritchard provided discussion on call intensities and body size. Capture, husbandry and behavioral studies were carried out under license of the responsible Bulgarian authorities (MOEW-Sofia and RIOSV-Ruse, 57/18.04.2006 and 100/04.07.2007). Brock Fenton and two anonymous referees provided insightful comments that helped to improve the manuscript.	ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Boonman A, 2002, J EXP BIOL, V205, P2865; BRACKENBURY JH, 1979, J EXP BIOL, V78, P163; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, CURR BIOL, V16, pR1003, DOI 10.1016/j.cub.2006.10.043; Brumm H, 2006, ANIM BEHAV, V72, P699, DOI 10.1016/j.anbehav.2006.01.020; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1157, DOI 10.1007/s00265-009-0743-4; COLES RB, 1989, J COMP PHYSIOL A, V165, P269, DOI 10.1007/BF00619201; Cooper SJB, 2001, J MAMMAL, V82, P328, DOI 10.1644/1545-1542(2001)082<0328:AOSBIA>2.0.CO;2; Cynx J, 2004, ANIM BEHAV, V67, P451, DOI 10.1016/j.anbehav.2003.04.008; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Dietz C., 2007, ASPECTS ECOMORPHOLOG; Dietz C., 2007, HDB FLEDERMAUSE EURO; Dietz C, 2006, ACTA CHIROPTEROL, V8, P523, DOI 10.3161/1733-5329(2006)8[523:EOFBOH]2.0.CO;2; Estok P, 2010, BIOL LETTERS, V6, P59, DOI 10.1098/rsbl.2009.0611; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; GERHARDT HC, 1975, J COMP PHYSIOL, V102, P1, DOI 10.1007/BF00657481; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Griffin DR, 1958, LISTENING DARK; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; Heffner RS, 1996, HEARING RES, V99, P13, DOI 10.1016/S0378-5955(96)00074-3; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Houston Robert D., 2003, P339; Jacobs DS, 2008, BEHAV ECOL, V19, P1333, DOI 10.1093/beheco/arn071; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; JONES G, 1990, J ANIM ECOL, V59, P587, DOI 10.2307/4882; JONES G, 1994, MAMMALIA, V58, P41, DOI 10.1515/mamm.1994.58.1.41; JONES G, 1994, FOLIA ZOOL, V43, P347; JONES G, 1992, MAMMALIA, V56, P189; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Jones Gareth, 1995, Rhinolophe, V11, P53; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Kazial KA, 2008, ETHOLOGY, V114, P469, DOI 10.1111/j.1439-0310.2008.01483.x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; KICK SA, 1982, J COMP PHYSIOL, V145, P431, DOI 10.1007/BF00612808; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Mehl B., 1988, ANIMAL SONAR PROCESS, P435, DOI DOI 10.1007/978-1-4684-7493-0_43; NEUWEILER G, 1984, J COMP PHYSIOL, V154, P133, DOI 10.1007/BF00605398; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; RITSCHARD M, 2010, ANIMAL BEHAV; Russo D, 2005, J ZOOL, V266, P327, DOI 10.1017/S0952836905006990; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2001, MAMMALIA, V65, P429, DOI 10.1515/mamm.2001.65.4.429; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; SAFI K, 2010, EVOLUTIONARY ECOLOGY; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Sanvito S, 2003, BIOACOUSTICS, V14, P47, DOI 10.1080/09524622.2003.9753512; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Shi LM, 2009, ACTA THERIOL, V54, P371, DOI 10.4098/j.at.0001-7051.099.2008; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; Skowronski MD, 2008, J ACOUST SOC AM, V124, P328, DOI 10.1121/1.2924122; STAPELLS DR, 1982, J ACOUST SOC AM, V72, P74, DOI 10.1121/1.388026; STILZ P, 2004, THESIS U TUBINGEN TU; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SURLYKKE A, 1993, BEHAV ECOL SOCIOBIOL, V33, P1, DOI 10.1007/BF00164341; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; TUTTLE MD, 1985, ANIM BEHAV, V33, P1369, DOI 10.1016/S0003-3472(85)80204-9; VOIGT CC, 2010, J COMP PHYSIOL B, V79, P877; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; WATERS DA, 1995, J EXP BIOL, V198, P475; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	81	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12842	10.1371/journal.pone.0012842	http://dx.doi.org/10.1371/journal.pone.0012842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862252	Green Published, gold, Green Submitted			2022-12-25	WOS:000281960800028
J	Shin, YK; Martin, B; Kim, W; White, CM; Ji, SG; Sun, YX; Smith, RG; Sevigny, J; Tschop, MH; Maudsley, S; Egan, JM				Shin, Yu-Kyong; Martin, Bronwen; Kim, Wook; White, Caitlin M.; Ji, Sunggoan; Sun, Yuxiang; Smith, Roy G.; Sevigny, Jean; Tschoep, Matthias H.; Maudsley, Stuart; Egan, Josephine M.			Ghrelin Is Produced in Taste Cells and Ghrelin Receptor Null Mice Show Reduced Taste Responsivity to Salty (NaCl) and Sour (Citric Acid) Tastants	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; COEXPRESSION PATTERNS; SODIUM TASTE; RAT; HORMONE; EXPRESSION; AMILORIDE; BUDS; LOCALIZATION; CHANNELS	Background: The gustatory system plays a critical role in determining food preferences, food intake and energy balance. The exact mechanisms that fine tune taste sensitivity are currently poorly defined, but it is clear that numerous factors such as efferent input and specific signal transduction cascades are involved. Methodology/Principal Findings: Using immunohistochemical analyses, we show that ghrelin, a hormone classically considered to be an appetite-regulating hormone, is present within the taste buds of the tongue. Prepro-ghrelin, prohormone convertase 1/3 (PC 1/3), ghrelin, its cognate receptor (GHSR), and ghrelin-O-acyltransferase (GOAT, the enzyme that activates ghrelin) are expressed in Type I, II, III and IV taste cells of mouse taste buds. In addition, ghrelin and GHSR co-localize in the same taste cells, suggesting that ghrelin works in an autocrine manner in taste cells. To determine a role for ghrelin in modifying taste perception, we performed taste behavioral tests using GHSR null mice. GHSR null mice exhibited significantly reduced taste responsivity to sour (citric acid) and salty (sodium chloride) tastants. Conclusions/Significance: These findings suggest that ghrelin plays a local modulatory role in determining taste bud signaling and function and could be a novel mechanism for the modulation of salty and sour taste responsivity.	[Shin, Yu-Kyong; Martin, Bronwen; Kim, Wook; White, Caitlin M.; Ji, Sunggoan; Maudsley, Stuart; Egan, Josephine M.] NIA, NIH, Baltimore, MD 21224 USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Smith, Roy G.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [Sevigny, Jean] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada; [Tschoep, Matthias H.] Univ Cincinnati, Div Endocrinol, Coll Med, Dept Med,Metab Dis Inst, Cincinnati, OH USA; [Tschoep, Matthias H.] Univ Cincinnati, Div Endocrinol, Coll Med, Dept Psychiat,Metab Dis Inst, Cincinnati, OH USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Baylor College of Medicine; Scripps Research Institute; Laval University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shin, YK (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	eganj@mail.nih.gov	Sévigny, Jean/AGH-9323-2022; Tschoep, Matthias H/I-5443-2014; Maudsley, Stuart/Q-4782-2019; Sevigny, Jean/E-8039-2012; Maudsley, Stuart/AAV-9929-2021	Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Maudsley, Stuart/0000-0002-1868-184X; Tschoep, Matthias/0000-0002-4744-371X; Martin, Bronwen/0000-0002-9185-6925; Ji, Sung Goan/0000-0003-1308-2474	NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000917, ZIAAG000325, ZIAAG000319, ZIAAG000915, ZIAAG000318, R01AG019230] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Bigiani A, 2007, J NEUROPHYSIOL, V98, P2483, DOI 10.1152/jn.00716.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; CONG WN, 2010, CNS NEUROL DISORD DR; DESIMONE JA, 1984, J GEN PHYSIOL, V83, P633, DOI 10.1085/jgp.83.5.633; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dotson CD, 2004, CHEM SENSES, V29, P489, DOI 10.1093/chemse/bjh051; Ghelardoni S, 2006, J ENDOCRINOL INVEST, V29, P115, DOI 10.1007/BF03344083; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Harrison JL, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-25; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Herness S, 2002, J NEUROSCI, V22, P10018; HIROHITO M, 2005, CHEM SENSES, V30, P367; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, ARCH ITAL BIOL, V143, P87; Iglesias MJ, 2004, CARDIOVASC RES, V62, P481, DOI 10.1016/j.cardiores.2004.01.024; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2008, REGUL PEPTIDES, V145, P2, DOI 10.1016/j.regpep.2007.09.023; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; O'Brien M, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-55; Ohgusu H, 2009, BIOCHEM BIOPH RES CO, V386, P153, DOI 10.1016/j.bbrc.2009.06.001; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Ruiz C, 2006, CHEM SENSES, V31, P813, DOI 10.1093/chemse/bjl024; Schuppe H, 2007, DEV NEUROBIOL, V67, P219, DOI 10.1002/dneu.20343; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shigemura N, 2005, CHEM SENSES, V30, P531, DOI 10.1093/chemse/bji046; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Stahler F, 2008, CHEMOSENS PERCEPT, V1, P78, DOI 10.1007/s12078-008-9006-4; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; VAN DER LELY AJ, 2004, ENDOCR REV, V25, P426; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang RB, 2004, J COMP NEUROL, V471, P59, DOI 10.1002/cne.20021; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; YOSHIO Y, 2006, NEUROSCI LETT, V402, P227; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200	68	78	86	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12729	10.1371/journal.pone.0012729	http://dx.doi.org/10.1371/journal.pone.0012729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856820	gold, Green Submitted, Green Published			2022-12-25	WOS:000281815700016
J	Gustavsson, C; Agardh, CD; Zetterqvist, AV; Nilsson, J; Agardh, E; Gomez, MF				Gustavsson, Carin; Agardh, Carl-David; Zetterqvist, Anna V.; Nilsson, Jan; Agardh, Elisabet; Gomez, Maria F.			Vascular Cellular Adhesion Molecule-1 (VCAM-1) Expression in Mice Retinal Vessels Is Affected by Both Hyperglycemia and Hyperlipidemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIABETIC-RETINOPATHY; ENDOTHELIAL DYSFUNCTION; TNF-ALPHA; INFLAMMATION; MARKERS; IMMUNE; MECHANISMS; COMPLICATIONS; PATHOGENESIS	Background: Inflammation has been proposed to be important in the pathogenesis of diabetic retinopathy. An early feature of inflammation is the release of cytokines leading to increased expression of endothelial activation markers such as vascular cellular adhesion molecule-1 (VCAM-1). Here we investigated the impact of diabetes and dyslipidemia on VCAM-1 expression in mouse retinal vessels, as well as the potential role of tumor necrosis factor-alpha (TNF alpha). Methodology/Principal Findings: Expression of VCAM-1 was examined by confocal immunofluorescence microscopy in vessels of wild type (wt), hyperlipidemic (ApoE(-/-)) and TNF alpha deficient (TNF alpha(-/-), ApoE(-/-)/TNF alpha(-/-)) mice. Eight weeks of streptozotocin-induced diabetes resulted in increased VCAM-1 in wt mice, predominantly in small vessels (<10 mu m). Diabetic wt mice had higher total retinal TNF alpha, IL-6 and IL-1 beta mRNA than controls; as well as higher soluble VCAM-1 (sVCAM-1) in plasma. Lack of TNF alpha increased higher basal VCAM-1 protein and sVCAM-1, but failed to up-regulate IL-6 and IL-1 beta mRNA and VCAM-1 protein in response to diabetes. Basal VCAM-1 expression was higher in ApoE(-/-) than in wt mice and both VCAM-1 mRNA and protein levels were further increased by high fat diet. These changes correlated to plasma cholesterol, LDL- and HDL-cholesterol, but not to triglycerides levels. Diabetes, despite further increasing plasma cholesterol in ApoE(-/-) mice, had no effects on VCAM-1 protein expression or on sVCAM-1. However, it increased ICAM-1 mRNA expression in retinal vessels, which correlated to plasma triglycerides. Conclusions/Significance: Hyperglycemia triggers an inflammatory response in the retina of normolipidemic mice and up-regulation of VCAM-1 in retinal vessels. Hypercholesterolemia effectively promotes VCAM-1 expression without evident stimulation of inflammation. Diabetes-induced endothelial activation in ApoE(-/-) mice seems driven by elevated plasma triglycerides but not by cholesterol. Results also suggest a complex role for TNF alpha in the regulation of VCAM-1 expression, being protective under basal conditions but pro-inflammatory in response to diabetes.	[Gustavsson, Carin; Agardh, Carl-David; Zetterqvist, Anna V.; Nilsson, Jan; Agardh, Elisabet; Gomez, Maria F.] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University	Gustavsson, C (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	maria.gomez@med.lu.se	Gomez, Maria F/D-3696-2014	Gomez, Maria F/0000-0001-6210-3142	Lund University; Skane County Council for Research and Development; Swedish Research Council; Foundation for Visually Impaired in Former Malmohus Lan; Malmo University Hospital Foundation at Lund University; Foundation of the National Board of Health and Welfare; Lund University Diabetes Centre (LUDC); Carmen and Bertil Regner; Crown Princess Margareta; Jarnhardt; Lars Hierta Memorial; Pahlsson; Knut and Alice Wallenberg Foundation; Swedish Diabetes Association; Swedish Heart & Lung Foundations	Lund University; Skane County Council for Research and Development; Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Visually Impaired in Former Malmohus Lan; Malmo University Hospital Foundation at Lund University; Foundation of the National Board of Health and Welfare; Lund University Diabetes Centre (LUDC); Carmen and Bertil Regner; Crown Princess Margareta; Jarnhardt; Lars Hierta Memorial; Pahlsson; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Swedish Heart & Lung Foundations(Swedish Heart-Lung Foundation)	The study was supported by grants from Lund University, the Skane County Council for Research and Development, the Swedish Research Council, the Foundation for Visually Impaired in Former Malmohus Lan, Malmo University Hospital Foundation at Lund University, the Foundation of the National Board of Health and Welfare, Lund University Diabetes Centre (LUDC), the Carmen and Bertil Regner, the Crown Princess Margareta, the Jarnhardt, the Lars Hierta Memorial, the Pahlsson, the Knut and Alice Wallenberg Foundation, the Swedish Diabetes Association and the Swedish Heart & Lung Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec-Mroczek J, 2008, GRAEF ARCH CLIN EXP, V246, P1665, DOI 10.1007/s00417-008-0868-6; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Agardh CD, 2006, METABOLISM, V55, P892, DOI 10.1016/j.metabol.2006.02.016; Agardh E, 2006, METABOLISM, V55, P168, DOI 10.1016/j.metabol.2005.08.009; AMELI S, 1994, CIRCULATION, V90, P1935, DOI 10.1161/01.CIR.90.4.1935; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Barile GR, 2005, INVEST OPHTH VIS SCI, V46, P2916, DOI 10.1167/iovs.04-1409; Barile GR, 1999, CURR EYE RES, V19, P219, DOI 10.1076/ceyr.19.3.219.5314; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; DE GOOYER TE, 2006, INVEST OPHTH VIS SCI, V47, P5561; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Dodson PM, 2009, EYE, V23, P997, DOI 10.1038/eye.2008.428; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Gustavsson C, 2008, J DIABETES COMPLICAT, V22, P309, DOI 10.1016/j.jdiacomp.2007.03.001; Gustavsson C, 2008, RETINA-J RET VIT DIS, V28, P645, DOI 10.1097/IAE.0b013e31815ec32d; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; HATCHELL DL, 1994, MICROVASC RES, V47, P344, DOI 10.1006/mvre.1994.1027; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; JOHNSENSORIANO S, GRAEFES ARCH CLIN EX, V248, P985; Joussen AM, 2009, MOL VIS, V15, P1418; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Khalfaoui T, 2008, J MOL HISTOL, V39, P243, DOI 10.1007/s10735-007-9159-5; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; Kruglov AA, 2008, CYTOKINE GROWTH F R, V19, P231, DOI 10.1016/j.cytogfr.2008.04.010; Leiter LA, 2005, DIABETES RES CLIN PR, V68, pS3, DOI 10.1016/j.diabres.2005.03.015; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Limb GA, 1999, INVEST OPHTH VIS SCI, V40, P2453; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Matsumoto K, 2002, DIABETIC MED, V19, P822, DOI 10.1046/j.1464-5491.2002.00799.x; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Nguyen TT, 2009, DIABETES CARE, V32, P1704, DOI 10.2337/dc09-0102; NILSSONOHMAN J, 2009, ARTERIOSCLER THROMB; Nowak M, 2008, CLIN EXP MED, V8, P159, DOI 10.1007/s10238-008-0173-z; Patel JI, 2008, EYE, V22, P223, DOI 10.1038/sj.eye.6702584; Soedamah-Muthu SS, 2006, J DIABETES COMPLICAT, V20, P188, DOI 10.1016/j.jdiacomp.2005.06.005; Spijkerman AMW, 2007, DIABETIC MED, V24, P969, DOI 10.1111/j.1464-5491.2007.02217.x; VAN BUUL JD, 2007, ARTERIOSCL THROM VAS, V27, P1870; Videm V, 2008, SCAND J IMMUNOL, V67, P523, DOI 10.1111/j.1365-3083.2008.02029.x; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; N ENGL J MED	57	79	81	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12699	10.1371/journal.pone.0012699	http://dx.doi.org/10.1371/journal.pone.0012699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856927	Green Published, gold, Green Submitted			2022-12-25	WOS:000281735700017
J	Jenkins, RH; Bennagi, R; Martin, J; Phillips, AO; Redman, JE; Fraser, DJ				Jenkins, Robert H.; Bennagi, Rasha; Martin, John; Phillips, Aled O.; Redman, James E.; Fraser, Donald J.			A Conserved Stem Loop Motif in the 5 ' Untranslated Region Regulates Transforming Growth Factor-beta(1) Translation	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; PROXIMAL TUBULAR CELLS; SECONDARY STRUCTURE; FACTOR-BETA; POSTTRANSCRIPTIONAL REGULATION; TGF-BETA-1 SYNTHESIS; NONCODING SEQUENCES; SIGNALING PATHWAYS; CYTOPLASMIC MRNP; BINDING-PROTEINS	Transforming growth factor-beta(1) (TGF-beta(1)) regulates cellular proliferation, differentiation, migration, and survival. The human TGF-beta(1) transcript is inherently poorly translated, and translational activation has been documented in relation to several stimuli. In this paper, we have sought to identify in cis regulatory elements within the TGF-beta(1) 5'Untranslated Region (5'UTR). In silico analysis predicted formation of stable secondary structure in a G/C-rich element between nucleotides + 77 to + 106, and demonstrated that this element is highly conserved across species. Circular dichroism spectroscopy confirmed the presence of secondary structure in this region. The proximal 5'UTR was inhibitory to translation in reporter gene experiments, and mutation of the secondary structure motif increased translational efficiency. Translational regulation of TGF-beta(1) mRNA is linked to altered binding of YB-1 protein to its 5'UTR. Immunoprecipitation-RT-qPCR demonstrated a high basal association of YB-1 with TGF-beta(1) mRNA. However, mutation of the secondary structure motif did not prevent interaction of YB-1 with the 5'UTR, suggesting that YB-1 binds to this region due to its G/C-rich composition, rather than a specific, sequence-dependent, binding site. These data identify a highly conserved element within the TGF-beta(1) 5'UTR that forms stable secondary structure, and is responsible for the inherent low translation efficiency of this cytokine.	[Jenkins, Robert H.; Bennagi, Rasha; Martin, John; Phillips, Aled O.; Fraser, Donald J.] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales; [Redman, James E.] Cardiff Univ, Sch Chem, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Jenkins, RH (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff, S Glam, Wales.	fraserdj@cf.ac.uk	Redman, James/B-7175-2008	Redman, James/0000-0001-5492-2869; Fraser, Donald/0000-0003-0102-9342; Jenkins, Robert/0000-0001-8500-9044	Kidney Research UK [RP32/2/2006]	Kidney Research UK(Kidney Research UK (KRUK))	This study was funded by Kidney Research UK, grant number RP32/2/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RSH, 1998, GROWTH FACTORS, V16, P89, DOI 10.3109/08977199809002120; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chen CY, 2000, GENE DEV, V14, P1236; Dong JJ, 2009, RNA BIOL, V6, P59, DOI 10.4161/rna.6.1.7458; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; EDDY S, 2002, SQUID UTILITIES; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; FOWLIS DJ, 1992, CELL GROWTH DIFFER, V3, P81; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fraser D, 2002, AM J PATHOL, V161, P1039, DOI 10.1016/S0002-9440(10)64265-4; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Fukuda T, 2004, NUCLEIC ACIDS RES, V32, P611, DOI 10.1093/nar/gkh223; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KIM SJ, 1992, J BIOL CHEM, V267, P13702; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LADOMERY M, 1994, NUCLEIC ACIDS RES, V22, P5582, DOI 10.1093/nar/22.25.5582; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; MINICH WB, 1993, EUR J BIOCHEM, V212, P633, DOI 10.1111/j.1432-1033.1993.tb17701.x; MINICH WB, 1992, BIOCHIMIE, V74, P477, DOI 10.1016/0300-9084(92)90088-V; Morrisey K, 2001, AM J PATHOL, V159, P1905, DOI 10.1016/S0002-9440(10)63037-4; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PHILLIPS AO, 1995, AM J PATHOL, V147, P362; Phillips AO, 1997, AM J PATHOL, V150, P1101; Phillips AO, 1996, KIDNEY INT, V50, P1546, DOI 10.1038/ki.1996.470; ROMEO DS, 1993, MOL ENDOCRINOL, V7, P759, DOI 10.1210/me.7.6.759; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Workman C, 1999, NUCLEIC ACIDS RES, V27, P4816, DOI 10.1093/nar/27.24.4816; Zasedateleva OA, 2002, J MOL BIOL, V324, P73, DOI 10.1016/S0022-2836(02)00937-3; Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	58	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12283	10.1371/journal.pone.0012283	http://dx.doi.org/10.1371/journal.pone.0012283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865036	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000281292100004
J	He, X; Arslan, AD; Pool, MD; Ho, TT; Darcy, KM; Coon, JS; Beck, WT				He, X.; Arslan, A. D.; Pool, M. D.; Ho, T-T; Darcy, K. M.; Coon, J. S.; Beck, W. T.			Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer	ONCOGENE			English	Article						splicing factors; polypyrimidine tract-binding protein; SRp20; siRNA; tissue microarray; epithelial ovarian cancer	TRACT-BINDING-PROTEIN; HUMAN BREAST-CANCER; MESSENGER-RNA; CONTINGENCY-TABLES; EXON; CD44; GENE; ABERRANT; VARIANT; PHOSPHORYLATION	Our previous study revealed that two splicing factors, polypyrimidine tract-binding protein (PTB) and SRp20, were upregulated in epithelial ovarian cancer (EOC) and knockdown of PTB expression inhibited ovarian tumor cell growth and transformation properties. In this report, we show that knockdown of SRp20 expression in ovarian cancer cells also causes substantial inhibition of tumor cell growth and colony formation in soft agar and the extent of such inhibition appeared to correlate with the extent of suppression of SRp20. Massive knockdown of SRp20 expression triggered remarkable apoptosis in these cells. These results suggest that overexpression of SRp20 is required for ovarian tumor cell growth and survival. Immunohistochemical staining for PTB and SRp20 of two specialized tissue microarrays, one containing benign ovarian tumors, borderline/low malignant potential (LMP) ovarian tumors as well as invasive EOC and the other containing invasive EOC ranging from stage I to stage IV disease, reveals that PTB and SRp20 are both expressed differentially between benign tumors and invasive EOC, and between borderline/LMP tumors and invasive EOC. There were more all-negative or mixed staining cases (at least two evaluable section cores per case) in benign tumors than in invasive EOC, whereas there were more all-positive staining cases in invasive EOC than in the other two disease classifications. Among invasive EOC, the majority of cases were stained all positive for both PTB and SRp20, and there were no significant differences in average staining or frequency of positive cancer cells between any of the tumor stages. Therefore, the expression of PTB and SRp20 is associated with malignancy of ovarian tumors but not with stage of invasive EOC. Oncogene (2011) 30, 356-365; doi:10.1038/onc.2010.426; published online 20 September 2010	[He, X.; Arslan, A. D.; Ho, T-T; Beck, W. T.] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [He, X.; Beck, W. T.] Univ Illinois, Coll Pharm, Core Lab Mol Pharmacol, GOG, Chicago, IL 60612 USA; [He, X.; Arslan, A. D.; Ho, T-T; Beck, W. T.] Univ Illinois, Ctr Canc, Chicago, IL 60612 USA; [Pool, M. D.; Coon, J. S.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Darcy, K. M.] Roswell Pk Canc Inst, GOG Stat & Data Ctr, Buffalo, NY 14263 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Roswell Park Cancer Institute	Beck, WT (corresponding author), Univ Illinois, Dept Biopharmaceut Sci MC 865, 833 S Wood St, Chicago, IL 60612 USA.	xiaohe@uic.edu; WTBeck@uic.edu			National Cancer Institute [CA40570, CA138762, CA27469, CA37517]; Rush University Medical Center; University of Illinois at Chicago; NCRR NIH [C06RR15482]; NATIONAL CANCER INSTITUTE [U10CA037517, R01CA040570, R01CA138762, U10CA027469] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015482] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rush University Medical Center; University of Illinois at Chicago; NCRR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Gynecologic Oncology Group (GOG) Tissue Bank for providing unstained ovarian tumor TMAs. We thank our colleague, Martina Vaskova, for her outstanding administrative assistance. We also thank Dr Richard Gemeinhart for allowing us to use his IX70 microscope and Ernest Gemeinhart for his excellent technical assistance with microscopy. This work was supported by the National Cancer Institute Grants CA40570 and CA138762 to WTB, CA27469 to the GOG, GOG Tissue Bank and GOG Molecular Pharmacology Core Lab and CA37517 to the GOG Statistical and Data Center as well as the Ovarian Cancer Research Fund (XH), Rush University Medical Center and the University of Illinois at Chicago. It was conducted in a facility constructed with support from the NCRR NIH grant C06RR15482.	Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; De Marzo AM, 1998, PROSTATE, V34, P162; Feltes CM, 2002, CANCER RES, V62, P6688; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Galiana-Arnoux D, 2003, J BIOL CHEM, V278, P32943, DOI 10.1074/jbc.M301090200; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin W, 2000, CANCER RES, V60, P1221; Jin W, 2003, CANCER RES, V63, P6154; Jumaa H, 2000, BBA-GENE STRUCT EXPR, V1494, P137, DOI 10.1016/S0167-4781(00)00233-5; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lockhart MS, 2001, ONCOL REP, V8, P145; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lou H, 1999, MOL CELL BIOL, V19, P78; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Lukas J, 2001, CANCER RES, V61, P3212; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Ries LAG, 2007, SEER CANC STAT REV 1; Schroder W, 1999, ANTICANCER RES, V19, P3901; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Silberstein GB, 1997, P NATL ACAD SCI USA, V94, P8132, DOI 10.1073/pnas.94.15.8132; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Stoilov P, 2002, DNA CELL BIOL, V21, P803, DOI 10.1089/104454902320908450; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang ZN, 2003, CANCER RES, V63, P655; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zang WQ, 2001, J VIROL, V75, P10779, DOI 10.1128/JVI.75.22.10779-10786.2001	55	73	77	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	3					356	365		10.1038/onc.2010.426	http://dx.doi.org/10.1038/onc.2010.426			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709DY	20856201	Green Accepted			2022-12-25	WOS:000286418800010
J	Krejbich-Trotot, P; Denizot, M; Hoarau, JJ; Jaffar-Bandjee, MC; Das, T; Gasque, P				Krejbich-Trotot, Pascale; Denizot, Melanie; Hoarau, Jean-Jacques; Jaffar-Bandjee, Marie-Christine; Das, Trina; Gasque, Philippe			Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses	FASEB JOURNAL			English	Article						alphavirus; blebs; macrophages; innate immunity; caspases; persistence	SEMLIKI-FOREST-VIRUS; PERSISTENT ALPHAVIRUS INFECTION; EQUINE ENCEPHALITIS; DEATH; PHAGOCYTOSIS; MACROPHAGES; CLEARANCE; MACROPINOCYTOSIS; REPLICATION; ENGULFMENT	Chikungunya virus (CHIKV) surprised medical workers by a massive outbreak in the Indian Ocean region, reaching Europe in 2007, with exceptional pathologies in infants and elderly patients. Although CHIKV was recently shown to persist in myo-blasts, monocytes, and macrophages, we argued that robust antiviral mechanisms, including apoptosis, are essential to ward off the virus. Herein, we tested the capacity of CHIKV to mobilize the apoptotic machinery in HeLa cells as well as primary fibroblasts, making use of several inhibitors of caspases, cell blebbing, and engulfment of the apoptotic blebs by neighboring cells. CHIKV triggered apoptosis through intrinsic and extrinsic pathways. Bystander apoptosis was also evidenced in neighboring cells in a caspase-8-dependent manner. Remarkably, by hiding in apoptotic blebs, CHIKV was able to infect neighboring cells. In HeLa cells, these events were inhibited specifically by zVAD-fmk and DEVD-cho (caspase inhibitors), blebbistatin, Y-27632 (ROCK inhibitor), and genistein, annexin V, and cytochalasin B (inhibitors of blebbing and engulfment). These CHIKV-apoptotic blebs were also capable of infecting macrophages (primary cultures, MM6- and THP1-PMA differentiated cells) otherwise refractory to infection by CHIKV alone. Remarkably, viral replication in macrophages did not yield a proinflammatory response. We describe a novel infectious mechanism by which CHIKV invades host cells and escapes the host response.-Krejbich-Trotot, P., Denizot, M., Hoarau, J.-J., Jaffar-Bandjee, M.-C., Das, T., Gasque, P. Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses. FASEB J. 25, 314-325 (2011). www.fasebj.org	[Krejbich-Trotot, Pascale; Denizot, Melanie; Hoarau, Jean-Jacques; Jaffar-Bandjee, Marie-Christine; Das, Trina; Gasque, Philippe] CHR, Grp Rech Immunopathol & Malad Infect GRI, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHR, Biol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHR, Microbiol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHR, Virol Unit, St Denis, Reunion, France; [Jaffar-Bandjee, Marie-Christine] CHR, Biochem Unit, St Denis, Reunion, France; [Krejbich-Trotot, Pascale; Denizot, Melanie; Hoarau, Jean-Jacques; Jaffar-Bandjee, Marie-Christine; Das, Trina; Gasque, Philippe] Univ La Reunion, St Denis, Reunion, France	CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; University of La Reunion	Krejbich-Trotot, P (corresponding author), Univ La Reunion, GRI IRG Immunopathol & Infect Res Grouping, CYROI, 2 Rue Maxime Riviere, St Clothilde 97491, Reunion, France.	pascale.krejbich-trotot@chr-reunion.fr; gasque@univ-reunion.fr		HOARAU, Jean-Jacques/0000-0002-7612-2018; Krejbich Trotot, Pascale/0000-0001-7329-1716	Institut National de la Sante et de la Recherche Medicale Contrat d'Interface; Regional Council fellowship; Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional; Ministere de l'Outre Mer; Programme Hospitalier de Recherche Clinique; Institut National de la Sante et de la Recherche Medicale Contrat d'Interface; Regional Council fellowship; Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional; Ministere de l'Outre Mer; Programme Hospitalier de Recherche Clinique	Institut National de la Sante et de la Recherche Medicale Contrat d'Interface(Institut National de la Sante et de la Recherche Medicale (Inserm)); Regional Council fellowship; Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional; Ministere de l'Outre Mer; Programme Hospitalier de Recherche Clinique; Institut National de la Sante et de la Recherche Medicale Contrat d'Interface(Institut National de la Sante et de la Recherche Medicale (Inserm)); Regional Council fellowship; Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional; Ministere de l'Outre Mer; Programme Hospitalier de Recherche Clinique	The authors thank Prof. Xavier de Lamballerie (Unite des Virus Emergents, Marseille, France), Biomerieux (Marcy l'Etoile, France), Prof. Vaclav Horejsi (Institute of Molecular Genetics, Prague, Czech Republic), and Dr. Marc Grandadam (Institut Pasteur, CNR Arbovirus, Paris, France) for kindly providing reagents used in this study. Financial support was provided by an Institut National de la Sante et de la Recherche Medicale Contrat d'Interface to P.G., a Regional Council fellowship to T.D., and laboratory funding from Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional, Ministere de l'Outre Mer, and Programme Hospitalier de Recherche Clinique. The authors declare no commercial connections that may pose a conflict of interest.	Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chen YB, 2006, CELL DEATH DIFFER, V13, P1318, DOI 10.1038/sj.cdd.4401964; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fazakerley JK, 2001, CURR TOP MICROBIOL, V253, P95; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garen PD, 1999, MODERN PATHOL, V12, P646; Glasgow GM, 1998, J GEN VIROL, V79, P2405, DOI 10.1099/0022-1317-79-10-2405; Griffin DE, 1997, ANNU REV MICROBIOL, V51, P565, DOI 10.1146/annurev.micro.51.1.565; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Jackson AC, 1997, ACTA NEUROPATHOL, V93, P349, DOI 10.1007/s004010050626; Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001; Jan JT, 1999, J VIROL, V73, P10296, DOI 10.1128/JVI.73.12.10296-10302.1999; Kenis H, 2006, EXP CELL RES, V312, P719, DOI 10.1016/j.yexcr.2005.11.023; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Moriishi K, 2002, VIROLOGY, V292, P258, DOI 10.1006/viro.2001.1206; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Orlando KA, 2006, EXP CELL RES, V312, P5, DOI 10.1016/j.yexcr.2005.09.012; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Poon I. K., CELL DEATH DIFFER, V17, P381; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROSEN A, 1995, J EXP MED, V181, P1557, DOI 10.1084/jem.181.4.1557; Sammin DJ, 1999, NEUROPATH APPL NEURO, V25, P236, DOI 10.1046/j.1365-2990.1999.00170.x; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Urban C, 2008, CELL DEATH DIFFER, V15, P1396, DOI 10.1038/cdd.2008.61; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054; Wertz IE, 1996, TRENDS BIOCHEM SCI, V21, P359, DOI 10.1016/0968-0004(96)40002-0; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	51	95	97	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					314	325		10.1096/fj.10-164178	http://dx.doi.org/10.1096/fj.10-164178			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20881210	Bronze			2022-12-25	WOS:000285869500028
J	Marcil, V; Seidman, E; Sinnett, D; Boudreau, F; Gendron, FP; Beaulieu, JF; Menard, D; Precourt, LP; Amre, D; Levy, E				Marcil, Valerie; Seidman, Ernest; Sinnett, Daniel; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Precourt, Louis-Philippe; Amre, Devendra; Levy, Emile			Modification in Oxidative Stress, Inflammation, and Lipoprotein Assembly in Response to Hepatocyte Nuclear Factor 4 alpha Knockdown in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR NRF2; UPSTREAM PROMOTER REGION; LOW-DENSITY LIPOPROTEIN; EPIDERMAL GROWTH-FACTOR; HUMAN FETAL INTESTINE; ACUTE-PHASE RESPONSE; GENE-EXPRESSION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a nuclear transcription factor mainly expressed in the liver, intestine, kidney, and pancreas. Many of its hepatic and pancreatic functions have been described, but limited information is available on its role in the gastrointestinal tract. The objectives of this study were to evaluate the anti-inflammatory and antioxidant functions of HNF4 alpha as well as its implication in intestinal lipid transport and metabolism. To this end, the HNF4A gene was knocked down by transfecting Caco-2 cells with a pGFP-V-RS lentiviral vector containing an shRNA against HNF4 alpha. Inactivation of HNF4 alpha in Caco-2 cells resulted in the following: (a) an increase in oxidative stress as demonstrated by the levels of malondialdehyde and conjugated dienes; (b) a reduction in secondary endogenous antioxidants (catalase, glutathione peroxidase, and heme oxygenase- 1); (c) a lower protein expression of nuclear factor erythroid 2-related factor that controls the antioxidant response elements- regulated antioxidant enzymes; (d) an accentuation of cellular inflammatory activation as shown by levels of nuclear factor-kappa B, interleukin-6, interleukin-8, and leukotriene B4; (e) a decrease in the output of high density lipoproteins and of their anti-inflammatory and anti-oxidative components apolipoproteins (apo) A-I and A-IV; (f) a diminution in cellular lipid transport revealed by a lower cellular secretion of chylomicrons and their apoB-48 moiety; and (g) alterations in the transcription factors sterol regulatory element-binding protein 2, peroxisome proliferator-activated receptor alpha, and liver X receptor alpha and beta. In conclusion, HNF4 alpha appears to play a key role in intestinal lipid metabolism as well as intestinal anti-oxidative and anti-inflammatory defense mechanisms.	[Marcil, Valerie; Seidman, Ernest] McGill Univ, Res Inst, Montreal, PQ H3G 1A4, Canada; [Seidman, Ernest; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Levy, Emile] Univ Sherbrooke, Fac Med & Hlth Sci, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Sherbrooke, PQ J1H 5N4, Canada; [Levy, Emile] CHU St Justine, GI Nutr Unit, Dept Pediat, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Precourt, Louis-Philippe; Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1C5, Canada	McGill University; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Levy, E (corresponding author), CHU St Justine, GI Nutr Unit, Dept Pediat, Res Ctr, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	emile.levy@recherche-ste-Justine.qc.ca	sinnett, daniel/S-4589-2017; Gendron, Fernand-Pierre/AAN-2965-2021; AMRE, DEVENDRA K/D-4988-2015	sinnett, daniel/0000-0003-3625-6676; 	Canadian Institutes of Health Research Team [CTP-82942]; J. A. DeSeve Research Chair in Nutrition; Canadian Institutes of Health	Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); J. A. DeSeve Research Chair in Nutrition; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research Team Grant CTP-82942, the J. A. DeSeve Research Chair in Nutrition (to E. L.), and the Canadian Institutes of Health research fellowship award (to V. M.).	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Antes TJ, 2001, DNA CELL BIOL, V20, P67, DOI 10.1089/104454901750070265; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brandsch C, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-50; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Crisafulli C, 2009, SHOCK, V32, P62, DOI 10.1097/SHK.0b013e31818bbad6; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Fiegel HC, 2003, STEM CELLS, V21, P98, DOI 10.1634/stemcells.21-1-98; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; GINSBURG GS, 1995, J CLIN INVEST, V96, P528, DOI 10.1172/JCI118065; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2003, AM J PHYSIOL-CELL PH, V284, pC1090, DOI 10.1152/ajpcell.00394.2002; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Kim YW, 2010, FREE RADICAL BIO MED, V48, P567, DOI 10.1016/j.freeradbiomed.2009.12.006; KLUCIS E, 1984, MOL CELL BIOCHEM, V65, P73; Kruidenier L, 2003, J PATHOL, V201, P17, DOI 10.1002/path.1408; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; KUTTY RK, 1982, J BIOL CHEM, V257, P9944; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; LEVY E, 1992, J LIPID RES, V33, P1607; Levy E, 1996, FEBS LETT, V393, P253, DOI 10.1016/0014-5793(96)00896-4; LEVY E, 1994, BIOCHEM BIOPH RES CO, V204, P1340, DOI 10.1006/bbrc.1994.2610; Levy E, 2002, J BIOL CHEM, V277, P16470, DOI 10.1074/jbc.M102385200; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li JX, 2000, GENE DEV, V14, P464; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIRDIGHI N, 1992, BIOCHIM BIOPHYS ACTA, V1175, P100, DOI 10.1016/0167-4889(92)90015-4; Loirdighi N, 1997, J CELL BIOCHEM, V66, P65, DOI 10.1002/(SICI)1097-4644(19970701)66:1<65::AID-JCB8>3.0.CO;2-W; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Mailhot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010446; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Mehran M, 1995, AM J PHYSIOL-GASTR L, V269, pG953, DOI 10.1152/ajpgi.1995.269.6.G953; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Natarajan R, 2001, J INTERF CYTOK RES, V21, P349, DOI 10.1089/107999001750277826; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Pippenger C E, 1998, Methods Mol Biol, V108, P299; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Precourt LP, 2009, INT J BIOCHEM CELL B, V41, P1628, DOI 10.1016/j.biocel.2009.02.013; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Qin B, 2010, EXP BIOL MED, V235, P199, DOI 10.1258/ebm.2009.009169; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rowley CW, 2006, AM J PHYSIOL-GASTR L, V290, pG466, DOI 10.1152/ajpgi.00431.2005; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sheena V, 2005, J LIPID RES, V46, P328, DOI 10.1194/jlr.M400371-JLR200; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SLADEK FM, 1993, RECEPTOR, V3, P223; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spalinger JH, 1998, AM J PHYSIOL-GASTR L, V275, pG652, DOI 10.1152/ajpgi.1998.275.4.G652; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Swenson ES, 1999, AM J PHYSIOL-GASTR L, V276, pG728, DOI 10.1152/ajpgi.1999.276.3.G728; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Terasaka N, 2005, FEBS J, V272, P1546, DOI 10.1111/j.1742-4658.2005.04599.x; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; WARD PA, 1985, J CLIN INVEST, V76, P517, DOI 10.1172/JCI112001; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	105	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40448	40460		10.1074/jbc.M110.155358	http://dx.doi.org/10.1074/jbc.M110.155358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20871093	hybrid, Green Published			2022-12-25	WOS:000285414400007
J	Liu, CY; Zha, ZY; Zhou, X; Zhang, H; Huang, W; Zhao, D; Li, TT; Chan, SW; Lim, CJ; Hong, WJ; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Liu, Chen-Ying; Zha, Zheng-Yu; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Chan, Siew Wee; Lim, Chun Jye; Hong, Wanjin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCF beta-TrCP E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL DIFFERENTIATION; SIGNALING PATHWAY; PROLIFERATION; SUPPRESSOR; APOPTOSIS; DROSOPHILA; KINASE; GROWTH; TRANSCRIPTION	The TAZ transcription co-activator promotes cell proliferation and epithelial-mesenchymal transition. TAZ is inhibited by the Hippo tumor suppressor pathway, which promotes TAZ cytoplasmic localization by phosphorylation. We report here that TAZ protein stability is controlled by a phosphodegron recognized by the F-box protein beta-TrCP and ubiquitylated by the SCF/CRL1(beta-TrCPE) 3 ligase. The interaction between TAZ and beta-TrCP is regulated by the Hippo pathway. Phosphorylation of a phosphodegron in TAZ by LATS primes it for further phosphorylation by CK1 epsilon and subsequent binding by beta-TrCP. Therefore, the Hippo pathway negatively regulates TAZ function by both limiting its nuclear accumulation and promoting its degradation. The phosphodegron-mediated TAZ degradation plays an important role in negatively regulating TAZ biological functions.	[Liu, Chen-Ying; Zhao, Shimin; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Zha, Zheng-Yu; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Chan, Siew Wee; Lim, Chun Jye; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Zhou, Xin/AAD-6937-2019; HONG, Wanjin/E-9927-2010; Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Liu, Chen-Ying/0000-0002-8930-6182; zha, zhengyu/0000-0002-8619-3661; Zhao, Di/0000-0001-6253-7127	National Institutes of Health; Chinese Ministry of Education [NCET-09-0315]; NSFC [30600112, 30871255, 31071192]; Shanghai key project [09JC1402300]; Shanghai Leading Academic Discipline Project [B110]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Education(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); Shanghai key project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants (to Y.X. and K.-L.G.). This work was also supported by the 985 Program and New Century Talent from the Chinese Ministry of Education (Grant No. NCET-09-0315) from the Chinese Ministry of Education, 863 (Grant No. 2006AA02A308), 973 (Grant No. 2009CB918401), NSFC (Grant No. 30600112, 30871255, 31071192), Shanghai key project (Grant No. 09JC1402300), Grant No. BK2006546, and the Shanghai Leading Academic Discipline Project, Project Number B110.	Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	34	357	368	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37159	37169		10.1074/jbc.M110.152942	http://dx.doi.org/10.1074/jbc.M110.152942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858893	hybrid, Green Published			2022-12-25	WOS:000284424000009
J	Zhu, L; Millen, L; Mendoza, JL; Thomas, PJ				Zhu, Li; Millen, Linda; Mendoza, Juan L.; Thomas, Philip J.			A Unique Redox-sensing Sensor II Motif in TorsinA Plays a Critical Role in Nucleotide and Partner Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; TOR1A DYT1 GENE; NUCLEAR-ENVELOPE; ENDOPLASMIC-RETICULUM; MUTANT TORSINA; PC12 CELLS; CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEINS; ATP HYDROLYSIS; DYSTONIA	Early onset dystonia is commonly associated with the deletion of one of a pair of glutamate residues (Delta E302/303) near the C terminus of torsinA, a member of the AAA+ protein family (ATPases associated with a variety of cellular activities) located in the endoplasmic reticulum lumen. The functional consequences of the disease-causing mutation, Delta E, are not currently understood. By contrast to other AAA+ proteins, torsin proteins contain two conserved cysteine residues in the C-terminal domain, one of which is located in the nucleotide sensor II motif. Depending on redox status, an ATP hydrolysis mutant of torsinA interacts with lamina-associated polypeptide 1 (LAP1) and lumenal domain like LAP1 (LULL1). Substitution of the cysteine in sensor II diminishes the redox-regulated interaction of torsinA with these substrates. Significantly, the dystonia-causing mutation, Delta E, alters the ability of torsinA to mediate the redox-regulated interactions with LAP1 and LULL1. Limited proteolysis experiments reveal redox- and mutation-dependent changes in the local conformation of torsinA as a function of nucleotide binding. These results indicate that the cysteine-containing sensor II plays a critical role in redox sensing and the nucleotide and partner binding functions of torsinA and suggest that loss of this function of torsinA contributes to the development of DYT1 dystonia.	[Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhu, Li] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zhuli@moon.ibp.ac.cn; Philip.Thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Mendoza, Juan/0000-0001-6972-7476	National Institutes of Health [DK49835]; Dystonia Medical Research Foundation; National Natural Science Foundation of China [30970570]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystonia Medical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK49835 (to P. J. T.). This work was also supported by grants from the Dystonia Medical Research Foundation (to L. Z. and P. J. T.) and National Natural Science Foundation of China Grant 30970570 (to L. Z.).	Asanuma Kotaro, 2005, J Med Invest, V52 Suppl, P272, DOI 10.2152/jmi.52.272; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Basham SE, 2001, DEVELOPMENT, V128, P4645; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Carbon M, 2008, MOVEMENT DISORD, V23, P234, DOI 10.1002/mds.21806; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Facundo HTF, 2007, FREE RADICAL BIO MED, V42, P1039, DOI 10.1016/j.freeradbiomed.2007.01.001; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Neuwald AF, 1999, GENOME RES, V9, P27; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Tavakoli N, 2001, PLANT J, V28, P51, DOI 10.1046/j.1365-313X.2001.01130.x; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37271	37280		10.1074/jbc.M110.123471	http://dx.doi.org/10.1074/jbc.M110.123471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861018	Green Published, hybrid			2022-12-25	WOS:000284424000020
J	Lu, B; Mahmud, H; Maass, AH; Yu, B; van Gilst, WH; de Boer, RA; Sillje, HHW				Lu, Bo; Mahmud, Hasan; Maass, Alexander H.; Yu, Bo; van Gilst, Wiek H.; de Boer, Rudolf A.; Sillje, Herman H. W.			The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro	PLOS ONE			English	Article							POLO-LIKE KINASE-1; BOX DOMAIN; CANCER-CELLS; SUBSTRATE; REVEALS; POLO-LIKE-KINASE-1; ACTIVATION; DIVISION; THERAPY; BI-2536	BI 2536 is a new anti-mitotic drug that targets polo-like kinase 1 (Plk1) and is currently under clinical development for cancer therapy. The effect of this drug on cancer cells has been extensively investigated, but information about the effects on primary dividing cells and differentiated non-dividing cells is scarce. We have investigated the effects of this drug on primary neonatal rat cardiac fibroblasts and on differentiated cardiomyocytes and explored the possibility to use this drug to enrich differentiated cell populations in vitro. BI 2536 had a profound effect on cardiac fibroblast proliferation in vitro and arrested these cells in mitosis with an IC50 of about 43 nM. Similar results were observed with primary human cells (HUVEC, IC50 = 30 nM), whereas the cancer cell line HeLa was more sensitive (IC50 of 9 nM). Further analysis revealed that prolonged mitotic arrest resulted in cell death for about 40% of cardiac fibroblasts. The remaining cells showed an interphase morphology with mostly multi-and micro-nucleated nuclei. This indicates that a significant number of primary fibroblasts are able to escape BI 2536 induced mitotic arrest and apparently become aneuploid. No effects were observed on cardiomyocytes and hypertrophic response (growth) upon endothelin-1 and phenylephrine stimulation was normal in the presence of BI 2536. This indicates that BI 2536 has no adverse effects on terminally differentiated cells and still allows proliferation independent growth induction in these cells. In conclusion, cardiomyocytes could be enriched using BI 2536, but the formation of aneuploidy in proliferating cells most likely limits this in vitro application and does not allow its use in putative cell based therapies.	[Lu, Bo; Mahmud, Hasan; Maass, Alexander H.; van Gilst, Wiek H.; de Boer, Rudolf A.; Sillje, Herman H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Yu, Bo] Harbin Med Coll, Affiliated Hosp 2, Dept Cardiol, Key Labs,Educ Minist Myocardial Ischemia Mech & T, Harbin, Peoples R China	University of Groningen; Harbin Medical University	Sillje, HHW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	h.h.w.sillje@thorax.umcg.nl	de Boer, Rudolf/ABE-9879-2020; Maass, Alexander/B-8534-2008; van Gilst, Wiek H/C-3828-2008; van Gilst, Wiek/R-1806-2019	Maass, Alexander/0000-0002-7936-360X; van Gilst, Wiek/0000-0003-2968-8585	Graduate School for Drug Exploration (GUIDE) of the University of Groningen	Graduate School for Drug Exploration (GUIDE) of the University of Groningen	B. Lu is a recipient of a fellowship by the Graduate School for Drug Exploration (GUIDE) of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVUGT MA, 2004, J BIOL CHEM, V279, P36841; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Brito DA, 2009, CELL MOTIL CYTOSKEL, V66, P437, DOI 10.1002/cm.20316; Elez R, 2003, ONCOGENE, V22, P69, DOI 10.1038/sj.onc.1206038; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maass A, 2003, J MOL CELL CARDIOL, V35, P823, DOI 10.1016/S0022-2828(03)00140-8; MAASS AH, 1995, EUR HEART J, V16, P12, DOI 10.1093/eurheartj/16.suppl_C.12; Maass Alexander H, 2007, Methods Mol Biol, V366, P321; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ren D, 2003, BRAIN RES BULL, V61, P547, DOI 10.1016/S0361-9230(03)00193-X; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SCHOFFSKI P, 2010, EUR J CANC; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Schraaa AJ, 2002, J CONTROL RELEASE, V83, P241, DOI 10.1016/S0168-3659(02)00206-7; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015	33	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12963	10.1371/journal.pone.0012963	http://dx.doi.org/10.1371/journal.pone.0012963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886032	Green Published, gold, Green Submitted			2022-12-25	WOS:000282122600005
J	Beissner, F; Brandau, A; Henke, C; Felden, L; Baumgartner, U; Treede, RD; Oertel, BG; Lotsch, J				Beissner, Florian; Brandau, Amadeus; Henke, Christian; Felden, Lisa; Baumgaertner, Ulf; Treede, Rolf-Detlef; Oertel, Bruno G.; Loetsch, Joern			Quick Discrimination of A(delta) and C Fiber Mediated Pain Based on Three Verbal Descriptors	PLOS ONE			English	Article							A-FIBER; SECONDARY HYPERALGESIA; NEUROPATHIC PAIN; STIMULATION; PERCEPTION; HUMANS; QUESTIONNAIRE; SKIN; PREVALENCE; ACTIVATION	Background: Ad and C fibers are the major pain-conducting nerve fibers, activate only partly the same brain areas, and are differently involved in pain syndromes. Whether a stimulus excites predominantly Ad or C fibers is a commonly asked question in basic pain research but a quick test was lacking so far. Methodology/Principal Findings: Of 77 verbal descriptors of pain sensations, "pricking'', "dull'' and "pressing'' distinguished best (95% cases correctly) between Ad fiber mediated (punctate pressure produced by means of von Frey hairs) and C fiber mediated (blunt pressure) pain, applied to healthy volunteers in experiment 1. The sensation was assigned to Ad fibers when "pricking'' but neither "dull'' nor "pressing'' were chosen, and to C fibers when the sum of the selections of "dull'' or "pressing'' was greater than that of the selection of "pricking''. In experiment 2, with an independent cohort, the three-descriptor questionnaire achieved sensitivity and specificity above 0.95 for distinguishing fiber preferential non-mechanical induced pain (laser heat, exciting Ad fibers, and 5-Hz electric stimulation, exciting C fibers). Conclusion: A three-item verbal rating test using the words "pricking'', "dull'', and "pressing'' may provide sufficient information to characterize a pain sensation evoked by a physical stimulus as transmitted via Ad or via C fibers. It meets the criteria of a screening test by being easy to administer, taking little time, being comfortable in handling, and inexpensive while providing high specificity for relevant information.	[Beissner, Florian; Henke, Christian] Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany; [Brandau, Amadeus; Felden, Lisa; Oertel, Bruno G.; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, Ctr Drug Res Dev & Safety ZAFES, Pharmazentrum Frankfurt, Frankfurt, Germany; [Baumgaertner, Ulf; Treede, Rolf-Detlef] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Div Neurophysiol, D-6800 Mannheim, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Beissner, F (corresponding author), Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de	Beissner, Florian/I-3474-2019; Baumgärtner, Ulf/L-4149-2019; Treede, Rolf-Detlef/I-3632-2014	Beissner, Florian/0000-0003-0513-7551; Baumgärtner, Ulf/0000-0001-6371-3073; Lotsch, Jorn/0000-0002-5818-6958; Treede, Rolf-Detlef/0000-0001-8065-1708	Horst Goertz Foundation	Horst Goertz Foundation	FB was financially supported by the Horst Goertz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; BLUMBERG H, 1991, REFLEX SYMPATHETIC D, P29; BOWSHER D, 1991, ACUPUNCT MED, V9, P58; BROMM B, 1984, HUM NEUROBIOL, V3, P33; Chen A, 1998, J PAIN, V7, P159; CHEN ACN, 1985, PAIN, V22, P67, DOI 10.1016/0304-3959(85)90149-6; COOPER BY, 1986, PAIN, V24, P93, DOI 10.1016/0304-3959(86)90030-8; Cordell WH, 2002, AM J EMERG MED, V20, P165, DOI 10.1053/ajem.2002.32643; HANCOCK GR, 1993, EDUC PSYCHOL MEAS, V53, P651, DOI 10.1177/0013164493053003006; Hasselstrom J, 2002, EUR J PAIN, V6, P375, DOI 10.1016/S1090-3801(02)00025-3; HOBSON AR, 2010, AM J PHYSIOL-GASTR L, V298, P631; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; HUIJER HA, 2010, LEBAN MED J, V58, P21; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; KOLTZENBURG M, 1993, PAIN, V53, P363, DOI 10.1016/0304-3959(93)90238-K; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laursen RJ, 1999, MUSCLE NERVE, V22, P1564, DOI 10.1002/(SICI)1097-4598(199911)22:11<1564::AID-MUS12>3.3.CO;2-V; LEBARS D, 1976, BRAIN RES, V115, P518, DOI 10.1016/0006-8993(76)90370-X; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; Liu SS, 1996, ANESTH ANALG, V82, P98, DOI 10.1097/00000539-199601000-00017; Lotsch J, 2003, PAIN, V102, P151, DOI 10.1016/S0304-3959(02)00349-4; MASSON EA, 1989, DIABETOLOGIA, V32, P724, DOI 10.1007/BF00274531; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nahra H, 2003, EUR J PAIN, V7, P189, DOI 10.1016/S1090-3801(02)00099-X; PITEI DL, 1994, DIABETIC MED, V11, P872, DOI 10.1111/j.1464-5491.1994.tb00371.x; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; TOREBJORK HE, 1973, EXP BRAIN RES, V16, P321; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; VEVES A, 1994, DIABETES CARE, V17, P1200, DOI 10.2337/diacare.17.10.1200; Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047; Wilkie DJ, 2001, J PAIN SYMPTOM MANAG, V22, P899, DOI 10.1016/S0885-3924(01)00351-7; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	39	74	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12944	10.1371/journal.pone.0012944	http://dx.doi.org/10.1371/journal.pone.0012944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886070	Green Submitted, gold, Green Published			2022-12-25	WOS:000282091100042
J	Chamilos, G; Ganguly, D; Lande, R; Gregorio, J; Meller, S; Goldman, WE; Gilliet, M; Kontoyiannis, DP				Chamilos, Georgios; Ganguly, Dipyaman; Lande, Roberto; Gregorio, Josh; Meller, Stephan; Goldman, William E.; Gilliet, Michel; Kontoyiannis, Dimitrios P.			Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of T-H-17 Responses	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; GROWTH-FACTOR-BETA; T-HELPER-CELLS; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; IMMUNE RECOGNITION; HOST-DEFENSE; DECTIN-1; INFECTION; INTERLEUKIN-23	Interleukin-17 (IL-17) producing T helper cells (T-H-17) comprise a newly recognized T cell subset with an emerging role in adaptive immunity to a variety of fungi. Whether different airborne fungi trigger a common signaling pathway for T-H-17 induction, and whether this ability is related to the inherent pathogenic behavior of each fungus is currently unknown. Here we show that, as opposed to primary pathogenic fungi (Histoplasma capsulatum), opportunistic fungal pathogens (Aspergillus and Rhizopus) trigger a common innate sensing pathway in human dendritic cells (DCs) that results in robust production of IL-23 and drives T-H-17 responses. This response requires activation of dectin-1 by the fungal cell wall polysaccharide b-glucan that is selectively exposed during the invasive growth of opportunistic fungi. Notably, unmasking of b-glucan in the cell wall of a mutant of Histoplasma not only abrogates the pathogenicity of this fungus, but also triggers the induction of IL-23 producing DCs. Thus, b-glucan exposure in the fungal cell wall is essential for the induction of IL-23/T-H-17 axis and may represent a key factor that regulates protective immunity to opportunistic but not pathogenic fungi.	[Chamilos, Georgios; Ganguly, Dipyaman; Lande, Roberto; Gregorio, Josh; Meller, Stephan; Gilliet, Michel] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Chamilos, Georgios; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Gilliet, Michel] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Goldman, William E.] Univ N Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Chamilos, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	mgilliet@mdanderson.org; dkontoyi@mdanderson.org	Meller, Stephan/GYA-5568-2022; Lande, Roberto/L-5803-2019; Lande, Roberto/B-9987-2016; Ganguly, Dipyaman/GON-3988-2022	Lande, Roberto/0000-0001-8398-4567; Lande, Roberto/0000-0001-8398-4567; Ganguly, Dipyaman/0000-0002-7786-1795; Goldman, William/0000-0002-1551-6718; Chamilos, Georgios/0000-0002-7987-4055	DANA Foundation; University of Texas [CA16672]; N.I.H. [AI25584]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025584] Funding Source: NIH RePORTER	DANA Foundation; University of Texas; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant of the DANA Foundation (to M. G.), the M.D. Anderson Cancer Center Core Grant (CA16672) from the University of Texas (to D. P. K.), and the N.I.H. research grant AI25584 (to W. E. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fridkin SK, 2005, CLIN INFECT DIS, V41, P1455, DOI 10.1086/497138; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ibrahim AS, 2005, ANTIMICROB AGENTS CH, V49, P721, DOI 10.1128/AAC.49.2.721-727.2005; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nucci M, 2005, CLIN INFECT DIS, V41, P521, DOI 10.1086/432060; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleyel CA, 2008, TRENDS IMMUNOL, V29, P18, DOI 10.1016/j.it.2007.10.001; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; TOMINAGA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1569, DOI 10.1080/00021369.1981.10864749; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	47	87	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12955	10.1371/journal.pone.0012955	http://dx.doi.org/10.1371/journal.pone.0012955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886035	Green Published, gold, Green Submitted			2022-12-25	WOS:000282091100050
J	Huang, XL; Fan, Z; Borowski, L; Mailliard, RB; Rolland, M; Mullins, JI; Day, RD; Rinaldo, CR				Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Rolland, Morgane; Mullins, James I.; Day, Richard D.; Rinaldo, Charles R.			Dendritic Cells Reveal a Broad Range of MHC Class I Epitopes for HIV-1 in Persons with Suppressed Viral Load on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD8(+) T-CELLS; MEMORY RESPONSES; PEPTIDE BINDING; AVIDITY; IMMUNIZATION; VACCINIA; HLA-A-ASTERISK-0201; POLYFUNCTIONALITY; PROLIFERATION	Background: HIV-1 remains sequestered during antiretroviral therapy (ART) and can resume high-level replication upon cessation of ART or development of drug resistance. Reactivity of memory CD8(+) T lymphocytes to HIV-1 could potentially inhibit this residual viral replication, but is largely muted by ART in relation to suppression of viral antigen burden. Dendritic cells (DC) are important for MHC class I processing and presentation of peptide epitopes to memory CD8(+) T cells, and could potentially be targeted to activate memory CD8(+) T cells to a broad array of HIV-1 epitopes during ART. Principal Findings: We show for the first time that HIV-1 peptide-loaded, CD40L-matured DC from HIV-1 infected persons on ART induce IFN gamma production by CD8(+) T cells specific for a much broader range and magnitude of Gag and Nef epitopes than do peptides without DC. The DC also reveal novel, MHC class I restricted, Gag and Nef epitopes that are able to induce polyfunctional T cells producing various combinations of IFN gamma, interleukin 2, tumor necrosis factor alpha, macrophage inhibitory protein 1 beta and the cytotoxic de-granulation molecule CD107a. Significance: There is an underlying, broad antigenic spectrum of anti-HIV-1, memory CD8(+) T cell reactivity in persons on ART that is revealed by DC. This supports the use of DC-based immunotherapy for HIV-1 infection.	[Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huang, XL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	rinaldo@pitt.edu	Mailiiard, Robbie/M-9723-2015	Mailliard, Robbie/0000-0001-5501-503X	National Institutes of Allergy and Infectious Diseases [P01 AI-055794, U01 AI-35041, R37 AI-41870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, P01AI055794, R37AI041870, P01AI057005] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Allergy and Infectious Diseases grants P01 AI-055794, U01 AI-35041 and R37 AI-41870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Betts MR, 2008, CURR OPIN HIV AIDS, V3, P349, DOI 10.1097/COH.0b013e3282fbaa81; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Dzutsev AH, 2007, INT IMMUNOL, V19, P497, DOI 10.1093/intimm/dxm016; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; GEPPERT TD, 1990, IMMUNOL REV, V117, P5, DOI 10.1111/j.1600-065X.1990.tb00566.x; Gnjatic S, 2003, J IMMUNOL, V170, P1191, DOI 10.4049/jimmunol.170.3.1191; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; HALVORSEN R, 1988, SCAND J IMMUNOL, V27, P555, DOI 10.1111/j.1365-3083.1988.tb02383.x; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Huang XL, 2009, CLIN VACCINE IMMUNOL, V16, P1504, DOI 10.1128/CVI.00104-09; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102; Kerry SE, 2005, IMMUNOLOGY, V114, P44, DOI 10.1111/j.1365-2567.2004.02070.x; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2009, APMIS, V117, P849, DOI 10.1111/j.1600-0463.2009.02544.x; KORBER BTM, 2006, HIV MOL IMMUNOLOGY; Kroger CJ, 2008, J IMMUNOL, V180, P5784, DOI 10.4049/jimmunol.180.9.5784; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; LEPONE L, CLIN VACCIN IN PRESS; Lopez-Abaitero A, 2009, J IMMUNOTHER, V32, P465, DOI 10.1097/CJI.0b013e3181a1c24e; MACATANGAY BJ, 2010, CLIN VACCIN IN PRESS; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Marsh S. G. E., 2000, HLA FACTSBOOK; Masson F, 2008, IMMUNOL CELL BIOL, V86, P333, DOI 10.1038/icb.2008.15; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Precopio ML, 2008, CYTOM PART A, V73A, P1071, DOI 10.1002/cyto.a.20646; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Riquelme E, 2009, EUR J IMMUNOL, V39, P2259, DOI 10.1002/eji.200939341; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Seth A, 2001, J INFECT DIS, V183, P722, DOI 10.1086/318816; SIA DY, 1988, IMMUNOL INVEST, V17, P77, DOI 10.3109/08820138809055720; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Thobakgale CF, 2007, J VIROL, V81, P12775, DOI 10.1128/JVI.00624-07; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wauben Marca H M, 2003, Novartis Found Symp, V252, P211; WAUBEN MH, 2003, NOVART FDN SYMP, V252, P257; WAUBEN MH, 2003, NOVART FDN SYMP, V252, P220; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2005, IMMUNOL REV, V207, P8; Yu K, 2002, MOL MED, V8, P137, DOI 10.1007/BF03402006; Yu QG, 2003, J IMMUNOL, V170, P1797, DOI 10.4049/jimmunol.170.4.1797; Zammit DJ, 2006, MICROBES INFECT, V8, P1108, DOI 10.1016/j.micinf.2005.12.002; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	61	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12936	10.1371/journal.pone.0012936	http://dx.doi.org/10.1371/journal.pone.0012936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886040	Green Published, gold			2022-12-25	WOS:000282091100035
J	Meijaard, E; Albar, G; Nardiyono; Rayadin, Y; Ancrenaz, M; Spehar, S				Meijaard, Erik; Albar, Guillaume; Nardiyono; Rayadin, Yaya; Ancrenaz, Marc; Spehar, Stephanie			Unexpected Ecological Resilience in Bornean Orangutans and Implications for Pulp and Paper Plantation Management	PLOS ONE			English	Article							PONGO-PYGMAEUS-MORIO; POPULATION-DENSITY; WEST KALIMANTAN; EAST KALIMANTAN; AERIAL SURVEYS; FORESTS; BIODIVERSITY; DEFORESTATION; CONSERVATION; SABAH	Ecological studies of orangutans have almost exclusively focused on populations living in primary or selectively logged rainforest. The response of orangutans to severe habitat degradation remains therefore poorly understood. Most experts assume that viable populations cannot survive outside undisturbed or slightly disturbed forests. This is a concern because nearly 75% of all orangutans live outside protected areas, where degradation of natural forests is likely to occur, or where these are replaced by planted forests. To improve our understanding of orangutan survival in highly altered forest habitats, we conducted population density surveys in two pulp and paper plantation concessions in East Kalimantan, Indonesia. These plantations consist of areas planted with fast-growing exotics intermixed with stands of highly degraded forests and scrublands. Our rapid surveys indicate unexpectedly high orangutan densities in plantation landscapes dominated by Acacia spp., although it remains unclear whether such landscapes can maintain long-term viable populations. These findings indicate the need to better understand how plantation-dominated landscapes can potentially be incorporated into orangutan conservation planning. Although we emphasize that plantations have less value for overall biodiversity conservation than natural forests, they could potentially boost the chances of orangutan survival. Our findings are based on a relatively short study and various methodological issues need to be addressed, but they suggest that orangutans may be more ecologically flexible than previously thought.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Albar, Guillaume] Soc Ornithol Polynesie, Taravao, Tahiti, France; [Nardiyono] Nat Conservancy Indonesia Program, Balikpapan, E Kalimantan, Indonesia; [Rayadin, Yaya] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Rayadin, Yaya] Mulawarman Univ, Fac Forestry, Samarinda, E Kalimantan, Indonesia; [Spehar, Stephanie] Univ Wisconsin, Dept Religious Studies & Anthropol, Oshkosh, WI 54901 USA	People & Nature Consulting International; Australian National University; Hokkaido University; Universitas Mulawarman; University of Wisconsin System	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@pnc-int.com	Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685	United States Agency for International Development (USAID); Sall Family Foundation	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Sall Family Foundation(European Commission)	The studies were financially supported by United States Agency for International Development (USAID) (www.usaid.gov/) and the Sall Family Foundation, who paid the salaries of Erik Meijaard and Nardiyono, and covered the field costs of the study. USAID agreed to the study being conducted. USAID, the Sall Family Foundation, and PNCI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Andau Patrick Mahedi, 1994, Oryx, V28, P263; BARR C, 2008, ROUNDT IND PULP PAP; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Dennis RA, 2006, SINGAPORE J TROP GEO, V27, P30, DOI 10.1111/j.1467-9493.2006.00238.x; DOI T, 1986, PRESENT STATUS LARGE; *FAO, 2006, 147 FAO UN; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; FULTON M, 1996, B ECOL SOC AM, V77, P217; HARTMAN P, 2010, ORANGUTAN CONSERVATI; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; Knop E, 2004, BIOL CONSERV, V120, P183, DOI 10.1016/j.biocon.2004.02.010; Koh LP, 2007, BIODIVERS CONSERV, V16, P3935, DOI 10.1007/s10531-007-9177-3; Koh LP, 2010, BIOTROPICA, V42, P67, DOI 10.1111/j.1744-7429.2009.00588.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; MacKinnon Kathy, 1994, Oryx, V28, P191, DOI 10.1017/S0030605300028556; MALINGREAU JP, 1985, AMBIO, V14, P314; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Marshall AJ, 2007, AM J PRIMATOL, V69, P212, DOI 10.1002/ajp.20341; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; Meijaard Erik, 2005, pi; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Morrogh-Bernard Helen C., 2009, P119; Myers N, 1996, ENVIRON CONSERV, V23, P156, DOI 10.1017/S0376892900038546; Prasetyo Didik, 2009, P269; RAYADIN Y, 2007, LAPORAN HASIL UNPUB; Rayadin Y, 2009, AM J PRIMATOL, V71, P393, DOI 10.1002/ajp.20666; Rijksen HD, 1999, OUR VANISHING RELATI; Russon Anne E., 2009, P135; Sheil D, 2010, BIOTROPICA, V42, P566, DOI 10.1111/j.1744-7429.2010.00687.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I., 2004, ORANGUTAN POPULATION; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stibig H.-J., 2007, JRC SCI TECHNICAL RE; THOMAS L., 2006, DISTANCE 5 0 RELEASE; vanSchaik CP, 1995, NEGLECTED APE, P109; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wilson KA, 2010, ECOL APPL, V20, P1721, DOI 10.1890/09-1051.1; WITKAMP H, 1932, TROPISCHE NATUUR, V21, P169; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x	53	64	65	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12813	10.1371/journal.pone.0012813	http://dx.doi.org/10.1371/journal.pone.0012813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877646	gold, Green Published, Green Submitted			2022-12-25	WOS:000282053100011
J	Wei, SJ; Shi, M; Chen, XX; Sharkey, MJ; van Achterberg, C; Ye, GY; He, JH				Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Sharkey, Michael J.; van Achterberg, Cornelis; Ye, Gong-Yin; He, Jun-Hua			New Views on Strand Asymmetry in Insect Mitochondrial Genomes	PLOS ONE			English	Article							DIRECTIONAL MUTATION PRESSURE; GENE REARRANGEMENTS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC UTILITY; TERMINATION FACTOR; ESCHERICHIA-COLI; DNA EVOLUTION; T MUTATIONS; TRANSCRIPTION; REPLICATION	Strand asymmetry in nucleotide composition is a remarkable feature of animal mitochondrial genomes. Understanding the mutation processes that shape strand asymmetry is essential for comprehensive knowledge of genome evolution, demographical population history and accurate phylogenetic inference. Previous studies found that the relative contributions of different substitution types to strand asymmetry are associated with replication alone or both replication and transcription. However, the relative contributions of replication and transcription to strand asymmetry remain unclear. Here we conducted a broad survey of strand asymmetry across 120 insect mitochondrial genomes, with special reference to the correlation between the signs of skew values and replication orientation/gene direction. The results show that the sign of GC skew on entire mitochondrial genomes is reversed in all species of three distantly related families of insects, Philopteridae (Phthiraptera), Aleyrodidae (Hemiptera) and Braconidae (Hymenoptera); the replication-related elements in the A+T-rich regions of these species are inverted, confirming that reversal of strand asymmetry (GC skew) was caused by inversion of replication origin; and finally, the sign of GC skew value is associated with replication orientation but not with gene direction, while that of AT skew value varies with gene direction, replication and codon positions used in analyses. These findings show that deaminations during replication and other mutations contribute more than selection on amino acid sequences to strand compositions of G and C, and that the replication process has a stronger affect on A and T content than does transcription. Our results may contribute to genome-wide studies of replication and transcription mechanisms.	[Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Ye, Gong-Yin; He, Jun-Hua] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Ye, Gong-Yin; He, Jun-Hua] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Shu-Jun] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Sharkey, Michael J.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [van Achterberg, Cornelis] Natl Museum Nat Hist, Dept Entomol, Leiden, Netherlands	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Beijing Academy of Agriculture & Forestry; University of Kentucky	Wei, SJ (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	xxchen@zju.edu.cn	Wei, Shu-Jun/C-1109-2011; van Achterberg, Kees/AFV-5150-2022; Chen, Xue-xin/D-1592-2010	Wei, Shu-Jun/0000-0001-7398-0968; Chen, Xue-xin/0000-0002-9109-8853; Zhang, Ming/0000-0001-6574-3006	National Science Fund for Distinguished Young Scholars [30625006]; 973 Program [2006CB102005]; National Science Foundation of China [30970384, 30700063, 30499341]; National Special Basic Research Funds [2006FY110500-3, 2006FY120100]; Special Fund for Agro-Scientific Research of the Public Interest [200803005-04]; Zhejiang Key Program of Agriculture [2009C12048]; NSF [EF-0337220]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Basic Research Funds; Special Fund for Agro-Scientific Research of the Public Interest; Zhejiang Key Program of Agriculture; NSF(National Science Foundation (NSF))	Funding for this study was provided jointly by the National Science Fund for Distinguished Young Scholars (30625006), the 973 Program (2006CB102005), the National Science Foundation of China (30970384, 30700063 and 30499341), the National Special Basic Research Funds (2006FY110500-3, 2006FY120100), Special Fund for Agro-Scientific Research of the Public Interest (200803005-04) and Zhejiang Key Program of Agriculture (2009C12048) to XXC, and the NSF (EF-0337220) to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beletskii A, 1998, BIOL CHEM, V379, P549; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Faith JJ, 2003, GENETICS, V165, P735; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Francino MP, 2001, MOL BIOL EVOL, V18, P1147, DOI 10.1093/oxfordjournals.molbev.a003888; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; JERMIIN LS, 1995, MOL BIOL EVOL, V12, P558; KILPERT F, 2006, BMC GENOMICS, V7, DOI DOI 10.1186/1471-2164-1187-1241; Lee YS, 2008, NUCLEIC ACIDS RES, V36, pD938, DOI 10.1093/nar/gkm763; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Min XJ, 2007, DNA RES, V14, P201, DOI 10.1093/dnares/dsm019; Miyako K, 1999, EUR J BIOCHEM, V259, P412, DOI 10.1046/j.1432-1327.1999.00056.x; Montooth KL, 2008, PLOS BIOL, V6, P1634, DOI 10.1371/journal.pbio.0060213; Morton RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-369; Nikolaou C, 2005, NUCLEIC ACIDS RES, V33, P6816, DOI 10.1093/nar/gki988; Nikolaou C, 2006, GENE, V381, P34, DOI 10.1016/j.gene.2006.06.010; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Rocha EPC, 2006, GENOME RES, V16, P1537, DOI 10.1101/gr.5525106; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Scouras A, 2006, MOL PHYLOGENET EVOL, V39, P323, DOI 10.1016/j.ympev.2005.11.004; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tang Q., 2006, DPS DATA PROCESSING; THAO M, 2004, BMC EVOLUTIONARY BIO, V4, DOI DOI 10.1186/1471-2148-1184-1125; Touchon M, 2004, NUCLEIC ACIDS RES, V32, P4969, DOI 10.1093/nar/gkh823; Wang XZ, 2007, GENE, V399, P11, DOI 10.1016/j.gene.2007.04.019; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	59	202	213	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12708	10.1371/journal.pone.0012708	http://dx.doi.org/10.1371/journal.pone.0012708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856815	Green Submitted, Green Published, gold			2022-12-25	WOS:000281815800008
J	Sievers, C; Billig, G; Gottschalk, K; Rudel, T				Sievers, Claudia; Billig, Gwendolyn; Gottschalk, Kathleen; Rudel, Thomas			Prohibitins Are Required for Cancer Cell Proliferation and Adhesion	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; M-AAA PROTEASE; 3'-UNTRANSLATED REGION; MITOCHONDRIAL PROTEINS; RNA INTERFERENCE; HELA-CELLS; MEMBRANE; POLYMORPHISM; APOPTOSIS; OPA1	Prohibitin 1 (PHB1) is a highly conserved protein that together with its homologue prohibitin 2 (PHB2) mainly localizes to the inner mitochondrial membrane. Although it was originally identified by its ability to inhibit G1/S progression in human fibroblasts, its role as tumor suppressor is debated. To determine the function of prohibitins in maintaining cell homeostasis, we generated cancer cell lines expressing prohibitin-directed shRNAs. We show that prohibitin proteins are necessary for the proliferation of cancer cells. Down-regulation of prohibitin expression drastically reduced the rate of cell division. Furthermore, mitochondrial morphology was not affected, but loss of prohibitins did lead to the degradation of the fusion protein OPA1 and, in certain cancer cell lines, to a reduced capability to exhibit anchorage-independent growth. These cancer cells also exhibited reduced adhesion to the extracellular matrix. Taken together, these observations suggest prohibitins play a crucial role in adhesion processes in the cell and thereby sustaining cancer cell propagation and survival.	[Sievers, Claudia; Billig, Gwendolyn; Gottschalk, Kathleen; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, Res Grp Mol Infect & Canc Biol, Berlin, Germany; [Sievers, Claudia; Billig, Gwendolyn] Free Univ Berlin, Dept Biochem, D-1000 Berlin, Germany; [Rudel, Thomas] Univ Wurzburg, Bioctr, Wurzburg, Germany	Max Planck Society; Free University of Berlin; University of Wurzburg	Sievers, C (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Res Grp Mol Infect & Canc Biol, Berlin, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Billig, Gwendolyn M/A-1297-2012; Schuck, Kathleen/AAQ-4664-2021		European Union [LSHB-CT-2004-005276]	European Union(European Commission)	This work was supported by the by funding under the Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004-005276) to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campbell IG, 2003, CANCER EPIDEM BIOMAR, V12, P1273; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Glenn HL, 2003, CELL MOTIL CYTOSKEL, V55, P265, DOI 10.1002/cm.10128; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jupe ER, 2001, LANCET, V357, P1588, DOI 10.1016/S0140-6736(00)04747-4; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Spurdle AB, 2002, LANCET, V360, P925, DOI 10.1016/S0140-6736(02)11043-9; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003	39	59	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12735	10.1371/journal.pone.0012735	http://dx.doi.org/10.1371/journal.pone.0012735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856874	Green Published, Green Submitted, gold			2022-12-25	WOS:000281815700019
J	Benameur, T; Soleti, R; Porro, C; Andriantsitohaina, R; Martinez, MC				Benameur, Tarek; Soleti, Raffaella; Porro, Chiara; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen			Microparticles Carrying Sonic Hedgehog Favor Neovascularization through the Activation of Nitric Oxide Pathway in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELLS; MATRIX METALLOPROTEINASES; CAPILLARY MORPHOGENESIS; VASCULAR FUNCTION; OXIDATIVE STRESS; SKELETAL-MUSCLE; MOUSE MODEL; ANGIOGENESIS; RATS	Background: Microparticles (MPs) are vesicles released from plasma membrane upon cell activation and during apoptosis. Human T lymphocytes undergoing activation and apoptosis generate MPs bearing morphogen Shh (MPs(Shh+)) that are able to regulate in vitro angiogenesis. Methodology/Principal Findings: Here, we investigated the ability of MPs(Shh+) to modulate neovascularization in a model of mouse hind limb ischemia. Mice were treated in vivo for 21 days with vehicle, MPs(Shh+), MPs(Shh+) plus cyclopamine or cyclopamine alone, an inhibitor of Shh signalling. Laser doppler analysis revealed that the recovery of the blood flow was 1.4 fold higher in MPs(Shh+)-treated mice than in controls, and this was associated with an activation of Shh pathway in muscles and an increase in NO production in both aorta and muscles. MPs(Shh+)-mediated effects on flow recovery and NO production were completely prevented when Shh signalling was inhibited by cyclopamine. In aorta, MPs increased activation of eNOS/Akt pathway, and VEGF expression, being inhibited by cyclopamine. By contrast, in muscles, MPs(Shh+) enhanced eNOS expression and phosphorylation and decreased caveolin-1 expression, but cyclopamine prevented only the effects of MPs(Shh+) on eNOS pathway. Quantitative RT-PCR revealed that MPs(Shh+) treatment increased FGF5, FGF2, VEGF A and C mRNA levels and decreased those of alpha 5-integrin, FLT-4, HGF, IGF-1, KDR, MCP-1, MT1-MMP, MMP-2, TGF beta 1, TGF beta 2, TSP-1 and VCAM-1, in ischemic muscles. Conclusions/Significance: These findings suggest that MPs(Shh+) may contribute to reparative neovascularization after ischemic injury by regulating NO pathway and genes involved in angiogenesis.	[Benameur, Tarek; Soleti, Raffaella; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] Univ Angers, Fac Med, CNRS, INSERM,UMR 6214,U771, Angers, France; [Porro, Chiara] Univ Foggia, Dept Biomed Sci, Sch Med, Foggia, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Foggia	Benameur, T (corresponding author), Univ Angers, Fac Med, CNRS, INSERM,UMR 6214,U771, Angers, France.	carmen.martinez@univ-angers.fr	soleti, raffaella/AAC-1678-2021; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; BENAMEUR, TAREK/P-9053-2019; B, T/ABD-6713-2020; SOLETI, RAFFAELLA/ABB-5455-2020; Porro, Chiara/G-7849-2018	SOLETI, RAFFAELLA/0000-0002-0271-0490; Porro, Chiara/0000-0002-7526-6968; Martinez, M Carmen/0000-0003-3897-7397; andriantsitohaina, ramaroson/0000-0002-4770-3585	Agence Nationale pour la Recherche [ANR-07-PHYSIO-010-01]; Fonds Europen pour le Developpement Regional; CNRS; INSERM; Universite Angers; French Education Ministry (MENRT)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fonds Europen pour le Developpement Regional; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Angers; French Education Ministry (MENRT)	This work was supported in part by grants from Agence Nationale pour la Recherche [M.C.M. ANR-07-PHYSIO-010-01]; Fonds Europen pour le Developpement Regional [R.A.]; CNRS; INSERM; and Universite Angers. T.B. is the recipient of a doctoral fellowship from French Education Ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FUND CLIN PHARMACOL, V21, P21; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bijlsma MF, 2010, EXP BIOL MED, V235, P447, DOI 10.1258/ebm.2009.009303; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dokucu AI, 2009, INT UROL NEPHROL, V41, P101, DOI 10.1007/s11255-008-9460-6; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Hoff J, 2000, LAB ANIMAL, V29, P47; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Luo JD, 2009, AM J PHYSIOL-ENDOC M, V297, pE525, DOI 10.1152/ajpendo.00308.2009; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Ozturk H, 2007, RENAL FAILURE, V29, P249, DOI 10.1080/08860220601166289; Podlasek CA, 2005, CURR PHARM DESIGN, V11, P4011, DOI 10.2174/138161205774913408; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Porro C, 2009, CURR SIGNAL TRANSD T, V4, P31, DOI 10.2174/157436209787048694; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Tuncer MC, 2007, WORLD J GASTROENTERO, V13, P3841; VAN HINSBERGH VWM, 2008, CARDIOVASC RES, V78, P203; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Watts VL, 2009, EXP BIOL MED, V234, P132, DOI 10.3181/0807-RM-233; Yang C, 2008, AM J PHYSIOL-REG I, V294, pR467, DOI 10.1152/ajpregu.00432.2007; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	38	81	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12688	10.1371/journal.pone.0012688	http://dx.doi.org/10.1371/journal.pone.0012688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856928	gold, Green Published			2022-12-25	WOS:000281735700013
J	Tan, W; Dean, M; Law, AJ				Tan, Wei; Dean, Michael; Law, Amanda J.			Molecular Cloning and Characterization of the Human ErbB4 Gene: Identification of Novel Splice Isoforms in the Developing and Adult Brain	PLOS ONE			English	Article							SCHIZOPHRENIA; EXPRESSION; NEUREGULIN-1; TRANSLATION; VARIANTS; DISEASE; CODE	ErbB4 is a growth factor receptor tyrosine kinase essential for neurodevelopment. Genetic variation in ErbB4 is associated with schizophrenia and risk-associated polymorphisms predict overexpression of ErbB4 CYT-1 isoforms in the brain in the disorder. The molecular mechanism of association is unclear because the polymorphisms flank exon 3 of the gene and reside 700 kb distal to the CYT-1 defining exon. We hypothesized that the polymorphisms are indirectly associated with ErbB4 CYT-1 via splicing of exon 3 on the CYT-1 background. We report via cloning and sequencing of adult and fetal human brain cDNA libraries the identification of novel splice isoforms of ErbB4, whereby exon 3 is skipped (del. 3). ErbB4 del. 3 transcripts exist as CYT-2 isoforms and are predicted to produce truncated proteins. Furthermore, our data refine the structure of the human ErbB4 gene, clarify that juxtamembrane (JM) splice variants of ErbB4, JM-a and JM-b respectively, are characterized by the replacement of a 75 nucleotide (nt) sequence with a 45-nt insertion, and demonstrate that there are four alternative exons in the gene. Our analyses reveal that novel splice variants of ErbB4 exist in the developing and adult human brain and, given the failure to identify ErbB4 del. 3 CYT-1 transcripts, suggest that the association of risk polymorphisms in the ErbB4 gene with CYT-1 transcript levels is not mediated via an exon 3 splicing event.	[Tan, Wei] Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA; [Dean, Michael] Natl Canc Inst Frederick, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA; [Law, Amanda J.] NIMH, Clin Brain Disorders Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, W (corresponding author), Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA.	lawa@mail.nih.gov	Law, Amanda J/G-6372-2012; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Pethe, Kevin/L-1199-2013	Law, Amanda J/0000-0002-2574-1564; Dean, Michael C/0000-0003-2234-0631; Pethe, Kevin/0000-0003-0297-0150; Dick, Thomas/0000-0002-9604-9452; Cliff, Penelope/0000-0001-6558-6039; Pethe, Kevin/0000-0003-0916-8873	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; MRC [G120/997] Funding Source: UKRI; Medical Research Council [G120/997] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD 20892, USA and federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Konrad A, 2009, NEUROPSYCHOPHARMACOL, V34, P641, DOI 10.1038/npp.2008.112; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rudloff U, 2010, CELL CYCLE, V9, P1487, DOI 10.4161/cc.9.8.11239; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	17	94	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12924	10.1371/journal.pone.0012924	http://dx.doi.org/10.1371/journal.pone.0012924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	21048946	gold, Green Published, Green Submitted			2022-12-25	WOS:000282091100028
J	Liang, YL; Gao, H; Lin, SY; Goss, JA; Brunicardi, FC; Li, KY				Liang, Yulong; Gao, Hong; Lin, Shiaw-Yih; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi			siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VIVO; HEPATOCELLULAR-CARCINOMA; LINES; GENE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; STRATEGIES; APOPTOSIS	Cyclin E is aberrantly expressed in many types of cancer including breast cancer. High levels of the full length as well as the low molecular weight isoforms of cyclin E are associated with poor prognosis of breast cancer patients. Notably, cyclin E overexpression is also correlated with triple-negative basal-like breast cancers, which lack specific therapeutic targets. In this study, we used siRNA to target cyclin E overexpression and assessed its ability to suppress breast cancer growth in nude mice. Our results revealed that cyclin E siRNA could effectively inhibit overexpression of both full length and low molecular weight isoforms of cyclin E. We found that depletion of cyclin E promoted apoptosis of cyclin E-overexpressing cells and blocked their proliferation and transformation phenotypes. Significantly, we further demonstrated that administration of cyclin E siRNA could inhibit breast tumor growth in nude mice. In addition, we found that cyclin E siRNA synergistically enhanced the cell killing effects of doxorubicin in cell culture and this combination greatly suppressed the tumor growth in mice. In conclusion, our results indicate that cyclin E, which is overexpressed in 30% of breast cancer, may serve as a novel and effective therapeutic target. More importantly, our study clearly demonstrates a very promising therapeutic potential of cyclin E siRNA for treating the cyclin E-overexpressing breast cancers, including the very malignant triple-negative breast cancers.	[Liang, Yulong; Gao, Hong; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Shiaw-Yih] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Liang, YL (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu	Liang, Yulong/A-2171-2013; Gao, Haichun/A-2160-2014	Liang, Yulong/0000-0001-8219-9575; Gao, Haichun/0000-0002-2647-6563	Susan Komen Breast Cancer Foundation; National Institutes of Health [NIH R01]	Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the Susan Komen Breast Cancer Foundation (to K. Li) and National Institutes of Health (NIH R01, to K. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales E, 2005, CANCER RES, V65, P692; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harwell RM, 2000, CANCER RES, V60, P481; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Jang SJ, 1999, EUR J SURG ONCOL, V25, P157, DOI 10.1053/ejso.1998.0619; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Li KY, 2003, CANCER RES, V63, P3593; Li KY, 1999, ONCOGENE, V18, P2617, DOI 10.1038/sj.onc.1202605; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; OVERMOYER BA, 1995, SEMIN ONCOL, V22, P2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takahashi N, 2002, CANCER RES, V62, P6909; van Hille B, 1999, ANTI-CANCER DRUG, V10, P551, DOI 10.1097/00001813-199907000-00007; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilda M, 2002, ONCOGENE, V21, P5716, DOI 10.1038/sj.onc.1205653; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119	42	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12860	10.1371/journal.pone.0012860	http://dx.doi.org/10.1371/journal.pone.0012860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	21203399	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200020
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000281815700006
